24.12.2012 Views

ASHG 2012 Program Guide - American Society of Human Genetics

ASHG 2012 Program Guide - American Society of Human Genetics

ASHG 2012 Program Guide - American Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ashg.org/<strong>2012</strong>meeting<br />

Discover • Network • Collaborate


whole exome sequencing<br />

– One Test –<br />

More Answers<br />

Developed jointly by the <strong>Human</strong> Genome Sequencing Center<br />

(HGSC), the Department <strong>of</strong> Molecular and <strong>Human</strong> <strong>Genetics</strong><br />

and the Medical <strong>Genetics</strong> Laboratories <strong>of</strong> the Baylor College <strong>of</strong><br />

Medicine, the Whole Genome Sequencing Laboratory (WGL)<br />

applies the power <strong>of</strong> next generation sequencing technology to<br />

clinical genetics in a CLIA high complexity testing laboratory with<br />

clinical interpretation <strong>of</strong> the sequence information. Whole Exome<br />

Sequencing (WES) is poised to change the current paradigm <strong>of</strong><br />

genetic testing for Mendelian disorders, pharmacogenetic traits,<br />

and potentially complex traits. Rather than limiting testing to a<br />

single gene or panel <strong>of</strong> genes and incurring diagnostic delays and<br />

escalating costs, the Whole Exome Sequencing test will sequence<br />

nucleotide by nucleotide, the human exome to the depth <strong>of</strong> coverage<br />

required to achieve a consensus sequence with high accuracy. Point<br />

mutations, small insertions and deletions <strong>of</strong> the exome are routinely<br />

detected by this methodology. The team curating the Whole Exome<br />

Sequencing test focuses the report on on known or predicted<br />

deleterious mutations in genes associated with patient’s clinical<br />

problems; however, significant potentially medically actionable<br />

findings in other genes <strong>of</strong> interest as well as the option for reporting<br />

autosomal recessive carrier status are included in the focused whole<br />

exome report.<br />

One Baylor Plaza, Nab 2015, Houston, Texas 77030 • 713-798-6555<br />

1-800-411-gene (4363) • www.bcmgeneticlabs.org • www.bcm.edu


Welcome to the <strong>ASHG</strong><br />

62 nd Annual Meeting<br />

Name: _____________________________________<br />

Email: _____________________________________


TABLE OF CONTENTS<br />

<strong>2012</strong> <strong>ASHG</strong> Board <strong>of</strong> Directors ................................................................................. 4<br />

Welcome from the President .................................................................................... 5<br />

<strong>2012</strong> <strong>ASHG</strong> <strong>Program</strong> Committee Members ............................................................ 6<br />

Welcome from the <strong>Program</strong> Chair ........................................................................... 7<br />

<strong>2012</strong> <strong>ASHG</strong> Abstract Reviewers ............................................................................... 9<br />

<strong>ASHG</strong> Administrative Offices/Staff ...................................................................... 10<br />

Annual Meeting Support ......................................................................................... 11<br />

Advertisers .............................................................................................................. 12<br />

Schedule <strong>of</strong> Scientific Sessions and Ancillary Events ........................................ 15<br />

Trainee Track: Meeting within the Meeting Schedule ............................................ 29<br />

Education Track ...................................................................................................... 31<br />

Clinical Track .......................................................................................................... 33<br />

Floor Plans and Maps<br />

Moscone Center (Convention Center) .................................................................... 37<br />

San Francisco Marriott Marquis Hotel (Headquarter Hotel) ................................. 39<br />

San Francisco Hotel Locator Map ......................................................................... 41<br />

BART Metro System ............................................................................................... 43<br />

General Information<br />

About the Meeting ................................................................................................ 45<br />

Abstracts/Abstract Search ................................................................................. 45<br />

Invited Sessions .................................................................................................. 45<br />

Plenary Session Presentations (abstract-driven) ............................................... 45<br />

Platform Sessions (abstract-driven) ................................................................... 45<br />

Poster Sessions (abstract-driven) ..................................................................... 46<br />

Mobile App/Mobile Web Site .............................................................................. 46<br />

Social Media ....................................................................................................... 46<br />

Session Tracks .................................................................................................... 46<br />

Registration, Badge and <strong>Program</strong> Pick up<br />

Registration Hours/Fees ..................................................................................... 47<br />

Replacement/Lost/Forgotten Badge .................................................................. 48<br />

Meeting Information, Services and Offices<br />

<strong>ASHG</strong> Office and Meeting Logistics ................................................................... 48<br />

<strong>ASHG</strong> Central/Membership Services ................................................................ 48<br />

Assistance for Attendees .................................................................................... 49<br />

Attire/Dress Code ............................................................................................... 49<br />

Business Center .................................................................................................. 49<br />

Career/Employment Opportunities ..................................................................... 49<br />

Cell Phone/Camera/Recording Policy ................................................................ 49<br />

CME/CEUs .......................................................................................................... 49<br />

Exhibits/Exhibit Registration and Management ................................................. 50<br />

Family/Nursing Mothers Room ........................................................................... 50<br />

First Aid ............................................................................................................... 50<br />

Food Service ....................................................................................................... 50<br />

Housing/Hotels .................................................................................................. 51<br />

Information .......................................................................................................... 51<br />

Internet Access/Cyber Cafè ............................................................................... 51<br />

Luggage Storage and Coat Check ..................................................................... 51


TABLE OF CONTENTS<br />

Message Center/Literature Tables...................................................................... 51<br />

Parking ................................................................................................................ 52<br />

Prayer Room ....................................................................................................... 52<br />

Press Office ........................................................................................................ 52<br />

Registration Management/Registration Help Desk ............................................ 52<br />

Restaurant/City Information Tours and Activities ............................................... 52<br />

Speaker-Presentation/Upload Room ................................................................. 52<br />

Speaker Conflict <strong>of</strong> Interest ................................................................................ 53<br />

Telephone Numbers for <strong>ASHG</strong> On-Site Offices ................................................. 53<br />

Travel and Visitor Information ............................................................................. 53<br />

Transportation/Getting Around .......................................................................... 54<br />

Daily Meeting Highlights and Workshops<br />

Tuesday ................................................................................................................. 55<br />

Wednesday ............................................................................................................. 56<br />

Thursday ................................................................................................................. 58<br />

Friday ...................................................................................................................... 59<br />

Saturday ................................................................................................................. 61<br />

Charles Epstein Trainee Awards for Excellence in<br />

<strong>Human</strong> <strong>Genetics</strong> Research ..................................................................................... 63<br />

<strong>2012</strong> FASEB MARC TRAVEL AWARDEES ............................................................. 66<br />

INVITED, PLATFORM AND AWARD SESSIONS<br />

Session #1 through Session #81 ....................................................................... 68<br />

Poster Sessions ..................................................................................................... 125<br />

Exhibitors ................................................................................................................ 267<br />

Floor Plan <strong>of</strong> Exhibit and Poster Area .................................................................. 271<br />

Alpha Listing <strong>of</strong> Exhibitors .................................................................................... 273<br />

Product and Service Index ................................................................................... 299<br />

Continuing Education (CEU/CME Credits) ......................................................... 325<br />

Speaker and Author Disclosures ......................................................................... 329<br />

Speaker and Author Index .................................................................................... 333<br />

Advertisements ...................................................................................................... 421<br />

3


AMERICAN SOCIETY OF HUMAN GENETICS<br />

DISCOVER • EDUCATE • ADVOCATE<br />

www.ashg.org<br />

The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (<strong>ASHG</strong>), founded in 1948, is the primary<br />

pr<strong>of</strong>essional membership organization for human genetics specialists worldwide. <strong>ASHG</strong><br />

serves research scientists, health pr<strong>of</strong>essionals, and the public by providing forums to:<br />

• Share research results at Annual Meetings and in The <strong>American</strong> Journal <strong>of</strong><br />

<strong>Human</strong> <strong>Genetics</strong>;<br />

• Advance genetic research by advocating for research support;<br />

• Enhance genetics education by preparing future pr<strong>of</strong>essionals and informing<br />

the public; and<br />

• Promote genetic services and support responsible social and scientific policies.<br />

<strong>ASHG</strong>’s nearly 8,000 members include researchers, academicians, clinicians,<br />

laboratory practice pr<strong>of</strong>essionals, genetic counselors, nurses and others who have<br />

a special interest in the field <strong>of</strong> human genetics. Members <strong>of</strong> <strong>ASHG</strong> entered the<br />

21st century with a commitment to become fluent in the language <strong>of</strong> the genome,<br />

understand human variation, and promote the public health. As we transfer new<br />

knowledge to the next generation <strong>of</strong> genetics pr<strong>of</strong>essionals and the public, we will<br />

translate new ideas into improved clinical practice. Visit the <strong>ASHG</strong> Web site for<br />

additional information: www.ashg.org.<br />

<strong>2012</strong> Board <strong>of</strong> Directors<br />

Mary-Claire King, President<br />

Jeffrey C. Murray, President-Elect Directors:<br />

Brendan Lee, Secretary David M. Altshuler<br />

Ge<strong>of</strong>frey M. Duyk, Treasurer Stylianos E. Antonarakis<br />

Leslie G. Biesecker<br />

Lynn B. Jorde, Past President 2011 Vivian G. Cheung<br />

Roderick R. McInnes, Past President 2010 Nancy J. Cox<br />

Kay E. Davies<br />

David Nelson, Editor Evan E. Eichler<br />

Richard A. Gibbs<br />

Neil J. Risch


WELCOME FROM THE PRESIDENT<br />

Dear Fellow Members <strong>of</strong> <strong>ASHG</strong>,<br />

Welcome to our <strong>2012</strong> Annual Meeting. The theme for our meeting this year is<br />

“The Scientist as a Citizen <strong>of</strong> the World.” This theme was selected for two reasons.<br />

First, this year has been an extraordinarily productive one for human genetics research<br />

based in populations from all parts <strong>of</strong> the world. <strong>Human</strong> genetics is inherently a science<br />

without borders. Now, economic constraints notwithstanding, we have reached a<br />

moment in which the scientific work <strong>of</strong> our field is carried out in very large part by<br />

geneticists from the places <strong>of</strong> origin <strong>of</strong> populations being studied. Some <strong>of</strong> this work<br />

is internationally collaborative, and the projects are true, not token, joint efforts.<br />

Our field owes this rapid democratization in part to the virtually overnight dissemination<br />

<strong>of</strong> next generation sequencing technology, and in part to the cleverness <strong>of</strong> human<br />

geneticists worldwide who exploit this technology by inventively integrating local,<br />

regional, and international capacities. A little outsourcing goes a long way in the right<br />

hands. Results <strong>of</strong> international collaborations are integrated into every session <strong>of</strong><br />

this <strong>ASHG</strong> meeting. I point out this feature <strong>of</strong> our meeting explicitly, because we take<br />

international collaboration so much for granted that we might not notice it otherwise.<br />

We are fortunate in this. It is not the way <strong>of</strong> the world as a whole.<br />

Second, what happens this week in the U.S. will have enormous consequences for us all.<br />

As human geneticists, we are in the privileged position <strong>of</strong> having far more awareness <strong>of</strong><br />

the world than most <strong>of</strong> our fellow citizens (wherever we are originally from), and therefore<br />

the responsibility to try to help the next years be ones <strong>of</strong> progress for our communities.<br />

Collectively, we are many (more than 8000), with considerable intellectual influence,<br />

if not explicit political power, in our communities. We enjoy more autonomy than most in<br />

exercising that influence, in part because we have each other. <strong>ASHG</strong> is both our home<br />

for productive science and for forming friendships that transcend borders. Collaboration<br />

bridges conflict for far more people than those engaged in the science itself.<br />

So welcome to the 62nd <strong>ASHG</strong> Annual Meeting. Enjoy a lovely week in this beautiful city,<br />

greet old friends, make new friends, arrange a post-doc or a sabbatical year in a place not<br />

previously your own, and think <strong>of</strong> fine projects together. It is a great pleasure to see you here.<br />

With all best wishes,<br />

Mary-Claire King<br />

President, <strong>ASHG</strong><br />

5


6 PROGRAM COMMITTEE<br />

THE AMERICAN SOCIETY OF HUMAN GENETICS 62 ND<br />

Annual Meeting<br />

November 6–10, <strong>2012</strong> • San Francisco, California<br />

<strong>ASHG</strong> gratefully acknowledges the expertise, hard work and<br />

dedication <strong>of</strong> the <strong>2012</strong> <strong>Program</strong> Committee<br />

************************************<br />

<strong>Program</strong> Committee<br />

Joel N. Hirschhorn, Chair<br />

Sally A. Camper Andrew S. McCallion<br />

Andrew G. Clark Karen L. Mohlke<br />

Tina M. Cowan Elaine A. Ostrander<br />

Clair A. Francomano Barbara R. Pober<br />

Chris Gunter Nazneen Rahman<br />

Jonathan L. Haines Michael R. Speicher<br />

Gail P. Jarvik Catherine A. Wicklund<br />

Sekar Kathiresan Alexander F. Wilson<br />

Nicolas Katsanis<br />

************************************


WELCOME FROM THE PROGRAM CHAIR<br />

On behalf <strong>of</strong> the <strong>ASHG</strong> <strong>Program</strong> Committee and the Board <strong>of</strong> Directors, welcome to<br />

the <strong>Society</strong>’s 62 nd Annual Meeting in San Francisco! The <strong>2012</strong> <strong>Program</strong> Committee<br />

has developed an exceptional program. This year, we received a record 3845 abstracts,<br />

from which 411 were chosen for plenary/platform oral presentations and over 3400<br />

<strong>of</strong> the remaining abstracts are being presented as scientific posters. In addition, there<br />

are 24 invited scientific sessions, chosen from the 95 proposals submitted this year.<br />

The program committee has worked to assemble an exciting and outstanding scientific<br />

program that balances basic, translational, and clinical research with sessions that<br />

address timely issues. The schedule once again features separate tracks (trainees,<br />

clinical and educational) to help you select the sessions most relevant to your interests.<br />

The meeting begins on Tuesday at 4:00 pm with the Presidential Address “The<br />

Scientist as a Citizen <strong>of</strong> the World” by Mary-Claire King. The address will be streamed<br />

live on the <strong>ASHG</strong> Web site and will be followed by the plenary abstract presentations<br />

with topics including comparative epigenomics, early exome sequencing in complex<br />

traits, large-scale identification <strong>of</strong> enhancers and cis-acting regulators <strong>of</strong> translation,<br />

and integrated genetic and functional studies <strong>of</strong> disease-causing variants (see page<br />

68 for details). Afterwards, we hope you join us to reconnect with friends and colleagues<br />

and make new connections at the Opening Mixer and Trainee Mixer-Within-A-Mixer<br />

starting at 7:00 pm in the San Francisco Marriott Marquis Hotel.<br />

Each day, you will have the opportunity to select from concurrent invited and platform<br />

presentations. Poster presentations will be held on each <strong>of</strong> three afternoons following<br />

the lunch period, and all posters will remain on display throughout the three days.<br />

The final session <strong>of</strong> the day on Wednesday is the invited Presidential Symposium<br />

entitled “Gene Discovery and Patent Law: Present Experience in the US and in Europe.”<br />

Please plan to join us from 4:30 pm until 6:30 pm to discuss the present state <strong>of</strong> gene<br />

patenting. Come prepared with your written questions for the well-known panelists:<br />

Hank Greely, Gert Matthijs, Mark Lemley and Lori Andrews. (See page 81 for further<br />

details).<br />

In response to survey requests from prior meeting attendees, the <strong>Program</strong> Committee<br />

lengthened the lunch break to 90 minutes and added evening workshops in a variety<br />

<strong>of</strong> topics. Workshops will cover interactive browser sessions (UCSC, Galaxy and<br />

Ensembl Browsers), NCBI databases (Sequence Read Archive, GenBank, GEO,<br />

dbSNP, dbVar and dbGaP) and clinical interpretation <strong>of</strong> databases (such as DECIPHER,<br />

7


8 WELCOME FROM THE PROGRAM CHAIR<br />

ISCA, DbVar). In addition, there will be a session on how scientists can use social<br />

media to benefit their career as well as a workshop on Diagnostic Dilemmas, with<br />

presentation <strong>of</strong> rare and unknown cases.<br />

The <strong>Society</strong>’s Board <strong>of</strong> Directors and the <strong>Program</strong> Committee continue to share a<br />

strong commitment for trainee academic development. Therefore, this year, we have<br />

increased the value <strong>of</strong> trainee awards. The awards were also renamed to honor the<br />

late Charles J. Epstein. We continue to <strong>of</strong>fer several events designed to assist our<br />

trainee members in their transition toward pr<strong>of</strong>essional independence. These events<br />

include: (1) the Undergraduate Faculty <strong>Genetics</strong> Education Workshop, (2) the Trainee-<br />

Mentor Luncheon, (3) the Trainee Development <strong>Program</strong> and Networking Reception,<br />

and (4) a Mock NIH Study Section Workshop. Please refer to page 29 for the “trainee<br />

meeting within the meeting” schedule.<br />

The meeting will conclude on Saturday with a special closing symposium entitled,<br />

“ <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong> and Beyond: Present Progress and Future Frontiers,” from<br />

12:00 pm to 1:00 pm. This symposium will feature a panel <strong>of</strong> five outstanding geneticists<br />

with diverse perspectives: Han Brunner, Hal Dietz, Dian Donnai, Lynn Jorde, and Jay<br />

Shendure. The panel will address exciting advances presented at this year’s meeting<br />

and will discuss the opportunities and challenges for the coming years. Attendees will<br />

have opportunities to ask questions <strong>of</strong> the panelists during the session in person and<br />

through social media. Chris Gunter will also pose relevant questions to attendees via<br />

social media during the meeting, and summarize the responses at the opening <strong>of</strong><br />

the session.<br />

Feedback<br />

To determine whether the programmatic changes implemented were successful, and<br />

to gather suggestions for future meetings, we will be sending an online survey after<br />

the meeting to all attendees. Please take the time to complete the survey and provide<br />

us with valuable feedback that we can consider for future meetings.<br />

Acknowledgments<br />

Developing a program for the <strong>ASHG</strong> Annual Meeting is a complex process, requiring the<br />

coordinated efforts <strong>of</strong> many individuals over thousands <strong>of</strong> person-hours. A description<br />

<strong>of</strong> how the <strong>Program</strong> Committee puts together the scientific content <strong>of</strong> the meeting can<br />

be found on page 327. This past year, I have had the privilege <strong>of</strong> working with a truly<br />

exceptional <strong>Program</strong> Committee — each member generously volunteering his/her<br />

expertise and time to develop an outstanding scientific program. I am also grateful to<br />

the Education, Social Issues, and Awards committees for their valuable contributions<br />

to the meeting. Finally, my deepest appreciation goes to our <strong>ASHG</strong> administrative staff<br />

(with a special note <strong>of</strong> thanks to Peggi McGovern, Pauline Minhinnett, and Dr. Joann<br />

Boughman) for their enthusiastic dedication and tireless work in making our Annual<br />

Meeting the success that it is.<br />

I hope that you enjoy the meeting, and again, a warm welcome to San Francisco!<br />

Joel N. Hirschhorn, MD, PhD<br />

<strong>2012</strong> <strong>Program</strong> Committee Chair<br />

Boston’s Children’s Hospital/Harvard Medical School<br />

Broad Institute


ABSTRACT REVIEWERS<br />

<strong>ASHG</strong> gratefully acknowledges the expertise, hard work and<br />

dedication <strong>of</strong> the <strong>2012</strong> Abstract Reviewers<br />

Kate G. Ackerman Katherine H. Kim<br />

Laura Almasy Jan Korbel<br />

Hans C. Andersson Beth A. Kozel<br />

Stylianos E. Antonarakis Michael Lovett<br />

Dimitrios Avramopoulos Richard Maas<br />

Blake C. Ballif Christa Lese Martin<br />

David R. Beier Rasika A. Mathias<br />

Cecelia A. Bellcross Andy McCallion<br />

Natalie Blagowidow Nazli McDonnell<br />

Joann A. Boughman Karen Mohlke<br />

Sally A. Camper Cynthia Morton<br />

Rita M. Cantor Maximilian Muenke<br />

Kimberly A. Chapman Christopher Newton-Cheh<br />

Andrew Clark Rasmus Nielsen<br />

Gregory M. Cooper Elaine A. Ostrander<br />

Tina M. Cowan Michael J. Parsons<br />

Gregory E. Crawford Robert Pilarski<br />

Dana C. Crawford Robert M. Plenge<br />

Paul de Bakker Barbara R. Pober<br />

Hal Dietz Nazneen Rahman<br />

Michael J. Dougherty Richard Redon<br />

Flavia M. Facio Catherine A. Reiser<br />

Clair A. Francomano Lawrence T. Reiter<br />

Thomas Glover Nathaniel H. Robin<br />

Chris Gunter Noah Rosenberg<br />

Jonathan L. Haines Richa Saxena<br />

Robert Hegele William K. Scott<br />

Joel N. Hirschhorn Michael R. Speicher<br />

Fuki M. Hisama Beth A. Sullivan<br />

Shama Jari Tricia A. Thornton-Wells<br />

Gail P. Jarvik Luk H. Vandenberghe<br />

Sekar Kathiresan Catherine A. Wicklund<br />

Nicholas Katsanis Alexander F. Wilson<br />

Brendan J. Keating Meredith Yeager<br />

9


10<br />

The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />

9650 Rockville Pike, Bethesda, Maryland 20814-3998<br />

Telephone: 301-634-7300 • 1-866-HUM-GENE • Fax: 301-634-7079<br />

E-mail: society@ashg.org or ashgmeetings@ashg.org<br />

<strong>ASHG</strong> Web site: www.ashg.org<br />

Annual Meeting Web site: www.ashg.org/<strong>2012</strong>meeting<br />

Meetings, Registration and Exhibits<br />

Pauline Minhinnett, Director <strong>of</strong> Meetings; paulinem@ashg.org<br />

Peggi McGovern, Senior Meetings Associate/Registrar; pmcgovern@ashg.org<br />

Carrie Morin, Exhibits, Sponsorship and Advertising Manager, cmorin@ashg.org<br />

<strong>ASHG</strong> Administrative Office<br />

Jennifer Hobin, Interim Executive Officer; jhobin@faseb.org<br />

Karen Goodman, Executive Assistant; kgoodman@ashg.org<br />

Education Department<br />

Michael J. Dougherty, Director <strong>of</strong> Education; mdougherty@ashg.org<br />

Katherine Lontok, Education <strong>Program</strong>s Manager; klontok@ashg.org<br />

Information Services<br />

Yimang Chen, Director, Information Technology; ychen@ashg.org<br />

Ray Wolfe, System Support Engineer/Web Site Coordinator; rwolfe@ashg.org<br />

Hubert Zhang, Systems Developer; hzhang@ashg.org<br />

Communications/Media<br />

Cathy Yarbrough, <strong>ASHG</strong> <strong>2012</strong> Communications Consultant; press@ashg.org<br />

Accounting<br />

Chuck Windle, Director <strong>of</strong> Administration and Finance; cwindle@ashg.org<br />

Membership<br />

Mary Shih, Membership Manager; mshih@ashg.org<br />

If you are unsure whom to contact, please e-mail ashgmeetings@ashg.org and your<br />

inquiry will be forwarded to the appropriate person. See page 53 for a list <strong>of</strong> on-site<br />

telephone numbers and <strong>of</strong>fices at the Convention Center during the <strong>2012</strong> <strong>ASHG</strong><br />

Annual Meeting.


ANNUAL MEETING SUPPORT<br />

The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> gratefully acknowledges the<br />

following Annual Meeting supporters<br />

BIOBASE<br />

Galaxy Workshop: Working with High-Throughput Data and Data Visualization<br />

G3: Genes, Genomes, <strong>Genetics</strong><br />

Educational Support<br />

Genzyme Corp.<br />

Cyber Café and WiFi<br />

Life Technologies<br />

Diagnostic Challenges: Review and Discussion <strong>of</strong> Unique Cases (Rare and<br />

Unknown)<br />

Roche<br />

Badge Holders<br />

11


12<br />

ADVERTISERS<br />

Affymetrix, Inc. (Booth 918) Back Cover<br />

<strong>ASHG</strong> Central (<strong>ASHG</strong>/AJHG)<br />

(Booth 913) Alphabetical, end <strong>of</strong> book, Page 421<br />

<strong>ASHG</strong> <strong>2012</strong> Mobile App Alphabetical, end <strong>of</strong> book, Page 422<br />

<strong>ASHG</strong> 2013 Call for Invited Sessions:<br />

Boston (Booth 913) Alphabetical, end <strong>of</strong> book, Page 423<br />

<strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong><br />

and Genomics (Booth 318) Alphabetical, end <strong>of</strong> book, Page 424<br />

Association <strong>of</strong> Pr<strong>of</strong>essors <strong>of</strong> <strong>Human</strong><br />

and Medical <strong>Genetics</strong> (APHMG) Alphabetical, end <strong>of</strong> book, Page 425<br />

Baylor College <strong>of</strong> Medicine, Medical<br />

<strong>Genetics</strong> Laboratories (Booth 711) Inside Front Cover<br />

European <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />

Conference 2013 (Booth 219) Alphabetical, end <strong>of</strong> book, Page 426<br />

JAMA Network (Booth 1201) Facing Inside Back Cover<br />

Life Technologies (Booth 601) Inside Back Cover<br />

Natera (Booth 504) Alphabetical, end <strong>of</strong> book, Page 427<br />

RainDance Technologies (Booth 910) Exhibit Hall Floor Plan Banner<br />

Sequenom, Inc. (Booth 519) Alphabetical, end <strong>of</strong> book, Page 428/429<br />

Shire (Booth 600) Exhibits Tab Divider


NOTES


NOTES


SCHEDULE OF SCIENTIFIC SESSIONS AND<br />

ANCILLARY EVENTS<br />

Ancillary and satellite meetings, exhibitor or other special workshops, reunion/university<br />

receptions or meetings <strong>of</strong> editorial boards, committees, etc., are not <strong>of</strong>ficial <strong>ASHG</strong> functions.<br />

Listings in bold face indicate the event is an <strong>ASHG</strong>-sponsored scientific session/event<br />

open only to scientific registrants.<br />

Indicates Trainee-focused events<br />

Indicates Education-focused events<br />

Indicates Clinical-focused events<br />

(*)Asterisk denotes meetings/events that the organizer specified are by invitation or preregistration<br />

only. Otherwise, attendance may be assumed to be open to all registrants on a<br />

first-come, first-served basis.<br />

MONDAY, November 5<br />

*3:00 PM -<br />

8:00 PM<br />

*4:00 PM -<br />

5:45 PM<br />

*6:00 PM -<br />

9:00 PM<br />

*6:00 PM -<br />

9:00 PM<br />

*6:00 PM -<br />

9:00 PM<br />

<strong>ASHG</strong> Board <strong>of</strong> Directors Meeting #1 Marriott Marquis Hotel<br />

Foothill E, 2nd Level<br />

ABMG Finance Committee Meeting Marriott Marquis Hotel<br />

Pacific E, 4th Level<br />

ABMG Accreditation Committee Meeting Marriott Marquis Hotel<br />

Pacific D, 4th Level<br />

ABMG Credentials Committee Meeting Marriott Marquis Hotel<br />

Pacific F, 4th Level<br />

ABMG MOC Committee Meeting Marriott Marquis Hotel<br />

Pacific E, 4th Level<br />

TUESDAY, November 6<br />

*7:30 AM -<br />

4:00 PM<br />

8:00 AM -<br />

5:00 PM<br />

8:00 AM -<br />

4:00 PM<br />

*8:00 AM -<br />

3:00 PM<br />

*8:00 AM -<br />

3:30 PM<br />

*8:00 AM -<br />

4:00 PM<br />

FSH <strong>Society</strong> Facioscapulohumeral Muscular<br />

Dystrophy [FSHD] <strong>2012</strong> International<br />

Research Consortium & Research Planning<br />

Meeting<br />

Marriott Marquis Hotel<br />

Club Room, 2nd Level<br />

Exhibitor Registration Open Moscone Center<br />

South Lobby<br />

Annual Meeting <strong>of</strong> the <strong>Society</strong> <strong>of</strong> Crani<strong>of</strong>acial<br />

<strong>Genetics</strong> and Developmental Biology: Stem<br />

Cells in Crani<strong>of</strong>acial Development and<br />

Disease<br />

<strong>ASHG</strong> Undergraduate Faculty<br />

<strong>Genetics</strong> Education Workshop<br />

(Advance registration required.)<br />

15<br />

UCSF, Parnassus Campus<br />

Health Sciences West, Room<br />

301<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

ABMG Board <strong>of</strong> Directors Meeting Marriott Marquis Hotel<br />

Sierra I, 5th Level<br />

ACMG Board Meeting Marriott Marquis Hotel<br />

Sierra A, 5th Level<br />

SCHEDULE


16 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />

*8:30 AM -<br />

2:30 PM<br />

8:30 AM -<br />

3:45 PM<br />

*9:00 AM -<br />

1:00 PM<br />

10:00 AM -<br />

7:00 PM<br />

*10:00 AM -<br />

3:00 PM<br />

11:00 AM -<br />

4:30 PM<br />

*11:00 AM -<br />

1:00 PM<br />

*11:00 AM -<br />

3:00 PM<br />

12:00 PM -<br />

4:00 PM<br />

*12:00 PM -<br />

4:00 PM<br />

1:00 PM -<br />

4:00 PM<br />

1:30 PM -<br />

3:30 PM<br />

2:00 PM -<br />

4:00 PM<br />

4:00 PM -<br />

4:30 PM<br />

4:30 PM -<br />

6:30 PM<br />

*6:45 PM -<br />

9:30 PM<br />

7:00 PM -<br />

8:30 PM<br />

<strong>ASHG</strong> High School Workshop for Local<br />

San Francisco Students and Teachers<br />

(Advance registration required.)<br />

HVP: Getting Ready for the <strong>Human</strong> Phenome<br />

Project (Separate registration required.)<br />

Philippine Genome Center Health <strong>Program</strong><br />

Scientific Advisory Committee Meeting<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Marriott Marquis Hotel<br />

Yerba Buena 7, Lower B2<br />

Level<br />

Moscone Center<br />

Room 220, East Mezzanine<br />

Level South<br />

Scientific Registration Open Moscone Center<br />

North Lobby<br />

<strong>ASHG</strong> Board <strong>of</strong> Directors Meeting #2 Moscone Center<br />

Room 222, East Mezzanine<br />

Level South<br />

Speaker Presentation/Upload Room Open<br />

Speakers are required to upload their<br />

presentations here. We recommend uploading<br />

at least 4 hours before your presentation time.<br />

Moscone Center<br />

Room 110, Lower Level<br />

South<br />

<strong>ASHG</strong> Social Issues Committee Meeting Moscone Center<br />

Room 214, East Mezzanine<br />

Level South<br />

<strong>ASHG</strong> <strong>Program</strong> Committee Meeting #1 Moscone Center<br />

Room 224/226, East<br />

Mezzanine Level South<br />

Ataxia-Telangiectasia & Genome Instability<br />

Workshop<br />

For further information contact:<br />

meyn@sickkids.ca<br />

European <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (ESHG)<br />

Executive Board Meeting<br />

Getting the Most from the <strong>Human</strong> Genome:<br />

Understanding Updates and Improvements in<br />

the Reference Assembly<br />

1st Meeting <strong>of</strong> the International Consortium<br />

for Autosomal Recessive Intellectual Disability<br />

(CARID)<br />

Clinical Utility <strong>of</strong> Whole Exome Sequencing:<br />

Baylor’s Initial Experience<br />

1. <strong>ASHG</strong> Presidential Address: The<br />

Scientist as a Citizen <strong>of</strong> the World<br />

Moscone Center<br />

Room 274/276, West<br />

Mezzanine Level South<br />

Moscone Center<br />

Room 270, West Mezzanine<br />

Level South<br />

Moscone Center<br />

Room 236/238, East<br />

Mezzanine Level South<br />

Moscone Center<br />

Room 272, West Mezzanine<br />

Level South<br />

Moscone Center<br />

Room 310, Esplanade Level<br />

South<br />

Moscone Center<br />

Hall D, Lower Level North<br />

2. Plenary Abstract Presentations Moscone Center<br />

Hall D, Lower Level North<br />

<strong>Genetics</strong> <strong>of</strong> Type 2 Diabetes Meeting Marriott Marquis Hotel<br />

Pacific I, 4th Level<br />

<strong>ASHG</strong> Opening Mixer and Trainee<br />

Mixer-within-a-Mixer (Open to all<br />

scientific registrants.)<br />

Marriott Marquis Hotel<br />

Yerba Buena 7/8/9, Lower<br />

B2 Level


*7:00 PM -<br />

8:00 PM<br />

*7:00 PM -<br />

9:00 PM<br />

SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 17<br />

ACMG Development Committee Meeting Marriott Marquis Hotel<br />

Sierra A, 5th Level<br />

<strong>American</strong> Journal <strong>of</strong> Medical <strong>Genetics</strong><br />

Editorial Board Meeting<br />

WEDNESDAY, November 7<br />

7:00 AM -<br />

5:00 PM<br />

7:00 AM -<br />

5:00 PM<br />

8:00 AM -<br />

10:00 AM<br />

8:00 AM -<br />

4:30 PM<br />

10:00 AM -<br />

4:30 PM<br />

10:00 AM -<br />

4:30 PM<br />

Marriott Marquis Hotel<br />

Golden Gate C2, B2 Level<br />

Scientific Registration Open Moscone Center<br />

North Lobby<br />

Speaker Presentation/Upload Room Open<br />

Speakers are required to upload their<br />

presentations here. We recommend uploading<br />

at least 4 hours before your presentation time.<br />

Moscone Center<br />

Room 110, Lower Level<br />

South<br />

Concurrent Invited Session I (3-10): Moscone Center<br />

3. Implementing Next-Generation<br />

Sequencing as a Clinical Test<br />

4. Assessing the Pathogenicity <strong>of</strong><br />

Genetic Variants: Translating in Vitro<br />

and in Silico Advances to the Clinic<br />

5. Gene Regulatory Change: The Engine<br />

<strong>of</strong> <strong>Human</strong> Evolution?<br />

6. Insights into <strong>Human</strong> Demography and<br />

Selection from Full Genome<br />

Sequencing<br />

7. Age-Related Macular Degeneration—<br />

GWAS and Beyond: Guiding Light for<br />

the Complex Neurodegenerative<br />

Diseases<br />

8. “Yes Virginia, Family Studies Really Are<br />

Useful for Complex Traits in the Next-<br />

Generation Sequencing Era” (session<br />

in honor <strong>of</strong> Dr. Robert Elston’s<br />

contributions to human genetics in the<br />

year <strong>of</strong> his 80th birthday)<br />

9. Surveying Customer Responses to<br />

Personal Genetic Services<br />

10. Metabolism, Metals, and<br />

Neurodegeneration: Toward<br />

Enhanced Understanding <strong>of</strong><br />

Disease Mechanisms and<br />

Rational Therapeutics<br />

Hall D, Lower Level North<br />

Gateway Ballroom 103,<br />

Lower Level South<br />

Room 135, Lower Level<br />

North<br />

Room 134, Lower Level<br />

North<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

Room 124, Lower Level<br />

North<br />

Room 132, Lower Level<br />

North<br />

Room 130, Lower Level<br />

North<br />

Exhibitor Registration Open Moscone Center<br />

South Lobby<br />

Career Resources Open<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Exhibits Open Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

SCHEDULE


18 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />

10:00 AM -<br />

4:30 PM<br />

10:30 AM -<br />

12:45 PM<br />

12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

1:45 PM<br />

12:45 PM -<br />

2:00 PM<br />

Posters Open Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Concurrent Platform (abstract-driven) Moscone Center<br />

Session A (11-19):<br />

11. <strong>Genetics</strong> <strong>of</strong> Autism Spectrum<br />

Hall D, Lower Level North<br />

Disorders<br />

12. New Methods for Big Data Gateway Ballroom 103,<br />

Lower Level South<br />

13. Cancer <strong>Genetics</strong> I: Rare Variants Room 135, Lower Level<br />

North<br />

14. Quantitation and Measurement <strong>of</strong><br />

Regulatory Oversight by the Cell<br />

15. New Loci for Obesity, Diabetes, and<br />

Related Traits<br />

Room 134, Lower Level<br />

North<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

16. Neuromuscular Disease and Deafness Room 124, Lower Level<br />

North<br />

17. Chromosomes and Disease Room 132, Lower Level<br />

North<br />

18. Prenatal and Perinatal <strong>Genetics</strong> Room 130, Lower Level<br />

North<br />

19. Vascular and Congenital Heart Disease Room 123, Lower Level<br />

North<br />

Lunch Break, Open Viewing for Posters<br />

and Exhibits<br />

<strong>ASHG</strong> Trainee-Mentor<br />

Luncheon (Advance ticket<br />

purchase required.)<br />

<strong>ASHG</strong> Workshop:<br />

Clinical Interpretation<br />

<strong>of</strong> Cytogenomic Arrays:<br />

Tools & Resources (Advance<br />

ticket purchase required.)<br />

<strong>ASHG</strong>/NCBI Workshop:<br />

Discovering Biological<br />

Data at NCBI (Advance<br />

ticket purchase required.)<br />

<strong>Human</strong> Variome Project International<br />

Scientific Advisory Committee Meeting<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

Complete Genomics Workshop: Whole<br />

Genome Sequencing as a Clinical Tool<br />

Roche Workshop: Genetic Diversity Analysis<br />

Using 454 and Nimblegen Sequencing<br />

Solutions<br />

Illumina Workshop: Integrated Tools for Next-<br />

Generation Sequencing & Genotyping<br />

Applications<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 307, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 270, West Mezzanine<br />

Level South<br />

Moscone Center Room 309,<br />

Esplanade Level South<br />

Moscone Center<br />

Room 236/238, East<br />

Mezzanine Level South<br />

Moscone Center<br />

Room 308, Esplanade Level<br />

South


12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

1:15 PM -<br />

2:15 PM<br />

2:15 PM -<br />

4:15 PM<br />

4:30 PM -<br />

6:30 PM<br />

6:30 PM -<br />

7:45 PM<br />

6:30 PM -<br />

8:00 PM<br />

6:30 PM -<br />

8:00 PM<br />

*6:30 PM -<br />

9:30 PM<br />

*6:30 PM -<br />

9:30 PM<br />

6:45 PM -<br />

8:45 PM<br />

SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 19<br />

Affymetrix Workshop: Enabling the Genome<br />

Generation #1: Population-Optimized<br />

Strategies and Genotyping Solutions for<br />

Expanding Our Understanding <strong>of</strong> the Genetic<br />

Variations in Complex Diseases<br />

Agilent Technologies Lunch Workshop: Better<br />

Sequencing, Better World: The Latest in<br />

HaloPlex & SureSelect NGS Target<br />

Enrichment for <strong>Human</strong> Disease Research<br />

<strong>Human</strong> Molecular <strong>Genetics</strong> Editorial Board<br />

Meeting<br />

DNAnexus: Taking the Guesswork and<br />

Complexity Out <strong>of</strong> Genomic Data Analysis<br />

with a Novel Collaborative and Scalable Data<br />

Technology Platform<br />

QIAGEN, Inc. Workshop: New Sample Prep<br />

Solutions & Multiplex Gene Panel Target<br />

Enrichment for Next-Generation Sequencing<br />

Ion Torrent Luncheon Workshop:<br />

Semiconductor Sequencing For All: Ion<br />

Proton and Ion PGM Systems, Ion<br />

AmpliSeq Technology & More<br />

ACMG <strong>Genetics</strong> Review Course Faculty<br />

Meeting<br />

Knome Workshop: Interpreting Whole<br />

Genomes to Understand Disease and Drug<br />

Response: Methods, Tools, and Case Studies<br />

Poster Session I (Wednesday Poster<br />

Authors Present)<br />

20. Invited Presidential Symposium: Gene<br />

Discovery and Patent Law: Present<br />

Experience in the U.S. and in Europe<br />

Ambry <strong>Genetics</strong> Workshop: The Power <strong>of</strong> the<br />

Diagnostic Exome<br />

Cleveland Clinic Genomic Medicine Institute<br />

Reception<br />

Progeny S<strong>of</strong>tware Workshop: How to<br />

integrate Family History into your EMR<br />

Moscone Center<br />

Room 302, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 250, West Mezzanine<br />

Level South<br />

Moscone Center<br />

Room 274/276, West<br />

Mezzanine Level South<br />

Moscone Center<br />

Room 301, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 310, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 222, East Mezzanine<br />

Level South<br />

Moscone Center<br />

Room 232/234, East<br />

Mezzanine Level South<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Room 307, Esplanade Level<br />

South<br />

Marriott Marquis Hotel<br />

Yerba Buena 1/2, Lower B2<br />

Level<br />

Moscone Center<br />

Room 236/238, East<br />

Mezzanine Level South<br />

ACMG MOC Meeting Marriott Marquis Hotel<br />

Sierra F, 5th Level<br />

ACMG Pr<strong>of</strong>essional Practice and <strong>Guide</strong>lines<br />

Committee Meeting<br />

Canadian College <strong>of</strong> Medical Geneticists:<br />

CIHR Institute <strong>of</strong> <strong>Genetics</strong> Mixer<br />

Marriott Marquis Hotel<br />

Sierra E, 5th Level<br />

Marriott Marquis Hotel<br />

Yerba Buena 5/6, Lower B2<br />

Level<br />

SCHEDULE


20 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />

*6:45 PM -<br />

9:45 PM<br />

*6:45 PM -<br />

10:30 PM<br />

7:00 PM -<br />

10:30 PM<br />

*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

8:30 PM<br />

7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

8:30 PM<br />

7:00 PM -<br />

9:00 PM<br />

7:00 PM -<br />

9:30 PM<br />

*7:00 PM -<br />

10:00 PM<br />

*7:00 PM -<br />

10:00 PM<br />

*7:00 PM -<br />

10:00 PM<br />

*7:00 PM -<br />

10:00 PM<br />

International Federation <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />

Societies (IFHGS) Executive Board Meeting<br />

Explore Art & Science with Life Technologies<br />

(By invitation only.)<br />

Moscone Center<br />

Room 224/226, East<br />

Mezzanine Level South<br />

San Francisco Museum <strong>of</strong><br />

Modern Art<br />

Agilent Customer Appreciation Event B Restaurant & Bar<br />

720 Howard Street<br />

<strong>ASHG</strong> Interactive Workshop<br />

on the UCSC Genome<br />

Browser for Intermediate/<br />

Advanced Users (Advance<br />

ticket purchase required.)<br />

<strong>ASHG</strong> Workshop: Social<br />

Media + Scientists = Success:<br />

Strategies for Using Social Media to<br />

Benefit Your Research, Your Career<br />

and Your Connections (Advance<br />

ticket purchase required.)<br />

DNASTAR, Inc. Workshop: Cancer Genomics<br />

Data Analysis Using Next-Gen Sequencing: A<br />

Case Study and Workflow<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 310, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 301, Esplanade Level<br />

South<br />

<strong>Human</strong> Mutation Editorial Board Meeting Marriott Marquis Hotel<br />

Nob Hill C/D, Lower B2 Level<br />

Baylor College <strong>of</strong> Medicine <strong>Genetics</strong><br />

Reception<br />

University <strong>of</strong> Michigan, Department <strong>of</strong> <strong>Human</strong><br />

<strong>Genetics</strong> Alumni Gathering<br />

<strong>2012</strong> Stanford University, Department <strong>of</strong><br />

<strong>Genetics</strong> Reunion<br />

ACMG Biochemical <strong>Genetics</strong> Subcommittee<br />

Meeting<br />

Marriott Marquis Hotel<br />

Yerba Buena 10/11/12/13,<br />

Lower B2 Level<br />

Marriott Marquis Hotel<br />

Pacific C, 4th Level<br />

Roe-SF<br />

651 Howard Street<br />

Marriott Marquis Hotel<br />

Sierra B, 5th Level<br />

ACMG Cytogenetics Subcommittee Meeting Marriott Marquis Hotel<br />

Sierra C, 5th Level<br />

ACMG Molecular <strong>Genetics</strong> Subcommittee<br />

Meeting<br />

THURSDAY, November 8<br />

7:00 AM -<br />

4:30 PM<br />

7:00 AM -<br />

5:00 PM<br />

7:00 AM -<br />

8:00 AM<br />

7:30 AM -<br />

5:00 PM<br />

Marriott Marquis Hotel<br />

Sierra A, 5th Level<br />

Posters Open Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Speaker Presentation/Upload Room Open<br />

Speakers are required to upload their<br />

presentations here. We recommend uploading<br />

at least 4 hours before your presentation time.<br />

Moscone Center<br />

Room 110, Lower Level<br />

South<br />

ACMG Education Committee Meeting Moscone Center<br />

Room 222, East Mezzanine<br />

Level South<br />

Scientific Registration Open Moscone Center<br />

North Lobby<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT


8:00 AM -<br />

10:00 AM<br />

8:00 AM -<br />

4:30 PM<br />

10:00 AM -<br />

4:30 PM<br />

10:00 AM -<br />

4:30 PM<br />

10:30 AM -<br />

12:45 PM<br />

SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 21<br />

Concurrent Invited Session II (21-28): Moscone Center<br />

21. Mendelian Randomization: Using<br />

Genetic Variants to Inform Causality in<br />

Observational Epidemiology<br />

22. Common and Rare CNVs: Genesis,<br />

Patterns <strong>of</strong> Variations and <strong>Human</strong><br />

Diseases<br />

23. Advancing Gene Therapy to the<br />

Clinic: Molecular Medicines<br />

Come <strong>of</strong> Age<br />

24. RNA Splicing in <strong>Human</strong> Development,<br />

Diseases and Natural Variation<br />

25. Genomic Medicine: ELSI Goes<br />

Mainstream<br />

26. Model Organism <strong>Genetics</strong>, <strong>Human</strong><br />

Biology and <strong>Human</strong> Disease<br />

27. Next-Generation Sequencing in<br />

Isolated Populations: Opportunities for<br />

Accelerated Gene Discovery in<br />

Complex Traits<br />

28. Transforming Medical Student<br />

Education in <strong>Genetics</strong> and<br />

Genomics: How Do We Improve<br />

Health and Individualize Care<br />

through Medical School Genetic<br />

and Genomic Curricula?<br />

Room 135, Lower Level<br />

North<br />

Hall D, Lower Level North<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

Room 124, Lower Level<br />

North<br />

Room 132, Lower Level<br />

North<br />

Gateway Ballroom 103,<br />

Lower Level South<br />

Room 134, Lower Level<br />

North<br />

Room 130, Lower Level<br />

North<br />

Exhibitor Registration Open Moscone Center<br />

South Lobby<br />

Career Resources Open<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Exhibits Open Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Concurrent Platform (abstract-driven) Moscone Center<br />

Session B (29-37):<br />

29. Next-Generation Sequencing: Methods Hall D, Lower Level North<br />

and Applications<br />

30. <strong>Genetics</strong> and Intellectual Disability Gateway Ballroom 103,<br />

Lower Level South<br />

31. GWAS from Head to Toe Room 135, Lower Level<br />

North<br />

32. Cardiovascular <strong>Genetics</strong>: GWAS and<br />

Beyond<br />

33. Clinical <strong>Genetics</strong>: Mutations,<br />

Mutations and Syndromes<br />

Room 134, Lower Level<br />

North<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

34. Cancer <strong>Genetics</strong> II: Clinical Translation Room 124, Lower Level<br />

North<br />

SCHEDULE


22 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />

12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:00 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:00 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

35. Ethical, Legal, Social and Policy<br />

Issues<br />

Room 132, Lower Level<br />

North<br />

36. Chipping Away at Autoimmune Disease Room 130, Lower Level<br />

North<br />

37. Metabolic Disease Discoveries Room 123, Lower Level<br />

North<br />

Lunch Break, Open Viewing for Posters<br />

and Exhibits<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

AJHG Editorial Board Luncheon Moscone Center<br />

Room 224/226, East<br />

Mezzanine Level South<br />

<strong>ASHG</strong> Information and Education Meeting Moscone Center<br />

Room 214, East Mezzanine<br />

Level South<br />

<strong>ASHG</strong> Workshop: Diagnostic<br />

Challenges: Review and Discussion<br />

<strong>of</strong> Unique Cases, Rare and Unknown<br />

Cases (Advance ticket purchase required.)<br />

Association <strong>of</strong> Pr<strong>of</strong>essors <strong>of</strong> <strong>Human</strong> and<br />

Medical <strong>Genetics</strong> (APHMG) and SIGs<br />

Business Meeting and Lunch<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

Clinical <strong>Genetics</strong> Editorial Board Meeting Moscone Center<br />

Room 274/276, West<br />

Mezzanine Level South<br />

Genetic Epidemiology Editorial Board Meeting Moscone Center<br />

Room 272, West Mezzanine<br />

Level South<br />

<strong>Human</strong> Variome Project <strong>Genetics</strong> Journal<br />

Editors Meeting<br />

Life Technologies Luncheon Workshop:<br />

Genetic Analysis at the Speed <strong>of</strong> Life<br />

SOLD<br />

OUT<br />

Illumina Workshop: Next-Generation<br />

Sequencing - Implications for the Clinical Lab<br />

Affymetrix Workshop: Enabling the Genome<br />

Generation #2: Next Generation Cytogenetics<br />

Solution for Constitutional and Cancer<br />

Research Applications<br />

Agilent Technologies Lunch Workshop:<br />

Microarrays & Beyond: Advancements in<br />

Cytogenetic Research Technologies -<br />

Maximizing Flexibility and Customization for<br />

Multiple Applications with NGS, FISH, and<br />

Microarrays<br />

Asuragen, Inc. Workshop: Next Generation<br />

Fragile X Testing: New Capabilities in Genetic<br />

Counseling, Reproduction, and Fertility<br />

Planning for Female FMR1 Carriers<br />

Moscone Center<br />

Room 270, West Mezzanine<br />

Level South<br />

Moscone Center<br />

Room 310, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 308, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 307, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 232/234, East<br />

Mezzanine Level South


12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

*1:00 PM -<br />

2:00 PM<br />

*1:00 PM -<br />

2:00 PM<br />

1:00 PM -<br />

2:15 PM<br />

2:15 PM -<br />

4:15 PM<br />

4:30 PM -<br />

6:45 PM<br />

*6:45 PM -<br />

8:15 PM<br />

6:45 PM -<br />

8:15 PM<br />

SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 23<br />

BGI Luncheon Workshop: <strong>Human</strong> Disease<br />

Research and Drug Development in the Era <strong>of</strong><br />

Next-Gen Sequencing<br />

BioNano Genomics Workshop: A Game-<br />

Changing Solution for Structural Variation<br />

Detection and Improving Assembly with<br />

Single-Molecule Visualization<br />

RainDance Technologies Workshop: Powering<br />

Recent Advances in <strong>Human</strong> <strong>Genetics</strong><br />

BioDiscovery Nexus CNV Workshop: Recent<br />

CNV Discoveries and Integrated Genomics<br />

from NGS and Microarray Data<br />

ACMG Social, Ethical and Legal Issues<br />

Committee Meeting<br />

Moscone Center<br />

Room 309, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 301, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 236/238, East<br />

Mezzanine Level South<br />

Moscone Center<br />

Room 302, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 220, East Mezzanine<br />

Level South<br />

ACMG Therapeutics Committee Meeting Moscone Center<br />

Room 222, East Mezzanine<br />

Level South<br />

Pacific Biosciences Workshop: Revealing the<br />

Genome through SMRT Biology: Discoveries<br />

and Applications<br />

Poster Session II (Thursday Poster Authors<br />

Present)<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46):<br />

38. A Sequencing Jamboree: Exomes to<br />

Genomes<br />

Moscone Center<br />

Room 250, West Mezzanine<br />

Level South<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Moscone Center<br />

Hall D, Lower Level North<br />

39. Admixture and Demography Gateway Ballroom 103,<br />

Lower Level South<br />

40. Analysis <strong>of</strong> Multilocus Systems Room 135, Lower Level<br />

North<br />

41. Genes Underlying Neurological<br />

Disease<br />

Room 134, Lower Level<br />

North<br />

42. Cancer <strong>Genetics</strong> III: Common Variants Gateway Ballroom 104,<br />

Lower Level South<br />

43. <strong>Genetics</strong> <strong>of</strong> Crani<strong>of</strong>acial and<br />

Musculoskeletal Disorders<br />

Room 124, Lower Level<br />

North<br />

44. Tools for Phenotype Analysis Room 132, Lower Level<br />

North<br />

45. Therapy <strong>of</strong> Genetic Disorders Room 130, Lower Level<br />

North<br />

46. Pharmacogenetics: From Discovery to<br />

Implementation<br />

UC Davis Integrative <strong>Genetics</strong> and Genomics<br />

Reception<br />

Room 123, Lower Level<br />

North<br />

Marriott Marquis Hotel<br />

Sierra H, 5th Level<br />

PALB2 Interest Group Meeting Moscone Center<br />

Room 270, West Mezzanine<br />

Level South<br />

SCHEDULE


24 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />

6:45 PM -<br />

9:00 PM<br />

*6:45 PM -<br />

9:30 PM<br />

6:45 PM -<br />

9:45 PM<br />

6:45 PM -<br />

10:00 PM<br />

6:45 PM -<br />

9:45 PM<br />

*7:00 PM -<br />

8:30 PM<br />

7:00 PM -<br />

8:30 PM<br />

7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

9:00 PM<br />

7:00 PM -<br />

9:00 PM<br />

7:00 PM -<br />

9:00 PM<br />

*7:00 PM -<br />

9:30 PM<br />

*7:00 PM -<br />

10:00 PM<br />

7:00 PM -<br />

10:00 PM<br />

*7:00 PM -<br />

8:00 PM<br />

7:30 PM -<br />

9:00 PM<br />

7:30 PM -<br />

9:30 PM<br />

8:30 PM -<br />

10:30 PM<br />

9:00 PM -<br />

11:00 PM<br />

Ion Torrent: Users Group Meeting W Hotel<br />

Great Room I/II<br />

Ingenuity Systems Reception<br />

TBA<br />

(By invitation only.)<br />

Emory University Department <strong>of</strong> <strong>Human</strong><br />

<strong>Genetics</strong> Reception<br />

Marriott Marquis Hotel<br />

Pacific J, 4th Level<br />

Reception for Friends <strong>of</strong> RUCDR Marriott Marquis Hotel<br />

Nob Hill A/B, Lower B2 Level<br />

ENCODE-Epigenomics Common Fund<br />

Tutorial<br />

<strong>ASHG</strong> Interactive Workshop:<br />

Galaxy 101: Data Integration,<br />

Analysis and Sharing (Separate<br />

registration required.)<br />

Association <strong>of</strong> Chinese Geneticists in America<br />

(ACGA) Annual Meeting and Career Workshop<br />

UCLA Medical <strong>Genetics</strong> Training <strong>Program</strong> and<br />

Department <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> Reception<br />

Harvard Medical School <strong>Genetics</strong> Alumni<br />

Reception<br />

Johns Hopkins Institute <strong>of</strong> Genetic Medicine<br />

Alumni Reception<br />

Mount Sinai Department <strong>of</strong> <strong>Genetics</strong> and<br />

Genomic Sciences Alumni Reception<br />

<strong>ASHG</strong> Trainee Development <strong>Program</strong><br />

and Networking: Science and Public<br />

Policy: Why Should Scientists Care<br />

About and Become Active in Public<br />

Policy Involving Science? (Separate<br />

registration required.)<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Marriott Marquis Hotel<br />

Golden Gate C1, B2 Level<br />

Marriott Marquis Hotel<br />

Yerba Buena 5/6, Lower B2<br />

Level<br />

Marriott Marquis Hotel<br />

Pacific C, 4th Level<br />

Marriott Marquis Hotel<br />

Pacific H, 4th Level<br />

Marriott Marquis Hotel<br />

Sierra C, 5th Level<br />

Moscone Center<br />

Room 309, Esplanade Level<br />

South<br />

ACMG Lab QA Committee Meeting Marriott Marquis Hotel<br />

Sierra A, 5th Level<br />

23andMe Bar Night at the B B Restaurant & Bar<br />

720 Howard Street<br />

GIANT Consortium Moscone Center<br />

Room 274/276, West<br />

Mezzanine Level South<br />

Ohio State Scarlet & Gray Reception Marriott Marquis Hotel<br />

Nob Hill C/D, Lower B2 Level<br />

University <strong>of</strong> Maryland School <strong>of</strong> Medicine/<br />

<strong>Program</strong> in Personalized and Genomic<br />

Medicine/Institute for Genome Sciences<br />

Reception<br />

University <strong>of</strong> Chicago Department <strong>of</strong> <strong>Human</strong><br />

<strong>Genetics</strong> Dessert & Wine Reception<br />

Marriott Marquis Hotel<br />

Pacific B, 4th Level<br />

Marriott Marquis Hotel<br />

Yerba Buena 10/11, Lower<br />

B2 Level<br />

CHOP/PENN Reunion Marriott Marquis Hotel<br />

Yerba Buena 4, Lower B2 Level<br />

SOLD<br />

OUT


FRIDAY, November 9<br />

7:00 AM -<br />

4:30 PM<br />

7:00 AM -<br />

5:00 PM<br />

7:30 AM -<br />

5:00 PM<br />

8:00 AM -<br />

10:15 AM<br />

8:00 AM -<br />

4:30 PM<br />

10:00 AM -<br />

4:30 PM<br />

10:00 AM -<br />

4:30 PM<br />

10:30 AM -<br />

11:15 AM<br />

11:15 AM -<br />

11:45 AM<br />

11:45 AM -<br />

12:45 PM<br />

12:45 PM -<br />

2:15 PM<br />

SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 25<br />

Posters Open Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Speaker Presentation/Upload Room Open<br />

Speakers are required to upload their<br />

presentations here. We recommend uploading<br />

at least 4 hours before your presentation time.<br />

Moscone Center<br />

Room 110, Lower Level<br />

South<br />

Scientific Registration Open Moscone Center<br />

North Lobby<br />

Concurrent Platform (abstract-driven) Moscone Center<br />

Session D (47-55):<br />

47. Structural and Regulatory Genomic Hall D, Lower Level North<br />

Variation<br />

48. Neuropsychiatric Disorders Gateway Ballroom 103,<br />

Lower Level South<br />

49. Common Variants, Rare Variants, and<br />

Everything in Between<br />

Room 135, Lower Level<br />

North<br />

50. Population <strong>Genetics</strong> Genome-Wide Room 134, Lower Level<br />

North<br />

51. Endless Forms Most Beautiful: Variant<br />

Discovery in Genomic Data<br />

52. Clinical <strong>Genetics</strong>: Complex<br />

Mechanisms and Exome-Discovery<br />

53. From SNP to Function in Complex<br />

Traits<br />

54. Genetic Counseling and Clinical<br />

Testing<br />

55. Mitochondrial Disorders and<br />

Ciliopathies<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

Room 124, Lower Level<br />

North<br />

Room 132, Lower Level<br />

North<br />

Room 130, Lower Level<br />

North<br />

Room 123, Lower Level<br />

North<br />

Exhibitor Registration Open Moscone Center<br />

South Lobby<br />

Career Resources Open<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Exhibits Open Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

56. Gruber <strong>Genetics</strong> Prize Award<br />

Presentation and Rosalind Franklin<br />

Young Investigator Award<br />

Announcement<br />

57. <strong>ASHG</strong> William Allan Award<br />

Presentation<br />

58. <strong>ASHG</strong> Membership amd Business<br />

Meeting<br />

Lunch Break, Open Viewing for Posters<br />

and Exhibits<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

SCHEDULE


26 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

12:45 PM -<br />

2:15 PM<br />

*1:00 PM -<br />

2:00 PM<br />

2:15 PM -<br />

4:15 PM<br />

4:30 PM -<br />

6:45 PM<br />

<strong>ASHG</strong> <strong>Program</strong> Committee Meeting #2 Moscone Center<br />

Room 224/226, East<br />

Mezzanine Level South<br />

<strong>ASHG</strong> Mock Study Section<br />

Workshop (Advance ticket<br />

purchase required.)<br />

<strong>ASHG</strong>/Galaxy Interactive<br />

Workshop: Working with<br />

High- Throughput Data and Data<br />

Visualization (Separate advance<br />

registration required.)<br />

NEBNext: Take the Next Step with Your NGS<br />

Library Prep Reagents<br />

QIAGEN, Inc. Workshop: Automated<br />

Solutions for Quality Control and Validation <strong>of</strong><br />

Next-Gen Sequencing<br />

Recent Advances in NGS Technologies for<br />

Rapid Discovery and Direct Clinical<br />

Applications<br />

Fluidigm Workshop: From Sample to<br />

Sequence Ready: Building robust amplicon<br />

libraries for targeted analysis and validation<br />

using the Access Array System<br />

CLC bio Workshop: Medical Resequencing<br />

Pipelines, and Streamlined Amplicon<br />

Sequence from NGS Data<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 302, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 232/234, East<br />

Mezzanine Level South<br />

Moscone Center<br />

Room 307, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 236/238, East<br />

Mezzanine Level South<br />

ISCA Consortium Luncheon Marriott Marquis Hotel<br />

Yerba Buena 1/2, Lower B2<br />

Level<br />

ACMG Economics Committee Meeting Moscone Center<br />

Room 222, East Mezzanine<br />

Level South<br />

Poster Session III (Friday Poster Authors<br />

Present)<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67):<br />

Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

Moscone Center<br />

59. Genome Structure and Variation Hall D, Lower Level North<br />

60. Advances in Neurodegenerative<br />

Disease<br />

61. Missing Heritability, Interactions and<br />

Sequencing<br />

62. Exome Sequencing Uncovers Etiology<br />

<strong>of</strong> Mendelian Disease<br />

63. Transcriptional Regulation, Variation<br />

and Complexity<br />

Gateway Ballroom 103,<br />

Lower Level South<br />

Room 135, Lower Level<br />

North<br />

Room 134, Lower Level<br />

North<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

64. Epigenetics Room 124, Lower Level<br />

North<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT


*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

9:00 PM<br />

8:00 PM -<br />

12:00<br />

midnight<br />

SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 27<br />

65. Advances in Ocular <strong>Genetics</strong> Room 132, Lower Level<br />

North<br />

66. Cancer <strong>Genetics</strong>: Somatic Variants Room 130, Lower Level<br />

North<br />

67. Developmental Insights into <strong>Human</strong><br />

Malformations<br />

Room 123, Lower Level<br />

North<br />

<strong>ASHG</strong> Trainee Awards Committee Meeting Moscone Center<br />

Room 224/226, East<br />

Mezzanine Level South<br />

<strong>ASHG</strong>/Ensembl Interactive<br />

Worshop: Ensembl<br />

Web- Based Genomic Tools<br />

for Intermediate/Advance Users<br />

(Advance ticket purchase required.)<br />

Drama, Discourse and<br />

Genomics: IRBs to IFs—<br />

An Interactive Play (Advance<br />

ticket purchase required.)<br />

UCSF Institute for <strong>Human</strong> <strong>Genetics</strong> and<br />

Medical <strong>Genetics</strong> Reception<br />

SATURDAY, November 10<br />

7:00 AM -<br />

10:30 AM<br />

7:30 AM -<br />

12:00 PM<br />

8:00 AM -<br />

8:20 AM<br />

8:20 AM -<br />

8:40 AM<br />

8:40 AM -<br />

8:45 AM<br />

8:45 AM -<br />

8:55 AM<br />

8:55 AM -<br />

9:20 AM<br />

9:40 AM -<br />

11:40 AM<br />

Speaker Presentation/Upload Room Open<br />

Speakers are required to upload their<br />

presentations here. We recommend uploading<br />

at least 4 hours before your presentation time.<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

Museum <strong>of</strong> the African<br />

Diaspora<br />

685 Mission Street<br />

Moscone Center<br />

Room 110, Lower Level<br />

South<br />

Scientific Registration Open Moscone Center<br />

North Lobby<br />

68. <strong>ASHG</strong> Award for Excellence in <strong>Human</strong><br />

<strong>Genetics</strong> Education<br />

69. <strong>ASHG</strong> Victor A. McKusick Leadership<br />

Award Presentation<br />

70. AJHG C.W. Cotterman Awards<br />

Announcement<br />

71. <strong>ASHG</strong> Charles J. Epstein Trainee<br />

Awards for Excellence in <strong>Human</strong><br />

<strong>Genetics</strong> Research: Announcement<br />

<strong>of</strong> Winners<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Hall D, Lower Level North<br />

72. <strong>ASHG</strong> Curt Stern Award Presentation Moscone Center<br />

Hall D, Lower Level North<br />

Concurrent Invited Session III (73-80): Moscone Center<br />

73. Returning Results from Large-<br />

Scale Sequencing: Where the<br />

Rubber Meets the Road<br />

74. Genomic Approaches to Mendelian<br />

Disorders<br />

75. Emerging Applications <strong>of</strong> Identity by<br />

Descent Segment Detection<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

Gateway Ballroom 103,<br />

Lower Level South<br />

Hall D, Lower Level North<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

SCHEDULE


28 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />

12:00 PM -<br />

1:00 PM<br />

76. The Functional Consequences <strong>of</strong><br />

microRNA Dysregulation in <strong>Human</strong><br />

Disease<br />

77. Centralizing the Deposition and<br />

Curation <strong>of</strong> <strong>Human</strong> Mutations<br />

Room 134, Lower Level<br />

North<br />

Room 132, Lower Level<br />

North<br />

78. Stem Cells and Personalized Medicine Room 135, Lower Level<br />

North<br />

79. Should Noninvasive Prenatal<br />

Diagnosis Augment or Replace<br />

Current Prenatal Screening and<br />

Diagnosis?<br />

80. Selection Signatures and the <strong>Genetics</strong><br />

<strong>of</strong> Autoimmunity and Infectious<br />

Diseases<br />

81. Closing Plenary: <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong><br />

and Beyond: Present Progress and<br />

Future Frontiers<br />

Room 124, Lower Level<br />

North<br />

Room 130, Lower Level<br />

North<br />

Moscone Center<br />

Hall D, Lower Level North


TUESDAY, November 6<br />

*8:00 AM -<br />

3:00 PM<br />

7:00 PM -<br />

8:30 PM<br />

TRAINEE “MEETING WITHIN THE MEETING” 29<br />

TRAINEE TRACK<br />

Trainee “Meeting within the Meeting”<br />

<strong>ASHG</strong> Undergraduate Faculty <strong>Genetics</strong><br />

Education Workshop (Advance registration<br />

required.)<br />

<strong>ASHG</strong> Opening Mixer and Trainee Mixerwithin-a-Mixer<br />

(Open to all scientific<br />

registrants.)<br />

WEDNESDAY, November 7<br />

10:00 AM -<br />

4:30 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

8:30 PM<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

Marriott Marquis Hotel<br />

Yerba Buena 7/8/9, Lower<br />

B2 Level<br />

Career Resources Open Moscone Center Exhibit<br />

Hall, Lower Level South<br />

<strong>ASHG</strong> Trainee-Mentor Luncheon<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong> Workshop: Clinical<br />

Interpretation <strong>of</strong> Cytogenomic<br />

Arrays: Tools & Resources<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong>/NCBI Workshop: Discovering<br />

Biological Data at NCBI<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong> Interactive Workshop on the<br />

UCSC Genome Browser for<br />

Intermediate/Advanced Users<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong> Workshop: Social Media +<br />

Scientists = Success: Strategies<br />

for Using Social Media to Benefit Your<br />

Research, Your Career and Your Connections<br />

(Advance ticket purchase required.)<br />

THURSDAY, November 8<br />

10:00 AM -<br />

4:30 PM<br />

*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

9:30 PM<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 307, Esplanade Level<br />

South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 310, Esplanade Level<br />

South<br />

Career Resources Open Moscone Center Exhibit<br />

Hall, Lower Level South<br />

<strong>ASHG</strong> Interactive Workshop:<br />

Galaxy 101: Data Integration,<br />

Analysis and Sharing<br />

(Separate registration required.)<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

<strong>ASHG</strong> Trainee Development <strong>Program</strong> and<br />

Networking: Science and Public Policy:<br />

Why Should Scientists Care About and<br />

Become Active in Public Policy Involving<br />

Science? (Separate registration required.)<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 309, Esplanade Level<br />

South<br />

TRAINEE TRACK


30 TRAINEE “MEETING WITHIN THE MEETING”<br />

FRIDAY, November 9<br />

10:00 AM -<br />

4:30 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

9:00 PM<br />

Career Resources Open Moscone Center<br />

Exhibit Hall, Lower Level<br />

South<br />

<strong>ASHG</strong> Mock Study Section Workshop<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong>/Galaxy Interactive Workshop:<br />

Working with High-Throughput Data<br />

and Data Visualization (Separate<br />

advance registration required.)<br />

<strong>ASHG</strong>/Ensembl Interactive Worshop:<br />

Ensembl Web-Based Genomic Tools<br />

for Intermediate/Advance Users<br />

(Advance ticket purchase required.)<br />

Drama, Discourse and Genomics:<br />

IRBs to IFs—An Interactive Play<br />

(Advance ticket purchase required.)<br />

SATURDAY, November 10<br />

8:40 AM -<br />

8:45 AM<br />

8:45 AM -<br />

8:55 AM<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

70. AJHG C.W. Cotterman Awards<br />

Announcement<br />

71. <strong>ASHG</strong> Charles J. Epstein Trainee<br />

Awards for Excellence in <strong>Human</strong><br />

<strong>Genetics</strong> Research: Announcement <strong>of</strong><br />

Winners<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

Moscone Center<br />

Hall D, Lower Level North<br />

Moscone Center<br />

Hall D, Lower Level North


TUESDAY, November 6<br />

*8:00 AM -<br />

3:00 PM<br />

EDUCATION TRACK<br />

<strong>ASHG</strong> Undergraduate Faculty <strong>Genetics</strong><br />

Education Workshop (Advance registration<br />

required.)<br />

WEDNESDAY, November 7<br />

8:00 AM -<br />

10:00 AM<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

8:30 PM<br />

EDUCATION TRACK 31<br />

Moscone Center<br />

Room 300, Esplanade Level<br />

South<br />

Concurrent Invited Sessions I (3-10): Moscone Center<br />

3. Implementing <strong>of</strong> Next-Generation<br />

Sequencing as a Clinical Test<br />

9. Surveying Customer Responses to<br />

Personal Genetic Services<br />

<strong>ASHG</strong> Workshop: Clinical<br />

SOLD<br />

OUT<br />

Interpretation <strong>of</strong> Cytogenomic<br />

Arrays: Tools & Resources<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong>/NCBI Workshop: Discovering SOLD<br />

OUT<br />

Biological Data at NCBI (Advance<br />

ticket purchase required.)<br />

<strong>ASHG</strong> Interactive Workshop on<br />

SOLD<br />

OUT<br />

the UCSC Genome Browser for<br />

Intermediate/Advanced Users<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong> Workshop: Social Media +<br />

SOLD<br />

Scientists = Success: Strategies for<br />

OUT<br />

Using Social Media to Benefit Your<br />

Research, Your Career and Your Connections<br />

(Advance ticket purchase required.)<br />

THURSDAY, November 8<br />

8:00 AM -<br />

10:00 AM<br />

*7:00 PM -<br />

8:30 PM<br />

Hall D, Lower Level North<br />

Room 132, Lower Level<br />

North<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 307, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 310, Esplanade Level<br />

South<br />

Concurrent Invited Session II (21-28): Moscone Center<br />

25. Genomic Medicine: ELSI Goes<br />

Room 132, Lower Level<br />

Mainstream<br />

North<br />

28. Transforming Medical Student<br />

Room 130, Lower Level<br />

Education in <strong>Genetics</strong> and Genomics:<br />

How Do We Improve Health and<br />

Individualize Care through Medical<br />

School Genetic and Genomic Curricula?<br />

North<br />

<strong>ASHG</strong> Interactive Workshop:<br />

Moscone Center<br />

Galaxy 101: Data Integration,<br />

SOLD<br />

OUT<br />

Room 304/306, Esplanade<br />

Analysis and Sharing (Separate<br />

registration required.)<br />

Level South<br />

EDUCATION TRACK


32 EDUCATION TRACK<br />

Friday, November 9<br />

*12:45 PM -<br />

2:15 PM<br />

*12:45 PM -<br />

2:15 PM<br />

*7:00 PM -<br />

8:30 PM<br />

*7:00 PM -<br />

9:00 PM<br />

<strong>ASHG</strong> Mock Study Section Workshop<br />

(Advance ticket purchase required.)<br />

<strong>ASHG</strong>/Galaxy Interactive Workshop:<br />

Working with High-Throughput Data<br />

and Data Visualization (Separate<br />

advance registration required.)<br />

<strong>ASHG</strong>/Ensembl Interactive Worshop:<br />

Ensembl Web-Based Genomic Tools<br />

for Intermediate/Advance Users<br />

(Advance ticket purchase required.)<br />

Drama, Discourse and Genomics:<br />

IRBs to IFs—An Interactive Play<br />

(Advance ticket purchase required.)<br />

Saturday, November 10<br />

9:40 AM -<br />

11:40 AM<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Moscone Center<br />

Room 300, Esplanade<br />

Level South<br />

Concurrent Invited Session III (73-80): Moscone Center<br />

77. Centralizing the Deposition and<br />

Curation <strong>of</strong> <strong>Human</strong> Mutations<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

Room 132, Lower Level<br />

North


WEDNESDAY, November 7<br />

8:00 AM -<br />

10:00 AM<br />

10:30 AM -<br />

12:45 PM<br />

*12:45 PM -<br />

2:15 PM<br />

CLINICAL TRACK 33<br />

CLINICAL TRACK CLINICAL TRACK<br />

Concurrent Invited Session I (3-10): Moscone Center<br />

3. Implementing Next-Generation<br />

Sequencing as a Clinical Test<br />

4. Assessing the Pathogenicity <strong>of</strong> Genetic<br />

Variants: Translating in Vitro and in<br />

Silico Advances to the Clinic<br />

10. Metabolism, Metals, and<br />

Neurodegeneration: Toward<br />

Enhanced Understanding <strong>of</strong> Disease<br />

Mechanisms and Rational Therapeutics<br />

Hall D, Lower Level North<br />

Gateway Ballroom 103,<br />

Lower Level South<br />

Room 130, Lower Level<br />

North<br />

Concurrent Platform (abstract-driven) Moscone Center<br />

Session A (11-19):<br />

18. Prenatal and Perinatal <strong>Genetics</strong> Room 130, Lower Level<br />

North<br />

<strong>ASHG</strong> Workshop: Clinical<br />

Interpretation <strong>of</strong> Cytogenomic<br />

Arrays: Tools & Resources<br />

(Advance ticket purchase required.)<br />

THURSDAY, November 8<br />

8:00 AM -<br />

10:00 AM<br />

10:30 AM -<br />

12:45 PM<br />

*12:45 PM -<br />

2:15 PM<br />

Moscone Center<br />

Room 304/306, Esplanade<br />

Level South<br />

Concurrent Invited Session II (21-28): Moscone Center<br />

22. Common and Rare CNVs: Genesis,<br />

Patterns <strong>of</strong> Variations and <strong>Human</strong><br />

Diseases<br />

23. Advancing Gene Therapy to the Clinic:<br />

Molecular Medicines Come <strong>of</strong> Age<br />

25. Genomic Medicine: ELSI Goes<br />

Mainstream<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37):<br />

33. Clinical <strong>Genetics</strong>: Mutations, Mutations<br />

and Syndromes<br />

Hall D, Lower Level North<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

Room 132, Lower Level<br />

North<br />

Moscone Center<br />

Gateway Ballroom 104,<br />

Lower Level South<br />

35. Ethical, Legal, Social and Policy Issues Room 132, Lower Level<br />

North<br />

<strong>ASHG</strong> Workshop: Diagnostic<br />

Challenges: Review and Discussion<br />

<strong>of</strong> Unique Cases, Rare and Unknown<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

Cases (Advance ticket purchase required.)<br />

Moscone Center<br />

Room 303/305, Esplanade<br />

Level South


34 CLINICAL TRACK<br />

4:30 PM -<br />

6:45 PM<br />

Concurrent Platform (abstract-driven) Moscone Center<br />

Session C (38-46):<br />

45. Therapy <strong>of</strong> Genetic Disorders Room 130, Lower Level<br />

North<br />

FRIDAY, November 9<br />

8:00 AM -<br />

10:15 AM<br />

4:30 PM -<br />

6:45 PM<br />

*7:00 PM -<br />

9:00 PM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55):<br />

52. Clinical <strong>Genetics</strong>: Complex<br />

Mechanisms and Exome-Discovery<br />

54. Genetic Counseling and Clinical<br />

Testing<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67):<br />

67. Developmental Insights into <strong>Human</strong><br />

Malformations<br />

Drama, Discourse and Genomics:<br />

IRBs to IFs—An Interactive Play<br />

(Advance ticket purchase required.)<br />

SATURDAY, November 10<br />

9:40 AM -<br />

11:40 AM<br />

Moscone Center<br />

Room 124, Lower Level<br />

North<br />

Room 130, Lower Level<br />

North<br />

Moscone Center<br />

Room 123, Lower Level<br />

North<br />

Moscone Center<br />

Room 300, Esplanade<br />

Level South<br />

Concurrent Invited Session III (73-80): Moscone Center<br />

SOLD<br />

OUT<br />

73. Returning Results from Large-Scale<br />

Sequencing: Where the Rubber Meets<br />

the Road<br />

77. Centralizing the Deposition and<br />

Curation <strong>of</strong> <strong>Human</strong> Mutations<br />

79. Should Noninvasive Prenatal Diagnosis<br />

Augment or Replace Current Prenatal<br />

Screening and Diagnosis?<br />

Gateway Ballroom 103,<br />

Lower Level South<br />

Room 132, Lower Level<br />

North<br />

Room 124, Lower Level<br />

North


floor plans<br />

Moscone Center, 747 Howard Street<br />

Tel: 415-974-4000


floor plans<br />

Marriott Marquis Hotel, 55 Fourth Street<br />

Tel: 415-896-1600<br />

Mission Street<br />

Mission Tunnel<br />

Corridor to<br />

Yerba Buena<br />

Ballroom<br />

Lower B2 Level.<br />

YERBA BUENA BALLROOM<br />

Howard Street<br />

Howard<br />

Street<br />

Loading<br />

Dock<br />

Kitchen<br />

Bake<br />

Shop<br />

Banquet<br />

Office<br />

Assembly<br />

Willow<br />

Walnut<br />

Freight Door 10' x 10.6'<br />

Salon 14<br />

Salon 13<br />

Salon 12<br />

Salon 11<br />

Salon 10<br />

To<br />

Lobby<br />

A<br />

Golden Gate<br />

Registration A<br />

Business<br />

Center<br />

Laurel<br />

Fourth Street<br />

B<br />

Golden Gate<br />

Prefunction Area<br />

Golden Gate<br />

Registration B<br />

Juniper<br />

Yerba Buena Lane<br />

Elevators<br />

Elevators<br />

C3<br />

C2<br />

C1<br />

Shipping<br />

Receiving<br />

Marriott Marquis Hotel, B2 Level<br />

Salon 9 Salon 8 Salon 7<br />

Nob Hill D<br />

Fourth Street<br />

Service Corridor<br />

Yerba Buena<br />

Grand Assembly<br />

Nob Hill C<br />

Nob Hill B<br />

Nob Hill A<br />

Freight<br />

Elevator<br />

Service<br />

Elevator<br />

Fourth Street<br />

Loading Dock<br />

Salon 15 Salon 1<br />

To Golden<br />

Gate Hall<br />

North<br />

Registration<br />

B South A B A<br />

Registration<br />

Yerba Buena Gardens<br />

Marriott Marquis Hotel, Lower B2 Level<br />

Salon 2<br />

Salon 3<br />

Salon 4<br />

Salon 5<br />

Salon 6<br />

Assembly<br />

Elevator


Pacific<br />

(Fourth Floor)<br />

PACIFIC & SIERRA CONFERENCE SUITES<br />

Fourth & Fifth Levels (All conference suites have windows)<br />

F<br />

Pacific<br />

Y<br />

J<br />

Elevator Elevator<br />

Atrium<br />

Full<br />

Service<br />

Health<br />

Club<br />

H<br />

A B C<br />

Marriott Marquis Hotel, Level 3<br />

G<br />

F<br />

E<br />

D<br />

Marriott Marquis Hotel<br />

K<br />

Elevator<br />

J H G<br />

Garden Deck<br />

Pool<br />

Atrium<br />

Whirlpool<br />

A B C<br />

F<br />

E<br />

D<br />

Sierra<br />

(Fifth Floor)<br />

39


Map/HoTEls In asHG<br />

<strong>of</strong>fICIal BloCK<br />

Hotel Questions: <strong>ASHG</strong>’s Official Housing<br />

Bureau: Convention Management Resources:<br />

Tel: 415-979-2272 or 1-800-750-4949. For onsite<br />

questions, visit the Housing Counter located in<br />

the Registration Area, Upper North Lobby.<br />

Marriott Marquis Hotel: 415-896-1600<br />

Courtyard by Marriott: 415-947-0700<br />

Grand Hyatt: 415-398-1234<br />

Hotel nikko: 415-394-1111<br />

Hotel palomar: 415-348-1111<br />

Intercontinental Hotel: 415-616-4500<br />

sir francis Drake Hotel: 415-392-7755<br />

W Hotel: 415-777-5300<br />

Westin Market street Hotel: 415-974-6400


The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />

Hotel Map and Key<br />

Civic Center<br />

BART/Muni<br />

4<br />

7<br />

8 3<br />

5 1<br />

Powell<br />

BART/Muni<br />

1 San Francisco Marriott Marquis<br />

2 Courtyard by Marriott San Francisco Downtown<br />

3 Grand Hyatt San Francisco<br />

4 Hotel Nikko San Francisco<br />

5 Hotel Palomar<br />

6 InterContinental San Francisco<br />

7 Parc 55 Wyndham San Francisco-Union Square<br />

8 Sir Francis Drake Hotel<br />

9 W San Francisco<br />

10 The Westin San Francisco Market Street<br />

BART/Muni Stations<br />

6<br />

Montgomery<br />

BART/Muni<br />

10<br />

Hotel Locator Map<br />

9<br />

Embarcadero<br />

BART/Muni<br />

2<br />

41


Map/san franCIsCo Bay arEa<br />

rapID TransIT (BarT)


San Francisco Bay Area Rapid Transit/BART<br />

43


ABOUT THE MEETING<br />

GENERAL INFORMATION<br />

All events for the 62nd Annual Meeting <strong>of</strong> The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />

will be held at the Moscone Center (Convention Center), unless otherwise indicated.<br />

The Convention Center is located at 747 Howard Street, San Francisco, CA 94103;<br />

Tel: 415-974-4000. Please see page 49 for telephone numbers and hotels in the <strong>ASHG</strong><br />

<strong>of</strong>ficial housing block.<br />

All Annual Meeting details are available on the <strong>ASHG</strong> <strong>2012</strong> Annual Meeting Web site<br />

at www.ashg.org/<strong>2012</strong>meeting. The Web site will serve as the <strong>of</strong>ficial e-publication<br />

<strong>of</strong> the <strong>2012</strong> Annual Meeting.<br />

Abstracts<br />

Abstracts <strong>of</strong> the plenary, platform and poster presentations may be viewed online only<br />

at the <strong>ASHG</strong> meeting Website (www.ashg.org/<strong>2012</strong>meeting). Abstracts will not<br />

be available in print. NOTE: Speakers in the invited sessions are not required to<br />

provide abstracts.<br />

Abstract Search/Itinerary Planner<br />

For your convenience, abstract search/printing stations will be located in the<br />

Registration Area, North Lobby <strong>of</strong> the Convention Center.<br />

Invited Sessions<br />

The <strong>2012</strong> program is highlighted by 24 invited scientific sessions that have been<br />

scheduled over three concurrent time periods: (1) Wednesday, November 7 from 8:00<br />

am until 10:00 am (see page 69); (2) Thursday, November 8, from 8:00 am until 10:00<br />

am (see page 82); and (3) Saturday, November 10, from 9:40 am until 11:40 am (see<br />

page 119).<br />

Plenary Session Presentations (abstract-driven)<br />

The plenary session includes a diverse set <strong>of</strong> six presentations, selected from the toprated<br />

abstracts submitted for this year’s annual meeting as determined by the <strong>2012</strong><br />

<strong>Program</strong> Committee. These six abstracts have been programmed from 4:30 pm until<br />

6:30 pm on Tuesday. Each author will give a 15-minute presentation, with an additional<br />

five minutes for discussion. The first author listed is the presenting author. See page<br />

68 for a complete description <strong>of</strong> this session.<br />

Platform Sessions (abstract-driven)<br />

The <strong>Program</strong> Committee has assembled 45 abstract-driven platform sessions totaling<br />

405 oral presentations. Each presenting author will give a 10-minute talk followed by<br />

five minutes <strong>of</strong> discussion. There are five sets <strong>of</strong> nine concurrent platform sessions<br />

as follows: (1) Wednesday, November 7 from 10:30 am until 12:45 pm (see page 73);<br />

(2) Thursday, November 8 from 10:30 am until 12:45 pm (see page 86); (3) Thursday,<br />

November 8 from 4:30 pm until 6:45 pm (see page 94); (4) Friday, November 9 from<br />

8:00 am until 10:15 am (see page 101); and (5) Friday, November 9 from 4:30 pm until<br />

6:45 pm (see page 110).<br />

45<br />

GENERAL INFORMATION


46 GENERAL INFORMATION<br />

Poster Sessions (abstract-driven)<br />

To encourage scientific discussions and to facilitate the exchange <strong>of</strong> information,<br />

posters are grouped by related topics, keyword (selected by the first author at the<br />

time <strong>of</strong> abstract submission), and alphabetical order by the last name <strong>of</strong> the first<br />

author. The first author listed is the presenting author. The program number and the<br />

abstract/poster board number are one and the same. It appears in bold print followed<br />

by the abstract title and author names. Each number is followed by a W (Wednesday),<br />

or T (Thursday), or F (Friday)to indicate the day on which authors must be present at<br />

their poster board. Each author is expected to be present for one <strong>of</strong> the two hours<br />

during that day. The posters are expected to remain on the boards for all three poster<br />

sessions. See page 125 for poster mounting/removal schedule and presentation<br />

times. Poster listings begin on page 127.<br />

Mobile App<br />

NEW<br />

Download the <strong>ASHG</strong> <strong>2012</strong> Mobile App to your smartphone (iOS, Android,<br />

and Blackberry platforms). The Mobile App gives you the meeting at your<br />

fingertips wherever you go. Once the App has been downloaded, you do not need an<br />

Internet connection to view information. Please refer to the ad on page 422.<br />

Mobile Web Site<br />

Access the <strong>ASHG</strong> <strong>2012</strong> mobile Web site at http://m.ashg.org and bookmark it on<br />

your Web-enabled mobile device so that you have important meeting information<br />

at your fingertips. The mobile Web site is an alternative option for those attendees<br />

that do not have a smartphone. An Internet connection is required when viewing the<br />

mobile Web site.<br />

Social Media<br />

This year, views <strong>of</strong> the meeting attendees will be followed through<br />

<strong>ASHG</strong>’s social media outlets and will be summarized at the closing<br />

session. Attendees are encouraged to post their thoughts on exciting<br />

scientific or clinical advances they have heard about during the meeting,<br />

and on challenges that the field will face, by using hashtag #<strong>ASHG</strong><strong>2012</strong>.<br />

Questions for the closing panelists can also be sent to Chris Gunler via<br />

twitter @girlscientist or our Facebook page, https://www.facebook.<br />

com/<strong>Genetics</strong><strong>Society</strong>. Follow <strong>ASHG</strong> on Twitter: @<strong>Genetics</strong><strong>Society</strong>.<br />

Please refer to the <strong>ASHG</strong> <strong>2012</strong> Annual Meeting Web site under general information<br />

for the do’s and don’ts <strong>of</strong> Social Media. Remember, everything is tweetable unless a<br />

speaker requests otherwise.<br />

Session Tracks<br />

The schedule once again features separate schedules that list sessions <strong>of</strong> relevance<br />

to Trainees, as well as Education and Clinical tracks. Please look for the following<br />

symbols and refer to page 29, 31 and 33 for the schedules.<br />

Indicates Clinical-focused events<br />

Indicates Education-focused events<br />

Indicates Trainee-focused events


REGISTRATION, BADGE AND PROGRAM PICK UP<br />

GENERAL INFORMATION 47<br />

Scientific meeting registration, badge, program, and bag pickup is located in the North<br />

Upper Lobby <strong>of</strong> the Convention Center and is open during the following hours:<br />

Tuesday, November 6 10:00 am – 7:00 pm<br />

Wednesday, November 7 7:00 am – 5:00 pm<br />

Thursday, November 8 7:00 am – 5:00 pm<br />

Friday, November 9 7:30 am – 5:00 pm<br />

Saturday, November 10 7:30 am – 10:30 am<br />

Exhibitor registration is located in the South Lobby. See page 48 for exhibitor registration<br />

hours.<br />

Registration Fees<br />

The registration fee includes entry to all invited scientific sessions, platform sessions,<br />

award presentations, poster sessions, exhibits, and to the opening mixer. The fee<br />

does not include admission to separate ticketed events and does not include meals<br />

or hotel costs. Registration may be paid by cash, check, money order or credit card<br />

(<strong>American</strong> Express, MasterCard or VISA).<br />

Registration fees are shown in U.S. dollars<br />

After September 4 Starting November 6<br />

<strong>ASHG</strong> Member $500 $600<br />

Nonmember $750 $850<br />

Trainee <strong>ASHG</strong> Member 1 $275 $300<br />

Trainee Non-member 1 $475 $525<br />

Developing Country 2 $350 $400<br />

Guest Registration 3 N/A $125<br />

One-day registration is not available.<br />

1 Trainees may register at the trainee rates for the meeting. Postdoctoral fellows and students working<br />

toward a degree in human genetics or an allied field qualify. Trainees will be asked to provide certain<br />

information to determine eligibility. Trainees who register at the meeting should bring a student ID card or a<br />

letter signed by their department or laboratory head to certify trainee/student/fellow status.<br />

2 Developing Country Delegates may register at this rate if they are from a country that is classified by the<br />

World Bank as lower income or lower-middle income. Identification such as a passport is required.<br />

3 Guest registration will be available on-site only for family members or special guests <strong>of</strong> registered<br />

delegates. Guest registration fee is $125 per guest and includes admission to the Opening Mixer and the<br />

Exhibit Hall. The guest registration does not include access to scientific sessions. In order to register as<br />

a guest, you must be accompanied by a paying scientific registrant. Please go to the Registration Help<br />

Counter located in the Registration Area. Guests will be issued different colored badges from scientific<br />

registrants.<br />

GENERAL INFORMATION


48 GENERAL INFORMATION<br />

Registration Receipt<br />

The back <strong>of</strong> your badge is your registration receipt. Please retain this for your records.<br />

Replacement, Lost or Forgotten Badges<br />

A $5 fee will be charged to registrants for each replacement badge requested i.e.,<br />

to replace badges that are left at home or in hotel rooms, lost or forgotten.<br />

Questions should be directed to the Registration Help Counter. Telephone: 415-978-<br />

3607.<br />

MEETING INFORMATION, SERVICES AND OFFICES<br />

<strong>ASHG</strong> Office and Meeting Logistics – Room 111, Lower Level North<br />

Questions about housing, ancillary meetings, audio-visual, on-site logistics, and lost<br />

and found should be directed to this <strong>of</strong>fice. CME and CEU tracking forms are also<br />

available. Telephone: 415-978-3600. The <strong>of</strong>fice hours are as follows:<br />

Tuesday, November 6 10:00 am – 6:00 pm<br />

Wednesday, November 7 7:00 am – 5:00 pm<br />

Thursday, November 8 7:00 am – 5:00 pm<br />

Friday, November 9 7:00 am – 5:00 pm<br />

Saturday, November 10 7:00 am – 12:30 pm<br />

Membership questions should be directed to the <strong>ASHG</strong> Booth at <strong>ASHG</strong> Central inside<br />

the Exhibit Hall.<br />

<strong>ASHG</strong> Central – Exhibit Hall, Lower Level South<br />

Visit <strong>ASHG</strong> Central to address membership questions, view sample publications,<br />

apply for membership, and to find out more about <strong>ASHG</strong>. Also available in <strong>ASHG</strong><br />

Central will be editors <strong>of</strong> the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> ( AJHG). The AJHG<br />

provides a record <strong>of</strong> research and review relating to heredity in humans, the application<br />

<strong>of</strong> genetic principles in medicine and public policy, and related areas <strong>of</strong> molecular and<br />

cell biology, behavioral, molecular, biochemical, population and clinical genetics. Also<br />

available is additional information on the city <strong>of</strong> Boston, Massachusetts, the site <strong>of</strong><br />

<strong>ASHG</strong>’s 2013 Annual Meeting and register to win a gift from the Boston Convention and<br />

Visitor’s Bureau!<br />

<strong>ASHG</strong> Central is located in booth #913, in the very center <strong>of</strong> the Exhibit Hall! It is<br />

open during exhibit hours and will have comfortable seating, charging stations, Wi-Fi<br />

access, and much more! We hope you stop by to see us while visiting the exhibits<br />

and posters. You can also meet <strong>ASHG</strong> <strong>2012</strong> Board and <strong>Program</strong> Committee members<br />

during poster session hours. Make <strong>ASHG</strong> Central your destination for networking,<br />

plugging in, and for all the <strong>ASHG</strong> information you need!


GENERAL INFORMATION 49<br />

Assistance for Attendees<br />

Registrants with questions regarding special needs for auxiliary requirements<br />

(such as hearing assistance/sign language interpretation), housing,<br />

and transportation should contact the <strong>ASHG</strong> <strong>of</strong>fice in advance by e-mailing<br />

ashgmeetings@ashg.org with your specific request. NOTE: It may not be possible to<br />

accommodate last-minute and on-site requests.<br />

For information on accessibility within San Francisco, visit http://www.acessnca.<br />

com. If you have difficulty in walking long distances, you may want to consider renting<br />

a mobile scooter from Scoot Around. For details or reservations, call 888-441-7575<br />

or visit www.scootaround.com. For a list <strong>of</strong> taxi companies that <strong>of</strong>fer ramp access,<br />

see page 54.<br />

Attire/Dress Code<br />

Attire for the meeting is business casual. Remember to dress in layers and wear<br />

comfortable walking shoes. You may want to carry a small umbrella as San Francisco<br />

can <strong>of</strong>ten have rain showers in November.<br />

Business Center – Lower Level South<br />

The Convention Center has a full-service business center for your convenience. It will<br />

be open from Tuesday through Friday. Hours will be posted outside the entrance. The<br />

business center will provide an array <strong>of</strong> services including copying, printing, faxing,<br />

Internet access, shipping, and <strong>of</strong>fice supplies. Please refer to page 51 for information<br />

on Internet and Wi-Fi access.<br />

Career/Employment Opportunities – Exhibit Hall, Lower Level South<br />

The <strong>ASHG</strong>/FASEB Career Center will operate Wednesday through Friday inside the<br />

Exhibit Hall during exhibit hours. Job seekers and employers should submit their<br />

résumés/job descriptions on 8½” x 11” paper to the <strong>ASHG</strong>/FASEB Career Center<br />

staff for posting on the employment poster boards inside the Exhibit Hall. Employers<br />

may also e-mail job descriptions to careers@faseb.org. Visit the FASEB/Career<br />

Resources Web site at http://careers.faseb.org for details.<br />

Cell Phone/Camera/Recording Policy<br />

Attendees are strictly prohibited from using cameras and all other recording<br />

devices in all meeting session rooms, on the Exhibit Hall floor, and in all poster/<br />

oral presentations. This means that attendees are not permitted to take pictures or<br />

videos <strong>of</strong> speaker slides, posters or exhibit booths. Attendees not adhering to this<br />

policy may be asked to leave the room and will be asked to delete all pictures or<br />

videos already taken, and further action may be taken with repeated or egregious<br />

<strong>of</strong>fenders. When registering, you agreed to adhere to this policy. Please remember to<br />

turn <strong>of</strong>f or place on silent cell phones or other devices before entering meeting rooms.<br />

CMEs and CEUs<br />

Please refer to page 325 for information. Tracking forms are located at the <strong>ASHG</strong><br />

Information Counter in the North Lobby, at <strong>ASHG</strong> Central inside the Exhibit Hall and<br />

at the <strong>Society</strong> Office, Room 111.<br />

GENERAL INFORMATION


50 GENERAL INFORMATION<br />

Exhibits – Exhibit Hall, Lower Level South<br />

Exhibits will be open daily on Wednesday, Thursday and Friday from 10:00 am until<br />

4:30 pm. The Exhibit Hall features hundreds <strong>of</strong> companies from around the world<br />

showing their latest products and services. More information on who is exhibiting can<br />

be found either through an alphabetical listing <strong>of</strong> companies with descriptions starting<br />

on page 269 or a listing by products and services where companies may be located<br />

by keyword beginning on page 299. Your barcoded badge will allow you to enter<br />

contests and request additional information from companies in the Exhibit Hall. For<br />

additional information on other features in the Exhibit Hall, please see page 267.<br />

NOTE: Children under the age <strong>of</strong> 18 may be admitted into the Exhibit Hall only if they<br />

are accompanied by a paid scientific registrant.<br />

Exhibit Registration and Exhibit Management – South Upper Lobby<br />

The Exhibit Management Office and Exhibit Registration are located in the South<br />

Lobby. Exhibitor Registration hours are as follows:<br />

Tuesday, November 6 8:00 am – 5:00 pm<br />

Wednesday, November 7 8:00 am – 4:30 pm<br />

Thursday, November 8 8:00 am – 4:30 pm<br />

Friday, November 9 8:00 am – 4:30 pm<br />

Family/Nursing Mothers Room – Room 203, East Mezzanine Level South<br />

The family room is open during registration hours. The purpose <strong>of</strong> the room is to<br />

give parents and children a place to relax during the convention. Attendees are not<br />

permitted to use this room for babysitting services. Room 218 has also been set aside<br />

for nursing mothers to have privacy.<br />

First Aid – Lower Level (North and South)<br />

There are two locations for first aid rooms. The first is located outside Hall D in the<br />

North building, telephone 415-974-4096 and the second is located outside Hall C<br />

in the South building, telephone 415-974-4090. The First Aid Room is staffed Monday<br />

through Saturday by trained personnel able to handle various medical problems and<br />

emergencies that might arise. If you are witness to a medical emergency inside the<br />

Convention Center, please dial 511 from any house phone, or 415-974-4021 from<br />

your mobile device. The number to call for emergencies outside <strong>of</strong> the Convention<br />

Center is 911.<br />

Food Service – Exhibit Hall, Lower Level<br />

Food concessions will be open in the Exhibit Hall (Wednesday through Friday) during<br />

exhibit and poster hours. Portable food stands will also be available in various areas<br />

throughout the Convention Center, Wednesday through Saturday. The concession<br />

stands will <strong>of</strong>fer a variety <strong>of</strong> “grab and go” foods. Hours will be posted on-site. <strong>ASHG</strong><br />

will provide c<strong>of</strong>fee service each morning outside session rooms and will provide light<br />

lunch refreshments inside the Exhibit Hall during the lunch period on Wednesday,<br />

Thursday and Friday.


GENERAL INFORMATION 51<br />

Housing/Hotels – North Upper Lobby<br />

See page 41 for the hotel locator map. For housing inquiries, visit the housing counter<br />

located in the registration area (Tuesday through Friday). Hours will be posted at the<br />

counter. The on-site telephone number is 415-978-3609. You may also contact the<br />

<strong>of</strong>ficial <strong>ASHG</strong> <strong>2012</strong> Housing Bureau: Telephone: 415-979-2272 or 1800-750-4949;<br />

e-mail ashghousing@cmrus.com. Below is a list <strong>of</strong> <strong>of</strong>ficial <strong>ASHG</strong> hotels.<br />

Marriott Marquis Hotel (Headquarter): 415-896-1600<br />

Courtyard by Marriott: 415-947-0700<br />

Grand Hyatt: 415-398-1234<br />

Hotel Nikko: 415-394-1111<br />

Hotel Palomar: 415-348-1111<br />

Intercontinental Hotel: 415-616-4500<br />

Sir Francis Drake Hotel: 415-392-7755<br />

W Hotel: 415-777-5300<br />

Westin Market Street Hotel: 415-974-6400<br />

We suggest you put the number <strong>of</strong> the hotel you are staying at into your mobile<br />

device/cell phone.<br />

Information – North Upper Lobby<br />

The information counter will be open during registration hours (see page 47).<br />

Telephone: 415-978-3606. Please stop by the information counter to pick up CME<br />

and CEU tracking forms.<br />

Internet (Wi-Fi) Access and Cyber Café<br />

Complimentary Wi-Fi (supported by Genzyme) is available in all public lobbies and<br />

meeting space <strong>of</strong> the Moscone Center. The service is not available inside the Exhibit<br />

Hall and Posters. Attendees who wish to use the Wi-Fi service should bring their own<br />

laptop or PDA with a wireless 802.11/g network card installed. To access this service,<br />

open your browser and set the SSID (wireless network identified) to <strong>ASHG</strong><strong>2012</strong>. You<br />

will need to set your network card to use DHCP. Open a web browser and click the login<br />

button to continue. Technical support will not be provided at the meeting. Remember<br />

to consider the security implications <strong>of</strong> using the wireless network and protect your<br />

laptop accordingly. The Cyber Café is located in the North Building, Lower Concourse<br />

Level and is open during registration hours. Attendees are asked to limit their time to<br />

15 minutes per visit.<br />

Luggage Storage and Coat Check – South Upper Lobby<br />

Facilities for luggage storage and coat check are available Wednesday through<br />

Saturday. This service is complimentary. Please do not take luggage into the session<br />

rooms. All items must be checked in and checked out on the same day. Items should<br />

not be left overnight.<br />

Message Center/Literature Area – South Building, Lower Level<br />

Leaving messages at the message center is the best way to contact another attendee for<br />

whom you do not have more direct contact information. Please note that it is not possible<br />

to page an attendee. Attendees can post fliers advertising social events or upcoming<br />

meetings. Exhibitors are not permitted to display materials in the literature area.<br />

GENERAL INFORMATION


52 GENERAL INFORMATION<br />

Parking<br />

The Convention Center does not have on-site parking. However, there are many parking<br />

garages nearby. View the Convention Center’s parking map at www.moscone.com<br />

to find a nearby parking garage. You can also visit the SFMTA Web site at<br />

www.sfmta.com for information on parking around the city.<br />

Prayer Room – Room 266, West Mezzanine Level South<br />

This room has been set aside for prayer and meditation and will be open during<br />

registration hours.<br />

Press Office – Room 113, Lower Level North<br />

Journalists should go directly to Room 113 to receive a press badge, program<br />

schedule, news releases and other media materials. The Press Office is open T uesday<br />

through Saturday only for registered journalists. For more information about press<br />

registration procedures, policies/guidelines and on-site media events at the <strong>2012</strong><br />

meeting, please contact Cathy Yarbrough at press@ashg.org.<br />

Registration Management/Registration Help Desk – North Upper Lobby<br />

Questions regarding registration should be directed to the Registration Help Desk.<br />

See registration hours listed on page 47. Telephone: 415-978-3607.<br />

Restaurant/City Information/Tours and Activities<br />

San Francisco Travel will provide city information at the permanent counter located in<br />

the South Upper Lobby. City maps and brochures on local attractions are available<br />

in this area.<br />

Not sure where to dine in San Francisco? Contact RESERVATIONS TONIGHT! at<br />

www.reservationstonight.com or call them toll free in the U.S. at 800-392-DINE (3463).<br />

Outside the U.S. call 707-795-4885. Assistance will be available at the Restaurant<br />

Reservations counter located in the Registration Area <strong>of</strong> the North Upper Lobby as<br />

follows:<br />

Wednesday 10:00 am – 5:00 pm<br />

Thursday 10:00 am – 5:00 pm<br />

Friday 10:00 am – 5:00 pm<br />

Speaker-Ready/Presentation Upload Room – Room 110, Lower Level North<br />

The Speaker-Ready/Presentation Upload Room will be open daily as follows:<br />

Tuesday 11:00 am – 4:30 pm<br />

Wednesday 7:00 am – 5:00 pm<br />

Thursday 7:00 am – 5:00 pm<br />

Friday 7:00 am – 5:00 pm<br />

Saturday 7:00 am – 11:00 am<br />

All speakers are required to upload their presentation in advance <strong>of</strong> the session.<br />

We encourage you to do this at least 4 hours before the start <strong>of</strong> your presentation<br />

time. Speakers are not permitted to take their laptop to the lectern for use during<br />

their presentation. On the day <strong>of</strong> presentation, speakers should arrive at the session<br />

room and check in with the audio-visual technicians and moderator about one-half<br />

hour before the scheduled start <strong>of</strong> the session. For speaker questions, please e-mail<br />

the <strong>ASHG</strong> Meeting Management Office at ashgmeetings@ashg.org.


GENERAL INFORMATION 53<br />

A speaker/author index begins on page 333. Names <strong>of</strong> all speakers, presenting authors<br />

and co-authors are listed followed by their session or abstract number(s).<br />

Speaker Conflict <strong>of</strong> Interest: Beginning on page 329 is an alphabetical list <strong>of</strong> invited<br />

session speakers and authors <strong>of</strong> abstracts who have disclosed the existence <strong>of</strong><br />

significant financial interest or other relationships the presenter has with companies or<br />

organizations that may be perceived to bias the presentation. This information allows<br />

the listener/attendee to be fully knowledgeable in evaluating the presentation, and<br />

is required to meet CME and CEU requirements. All speakers will have a conflict <strong>of</strong><br />

interest slide automatically inserted into their presentation. For speakers that indicated<br />

a conflict, the disclosure information you completed during your abstract submission<br />

or completion <strong>of</strong> the online conflict <strong>of</strong> interest form will automatically be used.<br />

Telephone Numbers for <strong>ASHG</strong> On-Site Offices<br />

All <strong>of</strong>fices are located at the Convention Center<br />

<strong>ASHG</strong> Office and Meeting Management, Room 111: 415-978-3600<br />

Exhibitor Registration and Management, South Upper Lobby: 415-978-3605<br />

Convention Center, Moscone Center Main Number: 415-974-4000<br />

First Aid, Moscone North, Lower Level: 415-974-4096<br />

First Aid, Moscone South, Lower Level: 415-974-4090<br />

Housing Counter, North Upper Lobby: 415-978-3609<br />

Information Counter, North Upper Lobby: 415-978-3606<br />

Message Counter, North Upper Lobby: 415-978-3606<br />

Press Office, Room 113: 415-9783614<br />

Registration Help Counter, North Upper Lobby: 415-978-3607<br />

Restaurant Reservations Counter, North Upper Lobby: 415-978-3621<br />

Security (<strong>ASHG</strong> Show Management): 415-978-3620<br />

Security (Convention Center): dial ‘511’ from any house phone<br />

Emergency/Police/Fire: dial ‘511’ from any house phone<br />

Non-emergency: dial ‘4021’ from any house phone<br />

Travel and Visitor Information<br />

San Francisco is famous for its scenic beauty, cultural attractions, diverse communities,<br />

and world-class cuisine. San Francisco’s landmarks include the Golden Gate Bridge,<br />

cable cars, Fisherman’s Wharf, Alcatraz, Chinatown, Union Square, and North Beach.<br />

The San Francisco Travel Visitors Center is located at 900 Market Street (on the<br />

lower level <strong>of</strong> Hallidie Plaza, next to the cable car turn table at Powell and Market<br />

Streets) and is open Monday through Friday from 9:00 am to 5:00 pm.<br />

Tax: Sales tax: 9.5%; Hotel tax: 15% occupancy tax, 1.5% tourism fee and $0.25<br />

commerce fee<br />

Temperature: Average high in November is 64°F or 18°C and average low is 51°F or<br />

10°C; average rain fall is 3 inches (80mm). The golden rule when packing for a trip to<br />

San Francisco is to wear layers! Fog can roll in at any time, and areas near the water<br />

can feel cool.<br />

GENERAL INFORMATION


54 GENERAL INFORMATION<br />

Tipping <strong>Guide</strong>lines: Tipping is expected in the U.S. Below are some guidelines to follow:<br />

• Waiters usually receive 15–20% <strong>of</strong> the bill. In some cases, the tip is automatically<br />

added to your bill. You should always check before adding a gratuity.<br />

• Maids usually receive $1-$2 per room per day. You should leave the tip daily<br />

and not at the end <strong>of</strong> your stay.<br />

• Taxi drivers usually receive 15% <strong>of</strong> the fare.<br />

• Doormen, Skycaps, and porters usually receive $1/bag<br />

Transportation/Getting Around<br />

Bay Area Rapid Transit (BART): BART is the fast, easy, inexpensive way to get to<br />

downtown San Francisco and around the Bay Area. BART operates five routes with<br />

service to 43 stations, including stops at SFO and OAK airports. The closest stations to<br />

<strong>ASHG</strong> <strong>of</strong>ficial hotels are the Powell Street station and the Montgomery Street station.<br />

Visit www.bart.gov for further information and station listings. See Map on page 43.<br />

Cable Cars and Historic Street Cars (operated by MUNI): San Francisco’s vintage<br />

electric streetcars run along the F-line. Stops can be found every few blocks on Market<br />

Street and The Embarcadero between the Castro District and Fisheman’s Wharf (<strong>of</strong>ten<br />

near glass bus stop shelters). The cable streetcars run along Powell Street to Hyde<br />

or Mason. The California street line goes from California and Market to California and<br />

Van Ness (a less crowded option)! If you are unsure what the difference is between<br />

cable cars and streetcars, remember: a street car has a trolley pole connected to an<br />

overhead wire, while a cable car runs on street rails and has no overhead wires.<br />

Parking: View the Convention Center’s parking map at www.moscone.com to find a<br />

nearby parking garage. You can also visit the SFMTA Web site at www.sfmta.com for<br />

information on parking around the city.<br />

San Francisco Municipal Railway (MUNI): MUNI provides transit within the city and<br />

county <strong>of</strong> San Francisco 24 hours a day, seven days a week. You can buy a Visitor<br />

Pass for unlimited rides on MUNI, including cable cars (good for three or seven<br />

consecutive days).<br />

Taxis: Using taxis is a great way to get around quickly. San Francisco can be<br />

challenging with its steep hills and attractions scattered around the city. The average<br />

price for a taxi from the airport is between $40 and $45, plus 15% tip. Regardless <strong>of</strong><br />

what taxi company you select, rates are set for all companies by the San Francisco<br />

Municipal Transportation Agency (SFMTA). Below are some taxi companies that<br />

operate in downtown San Francisco. These companies <strong>of</strong>fer ramped mini vans for<br />

those in wheelchairs or with scooters, advance reservations required:<br />

Checker 415-206-1900<br />

DeSoto 415-970-1300<br />

Luxor 415-282-4141<br />

Regents 415-487-1004<br />

Town Taxi 415-401-8900<br />

Yellow 415-626-2345<br />

Walking: San Francisco is a great city to walk and explore the unique neighborhoods.<br />

All hotels in the <strong>ASHG</strong> hotel block are within a short walk <strong>of</strong> the Convention Center.


DAILY MEETING HIGHLIGHTS 55<br />

DAILY MEETING HIGHLIGHTS AND WORKSHOPS<br />

Tuesday, November 6<br />

Undergraduate Faculty <strong>Genetics</strong> Education Workshop<br />

8:00 am – 3:00 pm, Room 300, Esplanade Level South<br />

This session for undergraduate faculty, organized by the <strong>ASHG</strong> Undergraduate<br />

Subcommittee, covers human genetics content and pedagogies. The goal is to<br />

encourage effective teaching <strong>of</strong> human genetics so that it contributes to improving<br />

the genetic literacy <strong>of</strong> students. Breakfast and lunch will be served. For further<br />

information, contact Katherine Lontok at klontok@ashg.org. The registration fee is<br />

not refundable. Separate advance registration required.<br />

High School Workshop for San Francisco Students and Teachers<br />

8:30 am – 2:30 pm, Room 303/305, Esplanade Level South<br />

The High School Workshop is organized by the <strong>ASHG</strong> Information and Education<br />

Committee. Students and teachers will interact with genetics researchers and learn<br />

about the field <strong>of</strong> human genetics. The workshop will include several inquiry-oriented<br />

genetics lessons on newborn screening, DNA forensics, epigenetics, complex traits,<br />

family history, and malaria/population genetics.<br />

Presidential Address<br />

4:00 pm – 4:30 pm, Hall D, Lower Level North<br />

The Presidential Address, entitled “The Scientist as a Citizen <strong>of</strong> the World” will be<br />

presented by Mary-Claire King. See page 68 for a description <strong>of</strong> this session. This<br />

session will be available for viewing live on the <strong>ASHG</strong> <strong>2012</strong> Meeting Web site at<br />

www.ashg.org/<strong>2012</strong>meeting.<br />

Plenary Abstract Presentations<br />

4:30 pm – 6:30 pm, Hall D, Lower Level North<br />

Six authors will present in this session. Each author will give a 15-minute presentation,<br />

with an additional five minutes for discussion. See page 68 for a description <strong>of</strong> this<br />

session.<br />

Opening Mixer and Trainee Mixer-within-a-Mixer<br />

7:00 pm – 8:30 pm, San Francisco Marriott Marquis Hotel, Yerba Buena 7, Lower<br />

B2 Level<br />

The opening mixer is open to all scientific registrants and registered guests. The<br />

mixer <strong>of</strong>fers a relaxed atmosphere in which attendees can become acquainted and<br />

reacquainted with colleagues. Light snacks, refreshments and a cash bar will be<br />

<strong>of</strong>fered.<br />

Trainees should look for the designated area. Trainees will receive one complimentary<br />

beverage ticket, which will be printed on trainee badges. Please<br />

remember to bring this ticket with you.<br />

For those interested in knowing the results <strong>of</strong> the U.S. general election, large screens<br />

airing the results will be located inside the Opening Mixer Ballroom after the conclusion<br />

<strong>of</strong> the plenary session.<br />

DAILY MEETING HIGHLIGHTS


56 DAILY MEETING HIGHLIGHTS<br />

Wednesday, November 7<br />

Trainee-Mentor Luncheon<br />

12:45 pm – 2:15 pm, Room 303/305, Esplanade Level South<br />

The Trainee-Mentor Luncheon is a wonderful opportunity for trainees (graduate<br />

students, postdoctoral fellows and clinical fellows) in the field <strong>of</strong> human genetics to<br />

meet and talk informally with senior members <strong>of</strong> the <strong>Society</strong> about career options,<br />

goals, and pr<strong>of</strong>essional opportunities. The luncheon is held on the first day <strong>of</strong> the<br />

meeting so that students can continue their discussions with these mentors at other<br />

times during the course <strong>of</strong> the meeting. Lunch will be served. Please see the <strong>ASHG</strong><br />

Meeting Web site (under workshops) for a list <strong>of</strong> mentors. Tickets are non-refundable.<br />

Separate advance registration required and admission is by advance ticket purchase<br />

only.<br />

Discovering Biological Data at NCBI<br />

12:45 pm–2:15 pm, Room 307, Esplanade Level South<br />

Peter Cooper from the National Center for Biotechnology Information (NCBI) will<br />

present this workshop, which will provide both general strategies for finding data at<br />

the NCBI and an introduction to various tools for visualizing and analyzing sequence<br />

data. This workshop will give a basic introduction to using the Entrez system performing<br />

searches, and finding data on human genes. Specific tasks covered include finding<br />

reference sequences, mapping variations, identifying homologous genes, exploring<br />

expression studies, and using My NCBI to save searches and manage data. Tickets are<br />

non-refundable. Separate advance registration required and admission is by advance<br />

ticket purchase only.<br />

Workshop requirements: Registrants must bring a laptop to this session in order to<br />

participate. Laptops should have full battery power and must have a wireless card.<br />

Clinical Interpretation <strong>of</strong> Cytogenomic Arrays: Tools and Resources<br />

12:45 pm – 2:15 pm, Room 304/306, Esplanade Level South<br />

Darrel Waggoner, University <strong>of</strong> Chicago, and Christa Lese Martin, Emory University,<br />

will present this workshop, which is geared for clinical geneticists and residents,<br />

genetic counselors and genetic counseling students, laboratory directors, laboratory<br />

training fellows, and other laboratory personnel. This interactive session will cover<br />

basic information about the differences between the various array platforms and will<br />

discuss strategies for choosing the appropriate platform for your patients, including<br />

issues related to repeating arrays utilizing different platforms. Tickets are nonrefundable.<br />

Separate advance registration required and admission is by advance ticket<br />

purchase only.<br />

Workshop requirements: Registrants must bring a laptop to this session in order to<br />

participate. Laptops should have full battery power and must have a wireless card.<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT


DAILY MEETING HIGHLIGHTS 57<br />

Presidential Symposium<br />

4:30 pm – 6:30 pm, Hall D, Lower Level North<br />

This symposium, organized by Mary-Claire King and entitled “Gene Discovery and<br />

Patent Law: Present Experience in the U.S. and in Europe,” will explore the present<br />

extraordinary pace <strong>of</strong> gene discovery, the question <strong>of</strong> who, if anyone, owns newly discovered<br />

genes will be critical to research and practice in human genetics. This issue<br />

has been before the U.S. Supreme Court and remanded to the Federal District Court<br />

<strong>of</strong> Appeals as Association for Molecular Pathology et al. v. Myriad <strong>Genetics</strong>. In order<br />

to understand the legal issues represented by this case, the role <strong>of</strong> this case in the<br />

larger context <strong>of</strong> legal issues in genetics, and the consequences <strong>of</strong> the decision on<br />

this case for research and services in human genetics, a panel <strong>of</strong> experts will discuss<br />

and educate us on this issue. See page 81 for a list <strong>of</strong> panelists and for a detailed<br />

description <strong>of</strong> this session.<br />

UCSC Genome Browser Interactive Workshop for<br />

Intermediate/ Advanced Users<br />

7:00 pm – 8:30 pm, Room 304/306, Esplanade Level South<br />

Robert Kuhn and Pauline Fujita, University <strong>of</strong> California, Santa Cruz, will present this<br />

interactive workshop on Web-based genomic tools. The workshop will demonstrate<br />

the use <strong>of</strong> Table Browser to access more than five terabytes <strong>of</strong> genomic data in the<br />

UCSC database. Methods for intersecting data between linked tables and filtering<br />

data to access specific subsets <strong>of</strong> large datasets will be covered. Automated program<br />

driven querying <strong>of</strong> data in the public MySQL database will also be demonstrated.<br />

Tickets are non-refundable. Separate advance registration required and admission<br />

is by advance ticket purchase only.<br />

Workshop requirements: Registrants must bring a laptop to this session in order to<br />

participate. Laptops should have full battery power and must have a wireless card.<br />

Social Media + Scientists = Success: Strategies for Using Social<br />

Media to Benefit Your Research, Your Career, and Your Connections<br />

7:00 pm – 8:30 pm, Room 310, Esplanade Level South<br />

This workshop, which is moderated by Jonathan Gitlin, NHGRI, will involve short presentations<br />

from panelists who have extensive experience using social media, followed<br />

by a highly interactive discussion with the audience. The panelists are drawn from<br />

a cross-section <strong>of</strong> the genomics community and include an early-stage researcher<br />

(Daniel MacArthur, Harvard University), a senior faculty investigator and <strong>2012</strong> <strong>Program</strong><br />

Committee Member/former editor for Nature (Chris Gunter, Hudson Alpha), and an<br />

industry representative in the commercial sector (Shirley Wu, 23andMe). The session<br />

will feature a brief “Social Media 101” tutorial and attendees will leave the workshop<br />

armed with knowledge about effective ways to use social media in the context <strong>of</strong> their<br />

genetics/genomics work. Tickets are non-refundable. Separate advance registration<br />

required and admission is by advance ticket purchase only.<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT<br />

DAILY MEETING HIGHLIGHTS


58 DAILY MEETING HIGHLIGHTS<br />

Thursday, November 8<br />

Diagnostic Challenges: Review and Discussion <strong>of</strong> Unique Cases<br />

(Rare and Unknown)<br />

12:45 pm – 2:15 pm, Room 303/305, Esplanade Level South<br />

This event is organized and moderated by Karen W. Gripp, A. I. duPont Hospital for<br />

Children, and Pedro Sanchez, Children’s Hospital Los Angeles/University <strong>of</strong> Southern<br />

California. The session provides an opportunity for registrants to present cases (rare<br />

and unknown) to a panel <strong>of</strong> expert clinical geneticists (see below) for discussion <strong>of</strong><br />

differential diagnosis, treatment and counseling options. The session provides a lively<br />

give-and-take discussion in an informal environment between the audience and the<br />

panel as each case is presented. Audience participation in suggesting diagnosis or<br />

testing is encouraged.<br />

Panelist Area <strong>of</strong> special interest<br />

Margaret Adam Dysmorphology/Teratology<br />

Cynthia Curry Dysmorphology<br />

Bill Dobyns Brain Malformation<br />

Dian Donnai Dysmorphology<br />

Karen Gripp Rasopathies/Dysmorphology<br />

Julie Hoover-Fong Skeletal Dysplasia<br />

Micheil Innes Dysmorphology<br />

Marilyn Jones Crani<strong>of</strong>acial Anomalies<br />

Stephen Kahler Metabolic Disorders<br />

Pedro Sanchez LDDB, Possum Database<br />

Anne Slavotinek Eye Malformation/Diaphragmatic Hernia<br />

Andrea Superti-Furga Skeletal Dysplasia<br />

Alain Verloes Dysmorphology<br />

Each case will be presented using PowerPoint, with a limit <strong>of</strong> six slides and three<br />

minutes per presentation. Best suited are “visuals” with plenty <strong>of</strong> images. Any slides<br />

depicting patient information or images must have the consent <strong>of</strong> the patient.<br />

It is each presenter’s responsibility to obtain consent prior to sharing identifiable<br />

information. The discussion by the expert panel will follow the presentation.<br />

Discussion will be limited to five minutes. Tickets are non-refundable. Separate<br />

advance registration required and admission is by advance ticket purchase only.<br />

Galaxy 101: Data Integration, Analysis and Sharing SOLD<br />

OUT<br />

7:00 pm – 8:30 pm, Room 304/306, Esplanade Level South<br />

Jennifer Hillman-Jackson, Penn State, and Jeremy Goecks, Emory University, will<br />

present this workshop which is an introduction to Galaxy’s basic functionality as an<br />

analysis and data integration framework for accessible, reproducible, and transparent<br />

biomedical research. In this workshop, participants will learn how to use the Galaxy<br />

Web server (http://usegalaxy.org/) to integrate and analyze biomedical data, including<br />

how to (1) load and integrate your own data with data from popular online resources;<br />

(2) perform common analysis/operations on genomic data; and (3) save, share, describe<br />

and publish your analysis and generated datasets. Tickets are non-refundable. Separate<br />

advance registration required and admission is by advance ticket purchase only.<br />

SOLD<br />

OUT


DAILY MEETING HIGHLIGHTS 59<br />

Workshop requirements: Registrants must bring a laptop to this session in order to<br />

participate. Laptops should have full battery power and must have a wireless card.<br />

Trainee Development <strong>Program</strong> and Networking Session<br />

7:00 pm – 9:30 pm, Room 309, Esplanade Level South<br />

This event is organized by the <strong>ASHG</strong> Pr<strong>of</strong>essional Development Committee, and will be<br />

led by Derek Scholes, NHGRI, and Tyrone Spady, FASEB. This year’s program will focus<br />

on science and public policy: Why should scientists care about and become active in<br />

public policy involving science? Consider the effect <strong>of</strong> policy on research and funding,<br />

education/training, and career development. Come take part in a discussion and see how<br />

you might engage with policy in ways that advance research, medicine, education, etc.<br />

A networking session follows the formal program. Tickets are non-refundable. Separate<br />

advance registration required and admission is by advance ticket purchase only.<br />

Friday, November 9<br />

Gruber <strong>Genetics</strong> Prize Presentation and Lecture/Rosalind Franklin Award<br />

Announcement<br />

10:30 am – 11:15 am, Hall D, Lower Level North<br />

The Gruber <strong>Genetics</strong> Prize honors scientists for distinguished contributions in any<br />

realm <strong>of</strong> genetic research. Dr. Douglas Wallace, Children’s Hospital <strong>of</strong> Philadelphia,<br />

will be presented with the <strong>2012</strong> Gruber <strong>Genetics</strong> Prize. An acceptance lecture is<br />

scheduled. The Rosalind Franklin Award winners will also be announced. See page<br />

107 for a description <strong>of</strong> this session and a list <strong>of</strong> past winners.<br />

William Allan Award: Presentation and Lecture<br />

11:15 am – 11:45 am, Hall D, Lower Level North<br />

The William Allan Award is presented annually to recognize substantial and far-reaching<br />

scientific contributions to human genetics, carried out over a sustained period <strong>of</strong><br />

scientific inquiry and productivity. Dr. Uta Francke, Stanford University, will be<br />

presented with the <strong>2012</strong> William Allan Award. An acceptance lecture is scheduled.<br />

See page 108 for a description <strong>of</strong> this session and a list <strong>of</strong> past winners.<br />

<strong>ASHG</strong> Membership/Business Meeting<br />

11:45 am – 12:45 pm, Hall D, Lower Level North<br />

Reports highlighting current <strong>Society</strong> business will be presented. This is an opportunity<br />

for members to learn about recent <strong>ASHG</strong> activities and to provide suggestions to<br />

leaders. There will be a moment <strong>of</strong> silence for those members and colleagues we have<br />

lost in <strong>2012</strong>. Discussion from the floor is encouraged.<br />

Mock Study Section Workshop<br />

12:45 pm – 2:15 pm, Room 303/305, Esplanade Level South<br />

Ron Adkins and Barbara Thomas, from NIH’s Center for Scientific Review, will lead<br />

the session. Did you ever wonder what really happens in study section meetings and<br />

how proposals get discussed? In this workshop, attendees will have the opportunity to<br />

work with NIH staff to learn about the proposal review process, including the typical<br />

dynamics <strong>of</strong> study section deliberations. The NIH streamlining process will be demonstrated,<br />

and the workshop will present examples <strong>of</strong> mistakes applicants commonly<br />

make. Tickets are non-refundable. Separate advance registration required and admission<br />

by advance ticket purchase only.<br />

SOLD<br />

OUT<br />

DAILY MEETING HIGHLIGHTS


60 DAILY MEETING HIGHLIGHTS<br />

Galaxy Advanced Users Workshop: Working with<br />

High-Throughput Data & Data Visualization<br />

12:45 pm – 2:15 pm, Room 304/306, Esplanade Level South<br />

Jennifer Hillman-Jackson, Penn State, and Jeremy Goecks, Emory University, will<br />

present this advanced level interactive workshop on the Galaxy tools. This workshop<br />

builds on the Galaxy 101 workshop, and basic knowledge <strong>of</strong> Galaxy will be helpful.<br />

Galaxy supports integration <strong>of</strong> data from multiple sources, including user-uploaded<br />

data and popular online resources, such as UCSC, BioMart and InterMine as well<br />

as complex bioinformatics analysis. You will learn to use the free public Galaxy Web<br />

server (http://usegalaxy.org/) to analyze NGS data, Galaxy’s visual analytics to iteratively<br />

guide analysis, etc. Tickets are non-refundable. Separate advance registration<br />

required and admission by advance ticket purchase only.<br />

Workshop requirements: Registrants must bring a laptop to this session in order to<br />

participate. Laptops should have full battery power and must have a wireless card.<br />

Ensembl Browser Interactive Workshop for<br />

Intermediate/Advanced Users<br />

7:00 pm – 8:30 pm, Room 304/306, Esplanade Level South<br />

Paul Flicek, Giulietta M. Spudich, and Bert Overduin from the European Bioinformatics<br />

Institute, will lead an interactive workshop on the Ensembl genomic tools<br />

(www.ensembl.org), introducing highlights and new ways <strong>of</strong> integrating information<br />

in the genome browser and analysis <strong>of</strong> variation data. Gene regulation tracks based<br />

on integrated analysis <strong>of</strong> ENCODE and human epigenome data will be explored and<br />

the presenters will also provide some pointers on accessing Ensembl through the<br />

MySQL and Perl APIs. Ensembl provides an infrastructure for genomic information for<br />

over 60 species, from storage to analysis and visualization. The workshop is tailored<br />

to intermediate/advanced users. Tickets are non-refundable. Separate advance registration<br />

required and admission is by advance ticket purchase only.<br />

Workshop requirements: Registrants must bring a laptop to this session in order to<br />

participate. Laptops should have full battery power and must have a wireless card.<br />

An Interactive Play: Drama, Discourse and Genomics: SOLD<br />

OUT<br />

From IRBs to IFs<br />

7:00 pm – 9:00 pm, Room 300, Esplanade Level South<br />

This interactive session weaves audience participation with the premiere <strong>of</strong> an<br />

original new vignette-play that illuminates ethical, psychological, social, legal, and<br />

policy concerns surrounding the sharing <strong>of</strong> information generated by next-generation<br />

sequencing. Between each act <strong>of</strong> the fictionalized play, audience and actors are engaged<br />

in discussion, as the vignettes evolve—from an Institutional Review Board (IRB)<br />

meeting through the informed consent process to the disclosure <strong>of</strong> incidental findings<br />

(IFs). The presenters, Lynn Bush and Karen Rothenberg, delve into controversial ethical<br />

issues and the dramatization is intended to foster a deeper appreciation for potential<br />

conflicts when disclosing genomic information. Tickets are non-refundable.<br />

Separate advance registration required and admission by advance ticket purchase only.<br />

SOLD<br />

OUT<br />

SOLD<br />

OUT


DAILY MEETING HIGHLIGHTS 61<br />

Saturday, November 10<br />

Award for Excellence in <strong>Human</strong> <strong>Genetics</strong> Education: Presentation and Lecture<br />

8:00 am – 8:20 am, Hall D, Lower Level North<br />

This award recognizes outstanding contributions to human genetics education.<br />

Nominees for this award must have made a contribution that is recognized nationally<br />

or internationally as being <strong>of</strong> exceptional quality and great importance to human<br />

genetics education. Dr. Alan Emery, Green Templeton College, University <strong>of</strong> Oxford,<br />

will be presented the <strong>2012</strong> Award for Excellence in <strong>Human</strong> <strong>Genetics</strong> Education. An<br />

acceptance lecture is scheduled. See page 116 for a description <strong>of</strong> this session and<br />

a list <strong>of</strong> past winners.<br />

Victor A. McKusick Leadership Award: Presentation and Lecture<br />

8:20 am – 8:40 am, Hall D, Lower Level North<br />

This award is presented to an individual whose pr<strong>of</strong>essional achievements have<br />

fostered and enriched the development <strong>of</strong> various human genetics disciplines. In 2008<br />

the Leadership Award was renamed to honor the memory <strong>of</strong> Victor A. McKusick (1921-<br />

2008). Dr. Francis Collins, National Institutes <strong>of</strong> Health, will be presented with the <strong>2012</strong><br />

Victor A. McKusick Leadership Award. An acceptance speech is scheduled. See page<br />

117 for a description <strong>of</strong> this session and a list <strong>of</strong> past winners.<br />

C. W. Cotterman Awards Announced<br />

8:40 am – 8:45 am, Hall D, Lower Level North<br />

The C. W. Cotterman Award winners will be announced and presented with certificates.<br />

Each September, the editorial board <strong>of</strong> the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />

selects two articles representing the best papers published in the Journal during the<br />

previous year by pre- or postdoctoral <strong>ASHG</strong> trainees.<br />

Trainee Research Award Winners Announced<br />

8:45 am – 8:55 am, Hall D, Lower Level North<br />

<strong>ASHG</strong> honors excellence in research conducted by predoctoral and postdoctoral<br />

trainees, including genetic counseling trainees, through merit-based awards that recognize<br />

highly competitive abstracts submitted for the Annual Meeting. These awards<br />

were renamed in <strong>2012</strong> to honor the late Charles Epstein. The six winners <strong>of</strong> the Charles<br />

J. Epstein Trainee Awards for Excellence in <strong>Genetics</strong> Research will be announced. See<br />

page 63 for a list <strong>of</strong> the 18 finalists and page 65 for a list <strong>of</strong> the 60 semifinalists.<br />

Curt Stern Award: Presentation and Lecture<br />

8:55 am – 9:20 am, Hall D, Lower Level North<br />

This award is presented yearly for outstanding scientific achievements in human<br />

genetics occurring in the last 10 years. The work may be a single major discovery or<br />

a series <strong>of</strong> contributions on a similar or related topic. This award honors the memory<br />

<strong>of</strong> Curt Stern (1902-1981) as an outstanding and pioneering human geneticist. Dr. Jay<br />

Shendure, University <strong>of</strong> Washington, will be presented the <strong>2012</strong> Curt Stern Award. An<br />

acceptance lecture is scheduled. See page 119 for a description <strong>of</strong> this session and<br />

a list <strong>of</strong> past winners.<br />

DAILY MEETING HIGHLIGHTS


62 DAILY MEETING HIGHLIGHTS<br />

Closing Symposium - <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong> and Beyond:<br />

Present Progress and Future Frontiers<br />

12:00 pm – 1:00 pm, Hall D, Lower Level North<br />

This year’s annual meeting will conclude with a special symposium that will include<br />

a panel <strong>of</strong> five outstanding geneticists, Han Brunner, Hal Dietz, Dian Donnai, Lynn Jorde,<br />

and Jay Shendure. This session will discuss the most exciting advances and upcoming<br />

challenges in several areas <strong>of</strong> human genetics. Panelists will answer questions<br />

from each other and from the audience. Views <strong>of</strong> the meeting attendees will be followed<br />

through <strong>ASHG</strong>’s social media outlets and will be summarized at the opening <strong>of</strong> the<br />

session. Attendees are encouraged to post their thoughts on exciting scientific or clinical<br />

advances they have heard about during the meeting, and on challenges that the<br />

field will face, by using hashtag #<strong>ASHG</strong><strong>2012</strong> on Twitter or Facebook page (https://<br />

www.facebook.com/<strong>Genetics</strong><strong>Society</strong>).<br />

<strong>ASHG</strong> <strong>2012</strong> MOBILE APP<br />

Download the <strong>ASHG</strong> <strong>2012</strong> Mobile App to your smartphone (iOS, Android, and<br />

Blackberry platforms). Refer to the ad on page 422.<br />

The mobile App brings the meeting to your fingertips wherever you go. Once the App<br />

has been downloaded, you do not need an Internet connection to view information.


DAILY MEETING HIGHLIGHTS 63<br />

<strong>ASHG</strong>/CHARLES J. EPSTEIN TRAINEE AWARDS FOR<br />

EXCELLENCE IN HUMAN GENETICS RESEARCH<br />

<strong>ASHG</strong> honors excellence in research conducted by predoctoral and postdoctoral<br />

trainees, including genetic counseling trainees, through merit-based awards that recognize<br />

highly competitive abstracts submitted for the Annual Meeting. These awards<br />

were renamed in <strong>2012</strong> to honor the late Dr. Charles Epstein.<br />

Congratulations to the 60 semifinalists. Semifinalists were selected based on abstract<br />

score and awarded complimentary registration plus $750 each. Of those semifinalists,<br />

18 finalists (selected by the Awards Committee) received an additional $250. The<br />

finalists’ presentations were reviewed by the <strong>ASHG</strong> Awards Committee and volunteer<br />

judges during the Annual Meeting. Six winners are chosen to receive an additional<br />

$1000 each. See below for the list <strong>of</strong> finalists and semi-finalists. The winners will be<br />

announced on Saturday, November 10 at the Awards session starting at 8:45 am.<br />

Members <strong>of</strong> the Awards Committee are Christopher Pearson, Chair; Goncalo Abecasis,<br />

Georgia Dunston, Maximilian Muenke, Pragna Patel, Sharon Plon; Mary-Claire King,<br />

ex <strong>of</strong>ficio.<br />

Name/Presentation Date & Time Session<br />

Number<br />

Li, Q.<br />

Tuesday, 5:50 pm (Plenary)<br />

Translational cis-regulation <strong>of</strong> gene ...<br />

Xifara, D.<br />

Wednesday, 10:30 am (Platform)<br />

The detection, structure and uses <strong>of</strong> ...<br />

Ordulu, Z.<br />

Wednesday, 10:30 am (Platform)<br />

Lessons learned from next-gen ...<br />

Doyle, A. J.<br />

Wednesday, 10:30 am (Platform)<br />

Heterozygous germline mutations in a ...<br />

O’Roak, B. J.<br />

Wednesday, 11:15 am (Platform)<br />

The discovery and validation <strong>of</strong> genes ...<br />

Powell, W. T.<br />

Wednesday, 11:15 am (Platform)<br />

A long, non-coding RNA from the ...<br />

Kitzman, J. O.<br />

Wednesday, 11:30 am (Platform)<br />

Noninvasive whole-genome<br />

sequencing <strong>of</strong> a ...<br />

<strong>Program</strong><br />

Number<br />

Award<br />

Category<br />

Room<br />

02 5 Postdoctoral Hall D<br />

Lower Level<br />

North<br />

12 16 Predoctoral Gateway<br />

Ballroom<br />

103 Lower<br />

Level South<br />

18 70 Postdoctoral Room 130<br />

Lower Level<br />

North<br />

19 79 Postdoctoral Room 123<br />

Lower Level<br />

North<br />

11 10 Postdoctoral Hall D<br />

Lower Level<br />

North<br />

17 64 Predoctoral Room 132<br />

Lower Level<br />

North<br />

18 74 Predoctoral Room 130<br />

Lower Level<br />

North<br />

TRAINEE AWARDS


64 DAILY MEETING HIGHLIGHTS<br />

Lee, Y.<br />

Wednesday, 12:00 noon (Platform)<br />

Association <strong>of</strong> genetic variation<br />

affecting ...<br />

Delaneau, O.<br />

Thursday, 11:00 am (Platform)<br />

Accurate haplotype estimation using<br />

phase ...<br />

Menelaou, A.<br />

Thursday, 11:15 am (Platform)<br />

An LD-based method for genotype<br />

calling ...<br />

Ruark, E.<br />

Thursday, 11:45 am (Platform)<br />

BRCA1 and BRCA2 mutational<br />

spectrum in a ...<br />

Snyder, M. W.<br />

Thursday, 12:00 noon (Platform)<br />

Methods for noninvasive prenatal ...<br />

Nguyen, K.-D. H.<br />

Thursday, 12:00 noon (Platform)<br />

High exome mutational burden in<br />

58 African ...<br />

Teslovich, T. M.<br />

Thursday, 4:30 pm (Platform)<br />

Whole-exome sequencing <strong>of</strong><br />

10,000 type 2 ...<br />

Tsetskhladze, Z.<br />

Friday, 9:15 am (Platform)<br />

Functional assessment <strong>of</strong> human<br />

coding ...<br />

Segurel, L.<br />

Friday, 10:00 am (Platform)<br />

When ancestry runs deep:<br />

Trans-species ...<br />

Arboleda, V.<br />

Friday, 5:15 pm (Platform)<br />

Domain-specific mutations in<br />

CDKN1C cause ...<br />

Wert, K. J.<br />

Friday, 6:30 pm (Platform)<br />

Gene therapy provides long-term<br />

visual ...<br />

14 40 Postdoctoral Room 134<br />

Lower Level<br />

North<br />

29 90 Postdoctoral Hall D<br />

Lower Level<br />

North<br />

29 91 Predoctoral Hall D<br />

Lower Level<br />

North<br />

34 138 Predoctoral Room 124<br />

Lower Level<br />

North<br />

29 94 Predoctoral Hall D<br />

Lower Level<br />

North<br />

32 121 Predoctoral Room 134<br />

Lower Level<br />

North<br />

38 169 Postdoctoral Hall D<br />

Lower Level<br />

North<br />

53 309 Postdoctoral Room 132<br />

Lower Level<br />

North<br />

50 285 Postdoctoral Room 134<br />

Lower Level<br />

North<br />

62 361 Predoctoral Room 134<br />

Lower Level<br />

North<br />

65 393 Predoctoral Room 132<br />

Lower Level<br />

North


<strong>2012</strong> TRAINEE AWARD SEMIFINALISTS<br />

Arboleda, Valerie, 361<br />

Buchan, Jillian, 220<br />

Carter, Calvin, 404<br />

de Ligt, Joep, 97<br />

Goldlust, Ian, 66<br />

Gorkin, David, 258<br />

Gymrek, Melissa, 333<br />

He, Zongxiao, 93<br />

Kitzman, Jacob, 74<br />

Kuchenbaecker, Karoline, 208<br />

Kulzer, Jennifer, 304<br />

Laurino, Mercy, 144<br />

Lim, Elaine, 11<br />

Maranville, Joseph, 248<br />

Menelaou, Androniki, 91<br />

Bryc, Katarzyna, 178<br />

Campbell, Catarina, 278<br />

Chaki, Moumita, 406<br />

Chu, Audrey, 51<br />

Chutake, Yogesh, 381<br />

Delaneau, Olivier, 90<br />

Doyle, Alexander, 79<br />

Fairfax, Benjamin, 373<br />

Girirajan, Santhosh, 14<br />

Gulsuner, Suleyman, 287<br />

Hibaoui, Youssef, 67<br />

Hung, Christina, 297<br />

Lee, Phil, 352<br />

Lee, Younghee, 40<br />

Li, Quan, 5<br />

GENERAL INFORMATION 65<br />

Predoctoral<br />

Michailidou, Kyriaki, 206<br />

Mullegama, Sureni, 103<br />

Nguyen, Khanh-Dung, 121<br />

Oz-Levi, Danit, 53<br />

Powell, Weston, 64<br />

Rowsey, Ross, 250<br />

Ruark, Elise, 138<br />

Semaka, Alicia, 265<br />

Sidore, Carlo, 177<br />

Snyder, Matthew, 94<br />

Soblet, Julie, 83<br />

Stimpson, Kaitlin, 69<br />

Wert, Katherine, 393<br />

Xifara, Dionysia Kiara, 16<br />

Yang, Wen-Yun, 180<br />

Postdoctoral<br />

Liu, Pengfei, 61<br />

Lloyd, Deborah, 219<br />

Meltz Steinberg, Karyn, 375<br />

Nord, Alex, 407<br />

O’Roak, Brian, 10<br />

Ordulu, Zehra, 70<br />

Pasaniuc, Bogdan, 89<br />

Sebro, Ronnie, 279<br />

Seeley, Andrea, 313<br />

Segurel, Laure, 285<br />

Smith, Robin, 246<br />

Teslovich, Tanya, 169<br />

Tsetskhladze, Zurab, 309<br />

Tuschl, Karin, 167<br />

Wilson Sayres, Melissa, 281<br />

The number next to each name indicates the authors abstract number.<br />

TRAINEE AWARDS


66 GENERAL INFORMATION<br />

<strong>2012</strong> FASEB MARC TRAVEL AWARDEES<br />

Each year, the <strong>ASHG</strong>/FASEB-MARC <strong>Program</strong> sponsors the Minority Travel Awards<br />

to help support the participation <strong>of</strong> faculty/mentors, postdoctoral fellows, and students<br />

from minority institutions and historically black colleges and universities in the United<br />

States. Underrepresented minority faculty, students, and postdoctoral fellows from<br />

majority institutions are also eligible to apply for these travel awards. The MARC travel<br />

awards provide up to $1,650 in funding for travel-related expenses.<br />

Elinette Albino-Rodriguez<br />

Sandra Brown-Ford<br />

Beatrice Monica Bowen<br />

Kristine Lacuesta Bucasas<br />

Calvin Carter<br />

Monique Courtenay<br />

Nadeem Fazal<br />

Michael Gonzalez<br />

Belen Hernandez<br />

James Hicks<br />

Crystal Humphries<br />

Janina Jeff<br />

Zura Liaqat<br />

Nataly Manjarrez-Orduno<br />

Candace Middlebrooks<br />

Maria Nieves-Colon<br />

Alba Pacheco-Torres<br />

Carmen Ramirez<br />

Aisha Rauf<br />

Nicole Restrepo<br />

Marquitta White


68 INVITED AND PLATFORM SESSIONS<br />

Tuesday, November 6<br />

4:00 PM–4:30 PM<br />

SESSION 1 – <strong>ASHG</strong> Presidential Address: The Scientist<br />

as a Citizen <strong>of</strong> the World<br />

Hall D, Lower Level North, Moscone Center<br />

Presenter:<br />

Mary-Claire King<br />

<strong>ASHG</strong> <strong>2012</strong> President,<br />

Univ. <strong>of</strong> Washington<br />

One <strong>of</strong> the most fulfilling features <strong>of</strong> our lives as<br />

scientists is to act as citizens <strong>of</strong> the world. We both<br />

take this citizenship for granted and take its<br />

responsibilities seriously. In one generation, this role<br />

has evolved dramatically, as scientists travel far more<br />

widely and as modern communication tools enable us<br />

to remain in contact with our colleagues worldwide. In<br />

my presidential address, I will specify some elements<br />

<strong>of</strong> the scientific life that lead naturally to world<br />

citizenship. Then I will focus in particular on how the<br />

intellectual structure <strong>of</strong> human genetics enables us to<br />

be particularly effective world citizens. I will also<br />

discuss migration as a force in our lives, as well as in<br />

human evolution, and will try to define the concept <strong>of</strong><br />

“home” for a scientist. Finally, I will suggest that<br />

scientific goals are both practical and idealistic, and<br />

that we should celebrate both.<br />

Tuesday, November 6<br />

4:30 PM–6:30 PM<br />

SESSION 2 – Plenary Abstract Presentations<br />

Hall D, Lower Level North, Moscone Center<br />

Moderator: Joel N. Hirschhorn, <strong>2012</strong> <strong>Program</strong><br />

Committee Chair Boston Children’s Hosp.,<br />

Harvard Med. Sch. and Broad Inst.<br />

1/4:30 A novel molecular and functional mechanism<br />

predisposing to ototoxicity. B. Wollnik, E. Pohl, N.<br />

Offenhäuser, A. Uzumcu, F. J. Kersten, A. K.<br />

Rzadzinska, O. Uyguner, B. Lorente, G. Nürnberg, M.<br />

Emiroglu, H. Kayserili, I. del Castillo, P. Nürnberg, T.<br />

Moser, C. Kubisch, K. P. Steel, P. P. Di Fiore, H.<br />

Kremer, Y. Li.<br />

2/4:50 Genome-wide comparison <strong>of</strong> genetic and<br />

epigenetic regulatory mechanisms in primates. Y.<br />

Gilad, A. Pai, R. Pique-Regi, C. Cain, J. Degner, N.<br />

Lewellen, K. Michelini, J. Pritchard.<br />

3/5:10 Multidisciplinary and translational task force<br />

for neonatal genomics. E. E. Davis, A. Sabo, N. C.<br />

Oien, S. H. Katsanis, H. Cope, K. Sheets, A.<br />

Sadeghpour, K. McDonald, M. Kousi, J. R. Willer, J.<br />

Kim, S. Dugan-Rocha, D. M. Muzny, A. Ashley-Koch,<br />

E. Hauser, M. Hauser, J. Sun, J. Kurtzberg, A. Murtha,<br />

B. Boyd, W. B. Gallentine, R. Goldberg, M. T.<br />

McDonald, R. A. Gibbs, M. Angrist, C. M. Cotten, N.<br />

Katsanis.<br />

4/5:30 Genome-wide identification and functional<br />

analysis <strong>of</strong> distant-acting crani<strong>of</strong>acial enhancers. C.<br />

Attanasio, Y. Zhu, M. J. Blow, A. S. Nord, V. Afzal, B.<br />

Hallgrimsson, D. FitzPatrick, H. Morrison, E. M. Rubin,<br />

L. A. Pennacchio, A. Visel.<br />

5/5:50 Translational cis-regulation <strong>of</strong> gene<br />

expression in human genome: The effect <strong>of</strong> human<br />

single nucleotide polymorphisms.Q . Li, A. Makri, Y.<br />

Lu, L. Marchand, R. Grabs, M. Rousseau, H. Ounissi-<br />

Benkalha1, H. Qu, C. Polychronakos.<br />

6/6:10 Lessons learned from the NHLBI-Exome<br />

Sequencing Project. S. M. Leal on behalf <strong>of</strong> NHLBI<br />

Exome Sequencing Project.<br />

The Opening Mixer and Trainee-Mixer-within-a-Mixer<br />

will follow the plenary session at the Marriott Marquis<br />

Hotel, Yerba Buena Ballroom. For those interested,<br />

large screens will display the U.S. election updates<br />

after the Plenary session has concluded.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 3 – Implementing Next-Generation<br />

Sequencing as a Clinical Test<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: Nazneen Aziz, Col. <strong>of</strong> <strong>American</strong><br />

Pathologists, Lexington, MA; Ira Lubin, Ctr. for Dis.<br />

Control and Prevent.<br />

Next-generation sequencing (NGS) is used widely in<br />

clinical research for the discovery <strong>of</strong> diseaseassociated<br />

genes and the clinical community is<br />

beginning to embrace this technology for diagnostic<br />

testing. The rapid evolution <strong>of</strong> NGS technologies<br />

presents significant opportunities and challenges for<br />

researchers and clinicians for improving health<br />

outcomes; particularly with respect to an increased<br />

emphasis on personalized and preventive medicine.<br />

Adoption <strong>of</strong> NGS in the clinical laboratory setting<br />

requires the adoption <strong>of</strong> many processes and<br />

procedures, such as, the analytic and clinical<br />

validation <strong>of</strong> the test, CLIA/CAP certification, standards<br />

for reference materials for pr<strong>of</strong>iciency testing, and<br />

questions regarding reimbursement and informed<br />

consent. This session will initially review the state <strong>of</strong><br />

NGS in the clinical setting today and what is<br />

anticipated in the near future. This will be followed by<br />

consideration for what is practically needed for clinical<br />

adoption <strong>of</strong> NGS such as regulatory and pr<strong>of</strong>essional<br />

standards, development, availability, and access to<br />

reference materials, and the laboratory pr<strong>of</strong>essional’s<br />

role for ensuring high quality test results that are useful<br />

for informing clinical decision making. This session will<br />

be informative and practical for the researcher and<br />

laboratorians who are considering launching NGS as a<br />

clinical test.<br />

8:00 AM Challenges <strong>of</strong> introducing NGS in the<br />

clinical laboratory. S. Richards. Oregon Hlth. & Sci.<br />

Univ.<br />

8:15 AM Addressing the fundamentals: NGS<br />

validation and implementation in a clinical setting.<br />

M. Hegde. Emory Univ.<br />

8:45 AM Pr<strong>of</strong>iciency testing, quality control and<br />

development <strong>of</strong> reference material for NGS clinical<br />

testing. E. Lyon. Univ. <strong>of</strong> Utah Sch. <strong>of</strong> Med.<br />

9:00 AM Development <strong>of</strong> accreditation standards<br />

for laboratories <strong>of</strong>fering NGS as a clinical test.<br />

N. Aziz. Col. <strong>of</strong> <strong>American</strong> Pathologists, Lexington, MA.<br />

9:30 AM Lessons from the clinic—What’s next? H.<br />

Jacob. Med. Col. <strong>of</strong> Wisconsin.<br />

INVITED AND PLATFORM SESSIONS 69<br />

Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 4 – Assessing the Pathogenicity <strong>of</strong> Genetic<br />

Variants: Translating in Vitro and in Silico Advances to<br />

the Clinic<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Marc S. Greenblatt, Univ. <strong>of</strong> Vermont;<br />

Sean V. Tavtigian, Univ. <strong>of</strong> Utah<br />

Interpreting which genetic variants are pathogenic and<br />

which are not remains a critical challenge in the<br />

genetics <strong>of</strong> hereditary cancer syndromes and other<br />

inherited disorders. Genetic testing for disorders such<br />

as Lynch syndrome (caused by mutations in DNA<br />

mismatch repair genes) and hereditary breast-ovarian<br />

cancer (BRCA1, BRCA2 genes) <strong>of</strong>ten identifies a<br />

`Variant <strong>of</strong> Uncertain Significance’ (VUS). As DNA<br />

sequencing capacity increases at a furious pace, there<br />

is an ever greater need to have effective methods to<br />

analyze these data. There is a consensus in the field <strong>of</strong><br />

genetic testing that proper classification <strong>of</strong> variants<br />

requires the integration <strong>of</strong> multiple types <strong>of</strong> data.<br />

Some lines <strong>of</strong> evidence are familiar to clinicians (e.g.,<br />

segregation <strong>of</strong> an allele with disease, detailed<br />

phenotype), and others are less familiar (e.g., in vitro<br />

protein functional assays, in silico algorithms based on<br />

gene sequence or protein structure). Ideally, integration<br />

can be done in a quantitative way, such as Bayesian<br />

probabilistic analysis, but qualitative data may be used<br />

if quantitative measurements are not possible. This<br />

session will 1) explore recent advances in applying<br />

and integrating statistical, laboratory, and<br />

computational methods in the classification <strong>of</strong><br />

missense, splice site, and other genetic variants, and<br />

2) report on international collaborations that are using<br />

these methods to classify variants in mismatch repair,<br />

BRCA, and other genes and disseminating validated<br />

conclusions to the cancer genetics community.<br />

8:00 AM Innovative in vitro and in vivo assays to<br />

investigate the function <strong>of</strong> mismatch repair gene<br />

variants in Lynch syndrome. N. de Wind. Leiden<br />

Univ. Med. Ctr., Netherlands.<br />

8:30 AM Analysis <strong>of</strong> splicing abnormalities to<br />

define pathogenic variants in cancer susceptibility<br />

genes. A. B. Spurdle. Queensland Inst. <strong>of</strong> Med. Res.,<br />

Australia.<br />

9:00 AM Integrating in silico with in vitro,<br />

statistical, and phenotype data to classify missense<br />

variants: A paradigm that is ready for translation to<br />

the clinic. S.V. Tavtigian. Univ. <strong>of</strong> Utah.<br />

9:20 AM CAGI: The Critical Assessment <strong>of</strong><br />

Genome Interpretation, a community experiment to<br />

evaluate phenotype prediction. S. E. Brenner. Univ.<br />

<strong>of</strong> California, Berkeley.<br />

9:40 AM International collaborations to establish<br />

standards for classifying genetic variants and to<br />

disseminate results. M. S. Greenblatt. Univ. <strong>of</strong><br />

Vermont.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


70 INVITED AND PLATFORM SESSIONS<br />

Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 5 – Gene Regulatory Change: The Engine <strong>of</strong><br />

<strong>Human</strong> Evolution?<br />

Room 135, Lower Level North, Moscone Center<br />

Moderators: James P. Noonan, Yale Univ. Sch. <strong>of</strong><br />

Med.; Nadav Ahituv, UCSF<br />

What makes us human? Classic human traits, such as<br />

language and sophisticated tool use, are the result <strong>of</strong><br />

physical changes during human evolution, including<br />

increased brain complexity and altered limb<br />

morphology. This session will focus on efforts to<br />

identify evolutionary changes in gene regulation that<br />

produced uniquely human phenotypes. Speakers will<br />

describe novel approaches that are empowering<br />

research in this emerging field, and the insights that<br />

are being gained. Topics to be discussed include: 1)<br />

Computational identification <strong>of</strong> putative gene<br />

regulatory elements that changed extensively during<br />

human evolution; 2) The role <strong>of</strong> repetitive elements in<br />

generating novel regulatory functions; 3) <strong>Human</strong>specific<br />

loss <strong>of</strong> developmental regulatory elements;<br />

4) New methods to link phenotypic and genotypic<br />

variation across closely related species, and the<br />

implications for understanding human-specific<br />

biology and disease; and 5) Identifying humanspecific<br />

developmental regulatory changes by<br />

direct comparisons <strong>of</strong> enhancer function and gene<br />

expression in embryonic human and nonhuman<br />

primate tissues using functional genomics. The<br />

session will illustrate how the synthesis <strong>of</strong> diverse<br />

computational and experimental approaches is<br />

beginning to reveal the genetic basis <strong>of</strong> unique human<br />

biology.<br />

8:00 AM Chromatin pr<strong>of</strong>iling <strong>of</strong> human embryonic<br />

tissues identifies regulatory elements with humanspecific<br />

developmental functions. J. P. Noonan. Yale<br />

Univ. Sch. <strong>of</strong> Med.<br />

8:25 AM Many human accelerated regions are<br />

developmental enhancers. K. S. Pollard. UCSF.<br />

8:50 AM Linking human and mammalian<br />

genotypes to phenotype. G. Bejerano. Stanford Univ.<br />

9:15 AM The role <strong>of</strong> repetitive elements in driving<br />

human and mammalian genome regulation. D.<br />

Odom. Cancer Research UK, Cambridge, U.K.<br />

9:40 AM Evidence <strong>of</strong> regulatory turnover in the<br />

human lineage revealed by comparing mammalian<br />

constraint, human diversity, and biochemical<br />

activity. M. Kellis. MIT.<br />

Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 6 – Insights into <strong>Human</strong> Demography and<br />

Selection from Full Genome Sequencing<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: Jeffrey M. Kidd, Univ. <strong>of</strong> Michigan; Carlos<br />

D. Bustamante, Stanford Univ.<br />

Next-generation sequencing allows geneticists to<br />

directly test the extent and pattern <strong>of</strong> natural selection<br />

in the human genome. These new genomic data<br />

address previous concerns <strong>of</strong> ascertainment bias and<br />

accurate identification <strong>of</strong> causal alleles. Recently,<br />

population geneticists have proposed multiple, strong<br />

positive sweeps related to diet and immune defense,<br />

pervasive negative selection in and nearby genes, and<br />

adaptation by allele frequency shifts from standing<br />

variation. The proportion <strong>of</strong> the human genome<br />

attributable to these different patterns is currently<br />

under intense debate. Furthermore, selection is<br />

operating on the background <strong>of</strong> complex human<br />

demography, such as long-range continental<br />

migrations and population-specific bottlenecks. This<br />

symposium aims to provide diverse viewpoints on the<br />

different modes <strong>of</strong> selection operating on the human<br />

genome and a discussion <strong>of</strong> how demographic<br />

processes may have constrained evolution in both<br />

recent and ancient human history.<br />

8:00 AM The effect <strong>of</strong> out-<strong>of</strong>-Africa migrations on<br />

the distribution <strong>of</strong> deleterious alleles in diverse<br />

human genomes. B. M. Henn. Stanford Univ.<br />

8:30 AM Genetic adaptations to new<br />

environments in humans. A. Di Rienzo. Univ. <strong>of</strong><br />

Chicago.<br />

9:00 AM Insights into selective sweeps and<br />

diversity from thousands <strong>of</strong> sequenced genomes.<br />

R. Hernandez. UCSF.<br />

9:30 AM A genomic view <strong>of</strong> the demographic and<br />

adaptive history <strong>of</strong> African pygmies. L. Quintana-<br />

Murci. Inst. Pasteur, Paris, France.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 7 – Age-Related Macular Degeneration–<br />

GWAS and Beyond: Guiding Light for the Complex<br />

Neurodegenerative Diseases<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderators: Anand Swaroop, NEI/NIH; Hemin Chin,<br />

NEI/NIH<br />

AMD is a complex multi-factorial neurodegenerative<br />

disease that is a major cause <strong>of</strong> visual impairment in<br />

the elderly. Genetic linkage and genome-wide<br />

association studies (GWAS) have been immensely<br />

successful in identifying genetic susceptibility loci in<br />

AMD and in providing insights into cellular pathways<br />

underlying pathogenesis <strong>of</strong> the disease. Numerous<br />

groups worldwide have validated the strong<br />

association <strong>of</strong> variants at CFH and ARMS2/HTRA1 loci<br />

with AMD risk, and genome-wide association studies<br />

have suggested the involvement <strong>of</strong> complement,<br />

extracellular matrix, angiogenesis and HDL cholesterol<br />

pathways. This session will discuss the current<br />

progress to carry out comprehensive genetic analyses<br />

<strong>of</strong> AMD, highlighting experimental approaches that<br />

may be applicable to other complex traits and<br />

multigenic diseases. The speakers in this session will<br />

provide the current status <strong>of</strong> meta-analysis <strong>of</strong> AMD-<br />

GWAS, targeted resequencing, and whole exome<br />

sequencing efforts to discover or search for rare<br />

causal variants and functional pathways, and<br />

diagnostic/therapeutic implications <strong>of</strong> genetic variants.<br />

Additionally, we will discuss the relevance <strong>of</strong> AMD<br />

genetics for other complex neurodegenerative<br />

diseases and the future <strong>of</strong> genetic studies.<br />

8:00 AM The bigger the better: Searching for<br />

novel loci for age-related macular degeneration in<br />

a large consortium effort. I. Heid. Regensburg Univ.<br />

Med. Ctr., Germany.<br />

8:30 AM From genetic association to causal<br />

alleles by resequencing and exome arrays: The<br />

stage after GWAS. G. Abecasis. Univ. <strong>of</strong> Michigan.<br />

9:00 AM An integrated hypothesis <strong>of</strong> the<br />

development and progression <strong>of</strong> age-related<br />

macular degeneration based upon available genetic<br />

and biological data. G. S. Hageman. Univ. <strong>of</strong> Utah.<br />

9:30 AM An updated recipe for Mendel’s pea<br />

soup. M. A. Pericak-Vance. Univ. <strong>of</strong> Miami Miller Sch.<br />

<strong>of</strong> Med.<br />

INVITED AND PLATFORM SESSIONS 71<br />

Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 8 – “Yes Virginia, Family Studies Really Are<br />

Useful for Complex Traits in the Next-Generation<br />

Sequencing Era” (session in honor <strong>of</strong> Dr. Robert<br />

Elston’s contributions to human genetics in the year<br />

<strong>of</strong> his 80th birthday)<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: Michael A. Province, Washington Univ. in<br />

St. Louis; Francoise Clerget-Darpoux, INSERM U781,<br />

Univ. Paris V, France.<br />

The pros and cons <strong>of</strong> family designs as NGS targets in<br />

dissecting complex traits are presented. In the linkage<br />

era, family studies were ubiquitous, but they were<br />

largely neglected in the GWAS era, which<br />

concentrated mostly on unrelated subjects. But as<br />

attention now moves from the common to the rare<br />

variants that can only be completely interrogated<br />

through sequencing, it is useful to at least consider<br />

whether the designs that were optimal for GWAS<br />

remain so for NGS studies. Pedigrees seem to have at<br />

least some advantages over studies <strong>of</strong> unrelateds for<br />

studying rare variation. First, it may be easier to<br />

distinguish true rare variant calls from sequence errors<br />

in family designs than it is in unrelated cohorts, since<br />

there is the added dimension <strong>of</strong> pedigree consistency<br />

information, especially for low coverage. Second, a<br />

key statistical challenge to analyzing the phenotype/<br />

genotype correlation with rare variants, is finding<br />

enough copies <strong>of</strong> any one variant allele with which to<br />

make inferences (hence the various collapsing or<br />

burden tests, which combine multiple nearby rare<br />

variants into a single test). For any given very rare<br />

allele, sampling additional unrelateds is an inefficient<br />

strategy to find more copies <strong>of</strong> that allele, whereas<br />

family members <strong>of</strong> allele carriers are much more likely<br />

to be allele carriers themselves. On the other hand, a<br />

disadvantage <strong>of</strong> family designs is that there is a<br />

smaller diversity <strong>of</strong> founder mutations, so less <strong>of</strong> the<br />

overall population <strong>of</strong> alleles is measured per individual.<br />

This session emphasizes the results <strong>of</strong> real sequencing<br />

studies in pedigrees as well as simulation results to<br />

delineate the areas in which family designs <strong>of</strong>fer<br />

advantages and where they <strong>of</strong>fer disadvantages over<br />

sequencing unrelated subjects, such as case-control<br />

designs.<br />

8:00 AM Whole genome sequencing in large<br />

pedigrees for the identification <strong>of</strong> human QTLs. J.<br />

Blangero. Texas Biomed. Res. Inst., Austin.<br />

8:30 AM Linkage and association information<br />

should be considered as complementary and not<br />

redundant. F. Clerget-Darpoux. INSERM U781, Univ.<br />

Paris V, France.<br />

9:00 AM Power to find rare causal variants in<br />

pedigrees. M. A. Province. Washington Univ. in St.<br />

Louis.<br />

9:30 AM Whither human genetics? R. C. Elston.<br />

Case Western Reserve Univ.<br />

Taking Photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


72 INVITED AND PLATFORM SESSIONS<br />

Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 9 – Surveying Customer Responses to<br />

Personal Genetic Services<br />

Room 132, Lower Level North, Moscone Center<br />

Moderator: J. Scott Roberts, Univ. <strong>of</strong> Michigan<br />

This session will feature presentation <strong>of</strong> empirical data<br />

on the responses <strong>of</strong> personal genome testing<br />

consumers to their individual genomic information. Dr.<br />

David Kaufman <strong>of</strong> Johns Hopkins University will<br />

discuss publicly available interpretations <strong>of</strong> individual<br />

whole genome sequence data in light <strong>of</strong> his Center’s<br />

prior work on direct-to-consumer (DTC) testing and<br />

return <strong>of</strong> individual genetic research results. Dr.<br />

Cinnamon Bloss <strong>of</strong> the Scripps Genomic Health<br />

Initiative (SGHI) will present new long-term follow-up<br />

data from the SGHI, including data related to DTC<br />

pharmacogenomic testing and genetic ancestry<br />

testing. Dr. Sandra Lee <strong>of</strong> Stanford University will<br />

describe an anthropological study <strong>of</strong> how the public<br />

integrates information on population genetic variation<br />

in their interpretation <strong>of</strong> individualized genetic risk<br />

information for disease and drug response. The<br />

session will conclude with a panel discussion<br />

moderated by Dr. Scott Roberts <strong>of</strong> the University <strong>of</strong><br />

Michigan, joint PI (with Dr. Robert Green at Brigham<br />

and Women’s Hospital) <strong>of</strong> the Impact <strong>of</strong> Personal<br />

Genomics (PGen) Study. The PGen Study is a<br />

longitudinal survey study examining consumers’<br />

response to personal genome testing, including their<br />

motivations and expectations, risk perceptions, health<br />

behaviors and intentions. Two personal genomics<br />

companies, 23andMe and Pathway Genomics, are<br />

collaborators on the PGen Study, and the closing<br />

panel will feature a discussion that includes company<br />

representatives Dr. Joanna Mountain and Dr. Tanya<br />

Moreno. In this discussion, panelists and audience<br />

members will share their perspectives on the potential<br />

benefits and risks involved in research partnerships<br />

between academicians and personal genomics<br />

companies.<br />

8:00 AM Interpretomics: Using studies <strong>of</strong> DTC<br />

testing and the return <strong>of</strong> research results to shape<br />

the interpretation <strong>of</strong> personal whole genomic<br />

sequence data. D. Kaufman. Genet. and Publ. Policy<br />

Ctr., Johns Hopkins Univ.<br />

8:30 AM Impact <strong>of</strong> DTC genomic testing at longterm<br />

follow-up. C. S. Bloss. Scripps Translational Sci.<br />

Inst. and Scripps Hlth.<br />

9:00 AM Rendering population differences<br />

meaningful: A study <strong>of</strong> consumer interpretation <strong>of</strong><br />

genetic diversity. S. S-J. Lee. Stanford Univ. Med.<br />

Sch.<br />

9:30 AM The role <strong>of</strong> personal genomic testing<br />

companies in research: A panel discussion<br />

featuring industry and academic perspectives.<br />

Panelists: J. Mountain 1 , T. Moreno 2 , J. S. Roberts 3 .<br />

1) 23andMe Inc., Mountain View, CA; 2) Genomics<br />

Corp., San Diego; 3) Univ. <strong>of</strong> Michigan.<br />

Wednesday, November 7<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session I (3-10)<br />

SESSION 10 – Metabolism, Metals, and<br />

Neurodegeneration: Toward Enhanced Understanding<br />

<strong>of</strong> Disease Mechanisms and Rational Therapeutics<br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Stephen G. Kaler, NICHD/NIH; Susan J.<br />

Hayflick, Oregon Hlth. & Sci. Univ.<br />

This session will focus on the expanding knowledge<br />

concerning the influence <strong>of</strong> inborn errors <strong>of</strong><br />

metabolism and disorders <strong>of</strong> trace metal homeostasis<br />

on neurodegeneration. Increasing numbers <strong>of</strong> clinical<br />

phenotypes and molecular defects are now associated<br />

with disordered metabolism in the central and<br />

peripheral nervous systems. These include Alzheimer<br />

and Parkinson diseases, Menkes and Wilson diseases,<br />

ATP7A-related distal motor neuropathy, acetyl CoA<br />

transporter 1-related hypocupremia, pantothenate<br />

kinase-associated neurodegeneration, infantile<br />

neuroaxonal dystrophy, dystonia-parkinsonism,<br />

Friedreich ataxia, hemochromatosis, and iron sulfur<br />

cluster scaffold myopathy. Expert speakers will discuss<br />

and review translational research advances relevant to<br />

these conditions, as well as emerging data on disease<br />

mechanisms, pathophysiology, and potential novel<br />

remedies.<br />

8:00 AM Alzheimer disease and the metal<br />

hypothesis. R. E. Tanzi. Massachusetts Gen. Hosp.<br />

8:30 AM Neurodegeneration with brain iron<br />

accumulation. S. J. Hayflick. Oregon Hlth. & Sci. Univ.<br />

9:00 AM Friedreich ataxia and diseases <strong>of</strong> iron<br />

sulfur cluster assembly. T. A. Rouault. NICHD/NIH.<br />

9:20 AM Neurodegeneration and disorders <strong>of</strong><br />

copper transport. S. G. Kaler. NICHD/NIH.<br />

9:40 AM Exploring the link between<br />

glucocerebrosidase mutations and Parkinson<br />

disease. E. Sidransky. NHGRI/NIH.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 11 – <strong>Genetics</strong> <strong>of</strong> Autism Spectrum Disorders<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: Fuki M. Hisama, Univ. <strong>of</strong> Washington; Dan<br />

E. Arking, Johns Hopkins Sch. <strong>of</strong> Med.<br />

7/10:30 Genetic epidemiology <strong>of</strong> autism spectrum<br />

disorder in a cohort <strong>of</strong> over 11,000 affected<br />

sibships and half-sibships: Evidence <strong>of</strong> genetic and<br />

maternal environmental effects. N. Risch, T. J.<br />

H<strong>of</strong>fmann, M. Anderson, L. A. Croen, J. Grether, G.<br />

Windham.<br />

8/10:45 Identifying inherited autism mutations using<br />

whole exome sequencing. T. W. Yu, M. H. Chahrour,<br />

M. E. Coulter, S. Jiralerspong, K. Okamura-Ikeda, K.<br />

Schmitz-Abe, G. H. Mochida, J. N. Partlow, R. S. Hill,<br />

M. Al-Saffar, N. M. Mukaddes, A. Hashmi, S. Balkhy,<br />

G. G. Gascon, O. Oner, S. Al-Saad, T. Ben-Omran, L.<br />

Al-Gazali, V. Eapen, C. Stevens, S. Gabriel, K.<br />

Markianos, H. Taniguchi, N. E. Braverman, E. M.<br />

Morrow, C. A. Walsh.<br />

9/11:00 Identical by descent filtering in extended<br />

families reveals novel autism genes detected by<br />

exome sequencing. H. N. Cukier, N. D. Dueker, S. H.<br />

Slifer, J. M. Lee, P. L. Whitehead, E. Lalanne, N. Leyva,<br />

I. Konidari, R. C. Gentry, W. F. Hulme, D. Van Booven,<br />

D. J. Hedges, V. Mayo, S. S. Ramsook, B. A.<br />

Barrionuevo, J. M. Jaworski, M. A. Schmidt, J. L.<br />

Haines, M. L. Cuccaro, J. R. Gilbert, M. A. Pericak-<br />

Vance.<br />

10/11:15 The discovery and validation <strong>of</strong> genes<br />

recurrently disrupted in autism spectrum disorders.<br />

B. J. O’Roak, L. Vives, A. Kumar, I. B. Stanaway, J.<br />

Egertson, E. Turner, C. Lee, G. L. Carvil, I. G. Phelps,<br />

D. R. O’Day, W. Fu, J. Hiatt, B. Martin, N. Krumm, B.<br />

P. Coe, R. Levy, E. Borenstein, D. A. Nickerson, H. C.<br />

Mefford, D. Doherty, J. M. Akey, R. Bernier, E. E.<br />

Eichler, J. A. Shendure.<br />

11/11:30 Rare complete human knockouts:<br />

Population distribution and significant role in<br />

autism spectrum disorders. E. T. Lim, M. J. Daly,<br />

ARRA Autism Sequencing Consortium.<br />

12/11:45 Exome-based discovery <strong>of</strong> CNVs in<br />

simplex autism families. N. Krumm, B. Nelson, S.<br />

Girirajan, M. Dennis, C. Baker, M. Malig, NHLBI Exome<br />

Sequencing Project, A. Quinlan, D. A. Nickerson, E. E.<br />

Eichler.<br />

13/12:00 Delta catenin (CTNND2): <strong>Genetics</strong> and<br />

function <strong>of</strong> a novel autism gene.T . Turner, E. Oh, Y.<br />

Liu, M. X. Sosa, S. Sanders, K. Sharma, D. Moreno-<br />

De-Luca, T. Plona, K. Pike, D. Soppet, M. W. Smith,<br />

M. State, S. W. Cheung, C. Lese Martin, R. Huganir, E.<br />

Cook, N. Katsanis, A. Chakravarti.<br />

INVITED AND PLATFORM SESSIONS 73<br />

14/12:15 Novel hotspots <strong>of</strong> recurrent copy number<br />

variation associated with autism spectrum disorder.<br />

S. Girirajan, M. Y. Dennis, C. Baker, M. M. Malig, B. P.<br />

Coe, C. D. Campbell, K. Mark, T. Vu, C. Alkan, Z.<br />

Cheng, R. Bernier, E. E. Eichler.<br />

15/12:30 Cluster analysis defines subgroups <strong>of</strong><br />

phenotypic expression for autism spectrum<br />

disorders. O. J. Veatch, B. Yaspan, N. Schnetz-<br />

Boutaud, M. A. Pericak-Vance, J. L. Haines.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


74 INVITED AND PLATFORM SESSIONS<br />

Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 12 – New Methods for Big Data<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Elizabeth Marchani, Univ. <strong>of</strong> Washington;<br />

Rita Cantor-Chiu, UCLA Sch. <strong>of</strong> Med.<br />

16/10:30 The detection, structure and uses <strong>of</strong><br />

haplotype identity in population genetic data.<br />

D. Xifara, I. Mathieson, G. McVean.<br />

17/10:45 Inferring and sequencing the founding<br />

bottleneck <strong>of</strong> Ashkenazim. I. Pe’er, S. Carmi, S.<br />

Mukherjee, N. Parlamee, M. Bowen, K. Hui, V. Joseph,<br />

P. F. Palamara, L. Ozelius, I. Peter, A. Darvasi, K. Offit,<br />

H. Ostrer, J. Cho, L. Clark, G. Atzmon, T. Lencz,<br />

Ashkenazi Genome Consortium.<br />

18/11:00 Statistical methods for association test <strong>of</strong><br />

rare variants using summarized data without<br />

individual-subject information. Q. Zhang, I. Borecki,<br />

M. A. Province.<br />

19/11:15 Testing for rare variant associations in the<br />

presence <strong>of</strong> missing data. P. Livermore Auer, S. Leal,<br />

G. Wang, NHLBI Exome Sequencing Project.<br />

20/11:30 Quantitative trait locus analysis for nextgeneration<br />

sequencing with the functional linear<br />

models. M. Xiong, L. Luo, Y. Zhu.<br />

21/11:45 A rapid and powerful method for proteinprotein<br />

interaction- and pathway-based association<br />

analysis in genome-wide association studies. M. Li,<br />

S. Kwan, H. Gui, P. Sham.<br />

22/12:00 Statistics for X-chromosome association.<br />

U. Ozbek, D. E. Weeks, W. Chen, J. Shaffer, S. M.<br />

Purcell, E. Feingold.<br />

23/12:15 Joint association analysis <strong>of</strong> pleiotropy<br />

SNPs using GWAS summary statistics. R. M. Salem,<br />

J. N. Hirschhorn.<br />

24/12:30 Multivariate regression-based analysis <strong>of</strong><br />

relative abundance data in metagenomics.<br />

O. Libiger, N. J. Schork.<br />

Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 13 – Cancer <strong>Genetics</strong> I: Rare Variants<br />

Room 135, Lower Level North, Moscone Center<br />

Moderators: Ellen L. Goode, Mayo Clin. Col. <strong>of</strong> Med.;<br />

John D. McPherson, Ontario Inst. for Cancer Res.,<br />

Canada<br />

25/10:30 Exome sequencing <strong>of</strong> more than 6,700<br />

samples and the study <strong>of</strong> genetic susceptibility to<br />

common cancer. A. Kiezun, A. McKenna, G. Kryukov,<br />

G. Getz.<br />

26/10:45 Exome sequencing <strong>of</strong> families severely<br />

affected with breast cancer suggests eight new<br />

candidate genes: ATR, BAP1, CHEK1, GEN1,<br />

KANK4, OBSL1, RAD51B and TP53BP1. C. H.<br />

Spurrell, A. M. Thornton, M. K. Lee, S. Casadei, S. Ng,<br />

T. Walsh, J. Shendure, M. C. King.<br />

27/11:00 Rare variants in XRCC2 as breast cancer<br />

susceptibility alleles. F. S. Hilbers, M. C. Völker-<br />

Albert, W. W. Wiegant, M. P. G. Vreeswijk, N.<br />

Hoogerbrugge, J. C. Oosterwijk, J. M. Collee, M. C.<br />

Southey, P. Peterlongo, P. Radice, F. J. Couch, K. Offit,<br />

I. G. Campbell, J. Benitez, C. J. van Asperen, H. van<br />

Attikum, P. Devilee.<br />

28/11:15 HOXB13 is a susceptibility gene for<br />

prostate cancer: Results from the International<br />

Consortium for Prostate Cancer <strong>Genetics</strong>. K.<br />

Cooney, W. Isaacs, J. Xu, E. Lange, L. Lu, S. Zheng,<br />

Z. Wong, L. Cannon-Albright, J. Stanford, E. A.<br />

Ostrander, C. Maier, J. Schleutker, D. Schaid, S.<br />

Thibodeau, G. Cancel-Tassin, F. Wiklund, R. Eeles,<br />

D. Easton, A. Wittemore, G. Giles, W. Catalona, D.<br />

Mandal, W. Foulkes, J. Carpten, D. Seminara on behalf<br />

<strong>of</strong> International Consortium for Prostate Cancer<br />

<strong>Genetics</strong>.<br />

29/11:30 Parkinson disease and melanoma:<br />

A common genetic pathway linked to PARKIN<br />

inactivation. H. Hu, N. Dumaz, S. Lesage, L. Michel,<br />

V. Descamps, S. Mourah, C. Lebbé, N. Basset-Seguin,<br />

M. Bagot, A. Bensussan, L. Deschamps, M.-T. Leccia,<br />

A. Tsalamlal, P. Sivaramakrishna Rachakonda, S.<br />

Klebe, K. Rajive, C. Kannengiesser, A. Couvelard, B.<br />

Grandchamp, L. Thomas, A. Brice, N. Soufir.<br />

30/11:45 Exome sequencing in families at high risk<br />

for lymphoid malignancies. L. R. Goldin, M. L.<br />

McMaster, M. Rotunno, K. B. Jacobs, L. Burdette, M.<br />

Malasky, A. Hutchinson, M. Cullen, J. Boland, M.<br />

Yeager, M. A. Tucker, S. J. Chanock, N. E. Caporaso.<br />

31/12:00 Rare allelic forms <strong>of</strong> PRDM9 associated<br />

with childhood leukemia. J. Hussin, D. Sinnett, F.<br />

Casals, Y. Idaghdour, V. Bruat, V. Saillour, J.-C. Grenier,<br />

J. Healy, T. de Malliard, J.-F. Spinella, M. Lariviere, S.<br />

Busche, G. Gibson, A. Andersson, L. Holmfeldt, J. Ma,<br />

L. Wei, J. Zhang, G. Andelfinger, J. R. Downing, C. M.<br />

Mullighan, P. Awadalla.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19) (SESSION 13, continued)<br />

32/12:15 De novo mutation <strong>of</strong> the TGF beta family<br />

in early-onset ovarian cancer. I. Tournier, F.<br />

Charbonnier, S. Coutant, K. Walton, R. Marlin, M.<br />

Vezain, J. Tinat, E. Angot, R. Sesboué, J.-C. Sabourin,<br />

D. Vaur, C. Harrison, T. Frebourg.<br />

33/12:30 Somatic activating mutations in PIK3CA<br />

cause progressive segmental overgrowth. M. J.<br />

Lindhurst, V. E. R. Parker, F. Payne, J. C. Sapp, S.<br />

Rudge, J. Harris, A. M. Witkowski, Q. Zhang, M. P.<br />

Groeneveld, C. E. Scott, A. Daly, S. M. Huson, L. L.<br />

Tosi, M. L. Cunningham, T. N. Darling, J. Geer, Z.<br />

Gucev, P. A. Kreiger, V. R. Sutton, M. M. Thacker, C.<br />

Tziotzios, A. K. Dixon, T. Helliwell, S. O’Rahilly, D. B.<br />

Savage, M. J. O. Wakelam, R. K. Semple, I. Barroso,<br />

L. G. Biesecker.<br />

INVITED AND PLATFORM SESSIONS 75<br />

Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 14 – Quantitation and Measurement <strong>of</strong><br />

Regulatory Oversight by the Cell<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: Richard M. Myers, HudsonAlpha Inst. for<br />

Biotechnol., Huntsville, AL; Jeffrey C. Barrett,<br />

Wellcome Trust Sanger Inst., U.K.<br />

34/10:30 ChipEnrich: Gene set enrichment testing<br />

for ChIP-seq data. R. P. Welch, C. Lee, L. J. Scott, R.<br />

A. Smith, P. Imbriano, M. A. Sartor.<br />

35/10:45 Enhanced exome sequencing to capture<br />

genome-wide common variants. I. C. R. M. Kolder,<br />

K. I. Morley, E. Birney, I. Dunham, J. C. Barrett.<br />

36/11:00 Complete HIV-1 genomes from<br />

sequencing single molecules: Simple and complex<br />

samples. M. P. S. Brown, M. Schaefer, Y. Gao, W.<br />

Kilembe, S. Allen, E. Hunter, E. E. Paxinos.<br />

37/11:15 DeTCT pipeline: A s<strong>of</strong>tware pipeline for<br />

the analysis <strong>of</strong> transcript count data. J. A. Morris, J.<br />

E. Collins, I. Sealy, N. Wali, E. Busch-Netwich, R.<br />

White, D. L. Stemple, J. C. Barrett.<br />

38/11:30 Fast genome-wide QTL association<br />

mapping with pedigrees. H. Zhou, E. M. Sobel, K.<br />

Lange.<br />

39/11:45 Discovering SNPs regulating human gene<br />

expression using allele specific expression from<br />

RNA-seq data. E. Eskin, E. Kang, B. Han, A. J. Lusis,<br />

L. Martin, S. Shiffman.<br />

40/12:00 Association <strong>of</strong> genetic variation affecting<br />

exon skipping to disease susceptibility. Y. Lee, H.<br />

Im, W. Hernandez, N. J. Cox.<br />

41/12:15 Haplotype-based variant detection and<br />

interpretation enables the population-scale analysis<br />

<strong>of</strong> multi-nucleotide sequence variants. E. Garrison,<br />

J. A. Rosenfeld, D. MacArthur, Y. Xue, Z. Iqbal, S.<br />

Balasubramanian, L. Habegger, R. Poplin, M. A.<br />

DePristo, G. Marth, M. B. Gerstein, C. Tyler-Smith,<br />

1000 Genomes Project.<br />

42/12:30 eQTL analysis identifies novel associations<br />

between genotype and gene expression in the<br />

human intestine. B. Kabakchiev, NIDDK IBD <strong>Genetics</strong><br />

Consortium, M. S. Silverberg.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


76 INVITED AND PLATFORM SESSIONS<br />

Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 15 – New Loci for Obesity, Diabetes, and<br />

Related Traits<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderators: Jose Florez, Massachusetts Gen. Hosp.;<br />

Richa Saxena, Massachusetts Gen. Hosp.<br />

43/10:30 A genome-wide association analysis <strong>of</strong><br />

early-onset severe obesity: The SCOOP project.<br />

E. Wheeler, N. Huang, E. Bochukova, S. Lindsay, J.<br />

Keogh, R. J. F. Loos, N. J. Wareham, S. O’Rahilly, M.<br />

Hurles, I. Barroso, I. S. Farooqi.<br />

44/10:45 Mapping obesity traits using an integrated<br />

`omics’ approach in adipose tissue from female<br />

twins. A. K. Hedman, J. K. Sandling, E. Grundberg, K.<br />

S. Small, E. Meduri, S. Keildson, A. Nica, A. Buil, J. T.<br />

Bell, J. Nisbet, M. Sekowska, A. Wilk, A. Barrett, N.<br />

Hassanali, T.-P. Yang, D. Glass, S.-Y. Shin, L. Parts, N.<br />

Soranzo, R. Durbin, K. Ahmadi, K. T. Zondervan, C. M.<br />

Lindgren, T. D. Spector, E. T. Dermitzakis, M. I.<br />

McCarthy, P. Deloukas for MuTHER Consortium.<br />

45/11:00 Whole exome sequencing identifies<br />

candidate causal genes for severe insulin<br />

resistance. F. Payne, A. Daly, W. Bottomley, E. Raffan,<br />

E. Goncalves Serra, A. Thompson, D. B. Savage, R. K.<br />

Semple, S. O’Rahilly, I. Barroso, UK10K Consortium.<br />

46/11:15 Exome analysis in 8,232 Finnish men<br />

identifies novel loci and low-frequency variants for<br />

insulin processing and secretion. J. R. Huyghe, A.<br />

U. Jackson, M. P. Fogarty, A. Stanáková, H. M.<br />

Stringham, M. L. Buchkovich, C. Fuchsberger, J.<br />

Paananen, P. S. Chines, T. M. Teslovich, J. M. Romm,<br />

H. Ling, I. McMullen, R. Ingersoll, E. W. Pugh, K. F.<br />

Doheny, J. Kuusisto, L. J. Scott, F. S. Collins, G. R.<br />

Abecasis, R. M. Watanabe, M. Boehnke, M. Laakso, K.<br />

L. Mohlke.<br />

47/11:30 Global genomic and transcriptomic<br />

variation in human pancreatic islets reveals novel<br />

loci associated with type 2 diabetes and related<br />

traits. J. Fadista, P. Vikman, I. Mollet, E. O. Laakso, U.<br />

Krus, O. Hansson, L. Groop.<br />

48/11:45 Identification <strong>of</strong> a novel genome-wide<br />

significant association with type 2 diabetes risk in<br />

Mexicans and Mexican <strong>American</strong>s. A. L. Williams, H.<br />

García-Ortiz, M. J. Gómez-Vázquez, C. A. Haiman, A.<br />

Huerta-Chagoya, A. K. Manning, C. Márquez-Luna, H.<br />

Moreno-Macías for SIGMA Type 2 Diabetes<br />

Consortium.<br />

49/12:00 Discovery and fine-mapping <strong>of</strong> type 2<br />

diabetes susceptibility loci through trans-ethnic<br />

meta-analysis. A. Mahajan, J. E. Below, W. Zhang, M.<br />

J. Go, E. Parra, A. P. Morris, AGEN-T2D, DIAGRAM,<br />

MA-T2D and SA-T2D Consortia.<br />

50/12:15 TCF7L2 genetic variation is associated<br />

with impaired incretin effect and lower glucagon. B.<br />

Chamarthi, K. R. Littleton, V. Kaur, L. Chen, A. K.<br />

Manning, M. K. Thomas, M. S. Hudson, J. C. Florez.<br />

51/12:30 Novel locus including FGF21 is associated<br />

with dietary macronutrient intake. A. Y. Chu, T.<br />

Workalemahu, N. P. Paynter, L. M. Rose, F. Giulianini,<br />

CHARGE Nutrition Working Group, Q. Qi, G. C.<br />

Curhan, E. B. Rimm, D. J. Hunter, L. R. Pasquale, P.<br />

M. Ridker, F. B. Hu, D. I. Chasman, L. Qi on behalf <strong>of</strong><br />

DietGen Consortium.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 16 – Neuromuscular Disease and Deafness<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: Anthony Antonellis, Univ. <strong>of</strong> Michigan;<br />

Thomas Glover, Univ. <strong>of</strong> Michigan<br />

52/10:30 The TRK-fused gene is mutated in<br />

hereditary motor and sensory neuropathy with<br />

proximal dominant involvement (HMSN-P). H.<br />

Ishiura, W. Sako, M. Yoshida, T. Kawarai, O. Tanabe, J.<br />

Goto, Y. Takahashi, H. Date, J. Mitsui, B. Ahsan, Y.<br />

Ichikawa, A. Iwata, H. Yoshino, Y. Izumi, K. Fujita, K.<br />

Maeda, S. Goto, H. Koizumi, R. Morigaki, M. Ikemura,<br />

N. Yamauchi, S. Murayama, G. Nicholson, H. Ito, G.<br />

Sobue, M. Nakagawa, R. Kaji, S. Tsuji.<br />

53/10:45 Mutation in the autophagy-related<br />

TECPR2 gene causes hereditary spastic<br />

paraparesis. D. Oz-Levi, B. Ben-Zeev, E. Ruzzo, Y.<br />

Hitomi, A. Gelman, K. Pelak, Y. Anikster, H. Reznik-<br />

Wolf, I. Bar-Joseph, T. Olender, A. Alkelai, M. Weiss, E.<br />

Ben-Asher, D. Ge, K. Shianna, Z. Elazar, D. Goldstein,<br />

E. Pras, D. Lancet.<br />

54/11:00 Spinal muscular atrophy associated with<br />

progressive myoclonic epilepsy is caused by<br />

mutations in ASAH1. J. Melki, J. Zhou, M. Tawk, F. D.<br />

Tiziano, J. Veillet, M. Bayés, F. Nolent, V. Garcia, S.<br />

Servidei, E. Bertini, F. Castro-Giner, Y. Renda, S.<br />

Carpentier, N. Andrieu-Abadie, I. Gut, T. Levade, H.<br />

Topaloglu.<br />

55/11:15 Genetic variants in chromatin modifying<br />

genes cause D4Z4 hypomethylation, DUX4<br />

expression, and contraction-independent<br />

facioscapulohumeral muscular dystrophy (FSHD2).<br />

D. G. Miller, R. J. L. F. Lemmers, L. M. Petek, J. Balog,<br />

P. J. van der Vliet, G. J. Block, J. W. Lim, G. N.<br />

Filippova, A. M. Amell, G. W. E. Santen, B. Bakker, M.<br />

J. Bamshad, S. J. Tapscott, R. Tawil, S. M. van der<br />

Maarel.<br />

56/11:30 Unexpected extension <strong>of</strong> the phenotype<br />

spectrum associated with SMAD3 mutations in<br />

aneurysms-osteoarthritis syndrome. M. Aubart, D.<br />

Gobert, N. Hanna, C. Muti, J. Roume, V. Cusin, B.<br />

Grandchamp, L. Gouya, D. Detains, G. Jondeau, C.<br />

Boileau.<br />

57/11:45 Whole-exome sequencing for autosomal<br />

recessive non-syndromic deafness: 93% <strong>of</strong> known<br />

genes covered and OTOGL and SLITRK6 are novel<br />

genes. M . Tekin, O. Diaz-Horta, D. Duman, J. Foster II,<br />

A. Sirmaci, M. Gonzalez, N. Mahdieh, M. Bonyadi, F.<br />

B. Cengiz, R. Ulloa, S. Zuchner, S. Blanton.<br />

58/12:00 Whole exome sequencing and more to<br />

unravel the genetics and genotype-phenotype<br />

correlations for deafness. H. Kremer, M. Schraders,<br />

C. Zazo Seco, J. Oostrik, I. Feenstra, A. M. M. Oonk,<br />

E. van Beelen, M. van Bers, K. Neveling, J. A. Veltman,<br />

R. J. C. Admiraal, H. P. M. Kunst, R. J. E. Pennings, E.<br />

H. Hoefsloot.<br />

INVITED AND PLATFORM SESSIONS 77<br />

59/12:15 A mutation in Ca2+ binding protein 2,<br />

expressed in cochlear inner hair cells, causes<br />

autosomal recessive hearing impairment.<br />

I . Schrauwen, S. Helfmann, A. Inagaki, F. Wolk,<br />

M. A. Tabatabaiefar, M. M. Picher, M. Sommen,<br />

C. Zazo Seco, H. Kremer, A. Dheedene, C. Claes,<br />

E. Fransen, M. A. Chaleshtori, P. Coucke, A. Lee,<br />

T. Moser, G. Van Camp.<br />

60/12:30 Comprehensive diagnosis for hearing loss<br />

using personal genomics: The first 100 cases.<br />

E . Shearer, E. A. Black-Ziegelbein, M. S. Hildebrand,<br />

A. P. DeLuca, R. W. Eppsteiner, S. E. Scherer,<br />

T. E. Scheetz, T. L. Casavant, R. J. H. Smith.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


78 INVITED AND PLATFORM SESSIONS<br />

Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 17 – Chromosomes and Disease<br />

Room 132, Lower Level North, Moscone Center<br />

Moderators: Christa Lese Martin, Emory Univ.; Blake<br />

Ballif, Signature Genomics, Spokane, WA<br />

61/10:30 Characterization <strong>of</strong> de novo copy-number<br />

variations in two subjects with a constitutional<br />

“CNV mutator” phenotype. P. Liu, K. Walter, K. Writzl,<br />

V. Gelowani, S. Lindsay, C. M. B. Carvalho, M.<br />

Withers, J. Wiszniewska, A. Patel, B. Rautenstrauss,<br />

M. Hurles, J. R. Lupski.<br />

62/10:45 Associations between gene expression<br />

and phenotypes in 16p11.2 rearrangements.<br />

E. Migliavacca, K. Mannik, F. Zufferey, N. D. Beckmann,<br />

L. Harewood, A. Mace, Z. Kutalik, L. Hippolyte, A.<br />

Maillard, V. Siffredi, R. M. Witwicki, G. Didelot, S.<br />

Jacquemont, S. Bergmann, J. S. Beckmann, 16p11.2<br />

European Consortium Collaborators.<br />

63/11:00 De novo triplication can arise from a<br />

duplication <strong>of</strong> the 17p12 region and confers a<br />

severe Charcot-Marie-Tooth, type 1A phenotype.<br />

V. Gelowani, P. Liu, F. Zhang, S. B. Shachar, S. D.<br />

Batish, E. Roney, V. Drory, A. Orr-Urtreger, J. R. Lupski.<br />

64/11:15 A long, non-coding RNA from the Prader-<br />

Willi critical region forms a subnuclear cloud and<br />

recruits transcriptional activating complexes to the<br />

SNORD 116 locus in postnatal neurons. W . T.<br />

Powell, R. Coulson, F. Crary, S. Wong, D. H. Yasui,<br />

J. M. LaSalle.<br />

65/11:30 Molecular analysis <strong>of</strong> patients whose<br />

clinical features overlap the 22q11.2 deletion<br />

syndrome. S. Saitta, T. Busse, D. McDonald-McGinn,<br />

E. Zackai, S. Woyciechowski, J. Garbarini, E.<br />

Goldmuntz, C. Van Ravenswaaij, L. Hoefsloot, B.<br />

Emanuel, D. Driscoll.<br />

66/11:45 Mouse model implicates GNB3copy<br />

number in a novel childhood obesity syndrome.<br />

I. S. Goldlust, K. E. Hermetz, L. M. Catalano, R. A.<br />

Cozad, R. T. Barfield, K. N. Conneely, J. G. Mulle, S.<br />

Dharamrup, M. Hegde, K. Kim, B. Angle, A. Colley, A.<br />

E. Webb, E. C. Thorland, J. Ellison, J. Rosenfeld, B. C.<br />

Ballif, L. G. Shaffer, L. A. Demmer, Unique Rare<br />

Chromosome Support, M. K. Rudd.<br />

67/12:00 Modeling neurogenesis impairment in<br />

Down syndrome using induced pluripotent stem<br />

cells from monozygotic twins discordant for<br />

trisomy 21. Y. Hibaoui, I. Grad, S. R. Sailani, A.<br />

Letourneau, S. Dahoun, S. Gimelli, M. F. Pelte, F.<br />

Béna, S. E. Antonarakis, A. Feki.<br />

68/12:15 Discovery and interpretation <strong>of</strong> balanced<br />

chromosomal aberrations in neurodevelopmental<br />

abnormalities and prenatal diagnostics. M. E.<br />

Talkowski, V. Pillalamarri, I. Blumenthal, C. Hanscom,<br />

Z. Ordulu, J. Rosenfeld, L. G. Shaffer, J. F. Gusella, C.<br />

C. Morton.<br />

69/12:30 Predisposition <strong>of</strong> acrocentric short arm<br />

fusions due to nuclear location, nucleolar<br />

disorganization, and telomere-induced DNA<br />

damage. K. M. Stimpson, L. L. Sullivan, S. Chen, B.<br />

A. Sullivan.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 18 – Prenatal and Perinatal <strong>Genetics</strong><br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Natalie Blagowidow, Harvey Inst. for<br />

<strong>Human</strong> Genet., Baltimore; David Chitayat, Mount Sinai<br />

Hosp., Toronto, Canada<br />

70/10:30 Lessons learned from next-gen<br />

cytogenetics: Whole genome sequence-based<br />

prenatal diagnosis <strong>of</strong> apparently balanced de novo<br />

chromosome rearrangements. Z. Ordulu,<br />

M. Talkowski, V. Pillalamarri, S. Pereira, I. Blumenthal,<br />

C. Hanscom, A. M. Lindgren, N. Hussain, S. Connolly,<br />

L. E. Wilkins-Haug, J. F. Gusella, C. C. Morton.<br />

71/10:45 The use <strong>of</strong> chromosome microarray<br />

analysis as a first-line test in pregnancies with a<br />

priori low risk for detection <strong>of</strong> submicroscopic<br />

chromosomal abnormalities. F. Fiorentino,<br />

S. Napoletano, C. Caiazzo, M. Sessa, S. Bono,<br />

L. Spizzichino, S. Michiorri, A. Gordon, A. Nuccitelli,<br />

G. Rizzo, M. Baldi.<br />

72/11:00 The challenge <strong>of</strong> preconceptional,<br />

preimplantation, and prenatal genetic diagnoses <strong>of</strong><br />

mitochondrial DNA disorders. J. Steffann, S.<br />

Monnot, N. Gigarel, P. Vachin, E. Herzog, P. Burlet,<br />

N. Frydman, A. Benachi, G. Chalouhi, Y. Ville, R.<br />

Frydman, A.-S. Lebre, A. Rotig, D. C. Samuels, C. Elie,<br />

A. Munnich, J.-P. Bonnefont.<br />

73/11:15 The incidence and spectrum <strong>of</strong> genomic<br />

imbalance in products <strong>of</strong> conception: New insights<br />

from SNP microarray analysis <strong>of</strong> 2,400 miscarriage<br />

specimens. B. Levy, S. Sigurjonsson, B. J. Pettersen,<br />

M. K. Maisenbacher, Z. P. Demko, R. Lathi, R. Tao,<br />

V. Aggarwal, M. Rabinowitz.<br />

74/11:30 Noninvasive whole-genome sequencing <strong>of</strong><br />

a human fetus. J. O. Kitzman, M. W. Snyder, M.<br />

Ventura, A. P. Lewis, R. Qiu, L. E. Simmons, H. S.<br />

Gammill, C. E. Rubens, D. A. Santillan, M. K. Santillan,<br />

J. C. Murray, H. K. Tabor, M. J. Bamshad, E. E. Eichler,<br />

J. A. Shendure.<br />

75/11:45 Spina bifida risk is conferred by multiple<br />

polymorphisms in folate one-carbon pathway<br />

genes. D. Gilbert, K. Lazaruk, J. Stein, J. Hardin, J.<br />

Witte, G. Shaw, E. Lammer, N. Marini, J. Rine.<br />

76/12:00 Bioinformatics approach for identifying the<br />

genetic contributions to preeclampsia. A.Uzun,<br />

I. Kurihara, J. Tavormina, R. Cabezas, A. Laliberte,<br />

A. Dewan, E. Triche, J. Padbury.<br />

INVITED AND PLATFORM SESSIONS 79<br />

77/12:15 Antenatal spectrum <strong>of</strong> CHARGE syndrome<br />

in 40 fetuses with CHD7 mutations. M. Legendre,<br />

M. Gonzales, G. Goudefroye, F. Bilan, P. Parisot,<br />

M. J. Perez, M. Bonnière, B. Bessières, J.<br />

Martinovic, A.-L. Delezoide, F. Jossic, C. Fallet-<br />

Bianco, M. Bucourt, J. Tantau, P. Loget, L. Loeuillet,<br />

N. Laurent, B. Leroy, H. Salhi, C. Rouleau, F. Guimiot,<br />

C. Chelin, A. Bazin, C. Alby, A. Kitzis, Y. Ville,<br />

F. Encha-Razavi, B. GilbertDussardier, M. Vekemans,<br />

T. Attié-Bitach, SOFFOET.<br />

78/12:30 Genetic normalization <strong>of</strong> day-3 embryos:<br />

Results from two independent preimplantation<br />

genetic screening laboratories. P. Brezina,<br />

E. Littman, Y. Sun, V. Phan, R. Anchan, A. Barker,<br />

M. Hughes, G. R. Cutting, W. G. Kearns.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


80 INVITED AND PLATFORM SESSIONS<br />

Wednesday, November 7<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session A (11-19)<br />

SESSION 19 – Vascular and Congenital Heart Disease<br />

Room 123, Lower Level North, Moscone Center<br />

Moderators: Amy Roberts, Children’s Hosp. Boston;<br />

Bart L. Loeys, Univ. <strong>of</strong> Antwerp., Belgium<br />

79/10:30 Heterozygous germline mutations in a<br />

prototypical TGF repressor cause Shprintzen-<br />

Goldberg syndrome with aortic aneurysm. A. J.<br />

Doyle, J. J. Doyle, M. E. Lindsay, S. L. Bessling, N.<br />

Huso, D. Schepers, L. Gillis, G. Mortier, L. Van Laer,<br />

D. W. Mohr, M. J. Caulfield, A. F. Scott, C. J. Curry, B.<br />

Loeys, A. S. McCallion, H. C. Dietz.<br />

80/10:45 Loss-<strong>of</strong>-function mutations inTGFB2<br />

cause Loeys-Dietz syndrome: Towards solving the<br />

TGF� paradox in aortic aneurysmal disease.<br />

B. Loeys, M. E. Lindsay, D. Schepers, N. Ajit Bolar,<br />

J. Doyle, E. Gallo, J. Fert-Bober, M. J. E. Kempers,<br />

E. Fishman, Y. Chen, L. Myers, D. Bjeda, G. Oswald,<br />

B. M. Anderlid, M. Y. Yang, E. M. H. F. Bongers,<br />

J. Timmermans, A. C. Braverman, N. Canham,<br />

G. R. Mortier, H. G. Brunner, P. H. Byers, J. Van Eyk,<br />

L. Van Laer, H. Dietz.<br />

81/11:00 Genetic dissection <strong>of</strong> aortic disease in the<br />

Marfan syndrome. F. Ramirez, L. Carta, M. Del Solar,<br />

M. Lindsay, H. Dietz, J. R. Cook.<br />

82/11:15 Bicuspid aortic valve, aortic coarctation<br />

and patent ductus associated with MATR3<br />

disruption in human and mouse. F. Quintero-<br />

Rivera, Q. J. Xi, K. M. Keppler-Noreuil, J. H. Lee, A.<br />

W. Higgins, R. Anchan, A. E. Roberts, G. A. P. Bruns,<br />

R. Berezney, B. D. Gelb, R. V. Lacro, D. J. Harris,<br />

A. Kamp, I. P. Moskowitz, W. Lu, C. C. Morton, J. F.<br />

Gusella, R. L. Maas.<br />

83/11:30 Identification <strong>of</strong> the cause <strong>of</strong> blue rubber<br />

bleb nevus syndrome. J. Soblet, N. Limaye, M.<br />

Cordisco, A. Dompmartin, O. Enjolras, S. Holden, A.<br />

D. Irvine, C. Labrèze, A. Lanoel, P. N. Rieu, S. Syed,<br />

C. J. van der Vleuten, R. Watson, S. J. Fishman, J. B.<br />

Mulliken, L. M. Boon, M. Vikkula.<br />

84/11:45 Identifying genetic determinants <strong>of</strong><br />

congenital heart defect in Down syndrome. M. R.<br />

Sailani, P. Makrythanasis, S. Deutsch, A. Valsesia,<br />

E. Migliavacca, F. Santoni, A. Sharp, C. Serra-Juhe,<br />

S. Vicari, R. Rabionet, Y. Grattau, G. Dembour, A.<br />

Megarbane, R. Touraine, S. Kitsiou, H. Fryssira, C.<br />

Chatzisevastou-Loukidou, E. Kanavakis, G. Merla, L.<br />

Perez-Jurado, X. Estivill, J. Delabar, S. E. Antonarakis.<br />

85/12:00 Transcriptome-wide decreased variation<br />

in gene expression <strong>of</strong> Down syndrome fibroblasts:<br />

Selection or canalization? K. Popadin, A.<br />

Letourneau, F. Santoni, S. E. Antonarakis.<br />

86/12:15 Mutations in OLFML2B within the QT<br />

interval associated region 1q23.3 disturb cardiac<br />

repolarization, predispose to Long-QT syndrome<br />

and to sudden infant death syndrome. A. Pfeufer,<br />

C. Congiu, Z. Schäfer, H. Prucha, M. Vennemann,<br />

I. Sinicina, N. Strutz-Seebohm, H. Kartmann, M.<br />

Schell, E. Kremmer, E. R. Behr, N. H. Bishopric, R. J.<br />

Myerburg, L. Crotti, P. J. Schwartz, A. A. Hicks, P. P.<br />

Pramstaller, W. Rottbauer, S. Kääb, T. Meitinger, M.<br />

Näbauer, M. Cohen, M. Donner, D. T. Mage, H. W.<br />

Mewes, T. Bajanowski, G. Seebohm, M. Ueffing, C. J.<br />

Gloeckner.<br />

87/12:30 The impact <strong>of</strong> inherited genetic variants<br />

associated with lipid pr<strong>of</strong>ile, hypertension, and<br />

coronary artery disease on the risk <strong>of</strong> intracranial<br />

and abdominal aortic aneurysms. F. N. G. van `t<br />

H<strong>of</strong>, Y. M. Ruigrok, A. F. Baas, L. A. L. M. Kiemeney,<br />

S. H. Vermeulen, A. G. Uitterlinden, F. Rivadeneira, A.<br />

H<strong>of</strong>man, G. J. E. Rinkel, P. I. W. de Bakker.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


INVITED AND PLATFORM SESSIONS 81<br />

Wednesday, November 7<br />

4:30 PM–6:30 PM<br />

SESSION 20 – Invited Presidential Symposium: Gene Discovery and Patent Law: Present Experience in the<br />

U.S. and in Europe<br />

Hall D, Lower Level North, Moscone Center<br />

With the present extraordinary pace <strong>of</strong> gene discovery, the question <strong>of</strong> who, if anyone, owns newly discovered<br />

genes will be critical to research and practice in human genetics. This issue was before the U.S. Supreme Court and<br />

remanded to the Federal Circuit Court <strong>of</strong> Appeals as Association for Molecular Pathology et al. v. Myriad <strong>Genetics</strong>,<br />

No. 11-725 where the decision was affirmed. In order to understand the many legal issues represented by this case,<br />

the role <strong>of</strong> this case in the larger context <strong>of</strong> legal issues in genetics, and the consequences <strong>of</strong> the decision on this<br />

case for research and services in human genetics, we have asked a panel <strong>of</strong> experts to educate us.<br />

Hank Greely, Pr<strong>of</strong>essor <strong>of</strong> Law and Director <strong>of</strong> the<br />

Center for Law and Biosciences at Stanford University,<br />

will moderate the panel and present an overview <strong>of</strong><br />

issues on which genetics and the law have come in<br />

contact in the U.S.<br />

Mark Lemley, Pr<strong>of</strong>essor <strong>of</strong> Law and Director <strong>of</strong> the<br />

<strong>Program</strong> in Law, Science, and Technology at Stanford<br />

University, will describe the meaning <strong>of</strong> patents in the<br />

context <strong>of</strong> intellectual property in general and gene<br />

discovery in particular.<br />

Lori Andrews, Pr<strong>of</strong>essor <strong>of</strong> Law at IIT Chicago-Kent<br />

College <strong>of</strong> Law and Fellow <strong>of</strong> the Hastings Institution,<br />

will describe the issues <strong>of</strong> the Myriad case and the<br />

roles <strong>of</strong> lawyers, practitioners and advocates in the<br />

evolution <strong>of</strong> the case.<br />

Gert Matthijs, Pr<strong>of</strong>essor and Head <strong>of</strong> the Laboratory<br />

for Molecular Diagnostics at the Center for <strong>Human</strong><br />

<strong>Genetics</strong> at University <strong>of</strong> Leuven, Belgium, will discuss<br />

the challenge to gene patenting brought to the<br />

European Patent Office by European human<br />

geneticists, the consequences for genetics services <strong>of</strong><br />

the 2008 EPO decisions, and the present issues <strong>of</strong><br />

gene patents in Europe.<br />

We intend these presentations to be educational rather than confrontational. Each speaker will present both their<br />

own views and alternative, opposing points <strong>of</strong> view. Our goal is to understand the complexity <strong>of</strong> these issues<br />

from the legal perspective. Considerable time after the presentations will be devoted to answering questions from<br />

the audience. We hope <strong>ASHG</strong> members will enjoy looking at these questions from a different angle and will find<br />

this perspective useful in their future research.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


82 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 21 – Mendelian Randomization: Using<br />

Genetic Variants to Inform Causality in Observational<br />

Epidemiology<br />

Room 135, Lower Level North, Moscone Center<br />

Moderators: David M. Evans, Univ. <strong>of</strong> Bristol, U.K.; Lyle<br />

J. Palmer, Univ. <strong>of</strong> Ontario, Canada<br />

A central problem in classical observational<br />

epidemiology concerns whether an association<br />

between a medically relevant exposure and a disease<br />

outcome reflects a causal relationship, or whether the<br />

purported association is a spurious result <strong>of</strong> latent<br />

confounding, bias or reverse causality. For example,<br />

does an inverse correlation between red wine drinking<br />

and heart disease, mean that red wine prevents<br />

heart attacks? The gold standard in proving whether<br />

an association reflects a causal relationship is the<br />

randomized controlled trial (RCT), in which participants<br />

are randomly assigned into groups that differ on<br />

average only in terms <strong>of</strong> their treatment (exposure)<br />

effect. However, RCTs are typically expensive, <strong>of</strong> long<br />

duration and in some cases, ethically or practically<br />

infeasible to implement. Mendelian randomization<br />

is a relatively new methodology that uses genetic<br />

variants that have been robustly associated with<br />

medically relevant exposures from genetic association<br />

studies (e.g. genetic variants related to BMI, smoking,<br />

alcohol etc.) to determine whether these exposures<br />

are truly causally related to disease outcomes. This<br />

session describes the principles behind Mendelian<br />

randomization, explains how Mendelian randomization<br />

can be used in epidemiological and gene expression<br />

studies to assess causality, describes its assumptions<br />

and limitations, and finally discusses extensions and<br />

promising alternatives to the method.<br />

8:00 AM Mendelian randomization: Overcoming<br />

the limitations. G . D. Smith. Univ. <strong>of</strong> Bristol, U.K.<br />

8:30 AM Utilizing multiple variants to improve<br />

Mendelian randomization studies. B . Pierce. Univ.<br />

<strong>of</strong> Chicago.<br />

9:00 AM Application <strong>of</strong> Mendelian randomization<br />

analyses in prospective studies from Denmark.<br />

A. Tybjærg-Hansen. Univ. <strong>of</strong> Copenhagen, Denmark.<br />

9:30 AM Mendelian randomization for HDL levels<br />

and implications for clinical risk prediction.<br />

B. F. Voight. Univ. <strong>of</strong> Pennsylvania Sch. <strong>of</strong> Med.<br />

Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 22 – Common and Rare CNVs: Genesis,<br />

Patterns <strong>of</strong> Variations and <strong>Human</strong> Diseases<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: Chack Yung Yu, Nationwide Children’s<br />

Hosp. and The Ohio State Univ.; Edward J. Hollox,<br />

Univ. <strong>of</strong> Leicester, U.K.<br />

Copy number variation (CNV) is a part <strong>of</strong> human<br />

genomic variation. There are two types <strong>of</strong> CNVs. The<br />

first type is common CNVs that occur at regions with<br />

complex genomic structures and engage genes<br />

involving in gene-environment interactions. The<br />

diversity <strong>of</strong> common CNVs both in terms <strong>of</strong> copy<br />

number and sequence variation is remarkable, yet<br />

because <strong>of</strong> their complex and challenging nature, they<br />

are under-studied. The second type is de novo or<br />

recent CNVs involved deletions and duplications <strong>of</strong><br />

genomic DNA fragments that are rare individually but<br />

moderately frequent collectively, particularly among<br />

subjects with developmental, neurologic and<br />

psychiatric disorders. This session will highlight the<br />

complexity <strong>of</strong> common CNVs and discuss their roles in<br />

immune-mediated and cognitive diseases. In addition,<br />

the session will feature mechanistic studies to<br />

understand the generation <strong>of</strong> CNVs, and illustrate<br />

techniques for the detection and quantification <strong>of</strong><br />

common and rare CNVs.<br />

8:00 AM CNVs engaged in immune complex<br />

handling and autoimmune diseases: Complement<br />

C4 and immunoglobulin Fc-gamma receptors.<br />

C. Y. Yu. Nationwide Children’s Hosp. and The Ohio<br />

State Univ.<br />

8:30 AM <strong>Human</strong> lineage-specific CNVs: DUF 1220<br />

domain copy number linked to cognitive disease<br />

and brain evolution. J. M. Sikela. Univ. <strong>of</strong> Colorado<br />

Sch. <strong>of</strong> Med., Aurora.<br />

8:55 AM TAR: A mixed genomic disorder caused<br />

by a low-frequency regulatory SNP combined with<br />

a 1q21.1 microdeletion. W. H. Ouwehand. Cambridge<br />

Univ. and Wellcome Trust Sanger Inst., Cambridge,<br />

U.K.<br />

9:20 AM Genetic and environmental risk factors<br />

for de novo CNVs. T. W. Glover. Univ. <strong>of</strong> Michigan.<br />

9:40 AM Frequency estimation <strong>of</strong> low-level<br />

somatic mosaicism for pathogenic CNVs.<br />

P. T. Stankiewicz. Baylor Col. <strong>of</strong> Med.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 23 – Advancing Gene Therapy to the Clinic:<br />

Molecular Medicines Come <strong>of</strong> Age<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderator: Beverly Davidson, Univ. <strong>of</strong> Iowa<br />

The first evidence for uptake and expression <strong>of</strong><br />

exogenous DNA in mammalian cells occurred in the<br />

60s and 70s, and in 1980 the first experiment was<br />

performed in which patients were given plasmid DNA<br />

expressing protein lacking in their blood cells. Over the<br />

next 25 years researchers focused on improved vector<br />

development and better delivery modalities, along with<br />

more appropriate clinical trial design, to improve<br />

the chances to positively impact disease course in<br />

patients with genetic diseases. In this symposium we<br />

will present exciting advances in gene therapy for the<br />

eye (Jean Bennett), the liver (Kathy High), blood<br />

disorders (Maria-Gracia Roncolo), the leukodystrophies<br />

(Nathalie Cartier), and lysosomal storage diseases<br />

affecting the brain (Beverly Davidson). Data presented<br />

will span from preclinical studies in animal models to<br />

advanced clinical trials in affected individuals using<br />

several vector platforms.<br />

8:00 AM Safety and efficacy <strong>of</strong> AAV-mediated<br />

gene transfer to liver for severe hemophilia B.<br />

K. High. Children’s Hosp. <strong>of</strong> Philadelphia.<br />

8:25 AM Safety and efficacy after AAV2<br />

re- administration in subjects with congenital<br />

blindness due to RPE65 mutations. J. Bennett. Univ.<br />

<strong>of</strong> Pennsylvania.<br />

8:45 AM Advancing gene therapy for ADA-SCID<br />

and beyond. M- G. Roncarolo. Univ. Vita-Salute San<br />

Raffaele., Milan, Italy.<br />

9:10 AM Gene therapy for the leukodystrophies.<br />

N. Cartier. Saint Vincent de Paul Hosp., Paris, France.<br />

9:30 AM AAV gene therapy for childhood onset<br />

neurological disease caused by lysosomal enzyme<br />

deficiencies. B. Davidson. Univ. <strong>of</strong> Iowa.<br />

INVITED AND PLATFORM SESSIONS 83<br />

Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 24 – RNA Splicing in <strong>Human</strong> Development,<br />

Diseases and Natural Variation<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: David E. Symer, The Ohio State Univ.<br />

Comprehen. Cancer Ctr.; Richard A. Padgett, Lerner<br />

Res. Inst., Cleveland<br />

RNA splicing has been identified and studied for<br />

decades, but its roles in normal human biology and in<br />

contributing to human diseases have not been fully<br />

described to date. The presentations in this session<br />

will address the latest breakthroughs in understanding<br />

how RNA splicing and processing contribute to human<br />

development, diseases including various cancers and<br />

neurodegeneration, and natural variation. Also<br />

discussed will be the development <strong>of</strong> animal models<br />

<strong>of</strong> aberrant RNA splicing, and optimization <strong>of</strong> the latest<br />

technologies <strong>of</strong> RNA-seq and bioinformatics analysis<br />

<strong>of</strong> RNA splicing variation.<br />

8:00 AM Functional consequences <strong>of</strong> minor<br />

spliceosomal snRNA mutations in human<br />

development and natural variation. D. E. Symer.<br />

The Ohio State Univ. Comprehen. Cancer Ctr.<br />

8:25 AM Multicopy snRNA genes and<br />

neurodegeneration. S. L. Ackerman. HHMI/The<br />

Jackson Lab., Bar Harbor, ME.<br />

8:50 AM Understanding the chemical mechanisms<br />

and biological implications <strong>of</strong> splicing reactions.<br />

R. A. Padgett. Lerner Res. Inst., Cleveland.<br />

9:15 AM Overlaying RNA maps onto human<br />

disease. R. B. Darnell. HHMI and Rockefeller Univ.<br />

9:40 AM “Seq-ins” the Myotonic Dystrophy Transcriptome.<br />

E. Wang. MIT<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


84 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 25 – Genomic Medicine: ELSI Goes<br />

Mainstream<br />

Room 132, Lower Level North, Moscone Center<br />

Moderators: Wylie Burke, Univ. <strong>of</strong> Washington; James<br />

P. Evans, Univ. <strong>of</strong> North Carolina at Chapel Hill<br />

Next-generation sequencing <strong>of</strong> the human genome<br />

has the potential to predict disease risk, identify<br />

disease causation, and refine therapeutic interventions.<br />

As research-based sequencing moves into clinical<br />

practice, however, a number <strong>of</strong> ethical and social<br />

questions will enter mainstream practice, and will need<br />

to be addressed in a practical manner to inform best<br />

practices. For example, how do key stakeholders<br />

(patients, providers, researchers, and the public) view<br />

the risks and benefits <strong>of</strong> genome sequencing, and how<br />

can benefits be optimized and risks mitigated? How<br />

do we address children’s rights as well as other family<br />

members’ rights with respect to potentially shared<br />

information learned from sequencing individuals?<br />

Empirical data can contribute to a better<br />

understanding <strong>of</strong> these issues; but what kinds <strong>of</strong> data<br />

are most relevant and how can they be used to inform<br />

practice and policy? How do we navigate the<br />

increasingly blurred line between research and clinical<br />

care? These issues will be discussed and empirical<br />

data presented by a panel <strong>of</strong> experts investigating the<br />

ethical and social issues <strong>of</strong> genome sequencing in a<br />

variety <strong>of</strong> research and patient populations.<br />

8:00 AM Views <strong>of</strong> patients, parents <strong>of</strong> patients,<br />

and clinicians toward whole genome sequencing<br />

for clinical care management. A. A. Lemke. Med.<br />

Col. <strong>of</strong> Wisconsin.<br />

8:30 AM My46: An innovative web-based<br />

approach to managing and returning results from<br />

exome and whole genome sequencing. H. K. Tabor.<br />

Seattle Children’s Hosp.<br />

9:00 AM Returning “actionable” results to family<br />

members in a pancreatic cancer biobank: Views <strong>of</strong><br />

probands and family members. B. Koenig. Sch. <strong>of</strong><br />

Nursing, UCSF.<br />

9:20 AM Approaches and attitudes on return <strong>of</strong><br />

WGS/WES results. K. Ormond. Stanford Univ.<br />

9:40 AM Next steps in development <strong>of</strong> best<br />

practices for use <strong>of</strong> genome sequencing in clinical<br />

care. A. McGuire. Baylor Col. <strong>of</strong> Med.<br />

Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 26 – Model Organism <strong>Genetics</strong>, <strong>Human</strong><br />

Biology and <strong>Human</strong> Disease<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Phil Hieter, Univ. <strong>of</strong> British Columbia; Hal<br />

Dietz, Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />

Yeast, worms, flies, zebrafish, and mice are key<br />

‘model’ organisms that <strong>of</strong>fer powerful experimental<br />

approaches for the study <strong>of</strong> biological processes<br />

relevant to human biology and disease. The genome<br />

sequencing projects <strong>of</strong> the 1990s reemphasized the<br />

striking extent to which all organisms are built from the<br />

same genes, and highlighted the enormous value <strong>of</strong><br />

model experimental organisms for the study <strong>of</strong><br />

evolutionarily conserved gene function. Few, if any,<br />

processes at the gene level are known to be unique to<br />

humans. Indeed, key aspects <strong>of</strong> most human<br />

disorders can be modeled in experimentally tractable<br />

organisms through the analysis <strong>of</strong> orthologous genes<br />

and pathways, using the genetic, biochemical and cell<br />

biological toolboxes that have been developed in each<br />

model organism. This symposium will accent the<br />

current relevance <strong>of</strong> model organism studies for the<br />

understanding, diagnosis, and treatment <strong>of</strong> human<br />

disease, and anticipate the future role <strong>of</strong> model<br />

organisms in human disease research. We chose to<br />

highlight a diverse set <strong>of</strong> biological processes and<br />

experimental systems to make the point that the<br />

principles <strong>of</strong> cross species analysis <strong>of</strong> basic gene<br />

function extend to the study <strong>of</strong> all human disorders.<br />

8:00 AM Budding yeast: Lessons from yeast<br />

applied to the study <strong>of</strong> human genetic diseases <strong>of</strong><br />

protein traffic. R. Schekman. Univ. <strong>of</strong> California,<br />

Berkeley.<br />

8:30 AM The nematode worm: Mechanisms<br />

regulating aging in worms and man. C. Kenyon.<br />

UCSF.<br />

9:00 AM The zebrafish: Zebrafish heart<br />

development and function. D. Stainier. Max Planck<br />

Inst. for Heart and Lung Res., Bad Nauheim, Germany.<br />

9:30 AM The laboratory mouse: Mouse models <strong>of</strong><br />

glaucoma and retinal ganglion cell loss. S. John.<br />

HHMI/The Jackson Lab., Bar Harbor, ME.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 27 – Next-Generation Sequencing in Isolated<br />

Populations: Opportunities for Accelerated Gene<br />

Discovery in Complex Traits<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: William K. Scott, Univ. <strong>of</strong> Miami; Jeffrey R.<br />

O’Connell, Univ. <strong>of</strong> Maryland Baltimore<br />

This session will present recent developments in the<br />

application <strong>of</strong> whole-exome or whole-genome<br />

sequencing (collectively `next-generation sequencing’<br />

or NGS) in samples from genetically isolated<br />

populations. Such populations have long been the<br />

focus <strong>of</strong> gene discovery efforts for complex traits<br />

because <strong>of</strong> the hypothesized reduction in the genetic<br />

complexity <strong>of</strong> the trait, and the enrichment <strong>of</strong> rare<br />

alleles. Prior genome-wide linkage efforts could detect<br />

large genomic regions potentially harboring rare<br />

alleles, while genome-wide association efforts could<br />

detect smaller areas with more common alleles. NGS<br />

allows the direct examination <strong>of</strong> both common and<br />

rare alleles and can be analyzed in both frameworks.<br />

Characterisics <strong>of</strong> isolated population may facilitate the<br />

blending <strong>of</strong> NGS with these prior approaches, by deep<br />

sequencing a small number <strong>of</strong> individuals to use as a<br />

reference panel for imputation within pedigrees or on<br />

the population level, by `filtering’ detected variants<br />

against pedigree relationships (or kinship estimates) in<br />

individuals with the trait. However, since the structure<br />

<strong>of</strong> the population must be taken into account,<br />

application <strong>of</strong> existing reference panels or methods for<br />

these analyses must be done carefully. The speakers<br />

for this session will discuss approaches to using NGS<br />

data for gene discovery for complex traits in isolated<br />

populations, reviewing methodologic approaches<br />

specific to such studies and illustrating their use in<br />

data sets drawn from such populations.<br />

8:00 AM Using low-pass whole genome<br />

sequencing to create a reference population for<br />

genome imputation in an isolated population:<br />

Examples from the SardiNIA study. S. Sanna.<br />

Cittadella Univ. di Monserrato, Italy.<br />

8:30 AM Fine-mapping linkage <strong>of</strong> age-related<br />

traits using whole-exome sequencing in a<br />

midwestern Amish population sample. W. K. Scott.<br />

Univ. <strong>of</strong> Miami.<br />

9:00 AM The many-<strong>of</strong>-few: The power <strong>of</strong> genetic<br />

isolates for discovery and function <strong>of</strong> rare variants.<br />

J. R. O’Connell. Univ. <strong>of</strong> Maryland Baltimore.<br />

9:30 AM Studying rare variants in the Genetic<br />

Research in Isolated Populations program. C. van<br />

Duijn. Erasmus Med. Ctr. Rotterdam, Netherlands.<br />

INVITED AND PLATFORM SESSIONS 85<br />

Thursday, November 8<br />

8:00 AM–10:00 AM<br />

Concurrent Invited Session II (21-28)<br />

SESSION 28 – Transforming Medical Student Education<br />

in <strong>Genetics</strong> and Genomics: How Do We Improve Health<br />

and Individualize Care through Medical School Genetic<br />

and Genomic Curricula?<br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Joann N. Bodurtha, Johns Hopkins Univ.;<br />

Joan Scott, NCHPEG, Lutherville, MD<br />

This session will provide national perspectives on<br />

integrating genetics and genomics in medical student<br />

education. Controversies, ranging from the marketing<br />

<strong>of</strong> curriculum change to addressing personal<br />

genotyping, and lessons learned will be emphasized.<br />

Challenges in 4-year integration, evaluation, ethical<br />

issues and competing priorities will be included.<br />

Drs. Valle, Burke, and Potocki will describe 3 different<br />

models <strong>of</strong> curriculum development and delivery.<br />

Drs. Demmer and Salari will provide contrasting<br />

experiences in introducing personal genotyping by<br />

students into the curriculum.<br />

8:00 AM Genes to <strong>Society</strong>—3 years <strong>of</strong><br />

implementation. D. Valle. Johns Hopkins Univ.<br />

8:30 AM The Vermont Integrated Curriculum: The<br />

UVM experience. L. Burke. Univ. <strong>of</strong> Vermont Col. <strong>of</strong><br />

Med.<br />

8:55 AM Effecting change: Building a genetics<br />

curriculum that supports the physicians <strong>of</strong><br />

tomorrow. L. Potocki. Baylor Col. <strong>of</strong> Med.<br />

9:20 AM Lessons learned from the introduction <strong>of</strong><br />

personalized genotyping into a medical school<br />

curriculum. L. Demmer. Carolinas Medical Center.<br />

9:40 AM Personal genotyping in a medical school<br />

curriculum on genomics and personalized<br />

medicine. K. Salari. Stanford Univ. Sch. <strong>of</strong> Med.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


86 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 29 – Next-Generation Sequencing: Methods<br />

and Applications<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: John S. Witte, UCSF; Priya Duggal, Johns<br />

Hopkins Bloomberg Sch <strong>of</strong> Publ. Hlth.<br />

88/10:30 The value <strong>of</strong> population-specific reference<br />

panels for genotype imputation in the age <strong>of</strong><br />

whole-genome sequencing. C. Fuchsberger, B.<br />

Howie, M. Laakso, M. Boehnke, G. Abecasis on behalf<br />

<strong>of</strong> <strong>Genetics</strong> <strong>of</strong> Type-2 Diabetes Consortium.<br />

89/10:45 Fast and accurate 1000 Genomes<br />

imputation using summary statistics or lowcoverage<br />

sequencing data. B. Pasaniuc, N. Zaitlen,<br />

G. Bhatia, A. Gusev, N. Patterson, A. L. Price.<br />

90/11:00 Accurate haplotype estimation using<br />

phase informative sequencing reads. O. Delaneau,<br />

J.-F. Zagury, J. Marchini.<br />

91/11:15 An LD-based method for genotype calling<br />

and phasing using low-coverage sequencing reads<br />

and a haplotype scaffold. A. Menelaou, J. Marchini.<br />

92/11:30 Mixed functional linear model for<br />

sequence-based quantitative trait association<br />

studies unifying population and family study<br />

designs. M. Cao, Y. Zhu, M. Xiong.<br />

93/11:45 Rare variant extensions <strong>of</strong> the<br />

transmission disequilibrium test detects<br />

associations with autism exome sequence data. Z.<br />

He, B. O’Roak, J. Smith, G. Wang, M. Kan, S. Hooker,<br />

B. Li, N. Krumm, D. Nickerson, E. Eichler, S. Leal.<br />

94/12:00 Methods for noninvasive prenatal<br />

determination <strong>of</strong> fetal genomes. M. W. Snyder,<br />

J. O. Kitzman, M. Ventura, A. P. Lewis, R. Qiu, L. E.<br />

Simmons, H. S. Gammill, C. E. Rubens, D. A. Santillan,<br />

M. K. Santillan, J. C. Murray, H. K. Tabor, M. J.<br />

Bamshad, E. E. Eichler, J. A. Shendure.<br />

95/12:15 Associating complex traits with rare<br />

variants identified by NGS: Improving power by a<br />

position-dependent kernel approach. U. Bodenh<strong>of</strong>er,<br />

S. Hochreiter.<br />

96/12:30 The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health and<br />

Aging: Demographic and behavioral influences on<br />

telomeres and relationship with all-cause mortality.<br />

C. Schaefer, S. Sciortino, M. Kvale, K. Lapham, J. Lin,<br />

D. Ranatunga, S. Rowell, M. Sadler, S. Miles,<br />

W. McGuire, D. Ludwig, L. Walter, I. Listerman, S. Van<br />

Den Eeden, R. Whitmer, C. Quesenberry, N. Risch,<br />

E. Blackburn.<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 30 – <strong>Genetics</strong> and Intellectual Disability<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Roger Reeves, Johns Hopkins Univ.; Heidi<br />

Rehm, Harvard Univ.<br />

97/10:30 Diagnostic exome sequencing in patients<br />

with intellectual disability <strong>of</strong> unknown cause. J. de<br />

Ligt, M. H. Willemsen, B. W. M. van Bon, T. Kleefstra,<br />

H. G. Yntema, T. Kroes, A. T. Vulto-van Silfhout, D. A.<br />

Koolen, P. de Vries, C. Gilissen, A. Hoischen, H.<br />

Scheffer, B. B. A. de Vries, H. G. Brunner,<br />

J. A. Veltman, L. E. L. M. Vissers.<br />

98/10:45 C-terminal deletions <strong>of</strong> the AUTS2 locus<br />

cause distinct syndromic features and cognitive<br />

impairment. E. Voorhoeve, G. Beunders, C. Golzio, L.<br />

Pardo, J. Rosenfeld, M. Talkowski, I. Simonic, A.<br />

Lionel, S. Vergult, R. Pyatt, J. van de Kamp, A. Nieuwint,<br />

M. Weiss, P. Rizzu, D. Posthuma, L. Verwer, H.<br />

Meijers-Heijboer, B. Menten, G. Mortier, S. Scherer,<br />

E. Eichler, S. Girirajan, N. Katsanis, A. Gr<strong>of</strong>fen, E.<br />

Sistermans.<br />

99/11:00 Autism traits in the RASopathies. I. Corbin,<br />

G. Desachy, K. Rauen, L. Weiss.<br />

100/11:15 Identification <strong>of</strong> novel recessive<br />

mutations in genes for intellectual disability. B. De<br />

Vries, J. H. M. Schuurs-Hoeijmakers, A. T. Vulto-van<br />

Silfhout, L. E. L. M. Vissers, J. de Ligt, C. Gilissen,<br />

I. van de Vondervoort, M. T. Greally, C. W. Ockeloen,<br />

M. H. Willemsen, E. M. Bongers, G. Hira, J. Y. Hehir-<br />

Kwa, R. Pfundt, T. Kleefstra, K. Neveling, S. Reinateo,<br />

A. Vitello, P. Failla, D. Greco, M. Fichera, O. Galesi,<br />

B. W. M. van Bon, J. A. Veltman, C. Romano,<br />

M. A. Willemsen, H. G. Brunner, H. van Bokhoven,<br />

A. P. M. de Brouwer.<br />

101/11:30 Causal de novo SNVs, indels and CNVs in<br />

children with undiagnosed developmental<br />

disorders. M. Hurles, M. van Kogelenberg, K. Morley,<br />

T. Fitzgerald, S. Gerety, A. Tivey, S. Gribble, S. Al-Turki,<br />

S. Clayton, C. Wright, J. Barrett, H. Firth, D.<br />

FitzPatrick, N. Carter on behalf <strong>of</strong> DDD Project.<br />

102/11:45 Making headway with the molecular and<br />

clinical definition <strong>of</strong> rare genetic disorders with<br />

intellectual disability. M. H. Willemsen, W. M.<br />

Wissink-Lindhout, L. E. M. Vissers, A. P. M. de<br />

Brouwer, J. H. M. Rensen, N. de Leeuw, R. Pfundt, H.<br />

G. Yntema, J. de Ligt, J. A. Veltman, H. G. Brunner,<br />

H. M. J. Lantman - de Valk, B. C. J. Hamel, H. van<br />

Bokhoven, T. Kleefstra.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37) (SESSION 30, continued)<br />

103/12:00 MBD5 dosage affects multiple<br />

neurodevelopmental pathways in common with<br />

other genetic syndromes. S. V. Mullegama, J. A.<br />

Rosenfeld, C. Orellana, B. W. M. van Bon, E. A.<br />

Repnikova, L. Brick, L. Dupuis, D. J. Stavropoulos, D.<br />

L. Thrush, J. G. Foster, K. Manickam, A. Lin, J. C.<br />

Hodge, M. E. Talkowski, J. F. Gusella, S. Schwartz, S.<br />

Aradhya, R. E. Pyatt, B. B. A. de Vries, R. Mendoza-<br />

Londono, L. G. Shaffer, S. H. Elsea.<br />

104/12:15 Exome sequencing in X-linked<br />

intellectual disability family assess the role <strong>of</strong><br />

the KIAA2022 gene in the etiology <strong>of</strong> intellectual<br />

disability. M. Rio, S. Mouton, AC. Mazery, C. Bole-<br />

Feysot, P. Nitschke, N. Bahi-Buisson, A. Munnich,<br />

L. Colleaux.<br />

105/12:30 Biallelic mutations <strong>of</strong> a ubiquitin-ligaseencoding<br />

gene cause an Ohdo-like intellectual<br />

disability syndrome. G. Borck, B. Dallapiccola, R.<br />

Ramirez-Solis, A. Segref, H. Thiele, A. Edwards, M. J.<br />

Arends, X. Miro, J. K. White, J. Desir, M. Abramowicz,<br />

M. L. Dentici, K. H<strong>of</strong>mann, A. Har-Zahav, E. Ryder, N.<br />

A. Karp, N. J. Ingham, G. Nuernberg, S. Abdelhak, M.<br />

Pasmanik-Chor, O. Konen, R. I. Kelley, M. Shohat, P.<br />

Nuernberg, J. Flint, K. P. Steel, T. Hoppe, C. Kubisch,<br />

D. J. Adams, L. Basel-Vanagaite.<br />

INVITED AND PLATFORM SESSIONS 87<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 31 – GWAS from Head to Toe<br />

Room 135, Lower Level North, Moscone Center<br />

Moderators: Erik Ingelsson, Karolinska Inst., Sweden;<br />

Nora Franceschini, Univ. <strong>of</strong> North Carolina at Chapel<br />

Hill<br />

106/10:30 Androgenetic alopecia: Identification<br />

<strong>of</strong> four new genetic risk loci and evidence for the<br />

contribution <strong>of</strong> WNT-signaling to its etiology.<br />

S. Heilmann, A. K. Kiefer, N. Kluck, D. Drichel, A. M.<br />

Hillmer, C. Herold, J. Y. Tung, N. Eriksson, S. Redler,<br />

R. C. Betz, R. Li, H. Stefansson, D. R. Nyholt, K. Song,<br />

S. H. Vermeulen, S. Kanoni, G. Dedoussis, N. G.<br />

Martin, L. A. Kiemeney, V. Mooser, K. Stefansson, J. B.<br />

Richards, T. Becker, F. F. Brockschmidt, D. Hinds,<br />

M. M. Nöthen.<br />

107/10:45 A polymorphism in human estrogenrelated<br />

receptor beta is associated with early<br />

indications <strong>of</strong> hearing loss from acoustic overload<br />

in young adult musicians. V. C. Henrich, S. L.<br />

Phillips, S. J. Richter, S. Teglas, R. Morehouse.<br />

108/11:00 Dissection <strong>of</strong> polygenic variation for<br />

human height into individual variants, specific loci<br />

and biological pathways from a GWAS metaanalysis<br />

<strong>of</strong> 250,000 individuals. T. Esko, A. R. Wood,<br />

S. Vedantam, J. Yang, S. Gustaffsson, S. I. Berndt, J.<br />

Karjalainen, H. M. Kang, A. E. Locke, A. Scherag, D.<br />

C. Croteau-Chonka, F. Day, R. Magi, T. Ferreira,<br />

J. Randall, T. W. Winkler, T. Fall, Z. Kutalik, T.<br />

Workalemahu, G. Abecasis, M. E. Goddard, L.<br />

Franke, R. J. F. Loos, M. N. Weedon, E. Ingelsson, P.<br />

M. Visscher, J. N. Hirschhorn, T. M. Frayling, GIANT<br />

Consortium.<br />

109/11:15 Genome-wide association studies metaanalysis<br />

for fracture risk points to loci related to<br />

hormonal and neurological pathways: The GEFOS<br />

Consortium. L. Oei, H. F. Zheng, E. E. Ntzani, C. M.<br />

Nielson, U. Styrkarsdottir, P. M. Ridker, K. K. Tsilidis,<br />

K. Estrada, A. Enneman, A. Vernon-Smith, R. D.<br />

Jackson, S. Trompet, T. Lehtimäki, S. Kaptoge, T. B.<br />

Harris, J. Eriksson, N. Amin, A. Metspalu, P. C. Sham,<br />

E. Evangelou, J. P. A. Ioannidis, G. Thorleifsson, A. G.<br />

Uitterlinden, S. A. Cummings, T. Spector, D. P. Kiel, D.<br />

Chasman, E. Orwoll, J. B. Richards, F. Rivadeneira,<br />

GEFOS Consortium.<br />

110/11:30 Genetic landscape <strong>of</strong> the red blood cell.<br />

J. C. Chambers, P. van der Harst, W. Zhang, I. Mateo<br />

Leach, J. Sehmi, N. Verweij, D. S. Paul, A. Rendon, U.<br />

Elling, H. Allayee, A. Radhakrishnan, J. S. Beckmann,<br />

G. V. Dedoussis, P. Deloukas, A. A. Hicks, S. Sanna,<br />

M. Uda, J. Penninger, C. Gieger, J. S. Kooner, W.<br />

Ouwehand, N. Soranzo, HaemGen RBC Consortium.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


88 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37) (SESSION 31, continued)<br />

111/11:45 Discovery and fine-mapping <strong>of</strong> serum<br />

protein loci through trans-ethnic meta-analysis. A.<br />

P. Morris, Y. Okada, F. J. A. van Rooij, B. P. Prins, M.<br />

F. Feitosa, M. Karakas, J. Felix, B. Z. Alizadeh, L. A.<br />

Cupples, J. R. B. Perry, N. Franceschini, CHARGE<br />

Consortium Protein Working Group.<br />

112/12:00 The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health<br />

and Aging: A genome-wide association study <strong>of</strong><br />

telomere length in a multi-ethnic cohort <strong>of</strong> 100,000<br />

subjects. M. Kvale, K. Lapham, T. H<strong>of</strong>fmann, S.<br />

Sciortino, L. Walter, Y. Banda, I. Listerman, J. Lin, S.<br />

Hesselson, P. Kwok, E. Blackburn, C. Schaefer, N.<br />

Risch.<br />

113/12:15 Heritability <strong>of</strong> the variation in aging in<br />

two longitudinal family cohort studies: SardiNIA/<br />

Progenia Study and Framingham Heart Study. J.<br />

Bragg-Gresham, S. Sanna, C. Sidore, A. Mulas, F.<br />

Busonero, A. Maschio, M. Urru, F. Reinier, R. Berutti,<br />

M. Marcelli, R. Cusano, M. Oppo, D. Pitzalis, M.<br />

Zoledziewska, A. Angius, C. Jones, A. Cao, M. Uda, S.<br />

Kardia, D. Schlessinger, F. Cucca, G. Abecasis.<br />

114/12:30 Over 250 novel associations with human<br />

morphological traits. N. Eriksson, C. B. Do,<br />

J. Y. Tung, A. K. Kiefer, D. A. Hinds, J. L. Mountain,<br />

U. Francke.<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 32 – Cardiovascular <strong>Genetics</strong>: GWAS and<br />

Beyond<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: Cristen J. Willer, Univ. <strong>of</strong> Michigan;<br />

Panagiotis Deloukas, Wellcome Trust Sanger Inst.,<br />

U.K.<br />

115/10:30 Coronary artery disease loci identified in<br />

over 190,000 individuals implicate lipid metabolism<br />

and inflammation as key causal pathways:<br />

Evidence for independent signals in many <strong>of</strong> the<br />

risk loci. S. Kanoni, C. Willenborg, M. Farrall, T. L.<br />

Assimes, J. R. Thompson, E. Ingelsson, D. Saleheen,<br />

J. Erdmann, M. P. Reilly, R. Collins, S. Kathiresan, A.<br />

Hamsten, U. Thorsteinsdottir, J. S. Kooner, J. Danesh,<br />

C. N. A. Palmer, R. Roberts, H. Watkins, H. Schunkert,<br />

N. J. Samani, P. Deloukas for CARDIoGRAMplusC4D<br />

Consortium.<br />

116/10:45 Genome-wide association study in Han<br />

Chinese identifies four new susceptibility loci for<br />

coronary artery disease. D. Gu, X. Lu, L. Wang, S.<br />

Chen, J. Huang, H. Li, X. Yang, Y. Hao, China<br />

Atherosclerosis <strong>Genetics</strong> Consortium.<br />

117/11:00 Discovery <strong>of</strong> 63 novel loci and refinement<br />

<strong>of</strong> known loci associated with lipid levels. C.<br />

Willer, G. R. Abecasis, M. Boehnke, L. A. Cupples, P.<br />

Deloukas, P. W. Franks, S. Gustafsson, E. Ingelsson,<br />

S. Kathiresan, K. L. Mohlke, G. M. Peloso, S. S. Rich,<br />

S. Ripatti, M. Sandhu, E. M. Schmidt, S. Sengupta,<br />

Global Lipids <strong>Genetics</strong> Consortium.<br />

118/11:15 The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health and<br />

Aging: Genome-wide association study <strong>of</strong> plasma<br />

HDL and LDL and treatment response in over<br />

100,000 subjects. T. J. H<strong>of</strong>fmann, M. N. Kvale, Y.<br />

Banda, S. E. Hesselson, L. Walter, S. Sciortino, D. K.<br />

Ranatunga, D. Ludwig, C. Iribarren, R. Grant, P. Kwok,<br />

C. Schaefer, N. Risch.<br />

119/11:30 Genome-wide screen with 1000 Genomes<br />

imputed data identifies 19 new lipid loci and new<br />

variants with stronger effects in previously known<br />

loci. I. Surakka, A.-P. Sarin, R. Mägi, M. Horikoshi, S.<br />

Wiltshire, T. Esko, T. Ferreira, L. Marullo, G.<br />

Thorleifsson, A. Mahajan, S. Hägg, A. Isaacs, M.<br />

Beekman, J. S. Ried, T. W. Winkler, C. P. Nelson, C.<br />

Willenborg, A. Morris, M. I. McCarthy, I. Prokopenko,<br />

S. Ripatti for ENGAGE Consortium.<br />

120/11:45 Rare coding variation and risk for<br />

myocardial infarction: an exome chip study <strong>of</strong><br />

~6,000 cases and controls. R. Do on behalf <strong>of</strong> NHLBI<br />

Exome Sequencing Project - Early Onset Myocardial<br />

Infarction.<br />

121/12:00 High exome mutational burden in 58<br />

African <strong>American</strong>s with persistent extreme blood<br />

pressure. K.-D. H. Nguyen, A. C. Morrison, A. Li,<br />

R. Gibbs, E. Boerwinkle, A. Chakravarti.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37) (SESSION 32, continued)<br />

122/12:15 Chipping a hole-in-one from the FAIRE<br />

way: Use <strong>of</strong> post-GWAS fine-mapping genotyping<br />

arrays for functional variant discovery. A. J. P.<br />

Smith, F. Drenos, P. Howard, C. Giambartolomei, P. J.<br />

Talmud, V. Plagnol, S. E. Humphries.<br />

123/12:30 Strong association <strong>of</strong> one carbon<br />

metabolism genes with stroke and change in postmethionine<br />

load homocysteine levels in the<br />

Framingham Heart and Vitamin Intervention for<br />

Stroke Prevention studies. S. R. Williams, Q. Yang,<br />

F. Chen, X. Liu, K. Keen, P. Jacques, W. M. Chen,<br />

G. Weinstein, F. C. Hsu, A. Beiser, L. Wang,<br />

K. F. Doheny, P. A. Wolf, M. Zilka, J. Selhub,<br />

B. B. Worrall, S. Seshadri, M. M. Sale, Genomics and<br />

Randomized Trials Network (GARNET).<br />

INVITED AND PLATFORM SESSIONS 89<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 33 – Clinical <strong>Genetics</strong>: Mutations, Mutations<br />

and Syndromes<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderators: Nathaniel Robin, Univ. <strong>of</strong> Alabama at<br />

Birmingham; Anne Slavotinek, UCSF<br />

124/10:30 Baraitser-Winter syndrome: Delineation<br />

<strong>of</strong> the phenotypic spectrum in a large series <strong>of</strong><br />

molecularly defined patients. A. Verloes, O. A.<br />

Abdul-Rahman, J. Allanson, J. F. Atkin, M. Baraitser, H.<br />

Brunner, N. Chassaing, K. Devriendt, V. Drouin, A. Fry,<br />

J. P. Fryns, F. Giuliano, K. W. Gripp, D. Lacombe, A.<br />

Lin, G. Mancini, M. Marble, M. Nezarati, M. Nowaczyk,<br />

S. Osimani, M. Rossi, C. Rusu, Y. Sznajer, C. Van<br />

Ravenswaaij, J. Masliah, J. B. Rivière, B. W. M. van<br />

Bon, A. Hoischen, W. Dobyns, D. Pilz.<br />

125/10:45 Three novel mutations in MED12 cause<br />

Ohdo syndrome Maat-Kievit-Brunner type. A. T.<br />

Vulto-van Silfhout, A. Hoischen, B. W. M. van Bon,<br />

W. M. Nillesen, C. Gilissen, F. Gao, J. M. Spaeth, B.<br />

C. Hamel, T. Kleefstra, M. A. A. P. Willemsen, H. van<br />

Bokhoven, H. G. Yntema, B. B. A. de Vries, H. G.<br />

Brunner, T. G. Boyer, A. P. M. de Brouwer.<br />

126/11:00 Heterogeneity <strong>of</strong> mutational mechanisms<br />

and modes <strong>of</strong> inheritance in auriculo-condylar<br />

syndrome. C. Gordon, A. Vuillot, A. Omarjee, S. Park,<br />

J. Horst, R. McGowan, E. Tobias, S. García-Miñaúr, M.<br />

Bitner, L. Jakobsen, P. Kroisel, A. Stewart, R. Palmer,<br />

A. Munnich, M. Holder, A. Lin, A. Henderson, L. Basel-<br />

Vanagaite, E. Gerkes, L. Wilson, M. Cunningham, S.<br />

Marlin, S. Lyonnet, J. Amiel.<br />

127/11:15 Genetic heterogeneity <strong>of</strong> Myhre<br />

syndrome. C. Le G<strong>of</strong>f, C. Michot, C. Mahaut,<br />

A. Abhyankar, W. Le G<strong>of</strong>f, V. Serre, A. Afenjar, A.<br />

Brooks, N. Brunetti-Pierri, P. Campeau, A. Destrée,<br />

M. di Rocco, D. Donnai, R. Hennekam, D. Heron, S.<br />

Jacquemont, S. Mansour, S. Marlin, R. McGowan, H.<br />

Murphy, M. Simon, I. Stolte- Dijkstra, J. Tolmie, R.<br />

Touraine, N. Van der Aa, T. Van Essen, A. Verloes, J. L.<br />

Casanova, A. Munnich, V. Cormier-Daire.<br />

128/11:30 Seven novel families with ADCL favor<br />

clinical and molecular homogeneity. C. Bodemer, B.<br />

Callewaert, M. Kempers, E. Bourrat, M. Renard, O.<br />

Vanakker, F. Malfait, J. De Backer, P. J. Coucke, S.<br />

Hadj-Rabia, A. De Paepe.<br />

129/11:45 Comprehensive clinical and molecular<br />

analysis <strong>of</strong> 12 families with type I recessive cutis<br />

laxa. B. Callewaert, C.-T. Su, T. Van Damme, P.<br />

Vlummens, F. Malfait, O. Vanakker, B. Schulz, M. Mac<br />

Neal, E. C. Davis, J. G. H. Lee, A. Salhi, S. Unger, K.<br />

Heimdal, S. De Almeida, U. Kornak, H. Gaspard, J.<br />

L. Bresson, K. Prescott, M. E. Gosendi, S. Mansour,<br />

G. E. Pierard, S. Madan-Khetarpal, F. C. Sciurba, S.<br />

Symoens, P. J. Coucke, L. Van Maldergem, Z. Urban,<br />

A. De Paepe.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


90 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37) (SESSION 33, continued)<br />

130/12:00 M694V mutation in Armenian-<strong>American</strong>s:<br />

A ten-year retrospective study <strong>of</strong> MEFV mutations<br />

testing for familial Mediterranean fever at UCLA.<br />

F. S. Ong, H. Vakil, Y. Xue, K. H. Shah, J. Z. Kuo, K. E.<br />

Bernstein, D. L. Rimoin, J. I. Rotter, J. L. Deignan, K.<br />

Das, W. W. Grody.<br />

131/12:15 Clinical features <strong>of</strong> individuals with<br />

Floating-Harbor syndrome due to mutations in<br />

SRCAP. S. M. Nikkel, A. Dauber, R. L. Hood, M.<br />

Feingold, M. Connolly, M. J. M. Nowaczyk, S. M.<br />

White, A. Afenjar, F. Brancati, I. Cordeiro, A. Destrée,<br />

F. Forzano, E. M. Honey, D. Héron, C. M. Jacob, S.<br />

G. Kant, U. Kini, E. Kirk, E. Lemos Silveira-Lucas, L.<br />

Silveira Lucas, L. Audi Delaney, B. Santos da Cunha,<br />

V. Mericq, K. Pope, S. Price, J. M. Wit, D. E. Bulman,<br />

K. M. Boycott, FORGE Canada Consortium.<br />

132/12:30 A prospective natural history study <strong>of</strong><br />

DICER1-related familial pleuropulmonary blastoma<br />

syndrome shows incomplete penetrance, pleiotropy<br />

and variable expressivity. D. R. Stewart, L. Doros,<br />

G. Glenn, A. Bauer, G. Williams, A. Carr, J. Ivanovich,<br />

R. Kase, L. Harney, K. A. Schultz, C. P. Kratz, L. P.<br />

Dehner, D. A. Hill, Y. Messinger.<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 34 – Cancer <strong>Genetics</strong> II: Clinical Translation<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: Robert Pilarski, The Ohio State Univ.;<br />

Stephen Thibodeau, Mayo Clin.<br />

133/10:30 Clinical implementation <strong>of</strong> a cancer care<br />

model based on comprehensive molecular pr<strong>of</strong>iling<br />

<strong>of</strong> tumor-normal pairs. J. C. Taylor, K. Kaur, S.<br />

Henderson, E. Domingo, A. Cutts, J. Woods, C.<br />

Motley, B. Dougherty, M. Middleton, B. Hassan, Y.<br />

Wang, E. Beasley, M. Naley, I. Tomlinson, A. Schuh,<br />

TSB LifeTech Consortium.<br />

134/10:45 Clinical implementation <strong>of</strong> single<br />

nucleotide polymorphism microarrays in pediatric<br />

cancer and non-malignant hematologic disorders.<br />

X. Lu, Y. Zhao, S. Gurusiddappa, C. Lau, J. Shohet,<br />

P. Rao, K. Rabin, S. E. Plon.<br />

135/11:00 A prospective clinical trial to evaluate<br />

DNA sequencing as a diagnostic tool to guide<br />

cancer therapy. A. M. K. Brown, P. L. Bedard, B. Tran,<br />

J. Dancey, E. Winquist, S. J. Hotte, G. Goss, S. Welch,<br />

T. Zhang, L. Stein, V. Ferretti, S. Watt, W. Jiao, K. Ng,<br />

P. Shaw, B. G. Neel, T. J. Hudson, J. D. McPherson, S.<br />

Kamel-Reid, L. Siu.<br />

136/11:15 Whole genome sequencing <strong>of</strong> a highly<br />

aggressive melanoma identified BRAFL597<br />

mutants associated with sensitivity to MEK<br />

inhibitors. Z. Zhao, K. B. Dahlman, J. Xia, H.<br />

Hutchinson, C. Ng, D. Hucks, P. Jia, M. Atefi, Z. Su,<br />

S. Branch, P. Lyle, D. J. Hicks, V. Bozon, J. A. Glaspy,<br />

J. L. Netterville, C. L. Vnencak-Jones, J. Sosman,<br />

A. Ribas, W. Pao.<br />

137/11:30 Identification <strong>of</strong> novel mechanisms <strong>of</strong><br />

drug resistance in BRCA1-deficient cancer by<br />

exome and RNA sequencing. K. K. Dhillon,<br />

T. Taniguchi.<br />

138/11:45 BRCA1 and BRCA2 mutational spectrum<br />

in a normal population: Implications for clinical<br />

diagnostics and incidental findings. E. Ruark, K.<br />

W. Lau, A. Renwick, E. Ramsay, F. Zhang, S. Seal, N.<br />

Rahman.<br />

139/12:00 Targeted re-sequencing <strong>of</strong> 10 ovarian<br />

cancer candidate genes in 2,240 cases and 355<br />

controls. H. Song, M. Cieck, J. Cunningham, B.<br />

Fridley, E. Dicks, P. Harrington, S. Ramus, S. Gayther,<br />

E. Goode, P. Pharoah.<br />

140/12:15 Enhanced detection <strong>of</strong> low-level mosaic<br />

mutations in RB1 gene in sporadic unilateral RB by<br />

ion torrent semiconductor sequencing: Risk <strong>of</strong><br />

second cancer. Z. Chen, S. Walther, K. Moran,<br />

D. Gerhart, T. Ganguly, A. Ganguly.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37) (SESSION 34, continued)<br />

141/12:30 Risk <strong>of</strong> colorectal cancer for monoallelic<br />

and biallelic MUTYH mutation carriers. A. K. Win, S.<br />

P. Cleary, J. G. Dowty, D. D. Buchanan, J. P. Young, N.<br />

M. Lindor, R. W. Haile, P. A. Newcomb, L. Marchand,<br />

J. L. Hopper, S. Gallinger, M. A. Jenkins, Colon Cancer<br />

Family Registry.<br />

INVITED AND PLATFORM SESSIONS 91<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 35 – Ethical, Legal, Social and Policy Issues<br />

Room 132, Lower Level North, Moscone Center<br />

Moderators: Maureen Smith, Northwestern Univ.; Neil<br />

Lamb, HudsonAlpha Inst. for Biotechnol., Huntsville,<br />

AL<br />

142/10:30 Newborn screening for cystic fibrosis:<br />

Preliminary results on the false positive experience.<br />

C. J. Barg, F. A. Miller, R. Z. Hayeems, P. Durie, J. C.<br />

Carroll, P. Chakraborty, B. K. Potter, Y. Bombard, K.<br />

Tam, L. Taylor, E. Kerr, C. Davies, J. Milburn, F. Ratjen,<br />

A. Guttmann.<br />

143/10:45 Conflicting views on newborn and infant<br />

genetic screening: Perspectives <strong>of</strong> relatives <strong>of</strong><br />

children with genetic conditions causing<br />

developmental delay and parents <strong>of</strong> healthy<br />

children. S. A. Metcalfe, A. D. Archibald, A. L.<br />

Atkinson, C. Hickerton, S. Lawton, B. J. McClaren,<br />

S. H. Wong.<br />

144/11:00 Do research participants really want to<br />

know? The Seattle Colorectal Cancer Family<br />

Registry experience on the return <strong>of</strong> research<br />

genetic test results. M. Laurino, D. Fisher, W. Grady,<br />

P. Newcomb.<br />

145/11:15 The student-athletes’ knowledge <strong>of</strong><br />

sickle cell trait and the impact <strong>of</strong> mandatory<br />

genetic testing. N. Lovick, L. Mar, M. Treadwell,<br />

J. Youngblom, C. Hartshorne.<br />

146/11:30 Impact <strong>of</strong> direct-to-consumer<br />

pharmacogenomic testing. C. S. Bloss, N. J. Schork,<br />

E. J. Topol.<br />

147/11:45 Impact <strong>of</strong> genomic risk for type 2<br />

diabetes on health behaviors. S. B. Haga, W. Barry,<br />

R. Mills, J. Sullivan, H. F. Willard, L. P. Svetkey,<br />

G. S. Ginsburg.<br />

148/12:00 African <strong>American</strong> attitudes toward exome<br />

and whole genome sequencing. J. Yu, J. Crouch,<br />

S. M. Jamal, H. K. Tabor, M. J. Bamshad.<br />

149/12:15 Personalized health literacy in the age <strong>of</strong><br />

personalized medicine: Results from a deliberative<br />

public engagement exercise. B. J. Wilson, J. C.<br />

Carroll, S. G. Nicholls, S. M. Craigie, H. Etchegary,<br />

D. Castle, B. K. Potter, J. Little, L. Lemyre on behalf <strong>of</strong><br />

Emerging Team in Genomics in Screening.<br />

150/12:30 Dynamics, definitions and discrepancies:<br />

Public perspectives on the systematic collection<br />

and use <strong>of</strong> family health history in routine health<br />

care. H. Etchegary, B. J. Wilson, S. M. Craigie, S. G.<br />

Nicholls, D. Castle, J. C. Carroll, J. Allanson, B. K.<br />

Potter, P. Chakraborty on behalf <strong>of</strong> CIHR Emerging<br />

Team in Genomics in Screening.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


92 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 36 – Chipping Away at Autoimmune Disease<br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Judy H. Cho, Yale Univ.; Soumya<br />

Raychaudhuri, Brigham and Women’s Hosp.<br />

151/10:30 Immunochip: Redefining the genetic<br />

architecture <strong>of</strong> multiple sclerosis. J. McCauley,<br />

International Multiple Sclerosis <strong>Genetics</strong> Consortium.<br />

152/10:45 Dense genotyping <strong>of</strong> candidate genes<br />

indentifies 16 new susceptibility loci in ankylosing<br />

spondylitis. A. Cortes, P. C. Robinson, P. Leo, D. M.<br />

David, M. A. Brown, International <strong>Genetics</strong> <strong>of</strong><br />

Ankylosing Spondylitis and Wellcome Trust Case<br />

Control Consortia.<br />

153/11:00 Dense fine-mapping study identifies<br />

novel disease loci and implicates coding and<br />

non-coding variation in primary biliary cirrhosis<br />

risk. J. Z. Liu, M. A. Almarri, D. J. Gaffney, G. F.<br />

Mells, L. Jostins, H. J. Cordell, S. Ducker, D. Day,<br />

M. A. Heneghan, J. M. Neuberger, P. T. Donaldson,<br />

A. Bathgate, A. Burroughs, M. Davies, D. E. Jones,<br />

G. J. Alexander, J. C. Barrett, R. N. Sandford, C. A.<br />

Anderson, UK PBC Consortium and Wellcome Trust<br />

Case Control Consortium 3.<br />

154/11:15 Fifteen novel psoriasis susceptibility loci:<br />

Disease-specific signals highlight the role <strong>of</strong> innate<br />

immunity. L. C. Tsoi, S. L. Spain, J. Knight, E.<br />

Ellinghaus, P. E. Stuart, F. Capon, J. Ding, Y. Li, T.<br />

Tejasvi, J. E. Gudjonsson, H. M. Kang, A. M. Bowcock,<br />

U. Mrowietz, S. Koks, T. Esko, J. J. Voorhees, M.<br />

Weichenthal, P. Rahman, D. Gladman, C. E. M.<br />

Griffiths, A. Reis, J. Kere, R. P. Nair, A. Franke, J. N. W.<br />

N. Barker, G. R. Abecasis, J. T. Elder, R. C. Trembath,<br />

Genetic Analysis <strong>of</strong> Psoriasis Consortium, Wellcome<br />

Trust Case Control Consortium 2.<br />

155/11:30 MHC fine-mapping in celiac disease<br />

reveals structural basis <strong>of</strong> HLA-gluten interaction.<br />

J. Gutierrez-Achury, G. Trynka, K. A. Hunt, J.<br />

Romanos, D. van Heel, C. Wijmenga, P. I. W. de<br />

Bakker.<br />

156/11:45 Host-microbe interactions shape genetic<br />

risk for inflammatory bowel disease. J. Barrett,<br />

International IBD <strong>Genetics</strong> Consortium.<br />

157/12:00 Sequencing-based and multiplatform<br />

genome-wide association study for multiple<br />

sclerosis and type 1 diabetes in Sardinians. I. Zara,<br />

E. Porcu, M. Zoledziewska, M. Pitzalis, M. Valentini,<br />

A. Mulas, F. Busonero, R. Atzeni, M. Oppo, F. Reinier,<br />

R. Berutti, R. Pilu, F. Deidda, C. Sidore, R. Piras, A. Loi,<br />

S. Sanna, E. Cocco, F. Poddie, G. Farina, G. Rosati,<br />

L. Lianas, G. Cuccuru, G. Zanetti, A. Angius, M. G.<br />

Marrosu, C. M. Jones, G. R. Abecasis, S. Sanna,<br />

F. Cucca.<br />

158/12:15 Admixture mapping for asthma in Latinos<br />

identifies additional heritable risk factors from<br />

genome-wide meta-analysis data. C. R. Gignoux,<br />

D. G. Torgerson, J. M. Galanter, L. A. Roth, C. Eng,<br />

D. Hu, S. Huntsman, R. D. Hernandez, R. A. Mathias,<br />

S. Sen, K. C. Barnes, E. G. Burchard.<br />

159/12:30 Deep exome sequencing <strong>of</strong> psoriasis<br />

identified new association signals contribute by<br />

INDELs, CNVs and rare SNPs. X. Jin, H. Tang, H.<br />

Jiang, D. Cao, H. Shao, Q. Li, J. Shen, L. Song, Y. Shi,<br />

J. Mei, X. Yang, L. Coin, Y. Li, X. Zhang, J. Wang.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

10:30 AM–12:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session B (29-37)<br />

SESSION 37 – Metabolic Disease Discoveries<br />

Room 123, Lower Level North, Moscone Center<br />

Moderators: Kimberly Chapman, Children’s Natl. Med.<br />

Ctr.; Hans Andersson, Tulane Univ. Med. Ctr.<br />

160/10:30 Mutations in DDHD2 cause recessive<br />

spastic paraplegia with intellectual disability, thin<br />

corpus callosum and periventricular white matter<br />

hyperintensities. A. P. M. de Brouwer, J. H. M.<br />

Schuurs-Hoeijmakers, E. J. Kamsteeg, S. Ben-Salem,<br />

S. T. de Bot, I. van de Vondervoort, S. Vermeer, J.<br />

Schwartzentruber, B. R. Ali, S. A. Al-Yahyaee, S. Tariq,<br />

T. Pramathan, R. Bayoumi, B. P. van de Warrenburg,<br />

W. M. van den Akker, C. Gilissen, J. A. Veltman, I. M.<br />

Janssen, A. T. Vulto-van Silfhout, S. van der Velde-<br />

Visser, A. Diekstra, C. E. Erasmus, M. A. Willemsen,<br />

L. E. L. M. Vissers, H. van Bokhoven, R. A. Wevers,<br />

L. Al-Gazali, M. T. Geraghty, B. B. A. de Vries.<br />

161/10:45 Lipidomics <strong>of</strong> Gaucher disease:<br />

Substrate composition and nature is dependent on<br />

tissue/region and acid �-glucosidase mutations:<br />

Phenotypic implications. Y. Sun, W. Zhang, Y. Xu,<br />

B. Quinn, N. Dasgupta, B. Liou, K. D. R. Setchell,<br />

G. A. Grabowski.<br />

162/11:00 Sterol precursors induce Niemann-Pick C<br />

disease phenotypes in Smith-Lemli-Opitz syndrome<br />

causing defective LDL-cholesterol utilization that<br />

is corrected by imino-sugars. C. A. Wassif, E. Lloyd-<br />

Evans, L. J. Haslett, I. M. Williams, C. L. Toth, F. D.<br />

Porter, F. M. Platt.<br />

163/11:15 Glucose kinetics in subjects with MELAS<br />

syndrome: Interim results. L. Emrick, A. El-Hattab,<br />

J. Hsu, F. Jarhoor, F. Scaglia, W. Craigen.<br />

164/11:30 Phenylbutyrate therapy for pyruvate<br />

dehydrogenase complex deficiency. R. Ferriero,<br />

E. Lamantea, P. W. Stacpoole, L. Bonafè, B. Lee,<br />

M. Zeviani, N. Brunetti-Pierri.<br />

165/11:45 Etiologies for neurocognitive delays in<br />

argininosuccinic aciduria. A. Erez, S. Nagamani, P.<br />

Campeau, O. Shchelochkov, J. Kho, K. Bissig, Q. Sun,<br />

N. Bryan, S. Cederbaum, B. Lee.<br />

166/12:00 Enzyme substitution therapy for<br />

phenylketonuria delivered orally using a genetically<br />

modified probiotic: Pro<strong>of</strong> <strong>of</strong> principle.<br />

J. Christodoulou, N. Al-Hafid, X.-Z. Tong, K. Carpenter,<br />

V. Wiley, S. Cunningham, I. E. Alexander.<br />

167/12:15 A new inborn error <strong>of</strong> manganese<br />

metabolism caused by mutations in SLC30A10,<br />

a newly identified human manganese transporter.<br />

K. Tuschl, P. T. Clayton, S. M. Gospe, Jr., S. Gulab, S.<br />

Ibrahim, P. Singhi, R. T. Ribeiro, M. S. Zaki, M. Luz del<br />

Rosario, S. Dyack, V. Price, R. A. Wevers, P. B. Mills.<br />

INVITED AND PLATFORM SESSIONS 93<br />

168/12:30 Combined methylmalonic acidemia and<br />

homocystinuria, cblC type: A prospective clinical<br />

protocol focusing on neurologic and<br />

neurodevelopmental parameters in a cohort <strong>of</strong> preschool<br />

children diagnosed on expanded newborn<br />

screening. J. D. Weisfeld-Adams, H. A. Bender, A. M.<br />

Akerstedt, E. Miles-Mason, T. P. Naidich, S. Lipson,<br />

T. Bottiglieri, S. P. Young, G. A. Diaz.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


94 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 38 – A Sequencing Jamboree: Exomes to<br />

Genomes<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: Nancy Cox, Univ. <strong>of</strong> Chicago; Orli Bahcall,<br />

Nature <strong>Genetics</strong><br />

169/4:30 Whole-exome sequencing <strong>of</strong> 10,000 type<br />

2 diabetes cases and controls from five major<br />

ancestry groups. T. M. Teslovich, A. P. Morris, P.<br />

Fontanillas, M. A. Rivas, X. Sim, J. Flannick, N. Burtt,<br />

H. Chen, A. G. Day-Williams, A. Mahajan, G. Atzmon,<br />

P. Cingolani, L. Moutsianas, H. M. Highland, T2D-<br />

GENES Consortium.<br />

170/4:45 Rare and low frequency coding variants<br />

are associated with LDL cholesterol levels:<br />

Findings from the NHLBI Exome Sequencing<br />

Project. L. A. Lange, Y. Hu, C. Xue, Z. Tang, C. Bizon,<br />

E. M. Lange, J. D. Smith, E. H. Turner, G. Jun, H.-M.<br />

Kang, K. P. Li, G. M. Peloso, C. L. Wassel, A. P.<br />

Reiner, E. Boerwinkle, B. M. Psaty, C. J. O’Donnell, S.<br />

Kathiresan, K. E. North, D. Lin, G. P. Jarvik, L. A.<br />

Cupples, C. Kooperberg, J. G. Wilson, D. A.<br />

Nickerson, G. R. Abecasis, S. S. Rich, R. P. Tracy, C. J.<br />

Willer on behalf <strong>of</strong> NHLBI Exome Sequencing Project.<br />

171/5:00 Exome sequencing <strong>of</strong> extreme phenotypes<br />

identifies DCTN4 and CAV2 as modifiers <strong>of</strong> chronic<br />

Pseudomonas aeruginosai nfection in cystic<br />

fibrosis. M. J. Emond, T. Louie, J. Emerson, S.<br />

McNamara, W. Zhao, R. A. Mathias, M. R. Knowles, F.<br />

A. Wright, M. J. Reider, H. K. Tabor, D. A. Nickerson, K.<br />

C. Barnes, R. L. Gibson, M. J. Bamshad.<br />

172/5:15 A high resolution study <strong>of</strong> type 2 diabetes<br />

genetic architecture through whole-genome<br />

sequencing <strong>of</strong> 2850 European individuals: The<br />

GoT2D Study. J. Flannick, C. Fuchsberger, K. J.<br />

Gaulton, N. P. Burtt, H. M. Kang, C. Hartl, R. D.<br />

Pearson, GoT2D Consortium.<br />

173/5:30 Mapping quantitative traits with integrated<br />

whole exome/genome/array panel in individuals <strong>of</strong><br />

European descent. X. Sim, M. A. Rivas, A. K.<br />

Manning, A. E. Locke, C. M. Lindgren, GoT2D<br />

Consortium.<br />

174/5:45 Whole genome sequence analyses<br />

describe the genetic architecture <strong>of</strong> complex<br />

traits: The Cohorts for Heart and Aging Research<br />

in Genetic Epidemiology Consortium. A. C.<br />

Morrison, A. Voorman, A. D. Johnson, X. Liu, J. Yu,<br />

A. Li, D. Muzny, F. Yu, K. Rice, G. Zhu, G. Heiss, C.<br />

J. O’Donnell, B. Psaty, L. A. Cupples, R. Gibbs, E.<br />

Boerwinkle.<br />

175/6:00 Genome sequencing and analysis in<br />

autism spectrum disorder. S. Walker, A. Prasad,<br />

L. Lau, B. Thiruvahindrapuram, B. Fernandez,<br />

R. Yuen, C. R. Marshall, E. Fombonne, W. Roberts,<br />

L. Zwaigenbaum, P. Szatmari, S. W. Scherer.<br />

176/6:15 Deep whole genome sequencing in<br />

pedigrees illuminates the contribution <strong>of</strong> low<br />

frequency and private mutations to the genetic<br />

architecture <strong>of</strong> metabolic quantitative traits.<br />

A. K. Manning, A. R. Wood, P. Fontanillas, G. Jun, P.<br />

Cingolani, M. Almeida, C. Fuchsberger, T. D. Dyer, M.<br />

Rivas, K. Gaulton, J. Maller, J. Curran, J. Grunstad,<br />

T. W. Blackwell, T. M. Teslovich, D. M. Lehman, R.<br />

Grossman, J. Laramie, S. E. Lincoln, M. Boehnke, M.<br />

I. McCarthy, T. M. Frayling, R. Sladek, R. Duggirala, J.<br />

Blangero, G. Abecasis, D. Altshuler, T2D-GENES.<br />

177/6:30 Whole genome sequencing <strong>of</strong> 2,100<br />

individuals in the founder Sardinian population.<br />

C. Sidore, S. Sanna, A. Kwong, H. M. Kang,<br />

R. Cusano, M. Pitzalis, M. Zoledziewska, A. Maschio,<br />

F. Busonero, M. Lobina, A. Angius, R. Lyons, B. Terrier,<br />

C. Brennan, R. Atzeni, A. Mulas, M. Dei, M. G. Piras,<br />

S. Lai, F. Reinier, R. Berutti, C. Jones, M. Marcelli, M.<br />

Urru, M. Oppo, D. Schlessinger, G. Abecasis, F. Cucca.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 39 – Admixture and Demography<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Katarzyna Bryc, Harvard Univ.; John<br />

Novembre, UCLA<br />

178/4:30 Differential relatedness <strong>of</strong> African<br />

<strong>American</strong>s to populations within West Africa.<br />

K. Bryc, A. Williams, N. Patterson, S. Musani,<br />

M. Sale, W. Chen, J. Divers, M. Ng, D. W. Bowden,<br />

J. G. Wilson, D. Reich.<br />

179/4:45 Fine scale population genetic structure<br />

<strong>of</strong> African <strong>American</strong>s. E. Y. Durand, M. Macpherson,<br />

B. T. Naughton, J. Mountain, C. B. Do.<br />

180/5:00 A model-based approach for analysis <strong>of</strong><br />

spatial structure in genetic data. W. Yang,<br />

J. Novembre, E. Eskin, E. Halperin.<br />

181/5:15 People <strong>of</strong> the British Isles: An analysis <strong>of</strong><br />

the genetic contributions <strong>of</strong> European populations<br />

to a UK control population. S. Leslie, B. Winney,<br />

G. Hellenthal, S. Myers, P. Donnelly, W. Bodmer.<br />

182/5:30 The applicability <strong>of</strong> the Balding-Nichols<br />

model to a dataset <strong>of</strong> over 100,000 Brazilian<br />

individuals. R. V. Rohlfs, A. Bhaskar, V. R. C. Aguiar,<br />

K. Lohmueller, A. M. Castro, A. C. S. Ferreira, F. S. V.<br />

Malta, Y. Song, I. D. Louro, R. Nielsen.<br />

183/5:45 Rare genetic variants in deep sequencing<br />

<strong>of</strong> neutral regions from a homogeneous population<br />

refine models <strong>of</strong> recent explosive human<br />

population growth. A. Keinan, E. Gazave, A.<br />

Coventry, S. Gottipati, D. Chang, L. Ma, D. Muzny,<br />

E. Boerwinkle, C. Sing, R. Gibbs, A. Clark.<br />

184/6:00 Estimating human population sizes using<br />

the coalescent with recombination. S. Sheehan,<br />

K. Harris, Y. S. Song.<br />

185/6:15 Reconstructing historical contributions<br />

to modern gene pools using the sequentially<br />

Markovian coalescent conditional sampling<br />

distribution. A. Platt, J. Novembre.<br />

186/6:30 On the Sardinian ancestry <strong>of</strong> the Tyrolean<br />

Iceman. M. Sikora, M. Carpenter, A. Moreno-Estrada,<br />

B. M. Henn, P. A. Underhill, I. Zara, M. Pitzalis,<br />

C. Sidore, F. Reinier, M. Marcelli, A. Angius, C. Jones,<br />

T. T. Harkins, A. Keller, A. Zink, G. Abecasis, S. Sanna,<br />

F. Cucca, C. D. Bustamante.<br />

INVITED AND PLATFORM SESSIONS 95<br />

Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 40 – Analysis <strong>of</strong> Multilocus Systems<br />

Room 135, Lower Level North, Moscone Center<br />

Moderators: Brendan Keating, Univ. <strong>of</strong> Pennsylvania;<br />

Laura Almasy, Texas Biomed. Res. Inst., San Antonio<br />

187/4:30 Gene-based epistasis analysis in genomewide<br />

association studies. L. Ma, A. Brautbar,<br />

E. Boerwinkle, C. F. Sing, A. G. Clark, A. Keinan.<br />

188/4:45 Building human phenotype networks from<br />

shared genetic risk variants. C. Darabos, K. Desai,<br />

M. Giacobini, M. Lupien, J. H. Moore.<br />

189/5:00 Incorporating network dynamics to<br />

prioritize genes through genome-wide association<br />

studies. L. Hou, M. Chen, C. K. Zhang, J. Cho,<br />

H. Zhao.<br />

190/5:15 Large-scale multi-phenotype metaanalysis<br />

evaluates pleiotropic effects at FADS1 and<br />

GIPR loci. V. Lagou, R. Mägi, K. Fischer, M. Akerlund,<br />

I. Surakka, M. Kaakinen, J. S. Ried, A. Mahajan, M.<br />

Horikoshi, L. Marullo, K. Strauch, C. Gieger, S. Ripatti,<br />

A. P. Morris, V. Lyssenko, I. Prokopenko for ENGAGE<br />

(European Network for Genetic and Genomic<br />

Epidemiology) Consortium.<br />

191/5:30 Building and assessing protein-protein<br />

interaction networks from genome-wide<br />

association results in cancer. L. T. Hiraki, A. D. Joshi,<br />

S. Lindstrom, A. T. Chan, S. Chanock, P. Kraft.<br />

192/5:45 A smoothed functional principal<br />

component analysis for pathway analysis with<br />

next-generation sequencing data. J. Zhao, Y. Zhu,<br />

E. Boerwinkle, M. Xiong.<br />

193/6:00 Variants in exons and in transcription<br />

factors affect gene expression in trans. A. Kreimer,<br />

I. Pe’er.<br />

194/6:15 The continuation <strong>of</strong> theory by other<br />

means: ForSim as a forward simulator for improved<br />

understanding <strong>of</strong> the genetic architecture <strong>of</strong><br />

complex traits and its evolution. K. M. Weiss, J. H.<br />

Lee, J. D. Terwilliger, B. W. Lambert.<br />

195/6:30 Incorporating phylogenetic conservation<br />

and pedigree information in tests <strong>of</strong> rare-variant<br />

association. H. Hu, C. D. Huff, H. Coon, S. Guthery,<br />

S. V. Tavtigian, J. C. Roach, Z. Kronenberg, J. Xing,<br />

A. F. A. Smit, G. Glusman, A. K. Holloway, V. Garg,<br />

B. Moore, R. Hubley, W. S. Watkins, H. Li, S. Z.<br />

Montsar<strong>of</strong>f, D. E. Abbott, L. E. Hood, K. S. Pollard,<br />

D. J. Galas, D. Srivastava, M. G. Reese, L. B. Jorde,<br />

M. Yandell.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


96 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 41 – Genes Underlying Neurological Disease<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: Stylianos Antonarakis, Univ. <strong>of</strong> Geneva<br />

Med. Sch.; Laurie Ozelius, Mount Sinai Med. Sch.<br />

196/4:30 TMTC4: A novel candidate gene for<br />

callosal development. L. Fernandez, J. Li, M.<br />

Wakahiro, E. Rider, T. Bartman, E. Sherr.<br />

197/4:45 CLK2 missense mutation in a family with<br />

pontocerebellar hypoplasia type 7. V. R. C. Eggens,<br />

Y. Namavar, M. A. Haagmans, K. Fluiter, E. J. Bradley,<br />

P. G. Barth, B. T. Poll-The, F. Baas.<br />

198/5:00 Missense mutations in ITPR1 cause<br />

autosomal dominant congenital nonprogressive<br />

spinocerebellar ataxia. J. Warman Chardon, L.<br />

Huang, M. Carter, K. Friend, T. Dudding, J.<br />

Schwartzentruber, R. Zou, P. Sch<strong>of</strong>ield, S. Douglas,<br />

D. Bulman, K. Boycott.<br />

199/5:15 VPS37A causes a novel form <strong>of</strong> complex<br />

hereditary spastic paraparesis. T. Falik-Zaccai, Y.<br />

Zivony-Elboum, W. Westbroek, D. Savitzki, Y. Shoval,<br />

Y. Anikster, A. Waters, R. Kleta.<br />

200/5:30 Genome-wide association study identifies<br />

two novel susceptibility loci for musician’s<br />

dystonia. K. Lohmann, A. Schmidt, A. Schillert, S.<br />

Winkler, K. Siegesmund, H.-C. Jabusch, M. Kasten,<br />

J. L. Groen, C. Hemmelmann, J. Hagenah, J. Graf,<br />

N. Brüggemann, A. Grünewald, F. Baas, A. Münchau,<br />

K. E. Zeuner, S. Schreiber, G. Deuschl, M. A. J. de<br />

Koning-Tijssen, E. Altenmüller, A. Ziegler, C. Klein.<br />

201/5:45 Autosomal recessive axonal neuropathy<br />

with neuromyotonia: A novel disease entity<br />

caused by mutations in HINT1. J. Baets, M. Zimon,<br />

L. Almeida-Souza, J. Nikodinovic, Y. Parman, E.<br />

Battaloglu, V. Guergueltcheva, I. Tournev, M. Auer-<br />

Grumbach, T. Müller, P. Van Damme, W. N. Löscher,<br />

N. Barisic, Z. Mitrovic, S. C. Previtali, H. Topaloglu,<br />

G. Bernert, A. Beleza-Meireles, S. Todorovic,<br />

B. Ishpekova, K. Peeters, A. F. Hahn, S. Züchner,<br />

V. Timmerman, V. Milic Rasic, A. R. Janecke,<br />

A. Jordanova, P. De Jonghe.<br />

202/6:00 De novo gain <strong>of</strong> function KCNT1 channel<br />

mutations cause seizures and developmental delay<br />

in malignant migrating partial seizures <strong>of</strong> infancy.<br />

G. Barcia, M. R. Fleming, A. Deligniere, V. Gazula,<br />

M. R. Brown, M. Langouet, H. Chen, J. Kronengold,<br />

A. Abhyankar, R. Cilio, P. Nitschke, A. Kaminska, N.<br />

Boddaert, J. L. Casanova, I. Desguerre, A. Munnich,<br />

O. Dulac, L. K. Kaczmarek, L. Colleaux, R. Nabbout.<br />

203/6:15 Investigating the genetic etiology <strong>of</strong><br />

familial epilepsies using next-generation<br />

sequencing. E. K. Ruzzo, E. L. Heinzen, R. Wedel,<br />

K. V. Shianna, I. E. Scheffer, S. F. Berkovic, R. Ottman,<br />

D. B. Goldstein.<br />

204/6:30 Autoregulation <strong>of</strong> the DYT6-gene THAP1.<br />

A. Erogullari, P. Seibler, D. Braunholz, A. Grünewald,<br />

R. Depping, J. Eckhold, A. Rakovic, T. Lohnau, G.<br />

Gillessen-Kaesbach, C. Klein, K. Lohmann, F. J. Kaiser.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 42 – Cancer <strong>Genetics</strong> III: Common Variants<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderators: Kathleen Cooney, Univ. <strong>of</strong> Michigan;<br />

Meredith Yeager, NCI/NIH<br />

205/4:30 Identification <strong>of</strong> 23 novel prostate cancer<br />

susceptibility loci using a custom array (the iCOGS)<br />

in an international consortium, PRACTICAL. R.<br />

Eeles, A. Amin Al Olama, S. Benlloch, E. Saunders, D.<br />

Leongamornlert, M. Tymrakiewicz, M. Ghoussaini, C.<br />

Luccarini, J. Dennis, S. Jugurnauth-Little, T. Dadaev,<br />

PROTECT Group, G. Giles, G. Severi, F. Wiklund, H.<br />

Gronberg, C. Haiman, F. Schumacher, B. Henderson,<br />

L. Le Marchand, S. Lindstrom, P. Kraft, D. Hunter,<br />

S. Gapstur, S. Chanock, S. Berndt, PRACTICAL<br />

Consortium, Z. Kote-Jarai, D. Easton.<br />

206/4:45 Large-scale genotyping identifies more<br />

than 40 novel breast cancer susceptibility loci. K.<br />

Michailidou, P. Hall, A. Gonzalez-Neira, M. Ghoussaini,<br />

J. Dennis, R. L. Milne, M. K. Schmidt, J. Chang-<br />

Claude, S. E. Bojesen, M. K. Humphreys, Q. Wang, M.<br />

Garcia-Closas, P. D. P. Pharoah, G. Chenevix-Trench,<br />

A. M. Dunning, J. Benitez, D. F. Easton, Breast Cancer<br />

Association Consortium.<br />

207/5:00 Genome-wide association study in BRCA1<br />

mutation carriers identifies novel loci associated<br />

with breast and ovarian cancer risk. A. C. Antoniou,<br />

X. Wang, L. McGuffog, A. Lee, M. M. Guedet, K. B.<br />

Kuchenbaecker, P. Soucy, J. Simard, K. Offit, D. F.<br />

Easton, G. Chenevix-Trench, F. J. Couch, Consortium<br />

<strong>of</strong> Investigators <strong>of</strong> Modifiers <strong>of</strong> BRCA1/2.<br />

208/5:15 Identification <strong>of</strong> the first locus to modify<br />

breast cancer risk specifically in BRCA2 mutation<br />

carriers. K. Kuchenbaecker, M. Gaudet, J. Vijai,<br />

R. Klein, T. Kirchh<strong>of</strong>f, L. McGuffog, D. Barrowdale,<br />

A. Dunning, A. Lee, P. Hall, F. Couch, J. Simard, D.<br />

Altshuler, D. Easton, G. Chenevix-Trench, A. Antoniou,<br />

K. Offit, Consortium <strong>of</strong> Investigators <strong>of</strong> Modifiers <strong>of</strong><br />

BRCA1/2 (CIMBA) Collaborators.<br />

209/5:30 Fine-scale mapping and functional<br />

analysis <strong>of</strong> the breast cancer 11q13 (CCND1) locus.<br />

M. Ghoussaini, K. B. Meyer, S. Edwards, J. D. French,<br />

K. Michailidou, S. Ahmed, S. Khan, M. J. Maranian,<br />

C. S. Healey, P. D. P. Pharoah, H. Nevanlinna,<br />

M. A. Brown, G. Chenevix-Trench, D. F. Easton,<br />

A. M. Dunning, BCAC.<br />

INVITED AND PLATFORM SESSIONS 97<br />

210/5:45 Three independent loci within the TERT-<br />

CLPTM1L locus associated with telomere length<br />

and risk <strong>of</strong> breast and ovarian cancer. G. Chenevix-<br />

Trench, S. E. Bojesen, K. A. Pooley, S. Johnatty,<br />

J. Beesley, K. Michailidou, J. Tyrer, S. L. Edwards,<br />

H. C. Shen, K. Lawrenson, H. Pickett, M. Stutz, C.<br />

Smart, J. French, P. L. Mai, M. H. Greene, S. Gayther,<br />

R. Reddel, P. D. P. Pharoah, E. L. Goode, A. Berchuk,<br />

D. F. Easton, A. C. Antoniou, A. M. Dunning on behalf<br />

<strong>of</strong> CIMBA, OCAC and BCAC.<br />

211/6:00 Statistical fine mapping <strong>of</strong> regions<br />

containing melanoma susceptibility genes identified<br />

through genome-wide association studies. J. H.<br />

Barrett, J. C. Taylor, M. Brossard, A. M. Goldstein,<br />

P. A. Kanetsky, E. M. Gillanders, J. A. Newton Bishop,<br />

D. T. Bishop, F. Demenais, M. M. Iles, GenoMEL<br />

Consortium.<br />

212/6:15 Combining expression phenotypes with<br />

high density imputation to identify melanoma risk<br />

genes. M. H. Law, G. W. Montgomery, K. M. Brown,<br />

A. E. Cust, N. G. Martin, G. J. Mann, N. K. Hayward,<br />

S. MacGregor, Q-MEGA and AMFS Investigators.<br />

213/6:30 Meta-analysis identifies four new loci for<br />

testicular germ cell tumor. C. C. Chung, Z. Wang,<br />

P. A. Kanetsky, C. Turnbull, K. McGlynn, R. L. Erickson,<br />

M. H. Greene, M. A. T. Hildebrandt, R. I. Skotheim,<br />

C. Kratz, M. B. Cook, F. Schumacher, R. Koster,<br />

M. Yeager, K. B. Jacobs, S. M. Schwartz, D. T. Bishop,<br />

H. K. Gjessing, V. Cortessis, N. Rahman, X. Wu,<br />

S. J. Chanock, K. L. Nathanson.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


98 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 43 – <strong>Genetics</strong> <strong>of</strong> Crani<strong>of</strong>acial and<br />

Musculoskeletal Disorders<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: Irini Manoli, NHGRI/NIH; Siddharth<br />

Prakash, Univ. <strong>of</strong> Texas Hlth. Sci. Ctr. at Houston<br />

214/4:30 Next-generation sequencing detects<br />

mutations in ISPD as a common cause <strong>of</strong> Walker-<br />

Warburg syndrome with defective glycosylation <strong>of</strong><br />

dystroglycan. T. Roscioli, E.-J. Kamsteeg, K. Buysse,<br />

I. Maystadt, J. van Reeuwijk, C. van den Elzen, E.<br />

van Beusekom, M. Riemersma, R. Pfundt, L. E. L. M.<br />

Vissers, M. Schraders, M. F. Buckley, H. G. Brunner, H.<br />

Zhou, J. A. Veltman, C. Gilissen, G. M. S. Mancini, M.<br />

A. Willemsen, D. Petkovi Ramada, D. Chitayat, C.<br />

Bennett, E. Sheridan, E. A. J. Peeters, G. M. B. Tan-<br />

Sindhunata, H. Kayserili, O. Abd El-Fattah El-Hashash,<br />

D. L. Stemple, D. J. Lefeber, Y.-Y. Lin, H. van<br />

Bokhoven.<br />

215/4:45 The identification <strong>of</strong> a novel gene<br />

identified by exome sequencing reveals the<br />

upstream components <strong>of</strong> the RAS/MAPK signaling<br />

pathway involved in Noonan syndrome. H. Yntema,<br />

W. Nillesen, J. Paardekooper Overman, M. Bonetti,<br />

J. de Ligt, H. Venselaar, M. Tartaglia, S. G. M. Frints,<br />

L. E. L. M. Vissers, J. den Hertog, I. van der Burgt.<br />

216/5:00 DYNC2H1 mutations are commonly<br />

found in Jeune asphyxating thoracic dysplasia<br />

(JATD) without extraskeletal features while IFT140<br />

mutations cause JATD with renal involvement.<br />

M. Schmidts, H. H. Arts, Z. Yap, E. M. H. F. Boengers,<br />

D. Anthony, M. M. Oud, S. Al-Turki, L. Duijkers,<br />

J. Stalker, J. B. Yntema, A. Hoischen, R. Bogdanovic,<br />

A. Peco Antic, C. Gillisen, H. Kayserili, I. Veltman,<br />

A. Kutkowska, E. J. Kamsteeg, R. C. M. Hennekam,<br />

P. Scambler, P. L. Beales, UK10K Consortium,<br />

N. V. A. M. Knoers, R. Roepman, H. M. Mitchison.<br />

217/5:15 Dominant missense mutations in<br />

ABCC9 cause Cantú syndrome. G. van Haaften,<br />

M. Harakalova, J. J. T. van Harssel, P. Terhal, S. van<br />

Lieshout, K. Duran, I. Renkens, D. J. Amor, L. C.<br />

Wilson, E. P. Kirk, C. L. S. Turner, D. Shears, S. García-<br />

Miñaúr, M. M. Lees, A. Ross, H. Venselaar, G. Vriend,<br />

H. Takanari, M. B. Rook, M. A. G. van der Heyden,<br />

M. E. Swinkels, I. J. Scurr, S. F. Smithson,<br />

N. V. Knoers, J. J. van der Smagt, I. J. Nijman,<br />

W. P. Kloosterman, M. M. van Haelst, E. Cuppen.<br />

218/5:30 Reduced dosage <strong>of</strong> ERF causes complex<br />

craniosynostosis in humans and mice, and links<br />

ERK1/2 signaling to regulation <strong>of</strong> osteogenesis.<br />

S. R. F. Twigg, I. Paraki, S. J. McGowan, M. Allegra,<br />

A. L. Fenwick, V. P. Sharma, E. Vorgia, A. Zaragkoulias,<br />

E. Sadighi Akha, S. J. Knight, H. Lord, T. Lester,<br />

L. Izatt, A. K. Lampe, S. N. Mohammed, F. J. Stewart,<br />

A. Verloes, L. C. Wilson, D. Johnson, S. A. Wall,<br />

P. Hammond, J. Hughes, S. Taylor, G. Mavrothalassitis,<br />

A. O. M. Wilkie.<br />

219/5:45 Mutations in the multidomain protein<br />

MEGF8 identify a new subtype <strong>of</strong> Carpenter<br />

syndrome associated with defective lateralization.<br />

D. L. Lloyd, S. R. Twigg, N. Elcioglu, D. Jenkins, C. D.<br />

O. Cooper, N. Akarsu, E. Taskiran, N. Al-Sannaa, A.<br />

Annagür, G. Gillessen-Kaesbach, I. Stefanova, S. J. L.<br />

Knight, J. A. Goodship, B. Keavney, P. L. Beales, O.<br />

Gileadi, S. McGowan, A. O. M. Wilkie.<br />

220/6:00 Increased frequency <strong>of</strong> FBN1 variants in<br />

adolescent idiopathic scoliosis. J. G. Buchan, D. A.<br />

Alvarado, M. C. Willing, M. B. Dobbs, C. A. Gurnett.<br />

221/6:15 Exome sequencing in idiopathic scoliosis<br />

reveals rare variants in VANGL, a planar cell<br />

polarity gene involved in axial development.<br />

S. Sharma, J. A. Herring, X. Gao, D. Zhang, C. Wise.<br />

222/6:30 Recessive mutations in FKBP10, a PPIase<br />

known to cause type XI OI, extend the phenotype<br />

to a congenital contracture syndrome (Kuskokwim<br />

disease), and cause diminished collagen crosslinking<br />

in matrix. A. M. Barnes, M. Weis, W. A.<br />

Cabral, E. Makareeva, E. L. Mertz, W. Paton,<br />

G. Duncan, C. Trujillo, S. Leikin, D. R. Eyre, S. J. Bale,<br />

J. C. Marini.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 44 – Tools for Phenotype Analysis<br />

Room 132, Lower Level North, Moscone Center<br />

Moderators: Donna Maglott, NCBI/NIH; Gregory E.<br />

Crawford, Duke Univ.<br />

223/4:30 PRIMUS: Pedigree Reconstruction and<br />

Identification <strong>of</strong> the Maximum Unrelated Set.<br />

J. Staples, D. Nickerson, J. Below.<br />

224/4:45 Pharmacogenoinformatics: Novel<br />

approach <strong>of</strong> in silico drug designing based on<br />

genetic variation <strong>of</strong> MDR1 gene involved in statin<br />

resistance. A. Munshi, M. Sai Babu, A. Venkateswara<br />

Rao, A. Jyothy.<br />

225/5:00 A general, integrated variant prioritization<br />

method for rapid determination <strong>of</strong> disease causing<br />

mutations from next-generation sequencing data.<br />

B. D. O’Fallon, W. Wooderchak-Donahue, P. Bayrak-<br />

Toydemir.<br />

226/5:15 Visually integrating and exploring high<br />

throughput phenome-wide association (PheWAS)<br />

results using PheWAS-view and PhenoGram. S. A.<br />

Pendergrass, S. Dudek, D. C. Crawford, M. D. Ritchie.<br />

227/5:30 PhenoDB: A new web-based tool for the<br />

collection, storage and analysis <strong>of</strong> phenotypic<br />

features. A. Hamosh, J. Hoover-Fong, V. R. Sutton,<br />

N. Sobreira, C. Boehm, F. Schiettecatte, D. Valle.<br />

228/5:45 A novel metabolomics analysis workflow<br />

provides new biological insights into the genetic<br />

basis <strong>of</strong> human metabolic variation. H. Dharuri,<br />

P. Henneman, D. O. Mook-Kanamori, K. Suhre,<br />

K. Willems van Dijk, P. A. C. `t Hoen.<br />

229/6:00 Integration <strong>of</strong> large-scale gene annotation,<br />

electronic medical records, and incidence data to<br />

produce phenotype-specific posterior probabilities<br />

to aid interpretation <strong>of</strong> genome-wide variant data.<br />

I. M. Campbell, S. W. Cheung, A. Patel, S. R. Lalani, P.<br />

Stankiewicz, M. B. Ramocki, J. R. Lupski, C. A. Shaw.<br />

230/6:15 The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health<br />

and Aging: CREX, computerized methodology to<br />

identify health conditions using the EMR for GWAS.<br />

S. Sciortino, L. Walter, D. Ranatunga, L. Shen, D.<br />

Ludwig, J. Kay, L. Sakoda, N. Risch, C. Schaefer.<br />

231/6:30 An informatics approach to analyzing the<br />

incidentalome. M. C. Adams, J. S. Berg, N. Nassar,<br />

C. Bizon, K. Lee, C. P. Schmitt, K. C. Wilhelmsen,<br />

J. P. Evans.<br />

INVITED AND PLATFORM SESSIONS 99<br />

Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 45 – Therapy <strong>of</strong> Genetic Disorders<br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Cynthia J.R. Curry, UCSF; Brunhilde<br />

Wirth, Univ. <strong>of</strong> Cologne, Germany<br />

232/4:30 Pathogenic exon-trapping by SVA<br />

retrotransposon and rescue in Fukuyama muscular<br />

dystrophy. M. Taniguchi, K. Kobayashi, M. Kanagawa,<br />

C. C. Yu, T. Oda, A. Kuga, H. Kurahashi, H. O. Akmen,<br />

S. DiMauro, T. Yokota, S. Takeda, T. Toda.<br />

233/4:45 Hematopoietic stem cell transplantation<br />

for adolescent and adult onset cerebral X-linked<br />

adrenoleukodystrophy. T. Matsukawa, T. Yamamoto,<br />

S. Seo, K. Kumano, M. Ichikawa, Y. Takahashi, H.<br />

Ishiura, J. Mitsui, M. Tanaka, J. Goto, M. Kurokawa,<br />

S. Tsuji.<br />

234/5:00 Treating Pelizaeus-Merzbacher disease<br />

with clinically applicable compounds, curcumin<br />

and chloroquine: Preclinical studies. K. Inoue,<br />

T. Morimura, Y. Numata, L.-H. Yu, L. Gotoh, R.<br />

Yamamoto, N. Inoue, B. Antalfy, K. Deguchi, H. Osaka,<br />

Y. Goto.<br />

235/5:15 Systemic L-threo-dihydroxyphenylserine<br />

corrects neurochemical abnormalities in a mouse<br />

model <strong>of</strong> Menkes disease. S. Kaler, A. Donsante, P.<br />

Sullivan, D. Goldstein, C. Holmes.<br />

236/5:30 Response to VPA therapy in SMA<br />

patients is concordant from blood to neurons and<br />

influenced by CD36. B. Wirth, L. Heesen, I. Hölker,<br />

T. Bauer, J. Schreml, K. Zimmermann, M. Thoenes,<br />

M. Walter, J. Dimos, M. Peitz, O. Brüstle, R. Heller,<br />

L. Garbes.<br />

237/5:45 Melatonin, a new biomarker reflecting<br />

brain serotonin metabolism in individuals with<br />

phenylketonuria: Evaluation <strong>of</strong> large neutral<br />

amino acid therapy by a randomized, double-blind<br />

crossover study. S. Yano, K. Moseley, C. Azen.<br />

238/6:00 Beyond cholesterol: Antioxidant treatment<br />

for patients with Smith-Lemli-Opitz syndrome.<br />

E. Elias, R. Braverman, S. Tong.<br />

239/6:15 Positive effects <strong>of</strong> short course androgen<br />

therapy on the neurodevelopmental outcome<br />

in boys with 47, XXY syndrome at 36 and 72<br />

months <strong>of</strong> age. C. Samango-Sprouse, E. Stapleton,<br />

T. Sadeghin, F. Mitchell, T. Dixon, M. Kingery, A.<br />

Gropman.<br />

240/6:30 A mechanism and treatment strategy for<br />

pregnancy-associated aortic dissection in Marfan<br />

syndrome. J. P. Habashi, N. Huso, D. Bedja, G. Rykiel,<br />

J. J. Doyle, H. C. Dietz.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


100 INVITED AND PLATFORM SESSIONS<br />

Thursday, November 8<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session C (38-46)<br />

SESSION 46 – Pharmacogenetics: From Discovery to<br />

Implementation<br />

Room 123, Lower Level North, Moscone Center<br />

Moderators: Toni Pollin, Univ. <strong>of</strong> Maryland Sch. <strong>of</strong><br />

Med.; Edward Ramos, NHGRI/NIH<br />

241/4:30 Pharmacogenomics, ancestry and clinical<br />

decision making for global populations. E. Ramos,<br />

A. Doumatey, H. Huang, D. Shriner, G. Chen, S. Callier,<br />

J. Zhou, A. Adeyemo, H. Mcleod, C. Rotimi.<br />

242/4:45 Cell line pr<strong>of</strong>iling in oncology (CELLO) as a<br />

discovery platform for systematic identification <strong>of</strong><br />

genetic and genomic biomarkers <strong>of</strong> drug<br />

sensitivity. J. Zhong, H. Niu, J. Cai, S. Middleton, H.<br />

Bian, J. Hakenberg, C. Saisanit, F. Birzele, W.<br />

Berk<strong>of</strong>sky-Fessler, J. Rosinski, N. Sanapareddy, Z.<br />

Albertyn, B. Chen, S. Bader, G. Chen, M. Xia, L.<br />

Vassilev, A. Belousov, L. Essioux.<br />

243/5:00 Screening <strong>of</strong> the TPMT gene before<br />

thiopurine treatment results in a lower leucopenia<br />

occurrence in patient with inflammatory bowel<br />

disease. M. J. H. Coenen, C. J. van Marrewijk, L. J.<br />

J. Derijks, S. H. Vermeulen, O. H. Klungel, A. L. M.<br />

Verbeek, H. Scheffer, B. Franke, H. J. Guchelaar, D. J.<br />

de Jong, TOPIC Study.<br />

244/5:15 PGRNseq: A new sequencing-based<br />

platform for high-throughput pharmacogenomic<br />

implementation and discovery. A. S. Gordon, J. D.<br />

Smith, Q. Xiang, M. L. Metzker, R. A. Gibbs, E. R.<br />

Mardis, D. A. Nickerson, R. S. Fulton, S. E. Scherer.<br />

245/5:30 Genetic variation in the GRK4 gene<br />

associates with susceptibility to hypertension<br />

and response to angiotensin receptor blockade.<br />

M. White, Z. Wang, H. Sanada, M. Yoneda, S. M.<br />

Williams, J. Bartlett, L. Gordon, S. Chen, L. Asico, C.<br />

Escano, V. Villar, C. Zeng, L. Wong, J. Jones, R. Felder,<br />

G. Eisner, P. Jose.<br />

246/5:45 Genome-wide discovery <strong>of</strong> drugdependent<br />

human liver enhancers. R. P. Smith, K.<br />

M. Morrissey, X. Sun, T. J. H<strong>of</strong>fman, K. M. Giacomini,<br />

N. Ahituv.<br />

247/6:00 Genome-wide association study <strong>of</strong><br />

vancomycin pharmacokinetics using a de-identified<br />

biorepository. S. L. Van Driest, T. L. McGregor, Z. Lu,<br />

S. Vear, C. B. Creech, P. J. Kannankeril, K. B. Brothers,<br />

A. Potts, E. Bowton, J. T. Delaney, Y. Bradford, S.<br />

Wilson, L. Olson, D. C. Crawford, B. Saville, D. M.<br />

Roden, J. C. Denny.<br />

248/6:15 Integrating multiple levels <strong>of</strong> phenotypic<br />

information to map genetic determinants <strong>of</strong><br />

glucocorticoid sensitivity. J. Maranville, S. Baxter,<br />

D. Witonsky, A. Di Rienzo.<br />

249/6:30 Common and rare genetic variation<br />

in maturity-onset diabetes <strong>of</strong> the young genes<br />

influence response to interventions for diabetes<br />

prevention. L. Billings, l. Tipton, A. Warner, J. McAteer,<br />

A. Shuldiner, D. Ehrmann, A. Manning, D. Dabelea,<br />

P. Franks, S. Kahn, T. Pollin, W. Knowler, D. Altshuler,<br />

K. Jablonski, J. Florez.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 47 – Structural and Regulatory Genomic<br />

Variation<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: Mike Lovett, Washington Univ. in St.<br />

Louis; Greg Elgar, MRC NIMR, London, U.K.<br />

250/8:00 Germline mosaicism does not explain the<br />

maternal age effect on trisomy. R. Rowsey,<br />

B. Murdoch, P. Hunt, C. Dickerson, T. Woodruff,<br />

T. Hassold.<br />

251/8:15 Female meiosis II errors prevalence and<br />

their impact on human embryo viability. A. Kuliev,<br />

Z. Zlatopolsky, I. Kirillova, J. Cieslak-Janzen.<br />

252/8:30 A population isolate reveals enriched<br />

recessive deleterious variants underlying<br />

neurodevelopmental traits. O. Pietiläinen, J.<br />

Suvisaari, W. Hennah, V. Leppä, T. Paunio, M.<br />

Torniainen, S. Ripatti, S. Ala-Mello, K. Rehnström, A.<br />

Tuulio-Henriksson, T. Varilo, J. Tallila, K. Kristiansson,<br />

M. Isohanni, J. Kaprio, J. Eriksson, M. Jarvelin, R.<br />

Durbin, J. Lonnqvist, M. Hurles, H. Stefansson, N.<br />

Freimer, M. Daly, A. Palotie.<br />

253/8:45 The role <strong>of</strong> trans-acting factors on<br />

recombination in oocytes with nondisjoined<br />

chromosomes 21. C. D. Middlebrooks, N.<br />

Mukhopadhyay, S. W. Tinker, E. G. Allen, L. J. H. Bean,<br />

F. Begum, R. Chowdhury, V. Cheung, E. Feingold,<br />

S. L. Sherman.<br />

254/9:00 Large-scale function-based enhancer<br />

discovery. D. E. Dickel, Y. Zhu, A. S. Nord, J. A.<br />

Akiyama, A. Visel, L. A. Pennacchio.<br />

255/9:15 A single enhancer on human chromosome<br />

11 directly controls >1,000 promoters and distal<br />

regulatory elements genome-wide. J . A.<br />

Stamatoyannopoulos, H. Wang, G. J. Cost, H. Quh, Y.<br />

Santago, J. Belton, R. McCord, S. Orlando, S. Neph,<br />

L. Zhang, T. Canfield, E. Giste, R. Sandstrom, R. S.<br />

Hansen, R. E. Thurman, P. D. Gregory, J. Dekker,<br />

F. D. Urnov.<br />

256/9:30 Identification <strong>of</strong> trait- and disease-relevant<br />

genetic polymorphisms in microRNA target sites.<br />

S. Busche, B. Ge, T. Kwan, K. Wong, S.-H. Chen, M.<br />

Georges, D. Ginzinger, T. Pastinen.<br />

257/9:45 Mapping functional p53 response<br />

elements and their variants in human genome.<br />

X. Wang, M. R. Campbell, V. G. Cheung, D. A. Bell.<br />

258/10:00 A SNP associated with skin cancer and<br />

pigmentation disrupts a melanocyte enhancer in an<br />

intron <strong>of</strong> IRF4. D. U. Gorkin, S. K. L<strong>of</strong>tus, D. Lee,<br />

M. A. Beer, W. J. Pavan, A. S. McCallion.<br />

INVITED AND PLATFORM SESSIONS 101<br />

Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 48 – Neuropsychiatric Disorders<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Dimitrios Avramopoulos, Johns Hopkins<br />

Univ.; Tatiana Foroud, Indiana Univ. Sch. <strong>of</strong> Med.<br />

259/8:00 Genetic and functional abnormalities <strong>of</strong><br />

the melatonin biosynthesis pathway in patients<br />

with bipolar disorder. S. Jamain, B. Etain, A.<br />

Dumaine, F. Bellivier, C. Pagan, L. Francelle, H.<br />

Goubran-Botros, S. Moreno, J. Deshommes, K.<br />

Moustafa, K. Le Dudal, F. Mathieu, C. Henry, J. P.<br />

Kahn, J. M. Launay, T. W. Mühleisen, S. Cichon, T.<br />

Bourgeron, M. Leboyer.<br />

260/8:15 Massively-parallel sequencing <strong>of</strong> the brain<br />

transcriptome reveals differential expression <strong>of</strong><br />

novel genes in bipolar disorder. N. Akula, J. Barb, X.<br />

Jiang, J. Wendland, K. Choi, S. Sen, B. K. Lipska, J. E.<br />

Kleinman, H. C. Bravo, D. T. Chen, P. J. Munson, F. J.<br />

McMahon.<br />

261/8:30 Rare and common gain-<strong>of</strong>-function<br />

alleles <strong>of</strong> the serotonin transporter gene, SLC6A4,<br />

associated with Tourette disorder.P. R. Moya, J. R.<br />

Wendland, A. M. Andrews, L. M. Rubenstein, K. R.<br />

Timpano, G. A. Heiman, J. A. Tischfield, R. A. King,<br />

S. Rammamoorthy, F. J. McMahon, D. L. Murphy.<br />

262/8:45 GLRB is the third major gene-<strong>of</strong>-effect in<br />

hyperekplexia or startle disease. S. K. Chung, A.<br />

Bode, C. A. Hunt, A. Derrick, T. D. Cushion, S. Wood,<br />

C. Drew, O. W. Howells, R. H. Thomas, J. G. Mullins,<br />

J. Lynch, M. I. Rees.<br />

263/9:00 Functional analysis <strong>of</strong> rare chimeric genes<br />

in schizophrenia. C. Rippey, C. Remmers, M. Cahill,<br />

A. Nord, T. Walsh, M. Lee, M. Gasperini, P. Penzes, J.<br />

McClellan, M.-C. King.<br />

264/9:15 Excess homozygosity in the major<br />

histocompatibility complex in schizophrenia.<br />

S. Mukherjee, S. Guha, M. Ikeda, N. Iwata,<br />

A. K. Malhotra, I. Pe’er, A. Darvasi, T. Lencz.<br />

265/9:30 Significant risk <strong>of</strong> new mutations for<br />

Huntington disease: CAG-size specific risk<br />

estimates <strong>of</strong> intermediate allele repeat instability.<br />

A. Semaka, C. Kay, C. Doty, J. A. Collins,<br />

M. R. Hayden.<br />

266/9:45 Mutations in AKT3 lead to<br />

hemimegalencephaly. A. Poduri, G. D. Evrony, X. Cai,<br />

P. C. Elhosary, R. Beroukhim, M. K. Lehtinen, L. B.<br />

Hills, E. L. Heinzen, A. Hill, R. S. Hill, B. J. Barry,<br />

B. F. D. Bourgeois, J. J. Riviello, A. J. Barkovich,<br />

P. M. Black, J. Madsen, K. L. Ligon, C. A. Walsh.<br />

267/10:00 De novo somatic mutations in<br />

components <strong>of</strong> the PI3K-AKT3-mTOR pathway<br />

cause hemimegalencephaly. J. Lee, M. Huynh,<br />

G. Mathern, J. Gleeson.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


102 INVITED AND PLATFORM SESSIONS<br />

Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 49 – Common Variants, Rare Variants, and<br />

Everything in Between<br />

Room 135, Lower Level North, Moscone Center<br />

Moderators: Steve Rich, Univ. <strong>of</strong> Virginia; Rasika<br />

Mathias, Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />

268/8:00 Minimal differences in single nucleotide<br />

variation calls between blood- and cell line-derived<br />

DNA from the same individuals. C. M. Schafer, N. G.<br />

Campbell, G. Cai, J. S. Sutcliffe, J. D. Buxbaum, K.<br />

Roeder, ARRA Autism Sequencing Consortium.<br />

269/8:15 The impact <strong>of</strong> genetic variation on<br />

diabetes-related quantitative traits from whole<br />

exome sequences: The T2D-GENES Consortium.<br />

H. M. Highland, X. Sim, A. Manning, M. Rivas, G.<br />

Atzmon, S. Choi, B. K. Cornes, J. Dupuis, J. C. Florez,<br />

P. Fontanillas, T. Frayling, E. R. Gamazon, I.-S. Huh,<br />

H. K. Im, J. Kim, Y. J. Kim, C. M. Lindgren, A. E. Locke,<br />

J. B. Meigs, A. P. Morris, N. Palmer, I. Prokopenko,<br />

T. M. Teslovich, T2D-GENES Consortium.<br />

270/8:30 Whole-exome sequencing in multiplex<br />

families identifies novel rare variants in multiple<br />

sclerosis. A. H. Beecham, J. L. McCauley, A.<br />

Hadjixen<strong>of</strong>ontos, P. L. Whitehead, I. Konidari, A.<br />

Aviram, Y. Pasco, S. L. Hauser, J. R. Oksenberg,<br />

D. J. Hedges, J. M. Vance, J. L. Haines, M. A. Pericak-<br />

Vance.<br />

271/8:45 A Mendelian randomization study on<br />

vitamin D status and blood pressure: A metaanalysis<br />

in up to 89,042 individuals. K. S.<br />

Vimaleswaran, D. J. Berry, A. Cavadino, M. R. Järvelin,<br />

E. Hyppönen, D-CarDia Collaboration.<br />

272/9:00 APOE modulates the relationship among<br />

triglycerides, cholesterol, and CHD through<br />

pleiotropy and gene-gene interactions.<br />

T . J. Maxwell, C. M. Ballantyne, J. M. Cheverud,<br />

C. S. Guild, C. E. Ndumele, E. Boerwinkle.<br />

273/9:15 Statistical inference <strong>of</strong> tissue-consistent<br />

and tissue-specific eQTLs. T. Flutre, X. Wen,<br />

J. Pritchard, M. Stephens.<br />

274/9:30 Estimates <strong>of</strong> penetrance for common<br />

pathogenic copy number variations. J. A. Rosenfeld,<br />

B. P. Coe, E. E. Eichler, H. Cuckle, L. G. Shaffer.<br />

275/9:45 Combining Illumina gene expression<br />

microarrays from different tissues: Methodological<br />

aspects. K. Heim, C. Schurmann, A. Schillert,<br />

C. Müller, T. Zeller, C. Herder, J. Kruppa, T. Illig,<br />

G. Homuth, K. Strauch, A. Peters, H. Wallasch<strong>of</strong>ski,<br />

M. Dörr, T. Meitinger, P. S. Wild, S. Blankenberg,<br />

U. Völker, M. Roden, A. Teumer, H. Prokisch, A. Ziegler<br />

on behalf <strong>of</strong> MetaXpress Consortium.<br />

276/10:00 A DNA variant caller adapted to assess<br />

mitochondrial DNA variation in lymphocytes from<br />

1,000 Sardinians. J. Ding, C. Sidore, O. Meirelles,<br />

M. K. Trost, F. Busonero, R. Nagaraja, F. Cucca,<br />

G. R. Abecasis, D. Schlessinger.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 50 – Population <strong>Genetics</strong> Genome-Wide<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: Melissa A. Wilson Sayres, Univ. <strong>of</strong><br />

California, Berkeley; Sarah Tishk<strong>of</strong>f, Univ. <strong>of</strong><br />

Pennsylvania<br />

277/8:00 Direct measure <strong>of</strong> human somatic basesubstitution<br />

mutation rate in monozygotic twins.<br />

J. B. Richards, R. Li, A. Montpetit, T. D. Spector, C.<br />

Polychronakos.<br />

278/8:15 Estimating human mutation rate using<br />

autozygosity in a founder population. C. D.<br />

Campbell, J. X. Chong, M. Malig, A. Ko, B. L. Dumont,<br />

L. Han, L. Vives, B. J. O’Roak, P. H. Sudmant,<br />

M. Abney, C. Ober, E. E. Eichler.<br />

279/8:30 The myth <strong>of</strong> random mating: Evidence<br />

<strong>of</strong> ancestry-related assortative mating across 3<br />

generations in Framingham, MA. R. Sebro, G.<br />

Peloso, J. Dupuis, N. Risch.<br />

280/8:45 Combined analysis <strong>of</strong> loss-<strong>of</strong>-function<br />

variants in protein-coding genes from over 16,000<br />

individuals. D. G. MacArthur, M. Lek, K. Shakir, S.<br />

Balasubramanian, E. Lim, B. M. Neale, L. Habegger,<br />

S. Gabriel, P. Sullivan, S. Kathiresan, M. I. McCarthy,<br />

M. Boehnke, S. Purcell, S. A. McCarroll, M. B. Gerstein,<br />

D. Altshuler, M. A. DePristo, M. J. Daly.<br />

281/9:00 Abundant selection explains low diversity<br />

on human Y chromosomes. M. Wilson Sayres, K.<br />

Lohmueller, R. Nielsen.<br />

282/9:15 The genomic geography <strong>of</strong> close relatives<br />

across Europe. P. Ralph, G. Coop.<br />

283/9:30 Evolutionary history and adaptation<br />

inferred from whole-genome sequences <strong>of</strong> diverse<br />

African hunter-gatherers. J. Lachance, B. Vernot,<br />

C. Elbers, B. Ferwerda, A. Froment, J. Bodo, G. Lema,<br />

W. Fu, T. Nyambo, T. Rebbeck, K. Zhang, J. Akey,<br />

S. Tishk<strong>of</strong>f.<br />

284/9:45 Mapping the human genome’s missing<br />

pieces using population admixture. G. Genovese,<br />

R. E. Handsaker, H. Li, N. Altemose, A. M. Lindgren,<br />

K. Chambert, B. Pasaniuc, A. Price, D. Reich, C. C.<br />

Morton, M. R. Pollak, J. G. Wilson, S. A. McCarroll.<br />

285/10:00 When ancestry runs deep: Trans-species<br />

polymorphisms in apes. L. Segurel, E. Leffler, Z. Gao,<br />

S. Pfeifer, A. Auton, O. Venn, L. Stevison, A. Venkat,<br />

J. L. Kelley, J. Kidd, C. Bustamante, R. Bontrop, M.<br />

Hammer, J. Wall, P. Donnelly, G. McVean,<br />

M. Przeworski.<br />

INVITED AND PLATFORM SESSIONS 103<br />

Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 51 – Endless Forms Most Beautiful: Variant<br />

Discovery in Genomic Data<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderators: Terry Furey, Univ. <strong>of</strong> North Carolina at<br />

Chapel Hill; Deanna Church, NCBI/NIH<br />

286/8:00 Dark matter <strong>of</strong> the diseasome: Annotating<br />

personal genomes for gene regulatory disease risk<br />

alleles. G. Bejerano.<br />

287/8:15 Causal mutation discovery using nextgeneration<br />

sequencing data: Development and<br />

application <strong>of</strong> a pipeline to reduce false positive<br />

calls and to map regions <strong>of</strong> shared homozygosity<br />

and IBD. S. Gulsuner, T. Walsh, A. C. Watts, M. K. Lee,<br />

T. Ozcelik, M. C. King.<br />

288/8:30 A new framework for large-scale genomic<br />

variant discovery and validation using pooled<br />

sequencing data. G. del Angel, M. Carneiro, E. Banks,<br />

R. Poplin, C. Hartl, M. A. DePristo.<br />

289/8:45 Discovery <strong>of</strong> genomic variants from RNAsequencing<br />

data. R. Piskol, G. Ramaswami, J. B. Li.<br />

290/9:00 zCall: A rare variant caller for array-based<br />

genotyping. J. I. Goldstein, A. Crenshaw, J. Carey, G.<br />

Grant, J. Maguire, M. Fromer, C. O’Dushlaine, J. L.<br />

Moran, K. Chambert, C. Stevens, P. Sklar, C. Hultman,<br />

S. Purcell, S. McCarroll, P. F. Sullivan, M. J. Daly, B.<br />

M. Neale, Swedish Schizophrenia Consortium, ARRA<br />

Autism Sequencing Consortium.<br />

291/9:15 Copy number detection and variant<br />

classification in the DDD project. T. W. Fitzgerald,<br />

K. I. Morley, M. van Kogelenberg, E. Bragin,<br />

P. Vijayarangakannan, A. Tivey, S. Clayton, S. Gribble,<br />

C. Wright, D. FitzPatrick, H. Firth, J. Barrett, N. Carter,<br />

M. Hurles.<br />

292/9:30 Removal <strong>of</strong> mapping biases in sequencebased<br />

functional data improves regulatory element<br />

identification at heterozygous variants.<br />

M. Buchkovich, K. L. Mohlke, T. S. Furey.<br />

293/9:45 SNP discovery in diverse human<br />

populations by rapid, very-low-cost next-generation<br />

sequencing <strong>of</strong> reduced representation libraries.<br />

T. F. Cooke, M. C. Yee, M. Muzzio, R. Bell,<br />

O. E. Cornejo, C. D. Bustamante, E. E. Kenny.<br />

294/10:00 HIBAG -- HLA genotype imputation with<br />

attribute bagging. X. Zheng, J. Shen, C. Cox,<br />

J. Wakefield, M. Ehm, M. Nelson, B. Weir.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


104 INVITED AND PLATFORM SESSIONS<br />

Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 52 – Clinical <strong>Genetics</strong>: Complex Mechanisms<br />

and Exome-Discovery<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: Michael Gambello, Emory Univ.; Antonie<br />

D. Kline, Harvey Inst. for <strong>Human</strong> Genet., Baltimore<br />

295/8:00 Systematic identification <strong>of</strong> causal<br />

mutations in Mendelian disorders using exome<br />

sequence data. M. Lek, N. F. Clarke, L. B. Waddell,<br />

B. Thomas, M. A. DePristo, M. J. Daly, K. N. North,<br />

D. G. MacArthur.<br />

296/8:15 Exome sequencing <strong>of</strong> a large cohort <strong>of</strong><br />

patients with congenital digestive system<br />

disorders. M. Yourshaw, S. F. Nelson, M. G. Martín.<br />

297/8:30 Novel defect in kinetochore assembly<br />

causes short stature and microcephaly <strong>of</strong> postnatal<br />

onset. C. Y. Hung, J. E. Dallman, O. Rittinger,<br />

J. W. Bauer, M. Tekin, O. A. Bodamer.<br />

298/8:45 Mutations in PIGO, a member <strong>of</strong> the GPI<br />

anchor synthesis pathway, cause<br />

hyperphosphatasia with mental retardation<br />

syndrome. P. M. Krawitz, Y. Murakami, J. Hecht, U.<br />

Krüger, S. E. Holder, G. R. Mortier, B. Chiaie, E. Baere,<br />

M. D. Thompson, T. Roscioli, S. Kielbasa, T. Kinoshita,<br />

S. Mundlos, P. N. Robinson, D. Horn.<br />

299/9:00 The 600 kb deletion syndrome at 16p11.2<br />

leads to energy imbalance and neuropsychiatric<br />

disorders. S. Jacquemont, F. Zufferey, E. H. Sherr, N.<br />

D. Beckmann, E. Hanson, A. Maillard, L. Hippolyte, A.<br />

Mace, C. Ferrari, Z. Kutalik, J. Andrieux, R. Bernier, S.<br />

Bouquillon, B. Delobel, W. Andrew-Faucett, R. P. Goin-<br />

Kochel, L. Harewood, S. Lebon, D. H. Ledbetter, C.<br />

Lese-Martin, K. Mannick, D. Martinet, M. B. Ramocki,<br />

S. J. Spence, K. Steinmann, J. Tjernagel, J. E. Spiro,<br />

A. Reymond, W. Chung, J. S. Beckmann on behalf<br />

<strong>of</strong> Simons VIP Consortium, and 16p11.2 European<br />

Consortium.<br />

300/9:15 Ras/MAPK dysregulation caused by MEK2<br />

haploinsufficiency: A novel mechanism for a<br />

RASopathy phenotype. M. J. M. Nowaczyk, B.<br />

Thompson, S. Zeesman, U. Moog, P. A. Sanchez-Lara,<br />

R. Falk, P. Magoulas, L. Brueton, S. M. Ahmudavalli,<br />

J. H. Fong, D. Batista, K. Rauen.<br />

301/9:30 Analysis <strong>of</strong> ESP5400 exomes for results <strong>of</strong><br />

clinical utility in genes for conditions tested as part<br />

<strong>of</strong> newborn screening programs and age-related<br />

macular degeneration. H. K. Tabor, S. M. Jamal,<br />

J. H. Yu, A. S. Gordon, W. S. Post, A. D. Johnson,<br />

T. A. Graubert, D. A. Nickerson, P. L. Auer, M. J.<br />

Bamshad on behalf <strong>of</strong> NHLBI Personal Genomics<br />

Project Team and NHLBI Exome Sequencing Project.<br />

302/9:45 High congenital malformation rates in a<br />

Chernobyl ionizing radiation impacted population<br />

isolate in Ukraine. W. Wertelecki, L. Yevtushok,<br />

N. Zymak-Zakutnia, S. Lachenko.<br />

303/10:00 Somatic mosaicism is responsible for<br />

congenital melanocytic naevus syndrome, and<br />

underpins the associated risk <strong>of</strong> melanoma.<br />

V. A. Kinsler, A. C. Thomas, N. W. Bulstrode,<br />

S. Abu-Amero, K. McKenzie, E. Chanudet, P. Stanier,<br />

E. Healy, N. J. Sebire, G. E. Moore.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 53 – From SNP to Function in Complex Traits<br />

Room 132, Lower Level North, Moscone Center<br />

Moderators: Praveen Sethupathy, Univ. <strong>of</strong> North<br />

Carolina at Chapel Hill; Aravinda Chakravarti,<br />

McKusick-Nathans Inst. <strong>of</strong> Genet. Med., Baltimore<br />

304/8:00 The type 2 diabetes risk allele <strong>of</strong><br />

rs11603334 increases ARAP1 promoter activity<br />

and is associated with increased ARAP1 mRNA<br />

in pancreatic islets. J. R. Kulzer, M. L. Stitzel, M. A.<br />

Morken, F. S. Collins, K. L. Mohlke.<br />

305/8:15 NOS1AP is the major genetic<br />

electrocardiographic QT-interval regulator.<br />

A. Kapoor, R. B. Sekar, V. Pihur, M. K. Halushka,<br />

G. F. Tomaselli, A. Chakravarti.<br />

306/8:30 A regulatory polymorphism in Csk, a Lyp<br />

binding partner, associates with systemic lupus<br />

erythematosus and affects B cell signaling,<br />

maturation and activation. N. Manjarrez-Orduño,<br />

E. Marasco, S. A. Chung, M. S. Katz, J. F. Kiridly,<br />

K. R. Simpfendorfer, J. Freudenberg, D. H. Ballard,<br />

E. Nashi, T. J. Hopkins, D. S. Cunninghame Graham,<br />

A. T. Lee, M. J. H. Coenen, B. Franke, D. S. Swinkels,<br />

R. Graham, R. P. Kimberly, P. M. Gaffney, T. J. Vyse, T.<br />

W. Behrens, L. A. Criswell, B. Diamond,<br />

P. K. Gregersen.<br />

307/8:45 ITGAM coding variant, rs1143679 (R77H)<br />

that is associated with systemic lupus<br />

erythematosus (SLE) susceptibility affects its<br />

own expression in monocytes and ligand binding<br />

activities in SLE patients. A. K. Maiti, X. Kim-Howard,<br />

P. Motghare, J. M. Anaya, L. Loogers, S. K. Nath.<br />

308/9:00 Loss-<strong>of</strong>-function <strong>of</strong> semaphorins 3C and<br />

3D in Hirschsprung disease. Q. Jiang, K. P. Kilambi,<br />

T. Heanue, M. X. Sosa, Q. Wang, J. J. Gray,<br />

A. L. Kolodkin, D. D. Ginty, A. Chakravarti.<br />

309/9:15 Functional assessment <strong>of</strong> human coding<br />

polymorphisms affecting skin pigmentation using<br />

zebrafish. Z. Tsetskhladze, V. Canfield, K. Ang,<br />

S. Wentzel, K. Reid, A. Berg, S. Johnson,<br />

K. Kawakami, K. Cheng.<br />

310/9:30 Dosage effects <strong>of</strong> 169 Chr21 genes on<br />

early development events in zebrafish. S. Edie,<br />

N. Zaghloul, D. Klinedinst, J. Lebron, N. Katsanis,<br />

R. Reeves.<br />

311/9:45 Two birds, one stone: Epistasis pr<strong>of</strong>iling <strong>of</strong><br />

many single-nucleotide variants in a human gene.<br />

O. Zill, J. Kitzman, J. Shendure, S. Fields.<br />

312/10:00 Discovery and replication <strong>of</strong> pathwaybased<br />

trans-eQTL associations. L. Wiley, W. Bush.<br />

INVITED AND PLATFORM SESSIONS 105<br />

Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 54 – Genetic Counseling and Clinical Testing<br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Susan Hahn, Univ. <strong>of</strong> Miami, Hussman<br />

Inst. for <strong>Human</strong> Genomics; Andrew Faucett, Geisinger<br />

Hlth. Syst., Danville, PA<br />

313/8:00 Utilization <strong>of</strong> chromosomal microarrays in<br />

pediatrics. A. H. Seeley, C. E. Keegan, C. S.<br />

Remmert, B. A. Tarini.<br />

314/8:15 Maximizing detection and minimizing<br />

noise: The first report <strong>of</strong> large scale whole exome<br />

sequencing data interpretation in a clinical<br />

laboratory. F. Xia, J. Beuten, M. Bainbridge, Z. Niu,<br />

M. Vatta, M. R. Bekheirnia, R. E. Person, M. Hardison,<br />

J. G. Reid, D. P. Sexton, A. C. Hawes, P. A. Pham, M.<br />

Wang, N. Saada, W. Liu, H. Sun, M. Scheel, Y. Ding,<br />

A. Roy, J. Wiszniewska, A. Willis, D. M. Muzny, S. E.<br />

Plon, J. R. Lupski, A. L. Beaudet, R. A. Gibbs, C. M.<br />

Eng, Y. Yang.<br />

315/8:30 Efficient detection <strong>of</strong> causative mutations<br />

for rare diseases: Rethinking clinical practice.<br />

H. Lee, J. Deignan, T. Toy, B. Harry, M. Yourshaw,<br />

P. Taylor, S. Webb, N. Dorrani, K. Das, F. Quintero,<br />

S. Kantarci, D. A. Wong, W. W. Grody, E. Vilain,<br />

S. F. Nelson.<br />

316/8:45 Intentions to receive individual results<br />

from whole-genome sequencing among<br />

participants in the ClinSeq study. B. B. Biesecker,<br />

F. M. Facio, H. Eidem, T. Fisher, S. Brooks, A. Linn,<br />

K. A. Kaphingst, L. G. Biesecker.<br />

317/9:00 Changes to control perceptions following<br />

disclosure <strong>of</strong> APOE-coronary artery disease<br />

associations during genetic susceptibility testing<br />

for Alzheimer’s disease: Findings from the REVEAL<br />

Study. K. Christensen, J. S. Roberts, W. R. Uhlmann,<br />

P. J. Whitehouse, T. O. Obisesan, D. L. Bhatt,<br />

L. A. Cupples, R. C. Green.<br />

318/9:15 Decreased prediction ability <strong>of</strong> common<br />

genetic variants on breast cancer risk with age:<br />

Possible underlying models and impact on risk<br />

prediction. H. Aschard, S. Lindstrom, P. Kraft.<br />

319/9:30 Large-sample size, comprehensive catalog<br />

<strong>of</strong> variants and advanced machine learning<br />

technique boost risk prediction for inflammatory<br />

bowel disease. Z. Wei, W. Wang, J. Bradfield,<br />

E. Frackelton, C. Kim, F. Mentch, R. Baldassano,<br />

H. Hakonarson, International IBD <strong>Genetics</strong><br />

Consortium.<br />

320/9:45 A comparison <strong>of</strong> risk estimates for<br />

complex diseases: Navigenics SNP-based testing<br />

and family history assessment. L. Aiyar, C. Shuman,<br />

R. Hayeems, L. Velsher, S. Wodak, D. Chitayat,<br />

J. Davies.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


106 INVITED AND PLATFORM SESSIONS<br />

Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55) (SESSION 54, continued)<br />

321/10:00 Web-based case conferencing: An<br />

effective source <strong>of</strong> cancer genetics training for<br />

community-based clinicians. K. Blazer, J. Weitzel.<br />

Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55)<br />

SESSION 55 – Mitochondrial Disorders and Ciliopathies<br />

Room 123, Lower Level North, Moscone Center<br />

Moderators: Catherine E. Keegan, Univ. <strong>of</strong> Michigan;<br />

Mitzi Murray, Univ. <strong>of</strong> Washington<br />

322/8:00 Combination <strong>of</strong> modern and traditional<br />

techniques identify MCKD1 causal frameshift<br />

variants within the MUC1 VNTR. A. Kirby, A. Gnirke,<br />

D. Jaffe, V. Bareová, N. Pochet, B. Blumenstiel, C. Ye,<br />

D. Aird, C. Stevens, J. Robinson, M. Calibi, I. Gat-Viks,<br />

E. Kelliher, R. Daza, M. DeFelice, H. Hlková, J. Sovová,<br />

C. Antignac, M. Guttman, R. Handsaker, K. Lindblad-<br />

Toh, S. Gabriel, P. S. Hart, A. Regev, C. Nusbaum,<br />

S. Kmoch, A. Bleyer, E. Lander, M. Daly.<br />

323/8:15 ARL13B, INPP5E, PDE6D and CEP164<br />

form a functional network involved in Joubert<br />

syndrome and nephronophthisis. S. Seo, M. C.<br />

Humbert, K. Weihbrecht, C. C. Searby, Y. Li, R. M.<br />

Pope, V. C. Sheffield.<br />

324/8:30 Mainzer-Saldino syndrome is a ciliopathy<br />

caused by mutations in the IFT140 gene. I. Perrault,<br />

S. Saunier, S. Hanein, E. Filhol, A. Bizet, F. Collins,<br />

M. Salih, S. Gerber, N. Delphin, E. Silva, V. Baudouin,<br />

M. Oud, N. Shannon, M. Le Merrer, O. Roche, C.<br />

Pietrement, C. Bole-Feysot, P. Nitschke, M. Zahrate, P.<br />

Beales, H. Arts, A. Munnich, J. Kaplan, C. Antignac, V.<br />

Cormier-Daire, J.-M. Rozet.<br />

325/8:45 Mutations in ALDH1B1, which encodes a<br />

mitochondrial protein belonging to the aldehyde<br />

dehydrogenase family, result in hepatic failure and<br />

mitochondrial respiratory chain deficiency. S. Salhi,<br />

V. Serre, M. Beinat, P. Nitschke, O. Bernard, A. Slama,<br />

A. Munnich, A. Rotig.<br />

326/9:00 Targeted exome sequencing <strong>of</strong> 102<br />

patients with clinical evidence <strong>of</strong> mitochondrial<br />

disease. D. S. Lieber, S. E. Calvo, K. Shanahan,<br />

N. G. Slate, S. Liu, S. G. Hershman, N. B. Gold,<br />

B. A. Chapman, M. Borowsky, D. R. Thorburn,<br />

G. T. Berry, J. D. Schmahmann, D. M. Mueller,<br />

K. B. Sims, V. K. Mootha.<br />

327/9:15 Genetic diagnosis <strong>of</strong> mitochondrial<br />

disorders by whole-exome sequencing. C. J. Carroll,<br />

V. Brilhante, P. Isohanni, R. Pöyhönen, L. Euro,<br />

U. Richter, T. Lahtinen, A. Götz, H. Almusa, P. Ellonen,<br />

H. Pihko, B. Battersby, H. Tyynismaa, A. Suomalainen.<br />

328/9:30 Constitutive activation <strong>of</strong> STIM1 causes<br />

tubular aggregate myopathy. J. Laporte, F.<br />

Chevessier, A. Maues de Paula, C. Koch, S. Attarian,<br />

C. Feger, D. Hantaï, P. Laforêt, K. Ghorab, J. M. Vallat,<br />

M. Fardeau, D. Figarella-Branger, J. Pouget, M. Koch,<br />

C. Ebel, N. Levy, B. Eymard, M. Bartoli, J. Bohm.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

8:00 AM–10:15 AM<br />

Concurrent Platform (abstract-driven)<br />

Session D (47-55) (SESSION 55, continued)<br />

329/9:45 Mutation in PNPT1 gene, which encodes a<br />

mitochondrial polyribonucleotide<br />

nucleotidyltransferase, causes encephalopathy with<br />

choreo-athetotic movements. V. Vedrenne, A.<br />

Gowher, P. De Lonlay, P. Nitschke, V. Serre, N.<br />

Boddaert, C. Altuzarra, A. M. Mager-Heckel, F.<br />

Chretien, N. Entelis, I. Tarassov, A. Munnich, A. Rotig.<br />

330/10:00 Comprehensive analysis <strong>of</strong> 101 nuclear<br />

genes for molecular diagnosis <strong>of</strong> mitochondrial<br />

disorders. R. Bai, J. Higgs, S. F. Suchy, S. Buchholz,<br />

D. Arjona, B. Boggs, C. Chinault, N. Smaoui, S.<br />

Benhamed, J. Compton, Y. Shevchenko, G. Richard,<br />

S. Bale, F. D. Kendall, S. Parikh, A. L. Gropman,<br />

W. Chung, A. Goldstein, S. E. Palmer, J. A. Panzer,<br />

S. W. Yum, M. J. Falk.<br />

INVITED AND PLATFORM SESSIONS 107<br />

Friday, November 9<br />

10:30 AM–11:15 AM<br />

SESSION 56 – Gruber <strong>Genetics</strong> Prize Award<br />

Presentation and Rosalind Franklin Young Investigator<br />

Award Announcement<br />

Hall D, Lower Level North, Moscone Center<br />

The <strong>Genetics</strong> Prize is awarded annually by The Gruber<br />

Foundation. The <strong>Genetics</strong> Prize is presented to a<br />

leading scientist, or up to three, in recognition <strong>of</strong><br />

groundbreaking contributions to any realm <strong>of</strong> genetics<br />

research. The recipient will be presented with a gold<br />

medal and a $500,000 unrestricted cash award.<br />

Recipient:<br />

Douglas Wallace, PhD<br />

Pr<strong>of</strong>. <strong>of</strong> Pathol. and Lab. Med., Univ. <strong>of</strong> Pennsylvania<br />

Ctr. <strong>of</strong> Mitochondrial and Epigenomic Med., Children’s<br />

Hosp. <strong>of</strong> Philadelphia<br />

The <strong>2012</strong> <strong>Genetics</strong> Prize <strong>of</strong> The Gruber Foundation will<br />

be presented to pioneering geneticist Douglas<br />

C. Wallace for the discovery <strong>of</strong> mutations in the<br />

mitochondrial genome and their impact on human<br />

health and disease.<br />

Dr. Wallace will deliver a lecture entitled, “A<br />

Bioenergetic Perspective on Origins, Health, and<br />

Disease”.<br />

Life is the interplay between structure (anatomy),<br />

energy (vital force), and the information to encode<br />

the structural and energetic systems. Classical<br />

Western biomedical thought has taken an anatomical<br />

perspective on disease and a Mendelian perspective<br />

on genetics. However, these perspectives are proving<br />

increasingly inadequate to explain the biological and<br />

genetic basis <strong>of</strong> complex diseases, cancer, and aging.<br />

To augment this classical perspective, we need to<br />

consider the bioenergetics <strong>of</strong> the eukarotic cell which<br />

is centered on the symbiotic bacterium known as the<br />

mitochondrion. The mitochondrion has its own DNA,<br />

the mitochondrial DNA (mtDNA), which encodes the<br />

core cellular energy genes. Mutations in the mtDNA<br />

have been found to cause the full range <strong>of</strong> complex<br />

disease phenotypes, the thousands <strong>of</strong> mtDNAs per<br />

cell provides an alternative explanation for quantitative<br />

genetic traits, and the analysis <strong>of</strong> mtDNA variation<br />

in human populations has <strong>of</strong>fered new insights<br />

into ancient ancestral migrations and adaptation<br />

to alternative environments. The causal role <strong>of</strong><br />

bioenergetic changes in complex disease has been<br />

validated by the introduction <strong>of</strong> mtDNA mutations into<br />

mice which then manifest common complex disease<br />

phenotypes. The recognition <strong>of</strong> the dichotomy<br />

between anatomical-chromosomal genes and<br />

bioenergetic-mtDNA genes has generated new insights<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


108 INVITED AND PLATFORM SESSIONS<br />

Friday, November 9<br />

10:30 AM–11:15 AM (SESSION 56, continued)<br />

into the molecular genetic basis <strong>of</strong> human health and<br />

disease, <strong>of</strong>fered a new perspective on the neutralistselectionist<br />

debate, and provided an explanation for<br />

the force that drives the evolution <strong>of</strong><br />

complex biological forms.<br />

The Gruber <strong>Genetics</strong> Prize has been presented<br />

annually since 2001. Laureates are: Rudolf Jaenisch,<br />

H. Robert Horvitz, David Botstein, Mary-Claire King,<br />

Robert H. Waterston, Elizabeth H. Blackburn, Maynard<br />

V. Olson, Allan C. Spradling, Janet Davison Rowley,<br />

Gerald Fink, Ronald Davis.<br />

Nominations for the 2013 Prize are currently open. The<br />

deadline is December 15, <strong>2012</strong>. For further information<br />

see www.gruberprizes.org.<br />

ROSALIND FRANKLIN YOUNG INVESTIGATOR<br />

AWARDS: Every three years, the Peter and Patricia<br />

Gruber Foundation presents the Rosalind Franklin Young<br />

Investigator Awards to two young women geneticists.<br />

One award is for research in genetics <strong>of</strong> humans and<br />

other mammals, and one award is for research in<br />

genetics <strong>of</strong> other model organisms. The awards are for<br />

career development and are $75,000 over three years.<br />

Winners <strong>of</strong> the Rosalind Franklin Award are in their first<br />

three years in an independent faculty level position<br />

in any area <strong>of</strong> genetics. The winners are selected by<br />

a committee <strong>of</strong> women geneticists, including former<br />

winners <strong>of</strong> the award. The recipients <strong>of</strong> the 2013–2015<br />

Rosalind Franklin Young Investigator Awards are:<br />

Valerie Horsley, PhD,<br />

Assistant Pr<strong>of</strong>essor <strong>of</strong> Molecular, Cellular, and<br />

Developmental Biology at Yale University, for her<br />

studies <strong>of</strong> the epithelial stem cell niche delineated by<br />

mouse genetic models;<br />

and<br />

Mary Gehring, PhD,<br />

Member <strong>of</strong> the Whitehead Institute and Assistant<br />

Pr<strong>of</strong>essor <strong>of</strong> Biology at MIT, for her studies <strong>of</strong><br />

imprinting and epigenetic regulation in Arabidopsis.<br />

Other finalists were Genevieve Konopka, PhD,<br />

Assistant Pr<strong>of</strong>essor <strong>of</strong> Neuroscience at UT<br />

Southwestern and Avital Rodal, PhD, Assistant<br />

Pr<strong>of</strong>essor <strong>of</strong> Biology at Brandeis University.<br />

Friday, November 9<br />

11:15 AM–11:45 AM<br />

SESSION 57 – <strong>ASHG</strong> William Allan Award Presentation<br />

Hall D, Lower Level North, Moscone Center<br />

The William Allan Award is presented annually by<br />

<strong>ASHG</strong> to recognize substantial and far-reaching<br />

scientific contributions to human and medical<br />

genetics, carried out over a lifetime <strong>of</strong> scientific inquiry<br />

and productivity.<br />

Introduction:<br />

Tayfun Özcelik<br />

Bilkent Univ., Ankara, Turkey<br />

Recipient:<br />

Uta Francke, MD<br />

Pr<strong>of</strong>. Em., Stanford Univ. Med. Ctr.<br />

Dr. Francke was chosen for her outstanding and<br />

tireless contributions to human and medical genetics<br />

fields, for her major impact on the study <strong>of</strong> many<br />

human disorders, for the breadth and depth <strong>of</strong> her<br />

applications <strong>of</strong> chromosomal analyses and molecular<br />

studies, and for her innovative uses <strong>of</strong> mouse models<br />

for understanding human genetic disease. The award<br />

recognizes her seminal work which extends back to<br />

the early days <strong>of</strong> medical and human genetics and<br />

includes more than 500 peer-reviewed publications.<br />

Among Francke’s exemplary achievements are<br />

advances in understanding Charcot-Marie-Tooth,<br />

Marfan, Rett, Prader-Willi, Williams, and Wiskott-<br />

Aldrich syndromes, which have had a major impact<br />

on the studying and treatment <strong>of</strong> these disorders.<br />

In essence, her lifetime <strong>of</strong> scientific discoveries and<br />

numerous contributions to the field over the decades<br />

have been far-reaching and have made a significant<br />

impact on advancing both basic and clinical human<br />

genetics. Dr. Francke has been one <strong>of</strong> the most<br />

respected scientists in the genetics community and is<br />

a stellar example <strong>of</strong> a tireless scientist, always seeking<br />

answers to important questions that interested her.<br />

Past Recipients: John Opitz (2011); Jurg Ott (2010);<br />

Hunt Willard (2009); Haig Kazazian (2008); Arthur<br />

Beaudet (2007); Dorothy Warburton (2006); Francis<br />

Collins (2005); Louis Kunkel (2004); David Weatherall<br />

(2003); Albert de La Chapelle (2002); Charles Epstein<br />

(2001); Stephen Warren (1999); Bert Vogelstein<br />

(1998); Philip Leder (1997); Robert Elston (1996);<br />

Kurt Hirschhorn (1995); Douglas Wallace (1994);<br />

Antonio Cao & Michael Kaback (1993); Alec Jeffreys<br />

(1992); Janet Rowley & Alfred Knudson (1991); Kary<br />

Mullis (1990); David Bostein & Ray White (1989); T.<br />

Caspersson (1988); L. L. Cavalli-Sforza (1987); Mary<br />

Lyon (1986); Joseph Goldstein & Michael Brown<br />

(1985); Y. W. Kan (1984); Frank Ruddle (1983);<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

11:15 AM–11:45 AM (SESSION 57, continued)<br />

Elizabeth Neufield (1982); Patricia Jacobs (1981);<br />

Walter Bodmer (1980); F. Clarke Fraser (1979);<br />

Charles Scriver (1978); Victor McKusick (1977);<br />

Philip Levin and A.S. Wiener (1975); Curt Stern (1974);<br />

Barton Childs (1973); Arno Motulsky (1970);<br />

Jerome Lejeune (1969); Harry Harris (1968);<br />

Vernon Ingram (1967); James Neel (1965);<br />

Newton Morton (1962).<br />

INVITED AND PLATFORM SESSIONS 109<br />

Friday, November 9<br />

11:45 AM–12:45 PM<br />

SESSION 58 – <strong>ASHG</strong> Membership and Business<br />

Meeting<br />

Hall D, Lower Level North, Moscone Center<br />

Reports highlighting current <strong>Society</strong> business will be<br />

presented. This is an opportunity for members to learn<br />

about recent <strong>ASHG</strong> activities and to provide<br />

suggestions to leaders. There will be a moment <strong>of</strong><br />

silence for those members and colleagues we have<br />

lost in <strong>2012</strong>. Discussion from the floor is encouraged.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


110 INVITED AND PLATFORM SESSIONS<br />

Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 59 – Genome Structure and Variation<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: John Moran, Univ. <strong>of</strong> Michigan Med. Sch.;<br />

Ryan Mills, Univ. <strong>of</strong> Michigan Med. Sch.<br />

331/4:30 A map <strong>of</strong> human genetic variation: Update<br />

from the 1000 Genomes Project. F. Yu, 1000<br />

Genomes Consortium.<br />

332/4:45 Towards a whole genome map <strong>of</strong> heritable<br />

copy number variation. S. Aradhya, L. Matyakhina,<br />

D. Pineda Alvarez, D. Riethmaier, A. Fuller, G. Richard,<br />

J. Meck.<br />

333/5:00 Charting the population-scale landscape<br />

<strong>of</strong> short tandem repeat variation in humans.<br />

M . Gymrek, J. Chen, C. O’Dushlaine, M. Daly,<br />

D. Reich, Y. Erlich.<br />

334/5:15 Whole-genome sequencing analysis <strong>of</strong><br />

iPSC lines uncovers lineage-manifested CNVs.<br />

A . E. Urban, A. Abyzov, D. Palejev, L. Rosenberg-<br />

Belmaker, Y. Zhang, J. Mariani, L. Tomasini,<br />

A. Ferrandino, A. Szekely, M. Wilson, M. Haney,<br />

E. Grigorenko, A. Huttner, S. Weissman, M. Gerstein,<br />

F. Vaccarino.<br />

335/5:30 SNP markers identify areas with restricted<br />

recombination suggesting structural variation<br />

across the human genome is widespread.<br />

P. G. Hysi, B. Tamraz, A. Nag, C. Venturini, J. S.<br />

Rahi, T. D. Spector, C. J. Hammond.<br />

336/5:45 Mapping the L1 interactome reveals RISCassociated<br />

helicase MOV10 as a potent inhibitor<br />

<strong>of</strong> retrotransposition. J. Goodier, L. Cheung, H. H.<br />

Kazazian.<br />

337/6:00 FoSTeS/MMBIR replicative repair<br />

mechanisms are error prone: High frequency <strong>of</strong><br />

nucleotide variation at the breakpoint junctions.<br />

C. M. B. Carvalho, M. B. Ramocki, D. Pehlivan,<br />

P. Fang, L. M. Franco, J. W. Belmont, P. J. Hastings,<br />

J. R. Lupski.<br />

338/6:15 Telomere position effect in patients with<br />

subtelomeric deletions. J. Gerfen, M. K. Rudd,<br />

H. Mason-Suares.<br />

339/6:30 De novo CNV formation in mouse<br />

embryonic stem cells occurs in the absence <strong>of</strong><br />

Xrcc4-dependent nonhomologous end joining.<br />

M . F. Arlt, S. Rajendran, S. R. Birkeland,<br />

K. M. McSweeney, T. E. Wilson, T. W. Glover.<br />

Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 60 – Advances in Neurodegenerative Disease<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Jeff Vance, Univ. <strong>of</strong> Miami;<br />

Tricia Thornton-Wells, Vanderbilt Univ.<br />

340/4:30 A genome-wide association study for<br />

cerebrospinal fluid tau and amyloid beta 42 identify<br />

new candidate variants implicated in Alzheimer’s<br />

disease. J. S. K. Kauwe, C. Cruchaga, O. Harari, K.<br />

Mayo, S. Bertelsen, M. Bailey, D. McKean, P. G. Ridge,<br />

T. J. Maxwell, E. Peskind, D. Galasko, A. M. Goate,<br />

ADGC, ADNI, GERAD.<br />

341/4:45 Analysis <strong>of</strong> whole transcriptome specific<br />

to the temporal pole <strong>of</strong> late-onset Alzheimer’s<br />

disease. C. E. Humphries, M. A. Kohli, P. W.<br />

Whitehead, W. F. Hulme, L. Nathanson, D. C. Mash,<br />

M. A. Pericak-Vance, J. R. Gilbert.<br />

342/5:00 Rare variants from high-density exome<br />

genotyping in late-onset Alzheimer’s disease:<br />

Update from Alzheimer’s Disease <strong>Genetics</strong><br />

Consortium. L.-S. Wang, A. C. Naj, C. Cruchaga,<br />

S. Mukherjee, C.-F. Lin, O. Valladares, L. B. Cantwell,<br />

R. Graham, T. Behrens, P. K. Crane, A. M. Goate,<br />

M. A. Pericak-Vance, G. D. Schellenberg, Alzheimer’s<br />

Disease <strong>Genetics</strong> Consortium.<br />

343/5:15 Common variants in ABCA7 and GRIN3B,<br />

HMHA1 and SBNO2, are associated with late-onset<br />

Alzheimer’s disease in African <strong>American</strong>s. C. Reitz,<br />

G. Jun, J. Buros, B. Vardarajan, L.-S. Wang, J. D.<br />

Buxbaum, E. B. Larson, N. Graff-Radford, D. Evans,<br />

N. Ertekin-Taner, M. Logue, C. T. Baldwin, R. C. Green,<br />

L. L. Barnes, L. B. Cantwell, M. D. Fallin, J. Manly,<br />

K. L. Lunetta, M. I. Kamboh, D. A. Bennett, K. Hall,<br />

A. M. Goate, G. S. Byrd, W. A. Kukull, T. M. Foroud,<br />

J. L. Haines, M. A. Pericak-Vance, L. A. Farrer, G.<br />

Schellenberg, R. Mayeux, ADGC Consortium.<br />

344/5:30 Genome-wide association analyses <strong>of</strong><br />

onset age in late-onset Alzheimer disease<br />

demonstrate no strong effect outside <strong>of</strong> the APOE<br />

region. A. C. Naj, Y. S. Park, R. Rajbhandary, K. L.<br />

Hamilton, G. W. Beecham, E. R. Martin, R. Mayeux,<br />

J. L. Haines, L. A. Farrer, G. D. Schellenberg,<br />

M. A. Pericak-Vance, Alzheimer’s Disease <strong>Genetics</strong><br />

Consortium.<br />

345/5:45 Identification by exome analysis <strong>of</strong> the<br />

molecular bases <strong>of</strong> familial idiopathic basal ganglia<br />

calcification not related to SLC20A2 mutation.<br />

G. Nicolas, C. Pottier, D. Maltête, S. Coutant,<br />

A. Rovelet- Lecrux, S. Legallic, Y. Vaschalde,<br />

L. Guyant-Maréchal, J. Augustin, O. Martinaud,<br />

L. Defebvre, P. Krystkowiak, J. Pariente, I. Le Ber,<br />

T. Frebourg, D. Hannequin, D. Campion.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67) (SESSION 60, continued)<br />

346/6:00 Mutations in DNAJ cause autosomal<br />

dominant Parkinson disease in the Mennonite<br />

community. C. Vilarino-Guell, A. Rajput, S. Appel-<br />

Cresswell, B. Shah, I. Yu, C. Thompson, C. Szu Tu, J.<br />

Trinh, M. Encarnacion, D. W. Dickson, A. J. Stoessl, M.<br />

L. Rajput, M. J. Farrer, A. H. Rajput.<br />

347/6:15 C9ORF72 repeat expansion is a risk factor<br />

for Parkinson disease. K. Nuytemans, G. Bademci,<br />

M. M. Kohli, G. Beecham, V. Inchausti, A. Dressen,<br />

L. Wang, J. I. Young, F. Nahab, C. Singer, E. R. Martin,<br />

J. R. Gilbert, M. Benatar, J. L. Haines, W. K. Scott,<br />

S. Zuchner, M. A. Pericak-Vance, J. M. Vance.<br />

348/6:30 Age-dependent penetrance <strong>of</strong> ALS+/-FTD<br />

due to C9orf72 hexanucleotide intronic repeat<br />

expansion mutations. B. N. Smith, S. Topp,<br />

J. Barnwell, A. Al-Chalabi, J. Kirby, P. J. Shaw, H. Pall,<br />

K. E. Morrison, V. de Jong, F. Bass, C. E. Shaw,<br />

C. M. Lewis.<br />

INVITED AND PLATFORM SESSIONS 111<br />

Friday, November 9<br />

4:30 PM–6:45PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 61 – Missing Heritability, Interactions and<br />

Sequencing<br />

Room 135, Lower Level North, Moscone Center<br />

Moderators: Dana Crawford, Vanderbilt Univ.;<br />

Alkes Price, Harvard Sch. <strong>of</strong> Publ. Hlth.<br />

349/4:30 Empirical and theoretical studies on<br />

genetic variance <strong>of</strong> rare variants for complex traits<br />

using whole genome sequencing in the CHARGE<br />

Consortium. C. Zhu, A. Morrison, J. Reid, C. J.<br />

O’Donnell, B. Psaty, L. A. Cupples, R. Gibbs, E.<br />

Boerwinkle, X. Liu.<br />

350/4:45 Leveraging admixture analysis to resolve<br />

missing and cross-population heritability in GWAS.<br />

N. Zaitlen, A. Gusev, B. Pasaniuc, G. Bhatia, S.<br />

Pollack, A. Tandon, E. Stahl, R. Do, B. Vilhjalmsson, E.<br />

Akylbekova, A. Cupples, M. Fornage, L. Kao, L. Lange,<br />

S. Musani, G. Papanicolaou, J. Rotter, I. Ruczinksi,<br />

D. Siscovick, X. Zhu, S. McCarroll, G. Lettre,<br />

J. Hirschhorn, N. Patterson, D. Reich, J. Wilson,<br />

S. Kathiresan, A. Price, CARe Analysis Core.<br />

351/5:00 Applying a quantitative genetics test <strong>of</strong><br />

evolutionary neutrality to finger ridge-count, a<br />

classical model trait in humans. S. E. Medland,<br />

P. M. Visscher, G. W. Montgomery, D. M. Evans,<br />

N. G. Martin.<br />

352/5:15 Does common variation contribute to the<br />

shared genetic basis for schizophrenia and autism?<br />

P. H. Lee, S. Ripke, S. Santangelo, M. Daly, Psychiatric<br />

GWAS Consortium - Schizophrenia & Autism Working<br />

Group.<br />

353/5:30 Ultrafast genome-wide interaction scan<br />

on case-control data implicates epistatic calcium<br />

channels in bipolar disorder. S. Prabhu, I. Pe’er.<br />

354/5:45 Computational challenges in the analysis<br />

<strong>of</strong> low coverage sequence data in thousands <strong>of</strong><br />

individuals. Y. Luo, L. Jostins, C. A. Anderson, J. C.<br />

Barrett, UK10K, UKIBDGC.<br />

355/6:00 Sparse sequencing <strong>of</strong> 6,000 cases and<br />

6,000 controls from Chinese women for genomewide<br />

association study <strong>of</strong> major depression.<br />

X. Gan, R. Mott, J. Flint, CONVERGE Consortium.<br />

356/6:15 Deep targeted sequencing <strong>of</strong> 12 breast<br />

cancer loci in 4,700 women across four different<br />

ethnicities. P. Kraft, S. Lindstrom, B. Chapman,<br />

G. Chen, C. Chen, O. H<strong>of</strong>man, D. Mirel, C. Haiman.<br />

357/6:30 Population stratification <strong>of</strong> human<br />

disease-associated SNPs, and their relevance to<br />

human disease networks. S. M. Raj, G. E. H<strong>of</strong>fman,<br />

A. G. Clark.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


112 INVITED AND PLATFORM SESSIONS<br />

Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 62 – Exome Sequencing Uncovers Etiology <strong>of</strong><br />

Mendelian Disease<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: Cheryl Maslen, Oregon Hlth. & Sci. Univ.;<br />

Jun Z. Li, Univ <strong>of</strong> Michigan<br />

358/4:30 Loss <strong>of</strong> function mutations in known<br />

human disease genes in 572 exomes. J. Johnston,<br />

K. Lewis, D. Ng, S. Gonsalves, J. Mullikin, L. G.<br />

Biesecker.<br />

359/4:45 The problem <strong>of</strong> multiple plausible<br />

molecular diagnoses in next-generation<br />

sequencing data: The NIH Undiagnosed Diseases<br />

<strong>Program</strong> experience. D. Adams, C. Boerkoel,<br />

K. Fuentes- Fajardo, P. Cherukuri, M. Sincan, C. Toro,<br />

C. Tifft, W. Gahl, T. Markello.<br />

360/5:00 Exome sequencing to identify the cause <strong>of</strong><br />

Mendelian diseases. J. Lupski, C. Gonzaga-<br />

Jauregui, W. Wiszniewski, D. Pehlivan, E. Karaca,<br />

A. Stray- Pedersen, S. Jhangiani, J. Reid, D. Muzny,<br />

R. A. Gibbs, Baylor-Hopkins Center for Mendelian<br />

Genomics.<br />

361/5:15 Domain-specific mutations in CDKN1C<br />

cause two disorders with opposing phenotypes:<br />

The undergrowth disorder IMAGe syndrome or<br />

the overgrowth disorder Beckwith-Wiedemann<br />

syndrome. V. Arboleda, H. Lee, R. Parnaik, A.<br />

Fleming, A. Banerjee, B. Ferraz-de-Souza, E. Delot,<br />

I. A. Rodriguez-Fernandez, D. Braslavsky, I. Bergadá,<br />

E. C. Dell’Angelica, S. F. Nelson, J. A. Martinez-<br />

Agosto, J. C. Achermann, E. Vilain.<br />

362/5:30 SCID newborn screening and exome<br />

sequencing identifies ataxia telangiectasia and low<br />

T cells early in life. J. M. Mallott, A. Kwan, J. Church,<br />

D. Gonzalez, S. Rana, U. Sunderam, R. Srinivasan,<br />

S. E. Brenner, L. F. Tang, F. Lorey, J. Puck.<br />

363/5:45 Identification <strong>of</strong> a new melanocyte<br />

differentiation gene underlying human autosomal<br />

recessive albinism. K. Grønskov, C. M. Dooley,<br />

E. Østergaard, R. N. Kelsh, L. Hansen, M. P. Levesque,<br />

K. Vilhelmsen, D. Stemple, T. Rosenberg.<br />

364/6:00 Exome sequencing results in 230 patients<br />

with severe developmental disorders in the DDD<br />

project. M. van Kogelenberg, K. Morley, T. Fitzgerald,<br />

S. Gerety, A. Tivey, S. Al-Turki, S. Clayton, C. Wright, J.<br />

Barrett, H. Firth, D. FitzPatrick, N. Carter, M. Hurles on<br />

behalf <strong>of</strong> DDD Project.<br />

365/6:15 Genetic etiology <strong>of</strong> isolated congenital<br />

asplenia. A. Bolze, L. Abel, A. Puel, N. Trede,<br />

L. Selleri, J.-L. Casanova.<br />

366/6:30 Whole genome sequencing in two<br />

brothers with heterotaxy reveals BCL9L as a<br />

novel gene associated with autosomal recessive<br />

heterotaxy (HTX6). C. J. Saunders, N. A. Miller,<br />

S. E. Soden, E. Farrow, D. L. Dinwiddie, N. P. Safina,<br />

S. Humphray, P. Saffrey, Z. Kingsbury, J. C. Weir,<br />

J. Betley, R. J. Grocock, J. E. Petrikin, K. P. Hall,<br />

S. F. Kingsmore.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 63 – Transcriptional Regulation, Variation and<br />

Complexity<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderators: Barbara Stranger, Brigham and Women’s<br />

Hosp., Harvard Med. Sch; Ross Hardison, Penn State<br />

367/4:30 The complete GENCODE human<br />

annotation: New insights into the functionality <strong>of</strong><br />

transcriptional complexity. J. M. Mudge, A. Frankish,<br />

GENCODE Consortium, T. Hubbard, J. L. Harrow.<br />

368/4:45 Genetic analyses in the Genotype-Tissue<br />

Expression (GTEx) project. K. Ardlie, N. Cox, D.<br />

DeLuca, E. Dermitzakis, B. Foster, G. Getz, R. Guigo,<br />

S. Jewell, D. Koller, J. Liu, J. Londsdale, D. Mash,<br />

M. McCarthy, M. Moser, D. L. Nicolae, A. Nobel, J.<br />

Pritchard, I. Rusyn, J. Thomas, W. Winckler, F. Wright,<br />

J. Zhu, GTEx Consortium.<br />

369/5:00 Characterizing the genetic basis <strong>of</strong><br />

transcriptome diversity in a large RNA sequencing<br />

study. A. Battle, S. Mostafavi, X. Zhu,<br />

S. B. Montgomery, J. B. Potash, M. M. Weissman,<br />

C. Haudenschild, C. McCormick, R. Mei, A. E. Urban,<br />

D. F. Levinson, D. Koller.<br />

370/5:15 Genetic and molecular basis <strong>of</strong> RNA-DNA<br />

sequence differences in humans. V. G. Cheung,<br />

A. Bruzel, L. McDaniel, A. L. Richards, J. M. Toung,<br />

I. X. Wang.<br />

371/5:30 Characterizing gene expression variation<br />

across seven diverse human populations.<br />

A. R. Martin, H. A. Costa, J. M. Kidd, B. M. Henn,<br />

M. C. Yee, F. Grubert, S. B. Montgomery, H. M. Cann,<br />

M. P. Snyder, C. D. Bustamante.<br />

372/5:45 Comparative eQTL analyses within and<br />

between seven tissue types suggest mechanisms<br />

underlying cell type specificity <strong>of</strong> eQTLs.<br />

B. Engelhardt, C. Brown.<br />

373/6:00 Identification <strong>of</strong> novel genetic<br />

determinants <strong>of</strong> induced innate immune responses<br />

and context specific eQTL in human primary<br />

monocytes. B. P. Fairfax, S. Makino, J. C. Knight.<br />

374/6:15 Gene-level and exon-level expression QTL<br />

signals in the UK Brain Expression Consortium<br />

dataset. M. E. Weale, A. Ramasamy, D. Trabzuni,<br />

R. Walker, C. Smith, M. Ryten, J. Hardy, UK Brain<br />

Expression Consortium.<br />

375/6:30 First complete haplotype <strong>of</strong> the human<br />

immunoglobulin heavy chain locus from a single<br />

individual and characterization <strong>of</strong> novel allelic and<br />

structural variation. K. Meltz Steinberg,<br />

C. T. Watson, J. Huddleston, P. H. Sudmant,<br />

R. L. Warren, M. Malig, J. Schein, A. J. Willsey,<br />

J. B. Joy, J. K. Scott, T. Graves, R. K. Wilson,<br />

R. A. Holt, F. Breden, E. E. Eichler.<br />

INVITED AND PLATFORM SESSIONS 113<br />

Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 64 – Epigenetics<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: Bernd Wollnik, Univ <strong>of</strong> Cologne, Germany;<br />

Beth A. Sullivan, Duke Univ.<br />

376/4:30 The epitranscriptome reveals novel<br />

mechanisms <strong>of</strong> RNA regulation and spatiotemporal<br />

dynamics. C. E. Mason, K. Meyer, Y. Saletore, P.<br />

Zumbo, O. Elemento, S. Jaffrey.<br />

377/4:45 Epigenome-wide pr<strong>of</strong>iling <strong>of</strong> circulating<br />

DNA in colorectal cancer. R. Cortese, Y. Li, A. Kwan,<br />

B. Zanke, Z. Zhang, A. Petronis.<br />

378/5:00 Alterations in genomically imprinted<br />

miRNA and snoRNA clusters in a mouse model <strong>of</strong><br />

fetal alcohol spectrum disorders. B. I. Laufer,<br />

K. Mantha, M. L. Kleiber, E. J. Diehl, S. M. F. Addison,<br />

S. M. Singh.<br />

379/5:15 KDM6A escapes X-inactivation and<br />

controls expression <strong>of</strong> reproduction-related<br />

homeobox genes in female ES cells and ovary:<br />

Deficiency may explain embryonic and ovarian<br />

failure in Turner. C. M. Disteche, J. B. Berletch,<br />

X. Deng, D. Nguyen.<br />

380/5:30 Genome-wide scan <strong>of</strong> DNA methylation<br />

in the aging brain and its relation to Alzheimer’s<br />

disease. P. L. De Jager, G. Srivastava, M. L. Eaton, L.<br />

E. Chibnik, B. Keenan, N. Taner, A. Myers,<br />

B. Bernstein, A. Meissner, M. Kellis, D. A. Bennett.<br />

381/5:45 RNA-mediated transcriptional silencing in<br />

Friedreich ataxia. Y. K. Chutake, A. M. Castro,<br />

S. I. Bidichandani.<br />

382/6:00 P53 regulates 5-hydroxymethylcytosinemediated<br />

epigenetic landscape through GADD45A.<br />

Y. Li, Y. Zhu, K. Szulwach, L. Lin, C. Street, H. Wu,<br />

D. Chen, P. Jin.<br />

383/6:15 Maps <strong>of</strong> open chromatin highlight cell<br />

type-specific patterns <strong>of</strong> regulatory sequence<br />

variation at hematological trait loci. C. A. Albers,<br />

D. S. Paul, A. Rendon, K. Voss, J. Stephens, P. van der<br />

Harst, J. C. Chambers, N. Soranzo, W. H. Ouwehand,<br />

P. Deloukas, HaemGen Consortium.<br />

384/6:30 Functional epialleles at an endogenous<br />

human centromere. B. A. Sullivan, K. A. Maloney,<br />

L. L. Sullivan, E. D. Strome, J. Matheny.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


114 INVITED AND PLATFORM SESSIONS<br />

Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 65 – Advances in Ocular <strong>Genetics</strong><br />

Room 132, Lower Level North, Moscone Center<br />

Moderators: Erica Davis, Duke Univ. Med. Ctr; Arupa<br />

Ganguly, Univ. <strong>of</strong> Pennsylvania<br />

385/4:30 Rare insertion polymorphisms identified<br />

by exome sequencing may be associated with agerelated<br />

macular degeneration. L. Farrer, J. Kozubek,<br />

M. Schu, J. Farrell, M. Morrison, K. Mayne, D. Morgan,<br />

R. Robinson, A. Swaroop, D. Schaumberg, K.-H. Park,<br />

E. E. Tsironi, G. Silvestri, I.-K.. Kim, R. Chen, C. Huff,<br />

G. Jun, M. deAngelis.<br />

386/4:45 The role <strong>of</strong> SIX6 in primary open-angle<br />

glaucoma. M. Ulmer, B. Whigham, D. Parker, X. Qin,<br />

N. Katsanis, Y. Liu, A. Ashley-Koch, R. R. Allingham,<br />

M. Hauser, NEIGHBOR Consortium Investigators.<br />

387/5:00 Topical ocular sodium 4-phenylbutyrate<br />

rescues glaucoma in a mouse model <strong>of</strong> primary<br />

open angle glaucoma. G. S. Zode, K. E. Bugge,<br />

E. M. Stone, V. C. Sheffield.<br />

388/5:15 Meta-analysis <strong>of</strong> GWAS on corneal<br />

thickness identifies a total <strong>of</strong> 27 associated loci,<br />

including six risk loci for eye disease keratoconus.<br />

S. Macgregor on behalf <strong>of</strong> CCT Consortium.<br />

389/5:30 Mouse models reveal an essential role<br />

for RERE in eye development. B. Kim, Z. Yu, O.<br />

Shchelochkov, M. Justice, B. Lee, D. Scott.<br />

390/5:45 Mutations in the nuclear NAD synthesizing<br />

enzyme NMNAT1 cause autosomal recessive Leber<br />

congenital amaurosis with early-onset severe<br />

macular atrophy and optic atrophy. J. Rozet,<br />

I. Perrault, S. Hanein, X. Zanlonghi, V. Serre,<br />

M. Nicouleau, S. Defoort-Delhemmes, N. Delphin,<br />

L. Fares-Taie, S. Gerber, O. Xerri, C. Edelson,<br />

A. Goldenberg, A. Duncombe, G. Le Meur, C. Hamel,<br />

E. Silva, P. Nitschke, P. Calvas, A. Munnich, O. Roche,<br />

H. Dollfus, J. Kaplan.<br />

391/6:00 RNA-DNA differences in miRNA<br />

transcriptome <strong>of</strong> retina and retinoblastoma.<br />

A. Ganguly, J. Leipzig, J. Richards, J. Purrazzella,<br />

T. Ganguly.<br />

392/6:15 Knock-in <strong>of</strong> human KIAA0649P in to the<br />

mouse Rb1 locus: Modeling the mechanism <strong>of</strong><br />

imprinted RB1 expression in humans. L. Steenpass,<br />

D. Kanber, M. Hiber, K. Buiting, D. Lohmann,<br />

B. Horsthemke.<br />

393/6:30 Gene therapy provides long-term<br />

visual function in a pre-clinical model <strong>of</strong> retinitis<br />

pigmentosa. K. J. Wert, R. J. Davis, S. H. Tsang.<br />

Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 66 – Cancer <strong>Genetics</strong>: Somatic Variants<br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Charis Eng, Cleveland Clinic; Jennelle<br />

Hodge, Mayo Clin.<br />

394/4:30 The genomic landscape <strong>of</strong> childhood pre-<br />

B acute lymphoblastic leukemia. J. Spinella,<br />

R. Vidal, J. Healy, V. Saillour, E. Bareke, C. Richer,<br />

S. Busche, B. Ge, T. Pastinen, D. Sinnett.<br />

395/4:45 Genomic analysis <strong>of</strong> serial chronic<br />

lymphocytic leukemia samples suggests that<br />

epigenetic changes, rather than clonal evolution,<br />

drive progression <strong>of</strong> disease. E. N. Smith,<br />

C. DeBoever, L. Rassenti, E. Ghia, S. Rozenzhak,<br />

P. Shepard, H. Alakus, O. Harismendy, C. Barrett,<br />

T. J. Kipps, K. A. Frazer.<br />

396/5:00 Whole-genome sequencing <strong>of</strong> liver<br />

cancers identifies etiological influences on<br />

mutation patterns and recurrent mutations in<br />

chromatin regulators. A. Fujimoto, Y. Totoki, T. Abe,<br />

K. A. Boroevich, F. Hosoda, H. H. Nguyen, M. Aoki,<br />

N. Hosono, M. Kubo, F. Miya, Y. Arai, H. Takahashi,<br />

T. Shirakihara, M. Nagasaki, T. Shibuya, K. Nakano,<br />

K. Watanabe-Makino, H. Tanaka, H. Nakamura, K.<br />

Chayama, N. Kamatani, S. Miyano, H. Nakagama,<br />

Y. Nakamura, T. Tsunoda, T. Shibata, H. Nakagawa.<br />

397/5:15 Breast cancer evolution revealed by deep<br />

whole-genome sequencing <strong>of</strong> early neoplasias and<br />

their concurrent carcinomas. A. Sidow, D. Kashef-<br />

Haghighi, D. Newburger, Z. Weng, T. Sweeney,<br />

S. Batzoglou, R. West.<br />

398/5:30 Intra-tumor genetic heterogeneity in<br />

cancer tissues: The key to assessing its<br />

significance is the distribution pr<strong>of</strong>ile <strong>of</strong> gene<br />

variants not just their presence in tumors.<br />

B. Gottlieb, C. Alvarado, C. Wang, B. Gharizadeh,<br />

F. Babrzadeh, L. K. Britel, M. Trifiro.<br />

399/5:45 Next generation sequencing and<br />

chromosomal microarray analysis provide novel<br />

insight into the genomic landscape <strong>of</strong> metastatic<br />

breast cancer. M. Li, Y. Wen, E. Fang, Y. Li, P. Chen,<br />

G. Douglas, C. Carmack, K. Osborne.<br />

400/6:00 The 3D topographic mapping <strong>of</strong> genetic<br />

variations in treatment <strong>of</strong> naïve advanced ovarian<br />

cancer.E. Cuppen, M. de Pagter, M. Hoogstraat,<br />

G. Cirkel, J. Kreeftmeijer, C. Lee, E. Levandowsky,<br />

T. Guy, K. Duran, R. `t Slot, T. Jonges, S. van Lieshout,<br />

M. Lolkema, R. Zweemer, M. Koudijs, I. Nijman,<br />

E. Voest, T. Harkins, W. Kloosterman.<br />

401/6:15 Transcriptome sequence analysis <strong>of</strong><br />

human colorectal cancer samples to reveal<br />

functional attributes. H. Ongen, T. F. Ornt<strong>of</strong>t,<br />

B. Oster, L. Romano, A. Planchon, C. L. Andersen,<br />

E. T. Dermitzakis.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67) (SESSION 66, continued)<br />

402/6:30 Regulatory regions are somatic mutation<br />

cold spots in cancer genomes. S. Sunyaev, P. Polak,<br />

M. S. Lawrence, R. E. Thurman, N. Stoletzki, P.<br />

Stojanov, E. Rynes, L. A. Garraway, S. Mirkin, G. Getz,<br />

J. A. Stamatoyannopoulos.<br />

INVITED AND PLATFORM SESSIONS 115<br />

Friday, November 9<br />

4:30 PM–6:45 PM<br />

Concurrent Platform (abstract-driven)<br />

Session E (59-67)<br />

SESSION 67 – Developmental Insights into <strong>Human</strong><br />

Malformations<br />

Room 123, Lower Level North, Moscone Center<br />

Moderators: Lucy Osborne, Univ. <strong>of</strong> Toronto, Canada;<br />

Rhona Schreck, Cedars-Sinai Med Ctr.<br />

403/4:30 TECTONIC3 mutations cause<br />

or<strong>of</strong>aciodigital syndrome type IV (Mohr-Majewski).<br />

S. Thomas, M. Legendre, S. Saunier, B. Bessières,<br />

C. Alby, M. Bonnière, A. Toutain, L. Loeuillet, K.<br />

Szymanska, F. Jossic, D. Gaillard, M. Tahar Yacoubi,<br />

S. Mougou-Zerelli, A. David, M.-A. Barthez, Y. Ville, C.<br />

Bole-Feysot, P. Nitschke, A. Munnich, C. A. Johnson,<br />

F. Encha-Razavi, V. Cormier-Daire, C. Thauvin-Robinet,<br />

M. Vekemans, T. Attié-Bitach.<br />

404/4:45 Abnormal development <strong>of</strong> NG2+PDGFR � +<br />

neural progenitor cells causes neonatal<br />

hydrocephalus in a ciliopathy mouse model. C . S.<br />

Carter, T. W. Vogel, Q. Zhang, T. O. Moninger, D. R.<br />

Thedens, K. M. Keppler-Noreuil, D. Y. Nishimura, C. C.<br />

Searby, K. Bugge, V. C. Sheffield.<br />

405/5:00 Malformation <strong>of</strong> the brain cortex, as the<br />

only expression <strong>of</strong> a ciliopathy, results from<br />

mutation in human Rotatin. G. M. S. Mancini, F. W.<br />

Verheijen.<br />

406/5:15 Whole exome resequencing identifies<br />

mutations in LRRC6 as a novel single-gene cause<br />

<strong>of</strong> primary cliary dyskinesia. M. Chaki, H. Y. Gee, E.<br />

A. Otto, K. Diaz, T. W. Hurd, J. Halbritter, S. J. Allen,<br />

M. B. Zariwala, M. R. Knowles, F. Hildebrandt.<br />

407/5:30 Temporally and spatially resolved<br />

catalogues <strong>of</strong> in vivo forebrain enhancers. A. S.<br />

Nord, L. Taher, J. Akiyama, M. J. Blow, A. Holt, R.<br />

Hosseini, S. Phouanenavong, I. Plajzer-Frick, M.<br />

Shoukry, V. Afzal, E. M. Rubin, I. Ovcharenko, J. L. R.<br />

Rubenstein, L. A. Pennacchio, A. Visel.<br />

408/5:45 SRY regulation <strong>of</strong> the RET gene suggests<br />

a potential role <strong>of</strong> the Y-chromosome gene in<br />

sexual dimorphism in Hirschsprung disease. Y. Li,<br />

Z. L. Tabatabai, M.-M. Garcia-Barceló, P. K. H. Tam,<br />

Y.-F. C. Lau.<br />

409/6:00 MAP3K1 mutations in 46 XY DGDs alter<br />

crosstalk in downstream signal transduction<br />

pathways to cause abnormal human gonadal<br />

development. J. Loke, A. Pearlman, H. Ostrer.<br />

410/6:15 S<strong>of</strong>t tissue aspects <strong>of</strong> the Williams-Beuren<br />

syndrome facial phenotype can be attributed to<br />

GTF2IRD1. S. J. Palmer, C. P. Canales, P. Carmona-<br />

Mora, P. Kaur, P. W. Gunning, E. C. Hardeman.<br />

411/6:30 Notch gain <strong>of</strong> function inhibits<br />

chondrocyte differentiation via Rbpj-dependent<br />

suppression. S. Chen, J. Tao, Y. Bae, M. Jiang, T.<br />

Bertin, Y. Chen, T. Yang, B. Lee.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


116 INVITED AND PLATFORM SESSIONS<br />

Saturday, November 10<br />

8:00 AM–8:20 AM<br />

SESSION 68 – <strong>ASHG</strong> Award for Excellence in <strong>Human</strong><br />

<strong>Genetics</strong> Education<br />

Hall D, Lower Level North, Moscone Center<br />

The <strong>ASHG</strong> Award for Excellence in <strong>Human</strong> <strong>Genetics</strong><br />

Education was established to recognize those who<br />

have made significant contributions <strong>of</strong> exceptional<br />

quality and great importance to human genetics<br />

education.<br />

Introduction:<br />

Kay Davies, Univ. <strong>of</strong> Oxford<br />

Recipient:<br />

Alan E. H. Emery, MD, PhD, DSc<br />

Em. Pr<strong>of</strong>. <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>,<br />

Univ. <strong>of</strong> Edinburgh; Hon. Fellow,<br />

GreenTempleton Col.,<br />

Univ. <strong>of</strong> Oxford<br />

Pr<strong>of</strong>essor Emery is being recognized for his<br />

distinguished work in education through lecturing,<br />

mentoring, establishment <strong>of</strong> programs, and for his<br />

writings, which include over 400 peer-reviewed articles<br />

and 26 books on all aspects <strong>of</strong> human and medical<br />

genetics (as well as poetry and the relationship<br />

between Medicine and Art). Indeed, Pr<strong>of</strong>essor Emery<br />

has been one <strong>of</strong> the most prolific authors <strong>of</strong> important<br />

genetics texts in the world.<br />

His books have covered all aspects <strong>of</strong> medical<br />

genetics, prenatal diagnosis, genetic counseling,<br />

statistics, molecular genetics, and historical<br />

perspectives. His texts including Elements <strong>of</strong> Medical<br />

<strong>Genetics</strong> (general), Methodology in Medical <strong>Genetics</strong><br />

(statistics), Introduction to Recombinant DNA<br />

(molecular genetics) and Principles and Practice <strong>of</strong><br />

Medical <strong>Genetics</strong> with David Rimoin (medical), remain<br />

among the most important texts in their fields. One <strong>of</strong><br />

his textbooks has been republished in twelve editions<br />

and translated into seven languages. Pr<strong>of</strong>essor Emery<br />

was the first to describe a form <strong>of</strong> muscular dystrophy<br />

now referred to as Emery-Dreifuss Muscular Dystrophy<br />

(EDMD or EMD) and the defective protein Emerin is<br />

named after him.<br />

Among his many accolades, Pr<strong>of</strong>essor Emery is a<br />

fellow or honorary fellow in ten different societies,<br />

including the Royal <strong>Society</strong> <strong>of</strong> Medicine and the Royal<br />

<strong>Society</strong> <strong>of</strong> Arts. Emery has also received many<br />

awards, including the Lifetime Achievement Award<br />

from the World Federation <strong>of</strong> Neurology and the<br />

Cockcr<strong>of</strong>t Medal from the University <strong>of</strong> Manchester,<br />

plus several honorary degrees. For many in the field <strong>of</strong><br />

human genetics, Pr<strong>of</strong>essor Emery is simply known as<br />

“the expert.”<br />

Past Recipients: Giovanni Romeo (2011); Thomas<br />

Gelehrter (2010); Bruce Korf (2009); John Carey,<br />

Lynn Jorde & Louisa Stark (2008); Robert Elston<br />

(2007); Roberta Pagon (2006); Joseph McInerney<br />

(2005); Robert Gorlin (2004); Joan Marks (2003); Kurt<br />

Hirschhorn (2002); Charles Scriver (2001); F. Clarke<br />

Fraser (2000); Arno Motulsky (1999); C.C. Li (1998);<br />

Victor McKusick (1997); Barton Childs (1996); Margaret<br />

Thompson (1995).<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Saturday, November 10<br />

8:20 AM–8:40 AM<br />

SESSION 69 – <strong>ASHG</strong> Victor A. McKusick Leadership<br />

Award Presentation<br />

Hall D, Lower Level North, Moscone Center<br />

<strong>ASHG</strong> established this prestigious award in honor <strong>of</strong><br />

Dr. Victor A. McKusick and his inspiring contributions<br />

to the human genetics field. The McKusick Leadership<br />

Award is presented to an individual whose<br />

pr<strong>of</strong>essional achievements have fostered and enriched<br />

the development <strong>of</strong> the field <strong>of</strong> human genetics.<br />

Recipients <strong>of</strong> this award exemplify the enduring<br />

leadership and vision required to ensure that the field<br />

<strong>of</strong> human genetics will flourish and successfully<br />

assimilate into the broader context <strong>of</strong> science,<br />

medicine, and health.<br />

Introduction:<br />

Joann A. Boughman, Univ. Syst. <strong>of</strong> Maryland<br />

Recipient:<br />

Francis S. Collins, MD, PhD<br />

Director, National Institutes <strong>of</strong> Health<br />

Dr. Collins has been named as the <strong>2012</strong> winner in<br />

recognition <strong>of</strong> his extensive achievements in genetics<br />

research, his efforts to advance health science<br />

and technology through policy and education, and<br />

his stellar leadership <strong>of</strong> the genetics community in<br />

mapping the human genome. The revolution that was<br />

dreamed <strong>of</strong> at the start <strong>of</strong> the <strong>Human</strong> Genome Project<br />

is currently being realized. Today’s medical geneticists,<br />

genetic counselors, and other health pr<strong>of</strong>essionals are<br />

increasingly able to identify and test genes associated<br />

with both single-gene and complex disease. Today’s<br />

medical researchers are increasingly able to<br />

investigate treatments and therapies for diseases with<br />

genetic causes. These medical and scientific advances<br />

would not have been possible without Dr. Collin’s<br />

leadership and dedication to studying the molecular<br />

genetics <strong>of</strong> diseases, for the benefit <strong>of</strong> health and<br />

medicine.<br />

During the completion <strong>of</strong> the NIH-based <strong>Human</strong><br />

Genome Project, Dr. Collins served as the Director <strong>of</strong><br />

the National <strong>Human</strong> Genome Research Institute.<br />

However, prior to taking on that leadership role, he<br />

had already contributed much to human genetics. He<br />

took part in the identification <strong>of</strong> the gene for cystic<br />

fibrosis in 1989, the gene for neur<strong>of</strong>ibromatosis in<br />

1990, and the gene for Huntington’s disease in 1993.<br />

His laboratory is known for its past and continuing<br />

focus on the function <strong>of</strong> genes involved in breast<br />

cancer, diabetes, Hutchinson-Gilford progeria<br />

syndrome, and many other conditions. In 2008, Dr.<br />

Collins stepped down from the NHGRI, and less than<br />

INVITED AND PLATFORM SESSIONS 117<br />

year later, he was chosen by President Obama to<br />

serve as the director <strong>of</strong> the National Institutes <strong>of</strong><br />

Health.<br />

Dr. Collins has received many awards for his<br />

achievements in science and technology, including the<br />

Presidential Medal <strong>of</strong> Freedom in November 2007, the<br />

National Medal <strong>of</strong> Science in 2009, and election into<br />

the Institute <strong>of</strong> Medicine and the National Academy <strong>of</strong><br />

Sciences.<br />

Dr. Collins has also made “singing for science” an<br />

emphasis <strong>of</strong> his pr<strong>of</strong>essional career. His efforts in<br />

education and outreach are commended by many.<br />

These efforts include, among many others, creating<br />

clinical partnerships with four historically black<br />

colleges and universities to develop clinical research<br />

degrees and conduct treatment trials among minority<br />

patients, and establishing the National Center for<br />

Advancing Translational Sciences to enhance the<br />

process <strong>of</strong> translating scientific discoveries into new<br />

drugs, diagnostics, and devices. Dr. Collins continues<br />

to play a vital role in the advancement <strong>of</strong> genetics and<br />

medical research and the improvement <strong>of</strong> health and<br />

medicine.<br />

Past Recipients: Leon E. Rosenberg (2011); Charles J.<br />

Epstein (2010); Arno G. Motulsky (2009); Victor A.<br />

McKusick (2008); Walter Nance (2007); David Rimoin<br />

(2006).<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


118 INVITED AND PLATFORM SESSIONS<br />

Saturday, November 10<br />

8:40 AM–8:45 AM<br />

SESSION 70 – AJHG C.W. Cotterman Awards<br />

Announcement<br />

Hall D, Lower Level North, Moscone Center<br />

Presenter: David L. Nelson, Editor, The <strong>American</strong><br />

Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />

Baylor Col. <strong>of</strong> Med<br />

Each September, the editorial board <strong>of</strong> The <strong>American</strong><br />

Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> elects two articles<br />

published in the journal in the previous year that best<br />

represent outstanding scientific contributions to the<br />

field <strong>of</strong> human genetics. Two Cotterman Awards are<br />

given annually. Monetary awards <strong>of</strong> $1000 and a<br />

certificate will be presented to the recipients for the<br />

top two papers published in the Journal during the<br />

previous year on which the first author was either a<br />

pre- or post- doctoral trainee and an <strong>ASHG</strong> member.<br />

Saturday, November 10<br />

8:45 AM–8:55 AM<br />

SESSION 71 – <strong>ASHG</strong> Charles J. Epstein Trainee Awards<br />

for Excellence in <strong>Human</strong> <strong>Genetics</strong> Research:<br />

Announcement <strong>of</strong> Winners<br />

Hall D, Lower Level North, Moscone Center<br />

Presenter: C. E. Pearson, Awards Committee Chair<br />

Hosp. for Sick Children<br />

<strong>ASHG</strong> honors excellence in research conducted by<br />

predoctoral and postdoctoral trainees, including<br />

genetic counseling trainees, through merit-based<br />

awards that recognize highly competitive abstracts<br />

submitted for the Annual Meeting. These awards were<br />

renamed in <strong>2012</strong> to honor the late Dr. Charles Epstein.<br />

60 Semifinalists were selected based on abstract<br />

score and awarded complimentary registration plus<br />

$750 each. Of those semifinalists, 18 finalists (selected<br />

by the Awards Committee) received an additional<br />

$250. The finalists’ presentations were reviewed by the<br />

<strong>ASHG</strong> Awards Committee and volunteer judges during<br />

the Annual Meeting.<br />

Six winners announced today will receive an additional<br />

$1000 each.<br />

Members <strong>of</strong> the Awards Committee are Christopher<br />

Pearson, Chair; Goncalo Abecasis, Georgia Dunston,<br />

Maximilian Muenke, Pragna Patel, Sharon Plon.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Saturday, November 10<br />

8:55 AM–9:20 AM<br />

SESSION 72 – <strong>ASHG</strong> Curt Stern Award Presentation<br />

Hall D, Lower Level North, Moscone Center<br />

The Curt Stern Award is given annually by <strong>ASHG</strong> in<br />

recognition <strong>of</strong> major scientific achievement in human<br />

genetics that has occurred in the last 10 years.<br />

The work could be a single discovery or a series <strong>of</strong><br />

contributions on similar or related topics. This Award<br />

honors the memory <strong>of</strong> Dr. Curt Stern (1902-1981), an<br />

outstanding pioneer in human genetics who served as<br />

<strong>ASHG</strong> president in 1956.<br />

Introduction:<br />

Evan Eichler, Univ. <strong>of</strong> Washington<br />

Recipient:<br />

Jay A. Shendure, MD, PhD<br />

Assoc. Pr<strong>of</strong>., Dept. <strong>of</strong> Genome<br />

Sciences, Univ. <strong>of</strong> Washington<br />

Dr. Shendure was selected for his outstanding<br />

contributions to the broad development and<br />

application <strong>of</strong> exome sequencing and its truly<br />

revolutionary effects on human genetics, as well as for<br />

the development <strong>of</strong> methods for high-throughput<br />

functional analysis <strong>of</strong> non-coding areas <strong>of</strong> DNA. This<br />

work has been - and will continue to be - <strong>of</strong> great<br />

impact to human disease gene discovery and<br />

understanding in clinical genetics. Importantly, these<br />

contributions have permitted individual (particularly<br />

small) clinical and laboratory groups to make<br />

significant contributions to our understanding <strong>of</strong><br />

disease. Most recently, Dr. Shendure and colleagues<br />

non-invasively sequenced the whole genome <strong>of</strong> a<br />

fetus, using DNA from the blood <strong>of</strong> the mother and the<br />

saliva <strong>of</strong> the father. This work will lead to major<br />

changes in prenatal diagnosis as the field moves<br />

toward non-invasive yet comprehensive testing. Dr.<br />

Shendure is one <strong>of</strong> the most promising young<br />

scientists in our genetics community. He will certainly<br />

continue to lead the way in developing techniques that<br />

will have great impact on patients.<br />

Past Recipients: David Altshuler (2011); Vivian Cheung<br />

(2010); David Haussler and James Kent (2009); Evan<br />

Eichler (2008); Jeffrey Murray (2007); Hal Dietz (2006);<br />

Patrick Brown (2005); Neil Risch (2004); David Page<br />

(2003); James Lupski (2002); Daniel Pinkel and Joe<br />

Gray (2001).<br />

INVITED AND PLATFORM SESSIONS 119<br />

Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 73 – Returning Results from Large-Scale<br />

Sequencing: Where the Rubber Meets the Road<br />

Gateway Ballroom 103, Lower Level South, Moscone<br />

Center<br />

Moderators: Leslie G. Biesecker, NHGRI/NIH; Robert<br />

C. Green, Brigham and Women’s Hosp.<br />

Medicine is on the brink <strong>of</strong> a revolution, as large-scale<br />

medical sequencing (LSMS) is now available for<br />

patient care, marking the dawn <strong>of</strong> genomic medicine.<br />

LSMS may be used in patients with a family history or<br />

symptoms <strong>of</strong> a disease for diagnosis or to predict<br />

future health risks for prevention and surveillance.<br />

Developing standards and procedures for the use <strong>of</strong><br />

LSMS in clinical medicine is critical and there is a<br />

need for empiric data to determine how to interpret,<br />

analyze, and return results. A critical question is how<br />

to handle secondary findings from LSMS. Speakers in<br />

this session will share their pioneering research<br />

initiatives that explore the translation <strong>of</strong> LSMS into<br />

meaningful clinical information and the delivery to<br />

patients. The speakers will report on a range <strong>of</strong><br />

studies, including patients ascertained with diseases,<br />

healthy volunteers, adults, and children, research<br />

versus clinical, and rare versus common disease. All <strong>of</strong><br />

the speakers will focus on results, and not just<br />

opinions, to inform the practice <strong>of</strong> genomic medicine<br />

and future research studies on the return <strong>of</strong> results. Dr.<br />

Biesecker will introduce the session and present<br />

ClinSeq, a large cohort LSMS study with return <strong>of</strong><br />

results to subjects. Dr. Green will present the results <strong>of</strong><br />

two efforts to formulate consensus on return <strong>of</strong><br />

incidental findings in LSMS. Dr. Kingsmore will present<br />

experience with neonatal and pediatric diagnosis by<br />

LSMS. Finally, Dr. Veltman will present the results <strong>of</strong><br />

a pilot using LSMS to diagnose genetically<br />

heterogeneous diseases with required return <strong>of</strong> all<br />

medically relevant results.<br />

9:40 AM ClinSeq: A pilot study <strong>of</strong> large-scale<br />

medical sequencing in research and implications<br />

for clinical genomic medicine. L. G. Biesecker.<br />

NHGRI/NIH.<br />

10:10 AM Expert concordance and discordance for<br />

return <strong>of</strong> incidental findings from whole genome<br />

sequencing. R. C. Green. Brigham and Women’s<br />

Hosp.<br />

10:40 AM Using next-generation sequencing for<br />

carrier testing for severe childhood recessive<br />

diseases. S. F. Kingsmore. Children’s Mercy Hosp.,<br />

Kansas City, KS.<br />

11:10 AM Diagnostic implementation <strong>of</strong> exome<br />

sequencing: Results from 500 patients. J. Veltman.<br />

Genomic Disorders Nijmegen, Netherlands.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


120 INVITED AND PLATFORM SESSIONS<br />

Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 74 – Genomic Approaches to Mendelian<br />

Disorders<br />

Hall D, Lower Level North, Moscone Center<br />

Moderators: Jay Shendure, Univ. <strong>of</strong> Washington; David<br />

Valle, Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />

Although the gene(s) underlying approximately 3,000<br />

Mendelian disorders are known, there are thousands<br />

<strong>of</strong> well-defined or suspected Mendelian disorders for<br />

which the genetic basis remains unknown. The past<br />

three years have been witness to an explosion <strong>of</strong><br />

interest in applying new technologies such as exome<br />

and genome sequencing to identify the genetic basis<br />

<strong>of</strong> Mendelian disorders that have proven intractable to<br />

conventional strategies. In this session, we will<br />

describe the progress as well as current challenges<br />

facing efforts to scale and accelerate the application <strong>of</strong><br />

next-generation technologies to Mendelian disorders,<br />

e.g. the U.S.-based Mendelian Genome Centers as<br />

well as related international efforts. Topics that will be<br />

explored include primary research results from leading<br />

groups in this field; advances and ongoing challenges<br />

in phenotype curation, sequencing technology, and<br />

data analysis; and the broader implications <strong>of</strong> these<br />

efforts for biology and medicine.<br />

9:40 AM Genomic approaches to Mendelian<br />

disorders. D. Valle. Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />

9:55 AM FORGE Canada: A nation-wide effort to<br />

understand the genomics <strong>of</strong> childhood disorders.<br />

K. Boycott. Children’s Hosp. <strong>of</strong> Eastern Ontario,<br />

Canada.<br />

10:10 AM Current challenges in exome or genomebased<br />

analysis <strong>of</strong> Mendelian disorders. J. Shendure.<br />

Univ. <strong>of</strong> Washington.<br />

10:40 AM Lessons from 500 diagnostic exomes. H.<br />

G. Brunner. Radboud Univ. Nijmegen Med. Ctr.,<br />

Netherlands.<br />

11:10 AM Genes, genomes and the future <strong>of</strong><br />

medicine. R. Lifton. Yale Univ.<br />

Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 75 – Emerging Applications <strong>of</strong> Identity by<br />

Descent Segment Detection<br />

Gateway Ballroom 104, Lower Level South, Moscone<br />

Center<br />

Moderators: Sharon R. Browning, Univ. <strong>of</strong> Washington;<br />

Brian L. Browning, Univ. <strong>of</strong> Washington<br />

Identity by descent (IBD) is fundamental to genetics<br />

and has diverse applications. Recently developed<br />

statistical methods and genome-wide SNP data have<br />

made it possible to detect haplotypes shared<br />

identically by descent between individuals with<br />

common ancestry up to 25-50 generations ago. With<br />

sequence data, shared haplotypes from even more<br />

distant ancestry can be detected. Patterns <strong>of</strong> IBD<br />

segment sharing within and between populations<br />

reveal important population demographic features<br />

including recent effective population size and migration<br />

patterns. IBD segment sharing is directly relevant to<br />

disease gene mapping and estimation <strong>of</strong> heritability.<br />

Individuals who share a genetic basis for a trait are<br />

more likely to have IBD sharing compared to randomly<br />

chosen individuals, and this forms the basis for IBD<br />

mapping and heritability estimation. Analysis <strong>of</strong> data<br />

from extended pedigrees was extremely difficult with<br />

standard linkage approaches, but is now possible<br />

using approaches based on detected IBD segments.<br />

Detected IBD can be present across pedigrees, which<br />

enhances power to detect association with the trait.<br />

Further, in population samples there is potential to<br />

utilize detected IBD segments to improve power to<br />

detect association when multiple variants within a<br />

gene influence the trait. IBD segments can also be<br />

used to greatly improve haplotype phase estimates,<br />

which is critical to understanding the functional<br />

consequence <strong>of</strong> genetic variation. IBD-based longrange<br />

phasing has previously been shown to be<br />

effective in isolated populations such as Iceland, but<br />

recent advances have extended its application to large<br />

outbred populations. In this session, we explore these<br />

exciting new developments.<br />

9:40 AM Sharing by descent, phasing, rare<br />

variants and population structure. A. Kong. deCODE<br />

Genet., Reykjavik, Iceland.<br />

10:10 AM Length distributions <strong>of</strong> identity by<br />

descent reveal fine-scale demographic history.<br />

I. Pe’er. Columbia Univ.<br />

10:40 AM Identity by descent within and between<br />

pedigrees. E. A. Thompson. Univ. <strong>of</strong> Washington.<br />

11:00 AM Using high resolution identity by descent:<br />

From detecting selection to explaining trait<br />

variability. M. Abney. Univ. <strong>of</strong> Chicago.<br />

11:20 AM Extending the limits <strong>of</strong> IBD segment<br />

detection with sequence data and new statistical<br />

methods. B. L. Browning. Univ. <strong>of</strong> Washington.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 76 – The Functional Consequences <strong>of</strong><br />

microRNA Dysregulation in <strong>Human</strong> Disease<br />

Room 134, Lower Level North, Moscone Center<br />

Moderators: Cheryl L. Thompson, Case Western<br />

Reserve Univ.; Ahmad Khalil, Case Western Reserve<br />

Univ.<br />

MicroRNAs (miRNAs) are an evolutionarily conserved<br />

class <strong>of</strong> small non-coding RNAs that have been shown<br />

to regulate the expression levels <strong>of</strong> numerous proteincoding<br />

genes. Although integral to animal biology, their<br />

role in human disease has only recently been studied.<br />

Previously, numerous miRNAs have been<br />

demonstrated to be dysregulated in multiple diseases,<br />

including cancer, cardiovascular disease, neurological<br />

disease and many others. However, the exact<br />

functions and mechanisms <strong>of</strong> these miRNAs in human<br />

diseases are yet to be fully elucidated. A number <strong>of</strong><br />

recent studies have now begun to shed light on the<br />

role <strong>of</strong> miRNAs in disease, providing insights into<br />

mechanisms for imitation and progression <strong>of</strong> disease<br />

as well as targets for preventive and therapeutic<br />

intervention. In this session we have assembled a<br />

group <strong>of</strong> world leaders in the field <strong>of</strong> miRNA and<br />

human diseases. The speakers will discuss their latest<br />

research on miRNAs, which will cover a range <strong>of</strong><br />

topics from targets <strong>of</strong> miRNAs, animal models <strong>of</strong><br />

miRNA action as well as the role <strong>of</strong> circulating miRNAs<br />

in diagnostics.<br />

9:40 AM OncomiR-1 in cancer and development:<br />

A tale <strong>of</strong> mice and men. A. Ventura. Sloan-Kettering<br />

Inst.<br />

10:10 AM microRNA reprogramming in cancer:<br />

Mechanisms and consequences. J. Mendell. Univ. <strong>of</strong><br />

Texas Southwestern Med. Ctr.<br />

10:40 AM Exploring circulating miRNAs as bloodbased<br />

diagnostic biomarkers. M. Shapero.<br />

Affymetrix, Santa Clara, CA.<br />

11:10 AM Circulating microRNAs in obesity and<br />

postmenopausal breast cancer. C. L. Thompson.<br />

Case Western Reserve Univ.<br />

INVITED AND PLATFORM SESSIONS 121<br />

Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 77 – Centralizing the Deposition and Curation<br />

<strong>of</strong> <strong>Human</strong> Mutations<br />

Room 132, Lower Level North, Moscone Center<br />

Moderators: Robert L. Nussbaum, UCSF; David H.<br />

Ledbetter, Geisinger Hlth. Syst., Danville, PA<br />

Hundreds <strong>of</strong> thousands <strong>of</strong> disease-causing variants<br />

have been identified in patients with disease, yet only<br />

a small fraction <strong>of</strong> that data, and the interpretation <strong>of</strong><br />

it, is accessible to researchers and clinicians. The<br />

centralization <strong>of</strong> data on human genomic variation is a<br />

critical step in accelerating advances within the field <strong>of</strong><br />

genomic medicine. Such centralization <strong>of</strong> variant data<br />

will not only enable more efficient approaches to data<br />

analysis, but will also ensure the use <strong>of</strong> a uniform set<br />

<strong>of</strong> standards across the many communities<br />

contributing data and intending to use the resources<br />

for research and clinical applications. This session will<br />

highlight groups that have recently joined efforts<br />

to solve this challenge and create a free and useful<br />

human genomic mutation database for the community.<br />

9:40 AM Improving the accuracy <strong>of</strong> variant<br />

identification. D. Church. NLM/NIH.<br />

10:10 AM The ISCA Consortium: Standardization<br />

and sharing <strong>of</strong> structural variation data. C. L.<br />

Martin. Emory Univ. Sch. <strong>of</strong> Med.<br />

10:40 AM Introducing ClinVar. D. Maglott. NCBI,<br />

NLM/NIH.<br />

11:10 AM Community involvement in centralized<br />

mutation curation. H. L. Rehm. Harvard Med. Sch.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


122 INVITED AND PLATFORM SESSIONS<br />

Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 78 – Stem Cells and Personalized Medicine<br />

Room 135, Lower Level North, Moscone Center<br />

Moderator: Stephen H. Tsang, Columbia Univ.<br />

Speakers will discuss applications <strong>of</strong> patient-specific<br />

and disease-specific stem cell lines, including disease<br />

modeling, drug screening, and regenerative medicine.<br />

Panelists will bring experience in clinical genetics,<br />

genetic manipulation in stem cells, and disease<br />

modeling. The FDA has recently approved phase I/II<br />

clinical trials to investigate the safety and efficacy <strong>of</strong><br />

embryonic stem cell-based retinal cell transplantation,<br />

but such therapy requires immunosuppression.<br />

Patient-specific stem cells may <strong>of</strong>fer an alternative to<br />

embryonic stem cells that will skirt the need for<br />

immunosuppressive therapy as well as the social and<br />

political ramifications <strong>of</strong> embryonic stem cell research,<br />

but their utility even extends far beyond such<br />

groundbreaking advances.<br />

9:40 AM Stem cells and personalized medicine in<br />

retinal degenerations. S. H. Tsang. Columbia Univ.<br />

10:10 AM Direct reprogramming to generate<br />

patient-specific stem cells and neurons. M. Wernig.<br />

Stanford Sch. <strong>of</strong> Med.<br />

10:40 AM A chemical approach to controlling cell<br />

fate. S. Ding. UCSF.<br />

11:10 AM Patient-specific stem cells and<br />

cardiovascular genetics. B. Conklin. UCSF.<br />

Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 79 – Should Noninvasive Prenatal Diagnosis<br />

Augment or Replace Current Prenatal Screening and<br />

Diagnosis?<br />

Room 124, Lower Level North, Moscone Center<br />

Moderators: Mark E. Nunes, Kaiser Permanente, San<br />

Diego; Mildred K. Cho, Stanford Univ.<br />

The discovery <strong>of</strong> circulating cell-free fetal nucleic acid<br />

(cffDNA) in maternal blood plasma in 1997 allowed for<br />

the development <strong>of</strong> noninvasive prenatal diagnosis<br />

(NIPD) <strong>of</strong>fered commercially in a medical setting in<br />

North America beginning in October 2011. From the<br />

initial discovery, ethical issues were raised in that<br />

the method could most easily be validated seeking<br />

circulating Y chromosome transcripts. The method<br />

subsequently has been validated for fetal Rh typing<br />

and fetal aneuploidy, but the next-generation<br />

sequencing methods used to analyze cffDNA allow<br />

any Mendelian trait or disorder with a known gene to<br />

be detected by the method. This technology<br />

convergence, coupled with the test being <strong>of</strong>fered at<br />

10-weeks gestation, could provide a level <strong>of</strong> access<br />

and choice in women’s reproductive decision making<br />

unprecedented since the introduction <strong>of</strong> oral<br />

contraception. We will briefly introduce the topic, and<br />

then debate the ethical, legal, and social issues <strong>of</strong><br />

broadening the scope and availability <strong>of</strong> NIPD. The<br />

technique will be placed in the context <strong>of</strong> the history<br />

<strong>of</strong> seeking fetal markers and cells in maternal<br />

circulation. The ethical context will be outlined, with<br />

competing issues <strong>of</strong> autonomy and societal interest.<br />

The legal context, within the current debate<br />

surrounding reproductive freedom, will be discussed.<br />

The possible impact on society and medical practice<br />

will be described.<br />

9:40 AM Lessons from the clinical introduction <strong>of</strong><br />

noninvasive prenatal diagnosis: How we got here.<br />

A. T. Bombard. Sequenom Inc., San Diego.<br />

10:05 AM Cell-free fetal DNA in prenatal diagnosis:<br />

Where we are going? D. Bianchi. Tufts Univ., Boston.<br />

10:30 AM Academia and industry in the<br />

development <strong>of</strong> noninvasive prenatal diagnosis. M.<br />

K. Cho. Stanford Univ.<br />

10:55 AM Ethical and policy implications <strong>of</strong> early<br />

noninvasive prenatal diagnosis. J. S. King. UC<br />

Hastings Col. <strong>of</strong> the Law, San Francisco.<br />

11:20 AM Discussion. M. E. Nunes. Kaiser<br />

Permanente, San Diego.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


Saturday, November 10<br />

9:40 AM–11:40 AM<br />

Concurrent Invited Session III (73-80)<br />

SESSION 80 – Selection Signatures and the <strong>Genetics</strong><br />

<strong>of</strong> Autoimmunity and Infectious Diseases<br />

Room 130, Lower Level North, Moscone Center<br />

Moderators: Judy H. Cho, Yale Univ.; Richard A.<br />

Spritz, Univ. <strong>of</strong> Colorado Denver Anschutz Med.<br />

Campus<br />

The overlap <strong>of</strong> autoimmune and infectious disease loci<br />

is one <strong>of</strong> the seminal findings <strong>of</strong> the GWAS era. The<br />

presence <strong>of</strong> a relatively limited and recurring number<br />

<strong>of</strong> major autoimmune and infectious disease-<br />

associated genes and pathways may well correspond<br />

with functional networks that evolved in response to<br />

historically significant infectious pathogens. It may be<br />

speculated that the plethora <strong>of</strong> common functional<br />

polymorphisms identified through GWAS in<br />

autoimmune diseases evolved through positive<br />

selection; in subsequent eras and environmental<br />

conditions, these once beneficial polymorphisms<br />

confer increased susceptibility to autoimmunity.<br />

Support for this concept is provided by the<br />

observation that uncommon, <strong>of</strong>ten highly penetrant,<br />

mutations in overlapping genes and pathways are<br />

INVITED AND PLATFORM SESSIONS 123<br />

associated in infectious diseases such as severe<br />

mycobacterial infections. Predictive functional<br />

networks may be optimized by integration <strong>of</strong><br />

complementary data sources, notably selection<br />

signatures. Novel approaches <strong>of</strong> identifying signatures<br />

<strong>of</strong> positive selection at single and multiple loci will<br />

require integration <strong>of</strong> genetic association data with<br />

biologic data that optimally models relevant selection<br />

conditions.<br />

9:40 AM <strong>Genetics</strong> and Autoimmunity. J. H. Cho.<br />

Yale Univ.<br />

9.55 AM The genetics <strong>of</strong> autoimmunity. R. A.<br />

Spritz. Univ. <strong>of</strong> Colorado Denver.<br />

10:10 AM Selection signatures and mechanisms <strong>of</strong><br />

host-microbe interactions. P. Sabeti. Harvard Univ.<br />

10:40 AM Interactions <strong>of</strong> HLA class I with killer-cell<br />

immunoglobulin-like receptors: Influences on<br />

human disease. P. Parham. Stanford Univ.<br />

11:10 AM Toward a genetic theory <strong>of</strong> infectious<br />

diseases. J.-L. Casanova. Rockefeller Univ.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />

INVITED AND PLATFORM SESSIONS


124 INVITED AND PLATFORM SESSIONS<br />

Saturday, November 10<br />

12:00 NOON–1:00 PM<br />

SESSION 81 – Closing Plenary: <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong><br />

and Beyond: Present Progress and Future Frontiers<br />

Hall D, Lower Level North, Moscone Center<br />

Moderator: Joel N. Hirschhorn, <strong>2012</strong> <strong>Program</strong><br />

Committee Chair Boston Children’s Hosp.,<br />

Harvard Med. Sch. and Broad Inst.<br />

Presenter: Chris Gunter, HudsonAlpha Inst. for Biotechnol.<br />

Panelists:<br />

Han Brunner<br />

Radboud Univ. Nijmegen<br />

Jay Shendure<br />

Univ. <strong>of</strong> Washington<br />

Dian Donnai<br />

Univ. <strong>of</strong> Manchester<br />

Lynn Jorde<br />

Univ. <strong>of</strong> Utah<br />

Hal Dietz Johns<br />

Hopkins Univ.<br />

An outstanding panel <strong>of</strong> expert human geneticists<br />

with varying perspectives will make will make brief<br />

presentations and then participate in a wide-ranging<br />

discussion on the most exciting advances and<br />

important upcoming challenges in their areas <strong>of</strong><br />

human genetics. Topics will be driven by questions<br />

from the panelists and the audience, but will include<br />

many <strong>of</strong> the following perspectives:<br />

• The importance <strong>of</strong> education for the public,<br />

scientists, and clinicians<br />

• The impact <strong>of</strong> new technology on human genetics<br />

and genomics<br />

• Advances that define biological mechanisms<br />

• Challenges <strong>of</strong> interpretation <strong>of</strong> exome and genome<br />

sequencing<br />

• Translation <strong>of</strong> advances into clinical care<br />

During the course <strong>of</strong> the 62nd Annual Meeting,<br />

registrants are encouraged to post their thoughts on<br />

scientific or clinical advances they have heard about at<br />

the meeting, and on upcoming important challenges<br />

in human genetics, via <strong>ASHG</strong>’s social media outlets<br />

(Twitter, Facebook).<br />

Twitter: Use hashtag #<strong>ASHG</strong><strong>2012</strong><br />

Facebook: https://www.facebook.com/<strong>Genetics</strong><strong>Society</strong><br />

You can also address your comments through Twitter<br />

directly to Chris Gunter, @girlscientist, during the<br />

meeting.<br />

Posts by meeting participants will be followed and<br />

summarized at the beginning <strong>of</strong> the session by Chris<br />

Gunter, <strong>2012</strong> <strong>Program</strong> Committee Member.<br />

After the brief presentations by the panelists, there will<br />

be opportunities for audience members to ask questions<br />

<strong>of</strong> one or more panel members.<br />

At the conclusion <strong>of</strong> the session, the moderator will<br />

provide a brief summary, and the meeting will be<br />

adjourned by the <strong>2012</strong> President, Mary-Claire King.<br />

Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.


POSTER SESSIONS<br />

Moscone Center, Exhibit Hall, Lower Level South<br />

POSTER SESSIONS 125<br />

The program and abstract/poster board number next to each listing is followed by a W (Wednesday), or<br />

T (Thursday), or F (Friday) to indicate the day on which authors must be present at their poster boards. To<br />

encourage discussion and to facilitate the exchange <strong>of</strong> information, posters are sorted by related topics.<br />

Refer to the schedule below for presentation times and for the poster mounting/removal schedule. Posters<br />

should remain up all three days.<br />

Wednesday, November 7<br />

10:00 am – 10:30 am Authors place posters on boards. Posters should remain up for all three days<br />

10:00 am – 4:30 pm Posters open for viewing<br />

2:15 pm – 4:15 pm Poster Session I (W)<br />

2:15 pm – 3:15 pm (odd poster board numbers; author must be present)<br />

3:15 pm – 4:15 pm (even poster board numbers; author must be present)<br />

Thursday, November 8<br />

7:00 am – 4:30 pm Posters open for viewing<br />

2:15 pm – 4:15 pm Poster Session II (T)<br />

2:15 pm – 3:15 pm (odd poster board numbers; author must be present)<br />

3:15 pm – 4:15 pm (even poster board numbers; author must be present)<br />

Friday, November 9<br />

7:00 am – 4:30 pm Posters open for viewing<br />

2:15 pm – 4:15 pm Poster Session III (F)<br />

2:15 pm – 3:15 pm (odd poster board numbers; author must be present)<br />

3:15 pm – 4:15 pm (even poster board numbers; author must be present)<br />

4:15 pm – 4:30 pm Authors must remove posters<br />

4:30 pm Exhibit Hall and Posters closed<br />

NOTE: For safety reasons, no registrant will be admitted into the Exhibit Hall or poster area for any<br />

reason after 4:30 pm on Friday. No exceptions can be made to this policy.<br />

IMPORTANT: Do not leave materials or belongings under poster boards or in the poster area. <strong>ASHG</strong> is not<br />

responsible for any articles left in the poster area or any other area.<br />

POSTER SESSIONS


126 POSTER SESSIONS<br />

Overview <strong>of</strong> Poster Schedule<br />

The program number and the abstract/poster board number are one and the same.<br />

It appears in bold print followed by the letter W (Wednesday), T (Thursday) or F (Friday).<br />

The title and author names follow. The first author listed is the presenting author.<br />

Please check the addendum for author changes or cancellations.<br />

Abstract/Poster<br />

Board Numbers Session Topic/Title Page<br />

412-600 Genome Structure, Variation and Function ................................ 127<br />

601-655 Pharmacogenetics ...................................................................... 134<br />

656-753 Metabolic Disorders .................................................................... 137<br />

754-804 Therapy for Genetic Disorders .................................................... 140<br />

805-854 Development ............................................................................... 143<br />

855-980 Cytogenetics ............................................................................... 145<br />

981-1279 Cancer <strong>Genetics</strong> ......................................................................... 150<br />

1280-1583 Statistical <strong>Genetics</strong> and Genetic Epidemiology .......................... 162<br />

1584-1715 Cardiovascular <strong>Genetics</strong> ............................................................. 174<br />

1716-1796 Genetic Counseling and Clinical Testing .................................... 180<br />

1797-1850 Ethical, Legal, Social and Policy Issues in <strong>Genetics</strong> .................. 183<br />

1851-1863 <strong>Genetics</strong> Education .................................................................... 185<br />

1864-1877 Health Services Research ........................................................... 186<br />

1878-2369 Complex Traits and Polygenic Disorders .................................... 187<br />

2370-2661 Psychiatric <strong>Genetics</strong>, Neurogenetics and Neurodegeneration ..... 209<br />

2662-2966 Molecular Basis <strong>of</strong> Mendelian Disorders .................................... 221<br />

2967-3034 Prenatal, Perinatal and Reproductive <strong>Genetics</strong> .......................... 234<br />

3035-3250 Clinical <strong>Genetics</strong> and Dysmorphology ........................................ 237<br />

3251-3414 Evolutionary and Population <strong>Genetics</strong> ........................................ 245<br />

3415-3525 Epigenetics ................................................................................. 252<br />

3526-3735 Bioinformatics and Genomic Technology ................................... 256


Genome Structure, Variation and<br />

Function<br />

412W Capture <strong>of</strong> chromosome conformation changes<br />

in breast cancer cell lines. C. Liu, C. Woo, P. Yim, S.<br />

Dong, J. Stevens.<br />

413F Myc-induced anchorage <strong>of</strong> the rDNA intergenic<br />

spacer region to nucleolar matrix modulates growthstimulated<br />

changes in higher-order rDNA architecture.<br />

C. Shiue, A. Nematollahi-Mahani, A. Wright.<br />

414W CENcode: Linear assembly and epigenetic<br />

annotation <strong>of</strong> human centromeres. K. E. Hayden, J.<br />

Kent.<br />

415F Impact <strong>of</strong> genetic variation on genome-wide<br />

epigenetic pr<strong>of</strong>iles and gene expression phenotypes.<br />

A. Reymond, H. Kilpinen, S. Waszak, A. Gschwind, E.<br />

Migliavacca, R. M. Witwicki, S. Raghav, A. Orioli, L.<br />

Romano-Palumbo, M. Wiederkehr, S. Turnherr, D. Hacker,<br />

M. Gutierrez-Arcelus, L. J. Core, J. T. Lis, N. Hernandez, B.<br />

Deplancke, E. T. Dermitzakis.<br />

416W Capturing long-range chromatin interactions<br />

<strong>of</strong> chromatin regulatory elements. N. Heidari, D. H.<br />

Phanstiel, W. Soon, M. P. Snyder.<br />

417F PRDM9 directs genetic recombination away from<br />

functional genomic elements. K. Brick, F. Smagulova, P.<br />

Khil, R. D. Camerini-Otero, G. Petukhova.<br />

418W ATRX interacts with the MRN complex to play<br />

a key role in the replication <strong>of</strong> non-canonical DNA<br />

structures associated with tandem repeats. R. Gibbons,<br />

D. Clynes, C. Jelinska, H. Ayyub, D. R. Higgs.<br />

419F Genome-wide copy number variation analysis<br />

<strong>of</strong> a branchio-oto-renal syndrome cohort identifies<br />

a recombination hotspot associated with an EYA1<br />

deletion and novel candidate genomic regions. F. Alasti,<br />

P. Brophy, B. Darbro, J. Dierdorff, C. Nishimura, B. Cobb,<br />

J. Clarke, M. Hakeman, A. Bassuk, R. J. H. Smith, J. R.<br />

Manak.<br />

420W Delineation <strong>of</strong> the reliability <strong>of</strong> in silico copy<br />

number variation calls from different Illumina SNP<br />

arrays. S. Herms, L. Priebe, F. Degenhardt, M. M.<br />

Noethen, S. Cichon, P. H<strong>of</strong>fmann.<br />

421F The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health and<br />

Aging: Detecting copy number variation in a multiethnic<br />

cohort <strong>of</strong> 100,000. C. Sabatti, Z. Zhang, Y. Banda,<br />

M. Kvale, T. H<strong>of</strong>fman, S. Hesselson, H. Tang, P.-Y. Kwok,<br />

C. Schaefer, N. Risch.<br />

422W Genomic copy number variation affects brain<br />

structure volumes in schizophrenia. T. H. Wassink,<br />

J. Manak, D. Rudd, E. Epping, F. Fleming, G. Zeien, S.<br />

Ziebell, B. C. Ho, N. C. Andreasen.<br />

POSTER SESSIONS 127<br />

423F The use <strong>of</strong> matepair sequencing in the detection<br />

<strong>of</strong> structural variation in patients with ID and/or<br />

congenital anomalies. S. Vergult, E. Van Binsbergen,<br />

T. Sante, S. Nowak, O. Vanakker, S. Janssens, K. Claes,<br />

B. Poppe, N. Van der Aa, F. Roelens, A. De Paepe, F.<br />

Speleman, E. Cuppen, W. Kloosterman, B. Menten.<br />

424W At the crossroads <strong>of</strong> structure and function: SNP<br />

genotypes indexed by copy number yield novel eQTLs.<br />

L. K. Davis, E. R. Gamazon, N. J. Cox.<br />

425F Extensive genetic variation in somatic human<br />

tissues. M. O’Huallachain, K. J. Karczewski, S. Weissman,<br />

A. E. Urban, M. Snyder.<br />

426W Copy number variations in a cohort <strong>of</strong><br />

Brazilian sickle cell anemia patients with and without<br />

cerebrovascular accident. G. Ananina, F. Menaa, M. A.<br />

Bezerra, A. S. Araujo, P. R. S. Cruz, G. P. Gil, F. F. Costa,<br />

M. B. Melo.<br />

427F Prevalence and effects <strong>of</strong> the obesity associated<br />

deletion on chromosome 16p11.2 in the Swedish<br />

Obese Subjects study. J. C. Andersson-Assarsson, S.<br />

Romeo, L. Sjöström, L. M. S. Carlsson.<br />

428W Molecular study <strong>of</strong> the inverted repeats<br />

responsible for triplication <strong>of</strong> the PLP1 locus. C. R.<br />

Beck, C. M. B. Carvalho, J. R. Lupski.<br />

429F Novel sequence-based CNV detection framework<br />

allows fine-mapping <strong>of</strong> the CFH region in 150 Chinese<br />

Singaporeans with age-related macular degeneration.<br />

E. Bellos, L. Coin, T. Y. Wong, C. Y. Cheng, G. Cheung, M.<br />

Hibberd, V. Kumar, S. Davila.<br />

430W Incidental copy-number variants identified by<br />

routine genome testing in a clinical population. P. M.<br />

Boone, Z. T. Soens, I. M. Campbell, P. Stankiewicz, S. W.<br />

Cheung, A. Patel, A. L. Beaudet, S. E. Plon, C. A. Shaw, A.<br />

L. McGuire, J. R. Lupski.<br />

431F Parental age and burden <strong>of</strong> genomic copy<br />

number variation. J. Buizer-Voskamp, H. M. Blauw, M. P.<br />

M. Boks, K. R. Van Eijk, J. H. Veldink, E. A. M. Hennekam,<br />

J. A. S. Vorstman, F. Mulder, H. Tiemeier, A. G. Uitterlinden,<br />

L. A. Kiemeney, L. H. Van den Berg, R. S. Kahn, C. Sabatti,<br />

R. A. Oph<strong>of</strong>f.<br />

432W Genome-wide analyses <strong>of</strong> recurrent genomic<br />

rearrangements: Identification <strong>of</strong> three novel genomic<br />

disorders. P. Dittwald, T. Gambin, P. Szafranski, J. Li,<br />

R. S. Amato, M. Divon, K. Maliszewski, E. E. Dolgado<br />

Bohorquez, L. Elton, A. C.-H. Tsai, D. Scott, S.-H. L.<br />

Kang, A. M. Breman, S. R. Lalani, C. Bacino, W. Bi, A.<br />

Milosavljevic, J. R. Lupski, A. L. Beaudet, C. A. Shaw, A.<br />

Patel, A. Gambin, S. W. Cheung, P. Stankiewicz.<br />

433F DUF1220 domain copy number loss implicated in<br />

1q21-associated microcephaly. L. Dumas, M. O’Bleness,<br />

J. Davis, C. M. Dickens, N. Anderson, J. G. Keeney, J.<br />

Jackson, M. Sikela, A. Raznahan, J. Giedd, J. Rapoport, S.<br />

S. C. Nagamani, A. Erez, N. Brunetti-Pierri, R. Sugalski, J.<br />

R. Lupski, T. Fingerlin, S. W. Cheung, J. M. Sikela.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


128 POSTER SESSIONS<br />

434W Age-related somatic structural changes in the<br />

nuclear genome <strong>of</strong> human blood cells. L. A. Forsberg,<br />

C. Rasi, H. R. Razzaghian, G. Pakalapati, L. Waite, K. S.<br />

Thilbeault, A. Ronowicz, N. E. Wineinger, H. K. Tiwari,<br />

D. Boomsma, M. P. Westerman, J. R. Harris, R. Lyle,<br />

M. Essand, F. Eriksson, T. L. Assimes, C. Iribarren, E.<br />

Strachan, T. P. O’Hanlon, L. G. Rider, F. W. Miller, V.<br />

Giedraitis, L. Lannfelt, M. Ingelsson, A. Piotrowski, N. L.<br />

Pedersen, D. Absher, J. P. Dumanski.<br />

435F Genome-wide scan <strong>of</strong> common copy number<br />

variant regions in post-traumatic stress disorder. G.<br />

Guffanti, A. Aiello, M. Uddin, D. Wildman, S. Galea, K.<br />

Koenen.<br />

436W Genetic variation among somatic cells revealed<br />

by single nucleus sequencing. I. M. Hall, M. L. Lindberg,<br />

J. Piper, K. J. Brennand, F. H. Gage, M. J. McConnell.<br />

437F Structural haplotypes and recent evolution <strong>of</strong> the<br />

human 17q21.31 locus. R. E. Handsaker, L. M. Boettger,<br />

M. C. Zody, S. A. McCarroll.<br />

438W Population genetics <strong>of</strong> haptoglobin and<br />

haptoglobin-related protein: 50 years <strong>of</strong> human copy<br />

number variation. E. Hollox, A. Menard, F. Yang, B. Fu, M.<br />

Sironi, R. Hardwick.<br />

439F Microduplication in 5p15.33 including CLPMT1L<br />

and TERT genes identified in a patient with cleft lip and<br />

palate, cardiopathy and urogenital abnormalities. G.<br />

Izzo, E. L. Freitas, A. C. V. Krepischi, D. R. Bertola, M. R.<br />

Passos-Bueno, C. Rosenberg.<br />

440W Integration <strong>of</strong> microarray and NGS generated<br />

data for copy number analysis. R. Keshavan, S. Verma,<br />

S. Shams.<br />

441F Comparative performance <strong>of</strong> three algorithms<br />

in detecting CNV associated with obesity and nonalcoholic<br />

fatty liver disease. W. Li, J. Littrell, S. Gawrieh,<br />

M. Olivier.<br />

442W Increased rate <strong>of</strong> rare genic copy number<br />

variants in Parkinson’s disease among Ashkenazi<br />

Jews. X. Liu, C. Cheng, S. Kisselev, H. Mejia-Santana, E.<br />

Louis, L. Cote, H. Andrews, C. Waters, B. Ford, S. Frucht,<br />

S. Fahn, K. Marder, J. Lee, L. Clark.<br />

443F A map <strong>of</strong> copy number variation in admixed<br />

populations in Xinjiang. H. Lou, S. Li, R. Fu, X. Pan, L.<br />

Jin, S. Xu.<br />

444W <strong>Human</strong> CNVs and ultraconserved elements: A<br />

rapid progression to mutual exclusivity. R. B. McCole,<br />

C. Y. Fonseka, C.-T. Wu.<br />

445F Prediction <strong>of</strong> 3551 human haploinsufficient<br />

genes. S. Meader, F. Honti, C. Webber.<br />

446W Prioritization <strong>of</strong> copy number variation loci<br />

associated with autism from AutDB: An integrative<br />

multi-study genetic database. I. Menashe, E. C. Larsen,<br />

S. Banerjee-Basu.<br />

447F Copy number variant analysis in a deeply<br />

phenotyped cohort <strong>of</strong> individuals with intellectual<br />

disability. E. Mercier, Y. Qiao, J. Gillis, S. Lewis, E.<br />

Separovic, P. Pavlidis.<br />

448W A novel susceptibility gene, UGT2B17, is<br />

associated with familial ankylosing spondylitis.<br />

D. O’Rielly, M. Uddin, R. Inman, D. Gladman, W.<br />

Maksymowych, R. Yazdani, P. Rahman.<br />

449F Evolution <strong>of</strong> copy number variation in the rhesus<br />

macaque b-defensin region. B. Ottolini, T. Schwarzacher,<br />

C. L. Bevins, J. V. Solnick, G. Doxiadis, E. J. Hollox.<br />

450W Characterization <strong>of</strong> copy number variation<br />

involving the salivary agglutinin gene DMBT1. S. Polley,<br />

D. Hains, E. Hollox.<br />

451F Single exon deletion in PCCA gene in patient with<br />

propionic acidemia highlights challenges to clinical<br />

whole exome CNV analysis. G. Scharer, G. Creadon-<br />

Swindell, E. Spector, C. Coughlin, T. Shaikh.<br />

452W Identifying autism loci using homozygosity<br />

analysis and copy number variation analysis. K. E.<br />

Schmitz-Abe, T. W. Yu, T. K. Kim, R. S. Hill, E. M. Morrow,<br />

M. E. Greenberg, K. Markianos, C. A. Walsh.<br />

453F Rare exonic deletions contribute to autoimmune<br />

diabetes susceptibility. C. Shtir, D. Smith, H. Guo, J.<br />

Barrett, M. Hurles, N. Walker, V. Plagnol, J. Cooper, J.<br />

Howson, O. Burren, S. Rich, J. Todd.<br />

454W An atypical microduplication overlapping the<br />

C2orf27A gene at 2q21.1 co-segregates with Tourette<br />

syndrome in a three generation family. M. Uddin,<br />

D. D. O’Reilly, P. Rahman, T. R. Purchase, H. White, S.<br />

Luscombe, S. J. Moore, T. L. Young, K. A. Hodgkinson.<br />

455F Detection <strong>of</strong> copy number variation from exomes<br />

in the DDD and UK10K projects. P. Vijayarangakannan,<br />

T. Fitzgerald, C. Joyce, S. McCarthy, M. Hurles, DDD and<br />

UK10K Projects.<br />

456W Alterations in RBFOX1: Real finding or red<br />

herring? L. Walters, A. Bailes, L. Erdman, A. McKinney,<br />

S. Ramsey, C. Weber, S. Hashimoto, L. Lamb Thrush, J.<br />

Atkin, G. Herman, S. Hickey, K. Manickam, C. Crowe, S.<br />

Thomas, C. Astbury, J. Gastier-Foster, S. Reshmi, R. E.<br />

Pyatt.<br />

457F Analyses <strong>of</strong> copy number variation reveal<br />

putative susceptibility loci in MTX-induced mouse<br />

neural tube defects. J.-H. Wang, X.-W. Wang, T. Guan,<br />

Q. Xiang, M.-S. Wang, Z. Zhang, Z. Guan, G.-L. Wang,<br />

Z.-Q. Zhu, Q. Xe, G.-N. Li, J. Guo, F. Wang, Z.-G. Wang,<br />

B. Niu, T. Zhang.<br />

458W Large range <strong>of</strong> copy number variation for human<br />

alpha-defensin genes DEFA1 and DEFA3: Lower copy<br />

number is a risk factor for autoimmune diseases.<br />

H. Wang, B. Zhou, Y. L. Wu, S. Bowden, R. H<strong>of</strong>fman,<br />

J. Ahearn, D. Birmingham, B. Rovin, L. Hebert, A.<br />

Schwaderer, D. Hains, C. Y. Yu.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


459F Analysis <strong>of</strong> structural variation in the Genome<br />

<strong>of</strong> the Netherlands project. K. Ye, V. Guryev, W.<br />

Kloosterman, L. Francioli, J. Y. Hehir-Kwa, E. Lameijer,<br />

A. Abdellaoui, J. de Ligt, V. Koval, N. Amin, F. van Dijk,<br />

L. C. Karssen, H. Mei, Genome <strong>of</strong> the Netherlands<br />

Consortium.<br />

460W Copy number variation <strong>of</strong> the Y chromosome<br />

in autism spectrum disorder. R. K. Yuen, E. Kolomietz,<br />

M. Vlasschaert, A. Merkoulovitch, J. R. MacDonald, C. R.<br />

Marshall, S. W. Scherer.<br />

461F Novel method <strong>of</strong> CNV analysis in FcgR locus<br />

and its application to immune-related diseases. A.<br />

Zhernakova, L. Franke, A. Ioan, G. Trynka, K. Fransen,<br />

R. Weersma, S. Rantapää-Dahlqvist, P. Gregersen, C.<br />

Wijmenga, T. Huizinga, R. Toes.<br />

462W An improved diagnostic workflow using SNP<br />

arrays reveals novel insights into CNVs in mental<br />

retardation. X. Zhou, J. M. Wang, B. Wang, J. Wang, T. Ji,<br />

X. Zhang, X. Ma, Y. Jiang.<br />

463F Copy number variation in autism spectrum<br />

disorders. B. Sheppard, C. Ladd-Acosta, B. K. Lee, J.<br />

Bonner, G. Windham, L. Schieve, L. Croen, A. Reynolds,<br />

D. Schendel, C. Newschaffer, M. D. Fallin.<br />

464W Understanding revisions to the human reference<br />

genome and assembly model. D. Church, P. Flicek, T.<br />

Graves, T. Hubbard, V. Schneider, The Genome Reference<br />

Consortium.<br />

465F Evolutionary history and genome organization<br />

<strong>of</strong> DUF1220 protein domains. M. O’Bleness, C. M.<br />

Dickens, D. Albracht, H. Kotkiewicz, T. Graves, R. Wilson,<br />

J. Sikela.<br />

466W Retrotransposition <strong>of</strong> gene transcripts leads<br />

to structural variation in mammalian genomes. A. D.<br />

Ewing, T. Ballinger, D. Earl, D. Haussler.<br />

467F Whole genome sequencing <strong>of</strong> iPS cells<br />

reveals somatic mutation arising at latest stages <strong>of</strong><br />

reprogramming. M. Cortes, J. S. Seo.<br />

468W Possible genomic impact <strong>of</strong> SVA retrotransposon<br />

in humans similar to that in gibbons. T. Hara, Y. Hirai, H.<br />

Hirai, A. Koga.<br />

469F Functional studies <strong>of</strong> tandem repeat variation<br />

in the human genome using multiplexed capture and<br />

high-throughput sequencing. A. Guilmatre, G. Highnam,<br />

D. Mittelman, A. J. Sharp.<br />

470W Meta-analysis with dbGaP data on genome-wide<br />

association studies for Alzheimer’s disease. J. H. Kim.<br />

471F A survey <strong>of</strong> the mutational load in genes<br />

associated with rare Mendelian disorders and autism.<br />

A. R. Rao, S. F. Nelson.<br />

472W Inferring mechanisms <strong>of</strong> indel mutation from<br />

whole genome sequence. I. H. C. Turner, Z. Iqbal, G.<br />

McVean.<br />

POSTER SESSIONS 129<br />

473F A complex rearrangement <strong>of</strong> the OCA2 gene in<br />

two unrelated albino patients. B. Arveiler, E. Lasseaux,<br />

D. Cailley, M. L. Vuillaume, C. Rooryck, A. Rouault, J.<br />

Toutain, D. Lacombe, F. Morice-Picard.<br />

474W A four base pair insertion in WNT16a identified<br />

through exome sequencing is associated with type 2<br />

diabetes. L. Been, M. Fortner, E. Howard, M. Lerner, D.<br />

Brackett, D. Sanghera.<br />

475F Obstetric complication-associated ANXA5<br />

promoter polymorphisms affect gene expression<br />

via DNA secondary structures. H. Inagaki, S. Ota, H.<br />

Nishizawa, H. Miyamura, K. Nakahira, M. Suzuki, S.<br />

Nishiyama, Y. Udagawa, I. Yanagihara, H. Kurahashi.<br />

476W The influence <strong>of</strong> genomic context on mutation<br />

patterns inferred from extremely rare variants. V. M.<br />

Schaibley, M. Zawistowski, D. Wegmann, D. Kessner,<br />

M. G. Ehm, M. R. Nelson, P. L. St. Jean, G. Abecasis, J.<br />

Novembre, S. Zöllner, J. Z. Li.<br />

477F Sequencing the unsequenceable: Expanded CGG<br />

repeats in the human FMR1 gene. P. Hagerman, J. Eid, P.<br />

Peluso, D. Rank, J. Yin, L. Hickey, E. Loomis.<br />

478W Three novel NR5A1 gene mutations in<br />

patients with 46,XY karyotype and disorders <strong>of</strong> sex<br />

development. H. C. Fabbri, J. G. Andrade, A. T. Maciel-<br />

Guerra, G. Guerra-Junior, M. P. de Mello.<br />

479F A deletion and a novel nonsense SRY mutation<br />

in 46,XY Brazilian patients with disorder <strong>of</strong> sex<br />

development. C. S. C. Piveta, B. P. B. Araújo, P. D.<br />

Pereira, F. B. Coeli-Lacchini, A. T. Maciel-Guerra, G.<br />

Guerra-Junior, I. L. Monlleó, M. P. de Mello.<br />

480W Whole genome sequencing in autism identifies<br />

hotspots for germline mutation. J. Michaelson, H.<br />

Zheng, M. Gujral, Y. Shi, D. Malhotra, X. Jin, D. Greer,<br />

A. Bhandari, R. Corominas, A. Peoples, A. Koren, S.<br />

McCarroll, L. Iakoucheva, Y. Li, J. Wang, J. Sebat.<br />

481F Molecular basis <strong>of</strong> male infertility: An Indian<br />

perspective. H. Sharma, R. Prasad, R. Mohan, S. K. Singh.<br />

482W Phase-defined complete HLA genotyping by<br />

amplicon sequencing and read-backed phasing. K.<br />

Hosomichi, T. Hayano, I. Inoue.<br />

483F Characterization <strong>of</strong> sequence variants from the first<br />

direct-to-consumer exome pilot project. A. Shmygelska,<br />

E. Harrington, C. McLean, A. Chowdry, B. Naughton.<br />

484W Targeted sequencing applications and project<br />

design. R. Fulton.<br />

485F Inverted low-copy repeats and genome<br />

instability: A genome-wide analysis. T. Gambin, P.<br />

Dittwald, C. Gonzaga-Jauregui, C. M. B. Carvalho, J. R.<br />

Lupski, A. Gambin, P. Stankiewicz.<br />

486W DNA from 1D to 3D: Effect <strong>of</strong> single nucleotide<br />

change on DNA conformational structure. P. W. Yim, C.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


130 POSTER SESSIONS<br />

Liu, C. Woo, Y. Shi, J. Stevens, S. Dong.<br />

487F Analysis <strong>of</strong> dinucleotide mutation rates and<br />

composition <strong>of</strong> human genome. G. Zhang, D. W. Nebert.<br />

488W The L141R and G153D variations associated with<br />

exfoliation glaucoma do not affect enzymatic functions<br />

<strong>of</strong> the lysyl oxidase-like protein 1. Y. Kim, S. Kim.<br />

489F Exploration <strong>of</strong> HIV susceptibility by exome<br />

sequencing. S. Liu, W. Scott, D. Dykxhoorn.<br />

490W Linkage disequilibrium analysis <strong>of</strong><br />

polymorphisms <strong>of</strong> FRAS1 related extracellular matrix 1<br />

(FREM1). J. F. Tuff, N. Kaplonski, V. Ly, B. Liang, S. Tyler, F.<br />

A. Plummer, M. Luo.<br />

491F Exome sequencing <strong>of</strong> subjects with familial<br />

1q21.1 CNV and variable phenotype. C. Harvard, F. Mo,<br />

F. Tang, Y. Qiao, S. Hamilton, S. Marles, B. McGillivary, C.<br />

Colins, M. E. S. Lewis, P. Pavlidis, E. Rajcan-Separovic.<br />

492W Deep resequencing <strong>of</strong> the NOS2 gene suggests<br />

multiple potential mechanisms underlying the<br />

association <strong>of</strong> several complex diseases with a<br />

common synonymous SNP. L. Wang, J. Santos, A.<br />

Dressen, A. Mehta, M. Pericak-Vance, J. Vance, W. Scott.<br />

493F Characteristics and analysis <strong>of</strong> exonic SNPs and<br />

indels discovered by low-pass and exome sequencing.<br />

J. Schmidt, J. Gollub, J. Barts, C. Davies, B. Wong, R.<br />

Shigeta, G. Hsiao, M. Nitzberg, E. Shell, J. Peete, S. Hsu,<br />

A. Kohli, T. Ha, D. Brown, L. Bellon, T. Webster.<br />

494W Somatic mosaicism in the blood compartment <strong>of</strong><br />

a 115-year-old woman. H. Holstege, D. Sie, W. Pfeiffer,<br />

T. Nicholas, M. A. Miller, T. Harkins, C. Lee, T. Ross, B.<br />

Ylstra, H. Meijers-Heijboer, M. Reinders, G. Holstege, E.<br />

Sistermans, S. Levy.<br />

495F High-resolution melting analysis <strong>of</strong> STAT3 involved<br />

in autosomal dominant hyper IgE syndrome using<br />

bulge-inducing primers to eliminate polymorphisms<br />

and snapback primers for genotyping. M. T. Seipp, N. H.<br />

Augustine, A. Kumanovics, H. R. Hill, C. T. Wittwer.<br />

496W PON-P: Integrated predictor for pathogenicity <strong>of</strong><br />

missense variants. M. Vihinen, A. Olatubosun, J. Väliaho,<br />

J. Härkönen, J. Thusberg.<br />

497F Data submissions to EBI variation archives.<br />

I. Lappalainen, V. Kumanduri, J. Almeida-King, L. Skipper,<br />

J. D. Spalding, M. Maguire, P. Flicek.<br />

498W The power <strong>of</strong> large numbers: frequencies <strong>of</strong> rare<br />

pathogenic mutations in the 23andMe database. E. R.<br />

Chang, D. A. Hinds, N. Eriksson, J. M. Macpherson, C. B.<br />

Do, B. T. Naughton.<br />

499F Finding from CAGI: The Critical Assessment <strong>of</strong><br />

Genome Interpretation, a community experiment to<br />

evaluate phenotype prediction. S. Brenner, S. Repo, J.<br />

Moult, CAGI Participants.<br />

500W Polymorphic regulation <strong>of</strong> gene expression by<br />

the histone demethylase KDM4C. B. L. Gregory, V. G.<br />

Cheung.<br />

501F Mitochondrial sequence variation in twins.<br />

Y. Bouhlal, S. Martinez, H. Gong, K. Dumas, J. T. C. Shieh.<br />

502W Polymorphisms in primer binding site affect<br />

genotyping accuracy <strong>of</strong> FCGR2B rs1050501 in<br />

Caucasians. J. M. Reynolds.<br />

503F Identification <strong>of</strong> rare variants contributing to<br />

pain sensitivity in the normal population: an exome<br />

sequencing study. B. Zhang, F. M. K. Williams, S. Scollen,<br />

D. Coa, Y. Memari, C. Hyde, Y. Shi, J. Harris, I. Harrow, A.<br />

Malarstig, B. Dougherty, R. McEwen, J. C. Stephens, K.<br />

Patel, C. Menni, D. Hodgkiss, G. Surdulescu, W. He, B.<br />

Sidders, D. Ziemek, N. Soranzo, X. Jin, S. B. McMahon, S.<br />

L. John, J. Wang, T. D. Spector.<br />

504W Discovering retrotransposon insertion<br />

polymorphisms associated with human phenotypes by<br />

TIP-chip. T. D. Babatz, D. Avramopoulos, J. D. Boeke, K.<br />

H. Burns.<br />

505F Fork stalling and template switching mechanism<br />

generates a novel rearrangement associated with<br />

incontinentia pigmenti. M. I. Conte, S. Raimo, M.<br />

Paciolla, A. Pescatore, E. Esposito, M. G. Miano, F. Fusco,<br />

M. V. Ursini.<br />

506W The ENCODE effort combining RNA-seq and<br />

RT-PCR-seq allows to catalog thousands <strong>of</strong> novel<br />

lncRNAs. C. Howald, A. Tanzer, J. Chrast, F. Kokocinski,<br />

T. Derrien, N. Walters, J. Manuel Gonzalez, A. Frankish, B.<br />

L. Aken, T. Hourlier, J. Vogel, S. White, S. M. J. Searle, J.<br />

Harrow, T. Hubbard, R. Guigò, A. Reymond.<br />

507F Evolution <strong>of</strong> microRNA-3’UTR interactions and<br />

their impact on whole transcriptome regulation. A. Z.<br />

Pietrzykowski, E. Kruse, N. Kinstlinger, L. Tejeda, S.<br />

Hamza, Y. Wang.<br />

508W Let-7 coordinately downregulates genes on<br />

the amino acid sensing pathway to repress mTOR<br />

and activate neuronal autophagy. A. N. Dubinsky,<br />

S. Djakovic, R. Zahra, C. Hsu, B. E. Morrison, A. R. La<br />

Spada.<br />

509F Deep sequencing <strong>of</strong> hypoxic breast cancer<br />

reveals deregulation <strong>of</strong> non-coding RNAs, non ploy-A<br />

RNAs and natural anti-sense transcripts. H. Choudhri,<br />

C. Camps, J. Shoedel, S. Oikonomopoulos, L. Winchester,<br />

F. Buffa, D. Moralli, E. Volpi, P. Ratcliffe, A. Harris, D. Mole,<br />

J. Ragoussis.<br />

510W Integrative annotation and functional<br />

characterization <strong>of</strong> human long non-coding RNAs in<br />

bladder cancer. W. Tang, L. Prokunina-Olsson.<br />

511F microRNA-xx regulates vascular smooth muscle<br />

cell phenotypes and prevents neointimal formation.<br />

Y. Wang, H. Wang, Y. Liao, P. Tsai, K. Chen, H. Cheng, R.<br />

Lin, S. Juo.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


512W Comparative analysis <strong>of</strong> strand-specific RNA<br />

sequencing approaches. D. Munafo, P. Liu, C. Sumner,<br />

L. Apone, B. Langhorst, E. Yigit, L. Merrill, F. Stewart, E.<br />

Dimalanta, T. Davis.<br />

513F microRNAs modulating the expression <strong>of</strong> FMR1<br />

mRNA: Implications in the pathophysiology <strong>of</strong> FXTAS.<br />

S. Zongaro, R. Hukema, L. Davidovic, S. D’Antoni, M. V.<br />

Catania, R. Willemsen, B. Mari, B. Bardoni.<br />

514W Dysfunction <strong>of</strong> miRNAs biogenesis in association<br />

with neuronal differentiation in focal cortical dysplasia.<br />

S. H. Avansini, F. R. Torres, D. B. Dogini, F. Rogério, A. C.<br />

Coan, R. Secolin, C. S. Rocha, A. F. Costa, A. L. F. Costa,<br />

A. C. S. Piaza, L. A. M. Reis, E. P. L. Oliveira, H. Tedeschi,<br />

L. S. Queiroz, F. Cendes, I. Lopes-Cendes.<br />

515F Genome-wide miRNA signatures <strong>of</strong> human<br />

longevity. A. ElSharawy, A. Keller, F. Flachsbart, A.<br />

Wendschlag, G. Jacobs, N. Kefer, T. Brefort, P. Leidinger,<br />

C. Backes, E. Meese, S. Schreiber, P. Rosenstiel, A.<br />

Franke, A. Nebel.<br />

516W Peripheral blood mononuclear cells microRNAs<br />

predict treatment outcome <strong>of</strong> chronic hepatitis C. E.<br />

Hsi, C. Huang, M. Yu, C. Dai, S. Juo, C. Chou, J. Huang,<br />

W. Chuang.<br />

517F Copy number variation <strong>of</strong> miRNA in individuals<br />

with intellectual disability. Y. Qiao, C. Harvard, E.<br />

Mercier, S. Lewis, P. Pavlidis, E. Rajcan-Separovic.<br />

518W Novel human variation in microRNAs associated<br />

with disease, biomarkers, and drug metabolism. R. Afi<br />

Rawlings-Goss, S. Tishk<strong>of</strong>f.<br />

519F The tale about MIR147B regulate catalase AEI by<br />

one SNP in the 5’- UTR. Z. Wang, B. Wang, K. Zhang, L.<br />

Jin, W. Huang.<br />

520W Inactivation <strong>of</strong> the miR-183/96/182 cluster results<br />

in syndromic retinal degeneration: The miR-183/96/182<br />

cluster is required for normal function <strong>of</strong> the retina and<br />

other sensory organs. S. Xu, S. Lumayag, C. Haldin, C.<br />

Cowan, B. Kovacs, P. Larsen, D. Valle, P. D. Witmer.<br />

521F microRNA analysis in human ocular scleral<br />

tissue. T. Young, X. Luo, F. Hawthorne, S. Feng, P.<br />

Gonzalez.<br />

522W Founder mutation in a transposable element<br />

leads to the identification <strong>of</strong> a long noncoding RNA in a<br />

progressive infantile encephalopathy. A. Henrion Caude,<br />

P. Munier, E. Benko, S. Hanein, E. Westh<strong>of</strong>, N. Boddaert,<br />

I. Desguerre, S. Bandiera, M. Girard, D. Rodriguez, A.<br />

Munnich, M. Fähling, S. Lyonnet, F. Cartault.<br />

523F <strong>Human</strong> single nucleotide polymorphisms<br />

influence non-coding RNA expression. V. Magadi<br />

Gopalaiah, H.-J. Westra, J. Karjalainen, D. V. Zhernakova,<br />

B. Hrdlickova, R. Almeida, A. Zhernakova, M. H. H<strong>of</strong>ker, J.<br />

Fu, S. With<strong>of</strong>f, L. Franke, C. Wijmenga.<br />

524W Identifying source locations for Alu transcripts<br />

within human testes. S. Linker, P. Deininger, D. Hedges.<br />

POSTER SESSIONS 131<br />

525F The genetic basis <strong>of</strong> human drug response<br />

variation. M. Kaganovich, D. Spacek, M. Snyder.<br />

526W Dietary protein regulates gene expression <strong>of</strong><br />

amino acid-degrading enzymes through PPARa. A. V.<br />

Contreras, C. Rangel, V. Ortiz, G. Aleman, B. Palacios, E.<br />

Tejero, N. Torres, A. R. Tovar.<br />

527F Patterns <strong>of</strong> allele-specific gene expression in ten<br />

human tissues. K. R. Kukurba, T. Nance, R. Piskol, M. H.<br />

Tan, J. B. Li, S. B. Montgomery.<br />

528W Gene expression variation in the response <strong>of</strong><br />

human monocyte-derived dendritic cells to LPS and<br />

influenza dNS1 stimulation. M. N. Lee, C. Ye, A. C.<br />

Villani, W. Li, P. I. Chipendo, M. H. Lee, P. L. De Jager, C.<br />

O. Benoist, A. Regev, N. Hacohen.<br />

529F Gene expression pr<strong>of</strong>iling in a large cohort <strong>of</strong><br />

Europeans with Sjögren’s syndrome reveals viral,<br />

immune, and interferon-related pathways. J. A. Ice,<br />

H. Li, J. A. Kelly, I. Adrianto, S. B. Glenn, K. S. Hefner, E.<br />

S. Vista, D. U. Stone, R. Gopalakrishnan, G. D. Houston,<br />

D. M. Lewis, M. D. Rohrer, P. Hughes, J. B. Harley, C. G.<br />

Montgomery, J. Chodosh, J. A. Lessard, J.-M. Anaya,<br />

B. M. Segal, N. L. Rhodus, L. Radfar, M. B. Frank, R. H.<br />

Sc<strong>of</strong>ield, C. J. Lessard, K. Moser Sivils.<br />

530W A normalization procedure for removal <strong>of</strong><br />

residual multiplex PCR amplification bias from ultradeep<br />

sequencing <strong>of</strong> the TCR repertoire. M. J. Rieder,<br />

C. Carlson, A. Sherwood, R. Emerson, C. Desmaris, M.<br />

Chung, J. Parsons, M. LaMadrid-Herrmannsfeldt, D.<br />

Williamson, R. Livingston, H. Robins.<br />

531F Expression QTL analysis <strong>of</strong> a gene expression<br />

signature which predicts advanced non-alcoholic fatty<br />

liver disease. M. Garrett, C. Moylan, J. Gibson, H. Yang,<br />

H. Pang, A. Dellinger, A. Suzuki, H. Tillmann, C. Guy, M.<br />

Abdelmalek, S. Murphy, A. Diehl, M. Hauser, A. Ashley-<br />

Koch.<br />

532W Bead-based method for capturing specific<br />

microRNA in human urine: A non invasive way <strong>of</strong><br />

detecting clinical conditions. M. Rath, T. Xu, C. Trinh, K.<br />

Tran, J. Stevens, A. Shi, M.-P. Gauthier.<br />

533F Experimental depletion and regeneration <strong>of</strong> human<br />

mitochondrial DNA to investigate its role in nuclear<br />

gene regulation. S. Kumar, C. Bellis, M. P. Johnson, H. H.<br />

H. Goring, T. D. Dyer, J. Blangero, J. E. Curran.<br />

534W Primary mitochondrial diseases dysregulate the<br />

transcriptional and post-transcriptional regulatory<br />

systems in a tissue-specific pattern. Z. Zhang, M.<br />

Tsukikawa, E. Polyak, J. Ostrovsky, C. Clarke, E. Place, E.<br />

Rappaport, G. Reiner, M. Yudk<strong>of</strong>f, R. Naviaux, R. Haas, J.<br />

Baur, M. Falk.<br />

535F Genetic variation in expression response to<br />

endoplasmic reticulum stress in human B cells. W.<br />

Bernal, M. Morley, V. Cheung.<br />

536W Dynamic network connectivity mapping <strong>of</strong><br />

T-cell activation in Caucasians and African <strong>American</strong>s<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


132 POSTER SESSIONS<br />

identifies a common set <strong>of</strong> asthma-associated hub<br />

genes. J. Chu, W. Qiu, V. Carey, K. Barnes, C. Ober, F.<br />

Martinez, R. Lemanske, A. Liu, S. London, S. Weiss, B. Raby.<br />

537F Immunity genes and pathways are associated<br />

with human microbiome composition at host body<br />

sites. R. Blekhman, J. Goodrich, K. Huang, R. Bukowski,<br />

Q. Sun, R. E. Ley, D. Gevers, A. G. Clark.<br />

538W Ribosome footprints on Williams syndrome<br />

region genes in the mouse brain. R. Weiss, M. Howard,<br />

L. Dai, J. Korenberg.<br />

539F Regulatory mutations in the 5’UTR <strong>of</strong> NMNAT1,<br />

encoding the nuclear is<strong>of</strong>orm <strong>of</strong> nicotinamide<br />

nucleotide adenylyltransferase 1, cause Leber<br />

congenital amaurosis. F. Coppieters, A. Baert, C. Van<br />

Cauwenbergh, M. Bauwens, S. De Jaegere, T. de Ravel,<br />

F. Meire, N. Abdelmoula Bouayed, L. Florentin-Arar, B. P.<br />

Leroy, E. De Baere.<br />

540W Disruption <strong>of</strong> a cis-acting microRNA site in<br />

FMR1 results in reduced translation <strong>of</strong> an FMRP<br />

reporter. J. Suhl, R. Muddashetty, G. Bassell, S.<br />

Warren.<br />

541F Is the biosynthesis <strong>of</strong> the major phospholipid<br />

class phosphatidylcoline in mammalian cells regulated<br />

by microRNA? K. Hokynar, S. Hänninen, M. Hermansson,<br />

P. Somerharju.<br />

542W Poly(A) binding protein nuclear 1 levels affect<br />

alternative polyadenylation. E. de Klerk, A. Venema, S.<br />

Y. Anvar, J. J. Goeman, O. Hu, J. T. den Dunnen, S. M. van<br />

der Maarel, V. Raz, P. A. C. ‘t Hoen.<br />

543F Identification <strong>of</strong> human RNA editing sites<br />

using publically available RNA-sequencing data.<br />

G. Ramaswami, J. B. Li.<br />

544W <strong>Human</strong> ADAR proteins regulate RNA editing and<br />

gene expression as revealed in systems study. I. Wang,<br />

J. Toung, A. Richards, E. So, Y. Zhao, W. Ankener, J.<br />

Devlin, Y. Liu, V. Cheung.<br />

545F Integrating functional and computational<br />

genomics to develop neuronal regulatory vocabularies.<br />

X. Reed, L. Taher, G. M. Burzynski, C. Fletez-Brant,<br />

D. Lee, D. S. Gary, M. A. Beer, I. Ovcharenko, A. S.<br />

McCallion.<br />

546W Transcriptome genomic analysis using RNA-seq<br />

in three tissues <strong>of</strong> a twin cohort. A. Buil, A. Brown, M.<br />

Davies, A. Viñuela, M. Gallardo, D. Glass, M. Blasco, R.<br />

Durbin, T. D. Spector, E. T. Dermitzakis for EUROBATS<br />

Consortium.<br />

547F The genetics <strong>of</strong> gene expression, splicing and<br />

transcriptional efficiency through poly-A selection<br />

and ribosomal depletion RNA sequencing in humans.<br />

M. Pala, M. Marongiu, A. Mulas, R. Cusano, F. Crobu, F.<br />

Reinier, R. Berutti, M. G. Piras, C. Joens, D. Schlessinger,<br />

G. Abecasis, A. Angius, S. Sanna, F. Cucca, S. B.<br />

Montgomery.<br />

548W Quantification <strong>of</strong> chitinase transcripts in human<br />

tissues. M. Ohno, K. Tsuda, M. Sakaguti, Y. Sugahara, F.<br />

Oyama.<br />

549F Two functional variants in the promoter region <strong>of</strong><br />

UBE2L3 confer risk for systemic lupus erythematosus.<br />

S. Wang, G. B. Wiley, F. Wen, J. Warner, J. Robertson, J.<br />

M. Guthridge, M. Dozmorov, J. D. Wren, J. A. James, P.<br />

M. Gaffney.<br />

550W A 660 kb deletion centromeric to the lamin B1<br />

gene (LMNB1) mimics LMNB1 duplication and causes<br />

adult-onset autosomal dominant leukodystrophy.<br />

E. Giorgio, D. Robyr, E. Di Gregorio, D. Lacerenza, G.<br />

Vaula, A. Brusco, S. E. Antonarakis, A. Brussino.<br />

551F Variation in transcription factor binding among<br />

humans. F. Grubert, M. Kasowski, C. Heffelfinger, M.<br />

Hariharan, A. Asabere, S. Waszak, L. Habegger, J.<br />

Rozowsky, M. Shi, A. Urban, M. Hong, K. Karczewski, W.<br />

Huber, S. Weissman, M. Gerstein, J. Korbel, M. Snyder.<br />

552W Widespread R-loop formation in the human<br />

genome: Implications for epigenetic control and<br />

beyond. Y. Lim, P. Ginno, P. Lott, I. Korf, F. Chedin.<br />

553F Genome-wide transcriptome pr<strong>of</strong>iling reveals the<br />

functional impact <strong>of</strong> rare de novo and recurrent CNVs<br />

in autism spectrum disorders. R. Luo, S. Sanders, Y.<br />

Tian, I. Voineagu, N. Huang, S. Chu, L. Klei, C. Cai, J. Ou,<br />

J. Lowe, M. Hurles, B. Devlin, M. State, D. Geschwind,<br />

ACE Network Consortium.<br />

554W Transcriptional alterations underlying variable<br />

phenotypic expressivity associated with 16p11.2<br />

microdeletion/microduplication syndrome within<br />

multiplex autism families. I. Blumenthal, J. Z. Levin, Y.<br />

Shen, C. Ernst, C. C. Morton, J. F. Gusella, M. E. Talkowski.<br />

555F Differential reduced expression <strong>of</strong> IRS-1 in<br />

visceral and subcutaneous adipose depots in morbidly<br />

obese and type2 diabetic subjects and their correlation<br />

with metabolic pr<strong>of</strong>iles with 2 novel mutations<br />

sequenced in Asian Indians. M. Sharma, K. Luthra, S.<br />

Aggarwal, N. Vikram, A. Misra.<br />

556W Quantitative analysis <strong>of</strong> the human beta cell<br />

transcriptome. A. C. Nica, H. Ongen, J. Irminger, S.<br />

Dupuis, A. Planchon, L. Romano, S. E. Antonarakis, P. A.<br />

Halban, E. T. Dermitzakis.<br />

557F Novel sequence motif regulates pluripotency. Y.<br />

Song, S. Bao, G. Niu, Y. Zhao, H. Zhu.<br />

558W Quantitative expression analysis <strong>of</strong> mouse<br />

chitinases: Acidic mammalian chitinase is the major<br />

transcript in stomach. F. Oyama, M. Ohno, K. Tsuda, M.<br />

Sakaguchi, Y. Sugahara.<br />

559F The Japanese firefly, Luciola cruciata, gene:<br />

Small intron and their insufficiency <strong>of</strong> splicing in CHO<br />

cells. M. Ishii, R. Kojima, S. Fukuda, M. Sakaguchi, Y.<br />

Sugahara, M. Kamaya, F. Oyama.<br />

560W Expression QTL interactions in a cohort <strong>of</strong> 869<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


individuals reveals sex specific, cis-cis, trans-cis and<br />

trans-trans interactions. J. Bryois, A. Buil, D. M. Evans,<br />

D. F. Conrad, S. M. Ring, M. Hurles, P. Deloukas, G. D.<br />

Smith, E. T. Dermitzakis.<br />

561F Tissue-specific effects <strong>of</strong> genetic variation and<br />

DNA methylation on gene regulation. E. T. Dermitzakis,<br />

M. Gutierrez-Arcelus, S. B. Montgomery, T. Lappalainen,<br />

H. Ongen, A. Yurovsky, J. Byrois, A. Buil, T. Giger, L.<br />

Romano, A. Planchon, E. Falconnet, I. Padioleau, C.<br />

Borrel, A. Letourneau, P. Makrythanasis, M. Guipponi, C.<br />

Gehrig, S. E. Antonarakis.<br />

562W Multi-scale integration systematically connects<br />

disease-associated variants to molecular pathology.<br />

K. J. Karczewski, J. T. Dudley, R. Chen, A. J. Butte, M.<br />

Snyder.<br />

563F Analysis <strong>of</strong> primary natural killer cells reveals<br />

multiple novel cell-specific eQTL. S. Makino, B. P.<br />

Fairfax, E. Ng, J. C. Knight.<br />

564W The impact <strong>of</strong> polymorphisms within probe<br />

sequences on expression QTL studies. A. Ramasamy,<br />

D. Trabzuni, R. J. Gibbs, A. Dillman, D. G. Hernandez,<br />

S. Arepalli, R. Walker, C. Smith, A. A. Shabalin, Y. Li, A.<br />

B. Singleton, M. R. Cookson, J. Hardy, M. Ryten, M. E.<br />

Weale, North <strong>American</strong> Brain Expression Consortium and<br />

UK Brain Expression Consortium.<br />

565F PGC-1a regulates TFEB to promote autophagy<br />

lysosome-mediated turnover <strong>of</strong> aggregate-prone<br />

neurodegenerative disease proteins. T. Tsunemi, B. E.<br />

Morrison, T. D. Ashe, A. R. La Spada.<br />

566W The SLE associated TT.A polymorphism<br />

downstream <strong>of</strong> TNFAIP3 demonstrates lower affinity<br />

for NF- B and SATB1 and reduced enhancer activity.<br />

F. Wen, A. K. Templeton, S. Wang, J. M. Guthridge, M. B.<br />

Humphrey, P. M. Gaffney.<br />

567F Transcriptome and genome sequencing<br />

uncovers functional variation in human populations.<br />

T. Lappalainen, M. Sammeth, N. Kurbatova, J. Monlong,<br />

M. Friedländer, M. A. Rivas, T. Wieland, O. Karlberg,<br />

M. Barann, P. A. C. ‘t Hoen, T. Griebel, M. Sultan, D.<br />

MacArthur, E. Lizano, T. Strom, S. Schreiber, H. Lerach, S.<br />

E. Antonarakis, G. J. van Ommen, R. Sudbrak, R. Häsler,<br />

A. Brazma, A.-C. Syvänen, P. Rosenstiel, T. Meitinger,<br />

R. Guigo, I. Gut, X. Estivill, E. T. Dermitzakis, Geuvadis<br />

Consortium.<br />

568W Impact <strong>of</strong> private variants on human<br />

transcriptome architecture. X. Li, K. Karczewski, K.<br />

Smith, K. Kukurba, S. Montgomery.<br />

569F Predicting disease-relevant cis-regulatory<br />

SNPs via tissue-specificity <strong>of</strong> allelic expression and<br />

chromatin state. N. Light, V. Adoue, P. Lundmark, B. Ge,<br />

T. Kwan, A.-C. Syvänen, T. Pastinen.<br />

570W Characterization <strong>of</strong> the basic regulatory<br />

elements involved in the regulation <strong>of</strong> OTC gene<br />

expression in human. O. Luksan, L. Dvorakova,<br />

M. Jirsa.<br />

POSTER SESSIONS 133<br />

571F Regulatory impact <strong>of</strong> alternative polyadenylation<br />

in human B-lymphoblastoid cells. O. K. Yoon, T. Y. Hsu,<br />

J. H. Im, R. B. Brem.<br />

572W Identification <strong>of</strong> a novel CFTR mRNA is<strong>of</strong>orm<br />

in nasal epithelial cells. A. Hinzpeter, A. de Becdelièvre,<br />

E. Bieth, F. Brémont, C. Costa, C. Gameiro, A. Aissat, M.<br />

Goossens, P. Fanen, E. Girodon.<br />

573F Cytokine induced genetic-epigenetic interactions<br />

at autoimmune thyroiditis susceptibility gene variants.<br />

M. Stefan, W. Zang, M. Keddache, Y. Tomer.<br />

574W DMD transcript imbalance regulates dystrophin<br />

levels. P. Spitali, J. C. van den Bergen, B. Wokke, A. A. M.<br />

Janson, R. van den Eijnde, J. J. G. M. Verschuuren, J. T.<br />

den Dunnen, P. A. C. ‘t Hoen, A. Aartsma-Rus.<br />

575F Protein inhibitor <strong>of</strong> activated STAT3 modulates<br />

the activity <strong>of</strong> anterior segment dysgenesis<br />

transcription factors in trabecular meshwork cells.<br />

T. Footz, L. Huang, M. Walter.<br />

576W Statin-induced alternative splicing in HepG2<br />

cells. C. Stormo, M. K. Kringen, O. K. Olstad, J. P. Berg,<br />

A. P. Piehler.<br />

577F Functional RNA editing sites identified by<br />

comparative transcriptome analysis. R. Zhang, G.<br />

Ramaswami, L. P. Keegan, T. Deng, M. A. O’Connell, J.<br />

B. Li.<br />

578W Meta-analysis <strong>of</strong> transcriptome data using<br />

pathway-based approach reveals biologically relevant<br />

asthma genes. T. Mersha, S. Amirisetty, G. Hershey.<br />

579F Whole transcriptome analysis <strong>of</strong> velocardi<strong>of</strong>acial<br />

syndrome using next-generation sequencing. Y. Zhang,<br />

J. Jin, X. Zhu, M. Haney, Y. Kluger, S. Weissman, A. Urban.<br />

580W Genome-wide search for novel human uORFs<br />

and N-terminal protein extensions using ribosomal<br />

footprinting. J. Hampe, C. Fritsch, A. Herrmann, M.<br />

Nothnagel, K. Szafranski, K. Huse, S. Schreiber, M. Platzer,<br />

M. Krawczak, M. Brosch.<br />

581F Variation in protein levels and its genetic<br />

determination in human lymphoblastoid cell lines. L.<br />

Wu, S. I. Candille, Y. Choi, H. Tang, M. Snyder.<br />

582W The impact <strong>of</strong> loss <strong>of</strong> function variants on the<br />

transcriptome. M. A. Rivas, T. Lappalainen, M. Sammeth,<br />

D. G. MacArthur, N. Kurbatova, T. Wieland, M. Lek, T.<br />

Griebel, M. Barann, M. Sultan, J. Carlsson, P. Hoen, T.<br />

Strom, S. Schreiber, H. Lehrach, S. E. Antonarakis, G. van<br />

Ommen, R. Sudbrak, R. Hasler, A. Brazma, A.-C. Syvänen,<br />

P. Rosenstiel, T. Meitinger, R. Guigo, I. Gut, X. Estivill, M. I.<br />

McCarthy, E. T. Dermitzakis, Geuvadis Consortium.<br />

583F Mapping cis and trans regulatory effects across<br />

multiple tissues in twins: The MuTHER Study. K. Small,<br />

E. Grundberg, A. Hedman, A. Nica, A. Buil, S. Keildson,<br />

J. Bell, T. Yang, A. Barrett, J. Nisbet, D. Meduri, S.-Y.<br />

Shin, D. Glass, J. Min, L. Parts, L. Tsaprouni, F. Nestle,<br />

S. O’Rahilly, N. Soranzo, C. M. Lindgren, K. Zondervan,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


134 POSTER SESSIONS<br />

K. Ahmadi, E. Schadt, K. Stefansson, G. Davey Smith,<br />

M. McCarthy, P. Deloukas, E. Dermitzakis, T. Spector,<br />

MuTHER Consortium.<br />

584W Identifying age- and sex-associated gene<br />

expression pr<strong>of</strong>iles in .7,000 whole-blood samples.<br />

M. J. Peters, R. Joehanes, T. Esko, K. Heim, H. Völzke,<br />

L. Pilling, J. Brody, Y. F. Ramos, B. E. Stranger, M. W.<br />

Christiansen, S. Gharib, R. Hanson, A. H<strong>of</strong>man, J.<br />

Kettunen, D. Levy, P. Munson, C. O’Donnell, B. Psaty, F.<br />

Rivadeneira, A. Suchy-Dicey, A. G. Uitterlinden, H. Westra,<br />

I. Meulenbelt, D. Enquobahrie, T. Frayling, A. Teumer, H.<br />

Prokisch, A. Metspalu, J. B. J. Van Meurs, A. D. Johnson<br />

on behalf <strong>of</strong> CHARGE Gene Expression Working Group.<br />

585F Simplified sample preparation and streamlined<br />

library preparation method for deep sequencing<br />

ribosome protected mRNA fragments. R. Vaidyanathan,<br />

S. Kuersten, A. Radek, S. Swami, D. Vo, L. Penalva.<br />

586W <strong>Genetics</strong> and epigenetic regulation <strong>of</strong> eukaryotic<br />

transcriptome. Y. Wakabayashi, T. Ni, D. Corcoran, W.<br />

Yang, U. Ohler, W. Peng, C. O’Donnell, J. Zhu.<br />

587F Differential protein expression in human-induced<br />

pluripotent and embryonic stem cells. S. Brown-Ford,<br />

M. Pellitteri-Hahn, A. De La Forest, B. Halligan, S. Duncan,<br />

M. Olivier.<br />

588W Understanding the molecular mechanisms<br />

underlying autism spectrum disorders using iPSCderived<br />

neurons. B. A. DeRosa, J. M. Van Baaren, G.<br />

K. Dubey, J. M. Lee, M. L. Cuccaro, J. M. Vance, M. A.<br />

Pericak-Vance, D. M. Dykxhoorn.<br />

589F Whole exome sequencing in familial non-HHT<br />

brain arteriovenous malformations. N. Bendjilali,<br />

L. Tang, D. E. Guo, R. Hernandez, M. Segal, C. E.<br />

McCulloch, S. Inoue, A. Koizumi, W. L. Young, L.<br />

Pawlikowska, H. Kim.<br />

590W The investigation <strong>of</strong> angiotensin converting<br />

enzyme I/D and plasminogen activator inhibitor-1<br />

4G/5G polymorphisms in venous thromboembolism<br />

patients in Turkish patients. H. Salifoglu, H. Kaya, M.<br />

Karkucak, D. Torun, Y. Tunca.<br />

591F Organization <strong>of</strong> alphoid sequence clusters on<br />

human chromosome 21. W. Ziccardi, C. Putonti, J.<br />

Doering.<br />

592W A high-resolution genome-wide map <strong>of</strong> meiotic<br />

double-strand breaks in humans. F. Pratto, K. Brick, P.<br />

Khil, F. Smagulova, G. Petukhova, R. D. Camerini-Otero.<br />

593F Genome-wide scan <strong>of</strong> disease-inversion<br />

association. J. Ma, C. I. Amos.<br />

594W HOXA11 and MMP2 gene expressions in women<br />

with pelvic organ prolapsus. N. Yilmaz, G. Ozaksit, Y. K.<br />

Terzi, S. Yilmaz, B. Budak, O. Aksakal, F. I. Sahin.<br />

595F Large scale whole genome and whole exome<br />

sequencing <strong>of</strong> rhesus monkeys (Macaca mulatta) in<br />

five primate research centers. M. Raveendran, D. Rio<br />

Deiros, G. L. Fawcett, Z. Johnson, N. H. Kalin, R. W.<br />

Wiseman, B. Ferguson, E. Vallender, S. Kanthaswamy, D.<br />

M. Muzny, R. Gibbs, J. Rogers.<br />

596W Whole genome haplotyping by dilution,<br />

amplification and sequencing. F. Kaper, S. Swamy, B.<br />

Klotzle, J. Cottrell, S. Munchel, M. Bibikova, S. Kruglyak,<br />

M. Ronaghi, M. A. Eberle, J. B. Fan.<br />

597F Mechanism and potential diversity <strong>of</strong> T-cell<br />

receptor rearrangement from sequence repertoires.<br />

A. Murugan, T. Mora, A. Walczak, C. Callan.<br />

598W Expression <strong>of</strong> mouse acidic mammalian<br />

chitinase in Escherichia coli and characterization <strong>of</strong> its<br />

properties. A. Kashimura, Y. Kida, M. Ohno, K. Ishikawa,<br />

M. Sakaguchi, F. Oyama.<br />

599F Functional analysis <strong>of</strong> mouse chitinase-like<br />

protein Ym1. Y. Kida, M. Sakaguchi, Y. Sugahara, F.<br />

Oyama.<br />

600F Targeted deep sequencing by mobile element<br />

scanning (ME-Scan) reveals Alu insertions throughout<br />

the genome and around the world. D. J. Witherspoon,<br />

W. S. Watkins, Y. Zhang, J. Xing, M. A. Batzer, L. B. Jorde.<br />

Pharmacogenetics<br />

601T Identification <strong>of</strong> HNRNPA1 as a novel regulator<br />

<strong>of</strong> cholesterol metabolism. C. Yu, E. Theusch, D. A.<br />

Nickerson, K. Lo, M. Kutilova, R. M. Krauss, M. W. Medina.<br />

602T Novel association <strong>of</strong> dual anti-platelet drug<br />

response with a functional variant in PPARG. A. S.<br />

Fisch, J. Liu, J. P. Lewis, L. M. Yerges-Armstrong, J. R.<br />

O’Connell, B. D. Mitchell, R. B. Horenstein, N. Ambulos, K.<br />

Ryan, Q. Gibson, J. Shelton, A. R. Shuldiner.<br />

603T Genetic variations associated with gemcitabine<br />

treatment outcome in pancreatic cancer. L. Li, B.<br />

Fridley, G. Jenkins, E. Carlson, K. Kalari, G. Petersen, R.<br />

McWilliams, L. Wang.<br />

604T Large scale phenotyping using the 1000 Genomes<br />

Project lymphoblastoid cell line panel. D. Spacek, M.<br />

Kaganovich, M. Snyder.<br />

605T The association <strong>of</strong> SLC6A4 with antidepressantinduced<br />

mania: The long and the short <strong>of</strong> it. J. M.<br />

Biernacka, D. L. Walker, J. Geske, S. Winham, S. Crow, M.<br />

Chauhan, S. McElroy, M. Frye.<br />

606T Interactions between polymorphisms in<br />

eicosanoid metabolism genes and vasodilator<br />

responses in humans. L. N. Gordon, C. R. Lee, M.<br />

Pretorius, R. N. Schuck, L. H. Burch, D. C. Zeldin, S. M.<br />

Williams, N. J. Brown.<br />

607T Pharmacogenetics <strong>of</strong> schizophrenia: Predicting<br />

early response to antipsychotic therapy. M. Gupta, S.<br />

Jain, R. Kukreti.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


608T Identification <strong>of</strong> novel polymorphisms associated<br />

with efficiency <strong>of</strong> metformin treatment in type 2<br />

diabetes patients. J. Klovins, L. Tarasova, L. Zarina, V.<br />

Pirags, OPTIMED Consortium.<br />

609T Cholesteryl ester transfer protein polymorphisms,<br />

statin use, and their impact on cholesterol levels and<br />

cardiovascular events. M. Leusink, N. C. Onland-Moret,<br />

F. W. Asselbergs, B. Ding, S. Kotti, N. R. van Zuydam,<br />

A. C. Papp, N. Danchin, L. Donnelly, A. D. Morris, D. I.<br />

Chasman, P. A. F. M. Doevendans, O. H. Klungel, P. M.<br />

Ridker, W. H. van Gilst, T. Simon, F. Nyberg, C. N. A.<br />

Palmer, W. Sadee, P. van der Harst, C. Verstuyft, P. I. W. de<br />

Bakker, A. de Boer, A.-H. Maitland-van der Zee.<br />

610T Association study <strong>of</strong> inflammation-related<br />

genes and depressive disorders and antidepressant<br />

response. M.-W. Lin, Y.-T. Chang, I.-H. Lin, Y.-M. Bai.<br />

611T Are CYP2C9 and VKORC1 polymorphisms<br />

associated with increased bleeding or thrombosis risk<br />

among Blacks receiving warfarin anticoagulation? F.<br />

Mili, T. A. Deans, W. C. Hooper, P. Weinstein, C. Lally, H.<br />

Austin, N. Wenger.<br />

612T Twelve candidate genes and antidepressant<br />

response in obsessive-compulsive disorder. G. Zai, E.<br />

Brandl, J. Deluce, J. L. Kennedy, M. A. Richter.<br />

613T A genome-wide integrative study <strong>of</strong> microRNAs<br />

in human liver. W. Liu, F. Innocenti, E. Gamazon, S.<br />

Mirkov, J. Ramirez, S. Huang, N. Cox, M. Ratain.<br />

614T Protein quantitative trait loci identify novel<br />

proteins predictive for chemotherapeutic induced<br />

phenotypes. A. L. Stark, R. J. Hause, Jr., L. K. Gorsic,<br />

N. N. Antao, S. S. Wong, D. F. Gill, S. H. Chung, S. M.<br />

Delaney, C. D. Brown, K. P. White, R. B. Jones, M. E.<br />

Dolan.<br />

615T Functional genetic variation in RHOA is<br />

associated with the cholesterol-lowering effects <strong>of</strong><br />

statin treatment. E. Theusch, D. Naidoo, F. Bauzon, K.<br />

Stevens, L. Mangravite, Y. L. Kuang, R. M. Krauss, M. W.<br />

Medina.<br />

616T The modulation <strong>of</strong> CYP3A4 expression by the<br />

efflux pump ABCB1 in HepG2 cells. W. Shou, B. Wang,<br />

Z. Wang, J. Shi, W. Huang.<br />

617T Genetic determinants <strong>of</strong> dabigatran plasma levels<br />

and their relation to bleeding. G. Pare, N. Eriksson,<br />

T. Lehr, S. Connolly, J. Eikelboom, M. D. Ezekowitz, T.<br />

Axelsson, S. Haertter, J. Oldgren, P. Reilly, A. Siegbahn,<br />

A.-C. Syvänen, C. Wadelius, M. Wadelius, H. Zimdahl-<br />

Gelling, S. Yusuf, L. Wallentin.<br />

618T Genome-wide study <strong>of</strong> resistant hypertension<br />

using existing genomic data and electronic medical<br />

records. L. Dumitrescu, M. D. Ritchie, J. C. Denny, S. J.<br />

Bielinski, P. Peissig, J. A. Pacheco, M. G. Hayes, G. P.<br />

Jarvik, R. Li, I. J. Kullo, C. G. Chute, R. L. Chisholm, E. B.<br />

Larson, C. A. McCarty, D. M. Roden, M. de Andrade, D. C.<br />

Crawford on behalf <strong>of</strong> eMERGE Network.<br />

POSTER SESSIONS 135<br />

619T Genetic and clinical determinants <strong>of</strong> warfarin<br />

dose: A RE-LY genomics substudy. N. Eriksson, L.<br />

Wallentin, L. Berglund, T. Axelsson, S. Connolly, M.<br />

Ezekowitz, J. Oldgren, P. Guillaume, P. Reilly, A. Siegbahn,<br />

A.-C. Syvänen, C. Wadelius, S. Yusuf, M. Wadelius.<br />

620T The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health and<br />

Aging: A genome-wide association study <strong>of</strong> quetiapineinduced<br />

weight gain derived from electronic medical<br />

records and outpatient pharmacy data. N. Gonzaludo,<br />

S. Sciortino, L. Walter, N. Risch, P. Y. Kwok, C. Schaefer.<br />

621T Genome-wide association analysis <strong>of</strong> pain<br />

reduction in rheumatoid arthritis patients treated with<br />

anti-TNF medication. M. Umicevic Mirkov, H. Scheffer, S.<br />

Krintel, S. H. Vermeulen, J. Johansen, W. Kievit, M. A. F.<br />

van de Laar, P. C. L. van Riel, B. Franke, M. Hetland, M. J.<br />

H. Coenen.<br />

622T A genome-wide association analysis <strong>of</strong><br />

corticosteroid response in asthmatics. Q. Duan, B. E.<br />

Himes, B. Schuemann, K. G. Tantisira, S. T. Weiss.<br />

623T microRNA-based approach expands on genomewide<br />

association study and identifies SNPs important<br />

for response to glucocorticoids in asthma patients.<br />

H. Im, E. R. Gamazon, D. Lenkala, K. Wu, G. Clemmer, S.<br />

T. Weiss, N. J. Cox, K. Tantisira, R. S. Huang.<br />

624T SLC9A9 variant as a novel biomarker <strong>of</strong> response<br />

to interferon beta: Results from a pharmacogenetic<br />

study on Italian, U.S. and French multiple sclerosis<br />

patients. F. Martinelli Boneschi, F. Esposito, E. Lim, P.<br />

Brambilla, M. Sorosina, M. Romeo, M. Rodegher, N.<br />

Bohossian, N. A. Patsopoulos, B. Kenan, V. Martinelli, D.<br />

Brassat, G. Comi, P. De Jager.<br />

625T Polygenic heritability estimates <strong>of</strong> asthma and<br />

treatment-related phenotypes. M. J. McGeachie, E. A.<br />

Stahl, B. E. Himes, S. A. Pendergrass, M. D. Ritchie, R. M.<br />

Plenge, K. G. Tantisira.<br />

626T Web-based phenotyping yields replication <strong>of</strong><br />

genetic associations with sensitivity to warfarin. J. L.<br />

Mountain, A. K. Kiefer, M. Mullins, T. K. Acquaye, C.<br />

B. Marsh, J. A. Johnson, H. L. McLeod, J. Y. Tung, N.<br />

Eriksson, K. E. Barnholt.<br />

627T Follow-up study <strong>of</strong> genetic risk factors for<br />

carbamazepine-induced cutaneous adverse drug<br />

reactions in Japanese population. T. Ozeki, T. Mushiroda,<br />

A. Takahashi, M. Kubo, Y. Shirakata, Z. Ikezawa, M. Iijima,<br />

T. Shiohara, K. Hashimoto, Y. Nakamura.<br />

628T Re-examination <strong>of</strong> the CATIE pharmacogenetics<br />

whole-genome dataset using a run <strong>of</strong> significiant<br />

findings approach, focus on tardive dyskinesia. C. Zai,<br />

V. Gonçalves, A. Tiwari, G. Oh, V. de Luca, D. Mueller, J.<br />

Knight, J. Kennedy.<br />

629T A Bayesian approach to genome-wide genetic<br />

association studies with survival time as outcome.<br />

L. Chien, I. Chang, C. Hsiung.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


136 POSTER SESSIONS<br />

630T IL28B genotypes associated with IFN-induced<br />

virologic response in clinical studies evaluating<br />

eltrombopag treatment in HCV-infected patients with low<br />

platelet counts. M. Chiano, L. Condreay, L. Briley, D. Pulford,<br />

D. Fraser, K. Johansson, D. Briley, E. Harris, S. Bhatti, D.<br />

Theodore, F. Campbell, S. Vasey, M. Arning, C. Spraggs.<br />

631T Mapping the incidentalome: Quantifying<br />

incidental findings generated through a clinical<br />

pharmacogenomics project. K. B. Brothers, M. J.<br />

Westbrook, M. F. Wright, S. L. Van Driest, T. L. McGregor,<br />

J. C. Denny, R. L. Zuvich, E. W. Clayton.<br />

632T The Coriell Personalized Medicine Collaborative<br />

pharmacogenomics appraisal and evidence scoring<br />

sytem. N. Gharani, M. A. Keller, C. A. Stack, T. J.<br />

Schmidlen, R. S. Kasper, J. P. Jarvis, N. P. Gerry, E. S.<br />

Gordon, M. F. Christman.<br />

633T PharmGKB: From pharmacogenomics knowledge<br />

to clinical interpretation and implementation. L. Gong,<br />

M. Whirl-Carrillo, J. M. Hebert, E. M. McDonagh, K.<br />

Sangkuhl, C. F. Thorn, D. Klein, R. B. Altman, T. E. Klein.<br />

634T Development <strong>of</strong> a scoring tool to prioritize clinical<br />

pharmacogenomic testing. S. F. Manzi.<br />

635T Pharmacogenomic research undertaken by<br />

PharmGKB consortia groups. E. M. McDonagh, M. Whirl<br />

Carrillo, L. Gong, J. M. Hebert, K. Sangkuhl, C. F. Thorn,<br />

D. Klein, R. B. Altman, T. E. Klein.<br />

636T Effects <strong>of</strong> CYP2C9 and VKORC1 polymorphisms<br />

on clinical outcomes and warfarin response: Focusing<br />

on personalized medicine. P. C. J. L. Santos, R. A. G.<br />

Soares, C. M. C. Strunz, J. E. Krieger, A. C. Pereira.<br />

637T Performance <strong>of</strong> a biomarker risk algorithm for a<br />

primary prevention trial <strong>of</strong> Alzheimer’s disease. M. W.<br />

Lutz, D. K. Burns, D. G. Crenshaw, A. M. Saunders, A. D.<br />

Roses.<br />

638T A study <strong>of</strong> asthma pharmacogenomics using RNAseq.<br />

B. E. Himes, R. Hu, P. Wagner, D. Chan, B. Klanderman,<br />

R. A. Panettieri Jr., K. Tantisira, S. T. Weiss, Q. Lu.<br />

639T Genetic moderators <strong>of</strong> treatment response<br />

to methylphenidate and guanfacine in children and<br />

adolescents with ADHD. E. L. Nurmi, K. S. Mallya, F.<br />

Whelan, C. P. Laughlin, J. J. McGough, S. K. Loo, R. M.<br />

Bilder, J. T. McCracken.<br />

640T Identifying genes that influence acute ethanol<br />

responsive behaviors in Caenorhabditis elegans. J. T.<br />

Alaimo, A. G. Davies, J. C. Bettinger.<br />

641T Characterization <strong>of</strong> Northeast Asian ADME gene<br />

variation via exome sequencing. D. H. Hovelson, Z. Xue,<br />

S. Rashkin, X. Zhan, M. G. Ehm, A. Yeo, I. J. Jang, I. Ieiri,<br />

J. E. Lee, L. R. Cardon, S. L. Chissoe, G. Abecasis, M. R.<br />

Nelson.<br />

642T Drug metabolizing enzyme genes and nicotine<br />

and cotinine metabolism. A. W. Bergen, H. S. Javitz, M.<br />

Michel, R. Krasnow, D. Nishita, C. N. Lessov-Schlaggar, H.<br />

Hops, N. J. Markward, S. Hall, T. Baker, D. V. Conti, R. F.<br />

Tyndale, N. L. Benowitz, G. E. Swan.<br />

643T Identification <strong>of</strong> a SNP in the UGT1A1 promoter<br />

associated with increased serum bilirubin levels. M. K.<br />

Kringen, A. P. Piehler, R. M. Grimholt, M. S. Opdal, K. B. F.<br />

Haug, P. Urdal.<br />

644T Well-characterized cohorts and exome data:<br />

Investigating antipsychotic pharmacogenomics in<br />

the South African context. B. Drogemoller, D. Niehaus,<br />

G. Wright, B. Chiliza, L. Asmal, L. Koen, R. Emsley, L.<br />

Warnich.<br />

645T Can genetic variation <strong>of</strong> CES1A predict<br />

methylphenidate response in ADHD patients?<br />

A. Cassidy, E. Sizer, D. Rutschow, K. Hogg, J. Berg, D.<br />

Coghill.<br />

646T Whole exome analysis <strong>of</strong> African <strong>American</strong><br />

warfarin pharmacogenomics. R. Daneshjou, K. Aquino-<br />

Michaels, B. Burkley, L. H. Cavallari, J. A. Johnson, N. A.<br />

Johnson, T. E. Klein, K. J. Karczewski, T. Langaee, S. R.<br />

Patel, M. Perera, H. Sagreiya, H. Tang, N. Tatonetti, R. B.<br />

Altman.<br />

647T Survey <strong>of</strong> rare variants in pharmacogenes for<br />

patients with statin-induced myopathy identified in<br />

a biorepository linked to electronic medical records.<br />

M. T. Oetjens, Q. Feng, A. R. Ramirez, E. Bowton, T. Clark,<br />

D. M. Roden, D. C. Crawford, R. A. Wilke.<br />

648T Genetic determinants <strong>of</strong> fetal hemoglobin<br />

response to hydroxyurea. V. A. Sheehan, A. Sabo, J.<br />

R. Crosby, T. A. Howard, D. M. Muzny, B. Davis, A. Li, U.<br />

Nagaswamy, E. Boerwinkle, R. A. Gibbs, R. E. Ware, J. M.<br />

Flannagan.<br />

649T Translating genetic associations to new<br />

medicines. M. G. Ehm, S. L. Chissoe, M. R. Nelson, D.<br />

M. Waterworth, L. C. McCarthy, H. Tipney, T. Pastinen, M.<br />

Saleh, P. Gros, P. Agarwal, M. Lathrop, L. R. Cardon, J. B.<br />

Richards, P. Sanseau.<br />

650T Association <strong>of</strong> CYP3A4 and CYP3A5 genotypes<br />

with treatment-related hyperlipidemy. L. E. Wong-<br />

Ley, L. E. Figuera, R. Ortiz-Orozco, M. Perez-Nuño,<br />

P. Aguiar-Garcia, F. A. Ortega-Gutierrez, A. Nuñez-<br />

Zenteno.ñ<br />

651T Pharmacogenetic investigation <strong>of</strong> diarrhea<br />

in pazopanib-treated patients with renal cell<br />

carcinoma. Z. Xue, L. Huang, C. N. Sternberg, R. A.<br />

Figlin, L. McCann, C. F. Spraggs, C. Carpenter, L. N.<br />

Pandite, C. Xu.<br />

652T Multi-ethnic glutathione S-transferase copy<br />

number pr<strong>of</strong>iling. S. Martis, R. Vijzelaar, J. Sload, H. Mei,<br />

L. Edelmann, R. J. Desnick, S. A. Scott.<br />

653T Pharmacogenomics <strong>of</strong> cardiovascular disease<br />

treatment in subjects from the Lithuanian population.<br />

A. Pranculis, I. Pepalyte˙ , J. Arasimavičius, Z. A.<br />

Kučinskiene˙ , V. Kučinskas.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


654T Systematic functional characterization <strong>of</strong><br />

cytochrome P450 2E1 promoter variants in the Chinese<br />

Han population. S. Qin, L. He.<br />

655T Influence <strong>of</strong> common polymorphisms in<br />

ABCB1 gene on interaction between methadone and<br />

p-glycoprotein. Y. Teng, C. Hung, M. Chiou.<br />

Metabolic Disorders<br />

656T Genetic regulation <strong>of</strong> circulating glycine<br />

concentration in the Finnish population. J. Kettunen, T.<br />

Tukiainen, M. Ala-Korpela, J. Eriksson, O. Raitakari, M. R.<br />

Järvelin, T. Lehtimäki, V. Salomaa, M. Perola, A. Palotie,<br />

S. Ripatti.<br />

657F Functional and physical interaction <strong>of</strong> the<br />

mitochondrial electron transport chain and fatty acid<br />

oxidation and its disruption in fatty acid oxidation<br />

deficient animals. J. Vockley, Y. Wang, E. Goetzman, J.<br />

Palmfeldt, N. Gregersen.<br />

658T Dysregulation <strong>of</strong> central nervous system<br />

sphingolipid metabolism as a unifying mechanism for<br />

neuro-cognitive manifestations <strong>of</strong> Gaucher disease<br />

and HIV infection. A. F. Elias, N. J. Haughey, K. Mackey,<br />

T. Pitman, A. W. Thomas, S. Wakefield, S. P. Yang.<br />

659F Autism spectrum disorders functioning levels<br />

and metabolic alterations. N. Arciniegas, N. Linares, M.<br />

Cabrera-Rios, S. Carlo.<br />

660T Creatine transporter deficiency: Novel mutations<br />

and functional studies. O. Ardon, X. Yin, N. Longo, A.<br />

Shilon-Hadass, G. Gabis, C. H<strong>of</strong>fman, M. Tzadok, G.<br />

Heimer, S. Sadan, B. Ben-Zeev, Y. Anikster.<br />

661F Mice deficient for succinyl-CoA synthetase<br />

exhibit functionally significant mtDNA depletion and<br />

are a model for mitochondrial disease. T. Donti, M. Ge,<br />

K. Eldin, B. Graham.<br />

662T Role <strong>of</strong> medium chain acyl-CoA dehydrogenase<br />

in the metabolism <strong>of</strong> sodium phenylbutyrate.<br />

K. Kormanik, H. Kang, D. Cuebas, B. Scharschmidt, J.<br />

Vockley, A.-W. Mohsen.<br />

663F Common dysfunctional variants <strong>of</strong> ABCG2<br />

decrease extra-renal urate excretion and cause<br />

hyperuricemia. H. Matsuo, T. Takada, A. Nakayama,<br />

T. Shimizu, H. Kasuga, H. Nakashima, T. Nakamura, Y.<br />

Takada, Y. Kawamura, Y. Utsumi, H. Ogata, M. Nakamura,<br />

Y. Sakurai, T. Hosoya, N. Shinomiya, H. Suzuki, K. Ichida.<br />

664T Exploring the phenotype <strong>of</strong> MMACHC deficiency<br />

(cblC) in zebrafish with morpholinos and zinc finger<br />

nuclease targeted mutagenesis. J. L. Sloan, K. Bishop, T.<br />

L. Blake, R. J. Chandler, B. P. Brooks, R. Sood, C. P. Venditti.<br />

665F Comparative study <strong>of</strong> gene expression pr<strong>of</strong>iling<br />

<strong>of</strong> skin fibroblasts <strong>of</strong> Leigh syndrome French Canadian<br />

subjects and controls. J. Tardif, C. Laprise, LSFC<br />

Consortium.<br />

POSTER SESSIONS 137<br />

666T SUCLG1 mutations causing mitochondrial depletion<br />

syndrome with congenital anomalies. H. C. Andersson, M.<br />

Landsverk, T. Yeh, D. Cejas, D. Singh, L. J. Wong.<br />

667F A mouse model <strong>of</strong> mitochondrial complex I<br />

deficiency exhibits progressive cardiac disease and<br />

seizures. W. J. Craigen, T. Donti, Y. C. Lai, S. Ather, X.<br />

Wehrens, B. H. Graham.<br />

668T Enzyme function affected by mutations in the<br />

sucrase-isomaltase gene. J. Huang, Z. Wu, S. Uhrich, C.<br />

R. Scott.<br />

669F Hyperammonemia and urea cycle homeostasis in<br />

methylmalonic acidemia. R. J. Chandler, H. Morizono, P.<br />

J. McGuire, C. P. Venditti.<br />

670T Propionic acidemia: Is there a decreased<br />

in tricarboxylic acid cycle enzyme functions?<br />

K. Chapman, A. Markowitz-Shulman, G. Cunningham,<br />

J. Cabrera-Luque, M. Summar.<br />

671F Cap myopathy: A distinct form <strong>of</strong> congenital<br />

myopathy. S. J. Piteau, G. Smith, S. Ludwin, J. MacKenzie.<br />

672T Mutations in the phospholipid remodeling<br />

gene SERAC1 impair mitochondrial function and<br />

intracellular cholesterol trafficking and cause dystonia<br />

and deafness. E. Morava, S. Wortmann, F. Vaz, T.<br />

Gardeitchik, L. E. L. M. Vissers, J. Schuurs-Hoeijmakers,<br />

R. Rodenburg, A. Grünewald, C. Klein, T. Kozicz, P.<br />

van Hasselt, M. Harakalova, W. Kloosterman, I. Barić,<br />

K. Naess, Z. Krumina, C. Gilissen, H. Bokhoven, J. A.<br />

Veltman, J. A. M. Smeitink, D. J. Lefeber, R. A. Wevers, A.<br />

P. M. de Brouwer.<br />

673F Somatic cell diagnostic studies may miss some<br />

patients with mutations in MMAA and MMAB genes<br />

responsible for isolated methylmalonic aciduria.<br />

L. Dempsey Nunez, M. L. Illson, J. Kent, Q. Huang, A.<br />

Brebner, D. Watkins, B. M. Gilfix, C. Wittwer, D. S. Rosenblatt.<br />

674T The clinical spectrum <strong>of</strong> combined malonic<br />

and methylmalonic aciduria, a defect in the<br />

intramitochondrial fatty-acid-biosynthesis pathway.<br />

I. Manoli, J. L. Sloan, J. J. Johnston, L. Peller, J. C. Sapp,<br />

L. G. Biesecker, C. P. Venditti.<br />

675F Neurochemical pr<strong>of</strong>iles in children with<br />

inborn errors <strong>of</strong> metabolism determined by in vivo<br />

1H-magnetic resonance spectroscopy. W. Al-Hertani,<br />

E. Mason, T. Tam, B. Schmitt, S. Blaser, H. Branson, A.<br />

Schulze.<br />

676T Analyzing functional phenotypes in fibroblasts<br />

from patients with clinically-diagnosed mitochondrial<br />

disease. B. Graham, T. Donti, A. Bessee, W. Craigen, P.<br />

Bonnen.<br />

677F Clinical molecular laboratory analysis <strong>of</strong> the<br />

genes <strong>of</strong> fatty acid oxidation. M. T. Hardison, M.<br />

Landsverk, L. Wong.<br />

678T Fabry disease: Molecular analysis <strong>of</strong> GLA in<br />

females with no family history. D. Doheny, I. Nazarenko,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


138 POSTER SESSIONS<br />

J. Kim, R. Dobrovolny, R. Desnick.<br />

679F Maple syrup urine disease due to a new point<br />

mutation at BCKDHB in Iranian family. M. Hamid, G. R.<br />

Shariati, A. H. Saberi, M. Mohammadi.<br />

680T Peanut consumption increases levels <strong>of</strong> plasma<br />

very long chain fatty acids in humans. C. T. Lam, D. A.<br />

Wong, S. D. Cederbaum, B. Lim, Y. Qu.<br />

681F Diagnostic testing for multiple treatable<br />

metabolic neurodegenerative disorders by nextgeneration<br />

sequencing. S. van Koningsbruggen, O. R.<br />

Mook, G. Visser, M. A. Haagmans, R. C. Hennekam, G. S.<br />

Salomons, P. Verwaijen, H. R. Waterham, F. A. Wijburg, M.<br />

M. Mannens.<br />

682T Prevalence <strong>of</strong> GNE p.M712T and hereditary<br />

inclusion body myopathy in Sangesar population <strong>of</strong><br />

Northern Iran. H. Khademian, R. Carbajo, E. Mehravar, L.<br />

Sandoval, J. Garcia-Figueroa, Z. Khokher, D. No, Y. Valles-<br />

Ayoub, D. Darvish.<br />

683F Clinical application <strong>of</strong> massively parallel sequencing<br />

for molecular diagnosis <strong>of</strong> genetically heterogeneous<br />

glycogen storage diseases. J. Wang, H. Cui, N.-C. Lee, W.-<br />

L. Hwu, Y. H. Chien, W. J. Craigen, L.-C. Wong, V.-W. Zhang.<br />

684T Findings from the ZOOM genetic screening<br />

study <strong>of</strong> Niemann-Pick disease type C in adults with<br />

neurological and psychiatric signs. P. Bauer, D. J.<br />

Balding, H. H. Klünemann, D. Linden, D. Ory, M. Pineda, J.<br />

Priller, F. Sedel, A. Muller, H. Chadha-Boreham, R. Welford,<br />

D. S. Strasser, J. E. Wraith, M. C. Patterson.<br />

685F Detection <strong>of</strong> mucopolysacchariduria in driedurine<br />

filter paper samples: A useful technique for<br />

regions where transportation <strong>of</strong> liquid samples is<br />

challenging. R. Giugliani, F. Bender, G. Marasca, R.<br />

Guidobono, J. De Mari, M. Burin, G. Civallero.<br />

686T Analysis <strong>of</strong> non-reducing ends <strong>of</strong><br />

glycosaminoglycans for the diagnosis and monitoring<br />

<strong>of</strong> therapy in mucopolysaccharidoses type I and type II.<br />

T. Yuzyuk, E. Schwarz, J. Brown, B. Crawford, M. Pasquali.<br />

687F Rare, bizarre, and complex illnesses with unusual<br />

medical events in patients should be a signal to trigger<br />

a mitochondrial work-up: Clinical decision tree for<br />

mitochondrial disorder workup is provided. A. Perszyk.<br />

688T Clinical re-sequencing <strong>of</strong> 450 genes to diagnose<br />

mitochondrial disorders: Results from the first 119<br />

patients. J. DaRe, V. Vasta, T. Tran, J. Penn, L. Susswein,<br />

J. Booker, S. Hahn.<br />

689F Insulin resistance: Development <strong>of</strong> a clinical<br />

assay for INSR mutation detection. M. Procter, O. Ardon,<br />

A. Carey, H. Amiri, N. Longo, R. Mao.<br />

690T Comparative transcriptome pr<strong>of</strong>iles in<br />

Gaucher disease mice treated with imiglucerase or<br />

velaglucerase alfa. N. Dasgupta, Y.-H. Xu, S. Oh, Y. Sun,<br />

L. Jia, S. Barnes, M. Keddache, G. A. Grabowski.<br />

691F Enzyme replacement therapy started at birth<br />

improves outcome in difficult-to-treat organs in<br />

mucopolysaccharidosis I mice. G. Baldo, F. Mayer, B.<br />

Martinelli, F. Meyer, P. de Oliveira, A. Tavares, L. Meurer, T.<br />

de Carvalho, U. Matte, R. Giugliani.<br />

692T Long-term bone mineral density response<br />

to enzyme replacement therapy in a retrospective<br />

pediatric cohort <strong>of</strong> Gaucher patients. B. Bembi, G.<br />

Ciana, L. Deroma, A. M. Franzil, A. Dardis.<br />

693F Evaluation <strong>of</strong> long-term enzyme replacement<br />

therapy for children with Fabry disease. A. M. Hebert, T.<br />

Taber, L. Lacbawan, M. Banikazemi, O. Goker-Alpan.<br />

694T Combined therapy in a patient with Gaucher<br />

type III. J. Navarrete, P. Galindo, R. Delgado, A. Limon.<br />

695F Biochemical characterization <strong>of</strong> myelin<br />

abnormalities in the corpus callosum in MPS I<br />

dogs. S.-H. Kan, S. Q. Le, J. K. Yee, M. Guzman, N. M.<br />

Ellinwood, P. I. Dickson.<br />

696T Enzyme replacement therapy in a Gaucher type<br />

3 patient: Report <strong>of</strong> a paradigmatic case. F. Vairo, A. D.<br />

Dornelles, S. D. Mittelstadt, M. Wilke, D. Doneda, C. B. O.<br />

Netto, I. V. D. Schwartz.<br />

697F Alteration in liver TGFb expression and signaling<br />

in MPS I canines and the effect <strong>of</strong> enzyme replacement<br />

therapy. M. Vera, S. Q. Le, S. H. Kan, P. I. Dickson.<br />

698T Korean experience with citrin deficiency. B. H.<br />

Lee, Y. M. Kim, G. H. Kim, K. M. Kim, H. W. Yoo.<br />

699F Molecular diagnosis in mitochondrial respiratory<br />

chain deficiency using exome sequencing.<br />

R. Kopajtich, T. B. Haack, B. Haberberger, K. Danhauser,<br />

J. A. Mayr, W. Sperl, U. Ahting, G. F. H<strong>of</strong>fmann, M.<br />

Tesarova, E. Frisch, M. Schülke, I. Wittig, P. Freisinger,<br />

D. Ghezzi, M. Zeviani, A. Rötig, E. Graf, T. M. Strom, T.<br />

Meitinger, H. Prokisch.<br />

700T Occurrence <strong>of</strong> lysosomal storage disorders in<br />

children with hepatomegaly or hepatosplenomegaly:<br />

An institutional experience. M. Mistri, C. Ankeleshwaria,<br />

A. Bavdekar, M. Kamate, C. Datar, F. Sheth, J. Sheth.<br />

701F Exome sequencing reveals that mutations in the<br />

genes encoding aminoacyl tRNA synthetases cause<br />

a variety <strong>of</strong> clinical syndromes. M. T. Geraghty, M. J.<br />

M. Nowaczyk, P. Humphreys, J. Schwartzentruber, C. L.<br />

Beaulieu, A. Smith, L. Huang, J. Majewski, D. E. Bulman,<br />

K. M. Boycott, FORGE Consortium.<br />

702T Novel mutations in the PC gene in patients with<br />

type B pyruvate carboxylase deficiency. E. Oestergaard,<br />

M. Duno, . LB. Møller, H. S. Kalkanoglu-Sivri, A. Dursun,<br />

D. Aliefendioglu, H. Leth, M. Dahl, E. Christensen, F.<br />

Wibrand.<br />

703F Bioinformatics and genotypic evaluation <strong>of</strong> the<br />

IDUA gene and protein in MPS I patients diagnosed in<br />

Colombia, Ecuador and Perú. H. Velasco, J. Gonzalez,<br />

T. Pineda.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


704T A founder mutation causing a severe<br />

methylenetetrahydr<strong>of</strong>olate reductase deficiency in<br />

Bukharian Jews. S. Ben-Shachar, T. Zvi, A. Rolfs, A. B.<br />

Klobus, Y. Yaron, A. Bar-Shira, A. Orr-Urtreger.<br />

705F Somatic cell and molecular studies on an<br />

atypical patient with combined homocystinuria and<br />

methylmalonic aciduria (cblC). A. Brebner, C. Ficicioglu,<br />

D. Watkins, T. Pastinen, D. S. Rosenblatt.<br />

706T Exome sequencing reveals a homozygous ABCD4<br />

mutation in an adolescent with hyperpigmentation,<br />

ischemia, hyperhomocysteinemia, and methylmalonic<br />

aciduria. J. C. Kim, A. Brebner, N. C. Lee, W. L. Hwu, Y.<br />

H. Chien, S. Fahiminiya, J. Majewski, D. Watkins, D. S.<br />

Rosenblatt.<br />

707F Molecular characterization <strong>of</strong> the GALK1 gene<br />

in Filipino patients with non-classical galactosemia.<br />

C. L. T. Silao, K. N. Hernandez, D. M. Canson, S. C.<br />

Estrada.<br />

708T Exome sequencing reveals a frequent Moroccan<br />

founder mutation in SLC19A3 as a new cause <strong>of</strong><br />

early-childhood fatal Leigh syndrome. H. Smeets, M.<br />

Gerards, R. Kamps, I. Boesten, E. Jongen, B. de Koning,<br />

K. Schoonderwoerd, A. Sefiani, I. Ratbi, W. Coppieters, L.<br />

Karim, I. de Coo, B. van den Bosch.<br />

709F SATB2 acts as an activator <strong>of</strong> the UPF3B gene.<br />

P. Leoyklang, K. Suphapeetiporn, C. Srichomthong, S.<br />

Tongkobpetch, H. Dorward, A. R. Cullinane, M. Huizing, W.<br />

A. Gahl, V. Shotelersuk.<br />

710T Low bone strength is a manifestation <strong>of</strong><br />

phenylketonuria in mice and is attenuated by a<br />

glycomacropeptide-based diet. R. D. Blank, P.<br />

Solverson, S. G. Murali, S. J. Litscher, D. M. Ney.<br />

711F Natural history study <strong>of</strong> patients with hereditary<br />

inclusion body myopathy. J. K. De Dios, J. Shrader, G.<br />

Joe, C. Ciccone, A. Mankodi, J. Dastgir, C. Bonnemann,<br />

M. Bevans, D. Draper, J. McKew, M. Huizing, W. A. Gahl,<br />

N. Carrillo-Carrasco.<br />

712T Hepatic carnitine palmitoyltransferase<br />

1A deficiency: Adulthood complications and a<br />

Durango, Mexico founder mutation. N. M. Gallant, N.<br />

Vatanavicharn, D. Salazar, W. R. Wilcox.<br />

713F Basis <strong>of</strong> immune dysregulation in Gaucher<br />

disease. C. Martin, L. Kozhaya, T. Taber, D. Unutmaz, O.<br />

Goker-Alpan.<br />

714T Longitudinal change in brain volumes and<br />

cognitive function in MPS IIIA. I. Nestrasil, K. Delaney,<br />

B. Yund, A. Ahmed, K. Rudser, V. Kovac, P. Haslett, C.<br />

Richard, C. Whitley, E. Shapiro.<br />

715F Is the pr<strong>of</strong>ile <strong>of</strong> medical signs and<br />

symptoms associated with specific genotype in<br />

mucopolysaccharidosis type I? A. Ahmed, R. Cooksley,<br />

C. Whitley, E. Shapiro.<br />

716T Prevalence <strong>of</strong> Fabry disease in patients with<br />

POSTER SESSIONS 139<br />

chronic pain. C. Goizet, V. Dousset, M. Cadenne,<br />

E. Maurat, S. François, C. Blanchard, P. Poulizac, S.<br />

Tabuteau, C. Hubert, S. Laborde, P. Casenave, X. Ferrer,<br />

G. Solé, I. Coupry, F. Bauduer, T. Levade, D. Lacombe.<br />

717F Infantile onset severe phenotype <strong>of</strong> cblG<br />

disorder in a patient and abnormal neurotransmitter<br />

metabolites. R. Jobling, S. Hewson, S. Mercimek-<br />

Mahmutoglu.<br />

718T Abnormal central tegmental tract signal in a<br />

patient with mild glycogen storage disease type 1a.<br />

D. L. Renaud, S. T. Janousek, D. K. Freese, W. F. Schwenk.<br />

719F Mild clinical and atypical somatic cell findings<br />

in a cblF patient detected by expanded newborn<br />

screening. D. Rosenblatt, A. Brebner, I. R. Miousse, J. C.<br />

Kim, M. T. Geraghty, D. Watkins, C. Armour.<br />

720T Fumarase deficiency. Expanding the phenotype. K.<br />

Siriwardena, W. Al-Hertani, J. Kronick, D. Chitayat.<br />

721F Renal growth in isolated methylmalonic acidemia.<br />

P. Kruszka, I. Manoli, J. Sloan, C. P. Venditti.<br />

722T Plasmalogen deficiency in the Pex7 hypomorphic<br />

mouse, a model <strong>of</strong> rhizomelic chondrodysplasia<br />

punctata, causes neonatal lethality associated with<br />

late lung maturational defects. N. Braverman, X. He,<br />

S. Jiralerspong, G. Nimmo, Y. Chen, J. Hacia, A. Moser,<br />

W. Cui.<br />

723F Phenylketonuria and defective metabolism <strong>of</strong><br />

tetrahydrobiopterin. A. Al-Aqeel.<br />

724T Two cases <strong>of</strong> neonatal onset type II citrullinemia<br />

diagnosed by urine organic acids based newborn<br />

screening. Y. Watanabe, K. Tashiro, K. Aoki, T. Inokuchi,<br />

Y. Seki, T. Yanagi, T. Mizuochi, J. Okada, M. Yoshino, T.<br />

Matsuishi.<br />

725F Translational research in newborn screening:<br />

Implementation <strong>of</strong> a consensus data set for the<br />

long-term follow-up <strong>of</strong> patients to improve scientific<br />

understanding and optimize health outcomes. S. Berry,<br />

K. Hassell, A. Brower, Joint Committee <strong>of</strong> NBSTRN Clinical<br />

Centers Workgroup and NCC/RC Long-Term Follow-Up<br />

Workgroup.<br />

726T Newborn screening for infantile Pompe disease:<br />

Report <strong>of</strong> a pilot study in National Center for Child<br />

Health and Development. M. Kosuga, K. Kida, N. Fuji, T.<br />

Okuyama.<br />

727F The identification <strong>of</strong> infants with Fabry, Pompe,<br />

and mucopolysaccharidosis-I from newborn blood<br />

spots. C. R. Scott, S. Elliott, N. Buroker, L. I. Thomas, M.<br />

Glass, F. Turecek, M. H. Gelb.<br />

728T Bare lymphocyte syndrome type III, a novel<br />

mutation in RFXAP and failure to identify with newborn<br />

screening for severe combined immunodeficiency. L.<br />

Randolph, J. Chase, M. Aguilera, J. Siles, J. Church.<br />

729F Standard value <strong>of</strong> urine HVA/VMA ratio in the<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


140 POSTER SESSIONS<br />

early neonatal period to screen for Menkes disease. M.<br />

Yagi, N. Kusunoki, T. Lee, H. Awano, T. Yokota, A. Miwa, A.<br />

Shibata, I. Morioka, Y. Takeshima, K. Iijima.<br />

730T Correlation <strong>of</strong> phenylalanine concentration with<br />

neuropsychiatric symptom scores in phenylketonuria<br />

patients. T. Morgan, N. Owen, A. Bawcom, G. Wey, L.<br />

Ashford, J. Phillips.<br />

731F A rare disease–simple treatment: Sepiapterin<br />

reductase deficiency with a novel mutation. I. M. Zamir,<br />

B. Ben-Zeev, A. Mimouni-Bloch, S. Msilaty-Gross, Y.<br />

Anikster.<br />

732T A phase 2a study to investigate the effects <strong>of</strong><br />

a single dose <strong>of</strong> migalastat HCl, a pharmacological<br />

chaperone, on alpha-Gal A activity in subjects<br />

with Fabry disease. F. K. Johnson, P. N. Mudd, Jr., S.<br />

Sitaraman, R. Winkler, J. Flanagan, R. Khanna, K. J.<br />

Valenzano, D. J. Lockhart, P. Boudes on Behalf <strong>of</strong> Study<br />

AT1001-013 Principal Investigators.<br />

733F A novel drug target site for medium chain acyl-<br />

CoA dehydrogenase deficiency: Implications for future<br />

drug therapy. H. Kang, J. Vockley, A.-W. Mohsen.<br />

734T Immune response against enzyme<br />

replacement therapy alters enzyme distribution in<br />

mucopolysaccharidosis I mice. S. Le, S.-H. Kan, M.<br />

Vera, P. Dicskon.<br />

735F Hepatic gene transfer <strong>of</strong> TFEB results in<br />

clearance <strong>of</strong> mutant alpha-1-antitrypsin. N. Pastore, P.<br />

Piccolo, F. Annunziata, R. M. Sepe, F. Vetrini, D. Palmer, P.<br />

Ng, K. Blomenkamp, J. Teckman, A. Ballabio, N. Brunetti-<br />

Pierri.<br />

736T Neuronal differentiation <strong>of</strong> induced pluripotent<br />

stem cells from Gaucher disease fibroblasts. J. B.<br />

Florer, C. N. Mayhew, Y. Sun, G. A. Grabowski.<br />

737F Resveratrol and bezafibrate both dramatically<br />

induce transcription <strong>of</strong> aspartoacylase: A potential<br />

new treatment for Canavan disease? B. S. Andresen, T.<br />

K. Doktor, J. O. Sass, J. Bastin, F. Djouadi, T. J. Corydon,<br />

E. Christensen, A. M. Lund, H. S. Andersen.<br />

738T The ingestion <strong>of</strong> a high protein diet during<br />

gestation magnifies the in vivo production <strong>of</strong><br />

metabolites in MMA mice in utero. D. Brown, J. Senac,<br />

J. Sloan, I. Manoli, C. Venditti.<br />

739F Danshen extract regulates energy metabolism by<br />

activating the AMPK-SIRT1-PGC-1a. Y. H. Cho, C. R.<br />

Ku, H. Lee, E. J. Lee.<br />

740T Protocols for sick day management and<br />

emergency interventions for mitochondrial disorder<br />

patients are important for family education, treatment<br />

and support. M. Fredrich, A. Perszyk.<br />

741F High fat diet paradoxically improves cold<br />

survival in a mouse model <strong>of</strong> medium-chain acyl-CoA<br />

dehydrogenase deficiency. S. E. McCandless, L. Rice,<br />

C. L. Hoppel.<br />

742T Sapropterin treatment for toddlers with PKU. N.<br />

L. Pallone.<br />

743F Ubiquinol preparations are numerous and<br />

selection <strong>of</strong> appropriate mitochondrial supplement<br />

requires careful scrutiny by family and doctor.<br />

N. Franklin, A. Perszyk.<br />

744T The role <strong>of</strong> N-acetylcysteine in treating<br />

mitochondrial liver disease. A.-K. Niemi, G. M. Enns.<br />

745F Phase 3 study <strong>of</strong> migalastat HCl for Fabry<br />

disease: Stage 1 results. K. Nicholls, C. Feliciani, S.<br />

Shankar, F. Ezgu, S. G. Janmohamed, S. M. Laing, R.<br />

Schroyer, A. C. Bragat, S. Sitaraman, V. Sniukiene, R. E.<br />

Winkler, P. Boudes.<br />

746T Differential risk for Parkinson disease in males<br />

and females with Gaucher disease. D. Elstein, R.<br />

Alcalay, T. Dinur, G. Altarescu, E. Ben-Chetrit, A. Zimran.<br />

747F Potential cluster <strong>of</strong> MPS IV A in Northeast Brazil.<br />

F. Kubaski, A. C. Brusius-Facchin, P. F. V. Medeiros, C. S.<br />

E. Gondim, R. Giugliani, S. Leistner-Segal.<br />

748T Persistent thrombocytopenia in type I Gaucher<br />

disease: Evaluation and management. H. Rosenbaum.<br />

749F Chemotactic factors critical for increased<br />

immunological cell invasion in Gaucher disease mice.<br />

M. K. Pandey, N. A. Jabre, G. A. Grabowski.<br />

750T Systematic screening for treatable inborn errors<br />

<strong>of</strong> metabolism in intellectual disability patients: First<br />

study results. S. Stockler, R. Salvarinova, G. Horvath,<br />

Y. Lillquist, H. Vallance, S. Sinclair, M. Lafek, T. Murphy,<br />

A. Lehman, M. Patel, M. Demos, M. Connolly, C. van<br />

Karnebeek, TIDE BC, Treatable Intellectual Disability<br />

Endeavor in British Columbia.<br />

751F A novel homozygous mutation in EARS2 causing<br />

a fatal multisystem infantile disease. A. Pyle, B.<br />

Talim, H. Griffin, H. Topaloglu, M. Santibanez-Koref, P. F.<br />

Chinnery, R. Horvath.<br />

752T Novel phenotype associated with OPA mutations?<br />

M. Tesarova, V. Stranecky, H. Kratochvilova, Z. Hajkova,<br />

J. Sladkova, J. Spacilova, H. Hansikova, T. Honzik, H.<br />

Hartmannova, L. Noskova, L. Piherova, E. Lalonde, J.<br />

Majewski, S. Kmoch, J. Zeman.<br />

753T Evaluating pain, negative mood, and resilience<br />

in patients affected by Fabry disease. A. M. Lelis, R.<br />

Duran, L. Beckman, J. Garbanati, W. Wilcox, J. Mirocha.<br />

Therapy for Genetic Disorders<br />

754W Comparison <strong>of</strong> the differentiation potential <strong>of</strong><br />

human mesenchymal stem cells and several animal<br />

species. F. Piryaei, M. Ramezani, M. Kadivar, F. Piryaei.<br />

755W Bone marrow-derived cells as a stable source <strong>of</strong><br />

sialic acid for mice with GNE myopathy. M. C. Malicdan,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


K. Momma, F. Funato, Y. K. Hayashi, I. Nonaka, M.<br />

Huizing, W. Gahl, C. F. Boerkoel, I. Nishino, S. Noguchi.<br />

756W Lysine restricted diet as novel therapy for<br />

pyridoxine dependent epilepsy: First observational<br />

study. C. van Karnebeek, H. Hartmann, S. Jaggawantru,<br />

J. P. Collet, B. Plecko, S. Stockler, Pyridoxine Dependent<br />

Epilepsy Consortium.<br />

757W High-fat diet rescues lethality <strong>of</strong> homozygous<br />

knockin R155H mice with VCP-associated disease.<br />

K. J. Llewellyn, A. Nalbandian, C. Nguyen, V. E. Kimonis.<br />

758W Serin diet relieves symptoms <strong>of</strong> hereditary<br />

sensory and autonomous neuropathy type 1A caused<br />

by a c.992 C.T, p.(Ser331Phe), mutation in SPTLC1.<br />

B. Rautenstrauss, E. Wilichowski, E. Holinski-Feder, T.<br />

Hornemann.<br />

759W Pilot trial <strong>of</strong> high-dose carnitine supplementation<br />

in young, non-dysmorphic males with autism spectrum<br />

disorders. R. Goin-Kochel, F. Scaglia, C. Schaaf, D. Dang,<br />

A. Laakman, K. Nowell, A. L. Beaudet.<br />

760W Results <strong>of</strong> the phase II multicenter, single<br />

arm, phase II controlled trial ‘IEDAT-01’. L. Chessa, V.<br />

Leuzzi, A. Plebani, R. Micheli, A. R. Soresina, I. Quinti, D.<br />

D’Agnano, C. Bozzao, P. Lulli, M. Magnani.<br />

761W Generation and characterisation <strong>of</strong> FRDA mouse<br />

model cell lines. C. Sandi, S. Al-Mahdawi, V. Ezzatizadeh,<br />

S. Virmouni, M. Sandi, M. Pook.<br />

762W Non-penetrance in RP17? An investigation<br />

into the molecular mechanisms underlying retinitis<br />

pigmentosa 17 with the view to developing novel genebased<br />

therapies. A. Pandor, S. Prince, R. Ramesar.<br />

763W Pharmacological evaluation <strong>of</strong> a CNP analogue<br />

for the treatment <strong>of</strong> achondroplasia. F. Lorget, N. Kaci,<br />

J. Peng, C. Benoist-Lasselin, E. Mugniery, T. Oppeneer, D.<br />

Wendt, S. Bullens, S. Bunting, L. Tsuruda, C. O’Neill, F. Di<br />

Rocco, A. Munnich, L. Legeai-Mallet.<br />

764W Role <strong>of</strong> vitamin D in osteoarthritis knee: A six<br />

month double blind, randomized, placebo control trial.<br />

S. R. Nath, D. Sanghi, S. Raj, K. Baghel, A. Mishra.<br />

765W Use <strong>of</strong> the amniotic fluid transcriptome to<br />

identify novel antenatal treatments for fetuses affected<br />

with Down syndrome. F. Guedj, L. Massingham, K.<br />

Johnson, U. Tantravahi, D. Bianchi.<br />

766W Treatment <strong>of</strong> basal cell carcinomas with a<br />

hedgehog pathway inhibitor vismodegib in basal cell<br />

nevus syndrome. A. Treherne, S. Bale, W. Chen, J. R.<br />

Toro.<br />

767W TGFb signaling exerts dimorphic effects on<br />

aortic aneurysm formation and progression in Marfan<br />

syndrome. L. Carta, J. R. Cook, M. Del Solar, E. Chiu, N.<br />

Clayton, C. Nelson, B. Wentworth, F. Ramirez.<br />

768W Safety <strong>of</strong> velaglucerase alafa in type 1 Gaucher<br />

disease patients with anti-imiglucerase antibodies. O.<br />

POSTER SESSIONS 141<br />

Goker-Alpan, G. M. Pastores, B. Rosenbloom, J. Ibrahim,<br />

G. M. Cohn, D. Zahrieh, P. K. Mistry.<br />

769W Safety and tolerability <strong>of</strong> velaglucerase alfa<br />

enzyme replacement therapy in patients aged $65<br />

years with type 1 Gaucher disease: A multicenter, open<br />

label trial. J. Ibrahim, G. M. Pastores, B. Rosenbloom, O.<br />

Goker-Alpan, G. M. Cohn, D. Zahrieh, P. K. Mistry.<br />

770W A double blind, placebo controlled trial <strong>of</strong><br />

minocycline in children with fragile X syndrome. R.<br />

Hagerman, M. J. Leigh, D. V. Nguyen, T. I. Winarni, S.<br />

Rivera, A. Schneider, T. Chechi, D. Hessl.<br />

771W Enhancing suppression <strong>of</strong> nonsense mutations<br />

in Duchenne muscular dystrophy. P. S. Lai, R.<br />

Elangovan, S. K. H. Tay, P. S. Low.<br />

772W Long-term safety <strong>of</strong> migalastat HCl in patients<br />

with Fabry disease. D. P. Germain, R. Giugliani, G. M.<br />

Pastores, K. Nicholls, S. Shankar, R. Schiffmann, D.<br />

Hughes, A. B. Mehta, S. Waldek, A. Jovanovic, K. Benistan,<br />

J. K. Simosky, V. Sniukiene, R. Winkler, P. F. Boudes.<br />

773W Eliglustat, an investigational oral therapy for<br />

Gaucher disease type 1: Phase 2 results after 4 years<br />

<strong>of</strong> treatment. M. J. Peterschmitt, E. Lukina, N. Watman,<br />

M. Dragosky, G. M. Pastores, E. Avila Arreguin, H.<br />

Rosenbaum, A. Zimran, E. Sysoeva, R. Aguzzi, L. H. Ross,<br />

A. C. Puga.<br />

774W Ammonia control in children ages 2 months<br />

through 5 years with urea cycle disorders: Comparison<br />

<strong>of</strong> sodium phenylbutyrate and glycerol phenylbutyrate.<br />

W. Smith, G. Diaz, U. Lichter-Konecki, S. A. Berry, C. O.<br />

Harding, S. E. McCandless, C. LeMons, K. A. Dickinson,<br />

D. Coakley, T. Moors, M. Mokhtarani, B. F. Scharschmidt,<br />

B. Lee.<br />

775W A comprehensive genetic and functional analysis<br />

<strong>of</strong> a large cohort <strong>of</strong> patients with Kabuki syndrome:<br />

Suggestions for therapy. L. Micale, C. Fusco, B. Augello,<br />

M. N. Loviglio, C. Maffeo, M. T. Pellico, L. Zelante, G.<br />

Merla.<br />

776W Differential effects <strong>of</strong> ramipril and losartan<br />

therapy on phenotype in mice model for Marfan<br />

syndrome. B. L. Lima, G. P. Cardozo, G. R. Fernandes, L.<br />

V. Pereira.<br />

777W Curcumin facilitates a transitory cellular stress<br />

response in Trembler-J mice. Y. Okamoto, K. Mehrdad,<br />

D. Pehlivan, W. Wiszniewski, G. Snipes, J. Lupski.<br />

778W Novel therapeutic assays for epidermolysis<br />

bullosa simplex. J. Lacroix, T. Farez, G. Leclerc, A.<br />

Dupérée, J. Powell, C. McCuaig, C. Morin, V. Legendre-<br />

Guillemin, M. Bchetnia, C. Laprise.<br />

779W Sodium butyrate and valproic acid as a splicing<br />

restoring agents in erythroid cells <strong>of</strong> b-thalassaemic<br />

patients. M. Taghizadeh, S. Mansoori Derakhsham, M.<br />

Shekari Khaniani, A. Hoseinpour Pheysi.<br />

780W Bisphosphonate therapy in Hajdu-Cheney<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


142 POSTER SESSIONS<br />

syndrome: Response, suggested protocol and future<br />

directions in treatment. M. D. Irving, W. M. Drake, J.<br />

Pittaway, D. Dafou, M. A. Simpson, R. T. Trembath.<br />

781W A small chemical, TG003, enhances skipping <strong>of</strong><br />

mutated dystrophin exons: The third example revealing<br />

a decrease <strong>of</strong> exonic splicing enhancer density in<br />

common. A. Nishida, Y. Takeshima, N. Kataoka, M. Yagi,<br />

H. Awano, T. Lee, K. Iijima, M. Hagiwara, M. Matsuo.<br />

782W Bezafibrate as treatment option in patients with<br />

mitochondrial complex I deficiency. B. M. Haberberger,<br />

P. Freisinger, V. Strecker, M. Steger, H. Heide, B. F. Müller,<br />

T. Beckhaus, K. Heim, U. Ahting, B. Rolinski, J. Mayr,<br />

A. Rötig, W. Sperl, M. Zeviani, I. Wittig, T. Meitinger, H.<br />

Prokisch.<br />

783W FMF patients homozygous for M694V have<br />

incomplete response to colchicine. H. Yonath, M. Lidar,<br />

N. Shechter, F. Sikron, S. Sadetzki, P. Langevitz, A. Livneh,<br />

E. Pras.<br />

784W CNS administration <strong>of</strong> recombinant human<br />

tripeptidyl peptidase-1 attenuates neurodegeneration,<br />

improves function, and increases lifespan in a canine<br />

model <strong>of</strong> classical late infantile neuronal ceroid<br />

lip<strong>of</strong>uscinosis. B. Vuillemenot, M. Katz, D. Kennedy, J.<br />

Coates, C. Sibigtroth, R. Whiting, F. Wininger, R. Reed,<br />

E. Adams, M. Butt, R. Cahayag, S. Keve, L. Tsuruda, D.<br />

Musson, C. O’Neill.<br />

785W Intrathecal enzyme replacement therapy<br />

improves diffusion tensor imaging abnormalities<br />

and volume loss in the corpus callosum in canine<br />

mucopolysaccharidosis I. P. Dickson, S. Chen, I.<br />

Nestrasil, V. Kovac, J. Jens, S. Q. Le, S.-h. Kan, M. A.<br />

Guzman, J. Provenzale, E. G. Shapiro, C. H. Vite, A.<br />

Mlikotic, N. M. Ellinwood.<br />

786W Enzyme replacement therapy using chemically<br />

modified enzyme markedly enhances therapeutic<br />

efficacies for bone lesions in mucopolysaccharidosis<br />

VII murine model. S. Tomatsu, D. Rowan, J. Grubb, B.<br />

Haupt, A. Montaño.<br />

787W A phase 2 multicenter, open label, switch<br />

over trial to evaluate the safety and efficacy <strong>of</strong><br />

Abcertin®(imiglucerase) in patients with type 1<br />

Gaucher disease previously treated with imiglucerase.<br />

H. W. Yoo, B. H. Lee, J. S. Lee, J. M. Ko, Y. B. Sohn.<br />

788W Results <strong>of</strong> 12 months use <strong>of</strong> taliglucerase alfa<br />

for Gaucher disease in an unselected cohort <strong>of</strong> adult<br />

patients on an Israeli compassionate use program. A.<br />

Zimran, H. Maayan, G. Altaescu, M. Tiomkin, M. Phillips,<br />

D. Elstein.<br />

789W Gaucher disease type 2: Outcomes <strong>of</strong> enzyme<br />

replacement therapy and impact on quality <strong>of</strong> life.<br />

C. Prada, R. Hopkin, L. Bailey, A. Lovell, N. Leslie, G.<br />

Grabowski.<br />

790W Efficiency <strong>of</strong> various antisense oligonucleotides<br />

for correcting ATM pre-mRNA in a patient with ataxiatelangiectasia<br />

with a deep intronic splicing mutation.<br />

S. Cavalieri, E. Pozzi, R. Cavalli, R. A. Gatti, A. Brusco.<br />

791W In utero brain-directed AAV gene therapy results<br />

in rapid, robust, and specific transduction <strong>of</strong> mouse<br />

choroid plexus epithelia. M. Haddad, A. Donsante, S. G.<br />

Kaler.<br />

792W Gene and stem cell treatment for alpha-1<br />

antitrypsin deficiency. B. Feinerman.<br />

793W Identifying motor neuron transduction<br />

efficiencies that are efficacious in SMA mice and<br />

achievable by intrathecal delivery in a large animal<br />

model. S. Cheng, M. Passini.<br />

794W Differential response to exogenous MeCP2 in<br />

mouse models <strong>of</strong> Rett syndrome. J. Young, V. Camarena,<br />

M. Saez, A. Abrams, K. Bayetti, A. Castle, K. Walz.<br />

795W Preclinical trial <strong>of</strong> trauma-induced osteoarthritis<br />

therapy by overexpressing matrix protein and reducing<br />

inflammation by gene-transfer. M. Z. C. Ruan, K. Guse,<br />

A. Erez, B. C. Dawson, Y. Chen, B. Lee.<br />

796W Towards lentiviral gene therapy for the treatment<br />

<strong>of</strong> MNGIE. R. De Coo, M. Stok, R. Yadak, H. Smeets, N.<br />

Van Til, G. Wagemaker.<br />

797W Directing miRNA-regulatory PNAs to breast<br />

cancer cells with synthetic targeting peptides. Y.-Y. Jin,<br />

C.-P. Chen, M. L. Thakur, E. Wickstrom.<br />

798W Effective inhibition <strong>of</strong> human cytomegalovirus gene<br />

expression and lytic replication by DNA-based external<br />

guide sequence. H. Li, X. Jia, L. Sun, T. Zhou, Z. Deng.<br />

799W Oncogenic EGFR allele specific inhibition by<br />

RNA interference for cancer therapy lacking adverse<br />

effects. M. Takahashi, T. Chiyo, T. Okada, H. Hohjoh.<br />

800W Remission induction <strong>of</strong> spinocerebellar ataxia 6<br />

by systems therapy with medicinal herbs. T. Okabe.<br />

801W Disease progression in MPS IIIA (Sanfilippo<br />

syndrome type A) is associated with genotype and age<br />

at diagnosis. C. B. Whitley, I. Nestrasil, K. Delaney, R.<br />

Cooksley, P. Haslett, C. Richard, E. Shapiro.<br />

802W Therapeutic efficacy <strong>of</strong> D-penicillamine<br />

encapsulated alginate/chitosan nanoparticles in rat model<br />

<strong>of</strong> copper toxicity with neurobehavioral impairments.<br />

R. Prasad, A. Pal, S. Attri, B. Thappa, R. Vasishta.<br />

803W High-efficiency gene correction <strong>of</strong> a Parkinson’s<br />

disease associated LRRK2 gene variant in patientderived<br />

iPS cells. B. Schuele, J. Laganiere, S. K. Mak,<br />

B. J. Vu, M. Vangipuram, Y. A. Huang, D. E. Paschon, O.<br />

Macaranas, A. Flierl, R. Sundararajan, P. D. Gregory, F. D.<br />

Urnov, J. W. Langston, H. S. Zhang.<br />

804W Inhibition <strong>of</strong> CTR1 by antisense oligonucleotides<br />

in mouse model for Wilson disease reduces copper<br />

accumulation and improves liver pathology. T. R.<br />

Grossman, P. Lincoln, M. McCaleb.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


Development<br />

805F Genome-wide identification <strong>of</strong> human cardiac<br />

developmental genes located within regions<br />

associated with congenital heart disease. K. D. Ajbro,<br />

T. A. Andersen, M. Bak, J. A. Rosenfeld, K. Møllgård, S. C.<br />

Eliasson, R. R. Jakobsen, E. Bendsen, N. Tommerup, L. G.<br />

Schaffer, K. Lage, l. A. Larsen.<br />

806F Voltage-gated sodium channels are required for<br />

proliferation <strong>of</strong> embryonic myocardium in zebrafish.<br />

J. Bennett, D. Stroud, J. Becker, D. Roden.<br />

807F Modeling early heart development in Down<br />

syndrome using sibling hESC lines. A. Bosman, A.<br />

Letourneau, M. Zuchelli, V. Tohonen, O. Hovatta, S. E.<br />

Antonarakis, M. E. Jaconi.<br />

808F Ofd1 controls dorso-ventral patterning and<br />

axoneme elongation during embryonic brain<br />

development. A. de Angelis, A. D’Angelo, B. Avallone, I.<br />

Piscopo, R. Tammaro, M. Studer, B. Franco.<br />

809F Exome sequencing identifies a single mutation<br />

in the CCDC114 gene as the cause for primary ciliary<br />

dyskinesia in the Volendam population. A. Onoufriadis,<br />

T. Paff, D. Anthony, A. Shoemark, D. Micha, B. Kuit, M.<br />

Schmidts, S. Petridi, R. Wilson, C. Hogg, R. Emes, UK10K,<br />

E. M. K. Chung, G. Pals, H. M. Mitchison.<br />

810F ALDH1A3 loss <strong>of</strong> function causes bilateral<br />

anophthalmia and hypoplasia <strong>of</strong> the optic nerve and<br />

optic chiasm. M. Yahyavi, A. S. De Preux Charles, T. Xiao,<br />

T. Bardakjian, A. Schneider, H. Baier, A. Slavotinek.<br />

811F Differential expression <strong>of</strong> lung function genes by in<br />

utero smoke exposure during human lung development.<br />

S. Sharma, A. Kho, K. Haley, C. Vyhlidal, R. Gaedigk, L.<br />

Kobzik, J. S. Leeder, K. G. Tantisira, S. T. Weiss.<br />

812F The C7orf58 locus is strongly associated with<br />

both bone mineral content and density at the pediatric<br />

distal radius. B. S. Zemel, M. Li, S. Deliard, C. E. Kim,<br />

L. Qu, R. M. Chiavacci, J. M. Lappe, H. J. Kalkwarf, V.<br />

Gilsanz, H. Hakonarson, S. E. Oberfield, J. A. Shepherd,<br />

S. F. A. Grant.<br />

813F A novel GNAI3 gain-<strong>of</strong>-function mutation<br />

associated with auriculo-condylar syndrome in a<br />

Brazilian family. V. L. R. Tavares, T. T. Torres, H. Buermans,<br />

C. Masotti, D. F. Bueno, J. A. Horst, R. M. Zechi-Ceide, M.<br />

L. Cunningham, M. L. Guion-Almeida, M. R. Passos-Bueno.<br />

814F Non-syndromic cleft lip/palate: A disease driven<br />

by deficiency in genomic repair? G. S. Kobayashi, L. A.<br />

Cruz, D. Y. Sunaga, D. F. Bueno, P. Francis-West, A. Kutta,<br />

B. V. P. Almada, S. G. Ferreira, M. Aguena, L. C. Andrade-<br />

Lima, C. F. Menck, M. R. Passos-Bueno.<br />

815F Genetic characterization <strong>of</strong> osteopenia and bone<br />

overgrowth in Marfan syndrome mice. S. Smaldone, J.<br />

R. Cook, M. Del Solar, F. Ramirez.<br />

816F Evaluating the genetic disruption <strong>of</strong> lung hypoplasia<br />

POSTER SESSIONS 143<br />

in a mouse model <strong>of</strong> CDH. S. C. Schecter, J. Wu, D. Miniati.<br />

817F The role <strong>of</strong> FMRP during early steps <strong>of</strong><br />

neurodevelopment. B. Bardoni, L. Davidovic, B. Mari, O.<br />

Khalfallah.<br />

818F rbm24a and rbm24b Are required for normal<br />

somitogenesis and crani<strong>of</strong>acial development and are<br />

essential for Notch signaling. S. Maragh, R. A. Miller, S.<br />

L. Bessling, W. Huang, M. J. Parsons, A. S. McCallion.<br />

819F Kabuki syndrome: Functional analysis <strong>of</strong><br />

MLL2 and KDM6A in vertebrate development. P. Van<br />

Laarhoven, L. Neitzel, E. A. Geiger, E. H. Zackai, K. B.<br />

Artinger, J. E. Ming, T. H. Shaikh.<br />

820F Fibulin-4b is required for cardiovascular and<br />

musculoskeletal development as an antagonist <strong>of</strong><br />

transforming growth factor-beta. Z. Urban, S. M. Khatri,<br />

A. B. Maxfield.<br />

821F Three-dimensional study <strong>of</strong> Ror2-/- and<br />

Wnta5-/- mice crani<strong>of</strong>acial phenotype using two<br />

imaging techniques. S. Beiraghi, V. Leon-Salazar, J.<br />

Zhang, D. Idiyatullin, M. Garwood, A. S. L. Fok, M. Maga,<br />

Y. Yang.<br />

822F Retinal disease gene identification and<br />

generation <strong>of</strong> photoreceptor gene regulatory networks<br />

by ChIP-seq analysis <strong>of</strong> multiple transcription factors.<br />

H. Hao, M. Brooks, M. Seifert, A. Swaroop.<br />

823F Genome-wide ChIP-seq analysis to identify<br />

mouse Foxl2 binding sites in vivo. M. Marongiu, A.<br />

Sbardellati, L. Marcia, A. Meloni, R. Cusano, A. Angius, G.<br />

Fotia, F. Cucca, L. Crisponi.<br />

824F Cc2d2a is required for cilia biogenesis. S. Veleri,<br />

T. J. Foskett, S. H. Manjunath, A. Longo, M. A. English, P.<br />

Liu, J. Lei, C. Gao, R. N. Fariss, R. Sood, R. A. Rachel, P.<br />

Liu, L. Dong, A. Swaroop.<br />

825F Prdm16 is required during mouse crani<strong>of</strong>acial<br />

development. B. C. Bjork, F. Schnutgen, L. Furlan, B.<br />

Nelson, D. R. Beier.<br />

826F Examination <strong>of</strong> lungs and kidneys in a mouse<br />

model <strong>of</strong> osteogenesis imperfecta. E. Carter, S. Doty, N.<br />

Pleshko, C. Raggio.<br />

827F Pathway analysis by quantitative pr<strong>of</strong>iling <strong>of</strong> gene<br />

expression patterns in developing mouse retina. M.<br />

J. Brooks, I. Nasonkin, S. Perez, S. Veleri, J. Roger, M.<br />

Seifert, A. Swaroop.<br />

828F Essential roles <strong>of</strong> FGF ligands in endochondral<br />

and intramembranous bone development. I. H. Hung, D.<br />

M. Ornitz, G. C. Schoenwolf, M. Lewandoski.<br />

829F Taking a different pathway: Notchless plays with<br />

p53 and Wnt during embryogenesis. A. C. Lossie, C.-L.<br />

Lo, J. B. Sherrill.<br />

830F Developmental defects in the retina <strong>of</strong> Pias3<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


144 POSTER SESSIONS<br />

conditional knockout mice. J. E. Roger, H. Breit, D.<br />

Cheng, L. Dong, A. Swaroop.<br />

831F Uncovering the function <strong>of</strong> TMED2 during<br />

trophoblast differentiation. T. Heba, A. Zakariyah, L. A.<br />

Jerome-Majewska.<br />

832F Mouse models <strong>of</strong> neurodevelopmental disorders:<br />

Overlap between FoxG1 and MeCP2. S. A. Adams, R.<br />

Woods, S. Luu, J. M. LaSalle.<br />

833F Comprehensive characterization <strong>of</strong> a zebrafish<br />

model for pseudoxanthoma elasticum. M. J. Hosen, O.<br />

M. Vanakker, A. Willaert, A. Huysseune, P. J. Coucke, A.<br />

De Paepe.<br />

834F Mouse model reveals the role <strong>of</strong> SOX7 in the<br />

development <strong>of</strong> congenital diaphragmatic hernia<br />

associated with recurrent deletions <strong>of</strong> 8p23.1. D. A.<br />

Scott, M. J. Wat, T. F. Beck, A. Hernández-García, Z. Yu,<br />

D. Veenma, M. Garcia, A. M. Holder, J. J. Wat, Y. Chen, C.<br />

A. Mohila, K. P. Lally, M. Dickinson, D. Tibboel, A. de Klein,<br />

B. Lee.<br />

835F Generation and characterization <strong>of</strong> humanized<br />

DUF1220 transgenic mice. J. G. Keeney, N. Anderson, D.<br />

Restrepo, J. M. Sikela.<br />

836F Overexpression <strong>of</strong> Sox9 in keratinocytes changes<br />

hair follicle cycling in mice. Y. Zhang, Z. H. Zheng, Y. Q.<br />

Xu, S. L. Zhou, L. Shi, X. Zhang.<br />

837F Integration <strong>of</strong> BAC transgenesis, evolutionary<br />

conservation, 3C, DNaseHS, and ChIP on chip data<br />

identifies a candidate osteoblast enhancer <strong>of</strong> Bmp2.<br />

E. M. Broeckelmann, S. Pregizer, D. P. Mortlock.<br />

838F The role <strong>of</strong> Filamin b in skeletogenesis and BMP<br />

signaling in mice. J. Zieba, A. Sarukhanov, M. Ivanova, A.<br />

S. Kim, A. E. Merrill, D. Krakow.<br />

839F The role <strong>of</strong> SOX7 in cardiovascular<br />

development. A. Hernández-Garcia, M. Wat, M. Garcia,<br />

T. F. Beck, Z. Yu, R. Schwartz, M. Dickinson, B. Lee, D.<br />

A. Scott.<br />

840F Novel mouse models reveal the role <strong>of</strong> in the<br />

development <strong>of</strong> inner ear phenotypes seen in 1p36<br />

deletions. H. Zaveri, B. J. Kim, O. A. Shchelochkov, F. A.<br />

Pereira, A. K. Groves, J. S. Oghalai, M. Justice, B. Lee, D.<br />

A. Scott.<br />

841F Xenopus laevis, a model for studying<br />

the involvement <strong>of</strong> HDAC6 in a novel form <strong>of</strong><br />

chondrodysplasia. K. Massé, C. Blanchard, D. Simon,<br />

M. Barillot, P. Helwi, C. Durand, P. Babin, A. Tingaud, P.<br />

Thiebaud, N. Thézé, D. Lacombe, B. Arveiler.<br />

842F Genetic interaction between Sox10 and<br />

b1 integrins during enteric nervous system<br />

development. Y. Watanabe, F. Bondon-Broders,<br />

P. Paul-Gilloteaux, B. Prosper, V. Baral, S. Dufour,<br />

N. Bondurand.<br />

843F Mowat-Wilson syndrome associated ZEB2<br />

zinc-finger mutations lead to phenotype-correlated<br />

impairment <strong>of</strong> the transcription factor function.<br />

J. Ghoumid, L. Drévillon, SM. Alavi-Naini, M. Rio, A.<br />

Briand-Suleau, L. Goodwin, P. Raymond, N. Bondurand,<br />

C. Yanicostas, M. Goossens, S. Lyonnet, D. Mowat, N.<br />

Soussi-Yanicostas, J. Amiel, I. Giurgea.<br />

844F Methylation status <strong>of</strong> a vault RNA, VTRNA2-1<br />

(MIR886), is co-segregated with neural tube defects in<br />

Chinese Han families. W. Li, C. Cai.<br />

845F A high frequency <strong>of</strong> genomic disorders in<br />

patients with congenital kidney malformations. S.<br />

Sanna-Cherchi, K. Kiryluk, K. E. Burgess, M. Bodria, M.<br />

G. Sampson, D. Hadley, S. N. Nees, M. Verbitsky, V. J.<br />

Lozanovski, A. Materna-Kiryluk, B. J. Perry, N. Ristoska-<br />

Bojkovska, M. Zaniew, H. Flogelova, K. Drnasin, V. Goj,<br />

R. P. Lifton, L. N. Clark, M. Saraga, A. F. Dominiczak, L.<br />

Gesualdo, Z. Gucev, L. Allegri, A. Latos-Bielenska, D.<br />

Cusi, F. Scolari, V. Tasic, H. Hakonarson, G. M. Ghiggeri,<br />

A. G. Gharavi.<br />

846F Genome-wide screening and proteome analysis<br />

<strong>of</strong> developing mice diastema region. J. Y. Kim, W. J.<br />

Sohn, Y. M. Chae, Y. J. Jin, B. J. Han, Y. K. Lee, J. K. Jung,<br />

S. H. Kim, M. O. Kim, J. Y. Suh, S. Lee.<br />

847F Foxl2, as Sox9, is involved in skeletal<br />

development through its role in cartilage maturation<br />

and bone mineralization. L. Marcia, A. Puddu, M. Lovicu,<br />

R. Piras, D. Schlessinger, A. Forabosco, M. Uda, L.<br />

Crisponi, M. Marongiu.<br />

848F Expression and functional analysis <strong>of</strong> MMACHC<br />

during mammalian development. M. Moreno-Garcia, M.<br />

Pupavac, D. S. Rosenblatt, L. A. Jerome-Majewska.<br />

849F Three novel human VANGL1 gene mutations in<br />

144 Slovakian, Romanian and German patients with<br />

neural tube defects. O. Bartsch, I. Kirmes, A. Thiede, S.<br />

Lechno, H. Gocan, I. S. Florian, T. Haaf, U. Zechner, L.<br />

Sabova, F. Horn.<br />

850F Identification <strong>of</strong> a new ENU-induced mouse<br />

model for neural tube defects. S. Lachance, M. C.<br />

Guyot, M. Justice, Z. Kibar.<br />

851F Involvement <strong>of</strong> sperm microRNAs in unidentified<br />

male factor infertility. M. G. Katz-Jaffe, B. R. McCallie, J.<br />

Stevens, W. B. Schoolcraft.<br />

852F Comparison <strong>of</strong> the osteogenic potential <strong>of</strong> adult<br />

stem cells from different sources. R. Fanganiello, F.<br />

A. A. Ishiy, L. P. Capelo, M. Aguena, D. F. Bueno, B. V. P.<br />

Almada, M. T. Martins, M. R. Passos-Bueno.<br />

853F The NINDS repository’s publicly accessible<br />

collections <strong>of</strong> highly characterized induced pluripotent<br />

stem cells and primary fibroblasts. C. Tarn, K. Fecenko-<br />

Tacka, M. O’Rourke, K. Panckeri, C. Rhoda, S. Heil, K.<br />

Hodges, M. Sutherland, R. Corriveau, M. Self.<br />

854F Deciphering the Hmx1 pathway in the mouse<br />

retina. A. Boulling, D. F. Schorderet.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


Cytogenetics<br />

855W Evaluation <strong>of</strong> vitamin B12 effects on DNA<br />

damage induced by paclitaxel. O. Khabour, K. Alzoubi,<br />

M. Khader.<br />

856T Evaluation <strong>of</strong> vitamin B12 effects on DNA damage<br />

induced by pioglitazone. K. Alzoubi, O. Khabour, N.<br />

Hussain, S. Al-azzam, N. Mhaidat.<br />

857W Cytogenetic study <strong>of</strong> induced pluripotent<br />

stem cells derived from senescent cells <strong>of</strong> elderly<br />

persons. F. Pellestor, L. Lapasset, F. Becker, J.<br />

Puechberty, A. Schneider, S. Taviaux, P. Sarda, J. M.<br />

Lemaitre, G. Lefort.<br />

858T Secondary aneuploidy in samples <strong>of</strong> balanced<br />

chromosomal rearrangements: No increased rate<br />

detected. O. Reish, R. Amiran, A. Kanesky, S. Gerafi, M.<br />

Mashevich.<br />

859W Telomere “loss” in people with Down syndrome<br />

with and without mild cognitive impairment more than<br />

doubles after T-lymphocytes have been frozen in liquid<br />

nitrogen and short-term cultured with PHA. E. Jenkins,<br />

L. Ye, S. Krinsky-McHale, W. Zigman, N. Schupf, W.<br />

Silverman.<br />

860T Study <strong>of</strong> aging consequences in human<br />

mesenchymal stem cells during tandem passages. H.<br />

Pour-Jafari, B. Pourjafari, F. Talebzadeh, A.R. Zamani, M.<br />

Hosseinipanah, H. Fazli.<br />

861W Telomere structure and function in Cornelia<br />

de Lange syndrome preserved despite evidence<br />

for premature aging. A. D. Kline, H. Riethman, K.<br />

Ravichandran, M. Kaur, A. Kimball, I. D. Krantz.<br />

862T Identifying genes associated with hearing loss<br />

through chromosomal translocations. B. B. Currall,<br />

N. G. Robertson, A. M. Lindgren, M. E. Talkowski, C. C.<br />

Morton.<br />

863W An unbalanced whole-arm translocation<br />

der(1;13)(q10;q10) in Burkitt lymphoma. Y. Seok, S. J.<br />

Park, S. J. Kim, E. Y. Lee, J. R. Choi.<br />

864T Two sibs with trisomy 2q 34-qter. Y. Wang, X. He,<br />

Y. Zhou, C. Wang, X. Yang, L. Zhu, Y. Yang, H. Wu, X. Liu,<br />

D. Shrestha, C. Lee, E. Carter, J. Martinez.<br />

865W Subtelomere sequences on human acrocentric<br />

chromosome short arms. S. Baaj, A. Clarke, P.<br />

Thakkar, E. Chan, M. Khan, S. Chawla, J. Leya,<br />

J. Doering.<br />

866T Multiple chromosomal losses and gain including<br />

the deletion <strong>of</strong> 12p13 region defined by cytogenetic<br />

microarray in a case <strong>of</strong> simultaneous T-cell<br />

prolymphocytic leukemia and renal cell carcinoma. J.<br />

Kim, J. Moon, M. Nam, J. Kim, S. Yoon.<br />

867W A case <strong>of</strong> therapy-related acute myeloid<br />

leukemia with t(19;21)(q13.4;q22). M. Nam, J. Moon, J.<br />

Kim, J. Kim, S. Yoon.<br />

POSTER SESSIONS 145<br />

868T Detection <strong>of</strong> donor cells with a clonal<br />

abnormality 20 years after transplantation: Is this<br />

evidence <strong>of</strong> donor cell leukemia? G. Velagaleti, V.<br />

Ortega, D. Means.<br />

869W Xp22.31 duplications: Indistinctly benign or<br />

inconspicuously pathogenic? E. D. Esplin, B. Li, V. Cox,<br />

R. Clark, C. Curry, A. Slavotinek, L. Hudgins.<br />

870T Refining the critical region associated with<br />

Jacobsen syndrome through the identification <strong>of</strong> a<br />

small interstitial deletion at 11q23.4-q24.1 by CGH<br />

array. S. Raskin, H. Salomão, F. R. Faucz, A. Bonalumi, J.<br />

Souza, P. Grossfeld, J. Rosenfeld, V. S. Sotomaior.<br />

871W Triploid-diploid mixoploidy presenting with<br />

gastrointestinal complaints and growth failure. F. I.<br />

Bhamani, G. L. Elsner, M. B. Beg, R. R. Lebel.<br />

872T Trisomy 14 mosaicism in a girl: Clinical<br />

cytogenetic and molecular analysis. R. Cruz-Alcivar, E.<br />

Lieberman, C. Salas, M. P. Navarrete Meneses, C. Cantú,<br />

K. Buiting, C. Durán-McKinster, V. Del Castillo-Ruiz, P.<br />

Pérez-Vera, Alcivar.<br />

873W Low Klinefelter mosaicism in a male with<br />

azoospermia detected by FISH. P. A. Delgado, B.<br />

Crandall, N. Rao, P. Bui, C. A. Tirado.<br />

874T A balanced translocation t(2;16)(q35;q24.1)<br />

associated with limb defects and crani<strong>of</strong>acial<br />

dysmorphism through presumptive misregulation <strong>of</strong><br />

the IHH (Indian hedgehog) gene. A. C. S. Fonseca, S.<br />

Antonini, A. Bonaldi, P. A. Otto, A. M. Vianna-Morgante.<br />

875W Detection <strong>of</strong> parental origin and meiotic error<br />

type in abortions and born alive with aneuploidies. S.<br />

Frias, S. P. Mendoza-Constantino, S. Sánchez, L. Torres,<br />

B. Molina, P. Grether, D. G. Mayén, R. Meléndez, E.<br />

Yokoyama, C. Villarroel, E. Lieberman, V. del Castillo.<br />

876T Non-mosaic trisomy 9: A new case report. T.<br />

Greer, B. Powell, N. Hauser, J. Shen, L. Mahon, R. Owen,<br />

T. Sahoo, A. Anguiano, F. Boyar.<br />

877W A unique phenotype <strong>of</strong> 2q24.3-2q32.1<br />

duplication: Infantile-onset epilepsy without mesomelic<br />

dysplasia. B. Lim, J. Ko, J. Choi, M. Woo, J. Chae.<br />

878T Importance <strong>of</strong> chromosome breakage testing<br />

in Fanconi’s anemia: Involvement <strong>of</strong> specific<br />

chromosomes. V. Mohan, G. Archana, T. Preethi.<br />

879W Collaborative multicenter cytogenetic study <strong>of</strong><br />

microdeletion syndromes: Brazilian Network. M. Riegel,<br />

N. Barcellos, R. Mergener, R. Gus, R. Giugliani, Brazilian<br />

Network Members.<br />

880T Iidentification <strong>of</strong> chromosome aberration<br />

in fragile X syndrome patients in Tamil Nadu<br />

population South India using cytogenetic techniques.<br />

A. Sundramoorthy.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


146 POSTER SESSIONS<br />

881W A defect in the TUSC3 gene is associated<br />

with syndromic intellectual disability. A. Battaglia, L.<br />

Bernardini, S. Loddo, V. Doccini, V. Parisi, A. Novelli, T.<br />

Filippi.<br />

882T An apparently balanced translocation t(5;6)<br />

(q35.2;p22.3) disrupting the CDKAL1 gene in a girl with<br />

clinical features <strong>of</strong> Silver-Russell syndrome. A. Bonaldi,<br />

S. A. S. Fonseca, A. C. S. Fonseca, A. M. Vianna-<br />

Morgante.<br />

883W Report <strong>of</strong> the first case <strong>of</strong> robertsonian<br />

translocation in Down-Turner mosaicism (mos 45, X /<br />

46,XX, 1 21, rob (21;21)(q10;q10)) with clinical evolution.<br />

M. F. Carvalho, E. F. Carvalho, K. M. Carvalho.<br />

884T Copy number variation in imprinted regions:<br />

Narrowing critical imprinted intervals. B. C. Ballif, N. J.<br />

Neill, J. E. Fox, M. Descartes, F. Brewer, T. Stroud, J. B.<br />

Ravnan, L. G. Shaffer, J. A. Rosenfeld.<br />

885W Detection <strong>of</strong> partial tetrasomy 12pter-12p11.22<br />

region by array CGH and FISH in a newborn with<br />

multiple congenital abnormality. S. Ebrahim, D.<br />

Stockton, A. M. Jay, M. Hankerd, D. Schl<strong>of</strong>f, M. Krist<strong>of</strong>ice,<br />

A. N. Mohamed.<br />

886T Duplication Xq28 and deletion <strong>of</strong> SHOX in a family<br />

with short stature, intellectual and developmental<br />

disability. E. F. Andersen, E. E. Baldwin, S. Ellingwood, R.<br />

Smith, A. N. Lamb.<br />

887W Deafness and infertility syndrome: An underdiagnosed<br />

cause <strong>of</strong> hearing loss? U. Aypar, N.<br />

Hoppman-Chaney, D. Babovic-Vuksanovic.<br />

888T Identification <strong>of</strong> 90 first-reported abnormal<br />

chromosome karyotypes in population <strong>of</strong> Eastern<br />

China with G-band and/or C-band banding techniques.<br />

L. Li, S. Zheng, J. Zhang, W. Fan.<br />

889W Genotype-phenotype correlation in individuals<br />

with MEF2C mutations and/or 5q14.3-q15 deletion<br />

syndrome. E. Pallesi-Pocachard, J. Andrieux, A.-M.<br />

Bisgaard Pedersen, A. Carabalona, R. Steensbjerre Moller,<br />

P.-H. Kaad, E. Parrini, D. Heron, B. Keren, B. Benyahia,<br />

M. Walsh, N. Sobreira, D. Batista, V. Malan, A. Represa, T.<br />

Wang, R. Guerrini, M. Kirchh<strong>of</strong>f, C. Cardoso, M. Holder-<br />

Espinasse.<br />

890T Full-blown expression <strong>of</strong> paternally inherited<br />

Fabry disease in a young woman due to complete<br />

skewed X-inactivation <strong>of</strong> a der(X)t(X;Y)(p22.13;p11.2)<br />

mat.ishYp11.3(SRY1). F. Vialard, K. Benistan, C. Beldjord,<br />

S. Heide, D. Molina-Gomes, F. Jabbour, P. De Mazancourt,<br />

D. P. Germain.<br />

891W Whole-genome array-CGH screening in patients<br />

with autosomal dominant sensorineural hearing loss<br />

points to novel susceptibility loci. E. L. Freitas, D. T.<br />

Uehara, V. G. L. Dantas, A. G. Silva, A. C. Krepischi, R. C.<br />

Mingroni-Netto, C. Rosenberg.<br />

892T Comparison <strong>of</strong> HER2/neu gene amplification<br />

assessment by fluorescent in situ hybridization and<br />

immunohistochemistry in Iranian breast cancer<br />

patients. M. Moradi Chaleshtori, Z. Hojati, H. Teimori, S.<br />

H. Ramazi.<br />

893W Array CGH <strong>of</strong> normal karyotype plasma cell<br />

neoplasms reveals hidden recurrent and individual<br />

genomic copy number alternations. G. Tang, H. Zhang,<br />

C. Shaw, P. Hixson, W. Bi, C. Borgan, M. Coyle, D.<br />

Freppon, D. Vo, J. O’Hare, J. Gonzalez Berjon, C. Chang,<br />

S. Cheung, A. Patel.<br />

894T Interstitial duplication/triplication 20q13.2:<br />

Clinical, cytogenetical and genetical characterization.<br />

A. Briand-Suleau, J. Martinovic, L. Tosca, B. Tou, S.<br />

Brisset, J. Bouligand, V. Delattre, I. Giurgea, C. Goumy,<br />

C. Francannet, A. Guiochon-Mantel, A. Benachi, J.<br />

Vermeesch, G. Tachdjian, P. Vago, M. Goossens, C. Métay.<br />

895W Array-based copy-number analysis in patients<br />

associating obesity and developmental delay/learning<br />

disabilities and additional features. C. D’Angelo, I. Kohl,<br />

C. de Castro, C. Kim, D. R. Bertola, C. Lourenço, A.-B.<br />

Perez, C. Koiffmann.<br />

896T Complex genomic reorganization in<br />

microdeletions/microduplications syndromes and<br />

molecular mechanisms for formation. L. Kulikowski,<br />

F. Piazzon, E. Zanardo, R. Dutra, A. Dias, M. Oliveira,<br />

M. Moreira, G. Novo-Filho, M. Basso, C. Negretto, A.<br />

Zandoná, M. Melaragno, C. Kim.<br />

897W Gene mapping in the Finnish national collection<br />

<strong>of</strong> balanced translocations and inversions. T. M.<br />

Luukkonen, M. Pöyhönen, P. Ellonen, S. Lagström, J. H.<br />

Lee, K. O. J. Simola, K. Aittomäki, J. Ignatius, R. Salonen,<br />

A. Palotie, J. D. Terwilliger, T. Varilo.<br />

898T Combined exon array CGH plus SNP genome<br />

analyses for optimized clinical diagnostics. A. Patel, W.<br />

Bi, C. Shaw, S.-H. Kang, A. N. Pursley, S. Lalani, P. Hixson,<br />

T. Gambin, A. C-H. Tsai, H.-G. Bock, M. Descartes, F.<br />

Probst, F. Sacaglia, A. L. Beaudet, J. R. Lupski, C. Eng, S.<br />

W. Cheung, C. Bacino, J. Wiszniewska.<br />

899W Facing current diagnostic challenges in<br />

array copy number analysis. F. B. Piazzon, R. Dutra,<br />

E. Zanardo, A. Dias, M. Moreira, G. Novo-Filho, D.<br />

Christ<strong>of</strong>olini, V. Meloni, M. Oliveira, A. Zandoná-Teixeira,<br />

M. Basso, C. Negretto, C. Moreira-Filho, M. Melaragno, C.<br />

Kim, L. Kulikowski.<br />

900T Genetic analyses <strong>of</strong> Korean patients with<br />

unexplained mental retardation and developmental<br />

delay using the multiple ligation-dependent probe<br />

amplification. S. Shim, S. Sung, S. Park, K. Kang, M. Lee,<br />

S. Lyu, D. Cha, M. Kim.<br />

901W Complex nature <strong>of</strong> apparently balanced<br />

chromosomal rearrangements in patients with autism<br />

spectrum disorder. A. C. Tabet, A. Verloes, M. Pilorge, B.<br />

Benzacken, C. Betancur.<br />

902T The identification <strong>of</strong> submicroscopic gains and<br />

losses at the breakpoints <strong>of</strong> apparently balanced<br />

rearrangements. B. Torchia, J. A. Rosenfeld, L. G. Shaffer.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


903W Complex phenotype associated with 17q21.31<br />

microdeletion. A. Pic-Taylor, H. Dornelles-Wawruk, C.<br />

Rosenberg, A. C. Krepischi, H. P. N. Safatle, I. Ferrari, J.<br />

F. Mazzeu.<br />

904T Association <strong>of</strong> a deletion downstream <strong>of</strong> NKX2-1<br />

with benign hereditary chorea: Transfer <strong>of</strong> a benign<br />

CNV to likely pathogenic category. U. Surti, J. Liao, K.<br />

C<strong>of</strong>fman, J. Hu, M. Sathanoori, S. Yatsenko, S. Madan-<br />

Khetarpal, M. McGuire, A. Rajkovic.<br />

905W Chromosomal microarray analysis in 22q11.2<br />

deletion syndrome: New insight to LCR-mediated<br />

rearrangement. A. Tsai, D. Klepacka, M. Dodge.<br />

906T Array CGH as a first line diagnostic test in place<br />

<strong>of</strong> karyotyping for postnatal referrals: Results from<br />

four years clinical application for over 7,800 patients.<br />

J. W. Ahn, S. Bint, A. Bergbaum, K. Mann, R. P. Hall, C.<br />

Mackie Ogilvie.<br />

907W Identification <strong>of</strong> the critical region for 7q32q34<br />

deletion syndrome in a 1.5 Mb region at 7q32.3q33. T.-<br />

J. Chen, J. H<strong>of</strong>fman, K. Phelan, H. C. Andersson.<br />

908T Clinical implementation <strong>of</strong> whole-genome array<br />

CGH in Korean patients with pediatric neurologic<br />

diseases and multiple congenital anomalies. E. Shin, K.<br />

Lee, B. Eun.<br />

909W Chromosome and segmental imbalances<br />

detected by array CGH in samples <strong>of</strong> product <strong>of</strong><br />

conception: a pilot study. S. Xu, X. Wang, W. Xu, F.<br />

Gong, J. Lee, X. Lu, S. Li.<br />

910T Hemophilia A and trigonocephaly in a male with<br />

a complex chromosome rearrangement involving<br />

chromosomes X and 1. J. Liu, J. Chernos, R. Lamont, R.<br />

Perrier, B. Argiropoulos.<br />

911W Identification <strong>of</strong> cryptic genomic imbalance<br />

in congenital and development abnormalities: An<br />

institutional experience. F. J. Sheth, J. Andrieux, M.<br />

Desai, J. Sheth, T. Mampilly, G. Mampilly, C. Neeradha, J.<br />

Vijayalakshmy, K. Godbole, S. Desai.<br />

912T Lack <strong>of</strong> evidence for biparental inheritance <strong>of</strong><br />

copy number variation contributing to pathogenic<br />

features in a series <strong>of</strong> clinical microarray cases. C.<br />

E. Cottrell, S. Kulkarni, H. Al-Kateb, M. Evenson, S.<br />

Anderson, D. Lamb Thrush, S. Hashimoto, A. K. Bailes, L.<br />

Erdman, A. McKinney, C. Weber, J. Weslow-Schmidt, S.<br />

Ramsey, C. Astbury, S. Reshmi, J. M. Gastier-Foster, R.<br />

E. Pyatt.<br />

913W 7q33 Deletion in a family with intellectual<br />

disability, dysmorphic features and behavioral<br />

changes. A. Fortuna, F. Lopes, S. Sousa, J. Silva, C.<br />

Gomes, P. Maciel.<br />

914T Investigation <strong>of</strong> the parental origin and genomic<br />

mechanisms involved in de novo pathogenic CNVs in<br />

congenital disorders. S. Hayashi, M. Naganawa, D. T.<br />

Uehara, J. Inazawa.<br />

POSTER SESSIONS 147<br />

915W Our experience <strong>of</strong> clinical implementation<br />

<strong>of</strong> whole-genome array CGH as a first-line test in<br />

postnatal cases. V. Malan, J.-M. Lapierrre, M.-C. de<br />

Blois, C. Ozilou, S. Nusbaum, O. Raoul, M. Le Merrer,<br />

A. Harroche, R. Caumes, G. Baujat, F. Cartault, M. Rio,<br />

J. Amiel, S. Lyonnet, V. Cormier-Daire, A. Munnich, M.<br />

Vekemans, S. Romana.<br />

916T Copy number variation in hereditary colorectal<br />

cancer. A. L. Martin, B. A. Talseth-Palmer, D. M. Grice,<br />

G. N. Hannan, R. J. Scott.<br />

917W Using macrocephaly as a quantitative<br />

endophenotype in autism patients to enhance the<br />

identification <strong>of</strong> novel candidate genes. J. Reiner, D.<br />

Moreno-De-Luca, E. B. Kaminsky, D. H. Ledbetter, C. L.<br />

Martin.<br />

918T Study <strong>of</strong> genomic changes in children with<br />

intellectual and developmental disabilities using<br />

chromosomal microarray. P. Sharma, N. Gupta, M. R.<br />

Chowdhury, R. Shukla, M. Ghosh, M. Kabra.<br />

919W Association <strong>of</strong> rare copy number variations and<br />

risk for Alzheimer’s disease. D. Villela, D. Schlesinger, C.<br />

K. Suemoto, L. T. Grinberg, A. C. Krepischi, C. Rosenberg.<br />

920T Coronary artery disease genomics: CNV findings<br />

in the group <strong>of</strong> patients from Lithuania. V. Kucinskas, I.<br />

Pepalyte˙, A. Pranculis, l. Bagdonaite, V. Dzenkeviciute, Z.<br />

Kucinskiene.<br />

921W An unbalanced translocation causing a 21q11.2<br />

deletion in an infertile male. I. Holm, K. Eiklid, C. Hauge,<br />

V. Rønning, H. Wold.<br />

922T Single cell copy number pr<strong>of</strong>iling in a 24-hour<br />

workflow with oligo aCGH. P. Costa, S. Fulmer-Smentek,<br />

A. De Witte.<br />

923W Four new polymorphic CNVs in cohort <strong>of</strong><br />

100 Bulgarian patients with intellectual disability/<br />

congenital malformations and autism. S. P.<br />

Hadjidekova, D. M. Avdjieva-Tzavella, B. B. Rukova, D. V.<br />

Nesheva, R. S. Tincheva, D. I. Toncheva.<br />

924T First detection <strong>of</strong> clonal trisomy 4 cells from 3<br />

cases <strong>of</strong> ossifying renal tumor <strong>of</strong> infancy. J. Liu, M.<br />

Guzman, B. Pawel, D. Pezanowski, J. Roth, G. Halligan, J.<br />

de Chadarévian1.<br />

925W 17p13.3 Microduplication syndrome: Report<br />

<strong>of</strong> additional findings. L. Mutesa, E. Chabchoub, J.-<br />

H. Caberg, A.-C. Hellin, M. Jamar, H. Peeters, G. van<br />

Buggenhout, G. Pierquin, J. Andrieux.<br />

926T Chromosome aberrations among 4617<br />

chromosomal studies at a pediatric Mexican hospital<br />

in 19-year period <strong>of</strong> time. J. M. Aparicio, M. L. Hurtado,<br />

M. P. Barrientos, W. B. San Martin, A. F. Nuñez, R. G. Ruiz,<br />

H. T. Gomez, S. P. Rodriguez, R. M. Zamudio, F. L. Cuellar,<br />

M. A. Cubillo, F. P. Sierra, M. G. Palma, H. O. Chavez, S.<br />

M. Chatelain.<br />

927W Study <strong>of</strong> sodium pertechnetate on bone marrow<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


148 POSTER SESSIONS<br />

cells <strong>of</strong> mice, in vivo: Micronucleus assay. I. Aranha.<br />

928T Cryptic translocactions <strong>of</strong> acrocentrics<br />

chromosomes in normal couples and couples with<br />

aneuploid miscarriages. S. Ramos, O. Castro, B. Molina,<br />

M. Angeles, P. Grether, D. Mayen, S. Frias.<br />

929W A comparative cytogenetic resolution analysis<br />

between classic chromosome aberrations and<br />

cytokinesis-block micronucleus cytome assay.<br />

R. Saraswathy.<br />

930T In vitro assessment <strong>of</strong> genotoxicity and<br />

cytotoxicity <strong>of</strong> methyl mercury chloride. S. Tayel, M.<br />

Naim Bushra, A. Abd Ruboh, S. Hilal, A. El Agwany.<br />

931W The deletion 5q in myelodysplasia: Correlation<br />

<strong>of</strong> cytogenetic, peripheral blood and bone marrow<br />

findings. V. M. Srivastava, S. Yuvarani, U. Sitaram, A.<br />

Nancy, R. Ahmed, A. Abraham, A. Vishwabandya, B.<br />

George, V. Mathews, A. Srivastava.<br />

932T The quality <strong>of</strong> the bone marrow sample for<br />

successful conventional cytogenetic analysis is<br />

important. E. Tegg, E. Raik.<br />

933W Parental interstitial translocation underlie<br />

deletion in Langer-Giedion syndrome. B. Min, M. Seo, T.<br />

Cho, W. Park.<br />

934T Concurrent deletions and duplications at 1p36. M.<br />

Gajecka, J. Karolak, J. Shen, C. Glotzbach, L. G. Shaffer.<br />

935W Multiple structural abnormalities involving 4q33<br />

in a spontaneous abortion. M. B. Sheridan, C. Wigner, D.<br />

A. S. Batista, K. Turner, C. DeScipio.<br />

936T When transmission modifies the complexity <strong>of</strong><br />

familial chromosome rearrangements. V. Gatinois, G.<br />

Lefort, C. Coubes, J. Puechberty, A. Schneider, S. Taviaux,<br />

M. Tournaire, M. Di Nicola, M. Girard, P. Sarda, F. Pellestor.<br />

937W Evidence <strong>of</strong> a trisomy 9 rescue event in amniotic<br />

fluid. L. E. Northrop, M. J. Macera, V. Johbanputra, B.<br />

Levy.<br />

938T Large-scale sequence analysis <strong>of</strong> translocation<br />

breakpoint junctions. B. Weckselblatt, M. K. Rudd.<br />

939W Analysis <strong>of</strong> the nucleotide sequence diversity<br />

within the SUZ12 gene and its pseudogene SUZ12P<br />

as a means to investigate the signature <strong>of</strong> nonallelic<br />

homologous gene conversion. T. Mussotter, J. Vogt, K.<br />

Bengesser, J. Högel, D. N. Cooper, H. Kehrer-Sawatzki.<br />

940T An examination <strong>of</strong> the origin <strong>of</strong> the excess <strong>of</strong><br />

males liveborn with trisomy 21. C. Walker, S. Gandy,<br />

J. Jones, A. Harden, T. Naluai-Cecchini, E. Cheng, S.<br />

Sherman, T. Oliver.<br />

941W Down - Turner mosaicism. L. Martelli, C. G.<br />

Picanço, C. H. P. Grangeiro, C. S. Pereira, R. M. Scaparo,<br />

S. A. Santos, J. Huber, E. S. Ramos.<br />

942T Accurate, precise, and tunable cytogenetics with<br />

next-generation sequencing. M. A. Eberle, T. Royce, F.<br />

Kaper, J. Cottrell, J.-B. Fan.<br />

943W Two new cases <strong>of</strong> interstitial 6q deletion,<br />

associated to microcephaly, corpus callosum<br />

hypoplasia and further brain and cerebellar<br />

malformations. V. Parisi, S. Loddo, L. Travaglini, A.<br />

Ferraris, G. Vitiello, G. Zanni, L. Bernardini, M. L. Di<br />

Sabato, M. C. Digilio, A. Novelli, E. Del Giudice, A. Rossi,<br />

E. Bertini, B. Dallapiccola, E. M. Valente.<br />

944T Ring chromosome 13: An eventual risk for<br />

intellectual disability, surdity, congenital malformations<br />

and leukemia. I. Ben-Abdallah-Bouhjar, H. Hannachi, S.<br />

Mougou-Zerelli, H. Ben-Khelifa, A. Labalme, D. Sanlaville,<br />

H. Elghezal, A. Saad.<br />

945W Use <strong>of</strong> oligo-SNP array for the detection <strong>of</strong><br />

abnormalities in CLL. N. C. Christacos, M. L. Slovak, M.<br />

A. Sanidad, Y. Hsu, J. C. Kelly, P. N. Mowrey, D. M. Jones.<br />

946T Array-based comparative genomic hybridization<br />

identifies unique copy number alterations in diffuse<br />

large B-cell lymphoma subtypes: A review <strong>of</strong> published<br />

microarray data. R. Garcia.<br />

947W Subtype <strong>of</strong> ETV6/ABL1 fusion transcript is<br />

associated with different leukemia phenotype. A. Kwon,<br />

J. Park, J. Lim, Y. Kim, K. Han, S. Lee, H. Kim, W. Min, J.<br />

Kim, M. Kim.<br />

948T Detecting chromosomal inversions using chromatid<br />

painting strategies: Applications. F. A. Ray, E. Zimmerman,<br />

M. N. Cornforth, E. H. Goodwin, J. S. Bedford, S. M. Bailey.<br />

949W Efficacy and implementation <strong>of</strong> a SNP<br />

microarray for the evaluation <strong>of</strong> patients with multiple<br />

myeloma. S. Schwartz, R. D. Burnside, J. McElligott, I.<br />

Gadi, J. Kesler, V. Jaswaney, K. Phillips, J. Tepperberg, B.<br />

Williford, P. Papenhausen.<br />

950T A de novo intragenic deletion <strong>of</strong> AUST2 in a<br />

patient with autism spectrum disorder. S. Kantarci, I. E.<br />

Amarillo, J. David, E. Vilain, X. Li.<br />

951W 22 q 11.2 Syndrome in a group <strong>of</strong> patients who<br />

attended Operation Smile Foundation in Colombia,<br />

between 2005 and <strong>2012</strong>. I. Briceno, J. C. Martinez, A.<br />

Venegas, O. Moreno, M. Sarmiento, S. Bohorquez, M.<br />

Montiel, A. Patino.<br />

952T Incidence <strong>of</strong> mosaicism detected by exontargeted,<br />

high-resolution array comparative genomic<br />

hybridization in 10,362 consecutive cases with special<br />

emphasis on detection <strong>of</strong> complex unbalanced structural<br />

rearrangements. W. Bi, J. Pham, C. Shaw, P. Hixson, A.<br />

Ester, A. Pursley, K. Plunkett, P. L. Magoulas, S.-H. L. Kang, S.<br />

R. Lalani, C. Bacino, P. Stankiewicz, A. Patel, S. W. Cheung.<br />

953W A cryptic derivative chromosome 12 detected by<br />

oligo-SNP array. Z. Dai, N. C. Christacos, S. Schonberg,<br />

J. Kelly, E. Wallenhorst, K. Sullivan, C. Adams, Y. Hsu, H.<br />

Walker, T. Simanivanh, P. Mowrey.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


954T GLUT1 deficiency and chromosome microarray<br />

analysis. A. J. Dawson, A. Mhanni, F. Booth, D. Bernier, M.<br />

Tomiuk, J. Hartley, M. Strecker, K. Hovanes.<br />

955W Clinically relevant mosaic findings in a total <strong>of</strong><br />

9,605 patients and parents by using genome-wide<br />

high resolution SNP array analysis in constitutional<br />

diagnosis. N. de Leeuw, J. Y. Hehir-Kwa, B. H. W. Faas,<br />

T. K. Rinne, M. J. E. Kempers, S. A. de Munnik, N. F.<br />

A. Leijsten, G. C. Machielsen, S. L. J. van Gessel, M.<br />

Wunderink, M. J. G. Banning, R. van Beek, M. del Rosario,<br />

B. B. A. de Vries, D. F. C. M. Smeets, R. Pfundt.<br />

956T Genomic differences between spontaneously<br />

aborted fetuses and live-born children with 45,X<br />

monosomy. J. Domínguez Ortiz, L. Torres, S. Sanchez, V.<br />

del Castillo, L. Orosco, A. Carnevale, P. Grether, D. Mayen,<br />

S. Frias.<br />

957W Characterization <strong>of</strong> a rare 16.25 Mb duplication<br />

<strong>of</strong> Xp21.2p22.2. M. J. Macera, E. Bornstein, V. Aggarwal,<br />

L. Northrop, M. Shirazi, A. Sorbrino, B. Levy, D. Warburton,<br />

V. Jobanputra.<br />

958T Single nucleotide polymorphism-based<br />

microarray comparison for detection <strong>of</strong> constitutional<br />

copy number variation and absence <strong>of</strong> heterozygosity.<br />

H. Mei, S. A. Scott, H. M. Kearney, D. del Gaudio, J. D.<br />

Weisfeld-Adams, M. P. Wasserstein, S. Das, N. Cohen, L.<br />

Edelmann.<br />

959W Atypical copy number abnormalities in patients<br />

with suggestive phenotype <strong>of</strong> 22q11.2 deletion<br />

syndrome. M. C. Molck, T. P. Vieira, I. C. Sgardioli, M.<br />

Simioni, A. C. Xavier, J. Souza, V. L. Gil-da-Silva-Lopes.<br />

960T Mosaicism in live born and spontaneous<br />

abortions with trisomy 13, 18, 21 and monosomy X.<br />

S. Sánchez, P. Grether, D. G. Mayén, B. Molina, M. J.<br />

Zavaleta, J. Domínguez, R. Meléndez, S. Frias.<br />

961W Array-CGH analysis in patients with Goldenhar<br />

syndrome. P. A. C. Santos, E. L. Freitas, H. P. N. Safatle,<br />

C. Rosenberg, I. Ferrari, S. F. Oliveira, J. F. Mazzeu.<br />

962T Complex rearrangements involving five<br />

chromosomes and at least fourteen breaks. J. Wang, B.<br />

Huang, R. Habibian, A. Hajianpour.<br />

963W Trisomy Xp and partial tetrasomy Xq resulted<br />

from gain <strong>of</strong> a rearranged X chromosome in a female<br />

fetus: Pathogenic or not? M. Yiu, Z. Qi, A. Ki, K.<br />

Hashimoto, M. Ernster, J. Yu.<br />

964T A de novo 0.24-Mb microdeletion <strong>of</strong> 16q24.3<br />

encompassing ANKRD11 in a patient with KBG<br />

syndrome. H.-J. Cho, E.-J. Seo, J.-H. Lim, J.-O. Lee, H.-<br />

W. Yoo, C. K. Cheon.<br />

965W The evaluation <strong>of</strong> subtelomeric fluorescent<br />

in situ hybridization analysis <strong>of</strong> idiopathic mental<br />

retardation / multiple congenital anomaly cases. B.<br />

Durmaz, E. Karaca, A. Durmaz, T. Atik, H. Akin, O. Cogulu,<br />

F. Ozkinay.<br />

POSTER SESSIONS 149<br />

966T Mechanism-based analysis <strong>of</strong> human cell lines <strong>of</strong><br />

Prader-Willi syndrome. Z. Tang, D. Berlin, M. Wineburg,<br />

A. MacMillan, D. Altamuro, L. Toji, C. Beiswanger, S.<br />

Madore, N. Gerry.<br />

967W A child with Pitt-Hopkins syndrome and maternal<br />

somatic mosaicism at 18q21.2. K. Doudney, V. Bickley,<br />

M. Robertson, J. Watt, J. Taylor, A. Kidd, P. George.<br />

968T Microarray benefits diagnostic pregnancy loss<br />

studies. D. L. Pickering, B. J. Dave, D. M. Golden, A. A.<br />

Haggerty, D. L. Bishay, R. L. Smith, S. A. Fisher, W. G.<br />

Sanger.<br />

969W Method comparison study <strong>of</strong> the Illumina<br />

InfiniumDx CytoSNP-12 assay for the detection <strong>of</strong><br />

chromosomal abnormalities in DNA extracted from<br />

peripheral blood. M. Porter, R. Golshani, J. Fabian, M.<br />

Harris.<br />

970T A CML case with normal karyotype and positive<br />

BCR/ABL1 fusion. C. A. Tirado, J. W. Boles, J. Ochoa,<br />

R. Collins.<br />

971W Computational methods for detecting wholegenome<br />

triploid samples with Agilent CGH1SNP<br />

arrays. A. Vadapalli, B. J. Peter, A. Ashutosh, J. Ghosh,<br />

B. Curry, A. Rajkovic, U. Surti, S. A. Yatsenko.<br />

972T Genome-wide resolution study <strong>of</strong> CNV<br />

detection by the CytoScan® HD Cytogenetics<br />

Array through a large-scale experiment. Y. S. Wang,<br />

A. H. Roter.<br />

973W A new case <strong>of</strong> inverted duplication with<br />

terminal deletion <strong>of</strong> chromosome 12p characterized<br />

by FISH and SNP array analysis. E. Pipiras,<br />

B. Jeandidier, S. Chantot-Bastaraud, B. Benzacken,<br />

A. Delahaye.<br />

974T GISH analysis <strong>of</strong> genome discrimination in two<br />

interspecific hybrid <strong>of</strong> sweet potato. Z. Li.<br />

975W Latest innovations in oligo FISH enable high<br />

resolution detection <strong>of</strong> chromosomal aberrations.<br />

M. Ruvolo, V. Kulkarni, B. Mullinax, A. Bergstrom Lucas,<br />

P. Tsang, N. Faravashi, A. De Witte, M. Srinivasan,<br />

E. LeProust, S. Fulmer-Smentek.<br />

976T Deletion 2q24.1q24.2 in a boy with<br />

generalized hypotonia and developmental delay:<br />

Further delineation. V. del Castillo, E. Yokoyama,<br />

C. Villarroel, J. L. Castrillo, S. Avila, S. Sánchez, B. Molina,<br />

S. Frías.<br />

977W SNP arrays provide incremental, clinically<br />

significant information for patients undergoing<br />

chromosome microarray testing. V. Aggarwal,<br />

O. Nahum, B. Marmol, K. Anayane-Yeboa, B. Levy.<br />

978T Non-mosaic duplication <strong>of</strong> chromosome<br />

6p in a child, inherited from his mother<br />

with a mosaic unbalanced der(14)t(6;14)<br />

(6pter➞6p22.3::14p13➞14qter). S. M. Bain, J. K.<br />

Nicholl, W. Waters, A. H. Attwood, J. Samuel, T. A.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


150 POSTER SESSIONS<br />

Hocking, S. G. Brown, E. A. Haan, S. Yu.<br />

979W Diagnostic array analysis and the necessity<br />

<strong>of</strong> high quality SNP information. R. Pfundt, J. Hehir-<br />

Kwa, N. Leijsten, S. van Gessel, M. Wunderink,<br />

T. Machielsen, R. van Beek, M. Banning, M. Rosario,<br />

N. de Leeuw.<br />

980T Copy-number variation and UPD(16) mosaicism<br />

in a patient with apple peel intestinal atresia, ocular<br />

anomalies, microcephaly and bone-marrow failure.<br />

F. A. T. de Vries, Y. van Bever, I. M. Appel, H. Kart, L. J. C.<br />

M. van Zutven, H. B. Beverloo.<br />

Cancer <strong>Genetics</strong><br />

981W Tumor suppression in Apc Min/1 mice by the<br />

prostaglandin D 2 receptor PTGDR. H. Lin, A. Kwong, O.<br />

Lee, V. Buslon, S. French, E. Salido.<br />

982T Effects <strong>of</strong> Western-style diet and genetic<br />

predisposition on the protein expression and cancer<br />

susceptibility in normal colonic mucosa. S. Lowndes,<br />

D. Dermadi Bebek, M. Pussila, N. Reyhani, L. Sarantaus,<br />

M. Nyström.<br />

983F The Jackson Laboratory Rare and Orphan<br />

Disease Center. S. Rockwood, C. Lutz, K. Fancher, A.<br />

Picard, M. Sasner, L. Reinholdt, S. Murray, D. Bergstrom,<br />

J. Morgan, L. Donahue, GRS Team.<br />

984W Genetic differences in transcript responses to<br />

low-dose ionizing radiation identify tissue functions<br />

associated with breast cancer susceptibility. A. J.<br />

Wyrobek, F. Marchetti, S. Bhatnagar, N. Duru, J. Han, Z.<br />

Hu, J.-H. Mao, J. W. Gray, A. M. Snijders.<br />

985T Association <strong>of</strong> the HLA-G gene polymorphisms<br />

with cervical cancer risk. T. Chang, Y. Yang, Y. Lee, T.<br />

Chen, S. Chang, W. Lin.<br />

986F Association <strong>of</strong> the HOXB13 G84E variant with<br />

familial, sporadic, and aggressive prostate cancer: The<br />

Mayo Clinic experience. M. S. DeRycke, L. S. Tillmans,<br />

S. K. McDonnell, S. M. Riska, J. Xu, Y. W. Asmann, D. J.<br />

Schaid, S. N. Thibodeau, International Consortium for<br />

Prostate Cancer <strong>Genetics</strong>.<br />

987W The miR-29 family <strong>of</strong> microRNA genes and let-7i<br />

associate with gastric cancer in European populations:<br />

Results from the EPIC-EURGAST study. Y. Espinosa-<br />

Parrilla, X. Muñoz, C. Bonet, N. García, A. Venceslá, E.<br />

Riboli, C. A. González, N. Sala on behalf <strong>of</strong> EPIC Gastric<br />

Cancer Working Group.<br />

988T 3’UTR variation in PTEN and PTENP1 :<br />

Implications for microRNA binding. B. G. Hernandez, C.<br />

LaViolette, T. Begay, J. A. Wilder.<br />

989F Replacement therapy for lung adenocarcinoma<br />

risk in never-smoking women. C. Hsiao, K. Chen, G.<br />

Chang, Y. Tsai, W. Su, Y. Chen, M. Huang, C. Hsiung, C.<br />

Chen, P. Yang, GELAC Study Group.<br />

990W Application <strong>of</strong> molecular diagnostic techniques<br />

on the study done on phosphatase and tensin<br />

homologue deleted on chromosome 10 (PTEN). R. Issa.<br />

991T Validation, fine-mapping, and characterization<br />

<strong>of</strong> six genes related to testicular germ cell tumor in a<br />

large Swedish-Norwegian case-parent, case-control<br />

sample. R. Karlsson, W. Kristiansen, K. E. Andreassen,<br />

E. L. Aschim, R. M. Bremnes, O. Dahl, S. D. Fosså, O.<br />

Klepp, C. W. Langberg, A. Solberg, S. Tretli, P. K. E.<br />

Magnusson, H.-O. Adami, T. B. Haugen, T. Grotmol, F.<br />

Wiklund.<br />

992F Genome-wide germline DNA autosomal copy<br />

number variation analysis in Finnish BRCA1/2-founder<br />

mutation-negative hereditary breast and/or ovarian<br />

cancer individuals. K. M. Kuusisto, O. Akinrinade, M.<br />

Vihinen, S.-L. Sallinen, J. Schleutker.<br />

993W Mediator complex subunit 12 (MED12) mutations<br />

in uterine leiomyosarcomas. M. M. McGuire, M. Jones,<br />

G. Trucco, U. Surti, R. P. Edwards, A. Rajkovic.<br />

994T Association <strong>of</strong> breast cancer risk factors and HLA-G<br />

gene indel 14bp polimorphyms in a Brazilian population.<br />

Y. C. N. Muniz, M. Damiani, L. D. Hausmann, B. S. Almeida,<br />

B. Fernandes, R. T. Simıes, A. R. Marrero, I. R. Souza.<br />

995F Fine-mapping <strong>of</strong> prostate cancer susceptibility<br />

locus 11q13.5. R. Nurminen, R. Lehtonen, T. L. Tammela,<br />

T. Wahlfors, J. Schleutker.<br />

996W Role <strong>of</strong> copy number variants in the nucleotide<br />

excision repair pathway genes and breast cancer risk in<br />

Puerto Rican women. A. Pacheco Torres, J. Matta, J. Dutil.<br />

997T Screening <strong>of</strong> Finnish RAD51C founder mutations<br />

in prostate and colorectal cancer patients. L. M.<br />

Pelttari, R. Nurminen, A. Gylfe, L. Aaltonen, J. Schleutker,<br />

H. Nevanlinna.<br />

998F Exome sequencing in a familial testicular germ<br />

cell tumor kindred. K. A. Schrader, S. Shah, V. Joseph, R.<br />

Murali, R. Rau-Murthy, K. Sarrel, I. Dolgalev, S. Cheguri,<br />

C. Manschreck, N. Socci, A. Viale, A. Heguy, G. Bosl, D.<br />

Feldman, M. Robson, Z. Stadler, K. Offit.<br />

999W SLX4 mutation in hereditary breast cancer.<br />

S. Shah, Y. Kim, I. Ostrovnaya, F. Lach, R. Murali, K.<br />

Schrader, V. Joseph, K. Sarrel, R. Rau-Murthy, N. Hansen,<br />

S. Cheguri, J. Littman, L. Zhang, K. Offit, A. Smogorzewska.<br />

1000T Contribution <strong>of</strong> ARLTS1 to prostate cancer<br />

susceptibility. S. Siltanen, H. Rauhala, T. L. Tammela, P.<br />

Kujala, T. Visakorpi, T. Wahlfors, J. Schleutker.<br />

1001F Meta-analysis <strong>of</strong> 25 prostate cancer associated<br />

SNPs in high-risk prostate cancer families: New<br />

evidence from the International Consortium for<br />

Prostate Cancer <strong>Genetics</strong>. C. Teerlink, S. Thibodeau, D.<br />

Schaid, K. Cooney, E. Lange, C. Maier, J. Stanford, E. A.<br />

Ostrander, J. Schleutker, G. Cancel-Tassin, O. Cussenot,<br />

R. Eeles, D. Easton, W. Isaacs, J. Xu, J. Carpten, J. E.<br />

Bailey-Wilson, F. Wiklund, A. Whittemore, W. Catalona,<br />

W. Foulkes, N. Camp, L. Cannon-Albright, International<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


Consortium for Prostate Cancer <strong>Genetics</strong>.<br />

1002W CDH1 mutations in patients with lobular<br />

carcinoma <strong>of</strong> the breast. A. L. Valente, S. Rummel, C. D.<br />

Shriver, R. E. Ellsworth.<br />

1003T Fine-mapping <strong>of</strong> breast cancer genome-wide<br />

association studies loci in women <strong>of</strong> African ancestry.<br />

Y. Zheng, T. O. Ogundiran, K. L. Nathanson, E. M. John,<br />

A. Hennis, S. Ambs, C. Adebamowo, S. M. Domchek, T.<br />

R. Rebbeck, M. S. Simon, B. Nemesure, S. Y. Wu, M. C.<br />

Leske, Q. Niu, J. Zhang, E. R. Gamazon, N. J. Cox, O. I.<br />

Olopade, D. Huo.<br />

1004F L1 encoded ORF1p facilitates tumorigenesis and<br />

suppresses nucleus accumulation <strong>of</strong> Smad-4 in HepG2<br />

cells. Y. Zhu, F. Feng, X. Gao, J. Yu, M. Hu, F. Zhang, Y.<br />

Wang, Q. Zhang, Y. Guo.<br />

1005W Copy number variation analysis in 222 mutation<br />

negative polyposis patients reveals potential new<br />

candidate genes. S. Aretz, S. Horpaopan, S. Vogt,<br />

I. Spier, A. M. Zink, S. Herms, A. Laner, K. Wöllner, S.<br />

Pasternack, M. Draaken, D. Stienen, S. Uhlhaas, E.<br />

Holinski-Feder, M. M. Nöthen, P. H<strong>of</strong>fmann.<br />

1006T Evaluation <strong>of</strong> the RHINO gene for breast cancer<br />

predisposition in Finnish breast cancer families.<br />

T. Heikkinen, E. Huovari, S. Vilske, C. Blomqvist, J.<br />

Schleutker, A. Kallioniemi, K. Aittomäki, H. Nevanlinna.<br />

1007F A gene-based association approach prioritizes<br />

candidate susceptible genes for chronic myeloid<br />

leukemia. J.-H. Park, H.-H. Won, J.-W. Kim, D. H. Kim,<br />

S.-T. Lee, S. Kim, S.-H. Kim, C. W. Jung.<br />

1008W Proteomic analysis <strong>of</strong> gastric cancer from<br />

individuals <strong>of</strong> Northern Brazil. M. F. Leal, J. Chung, D. Q.<br />

Calcagno, P. P. Assumpção, S. Demachki, I. D. C. G. Silva,<br />

R. Chammas, R. R. Burbano, M. A. C. Smith.<br />

1009T Fine-mapping <strong>of</strong> IL-16 gene and prostate cancer<br />

risk in African <strong>American</strong>s. K. Batai, E. Shah, M. Ruden,<br />

J. Newsome, A. B. Murphy, C. Ahaghotu, R. A. Kittles.<br />

1010F Fas signaling pathway-based analysis <strong>of</strong><br />

genome-wide data and risk <strong>of</strong> gastric cancer. P. L.<br />

Hyland, S.-W. Lin, N. Hu, Z.-Z. Tang, L. Wang, C. Wang, H.<br />

Su, T. Ding, J.-H. Fan, Y.-L. Qiao, X. Xiong, W. Wheeler, C.<br />

Griffen, K. Yu, Z. Wang, L. Burdett, S. J. Chanock, S. M.<br />

Dawsey, M. A. Tucker, N. D. Freedman, A. M. Goldstein, C.<br />

C. Abnet, P. R. Taylor.<br />

1011W Fine-mapping identifies multiple prostate<br />

cancer risk loci at 5p15, one <strong>of</strong> which associates<br />

with TERT expression. Z. Kote-Jarai, E. Saunders,<br />

D. Leongamornlert, M. Tymrakiewicz, T. Dadaev, S.<br />

Jugurnauth-Little, H. Ross-Adams, A. Al-Olama, S.<br />

Benlloch, S. Halim, R. Russel, A. Dunning, D. Neal, F.<br />

Hamdy, J. Donovan, D. Easton, R. Eeles, UK <strong>Genetics</strong><br />

Prostate Cancer Study Collaborators, PRACTICAL<br />

Consortium.<br />

1012T Fine mapping <strong>of</strong> 12q24 shows a promising<br />

association locus for renal cell carcinoma. J. R. Toro,<br />

POSTER SESSIONS 151<br />

S. Han, M. Yeager, L. Moore, M. Purdue, M. Johansson,<br />

G. Scelo, V. Gaborieau, C. Berg, R. Grubb, V. Stevens, M.<br />

Thun, W. Diver, D. Albanes, S. Weinstein, J. Virtamo, L.<br />

Burdett, A. Brisuda, J. McKay, J. Fraumeni, N. Chartterjee,<br />

P. Rosenberg, N. Rothman, P. Brennan, W. H. Chow, M.<br />

Tucker, S. Chanock.<br />

1013F Array CGH analyses in a patient with multifocal<br />

recurrent meningioma. Z. Yilmaz Celik, Y. K. Terzi, N.<br />

Altinors, F. I. Sahin.<br />

1014W Haplotype-resolved sequencing and structural<br />

analysis <strong>of</strong> the HeLa cancer genome. A. C. Adey, J. O.<br />

Kitzman, J. Burton, J. Shendure.<br />

1015T Role <strong>of</strong> somatic mutations in the<br />

etiopathogenesis <strong>of</strong> Maffucci syndrome. M. Amyere,<br />

M. Limaye, N. Mulliken, J. B. Dompmartin, A. Enjorlas, O.<br />

Kaitila, I. Docquier, P.-L. Godfraind, L. M. Boon, M. Vikkula.<br />

1016F Association <strong>of</strong> polymorphisms in NNK<br />

metabolizing genes and lung cancer risk. J. L. Engle,<br />

A. K. Hull, G. Liu, A. S. Berg, C. J. Gallagher, P. Lazarus, J.<br />

E. Muscat.<br />

1017W Myeloproliferative neoplasms and somatic<br />

mosaicism in the 23andMe participant community. D.<br />

A. Hinds, K. E. Barnholt, J. L. Zehnder, A. K. Kiefer, C. B.<br />

Do, N. Eriksson, J. L. Mountain, U. Francke, J. Y. Tung, R.<br />

L. Levine, R. A. Mesa, J. R. Gotlib.<br />

1018T Acute myeloid leukemia associated with<br />

chromosome 6: Clinical and phenotypical implications<br />

in two pediatric patients with chromosome trisomy and<br />

translocation. L. Hurtado-Hernandez, J. M. Aparicio, F. L.<br />

Cuellar, M. A. L. Cubillo, M. A. H. Garrido, S. M. Chatelain.<br />

1019F Correlating genetic alterations from array<br />

comparative genome hybridization and nextgeneration<br />

sequencing with histology and clinical<br />

outcome in melanocytic neoplasms. Y. Liu, Y. Zhou, E.<br />

George.<br />

1020W Molecular pr<strong>of</strong>iling <strong>of</strong> the therapy-resistant<br />

clones in the recurrent embryonal carcinomas <strong>of</strong><br />

the testes based upon FISH and NGS <strong>of</strong> the isolated<br />

chromosomes. R. Malecki, M. Malecki.<br />

1021T Detection <strong>of</strong> large rearrangements in BRCA1<br />

and BRCA2 by microarray-CGH. D. Mancini-DiNardo,<br />

T. Judkins, N. Woolstenhulme, C. Burton, S. Chen, J.<br />

Schoenberger, M. Ryder, A. Murray, M. Balzotti, N. Gutin,<br />

J. Holladay, J. Craft, C. Colvin, J. Trost, L. A. Burbidge, C.<br />

Arnell, E. Rosenthal, B. Roa.<br />

1022F Effect <strong>of</strong> insecticide exposure in the generation<br />

<strong>of</strong> alterations in MLL, a gene associated with acute<br />

lymphoblastic leukemia. M. P. Navarrete Meneses,<br />

M. Betancourt, E. Bonilla, M. Altamirano, A. Reyes,<br />

P. Pérez-Vera.<br />

1023W Genomic analyses <strong>of</strong> paired diagnostic/relapse<br />

childhood acute lymphoblastic leukemias identify<br />

relapse-associated genetic features <strong>of</strong> pathogenetic and<br />

clinical importance. L. Olsson, A. Castor, M. Behrendtz, A.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


152 POSTER SESSIONS<br />

Biloglav, E. Forestier, K. Paulsson, B. Johansson.<br />

1024T Loss <strong>of</strong> chromosomes is the primary event in<br />

near-haploid and low hypodiploid acute lymphoblastic<br />

leukemia. S. Safavi, E. Forestier, I. Golovleva, G. Barbany,<br />

K. H. Nord, A. V. Moorman, C. J. Harrison, B. Johansson,<br />

K. Paulsson.<br />

1025F Detection <strong>of</strong> the t(8;14) chromosomal<br />

rearrangements in paraffin embedded tissue sections<br />

<strong>of</strong> Burkitt lymphoma patients with quantitative<br />

polymerase chain reaction and fluorescence in situ<br />

hybridization methods. N. Selvi, M. Hekimgil, B. Tezcanli<br />

Kaymaz, S. Aktas, N. Ozhan, C. Gunduz, B. Kosova, Y.<br />

Dodurga, N. Topcuoglu.<br />

1026W Molecular changes in Lynch syndrome<br />

associated and sporadic ovarian carcinomas. A.<br />

Tieva, S. Kaur, L. Renkonen-Sinisalo, H. J. Järvinen, J.-P.<br />

Mecklin, R. Bützow, P. Peltomäki.<br />

1027T A comprehensive genetic and epigenetic<br />

study <strong>of</strong> hepatocellular carcinoma with microarrays.<br />

G. Zhang, C. Wu, D. Yu, J. Chang, W. Sun, M. Li, L. Liang,<br />

Y. Li, D. Lin.<br />

1028F Congenital leukemia with insertion <strong>of</strong> MLL into<br />

19p13.3 and a deletion <strong>of</strong> half a megabase <strong>of</strong> 19p13.3:<br />

Case report. H. Al-Kateb, M. Evenson, S. Kulkarni.<br />

1029W Cytogenetic pr<strong>of</strong>iles <strong>of</strong> 370 cases with renal cell<br />

carcinoma: UCLA experience. P. H. Bui, P. N. Rao.<br />

1030T Identifying <strong>of</strong> cryptic genomic alterations by<br />

high-resolution microarrays in LLA-B and LLA-T<br />

Mexican patients. C. Córdova-Fletes, B. Macias-García,<br />

A. Lugo-Trampe, N. Mendez-Ramírez, R. De la Rosa-<br />

Alvarado, H. Gutiérrez-Aguirre, D. Gómez-Almaguer, A.<br />

Hidalgo, R. Salazar-Riojas, P. Ruíz-Flores, P. Villarreal-<br />

Quiroga, O. González-Llano, A. Rojas-Martínez, H.<br />

Decanini-Arcaute, R. Ortiz-López.<br />

1031F An unusual case <strong>of</strong> APL in a 14-year-old girl with<br />

t(15;17)(q22;q21) and t(9;22)(q34;q11.2). V. Jobanputra,<br />

C. Freeman, S. Hussein, M. J. Macera, B. Levy, V. V. Murty,<br />

M. L. Sulis, G. Bhagat.<br />

1032W Integration <strong>of</strong> cytogenetics and FISH studies<br />

for accurate evaluation <strong>of</strong> chromosome abnormalities.<br />

N. Qin, M. Hibbard.<br />

1033T Evaluation <strong>of</strong> FGFR1 gene amplification status<br />

and its association with clinicopathological features in<br />

breast cancer. R. M. Rodrigues-Peres, J. K. Heinrich, L.<br />

O. Z. Sarian.<br />

1034F Large scale identification <strong>of</strong> chromosomal<br />

abnormalities in familial breast and ovarian cancer. H.<br />

W. H. Yin, L. L. Wang, E. Tsui, Y. Elshimali, D. C. Chen.<br />

1035W Homozygous deletions <strong>of</strong> CDKN2A are present<br />

in all dic(9;20)(p13.2;q11.2)-positive BCP ALLs and<br />

may be important for leukemic transformation.<br />

V. Zachariadis, J. Schoumans, G. Barbany, M. Heyman, E.<br />

Forestier, B. Johansson, M. Nordenskjöld, A. Nordgren.<br />

1036T C-MYC and IGH amplification in patients with<br />

intermediate high grade B-cell lymphomas. A. Zaslav,<br />

M. Bellone, F. Lan, T. Mercado, H. Lee, Y. Hu.<br />

1037F Two deletions in the APC gene (an inherited<br />

deletion in exon 1 and a de novo deletion in exon<br />

12) and a de novo MUTYH deletion causing familial<br />

adenomatous polyposis. G. A. Molfetta, O. C. Vincenzi,<br />

J. Huber, A. A. Marques, W. A. Silva, Jr.<br />

1038W Mutation screening in adenomatous polyposis<br />

coli gene in patients clinically diagnosed as familial<br />

adenomatous polyposis. O. C. Vincenzi, G. A. Molfetta,<br />

J. Huber, C. Ayres, W. A. Silva, Jr.<br />

1039T High-precision CNV analysis <strong>of</strong> FFPE samples<br />

with the nCounter Analysis System. G. Geiss.<br />

1040F Germline copy number variation in high-risk<br />

African <strong>American</strong> families with prostate cancer. E.<br />

Ledet, X. Hu, O. Sartor, W. Rayford, M. Li, D. Mandal.<br />

1041W hapLOH: Powerful haplotype-based pr<strong>of</strong>iling <strong>of</strong><br />

allelic imbalance in impure tumor samples. P. Scheet,<br />

R. Xia, S. Vattathil.<br />

1042T Protein tyrosine phosphatase receptor type J is<br />

implicated in lymphomagenesis <strong>of</strong> follicular and diffuse<br />

large B-cell lymphomas. C. A. Aya-Bonilla, M. R. Green,<br />

E. Camilleri, M. Benton, C. Keane, P. Marlton, R. Lea, M. K.<br />

Gandhi, L. R. Griffiths.<br />

1043F Computational techniques to detect BFB in<br />

tumor genomes. S. Zakov, M. Kinsella, V. Bafna.<br />

1044W Evaluation <strong>of</strong> cytogenetic and gene<br />

polymorphic variants in workers occupationally<br />

exposed to silica-stone quarry industry. R.<br />

Chandirasekar, K. Sasikala, B. Lakshman Kumar, R.<br />

Raichel Jacob, H. Kavitha.<br />

1045T Differential expression <strong>of</strong> AURKA and AURKB<br />

genes in bone marrow stromal mesenchymal cells <strong>of</strong><br />

myelodisplastic syndrome: Correlation with G-banding<br />

analysis and FISH. F. M. Oliveira, A. R. Lucena-Araujo,<br />

M. C. Favarin, E. M. Rego, R. P. Falcão, B. P. Simıes, D. T.<br />

Covas, A. M. Fontes.<br />

1046F A new function for the VHL tumor suppressor<br />

protein: Prevention <strong>of</strong> genome instability through<br />

promotion <strong>of</strong> homologous recombinational DNA repair.<br />

M. S. Meyn, J. L. Metcalf, P. S. Bradshaw, M. Komosa, S.<br />

N. Greer, W. Y. Kim, M. Ohh.<br />

1047W A new role for the ATM protein: Homologous<br />

recombination repair <strong>of</strong> DNA damage. P. Bradshaw, M.<br />

Komosa, M. S. Meyn.<br />

1048T A crosstalk between ATM and FA/BRCA proteins<br />

is necessary to preserve DNA integrity during G2/M<br />

phase. L. C. Torres Maldonado, D. Sosa, M. Castañon, A.<br />

Rodriguez, B. Molina, C. Lopez Camarillo, S. Frias.<br />

1049F A dynamic model <strong>of</strong> the FA/BRCA DNA repair<br />

pathway. A. Rodriguez, L. Torres, D. Sosa, E. Cortes, A.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


M. Salazar, R. Ortoz, P. Ostrosky, L. Mendoza, S. Frias.<br />

1050W Fanconi anemia pathway proteins act<br />

together and independently to regulate homologous<br />

recombination and synthesis <strong>of</strong> telomeric DNA in<br />

ALT-immortalized human cells. H. Root, M. Komosa, A.<br />

Larsen, D. Bazett-Jones, M. S. Meyn.<br />

1051T Transcriptome sequencing <strong>of</strong> tumor<br />

subpopulations reveals a spectrum <strong>of</strong> therapeutic<br />

options in squamous cell lung cancer. C. L. Barrett,<br />

R. B. Schwab, H. Jung, B. Crain, D. J. G<strong>of</strong>f, C. H. M.<br />

Jamieson, P. A. Thistlethwaite, O. Harismendy, D. A.<br />

Carson, K. A. Frazer.<br />

1052F A novel bi-allelic MSH2 mutation associated<br />

with constitutional mismatch repair deficiency<br />

syndrome, and review <strong>of</strong> the clinical phenotype. P.-Y. B.<br />

Au, R. Perrier, E. G. Puffenberger, S. Hume, R. Anderson,<br />

L. Lafay-Cousin, D. Strother, B. McInnes, J. Parboosingh,<br />

F. Bernier.<br />

1053W Clinical and histopathologic characteristics<br />

between familial and sporadic melanoma in Barcelona,<br />

Spain. C. Badenas, P. Aguilera, C. Carrera, J. Malvehy, J.<br />

A. Puig-Butille, E. Martinez-Barrios, J. Palou, S. Puig.<br />

1054T A survey <strong>of</strong> stromal responses and their clinical<br />

associations defined by the fibromatosis signature in<br />

different types <strong>of</strong> carcinomas. J. L. Chen, I. Espinosa, A.<br />

Y. Lin, O. Y. Liao, M. van de Rijn, R. B. West.<br />

1055F Anticipation in hereditary paraganglioma and<br />

pheochromocytoma syndromes. H. Druker, D. Malkin,<br />

S. Meyn.<br />

1056W Evaluation <strong>of</strong> mtDNA D-loop polymorphisms<br />

in Iranian breast cancer patients. M. Ghaffarpour, S.<br />

Eslamizadeh, M. Arabzadeh, B. Motahari, N. Moazami, M.<br />

Houshmand.<br />

1057T Does high HERV-K expression participate<br />

in acute leukemia pathogenesis in children?<br />

D. Januszkiewicz-Lewandowska, K. Nowicka, J.<br />

Rembowska, J. Nowak.<br />

1058F SMAD4 loss-<strong>of</strong>-function mutations cause<br />

wide range <strong>of</strong> clinical disorders with unpredictable<br />

age-related penetrance. N. M. Lindor, K. E. Wain, M. S.<br />

Ellingson, J. McDonald, A. D. Gammon, M. E. Roberts, D.<br />

L. Riegert-Johnson.<br />

1059W Automatic endometrial tumor screening for<br />

Lynch syndrome. M. Myers, P. Conrad, J. Rabban, J.<br />

Terdiman, K. Loranger, A. Blanco, L. Chen.<br />

1060T Detection <strong>of</strong> EGFR mutations by TaqMan®<br />

Mutation Detection Assays powered by Competitive<br />

Allele-Specific TaqMan® PCR Technology (castPCR).<br />

N. Normanno, C. Roma, R. Pasquale, A. M. Rachiglio,<br />

C. Esposito, F. Fenizia, M. L. La Porta, A. Iannaccone, F.<br />

Bergantino, S. Costantini, A. Rico, R. Petraroli.<br />

1061F Germline mutations and microsatellite instability<br />

status in a population-based study <strong>of</strong> women with<br />

POSTER SESSIONS 153<br />

ovarian cancer. T. Pal, A. Mohammad, P. Sun, J. Lee, J.<br />

Fulp, Z. Thompson, A. Doty, D. Coppola, S. Nicosia, T.<br />

Sellers, J. McLaughlin, H. Risch, B. Rosen, J. Schildkraut,<br />

S. Narod.<br />

1062W BRCA2 mutations might be detected at a high<br />

rate in a subset <strong>of</strong> cutaneous melanoma patients with<br />

pancreatic cancer in the familial history. N. Soufir, E.<br />

Rouleau, C. Derouet, A. Riffault, H. H. Hu, S. Caputo, P.<br />

Hammel, V. Descamps, N. Basset-Seguin, P. Saiag, A.<br />

Bensussan, M. Bagot, R. Lidereau, B. Grandchamp.<br />

1063T SUFU germline mutation in a patient with Gorlin<br />

syndrome identified by next-generation sequencing. J.<br />

B. Geigl, E. Heitzer, I. Wolf, L. Cerroni, M. R. Speicher.<br />

1064F Li-Fraumeni syndrome: A clinical, genetic, and<br />

epidemiologic cohort study. P. L. Mai, J. A. Peters, L.<br />

Hoskins, F. Walcott, R. Bremer, S. A. Savage.<br />

1065W Early detection <strong>of</strong> cystic pleuropulmonary<br />

blastoma and cystic nephroma in an asymptomatic<br />

child with DICER1 mutation—Screening<br />

considerations. F. Plourde, V. Larouche, N. Ferguson,<br />

M. St-Amant, I. Harvey, N. Taherian, N. Sabbaghian, J. R.<br />

Priest, W. D. Foulkes.<br />

1066T Impact <strong>of</strong> gynecological screening in Lynch<br />

syndrome carriers with an MSH2 mutation. S.<br />

Stuckless, P. Parfrey, L. Dawson, B. Barrett, J. Green.<br />

1067F Evaluation <strong>of</strong> mismatch repair gene sequence<br />

variants in the Colon Cancer Family Registry using<br />

multifactorial likelihood analysis. B. A. Thompson, D.<br />

E. Goldgar, M. Clendenning, R. Walters, M. T. Parsons,<br />

S. Gallinger, R. W. Haile, J. L. Hopper, M. A. Jenkins,<br />

L. LeMarchand, N. M. Lindor, P. A. Newcomb, S. N.<br />

Thibodeau, J. P. Young, D. D. Buchanan, S. V. Tavtigian, A.<br />

B. Spurdle, Colon Cancer Family Registry.<br />

1068W Development <strong>of</strong> a custom targeted AmpliSeq<br />

multiplex sequencing assay for the detection <strong>of</strong> tumorderived<br />

somatic mutations and application as part<br />

<strong>of</strong> a clinical trial. C.-J. Lih, D. J. Sims, M. G. Mehaffey,<br />

M. Dindinger, E. Levandowsky, C. C. Lee, T. T. Harkin, P.<br />

Brzoska, B. Conley, S. Kummar, P. M. Williams.<br />

1069T A 30-year perspective <strong>of</strong> International Fanconi<br />

Anemia Registry. A. D. Auerbach, IFAR Collaboration<br />

Team.<br />

1070F Histology and prognostic markers are powerful<br />

tools for predicting BRCA mutation status. C. D.<br />

Delozier, A. Rahman, T. Liu, C. J. Curry.<br />

1071W Variants <strong>of</strong> uncertain significance in BRCA<br />

testing: Surgical decisions, risk perception, cancer<br />

distress, and evaluation <strong>of</strong> the genetic cancer risk<br />

assessment process. J. O. Culver, C. D. Brinkerh<strong>of</strong>f, J.<br />

Clague, K. Yang, K. E. Singh, S. R. Sand, J. N. Weitzel.<br />

1072T The contribution <strong>of</strong> predisposition<br />

polymorphisms for body size to the inherited risk <strong>of</strong><br />

colorectal cancer. L. Carvajal-Carmona, G. Casey, O.<br />

Sieber, G. Montgomery, J. Young, P. Baird, D. Kerr, R.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


154 POSTER SESSIONS<br />

Houlston, M. Dunlop, I. Tomlinson, Colon Cancer Family<br />

Registry, COGENT Consortium.<br />

1073F The combined effect <strong>of</strong> the functional variants<br />

in cell death pathway genes on cervical cancer. K.<br />

Chattopadhyay, C. Dandara, A. Hazra, A. L. Williamson.<br />

1074W Genetic ancestry is associated to changes in<br />

DNA repair capacity in non-melanoma skin cancer<br />

patients from Puerto Rico. H. J. Diaz-Zabala, L. Morales,<br />

J. Matta, J. Dutil.<br />

1075T Genetic ancestry and breast cancer survival in<br />

U.S. Latinas. L. Fejerman, D. Hu, S. Huntsman, C. Eng, E.<br />

Gonzalez Burchard, E. M. John, M. C. Stern, E. Perez-<br />

Stable, E. Ziv.<br />

1076F Genetic polymorphisms in candidate<br />

inflammation-related genes and risk <strong>of</strong> esophageal<br />

squamous cell carcinoma. A. Golozar, T. Beaty, P. Gravitt,<br />

I. Ruczinski, Y. L. Qiao, J. H. Fan, T. Ding, Z. Z. Tang, A.<br />

Etemadi, N. Hu, S. M. Dawsey, N. D. Freedman, C. C.<br />

Abnet, A. Goldstein, P. R. Taylor.<br />

1077W Frequency <strong>of</strong> VNTR polymorphism in IL-1Ra<br />

gene in colorectal cancer. I. A. Gutíerrez, E. Cortes, A. M.<br />

Puebla, M. P. Gallegos.<br />

1078T Individual ancestry influences the gene<br />

expression pr<strong>of</strong>ile in breast cancer patients <strong>of</strong> admixed<br />

populations. D. Hu, E. Ziv.<br />

1079F Risks <strong>of</strong> colorectal and other cancers following<br />

endometrial cancer in Lynch syndrome. M. A. Jenkins,<br />

N. M. Lindor, R. W. Haile, P. A. Newcomb, L. Le Marchand,<br />

S. Gallinger, J. L. Hopper, A. K. Win.<br />

1080W Prevalence and clinical features <strong>of</strong> HOXB13<br />

mutation carriers in prostate cancer patients from<br />

Germany. C. Maier, J. Xu, S. L. Zheng, M. Luedeke, A. E.<br />

Rinckleb, W. Vogel, S. N. Thibodeau, K. A. Cooney, W. B.<br />

Isaacs on behalf <strong>of</strong> ICPCG.<br />

1081T Histologic types and risk factors in familial lung<br />

cancer cases from Southern Louisiana. D. Mandal,<br />

M. Haskins, A. Bencaz, J. Hutchinson, J. Chambliss, H.<br />

Rothschild, J. E. Bailey-Wilson.<br />

1082F Using an 18 locus genotype to predict risk <strong>of</strong><br />

breast cancer, and the relationship between age,<br />

estrogen receptor status and genetic risk. C. Merrick,<br />

C. Purdie, L. Jordan, C. Palmer, R. Tavendale, A. Ashfield,<br />

P. Quinlan, P. Armory, A. Thompson, J. Berg.<br />

1083W Association between prostate cancer occurrence<br />

and Y-chromosomal STRs. M. Miri Nargesi, A. Nazemi, P.<br />

Amini, P. Ismail, R. Vasudevan, P. Pasalar, A. H. Abdul Razack.<br />

1084T The clinical phenotype <strong>of</strong> endometrial cancer in<br />

women <strong>of</strong> Newfoundland and Labrador with a MSH2<br />

Lynch syndrome mutation. A. H. G. Nichols, L. M.<br />

Dawson, J. Green, E. Dicks, P. Parfrey.<br />

1085F A unique African prostate cancer cohort to<br />

investigate genetic and environmental risk factors <strong>of</strong><br />

aggressive disease within Africa. E. A. Tindall, M. S. R.<br />

Bornman, S. van Zyl, D. C. Petersen, A. M. Segone, L. R.<br />

Monare, P. A. Venter, V. M. Hayes.<br />

1086W Insulin-like growth factor biomarkers<br />

and genetic polymorphisms are associated with<br />

adenomatous polyp risk. C. B. Vaughn, H. Ochs-Balcom,<br />

J. Nie, Z. Chen, C. L. Thompson, L. Li.<br />

1087T An unusual BRCA mutation distribution in a high<br />

risk cancer genetics clinic. A. C. Nelson-Moseke, J. M.<br />

Jeter, H. Cui, D. Roe, S. K. Chambers, C. M. Laukaitis.<br />

1088F Functional characterization <strong>of</strong> the pancreatic<br />

cancer TERT-CLPTM1L risk locus on Chr5p15.33. J. Jia,<br />

A. Thompson, A. Bosley, H. Parikh, Z. Wang, I. Collins, G.<br />

Petersen, C. Westlake, T. Andresson, L. Amundadottir.<br />

1089W A comprehensive approach to evaluating the<br />

impact <strong>of</strong> sequence variants <strong>of</strong> uncertain significance<br />

in 24 breast cancer genes on transcript splicing. S.<br />

Casadei, T. Walsh, C. H. Spurrell, A. M. Thornton, J. B.<br />

Mandell, S. M. Stray, M. K. Lee, M. C. King.<br />

1090T Functional analysis <strong>of</strong> germline TP53 mutations<br />

in lymphocytes from Li-Fraumeni patients reveals a<br />

drastic biological impact <strong>of</strong> missense mutations. J.-M.<br />

Flaman, Y. Zerdoumi, C. Durambure, J. Laury-Andas, G.<br />

Bougeard-Denoyelle, T. Frebourg, French LFS Working<br />

Group.<br />

1091F Investigation <strong>of</strong> the bladder cancer association<br />

within TP63 gene region. Y.-P. Fu, I. Kohaar, J. Earl,<br />

W. Tang, J. D. Figueroa, N. Malats, M. Garcia-Closas,<br />

N. Chatterjee, M. Kogevinas, P. Porter-Gill, D. Baris, D.<br />

Albanes, M. P. Purdue, A. Carrato, A. Tardón, C. Serra, R.<br />

García-Closas, J. Lloreta, A. Johnson, M. Schwenn, M. R.<br />

Karagas, A. Schned, W. R. Diver, S. M. Gapstur, M. Thun,<br />

J. Virtamo, D. T. Silverman, N. Rothman, F. X. Real, L.<br />

Prokunina-Olsson.<br />

1092W Genetic variant as a selection marker for anti-<br />

PSCA immunotherapy <strong>of</strong> bladder cancer. I. Kohaar,<br />

P. Porter-Gill, P. Lenz, Y. P. Fu, A. Mumy, W. Tang, A. B.<br />

Apolo, N. Rothman, D. Baris, A. R. Schned, K. Ylaya, M.<br />

Schwenn, A. Johnson, M. Jones, M. Kida, D. T. Silverman,<br />

S. M. Hewitt, L. E. Moore, L. Prokunina-Olsson.<br />

1093T Tumor microenvironment and genetic<br />

association with colorectal cancer risk. V. Peltekova, M.<br />

Lemire, Q. Trinh, A. Qazi, R. Bielecki, L. Hodgson-Jensen,<br />

D. D’Souza, S. Zandi, T. Chong, R. De Borja, L. Timms, J.<br />

Rangrej, M. Volar, M. Chan-Seng-Yue, T. Beck, J. Kwan, K.<br />

Kozak, C. Ash, L. D. Stein, J. E. Dick, J. D. McPherson, B.<br />

W. Zanke, A. Pollett, S. Gallinger, T. H. Hudson.<br />

1094F Evaluation <strong>of</strong> the functional effects on cell<br />

signaling caused by allelic forms <strong>of</strong> prostate stem cell<br />

antigen. P. Porter-Gill, A. Mumy, W. Tang, I. Kohaar, L.<br />

Prokunina-Olsson.<br />

1095W Discovery and functional characterization <strong>of</strong><br />

somatic mutations in the novel tumor suppressor<br />

DEAR1. J. Reuther, N. Chen, S. Balasenthil, A. Killary.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1096T rs28381943 and rs2032586 SNPs <strong>of</strong> ABCB1<br />

gene may be the reason <strong>of</strong> mRNA stabilization which<br />

may lead to gene overexpression. M. S. Shahbazi,<br />

M. M. Mansoori, M. G. Golalipour, S. A. Alizadeh, A. J.<br />

Jahangirerad, A. T. Tahmasebifar, S. R. K. Khanduzi.<br />

1097F Identification and functional characterization <strong>of</strong><br />

a novel splicing form <strong>of</strong> the TPCN2 gene on 11q13.3<br />

within a region associated with prostate cancer<br />

risk. N. Sikdar, C. Chung, J. Fang, M. Tarway, W. Tang,<br />

S. Mukherjee Dey, S. Ambs, L. Prokunina-Olsson, S.<br />

Chanock.<br />

1098W An integrated analysis <strong>of</strong> genomic variation<br />

and transcriptome sequencing to identify novel<br />

susceptibility genes for breast cancer. E. Wagner, S.<br />

Clare, M. Radovich, Y. Liu, B. Schneider, A. M. Storniolo,<br />

C. He.<br />

1099T Effects <strong>of</strong> breast cancer associated PALB2<br />

c.1592delT founder mutation at the cellular level.<br />

R. Winqvist, J. Nikkilä, K. Pylkäs, H. Peltoketo, B. Xia, H.<br />

Pospiech.<br />

1100F Global correlation <strong>of</strong> expression with prostate<br />

cancer associated variants identifies IRX4 as a<br />

prostate cancer expression trait locus. X. Xu, W. M.<br />

Hussain, N. Kitabayashi, M. A. Rubin, F. Demichelis, R. J.<br />

Klein.<br />

1101W Interplay <strong>of</strong> tumor suppressor genes and<br />

oncogenes in ovarian cancer. M. Zhao, S. Sun, Z. Zhao.<br />

1102T Establishment <strong>of</strong> breast, leiomyosarcoma<br />

and thyroid cancer stem cells derived from carriers<br />

<strong>of</strong> p.R337H TP53 germline mutation within one Li-<br />

Fraumeni syndrome family. L. I. Mambelli, I. Kerkis, F.<br />

Fortes, P. Hainaut, M. I. W. Achatz.<br />

1103F Functional validation using eQTL needs cellspecific<br />

approaches. S. Kim, H.-H. Won, J.-W. Kim, D. H.<br />

Kim, S.-T. Lee, S. Kim, S.-H. Kim, C. W. Jung.<br />

1104W Functional characterization <strong>of</strong> HLA allelotypes<br />

associated with follicular lymphoma risk. F. C. M. Sillé,<br />

L. Conde, C. F. Skibola.<br />

1105T microRNA expression for classification <strong>of</strong><br />

histiocytic sarcomas in dogs. J. Aguirre Hernandez, J. M.<br />

Dobson, T. M. Hoather, D. R. Sargan, F. Constantino-Casas.<br />

1106F Molecular urine assay <strong>of</strong> PCA3, MMP2, MMP9<br />

and KLK3 in men with prostate cancer and benign<br />

prostatic hyperplasia. H. Akin, A. Simsir, F. Hazan, T. R.<br />

Ozdemir, I. Cureklibatir, G. Itirli, C. Gunduz, C. Ozkinay, F.<br />

Ozkinay.<br />

1107W The effect <strong>of</strong> copy number variation in the<br />

phase II detoxification genes, UGT2B17 and UGT2B28,<br />

on colorectal cancer risk. A. Y. Angstadt, A. S. Berg, J.<br />

Zhu, P. Miller, T. J. Hartman, S. M. Lesko, J. E. Muscat, P.<br />

Lazarus, C. J. Gallagher.<br />

1108T Genetic sequence variant in microRNA genes<br />

and survival in non-small cell lung cancer. A.K. Azad,<br />

POSTER SESSIONS 155<br />

X. Qiu, T. Popper, K. Boyd, Q. Kuang, Y.B. Berhane, H.<br />

Henrique, N. Perera, P. Prakruthi, D. Patel, S. Momin, M.<br />

Nakhla, E. Marjan, Z. Chen, D. Cheng, R. Feld, N.B. Leighl,<br />

F.A. Shepherd, M.-S. Tsao, W. Xu, G. Liu, S. Cuffe.<br />

1109F The PROFILE Study: Genetic prostate cancer<br />

risk stratification for targeted screening. E. K. Bancr<strong>of</strong>t,<br />

E. C. Castro, N. Taylor, E. Page, E. Saunders, T. Dadaev, A.<br />

Lee, A. Antoniou, Z. Kote-Jarai, R. Eeles.<br />

1110W Lgr5 expression and its relatedness with<br />

other tumor stem cell markers in human gastric<br />

adenocarcinoma. W. Fan, Y. W. Guo, Y. Y. Xie, Y.S. Li, W.<br />

Chen.<br />

1111T The TP53 16 bp duplication polymorphism is<br />

associated with breast cancer. M. Gallegos, Jr., A.<br />

Gutiérrez, A. Ramos, E. Salas, J. M. Castro, A. M. Puebla,<br />

L. E. Figuera, G. M. Zúñiga.<br />

1112F Statistics <strong>of</strong> cellular evolution in leukemia:<br />

Allelic variations in patient trajectories based on<br />

immune repertoire sequencing. H. Gao, C. Wang, A.<br />

C. Logan, C. D. Bustamante, J. Seok, D. B. Miklos, R. W.<br />

Davis, M. W. Feldman, W. Xiao.<br />

1113W Genetic polymorphisms and colorectal cancer<br />

risk: A systematic review <strong>of</strong> meta-analyses. B. Haerian,<br />

M. Haerian.<br />

1114T NRF2 and sulfiredoxin genetic polymorphisms<br />

and protein expression predict outcome in breast<br />

cancer. J. M. Hartikainen, M. Tengström, V.-M. Kosma, V.<br />

Kinnula, A. Mannermaa, Y. Soini.<br />

1115F Complex tumor genomes inferred from plasma-<br />

DNA and circulating tumor cells <strong>of</strong> patients with<br />

cancer. E. Heitzer, M. Auer, E. M. H<strong>of</strong>fmann, C. Beneken,<br />

M. Pichler, P. Ulz, S. Lax, J. Waldispuehl-Geigl, O.<br />

Mauermann, G. Pristauz, C. Lackner, G. Höfler, F. Eisner,<br />

E. Petru, H. Sill, H. Samonigg, K. Pantel, S. Riethdorf, T.<br />

Bauernh<strong>of</strong>er, J. B. Geigl, M. R. Speicher.<br />

1116W Novel integrative genomics approach for<br />

associating GWAS information with triple negative<br />

breast cancer. C. Hicks, K. Backus, A. Pannuti, L. Miele.<br />

1117T Germline variation in TP53 regulatory network<br />

genes associates with breast cancer survival and<br />

treatment outcome. M. Jamshidi, M. K. Schmidt, T. Dörk,<br />

M. Garcia-Closas, T. Heikkinen, S. Cornelissen, S. van<br />

den Broek, P. Schürmann, A. Meyer, T. W. Park-Simon,<br />

J. Figueroa, M. Sherman, J. Lissowska, G. T. Keong,<br />

A. Irwanto, M. Laakso, S. Hautaniemi, K. Aittomäki, C.<br />

Blomqvist, J. Liu, H. Nevanlinna.<br />

1118F Detection <strong>of</strong> FLT3 internal tandem duplication<br />

and D835 mutations in Iranian patients with acute<br />

myeloid leukemia. L. Kokabee, A. Ahmadzadeh, M.<br />

Kokabee, M. Karimipoor.<br />

1119W Association <strong>of</strong> gastric cancer with Amerindian<br />

ancestry, socioeconomic and nutritional factors and<br />

a gene candidate study in a Latin <strong>American</strong> admixed<br />

population. L. Lacorte, R. Zamudio, G. Soares-Souza,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


156 POSTER SESSIONS<br />

P. Herrera, L. Cabrera, C. Hooper, J. Cok, J. Combe,<br />

G. Vargas, W. Prado, S. Schneider, M. Rodrigues, S.<br />

Chanock, D. Berg, R. Gilman, E. Tarazona-Santos,<br />

F. Kehdy.<br />

1120T Detection <strong>of</strong> P16 expression and human<br />

papillomavirus in oropharyngeal squamous cell<br />

carcinoma. S. Lai, V. Sandulache, J. Zevallos.<br />

1121F BORIS expression in squamous intraepithelial<br />

lesions and cervical cancer. B. Lazalde, N. Velazquez-<br />

Hernandez, M. Barragán-Hernandez, M. A. Reyes-<br />

Romero.<br />

1122W An informative clinical applicable serum<br />

miRNAs 371-3 and 302/367 test for (germ cell)<br />

cancer patients. L. H. J. Looijenga, A. J. M. Gillis, M. A.<br />

Rijlaarsdam, R. Eini, L. C. J. Dorssers, Y. van der Zwan, C.<br />

M. de Boer, S. J. White.<br />

1123T Gene variants in chemokine and chemokine<br />

receptor with risk <strong>of</strong> prostate cancer in North Indian<br />

cohort. R. D. Mittal, R. K. Mandal.<br />

1124F The regulatory BCL2 promoter polymorphism<br />

(-938C,A) is associated in Iranian women breast cancer<br />

patients. B. Motahari, M. Ghaffarpour, G. H. Javadi, M.<br />

Houshmand.<br />

1125W Type II transmembrane serine protease gene<br />

variants associate with breast cancer. K. M. Nieminen,<br />

J. M. Hartikainen, V. Kataja, V.-M. Kosma, A. Mannermaa.<br />

1126T Prevalence and prognostic impact <strong>of</strong> Ikaros<br />

deletions in childhood acute lymphoblastic leukemia<br />

treated according to NOPHO protocols. I. Ofverholm, A. N.<br />

Tran, G. Barbany, A. Nordgren, M. Heyman, M. Nordenskjöld.<br />

1127F Genotype proline/proline <strong>of</strong> TP53 codon 72<br />

polymorphism is enriched in breast cancer. A. M.<br />

Puebla, A. Gutiérrez, A. Ramos, E. Salas, J. M. Castro, R.<br />

Ramírez, M. P. Gallegos.<br />

1128W 3R/3R genotype <strong>of</strong> TYMS gene is associated<br />

with non response <strong>of</strong> chemotherapy in breast cancer<br />

patients. A. Ramos, E. Salas, J. M. Castro, L. E. Figuera,<br />

A. M. Puebla, M. P. Gallegos.<br />

1129T Characterization <strong>of</strong> breast cancer intrinsic<br />

subtypes in Mexican women using integrative<br />

multiplatform analysis. C. Rangel-Escareño, I. Imaz-<br />

Rosshandler, S. Muñoz-Montero, J. E. Castillo-Fernandez,<br />

A. Hidalgo-Miranda.<br />

1130F International collaborative analysis <strong>of</strong> the<br />

InSiGHT database quantifies unique reports and<br />

redefines the V.U.S. challenge for DNA mismatch repair<br />

genes (MMR). R. P. Raval, L. Baez-Cabrera, J. P. Plazzer,<br />

S. Okochi, F. Macrae, M. Genuardi, T. K. Weber.<br />

1131W Frequency <strong>of</strong> non-DNA-binding Ikaros is<strong>of</strong>orms<br />

in childhood acute lymphoblastic leukemia and relapse<br />

or death risk. A. Reyes-León, R. Juárez-Velázquez,<br />

A. Medrano-Hernández, T. Cuenca-Roldán, C. Salas-<br />

Labadía, P. Navarrete-Meneses, R. Paredes-Aguilera, R.<br />

Rivera-Luna, R. Cárdenas-Cardos, G. López-Hernández,<br />

R. Bernaldez, P. Pérez-Vera.<br />

1132T Gene expression pr<strong>of</strong>ile <strong>of</strong> human telomere and<br />

telomerase complex in gastric cancer. L. C. Santos, F.<br />

Wisnieski, D. Q. Calcagno, M. F. Leal, T. B. Pontes, C. O.<br />

Gigek, E. S. Chen, S. Demachki, P. P. Assumpção, R. R.<br />

Burbano, M. A. C. Smith.<br />

1133F Chemotherapy response in ovarian cancer is<br />

modulated by the DNA encoded microRNA family<br />

miR-17-92a. I. Shapira, A. Lee, M. Oswald, J. Lovecchio,<br />

A. Menzin, J. Whyte, L. Dos Santos, K. Sultan, V. John, K.<br />

Cheng, S. Liang, T. Bradley, D. Budman.<br />

1134W Single-nucleotide polymorphisms in genes<br />

encoding Toll-like receptor -2, -3, -4, and -9 in casecontrol<br />

study with bladder cancer susceptibility in<br />

North Indian population. V. Singh, N. Srivastava, R.<br />

Kapoor, R. D. Mittal.<br />

1135T Clinical impact <strong>of</strong> MMP-3 and TIMP-3 gene<br />

polymorphisms in prostate cancer. P. Srivastava, R.<br />

Kapoor, R. D. Mittal.<br />

1136F Role <strong>of</strong> SOCS3 promoter methylation in the<br />

pathogenesis <strong>of</strong> myeloproliferative neoplasms and<br />

secondary/reactive erythrocytosis/thrombocythemia.<br />

D. Torun, O. Nevruz, M. Akyol, S. Kozan, M. Bahce, S.<br />

Guran, C. Beyan.<br />

1137W Association <strong>of</strong> common polymorphisms in<br />

TNF-a pathway genes and apoptotic genes with risk<br />

and prognosis <strong>of</strong> esophageal cancer. M. Umar, R.<br />

Upadhyay, S. Kumar, U. C. Ghoshal, B. Mittal.<br />

1138T Colon cancer in a 9-year-old female due to<br />

combined inherited EPCAM deletion and hMSH2 missense<br />

mutation leading to tissue-specific bi-allelic loss<br />

<strong>of</strong> expression <strong>of</strong> hMSH2. P. J. Ainsworth, H. H. Li Chang,<br />

H. Levin, D. K. Driman, V. M. Siu, A. E. L. Cairney, N. L.<br />

Scanlan, K. Buckley.<br />

1139F NF1 second hit leads to the upregulation<br />

<strong>of</strong> HLA class II genes and recruitment <strong>of</strong> Tregs in<br />

neur<strong>of</strong>ibromas. E. M. Jouhilahti, S. Peltonen, E. P.<br />

Jokinen, T. Callens, H. Aho, E. Legius, O. Lassila, L.<br />

Messiaen, J. Peltonen.<br />

1140W Genetic screening <strong>of</strong> colorectal cancer<br />

patients for the Lynch syndrome detection in Estonian<br />

population. M. Kask, E. Oitmaa, K. Toome, K. Raime, K.<br />

Vaidla, P. Laidre, J. Jaal, J. Soplepmann, V. Afanasjev, T.<br />

Erm, H. Roomere.<br />

1141T CASP8AP2 and H2AFZ expression as a<br />

prognosis factor in childhood acute lymphoblastic<br />

leukemia. R. Juárez-Velázquez, A. Reyes-León, C.<br />

Salas, R. Paredes, R. Cardenas, G. López-Hernández,<br />

A. Lopez, A. Carnevale, R. Ortiz, R. Bernaldez,<br />

P. Perez-Vera.<br />

1142F Circulating miRNAs as non-invasive blood based<br />

diagnostic biomarkers. R. Duttgupta, R. Jiang, J. Gollub,<br />

T. Stamato, B. C. Getts, K. W. Jones.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1143W Comparison <strong>of</strong> PCR method and RUT test for<br />

detection <strong>of</strong> Helicobacter pylori infection in gastric<br />

tissue. N. Bagheri, L. Salimzadeh, F. Azadegan, G.<br />

Rahimian, A. Taghikhani, M. Hashemzadeh, H. Shirzad.<br />

1144T Lowered PTEN protein dosage predicts for<br />

underlying germline PTEN mutations amongst patients<br />

presenting with thyroid cancer and Cowden-like<br />

phenotypes. J. Ngeow, X. He, J. Mester, J. Lei, T. Romigh,<br />

M. Milas, M. Orl<strong>of</strong>f, C. Eng.<br />

1145F Cellular uterine leiomyomata with<br />

chromosome 1p deletions represent a distinct entity.<br />

J. C. Hodge, A. T. Florin, K. E. Pearce, A. C. Clayton,<br />

E. A. Stewart.<br />

1146W Cancer biomarker research using castPCR<br />

technology. T. Hartshorne, Y. Bao, B. Ching, M.<br />

Mouanoutoua, Y. Wang, D. Keys, S. Desai, J. Stevens.<br />

1147T Naturally missing teeth and ovarian cancer: A<br />

potential genetic link. L. Morford, A. Vu, K. Kirk, M. Gilbey,<br />

G. Falcao-Alencar, M. Sakamoto, D. Fardo, J. Hartsfield Jr.<br />

1148F A meta-analysis <strong>of</strong> genome-wide association<br />

studies to identify prostate cancer susceptibility<br />

loci associated with aggressive and non-aggressive<br />

disease. A. Amin Al Olama, Z. Kote-Jarai, F. R.<br />

Schumacher, F. Wiklund, S. I. Berndt, S. Benlloch, G. G.<br />

Giles, G. Severi, D. E. Neal, F. C. Hamdy, J. L. Donovan, D.<br />

J. Hunter, B. E. Henderson, S. Chanock, H. Gronberg, C.<br />

A. Haiman, P. Kraft, D. F. Easton, R. A. Eeles, PRACTICAL<br />

Consortium.<br />

1149W Identifying genetic modifiers in two p16<br />

melanoma pedigrees. M. H. Bailey, C. Teerlink, J. M.<br />

Farnham, L. Cannon-Albright.<br />

1150T Genome-wide association studies identify four<br />

novel ER-negative specific breast cancer risk loci. F.<br />

J. Couch, M. Garcia-Closas, S. Lindstrom, K. Michailidou,<br />

M. K. Schmidt, M. Brook, N. Orr, S. Slager, D. J. Hunter,<br />

J. Simard, J. Benitez, A. Dunning, M. E. Sherman, G.<br />

Chenevix-Trench, S. J. Chanock, P. Hall, P. Pharoah, C.<br />

Vachon, D. F. Easton, C. A. Haiman, P. Kraft for BPC3,<br />

TNBCC, and BCAC.<br />

1151F cAMP and cGMP signaling may play an<br />

important role in the development <strong>of</strong> prostate cancer.<br />

R. de Alexandre, A. Horvath, A. Manning, D. Carraro, F.<br />

Soares, M. Nesterova, S. Constantine, F. Faucz.<br />

1152W Genome-wide association for multiple myeloma<br />

reveals overlap between variants associated with<br />

susceptibility and survival. E. Dean, D. Hu, P. Bracci, V.<br />

Krepkiy, T. Martin, J. Wolf, E. Ziv.<br />

1153T Genetic risk factors for malignant pleural<br />

mesothelioma: A genome-wide association study. I.<br />

Dianzani, S. Guarrera, M. Betti, G. Fiorito, D. Ferrante,<br />

F. Voglino, G. Cadby, A. Russo, C. Di Gaetano, F. Rosa,<br />

E. Casalone, M. Padoan, M. Giordano, A. Aspesi, C.<br />

Casadio, F. Ardissone, E. Ruffini, P. G. Betta, R. Libener, R.<br />

Guaschino, E. Piccolini, L. Palmer, M. Neri, D. Mirabelli, D.<br />

Ugolini, S. Bonassi, C. Magnani, G. Matullo.<br />

POSTER SESSIONS 157<br />

1154F A region <strong>of</strong> autozygosity at 8q21.3 and lung<br />

cancer risk. M. T. Landi, K. Jacobs, M. Yeager, D.<br />

Albanes, M. Thun, N. E. Caporaso, S. Chanock, J. Shi.<br />

1155W IL28B allelic protein is<strong>of</strong>orms differentially<br />

activate interferon-stimulated genes. A. Mumy, B.<br />

Muchmore, W. Tang, H. Park, F. Sheikh, B. Rehermann, R.<br />

Donnelly, L. Prokunina-Olsson.<br />

1156T Three novel common susceptibility loci for<br />

ovarian cancer identified by GWAS meta-analysis and<br />

replication. S. J. Ramus, P. D. P. Pharoah, Y. Y. Tsai, C. M.<br />

Phelan, A. N. A. Monteiro, S. A. Gayther, J. M. Schildkraut,<br />

T. A. Sellers on behalf <strong>of</strong> Ovarian Cancer Association<br />

Consortium.<br />

1157F Insights into pancreatic cancer etiology from<br />

pathway analysis <strong>of</strong> genome-wide association study<br />

data. P. Wei, H. Tang, D. Li.<br />

1158W Pathway-based analysis <strong>of</strong> genomewide<br />

SNP data reveals new candidate genes for<br />

susceptibility to melanoma. M. Brossard, A. Vaysse,<br />

E. Corda, P. Jeannin, H. Mohamdi, V. Chaudru, N.<br />

Lavielle, B. Bressac-de Paillerets, M. F. Avril, M. Lathrop,<br />

F. Demenais.<br />

1159T Susceptibility loci associated with specific and<br />

shared subtypes <strong>of</strong> lymphoid malignancies. V. Joseph,<br />

T. Kirchh<strong>of</strong>f, J. Brown, K. A. Schrader, A. Dutra-Clarke,<br />

C. Manschreck, N. Hansen, R. Rau-Murthy, K. Sarrel, J.<br />

Przybylo, S. Shah, S. Cheguri, Z. Stadler, L. Zhang, O.<br />

Paltiel, D. Yehuda, A. Viale, C. Portlock, D. Strauss, S. L.<br />

Lipkin, M. Lacher, M. Robson, R. J. Klein, A. Zelenetz,<br />

K. Offit.<br />

1160F Second generation DCEG Reference Set<br />

improves performance <strong>of</strong> genotype imputation.<br />

Z. Wang, K. B. Jacobs, M. Yeager, A. Hutchinson, J.<br />

Sampson, M. Tucker, S. J. Chanock.<br />

1161W Are there genetic variants that confer shared<br />

genetic susceptibility to pancreatic cancer and<br />

melanoma? L. Wu, K. Rabe, G. Petersen.<br />

1162T Oncogenic rewiring by the t(11;19)(q21;p13)<br />

coactivator fusion, CRTC1/MAML2, involves direct<br />

activation <strong>of</strong> the pluripotency factor MYC. A. L. Amelio,<br />

F. X. Schaub, M. Fallahi-Sichani, M. B. Lawani, M. R.<br />

Southern, B. M. Young, L. Wu, F. J. Kaye, J. L. Cleveland,<br />

M. D. Conkright.<br />

1163F Meta-analysis identifies microRNA expression<br />

signature in non-small-cell lung cancer. T. Annilo, U.<br />

Vısa, T. Vooder, R. Kolde, J. Vilo, A. Metspalu.<br />

1164W The effect <strong>of</strong> non-viral magnet assisted<br />

transfection on chronic myeloid leukemia cell line with<br />

downregulated miR-150. T. Balci, C. Birayavci, S. Yilmaz,<br />

Z. O. Dogan Sigva, G. Saydam, C. Gunduz.<br />

1165T The novel resequencing diagnostic microarray:<br />

RDMGGA1.0, can detect at a diagnose level<br />

mutations in patients with breast, ovarian, colon,<br />

skin and multiple cancers. D. Bercovich, Y. Plotsky,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


158 POSTER SESSIONS<br />

T. Morad, S. Allon-Shalev, AM. Lichanska, LA. Borsuk,<br />

C. Tibbetts.<br />

1166F A new approach for an anti-diabetic drug<br />

metformin in prostate cancer. C. Biray Avci, E. Harman,<br />

S. Yilmaz, Y. Dodurga, C. Gunduz.<br />

1167W mRNA-seq <strong>of</strong> single prostate cancer circulating<br />

tumor cells reveals recapitulation <strong>of</strong> gene expression<br />

and pathways found in prostate cancer. G. Cann, Z.<br />

Gulzar, S. Cooper, M. Tat, R. Li, S. Stuart, S. Luo, M.<br />

Ronaghi, J. Brooks, A. Talasar.<br />

1168T Detection <strong>of</strong> sequences <strong>of</strong> MMTV-like<br />

retroviruses in breast cancer from Mexican women.<br />

A. Cedro-Tanda, I. A. Cordova-Solis, D. J. Arenas-<br />

Aranda, J. Torres-López, F. A. Salamanca-Gomez, C.<br />

Moctezuma-Meza, G. Castelazo-Rodriguez, N. Garcia-<br />

Hernandez.<br />

1169F Expression <strong>of</strong> stem cell gene, Piwil2 and<br />

testis specific genes TSGA10, TEX101 and ODF3<br />

in breast cancer. M. Dianatpour, P. Mehdipour, M.<br />

Miryounesi, S. Savad, F. Yazarlou, M. Mobasheri, M. H.<br />

Modarressi.<br />

1170W PMS2 screening: Could massive parallel<br />

sequencing facilitate gene analysis? J. Duclos, F. Pires,<br />

G. Legrand, C. Colas, J. Lefevre, M. Eyries, C. Wang, Y.<br />

Parc, F. Soubrier, F. Coulet.<br />

1171T FANCD2 immunohistochemical expression is<br />

a prognostic marker in breast cancer. R. Fagerholm,<br />

K. M. Sprott, T. Heikkinen, J. Bartkova, P. Heikkilä, K.<br />

Aittomäki, J. Bartek, D. T. Weaver, C. Blomqvist, H.<br />

Nevanlinna.<br />

1172F Effects <strong>of</strong> cassia extracts on cytotoxicity,<br />

apoptosis and gene expression in HL-60 cells. C.<br />

Gündüz, S. Yilmaz Süslüer, B. Agrap, C. Biray Avci, F.<br />

Lermioglu.<br />

1173W Universal Lynch syndrome screening result<br />

notification: Efficacy affected by method. H. Hampel, I.<br />

Lattimer, W. L. Frankel.<br />

1174T Allele-specific expression imbalances <strong>of</strong> MCC<br />

and reduced susceptibility to colorectal cancer in<br />

schizophrenia. L. He, G. He.<br />

1175F RAD51 polymorphisms and breast cancer risk.<br />

M. Hosseini, M. Houshmand, A. Ebrahimi.<br />

1176W Design and development <strong>of</strong> a next-generation<br />

sequencing assay for multiplex detection <strong>of</strong> somatic<br />

mutations in FFPE tissues. E. B. Jaeger, R. Haigis, M.<br />

Bauer, J. Yeakley, J. Betley, N. Udar.<br />

1177T Genotypic distribution <strong>of</strong> MMP1 (1607, 1G/2G)<br />

promoter in childhood malignant gliomas. P. Kawal, R.<br />

Kumar, A. Chandra, T. N. Dhole, B. K. Ojha.<br />

1178F Antileukemic effect <strong>of</strong> paclitaxel in combination<br />

with metformin in HL-60 cell line. C. Kayabasi, C.<br />

Birayavci, S. Yilmaz Susluer, Z. O. Dogan Sigva, T. Balci,<br />

G. Saydam, C. Gunduz.<br />

1179W The X-linked tumor suppressor TSPX disrupts<br />

the positive feedback loop <strong>of</strong> the viral oncoprotein HBx<br />

in HBV-associated hepatocarcinogenesis. T. Kido, Y.-F.<br />

C. Lau.<br />

1180T Comparison <strong>of</strong> minor groove binding<br />

ligands and known carcinogen blastomogenic,<br />

recombinogenic and mutagenic activity revealed by<br />

SMART in wts/1 hetesozygous flies. K. Kirsanov, E.<br />

Lesovaya, G. Belitsky, M. Yakubovskaya.<br />

1181F GR-mediated regulation <strong>of</strong> gene expression by<br />

standard glucocorticoids and selective glucocorticoid<br />

receptor agonists in lymphoma cells. E. Lesovaya, A.<br />

Yemelyanov, K. Kirsanov, V. Gasanova, M. Yakubovskaya,<br />

I. Budunova.<br />

1182W Sub-cellular localization <strong>of</strong> Y-box protein 1<br />

regulates proliferation, migration and tumorigenicity<br />

in astrocytomas. X. Liu, D. Faury, C. Sollier, N. Gerges,<br />

B. Meehan, Z. Dong, P. Siegel, A. Korshunov, S. Pfister, J.<br />

Rak, N. Jabado.<br />

1183T Integrative analysis <strong>of</strong> TCGA clinical and<br />

genomic data reveals conflicting roles <strong>of</strong> REST<br />

gene expression in recurrent glioblastoma. J.<br />

Madhusoodanan, M. Shekar, J. Su, I. Kupershmidt.<br />

1184F Analysis <strong>of</strong> MRE11/RAD50/NBN genes in<br />

childhood acute lymphoblastic leukemia. J. Nowak,<br />

M. Mosor, I. Ziolkowska-Suchanek, K. Nowicka, D.<br />

Januszkiewicz-Lewandowska.<br />

1185W Validation <strong>of</strong> a prostate cancer metastasis<br />

signature in a FFPE cohort <strong>of</strong> primary tumors. A.<br />

Pearlman, C. Campbell, J. Loke, S. Freedland, Y. Shao,<br />

H. Ostrer.<br />

1186T Molecular characterization <strong>of</strong> small cell<br />

carcinoma <strong>of</strong> the ovary. P. Ramos, M. L. Russell, L.<br />

Nordstrom, S. Smith, M. T. Barrett, T. Holley, E. Lenkiewitz,<br />

J. G. Pressey, J. Farley, S. P. Anthony, G. Hostetter, A. E.<br />

McCullough, K. A. Furge, B. B. Haab, J. M. Trent, H. E.<br />

Cunliffe.<br />

1187F Effects <strong>of</strong> Helicobacter pylori infection on<br />

MGMT and MLH1 promoter methylation status<br />

and microsatellite instability in pediatric and adult<br />

patients. M. L. Ribeiro, M. C. Alvarez, J. C. Santos,<br />

N. M. Maniezzo, M. S. Ladeira, I. C. A. Scaletsky, J.<br />

Pedrazzoli, Jr.<br />

1188W Role <strong>of</strong> novel and GWAS identified PLCE1<br />

genetic variants to gallbladder cancer susceptibility<br />

in north Indian population. K. L. Sharma, S. Misra, A.<br />

Kumar, B. Mittal.<br />

1189T Serum metabolomics and prostate cancer<br />

survival. R. Szulkin, R. Karlsson, A. Heuberger, M. Hong,<br />

C. Broeckling, J. Prenni, J. Prince, F. Wiklund.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1190F Analysis <strong>of</strong> TCGA patient and curated public<br />

genomic data identifies differentially regulated<br />

processes in breast cancer metastases. R. Wisotzkey,<br />

A. Umesh, J. Park, J. Shima, J. Delaney, E. Kelly, E. Chiu,<br />

M. Shekar, I. Kupershmidt.<br />

1191W Extreme breast/ovarian cancer phenotypes<br />

in non BRCA1 and BRCA2 families <strong>of</strong> Greek ancestry.<br />

F. Fostira, A. V. Stavropoulou, I. Konstantopoulou, D.<br />

Yannoukakos.<br />

1192T Modeling carcinogenesis in BRCA1 and BRCA2<br />

heterozygous mammary epithelial cells. M. E. Keith, M.<br />

Tenniswood.<br />

1193F Integrated transcriptional and functional<br />

screening identifies novel regulators <strong>of</strong> lymphoid<br />

lineage determination. E. Laurenti, S. Doulatov, I. Plumb,<br />

M. Doedens, C. April, J. B. Fan, J. Dick.<br />

1194W microRNA in bi<strong>of</strong>luids—robust biomarkers<br />

for disease, toxicology or injury studies: The case<br />

<strong>of</strong> minimally invasive colorectal cancer detection. P.<br />

Mouritzen, T. Blondal, D. Andreasen, N. Tolstrup, M. W.<br />

Teilum, A. Baker, S. J. Nielsen.<br />

1195T Detection <strong>of</strong> KRAS, BRAF, NRAS and PIK3CA<br />

cancer markers by castPCR technology. J. Au-Young,<br />

D. Keys, B. Ching, M. Mouanoutoua, D. Merrill.<br />

1196F Identifying the causes <strong>of</strong> dyskeratosis<br />

congenita: The prototypical telomere biology disorder.<br />

S. A. Savage, N. Giri, B. Ballew, B. P. Alter.<br />

1197W Germline BAP1 mutation: Additional case report<br />

and expanding clinical phenotype. R. Pilarski, C. M.<br />

Cebulla, T. Rich, L. Strong, M. H. Abdel-Rahman.<br />

1198T Detection <strong>of</strong> human breast cancer gene<br />

fusions from RNA-sequencing analysis <strong>of</strong><br />

formalin-fixed paraffin-embedded tissue specimens.<br />

Y. Ma, J. Stephans, R. Ambannavar, J. Jeong, J.<br />

Morlan, A. Dei Rossi, M. Liu, D. Sinicropi, J. Baker,<br />

K. Qu.<br />

1199F Analysis <strong>of</strong> quantitative trait loci (eQTLs) in<br />

pancreatic cancer by RNA sequencing. H. Parikh, J. Jia,<br />

W. Xiao, I. Collins, J. Hoskins, J. Powell, S. Thorgeirsson,<br />

J. Shi, G. Petersen, L. Amundadottir.<br />

1200W Identification <strong>of</strong> fusion transcripts and copy<br />

number variations in acute lymphoblastic leukemia by<br />

next-generation RNA and DNA sequencing. M. Bonin,<br />

C. Schroeder, M. Sturm, U. Pflückhahn, M. Feldhahn,<br />

O. Kohlbacher, H. G. Rammensee, P. Lang, O. Riess, P.<br />

Bauer, M. Walter.<br />

1201T Admixture rate estimation and post-call<br />

correction for complete genomics matched tumornormal<br />

whole genome sequencing data. M. Chen, Z.<br />

Omay, A. Serin, M. Gunel, H. Zhao.<br />

1202F Transcriptome analysis <strong>of</strong> blast cells <strong>of</strong> patients<br />

with acute lymphoblastic leukemia in diagnosis<br />

and relapse. M. A. Chiabai, G. R. Fernandes, L. H. T.<br />

Sakamoto, R. Pogue, R. W. Pereira.<br />

POSTER SESSIONS 159<br />

1203W Comprehensive germline susceptibility variant<br />

discovery in ovarian cancer using exome sequencing<br />

data. L. Ding, K. Johnson, K. Kanchi, M. Mclellan, C. Lu,<br />

Q. Zhang, D. Koboldt, C. Kandoth, T. Graubert, T. Ley, E.<br />

Mardis, R. Wilson.<br />

1204T Whole-exome sequencing <strong>of</strong> four patients with<br />

critera <strong>of</strong> familial hyperplastic polyposis. C. Garrec,<br />

S. Küry, P. Lindenbaum, V. Vidal, F. Airaud, J. Chettrit, E.<br />

Cauchin, J. F. Mosnier, S. Bézieau.<br />

1205F RAD51 paralogs mutation screening in<br />

breast and ovarian cancer families. L. Golmard,<br />

V. Caux-Moncoutier, G. Davy, E. Al Ageeli, B. Poirot,<br />

C. Tirapo, D. Michaux, C. Barbaroux, C. Dubois<br />

d’Enghien, L. Castéra, M.-H. Stern, C. Houdayer, D.<br />

Stoppa-Lyonnet.<br />

1206W MLH1, MSH2 and MSH6 mutations identified by<br />

DNA sequencing and MLPA analysis: Experience from<br />

the Colon Cancer Family Registry. S. R. Gunawardena,<br />

M. S. DeRycke, N. M. Lindor, M. A. Jenkins, J. L.<br />

Hopper, D. D. Buchanan, S. Gallinger, P. Newcomb, L.<br />

LeMarchand, R. W. Haile, S. N. Thibodeau, Colon Cancer<br />

Family Registry.<br />

1207T Whole-exome sequencing <strong>of</strong> a rare case <strong>of</strong><br />

familial childhood acute lymphoblastic leukemia. J.<br />

Healy, C. Richer, J. F. Spinella, V. Saillour, R. Vidal, E.<br />

Bareke, S. Busche, B. Ge, T. Pastinen, D. Sinnett.<br />

1208F Comprehensive BRCA1 and BRCA2 mutational<br />

pr<strong>of</strong>ile in Lithuania. R. Janavicius, V. Rudaitis, L.<br />

Griskevicius.<br />

1209W A broad re-sequencing study <strong>of</strong> 409 genes<br />

in NCI-60 cell lines using the Ion Ampliseq<br />

Comprehensive Cancer Panel and Ion PGM<br />

semiconductor sequencing reveals previously<br />

unreported cell line-specific mutations. B. S. G. Kong,<br />

M. Shannon, I. Casuga, D. Joun, S. M. Chen, C.-Y. Li, D.<br />

Ruff, R. Bennett.<br />

1210T Germline sequencing for aggressive prostate<br />

carcinoma. D. Larson, D. Koboldt, E. Appelbaum, M.<br />

O’Laughlin, R. Fulton, J. Haslag-Min<strong>of</strong>f, I. Borecki, A.<br />

Kibel, R. Wilson, E. Mardis.<br />

1211F A next-generation sequencing diagnostic<br />

panel to test all cancer susceptibility genes. S. S.<br />

Mahamdallie, E. Ruark, K.-W. Lau, A. Renwick, S. Seal, E.<br />

Ramsay, S. Hanks, J. Douglas, N. Rahman.<br />

1212W New germline MET variants inhereditary<br />

papillary type 1 renal carcinomas within the French<br />

population. E. Rouleau, C. Lefol, S. Caputo, V. Verkarre,<br />

C. Guy, F. Copigny, C. Maugard, O. Caron, F. Eisinger, P.<br />

Berthet, Y.-J. Bignon, J. Chiesa, A. David, T. Frebourg,<br />

S. Giraud, S. Lejeune, J.-M. Limacher, H. Zattara, S.<br />

Deveaux, I. Bieche, S. Richard, R. Lidereau.<br />

1213T Rare mutations in XRCC2 confer increased risk<br />

<strong>of</strong> breast cancer. M. Southey, D. J. Park, F. Lesueur, T.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


160 POSTER SESSIONS<br />

Nguyen-Dumont, M. Pertesi, F. A. Odefrey, F. Hammet, S.<br />

L. Neuhausen, E. M. John, I. L. Andrulis, M. B. Terry, M.<br />

Daly, S. Buys, F. Le Calvez-Klem, A. Lonie, B. J. Pope, H.<br />

Tsimiklis, C. Voegele, F. M. Hilbers, N. Hoogerbrugge, A.<br />

Barroso, A. Osorio, G. G. Giles, P. Devilee, J. Benitez, J. L.<br />

Hopper, S. V. Tavtigian, D. E. Goldgar, kConFab, BCFR.<br />

1214F Identification <strong>of</strong> genetic susceptibility loci<br />

for familial prostate cancer through whole exome<br />

sequencing: The ICPCG study design. S. N. Thibodeau,<br />

M. DeRycke, S. McDonnell, S. Gunawardena, Y. W.<br />

Asmann, S. Middha, L. Cannon-Albright, J. L. Stanford,<br />

E. A. Ostrander, W. B. Isaacs, J. Xu, J. Schleutker, K. A.<br />

Cooney, E. M. Lange, J. D. Carpten, J. E. Bailey-Wilson,<br />

O. Cussenot, G. G. Giles, G. Severi, C. Maier, A. S.<br />

Whittemore, C. L. Hsieh, F. Wiklund, W. J. Catalona, W. D.<br />

Foulkes, D. Mandal, R. Eeles, D. Easton, D. Seminara, D.<br />

Schaid on behalf <strong>of</strong> International Consortium for Prostate<br />

Cancer <strong>Genetics</strong>.<br />

1215W Discovery <strong>of</strong> novel long noncoding RNAs<br />

and aberrant alternative splicing events by RNAsequencing<br />

in childhood acute lymphoblastic leukemia.<br />

R. Vidal, J. F. Spinella, V. Saillour, C. Richer, J. Healy, E.<br />

Bareke, S. Busche, B. Ge, T. Pastinen, A. Droit, D. Sinnett.<br />

1216T Association <strong>of</strong> polymorphisms in the FOXE1<br />

gene, but not NKX2-1, with familial papillary thyroid<br />

carcinoma. S. G. Wilson, C.-Y. Yan, L. Ward, S. Chew,<br />

V. Panicker, S. J. Brown, S. Chiripal, J. Goldblatt, T. D.<br />

Spector, J. Walsh.<br />

1217F XPC gene founder splicing site mutation<br />

is common in Brazilian xeroderma pigmentosum<br />

patients. M. I. W. Achatz, K. M. Santiago, F. P. Vairo, P.<br />

Ashton-Prolla, P. F. V. de Medeiros, R. M. Rocha, S. R.<br />

Rogatto.<br />

1218W Rare variants in genes from esophageal<br />

squamous cell carcinoma genome-wide association<br />

studies identified by exome/whole genome sequencing<br />

<strong>of</strong> high-risk upper gastrointestinal cancer families. A.<br />

M. Goldstein, N. Hu, K. J. Jacobs, L.-J. He, X.-Y. Han, M.<br />

Rotunno, M. Cullen, J. Boland, H. Su, L. Wang, C. Wang,<br />

L. Burdett, M. Malasky, A. Hutchinson, M. Yeager, T. Ding,<br />

C. Giffen, M. A. Tucker, S. J. Chanock, M. Lee, P. R. Taylor.<br />

1219T Identification <strong>of</strong> breast cancer susceptibility<br />

genes. L. Guidugli, J. N. Weitzel, X. Wang, S. Hart, F. J.<br />

Couch, C. Szabo.<br />

1220F Mutations in SDHA are a common cause <strong>of</strong><br />

paragangliomas and pheochromocytomas and give<br />

rise to a diverse tumor spectrum. A. R. Mensenkamp, J.<br />

U. Rao, K. L. I. van Gassen, B. Kusters, J. W. M. Lenders,<br />

H. P. M. Kunst, H. J. L. M. Timmers, M. J. L. Ligtenberg.<br />

1221W Identifying novel cancer susceptibility genes<br />

through exome sequencing and copy number analysis<br />

<strong>of</strong> individuals with Li Fraumeni-like cancer phenotypes.<br />

S. E. Plon, L. C. Strong, B. Powell, L. Jiang, H. Cheung, D.<br />

Ritter, D. M. Muzny, D. A. Wheeler, R. A. Gibbs.<br />

1222T Development and validation <strong>of</strong> NGS-based<br />

molecular diagnosis <strong>of</strong> inherited forms <strong>of</strong> colorectal<br />

cancer. J. Tinat, F. Charbonnier, S. Coutant, R. Marlin,<br />

G. Bougeard-Denoyelle, S. Baert-Desurmont, M. Tosi, T.<br />

Frebourg, I. Tournier.<br />

1223F Interpretation <strong>of</strong> variants <strong>of</strong> unknown<br />

significance with a large database <strong>of</strong> genotyped and<br />

phenotyped individuals. B. T. Naughton, A. Chowdry, J.<br />

M. Macpherson, G. M. Benton.<br />

1224W Exome sequencing identifies rare deleterious<br />

mutations in DNA repair genes FANCC and BLM as<br />

potential breast cancer susceptibility alleles. E. R.<br />

Thompson, M. A. Doyle, S. M. Rowley, D. Y. H. Choong,<br />

G. K. Philip, A. H. Trainer, P. A. James, G. Mitchell, I. G.<br />

Campbell, kConFab.<br />

1225T Cancer genetic testing panels: Preliminary<br />

experience within an adult genetics practice. C. G.<br />

Selkirk, S. M. Weiss, K. J. Vogel, A. C. Newlin, S. M.<br />

Weissman, P. J. Hulick.<br />

1226F Thirty percent <strong>of</strong> breast cancer families negative<br />

by commercial BRCA1/BRCA2 testing are resolved by<br />

mutations in 13 other breast cancer genes, by BRCA1/<br />

BRCA2 phenocopies, and by BRCA1/BRCA2 CNVs.<br />

T. Walsh, S. Casadei, A. M. Thornton, G. Bernier, C. H.<br />

Spurrell, S. M. Stray, J. Mandell, M. K. Lee, M.-C. King.<br />

1227W Comparison <strong>of</strong> next-generation sequencing<br />

with traditional sequencing and MLPA for BRCA1 and<br />

BRCA2 testing. K. Chun, A. Brown, K. Ng, R. Denroche, J.<br />

D. McPherson.<br />

1228T Genomic capture and massively parallel<br />

sequencing reveals inherited loss-<strong>of</strong>-function<br />

mutations in 8 genes in 19% <strong>of</strong> familial breast cancer<br />

patients from Greece. A. Stavropoulou, T. Walsh, F.<br />

Fostira, M. Tsitlaidou, S. Casadei, S. Glentis, G. Fountzilas,<br />

I. Konstantopoulou, M. C. King, D. Yannoukakos.<br />

1229F Elevated rate <strong>of</strong> somatic L1 retrotransposition in<br />

colorectal tumors. S. Solyom, A. D. Ewing, E. Rahrmann,<br />

T. Doucet, H. H. Nelson, D. F. Sigmon, A. Casella, B.<br />

Erlanger, S. Wheelan, G. Faulkner, D. Haussler, D.<br />

Largaespada, H. H. Kazazian.<br />

1230W Mutational analysis <strong>of</strong> splicing machinery genes<br />

SF3B1, U2AF1 and SRSF2 in myelodysplasia and other<br />

common tumors. S. Lee, E. Je, M. Kim, J. Oh, N. Yoo.<br />

1231T Calling allele or haplotype-specific copy<br />

number in tumor sequence data. N. Dewal, Y. Hu, M.<br />

L. Freedman, T. LaFramboise, I. Pe’er, R. A. Gibbs, D. A.<br />

Wheeler.<br />

1232F Somatic mutation detection <strong>of</strong> tumor and<br />

matched-normal samples for semiconductor-based<br />

sequencing. A. H. Joyner, S. Utiramerur, D. Brinza, H.<br />

Breu, B. Krishnaswami, A. Shukla, J. Zhai, Y. Lou, F.<br />

Hyland, D. Thomas, E. Beasley.<br />

1233W Acute lymphoblastic leukemia: Novel<br />

therapeutic approach based on an active patientindividualized<br />

multipeptide vaccination. C. Schroeder,<br />

M. Sturm, U. Pflückhahn, M. Feldhahn, O. Kohlbacher,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


S. Stevanovic, H. G. Rammensee, P. Lang, O. Riess,<br />

P. Bauer.<br />

1234T No evidence for the role <strong>of</strong> somatic mutations<br />

and promoter hypermethylation <strong>of</strong> FH gene in the<br />

tumorigenesis <strong>of</strong> nonsyndromic uterine leiomyomas. S.<br />

Vaidya, K. P. Rao, Q. Hasan.<br />

1235F Somatic mutation spectrum <strong>of</strong> metastatic<br />

melanoma through exome sequencing <strong>of</strong> 48 tumornormal<br />

pairs. M. D. Willard, J. N. Calley, S.-S. Wong, R.<br />

H. Higgs, X. Ma, P. J. Ebert, S. M. Bray, I. H. Wulur, Y. Yue,<br />

Y. Lin, J. Wang, A. Aggarwal, S. Li, C. R. Reinhard, A. B.<br />

West, T. D. Barber.<br />

1236W RNA-seq identifies differentially expressed<br />

genes and mutations in oligodendrogliomas. E.<br />

Schrock, K. Szafranski, J. A. Campos Valenzuela, S.<br />

Schauer, D. Krex, A. Rump, K. Hackmann, G. Schackert,<br />

L. Kaderali, M. Platzer, B. Klink.<br />

1237T Identification and quantification <strong>of</strong> somatic<br />

mutations with the Ion AmpliSeq Cancer Panel. M.<br />

Andersen, S. Roman, K. Rhodes, C. VanLoy, A. Broomer,<br />

D. Topacio, G. Roma, R. Bennett, T. Neff, C. Beadling, C.<br />

Corless.<br />

1238F Whole-genome and targeted sequencing<br />

analysis <strong>of</strong> early stage high-grade serous ovarian<br />

cancer. M. Bibikova, S. Humphray, R. Grocock, J.<br />

Peden, F. Nielsen, Z. Kingsbury, J. Chien, E. L. Goode,<br />

V. Ho, C. April, S. Munchel, J. Cottrell, Y. Tarabishy, J. M.<br />

Cunningham, S. Kaufmann, L. C. Hartmann, K. R. Kalli, V.<br />

Shridhar, J.-B. Fan, G. Heath, D. Bentley.<br />

1239W Detection <strong>of</strong> somatic mutations in tumor<br />

genomes using de novo assembly with assembly to<br />

assembly mapping. A. R. Carson, W. Pfeiffer, T. Schwartz,<br />

G. Oliveira, T. Nicholas, G. Zhang, M. A. Miller, E. J. Topol,<br />

S. Levy.<br />

1240T Identification <strong>of</strong> therapeutic targetable<br />

mutations in cancer by whole transcriptome and<br />

genome sequencing. D. W. Craig, W. Liang, W. Tembe, A.<br />

Christ<strong>of</strong>orides, J. Aldrich, T. Izatt, J. M. Trent, J. D. Carpten.<br />

1241F Identification <strong>of</strong> somatic mutations in<br />

parathyroid tumors using whole exome sequencing. M.<br />

K. Cromer, L. F. Starker, M. Choi, R. Udelsman, C. Nelson-<br />

Williams, R. P. Lifton, T. Carling.<br />

1242W Exome sequencing <strong>of</strong> metastatic prostate<br />

tumors, GWAS and functional analysis <strong>of</strong> the<br />

methylation regulator TET2 in prostate cancer. M. Dean,<br />

M. Nickerson, K. M. Im, K. J. Misner, W. Tan, H. Lou, D.<br />

W. Wells, K. Frederickson, T. Harkins, T. Naab, B. Gold, T.<br />

Andersson, B. Zbar, W. M. Linehan, G. S. Bova, H. Li, S.<br />

Anderson, M. Yeager.<br />

1243T Identification <strong>of</strong> novel driver mutation in EGFR/<br />

KRAS/ALK: Negative lung adenocarcinoma <strong>of</strong> never<br />

smokers by whole exome sequencing. S. Han, J. Yoon,<br />

J. Ahn, H. Jang, M. Lee, H. Kim, B. Cho, J. Lee.<br />

1244F Detection <strong>of</strong> low frequency tumorigenesis<br />

POSTER SESSIONS 161<br />

variants by ultra deep sequencing (.1000x) across<br />

409 oncogenes. T. T. Harkins, C. C. Lee, M. Andersen,<br />

E. Levandowsky, M. Dindinger, J. Spangler, T. Ross, S.<br />

McLaughlin, V. Sheth.<br />

1245W Targeted sequencing <strong>of</strong> clinically relevant<br />

genes using TargetRich gene panels. K. Jansen<br />

Spayd, I. A. Vasenkova, T. Shvetsova, D. A. Kloske, R. C.<br />

Bachmeyer, D. T. Moore, K. E. Varley.<br />

1246T Rapid and economical re-sequencing <strong>of</strong><br />

hundreds <strong>of</strong> genes from sample-limited specimens<br />

using the Ion AmpliSeq Comprehensive Cancer<br />

Panel and Ion PGM semiconductor sequencing. D.<br />

Joun, S, M. Chen, B. Kong, I. Causga, C.-Y. Li, D. Ruff, R.<br />

Bennett, M. Shannon.<br />

1247F Bayes-MutSig: A novel approach to determine<br />

significantly mutated genes. N. B. Larson, H. Sicotte, J.<br />

Sinnwell, K. R. Kalari, E. Wieben, L. Wang, J. C. Boughey,<br />

M. Goetz, R. Weinshilboum, B. L. Fridley.<br />

1248W The transcriptional landscape and mutational<br />

pr<strong>of</strong>ile <strong>of</strong> lung adenocarcinoma. W. Lee, Y. Ju, J. Shin,<br />

J. Lee, B. Thomas, J. Lee, Y. Jung, J. Kim, J. Shin, S. Yoo,<br />

J. Kim, E. Lee, C. Kang, I. Park, H. Rhee, S. Lee, J. Kim, J.<br />

Kang, Y. Kim, J. Seo.<br />

1249T Genes with single nucleotide variations in earlyonset<br />

female breast cancer patients identified through<br />

exome sequencing. C. Lee, N. Leng, W. Kuo, H. Yang,<br />

K. Nobuta, C. Lin, C. Chang, Y. Lu, K. Lo, L. Hu, H. Chu,<br />

W. Chou, C. Chen, W. Yao, K. Chiu, A. Cheng, C. Shen, K.<br />

Chang, C. Haudenschild, C. Chen.<br />

1250F Pathway analysis <strong>of</strong> somatic mutations in<br />

the whole genome sequence <strong>of</strong> aggressive tumors<br />

in African <strong>American</strong> prostate cancer patients. K.<br />

Lindquist, R. Kazma, J. A. Mefford, T. J. H<strong>of</strong>fmann, N.<br />

Cardin, B. A. Rybicki, D. A. Chitale, A. Levin, J. S. Witte.<br />

1251W SeqWright’s next-gen sequencing <strong>of</strong> FFPE<br />

tumor tissue allows for analysis <strong>of</strong> multiple cancer<br />

markers with high sensitivity and excellent correlation<br />

to other validated clinical methods. A. C. Pond, X. X.<br />

Tan, L. T. Szkotnicki, V. Venegas, E. Zhou, Y. Mou, K. B.<br />

Thomas, P. Choppa, K. Guekunst, F. Lu.<br />

1252T Amplicon sequencing <strong>of</strong> tumors from xenograft,<br />

FFPE and fresh frozen samples. B. Riley-Gillis, C. Qiu, O.<br />

Puig, R. Benayed.<br />

1253F Loss <strong>of</strong> the canonical Notch mediator RBPJ is<br />

recurrent in oligoastrocytomas. P. Salo, E. I. Gaál, O.<br />

Tynninen, M. Niemelä, A. Laakso, A. Karppinen, A. Paetau,<br />

H. Mäenpää, J. Hernesniemi, M. Perola.<br />

1254W Characterization <strong>of</strong> a small cell prostate cancer<br />

using exome sequencing. A. F. Scott, D. W. Mohr, H.<br />

Ling, G. S. Liptak.<br />

1255T Pr<strong>of</strong>iling mutations in circulating tumor cells<br />

from breast cancer patients by targeted sequencing. Y.<br />

Shen, X. Xu, W. DeWitt, N. Xu, F. Z. Bisch<strong>of</strong>f, K. D. Crew,<br />

D. L. Hershman, M. A. Maurer, R. Parsons, K. Kalinsky.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


162 POSTER SESSIONS<br />

1256F Exome and whole genome mutational landscape<br />

in pancreatic ductal adenocarcinoma. L. Timms, A.<br />

Panchal, L. Mullen, J. Johns, R. Denroche, R. De Borja,<br />

F. Yousif, Z. Zha, M. Sam, A. M. K. Brown, T. Beck, J. D.<br />

McPherson.<br />

1257W De novo germline mosaic BRCA1 exon deletion<br />

associated with bilateral breast cancer. M. Tischkowitz,<br />

I. Delon, A. Taylor, A. Molenda, J. Drummond, K. Oakhill,<br />

A. Girling, H. Liu, J. Whittaker, R. Treacy.<br />

1258T Single-nucleotide variant calling from lowcoverage<br />

single-cell sequence data using tumor<br />

population structure. S. Vattathil, N. Navin, P. Scheet.<br />

1259F Initial genomic analysis <strong>of</strong> a pure erythroid<br />

leukemia developing in association with hydroxyurea<br />

treatment for sickle cell anemia. Z. Wang, D. Darbari, Z.<br />

McIver, I. Maric, L. Diaw, Y. Song, P. Johansson, J. B. He,<br />

J. Wei, A. J. Barrett, J. Khan, J. G. Taylor.<br />

1260W Novel L1 and Alu retrotransposon insertions<br />

in cancer-related gene loci in the NCI-60 cancer cell<br />

lines. J. Zampella, K. Burns.<br />

1261T Exome sequencing approach for identification<br />

<strong>of</strong> causative mutations in neur<strong>of</strong>ibromatosis type<br />

1-associated plexiform neur<strong>of</strong>ibromas. A. Pemov,<br />

H. Li, M. Wallace, D. R. Stewart, NISC Comparative<br />

Sequencing <strong>Program</strong>, NHGRI, NIH Intramural Sequencing<br />

Center.<br />

1262F DICER1 RNAseIIIb domain is mutated at two<br />

different sites in two different lesions in the same<br />

patient. M. Wu, N. Sabbaghian, N. Hamel, C. Choong, A.<br />

Charles, W. Foulkes.<br />

1263W Multiplex PCR-based targeted deep<br />

sequencing <strong>of</strong> the comprehensive human lung cancer<br />

gene panel for the detection <strong>of</strong> KRAS and EGFR<br />

mutations. Q. Peng, R. Gardner, N. Slepushkina, V.<br />

Devgan.<br />

1264T Highly sensitive detection <strong>of</strong> rare somatic<br />

mutations in tissue and plasma. A. Marziali.<br />

1265F Integrative investigation on breast cancer by<br />

ER, PR and HE2-defined subgroups using mRNA<br />

and microRNA expression pr<strong>of</strong>iling and cancer<br />

core pathway analysis. X. Dai, S. Khan, T. Heikkinen,<br />

P. Heikkilä, K. Aittomäki, C. Blomqvist, D. Greco, H.<br />

Nevanlinna.<br />

1266W Novel oligoheterocycles and potential ability as<br />

anti-cancer therapy. S. Al-Aqeel.<br />

1267T Relative telomere length differs according<br />

to DNA extraction method. L. Boardman, K.<br />

Litzelman, R. Johnson, M. Devine, R. Firl, A. Johnson,<br />

M. Vincent, J. Cunningham, C. Engelman, S. Seo,<br />

R. Gangnon, D. Rider, G. Petersen, S. Thibodeau, H.<br />

Skinner.<br />

1268F Hereditary breast/ovarian cancer in Algerian<br />

population: Molecular analysis <strong>of</strong> BRCA1 and BRCA2<br />

genes. F. Cherbal, R. Bakour, S. Adane, K. Boualga, N.<br />

Salhi, A. Chikh, P. Maillet.<br />

1269W GENECAPP: Sequence-specific in vivo analysis<br />

<strong>of</strong> protein-DNA interactions in human cancer cell<br />

lines. H. Guillen Ahlers, A. Ludwig-Kubinski, S. Tian,<br />

C. Anderson, A. M. Greene, J. Kennedy-Darling, M.<br />

Levenstein, R. Knoener, M. Chesnik, M. Scalf, Y. Yuan, R.<br />

Cole, M. Shortreed, L. Cirillo, R. Stewart, L. M. Smith, M.<br />

Olivier.<br />

1270T Examination <strong>of</strong> UVR-induced DNA damage and<br />

repair and its association with apoptosis in human<br />

keratinocytes and fibroblasts. M. Karbaschi, M. D.<br />

Evans, S. Macip, M. S. Cooke.<br />

1271F The IRS1 rs2943641 genetic variant and the<br />

protection against cancer. S. Romeo, C. Maglio, J.<br />

Andersson Assarsson, K. Sjöholm, L. Sjöström, L. M.<br />

Carlsson.<br />

1272W Lynch syndrome: Awareness among medical<br />

students at a United States medical school. J. S. Taylor,<br />

M. K. Frey, M. Biewald, M. Worley, Jr., S. Lin, K. Holcomb.<br />

1273T Characterization <strong>of</strong> active chromatin signatures<br />

in testicular germ cell tumor cell lines. S. J. White,<br />

Y. van de Zwan, C. M. de Boer, F. Rossello, L. H. J.<br />

Looijenga, A. J. Notini.<br />

1274F Single nucleotide polymorphisms and cancer<br />

risk in individuals with Costello syndrome. B. A.<br />

Thompson, G. Desachy, J. Quinn, A. E. Toland, L. A.<br />

Weiss, K. A. Rauen.<br />

1275W Assessment <strong>of</strong> Individuals with BRCA1 and<br />

BRCA2 large genomic rearrangements in high-risk<br />

breast cancer and ovarian cancer families. L. Zhang, A.<br />

Arnold, M. Harlan, M. Robson.<br />

1276T Genetic background <strong>of</strong> familial colorectal<br />

cancer type X. T. T. Nieminen, J.-P. Mecklin, H. J.<br />

Järvinen, P. Peltomäki.<br />

1277F Development <strong>of</strong> a robust method for<br />

establishing B cell lines using Epstein-Barr virus. I.<br />

Danjoh, R. Shirota, Y. Nakamura.<br />

1278W Association <strong>of</strong> single nucleotide<br />

polymorphisms in ERa, ERb, CYP17A1 and CYP19A1<br />

with breast cancer risk: A case control study from<br />

North India. S. Chattopadhyay, S. V. S. Deo, N. K.<br />

Shukla, S. A. Husain.<br />

1279T Efficacy <strong>of</strong> Sequenom Sample ID Plus®<br />

SNP genotyping in identification <strong>of</strong> FFPE tumor<br />

samples. J. K. Miller, N. Buchner, D. Pasternack, J. D.<br />

McPherson.<br />

Statistical <strong>Genetics</strong> and Genetic<br />

Epidemiology<br />

1280W Gene-specific accelerated transcriptional<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


aging in type 2 diabetes. J. Kent, M. Almeida, J. Peralta,<br />

H. H. H. Göring, J. Curran, M. Johnson, T. Dyer, S.<br />

Cole, J. Jowett, A. Comuzzie, M. Mahaney, L. Almasy,<br />

J. MacCluer, E. Moses, R. Duggirala, J. Blangero, S.<br />

Williams-Blangero.<br />

1281T Integrating metabolomic information in genomewide<br />

association studies. R. Rueedi, M. Ledda, T. Corre,<br />

R. Salek, V. Mooser, P. Vollenweider, G. Waeber, U. K.<br />

Genick, Z. Kutalik, S. Bergmann.<br />

1282F Application <strong>of</strong> principal components analysis<br />

to the investigation <strong>of</strong> expression pr<strong>of</strong>ile data. H. H. H.<br />

Göring, A. R. Sanders, E. I. Drigalenko, W. Moy, J. Duan,<br />

J. E. Curran, M. P. Johnson, E. K. Moses, J. Blangero, P.<br />

V. Gejman.<br />

1283W Prioritization <strong>of</strong> SNPs identified in microRNAs<br />

and their targeted genes by integrated analysis <strong>of</strong> high<br />

throughput datasets. X. Chen, H. Zhao.<br />

1284T Cis- and trans-eQTL analysis in 5,311 unrelated<br />

peripheral blood samples identifies novel disease<br />

pathways and helps to pinpoint causal variants.<br />

H. Westra, T. Esko, M. J. Peters, C. Schurmann, H.<br />

Yaghootkar, J. Kettunen, M. W. Christiansen, R. S. N.<br />

Fehrmann, G. J. te Meerman, A. H<strong>of</strong>man, F. Rivadeneira,<br />

E. Reinmaa, R. C. Jansen, J. Brody, S. A. Gharib, A.<br />

Suchy-Dicey, D. Enquobahrie, A. G. Uitterlinden, C.<br />

Wijmenga, B. M. Psaty, S. Ripatti, T. Frayling, A. Teumer, A.<br />

Metsepalu, J. B. J. van Meurs, L. Franke.<br />

1285F Ridge regression for genetic data: A semiautomatic<br />

method to guide the choice <strong>of</strong> ridge<br />

parameter. E. Cule, M. De Iorio.<br />

1286W Defining the functional significance <strong>of</strong> genes<br />

using natural human knockouts. J. D. H<strong>of</strong>fman, K. O.<br />

Polzin, A. E. Fish, P. Mayo, N. Schnetz-Boutaud, J. L.<br />

Haines.<br />

1287T Intronic single nucleotide polymorphism<br />

<strong>of</strong> CALM-1 gene is significantly associated with<br />

osteoarthritis knee. S. Raj, R. Srivastava, D. Sanghi, S.<br />

Awasthi, A. Mishra.<br />

1288F Genetic risk factor in development and<br />

progression <strong>of</strong> osteoarthritis knee. R. N. Srivastava, A.<br />

Mishra, S. Raj, D. Sanghi.<br />

1289W Functional variant within vitamin D metabolism<br />

gene ACADSB is associated with a more severe<br />

disease in multiple sclerosis. M. F. George, F. B. S.<br />

Briggs, P. P. Ramsay, H. Quach, A. Bernstein, B. Acuna, L.<br />

Shen, E. Mowry, C. Schaefer, L. F. Barcellos.<br />

1290T Homozygous c.14576G.A variant <strong>of</strong> RNF213<br />

predicts early-onset and severe form <strong>of</strong> Moyamoya<br />

disease. S. Miyatake, N. Miyake, H. Touho, H. Doi, H.<br />

Saitsu, K. Shimojima, T. Yamamoto, N. Okamoto, N.<br />

Kawahara, Y. Kuroiwa, M. Taguri, S. Morita, Y. Matsubara,<br />

S. Kure, N. Matsumoto.<br />

1291F C-reactive protein as a prognostic marker in<br />

melanoma progression. S. Fang, Y. Wang, D. Sui, H. Liu,<br />

POSTER SESSIONS 163<br />

C. Schacherer, J. Gardner, M. Ross, J. Gershenwald, J.<br />

Reveille, L. Wang, Q. Wei, C. Amos, J. Lee.<br />

1292W TGFBR1 variant associated with constitutively<br />

decreased TGF-b signaling and risk for colorectal<br />

cancer. M. J. Pennison, N. Bellam, J. Zimmerman, Q.<br />

Zeng, M. Wang, M. Sadim, V. Kaklamani, N. Yi, K. Zhang,<br />

J. Baron, D. O. Stram, B. Pasche, CCFR Investigators,<br />

Colon Cancer Family Registry, National Cancer Institute.<br />

1293T Limited survival <strong>of</strong> MEN1 patients with<br />

mutations in the JunD interacting domain and<br />

first elements for intrafamilial correlation in MEN1<br />

syndrome: A study from the GTE cohort. J. Thevenon,<br />

A. Bourredjem, L. Faivre, A. Costa, E. Gautier, C.<br />

Bonithon-Kopp, A. Calender, C. Binquet, P. Goudet,<br />

Members <strong>of</strong> Groupe d’…tude des Tumeurs Endocrines.<br />

1294F Association <strong>of</strong> vitamin D receptor gene<br />

polymorphism and vitamin D status in knee<br />

osteoarthritis. D. Sanghi, R. Srivastava, S. Raj.<br />

1295W Association between neural genes DRD2,<br />

AVPR1a, and ASPM and endophenotypes <strong>of</strong> speech<br />

sound disorder. C. M. Stein, F. Qiu, B. Truitt, R.<br />

Raghavendra, P. Joseph, A. A. Avrich, R. P. Igo, Jr., J. Tag,<br />

L. Freebairn, H. G. Taylor, B. A. Lewis, S. K. Iyengar.<br />

1296T Parent-<strong>of</strong>-origin effects and gender differences<br />

influence age-at-onset variation in FAP ATTRV30M<br />

kindreds. C. Lemos, T. Coelho, A. Martins-da-Silva, J.<br />

Sequeiros, A. Sousa.<br />

1297F Genome-wide analysis <strong>of</strong> germline copy number<br />

aberrations and association with breast cancer<br />

susceptibility. Y. Sapkota, B. S. Sehrawat, S. Ghosh, P. J.<br />

Robson, C. E. Cass, J. R. Mackey, S. Damaraju.<br />

1298W Whole-genome detection <strong>of</strong> disease-associated<br />

deletions or homozygosity in a case-control study <strong>of</strong><br />

rheumatoid arthritis. C. C. Wu, S. Shete, E. J. Jo, Y. E.<br />

Lu, Y. Xu, W. V. Chen, C. I. Amos.<br />

1299T T1D risk score modeling using dense genotypes<br />

in autoimmune associated genomic regions in 6,670<br />

cases and 9,416 controls and validation in 2,601<br />

affected sibpair families and 69 trio families. W.-M.<br />

Chen, S. Onengut-Gumuscu, P. Concannon, S. S. Rich,<br />

T1DGC.<br />

1300F Variants in/near DNER are reproducibly<br />

associated with type 2 diabetes in Pima Indians. Y. L.<br />

Muller, M. AbdusSamad, R. Hanson, W. C. Knowler, C.<br />

Bogardus, L. Baier.<br />

1301W Two multiple sclerosis risk variants from a<br />

large genome-wide association study are associated<br />

with disease progression in a population-based case<br />

cohort. H. Quach, M. F. George, F. B. S. Briggs, P. P.<br />

Ramsay, B. Acuna, L. Shen, E. Mowry, A. Bernstein, C.<br />

Schaefer, L. F. Barcellos.<br />

1302T Unraveling phenotype heterogeneity in prostate<br />

cancer susceptibility in Finland utilizing covariatebased<br />

analysis. C. D. Cropp, C. L. Simpson, T. Wahlfors,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


164 POSTER SESSIONS<br />

A. George, M. P. S. Jones, U. Harper, D. Ponciano-<br />

Jackson, T. L. Tammela, J. Schleutker, J. E. Bailey-Wilson.<br />

1303F A search for genetic variants predisposing<br />

to radiation-induced meningioma. R. Bruchim, B.<br />

Oberman, R. Milgram, I. Novikov, S. Sadetzki.<br />

1304W Variants in one-carbon metabolism and<br />

blood folate, homocysteine and B12 deficiency in a<br />

population-based study. K. S. Crider, D. R. Maneval, N.<br />

F. Dowling, L. B. Bailey, G. Kaudwell, L. Hao, Z. Li, R. J.<br />

Berry.<br />

1305T Disease-associated genotype and allele sharing<br />

among human populations from throughout the world.<br />

M. M. DeAngelis, M. A. Morrison, D. J. Morgan, K. Mayne,<br />

R. Robinson, G. Silvestri, D. A. Schaumberg, E. E. Tsironi,<br />

I. K. Kim, J. Ramke, K. H. Park, L. A. Farrer.<br />

1306F Hidden heritability and risk prediction based<br />

on genome-wide association studies. N. Chatterjee, B.<br />

Wheeler, J. Sampson, P. Hartge, S. Chanock, J. Park.<br />

1307W Obesity susceptibility loci and associations<br />

across the pediatric body mass index distribution. S. F.<br />

A. Grant, H. Hakonarson, T. R. Rebbeck, J. A. Mitchell.<br />

1308T Large-scale genome-wide association metaanalysis<br />

using imputation from 2188-haplotype<br />

1000 Genomes reference panel identifies five novel<br />

susceptibility loci for BMI and additional novel sexspecific<br />

loci for BMI and WHR. M. Horikoshi, R. Mägi, I.<br />

Surakka, S. Wiltshire, A. Sarin, A. Mahajan, L. Marullo, T.<br />

Ferreira, S. Hägg, J. S. Ried, T. Winkler, G. Thorleifsson,<br />

N. Tsernikova, T. Esko, C. Willenborg, C. P. Nelson, M.<br />

Beekman, S. M. Willems, A. P. Morris, C. M. Lindgren, M. I.<br />

McCarthy, S. Ripatti, I. Prokopenko on behalf <strong>of</strong> ENGAGE<br />

Consortium.<br />

1309F A two-stage genome-wide association study to<br />

identify single nucleotide polymorphisms associated<br />

with development <strong>of</strong> erectile dysfunction following<br />

radiotherapy for prostate cancer. S. Kerns, R. Stock,<br />

N. Stone, M. Buckstein, Y. Shao, C. Campbell, L. Rath,<br />

R. Hixson, J. Cesaretti, M. Terk, H. Ostrer, B. Rosenstein,<br />

Collaboration developed under Radiogenomics<br />

Consortium.<br />

1310W Genetic variation and vitamin D sufficiency in<br />

the U.S. population (NHANES III). C. O. S. Neal, J. M.<br />

Jackson, K. S. Crider.<br />

1311T The genome-wide association study <strong>of</strong><br />

phenotypic robustness in human: A canalization study.<br />

R. Li, T. D. Spector, J. B. Richards.<br />

1312F A genome- and phenome-wide association<br />

study to identify genetic variants influencing platelet<br />

count and volume and their pleiotropic effects. K.<br />

Shameer, J. C. Denny, K. Ding, D. R. Crosslin, C. G. Chute,<br />

P. Peissig, J. Pacheco, R. Li, M. de Andrade, M. D. Ritchie,<br />

D. R. Masys, R. L. Chisholm, E. B. Larson, C. A. McCarty,<br />

D. M. Roden, G. P. Jarvik, I. J. Kullo.<br />

1313W Heterogeneity in polygenic contribution to<br />

ischemic stroke subtypes by age at onset. M. Traylor,<br />

H. S. Markus, S. Bevan, M. Dichgans, R. Malik, H. Segal,<br />

P. M. Rothwell, C. L. Sudlow, C. M. Lewis, Wellcome Trust<br />

Case Control Consortium (WTCCC2).<br />

1314T Strategies for developing prediction models with<br />

increased discriminatory accuracy from genome-wide<br />

association studies. J. Wu, R. M. Pfeiffer, M. H. Gail.<br />

1315F Concurrent modeling <strong>of</strong> multiple phenotypes<br />

and genotypes in family data: Implications for cleft<br />

gene discovery. M. Govil, N. Mukhopadhyay, R. M.<br />

Silva, A. R. Vieira, S. M. Weinberg, K. Neiswanger, M. L.<br />

Marazita.<br />

1316W A phenome-wide association study using<br />

multiple National Health and Nutrition Examination<br />

Surveys to identify pleiotropy. M. A. Hall, A. Verma, K.<br />

D. Brown-Gentry, R. Goodloe, J. Boston, S. Wilson, B.<br />

McClellan, C. Sutcliffe, H. H. Dilks, N. B. Gillani, H. Jin, P.<br />

Mayo, M. Allen, N. Schnetz-Boutaud, S. A. Pendergrass,<br />

D. C. Crawford, M. D. Ritchie.<br />

1317T Genetic variants in pigmentation genes, skin<br />

color, and risk <strong>of</strong> skin cancer in Japanese. T. Suzuki, Y.<br />

Abe, J. Yoshizawa, Y. Hozumi, T. Nakamura, G. Tamiya.<br />

1318F Validity <strong>of</strong> the Mendelian randomization<br />

approach: Do the principles really hold? M. Taylor, N. J.<br />

Timpson, J. P. Kemp, B. St. Pourcain, D. M. Evans, S. M.<br />

Ring, D. A. Lawlor, G. Davey Smith.<br />

1319W Polygenic modeling <strong>of</strong> healthy aging. N. E.<br />

Wineinger, G. Atzmon, N. Barzilai, N. J. Schork.<br />

1320T Extended haplotype association study in<br />

Crohn’s disease identifies a novel Ashkenazi Jewishspecific<br />

missense mutation in the NF- B pathway<br />

gene, HEATR3. K. Y. Hui, W. Zhang, A. Gusev, N. Warner,<br />

G. Nuñez, I. Pe’er, I. Peter, J. H. Cho.<br />

1321F Association analysis <strong>of</strong> CYP2A6 polymorphism<br />

in SIDS. Y. Inaoka, M. Nakatome, F. Satoh, I. Hasegawa,<br />

M. Q. Fujita, M. Osawa.<br />

1322W Do severity <strong>of</strong> early lung disease and meconium<br />

ileus in cystic fibrosis have common genetic<br />

contributors? W. Li, D. Su, T. Chiang, X. Li, M. R. Miller,<br />

K. Keenan, H. Corvol, F. A. Wright, S. Blackman, M. L.<br />

Drumm, G. R. Cutting, M. R. Knowles, P. R. Durie, J. M.<br />

Rommens, L. Sun, L. J. Strug.<br />

1323T Influence <strong>of</strong> host genetics and environment on<br />

nasal carriage <strong>of</strong> Staphylococcus aureus in Danish<br />

middle-aged and elderly twins. P. S. Andersen, J. K.<br />

Pedersen, P. Fode, R. L. Skov, V. G. Fowler, Jr., M. Stegger,<br />

K. Christensen.<br />

1324F Polygenes and estimated heritability <strong>of</strong> prostate<br />

cancer in an African <strong>American</strong> sample using GWAS<br />

data. J. He, G. Chen, B. Henderson, C. Haiman, D. Stram,<br />

Genome-Wide Association Studies <strong>of</strong> Prostate Cancer in<br />

African <strong>American</strong>s.<br />

1325W Using identity-by-descent information to detect<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


de novo and recent mutations in population-based<br />

exome-sequencing studies. N. Solovieff, M. Fromer, D.<br />

Ruderfer, J. Moran, K. Chambert, C. Hultman, P. Sullivan,<br />

H. Williams, E. Rees, P. Gormley, A. Palotie, G. Kirov, M.<br />

Owen, M. O’Donovan, P. Sklar, S. McCarroll, S. Purcell.<br />

1326T Mitochondrial DNA polymorphism 13704 (C/T)<br />

might induce hematologic malignancy predisposition<br />

in Turkish population. N. Duzkale, A. Tatar.<br />

1327F Significant association <strong>of</strong> LPL polymorphisms<br />

with HDL- cholesterol level in Tongan adults. I. Naka, R.<br />

Kimura, T. Inaoka, Y. Matsumura, J. Ohashi.<br />

1328W Personalized risk prediction for prostate cancer<br />

according to specific family history. L. Cannon-Albright,<br />

F. Albright, W. Lowrance, R. Stephenson.<br />

1329T Estimating disease risk from environmental<br />

and genetic factors to motivate behavioral changes.<br />

C. M. Lewis, J. M. Yarnall, G. H. M. Goddard, D. J. M.<br />

Crouch.<br />

1330F Improving celiac disease risk prediction by<br />

testing non-HLA variants additional to HLA variants.<br />

J. Romanos, A. Rosen, V. Kumar, G. Trynka, L. Franke,<br />

A. Szperl, J. Gutierrez-Achury, C. C. van Diemen,<br />

R. Kanninga, S. A. Jankipersadsing, A. K. Steck, G.<br />

Eisenbarth, D. A. van Heel, B. Cukrowska, V. Bruno, M. C.<br />

Mazzilli, C. Nunez, J. R. Bilbao, M. L. Mearin, D. Barisani,<br />

M. Rewers, J. Norris, A. Ivarsson, H. M. Boezen, E. Liu, C.<br />

Wijmenga, PreventCD Group.<br />

1331W Bayesian polygenic prediction <strong>of</strong> myocardial<br />

infarction risk and lipid levels. B. Vilhjalmsson, R. Do,<br />

E. A. Stahl, B. Pasaniuc, S. Pollack, N. Zaitlen, J. Yang,<br />

M. E. Goddard, P. M. Visscher, P. Kraft, N. Patterson, S.<br />

Kathiresan, A. L. Price.<br />

1332T Testing for the presence <strong>of</strong> liability models. C.<br />

Herold, T. Vaitsiakhovich, T. Becker.<br />

1333F Alcohol and aldehyde dehydrogenase<br />

polymorphisms and blood pressure elevation in<br />

Japanese over 20 years. M. Isomura, T. Wang, Y.<br />

Yoshida, T. Nabika.<br />

1334W The PPP6R3/LRP5 locus influences lean<br />

mass in children <strong>of</strong> different ethnic background<br />

and highlights pleiotropic effects on muscle-bone<br />

interactions. M. C. Medina Gomez, D. H. M. Heppe, K.<br />

Estrada, J. Van Meurs, A. H<strong>of</strong>man, Y.-H. Hsu, D. Karasik,<br />

V. W. V. Jaddoe, M. C. Zillikens, A. G. Uitterlinden, F.<br />

Rivadeneira, GEFOS Consortium.<br />

1335T Examining the interaction effect <strong>of</strong> SNPs<br />

associated with urinary bladder cancer. H. Schwender,<br />

S. Selinski, T. Stöcker, M. Blaszkewicz, R. Marchan, K.<br />

Ickstadt, K. Golka, J. Hengstler.<br />

1336F Multivariate modeling for a more powerful<br />

genetic association analysis. S. Eyheramendy, C. Meza.<br />

1337W Random-effects model for massive meta<br />

analysis in genome-wide association study with<br />

POSTER SESSIONS 165<br />

structured populations. E. Kang, N. Furlotte, B. Han, J.<br />

Joo, R. Davis, A. Lusis, E. Eskin.<br />

1338T Comparison <strong>of</strong> rare variant tests. J. Lihm, E. J.<br />

Yoon, H. Wu, T. Harris, C. Wong, J. Ceris, J. Weisburd, N.<br />

R. Mendell, W. Kim, K. Ahn, D. Gordon, S. J. Finch.<br />

1339F Artificial intelligence analysis <strong>of</strong> prostate cancer<br />

susceptibility using a pareto-optimized computational<br />

evolution system. J. H. Moore, D. P. Hill, A. Sulovari, L.<br />

Kidd.<br />

1340W A simple Bayesian method for modeling effect<br />

heterogenity across genetic studies. C. C. A. Spencer,<br />

P. J. Donnelly, M. Pirinen.<br />

1341T Effectively identifying and characterizing eQTLs<br />

from multiple tissues using a meta-analytic approach.<br />

J. Sul, B. Han, C. Ye, T. Choi, E. Eskin.<br />

1342F PEDF gene polymorphism (p.Met72Thr) analysis<br />

in diabetic retinopathy cases. S. Passan, V. Vanita.<br />

1343W Chromosome 10 gene may be associated to<br />

response to Leishmania antigens. L. Pereira, J. Pescarini,<br />

R. Ferreira, L. M. Camargo, H. Krieger, L. M. Garrido.<br />

1344T Genetic associations with essential amino acids<br />

in infants with patent ductus arteriosus. K. K. Ryckman,<br />

J. M. Dagle, O. A. Shchelochkov, S. L. Berberich, J. C.<br />

Murray.<br />

1345F Low frequency SNPs are associated with<br />

congenital and severe clinical phenotypes in an<br />

eectronic medical record. J. D. Mosley, D. M. Roden, J.<br />

D. Denny.<br />

1346W Rare variant testing for meta-analysis and<br />

survival analysis. H. Chen, T. Lumley, J. Dupuis, J. Brody,<br />

A. Morrison, B. Cornes, D. J. Lybarger, B. Davis, C. Sitlani,<br />

D. Siscovick, J. B. Meigs, L. A. Cupples.<br />

1347T Selection <strong>of</strong> sequence variants for quantitative<br />

traits using penalized regression: Using LASSO, LARS<br />

and elastic net in the tiled regression framework. Y.<br />

Kim, B. Suktitipat, A. J. M. Sorant, A. F. Wilson.<br />

1348F Identification <strong>of</strong> genome-wide SNPs that are<br />

informative for individual genetic heritage in the family<br />

investigation <strong>of</strong> nephropathy and diabetes. R. C.<br />

Williams, FIND Research Group.<br />

1349W Testing copy number variant/trait associations<br />

detected using Manhattan plots. G. A. Satten, D.<br />

Ramachandran, J. G. Mulle, A. S. Allen, L. J. H. Bean, C.<br />

Maslen, S. L. Sherman, R. H. Reeves, M. E. Zwick.<br />

1350T A novel collapsing method for rare copy number<br />

variants. J. P. Szatkiewicz, P. F. Sullivan, J. Y. Tzeng.<br />

1351F A pseudo-score-based meta-analysis in genetic<br />

association studies: Application to Mayo Genome<br />

Consortia data. E. Ryu, R. E. Gullerud, P. A. Decker, J.<br />

Pathak, P. J. Limburg, S. J. Bielinski.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


166 POSTER SESSIONS<br />

1352W Diacylglycerol kinase K variants impact<br />

hypospadias in a California study population. S. L.<br />

Carmichael, N. Mohammed, C. Ma, D. Iovannisci, S.<br />

Choudhry, L. S. Baskin, J. S. Witte, G. M. Shaw, E. J.<br />

Lammer.<br />

1353T GEEWAS: Family-based genome-wide<br />

association studies for non-normal responses. C.<br />

Ekstrom.<br />

1354F An multiple testing procedure for association<br />

studies appropriately incorporating admixture signals.<br />

G. Gao, W. Chen.<br />

1355W Correcting for population structure due to rare<br />

and common variants with an approximate Bayesian<br />

regression framework. G. E. H<strong>of</strong>fman, J. G. Mezey.<br />

1356T Unified association analysis <strong>of</strong> genes, regions<br />

or pathways containing multiple SNPs. L. C. Lazzeroni,<br />

A. Ray.<br />

1357F Genome-wide association study on the variation<br />

<strong>of</strong> quantitative trait as a tool to identify important<br />

genetic variants for related complex diseases: An<br />

example <strong>of</strong> CHD risk in T2D patients. Z. Liu, Q. Qi, F. Hu,<br />

L. Qi, L. Liang.<br />

1358W Power and sample size calculations for genetic<br />

association tests in the presence <strong>of</strong> pleiotropy. D.<br />

Londono, D. Gordon.<br />

1359T Using regression residuals to map association<br />

between genetic variants and environmentally<br />

influenced longitudinal phenotypes. A. Musolf, D.<br />

Londono, R. Wang, J. Brandon, J. A. Herring, C. A. Wise,<br />

H. Zou, M. Jin, L. Yu, S. J. Finch, T. C. Matise, D. Gordon.<br />

1360F Enabling mixed model association analysis<br />

for large case-control studies. A. Price, N. Zaitlen, B.<br />

Vilhjalmsson, T. Hayeck, S. Pollack, J. Yang, G. B. Chen,<br />

M. Goddard, P. Visscher, N. Patterson.<br />

1361W Accounting for parent-<strong>of</strong>-origin effects<br />

detects association between 4q35 genetic variants<br />

and combined asthma-plus-rhinitis phenotype. C.<br />

Sarnowski, G. Malerba, Q. Vincent, C. Laprise, K. Rohde,<br />

M. F. M<strong>of</strong>fatt, P. Margaritte-Jeannin, M.-H. Dizier, P. F.<br />

Pignatti, W. O. C. Cookson, M. Lathrop, F. Demenais, E.<br />

Bouzigon, EGEA Collaborative Group.<br />

1362T Evaluation <strong>of</strong> classical multivariate methods for<br />

gene-based tests <strong>of</strong> association with multiple related<br />

traits. Y. Shu, R. Watanabe, J. Lewinger.<br />

1363F A two-stage random forest approach to<br />

identify genetic variants using recombination hotspot<br />

information. S. Szymczak, Q. Li, Y. Kim, A. Dasgupta, J.<br />

D. Malley, J. E. Bailey-Wilson.<br />

1364W Effect size distribution for prioritizing results <strong>of</strong><br />

association studies. D. Zaykin, C.-L. Kuo.<br />

1365T Modeling multivariate and correlated data in<br />

genetic association analysis. J. H. Zhao, F. Xue, Q. Tan,<br />

S. Li, J. A. Luan.<br />

1366F A novel spatial mapping method identifies<br />

shared genetic effects across immune-mediated<br />

diseases. C. Cotsapas, J. Kasvin-Felton.<br />

1367W Adjust local ancestry to detect rare variants in<br />

next-generation sequencing data. X. Wang, X. Zhao.<br />

1368T Detecting association for low-frequency variants<br />

in case-control studies. C. Xing, C. Y. Lin.<br />

1369F The empirical assessment <strong>of</strong> statistical power <strong>of</strong><br />

rare variant association methods. K. Hao, H. Chen, H.<br />

Zhou, Z. Kan, H. Zheng, X. Liu, S. Li, T. Barber, Z. Gong,<br />

H. Gao, M. Willard, J. Xu, R. Hauptschein, P. Rejto, G.<br />

Wang, Q. Zhang, R. Cheng, K. Sung, Z. Peng, C. Zhang,<br />

Q. Zhang, R. Poon, S. Fan, J. Wang, J. Hardwick, C.<br />

Reinhard, Y. Li, J. Luk, M. Mao, H. Dai.<br />

1370W Rare variant burden tests and meta-analysis<br />

using summary level statistics. D. Liu, G. Abecasis.<br />

1371T A geometric framework for the evaluation <strong>of</strong><br />

rare variant tests <strong>of</strong> association. N. Tintle, K. Liu, S.<br />

Fast, M. Zawistowski.<br />

1372F Subset-based approach to combined genetic<br />

association analysis <strong>of</strong> heterogeneous phenotypes. S.<br />

Bhattacharjee, S. M. Boca, P. Rajaraman, K. B. Jacobs,<br />

W. A. Wheeler, B. S. Melin, P. Hartge, M. Yeager, C.<br />

C. Chung, S. J. Chanock, N. Chatterjee, GliomaScan<br />

Consortium.<br />

1373W Genome-wide significance thresholds for SNPs<br />

ascertained by sequencing. T. Blackwell, A. K. Manning,<br />

GoT2D Investigators.<br />

1374T On the analysis <strong>of</strong> imputed genotypes in familybased<br />

association studies. A. Cobat, A. Alcaïs, E. Schurr.<br />

1375F Sex-specific and X-chromosome association<br />

studies <strong>of</strong> venous thromboembolism. M. de Andrade, S.<br />

M. Armasu, L. L. Chan, J. A. Heit.<br />

1376W Correcting for the effect <strong>of</strong> cryptic relatedness<br />

and population structure among cohorts in metaanalysis<br />

<strong>of</strong> GWAS. T. Feng, N. Morris, X. Zhu.<br />

1377T Genome-wide association study-identified<br />

genetic variants for lipid traits are associated with<br />

gallstone disease in the diverse Third National Health<br />

and Nutrition Examination Survey. R. Goodloe, K.<br />

Brown-Gentry, N. Gillani, H. Jin, P. Mayo, M. Allen, B.<br />

McClellan, J. Boston, C. Sutcliffe, N. Schnetz-Boutaud, H.<br />

Dilks, D. Crawford.<br />

1378F A unified framework for testing for genetic<br />

associations integrating environmental exposures. S.<br />

S. Han, P. S. Rosenberg, N. Chatterjee.<br />

1379W Efficient association analysis for groups <strong>of</strong><br />

genetic markers that avoids confounding by genetic<br />

structure. D. Heckerman, C. Lippert, J. Listgarten.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1380T A non-threshold region-specific method for<br />

detecting rare variants in common diseases. A. R.<br />

Hsieh, C. C. Chang, C. S. J. Fann.<br />

1381F Joint admixture and association test on African<br />

<strong>American</strong> inflammatory bowel disease identifies<br />

novel significant loci. C. Huang, S. Kugathasan, D. P.<br />

McGovern, J. H. Cho, R. H. Duerr, J. D. Rioux, M. S.<br />

Silverberg, T. Dassopoulos, L. W. Datta, L. W. H. Kao, S.<br />

R. Brant.<br />

1382W Comparison <strong>of</strong> phylogenetic and haplotype<br />

methods for the study <strong>of</strong> genotype/phenotype<br />

association in genome-wide studies. M. G. Johnson, D.<br />

L. Sw<strong>of</strong>ford, M. W. Lutz, D. G. Crenshaw, A. D. Roses.<br />

1383T Benefits <strong>of</strong> using local whole exome reference<br />

panels for the imputation <strong>of</strong> rare variants in two<br />

European populations. P. Joshi, R. M. Fraser, V. Vitart, C.<br />

Hayward, R. McQuillan, O. Polasek, S. H. Wild, N. Hastie,<br />

A. F. Wright, H. Campbell, I. Rudan, C. Haley, P. Navarro,<br />

J. F. Wilson.<br />

1384F Combined linkage and association analyses<br />

identify a novel locus for obesity near PROX1 in Asians.<br />

H. Kim, Y. Yoo, Y. Ju, S. Lee, S. Cho, J. Sung, J. Kim, J.<br />

Seo.<br />

1385W A more powerful burden tests to detect rare<br />

genetic variants. J. Kim, J. Lee, S. Choi, M. S. Kwon,<br />

T. Park.<br />

1386T Efficiently identifying significant associations in<br />

genome-wide association studies. E. Kostem, E. Eskin.<br />

1387F A multi-SNP locus-association method reveals<br />

a substantial fraction <strong>of</strong> the missing heritability. Z.<br />

Kutalik, G. Ehret, D. Lamparter, C. Hoggart, J. Whittaker, J.<br />

S. Beckmann, GIANT Consortium.<br />

1388W Leveraging input and output structures for joint<br />

association mapping <strong>of</strong> epistatic and marginal eQTLs.<br />

S. Lee, E. Xing.<br />

1389T Evaluating the power <strong>of</strong> single variant<br />

association tests for low frequency variants in joint<br />

and meta-analysis. C. Ma, T. Blackwell, M. Boehnke, L. J.<br />

Scott, GoT2D Investigators.<br />

1390F One thousand genomes imputation in the NCI<br />

Breast and Prostate Cancer Cohort Consortium (BPC3)<br />

aggressive prostate cancer genome-wide association<br />

study. M. J. Machiela, C. Chen, L. Liang, W. R. Diver, V. L.<br />

Stevens, K. K. Tsilidis, S. J. Chanock, D. J. Hunter, P. Kraft,<br />

NCI Breast and Prostate Cancer Cohort Consortium.<br />

1391W SHAVE—Shrinkage estimator measured for<br />

multiple visits increases power in GWAS <strong>of</strong> quantitative<br />

traits. O. Meirelles, J. Ding, T. Tanaka, S. Sanna, H. Yang,<br />

D. B. Dudekula, F. Cucca, L. Ferrucci, G. Abecasis, D.<br />

Schlessinger.<br />

1392T To adjust or not to adjust, how and when to<br />

incorporate covariates into GWA studies. G. P. Page, N.<br />

Garge, E. O. Johnson.<br />

POSTER SESSIONS 167<br />

1393F Refining association mapping in a<br />

heterogeneous population: An example in a<br />

schizophrenia case-control study. A. Ray, L. C.<br />

Lazzeroni.<br />

1394W Improved heritability estimation from genomewide<br />

SNP data with application to epilepsy. D. Speed,<br />

G. Hemani, M. Johnson, D. Balding.<br />

1395T GLOMS: A mixed model-score test-based<br />

system for association studies <strong>of</strong> binary traits with<br />

risk covariates in populations <strong>of</strong> related individuals. S.<br />

Stanhope, M. Abney.<br />

1396F Tiled regression improves the false discovery<br />

rate in genome-wide association studies. B. Suktitipat,<br />

Y. Kim, A. J. M. Sorant, H. Sung, A. F. Wilson.<br />

1397W Gene-based association tests using dimension<br />

reduction methods and marker correlation structure.<br />

D. M. Swanson, C. Lange.<br />

1398T Impact <strong>of</strong> hidden sample structure on meta- and<br />

joint-analysis in genome-wide association studies. P. J.<br />

Walter, H. M. Kang.<br />

1399F Natural and orthogonal association framework<br />

to detect parent-<strong>of</strong>-origin effects. F. Xiao, J. Ma, C.<br />

Amos.<br />

1400W Efficient calculation for multi-SNP genetic risk<br />

scores. T. Johnson.<br />

1401T Gene-gene co-association and pathwaybased<br />

co-association studies for next-generation<br />

sequencing. L. Luo, M. Xiong.<br />

1402F May consanguinity between parents be a risk<br />

factor for insulin resistance in childhood obesity?<br />

Role <strong>of</strong> mitochondrial uncoupling protein 2 gene<br />

polymorphism. S. Oguzkan Balci, N. Col-Araz, M. Nacak,<br />

M. Araz, S. Halime, A. Balat, S. Pehlivan.<br />

1403W A gene-based association statistic for metaanalysis.<br />

P. Chanda, H. Huang, A. Alonso, J. S. Bader, D.<br />

E. Arking.<br />

1404T Joint testing <strong>of</strong> rare and common variants in<br />

admixed populations. H. Qin, J. Li, H.-W. Deng.<br />

1405F The role <strong>of</strong> KIR genes polymorphisms in<br />

Brazilian patients with rheumatoid arthritis and<br />

systemic lupus erythematosus. A. R. Marrero, T. D. J.<br />

Farias, C. C. Coêlho, L. D. Hausmann, D. G. Augusto, M.<br />

L. Petzl-Erler, I. A. Pereira, A. F. Zimmermann, S. C. M. S.<br />

Fialho, Y. C. N. Muniz, I. R. Souza.<br />

1406W Genome-wide linkage, association and gene<br />

expression analysis <strong>of</strong> antibody levels against 13<br />

common infections. R. Rubicz, R. Yolken, E. Drigalenko,<br />

M. A. Carless, T. D. Dyer, P. E. Melton, J. W. Kent, Jr.,<br />

R. Duggirala, J. E. Curran, M. P. Johnson, S. A. Cole,<br />

L. Almasy, E. K. Moses, N. V. Dhurandhar, E. Kraig, J.<br />

Blangero, C. T. Leach, H. H. H. Goring.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


168 POSTER SESSIONS<br />

1407T Combining affected families, independent<br />

cases, and controls to obtain a single, more powerful<br />

test <strong>of</strong> association. W. Stewart, J. Cerise.<br />

1408F Mixture modeling <strong>of</strong> rare variant association<br />

within exome sequencing data. B. A. Logsdon, J. Y.<br />

Dai, P. L. Auer, S. K. Ganesh, N. L. Smith, J. G. Wilson,<br />

T. A. Graubert, R. P. Tracy, L. A. Lange, H. Tang, S. Rich,<br />

G. Lettre, C. S. Carlson, R. Jackson, C. O’Donnell, M.<br />

M. Wurfel, D. A. Nickerson, C. Kooperberg, A. P. Reiner,<br />

NHLBI Exome Sequencing Project, Exome Sequencing<br />

Project Blood Counts Project Team.<br />

1409W Detecting association <strong>of</strong> rare variants by<br />

testing an optimally weighted combination <strong>of</strong><br />

variants in family-based designs. Q. Sha, S. Fang, S.<br />

Zhang.<br />

1410T Haplotype-based methods for detecting<br />

uncommon causal variants with common SNPs. N. Liu,<br />

W. Lin, N. Yi, D. Zhi, K. Zhang, G. Gao, H. Tiwari.<br />

1411F Multivariate adjusted sequence kernel<br />

association test for rare variants controlling for cryptic<br />

and family relatedness. K. Oualkacha, R. Li, B. Richards,<br />

A. Ciampi, C. Greenwood, UK10K Cohorts Goup.<br />

1412W Robust and powerful tests for rare variants<br />

using Fisher’s method to combine evidence <strong>of</strong><br />

association from two or more complementary tests. A.<br />

Derkach, J. F. Lawless, L. Sun.<br />

1413T Leveraging family history in genome-wide<br />

association studies. A. Ghosh, S. Wacholder, P. Hartge,<br />

M. Purdue, S. Chanock, N. Chatterjee.<br />

1414F Identifying environmental exposures for geneenvironment<br />

investigations using LASSO penalized<br />

regression methods. E. Mowry, X. Shao, F. B. S. Briggs,<br />

B. Acuna, L. Shen, A. Bernstein, C. Schaefer, L. F.<br />

Barcellos.<br />

1415W Application <strong>of</strong> targeted maximum likelihood<br />

estimation using genome-wide association data<br />

reveals new genetic predictors <strong>of</strong> disease severity in<br />

multiple sclerosis. X. Shao, M. van der Laan, F. Briggs,<br />

P. De Jager, L. Barcellos, International Multiple Sclerosis<br />

<strong>Genetics</strong> Consortium.<br />

1416T Case-sibling studies that acknowledge<br />

unstudied parents and enroll unmatched individuals.<br />

M. Shi, D. M. Umbach, C. R. Weinberg.<br />

1417F A variable-selection-based novel statistical<br />

approach to identify susceptible rare variants<br />

associated with complex diseases with deep<br />

sequencing data. H. Sun, S. Wang.<br />

1418W Causal-Seek: A strategy for finding causal<br />

variants via trans-ethnic fine-mapping. X. Wang, Y. Teo.<br />

1419T Novel insights into the genetics <strong>of</strong> Parkinson’s<br />

disease on chromosome 17. W. W. S. Lau.<br />

1420F Joint statistical modeling <strong>of</strong> multiple phenotypes<br />

in samples with related individuals. Z. Wang.<br />

1421W Association <strong>of</strong> three polymorphisms <strong>of</strong> IL-18<br />

genes (137G/C, 607C/A,133C/G) in patients with<br />

allergic rhinitis in the Iranian population. S. Ramazi,<br />

M. Motovalibashi, H. Khazraei, M. Hashemzadeh<br />

Chaleshtori.<br />

1422T Accounting for population stratification in DNA<br />

methylation studies. R. T. Barfield, L. M. Almli, V. Kilaru,<br />

A. K. Smith, K. B. Mercer, T. Klengel, D. Mehta, E. B.<br />

Binder, K. J. Ressler, K. N. Conneely.<br />

1423F Genetic case-control matching strategies for<br />

rare-variants analysis in genome-wide association<br />

studies. A. Lacour, T. Becker.<br />

1424W Ancestry informative principal components<br />

analysis in structured samples with known or cryptic<br />

relatedness. T. Thornton, M. Conomos.<br />

1425T Admixture and association mapping identifies<br />

marker in FAM19A2 associated with FEV 1 /FVC in<br />

African <strong>American</strong>s. M. M. Parker, M. G. Foreman, R. A.<br />

Mathias, T. H. Beaty, C. R. Gignoux, E. G. Burchard, J.<br />

B. Hetmanski, E. K. Silverman, J. D. Crapo, COPDGene<br />

Investigators.<br />

1426F The gamma method for gene set analysis <strong>of</strong><br />

RNA-seq data: Simulation results and application to a<br />

smallpox vaccine study. B. L. Fridley, G. D. Jenkins, D.<br />

E. Grill, J. M. Biernacka, R. B. Kennedy, G. A. Poland, A.<br />

L. Oberg.<br />

1427W Evaluation <strong>of</strong> SNP and indel imputation quality<br />

using reference haplotypes from the 1000 Genomes<br />

Project. Q. Duan, E. Y. Liu, K. L. Mohlke, D. C. Croteau-<br />

Chonka, Y. Li.<br />

1428T An efficient design to detect transplant donor<br />

and recipient genetic interactions. W. Guan, A. K. Israni.<br />

1429F Dissecting features <strong>of</strong> causal variants. S.<br />

Sengupta, X. Wen, G. Abecasis.<br />

1430W Genetic programming for detecting interactions<br />

<strong>of</strong> SNPs with fuzzy genotypes in association studies. T.<br />

Stöcker, H. Schwender.<br />

1431T Rare variant analysis for family-based design. W.<br />

Yip, G. De, I. Ionita-Lazza, N. Laird.<br />

1432F BMI trajectory from early childhood associates<br />

with leukocyte telomere length in Northern Finnish<br />

women. S. Das, J. L. Buxton, A. Rodriguez, A. Couto, M.<br />

Kaakinen, S. Sebert, P. O’Reilly, L. Coin, A. I. F. Blakemore,<br />

M.-R. Jarvelin.<br />

1433W A model for combining data on de novo<br />

mutations with case-control data to identify risk<br />

genes. X. He, S. Sanders, L. Liu, M. State, B. Devlin, K.<br />

Roeder.<br />

1434T Variable selection in high-dimensional meta-<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


analysis for genetic data. Q. He, H. Zhang, D. Y. Lin, C.<br />

L. Avery.<br />

1435F Integrative approaches for genetic association<br />

studies via Bayesian model uncertainty. M. A. Quintana,<br />

D. V. Conti.<br />

1436W Meta-analysis <strong>of</strong> co-regulated subnetworks<br />

in transciptomics data: Towards functional marker<br />

pr<strong>of</strong>iles <strong>of</strong> human aging. E. B. van den Akker, W. M.<br />

Passtoors, E. W. van Zwet, J. J. Goeman, M. Hulsman, V.<br />

Emilsson, M. Perola, B. T. Heijmans, A. B. Maier, J. N. Kok,<br />

P. E. Slagboom, M. J. T. Reinders, M. Beekman.<br />

1437T Integrative analysis <strong>of</strong> sequencing and GWAS<br />

data improves statistical power in detecting rare<br />

variants associated with complex diseases. Y. J. Hu, Y.<br />

Li, L. A. Lange, E. M. Lange, C. Bizon, P. L. Auer, G. Heiss,<br />

C. Kooperberg, N. Franceschini, U. Peters, A. P. Reiner, L.<br />

Hsu, S. Jiao, C. S. Carlson, K. E. North, D. Y. Lin, NHLBI<br />

GO Exome Sequencing Project.<br />

1438F Regionally-smoothed meta-analysis for GWAS<br />

studies. F. Begum, E. Feingold.<br />

1439W Phenotype mapping using Information Explorer.<br />

Y. Arens, J. L. Ambite, C. N. Hsu, L. Lange, S. Sharma, S.<br />

Voinea.<br />

1440T Data reduction techniques to construct new<br />

cellular and whole system biomarkers for aging.<br />

A. Brown, Z. Ding, L. Parts, D. Glass, D. Knowles, P.<br />

Deloukas, E. Dermitzakis, M. McCarthy, T. Spector, J.<br />

Winn, R. Durbin, MuTHER Consortium.<br />

1441F Prioritization <strong>of</strong> next-generation sequencing<br />

variants using data visualization. A. Bigelow, M. Meyer,<br />

N. J. Camp.<br />

1442W Integrating genome-wide gene expression<br />

and genotype data to predict HDL cholesterol levels<br />

in the Cholesterol and Pharmacogenetic Study. E.<br />

Holzinger, S. Dudek, A. Frase, M. Medina, R. Krauss, M.<br />

Ritchie.<br />

1443T ATOMIC : Assess genotype calling quality using<br />

R or Affymetrix’ genotyping console s<strong>of</strong>tware. A.<br />

Ziegler, A. Schillert.<br />

1444F Single center experience with peripheral blood<br />

gene expression pr<strong>of</strong>iling in a large cardiovascular<br />

cohort. E. Burns, S. Feng, C. Haynes, K. Abramson, M.<br />

Chryst-Ladd, E. R. Hauser, L. K. Newby, S. G. Gregory, W.<br />

E. Kraus, S. H. Shah.<br />

1445W Best practices and joint calling <strong>of</strong> the Illumina<br />

<strong>Human</strong>Exome BeadChip: The CHARGE consortium.<br />

M. L. Grove, B. J. Cochran, T. Haritunians, J. C. Bis,<br />

K. D. Taylor, M. Hansen, C. J. O’Donnell, J. I. Rotter,<br />

E. Boerwinkle, CHARGE Exome Chip Genotyping<br />

Committee.<br />

1446T A supervised approach for filtering and<br />

genotyping high quality short indels from nextgeneration<br />

sequencing data. A. Tan, H. M. Kang.<br />

POSTER SESSIONS 169<br />

1447F Merging genomic data for research in the<br />

Electronic MEdical Records and GEnomics Network:<br />

Lessons learned in eMERGE. M. D. Ritchie, S. Setia, G.<br />

Armstrong, L. Armstrong, Y. Bradford, D. C. Crawford, D.<br />

R. Crosslin, M. de Andrade, K. Doheny, M. G. Hayes, G.<br />

Jarvik, I. J. Kullo, R. Li, T. Manolio, M. Matsumoto, C. A.<br />

McCarty, D. Mirel, S. Nelson, L. Olson, E. Pugh, S. Purcell,<br />

G. Tromp, J. L. Haines.<br />

1448W Detecting sample contamination. M. Flickinger,<br />

G. Jun, K. F. Doheny, J. Romm, K. N. Hetrick, G. R.<br />

Abecasis, M. Boehnke, H. M. Kang.<br />

1449T Regression models to ‘explain’ departure from<br />

Hardy-Weinberg equilibrium. D. J. Schaid, J. P. Sinnwell,<br />

G. D. Jenkins.<br />

1450F SNP genotyping is a valuable tool for assessing<br />

the quality <strong>of</strong> next-generation sequencing data. J. Park,<br />

B. Vecchio-Pagán, H. Cuppens, G. Cutting.<br />

1451W Imputation quality thresholds for rare and<br />

common variants. G. Pistis, C. Sidore, A. Mulas, M.<br />

Zoledziewska, R. Berutti, F. Reinier, M. F. Urru, A. Maschio,<br />

M. Marcelli, A. Angius, C. Jones, G. Abecasis, S. Sanna,<br />

F. Cucca.<br />

1452T Error rates for very low MAF SNPs on the<br />

Illumina exome array. E. W. Pugh, H. Ling, J. M. Romm, I.<br />

A. McMullen, J. R. Huyghe, M. Boehnke, K. F. Doheny.<br />

1453F An algorithm for identifying high-order genegene<br />

interactions from pairwise statistical epistasis<br />

networks. T. Hu, A. S. Andrews, M. R. Karagas, J. H.<br />

Moore.<br />

1454W Fine-mapping in a covariate-based genomewide<br />

linkage scan <strong>of</strong> lung cancer susceptibility. C. L.<br />

Simpson, T. Green, B. Doan, C. I. Amos, S. M. Pinney, E.<br />

Y. Kupert, M. de Andrade, P. Yang, A. G. Schwartz, P. R.<br />

Fain, A. Gazdar, J. Minna, J. S. Wiest, H. Rothschild, D.<br />

Mandal, M. You, T. A. Coons, C. Gaba, M. W. Anderson, J.<br />

E. Bailey-Wilson.<br />

1455T Meta-analysis <strong>of</strong> 2,526 individuals demonstrates<br />

strong evidence for gene-environment interaction<br />

between NAT1 and tobacco smoke exposure in<br />

multiple sclerosis. F. B. S. Briggs, B. Acuna, L. Shen, P.<br />

Ramsay, H. Quach, A. Bernstein, I. Kockum, L. Alfredsson,<br />

T. Olsson, C. Schaefer, L. F. Barcellos.<br />

1456F Algebraic satistics and Markov bases in geneenvironment<br />

interactions. M. Rao, S. Venkatesan.<br />

1457W AprioriGWAS, a frequent itemset mining<br />

approach, detects angiogenesis gene interacting with<br />

CFH in age-related macular degeneration. Q. Zhang,<br />

Q. Long.<br />

1458T Genotype-by-environment interaction for<br />

multivariate environments using the Mahalanobis<br />

distance. V. P. Diego, H. H. H. Göring, J. Blangero.<br />

1459F Interactions between maternal genotypes<br />

and metabolites are associated with incidence <strong>of</strong><br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


170 POSTER SESSIONS<br />

congenital heart defects. S. Erickson, S. Chowdhury, S.<br />

L. MacLeod, M. A. Cleves, S. Melnyk, S. J. James, P. Hu,<br />

C. A. Hobbs.<br />

1460W A unified generalized multifactor reduction<br />

method for detecting gene-gene interactions in family<br />

and unrelated samples with application to nicotine<br />

dependence. X. Lou, G. Chen, N. Liu, Y. Klimentidis, X.<br />

Zhu, D. Zhi, X. Wang.<br />

1461T The 5p15 locus is associated with bronchial<br />

hyperresponsiveness in siblings unexposed to tobacco<br />

smoke in early life in French families ascertained<br />

through asthma. R. Nadif, P. Margaritte-Jeannin, E.<br />

Bouzigon, F. Kauffmann, M. Lathrop, F. Demenais, M.-H.<br />

Dizier.<br />

1462F Systematic identification <strong>of</strong> interaction effects<br />

between genome- and environment-wide associations<br />

in type 2 diabetes mellitus. C. J. Patel, R. Chen, K.<br />

Kodama, J. P. A. Ioannidis, A. J. Butte.<br />

1463W A new Bayesian framework for detecting geneenvironment<br />

interaction. X. Wen, M. Stephens, P. Zheng.<br />

1464T Overlapping G x G interactions associated with<br />

caries in permanent and primary dentition. K. Cuenco,<br />

M. K. Lee, Z. Zeng, J. R. Shaffer, X. Wang, E. Feingold,<br />

D. E. Weeks, S. M. Levy, R. J. Weyant, R. J. Crout, D. W.<br />

McNeil, M. L. Marazita.<br />

1465F Associations and interactions <strong>of</strong> genetic<br />

polymorphisms in innate immunity genes with early<br />

viral infections and susceptibility to asthma and<br />

asthma-related phenotypes. D. Daley, J. E. Park, J. He,<br />

J. Yan, L. Akhabir, D. Stefanowicz, A. B. Becker, M. Chan-<br />

Yeung, Y. Bossé, A. L. Kozyrskyj, A. L. James, A. W. Musk,<br />

C. Laprise, R. G. Hegele, P. D. Paré, A. J. Sandford.<br />

1466W Evidence for genetic interactions beyond<br />

variability explained by single SNPs in ulcerative<br />

colitis. M. H. Wang, X. Zhu, R. H. Duerr, C. Fiocchi, J. P.<br />

Achkar, Wellcome Trust Case Control Consortium.<br />

1467T Influence <strong>of</strong> SNPxSNP interaction on BMI in<br />

European <strong>American</strong> adolescents: Findings from the<br />

National Longitudinal Study <strong>of</strong> Adolescent Health. K.<br />

L. Young, M. Graff, K. E. North, A. S. Richardson, L. A.<br />

Lange, E. M. Lange, K. M. Harris, P. Gordon-Larsen.<br />

1468F Analyzing genome-wide SNP interactions using<br />

the Random Forest Fishing method. W. Yang, J. Chu,<br />

C. C. Gu.<br />

1469W Hunting for rare genetic variants in a complex<br />

disease? Do not forget about gene-environment<br />

interactions! R. Kazma, J. Witte.<br />

1470T Searching for an enrichment <strong>of</strong> genetic<br />

interaction signals in SNPs within known proteinprotein<br />

interactions. J. E. Mollon, B. Lehne, S. Sacks, T.<br />

Schlitt, M. E. Weale.<br />

1471F RAPID detection <strong>of</strong> gene-gene interactions<br />

underlying quantitative traits. N. Udpa, V. Bafna.<br />

1472W Evidence <strong>of</strong> gene-environment interaction for<br />

the chromosome 4 and environmental tobacco smoke<br />

in controlling the risk <strong>of</strong> cleft lip with/without cleft<br />

palate. T. Wu, I. Ruczinski, J. C. Murray, M. L. Marazita,<br />

R. G. Munger, J. B. Hetmanski, T. Murray, R. J. Redett, M.<br />

D. Fallin, K. Y. Liang, P. J. Patel, S. C. Jin, T. X. Zhang, H.<br />

Schwender, Y. H. Wu-Chou, P. K. Chen, S. S. Chong, F.<br />

Cheah, V. Yeow, X. Ye, H. Wang, S. Huang, E. W. Jabs, B.<br />

Shi, A. J. Wilcox, R. T. Lie, S. H. Jee, K. Christensen, A. F.<br />

Scott, T. H. Beaty.<br />

1473T Pathway-based analysis <strong>of</strong> gene-gene<br />

interactions for complex diseases. J. G. Zhang, J. Li, H.<br />

W. Deng.<br />

1474F Identification <strong>of</strong> host gene-gene interaction in<br />

saliva flow and Streptococcus mutans using MDR.<br />

M. Lee, K. T. Cuenco, Z. Zeng, X. Wang, J. R. Shaffer, E.<br />

Feingold, D. E. Weeks, R. J. Weyant, R. J. Crout, D. W.<br />

McNeil, M. L. Marazita.<br />

1475W Meta-analysis <strong>of</strong> gene by gene interaction. R. G.<br />

H<strong>of</strong>fmann, K. Yan, T. J. H<strong>of</strong>fmann, P. Simpson.<br />

1476T Identification <strong>of</strong> gene-gene interactions for<br />

Alzheimer disease using cooperative game theory.<br />

B. Vardarajan, G. Jun, R. Mayeux, J. L. Haines, M. A.<br />

Pericak-Vance, G. Schellenberg, K. L. Lunetta, L. A. Farrer,<br />

Alzheimer’s Disease <strong>Genetics</strong> Consortium.<br />

1477F Overestimation <strong>of</strong> relatedness in admixed and<br />

ancestrally heterogeneous populations using method<br />

<strong>of</strong> moments estimation. J. Morrison.<br />

1478W Genome-wide patterns <strong>of</strong> identity-by-descent<br />

sharing in the French Canadian founder population. H.<br />

Gauvin, C. Moreau, J.-F. Lefebvre, H. Vézina, D. Labuda,<br />

M.-H. Roy-Gagnon.<br />

1479T Identity-by-descent-based heritability analysis<br />

in the Northern Finland Birth Cohort. S. R. Browning, B.<br />

L. Browning.<br />

1480F Efficient and flexible IBD mapping in genomewide<br />

association studies based on graph representation<br />

<strong>of</strong> IBD information. B. Han, E. Y. Kang, V. Ramensky, N.<br />

Freimer, J. Scharf, C. Mathews, D. Yu, A. Ruiz-Linares, G.<br />

Rouleau, N. Cox, D. Pauls, E. Eskin, TSAICG.<br />

1481W Optimization <strong>of</strong> sequencing studies in<br />

population isolates using shared ancestral haplotypes.<br />

D. Glodzik, P. Navarro, V. Vitart, R. McQuillan, S. Wild, H.<br />

Campbell, A. Wright, J. Wilson, P. McKeigue.<br />

1482T Novel statistical model and computational<br />

methods for predicting HLA alleles from dense<br />

genotype data. Y. Guan, Y. Shen.<br />

1483F Haplotype clusters <strong>of</strong> rare variants in Korean<br />

genomes. S. Hochreiter, G. Klambauer, G. Povysil, D.-A.<br />

Clevert.<br />

1484W Evaluation <strong>of</strong> different phasing and imputation<br />

strategies in an isolated population with a mixture<br />

<strong>of</strong> unrelated individuals and extended pedigrees. J.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


O’Connell, O. Delaneau, N. Pirastu, S. Ulivi, P. Gasparini,<br />

J. Marchini.<br />

1485T Local ancestry inference using identity by<br />

descent. Z. Cai, B. L. Browning, S. R. Browning.<br />

1486F Detection <strong>of</strong> identity by descent based on rare<br />

variants. G. Povysil, G. Klambauer, S. Hochreiter.<br />

1487W Refined IBD: A new method for detecting<br />

identity by descent in population samples. B. L.<br />

Browning, S. R. Browning.<br />

1488T IBD estimation with whole-genome sequence<br />

data. L. Han, M. Abney.<br />

1489F Evaluating type 1 error and power for<br />

association and linkage in large complex pedigrees. A.<br />

C. Cummings, E. Torstenson, M. F. Davis, L. N. D’Aoust,<br />

W. K. Scott, M. A. Pericak-Vance, W. S. Bush, J. L. Haines.<br />

1490W Loss-<strong>of</strong>-co-homozygosity mapping: a novel<br />

non-parametric linkage analysis leveraging exome<br />

sequencing data. Y. Okada, N. Gupta, D. Mirel, S. Gabriel,<br />

T. Arayssi, F. Mouassess, W. A. L. Achkar, L. A. Kazkaz, R.<br />

M. Plenge.<br />

1491T Patterns <strong>of</strong> indel variation: Comparison <strong>of</strong><br />

calling methods and LD with SNPs. K. Huang, M. Ehm,<br />

N. Bing, Y. Liu, J. Xu, A. Slater, D. Fraser, J. Novembre, J.<br />

Li, M. Neison, Y. Li.<br />

1492F Estimating disease associations with common,<br />

low-risk alleles using pedigree data: Applications to<br />

breast cancer. D. R. Barnes, D. Barrowdale, J. Hopper, D.<br />

Goldgar, G. Chenevix-Trench, A. C. Antoniou, G. Mitchell,<br />

kConFab Investigators, AOCS Group.<br />

1493W Improving association tests by learning mode<br />

<strong>of</strong> inheritance from parental data. Z. Yu, D. Gillen, C. Li,<br />

M. Demetriou.<br />

1494T Enhanced maternal origin <strong>of</strong> the 22q11.2<br />

deletion in velo-cardio-facial/DiGeorge syndrome. M.<br />

Delio, T. Guo, D. McDonald-McGinn, E. Zackai, S. Herman,<br />

A. Higgins, K. Coleman, T. Wang, A. Auton, R. Shprintzen,<br />

B. Emanuael, B. Morrow.<br />

1495F Connection between heritability and polygenic<br />

risk score: Implications for the genetic architecture <strong>of</strong><br />

complex traits. V. V. Trubetskoy, E. R. Gamazon, M. E.<br />

Dolan, N. J. Cox, H. K. Im.<br />

1496W Genetic variants in DNA repair pathway genes<br />

and upper aerodigestive tract cancers: Combined<br />

analysis <strong>of</strong> data from genome-wide association<br />

studies. M.-C. Babron, R. Kazma, V. Gaborieau, J. D.<br />

McKay, P. Brennan, A. Sarasin, S. Benhamou, INHANCE<br />

Consortium.<br />

1497T Venous thromboembolism-susceptibility<br />

pathways by gene set analyses. J. Heit, S. M. Armasu, J.<br />

P. Sinnwell, D. J. Schaid, M. de Andrade.<br />

POSTER SESSIONS 171<br />

1498F Genetic pathways for ADHD show association to<br />

hyperactive/impulsive symptoms. A. Arias Vásquez, J.<br />

Bralten, B. Franke, I. Waldan, S. Faraone, J. Buitelaar.<br />

1499W Graphical models and intervention calculus for<br />

causal inference <strong>of</strong> genetic epidemiology studies. P.<br />

Wang, L. Jin, M. Xiong.<br />

1500T Multi-SNP analysis <strong>of</strong> GWAS reveals important<br />

gene-gene interactions and gene networks implicated<br />

in breast cancer. L. Briollais, A. Dobra, H. Massam, H.<br />

Ozcelik.<br />

1501F Connecting genome-wide association studies<br />

with a biological gene interaction network to<br />

uncover epistasis. D. S. Himmelstein, J. S. Witte, O. G.<br />

Troyanskaya, C. S. Greene.<br />

1502W Gene-based collapsing methods may not be<br />

powerful for pathway-based association analysis for<br />

exome sequencing data. G. Wu, D. Zhi.<br />

1503T Gene function prediction based on 80,000<br />

expression samples identifies downstream effects<br />

<strong>of</strong> many trait-associated SNPs in an eQTL dataset<br />

<strong>of</strong> 5,311 samples. J. Karjalainen, H. Westra, R. S. N.<br />

Fehrmann, T. Esko, M. J. Peters, E. M. Festen, G. J. te<br />

Meerman, S. B. Felix, H. Yaghootkar, J. Kettunen, M. W.<br />

Christiansen, A. H<strong>of</strong>man, F. Rivadeneira, E. Reinmaa, R.<br />

C. Jansen, J. Brody, S. A. Gharib, A. Suchy-Dicey, D.<br />

Enquobahrie, A. G. Uitterlinden, C. Wijmenga, B. M. Psaty,<br />

S. Ripatti, T. Frayling, A. Teumer, A. Metsepalu, J. B. J. van<br />

Meurs, L. Franke.<br />

1504F Constructing biological network using RNA-seq<br />

data. Y. Choi, M. Coram, H. Tang.<br />

1505W Network inference, integrative dynamic<br />

omics and personalized medicine. G. I. Mias, H. Im, E.<br />

Mitsunaga, R. Chen., J. Li-Pook-Than, L. Jiang, M. Snyder.<br />

1506T Stress-induced changes in gene interactions in<br />

human cells. R. Nayak, M. Kearns, V. G. Cheung.<br />

1507F An exploration <strong>of</strong> the use <strong>of</strong> low coverage whole<br />

genome sequencing datasets as additional controls<br />

for exome sequenced case series. D. Gurdasani, M. S.<br />

Sandhu, P. Kellam, P. J. Openshaw, J. K. Baillie, MOSAIC<br />

and GenISIS Investigators.<br />

1508W Genome pr<strong>of</strong>ile-based disease risk prediction.<br />

P. Hu, E. Boerwinkle, L. Jin, M. Xiong.<br />

1509T Whole genome sequencing-based imputation: A<br />

comparison between the 1000 Genomes data and the<br />

UK10K sequencing data. J. Huang.<br />

1510F EPACTS : A flexible and efficient sequencebased<br />

genetic analysis s<strong>of</strong>tware package. H. M. Kang,<br />

X. Zhan, X. Sim, C. Ma.<br />

1511W A Monte Carlo procedure for assessing cooccurring<br />

and anti-co-occurring gene mutations in<br />

cancer genome sequencing studies. P. Liu, X. Hua, H.<br />

Xu, Y. Lu.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


172 POSTER SESSIONS<br />

1512T Using whole exome sequencing to identify rare<br />

causal variants for oral clefts in multiplex families.<br />

T. H. Beaty, I. Ruczinski, M. M. Parker, J. B. Hetmanski,<br />

P. Duggal, M. A. Taub, S. Szymczak, Q. Li, C. Cropp, H.<br />

Ling, E. W. Pugh, Y. H. Wu-Chou, J. E. Bailey-Wilson, M.<br />

L. Marazita, J. C. Murray, E. Mangold, M. M. Noethen, K.<br />

Ludwig, A. F. Scott.<br />

1513F Analyzing deep whole genome sequence<br />

and genotype data <strong>of</strong> .1,000 individuals from large<br />

Mexican-<strong>American</strong> pedigrees in the T2D-GENES<br />

study. G. Jun, M. Almeida, P. Cingolani, A. Wood, C.<br />

Fuchsberger, T. M. Teslovich, T. Dyer, M. Rivas, K. Gaulton,<br />

J. Maller, J. Curran, J. Grunstad, T. Blackwell, D. Lehman,<br />

R. Grossman, S. Lincoln, J. Laramie, M. Boehnke, M.<br />

McCarthy, T. Frayling, R. Sladek, R. Duggirala, J. Blangero,<br />

G. Abecasis.<br />

1514W A flexible and effective Poisson mixed model<br />

framework for RNA sequencing and other count data.<br />

X. Zhou, J. Tung, Y. Gilad, S. Mukherjee, M. Stephens.<br />

1515T Sequence-based analysis identifies variants<br />

associated with serum lipids in African <strong>American</strong>s.<br />

A. Bentley, D. Shriner, A. Doumatey, J. Zhou, H. Huang,<br />

J. Mullikin, R. Blakesley, N. Hansen, G. Bouffard, P.<br />

Cherukuri, B. Maskeri, A. Young, A. Adeyemo, C. Rotimi.<br />

1516F Genetic factors associated with levels <strong>of</strong><br />

immune cell types. M. Steri, V. Orrù, E. Fiorillo, G. Sole,<br />

C. Sidore, F. Virdis, M. Dei, S. Lai, A. Mulas, M. G. Piras,<br />

M. Lobina, M. Marongiu, M. Zoledziewska, M. Congia, F.<br />

Busonero, A. Maschio, M. F. Urru, M. Marcelli, R. Atzeni, D.<br />

Firinu, M. Valentini, W. Mentzen, S. Naitza, M. B. Whalen,<br />

A. Angius, C. M. Jones, D. Schlessinger, G. Abecasis, S.<br />

Sanna, F. Cucca.<br />

1517W Characterization <strong>of</strong> rare variants in melanomaassociated<br />

genes in melanoma-prone families without<br />

CDKN2A/CDK4 mutations using exome sequencing<br />

data. R. Yang, K. Jacobs, M. Cullen, J. Boland, L. Burdett,<br />

M. Malasky, M. Rotunno, M. Yeager, S. Chanock, M.<br />

Tucker, A. Goldstein.<br />

1518T Comparison <strong>of</strong> variant calling strategies for<br />

large-scale exome sequencing projects. J. Floyd,<br />

A. Hendricks, L. Crooks, K. Walter, S. McCarthy, C.<br />

Anderson, UK10K Consortium.<br />

1519F A catalogue <strong>of</strong> structural variants identified in<br />

disease-based whole genome sequencing. A. Kumar,<br />

R. D. Pearson, R. E. Handsaker, K. J. Gaulton, S. A.<br />

McCarroll, M. I. McCarthy, GoT2D Consortium.<br />

1520W On the analysis <strong>of</strong> rare, exonic variation<br />

amongst subjects with autism spectrum disorders and<br />

population controls. L. Liu, E. Boerwinkle, J. Buxbaum,<br />

E. Cook, Jr., B. Devlin, G. Schellenberg, J. Sutcliffe, M.<br />

Daly, R. Gibbs, K. Roeder, ARRA Autism Sequencing<br />

Consortium.<br />

1521T Resolving dependence between overlapping<br />

reads in next-generation sequencing data. Y. Lo, G.<br />

Abecasis, S. Zöllner.<br />

1522F Single point and rare variant analysis by whole<br />

genome sequencing in 4,000 samples in the UK10K<br />

cohorts project. J. L. Min, UK10K Consortium Cohorts<br />

Group.<br />

1523W A statistical framework for the evaluation <strong>of</strong> de<br />

novo variation in psychiatric disease. K. E. Samocha,<br />

B. M. Neale, M. J. Daly, ARRA Autism Sequencing<br />

Consortium.<br />

1524T Efficient two-stage analysis approach for<br />

complex trait association with arbitrary depth<br />

sequencing data. S. Yan, Y. Li.<br />

1525F Improving the accuracy and efficiency <strong>of</strong><br />

sequencing experiments, by using previously<br />

sequenced genomes. X. Zhan, H. M. Kang, G. Abecasis.<br />

1526W Estimating and testing genetic effects for<br />

complex traits in sequence-based association studies<br />

and power comparisons. J. Zhou, N. Laird.<br />

1527T A unified statistical framework to correct for<br />

unknown population stratification, family structure and<br />

cryptic relatedness in the sequence-based association<br />

studies. Y. Zhu, J. Zhao, Y. Shugart, M. Xiong.<br />

1528F Genome-wide association study <strong>of</strong> primary<br />

tooth eruption identifies pleiotropic loci association<br />

with crani<strong>of</strong>acial distances. G. Fatemifar, C. Hoggart, L.<br />

Paternoster, J. P. Kemp, I. Prokopenko, M. Horikoshi, J. H.<br />

Tobias, S. Richmond, F. Geller, B. Feenstra, M. Melbye, T.<br />

Sørensen, A. Zhurov, A. M. Toma, S. Ring, B. S. Pourcain,<br />

N. J. Timpson, G. D. Smith, M. R. Jarvelin, D. M. Evans.<br />

1529W General framework for meta-analysis for<br />

sequencing association studies. S. Lee, X. Lin.<br />

1530T General class <strong>of</strong> family-based association tests<br />

for sequence data, and comparisons with populationbased<br />

association tests. I. Ionita-Laza, S. Lee, V.<br />

Makarov, J. D. Buxbaum, X. Lin.<br />

1531F A novel statistical approach to prioritize variants<br />

from deeply sequenced NGS samples using publicly<br />

available sequence controls. L. J. Strug, A. Derkach, T.<br />

Chiang, L. Addis, S. Dobbins, I. Tomlinson, R. Houlston,<br />

D. K. Pal.<br />

1532W Variable selection based weighting schemes for<br />

implicating rare variants in sequence data. A. E. Byrnes,<br />

M. Li, M. C. Wu, F. A. Wright, Y. Li.<br />

1533T Accurate local ancestry inference in exome<br />

sequence samples. Y. Hu, G. Abecasis, H. Kang.<br />

1534F Internal reference panel selection methods<br />

for genotype imputation: A novel sequencing study<br />

design strategy for genotyped samples. P. Zhang, N. A.<br />

Rosenberg, S. Zöllner.<br />

1535W Statistical methods for inference in population<br />

genetic studies with uncertain genotype data. E. Han.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1536T On association analysis <strong>of</strong> rare variants<br />

under population-substructure: An approach for<br />

the detection <strong>of</strong> subjects that can cause bias in the<br />

analysis. D. Qiao, M. Mattheisen, C. Lange.<br />

1537F Identity-by-descent analysis <strong>of</strong> sequence data.<br />

S. M. Smith, S. R. Browning, B. L. Browning.<br />

1538W Robust similarity regression for population<br />

substructure in rare variant aggregation analyses. J.<br />

Tzeng, C. Smith.<br />

1539T Detecting differential expression in splice<br />

variants in the absence <strong>of</strong> annotated is<strong>of</strong>orms using<br />

RNAseq. N. J. I. Lewin-Koh, T. Bhangale, M. Huntley, J.<br />

Kaminker, F. Cai, M. van der Brug.<br />

1540F Identification <strong>of</strong> new genetics variants for T2D in<br />

WTCCC data using genome-wide interaction analysis<br />

followed by core SNP and gene determination. Z.-X.<br />

Zhu, Z.-H. Zhu, X. Tong, M. Liang, W.-C. Cui, M. Yang, L.<br />

Zhou, M. D. Li, J. Zhu.<br />

1541W Imputing genotypes in large pedigrees: A<br />

comparison between GIGI and BEAGLE. C. Y. K.<br />

Cheung, E. Wijsman.<br />

1542T A hidden Markov model for coalescent-based<br />

mapping <strong>of</strong> complex trait loci from sequencing data in<br />

large-scale case-control studies. Z. Geng, P. Scheet, S.<br />

Zoellner.<br />

1543F Genetic Simulation Resources: A website for the<br />

registration and discovery <strong>of</strong> genetic data simulators.<br />

B. Peng, B. Racine, H. Chen, L. Mechanic, L. Clarke, E.<br />

Gillanders, E. Feuer.<br />

1544W Rare-variant tests in stratified populations. M.<br />

Schmidt, D. Kinnamon, E. Martin.<br />

1545T S<strong>of</strong>tware pipeline to detect SNPs and call their<br />

genotypes. M. Trost, H. M. Kang, G. Jun, G. R. Abecasis.<br />

1546F Bidimensional scale analysis: A novel approach<br />

to genographic analysis. Q. Huang, Y. Wu, Z. Li, X. Liu,<br />

W. Xie.<br />

1547W Genotype probability distributions on complex<br />

pedigrees, with applications to relationship testing. M.<br />

Vigeland, T. Egeland.<br />

1548T Trait specific genetic relatedness matrices for<br />

heritability estimates using linear mixed models. J.<br />

Mefford, J. Witte.<br />

1549F The confounding effect <strong>of</strong> cryptic relatedness<br />

on cohort studies for environmental risks. K. Shibata,<br />

G. Tamiya, M. Ueki, T. Nakamura, H. Narimatsu, I. Kubota,<br />

Y. Ueno, T. Kato, H. Yamashita, A. Fukao, T. Kayama,<br />

Yamagata University Genomic Cohort Consortium.<br />

1550W Genome wide mutation-rate map for the analysis<br />

<strong>of</strong> recurrent de novo mutations. P. Polak, S. R. Sunyaev.<br />

POSTER SESSIONS 173<br />

1551T JBASE: A Bayesian mixture model for joint<br />

analysis <strong>of</strong> sub-phenotypes and epistasis. R. Colak, T.<br />

Kim, H. Kazan, P. M. Kim, A. Goldenberg.<br />

1552F IMProve: An R package for parallelizing 1000<br />

Genomes based genotype imputation, statistical<br />

analyses, and extraction <strong>of</strong> independent hit loci. T. A.<br />

Johnson, Y. Nakamura, M. Kubo, T. Tsunoda.<br />

1553W An automatic toolbox for genome-wide<br />

association analyses. J. Luan, S. J. Sharp, N. J.<br />

Wareham, J. H. Zhao.<br />

1554T Variant association tool: A pipeline to perform<br />

quality control and association analysis <strong>of</strong> sequence<br />

and exome chip data. G. Wang, B. Peng, S. M. Leal.<br />

1555F MaCH-Admix: Genotype imputation for admixed<br />

populations. E. Y. Liu, M. Li, W. Wang, Y. Li.<br />

1556W Two roads both taken: Walking the phenotypic<br />

and genotypic paths to disease gene implication. A.<br />

Javed, P. Ng.<br />

1557T Inferring highly polymorphic gene alleles using<br />

sequence data and SNP genotypes in the Han Chinese<br />

population. S. Chang, C. Fann, A. Hsieh, C. Shiu.<br />

1558F The design <strong>of</strong> custom-made genotyping arrays<br />

to study asthma in populations <strong>of</strong> African descent.<br />

J. Gao, Y. Hu, J. S. Lee, N. Pearson, G. Abecasis, I.<br />

Ruczinski, T. H. Beaty, Z. Qin, R. A. Mathias, K. C. Barnes.<br />

1559W Detecting rare variants for both quantitative<br />

and qualitative traits using pedigree data. W. Guo, Y. Y.<br />

Shugart.<br />

1560T IsoDOT detects differential RNA-is<strong>of</strong>orm usage<br />

between two or more samples with high sensitivity and<br />

specificity. W. Sun.<br />

1561F Identification <strong>of</strong> loss <strong>of</strong> heterozygosity from<br />

unpaired tumor samples using next-generation<br />

sequencing. J. Lee, N. Pearson.<br />

1562W A robust and well-defined method for single<br />

nucleotide variant and indel detection. N. Tuzov.<br />

1563T DETECTANCE: Graphical s<strong>of</strong>tware for study<br />

design and planning, based on evaluation <strong>of</strong> the<br />

detectance distributions for probands conditional on<br />

the phenotypes <strong>of</strong> relatives. T. Hiekkalinna, P. Norrgrann,<br />

J. H. Lee, K. M. Weiss, M. Perola, J. D. Terwilliger.<br />

1564F Genetic instrumental variable studies <strong>of</strong> the<br />

effects <strong>of</strong> maternal risk factors on oral clefts. G. L.<br />

Wehby, L. M. Moreno, P. Romitti, K. Christensen, L.<br />

DeRoo, A. Wilcox, R. Munger, R. Lie, J. C. Murray.<br />

1565W The prevalence <strong>of</strong> X-linked hypohidrotic<br />

ectodermal dysplasia in Denmark. M. Nguyen-Nielsen,<br />

S. Skovbo, D. Svaneby, L. Pedersen, J. Fryzek.<br />

1566T The PhenX Toolkit: Standard measures facilitate<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


174 POSTER SESSIONS<br />

cross-study analyses. C. M. Hamilton, W. Huggins,<br />

H. Pan, D. B. Hancock, J. G. Pratt, J. A. Hammond, T.<br />

Hendershot, D. R. Maiese, K. A. Tryka, K. Sher, K. Conway,<br />

M. Scott, W. R. Harlan, J. Haines, L. C. Strader, H. A.<br />

Junkins, E. M. Ramos.<br />

1567F Comparison <strong>of</strong> genome-wide association<br />

studies for smoking behavior between self-reported<br />

and biomarker measures. A. I. Stiby, N. Timpson, M.<br />

Hickman, D. Evans, J. Kemp, G. Davey Smith, S. Ring, B.<br />

St. Pourcain, J. Henderson, J. Macleod.<br />

1568W Design <strong>of</strong> sequencing studies in family<br />

samples, with application to the study <strong>of</strong> substance<br />

use disorders. S. Feng, S. Vrieze, B. Tarrier, J. Bragg-<br />

Gresham, X. Zhan, C. Sidore, M. McGue, W. Iacono, G.<br />

Abecasis.<br />

1569T Family-based designs for sequencing studies.<br />

D. Thomas.<br />

1570F From a large-scale discovery study to a<br />

replication study. C. Kuo, D. Zaykin.<br />

1571W Optimal sample selection for large-scale<br />

next-generation sequencing experiments. G. W.<br />

Beecham, R. Rajbhandary, E. R. Martin, L. S. Wang, K.<br />

Lunetta, R. Mayeux, J. L. Haines, L. Farrer, M. Pericak-<br />

Vance, G. Schellenberg, Alzheimer’s Disease <strong>Genetics</strong><br />

Consortium.<br />

1572T Meta-analysis <strong>of</strong> ITGAM coding variant,<br />

rs1143679 (R77H) in systemic lupus erythematosus<br />

cases and controls. X. Kim-Howard, V. Pradhan, K. H.<br />

Chua, A. Maiti, K. Ghosh, S. Nath.<br />

1573F Understanding missing data in a large STR<br />

dataset <strong>of</strong> over 100,000 Brazilian individuals genotyped<br />

with PowerPlex 16 kit. V. R. C. Aguiar, R. V. Rohlfs, K. E.<br />

Lohmueller, A. M. Castro, F. S. V. Malta, A. C. S. Ferreira, I.<br />

D. Louro, R. Nielsen.<br />

1574W Population based study <strong>of</strong> permanent teeth<br />

agenesis in Japanese schoolchildren. J. Machida, T.<br />

Nishiyama, M. Kamamoto, S. Yamaguchi, M. Kimura,<br />

A. Shibata, K. Yamamoto, S. Makino, H. Miyachi, K.<br />

Shimozato, Y. Tokita.<br />

1575T Are heritability estimates <strong>of</strong> binary traits<br />

meaningful? P. H. Benchek, N. J. Morris.<br />

1576F Genetic ancestry and mammographic density<br />

among U.S. Caucasians. J. L. Caswell, K. Kerlikowske,<br />

J. Shepherd, S. R. Cummings, D. Hu, S. Huntsman,<br />

E. Ziv.<br />

1577W Robust partitioning <strong>of</strong> local heritability at<br />

associated GWAS loci. A. Gusev, G. Bhatia, B. Pasaniuc,<br />

N. Zaitlen, A. L. Price.<br />

1578T Multiple mediation analysis in case-control<br />

studies: Application to detecting joint mediating<br />

effects <strong>of</strong> smoking and chronic obstructive<br />

pulmonary disease on the association between<br />

CHRNA5-A3 genetic locus and lung cancer risk. J.<br />

Wang, S. Shete.<br />

1579F Bayesian-optimized linkage disequilibrium<br />

improves gene-based association tests. H. Huang, S.<br />

Zahid, P. Chanda, D. E. Arking, J. S. Bader.<br />

1580W Statistical models and inference methods<br />

for the in vivo DNA methylation process. A. Q. Fu, D.<br />

P. Genereux, R. Stoeger, A. F. Burden, C. D. Laird, M.<br />

Stephens.<br />

1581T A comparison <strong>of</strong> statistical methods for the<br />

analysis <strong>of</strong> methylome data. M. LeBlanc, B. Kulle.<br />

1582F Designing GWAS arrays for efficient imputationbased<br />

coverage. Y. Zhan, Y. Lu, T. Webster, J. Schmidt.<br />

1583W Does a higher BMI directly influence levels <strong>of</strong><br />

physical activity in children? Mendelian randomization<br />

using genotypic scores. R. C. Richmond, G. Davey<br />

Smith, D. M. Evans, B. St. Pourcain, J. P. Kemp, A. R.<br />

Ness, S. M. Ring, K. Tilling, N. J. Timpson.<br />

Cardiovascular <strong>Genetics</strong><br />

1584T Role <strong>of</strong> GATA5, FBN1 and TGFBR2 mutation in<br />

patients with bicuspid aortic valve. N. Abdulkareem, J.<br />

A. Aragon-Martin, G. Arno, V. Ramachandran, A. Child, M.<br />

Jahangiri.<br />

1585T Re-sequencing <strong>of</strong> 3699 individuals reveals novel<br />

low-frequency missense polymorphism in SCN10A<br />

associated with PR interval that alters channel<br />

activation. J. Brody, V. S. Macri, D. E. Arking, X. Yin, C.<br />

Liu, A. C. Morrison, A. Alonso, J. C. Bis, S. R. Heckbert,<br />

T. Lumley, C. Sitlani, L. A. Cupples, S. Pulit, C. Newton-<br />

Cheh, C. J. O’Donnell, E. J. Benjamin, D. Muzny, R. Gibbs,<br />

R. Jackson, J. W. Magnani, S. S. Rich, B. M. Psaty, E.<br />

Boerwinkle, P. T. Ellinor, N. Sotoodehnia, Cohorts for Heart<br />

and Aging Research in Genetic Epidemiology, NHLBI<br />

Exome Sequencing Project.<br />

1586T A functional SNP at APLN gene confers a risk<br />

to arterial stiffness in Chinese women. Y. C. Liao, S. W.<br />

Huang, Y. S. Wang, K. C. Chen, S. H. H. Juo.<br />

1587T Impact <strong>of</strong> inflammatory gene polymorphisms on<br />

left ventricular dysfunction in coronary artery disease<br />

patients. A. Mishra, A. Srivastava, T. Mittal, N. Garg, B.<br />

Mittal.<br />

1588T Identification <strong>of</strong> a new chromosomal locus for a<br />

mutation causing left ventricular non-compaction with<br />

ventricular tachycardia cardiopathology. E. Muhammad,<br />

A. Levitas, V. Sheffield, R. Parvari.<br />

1589T Sequencing candidate genes associated with<br />

conotruncal heart defects. K. Osoegawa, M. Ladner, K.<br />

Schultz, C. Parodi, N. Mohammed, D. Noonan, G. Shaw,<br />

E. Trachtenberg, E. Lammer.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1590T Significant association <strong>of</strong> two genetic variants in<br />

the ENPEP gene with lone atrial fibrillation in Koreans.<br />

D. Shin, H. Hwang, A. Park, N. Son, E. Shin, J. Lee, H.<br />

Pak, M. Lee, Y. Jang.<br />

1591T Molecular Investigation in sudden unexplained<br />

death syndromes in New York City. Y. Tang, D. Wang, L.<br />

Eng, K. Shah, S. Um, B. Zhou, M. Prinz, B. Sampson.<br />

1592T Associations <strong>of</strong> NINJ2 sequence variation with<br />

incident ischemic stroke: Analysis <strong>of</strong> common and rare<br />

variants in the Cohorts for Heart and Aging in Genomic<br />

Epidemiology Consortium. J. C. Bis, M. Fornage, A. L.<br />

DeStefano, J. Brody, M. A. Ikram, C. van Duijn, R. Gibbs,<br />

J. G. Reid, E. Boerwinkle, W. T. Longstreth, T. H. Mosley,<br />

S. Seshadri on behalf <strong>of</strong> CHARGE Neurology Working<br />

Group.<br />

1593T CCR5, TNF/LTA, CCL2, IL12B, IL10, MAL/TIRAP,<br />

ACTC1 genes are associated to the development <strong>of</strong><br />

chronic Chagas’ disease cardiomyopathy. C. Chevillard,<br />

A. F. Frade, P. Teixeira, B. Ianni, C. Wide Pissetti, A.<br />

Fragata, M. Hirata, M. Sampaio, B. Saba, F. Dias, E.<br />

Donadi, V. Rodrigues Jr., A. Pereira, J. Kalil, E. Cunha-<br />

Neto.<br />

1594T Analysis <strong>of</strong> candidate genes associated<br />

with intermediate traits identifies novel variants<br />

associated with coronary artery disease presence<br />

and severity. D. M. Craig, E. R. Hauser, E. Burns,<br />

M. Chryst-Ladd, C. Haynes, W. E. Kraus, I. C.<br />

Siegler, B. H. Brummett, R. C. Becker, R. B. Williams,<br />

S. H. Shah.<br />

1595T The shared allelic architecture <strong>of</strong> adiponectin<br />

levels and coronary artery disease. Z. Dastani, T.<br />

Johnson, F. Kronenberg, C. Nelson, T. L. Assimes,<br />

W. März, J. B. Richards, CARDIoGRAM Consortium,<br />

ADIPOGen Consortium.<br />

1596T Investigation <strong>of</strong> mutations in exons 19 and<br />

22 MYH7 gene in HCM patients in Chaharmahal<br />

va Bakhtiyari Province, Iran. S. Heydari Sodjani, R.<br />

Pourahmad, A. Khaledifar, M. Hashemzadeh, F. Azadegan,<br />

N. Bagheri, S. Badfar.<br />

1597T Polymorphisms in CHRNA3-CHRNA5-CHRNB4<br />

are associated with body mass index and systolic<br />

blood pressure in smokers in the Northern Finland<br />

Birth Cohort 1966. M. Kaakinen, F. Ducci, M. J. Sillanpää,<br />

E. Läärä, M.-R. Järvelin.<br />

1598T Genetic association studies <strong>of</strong> left ventricle<br />

dysfunction in coronary artery disease patients. B.<br />

Mittal, A. Mishra, A. Srivastava, T. Mittal, N. Garg.<br />

1599T Associations <strong>of</strong> sequenced regions SLC17A4<br />

and PIK3CG with common carotid intima-media<br />

thickness and plaque: A common and rare variant<br />

meta-analysis in the Cohorts for Heart and Aging in<br />

Genomic Epidemiology Consortium. C. J. O’Donnell, C.<br />

C. White, N. Franceschini, J. Brody, D. Muzny, R. Gibbs, E.<br />

Boerwinkle, B. Psaty, K. E. North, L. A. Cupples, J. C. Bis<br />

on behalf <strong>of</strong> CHARGE Subclinical Atherosclerosis Working<br />

Group.<br />

POSTER SESSIONS 175<br />

1600T CNVs contributing to the cause <strong>of</strong> congenital<br />

heart defects may include not only those containing<br />

candidate genes but regions more commonly<br />

associated with autism and other disorders.<br />

D. Warburton, M. Ronemus, J. Kline, M. Wigler, V.<br />

Jobanputra, D. Levy, K. Anyane-Yeboa, W. Chung, D.<br />

Awad.<br />

1601T Whole exome sequencing and hypertrophic<br />

cardiomyopathy. F. Dewey, S. Cordero, M. Wheeler, A.<br />

Pavlovic, K. Bommakanti, S. Pan, C. Caleshu, R. Chen, M.<br />

Snyder, E. Ashley.<br />

1602T Fine mapping the SCN10A gene region<br />

identifies novel associations with PR interval in<br />

African <strong>American</strong>s from an electronic medical record<br />

population. J. Jeff, M. Ritchie, J. Denny, H. Dilks, C.<br />

Sutcliffe, M. Basford, D. Roden, D. Crawford.<br />

1603T Association between 4q25 variants and<br />

cardioembolic stroke in the Vienna Stroke Registry.<br />

M. M. Luke, C. H. Tong, J. J. Catanese, J. J. Devlin, S.<br />

Greisenegger, C. Mannhalter.<br />

1604T Common genetic variants do not predict CAD<br />

in familial hypercholesterolemia. E. P. A. van Iperen,<br />

S. Sivapalaratnam, S. M. Boekholdt, G. K. Hovingh, S.<br />

Maiwald, M. W. Tanck, N. Soranzo, J. C. Stephens, J. G.<br />

Sambrook, M. Levi, W. H. Ouwehand, J. J. P. Kastelein, M.<br />

D. Trip, A. H. Zwinderman.<br />

1605T Genetic sources <strong>of</strong> variation in proprotein<br />

convertase subtilisin/kexin type 9, a protein that<br />

mediates degradation <strong>of</strong> LDL receptors and increases<br />

LDL levels. E. A. Rosenthal, R. Rajagopalan, J. Ranchalis,<br />

D. Szeto, K. Akinsanya, T. P. Roddy, J. M. Castro-Perez,<br />

G. Forrest, G. Wolfbauer, J. J. Albers, J. D. Brunzell, A. G.<br />

Motulsky, M. J. Rieder, D. A. Nickerson, E. M. Wijsman, G.<br />

P. Jarvik.<br />

1606T Twenty-three unreported genetic associations<br />

with lipid phenotypes: A dense gene-centric metaanalysis<br />

in 66,240 individuals across 32 studies. Y. Guo,<br />

F. W. Asselbergs, E. P. A. van Iperen, S. Sivapalaratnam,<br />

V. Tragante, C. Elbers, H. Hakonarson, B. J. Keating, F.<br />

Drenos, IBC-Lipids Consortium.<br />

1607T After LDLR, APOB and PCSK9, APOE is<br />

another major gene <strong>of</strong> autosomal dominant<br />

hypercholesterolemia. M. Varret, M. Marduel, K.<br />

Ouguerram, V. Serre, D. Bonnefont-Rousselot, K. E. Berge,<br />

M. Devillers, G. Luc, J.-M. Lecerf, L. Tosolini, M. Abifadel,<br />

T. P. Leren, J.-P. Rab&egrave;s, C. Boileau.<br />

1608T Trans-ethnic fine-mapping <strong>of</strong> lipid loci in<br />

African <strong>American</strong>s, East Asians, and Europeans<br />

identifies population-specific signals and extensive<br />

allelic heterogeneity that increases the trait variance<br />

explained. Y. Wu, L. Waite, A. Jackson, S. Buyske, C.<br />

Carty, I. Cheng, D. Duggan, L. Dumitrescu, C. Haiman, L.<br />

Hindorff, C. Hsiung, S. Hunt, K. Hveem, J. Juang, E. Kim,<br />

M. Laakso, I. Njølstad, U. Peters, R. Rauramaa, W. Sheu,<br />

Y. Sung, J. Tuomilehto, T. Wang, Y. Chen, C. Kooperberg,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


176 POSTER SESSIONS<br />

M. Boehnke, D. Crawford, T. Assimes, K. North, K. L.<br />

Mohlke.<br />

1609T Identification <strong>of</strong> a major genetic modifier in<br />

mouse models <strong>of</strong> TGFb vasculopathies. J. Calderon, H.<br />

Dietz.<br />

1610T Upregulation <strong>of</strong> Twist1 expression during acute<br />

myocardial infarction. J. B. Nevado.<br />

1611T Venous malformation-causing TIE2-mutations<br />

lead to AKT-mediated downregulation <strong>of</strong> PDGFB. M.<br />

Uebelhoer, M. Nätynki, J. Kangas, J. Soblet, A. Mendola,<br />

C. Godfraind, L. M. Boon, L. Eklund, N. Limaye, M.<br />

Vikkula.<br />

1612T Islet1 is a direct transcriptional target <strong>of</strong> the<br />

homeodomain transcription factor Shox2 in the<br />

sinoatrial node <strong>of</strong> the developing heart. G. A. Rappold,<br />

I. M. Berger, A. Glaser, C. Bacon, L. Li, K. U. Schneider, N.<br />

Gretz, H. Steinbeisser, W. Rottbauer, S. Just, S. H<strong>of</strong>fmann.<br />

1613T Analysis <strong>of</strong> sub-category for 141 cases <strong>of</strong><br />

congenital heat disease that have been surgically<br />

corrected during neonatal period. Q.-Y. Cao, J.-Z. Zhu,<br />

N. Zhong.<br />

1614T Analysis <strong>of</strong> cardiomyopathy using whole<br />

genome sequencing. E. M. McNally, J. R. Golbus,<br />

L. L. Pesce, D. Wolfgeher, L. Dellefave-Castillo, M. J.<br />

Puckelwartz.<br />

1615T The association between NOS3 gene variations<br />

and Brugada syndrome. S. Mehrtashfar, A. Ebrahimi, M.<br />

Moghadam, A. S. Khatir.<br />

1616T Targeted sequence capture and 454 sequencing<br />

<strong>of</strong> 23 cardiomyopathy genes: Implementation into<br />

diagnostics. O. Mook, M. Haagmans, R. Lekanne dit<br />

Deprez, F. Baas, M. Jakobs, N. H<strong>of</strong>man, I. Christiaans, M.<br />

Mannens.<br />

1617T Targeted next-generation sequencing <strong>of</strong><br />

thoracic aortic aneurysmal genes. L. Van Laer, D.<br />

Proost, G. Vandeweyer, J. Saenen, B. Paelinck, C. Vrints,<br />

B. Loeys.<br />

1618T The use <strong>of</strong> next-generation sequencing in<br />

clinical diagnostics <strong>of</strong> familial hypercholesterolaemia.<br />

J. Vandrovcova, E. Thomas, S. Atanur, P. Norsworthy,<br />

C. Neuwirth, Y. Tan, L. Game, A. Soutar, T. J. Aitman,<br />

Generation Scotland.<br />

1619T Targeted next-generation sequencing as a<br />

diagnostic test in patients with cardiomyopathies. Y. J.<br />

Vos, B. Sikkema-Raddatz, L. F. Johansson, E. N. de Boer,<br />

L. G. Boven, K. Y. van Spaendonck-Zwarts, M. P. van den<br />

Berg, J. P. van Tintelen, J. D. H. Jongbloed, R. J. Sinke.<br />

1620T Population sampling and in vitro modeling <strong>of</strong> a<br />

25bp deletion in MYBPC3 associated with hypertrophic<br />

cardiomyopathy. A. B. Chowdry, M. A. Mandegar, G. M.<br />

Benton, B. T. Naughton, B. R. Conklin.<br />

1621T Co-localization <strong>of</strong> lipid biomarker associations<br />

with gene expression across human tissues. C.<br />

Giambartolomei, H.-J. Westra, M. Kivimaki, M. Kumari, E.<br />

Schadt, L. Franke, A. Hingorani, V. Plagnol.<br />

1622T Silencing <strong>of</strong> Atp2b1 increases blood pressure<br />

through vasoconstriction. B. Oh, Y.-B. Shin, S.-M. Ji,<br />

S.-Y. Park, H.-J. Lee, K.-W. Hong, J.-E. Lim, M. Lim, Y.-H.<br />

Lee.<br />

1623T Metabolic imprints <strong>of</strong> genetically elevated body<br />

mass index in young adults. P. Würtz, A. J. Kangas, P.<br />

Soininen, O. Raitakari, T. Lehtimäki, M. R. Järvelin, M. Ala-<br />

Korpela, S. Ripatti.<br />

1624T Mendelian randomization studies do not support<br />

a causal effect <strong>of</strong> plasma lipids on insulin sensitivity. T.<br />

Fall, W. Xie, K. Hao, J. Ärnlöv, F. Abbasi, E. E. Schadt, G.<br />

Boran, T. Hansen, D. Greenawalt, J. J. Nolan, O. Pedersen,<br />

H. Häring, E. Ferrannini, A.-C. Syvänen, T. Quertermous,<br />

U. Smith, T. L. Assimes, M. Laakso, M. Walker, J. W.<br />

Knowles, M. N. Weedon, E. Ingelsson, T. M. Frayling on<br />

behalf <strong>of</strong> GENESIS Consortium.<br />

1625T Dissecting the genetic architecture <strong>of</strong> coronary<br />

artery disease by genome engineering. D. J. Segal, M.<br />

S. Bhakta, K. ThevaDas, C. Sun, N. M. Grace, J. A. Nolta,<br />

A. A. Knowlton, D. M. Rocke.<br />

1626T Application <strong>of</strong> Mendelian randomization on<br />

ascorbic acid and hypertension in .11,000 participants<br />

from 4 independent studies. K. H. Wade, N. J. Timpson,<br />

N. G. Forouhi, M.-J. Brion, R. M. Harbord, D. G. Cook, P.<br />

Johnson, A. McConnachie, R. W. Morris, S. Rodriguez,<br />

Z. Ye, S. Ebrahim, S. Padmanabhan, G. Watt, K. R.<br />

Bruckdorfer, N. J. Wareham, P. H. Whincup, S. Chanock,<br />

N. Sattar, D. A. Lawlor, G. Davey Smith.<br />

1627T Identification <strong>of</strong> a regulatory variant that binds<br />

C/EBPb at the GALNT2 human high-density lipoprotein<br />

cholesterol locus. T. S. Roman, M. P. Fogarty, S.<br />

Vadlamudi, A. F. Marvelle, K. J. Gaulton, A. J. Gonzalez, Y.<br />

Li, K. L. Mohlke.<br />

1628T Maternally transmitted coronary heart disease is<br />

associated with the mitochondrial tRNAThr 15927G.A<br />

mutation. M. X. Guan.<br />

1629T Mitochondrial haplogroups and genomic<br />

ancestry showed association with heart failure in<br />

Brazilians. C. Fridman, M. M. S. G. Cardena, A. K.<br />

Ribeiro-dos-Santos, S. E. Santos, J. E. Krieger, A. C.<br />

Pereira.<br />

1630T RNAi-based functional pr<strong>of</strong>iling <strong>of</strong> loci from<br />

blood lipid genome-wide association studies. H. Runz,<br />

P. Blattmann, C. Schuberth, R. Pepperkok.<br />

1631T A fine mapping <strong>of</strong> the genetic variation<br />

influencing the ratio <strong>of</strong> alternatively spliced CD40<br />

transcripts and conferring susceptibility to Kawasaki<br />

disease. Y. Onouchi, K. Ozaki, M. Terai, H. Hamada, H.<br />

Suzuki, T. Suenaga, Y. Suzuki, K. Yasukawa, R. Ebata,<br />

T. Saji, Y. Kemmotsu, K. Ouchi, F. Kishi, T. Yoshikawa, T.<br />

Nagai, K. Hamamoto, Y. Sato, K. Sasago, A. Takahashi, M.<br />

Kubo, T. Tsunoda, A. Hata, Y. Nakamura, T. Tanaka.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1632T The AA genotype <strong>of</strong> tumor necrosis factor<br />

induced protein 2 rs8126 polymorphism is associated<br />

with increased mortality in septic shock. S. A. Thair, J.<br />

H. Boyd, T. A. Nakada, J. A. Russell, K. R. Walley.<br />

1633T Significance <strong>of</strong> the NODAL p.H165R variant in<br />

complex cardiovascular malformations: A report <strong>of</strong> two<br />

lethal cases with an asymptomatic parent. Z. Ammous,<br />

A. Rajadhyaksha, P. Jayakar.<br />

1634T Parent <strong>of</strong> origin effect in HDL levels. J. S. Lilley,<br />

I. M. Predazzi, W. S. Bush, M. F. Linton, S. M. Williams, S.<br />

Fazio.<br />

1635T Loci on chromosomes 2q12, 6p21 and 13q14<br />

modulate the effect <strong>of</strong> smoking on carotid intimamedia<br />

thickness in whites, blacks and Hispanics. C.<br />

Dong, L. Wang, A. Beecham, D. Cabral, C. B. Wright, S. H.<br />

Blanton, T. Rundek, H. Zhao, R. L. Sacco.<br />

1636T A genome-wide gene-by-environment scan<br />

for mobile source air pollution in atherosclerosis and<br />

myocardial infarction identifies PIGR and HCN4. C. K.<br />

Ward-Caviness, L. Neas, C. Haynes, C. Blach, E. Burns, K.<br />

LaRocque-Abramson, E. Dowdy, W. Cascio, R. Devlin, D.<br />

Diaz-Sanchez, W. E. Kraus, S. H. Shah, S. G. Gregory, M.<br />

L. Miranda, E. R. Hauser.<br />

1637T Genome-wide association analysis <strong>of</strong> blood<br />

pressure incorporating gene-age interactions in the<br />

CHARGE, GBPgen, and ICBP Consortia. J. Simino,<br />

CHARGE, GBPgen, and ICBP Investigators.<br />

1638T A genome-wide association study <strong>of</strong> carotid<br />

intima-medial thickness, a preclinical marker <strong>of</strong><br />

atherosclerosis. S. H. Blanton, A. H. Beecham, L. Wang,<br />

C. Dong, D. Cabral, B. I. Hudson, M. Kiryiya, F. Jasmine,<br />

B. Pierce, R. Demmer, A. Habibul, M. Desvarieux, R.<br />

Sacco, T. Rundek.<br />

1639T Genome-wide association analyses <strong>of</strong> long-term<br />

blood pressure traits. S. K. Ganesh, G. B. Ehret, A.<br />

Chakravarti on behalf <strong>of</strong> CHARGE-BP and ICBP Consortia.<br />

1640T A genome-wide association study in a Lebanese<br />

population identifies three new loci for coronary artery<br />

disease. M. Ghassibe, J. Hager, J. B. Cazier, D. Platt, Y.<br />

Kamatani, M. Farrall, D. Gauguier, P. Zalloua.<br />

1641T An assessment <strong>of</strong> association <strong>of</strong> blood pressure<br />

with DNA variants in the Long Life Family Study and<br />

other studies. A. T. Kraja, J. H. Lee, R. Straka, I. B.<br />

Borecki, C. Kammerer, M. A. Province.<br />

1642T Novel tissue-specific transcriptomic signatures<br />

revealed by experimental endotoxemia in healthy<br />

human subjects. Y. Liu, J. Feguson, I. Silverman, B.<br />

Gregory, M. Li, M. Reilly.<br />

1643T Genome-wide association study for atrial<br />

fibrillation in the Japanese population. K. Ozaki, Y.<br />

Onouchi, N. Kamatani, T. Tsunoda, M. Kubo, Y. Nakamura,<br />

T. Tanaka.<br />

1644T Cardiovascular genetics. D. Seo, Z. Liu, N. Sikka,<br />

POSTER SESSIONS 177<br />

P. Goldschmidt-Clermont, M. A. Pericak-Vance, G. W.<br />

Beecham.<br />

1645T Functional relationship <strong>of</strong> the COL4A1/COL4A2<br />

locus on chromosome 13q34 to coronary artery disease.<br />

A. Turner, P. Lau, S. Soubeyrand, O. Jarinova, R. McPherson.<br />

1646T De novo copy number variants in non-syndromic<br />

left ventricular outflow tract obstruction. L. A. Umana,<br />

N. A. Hanchard, G. A. Zender, S. M. Fitzgerald-Butt, G.<br />

Zapata, P. Hernandez, M. S. Azamian, D. J. Penny, J. W.<br />

Belmont, K. L. McBride.<br />

1647T Genetic association <strong>of</strong> CVD-related loci with<br />

lipid traits in the Heart Strategies Concentrating on<br />

Risk Evaluation (Heart SCORE) Study. X. B. Wang,<br />

S. Reis, M. M. Barmada, I. Halder, F. Y. Demirci, M. I.<br />

Kamboh.<br />

1648T Genetic analysis <strong>of</strong> vascular disease in the<br />

Diabetes Heart Study. A. J. Cox, M. C. Y. Ng, J. Xu, C. D.<br />

Langefeld, J. J. Carr, B. I. Freedman, D. W. Bowden.<br />

1649T SNPs associated with plasma triglyceride levels<br />

influence response during intensive cardiovascular risk<br />

reduction. D. L. Ellsworth, A. Decewicz, M. Hicks, K. A.<br />

Mamula, A. Burke, M. J. Haberkorn, H. L. Patney, M. N.<br />

Vernalis.<br />

1650T Sex-specific association <strong>of</strong> cadherin with high<br />

density-lipoprotein cholesterol in the Long Life Family<br />

Study. M. F. Feitosa, A. T. Kraja, J. Lee, K. Christensen, J.<br />

Wang, C. Kammerer, M. A. Province, I. B. Borecki.<br />

1651T A genome-wide association study identifies<br />

KNG1 as a genetic determinant <strong>of</strong> plasma factor XI<br />

level and activated partial thromboplastin time. J.<br />

M. Soria, M. Sabater-Lleal, A. Martinez-Perez, A. Buil,<br />

L. Folkersen, J. C. Souto, M. Bruzelius, M. Borrell, J.<br />

Odeberg, S. Silveira, P. Eriksson, A. Almasy, A. Hamsten.<br />

1652T Gene variants are associated with s<strong>of</strong>t lipid-rich<br />

coronary plaque in African <strong>American</strong>s with replication<br />

in European <strong>American</strong>s. L. R. Yanek, B. G. Kral, D.<br />

Vaidya, T. F. Moy, L. C. Becker, D. M. Becker.<br />

1653T Genetic variation for leukocyte telomere<br />

length predicts incident coronary heart disease: The<br />

Framingham Heart Study. S. Hwang, A. Aviv, D. Levy,<br />

M. Mangino, S. Hunt, A. L. Fitzpatrick, J. C. Bis, E. S.<br />

Smith.<br />

1654T Genome-wide association analysis <strong>of</strong> plasma<br />

triglyceride in Korean population. B. Gombojav, D. H.<br />

Lee, M. K. Lee, Y. M. Song, K. Lee, J. Sung.<br />

1655T Genome-wide association study <strong>of</strong> calcific<br />

aortic valve disease. S. Guauque-Olarte, M. Lamontagne,<br />

N. Gaudreault, P. Mathieu, P. Pibarot, Y. Bossé, D.<br />

Messika-Zeitoun.<br />

1656T Genetic variants explaining sodium intake in<br />

a population with higher sodium intake level: The<br />

Healthy Twin Study, Korea. M. Kho, Y.-M. Song, K. Lee,<br />

J.-E. Lee, K. Kim, J. Sung.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


178 POSTER SESSIONS<br />

1657T Dietary intake <strong>of</strong> saturated fatty acids<br />

modulates the genetic effects on triglyceride<br />

concentrations in a Korean genome-wide study. H.<br />

Lee, H. Jang, M. Go, J. Park, J. Choi, J. Park, Y. Ahn, B.<br />

Han, J. Lee, J. Song.<br />

1658T A GWAS approach in search for modifiers<br />

<strong>of</strong> congenital heart disease in 22q11 microdeletion<br />

syndrome. G. M. Repetto, C. Vial, S. McGhee, N. K.<br />

Henderson-MacLennan, M. L. Guzman, M. Palomares, G.<br />

Lay-Son, K. Espinoza, T. Guo, B. Morrow.<br />

1659T Novel genes related to hypertension: A genecentric<br />

meta-analysis with over 127,000 individuals.<br />

V. Tragante do O., S. K. Ganesh, W. Guo, Y. Guo, E. N.<br />

Smith, M. B. Lanktree, T. Johnson, B. Almoguera Castillo,<br />

J. Barnard, J. Baumert, A. G. Uitterlinden, P. van der Harst,<br />

Y. T. van der Schouw, N. J. Samani, P. B. Munroe, P. I. W.<br />

de Bakker, X. Zhu, D. Levy, B. Keating, F. W. Asselbergs,<br />

IBC BP Consortium.<br />

1660T Additional variance <strong>of</strong> serum lipid levels<br />

explained by incorporating less significant genetic<br />

variants and allelic heterogeneity. R. Deka, G. Zhang,<br />

R. Karns, G. Sun, S. R. Indugula, H. Cheng, D. Havas-<br />

Augustin, N. Novokmet, Z. Durakovic, S. Missoni, R.<br />

Chakraborty, P. Rudan.<br />

1661T Admixture mapping <strong>of</strong> coronary artery calcified<br />

plaque in African <strong>American</strong>s with type 2 diabetes. J.<br />

Divers, N. D. Palmer, L. Lu, T. C. Register, J. J. Carr, P. J.<br />

Hicks, R. C. Hightower, S. C. Smith, J. Xu, A. J. Cox, K.<br />

A. Hruska, D. W. Bowden, C. E. Lewis, G. Heiss, M. A.<br />

Province, I. B. Borecki, K. F. Kerr, Y. D. Chen, W. Palmas,<br />

J. I. Rotter, C. L. Wassel, A. Bertoni, D. Herrington, L. E.<br />

Wagenknecht, C. D. Langefeld, B. I. Freedman.<br />

1662T Genome-wide association studies <strong>of</strong> NMR-based<br />

lipoprotein subclasses in African <strong>American</strong> populations<br />

elucidate subfractions affected by SNP variation. Y.<br />

Huang, WM. Chen, K. L. Keene, F. Chen, U. Nayak, X. Hou, I.<br />

J. Spruill, K. J. Hunt, J. K. Fernandes, K. H. Lok, J. Divers, J.<br />

C. Mychaleckyj, D. L. Kamen, W. Post, S. S. Rich, J. I. Rotter,<br />

G. S. Gilkeson, W. T. Garvey, M. Cushman, M. M. Sale.<br />

1663T Redefining fibromuscular dysplasia <strong>of</strong> the<br />

arteries as a TGF-b pathway disorder. R. Morissette, S.<br />

Ganesh, B. Griswold, L. Sloper, N. McDonnell.<br />

1664T Integrated microRNA and mRNA pr<strong>of</strong>iling <strong>of</strong><br />

the mouse ventricles during development <strong>of</strong> severe<br />

hypertrophic cardiomyopathy and heart failure. R. D.<br />

Bagnall, T. Tsoutsman, R. E. Shephard, W. Ritchie, C.<br />

Semsarian.<br />

1665T Novel transcripts and pathways identified in blood<br />

one week following implant <strong>of</strong> continuous-flow left<br />

ventricular assist device. J. L. Hall, W. Guan, A. Mitchell, R.<br />

Staggs, S. Grindle, N. Adhikari, S. Hozayen, P. Eckman.<br />

1666T Activation <strong>of</strong> TLR signaling in atherosclerosis<br />

and ischemic stroke. C.-C. Huang, R. Sieberg, G. Feng,<br />

S. Wang, M. Yu.<br />

1667T Genetic insights into nonalcoholic fatty liver<br />

disease from the proteomic analysis <strong>of</strong> HDL particles.<br />

K. Merath, M. Zickus, R. Komorowski, J. Wallace, M.<br />

Goldbladtt, S. Gawrieh, M. Olivier.<br />

1668T Do variations in genes encoding the argonaute<br />

proteins confer risk or protection from cardiovascular<br />

disease in Europeans? I. Predazzi, W. Bush, S. Williams.<br />

1669T Gene expression pr<strong>of</strong>iling in peripheral blood cells<br />

in patients with myocardial infarction at young age. T.<br />

Zeller, C. Müller, A. Schillert, M. O. Scheinhardt, S. Szymczak,<br />

F. Ojeda, C. R. Sinning, R. B. Schnabel, S. Wilde, P. S. Wild,<br />

K. J. Lackner, T. Munzel, A. Ziegler, S. Blankenberg.<br />

1670T A genetic study <strong>of</strong> familial intracranial<br />

aneurysm in French-Canadian and Inuits through<br />

exome sequencing. S. Zhou, L. Xiong, C. Bourassa, M.<br />

Bojanowski, N. Dupré, M. Dubé, A. Dionne-Laporte, D.<br />

Spiegelman, E. Henrion, O. Diallo, P. Dion, G. Rouleau.<br />

1671T Rare variant APOC3 R19X is associated with<br />

cardio-protective pr<strong>of</strong>iles in a diverse populationbased<br />

survey as part <strong>of</strong> the Population Architecture<br />

using Genomics and Epidemiology (PAGE) Study. D. C.<br />

Crawford, L. Dumitrescu, R. Goodloe, K. Brown-Gentry, C.<br />

Sutcliffe, R. Wiseman, P. Baker, H. H. Dilks, J. Boston, B.<br />

McClellan, Jr., P. Mayo, M. Allen, N. Schnetz-Boutaud, J.<br />

L. Haines, T. I. Pollin.<br />

1672T Resequencing <strong>of</strong> the cholesteryl ester transfer<br />

protein gene (CETP) in U.S. Whites and African Blacks<br />

with extreme HDL-C levels. D. Pirim, F. Y. Demirci, X.<br />

Wang, J. E. Hokanson, R. F. Hamman, C. H. Bunker, C. M.<br />

Kammerer, M. M. Barmada, M. I. Kamboh.<br />

1673T Comprehensive evaluation <strong>of</strong> the effects <strong>of</strong><br />

APOE genetic variation on plasma lipoprotein traits<br />

in U.S. Whites and African Blacks. Z. H. Radwan, F.<br />

Y. Demirci, X. Wang, F. Waqar, J. E. Hokanson, R. F.<br />

Hamman, C. H. Bunker, C. M. Kammerer, M. M. Barmada,<br />

M. I. Kamboh.<br />

1674T Filamin-C: A novel candidate for familial<br />

restrictive cardiomyopathy identified by whole-exome<br />

sequencing. M. Tariq, E. Miller, S. Ware.<br />

1675T Mutations in SMAD3 in a British cohort <strong>of</strong><br />

thoracic aortic aneurysm and dissection patients.<br />

G. Arno, J. A. Aragon-Martin, O. Song, N. P. Kamali, A.<br />

Saggar, M. Jahangiri, A. H. Child.<br />

1676T Distribution <strong>of</strong> sarcomere versus non-sarcomere<br />

gene mutations in over 2400 hypertrophic and dilated<br />

cardiomyopathy patients. S. Baxter, A. Daly, D. Macaya,<br />

N. Smaoui, G. Richard, W. Chung.<br />

1677T Burden <strong>of</strong> rare sarcomere gene variants in the<br />

Framingham and Jackson Heart Study cohorts. A.<br />

G. Bick, J. Flannick, K. Ito, S. Cheng, R. S. Vasan, M.<br />

G. Parfenov, D. S. Herman, S. R. DePalma, N. Gupta,<br />

S. B. Gabriel, B. H. Funke, H. L. Rehm, E. J. Benjamin,<br />

J. Aragam, H. A. Taylor, E. R. Fox, C. Newton-Cheh, S.<br />

Kathiresan, C. J. O’Donnell, J. G. Wilson, D. Altshuler, J. N.<br />

Hirschhorn, J. G. Seidman, C. Seidman.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1678T Whole-exome sequencing for identification<br />

<strong>of</strong> novel genes and variants underlying the risk <strong>of</strong><br />

long-QT syndrome. M. Chaix, P. Goyette, A. Alikashani,<br />

F. Latour, L. Robb, B. Mondesert, L. Rivard, S. Foisy, M.<br />

Ladouceur, R. M. Hamilton, M. Talajic, J. D. Rioux.<br />

1679T A rare genetic mutation (FBLN-4 mutation)<br />

found in a patient presenting with diffuse severe<br />

aortopathy. K. Coleman, P. Fernh<strong>of</strong>f, S. Shankar, C.<br />

Hebson, M. Clabby, B. Kogon, B. Loeys.<br />

1680T Rare variants in Notch pathway genes among<br />

individuals with congenital heart defects. K. McBride,<br />

G. Zender, S. Fitzgerald-Butt, J. Stemming, A. Hooper.<br />

1681T TTN mutations from exome sequences <strong>of</strong> 17<br />

DCM families: Clinical implications. A. Morales, N.<br />

Norton, D. Li, E. Rampersaud, E. Martin, S. Zuchner, S.<br />

Guo, M. Gonzalez, R. Hershberger.<br />

1682T A novel Ser33045Ala variant <strong>of</strong> TTN gene in<br />

a family with left ventricular non-compaction and<br />

syncope: Is there a linked etiopathogenesis? A.<br />

Psychogios, A. Marsidi.<br />

1683T Molecular autopsy for sudden death using<br />

whole genome sequencing. M. J. Puckelwartz, L.<br />

Dellefave-Castillo, D. Wolfgeher, V. Nelakuditi, M. T.<br />

Campbell, J. R. Golbus, E. M. McNally.<br />

1684T High incidence <strong>of</strong> GLA variants in a nonselected<br />

heart disease patient population suggests<br />

that the Fabry trait is a common cardiovascular<br />

genetic risk factor. R. Schiffmann, S. Forni, C. Swift,<br />

X. Wu, D. J. Lockhart, M. Chee, T. Kitaoka, E. Chudin,<br />

S. Pond, N. H. McNeill, K. Sims, E. R. Benjamin, L.<br />

Sweetman.<br />

1685T Exome sequencing identifies homozygous<br />

truncation mutations in MYOM2 in arrhythmogenic<br />

ventricular dysplasia/cardiomyopathy. J. Wang, C.<br />

Silverstein, H. Lee, E. Mokhonova, A. Seki, S. P. Taylor, M.<br />

Fishbein, M. Spencer, S. F. Nelson.<br />

1686T Replication <strong>of</strong> associations from large scale<br />

re-sequencing studies. D. Waterworth, L. Li, R. Scott,<br />

C. Gillson, J. Aponte, L. Warren, M. Nelson, M. Ehm, N.<br />

Wareham, S. Chissoe.<br />

1687T Rare copy number variants in congenital heart<br />

disease affecting gene structure. K. Dumas, Y. Bouhlal,<br />

M. McKeon, J. T. C. Shieh.<br />

1688T Rare variants in the APOA5 promoter are<br />

associated with a paradoxical HDL-C decrease in<br />

response to fen<strong>of</strong>ibric acid therapy. A. Brautbar, M.<br />

Barbalic, F. Chen, J. Belmont, S. Virani, S. Scherer, R.<br />

Hegele, C. Ballantyne.<br />

1689T COL4A1 and COL4A2 mutations cause<br />

genetically modifiable hemorrhagic stroke. M.<br />

Jeanne, J. Jorgensen, C. Labelle-Dumais, Y. Weng, W. B.<br />

Kauffman, M. de Leau, S. M. Greenberg, J. Rosand, J.<br />

Favor, D. B. Gould.<br />

POSTER SESSIONS 179<br />

1690T Association <strong>of</strong> 87 traits related to coronary<br />

heart disease and rare sequence variants in the<br />

ClinSeq Study. H. Sung, B. Suktitipat, K. Lewis, D. Ng,<br />

S. Gonsalves, J. K. Teer, N. F. Hansen, J. C. Mullikin, L. G.<br />

Biesecker, A. F. Wilson, NISC Comparative Sequencing<br />

<strong>Program</strong>.<br />

1691T Exome sequencing identifies a novel splice<br />

site mutation in LMNA and multigenic heterozygosity<br />

<strong>of</strong> potential modifiers in a multi-generation family<br />

with sick sinus syndrome, dilated cardiomyopathy<br />

and sudden cardiac death. M. V. Zaragoza, E. Jensen,<br />

F. Oh, C. K. Tran, V. Hoang, S. Hakim.<br />

1692T Whole-exome sequencing and quantitative<br />

analysis <strong>of</strong> genetic variants associated with blood<br />

pressure: The NHLBI Exome Sequencing Project. S. L.<br />

Pulit, ESP Blood Pressure Project Team, NHLBI Exome<br />

Sequencing Project.<br />

1693T Identification <strong>of</strong> novel genes and their mutations<br />

associated with hypertrophic cardiomyopathy. X. Liu,<br />

Q. Huang, X. Dai, W. Xie.<br />

1694T Linkage analysis and exome sequencing<br />

to identify causal variants for familial combined<br />

hyperlipidemia. A. Mak, C. R. Pullinger, M. J. Malloy, P. L.<br />

F. Tang, R. Deo, P. Y. Kwok.<br />

1695T Exome sequencing reveals a truncation<br />

mutation in the novex-3 is<strong>of</strong>orm <strong>of</strong> TTN that disrupts<br />

cardiomyocyte ultrastructure and segregates with<br />

familial dilated cardiomyopathy. J. L. Theis, V. V.<br />

Michels, S. Middha, S. Baheti, P. C. Abell Aleff, T. M.<br />

Olson.<br />

1696T Challenges in interpreting secondary variants<br />

from massively parallel sequencing, perspectives from<br />

the ClinSeq study. D. Ng, J. J. Johnston, K. L. Lewis,<br />

S. G. Gonsalves, L. N. Singh, L. C. Peller, J. K. Teer, J. C.<br />

Mullikin, L. G. Biesecker.<br />

1697T An intronic mutation affecting pre-mRNA<br />

splicing in the COL3A1 gene as novel mechanisms<br />

causing vascular Ehlres-Danlos syndrome. A.<br />

Watanabe, B. T. Naing, M. Sasaki, K. Akutsu, S. Kosaihira,<br />

A. Gemma, T. Shimada.<br />

1698T Impaired basement membrane function causes<br />

dilated cardiomyopathy in Marfan syndrome. J. R.<br />

Cook, L. Carta, L. Benard, E. R. Chemaly, E. Chiu, T.<br />

Hampton, N. Clayton, C. Nelson, B. Wentworth, R. J.<br />

Hajjar, F. Ramirez.<br />

1699T Oxidative stress as a modifier <strong>of</strong> cardiovascular<br />

disease in a mouse model <strong>of</strong> Williams Beuren<br />

syndrome. B. Kozel, L. Ye, R. Knutsen.<br />

1700T The National Registry <strong>of</strong> Genetically Triggered<br />

Thoracic Aortic Aneurysms (GenTAC): Registry<br />

progress and research successes. C. Maslen, GenTAC<br />

Consortium.<br />

1701T Association <strong>of</strong> CRP gene variation in Asian<br />

Indian Takayasu’s arteritis patients. K. Shah, D.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


180 POSTER SESSIONS<br />

Danda, R. Shah, S. Prasanna, P. Chandna, R. Chopra,<br />

S. Danda.<br />

1702T Cardiomyopathy as an emerging phenotype<br />

in hereditary inclusion body myopathy. S. Siebel, S.<br />

McGehee, A. Br<strong>of</strong>ferio, C. Ciccone, M. Huizing, L. Medne,<br />

R. Finkel, J. McKew, W. A. Gahl, N. Carrillo-Carrasco.<br />

1703T Role <strong>of</strong> the Pro12Ala, G972R, G1057D<br />

polymorphism <strong>of</strong> the PPAR- g 2, IRS1 and IRS2 genes<br />

in type 2 diabetes and coronary artery disease. S. Vats,<br />

K. Matharoo, V. Sambyal, A. J. S. Bhanwer.<br />

1704T Genetic causes <strong>of</strong> cardiomyopathy in pediatric<br />

transplant recipients. L. Zahavich, A. Al-Maawali, A.<br />

Dipchand, C. Manlhiot, S. Bowdin.<br />

1705T Is your mother or father’s family history more<br />

important when assessing your risk <strong>of</strong> having high<br />

blood pressure: Studies in humans and mice. C. L.<br />

Chiu, C. T. Morgan, S. J. Lupton, S. Lujic, J. M. Lind.<br />

1706T Analysis <strong>of</strong> variations from exome sequence<br />

data with subclinical cardiovascular disease in the<br />

diabetes heart study: Variations from exome sequence<br />

data with subclinical cardiovascular disease in the<br />

diabetes heart study. J. Adams, A. Cox, B. Freedman, J.<br />

Carr, D. Bowden.<br />

1707T Common familial effects on ischemic stroke and<br />

myocardial infarction: A Swedish national cohort study.<br />

K. Kasiman, C. Lundholm, S. Sandin, N. Malki, P. Sparén,<br />

E. Ingelsson.<br />

1708T Jervell and Lange-Nielson syndrome:<br />

Homozygous missense mutation in KCNQ1 in a Turkish<br />

family. S. Temel, O. Bostan, H. Cangul, E. Cil.<br />

1709T Genetic risk pr<strong>of</strong>iles for incident coronary<br />

heart disease using a 28 SNP marker panel in four<br />

prospective cohorts. E. Tikkanen, A. S. Havulinna, A.<br />

Palotie, V. Salomaa, S. Ripatti.<br />

1710T Vascular stiffness in a healthy high risk African<br />

<strong>American</strong> population is modified by the extent <strong>of</strong><br />

European admixture. D. Vaidya, R. A. Mathias, L. R.<br />

Yanek, L. C. Becker, D. M. Becker.<br />

1711T A Dutch founder mutation in the cardiac<br />

regulatory light chain (MYL2). I. P. C. Krapels, G. R. F.<br />

Claes, M. B. Hoos, Y. E. G. Barrois, J.-W. Sels, A. T. J.<br />

M. Helderman-van den Enden, P. G. A. Volders, H. J. M.<br />

Smeets, A. Van den Wijngaard.<br />

1712T Genome-wide DNA methylation pr<strong>of</strong>iling in<br />

myocardial infarction. A. Russo, G. Fiorito, S. Guarrera,<br />

C. Di Gaetano, F. Ricceri, F. Rosa, A. Allione, F. Voglino,<br />

L. Iacoviello, M. C. Giurdanella, R. Tumino, S. Grioni, V.<br />

Krogh, A. Mattiello, S. Panico, P. Vineis, C. Sacerdote, G.<br />

Matullo.<br />

1713T Common cardiovascular disease risk factors are<br />

associated with mitochondrial DNA levels. S. Mitchell,<br />

K. Brown-Gentry, M. Allen, L. Hunt, P. Mayo, N. Schnetz-<br />

Boutaud, D. C. Crawford, D. G. Murdock.<br />

1714T Assessing change in quality <strong>of</strong> life in patients<br />

participating in Additional KIF6 Risk Offers Better<br />

Adherence to Statins trial. H. R. Superko, S. L. Charland,<br />

B. C. Agatep, V. Herrera, M. Ryvkin, B. J. Schrader, J.<br />

Shabbeer, J. J. Devlin, E. J. Stanek.<br />

1715T Heritability <strong>of</strong> John Henryism, and correlation<br />

between John Henryism and hypertension in the<br />

Jackson Heart Study. S. G. Buxbaum, P. Goel, W. White,<br />

M. Gregoski, S. H. Dunn.<br />

Genetic Counseling and Clinical<br />

Testing<br />

1716W Assessment <strong>of</strong> health information technology<br />

tools use among cancer genetic counselors. M. Doerr,<br />

T. Vu, C. Eng.<br />

1717W Behavior and food-related concerns in<br />

children with Smith-Magenis syndrome are similar<br />

to Prader-Willi syndrome. L. V. Barton, T. P. York, S. H.<br />

Elsea.<br />

1718W Genetic counseling future in historicist Middle<br />

East culture. A. Haghighatfard, M. Mahdavi.<br />

1719W Pre-conception genetic counseling awareness<br />

in a post-secondary educational institute. A. Neogi, A.<br />

Mahesh, D. Jalaluddin Shariff.<br />

1720W Genetic counseling in India: Challenges in a<br />

developing country. R. Puri, U. Kotecha, R. Saxena, J.<br />

Verma, S. Movva, S. Kohli, I. C. Verma.<br />

1721W A novel GLI2 mutation and discordant<br />

holoprosencephaly phenotypes in monozygotic twins.<br />

C. Quindipan, M. Van Hirtum-Das, S. Saitta.<br />

1722W Furnishing appropriate information on<br />

mitochondrial diseases to patients and their families.<br />

Y. Sato, Y. Goto.<br />

1723W A special thalassemia case with probable<br />

uniparental disomy. Y. Zhang, J. Wu, M. Q. Mai, A. H. Yin,<br />

H. K. Ding, D. Q. Qin, Q. Y. Du, J. Q. Liang.<br />

1724W Understanding the needs <strong>of</strong> parents <strong>of</strong> children<br />

with a genetic diagnosis: Can it improve clinical<br />

practice? L. Bryson, J. Dunlop, A. Anderson, J. Berg.<br />

1725W A diagnostic assay for predicting medullary<br />

cystic kidney disease type 1. B. Blumenstiel, M.<br />

DeFelice, A. Kirby, A. Gnirke, A. Bleyer, S. Gabriel, M. Daly.<br />

1726W Studding the importance <strong>of</strong> common<br />

a-deletions among b-thalassemia minor individuals in<br />

an Iranian population based on their frequencies and<br />

CBC indexes. A. Moosavi, M. Karimipoor, S. Zeinali, B.<br />

Zarbakhsh.<br />

1727W Genomic data interpretation challenges:<br />

Healthy older relatives as super controls. M. S.<br />

Naslavsky, R. C. M. Pavanello, N. C. V. Lourenço, A.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


Cerqueira, M. Lazar, M. Vainz<strong>of</strong>, D. Schlesinger, M. Zatz.<br />

1728W Assessment <strong>of</strong> cascade testing in families <strong>of</strong><br />

carriers identified through newborn screening for<br />

cystic fibrosis in western Brittany, France. C. Ferec, I.<br />

Dugueperoux, M.-P. Audrezet, P. Parent, V. Scotet.<br />

1729W NextGen sequencing <strong>of</strong> HEXA: A more<br />

sensitive assay. J. H<strong>of</strong>fman, M. Umbarger, C. Kennedy,<br />

B. Bishop, P. Saunders, G. Porreca, E. Strovel, M.<br />

Blitzer, J. Douyard, J. Davies, S. Hallam, V. Greger, C.<br />

Towne.<br />

1730W No association between ATXN2 (SCA2)<br />

CAG repeat expansion and amyotrophic lateral<br />

sclerosis /parkinsonism-dementia complex <strong>of</strong> the<br />

Kii Peninsula, Japan. H. Tomiyama, C. Yamashita, R.<br />

Sasaki, Y. Li, M. Funayama, N. Hattori, S. Kuzuhara, Y.<br />

Kokubo.<br />

1731W Assigning disease liability <strong>of</strong> mutations in<br />

the CFTR gene improves detection rate <strong>of</strong> CF carrier<br />

screening. K. R. Siklosi, P. R. Sosnay, F. Van Goor, K.<br />

Kaniecki, M. Corey, A. S. Romalho, M. D. Amaral, R.<br />

Dorfman, R. Karchin, M. H. Lewis, H. Yu, J. Zielenski,<br />

J. M. Rommens, C. Castellani, C. M. Penland, G. R.<br />

Cutting.<br />

1732W Mutational screening <strong>of</strong> C9ORF72, SOD1,<br />

TARDBP and FUS genes in an ALS cohort from the<br />

Northeastern part <strong>of</strong> Italy. C. Bertolin, J. Agostini,<br />

C. D’Ascenzo, F. Boaretto, C. Salvoro, C. Angelini, E.<br />

Pegoraro, G. Sorarù, M. L. Mostacciuolo.<br />

1733W Cree leukoencephalopathy and Cree<br />

encephalitis carrier screening program: Live<br />

experiences <strong>of</strong> carrier and non-carrier couples. J. Le<br />

Clerc-Blain, H. Denoncourt, A. Richter, A. M. Laberge.<br />

1734W Diagnostic exome sequencing in movement<br />

disorders. E. J. Kamsteeg, C. F. H. A. Gilissen, K.<br />

Neveling, H. J. E. de Reuver, B. P. C. van de Warrenburg,<br />

M. A. A. P. Willemsen, S. Vermeer, H. G. Brunner, M. R.<br />

Nelen, H. Scheffer.<br />

1735W Whole exome sequencing as an approach to<br />

the diagnosis <strong>of</strong> the ataxic patients. Y. Yang, M. Vatta,<br />

Z. Niu, Y. Ding, H. Sun, M. Scheel, N. Saada, W. Liu, M.<br />

Wang, D. P. Sexton, A. C. Hawes, M. N. Bainbridge, P. A.<br />

Pham, J. G. Reid, D. M. Muzny, A. A. Braxton, P. A. Ward,<br />

T. M. Balmakund, W. K. Chung, A. Willis, S. E. Plon, J. R.<br />

Lupski, R. A. Gibbs, A. L. Beaudet, C. M. Eng.<br />

1736W A retrospective genetic analysis <strong>of</strong> cases<br />

reported using an XLMR/XLID next-generation<br />

sequencing panel. M. Parra, S. Mexal, R. Hoiness, K.<br />

Waller, I. Lu, C. Gau, J. A. Neidich, J. Wei.<br />

1737W Principles and informatic infrastructure<br />

for implementing diagnostic next-generation<br />

sequencing for genetically heterogeneous<br />

conditions. S. Topper, V. Nelakuditi, C. Tan, A. Reeder,<br />

D. del Gaudio, S. Das.<br />

1738W Clinical characterization <strong>of</strong> patients<br />

POSTER SESSIONS 181<br />

undergoing molecular testing for Ehlers Danlos<br />

syndrome at The Hospital for Sick Children in Toronto,<br />

Canada: Five year experience. L. Dupuis, M. A.<br />

Qoqandi, P. Kannu, L. Fishman, D. Chitayat, S. Bowdin,<br />

R. Mendoza-Londono.<br />

1739W Detection <strong>of</strong> oipA using PCR method can help<br />

to the diagnosis <strong>of</strong> Helicobacter pylori in the dyspeptic<br />

patients. L. Salimzadeh, N. Bagheri, F. Azadegan, G.<br />

Rahimian, A. Taghikhani, M. Hashemzadeh, H. Shirzad.<br />

1740W Connecting family branches through recurrent<br />

BRCA mutations. A. Toland, M. O’Connor, L. Senter.<br />

1741W Low prevalence <strong>of</strong> large genomic<br />

rearrangements in BRCA1/2 found in at-risk Southern<br />

California population. T. H<strong>of</strong>fman, M. Alvarado.<br />

1742W Clinical whole exome sequencing for the<br />

diagnosis <strong>of</strong> Mendelian disorders: <strong>Program</strong> design,<br />

implementation, and first year reporting experience.<br />

C. M. Eng, D. Muzny, J. Reid, M. Bainbridge, P. Pham, M.<br />

R. Bekheirnia, J. Beuten, M. Hardison, Z. Niu, R. Person,<br />

M. Vatta, F. Xia, A. Hawes, M. Wang, Y. Ding, H. Sun, M.<br />

Scheel, N. Saada, W. Liu, A. Braxton, P. Ward, A. Willis, J.<br />

Wiszniewska, S. E. Plon, J. R. Lupski, A. L. Beaudet, R. A.<br />

Gibbs, Y. Yang.<br />

1743W Diagnostic yield <strong>of</strong> single nucleotide<br />

polymorphism array-based genotyping is equivalent<br />

to metaphase cytogenetics for Turner syndrome. S. K.<br />

Prakash, D. C. Guo, C. L. Maslen, M. Silberbach, D. M.<br />

Milewicz, C. A. Bondy, GenTAC Investigators.<br />

1744W High resolution copy number pr<strong>of</strong>iling <strong>of</strong> the X<br />

chromosome in clinical diagnosis. S. A. Yatsenko, S.<br />

Madan-Khetarpal, U. Surti, A. Rajkovic.<br />

1745W MLPA-based strategy for discrete CNV<br />

genotyping: CNV-miRNAs as an example. M.<br />

Marcinkowska, P. Kozlowski.<br />

1746W Turkish medical students perceived genetic<br />

counseling style and the use <strong>of</strong> hypothetical genetic<br />

testing across 5 psychiatric and 3 non-psychiatric<br />

disorders. D. Kinney, E. A. Ergul, K. Munir, O. Kutuk, F.<br />

Topuz, A. Kanik.<br />

1747W Non-optical massive parallel DNA sequencing<br />

<strong>of</strong> BRCA1 and BRCA2 genes: Towards the diagnostic<br />

setting. J. L. Costa, S. Sousa, R. Fernandes, L. Cirnes, J.<br />

C. Machado.<br />

1748W Identifying the genetic cause <strong>of</strong> primary<br />

immunodeficiency diseases: Development <strong>of</strong> a<br />

next-generation sequencing approach for routine<br />

diagnostics. S. C. Drury, C. Bacchelli, S. Bibi, F. McKay,<br />

L. Jenkins, H. B. Gaspar, C. M. Cale, K. C. Gilmour, N. J.<br />

Lench.<br />

1749W Exome sequencing analysis for diagnostics.<br />

C. Gilissen, M. Nelen, K. Neveling, R. de Reuver, L. E. L.<br />

M. Vissers, N. Wieskamp, H. G. Yntema, J. de Ligt, M.<br />

Rosario, H. G. Brunner, H. Scheffer, J. A. Veltman.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


182 POSTER SESSIONS<br />

1750W Detection and mapping the breakpoints <strong>of</strong><br />

heteroplasmic mtDNA deletions by massively parallel<br />

sequencing. F.-Y. Li, H. Cui, D. Gonzalez, J. Wang, V.<br />

Zhang, L.-J. Wong.<br />

1751W Three novel AGL mutations in glycogen storage<br />

disease type III in Tunisian families. A. Mili, O. Mamaï, I.<br />

Ben Charfeddine, A. Amara, S. Pagliarani, S. Lucchiari, A.<br />

Saad, K. Limem, M. Gribaa.<br />

1752W Multiplex PCR assay for detection <strong>of</strong> the 2<br />

most common mutations in the pr<strong>of</strong>ilaggrin gene (FLG)<br />

involved in ichthyosis vulgaris. G. Pont-Kingdon, L.<br />

Hubley, E. E. Baldwin, E. Lyon.<br />

1753W GeneReviews as a source <strong>of</strong> medically<br />

actionable information for coincidentally diagnosed<br />

disorders. M. P. Adam, C. R. Dolan, A. R. Amemiya, M.<br />

Espeseth, T. D. Bird, K. Stephens, R. A. Pagon.<br />

1754W Comprehensive diagnostic hearing loss testing<br />

on a single platform: The OtoGenome test. S. S. Amr, T.<br />

J. Pugh, E. Duffy, L. Farwell, S. Gowrisankar, A. Lovelette-<br />

Hernandez, B. H. Funke, H. L. Rehm.<br />

1755W Allele drop out and MECP2 genetic testing. E.<br />

Bettella, R. Polli, E. Leonardi, A. Murgia.<br />

1756W Screening for and Identification <strong>of</strong> pathogenic<br />

mutations in patients with inherited retinal<br />

degenerations using targeted enrichment and<br />

next-generation sequencing. M. B. Consugar, Z. D.<br />

Fonseca-Kelly, E. M. Place, E. Au, S. M. Harper, X. Gai, E.<br />

L. Berson, E. A. Pierce.<br />

1757W Validation <strong>of</strong> whole exome sequencing assay<br />

for clinic service at Baylor College <strong>of</strong> Medicine. Y. Ding,<br />

D. M. Muzny, J. G. Reid, M. Wang, Y. Han, H. Dinh, D. P.<br />

Sexton, M. N. Bainbridge, A. C. Hawes, P. Pham, B. Yin,<br />

D. P. C. Ng, C. J. Buhay, J. Wiszniewska, M. Scheel, N.<br />

Saada, W. Liu, H. Sun, R. A. Gibbs, A. L. Beaudet, C. M.<br />

Eng, Y. Yang.<br />

1758W Advancing from targeted resequencing to whole<br />

exome sequencing for improving the molecular diagnosis<br />

<strong>of</strong> congenital disorders <strong>of</strong> glycosylation. M. A. Jones, B.<br />

G. Ng, P. He, M. E. Losfeld, S. Bhide, D. Rhodenizer, E. L. H.<br />

Chin, M. He, H. H. Freeze, M. R. Hegde.<br />

1759W A novel splice site variant (IVS44-3T.C) in<br />

COL3A1 results in small amounts <strong>of</strong> exon skipping<br />

and complicates genetic counseling in a family with<br />

features <strong>of</strong> hypermobility Ehlers-Danlos syndrome. D.<br />

F. Leistritz, U. Schwarze, D. Sarroza, P. D. Steele, C. Boni,<br />

B. A. Salbert, P. H. Byers.<br />

1760W A DNA-based method for detecting<br />

homologous blood doping. I. Manokhina, J. L. Rupert.<br />

1761W Identification <strong>of</strong> ARID1B mutations in<br />

intellectual disability/C<strong>of</strong>fin-Siris patients by clinical<br />

whole exome sequencing analysis. Z. Niu, M. Vatta, A.<br />

Willis, Y. Ding, H. Sun, M. Scheel, N. Saada, W. Liu, M.<br />

Wang, D. P. Sexton, A. C. Hawes, M. N. Brainbridge, P.<br />

Pham, J. G. Reid, D. M. Muzny, P. A. Ward, A. A. Braxton,<br />

A. Scheuerle, M. K. Koenig, S. E. Plon, J. R. Lupski, R. A.<br />

Gibbs, A. L. Beaudet, Y. Yang, C. M. Eng.<br />

1762W National Institutes <strong>of</strong> Health Genetic Testing<br />

Registry. W. S. Rubinstein, D. Maglott, B. L. Kattman,<br />

A. Malheiro, J. Lee, M. Ovetsky, V. Hem, G. Song, V.<br />

Gorelenkov, C. Fomous, J. Ostell.<br />

1763W EuroGentest Clinical Utility Gene Cards:<br />

Progress and perspectives. J. Schmidtke, A. Dierking.<br />

1764W Mutation screening <strong>of</strong> genes causing inherited<br />

immunodeficiency and bone marrow failure using nextgeneration<br />

sequencing. T. A. Sivakumaran, A. Husami, D.<br />

Kissell, K. Zhang.<br />

1765W Mutation analysis <strong>of</strong> the SOX2 and OTX2 genes<br />

in 235 patients with developmental eye disorders. N.<br />

Smaoui, B. Williams, S. Aradhya, S. Bale, S. Suchi, G.<br />

Richard.<br />

1766W Digitizing clinical genetic literature: A<br />

comprehensive, accurate and scalable approach. M.<br />

Sommargren, Locus Development, Inc.<br />

1767W Estimated variant rate for a next-generation<br />

sequencing panel <strong>of</strong> 13 genes associated with hereditary<br />

colon cancer. A. J. Stuenkel, S. L. Tandy, J. D. Siegfried.<br />

1768W Simple and accurate assays for targeting<br />

CFTR mutations <strong>of</strong> specific geographic/ethnic<br />

origins by PCR allelic discrimination: still a place for<br />

targeted tools. C. Vasseur, A. LeFloch, B. Costes, A. de<br />

Becdeli&egrave;vre, T. Casals, C. Costa, M. Goossens, E.<br />

Girodon.<br />

1769W The CLARITY Challenge: Children’s leadership<br />

award for the reliable interpretation and appropriate<br />

transmission <strong>of</strong> your genomic information. C. A.<br />

Brownstein, E. T. DeChene, K. C. Flannery, S. W. Kong, M.<br />

C. Connolly, I. S. Kohane, A. H. Beggs, D. M. Margulies.<br />

1770W What is a clinical grade genome? F. De La Vega,<br />

A. Russell, M. A. Morales, C. D. Bustamante, M. G. Reese.<br />

1771W The mutation type and effect <strong>of</strong> variants<br />

underlying human genetic diseases. J. Westbrook, Y.<br />

Kobayashi, Locus Development, Inc.<br />

1772W Application <strong>of</strong> next-generation sequencing<br />

technology in the study <strong>of</strong> mitochondrial diseases. Y.<br />

Ma, Y. Cao, Z. Chen, H. Pan, Y. Qi.<br />

1773W A combined next-generation sequencing and<br />

exon-level aCGH diagnostic gene panel for severe<br />

developmental delay and epilepsy phenotypes. N.<br />

J. Lench, H. Moody, A. McTague, E. Meyer, S. Drury, S.<br />

Fielding, R. Palmer, M. A. Kurian, R. H. Scott.<br />

1774W High-throughput mutation screening in patients<br />

with inherited retinal dystrophies. X. Wang, A. Turner, M.<br />

Brooks, H. Rajasimha, K. Johnson, Y. Fann, A. Swaroop.<br />

1775W Predictive testing for neurodegenerative<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


conditions is <strong>of</strong>ten not predictive. C. L. Goldsmith, D. A.<br />

Dyment, K. M. Boycott.<br />

1776W Large scale population analysis challenges<br />

the current criteria for the molecular diagnosis <strong>of</strong><br />

fascioscapulohumeral muscular dystrophy. I. Scionti,<br />

F. Greco, G. Ricci, M. Govi, P. Arashiro, L. Vercelli, T.<br />

Mongini, A. Berardinelli, C. Angelini, G. Antonini, M. Cao,<br />

A. Di Muzio, M. Moggio, L. Morandi, E. Ricci, C. Rodolico,<br />

L. Ruggiero, L. Santoro, G. Siciliano, G. Tomelleri, C. P.<br />

Trevisan, G. Galluzzi, W. Wright, M. Zatz, R. Tupler.<br />

1777W Identification <strong>of</strong> a common pan-ethnic<br />

haplotype enriched on SMN1 duplication alleles<br />

improves the detection <strong>of</strong> silent (210) SMA carriers and<br />

significantly modifies residual risk estimates. M. Luo,<br />

L. Liu, I. Peter, J. Zhu, S. A. Scott, G. Zhao, C. Eversley, R.<br />

Kornreich, R. J. Desnick, L. Edelmann.<br />

1778W Multiplexing test for molecular diagnosis <strong>of</strong><br />

skeletal dysplasia (by CGC mutation panel). P. Tavares,<br />

A. Lopes, L. Lameiras, L. Dias, J. Sá, A. Palmeiro, P.<br />

Rendeiro.<br />

1779W A combination <strong>of</strong> panel and exome sequencing<br />

to identify novel human retinitis pigmentosa genes. F.<br />

Wang, H. Wang, J. Zaneveld, K. Zhang, R. Koenekoop,<br />

G. Silvestri, N. Solanki, J. Cheng, I. Lopez, H. Ren, D.<br />

Simpson, R. Chen.<br />

1780W Evaluation <strong>of</strong> BRCA1 mutations in patients with<br />

family history <strong>of</strong> breast cancer. S. Rummel, C. D. Shriver,<br />

R. E. Ellsworth.<br />

1781W Measuring clinician satisfaction with disclosure<br />

<strong>of</strong> genetic susceptibility test results: Findings from the<br />

REVEAL Study. S. L. Everhart, B. M. Wood, K. Valverde, L.<br />

Medne, J. S. Roberts, C. A. Chen, K. D. Christensen, R. C.<br />

Green, REVEAL Study Group.<br />

1782W Reactions to direct-to-consumer BRCA test<br />

results. U. Francke, C. Dijamco, A. K. Kiefer, N. Eriksson,<br />

J. Y. Tung, J. L. Mountain.<br />

1783W Targeted gene capture <strong>of</strong> BRCA1 using short,<br />

explicitly non-gene-specific, peptide nucleic acid baits.<br />

S. V. Tavtigian, K. Tao, R. Bell, J. Rosenthal, W. Kohlmann.<br />

1784W Predictive testing for idiopathic scoliosis: Are<br />

orthopedic surgeons and pediatricians ready and<br />

willing? A. M. Laberge, A. Moreau.<br />

1785W Myocilin genetic screening in severe<br />

glaucoma cases and cascade testing in the<br />

Australian and New Zealand Registry <strong>of</strong> Advanced<br />

Glaucoma. E. Souzeau, K. P. Burdon, B. Usher-Ridge,<br />

A. Dubowsky, J. E. Craig.<br />

1786W Parental awareness, attitudes, and experiences<br />

<strong>of</strong> genetic testing in autism spectrum disorders. A.<br />

Rupchock, M. Cuccaro, M. Alessandri, J. M. Lee.<br />

1787W Genetic testing in autism: Parental attitudes<br />

and expectations. M. Cuccaro, K. Czape, J. M. Lee, A.<br />

Rupchock, E. Bendik, M. Alessandri, S. Hahn.<br />

POSTER SESSIONS 183<br />

1788W Underestimated intimate issues after bilateral<br />

prophylactic mastectomy with breast reconstruction in<br />

healthy BRCA mutation carriers. A. Tibben, J. Gopie, C.<br />

Seynaeve, M. Ter Kuile, M. Menke-Pluymers, R. Timman,<br />

M. Mureau.<br />

1789W Risk <strong>of</strong> peripartum acute aortic dissection in<br />

women with ACTA2 mutations. E. Regalado, D. Guo, D.<br />

Milewicz.<br />

1790W Translational impact <strong>of</strong> VEGFA variants on the<br />

prediction and follow-up <strong>of</strong> ocular complications in<br />

pseudoxanthoma elasticum. E. De Vilder, M. J. Hosen,<br />

L. M. Martin, B. P. Leroy, J. M. Ebran, P. J. Coucke, A. De<br />

Paepe, O. M. Vanakker.<br />

1791W Familial occurrence and associated symptoms<br />

in a population <strong>of</strong> individuals with non-syndromic<br />

craniosynostosis. J. Greenwood, S. Boyadjiev, K. Osann,<br />

P. Flodman, V. Kimonis.<br />

1792W Personalized risk prediction in a populationbased<br />

biobank: The Estonian experience. K. Fischer, K.<br />

Läll, L. Leitsalu-Moynihan, P. C. Ng, T. Haller, T. Esko, A.<br />

Metspalu.<br />

1793W Acquired thrombophilias; The reproductive<br />

geneticist’s dilemma. T. Goldwaser, K. Bajaj, S. Klugman.<br />

1794W Family history and risk assessment in black<br />

South African women with breast cancer. T. Wainstein,<br />

C. van Wyk, A. Krause.<br />

1795W Support for patients with Young-Simpson<br />

syndrome, their families and other peoples concerned:<br />

Study <strong>of</strong> patients and family group meetings.<br />

Y. Yamanouchi, T. Nishikawa, K. Enomoto, N. Furuya,<br />

S. Mizuno, T. Kondo, M. Adachi, K. Muroya, M. Masuno,<br />

K. Kurosawa.<br />

1796W Duplications Xq28 are questionable for genetic<br />

counseling. C. Costa, A. Briand, C. Rothschild, E. Bieth,<br />

J. Melki, C. Metay, M. Goossens.<br />

Ethical, Legal, Social and Policy<br />

Issues in <strong>Genetics</strong><br />

1797W Surname leakage from personal genomes.<br />

Y. Erlich, M. Gymrek, D. Golan, E. Halprein, A. L. McGuire.<br />

1798F Optional enrollment into access controlled<br />

genomic databases: Decision making in hispanics<br />

versus non-Hispanics. S. Scollon, S. Gutierrez,<br />

A. L. McGuire, S. Hicks, S. E. Plon.<br />

1799W Development <strong>of</strong> institutional genomic research<br />

infrastructure in an academic pediatric hospital setting<br />

to enable large-scale enrollment, education and<br />

discovery. C. M. Clinton, S. K. Savage, C. A. Brownstein,<br />

I. A. Holm, D. M. Margulies, W. A. Wolf.<br />

1800F A proposal: A family driven social network<br />

model for clinical data sharing and research in<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


184 POSTER SESSIONS<br />

intellectual deficiencies and other neurodevelopmental<br />

disorders with specific genetic causes. J.-L. Mandel,<br />

J. S. Beckmann.<br />

1801W Turkish medical students attitude towards<br />

the ethics <strong>of</strong> genetic testing and genetic information<br />

disclosure in fragile X syndrome, breast cancer and<br />

Huntington disease. E. A. Ergul, I. Gun.<br />

1802F Hope and hype in sight: Multi-stakeholder<br />

perspectives on ocular gene therapy. S. Benjaminy,<br />

T. Bubela, M. Bieber, I. MacDonald.<br />

1803W Social and ethical implications <strong>of</strong> families’<br />

experiences <strong>of</strong> pediatric genetics: Key findings from a<br />

U.K. qualitative study exploring families’ expectations,<br />

their responses to diagnosis and their approach to<br />

managing the uncertainties <strong>of</strong> genetic investigations.<br />

J. McLaughlin, M. Wright, E. K. Clavering, E. Haimes.<br />

1804F Driving research forward, but in what direction?<br />

Scientist perspectives on goals and groups invested in<br />

autism genetic research. L. C. Milner, M. K. Cho.<br />

1805W Experiential process <strong>of</strong> securing free prior<br />

informed consent for genetics research from an<br />

indigenous population in the Philippines. C. D. Padilla,<br />

A. L. Sur, M. T. Guia-Padilla, M. Baluyot, E. M. Cutiongcode<br />

la Paz, S. Padilla.<br />

1806F The essential ethical considerations for using<br />

human genome sequencing as a diagnostic tool in<br />

clinical medicine. A. D. Zellers.<br />

1807W The evaluation <strong>of</strong> low template, degraded and<br />

mixed DNA pr<strong>of</strong>iles in forensic science. D. Balding.<br />

1808F Legal considerations regarding participant<br />

privacy in the genomic era <strong>of</strong> research on the African<br />

continent. G. E. B. Wright, P. Koornh<strong>of</strong>, N. Tiffin.<br />

1809W Insurance coverage <strong>of</strong> preventive services for<br />

individuals with genetic predispositions to cancer.<br />

A. Prince.<br />

1810F The implementation and impact <strong>of</strong> student<br />

athlete sickle cell trait screening: A survey <strong>of</strong> Division I<br />

California universities. L. Mar, N. Lovick, C. Hartshorne,<br />

M. Treadwell, J. Youngblom.<br />

1811W Direct to consumer genetic testing: What<br />

information for which consent? J. Atia, E. Rial-Sebbag,<br />

V. Anastosova, A. Cambon-Thomsen, F. Taboulet.<br />

1812F Genetic discrimination and the relevance <strong>of</strong> the<br />

United Nations Convention on the Rights <strong>of</strong> Persons<br />

with Disabilities. A. de Paor.<br />

1813W Representing the indigenous community:<br />

Researcher and physician voices spark debate over<br />

newborn screening <strong>of</strong> CPT1A in Alaska Native and First<br />

Nations populations. N. Garrison.<br />

1814F Next-generation sequencing <strong>of</strong> pluripotent stem<br />

cell lines: Ethical, social and policy considerations.<br />

R. Isasi.<br />

1815W Research policy <strong>of</strong> the “Genome Science”<br />

project in Japan. J. Minari, T. Shirai, G. Yoshizawa,<br />

K. Okada, N. Yamamoto, K. Kato.<br />

1816F Cultural influences on genetic testing in East<br />

Asia. H. Numabe.<br />

1817W The need for an ELSI watch <strong>of</strong> epigenetic<br />

information. E. Rial-Sebbag, A. Soulier, C. Delpierre.<br />

1818F Pervasive sequence patents cover the entire<br />

human genome. J. A. Rosenfeld, P. Zumbo, C. E. Mason.<br />

1819W The revised points <strong>of</strong> ethical guidelines for<br />

human genome research in Japan. Z. Yamagata,<br />

K. Muto.<br />

1820F Does evidence justify the use <strong>of</strong> multigene<br />

sequencing panels for rare genetic disorders?<br />

D. Allingham-Hawkins, A. Lea, L. Cushman-Spock,<br />

L. Wieselquist, S. Levine.<br />

1821W The student-athlete’s knowledge, behaviors,<br />

concerns and perceptions in regards to mandatory<br />

sickle cell trait testing. N. E. Thompson, B. W. Harrison,<br />

F. Ampy, R. F. Murray, Jr.<br />

1822F Primary care patients’ experience <strong>of</strong><br />

and reactions to direct-to-consumer genomic testing:<br />

A longitudinal qualitative study. K. Wasson, T. N.<br />

Sanders, N. S. Hogan, S. Cherny, K. J. Helzlsouer.<br />

1823W Whole genome sequencing: Will it destroy<br />

newborn screening? C. Allen, D. Avard, B. M. Knoppers.<br />

1824F Patient and provider perspectives on<br />

personalized genomic medicine: Qualitative substudy<br />

<strong>of</strong> a multicenter feasibility study <strong>of</strong> genomic<br />

sequencing in advanced cancer patients. J. P.<br />

Bytautas, F. A. Miller, R. Z. Hayeems, S. Ernst, H. Hirte,<br />

S. Hotte, A. Oza, A. Razak, S. Welch, E. Winquist, P. L.<br />

Bedard, J. Dancey, L. L. Siu.<br />

1825W Consumer genomics: Motivations and<br />

intentions. R. C. Green, J. Mountain, A. Kiefer, T. Moreno,<br />

E. MacBean, S. S. Kalia, J. S. Roberts, PGen Study Group.<br />

1826F The Ethical, Legal and Social Implications<br />

<strong>Program</strong>: Impact on federal policy. D. Mathews,<br />

B. Drehman.<br />

1827W Public perspectives regarding personalized<br />

medicine and genomic risk pr<strong>of</strong>iling within colorectal<br />

cancer screening. S. G. Nicholls, B. J. Wilson, S. Craigie,<br />

H. Etchegary, D. Castle, J. C. Carroll, B. K. Potter,<br />

L. Lemyre, J. Little on behalf <strong>of</strong> CIHR Emerging Team in<br />

Genomics in Screening.<br />

1828F Pursuing pharmacogenomic testing within<br />

a nonpr<strong>of</strong>it healthcare system: A comparison <strong>of</strong><br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


stakeholders’ perspectives. S. M. Fullerton,<br />

S. B. Trinidad, J. D. Ralston, J. T. Tufano, G. P. Jarvik,<br />

E. B. Larson.<br />

1829W Public preferences for the use <strong>of</strong> email and<br />

Internet communication in large-scale genetic and<br />

biobank research. J. Murphy Bollinger, R. Dvoskin,<br />

K. Kreger, D. Kaufman.<br />

1830F Public attitudes towards consumer genetics in<br />

Japan, South Korea and Taiwan. K. Muto, M. Sato, H.<br />

Hong, C. Chang.<br />

1831W Japanese networkers&#146; attitudes toward<br />

personal genome services. T. Kido, M. Kawashima.<br />

1832F Genetic risk predictions: Attitude <strong>of</strong> the Estonian<br />

public. L. Leitsalu-Moynihan, A. Allik, M. L. Tammesoo,<br />

A. Metspalu.<br />

1833W Attitude change for four years toward genetic<br />

testing <strong>of</strong> children for common disease risk in Japan.<br />

I. Ishiyama, K. Muto, A. Tamakoshi, T. Maeda, A. Nagai, Z.<br />

Yamagata.<br />

1834F African <strong>American</strong>s in South Florida&#146;s<br />

perceptions about genetic research participation:<br />

Opportunities and barriers. J. M. Lee, M. Gavier, S. E.<br />

Hahn, L. Adams, D. A. Caldwell, K. G. Murphy, C. Jean,<br />

M. A. Pericak-Vance.<br />

1835W Unexpected results in biobank research:<br />

Experiences <strong>of</strong> information delivery and direction to<br />

health care after detection <strong>of</strong> mutations leading to long<br />

QT syndrome. H. Kaariainen, E. Kujala, P. Alha,<br />

V. Salomaa, S. Koskinen, H. Swan, A. Haukkala.<br />

1836F The Gene Partnership: A model for pediatric<br />

genetic repositories in the age <strong>of</strong> the incidentalome.<br />

I. A. Holm, C. M. Clinton, S. K. Savage, P. L. Taylor, K.<br />

D. Mandl, J. P. Bickel, D. J. Nigrin, I. S. Kohane, D. M.<br />

Margulies, L. M. Kunkel.<br />

1837W The Medical College <strong>of</strong> Wisconsin <strong>Program</strong> in<br />

Genomics and Ethics: An empirical bioethics venture.<br />

K. A. Strong, T. May, K. L. Zusevics, A. R. Derse.<br />

1838F Evaluation <strong>of</strong> a scalable method for returning<br />

results and genetic findings from genomic research to<br />

research participants. J. Y. Tung, S. Wu, B. T. Naughton,<br />

J. L. Mountain.<br />

1839W Perceptions <strong>of</strong> genetic counseling services<br />

in direct-to-consumer personal genomic testing. B.<br />

F. Darst, N. J. Schork, E. J. Topol, C. S. Bloss.<br />

1840F Shared decision-making: Seeking a change in<br />

the genetics consult. S. Adam, P. H. Birch, A. Townsend,<br />

F. Rousseau, J. M. Friedman.<br />

1841W Personal genomics: A study assessing the<br />

safety and health outcomes <strong>of</strong> receiving whole exome<br />

sequencing results. Y. Bombard, K. Schrader,<br />

E. Glogowski, R. Rau-Murthy, S. Patil, A. Eaton, E. Elkin,<br />

M. J. Massie, J. Hay, S. Shah, J. Vijai, N. Kauff, Z. Stadler,<br />

M. Robson, K. Offit.<br />

POSTER SESSIONS 185<br />

1842F Integrating exome/genome sequencing into<br />

clinical genetics practice. S. M. Jamal, H. K. Tabor,<br />

J. Conta, J. Yu, M. J. Bamshad.<br />

1843W A proposed approach to the integration <strong>of</strong><br />

sequence data at a pediatric academic institution.<br />

S. K. Savage, C. M. Clinton, I. A. Holm, I. S. Kohane,<br />

D. M. Margulies.<br />

1844F Assessing participant preferences for the return<br />

<strong>of</strong> genomic research results. L. Shahmirzadi, M. K. Cho,<br />

S. Soo-Jin Lee, K. E. Ormond.<br />

1845W The NHGRI/NIH Clinical Sequencing Exploratory<br />

Research <strong>Program</strong>. B. A. Ozenberger, L. A. Hindorff,<br />

S. D. Schully, J. Boyer, N. Lockhart, L. Lund, C. Mahomva,<br />

A. Felsenfeld, J. E. McEwen.<br />

1846W Genomic incidental findings: Perspectives <strong>of</strong><br />

geneticists and genetic counselors in the context <strong>of</strong><br />

clinical sequencing. Z. Lohn, S. Adam, P. H. Birch,<br />

A. Townsend, J. M. Friedman.<br />

1847W Accounting for racial disparities in mortality<br />

among children with Down syndrome. S. Santoro,<br />

A. Esbensen, L. Hendershot, F. Hickey, B. Patterson.<br />

1848W ELSI 2.0: A new initiative to create an international<br />

infrastructure for the ethical, legal and social implications<br />

<strong>of</strong> genomic research. K. Kato, J. Kaye, E. M. Meslin,<br />

B. M. Knoppers, E. T. Juengst, M. Deschenes, A. Cambon-<br />

Thomsen, D. Chalmers, J. De Vries, K. Edwards, N. Hoppe,<br />

A. Kent, C. Adebamowo, P. Marshall.<br />

1849W The challenges <strong>of</strong> defining a phenotype for<br />

addiction: In the words <strong>of</strong> addiction scientists.<br />

J. B. McCormick, J. E. Ostergren, R. R. Hammer, H. S.<br />

Harvey, M. Dingel, B. A. Koenig.<br />

1850W Discriminating faces: Visual cues <strong>of</strong> ancestry.<br />

J. Wagner, P. Claes, M. Shriver.<br />

<strong>Genetics</strong> Education<br />

1851F Integrating medical genetics into primary health<br />

care: Report <strong>of</strong> a pilot program in Brazil. T. Vieira,<br />

C. Giugliani, L. Silva, L. Faccini, J. Leite, O. Artigalás,<br />

M. Lenz, M. Rojas, R. Giugliani.<br />

1852F The Gene Messenger impact project: A<br />

genetics e-learning program for family physicians.<br />

J. C. Carroll, R. Grad, P. Pluye, J. Allanson, J. Permaul,<br />

N. Pimlott, B. J. Wilson.<br />

1853F Examining the research training <strong>of</strong> recent<br />

genetic counseling graduates. S. Hahn, A. Rupchock,<br />

E. Bendik, E. Burkett, E. Heise.<br />

1854F Increasing the number <strong>of</strong> URMs in genomic<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


186 POSTER SESSIONS<br />

science. D. Murray, D. Whittington, R. Gibbs.<br />

1855F Pharmacotherapy <strong>of</strong> Inherited Metabolic<br />

Diseases PharmD Fellowship Training <strong>Program</strong>. J. Utz,<br />

W. Whitley.<br />

1856F Promoting student engagement and critical<br />

thinking in genetics: An evaluation <strong>of</strong> “Luck <strong>of</strong> the<br />

Draw” game. M. Godfrey, A. Bower, K. L. Tracy, R.<br />

Anderson, A. Jameton, B. Arobba, C. Ryan.<br />

1857F Genetic numeracy in college students:<br />

A quantitative analysis. M. Bergman, H. Honore Goltz.<br />

1858F The Growing Stronger Organization and the<br />

Acondroplasia - Achondroplasia Blog: A parents’<br />

initiative to share knowledge and foster alliances<br />

towards potential therapeutic approaches for<br />

achondroplasia. M. Kaisermann.<br />

1859F <strong>Genetics</strong> Home Reference, ten years in: Where<br />

we are now. S. M. Morrison, M. L. Cheh, S. Calvo, H.<br />

Collins, J. Fun, K. Greenberg, L. Forman-Neall.<br />

1860F Investigating a conceptual change strategy<br />

to improve student understanding <strong>of</strong> basic genetics<br />

concepts in undergraduate non-science major and<br />

nursing student populations. B. Bowling, M. Glassford,<br />

S. Barnes, S. Borgman, E. Reilly, T. Beery, C. Huether.<br />

1861F Alignment and assessment problems in the<br />

undergraduate genetics curriculum. M. Dougherty,<br />

T. McElhinny, B. Bowling, J. Libarkin.<br />

1862F YouTube as an educational resource for visual<br />

and kinesthetic learners: A study <strong>of</strong> DNA replication<br />

animations. J. M. Lind.<br />

1863F Genetic counseling in India: Current certification<br />

courses and a need for the development <strong>of</strong> a master’s<br />

training program. K. Shah.<br />

Health Services Research<br />

1864F A strategy <strong>of</strong> applying comprehensive<br />

therapeutic approaches for training children with<br />

autism. H. Xu, N. Zhong.<br />

1865F <strong>Genetics</strong> and public health: The experience<br />

<strong>of</strong> a referral center for diagnosis <strong>of</strong> 22q11.2 deletion<br />

in Brazil and suggestions for implementing genetic<br />

testing. T. Vieira, I. Sgardioli, V. Gil-da-Silva-Lopes.<br />

1866F Outreach, genetic counseling and testing <strong>of</strong><br />

patients at risk for hereditary breast and ovarian<br />

cancer ascertained through the use <strong>of</strong> the electronic<br />

medical record. H. Kershberg, E. Parkhurst, M. Alvarado,<br />

H. Zhou, J. Natoli, G. Tiller.<br />

1867F Prevalence <strong>of</strong> Down syndrome in the United<br />

States. A. P. Presson, G. Partyka, K. M. Jensen, S. A.<br />

Rasmussen, O. J. Devine, L. McCabe, E. R. B. McCabe.<br />

1868F Rare disease initiatives in Europe: Centers<br />

<strong>of</strong> expertise in Germany. C. Huebner, M. Stuhrmann-<br />

Spangenberg, C. Zeidler, J. Schmidtke.<br />

1869F Implementation <strong>of</strong> universal Lynch syndrome<br />

screening in an integrated health-care delivery system.<br />

K. A. B. Goddard, T. Kauffman, M. Morse, J. Davis, C.<br />

Young, E. Esterberg, C. McGinley, J. Reiss.<br />

1870F Beyond NGS technology: Overcoming key<br />

challenges for nation-wide implementation <strong>of</strong> nextgeneration<br />

sequencing into routine diagnostics.<br />

T. Vrijenhoek on behalf <strong>of</strong> Centre for Genome Diagnostics.<br />

1871F Inherited Neuropathies Consortium: A<br />

collaborative approach to genetic research in<br />

Charcot-Marie-Tooth disease. F. Speziani, S. M. E.<br />

Feely, C. Siskind, S. H. Blanton, G. Beecham, J. M. Vance,<br />

M. Shy, S. Zuchner, Inherited Neuropathies Consortium.<br />

1872F Genomic technologies: Effective integration<br />

into pediatric clinical care. R. Hayeems, N. Hoang, S.<br />

Chenier, J. Stavropoulos, S. Pu, S. Wodak, R. Babul-Hirji,<br />

J. Davies, L. Velsher, J. Aw, R. Weksberg, C. Shuman.<br />

1873F Genomic technologies: Effective integration<br />

into adult preventive medicine. N. Hoang, R. Hayeems,<br />

J. Davies, L. Velsher, J. Aw, S. Chenier, J. Stavropoulos,<br />

S. Pu, S. Wodak, R. Babul-Hirji, R. Weksberg, C. Shuman.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1874F Evaluating laboratories’ interpretation <strong>of</strong> genetic<br />

test results through a EuroGentest Pr<strong>of</strong>iciency Testing<br />

survey. E. Girodon, S. Berwouts, M. Rodriguez de Alba<br />

Freiria, AF. Roux, D. Barton, L. Hoefsloot, S. Gardner,<br />

O. Kamarainen, B. Fowler, M. A. Morris, E. Dequeker,<br />

R. Hastings.<br />

1875F Interstate compatibility and emergency<br />

preparedness <strong>of</strong> newborn screening laboratories at<br />

the interface <strong>of</strong> clinical medicine and public health.<br />

J. Mulvihill, P. Hopkins, S. Berberich.<br />

1876F Evaluation <strong>of</strong> the Bogotá Congenital<br />

Malformations Surveillance <strong>Program</strong>. I. Zarante,<br />

C. Mallarino, G. Gracia.<br />

1877F Drivers, barriers and opportunities for genetic<br />

testing services in emerging economies: The Genetic<br />

Testing in Emerging Economies project. I. Nippert,<br />

A. Christianson, D. D. G. Horovitz, R. Raouf, C. D. Padilla,<br />

V. Penchaszadeh, A. Rajab, I. C. Verma, N. Zhong,<br />

L. Gribaldo, U. Krist<strong>of</strong>fersson, J. Schmidtke.<br />

Complex Traits and Polygenic<br />

Disorders<br />

1878W Genetic variation in susceptibility to<br />

hypothyroidism induced hearing impairment. Q. Fang,<br />

T. J. Jones, T.-W. Gong, A. H. Mortensen, M. T. Fleming,<br />

D. F. Dolan, M. I. Lomax, K. R. Johnson, M. Mustapha,<br />

S. A. Camper.<br />

1879T Transethnic mapping <strong>of</strong> putative diabetic<br />

nephropathy loci in African <strong>American</strong>s. N. D. Palmer,<br />

M. C. Y. Ng, J. N. Cooke, M. Petrulis, B. I. Freedman,<br />

D. W. Bowden.<br />

1880F The exon 3 deleted/full-lenght polymorphism<br />

<strong>of</strong> the growth hormone receptor in the Brazilian<br />

population: Association with idiopathic short<br />

stature and body composition measurements in<br />

osteoporosis. F. A. Marques, T. C. L. Lins, C. T. Neves,<br />

M. T. O. Cardoso, R. M. Lima, R. J. Oliveira, R. W.<br />

Pereira, R. Pogue.<br />

1881W Variants in PTPN22 and SMOC2 genes and the<br />

risk <strong>of</strong> thyroid disease in the Jordanian population.<br />

A. Alkhateeb, N. Marzouka, R. Tashtosh.<br />

1882T Genetic associations with neonatal thyroid<br />

stimulating hormone levels. F. Alul, O. Shchelochkov,<br />

S. Berberich, J. Murray, K. Ryckman.<br />

1883F TNF-b Nco1 polymorphism in relation to<br />

postoperative sepsis outcome in joint care surgery.<br />

K. Baghel, R. Srivastava, S. Raj, D. Sanghi.<br />

1884W Preeclampsia is associated with variation in<br />

endoglin pathway genes. M. J. Bell, J. M. Roberts, S. A.<br />

Founds, A. Jeyabalan, L. Terhorst, Y. P. Conley.<br />

POSTER SESSIONS 187<br />

1885T Genetic polymorphisms in ESR1 and ESR2<br />

genes and risk <strong>of</strong> hypospadias in a multi-ethnic<br />

study population. S. Choudhry, E. J. Lammer, J. S.<br />

Witte, S. Dasgupta, C. Ma, G. M. Shaw, L. S. Baskin,<br />

S. L. Carmichael.<br />

1886F A missense mutation in exon 2 <strong>of</strong> adiponectin<br />

receptor 2 is associated with serum insulin in<br />

overweight and obese African-<strong>American</strong> subjects.<br />

A. Doumatey, G. Chen, J. Zhou, H. Huang, A. Adeyemo,<br />

C. Rotimi.<br />

1887W Common variants associated with normal<br />

tension glaucoma and optic nerve degeneration<br />

are also associated with glaucoma in exfoliation<br />

syndrome. B. Fan, S. Loomis, J. H. Kang, D. Y. Wang,<br />

B. Yaspan, M. A. Hauser, L. R. Pasquale, J. L. Haines,<br />

J. L. Wiggs.<br />

1888T Genetic variants in selenoprotein P plasma<br />

1 gene (SEPP1) are associated with fasting insulin<br />

and first phase insulin response in Hispanics. J. N.<br />

Hellwege, N. D. Palmer, J. T. Ziegler, C. D. Langefeld,<br />

C. Lorenzo, J. M. Norris, T. Takamura, D. W. Bowden.<br />

1889F Replication <strong>of</strong> GWAS meta-analysis associations<br />

in a large Amish pedigree support VWF, ABO, STXBP5,<br />

STAB2, and SCARA5 as modifiers <strong>of</strong> VWF and FVIII<br />

levels. J. Hinckley, K. Wang, T. Burns, L. Law, A. Shapiro,<br />

J. Di Paola.<br />

1890W Mutation analysis in zinc finger protein<br />

is<strong>of</strong>orm 1 (ZNF644) in cases with moderate and high<br />

myopia. N. Kaur, S. Saini, V. Vanita.<br />

1891T To study the association <strong>of</strong> peroxisome<br />

proliferator-activated receptor gamma (PPARG) gene<br />

polymorphism (p.Pro12Ala) with diabetic retinopathy.<br />

R. Kaur, S. Goyal, V. Vanita.<br />

1892F Association <strong>of</strong> the IL17 gene polymorphisms<br />

with lumbar disc disease. A. Kelempisioti, I. Daavittila,<br />

N. Noponen, S. Barral, J. Ott, J. Niinimaki, T. Koskelainen,<br />

L. Ala-Koko, J. Karppinen, M. Männikkö.<br />

1893W Association and interaction <strong>of</strong> polymorphisms<br />

in angiogenic genes with endometriosis. M. M. Latha,<br />

Q. Hasan, V. L. Kodati.<br />

1894T The HLA-DPB1 and DRB1 genes are<br />

synergistically associated with Graves disease in<br />

Han Chinese children. Y. Lee, C. Huang, W. Ting, F. Lo,<br />

T. Chang, C. Chu, Y. Wu, S. Chang, W. Lin, M. Lin.<br />

1895F Fine-mapping within regions <strong>of</strong> admixture<br />

linkage to sarcoidosis risk in African <strong>American</strong>s.<br />

A. M. Levin, P. McKeigue, I. Datta, C. G. Montgomery,<br />

I. Adrianto, M. Colombo, M. C. Iannuzzi, B. A. Rybicki.<br />

1896W Fine-mapping <strong>of</strong> central adiposity loci using<br />

association results from multi-ethnic populations.<br />

C. Liu, CHARGE, GIANT, CARe, and African <strong>American</strong><br />

Central Adiposity Consortia.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


188 POSTER SESSIONS<br />

1897T Investigation <strong>of</strong> genetic variation in scavenger<br />

receptor class B, member 1 (SCARB1) and association<br />

with serum carotenoids. G. J. McKay, E. Loane, J. M.<br />

Nolan, S. Beatty, G. Silvestri.<br />

1898F Genetic analysis <strong>of</strong> FUS/TLS gene in essential<br />

tremor. K. Mirzozoda, N. Parmalee, S. Kisselev, N. Merner,<br />

P. Dion, G. Rouleau, E. D. Louis, L. Clark.<br />

1899W Genetic and functional data implicates BCHE<br />

as a novel vitiligo candidate gene. L. Nascimento,<br />

C. Castro, V. Fava, R. Werneck, M. Mira.<br />

1900T Targeted deep-resequencing <strong>of</strong> the CLDN1<br />

gene in African <strong>American</strong>s for asthma. N. M. Rafaels,<br />

L. Huang, C. Vergara, R. Lewis, L. Gao, I. Ruczinski,<br />

T. H. Beaty, A. De Benedetto, L. A. Beck, R. A. Mathias,<br />

K. C. Barnes.<br />

1901F Targeted resequencing <strong>of</strong> SLE susceptible loci.<br />

E. Rai, B. Wakeland, C. Liang, P. Raj, K. Viswanathan,<br />

D. Karp, N. Olsen, I. Dozmorov, L. Davis, P. Doshi, Q. Z. Li,<br />

G. Wiley, K. Kaufman, J. A. Kelly, J. Harley, P. Gaffney, E.<br />

K. Wakeland.<br />

1902W Study <strong>of</strong> BMP4 gene in a Brazilian sample with<br />

congenital anomalies <strong>of</strong> kidney and urinary tract.<br />

G. S. Reis, A. C. S. Silva, T. R. Heilbuth, I. S. Freitas, L. A.<br />

de Marco, D. M. Miranda.<br />

1903T Detection <strong>of</strong> 4 new mutations related to oral<br />

clefts by direct sequencing. M. Simioni, T. K. de Araujo,<br />

R. G. Faria, C. V. Maurer-Morelli, V. L. Gil-da-Silva-Lopes.<br />

1904F Meta-analysis demonstrates that an<br />

interleukin-6 polymorphism is protective against<br />

preterm birth in women <strong>of</strong> European descent. W. Wu,<br />

E. Clark, G. Stoddard, S. Esplin, T. Manuck, J. Xing,<br />

M. Varner, L. Jorde.<br />

1905W Gender-specific association <strong>of</strong> the interleukin<br />

18 gene with gallstone disease. H. Yang, S. Shih,<br />

T. Chang, H. Wang, K. Hu, C. Chang, C. Chang, C. Hung,<br />

H. Chan, M. Lin, Y. Lee.<br />

1906T Search for new modifiers <strong>of</strong> disease severity<br />

in Jamaican sickle cell disease patients using wholeexome<br />

DNA sequencing. G. Lettre, G. Galarneau,<br />

M. Beaudoin, K. S. Lo, M. Reid, G. Serjeant, I. R.<br />

Hambleton, J. N. Hirschhorn, C. A. McKenzie.<br />

1907F Complex trait alleles are enriched for cellspecific<br />

chromatin marks. S. Raychaudhuri, G. Trynka,<br />

H. Xu, B. E. Stranger, X. S. Liu.<br />

1908W A regulatory variant in FZD6 gene contributes<br />

to nonsyndromic cleft lip and palate. J. Hecht, N.<br />

Cvjetkovic, L. Maili, A. M. Letra, M. Raia, E. C. Swindell,<br />

J. F. Teichgraeber.<br />

1909T Next-generation sequencing <strong>of</strong> unresolved<br />

Meckel syndrome pedigrees reveals a complex genetic<br />

makeup. K. Hopp, C. M. Heyer, J. L. Sundsbak, S. J.<br />

Koon, V. J. Kubly, V. E. Torres, P. C. Harris.<br />

1910F Role <strong>of</strong> the PRICKLE genes in neural tube<br />

defects in humans. R. Allache, V. Capra, M. Q. Wang,<br />

C. M. Bosoi, P. Drapeau, A. G. Bassuk, Z. Kibar.<br />

1911W Investigation <strong>of</strong> complex copy number<br />

polymorphisms and age-related macular degeneration.<br />

S. Cantsilieris, S. White, R. Guymer, P. Baird.<br />

1912T Identification <strong>of</strong> a pleiotropic effect locus<br />

associated with a composite CVD risk trait in the<br />

genetic isolate <strong>of</strong> Norfolk Island. L. R. Griffiths, M.<br />

Benton, H. Cox, C. Bellis, M. Carless, M. Hanna, D.<br />

Eccles, J. Blangero, R. A. Lea.<br />

1913F Association <strong>of</strong> BMI and waist-related genetic<br />

variants with visceral adipose tissue volume in the<br />

Family Heart Study. A. Justice, M. Graff, N. Franceschini,<br />

A. P. Reiner, M. F. Feitosa, J. J. Carr, J. G. Terry, P. Gordon-<br />

Larsen, M. K. Wojczynski, I. B. Borecki, K. E. North.<br />

1914W Follow up analyses <strong>of</strong> the APOL1/MYH9 locus<br />

and non-diabetic end stage renal disease (non-DM<br />

ESRD) in African <strong>American</strong>s: The FIND Consortium.<br />

M. Li, FIND Consortium.<br />

1915T HLA typing <strong>of</strong> a large type 1 diabetes cohort<br />

using SNP genotyping <strong>of</strong> the extended MHC.<br />

J. Bradfield, D. S. Monos, H. Q. Qu, C. Kim, M. Rossman,<br />

K. D. Rosenman, S. F. A. Grant, C. Polychronakos, H.<br />

Hakonarson.<br />

1916F Systematic evaluation <strong>of</strong> validated type 2<br />

diabetes and glycemic trait loci for association with<br />

insulin clearance. M. O. Goodarzi, X. Guo, J. Cui, M. R.<br />

Jones, T. Haritunians, A. H. Xiang, Y. I. Chen, K. D. Taylor,<br />

T. A. Buchanan, W. A. Hsueh, L. J. Raffel, J. I. Rotter.<br />

1917W Whole genome sequencing to identify<br />

functional variants that contribute to type 2 diabetes<br />

and obesity in Pima Indians. K. Huang, C. Bogardus,<br />

L. Baier.<br />

1918T Tracking elusive modifier loci using identity-bydescent<br />

and influential alleles. E. Marchani, E. Wisjman.<br />

1919F Genetic dissection <strong>of</strong> Chiari type I malformation<br />

using stratified whole genome linkage approaches.<br />

C. Markunas, K. Soldano, K. Dunlap, H. Cope, E. Asiimwe,<br />

J. Stajich, D. Enterline, G. Grant, H. Fuchs, S. Gregory, A.<br />

Ashley-Koch.<br />

1920W Heritability and linkage analysis <strong>of</strong> the scale<br />

<strong>of</strong> aging vigor in epidemiology in the Long Life Family<br />

Study. J. L. Sanders, J. Singh, R. L. Minster, C. M.<br />

Kammerer, M. M. Barmada, E. W. Daw, M. Feitosa,<br />

R. Costa, N. Schupf, J. Walston, A. B. Newman.<br />

1921T Genome-wide linkage analyses <strong>of</strong> hematological<br />

phenotypes in Long Life Family Study. J. Singh, R. L.<br />

Minster, M. M. Barmada, E. W. Daw, B. Thyagarajan,<br />

K. Christensen, A. B. Newman, C. M. Kammerer.<br />

1922F Effect <strong>of</strong> DNA polymorphisms <strong>of</strong> apolipoprotein<br />

B gene on lipid homeostasis in obese Egyptians. G. El-<br />

Kannishy, R. Elbaz, A. Wafa, H. AbdElHafez, A. Settin.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1923W Identification <strong>of</strong> genes influencing serum levels<br />

<strong>of</strong> brain-derived neurotrophic factor in large Mexican<br />

<strong>American</strong> pedigrees. M. A. Almeida, J. M. Peralta, J. W.<br />

Kent, J. E. Curran, T. D. Dyer, G. Juan, T. M. Teslovich,<br />

C. Fuchsberger, A. R. Wood, T. M. Frayling, P. Cingolani,<br />

T. W. Blackwell, R. Sladek, G. Atzmon, J. Laramie, S. Lincoln,<br />

D. M. Lehman, G. Abecasis, L. A. Almasy, R. Duggirala,<br />

D. C. Glahn, J. Blangero.<br />

1924T First genome-wide analysis in pediatric multiple<br />

sclerosis (MS) confirms a role for adult MS risk<br />

variants and reveals new candidates. L. F. Barcellos, J.<br />

R. Oksenberg, E. Elboudwarej, H. Quach, F. Briggs,<br />

A. Belman, A. Chokkalingam, P. A. Buffler, L. Krupp,<br />

E. Waubant.<br />

1925F Metabochip analysis in over 12,000 African<br />

<strong>American</strong>s identifies several variants associated with<br />

metabolic syndrome: Results from the Population<br />

Architecture using Genomics and Epidemiology (PAGE)<br />

Study. C. L. Carty, J. Haessler, I. Cheng, V. Aroda,<br />

T. Thornton-Wells, C. N. Hsu, S. Liu, R. Jackson, C.<br />

Carlson, L. A. Hindorff, L. LeMarchand, J. S. Pankow,<br />

U. Peters, K. E. North, C. Kooperberg.<br />

1926W Power <strong>of</strong> population diversity and positive<br />

selection in probing the biology <strong>of</strong> asthma disparities.<br />

G. Dunston, T. Mason, L. Ricks-Santi.<br />

1927T Conditional analysis identifies three novel<br />

major histocompatibility complex loci associated with<br />

psoriasis. J. Knight, S. L. Spain, F. Capon, J. N. Barker,<br />

M. E. Weale, R. C. Trembath, WTCCC2, Genetic Analysis<br />

<strong>of</strong> Psoriasis Consortium, I-chip for Psoriasis Consortium.<br />

1928F Prevalence <strong>of</strong> MYH9 common variants<br />

associated with non-diabetic end-stage renal disease<br />

and chronic kidney disease in the diverse National<br />

Health and Nutrition Examination Surveys as part <strong>of</strong><br />

the Epidemiologic Architecture for Genes Linked to<br />

Environment (EAGLE). S. Wilson, K. Brown-Gentry, N.<br />

Gillani, H. Jin, B. McClellan, J. Boston, C. Sutcliffe, H.<br />

Dilks, D. Crawford.<br />

1929W Both classical and non-classical human<br />

leukocyte antigen (HLA) loci in the HLA region<br />

contribute to Graves disease susceptibility. P. Chen,<br />

W. Yang, T. Chang.<br />

1930T Fine mapping on chromosome 10q24.2 implicates<br />

ADD3 in biliary atresia. M.-M. Garcia-Barceló, G. Cheng,<br />

C. S. M. Tang, X. L. Liu, R.Z. Zhang, M. T. So, E. H. M.<br />

Wong, P. H. Y. Chung, I. H. Y. Chan, J. Liu, W. Zhong, H. Xia,<br />

J. Yu, K. K. Y. Wong, S. S. Cherny, P. C. Sham, P. K. H. Tam.<br />

1931F Whole exome sequencing and subsequent<br />

association studies reveals novel candidate variants<br />

associated with severe types <strong>of</strong> alopecia areata.<br />

S. Lee, C. Park, O.-S. Kwon, J.-I. Kim, J. S. Seo.<br />

1932W Next-generation sequencing <strong>of</strong> 11 targeted<br />

genes show serum urate levels and gout age <strong>of</strong> onset<br />

are influenced by both rare and common variants. A.<br />

Tin, L. C. Shimmin, A. Kottgen, E. Boerwinkle, J. Coresh,<br />

J. E. Hixson, W. H. Kao.<br />

POSTER SESSIONS 189<br />

1933T Genetic variation in vitamin D pathway genes<br />

impacts serum vitamin D deficiency and cardiometabolic<br />

traits in individuals with and without type<br />

2 diabetes. T. R. Braun, L. F. Been, P. R. Blackett, D. K.<br />

Sanghera.<br />

1934F Coding variants at a single multiallelic amino<br />

acid position <strong>of</strong> a HLA class II gene influence follicular<br />

lymphoma risk in Europeans and Asians. J. N. Foo,<br />

K. E. Smedby, P. I. W. de Bakker, I. D. Irwan, H. Darabi,<br />

X. Jia, L. Padyukov, D. E. K. Tan, H. Hjalgrim, A. Seow,<br />

K. Humphreys, J. J. Liu.<br />

1935W Common polymorphisms <strong>of</strong> dopamine<br />

D2 receptor (DRD2) gene are not associated with<br />

adolescent obesity, but with hyperinsulinemia. N. Col<br />

Araz, M. Nacak, S. Oguzkan Balci, N. Benlier, S. Pehlivan,<br />

A. Balat, M. Araz.<br />

1936T Association analysis <strong>of</strong> chromosome 3q markers<br />

in nonsyndromic cleft lip/palate. A. Letra, M. Cooper,<br />

T. McHenry, E. Czeizel, F. W. B. Deleyiannis, L. Ma, E. E.<br />

Castilla, F. Poletta, L. L. Field, A. R. Vieira, R. M. Silva,<br />

M. L. Marazita.<br />

1937F Genotype-phenotype correlations <strong>of</strong> facial<br />

shape and asymmetry in unaffected relatives <strong>of</strong><br />

children with non-syndromic cleft lip/palate and<br />

controls. S. Miller, N. Nidey, S. Weinberg, M. L. Marazita,<br />

J. C. Murray, G. L. Wehby, L. M. Moreno.<br />

1938W Cannabinoid receptor-1 (CNR-1) gene 1359G/A<br />

polymorphism is related with childhood obesity, but<br />

not with insulin resistance. M. Nacak, N. Col Araz,<br />

S. Oguzkan Balci, N. Benlier, S. Pehlivan, A. Balat,<br />

M. Araz.<br />

1939T Altered expression but no genetic association <strong>of</strong><br />

the epidermal transglutaminases in atopic dermatitis.<br />

M. C. G. Winge, A. Lieden, A. Sääf, I. Kockum, E. Ekelund,<br />

E. Rodriguez, T. Hoppe, R. Fölster-Holst, A. Franke, M.<br />

Tengvall-Linder, H. Baurecht, S. Weidinger, C. F. Wahlgren,<br />

M. Nordenskjöld, M. Bradley.<br />

1940F Genetic variation and epigenetic modification <strong>of</strong><br />

TACR1 gene are associated with postoperative nausea<br />

and vomiting in surgical patients. T. Hayase, S. Sugino,<br />

M. Yamakage.<br />

1941W Identification <strong>of</strong> a novel 1p31 locus<br />

associated with the combined asthma plus allergic<br />

rhinitis phenotype through positional cloning<br />

in asthma-ascertained families. M.-H. Dizier, P.<br />

Margaritte-Jeannin, A.-M. Madore, I. Annesi-Maesano,<br />

J. Just, F. Kauffmann, C. Laprise, M. Lathrop, E.<br />

Bouzigon, F. Demenais.<br />

1942T Dense genotyping <strong>of</strong> six atopic dermatitis and<br />

180 autoimmune risk loci in 2,425 atopic dermatitis<br />

patients. D. Ellinghaus, E. Rodríguez, H. Baurecht,<br />

J. Esparza Gordillo, Y.-A. Lee, S. Cichon, C. Gieger,<br />

H.-E. Wichmann, R. Duerr, C. Büning, S. Brand,<br />

S. Schreiber, S. Weidinger, A. Franke.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


190 POSTER SESSIONS<br />

1943F Identification <strong>of</strong> functional variants in<br />

FOXO3A, a confirmed candidate gene influencing<br />

human longevity: Genetic investigation requires<br />

special attention to sequence homology with<br />

FOXO3B. F. Flachsbart, L. Gentschew, C. Däumer,<br />

N. Badarinarayan, A. Caliebe, M. Krawczak, S. Schreiber,<br />

A. Nebel.<br />

1944W PDGFRa mutations in humans with isolated cleft<br />

palate. V. Shotelersuk, S. Rattanasopha, S. Tongkobpetch,<br />

C. Srichomthong, P. Siriwan, K. Suphapeetiporn.<br />

1945T Copy-number variation in chromosome 5q31-<br />

33 is associated with Graves’ disease susceptibility.<br />

X. Chu, M. Shen, Y. Bai, F. Xie, W. Huang.<br />

1946F Genetic analysis <strong>of</strong> HLA-G gene: Association<br />

study in a Brazilian cohort relating the 14bp indel<br />

frequencies in a psoriasis case/control study.<br />

G. Debortoli, B. S. Almeida, A. Firmino, D. H. Nunes,<br />

M. M. Sens, V. P. M. da Silva, A. R. Marrero, Y. C. N.<br />

Muniz, I. R. Souza.<br />

1947W Lung eQTL in the major histocompatibility<br />

complex. M. Lamontagne, C. Couture, M. Laviolette,<br />

Y. Bossé, Merck-Laval-UBC-Groningen Lung eQTL<br />

Consortium.<br />

1948T Rare TLR pathways gene variants and<br />

susceptibility to invasive pneumococcal disease:<br />

A population-based study. K. S. Elliott, M. K. Ellis,<br />

A. Rautanen, M. A. Rivas, D. W. Crook, A. V. S. Hill,<br />

S. J. Chapman.<br />

1949F Association <strong>of</strong> VPS26 variants with<br />

susceptibility to infection by Leishmania in Brazil,<br />

Iran and Sudan. A. Romano, H. Dessein, A. Muller,<br />

F. Santoro, A. Salhi, S. Rafati, S. El Saafi, J. P. Gorvel,<br />

L. Argiro, A. Dessein.<br />

1950W MTHFR 677 C.T polymorphism does not<br />

influence the risk <strong>of</strong> polycystic ovarian syndrome.<br />

S. Rajender, J. Carlus, K. Singh, K. Thangaraj.<br />

1951T Mapping <strong>of</strong> a novel locus modifying glaucoma<br />

severity within the GLC1K region at 20p12. P. Belleau,<br />

S. Dubois, K. Lebel, R. Arseneault, E. Shink, J. L. Anctil,<br />

G. Côté, M. A. Walter, M. Amyot, V. Raymond.<br />

1952F Fine-mapping <strong>of</strong> eight psoriasis susceptibility<br />

loci. S. Das, P. E. Stuart, J. Ding, T. Tejasvi, Y. Li, L. C.<br />

Tsoi, V. Chandran, J. Fischer, C. Helms, K. C. Duffin,<br />

J. J. Voorhees, A. M. Bowcock, G. G. Krueger, G. M.<br />

Lathrop, R. P. Nair, P. Rahman, G. R. Abecasis,<br />

D. Gladman, J. T. Elder.<br />

1953W Association <strong>of</strong> markers in DOCK6 with total<br />

cholesterol concentration in <strong>American</strong> Indians.<br />

J. K. DiStefano, M. Khosroheidari, E. Eddy, S. Kobes,<br />

W. C. Knowler, R. L. Hanson.<br />

1954T Fine-scale genetic mapping reveals multiple<br />

signals <strong>of</strong> association in waist-hip ratio loci and shows<br />

evidence <strong>of</strong> sexually dimorphic genetic effects.<br />

T. Ferreira, D. Shungin, D. C. Croteau-Chonka,<br />

T. W. Winkler, A. E. Locke, R. Mägi, R. J. Strawbridge,<br />

T. Workalemahu, K. Fischer, J. Wu, A. U. Jackson, F. Day,<br />

M. C. Zillikens, A. E. Justice, H. Völzke, I. Barrsos,<br />

C. S. Fox, E. Ingelsson, M. I. McCarthy, E. K. Speliotes,<br />

P. W. Franks, L. Qi, J. N. Hirschhorn, R. J. F. Loos, K. E.<br />

North, I. M. Heid, L. A. Cupples, A. P. Morris, K. L. Mohlke,<br />

C. M. Lindgren on behalf <strong>of</strong> Genetic Investigation <strong>of</strong><br />

ANthropometric Traits (GIANT) Consortium.<br />

1955F The FTO gene polymorphisms are associated<br />

with obesity in the Chinese population: The SAPPHIRe<br />

follow-up study. C.-M. Hwu, M.-W. Lin, P.-T. Tsai,<br />

C.-A. Hsiung, L.-M. Chuang, W. H.-H. Sheu, Y.-R. Hung,<br />

L.-T. Ho.<br />

1956W Consanguinity in Pakistani families reveals new<br />

loci in a complex genetic trait: Stuttering. M. H. Raza,<br />

R. Amjad, S. Riazuddin, D. Drayna.<br />

1957T Genome-wide linkage scan <strong>of</strong> male sexual<br />

orientation. A. R. Sanders, K. Dawood, G. Rieger, J. A.<br />

Badner, E. S. Gershon, R. S. Krishnappa, A. B. Kolundzija,<br />

S. Guo, G. W. Beecham, E. R. Martin, J. M. Bailey.<br />

1958F Linkage studies in a large stuttering family<br />

indicate multiple novel loci and possible assortative<br />

mating. A. A. Schaffer, M. H. Raza, E. M. Gertz,<br />

J. Mundorff, J. Lukong, J. Kuster, D. Drayna.<br />

1959W Fine mapping <strong>of</strong> 6q27 for association with<br />

blood pressure. B. Tayo, B. Salako, A. Luke, X. Zhu,<br />

A. Adeyemo, C. Rotimi, A. Ogunniyi, R. Cooper.<br />

1960T Efficient pooled sequencing <strong>of</strong> 1,077 candidate<br />

genes in individuals with short stature. S. R. Wang,<br />

D. B. Mirel, A. Dauber, J. N. Hirschhorn.<br />

1961F Molecular analysis <strong>of</strong> common tag<br />

polymorphisms in hemochromatosis (HFE) genes in<br />

Iranian patients affected with PCOS. S. Matoo, A. Yasari<br />

Mazandarani, N. Hatamnejadian, B. Sedaghati Khayat,<br />

M. Moghaddam, A. Ebrahimi.<br />

1962W Molecular analysis <strong>of</strong> hepcidin common<br />

polymorphisms in Iranian patients affected with PCOS.<br />

A. Yasari Mazandarani, S. Matoo, N. Hatamnejadian,<br />

B. Sedaghati Khayat, M. Moghaddam, A. Ebrahimi.<br />

1963T Mitochondrial haplogroups and age-related<br />

maculopathy. Y. P. Conley, Y. Jiang, M. C. Kenney,<br />

N. Udar, R. E. Ferrell, D. E. Weeks, M. B. Gorin.<br />

1964F Candidate genes as a modifier <strong>of</strong> age at<br />

Huntington disease motor onset. E. M. Ramos,<br />

J. Latourelle, J.-H. Lee, T. Gillis, J. S. Mysore, J. F. Gusella,<br />

J.-M. Lee, I. Alonso, J. Sequeiros, R. H. Myers, M. E.<br />

MacDonald.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


1965W Variations in potassium channel genes are<br />

associated with persistent breast pain after breast<br />

cancer surgery. D. J. Langford, B. McCann, T. Koetters,<br />

C. Baggott, C. West, J. D. Levine, C. Elboim, G. Abrams,<br />

D. Hamolsky, L. Dunn, H. Rugo, M. Dodd, S. M. Paul,<br />

J. Neuhaus, B. A. Cooper, B. Schmidt, J. Cataldo,<br />

A. Dhruva, B. E. Aouizerat.<br />

1966T HLA haplotypes influence hearing in old age.<br />

T. Solomon, D. L. Newman.<br />

1967F A Y chromosome association study in<br />

inflammatory bowel disease. L. Jostins, C. A. Anderson,<br />

J. C. Barrett, International IBD <strong>Genetics</strong> Consortium.<br />

1968W Prevalence <strong>of</strong> alpha-1 antitrypsin deficiency<br />

and hereditary hemochromatosis gene mutations in<br />

Algarve, Portugal. V. Gaio, A. Fernandes, F. Mendonça,<br />

F. Orta Correia, A. Beleza, A. Gil, M. Bourbon, A. M.<br />

Vicente, C. M. Dias, M. Barreto da Silva.<br />

1969T Menarche timing-related variants identified by<br />

recent GWAS are associated with growth outcomes in<br />

male and female children. C. He, E. Wagner, G. Eckert,<br />

Z. Yu, H. Pratt, W. Tu.<br />

1970F Haplotypes <strong>of</strong> the inducible nitric oxide synthase<br />

gene are strongly associated with levels <strong>of</strong> exhaled<br />

nitric oxide in adults: A population-based study.<br />

S. Dahgam, L. Modig, A. T. Naluai, A. C. Olin, F. Nyberg.<br />

1971W Identification <strong>of</strong> genetic factors for<br />

chronic otitis media with effusion using a targeted<br />

resequencing approach. E. Allen, J. Mychaleckyj, X. Hou,<br />

W. Chen, A. Quinlan, K. Keene, S. Rich, K. Daly, M. Sale.<br />

1972T Genetic polymorphisms <strong>of</strong> long pentraxin-3 are<br />

associated with polypoidal choroidal vasculopathy and<br />

exudative age-related macular degeneration.<br />

J. H. Chen, Y. Yang, Y. Zheng, C. Xu, W. Chen, M. Zhang,<br />

H. Chen, C. P. Pang.<br />

1973F Contribution <strong>of</strong> the reading disability risk locus<br />

DYX2 and dopamine signaling factors ANKK1/DRD2 to<br />

language impairment and brain imaging phenotypes. J.<br />

D. Eicher, N. R. Powers, L. L. Miller, K. L. Mueller,<br />

J. B. Tomblin, S. M. Ring, J. R. Gruen, Pediatric Imaging<br />

Neurocognition <strong>Genetics</strong> Study.<br />

1974W The maternal folate hydrolase gene<br />

polymorphism is associated with neural tube defects<br />

in a high-risk Chinese population. J. Guo, J. H. Wang, H.<br />

Xie, H. Z. Zhao, F. Wang, C. Liu, L. Wang, X. L. Lu,<br />

Y. H. Bao, J. Z. Zou, G. L. Wang, B. Niu, T. Zhang.<br />

1975T Association study <strong>of</strong> NPR3 polymorphisms with<br />

aspirin exacerbated respiratory disease. J. H. Kim,<br />

B. L. Park, C. S. Park, H. D. Shin.<br />

1976F Identification <strong>of</strong> DNA variants in 11 candidate<br />

genes for developmental dyslexia by next-generation<br />

sequencing. H. Matsson, E. Tiraboschi, M. Huss,<br />

J. Noppola-Hemmi, H. Lyytinen, P. H. T. Leppanen,<br />

N. Neuh<strong>of</strong>f, A. Warnke, G. Schulte-Körne, M. M. Nöthen,<br />

J. Schumacher, M. Peyrard-Janvid, J. Kere.<br />

POSTER SESSIONS 191<br />

1977W Sequencing <strong>of</strong> IL10 in Behçet’s disease<br />

patients. I. Sousa, J. M. Xavier, N. Rei, F. Barcelos,<br />

P. Abrantes, J. Vedes, G. Jesus, M. Salgado, F. Fontes,<br />

J. V. Patto, J. Crespo, S. A. Oliveira.<br />

1978T Variants <strong>of</strong> XBP1 are associated with vitiligo<br />

in the presence <strong>of</strong> autoimmunity. R. G. Tarlé, L. M.<br />

Nascimento, C. C. S. De Castro, R. I. Werneck, V. M. Fava,<br />

M. T. Mira.<br />

1979F Genetic association <strong>of</strong> SLE with CD247 (CD3z).<br />

M. Martins, A. H. Williams, M. E. Alarcón-Riquelme,<br />

J. M. Anaya, S. C. Bae, S. A. Boackle, L. A. Criswell,<br />

G. S. Gilkeson, D. L. Kamen, C. O. Jacob, J. A. James,<br />

J. A. Kelly, K. L. Moser, R. H. Sc<strong>of</strong>ield, R. P. Kimberly,<br />

J. C. Edberg, L. M. Vila, M. Petri, R. Ramsey-Goldman,<br />

M. E. Comeau, J. Ziegler, M. C. Marion, J. T. Merrill,<br />

T. B. Niewold, B. P. Tsao, B. I. Freedman, S. B. Glenn,<br />

J. B. Harley, C. D. Langefeld, C. Fesel.<br />

1980W Estrogen receptor beta genetic variants are<br />

associated with intraocular pressure elevation in<br />

women. F. Mabuchi, Y. Sakurada, K. Kashiwagi,<br />

Z. Yamagata, H. Iijima, S. Tsukahara.<br />

1981T Expression <strong>of</strong> alternatively spliced transcripts <strong>of</strong><br />

MAP2K4 gene in rheumatoid arthritis. K. Shchetynsky,<br />

M. Ronninger, L. Padyukov.<br />

1982F RNA-seq survey <strong>of</strong> human lymphoid and myeloid<br />

cells: A resource for identifying causal genes in<br />

validated immune-mediated disease loci. S. Foisy,<br />

C. Beauchamp, A. Alikashani, F. Latour, M. Ladouceur,<br />

S. Lessage, J. D. Rioux.<br />

1983W Preliminary data suggest an upstream<br />

IRX1 sequence variant identified in a family with<br />

kyphoscoliosis disrupts the wild-type expression<br />

pattern in zebrafish. C. M. Justice, K. Bishop,<br />

B. Carrington, P. Cruz, K. Swindle, R. Sood, N. H. Miller,<br />

A. F. Wilson, NISC Comparative Sequencing <strong>Program</strong>.<br />

1984T Phenotypic analysis <strong>of</strong> peptidylarginine<br />

deiminase type 4 knockout mice. A. Suzuki, Y. Kochi,<br />

H. Shoda, K. Fujio, E. Kanno, T. Sawada, R. Yamada,<br />

K. Yamamoto.<br />

1985F Rs34424835 PGRN gene variation a possible<br />

modifier in frontotemporal lobar degeneration. E. Vitale,<br />

A. Iuliano, A. Polverino, V. Agosti, C. Vitale, A. Postiglione,<br />

P. Sorrentino, S. Pappatà, G. Milan, G. Sorrentino.<br />

1986W Proteomic analysis <strong>of</strong> Shank3 overexpression<br />

in mouse neuroblastoma cultures showed<br />

differentially expressed proteins involved in glycolysis,<br />

cytoskeleton,biosynthetic and cell cycle processes, and<br />

ubiquitin-proteasome. N. Zhong, W. Ju, W. Yan, X.-L. Zhao,<br />

E. C. Jenkins, W. T. Brown, Y. Wang, J. H. Zhou.<br />

1987T Transcription factor pr<strong>of</strong>ile <strong>of</strong> a single nucleotide<br />

polymorphism located -224 A/G in neuropeptide<br />

receptor Y2 (NPY2R) gene in predisposition to<br />

hypertension. E. Albino, K. Sugimoto, T. Katsuya,<br />

A. Deng, J. Dutil.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


192 POSTER SESSIONS<br />

1988F Functional assessment <strong>of</strong> CRY2 type II diabetes<br />

variants using a targeted circadian luciferase assay.<br />

J. Lane, A. Tare, C. Cowan, R. Saxena.<br />

1989W Modification <strong>of</strong> endothelial progenitor<br />

cell recruitment by tyrosinase in oxygen-induced<br />

retinopathy. B. E. O’Bryhim, R. S. White, R. C. A. Symons.<br />

1990T Understanding the impact <strong>of</strong> body mass index<br />

and associated SNPs on serum metabolites. J. Kumar,<br />

R. Karlsson, J. Prince, M. Hong, C. Broeckling, J. Prenni,<br />

E. Ingelsson, F. Wiklund.<br />

1991F Biological processes <strong>of</strong> human development and<br />

genome-wide linkage disequilibrium. I. Culminskaya,<br />

A. Kulminski, A. Yashin.<br />

1992W The type 1 diabetes gene CLEC16A functions<br />

in NK cells to restrain secretory functions including<br />

cytokine release and cytotoxicity. M. Bakay, R. Pandey,<br />

A. Mohamed-Hadley, P. Banerjee, H. H. Hakonarson.<br />

1993T Influence <strong>of</strong> ethnicity with type 2 diabetes in<br />

association <strong>of</strong> UCP2 -866G/A, PGC1a (Gly 482 Ser) and<br />

SIRT1 -1400T/C polymorphisms in North Indian Punjabi<br />

population groups. A. Bhanwer, N. Kaul, R. N. K. Bamezai.<br />

1994F Allelic variation in the protein stability <strong>of</strong><br />

HLA shapes genetic association <strong>of</strong> HLA with type 1<br />

diabetes. H. Miyadera, J. Ohashi, K. Tokunaga.<br />

1995W Functional characterization <strong>of</strong> gene regulatory<br />

elements associated with epilepsy. R. Y. Birnbaum,<br />

Y. Zhang, C. Wei, N. Ahituv.<br />

1996T Differential behavior <strong>of</strong> splice is<strong>of</strong>orms <strong>of</strong> the<br />

asthma susceptibility gene DENND1B. M. E. March,<br />

P. M. A. Sleiman, C. Hou, J. Bradfield, C. E. Kim,<br />

E. Frackelton, J. T. Glessner, H. Hakonarson.<br />

1997F Targeted resequencing identifies secretiondefective<br />

variants <strong>of</strong> decoy receptor 3 in pediatric-onset<br />

inflammatory bowel disease. C. J. Cardinale,<br />

S. Panossian, F. Wang, E. Frackelton, C. E. Kim,<br />

F. D. Mentch, R. M. Chiavacci, K. E. Kachelries, R. Pandey,<br />

S. F. A. Grant, R. N. Baldassano, H. Hakonarson.<br />

1998W A population-based immunologic phenotype<br />

study for the identification <strong>of</strong> high risk individuals to<br />

childhood infectious diseases in Vietnam. R. Miyahara,<br />

L. M. Yoshida, H. Nakamura, K. Takahashi, X. M. Trinh,<br />

D. A. Dang, N. H. Tran, K. Ariyoshi, M. Yasunami.<br />

1999T A birth-cohort study for the identification <strong>of</strong><br />

genetic risk for childhood infectious diseases in<br />

Vietnam. M. Yasunami, L. M. Yoshida, R. Miyahara,<br />

H. Nakamura, K. Takahashi, H. Moriuchi, D. A. Dang,<br />

N. H. Tran, K. Ariyoshi.<br />

2000F Variant genotypes <strong>of</strong> PKR1 and PKR2 in patients<br />

<strong>of</strong> recurrent pregnancy loss. M. Su, L. Wu, P. Kuo.<br />

2001W Post GWAS analysis <strong>of</strong> the BCL11A intronic<br />

region to define its role in regulating HbF levels.<br />

F. Anedda, S. Sanna, I. Asunis, G. Usala, F. Danjou,<br />

L. Perseu, A. Cabriolu, C. A. Caria, L. Porcu, M. G. Marini,<br />

M. Marongiu, C. Sidore, R. Berutti, M. Pala, A. Angius,<br />

F. Busonero, A. Maschio, S. Satta, F. Demartis, L. Maccioni,<br />

A. Meloni, R. Nagaraja, G. Abecasis, D. Schlessinger,<br />

M. S. Ristaldi, R. Galanello, P. Moi, F. Cucca, S. Sanna,<br />

M. Uda.<br />

2002T Additional patients and an association study<br />

support a role <strong>of</strong> SOX9 in CD-ACD-PRS phenotypic<br />

continuum and in CPO. M. Quentric, L. Desmyter,<br />

M. Ghassibe, W. Courtens, S. Kivirikko, H. Antoine-Poirel,<br />

G. Ameye, B. Bayet, G. Francois, R. Vanwijck, O. Boute,<br />

P. Pellerin, M. Rubini, M. Vikkula.<br />

2003F The impact <strong>of</strong> amino acid polymorphisms<br />

in four genes <strong>of</strong> the tumor necrosis factor (TNF)<br />

and interferon-gamma pathways on BCG-triggered<br />

production <strong>of</strong> TNF. T. Yu, L. de Léséleuc, A. Cobat,<br />

L. Simkin, G. F. Black, K. Stanley, P. van Helden, L. Abel,<br />

A. AlcaÔs, E. G. Hoal, E. Schurr.<br />

2004W Functional variants <strong>of</strong> NFKBIE and RTKN2 genes<br />

are associated with rheumatoid arthritis susceptibility<br />

in Japanese. K. Myouzen, Y. Kochi,<br />

Y. Okada, C. Terao, A. Suzuki, K. Ikari, T. Tsunoda,<br />

A. Takahashi, M. Kubo, A. Taniguchi, F. Matsuda,<br />

K. Ohmura, S. Momohara, T. Mimori, H. Yamanaka,<br />

N. Kamatani, R. Yamada, Y. Nakamura, K. Yamamoto.<br />

2005T Resequencing ITGAM reveals two functionally<br />

deleterious rare variants in systemic lupus<br />

erythematosus cases. A. L. Roberts, E. R. A. Thomas,<br />

S. Bhosle, L. Game, O. Obraztsova, T. J. Aitman,<br />

T. J. Vyse, B. Rhodes.<br />

2006F DcR3 mutations in systemic lupus<br />

erythematosus patients lead to enhanced lymphocyte<br />

proliferation. K. Suphapeetiporn, C. Chokdeemeeboon,<br />

P. Ammarinthnukrowh, S. Tongkobpetch, C. Srichomthong,<br />

T. Deekajorndech, P. Rianthavorn, P. Kingwattanakul,<br />

Y. Avihingsanon, V. Hoven, S. Edwards, N. Hirankarn,<br />

V. Shotelersuk.<br />

2007W A CD14 promoter polymorphism is implicated<br />

in tuberculosis susceptibility in a South African<br />

population. M. Möller, C. Wagman, M. Daya,<br />

C. Kok, L. van der Merwe, P. D. van Helden, E. G. Hoal.<br />

2008T Effects <strong>of</strong> IL9 and IL9 receptor gene<br />

polymorphisms on allergic rhinitis in Iranian females.<br />

F. Fatahi, H. Khazraee, K. Ghatreh, M. Hashemzadeh.<br />

2009F TRIB1 is involved in the susceptibility <strong>of</strong> nonalcoholic<br />

fatty liver disease. S. Iwamoto, Y. Ishizuka, Y.<br />

Kitamura, S. Makishima, S. Boonvisut, K. Nakayama.<br />

2010W Alleles <strong>of</strong> a rapidly-evolving ETV6 binding<br />

site in DCDC2 confer risk <strong>of</strong> reading and language<br />

impairment. N. R. Powers, J. D. Eicher, F. Butter,<br />

L. L. Miller, S. M. Ring, M. Mann, J. R. Gruen.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2011T Polymorphisms in phosphatidylethanolamine<br />

N-methyltransferase (PEMT) gene associates with<br />

obesity and gene expression. S. K. Das, K. A. Langberg,<br />

A. K. Mondal, N. K. Sharma.<br />

<strong>2012</strong>F Identification <strong>of</strong> a cis regulatory variant that<br />

binds a transcriptional repressor complex including<br />

PDX1 at the JAZF1 type 2 diabetes locus. M. P. Fogarty,<br />

T. M. Panhuis, S. Vadlamudi, M. L. Buchkovich,<br />

K. L. Mohlke.<br />

2013W Investigation <strong>of</strong> mtDNA mutations in nonsyndromic<br />

hearing loss patients in Fars Province, Iran,<br />

using PCR- RFLP procedure. S. Heydari Sodejani,<br />

M. Montazer Zohori, E. Farokhi, A. Shirmardi, G. Banitalebi,<br />

S. Reisi, M. Abolhasani, M. Akbari, M. Hashemzadeh.<br />

2014T Genetic and environmental predictors <strong>of</strong> serum<br />

vitamin D3 levels in African <strong>American</strong>s. R. A. Kittles,<br />

K. Batai, E. Shah, M. Ruden, J. Newsome, S. Agate,<br />

A. Murphy, H. Y. Chen.<br />

2015F Vitamin D receptor ChIP-seq in human CD 41<br />

T-cells and association with multiple sclerosis.<br />

A. Handel, G. Disanto, G. Giovannoni, G. Ebers,<br />

S. Ramagopalan.<br />

2016W Gene-gene interaction in disease association<br />

for systemic lupus erythematosus in Asian<br />

populations. J. Yang, Y. Zhang, X. Zhang, Y. Lau, W. Yang.<br />

2017T Prevalence <strong>of</strong> diabetes-associated gene<br />

variants and its association with blood glucose levels<br />

in the Algarve population, Portugal. M. Barreto da Silva,<br />

V. Gaio, A. Fernandes, F. Mendonça, F. Orta Gomes,<br />

A. Beleza, A. Gil, M. Bourbon, A. M. Vicente, C. M. Dias.<br />

2018F Genome-wide methylation analysis <strong>of</strong> DNA<br />

from <strong>of</strong>fspring exposed to a diabetic intrauterine<br />

environment. M. del Rosario, R. L. Hanson, V. Ossowsky,<br />

W. C. Knowler, C. Bogardus, L. J. Baier.<br />

2019W HNF1a and ABCA1 genes polymorphisms in<br />

gestational diabetes mellitus. E. Zamarron-Licona,<br />

M. C. Martinez-Lopez, R. Diaz-Martinez.<br />

2020T External sources <strong>of</strong> vitamin D modify the effects<br />

<strong>of</strong> the GC and CYP2R1 genes on 25-hydroxyvitamin<br />

D concentrations: CAREDS. C. D. Engelman, K. J. Meyers,<br />

S. K. Iyengar, Z. Liu, C. Karki, R. P. Igo, Jr., B. Truitt, J.<br />

Robinson, G. E. Sarto, R. Wallace, L. Tinker,<br />

E. LeBlanc, Y. Song, J. A. Mares, A. E. Millen.<br />

2021F Mapping variation in the response to vitamin D<br />

in peripheral blood. C. Jeong, J. C. Maranville, S. Baxter,<br />

A. Di Rienzo.<br />

2022W The interaction between adolescent parental<br />

knowledge and genetic risk for alcohol dependence<br />

predicts adult alcohol dependence. J. L. Meyers, J. E.<br />

Salvatore, R. J. Rose, J. Kaprio, D. M. Dick.<br />

POSTER SESSIONS 193<br />

2023T Association study <strong>of</strong> FUT2 (rs601338) with celiac<br />

disease and inflammatory bowel disease in the Finnish<br />

population. A. S. Parmar, N. Alakulppi, P. Paavola-<br />

Sakki, K. Kurppa, L. Halme, M. Färkkilä, U. Turunen, M.<br />

Lappalainen, K. Kontula, K. Kaukinen, M. Mäki,<br />

K. Lindfors, J. Partanen, P. Sistonen, J. Mättö, P. Wacklin,<br />

P. Saavalainen, E. Einarsdottir.<br />

2024F Identifying novel gene-environment interactions<br />

for HDL-cholesterol. L. Parnell, K. Richardson, C. Q. Lai,<br />

J. M. Ordovas.<br />

2025W Genetically-determined differences in arsenic<br />

metabolism efficiency influence risk for arsenic-induced<br />

skin lesions: A Mendelian randomization study. B. Pierce,<br />

L. Tong, M. Argos, F. Jasmine, M. Kibriya, H. Ahsan.<br />

2026T The ubiquitin proteasome system: Geneenvironment<br />

interactions in Parkinson&#146;s disease.<br />

S. Rhodes, B. Ritz.<br />

2027F Genetic trade-<strong>of</strong>fs may explain some paradoxes<br />

<strong>of</strong> genetics <strong>of</strong> human longevity. S. Ukraintseva, K.<br />

Arbeev, A. Kulminski, I. Akushevich, D. Wu, A. Yashin.<br />

2028W Interaction analysis <strong>of</strong> exogenous estrogen in<br />

age-related macular degeneration: New gene-based<br />

2-degree-<strong>of</strong>-freedom joint test finds joint effects<br />

within the VEGF signaling pathway. M. D. Courtenay,<br />

W. H. Cade, P. L. Whitehead, S. G. Schwartz, J. L. Kovach,<br />

G. Wang, A. Agarwal, J. L. Haines, M. A. Pericak-Vance,<br />

W. K. Scott.<br />

2029T Heritability and host SNP associations <strong>of</strong><br />

microbial species in the human gut. J. K. Goodrich,<br />

R. Blekhman, J. T. Bell, T. D. Spector, A. G. Clark,<br />

R. E. Ley.<br />

2030F SNPs for BMI demonstrate consistent results<br />

through the lifecourse. N. Heard-Costa, L. D. Atwood,<br />

C. Jaquish, C. T. Liu, L. A. Cupples, C. S. Fox.<br />

2031W Examining the roles <strong>of</strong> diet, age, and sex on the<br />

composition <strong>of</strong> the human fecal microbiome.<br />

E. R. Davenport, O. Mizrahi-Man, L. B. Barreiro, C. Ober,<br />

Y. Gilad.<br />

2032T Gene-to-gene interaction in the development <strong>of</strong><br />

gout. A. Taniguchi, W. Urano, N. Ichikawa, H. Yamanaka.<br />

2033F The genetic basis <strong>of</strong> preeclampsia in<br />

populations adapted to high altitude. P. Ortiz-Tello,<br />

K. Sandoval Mendoza, V. Villanueva Dávalos, A. Moreno<br />

Estrada, J. Manzaneda, F. Manzaneda, A. McKenney,<br />

L. Enriquez Lencinas, C. Bustamante, J. Baker.<br />

2034W The effect <strong>of</strong> race, sex, age, socioeconomic,<br />

behavioral factors, and genetics on dental caries in<br />

different tooth surfaces. D. Lewis, E. Feingold, Z. Zeng,<br />

J. Shaffer, X. Wang, R. Weyant, D. W. McNeil, M. Marazita.<br />

2035T Telomere length in human blood cells and the<br />

prediction <strong>of</strong> survival. J. Deelen, M. Beekman, V. Codd,<br />

H. E. D. Suchiman, A. J. M. de Craen, N. J. Samani,<br />

J. J. Houwing-Duistermaat, P. E. Slagboom.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


194 POSTER SESSIONS<br />

2036F Early life infection associated with shorter adult<br />

blood telomere lengths in Cebu, the Philippines. D. T. A.<br />

Eisenberg, J. Borja, M. G. Hayes, C. W. Kuzawa.<br />

2037W Characterization and generalization <strong>of</strong> HFE<br />

rs1800562 genotype-phenotype relationships in the<br />

diverse National Health and Nutrition Examination<br />

Surveys as part <strong>of</strong> the Epidemiologic Architecture for<br />

Genes Linked to Environment. K. Brown-Gentry,<br />

B. Niloufar, J. Hailing, B. McClellan, J. Boston, C. Sutcliffe,<br />

H. Dilks, D. Crawford.<br />

2038T Analysis <strong>of</strong> established type 2 diabetes<br />

associated variants in <strong>American</strong> Indians. R. Hanson,<br />

S. Kobes, W. Knower, C. Bogardus, L. Baier.<br />

2039F Describing the contribution <strong>of</strong> multiple sclerosis<br />

genetic risk factors in Sardinian multiple sclerosis<br />

cases. A. Hadjixen<strong>of</strong>ontos, L. Foco, V. Bakthavachalam,<br />

P.-A. Gourraud, A. Ticca, P. Bitti, R. Pastorino,<br />

L. Bernardinelli, J. L. McCauley.<br />

2040W Heritability and linkage analysis <strong>of</strong> the Health<br />

Aging Index in the Long Life Family Study. M. M. Barmada,<br />

J. L. Sanders, A. M. Matteini, K. Christensen, R. Mayeux,<br />

T. Perls, I. Borecki, Q. Zhang, A. B. Newman, Long Life<br />

Family Study.<br />

2041T Genetic determinants <strong>of</strong> age-related macular<br />

degeneration in diverse populations: The Population<br />

Architecture using Genomics and Epidemiology Study.<br />

N. Restrepo, K. Spencer, R. Goodloe, T. Garrett, G. Heiss,<br />

P. Buzkova, N. Jørgensen, R. Jensen, T. Matise, B. Klein,<br />

R. Klein, W. Tien Yin, B. Cornes, E. Shyong Tai, M. Ritchie,<br />

J. Haines, D. Crawford.<br />

2042F Genetic variation and age at natural menarche<br />

and menopause in African <strong>American</strong> women from<br />

the Population Architecture using Genomics and<br />

Epidemiology (PAGE) Study. J. Malinowski, K. L. Spencer,<br />

C. L. Carty, N. Franceschini, L. Fernández-Rhodes,<br />

A. Young, I. Cheng, M. D. Ritchie, C. A. Haiman, L. Wilkens,<br />

C. Wu, T. C. Matise, C. S. Carlson, K. Brennan, A. Park,<br />

A. Rajkovic, L. A. Hindorff, S. Buyske, D. C. Crawford.<br />

2043W African ancestry is a risk factor for asthma and<br />

high total IgE levels in African admixed populations.<br />

C. I. Vergara, T. Murray, N. Rafaels, R. Lewis, M. Campbell,<br />

C. Foster, L. Gao, M. Faruque, R. Riccio Oliveira, E. Carvalho,<br />

M. I. Araujo, A. A. Cruz, H. Watson, D. Mercado, J. Knight-<br />

Madden, I. Ruczinski, G. Dunston, J. Ford, L. Caraballo,<br />

T. Beaty, R. A. Mathias, K. C. Barnes.<br />

2044T Validation <strong>of</strong> the HELIC population isolate<br />

collections as cohorts for complex trait association<br />

mapping. E. Zeggini, I. Tachmazidou, A. Farmaki,<br />

L. Southam, N. W. Rayner, K. Daoutidou, A. Kolb-<br />

Kokocinski, K. Panoutsopoulou, E. Tsafantakis,<br />

M. Karaleftheri, G. Dedoussis.<br />

2045F Evidence <strong>of</strong> natural selection at Crohn’s GWAS loci<br />

based on population genetic variation. B. M. P. M. Bowen,<br />

J. H. Cho.<br />

2046W Genetic associations with serologic autoimmunity<br />

in a large multi-ancestral systemic lupus erythematosus<br />

cohort. S. N. Kariuki, B. S. Franek, A. A. Kumar, M. Kumabe,<br />

K. M. Kaufman, J. M. Anaya, M. E. Alarcón-Riquelme,<br />

S. C. Bae, E. E. Brown, B. I. Freedman, G. S. Gilkeson,<br />

C. O. Jacob, J. A. James, R. P. Kimberly, J. Martin,<br />

J. T. Merrill, B. Pons-Estel, B. P. Tsao, T. J. Vyse,<br />

C. D. Langefeld, J. B. Harley, K. L. Moser, P. M. Gaffney,<br />

A. D. Skol, T. B. Niewold.<br />

2047T HLA DRB1 amino acid position 11 is highly<br />

associated with rheumatoid arthritis in African<br />

<strong>American</strong>s. R. J. Reynolds, S. Raychaudhuri, P. I. W. de<br />

Bakker, X. Jia, M. I. Danila, A. F. Ahmed, L. W. Moreland,<br />

R. Brasington, L. F. Callahan, E. A. Smith, R. M. Plenge,<br />

S. L. Bridges, Jr., CLEAR Investigators.<br />

2048F GCKR polymorphism and insulin resistance in<br />

<strong>American</strong>s <strong>of</strong> Mexican origin. Y. Lu, H. Q. Qu, Q. Li,<br />

S. P. Fisher-Hoch, J. B. McCormick.<br />

2049W Characterization <strong>of</strong> clinical characteristics and<br />

genetic burden <strong>of</strong> multiple sclerosis in Hispanics.<br />

I. Konidari, A. Hadjixen<strong>of</strong>ontos, C. P. Manrique,<br />

A. H. Beecham, P. L. Whitehead, V. Bakthavachalam,<br />

P.-A. Gourraud, M. A. Pericak-Vance, L. Tornes, M. Ortega,<br />

K. W. Rammohan, S. Delgado, J. L. McCauley.<br />

2050T Investigating a role for functional variation in HIV-1<br />

control through exome sequencing. P. J. McLaren,<br />

P. Shea, I. Bartha, K. V. Shianna, D. B. Goldstein, J. Fellay.<br />

2051F The effect <strong>of</strong> genetic and interaction factors for<br />

risk prediction in type 2 diabetes. D. Shigemizu, T. Abe,<br />

T. Morizono, T. A. Johnson, K. A. Boroevich, M. Kubo, Y.<br />

Nakamura, S. Maeda, T. Tsunoda.<br />

2052W Genome-wide association study <strong>of</strong> structural<br />

foot disorders (lesser-toe deformity, hallux valgus<br />

and plantar s<strong>of</strong>t-tissue atrophy) in older Caucasian<br />

populations. Y.-H. Hsu, C.-H. Cheng, Y. Liu, L. A. Cupples,<br />

J. Jordan, M. Hannan.<br />

2053T Multi-stage genome-wide association metaanalyses<br />

identified two new loci for bone mineral<br />

density. L. Zhang, J. Li, Y. F. Pei, Y. Lin, H. Shen, K. Estrada,<br />

F. Rivadeneira, A. G. Uitterlinden, C. S. Shin, H. J. Choi,<br />

E. L. Duncan, P. J. Leo, M. A. Brown, Y. Z. Liu, Y. J. Liu,<br />

J. G. Zhang, Q. Tian, Y. P. Wang, X. Z. Zhu, S. Y. Wu,<br />

C. J. Papasian, H. W. Deng.<br />

2054F <strong>Genetics</strong> <strong>of</strong> left- and right-hemisphere<br />

subcortical structures in the human brain. M. E. Renteria,<br />

A. Wallace, L. Strike, K. Johnson, D. P. Hibar, J. L. Stein, G.<br />

De Zubicaray, K. L. McMahon, G. W. Montgomery,<br />

P. M. Thompson, N. G. Martin, S. E. Medland, M. J. Wright.<br />

2055W Variant in the HLA-DPB1 region inversely<br />

associated with follicular lymphoma risk in metaanalysis<br />

<strong>of</strong> two genome-wide association studies.<br />

L. Conde, K. E. Smedby, J. N. Foo, J. Riby, K. Humphreys,<br />

F. C. M. Sillé, H. Darabi, S. Sanchez, H. Hjalgrim, J. Liu,<br />

P. M. Bracci, C. F. Skibola.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2056T Genome-wide linkage and association analyses<br />

in uterine leiomyomata reveal FASN as a risk gene.<br />

S. L. Eggert, K. L. Huyck, P. Somasundaram, R. Kavalla,<br />

E. A. Stewart, A. T. Lu, J. N. Painter, G. W. Montgomery,<br />

S. E. Medland, S. A. Treloar, K. T. Zondervan, D. R. Nyholt,<br />

A. C. Heath, P. A. F. Madden, L. Rose, P. M. Ridker,<br />

D. I. Chasman, N. G. Martin, R. M. Cantor, C. C. Morton.<br />

2057F X chromosome markers associated with COPD:<br />

A meta-analysis in 3 cohorts. M. Hardin, M. McDonald,<br />

M. Matthiessen, M. Cho, E. Wan, P. Castaldi, D. Lomas,<br />

P. Bakke, A. Gulsvik, J. Crapo, T. Beaty, C. Lange,<br />

E. K. Silverman, D. DeMeo, COPDGene and ECLIPSE<br />

Investigators.<br />

2058W Periodontitis shares IL2RA as a genetic risk<br />

factor with rheumatoid arthritis, multiple sclerosis,<br />

type 1 diabetes, and Crohn’s disease. A. S. Schaefer,<br />

M. Nothnagel, C. Graetz, Y. Jockel, I. Harks, I. Staufenbiel,<br />

J. Eberhardt, E. Guzeldemir, N. Cine, E. Yilmaz, R.<br />

Nohutcu, B. Ehmke, P. Eickholz, M. Folwaczny, J. Meyle,<br />

U. Schlagenhauf, M. Laine, H. Dommisch, C. Bruckmann,<br />

B. Noack, B. Groessner-Schreiber, C. Doerfer, A. Franke,<br />

S. Jepsen, B. G. Loos, S. Schreiber.<br />

2059T Genetic factors underlying birth weight and<br />

cardiovascular disease: A study <strong>of</strong> 17,048 Finns.<br />

K. Auro, E. Widen, J. Eriksson, A. Palotie, T. Lehtimäki,<br />

O. Raitakari, M. Perola.<br />

2060F Genome-wide association study <strong>of</strong> orthostatic<br />

hypotension and supine-standing blood pressure<br />

changes in two Korean populations. K. Hong, Y. Kim.<br />

2061W Genetic association <strong>of</strong> erythrocyte and platelet<br />

phenotypes in Mexican <strong>American</strong>s. P. E. Melton,<br />

J. E. Curran, M. Carless, M. P. Johnson, T. D. Dyer,<br />

J. W. MacCluer, E. K. Moses, H. H. H. Goring,<br />

R. Duggirala, D. Glahn, J. Blangero, L. Almasy.<br />

2062T GWAS in an isolated Sardinian population<br />

contribute to elucidate the genetic control <strong>of</strong> serum<br />

angiotensin converting enzyme level. I. Persico,<br />

M. P. Concas, G. B. Maestrale, L. Portas, F. Murgia,<br />

M. Cosso, D. Serra, M. Pirastu.<br />

2063F Flipping sign test <strong>of</strong> GWAS summary statistics<br />

on multiple correlated traits. Z. Zhang, N. Franceschini,<br />

T. Edwards, B. Keating, B. Tayo, E. Fox, A. Johnson,<br />

Y. Sun, Y. Sung, M. Nalls, J. Hunter, A. Dresbach,<br />

S. Musani, G. Papanicolaou, G. Lettre, A. Adebowale,<br />

R. Cooper, A. P. Reiner, D. Rao, D. Levy, X. Zhu.<br />

2064W Association study on the X chromosome<br />

identifies novel genes associated with systemic lupus<br />

erythematosus in Asian populations. W. Yang, Y. Zhang,<br />

N. Hirankarn, X. Zhang, Y. Lau.<br />

2065T Genetic modifiers <strong>of</strong> the palatal phenotype in<br />

22q11 microdeletion syndrome: Preliminary results <strong>of</strong> a<br />

genome-wide association study. C. Vial, G. M. Repetto,<br />

M. Palomares, S. McGhee, N. K. Henderson-MacLennan,<br />

M. L. Guzman, K. Espinoza, G. Lay-Son.<br />

POSTER SESSIONS 195<br />

2066F Genome-wide copy number variation in anorectal<br />

malformations. S. S. Cherny, E. H. M. Wong, L. Cui,<br />

C. L. Ng, C. S. M. Tang, M. T. So, B. H. K. Yip, G. Cheng,<br />

V. C. H. Liu, P. C. Sham, P. K. H. Tam, M.-M. Garcia-Barceló.<br />

2067W A genome-wide meta-analysis <strong>of</strong> copy number<br />

variation identifies novel childhood obesity loci.<br />

D. Hadley, J. Bradfield, H. Hakonarson, S. Grant on behalf<br />

<strong>of</strong> Early Growth <strong>Genetics</strong> Consortium.<br />

2068T Copy number variation analysis implicates locus<br />

5q21.2 with raised intra-ocular pressure. A. Nag,<br />

P. G. Hysi, C. Venturini, S. MacGregor, A. W. Hewitt,<br />

T. L. Young, P. Mitchell, A. C. Viswanathan, D. A. Mackey,<br />

C. J. Hammond, WTCCC2.<br />

2069F Genome- wide analysis <strong>of</strong> copy number variants<br />

in Down syndrome-associated congenital heart<br />

defects. D. Ramachandran, J. Mulle, A. E. Locke,<br />

P. Bose, L. J. Bean, S. Le, T. Rosser, K. Dooley,<br />

D. J. Cutler, E. Feingold, S. Y. Cheong, C. L. Cua,<br />

C. L. Maslen, R. H. Reeves, S. L. Sherman, M. E. Zwick.<br />

2070W Rare genetic variation in relation to circulating<br />

adiponectin. S. Gustafsson, L. Lind, A. Mahajan,<br />

S. Söderberg, A. Flyvbjerg, C. M. Lindgren, A. P. Morris, I.<br />

Ingelsson.<br />

2071T Comprehensive evaluation <strong>of</strong> type 2 diabetes<br />

susceptibility loci in East Asians by using 1000<br />

Genomes Project data. K. Hara, H. Fujita, T. A. Johnson,<br />

S. Maeda, T. Tsunoda, M. Kubo, T. Kadowaki.<br />

2072F Genome-wide association study <strong>of</strong> age-related<br />

macular degeneration identifies associated variants in<br />

the TNXB-FKBPL-NOTCH4 region <strong>of</strong> chromosome 6p21.3.<br />

V. Cipriani, H.-T. Leung, V. Plagnol, C. Bunce,<br />

J. C. Khan, H. Shahid, A. T. Moore, S. P. Harding,<br />

P. N. Bishop, C. Hayward, S. Campbell, A. M. Armbrecht,<br />

B. Dhillon, I. J. Deary, H. Campbell, M. Dunlop, A. F.<br />

Dominiczak, S. S. Mann, S. A. Jenkins, A. R. Webster, A. C.<br />

Bird, M. Lathrop, D. Zelenika, A. J. Cree, J. Gibson, S. Ennis,<br />

A. J. Lotery, A. F. Wright, D. G. Clayton, J. R. W. Yates.<br />

2073W Evidence for association and biologic support<br />

<strong>of</strong> a novel locus for serum albumin. N. Franceschini,<br />

F. J. A. van Rooij, B. P. Prins, M. F. Feitosa, M. Karakas,<br />

Q. Wu, C. A. Winkler, J. Kopp, J. F. Felix, K. E. North,<br />

B. Z. Alizadeh, L. A. Cupples, J. R. B. Perry, A. P. Morris on<br />

behalf <strong>of</strong> CHARGE Consortium Protein Working Group.<br />

2074T Gene-based meta-analysis <strong>of</strong> genome-wide<br />

association studies implicates new susceptibility loci<br />

for obesity. S. Hägg, Y. Pawitan, E. Ingelsson on behalf <strong>of</strong><br />

GIANT Consortium.<br />

2075F Homozygosity mapping in a Sindh Pakistan<br />

family identifies new candidate regions for primary<br />

autosomal recessive microcephaly. P. Lemay, M. Sindhi,<br />

N. Sehar, S. Kashif, Q. Brohi, J. Michaud, Z. Kibar.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


196 POSTER SESSIONS<br />

2076W Large-scale rare-variant analyses <strong>of</strong> eight<br />

quantitative traits reveal novel loci for triglycerides and<br />

fasting insulin in genome-wide studies imputed from<br />

2188-haplotype 1000 Genomes reference panel. R. Mägi,<br />

M. Horikoshi, I. Surakka, S. Wiltshire, A.-P. Sarin, T. Esko, A.<br />

Mahajan, T. Ferreira, M. Beekman, S. Gustafsson,<br />

S. Hägg, C. Ladenvall, L. Marullo, C. P. Nelson, J. S. Ried,<br />

G. Thorleifsson, N. Tsernikova, S. M. Willems, C. Willenborg,<br />

T. Winkler, C. M. Lindgren, M. I. McCarthy, S. Ripatti,<br />

I. Prokopenko, A. P. Morris for ENGAGE Consortium.<br />

2077T Common genetic variants underlie<br />

endometriosis and fat distribution but not overall<br />

adiposity. N. Rahmioglu, S. Macgregor, H. R. Harris,<br />

A. Morris, S. A. Missmer, G. W. Montgomery, C. M.<br />

Lindgren, K. T. Zondervan, International EndoGene<br />

Consortium, GIANT Consortium.<br />

2078F Genome-wide association <strong>of</strong> single nucleotide<br />

polymorphisms with weight loss outcomes following<br />

Roux-en-Y gastric bypass surgery. E. Rinella, C. Still,<br />

Y. Shao, G. C. Wood, X. Chu, B. Salerno, G. S. Gerhard,<br />

H. Ostrer.<br />

2079W Identification <strong>of</strong> common and specific genetic<br />

determinants to skin prick test reactivity using<br />

genome-wide association study and gene-based test<br />

approaches. P.-E. Sugier, A. Vaysse, C. Loucoubar,<br />

C. Sarnowski, P. Margaritte-Jeannin, M.-H. Dizier,<br />

M. Lathrop, F. Demenais, E. Bouzigon, EGEA Collaborative<br />

Group.<br />

2080T A genome-wide meta-analysis <strong>of</strong> circulating<br />

levels <strong>of</strong> IGF-I and IGFBP-3. A. Teumer, R. S. Vasan, M.<br />

Bidlingmaier, T. Tanaka, N. L. Glazer, M. Nethander,<br />

T. Harris, M. Beekman, R. Westendorp, E. Slagboom, J<br />

. I. Rotter, P. P. Pramstaller, Q. Sun, C. Zhang, C. S. P. Lam,<br />

M. O. Goodarzi, K. Rice, B. M. Psaty, G. Li, J. B. Meigs,<br />

L. Kuller, M. N. Pollak, C. van Duijn, A. Tönjes, S. Berndt,<br />

E. Ziv, X. Xue, C. Ohlsson, H. Wallasch<strong>of</strong>ski, R. C. Kaplan<br />

on behalf <strong>of</strong> CHARGE Insulin-Like Growth Factor Working<br />

Group.<br />

2081F Phenotypic refinement and genome-wide<br />

association analysis identifies a functional variant in<br />

ADCY3 associated with BMI. N. J. Timpson, R. Gaillard,<br />

E. Stergiakouli, H. R. Taal, D. M. Evans, F. Rivadeneira,<br />

B. St. Pourcain, A. G. Uitterlinden, J. Kemp, A. H<strong>of</strong>man,<br />

S. Ring, V. W. V. Jaddoe, G. Davey Smith.<br />

2082W A genome-wide association study <strong>of</strong> kidney<br />

transplant survival: Donors recipients and interactions.<br />

C. Franklin, M. Hernandez Fuentes, J. Mollon, I. Rebollo<br />

Mesa, E. Perucha, P. Conlon, N. Anyanwu, S. H. Sacks,<br />

M. E. Weale, N. Soranzo, G. Lord, United Kingdom and<br />

Ireland Renal Transplant Consortium, the Wellcome Trust<br />

Case-Control Consortium 3.<br />

2083T Admixture mapping <strong>of</strong> vitamin D in African<br />

<strong>American</strong>s. I. Halder, L. Pearson, .S. Mulukutla,<br />

M. Shriver, V. Causer, G. Huggins, S. Reis.<br />

2084F A genome-wide association study establishes<br />

multiple susceptibility loci for Sjögren’s syndrome.<br />

C. J. Lessard, H. Li, I. Adrianto, J. A. Ice, R. Jonsson,<br />

G. G. Illei, M. Rischmueller, G. Nordmark, X. Mariette,<br />

C. Miceli-Richard, M. Wahren-Herlenius, T. Witte, M.<br />

Brennan, R. Omdal, P. M. Gaffney, J. A. Lessard, W.-F. Ng,<br />

N. Rhodus, B. Segal, R. H. Sc<strong>of</strong>ield, J. A. James, J.-M.<br />

Anaya, J. B. Harley, C. G. Montgomery, K. Moser Sivils.<br />

2085W Pooling-based genome-wide association study<br />

for intracranial aneurysms in the Portuguese population.<br />

P.C. S. Abrantes, I. Sousa, M. M. Santos, V. Francisco,<br />

T. Krug, J. M. Xavier, A. Jacinto, D. Coiteiro, S. A. Oliveira.<br />

2086T Genetic variants at the IGHC locus are associated<br />

with IgG levels in multiple sclerosis patients. E. Albrecht,<br />

D. Buck, M. Aslam, A. Goris, N. Hauenstein, A. Jochim,<br />

S. Cepok, V. Grummel, B. Dubois, A. Berthele, P. Lichtner,<br />

C. Gieger, J. Winkelmann, B. Hemmer.<br />

2087F A web-based initiative to accelerate research on<br />

genetics and disease in African <strong>American</strong>s. K. E. Barnholt,<br />

A. K. Kiefer, H. L. Gates, Jr., M. Nelson, M. Mullins, E. Baker,<br />

J. Frank, C. D. Bustamante, T. W. Love, R. A. Kittles,<br />

N. Eriksson, J. L. Mountain.<br />

2088W First systematic association study <strong>of</strong> achalasia<br />

points to a strong involvement <strong>of</strong> the HLA region in the<br />

disease process. J. Becker, M. Knapp, M. M. Wouters,<br />

G. Trynka, V. Kumar, L. Franke, H.-J. Westra, C. Wijmenga,<br />

G. E. Boeckxstaens, M. M. Nöthen, I. Gockel, J. Schumacher.<br />

2089T Genetic variants associated with breast size also<br />

influence breast cancer risk. G. Benton, N. Eriksson,<br />

C. B. Do, A. K. Kiefer, J. L. Mountain, D. A. Hinds,<br />

U. Francke, J. Y. Tung.<br />

2090F Meta-analysis <strong>of</strong> genetic associations in up<br />

to 339,224 individuals identify 67 new loci for BMI,<br />

confirming a neuronal contribution to body weight<br />

regulation and implicating several novel pathways.<br />

S. I. Berndt, S. Vedantam, F. Day, S. Gustafsson,<br />

A. E. Locke, C. Powell, B. Kahali, D. C. Croteau-Chonka, T.<br />

W. Winkler, A. Scherag, I. Barroso, J. S. Beckmann,<br />

A. Justice, C. M. Lindgren, T. Pers, P. Visscher, J. Yang,<br />

M. Boehnke, G. Abecasis, C. J. Willer, K. L. Mohlke,<br />

K. E. North, J. N. Hirschhorn, E. Ingelsson, R. J. F. Loos,<br />

E. K. Speliotes for GIANT Consortium.<br />

2091W Selective immunoglobulin A deficiency is<br />

associated with IFIH1, TNFAIP3, PVT1, FAS, CDH23 and<br />

TM7SF3 in a genome-wide association study and metaanalysis.<br />

P. G. Bronson, A. P. Manoharan, T. R. Bhangale,<br />

W. Ortmann, R. C. Ferreira, Q. Pan-Hammarström,<br />

L. Hammarström, R. R. Graham, T. W. Behrens.<br />

2092T Three new susceptibility loci for hyperuricemia<br />

identified through a genome-wide association analysis<br />

in Han Chinese. C.-H. Chen, Y.-T. Chen, Y.-T. Chen,<br />

J.-Y. Wu.<br />

2093F Candidate genetic loci for telomere length:<br />

A family based association study <strong>of</strong> Long Life Family<br />

Study. R. Cheng, J. H. Lee, M. S. Kang, M. A. Province,<br />

R. Mayeux, L. S. Honig.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2094W Common variations at chromosome 21q22<br />

influences the risk <strong>of</strong> age-related nuclear cataract: The<br />

Singapore Malay Eye Study. C. Y. Cheng, J. Liao, X. Li,<br />

C. C. Khor, W. T. Tay, A. G. Tan, J. J. Wang, P. Mitchell,<br />

Y. Y. Teo, E. S. Tai, S. M. Saw, T. Aung, T. Y. Wong.<br />

2095T A genome-wide association study on<br />

progressive and bout-onset multiple sclerosis patients.<br />

F. Clarelli, P. Brambilla, F. Esposito, G. Giacalone,<br />

M. Rodegher, M. Sorosina, C. Guaschino, N. Barizzone,<br />

P. Cavalla, E. Patti, D. Galimberti, E. Scarpini, S. Lupoli,<br />

R. Capra, G. Tedeschi, G. Mancardi, G. Coniglio,<br />

L. Grimaldi, A. Ghezzi, D. Cusi, V. Martinelli, M. Leone,<br />

S. D’Alfonso, G. C. Comi, F. Martinelli Boneschi.<br />

2096F Novel loci for caffeinated c<strong>of</strong>fee consumption<br />

revealed by a genome-wide meta-analysis <strong>of</strong> 91,000<br />

individuals. M. Cornelis on behalf <strong>of</strong> C<strong>of</strong>fee & Caffeine<br />

<strong>Genetics</strong> Consortium.<br />

2097W Genome-wide association study <strong>of</strong> Tanner<br />

puberty staging in males and females. D. Cousminer,<br />

N. Timpson, D. Berry, W. Ang, I. Ntalla, M. Groen-Blokhuis,<br />

M. Guxens, M. Kähönen, J. Viikari, T. Lehtimäki, K.<br />

Panoutsopoulou, D. Boomsma, E. Zeggini, G. Dedoussis,<br />

C. Pennell, O. Raitakari, E. Hyppönen, G. Davey Smith, M.<br />

McCarthy, E. Widén, Early Growth <strong>Genetics</strong> Consortium.<br />

2098T Genetic variation associated with circulating<br />

monocyte count in the eMERGE Network. D. Crosslin,<br />

A. McDavid, N. Weston, X. Zheng, E. Hart, M. de Andrade,<br />

I. Kullo, C. McCarty, K. Doheny, E. Pugh, A. Kho,<br />

M. Hayes, M. Ritchie, A. Saip, D. Crawford, P. Crane,<br />

K. Newton, R. Li, D. Mirel, A. Crenshaw, E. Larson,<br />

C. Carlson, G. Jarvik.<br />

2099F A genome-wide association study <strong>of</strong> systemic<br />

lupus erythematosus in North <strong>American</strong>s <strong>of</strong> European<br />

ancestry. F. Y. Demirci, X. Wang, A. H. Kao, A. Clarke, R.<br />

Ramsey-Goldman, S. Manzi, M. M. Barmada,<br />

M. I. Kamboh.<br />

2100W Genome-wide association study <strong>of</strong> sexual<br />

orientation in a large, web-based cohort. E. M. Drabant,<br />

A. K. Kiefer, N. Eriksson, J. L. Mountain, U. Francke,<br />

J. Y. Tung, D. A. Hinds, C. B. Do.<br />

2101T Identification <strong>of</strong> multiple novel susceptibility<br />

regions for primary sclerosing cholangitis through dense<br />

genotyping <strong>of</strong> autoimmunity risk loci. E. Ellinghaus,<br />

J. Z. Liu, T. Folseraas, A. Franke, C. A. Anderson, T. H.<br />

Karlsen on behalf <strong>of</strong> International Primary Sclerosing<br />

Cholangitis Study Group and Immunochip Consortium.<br />

2102F Screening <strong>of</strong> inflammation-related SNPs<br />

identifies a functional IL6 receptor variant as a risk<br />

factor for atopic dermatitis. J. Esparza Gordillo,<br />

H. Schaarschmidt, L. Liang, W. O. C. M. Cookson,<br />

M. L. Lee-Kirsch, J. Henderson, L. Paternoster, J. I.<br />

Harper, E. Mangold, M. M. Nothen, F. Rüschendorf,<br />

T. Kerscher, I. Marenholz, A. Matanovic, S. Lau, T. Keil,<br />

C. P. Bauer, M. Kurek, A. Ciechanowicz, M. Macek, A.<br />

Franke, M. Kabesch, N. Hubner, G. Abecasis,<br />

S. Weidinger, M. F. M<strong>of</strong>fatt, Y. A. Lee.<br />

POSTER SESSIONS 197<br />

2103W A novel sarcoidosis risk locus for Europeans on<br />

chromosome 11q13.1. A. Fischer, B. Schmid,<br />

D. Ellinghaus, M. Nothnagel, K. I. Gaede, M. Schürmann,<br />

S. Lipinski, P. Rosenstiel, G. Zissel, K. Höhne, M. Petrek,<br />

V. Kolek, S. Pabst, C. Grohé, J. Grunewald, M. Ronninger,<br />

A. Ecklund, L. Padyukov, C. Gieger, H.-E. Wichmann,<br />

A. Nebel, A. Franke, J. Müller-Quernheim, S. H<strong>of</strong>mann,<br />

S. Schreiber.<br />

2104T A GWAS on age-related hearing impairment in a<br />

European population. E. Fransen, S. Bonneux,<br />

I. Schrauwen, F. Di Berardini, I. Dhooge, J. J. Corneveaux,<br />

J. D. Ohmen, P. H. Van de Heyning, R. Friedman,<br />

M. J. Huentelman, G. Van Camp.<br />

2105F An extensive literature-based multilocus genetic<br />

score is associated with all-cause-mortality and major<br />

diseases: The Rotterdam and TwinGene studies.<br />

A. Ganna, A. C. Janssens, A. H<strong>of</strong>man, F. Rivadeneira,<br />

A. G. Uitterlinden, P. K. E. Magnusson, N. L. Pedersen,<br />

E. Ingelsson, H. Tiemeier.<br />

2106W Large-scale meta-analysis in up to 40,429<br />

Europeans identifies genetic loci associated with<br />

non-fasting plasma glucose and reveals links to<br />

glucose uptake in muscle. K. S. Gutierrez, V. Lagou,<br />

A. Isaacs, J. B. Meigs, Y. S. Aulchenko, I. Prokopenko for<br />

MAGIC (Meta-Analyses <strong>of</strong> Glucose and Insulin-Related<br />

Traits Consortium) Investigators.<br />

2107T Genome-wide association study detects multiple<br />

novel loci associated with nuclear magnetic resonance<br />

spectroscopy detected metabolites in human serum.<br />

P. Henneman, A. Verhoeven, H. Dharuri, J. van Klinken,<br />

A. Meissner, S. Göraler, A. Deelder, R. Frants, L. Karssen,<br />

B. Oostra, K. Willems van Dijk, C. van Duijn.<br />

2108F Ontology, visual, and informatics enhancements<br />

to the NHGRI genome-wide association study catalog.<br />

L. A. Hindorff, J. A. L. MacArthur, D. Welter, T. Burdett,<br />

P. Hall, H. A. Junkins, H. Parkinson.<br />

2109W Genome-wide association study <strong>of</strong> time-to<br />

diabetic retinopathy . S. M. Hosseini, A. P. Boright, L.<br />

Sun, K. Howard, A. J. Canty, S. B. Bull, B. E. Klein, R.<br />

Klein, A. D. Paterson, DCCT/EDIC Research Group.<br />

2110T Genome-wide screen for telomere length loci<br />

identifies a cancer risk associated gene in Finnish<br />

cohorts. I. Hovatta, I. Surakka, I. Sirén, J. Kettunen, J. G.<br />

Eriksson, P. Knekt, V. Salomaa, J. Kaprio, S. Ripatti.<br />

2111F GWAS identifies 13 polymorphisms associated<br />

with motion sickness. B. S. Hromatka, E. R. Chang, J. Y.<br />

Tung, J. L. Mountain, U. Francke, C. B. Do, N. Eriksson.<br />

2112W Identification <strong>of</strong> leprosy host genetic<br />

susceptibility loci. A. Irwanto, L. Hong, F. Zhang, J. Liu.<br />

2113T Genetic risk score in multiple sclerosis: Back<br />

to the individual in the post-GWAS era. N. Isobe, P.<br />

KhanKhanian, B. Vinod, S. Cailler, H. Harbo, A. Santaniello,<br />

S. Hauser, J. Oksenberg, P. Gourraud.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


198 POSTER SESSIONS<br />

2114F A genome-wide association study <strong>of</strong> HIV-1<br />

infection in African <strong>American</strong> and European <strong>American</strong><br />

injection drug users. E. Johnson, D. Hancock, J. Levy,<br />

G. Page, S. Novak, C. Glasheen, N. Gaddis, N. Saccone,<br />

J. Rice, Q. Wang, M. Moreau, K. Doheny, J. Romm, A.<br />

Brook, L. Bierut, A. Kral.<br />

2115W <strong>Genetics</strong> <strong>of</strong> myopia in a participant driven, webbased<br />

cohort. A. K. Kiefer, J. Y. Tung, C. B. Do,<br />

D. A. Hinds, J. L. Mountain, U. Francke, N. Eriksson.<br />

2116T A meta-analysis <strong>of</strong> 52,439 individuals identifies<br />

four loci associated with leptin levels independent <strong>of</strong><br />

adiposity. T. O. Kilpeläinen, Q. Sun, Z. Kutalik,<br />

K. Kristiansson, M. Mangino, M. Su, P. P. Framstaller,<br />

D. Pasko, T. Tanaka, Y. J. Sung, P. Henneman, A. Mahajan,<br />

M. Beekman, M. E. Kleber, T. I. A. Sørensen, L. J.<br />

Rasmussen-Torvik, O. T. Raitakari, L. Perusse, C. Ohlsson,<br />

M. Walker, S. M. Willems, R. H. Myers, J. Eriksson,<br />

V. Salomaa, H. Grallert, T. B. Harris, O. Pedersen, R. J.<br />

Loos for LEPGen Consortium.<br />

2117F Pathway-based analysis <strong>of</strong> genome-wide<br />

association studies for the personality traits. H. Kim,<br />

S. Roh, C. Hong, E. Lee, Y. Sung, H. Lee, H. Chung,<br />

J. Lee, H. Kim.<br />

2118W A genome-wide association study identifies<br />

a novel susceptible locus for refractive error at<br />

19q13.12 in Korea. W. R. Kim, T. Y. Chung, Y. M. Song,<br />

K. Lee, J. Sung.<br />

2119T A genome-wide association study on hallux<br />

valgus angle identifies candidate loci: The Healthy Twin<br />

Study Korea. S.-J. Lee, D. Lee, J.-H. Hwang, Y.-M. Song,<br />

K. Lee, J. Sung.<br />

2120F Sciatica in young adult population: A genomewide<br />

association study in the young Finns. S. Lemmelä,<br />

S. Solovieva, R. Shiri, T. Lehtimäki, I. Seppälä,<br />

M. Kähönen, M. Juonala, J. Viikari, O. Raitakari, E. Viikari-<br />

Juntura, K. Husgafvel-Pursiainen.<br />

2121W GWAS <strong>of</strong> blood cell traits identifies novel<br />

associated loci and epistatic interactions in Caucasian<br />

and African <strong>American</strong> children. J. Li, J. T. Glessner, H.<br />

Zhang, C. Hou, Z. Wei, J. Bradfield, F. D. Mentch, Y. Guo,<br />

C. Kim, Q. Xia, R. M. Chiavacci, K. A. Thomas, H. Qiu, S.<br />

Grant, S. L. Furth, H. Hakonarson, P. M. A. Sleiman.<br />

2122T A genome-wide analysis <strong>of</strong> longitudinal forced<br />

expiratory volume in one second in the Framingham<br />

Heart Study. S.-Y. Liao, X. Lin, D. C. Christiani.<br />

2123F Hundreds <strong>of</strong> loci contribute to body fat<br />

distribution and central adiposity. A. E. Locke, D.<br />

Shungin, T. Ferreira, T. W. Winkler, D. C. Croteau-Chonka,<br />

R. Magi, T. Workalemahu, K. Fischer, J. Wu, R. J.<br />

Strawbridge, A. Justice, F. Day, N. Heard-Costa, C. S. Fox,<br />

M. C. Zillikens, E. K. Speliotes, H. Völzke, L. Qi, I. Barroso,<br />

I. M. Heid, K. E. North, P. W. Franks, M. I. McCarthy, J.<br />

N. Hirschhorn, L. A. Cupples, E. Ingelsson, A. P. Morris,<br />

R. J. F. Loos, C. M. Lindgren, K. L. Mohlke, Genetic<br />

Investigation <strong>of</strong> ANthropometric Traits Consortium.<br />

2124W Significant evidence for association in genomewide<br />

analyses <strong>of</strong> lipid levels in Pima Indians. A.<br />

Malhotra, S. Kobes, W. C. Knowler, L. J. Baier,<br />

R. L. Hanson.<br />

2125T Investigation <strong>of</strong> lipid pathway genes in late<br />

onset Alzheimer’s disease. L. L. McClain, X. Wang,<br />

M. M. Barmada, F. Y. Demirci, O. L. Lopez, M. I. Kamboh.<br />

2126F Genome-wide association study identifies<br />

genetic loci associated with iron overload in HFE<br />

hemochromatosis. J. Mosser, R. Bouvet, J. Morcet,<br />

M. Perrin, A. M. Jouanolle, M. P. Roth, E. Génin, Y.<br />

Deugnier, M. de Tayrac.<br />

2127W Not a stretch: Variant near the dermal gene<br />

elastin is associated with stretch marks. M. E. Mullins,<br />

N. Eriksson, A. K. Kiefer, J. Y. Tung.<br />

2128T Identification <strong>of</strong> three new genes associated to<br />

serum butyrylcholinesterase activity by GWAS in two<br />

genetically distant isolated populations. F. Murgia,<br />

L. Portas, S. Ulivi, N. Pirastu, S. Vaccargiu, D. Parracciani,<br />

P. Gasparini, M. Pirastu.<br />

2129F Common genetic variants <strong>of</strong> primary open-angle<br />

glaucoma in Japanese population. M. Nakano, Y. Ikeda,<br />

Y. Tokuda, M. Fuwa, R. Sato, N. Omi, H. Adachi, M. Ueno,<br />

K. Mori, S. Kinoshita, K. Tashiro.<br />

2130W The associations <strong>of</strong> HLA-DP locus with chronic<br />

hepatitis B and viral clearance are widely replicated in<br />

East-Asian populations. N. Nishida, Y. Tanaka, H. Sawai,<br />

Y. Mawatari, M. Yamaoka, A. Koike, K. Matsuura, M.<br />

Sugiyama, K. Murata, M. Korenaga, N. Masaki, K.-H. Han,<br />

K. Tokunaga, M. Mizokami.<br />

2131T Three novel loci identified with BMI in a<br />

genome-wide association study <strong>of</strong> 47,098 men and<br />

women <strong>of</strong> African ancestry. K. E. North, K. L. Monda,<br />

G. K. Chen, K. T. Taylor, L. A. Lange, C. Palmer, R. J. Loos,<br />

A. P. Reiner, D. R. Velez Edwards, M. C. Ng, T. L. Edwards,<br />

C. Kooperbeerg, B. E. Henderson, G. J. Papanicolaou,<br />

J. N. Hirschhorn, C. Haiman, African <strong>American</strong> BMI<br />

Consortium.<br />

2132F Genetic determinants <strong>of</strong> IL-1 receptor<br />

antagonist in the circulation. M.-L. Nuotio, K.<br />

Kristiansson, M. Perola, V. Salomaa.<br />

2133W Multi-ethnic GWA meta-analysis identifies new<br />

endometriosis risk loci. D. R. Nyholt, S.-K. Low, C. A.<br />

Anderson, J. P. Painter, S. Uno, A. P. Morris, S. MacGregor,<br />

S. D. Gordon, A. K. Henders, N. G. Martin, J. Attia, E. G.<br />

Holliday, M. McEvoy, R. J. Scott, S. H. Kennedy, S. A.<br />

Treloar, S. A. Missmer, S. Adachi, K. Tanaka, Y. Nakamura,<br />

K. T. Zondervan, H. Zembutsu, G. W. Montgomery.<br />

2134T Genome-wide association study reveals new<br />

candidate loci for hand osteoarthritis. A. Näkki, J.<br />

Eriksson, E. Widen, A. Palotie, U. M. Kujala, J. Saarela.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2135F Genome-wide association study and metaanalysis<br />

<strong>of</strong> intraocular pressure in primary open-angle<br />

glaucoma cases and controls in the NEIGHBOR,<br />

GLAUGEN and AMD-MMAP MI Consortia. A. B. Ozel,<br />

S. Moroi, D. Reed, E. Trager, K. Scott, J. Gilbert, S. Garnai,<br />

S. Akbari, M. Nika, C. Schmidt, B. Yaspan, K. Branham,<br />

W. Chen, J. Heckenlively, A. Swaroop, G. Abecasis,<br />

A. Ashley-Koch, M. Ulmer, M. Hauser, J. Haines, L. R.<br />

Pasquale, J. Wiggs, J. Richards, J. Z. Li, NEIGHBOR<br />

Consortium.<br />

2136W Haplotype association mapping in 33 inbred<br />

mouse strains identifies genetic regions contributing<br />

to chronic hypoxia-induced pulmonary hypertension.<br />

M. W. Pauciulo, D. Koller, P. Hale, T. D. Le Cras, P. Pastura,<br />

B. Aronow, C. Tolentino, D. Li, T. Foroud, W. C. Nichols.<br />

2137T Large-scale genome-wide association metaanalysis<br />

<strong>of</strong> fasting glycemic traits using imputation<br />

from 2188-haplotype 1000 Genomes reference panel<br />

within ENGAGE consortium. I. Prokopenko, R. Mägi,<br />

M. Horikoshi, I. Surakka, S. Wiltshire, A.-P. Sarin,<br />

A. Mahajan, L. Marullo, T. Ferreira, S. Hägg, J. S. Ried,<br />

G. Thorleifsson, T. Esko, S. M. Willems, A. P. Morris, M. I.<br />

McCarthy, S. Ripatti, European Network for Genetic and<br />

Genomic Epidemiology Consortium.<br />

2138F BRC allergene study: A TwinsUK GWAS <strong>of</strong> a<br />

metabolite associated with allergic response to nickel.<br />

L. Quaye, L. Bevan, T. Tsakok, C. Menni, A. Moayyeri,<br />

I. Erte, T. D. Spector, C. J. Hammond, F. O. Nestle.<br />

2139W Experience with Illumina Infinium FFPE DNA<br />

restoration solution. J. Romm, S. Pottinger, L. Aker,<br />

C. Hilton, C. Ongaco, K. Doheny.<br />

2140T The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health and<br />

Aging: A genome-wide association analysis <strong>of</strong> type<br />

2 diabetes. L. C. Sakoda, L. Shen, S. Sciortino, D. K.<br />

Ranatunga, R. W. Grant, T. J. H<strong>of</strong>fmann, M. N. Kvale,<br />

S. Hesselson, Y. Banda, P. Kwok, N. Risch, C. Schaefer,<br />

A. Ferrara.<br />

2141F A genome-wide association study <strong>of</strong> Helicobacter<br />

pylori infection susceptibility. C. Schurmann, J. Mayerle,<br />

L. Stolk, M. J. Peters, G. Homuth, A. G. Uitterlinden, M. M.<br />

Lerch, E. Kuipers.<br />

2142W GWAS needs a good phenotype: Clustering<br />

tooth surfaces into biologically-informative dental<br />

caries outcomes. J. R. Shaffer, E. Feingold, X. Wang,<br />

M. Lee, K. T. Cuenco, D. E. Weeks, R. J. Weyant, R. Crout,<br />

D. W. McNeil, M. L. Marazita.<br />

2143T X chromosome SNPs not strongly associated<br />

with juvenile idiopathic arthritis. M. Sudman, M. Marion,<br />

T. Howard, J. Haas, S. Prahalad, J. Bohnsack, C. Wise,<br />

M. Punaro, C. Rose, M. Ryan, M. Wagner, C. D. Langefeld,<br />

D. Glass, S. Thompson.<br />

2144F In quest <strong>of</strong> aging- and longevity-associated<br />

genetic markers. R. Tamm, M. Alver, K. Fischer, R. Magi,<br />

A. Metspalu.<br />

POSTER SESSIONS 199<br />

2145W Genome-wide association scan <strong>of</strong> osteoporotic<br />

fracture: A meta-analysis <strong>of</strong> 10,012 African <strong>American</strong><br />

women. K. C. Taylor, D. Edwards, T. Edwards, D. S.<br />

Evans, G. Li, K. E. North, N. Franceschini, R. Jackson,<br />

M. Donneyong, A. Z. LaCroix, J. A. Robbins, B. Lewis,<br />

M. L. Stefanick, Y. Liu, M. Garcia, T. B. Harris, J. A. Cauley.<br />

2146T Genome-wide association analysis <strong>of</strong> percent<br />

body fat in adults from the Fels Longitudinal Study.<br />

B. Towne, J. Blangero, A. C. Choh, J. E. Curran, C. Bellis,<br />

T. D. Dyer, E. W. Demerath, M. Lee, R. M. Siervogel,<br />

S. A. Czerwinski.<br />

2147F Genome-wide association meta-analyses in<br />

over 210,000 individuals identify 20 sexually dimorphic<br />

genetic variants for body fat distribution. T. W. Winkler,<br />

D. C. Croteau-Chonka, T. Ferreira, K. Fischer, A. E. Locke,<br />

R. Mägi, D. Shungin, T. Workalemahu, J. Wu, F. Day,<br />

A. U. Jackson, A. Justice, R. Strawbridge, H. Völzke,<br />

L. Qi, M. C. Zillikens, C. S. Fox, E. K. Speliotes, I. Barroso,<br />

E. Ingelsson, J. N. Hirschhorn, M. I. McCarthy, P. W.<br />

Franks, A. P. Morris, L. A. Cupples, K. E. North, K. L.<br />

Mohlke, R. J. F. Loos, I. M. Heid, C. M. Lindgren, GIANT<br />

Consortium.<br />

2148W 1000 Genomes imputation identifies low<br />

frequency-large effect circulating biomarker associations<br />

undetected by HapMap-based imputation. A. R. Wood,<br />

J. Tyrrell, D. G. Hernandez, M. A. Nalls, H. Yaghootkar, J. R.<br />

Gibbs, L. W. Harries, S. Chong, M. Moore, J. M. Guralnik,<br />

S. Bandinelli, A. Murray, L. Ferrucci, A. B. Singleton,<br />

D. Melzer, M. N. Weedon, T. M. Frayling.<br />

2149T So fresh or so clean? A genetic variant near<br />

olfactory receptor genes associates with cilantro taste<br />

preference. S. Wu, J. Y. Tung, A. B. Chowdry, A. K. Kiefer,<br />

J. L. Mountain, N. Eriksson.<br />

2150F Genome-wide association study for<br />

Beh&#231;et&#146;s disease in an Iranian dataset<br />

using a DNA pooling approach. J. Xavier, M. Martins,<br />

J. Sobral, F. Shahram, F. Davatchi, B. S. Abdollahi,<br />

A. Nadji, N. M. Shafiee, F. Ghaderibarim, S. A. Oliveira.<br />

2151W A genome-wide association study identifies<br />

susceptibility loci for non-syndromic sagittal<br />

craniosynostosis on chromosomes 20 and 7. G. Yagnik,<br />

C. M. Justice, Y. Kim, I. Peter, E. W. Jabs, X. Ye, L. Shi,<br />

M. L. Cunningham, V. Kimonis, T. Roscioli, S. A. Wall,<br />

A. O. M. Wilkie, J. Stoler, J. T. Richtsmeier, Y. Heuzé, P. A.<br />

Sanchez-Lara, M. F. Buckley, C. M. Druschel, J. L. Mills,<br />

M. Caggana, P. A. Romitti, D. M. Kay, C. Senders, P. J.<br />

Taub, O. D. Klein, J. Boggan, C. Naydenov, J. Kim, A. F.<br />

Wilson, S. A. Boyadjiev.<br />

2152T Finding genome-transcriptome-phenome<br />

association with structured association mapping and<br />

visualization in GenAMap. J. Yin, R. E. Curtis, E. P. Xing.<br />

2153F A genome-wide association study <strong>of</strong> central<br />

corneal thickness in Latinos. X. Gao, W. J. Gauderman,<br />

P. Marjoram, M. Torres, T. Haritunians, J. Z. Kuo, Y. I.<br />

Chen, K. D. Taylor, J. I. Rotter, R. Varma.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


200 POSTER SESSIONS<br />

2154W CDKN2BAS genotype: Primary open angle<br />

glaucoma feature correlations in the GLAUGEN study<br />

and the NEIGHBOR consortium. L. R. Pasquale, S. J.<br />

Loomis, J. H. Kang, B. L. Yaspan, D. L. Budenz, D. S.<br />

Friedman, D. Gaasterland, T. Gaasterland, R. K. Lee,<br />

P. R. Lichter, Y. Liu, C. A. McCarty, S. Moroi, L. M. Olson,<br />

T. Realini, J. S. Schuman, K. Singh, D. Vollrath,<br />

G. Wollstein, D. J. Zack, W. Abdrabou, M. A. Hauser, E.<br />

Delbono, R. R. Allingham, M. A. Pericak-Vance,<br />

R. N. Weinreb, K. Zhang, J. E. Richards, J. L. Haines,<br />

J. L. Wiggs.<br />

2155T Ethnicity and ancestry information from<br />

genome-wide association studies: The NHGRI GWAS<br />

catalog. H. A. Junkins, J. A. L. MacArthur, P. Hall,<br />

K. A. Harvey, T. A. Manolio, L. A. Hindorff.<br />

2156F OFCD syndrome gene BCOR is associated with<br />

dental caries. X. Wang, Z. Zeng, J. R. Shaffer, E. Feingold,<br />

D. E. Weeks, M. Lee, K. T. Cuenco, R. J. Weyant, R. Crout,<br />

D. W. McNeil, M. L. Marazita.<br />

2157W Sickle-cell locus is a major modifier <strong>of</strong> human<br />

susceptibility to invasive bacterial infection: A genomewide<br />

association study <strong>of</strong> bacteremia susceptibility.<br />

A. Rautanen, M. Pirinen, C. Spencer, T. Mills, S. Chapman,<br />

K. Rockett, J. A. Scott, T. N. Williams, P. Donnelly, A. V. Hill.<br />

2158T Using genomics to decipher causation in severe<br />

edematous childhood malnutrition: A pilot GWAS. N. A.<br />

Hanchard, S. Howell, K. Marshall, T. Forrester, M. Reid,<br />

X. Wang, L. M. Franco, J. W. Belmont, C. A. McKenzie.<br />

2159F Genome-wide association study <strong>of</strong> body mass<br />

index in Samoans. R. L. Minster, G. Sun, S. R. Indugula,<br />

H. Cheng, N. L. Hawley, S. Viali, R. Deka, D. E. Weeks,<br />

S. T. McGarvey.<br />

2160W Variants in RUNX3 contribute to susceptibility<br />

to psoriatic arthritis exhibiting further common ground<br />

with ankylosing spondylitis. A. Reis, M. Apel, S. Uebe,<br />

J. Bowes, E. Giardina, E. Korendowych, K. Juneblad, F.<br />

Pasutto, A. B. Ekici, R. McManus, P. Ho, I. N. Bruce, A.<br />

W. Ryan, F. Behrens, B. Böhm, H. Traupe, J. Lohmann, C.<br />

Gieger, H. E. Wichmann, L. Padyukov, O. FitzGerald, G. M.<br />

Alenius, N. McHugh, G. Novelli, H. Burkhardt, A. Barton,<br />

U. Hüffmeier.<br />

2161T Association analysis between X-chromosome<br />

variants and asthma in 50,000 individuals. C. S. Tang,<br />

D. Hinds, M. A. R. Ferreira.<br />

2162F Early adiposity phenotypes associate with<br />

common variants at LEPR, FTO, TFAP2B and<br />

GNPDA2. M.-R. Jarvelin, S. Das, H. R. Taal, U. Sovio,<br />

D. Mook-Kanamori, N. M. Warrington, N. J. Timpson,<br />

D. L. Cousminer, E. Thiering, I. Y. Millwood, J. L. Buxton,<br />

S. Sebert, M. Kaakinen, A. I. F. Blakemore, J. Eriksson,<br />

P. Froguel, M. McCarthy, L. Coin, P. O’Reilly, V. W. V.<br />

Jaddoe, Early Growth <strong>Genetics</strong> Consortium.<br />

2163W Multiple human genetic variants associated<br />

with Epstein-Barr virus load in the 1000 Genomes and<br />

HapMap lymphoblastoid cell lines. C. Houldcr<strong>of</strong>t, A. Gall,<br />

J. Z. Liu, A. L. Palser, S. J. Watson, C. A. Anderson, P. Kellam.<br />

2164T Genome-wide association study on expressive<br />

language development in children from the general<br />

population links early word production to common<br />

variation at 3p12.3. B. St Pourcain, R. Cents, W. Ang,<br />

P. F. O’Reilly, F. Velders, N. Warrington, C. M. A. Haworth,<br />

O. S. P. Davis, A. Whitehouse, N. Timpson, J. Kemp, D. M.<br />

Evans, M. Marinelli, Y. Wren, S. Roulstone, R. Plomin,<br />

V. Jaddoe, M.-R. Jarvelin, C. Pennell, H. Tiemeier,<br />

G. Davey Smith, EAGLE.<br />

2165F A genome-wide association study <strong>of</strong> early<br />

menopause and the predictive impact <strong>of</strong> identified<br />

variants on risk. J. R. B. Perry, T. Corre, T. Esko,<br />

S. Chanock, D. Chasman, E. Demerath, M. Garcia,<br />

S. Hankinson, F. Hu, D. Hunter, K. Lunetta, A. Metspalu,<br />

G. Montgomery, J. Murabito, A. Newman, K. Ong,<br />

T. Spector, K. Stefansson, A. Swerdlow, U. Thorsteinsdottir,<br />

R. Van Dam, A. G. Uitterlinden, J. Visser, P. Vollenweider,<br />

D. Toniolo, A. Murray on behalf <strong>of</strong> Reprogen Consortium.<br />

2166W Genome-wide association study <strong>of</strong> nocturnal<br />

awakening in asthma. D. Chhabra, A. Dahlin, Q. Duan,<br />

B. Himes, S. T. Weiss, K. G. Tantisira.<br />

2167T Preliminary meta-analysis <strong>of</strong> genome-wide<br />

association studies <strong>of</strong> lung function in children.<br />

M. Kowgier, M. Bustamante, J. Sunyer, J. Heinrich,<br />

C. Flexeder, G. Koppelman, M. Kerkh<strong>of</strong>, E. S. Schultz,<br />

E. Melen, S. Birch, R. Granell, E. Kreiner-Møller,<br />

H. Bisgaard, J. Henderson, L. J. Palmer.<br />

2168F A genome-wide meta-analysis identifies<br />

common variants in LOC<strong>2012</strong>29 and NOS2A associated<br />

with fractional exhaled nitric oxide in childhood. R. J. P.<br />

van der Valk, L. Duijts, M. T. Salam,<br />

J. Sunyer, E. Melen, G. Koppelman, A. Custovic,<br />

J. Heinrich, H. Bisgaard, A. J. Henderson, V. W. V. Jaddoe,<br />

J. C. de Jongste on behalf <strong>of</strong> GABRIEL and EArly <strong>Genetics</strong><br />

and Lifecourse Epidemiology Consortia.<br />

2169W Phenotypic dissection <strong>of</strong> bone mineral<br />

density facilitates the identification <strong>of</strong> skeletal site<br />

specificity on the genetic regulation <strong>of</strong> bone. J. P.<br />

Kemp, C. Medina-Gomez, K. Estrada, D. H. M. Heppe,<br />

M. C. Zillikens, N. J. Timpson, B. St. Pourcain, S. M.<br />

Ring, A. H<strong>of</strong>man, V. W. V. Jaddoe, G. Davey Smith, A. G.<br />

Uitterlinden, J. H. Tobias, F. Rivadeneira, D. M. Evans.<br />

2170T A multiethnic genome-wide association study<br />

<strong>of</strong> HIV-1 viral load among injection drug users. D. B.<br />

Hancock, J. L. Levy, G. P. Page, S. P. Novak, C. Glasheen,<br />

N. C. Gaddis, N. L. Saccone, J. P. Rice, Q. Wang,<br />

M. Moreau, K. Doheny, J. Romm, A. I. Brooks, L. J. Bierut,<br />

A. H. Kral, E. O. Johnson.<br />

2171F Genetic variants near the NTRK2 gene are<br />

associated with weight at birth in twins. S. J. Metrustry,<br />

T. Spector, A. M. Valdes.<br />

2172W A systematic meta-analysis <strong>of</strong> associations <strong>of</strong><br />

genetic variants influencing protein phosphorylation<br />

with bone mineral density phenotypes. T. Niu, L. Zhang,<br />

F.-Y. Deng, J. Li, Y.-F. Pei, Y. Liu, H. Shen, Y.-Z. Liu,<br />

H.-W. Deng.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2173T Chromosome X revisited: Variants in Xq21.1<br />

associate with adult stature in a meta-analysis <strong>of</strong> 14,700<br />

Finns. T. Tukiainen, J. Kettunen, A.-P. Sarin, J. G. Eriksson,<br />

A. Jula, V. Salomaa, O. T. Raitakari,<br />

M.-R. Järvelin, S. Ripatti.<br />

2174F A genome-wide association study identifies two<br />

susceptibility loci for Crohn’s disease in a Japanese<br />

population. K. Yamazaki, J. Umeno, A. Takahashi,<br />

A. Hirano, T. Johnson, N. Kumasaka, T. Morizono,<br />

N. Hosono, T. Kawaguchi, M. Takazoe, T. Yamada,<br />

Y. Suzuki, H. Tanaka, S. Motoya, M. Hosokawa, Y. Arimura,<br />

Y. Shinomura, T. Matsui, T. Matsumoto, M. Iida, T. Tsunoda,<br />

Y. Nakamura, N. Kamatani, M. Kubo.<br />

2175W Large scale GWAS-meta analysis identifies<br />

novel variants associated with mean leukocyte<br />

telomere length. V. Codd, C. P. Nelson, E. Albrecht,<br />

P. van der Harst, M. Mangino, J. Deelen, J. L. Buxton, J. J.<br />

Hottenga, K. Fischer, I. Surakka, L. Broer, D. R. Nyholt, P.<br />

Salo, S. Hagg, P. J. Talmud, N. L. Pedersen, M. Perola, J.<br />

Kaprio, N. G. Martin, C. M. van Duijn, I. Hovatta, C. Gieger,<br />

A. Metspalu, D. I. Boomsma, M. R. Jarvelin, W. H. van<br />

Gilst, P. E. Slagboom, T. D. Spector, N. J. Samani,<br />

ENGAGE Consortium.<br />

2176T Suggestive loci for osteoporosis: A variance<br />

components linkage analysis <strong>of</strong> extended pedigrees.<br />

S. C. Nguyen, N. D. Nguyen, J. C. Center, J. A. Eisman,<br />

T. V. Nguyen.<br />

2177F Linkage analysis for identification <strong>of</strong> rare, highpenetrance<br />

celiac disease risk variants in the Finnish<br />

and Hungarian populations. E. Einarsdottir, K. Kurppa,<br />

K. Kaukinen, I. Korponay-Szabo, K. Mustalahti, M. Balogh,<br />

M. Mäki, P. Saavalainen.<br />

2178W Whole genome linkage analysis to identify<br />

genes for childhood dental caries. N. Mukhopadhyay,<br />

M. Govil, Z. Zheng, E. Feingold, D. E. Weeks, J. R. Shaffer,<br />

X. Wang, R. J. Weyant, R. Crout, D. W. McNeil, M. L.<br />

Marazita.<br />

2179T simQTL: S<strong>of</strong>tware for simulation <strong>of</strong> a complex<br />

etiological model under a set <strong>of</strong> epidemiological<br />

model parameters. J. D. Terwilliger, K. M. Weiss, J. H.<br />

Lee, B. Lambert.<br />

2180F A hybrid likelihood model for sequence-based<br />

disease association studies. Y. Chen, H. Carter, J. Parla,<br />

M. Kramer, F. S. Goes, M. Pirooznia, P. P. Zandi, W. R.<br />

McCombie, J. B. Potash, R. Karchin.<br />

2181W Novel methods for combined linkage and<br />

association analyses <strong>of</strong> complex quantitative traits in<br />

very large families sheds light on genetics <strong>of</strong> musical<br />

aptitude. Y. Huang, J. Oikkonen, L. Ukkola-Vuoti, P.<br />

Raijas, K. Karma, P. Onkamo, A. Thomas, I. Jarvela,<br />

V. J. Vieland.<br />

2182T Linkage and genome-wide association studies<br />

reveal distinct facets <strong>of</strong> the genetic architecture <strong>of</strong><br />

alopecia areata. L. Petukhova, A. M. Christiano.<br />

POSTER SESSIONS 201<br />

2183F Rare and common variants in extracellular<br />

matrix gene, FBN2, are associated with Mendelian and<br />

multifactorial macular degenerative disease. R. R. Priya,<br />

X. Zhan, R. N. Fariss, C. F. Chakarova, K. E. Branham,<br />

M. M. Campos, J. S. Friedman, B. Brooks, H. K. Rajasimha,<br />

M. A. Morrison, S. G. Jacobson, M. L. Klein, E. Y. Chew,<br />

D. Stambolian, M. M. DeAngelis, S. S. Bhattacharya, J. R.<br />

Heckenlively, G. R. Abecasis, A. Swaroop.<br />

2184W Genetic evidence for an ethnic diversity in the<br />

susceptibility to Ménière’s disease. J. Ohmen, C. White,<br />

J. Wang, L. Fisher, H. Zhang, M. Derebery, R. Friedman.<br />

2185T Genomics <strong>of</strong> response to healing following a<br />

meniscectomy. D. D. Vance, L. Wang, E. Rampersaud,<br />

T. Guettouche, W. H. Cade, R. L. Belton, B. P. Lesniak,<br />

J. M. Vance, M. A. Pericak-Vance, L. D. Kaplan.<br />

2186F GWAS <strong>of</strong> host-pathogen interactions implicates<br />

methionine salvage and microtubules in regulation <strong>of</strong><br />

inflammatory cell death. D. C. Ko, K. P. Shukla, S. I. Miller.<br />

2187W An integrative approach to mapping complex,<br />

glycemic traits in skeletal muscle tissue. S. Keildson,<br />

J. Fadista, C. Ladenvall, A. K. Hedman, H.-F. Zheng,<br />

L. Groop, P. Franks, O. Hansson, C. M. Lindgren, MuTHER<br />

Consortium.<br />

2188T -eQTL analysis <strong>of</strong> dysregulated interferonpathway<br />

genes identifies OAS1 as a novel candidate for<br />

susceptibility to Sjögren’s syndrome. H. Li, J. A. Ice,<br />

J. A. Kelly, I. Adrianto, S. B. Glenn, K. S. Hefner, E. S.<br />

Vista, D. U. Stone, R. Gopalakrishnan, G. D. Houston,<br />

D. M. Lewis, M. D. Rohrer, P. Hughes, J. B. Harley, C. G.<br />

Montgomery, J. Chodosh, J. A. Lessard, J.-M. Anaya, B. M.<br />

Segal, N. L. Rhodus, L. Radfar, M. B. Frank, R. H. Sc<strong>of</strong>ield,<br />

C. J. Lessard, K. Moser Sivils.<br />

2189F Integrative genomic analysis identifies multiple<br />

loci influencing the human immune response to<br />

influenza vaccination. L. M. Franco, K. L. Bucasas,<br />

J. M. Wells, D. Nino, X. Wang, G. E. Zapata, N. Arden,<br />

J. M. Quarles, M. S. Bray, R. B. Couch, J. W. Belmont,<br />

C. A. Shaw.<br />

2190W Barrett’s esophagus and esophageal<br />

adenocarcinoma show substantial polygenetic variance,<br />

with genetic overlap between the diseases. W. E. Ek,<br />

D. Whiteman, D. M. Levine, T. L. Vaughan, S. MacGregor on<br />

behalf <strong>of</strong> BEAGESS Study Investigators.<br />

2191T Rare germline copy number variants in Hodgkin<br />

lymphoma families. M. Rotunno, M. L. McMaster,<br />

L. R. Goldin.<br />

2192F The proportion <strong>of</strong> heritability <strong>of</strong> type 2 diabetes<br />

estimated through GWAS that is attributable to<br />

functional genetic variation. J. M. Torres, E. R. Gamazon,<br />

S. K. Das, H. M. Highland, G. I. Bell, C. L. Hanis, N. J. Cox.<br />

2193W Proportion <strong>of</strong> heritability and implications <strong>of</strong><br />

pleiotropy attributable to GWAS hits for ECG phenotypes<br />

in the Erasmus Rucphen Family Study. A. Isaacs, C. Silva,<br />

J. A. Kors, B. A. Oostra, C. M. van Duijn.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


202 POSTER SESSIONS<br />

2194T The role <strong>of</strong> genes and life-course-related<br />

processes in onset <strong>of</strong> common diseases in late life.<br />

A. Kulminski, I. Culminskaya, K. Arbeev, S. Ukraintseva,<br />

L. Arbeeva, A. Yashin.<br />

2195F Ancestry-directed sequence analysis for rare<br />

variants in admixed populations. E. Ziv, D. Hu.<br />

2196W The convergence <strong>of</strong> functional genomics,<br />

heritability estimation and polygenic modeling:<br />

Emerging spectrum <strong>of</strong> allelic variation in bipolar<br />

disorder. E. R. Gamazon, H. K. Im, C. Liu, D. L. Nicolae,<br />

N. J. Cox.<br />

2197T Contributions <strong>of</strong> cis and trans eQTLs to the<br />

heritability <strong>of</strong> schizophrenia. C. Jumper, E. R. Gamazon,<br />

A. Konkashbaev, C. Liu, D. L. Nicolae, N. J. Cox.<br />

2198F The contribution <strong>of</strong> sequencing-based GWAS in<br />

explaining the missing heritability <strong>of</strong> quantitative traits.<br />

E. Porcu, C. Sidore, M. Steri, F. Busonero, A. Mulas,<br />

M. Dei, S. Lai, M. G. Piras, S. Naitza, D. Schlessinger,<br />

G. Abecasis, S. Sanna, F. Cucca.<br />

2199W Polygenic analysis shows that low frequency<br />

SNPs confer early onset myocardial infarction risk.<br />

E. Stahl, R. Do, B. Vilhjalmsson, N. Stitziel, S. Sunyaev, A.<br />

Price, R. M. Plenge, S. Kathiresan, S. Raychaudhuri.<br />

2200T Ubiquitous polygenicity <strong>of</strong> human complex<br />

traits: Genome-wide analysis <strong>of</strong> 49 traits in Koreans.<br />

J. Yang, T. Lee, J. Kim, S. Cho, P. Visscher, H. Kim.<br />

2201F Prediction <strong>of</strong> human height with large panels <strong>of</strong><br />

SNPs: Insights into genetic architecture. Y. C. Klimentidis,<br />

A. I. Vazquez, G. de los Campos.<br />

2202W Heritability estimation <strong>of</strong> height from common<br />

genetic variants in a large sample <strong>of</strong> African <strong>American</strong>s.<br />

F. Chen, G. K. Chen, R. C. Millikan, E. M. John, C. B.<br />

Ambrosone, L. Berstein, W. Zheng, J. J. Hu, R. G. Ziegler,<br />

S. L. Deming, E. V. Bandera, W. J. Blot, S. S. Strom, S. I.<br />

Berndt, R. A. Kittles, B. A. Rybicki, W. Issacs, S. A. Ingles,<br />

J. L. Stanford, W. R. Diver, J. S. Witte, L. B. Signorello, S. J.<br />

Chanock, L. Le Marchand, L. N. Kolonel, B. E. Henderson,<br />

C. A. Haiman, D. O. Stram.<br />

2203T Optimizing risk stratification to discover novel<br />

neuroblastoma genes. A. Goldenberg, B. Wang, S. Diskin,<br />

J. M. Maris, M. Irwin.<br />

2204F Correlations between associated SNPs cause<br />

upward bias in whole genome-based heritability<br />

estimation. C. Li, C. Yang, J. Ferguson, J. Cho, H. Zhao.<br />

2205W Enrichment <strong>of</strong> rare non-synonymous variants<br />

in 196 lipid-associated genes in subjects with extreme<br />

levels <strong>of</strong> HDL-C: Evidence for rare allele model in<br />

etiology <strong>of</strong> dyslipidemia. M. M. Motazacker, J. Peter, M.<br />

Treskes, J. A. Kuivenhoven, G. K. Hovingh.<br />

2206T Missing heritability and the use <strong>of</strong> genome-wide<br />

expression data as an indicator <strong>of</strong> genetic variation in<br />

genome scans. P. Schliekelman, G. Sun, S. Zhang.<br />

2207F Estimating the proportion <strong>of</strong> variation in<br />

susceptibility to PTSD captured by common SNPs.<br />

C. Yang, J. Gelernter, C. Li, H. Kranzler, L. Farrer, H. Zhao.<br />

2208W Simulation-based study investigating “missing<br />

heritability”: A euphemism for the abject failure <strong>of</strong><br />

modern genomics to elucidate the etiology <strong>of</strong> complex<br />

traits. J. H. Lee, R. Cheng, K. M. Weiss, T. Hiekkalinna,<br />

J. D. Terwilliger.<br />

2209T A quantitative population genetic framework to<br />

constrain the range <strong>of</strong> genetic architectures underlying<br />

complex human traits. V. Agarwala, J. Flannick, S. Sunyaev,<br />

D. Altshuler.<br />

2210F Multi-ethnic polygenic prediction in CARe and<br />

other cohorts contrasts the genetic architectures <strong>of</strong><br />

height and body mass index. E. K. Speliotes, J. O’Connell,<br />

R. Do, B. Vilhjalmsson, S. Pollack, Y. Gong, N. Patterson, M.<br />

Akylbekova, A. Cupples, M. Fornage, J. Hirschhorn, W. H. L.<br />

Kao, L. Lange, G. Lettre, M. Li, J. Mychaleckyj, S. Musani,<br />

G. Papanicolaou, J. I. Rotter, D. Siscovick, X. Zhu, J. G.<br />

Wilson, . GIANT Consortium, J. Johnson, P. I. W. de Bakker,<br />

S. Raychaudhuri, R. M. Plenge, A. Price, E. A. Stahl.<br />

2211W Can &#145;asthma genes&#146; predict asthma?<br />

J. A. Curtin, D. Belgrave, J. Hankinson, A. Custovic,<br />

A. Simpson.<br />

2212T What is the total SNP-associated heritability<br />

for alcohol dependence? N. G. Martin, G. Zhu, P. A.<br />

Lind, A. C. Heath, P. A. F. Madden, M. L. Pergadia, G. W.<br />

Montgomery, J. B. Whitfield.<br />

2213F A knockout mouse model for canine juvenile<br />

epilepsy. E. M. Nevalainen, E. Seppala, H. Lohi.<br />

2214W ER stress response genes and their natural<br />

variation, discovered using the Drosophila model<br />

system. C. Y. Chow, M. F. Wolfner, A. G. Clark.<br />

2215T Physical and genetic interactions between BBS<br />

genes and CEP290. Y. Zhang, K. Bugge, C. C. Searby,<br />

R. F. Mullins, S. Seo, V. C. Sheffield.<br />

2216F Vacuolated lens-associated neural tube defects<br />

are regulated on a multigenic basis by Cdx and retinoic<br />

acid signaling pathway. B. Li, P. Matteson, M. Ababon,<br />

A. Q. Nato, T. Matise, V. Nanda, J. Millonig.<br />

2217W HLA class-I supertypes are associated with<br />

specific M. tuberculosis strain infections. M. Salie, L. van<br />

der Merwe, M. Moller, M. Martin, X. Gao, R. Warren, M.<br />

Carrington, E. Hoal.<br />

2218T Peripheral blood cell counts are heritable in a<br />

large, unselected rhesus macaque pedigree. A. Vinson,<br />

A. D. Mitchell, D. T<strong>of</strong>fey.<br />

2219F A copy number variant at the KIT ligand locus<br />

confers risk for canine squamous cell carcinoma <strong>of</strong> the<br />

digit. E. A. Ostrander, B. Decker, E. Carlins, B. VonHoldt,<br />

G. Carpintero-Ramirez, H. G. Parker, R. K. Wayne, D. M.<br />

Karyadi.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2220W Large-scale transcriptional and epigenetic<br />

changes bridge maternal nutritional imbalance and<br />

metabolic syndrome. X. Yang, L. Peterson, T. Fare,<br />

J. Zhu, R. Kleinhanz, C. Suver, A. M. Cumiskey, R. L. Rosa,<br />

A. Vosatka, M. Skinner, E. E. Schadt, P. Y. Lum.<br />

2221T Gene expression pr<strong>of</strong>iling in mild traumatic brain<br />

injury, post-traumatic stress disorder, sleep disorders<br />

and depression among redeployed military personnel.<br />

H. Lee, D. Wang, R. Pierce, T. Baxter, R. Dionne, H. Kim,<br />

V. Mysliwiec, T. Barr.<br />

2222F <strong>Genetics</strong> <strong>of</strong> obesity across development in a<br />

model system. C. A. Schmitt, S. Service, R. M. Cantor,<br />

A. J. Jasinska, M. J. Jorgensen, J. R. Kaplan, N. B. Freimer.<br />

2223W Modeling 3D facial shape in relation to sex and<br />

genomic ancestry estimated from DNA. M. D. Shriver,<br />

P. Claes, D. K. Liberton, K. M. Rosana, E. E. Quillen,<br />

L. N. Pearson, B. McEvoy, M. Bauchet, H. Tang, G. Barsh,<br />

D. M. Absher, D. A. Puts, J. Rocha, S. Beleza, R. W. Pereira,<br />

J. K. Wagner, J. Boster.<br />

2224T Endogenous DUX4 induces myotube-specific<br />

apoptosis in FSHD muscular dystrophy and is<br />

regulated by Wnt/b-catenin signaling. G. J. Block,<br />

D. Narayanan, A. M. Amell, L. M. Petek, D. G. Miller.<br />

2225F Development <strong>of</strong> a novel Col3a1 transgenic<br />

mouse model for vascular Ehlers-Danlos syndrome.<br />

F. Malfait, Y. Kang, S. Symoens, P. Coucke, M. Renard, B.<br />

Guillemyn, J. De Backer, F. Branco-Madeira, W. Toussaint,<br />

L. Vanhoutte, S. Janssens, B. Descamps, C. Vanhove, P.<br />

Segers, B. Lambrecht, A. De Paepe.<br />

2226W An integrative genetic and metabolomic analysis<br />

suggests altered phosphatidylcholine metabolism in<br />

asthma. J. S. Ried, H. Baurecht, F. Stückler, J. Krumsiek,<br />

J. Adamski, C. Gieger, J. Heinrich, M. Kabesch, A. Peters,<br />

E. Rodriguez, K. Suhre, R. Wang-Sattler, K. Strauch, H.-E.<br />

Wichmann, F. J. Theis, T. Illig, S. Weidinger.<br />

2227T Genomic data integration reveals molecular<br />

modularity <strong>of</strong> Parkinson disease. A. Dumitriu, Y. Xia,<br />

R. H. Myers.<br />

2228F Pathway analysis <strong>of</strong> the GENEVA Alcohol<br />

Consumption GWAS meta-analysis. O. Harari, A. Goate,<br />

GENEVA Alcohol Consumption Working Group.<br />

2229W Pathway-based meta analysis <strong>of</strong> ulcerative<br />

colitis genome-wide association studies. C. Kao,<br />

Z. Wei, J. Li, W. Wang, J. Glessner, C. Cardinale,<br />

J. Bradfield, E. Frackelton, C. Kim, F. Mentch, H. Qui,<br />

S. Grant, R. Baldassano, H. Hakonarson, International IBD<br />

<strong>Genetics</strong> Consortium.<br />

2230T Shared genetic variants between traits and<br />

diseases reveal novel disease risk factors. L. Li, D.<br />

Ruau, C. Patel, R. Chen, A. Butte.<br />

2231F Comparison <strong>of</strong> pathways implicated in anticitrillunated<br />

peptide antibody positive and negative<br />

rheumatoid arthritis patients. P. Martin, S. Viatte, A. Brass,<br />

S. Eyre, Rheumatoid Arthritis Consortium for Immunochip.<br />

POSTER SESSIONS 203<br />

2232W Patterns <strong>of</strong> genetic expression in mental<br />

retardation associated or not with microcephaly.<br />

T. F. Almeida, D. V. Bernardo, C. R. D. C. Quaio, G. L.<br />

Yamamoto, E. D. F. Carvalho, C. A. Kim, D. R. Bertola.<br />

2233T Molecular analysis <strong>of</strong> GABRA1 and EFHC1 genes<br />

in patients with juvenile myoclonic epilepsy and other<br />

idiopathic generalized epilepsies. C. V. Soler, M. C.<br />

Gonsales, F. A. Oliveira, L. E. Betting, F. Cendes, I. Lopes-<br />

Cendes.<br />

2234F Genome-wide expression analysis <strong>of</strong> idiopathic<br />

scoliosis endophenotypes. K. Gorman, S. Bouhnik,<br />

Q. Yuan, C. Julien, A. Franco, K. Choquet, L. Suvarnan,<br />

M.-Y. Akoume, A. Moreau.<br />

2235W Molecular pr<strong>of</strong>iling <strong>of</strong> osteogenic disregulation<br />

in non-syndromic craniosynostosis: New insights<br />

from microarray and morphological studies. M. Barba,<br />

W. Lattanzi, G. Tamburrini, M. C. Geloso, L. Massimi,<br />

M. A. Puglisi, M. Caldarelli, C. Di Rocco, F. Michetti,<br />

C. Bernardini.<br />

2236T Network-based genomic mapping highlights<br />

the influence <strong>of</strong> central-nervous system pathways on<br />

obesity. M. Nikpay, P. Lau, R. Dent, R. McPherson.<br />

2237F A comprehensive knowledgebase <strong>of</strong> autism<br />

genetic evidence. Y. Huang, L. Xu, J. Li, M. Zhao,<br />

X. Tang, L. Wei.<br />

2238W Mathematical modeling <strong>of</strong> the insulin signal<br />

transduction pathway for prediction <strong>of</strong> insulin<br />

sensitivity from expression data. C. K. Ho, J. C. Liao,<br />

G. Sriram, K. M. Dipple.<br />

2239T Examining genetic risk factors <strong>of</strong> obesity:<br />

Pathway analysis <strong>of</strong> GWAS data. M. A. Simonson,<br />

M. C. Keller, M. B. McQueen.<br />

2240F Hypothesis independent pathway analysis<br />

identifies biologic pathways implicated in POAG<br />

etiology. B. L. Yaspan, J. L. Wiggs, L. R. Pasquale,<br />

S. J. Loomis, J. H. Kang, D. L. Budenz, D. S. Friedman,<br />

D. Gaasterland, T. Gaasterland, R. K. Lee, P. R. Lichter,<br />

Y. Liu, C. A. McCarty, S. E. Moroi, L. M. Olson, J. E.<br />

Richards, T. Realini, J. S. Schuman, K. Singh, D. Vollrath,<br />

G. Wollstein, D. J. Zack, R. R. Allingham, M. A. Pericak-<br />

Vance, R. N. Weinreb, K. Zhang, M. A. Hauser, J. L. Haines.<br />

2241W Selecting likely causal genes from genome-wide<br />

association studies <strong>of</strong> BMI and height by integrative<br />

network-based analysis. T. H. Pers, S. Vedantam, T. Esko,<br />

F. Day, S. Berndt, S. Gustafsson, A. E. Locke, A. R. Wood,<br />

B. Kahali, D. C. Croteau-Chonka, C. Powell, P. Dworzynski,<br />

C. E. Thomas, A. G. Pedersen, S. Brunak, A. Justice,<br />

K. L. Mohlke, E. Ingelsson, R. J. F. Loos, E. K. Speliotes,<br />

T. M. Frayling, J. N. Hirschhorn, Genetic Investigation <strong>of</strong><br />

ANthropometric Traits Consortium.<br />

2242T A systems biology approach to ionotropic<br />

GABAergic networks in epilepsy, a model <strong>of</strong> complex<br />

neurogenetic disease. M. Jaworski.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


204 POSTER SESSIONS<br />

2243F P2RX7 SNPs and external apical root resoprtion<br />

during orthodontia. J. Hartsfield, G. Falcao-Alencar,<br />

J. Dempsey, E. Jacobson, G. Kluemper, D. Fardo, J. Macri,<br />

L. Morford.<br />

2244W Pathway analysis <strong>of</strong> variation in DNA repair<br />

genes indicates involvement <strong>of</strong> repair <strong>of</strong> oxidative DNA<br />

lesions in human longevity. M. Soerensen, B. Debrabant,<br />

J. Mengel-From, T. Stevnsner, V. A. Bohr, K. Christensen,<br />

Q. Tan, L. Christiansen.<br />

2245T Constructing endophenotypes <strong>of</strong> complex<br />

disease using nonnegative matrix factorization and<br />

adjusted Rand index. H. M. Wang, C. L. Hsiao,<br />

A. R. Hsieh, Y. C. Lin, S. J. Fann.<br />

2246F Candidate genes <strong>of</strong> several complex diseases<br />

via an integrated analysis <strong>of</strong> GWAS and eQTL. C. Fuller,<br />

X. He, Y. Song, H. Li.<br />

2247W Association study-based gene-set enrichment<br />

analysis identified biological pathways associated with<br />

fetal hemoglobin levels in sickle cell disease patients.<br />

G. Galarneau, S. Coady, M. Puggal, N. Jeffries, D. Paltoo,<br />

A. Kutlar, G. J. Papanicolaou, G. Lettre.<br />

2248T Performances <strong>of</strong> single-SNP and pathway-based<br />

analyses <strong>of</strong> genome-wide data to detect genetic factors<br />

shared by eosinophil and basophil counts in asthmaascertained<br />

families. C. Loucoubar, M. Brossard, P.-E.<br />

Sugier, A. Vaysse, P. Jeannin, M.-H. Dizier, M. Lathrop, E.<br />

Bouzigon, F. Demenais, EGEA Collaborative Group.<br />

2249F Association <strong>of</strong> common genetic variants with<br />

hypoxemia among non-Hispanic White and African<br />

<strong>American</strong> COPD cases highlights hematological<br />

disease genes. M. N. McDonald, M. H. Cho, E. Wan,<br />

P. Castaldi, D. A. Lomas, H. O. Coxson, L. D. Edwards,<br />

W. MacNee, J. Vestbo, J. C. Yates, A. Agusti, P. M. A.<br />

Calverley, B. Celli, C. Crim, S. Rennard, E. Wouters, P.<br />

Bakke, X. Kong, R. Tal-Singer, B. Miller, A. Gulsvik, E.<br />

A. Regan, B. J. Makke, C. Lange, J. E. Hokanson, J. D.<br />

Crapo, T. H. Beaty, E. K. Silverman, C. P. Hersh on behalf<br />

<strong>of</strong> ECLIPSE and COPDGene Coauthors.<br />

2250W ICAM3 expression level integrates the<br />

effects <strong>of</strong> six MS susceptibility alleles: Dissecting<br />

a molecular cascade relevant to MS susceptibility.<br />

T. Raj, M. Kuchroo, L. B. Chibnik, L. Ottoboni, X. Hu, B. T.<br />

Keenan, S. Raychaudhuri, B. E. Stranger, P. L. De Jager.<br />

2251T Random enrichment <strong>of</strong> minor alleles <strong>of</strong> common<br />

SNPs affects complex traits and diseases in model<br />

organisms and humans. S. Huang, X. Tan, J. Liang,<br />

C. Zeng, J. Zhang, J. Chen, L. Ma, A. Dogan,<br />

G. Brockmann, O. Goldmann, E. Medina, M. Xian, K. Yi,<br />

Y. Li, Q. Lu, Y. Huang, D. Wang, J. Yu, H. Guo, K. Xia,<br />

Z. Zhu, D. Yuan.<br />

2252F Functional characterization <strong>of</strong> DcR3 and NF-kB in<br />

EBV transformed cell lines from IBD patients <strong>of</strong> different<br />

allelic background and role in disease pathogenesis.<br />

R. Pandey, C. J. Cardinale, S. Panossian, F. Wang, E.<br />

Frackelton, C. Kim, F. Mentch, R. Chiavacci, K. Kachelries,<br />

S. Grant, R. Baldassano, H. Hakonarson.<br />

2253W Integrative analysis <strong>of</strong> whole-gene coexpression<br />

network and exome sequence data to<br />

characterize pathways relevant to rheumatoid arthritis.<br />

H. Nakaoka, S. Mitsunaga, H. Inoko, I. Inoue.<br />

2254T Integrating genetic linkage analysis and<br />

computational prioritization in identifying host genetic<br />

factors response to influenza A virus infection. S. Bao,<br />

X. Zhou, X. Zhang, P. Tang, J. Zhou, Y. Li, K. To, Y. Song.<br />

2255F Molecular markers <strong>of</strong> severe cerebral malaria:<br />

Expression <strong>of</strong> complement and Toll-like receptor pathway<br />

genes associates with the malaria severity in Mali.<br />

R. Sobota, J. Manning, A. Dara, A. Niangaly, A. Djimde,<br />

O. Doumbo, A. Kone, M. Thera, G. Vernet, P. Leissner,<br />

C. Plowe.<br />

2256W Cross-ethnic gene co-expression network<br />

analysis in human adipose reveals novel triglyceride<br />

genes. D. Weissglas, B. E. Haas, S. Horvath, K. H.<br />

Pietiläinen, R. M. Cantor, E. Nikkola, A. Rissanen, M.<br />

Civelek, I. Cruz-Bautista, L. Riba, J. Kuusisto, J. Kaprio, T.<br />

Tusie-Luna, M. Laakso, C. A. Aguilar-Salinas, P. Pajukanta.<br />

2257T Discovery and replication <strong>of</strong> nuclear genes<br />

influenced by mitochondrial genetic variation. J. Hall,<br />

W. Bush.<br />

2258F Polygenic inheritance <strong>of</strong> paclitaxel-induced<br />

peripheral neuropathy driven by axon outgrowth gene<br />

sets. A. Chhibber, J. Mefford, S. A. Pendergrass, R. M.<br />

Plenge, M. D. Ritchie, E. A. Stahl, J. S. Witte, D. L. Kroetz.<br />

2259W Association <strong>of</strong> adrenomedullin gene<br />

polymorphisms and lipid levels in Chinese population.<br />

S. Chen, X. Lu, L. Wang, H. Li, J. Huang, D. Gu.<br />

2260T A high-throughput molecular assay for detection <strong>of</strong><br />

renal graft acute cellular rejection using peripheral blood.<br />

M. Mikula, O. Zhukov, F. M. Hantash, N. Park, K. Zhang, J. R.<br />

Rion, P. Putheti, C. Snopkowski, A. Buller-Burckle, J. Popov,<br />

W. Sun, B. Crossley, M. P. Hernandez-Fuentes, S. Sacks, M.<br />

Suthanthiran, T. B. Strom, C. M. Strom, S. J. Naides.<br />

2261F Protein interaction networks reveal novel autism<br />

risk genes within GWAS statistical noise. C. Correia,<br />

Y. Diekmann, G. Oliveira, J. B. Pereira- Leal, A. M. Vicente,<br />

Autism Genome Project.<br />

2262W Systems biology in a non-human primate model:<br />

Transcriptomes <strong>of</strong> normal development in the vervet<br />

monkey. A. J. Jasinska, N. Tran, C. Blum, J. DeYoung,<br />

O.-W. Choi, Y. Huang, P. Thomas, E. Eskin, K. Dewar,<br />

J. Wasserscheid, G. M. Weinstock, W. Warren, M. Jorgensen,<br />

R. Cantor, R. Woods, G. Coppola, N. Freimer.<br />

2263T Estrogen pathway polymorphisms in relation<br />

to primary open angle glaucoma in the GLAUGEN<br />

study and the NEIGHBOR consortium. S. Loomis,<br />

L. R. Pasquale, B. L. Yaspan, J. H. Kang, D. Gaasterland,<br />

T. Gaasterland, R. K. Lee, P. R. Lichter, Y. Liu, C. A.<br />

McCarty, S. E. Moroi, L. Olson, J. S. Schuman, K. Singh,<br />

D. Vollrath, G. Wollstein, D. J. Zack, R. R. Allingham, M. A.<br />

Pericak-Vance, R. N. Weinreb, K. Zhang, M. A. Hauser, J. E.<br />

Richards, J. L. Haines, J. L. Wiggs, NEIGHBOR Consortium.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2264F Possible roles <strong>of</strong> miRNA to regulate effective<br />

signaling network in controlling cell fate. M. Nomura,<br />

S. Kondo, T. Nagashima, Y. Suzuki, M. Okada-<br />

Hatakeyama.<br />

2265W Unraveling the molecular mechanisms<br />

underlying the teratogenicity <strong>of</strong> Topamax (topiramate).<br />

S. K. Rafi, A. J. Olm-Shipman, I. Saadi.<br />

2266T The CARTaGENE Genomics Project: Systems<br />

genetics <strong>of</strong> cardiometabolic phenotypes. Y. Idaghdour,<br />

J.-P. Goulet, J. Hussin, A. Hodgkinson, E. Gbeha, J.-C.<br />

Grenier, T. de Malliard, V. Bruat, E. Hip-Ki, C. Boileau, Y.<br />

Payette, P. Awadalla.<br />

2267F Association <strong>of</strong> insulin-like growth factor-1<br />

gene polymorphism in Kuwaiti Arab patients with<br />

rheumatoid arthritis. M. Haider, G. S. Dhaunsi,<br />

S. S. Uppal.<br />

2268W Variations within ARID5B, CEBPE, and<br />

IKZF1 and risk <strong>of</strong> childhood leukemia. L. Hsu,<br />

A. Chokkalingam, C. Metayer, J. Wiemels, P. Buffler.<br />

2269T Contribution <strong>of</strong> common PCSK1 genetic variants<br />

to obesity in a sample <strong>of</strong> 8,359 subjects from two<br />

multi-ethnic <strong>American</strong> populations. H. Choquet,<br />

J. Kasberger, A. Hamidovic, M. Fornage, E. Jorgenson.<br />

2270F Association between IRF6 gene and nonsyndromic<br />

cleft lip and/or palate in Brazil. T. Felix,<br />

L. T. Souza, T. W. Kowalski, I. L. Monlleó, E. M. Ribeiro, J.<br />

Souza, G. F. Leal, A. C. Fett-Conte, V. Gil-da-Silva-Lopes.<br />

2271W Validation <strong>of</strong> the PPP1R12B as a candidate gene<br />

for childhood asthma susceptibility. M. B. Freidin, A. V.<br />

Polonikov.<br />

2272T Association <strong>of</strong> the SNP rs 9939609 <strong>of</strong> the fat<br />

mass and obesity associated gene (FTO) with the risk<br />

for obesity in children from Yucatan, Mexico.<br />

L. Gonzalez-Herrera, N. Mendez-Dominguez, F. Herrera-<br />

Sanchez, G. Uicab-Pool, V. Hernandez-Escalante, L. Ruiz-<br />

Ortiz, G. Storey-Montalvo, J. Zavala-Castro.<br />

2273F Shared genetic loci between leprosy and<br />

inflammatory bowel disease in Korean patients.<br />

Y. Jung, M. Hong, J. Baek, S. Yang, K. Song.<br />

2274W Fatness related allelic variant near insulin<br />

receptor substrate 1 gene is associated with low<br />

low-density lipoprotein cholesterol in childhood and<br />

a better cardiometabolic pr<strong>of</strong>ile in their adulthood:<br />

The Bogalusa Heart Study. S. Li, W. Chen, E. N. Smith,<br />

S. S. Murray, C. Fernandez, J. Xu, S. R. Srinivasan, N. J.<br />

Schork, G. S. Berenson.<br />

2275T Genetic variants associate with nonalcoholic<br />

fatty liver disease in African and Hispanic <strong>American</strong>s.<br />

S. K. Musani, N. D. Palmer, M. F. Feitosa, M. A. Jhun, L. M.<br />

Yerges-Armstrong, R. Hernaez, J. Liu, B. Kahali, J. J. Carr,<br />

T. B. Harris, A. V. Smith, L. E. Wagenknecht, I. B. Borecki,<br />

E. K. Speliotes, L. F. Bielak for <strong>Genetics</strong> <strong>of</strong> Obesity-Related<br />

Liver Disease Consortium.<br />

POSTER SESSIONS 205<br />

2276F Genetic association to ERAP1 in psoriasis<br />

is confined to disease onset after puberty and not<br />

dependent on HLA-C*06. P. Nikamo, J. Lysell,<br />

L. Padyukov, I. Kockum, M. Ståhle.<br />

2277W On the association <strong>of</strong> common polygenic variation<br />

with body mass index across adolescent development:<br />

A longitudinal twin study. R. E. Peterson, B. T. Webb, E. C.<br />

Prom-Wormley, J. L. Silberg, L. J. Eaves, H. H. Maes.<br />

2278T Absence <strong>of</strong> the chromosome 16p11.2<br />

duplication in metabolically normal, constitutionally<br />

thin individuals with extremely low BMI. J. Hager,<br />

N. Germain, E. Meugnier, B. Galusca, H. Vidal, B. Estour.<br />

2279F Lack <strong>of</strong> association <strong>of</strong> genetic variants in<br />

PROX1, ADCY5, SLC2A2, DGKB-TMEM195, ADRA2A,<br />

CRY2, FADS1, IGF1 and C2CD4B with glucose- and<br />

insulin-related traits in Chinese adolescents. R. C. W.<br />

Ma, C. Tam, G. Jiang, J. Ho, V. Lam, Y. Wang, H. M. Lee,<br />

A. Kong, W. Y. So, J. Chan.<br />

2280W Combined effects <strong>of</strong> genetic variants identified<br />

from genome-wide association studies increased risk<br />

<strong>of</strong> type 2 diabetes in Chinese. C. Tam, J. Ho, Y. Wang,<br />

V. Lam, M. Ng, R. Ma, W. So, J. Chan.<br />

2281T AGRP SNPs and gender effects on obesity in<br />

African <strong>American</strong>s. E. Shah, A. Patterson, U. Al-Alem,<br />

R. A. Kittles.<br />

2282F Pleiotropic effects <strong>of</strong> obesity-susceptibility loci<br />

on metabolic traits: A meta-analysis <strong>of</strong> up to 37,874<br />

individuals. J. van Vliet-Ostaptchouk, M. den Hoed, J.<br />

Luan, J.-H. Zhao, K. K. Ong, P. J. van der Most, A. Wong, R.<br />

Hardy, D. Kuh, M. M. van der Klauw, M. Bruinenberg, B. H. R.<br />

Wolffenbuttel, N. J. Wareham, H. Snieder, R. J. F. Loos.<br />

2283W Investigation <strong>of</strong> celiac disease susceptibility<br />

variants in the Irish population using the immunochip.<br />

C. Coleman, E. Quinn, A. W. Ryan, J. Conroy, S. Ennis,<br />

V. Trimble, R. McManus.<br />

2284T Risk alleles associated with ANA production in<br />

healthy population or transition to autoimmunity. E.<br />

Wakeland, P. Raj, E. Rai, Q. Z. Li, D. Karp, P. Doshi,<br />

N. Olsen, K. M. Sivils, J. James, J. Kelly, B. Lauwerys.<br />

2285F Interleukin-18 genetic polymorphism and<br />

Kawasaki disease in Han Chinese children. H. Chi,<br />

M.-R. Chen, N.-C. Chiu, F.-Y. Huang, H.-W. Chan, S.-C.<br />

Chang, C.-L. Lin, Y.-J. Lee.<br />

2286W Association between IL1A, IL1B and TNFA<br />

polymorphisms and glaucoma in a Brazilian population.<br />

M. B. Oliveira, J. P. C. Vasconcellos, V. P. Costa, M. B. Melo.<br />

2287T Evaluation <strong>of</strong> new classification criteria for<br />

HLA-DRB1 alleles based on three amino acid positions<br />

(11, 71 and 74) in Japanese RA patients: Disease<br />

susceptibility and severity. S. Yoshida, K. Ikari, K. Yano,<br />

Y. Toyama, A. Taniguchi, H. Yamanaka, S. Momohara.<br />

2288F Genetic susceptibility to leptospirosis in the<br />

Azorean island <strong>of</strong> São Miguel population. L. M. Esteves,<br />

S. M. Bulhıes, M. J. Brilhante, C. C. Branco, F. M. Mota, C.<br />

Paiva, M. L. Vieira, L. Mota-Vieira.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


206 POSTER SESSIONS<br />

2289W A replication study supports NOD2 and CCDC122<br />

as leprosy susceptibility genes. H. Salomão, W. L. Silva,<br />

P. Medeiros, V. M. Fava, I. M. F. Dias-Baptista, M. L. C.<br />

Virmond, M. O. Moraes, M. T. Mira, A. C. Pereira-Latini.<br />

2290T Positive association <strong>of</strong> apolipoprotein E4<br />

polymorphism with recurrent pregnancy loss in Iranian<br />

patients. M. T. Akbari, N. Asgari.<br />

2291F Investigation <strong>of</strong> rs4236601 and rs4977756 SNPs<br />

in a primary open-angle glaucoma Brazilian population.<br />

H. F. Nunes, M. B. Oliveira, J. P. C. Vasconcellos, V. P.<br />

Costa, M. B. de Melo.<br />

2292W Role <strong>of</strong> genetic variation at the FTO gene<br />

in genetic susceptibility to osteoarthritis. K.<br />

Panoutsopoulou, S. Metrustry, S. Doherty, L. L. Laslett, R.<br />

A. Maciewicz, D. J. Hart, W. Zhang, K. R. Muir, M. Wheeler,<br />

arcOGEN Consortium, C. Cooper, T. Spector, F. M. Cicuttini,<br />

G. Jones, N. K. Arden, M. Doherty, E. Zeggini, A. Valdes.<br />

2293T Association <strong>of</strong> COX-2, IL-1b and IL-1 RN<br />

gene polymorphisms with susceptibility to chronic<br />

periodontitis in North India population. G. Prakash,<br />

S. Ajay, K. K. Gupta, J. Dixit, D. Bali, B. Mittal.<br />

2294F A variant <strong>of</strong> filaggrin are associated with<br />

susceptibility to food allergy in the Japanese<br />

population. T. Hirota, M. Ebisawa, T. Imai, Y. Suzuk,<br />

N. Shimojo, Y. Kohno, M. Kubo, M. Tamari.<br />

2295W AKT1 fails to replicate as a longevity-associated<br />

gene in Danish and German nonagenarians and<br />

centenarians. M. Nygaard, M. Soerensen,<br />

F. Flachsbart, J. Mengel-From, Q. Tan, S. Schreiber,<br />

A. Nebel, K. Christensen, L. Christiansen.<br />

2296T Association <strong>of</strong> HLA-DRB1 and HLA-DQB1 genes<br />

with asthma in the Spanish population. M. Pino-Yanes,<br />

A. Corrales, M. Acosta-Herrera, J. Cumplido, F. Sánchez-<br />

García, R. González, J. Figueroa, I. Sánchez-Machín,<br />

O. Acosta, A. Sánchez-Palacios, J. C. García-Robaina,<br />

J. Villar, E. G. Burchard, T. Carrillo, C. Flores.<br />

2297F Turning the GWAS upside down: A PheWAS<br />

approach in studying human disease. S. Hebbring,<br />

S. Schrodi, Z. Ye, Z. Zhou, D. Page, M. Brilliant.<br />

2298W Assessment <strong>of</strong> bias in an EMR-derived cohort.<br />

W. S. Bush, L. C. Dumitrescu, D. C. Crawford.<br />

2299T Defining the use <strong>of</strong> electronic medical records<br />

in genetic studies <strong>of</strong> multiple sclerosis. M. F. Davis, J. L.<br />

McCauley, J. C. Denny, J. R. Oksenberg, S. L. Hauser, M.<br />

A. Pericak-Vance, J. L. Haines.<br />

2300F The NINDS Repository: A public resource <strong>of</strong><br />

biomaterials for genetic, mechanistic and biomarker<br />

discovery for neurological disorders. A. Scutti, M. Self,<br />

K. Reeves, J. Santana, S. Heil, C. Pérez, A. Nasuti, R.<br />

Corriveau, C. Tarn.<br />

2301W Mutation <strong>of</strong> SLC45A3 in familial and sporadic<br />

Ménière’s disease. C. A. Campbell, B. J. Boese, C. C.<br />

Della Santina, C. Li, N. C. Meyer, L. T. TeGrootenhuis,<br />

J. Webster, D. A. Stephan, H. Najmabadi, A. Danashi, A. P.<br />

May, K. Fredrickson, B. J. Gantz, J. P. Carey, L. B. Minor,<br />

M. R. Hansen, T. T. Harkins, R. J. H. Smith.<br />

2302T Next-generation sequencing identifies genes<br />

dysregulated in otosclerotic stapes bone and provides<br />

a candidate gene set for filtering <strong>of</strong> whole exome<br />

sequence data in familial cases. J. L. Ziff, J. Lavy, H.<br />

Powell, S. Khalil, K. P. Steel, S. R. Saeed, S. J. Dawson.<br />

2303F Dissection <strong>of</strong> healthy aging by whole genome<br />

and exome sequencing <strong>of</strong> supercentenarian genomes.<br />

X. Estivill, N. Badarinarayan, P. Rosenstiel, M. Bayés, S.<br />

Ossowski, C. Tornador, H. Blanche, G. Escaramís, M. Gut,<br />

S. Heath, F. Flachsbart, A. Nebel, M. Lathrop, A. Franke,<br />

M. Gratac&ograve;s, S. Schreiber, I. Gut, D. Trujillano.<br />

2304W Whole exome sequencing cases: Fnding and<br />

testing with external controls. A. Hendricks on behalf <strong>of</strong><br />

UK10K Statistics Group.<br />

2305T Whole-exome sequencing study <strong>of</strong> four families<br />

with bipolar disorder. E. Elhaik, M. Pirooznia, F. S. Goes,<br />

J. Parla, R. Karchin, A. Chakravarti, P. P. Zandi, W. R.<br />

McCombie, J. B. Potash.<br />

2306F Whole exome sequencing <strong>of</strong> five<br />

consanguineous families with juvenile myoclonic<br />

epilepsy. B. Ouled Amar Bencheikh, J. Gauthier, F.<br />

Lahjouji, l. Jouan, P. La Chance Touchette, K. Khaldi, H.<br />

Lamghari, C. Bourassa, D. Spiegelman, A. Dionne laporte,<br />

H. Daoud, F. Hamdan, H. Belaidi, O. Ouazzani, P. Dion, P.<br />

Cossette, G. Rouleau.<br />

2307W GEnetics <strong>of</strong> Nephropathy–an International<br />

Effort (GENIE): CNV analysis. Y. Meng, R. M. Salem, A.<br />

J. McKnight, E. P. Brennan, N. Sandholm, C. Forsblom,<br />

J. Florez, C. Godson, P.-H. Groop, A. P. Maxwell, J. N.<br />

Hirschhorn for GENIE Consortium.<br />

2308T Whole genome sequencing identifies coding<br />

variants influencing canonical lipid species in Mexican<br />

<strong>American</strong> families. C. Bellis, P. J. Meikle, J. M. Weir, J.<br />

B. Jowett, T. M. Teslovich, G. Jun, S. Kumar, M. Almeida,<br />

J. M. Peralta, E. E. Quillen, C. Fuchsberger, A. R. Wood,<br />

T. M. Frayling, P. Cingolani, T. W. Blackwell, R. Sladek,<br />

G. Atzmon, J. Laramie, S. Lincoln, D. M. Lehman, G.<br />

Abecasis, M. C. Mahaney, T. D. Dyer, L. Almasy, R.<br />

Duggirala, J. Blangero, J. E. Curran.<br />

2309F Identifying non-synonymous variants exhibiting<br />

pleiotropic effects on preeclampsia and CVD risk<br />

traits. M. P. Johnson, S. P. Brennecke, J. M. Peralta, T.<br />

D. Dyer, M. A. Almeida, J. M. Pr<strong>of</strong>fitt, C. E. East, A. G.<br />

Comuzzie, M. C. Mahaney, L. Almasy, J. E. Curran, J.<br />

Blangero, E. K. Moses.<br />

2310W Analysis <strong>of</strong> coding variants identified from<br />

exome sequencing in diabetic and non-diabetic<br />

nephropathy genes in African <strong>American</strong>s. J. N. Cooke,<br />

N. D. Palmer, M. C. Y. Ng, P. J. Hicks, J. A. Bonomo, J. M.<br />

Hester, C. D. Langefeld, B. I. Freedman, D. W. Bowden.<br />

2311T Assessing the role <strong>of</strong> low-frequency variants in<br />

type 2 diabetes risk using exome sequencing <strong>of</strong> 2,000<br />

Danish individuals. K. E. Lohmueller, T. Sparso, Q. B. Li,<br />

E. Andersson, N. Grarup, A. Albrechtsen, T. Korneliussen,<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


K. Kristiansen, T. Hansen, G. Sanchez, I. Hallgrímsdóttir,<br />

J. Wang, R. Nielsen, O. Pedersen.<br />

2312F Whole exome sequencing identifies a novel<br />

mutation within the FOXP3 gene in 2-generational<br />

family with inflammatory bowel disease. D. T. Okou,<br />

K. Mondal, L. J. Kobrynski, J. G. Mulle, D. Ramachandran,<br />

V. C. Patel, P. Bose, J. P. Waters, P. Sampath, D. J. Cutler,<br />

M. E. Zwick, S. Kugathasan.<br />

2313W Identification <strong>of</strong> rare genetic variants that<br />

contribute to diabetic nephropathy in type 2 diabetes<br />

through family-based targeted exome sequencing.<br />

M. G. Pezzolesi, J. Jeong, A. M. Smiles, J. Skupien, J. C.<br />

Mychaleckyj, S. S. Rich, J. H. Warram, A. S. Krolewski.<br />

2314T Exome sequencing and functional data identify<br />

PRDM1 and NPD52 as susceptibility factors in<br />

Crohn&#146;s disease. A. Franke, D. Ellinghaus,<br />

H. Zhang, S. Schreiber, M. Parkes.<br />

2315F Exome sequencing for Crohn&#146;s disease<br />

pedigrees. B.-S. Petersen, Y. Zeissig, M. Kohl, S.<br />

Schreiber, S. Zeissig, A. Franke.<br />

2316W Whole-exome sequencing <strong>of</strong> patients with<br />

isolated biliary atresia. E. A.-L. Tsai, S. Sukhadia,<br />

C. Grochowski, C.-F. Lin, O. Valladares, L.-S. Wang,<br />

L. Leonard, G. D. Schellenberg, K. M. Loomes, B. A.<br />

Haber, M. Devoto, N. B. Spinner.<br />

2317T Identification <strong>of</strong> low-frequency and common<br />

variants associated with circulating levels <strong>of</strong> vitamin<br />

B 12 and folate. N. Grarup, C. H. Sandholt, P. Sulem,<br />

T. S. Ahluwalia, T. Sparsø, A. Albrechtsen, L. Husemoen,<br />

D. R. Witte, Y. Li, A. Linneberg, R. Nielsen, T. Jørgensen, J.<br />

Wang, T. Hansen, U. Thorsteinsdottir, K. Stefansson,<br />

O. Pedersen.<br />

2318F Whole-exome sequencing in age-related<br />

macular degeneration (AMD) using a highly-discordant<br />

phenotype and genotype design: Evidence for novel<br />

loci underlying bilateral late AMD. W. K. Scott, W. H.<br />

Cade, M. D. Courtenay, P. L. Whitehead, I. Konidari,<br />

W. F. Hulme, S. G. Schwartz, J. L. Kovach, G. Wang,<br />

A. Agarwal, J. L. Haines, M. A. Pericak-Vance.<br />

2319W Deep resequencing <strong>of</strong> GWAS loci identifies a<br />

novel rare variant in RNF186 associated with ulcerative<br />

colitis. P. Goyette, M. Beaudoin, G. Boucher, C. Stevens,<br />

K. S. Sin Lo, A. Alikashani, M. Ladouceur, M. A. Rivas,<br />

S. R. Brant, R. H. Duerr, D. P. McGovern, M. S. Silverberg,<br />

M. D’Amato, A. Franke, S. Vermeire, G. Lettre, J. H.<br />

Cho, R. J. Xavier, M. J. Daly, J. D. Rioux, NIDDK and<br />

International IBD <strong>Genetics</strong> Consortia.<br />

2320T Traits <strong>of</strong> human disease significance segregating in<br />

the non-human primate vervet. W. Warren, A. J. Jasinska,<br />

N. Tran, Y. Huang, K. Dewar, J. Kaplan, P. Minx, L. Hillier, R. K.<br />

Wilson, M. Nordborg, G. M. Weinstock, N. B. Freimer.<br />

2321F Association and replication <strong>of</strong> rare allele<br />

windows within cis-regulatory regions to nearby gene<br />

expression. A. Fish, L. Wiley, W. Bush.<br />

Than, K. Nadeau, M. Snyder.<br />

POSTER SESSIONS 207<br />

2323T Whole-genome deep-coverage sequencing<br />

<strong>of</strong> asthma genomes. M. A. R. Ferreira, C. S. Tang, G.<br />

Chenevix-Trench.<br />

2324F Rare non-coding variant prioritization and<br />

burden testing in whole genome sequencing <strong>of</strong><br />

complex traits. K. J. Gaulton, M. A. Rivas, M. van de<br />

Bunt, C. M. Lindgren, M. I. McCarthy, GoT2D Consortium.<br />

2325W Deep sequencing <strong>of</strong> genomic regions<br />

associated with cleft lip susceptibility. C. Harris,<br />

E. Leslie, R. Fulton, T. Miner, E. Appelbaum, C. Fronick,<br />

M. Mead, D. Larson, M. Adela Mansilla, A. Lidral,<br />

L. Moreno, J. Hecht, M. Marazita, A. Scott, T. Beaty,<br />

J. Murray, R. Wilson, G. Weinstock.<br />

2326T Exome sequencing identifies rare variants<br />

associated with the common pain disorder<br />

fibromyalgia. H. Hor, E. Docampo, R. Rabionet, M. Gut,<br />

M. Bayés, I. Gut, A. Collado, S. Ossowski, X. Estivill.<br />

2327F Application <strong>of</strong> whole genome sequencing<br />

to identify susceptibility loci for polycystic ovary<br />

syndrome. G. Kosova, R. S. Legro, A. Dunaif, M. Urbanek.<br />

2328W CYP1B1, MYOC and LTBP2 mutations in primary<br />

congenital glaucoma patients in the United States. S.<br />

Lim, K. Tran-Viet, T. Yanovitch, S. Freedman,<br />

T. Klemm, W. Call, C. Powell, A. Ravichandran, R.<br />

Metlapally, E. Nading, S. Rozen, T. Young.<br />

2329T Enhancing sequencing lab workflows in the<br />

SardiNIA project. A. Maschio, F. Busonero, C. Sidore,<br />

E. A. Ketterer, E. B. Pedersen, A. M. Chidester, A. M.<br />

Gurkan, M. R. Coon, M. Dei, S. Lai, A. Mulas, M. G. Piras,<br />

M. Lobina, B. Tarrier, S. Sanna, C. A. Brennan, G. R.<br />

Abecasis, F. Cucca, R. H. Lyons.<br />

2330F Whole-exome sequencing identifies novel risk<br />

variants for thrombotic storm. P. Whitehead, N. D.<br />

Dueker, G. Beecham, D. Hedges, A. Beecham, S. Hahn,<br />

N. H<strong>of</strong>mann, J. W. Lawson, D. Erkan, L. R. Brandao, A. H.<br />

James, M. J. Manco-Johnson, R. Kulkarni, C. S. Kitchens,<br />

T. L. Ortel, J. M. Vance, M. A. Pericak-Vance.<br />

2331W Identification <strong>of</strong> genetic modifiers associated<br />

with risk <strong>of</strong> stroke in children with sickle cell anemia.<br />

J. M. Flanagan, H. Linder, V. Sheehan, T. A. Howard, B.<br />

Aygun, J. S. Hankins, M. Wang, G. A. Neale, R. E. Ware.<br />

2332T Implication <strong>of</strong> rare variants from European-derived<br />

adiposity loci in African <strong>American</strong>s. J. Hester, P. Mudgal, J.<br />

Li, J. Xu, P. Hicks, B. Freedman, D. Bowden, M. Ng.<br />

2333F Assessing the effect <strong>of</strong> rare variants on cancer<br />

drug-induced cytotoxicity phenotypes using whole<br />

genome sequence data. A. Tikhomirov, A. Pluzhnikov, C.<br />

R. King, A. Konkashbaev, E. Gamazon, M. E. Dolan, D. L.<br />

Nicolae, N. J. Cox.<br />

2334W Detecting rare variant effects using extreme<br />

phenotype sampling in sequencing association<br />

studies. I. Barnett, S. Lee, X. Lin.<br />

2335T Whole genome sequencing to identify rare genetic<br />

2322W Asthma: An omics view through discordant<br />

monozygotic twins. R. Chen, S. Runyon, J. Li-Pook-<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


208 POSTER SESSIONS<br />

variation responsible for resistance to HIV infection. P. R.<br />

Shea, K. Pelak, K. V. Shianna, D. Ge, D. B. Goldstein, NIAID<br />

Center for HIV/AIDS Vaccine Immunology (CHAVI).<br />

2336F Rare variants are strongly associated with<br />

age <strong>of</strong> menarche: First results from NHLBI-Exome<br />

Sequencing Project. K. L. Bucasas, G. T. Wang, P. L.<br />

Auer, M. Kan, J. M. Murabito, N. Franceschini, E. W.<br />

Demerath, K. L. Lunetta, A. Rodriguez, L. A. Lange, R. D.<br />

Jackson, S. M. Leal, NHLBI Exome Sequencing Project.<br />

2337W Detecting rare variant associations with<br />

waist-to-hip ratio in NHLBI-ESP female cohorts. M.<br />

Kan, K. L. Bucasas, P. L. Auer, G. Wang, A. Rodriguez,<br />

J. Ellis, L. A. Cupples, Y. D. I. Chen, J. Dupuis, C. Fox,<br />

M. D. Gross, N. Heard-Costa, J. B. Meigs, J. S. Pankow,<br />

J. I. Rotter, D. Siscovick, J. G. Wilson, J. Shendure, R.<br />

Jackson, U. Peters, E. Whitsel, J. Zhong, D. Lin, L. Hsu,<br />

N. Franceschini, C. Carlson, K. E. North, L. A. Lange, A. P.<br />

Reiner, S. M. Leal, NHLBI Exome Sequencing Project.<br />

2338T Identification <strong>of</strong> rare susceptibility variants for<br />

bipolar disorder by exome sequencing. C. Cruceanu, A.<br />

Ambalavanan, J. P. Lopez, J. Gauthier, D. Spiegelman, R. G.<br />

Lafreni&egrave;re, P. Gr<strong>of</strong>, M. Alda, G. Turecki, G. Rouleau.<br />

2339F Deep sequencing in extended pedigrees reveals<br />

both common and rare non-synonymous variants<br />

influencing free triiodothyronine levels. J. E. Curran, S.<br />

Kumar, M. Almeida, J. M. Peralta, T. D. Dyer, T. M. Teslovich,<br />

G. Jun, C. Fuchsberger, A. R. Wood, T. M. Frayling, P.<br />

Cingolani, T. W. Blackwell, R. Sladek, G. Atzmon, S. P.<br />

Fowler, V. S. Farook, S. Puppala, J. Laramie, S. Lincoln, D.<br />

M. Lehman, G. R. Abecasis, R. Duggirala, J. Blangero.<br />

2340W Exome sequencing to identify causal variants in<br />

a multiplex anencephaly family. D. Krupp, K. LaRocque-<br />

Abramson, K. Soldano, M. E. Garrett, A. E. Ashley-Koch,<br />

S. G. Gregory.<br />

2341T Statistical power and effect size overestimation for<br />

combined single point and sequence kernel association<br />

tests in case-control studies. A. M. Valdes, F. Lari.<br />

2342F Exome sequencing <strong>of</strong> cluster headache patients<br />

with Sardinian ancestry. L. Jouan, H. Daoud, B. Ouled<br />

Amar Bencheikh, A. Dionne-Laporte, D. Spiegelman,<br />

O. Diallo, E. Henrion, A. Szuto, J. Gauthier, P. A. Dion,<br />

M. Manchia, M. Alda, M. Del Zompo, G. A. Rouleau.<br />

2343W Whole-genome sequencing analysis <strong>of</strong> more<br />

than 700 members <strong>of</strong> an extended pedigree. Y. Huang,<br />

A. Jasinska, V. Ramensky, N. Juretic, S. Service, N. Tran,<br />

R. Wilson, W. Warren, G. Weinstock, K. Dewar, N. Freimer.<br />

2344T Sequencing Initiative Suomi: Identification <strong>of</strong> loss<br />

<strong>of</strong> function variants enriched in the Finnish population. K.<br />

Rehnström, E. T. Lim, A. Palotie on behalf <strong>of</strong> SISu Consortium.<br />

2345F Diabetes related DNA mutations in <strong>American</strong>s<br />

<strong>of</strong> Mexican origin with health disparities disclosed by<br />

next-gen sequencing. H. Q. Qu, Q. Li, Y. Lu, S. P. Fisher-<br />

Hoch, J. B. McCormick.<br />

2346W Exome sequencing in severe COPD cases<br />

and resistant smoking controls from COPDGene. M.<br />

H. Cho, M. Emond, R. A. Mathias, J. E. Hokanson, T. H.<br />

Beaty, N. Laird, C. Lange, K. C. Barnes, M. Bamshad, J. D.<br />

Crapo, E. K. Silverman, COPDGene Investigators, NHLBI<br />

Exome Sequencing Project.<br />

2347T Meta-analyses <strong>of</strong> 6391 Danish individuals<br />

identify novel genetic loci associated with circulating<br />

levels <strong>of</strong> interleukin 18, insulin-like growth factorbinding<br />

protein 1, and heat shock 70kda protein 1b.<br />

T. S. Ahluwalia, N. Grarup, A. Albrechtsen, T. Sparsø,<br />

C. H. Sandholt, T. Lauritzen, D. R. Witte, T. Jørgensen,<br />

S. Hamren, M. Rowe, J. A. Kolberg, Y. Li, R. Nielsen,<br />

J. Wang, T. Hansen, O. Pedersen.<br />

2348F Further analysis <strong>of</strong> a visual migraine aura locus<br />

on chromosome 9q21-q22 using exome sequencing.<br />

M. E. Hiekkala, M. A. Kaunisto, B. S. Winsvold, E.<br />

Hämäläinen, V. Artto, S. Vepsäläinen, M. Färkkilä, M.<br />

Kallela, A. Palotie, M. Wessman.<br />

2349W Extensions <strong>of</strong> <strong>Human</strong> Variation Database in<br />

Japanese Integrated Database Project. A. Koike, N.<br />

Nishida, M. Yoshida, M. Kawashima, I. Inoue, S. Tsuji,<br />

K. Tokunaga.<br />

2350T Genetic burden analysis <strong>of</strong> common associated<br />

variants in an isolate population <strong>of</strong> Southern<br />

Ostrobothnia and in extended multiplex families.<br />

V. Leppä, E. Jakkula, S. Ripatti, P.-A. Gourraud, K.<br />

Koivisto, P. Tienari, J. Kaprio, J. Eriksson, T. Lehtimäki, S.<br />

Koskinen, A. Palotie, J. Saarela.<br />

2351F Assessing association between known PTPN22<br />

and SUMO4 variants and type 1 diabetes in an Indian<br />

population. S. R. Manyam, U. Ratnamala, K. R. S. S. Rao,<br />

S. K. Nath, U. Radhakrishna.<br />

2352W Duffy interaction with chromosome 4 determine<br />

the number <strong>of</strong> malaria episodes <strong>of</strong> individuals from<br />

Western Brazilian Amazon. J. Pescarini, L. M. Garrido, L.<br />

C. Pereira, R. G. M. Ferreira, L. M. A. Camargo, H. Krieger.<br />

2353T Role <strong>of</strong> genetic variants <strong>of</strong> inflammatory genes<br />

with inflammation, malnutrition and susceptibility to<br />

end-stage renal disease in North Indian population.<br />

R. Sharma, R. K. Sharma, A. Saxena, S. Agrawal.<br />

2354F Genetic predisposition to hypertension associates<br />

with increased risk <strong>of</strong> type 2 diabetes. Q. Qi, J. Forman,<br />

F. Hu, L. Qi.<br />

2355W A systemic monitoring <strong>of</strong> cleft lip/palate in Hebei<br />

Province <strong>of</strong> China through a birth defect surveillance: A<br />

15-year (1996-2010) report. J.-Z. Zhu, N. Zhong.<br />

2356T De novo and inherited copy number variants<br />

are a common cause <strong>of</strong> short stature. C. T. Thiel, D.<br />

Zahnleiter, U. Trautmann, A. B. Ekici, D. Wieczorek, E.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


Psychiatric <strong>Genetics</strong>, Neurogenetics<br />

and Neurodegeneration<br />

2370W Genetic association analysis between glycine<br />

cleavage system and schizophrenia. A. Yoshikawa,<br />

F. Nishimura, H. Hibino, K. Kohda, M. Tochigi, Y. Kawamura,<br />

T. Umekage, T. Sasaki, K. Kasai, C. Kakiuchi.<br />

2371T A gene search for a new spinocerebellar ataxia.<br />

K. Ishikawa, N. Sato, Y. Hashimoto, M. Obayashi,<br />

H. Matsuo, H. Mizusawa.<br />

2372F Combining genotype and gene expression data to<br />

unravel the genetics <strong>of</strong> major depressive disorder.<br />

S. Mostafavi, A. Battle, X. Zhu, S. Montgomery, J. B. Potash,<br />

M. M. Weissman, C. Haudenschild, C. McCormick, K. B.<br />

Beckman, R. Mei, A. Urban, D. Koller, D. F. Levinson.<br />

2373W Transcript pr<strong>of</strong>ile analysis <strong>of</strong> interleukin-1<br />

beta gene in immature and adult zebrafish brain after<br />

seizure. P. G. Barbalho, F. R. Pinto, R. Mangolin, C. V.<br />

Maurer-Morelli.<br />

2374T An integrative analysis pinpoints the pathogenesis<br />

<strong>of</strong> autism in the cerebellar vermis. D.-A. Clevert,<br />

S. Hochreiter.<br />

2375F Common genetic variants in the GNB3, ARNTL,<br />

and NPAS2 loci are associated with objectively<br />

measured sleep traits in the elderly. D. S. Evans,<br />

N. Parimi, C. M. Nievergelt, K. L. Stone, T. Blackwell, S.<br />

Redline, S. Ancoli-Israel, E. S. Orwoll, S. R. Cummings,<br />

G. J. Tranah, Study <strong>of</strong> Osteoporotic Fractures and<br />

Osteoporotic Fractures in Men Study Groups.<br />

2376W GWAS <strong>of</strong> alcohol abuse and dependence in the<br />

CATIE schizophrenia sample. V. F. Gonçalves, C. Zai, A.<br />

Paterson, L. Sun, J. L. Kennedy, J. Knight.<br />

2377T Familial study <strong>of</strong> essential tremor at Columbia<br />

University. N. Hernandez, D. Tirri, L. Clark, E. Louis.<br />

2378F Significant linkage <strong>of</strong> familial essential tremor to<br />

a novel locus on chromosome 5. J. E. Hicks, I. Konidari,<br />

J. R. Gilbert, W. K. Scott.<br />

2379W Autism and obesity: Is there any mechanistic<br />

connection? Z. Talebizadeh, M. Miralles.<br />

2380T Haplotypes in the expression quantitative<br />

trait locus <strong>of</strong> interleukin-1� gene are associated with<br />

schizophrenia. M. Yoshida, K. Shiroiwa, K. Mouri, T.<br />

Sasada, H. Ishiguro, T. Inada, T. Arinami, O. Shirakawa, A.<br />

Hishimoto.<br />

2381F Selection <strong>of</strong> candidate genes from linkage<br />

regions identified by the individual behavioral domains<br />

<strong>of</strong> autism spectrum disorders. A. Hare, J. Flax, Z.<br />

Fermano, M. Azaro, A. Seto, S. Y. Cheong, S. Buyske, B.<br />

Zimmerman-Bier, C. W. Bartlett, L. M. Brzustowicz.<br />

POSTER SESSIONS 209<br />

2382W Association <strong>of</strong> Neuregulin 1 polymorphisms<br />

with a North Indian schizophrenia cohort. P. Kukshal,<br />

T. Bhatia, A. M. Bhagwat, R. E. Gur, R. C. Gur, S. N.<br />

Despande, V. L. Nimgaonkar, B. K. Thelma.<br />

2383T Single nucleotide polymorphism fine mapping <strong>of</strong><br />

the AVPR1A and OXTR loci reveals an OXTR association<br />

with a social memory endophenotype in probands<br />

with autism and their family members. A. Lori, I. Lee,<br />

J. F. Cubells, E. B. Binder, T. Lehtimäki, K. Puura, K. N.<br />

Conneely, L. J. Young, D. Skuse.<br />

2384F The effects <strong>of</strong> ABCB1 polymorphisms and<br />

expression in perinatal depression. S. E. Parets, A. Lori,<br />

M. N. To, D. J. Newport, Z. N. Stowe, J. F. Cubells, A. K.<br />

Smith.<br />

2385W HMNC1 and COMT gene polymorphism<br />

associated with postpartum depression.<br />

M. Romano-Silva, D. M. Miranda, P. Figueira,<br />

H. Correa, A. Alvim-Soares.<br />

2386T Disrupted in schizophrenia 1 gene in autist<br />

patients. P. Sarda, J. Puechberty, M. Girard, A. Schneider,<br />

S. Taviaux, G. Lefort, D. Genevieve, A. Baghdadli.<br />

2387F Phenotypic description <strong>of</strong> a child with a<br />

10q23.1 deletion involving only NRG3. N. Sobreira, D.<br />

Avramopoulos, A. Pulver, B. Menten, B. Loeys, D. Valle.<br />

2388W Determination <strong>of</strong> a rare variant and common<br />

variants in COMT for their involvement in the etiology<br />

<strong>of</strong> smoking dependence using Mid-South Tobacco<br />

Case-Control study samples. J. Yang, S. Wang, J. Z. Ma,<br />

T. J. Payne, M. D. Li.<br />

2389T Copy number variations and agenesis <strong>of</strong><br />

the corpus callosum, narrowing the recurrent 8p<br />

duplication interval. S. Esmaeeli Nieh, L. Fernandez, S.<br />

Sajan, E. Rider, P. Bukshpun, M. Wakahiro, J. T. Glessner,<br />

H. Hakonarson, S. L. Christian, W. B. Dobyns, E. H. Sherr.<br />

2390F Serotonin transporter and receptor genes<br />

significantly impact nicotine dependence through<br />

genetic interactions in both European <strong>American</strong> and<br />

African <strong>American</strong> smokers. Z. Yang, C. Seneviratne, S.<br />

Wang, J. Z. Ma, T. J. Payne, J. Wang, M. D. Li.<br />

2391W Genetic association <strong>of</strong> FKBP5 and CRHR1<br />

with cortisol response to acute psychosocial stress in<br />

healthy adults. P. B. Mahon, P. P. Zandi, J. B. Potash,<br />

G. Nestadt, G. S. Wand.<br />

2392T Associations <strong>of</strong> genetic polymorphisms in<br />

GRIN2B and GABRG2 with epilepsy susceptibility. C.<br />

Chen, C. Hung, Y. Kao, H. Liou.<br />

2393F Interpreting the impact <strong>of</strong> mutations in SCN1A<br />

in the context <strong>of</strong> the most severe phenotypes amongst<br />

the generalized epilepsies with febrile seizures plus.<br />

M. Gonsales, P. Preto, M. A. Montenegro, M. M. Guerreiro,<br />

I. Lopes-Cendes.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


210 POSTER SESSIONS<br />

2394W Next-generation sequencing and mutation<br />

screening in patients with familial mesial temporal<br />

lobe epilepsy: Investigating the chromosome 18p11.31<br />

candidate locus. R. O. Santos, M. G. Borges, W. T. S.<br />

T. Ide, C. S. Rocha, R. Secolin, F. M. Artiguenave, C. L.<br />

Yasuda, A. C. Coan, M. E. Morita, F. Cendes, C. V. Maurer-<br />

Morelli, I. Lopes-Cendes.<br />

2395T Characterization <strong>of</strong> a GEFS� locus on<br />

6q16.3q22.31. P. Szafranski, G. Von Allmen, B. Graham,<br />

S. Fogarty, A. A. Wilfong, S.-H. L. Kang, J. A. Fereira,<br />

W. Bi, J. A. Rosenfeld, L. G. Shaffer, S. W. Cheung,<br />

P. Stankiewicz, S. R. Lalani.<br />

2396F Identifying disease genes in a large highly inbred<br />

consanguineous kindred from Turkey with idiopathic<br />

generalized epilepsy. F. N. Tuncer, S. A. Ugur Iseri, M.<br />

Calik, A. Iscan, G. Altiokka Uzun, U. Ozbek.<br />

2397W Haplotype sharing and linkage analyses <strong>of</strong><br />

multigenerational families with multiple sclerosis<br />

identified two chromosomal regions at 12p12.3-q12<br />

and 16q21-q22.3. N. Matsunami, J. Stevens, L. Baird, B.<br />

Otterud, T. Varvil, T. Leppert, J. W. Rose, M. F. Leppert.<br />

2398T Homozygosity mapping and exome sequencing<br />

identifies a gene on 11q24.2 for non-syndromic<br />

autosomal recessive intellectual disability in a<br />

Pakistani family. M. A. Rafiq, I. A. Balouch, K. Mittal, A.<br />

Mikhailov, M. Ayub, P. John, J. B. Vincent.<br />

2399F Investigation <strong>of</strong> inherited copy number<br />

variations in extended Asperger syndrome families.<br />

M. Rossi, K. Rehnström, O. Pietiläinen, V. Leppä, T.<br />

Hiekkalinna, T. Nieminen-von Wendt, J. Barrett, I. Hovatta,<br />

S. Ripatti, A. Palotie.<br />

2400W Gene analysis <strong>of</strong> familial and sporadic<br />

amyotrophic lateral sclerosis in Kyushu island <strong>of</strong><br />

Japan. H. Furuya, A. Watanabe, H. Arahata, Y. Kawano, N.<br />

Fujii, H. Kikuchi, T. Fujiwara, T. Hokonohara, A. Iwaki, H.<br />

Shibata, Y. Fukumaki.<br />

2401T Replication and generalization <strong>of</strong> genetic risk<br />

factors for depression, anxiety and panic attack in a<br />

population-based cohort with African, European and<br />

Mexican ancestries. J. N. Vega, K. Brown-Gentry, D. C.<br />

Crawford, T. A. Thornton-Wells.<br />

2402F Genome-wide genetic studies <strong>of</strong> two<br />

consanguineous Pakistani multiplex pedigrees with<br />

schizophrenia and bipolar disorder. L. Xiong, S. Zhou,<br />

M. Christian, S. Provost, G. Asselin, Q. Brohi, M. Denton,<br />

R. Joober, L. E. DeLisi, G. A. Rouleau.<br />

2403W A comprehensive genotype-phenotype study<br />

for CHRNA7 and CHRFAM7A in autism and intellectual<br />

disability. J. Ge, C. P. Schaaf, B. Zhang, A. L. Hall,<br />

M. Ali, S. Tinschert, U. Moog, A. Patel, P. Stankiewicz,<br />

A. L. Beaudet.<br />

2404T Genetic variant <strong>of</strong> AKT1 and AKTIP associated<br />

with risk for late-onset depression in a Brazilian<br />

population. P. Pereira, M. Romano-Silva, M. Bicalho, E.<br />

Moraes, L. Malloy-Diniz, R. Nicolato, G. Pimenta, M. Mello,<br />

I. Bozzi, D. Miranda.<br />

2405F Whole genome gene expression analysis <strong>of</strong><br />

patients with 22q11 deletion syndrome and controls.<br />

K. K. Mantripragada, S. Chawner, M. B. van den Bree,<br />

R. G. Thomas, L. Bates, M. J. Owen, N. M. Wiliams.<br />

2406W Fine-mapping <strong>of</strong> a region <strong>of</strong> interest in an<br />

extended family with multiple cases <strong>of</strong> autism. N. H.<br />

Chapman, K. Ankeman, R. Bernier, A. Estes, J. Munson,<br />

Z. Brkanac, W. Raskind, H. Coon, E. M. Wijsman.<br />

2407T Investigation <strong>of</strong> GWAS findings in schizophrenia<br />

in a case control and a family sample from Indonesia.<br />

D. B. Wildenauer, W. Qin, M. D. B. Wildenauer, A. A. A. A.<br />

Kusumawhardani, B. Benyamin, S. G. Schwab, Indonesia<br />

Schizophrenia <strong>Genetics</strong> Consortium.<br />

2408F Association analysis <strong>of</strong> mitochondrial DNA<br />

with suicidal behavior in schizophrenia. V. De Luca, A.<br />

Hassan, N. Hettige, C. Borlido, G. Polsinelli.<br />

2409W Application <strong>of</strong> whole genome resequencing to<br />

identify the causative gene for an autosomal recessive<br />

oculopharyngodistal myopathy. M. Taira, H. Ishiura, Y.<br />

Ichikawa, B. Ahsan, Y. Fukuda, J. Mitsui, Y. Takahashi, K.<br />

Higasa, J. Yoshimura, I. Nishino, J. Shimizu, S. Murayama,<br />

E. Uyama, S. Morishita, J. Goto, S. Tsuji.<br />

2410T Glucocerebrosidase mutations and dementia<br />

with Lewy bodies. L. Clark, K. Mirzozoda, J. H. Lee, R.<br />

Mayeux, L. S. Honig.<br />

2411F Both ISRE and GAS interferon regulatory<br />

sequences found in chromosome 21 genes that<br />

are important in brain development and function.<br />

A. Jagadeesh, J. Nagappa, K. Sampson, H. North, L.<br />

Gutman, P. Lenferna de la Motte, M. Sellers, I. Dhanoya,<br />

D. Elyaman, J. Husni, L. E. Maroun.<br />

2412W Genome-wide SNP analysis in a large<br />

consanguineous Turkish family reveals diagnosis as<br />

Unverricht-Lundborg disease. U. Ozbek, S. A. Ugur Iseri,<br />

F. N. Tuncer, I. Karacan, O. Ozdemir, G. Altiokka Uzun, M.<br />

Calik, A. Iscan.<br />

2413T CRHR2 differentially modulates anxious<br />

temperament and plasma cortisol in a rhesus<br />

macaque model <strong>of</strong> childhood anxiety. G. L. Fawcett,<br />

M. Raveendran, J. A. Oler, A. S. Fox, S. E. Shelton, N.<br />

H. Kalin, J. M. Cheverud, D. M. Muzny, R. A. Gibbs, J.<br />

Rogers.<br />

2414F Deregulation <strong>of</strong> neuronal cytoskeleton dynamics<br />

and androgen receptor gene pathways converge<br />

to aberrant synapse modulation in autism. K. Griesi<br />

Oliveira, D. Y. Sunaga, L. A. Cruz, E. Vadasz, M. R.<br />

Passos-Bueno.<br />

2415W Calcium channel genes are associated with<br />

autism spectrum disorders. A. Lu, X. Dai, R. M. Cantor.<br />

2416T X-chromosomal dystonia parkinsonism<br />

syndrome: Disease-specific sequence change DSC3<br />

<strong>of</strong> TAF1/DYT3 multiple transcript system affects<br />

dopamine metabolism, vesicular transport, and<br />

synapse function. U. Mueller, D. Nolte, A. H<strong>of</strong>mann, J.<br />

Schultze, T. Herzfeld.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2417F Identification <strong>of</strong> microduplications <strong>of</strong> the ATRX<br />

gene in autism spectrum disorders. B. A. Oliveira, I. C.<br />

Conceição, C. Correia, P. Jorge, R. Santos, C. Café, J.<br />

Almeida, S. Mouga, F. Duque, G. Oliveira, A. M. Vicente.<br />

2418W Alanyl-tRNA synthetase mutation in dominant<br />

distal hereditary motor neuropathy and Charcot-Marie-<br />

Tooth disease. H. Takashima, A. Hashiguchi, J. Hu, Z.<br />

Zhao, Y. Higuchi, Y. Sakiyama, S. Tokunaga, Y. Okamoto,<br />

A. Yoshimura.<br />

2419T Association <strong>of</strong> interleukin 6 gene polymorphisms<br />

with genetic susceptibilities to spastic tetraplegia in<br />

males: A case-control study. Q. Xing, M. Chen, T. Li, S.<br />

Lin, D. Bi, D. Zhu, Q. Shang, C. Ma, Q. Li, L. He, C. Zhu.<br />

2420F ADCYAP1R1 genotype associates with posttraumatic<br />

stress symptoms in highly-traumatized<br />

African <strong>American</strong> females. L. M. Almli, K. B. Mercer, H.<br />

Feng, K. N. Conneely, B. Bradley, K. J. Ressler.<br />

2421W EFHC2 shows female-specific association with<br />

autism. K. M. Tsang, Y. Cheng, J. F. Quinn, L. A. Weiss.<br />

2422T Ataxia with oculomotor apraxia type 2 in the<br />

Canadian aboriginal population: Expanding the disease<br />

distribution. E. R. Dola, J. N. Hartley, F. A. Booth, A. A.<br />

Mhanni.<br />

2423F Lamin B1 is a novel regulator <strong>of</strong> myelin and<br />

mediates cell-autonomous neuropathology in a murine<br />

model <strong>of</strong> autosomal dominant leukodystrophy. M. Y.<br />

Heng, L. J. Ptacek, Y. H. Fu.<br />

2424W Weight loss and low serum glucose levels in<br />

Machado-Joseph disease/spinocerebellar ataxia type<br />

3. L. B. Jardim, G. N. Souza, A. D. Russo, T. L. Monte, R.<br />

M. Castilhos, A. F. S. Schuh, K. C. Donis, R. D’Ávila, T. C.<br />

Gheno, G. V. Furtado, D. O. G. Souza, M. L. Saraiva-Pereira,<br />

L. V. C. Portela, C. R. M. Rieder, J. Dubois, J. A. M. Saute.<br />

2425T Spinocerebellar ataxias with hypogonadism:<br />

Unraveling a rare group <strong>of</strong> neuroendocrinologic<br />

syndromes. C. Lourenco, C. Sobreira, V. Cintra, R.<br />

Giugliani, W. Marques, Jr.<br />

2426F A neuronal cellular model <strong>of</strong> 22q11.2 DS exhibits<br />

disruptions to the miRNA regulatory pathway and may<br />

increase the rate <strong>of</strong> schizophrenia in individuals with<br />

22q11.2 DS. W. Manley, M. R. Ababon, P. G. Matteson,<br />

J. H. Millonig, L. M. Brzustowicz.<br />

2427W Analysis <strong>of</strong> aging phenotypes from long-term<br />

expression <strong>of</strong> the progeria mutation in the brain. J.<br />

Baek, E. Schmidt, S. Rodriguez, C. Strandgren, B. Rozell,<br />

E. Mugnaini, M. Eriksson.<br />

2428T Neurodegeneration and associated phenotypes<br />

in adults with 22q11.2 deletion syndrome. N. J. Butcher,<br />

T.-R. Kiehl, E. Chow, E. Rogaeva, A. E. Lang, A. S. Bassett.<br />

2429F CXCR4 (chemokine receptor) expression analysis<br />

in chronic cuprizone mouse model <strong>of</strong> multiple sclerosis.<br />

G. Celikyapi, T. Avsar, G. Terzioglu, S. Uyar Bozkurt, G.<br />

Yanikkaya Demirel, A. Siva, T. Altug, E. Tahir Turanli.<br />

POSTER SESSIONS 211<br />

2430W Increased error-related brain activity in youth<br />

with obsessive-compulsive disorder and unaffected<br />

siblings. G. Hanna, M. Carrasco, S. Harbin, J. Nienhuis,<br />

K. Fitzgerald, W. Gehring.<br />

2431T Bipolarity in children with dyslexia. C. C. Mignot,<br />

F. X. Coude.<br />

2432F Sequential processing deficit as a cognitive<br />

endophenotype in a multigenerational family with a<br />

severe speech sound disorder. B. Peter, K. Chapman,<br />

W. Raskind.<br />

2433W Investigation <strong>of</strong> the role <strong>of</strong> serotonin and<br />

histamine pathways in the etiology <strong>of</strong> Tourette’s<br />

syndrome. N. Sun, G. A. Heiman, L. Deng, M. Sheldon,<br />

J. C. Moore, A. J. Toro-Ramos, R. P. Hart, Z. Pang, J. A.<br />

Tischfield.<br />

2434T Is DS22q11.2 distal a frequent etiology <strong>of</strong><br />

mathematical learning disability? M. R. S. Carvalho, G.<br />

S. Vianna, L. F. S. Oliveira, B. C. Moreira, R. Sturzeneker,<br />

M. J. B. Aguiar, L. Leão, G. Paskulin, P. Zen, V. G. Haase.<br />

2435F DNA methylation alterations in first-episode<br />

schizophrenia patients: Comprehensive analysis using<br />

peripheral blood cells. M. Nishioka, M. Bundo, S. Koike,<br />

C. Kakiuchi, T. Araki, K. Kasai, K. Iwamoto.<br />

2436W Clinical and molecular genetic analysis in<br />

Ullrich congenital muscular dystrophy with dominant<br />

and recessive inheritance. B. Bozorgmehr, A.<br />

Kariminejad, S. Nafisi, U. Andoni, C. Gartioux, C. Ledevil,<br />

V. Allamand, P. Richard, M. Kariminejad.<br />

2437T Epigenomes landscaped by histone H3K9me3<br />

contribute to the pathology <strong>of</strong> Huntington’s disease. J.<br />

Shin, J. Lee, Y. Hwang, W. Lee, J. Wie, K. Kim, M. Lee, D.<br />

Hwang, R. Ratan, N. Kowall, I. So, J. Kim, H. Ryu.<br />

2438F Novel PRRT2 mutation in an African-<strong>American</strong><br />

family with paroxysmal kinesigenic dyskinesia. M. S.<br />

LeDoux, J. Xiao, P. Hedera, A. Puschmann, D. Momč ilović ,<br />

S. W. Wu.<br />

2439W Incomplete penetrance versus variable<br />

expressivity in del 16p11.2: analysis <strong>of</strong> cognitive<br />

performance and social functioning as quantitative<br />

rather than dichotomous traits. A. Moreno-De-Luca, S.<br />

M. Myers, T. D. Challman, D. W. Evans, R. P. Goin-Kochel,<br />

E. Hanson, R. Bernier, L. Green Snyder, J. E. Spiro, W. K.<br />

Chung, J. N. Constantino, D. H. Ledbetter.<br />

2440T How to best phenotype the broader autism<br />

phenotype in adults. T. Nishiyama, H. Kishino, K. Okada,<br />

S. Sakai, Y. Kamio, M. Suzuki, K. Adachi, S. Sumi, M.<br />

Kojima, S. Suzuki.<br />

2441F Executive dysfunction and bipolarity disorder in<br />

school-age children with academic impairment. F. X.<br />

Coude, C. C. Mignot.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


212 POSTER SESSIONS<br />

2442W Identification <strong>of</strong> a dosage-sensitive brain<br />

development gene within the critical region <strong>of</strong> 1q<br />

deletion syndrome. E. A. Erickson, W. A. Gahl, C.<br />

Boerkoel.<br />

2443T Results <strong>of</strong> genome-wide analyses on<br />

neurodevelopmental phenotypes at four-year follow-up<br />

following cardiac surgery in infancy. D. S. K. Kim, I. B.<br />

S. Stanaway, R. R. Rajagopalan, G. W. Wernovsky, J. B.<br />

Bernbaum, C. B. S. Solot, N. B. Burnham, E. Z. Zackai,<br />

R. R. C. Clancy, S. C. N. Nicolson, M. G. Gerdes, D. A.<br />

Nickerson, H. H. Hakonarson, J. W. G. Gaynor, G. P. Jarvik.<br />

2444F BrainSpan Atlas <strong>of</strong> the developing human brain.<br />

S. Sunkin, A. Bernard, T. Chen, C. Dang, S. Ding, A.<br />

Ebbert, O. Evgrafov, B. Fischl, M. Gerstein, D. Geschwind,<br />

A. Harmanci, J. Hohmann, S. Horvath, T. Hyde, A. Jones,<br />

Y. Kawasawa, R. Kitchen, J. Kleinman, P. Levitt, M. Li,<br />

S. Mane, N. Parikshak, A. Sboner, E. Shen, K. Smith, D.<br />

Weinberger, M. Hawrylycz, J. Knowles, N. Sestan, E. Lein.<br />

2445W Knockdown <strong>of</strong> putative human autism genes,<br />

SHANK3 and SYNGAP1, produces common behavioral<br />

phenotypes in zebrafish. J. E. Dallman, R. Kozol, Q. Yan,<br />

H. N. Cukier, V. Mayo, A. J. Griswold, P. L. Whitehead, J.<br />

L. Haines, J. R. Gilbert, M. L. Cuccaro, E. R. Martin, M. A.<br />

Pericak-Vance.<br />

2446T Short tandem repeat: A versatile marker in<br />

diagnosis <strong>of</strong> genetic disorders. S. Muthuswamy, A.<br />

Kumar, S. Agarwal.<br />

2447F Genomic rearrangements in idiopathic cerebral<br />

palsy. R. Segel, H. Ben-Pazi, S. Zeligson, A. Fattal-<br />

Valevski, A. Aran, V. Gross, N. Shneebaum, D. Shmueli, D.<br />

Lev, L. Blumkin, S. Perlberg, E. Levy-Lahad.<br />

2448W Gain <strong>of</strong> function Na v 1.7 mutations in patients<br />

with small fiber neuropathy. M. M. Gerrits, C. G. Faber,<br />

J. G. J. Hoeijmakers, D. M. L. Merckx, H. J. M. Smeets, S.<br />

D. Dib-Haij, S. G. Waxman, I. S. J. Merkies.<br />

2449T A new screening test for Fragile X syndrome:<br />

Quantitative measurement <strong>of</strong> FMRP in dried blood<br />

spots. W. T. Brown, T. Adayev, R. Kascsak, R. Kascsak, C.<br />

Dobkin, S. Nolin, G. LaFauci.<br />

2450F Disease specific pathway analysis in multiple<br />

sclerosis. T. Avsar, M. Durasi, S. Saip, O. U. Sezerman,<br />

A. Siva, E. Tahir Turanli.<br />

2451W Diagnosing complex neurological disease<br />

by next-generation sequencing. K. Haugarvoll, S.<br />

Johansson, C. Tzoulis, B. I. Haukanes, C. Bredrup, H.<br />

Boman, P. M. Knappskog, L. A. Bind<strong>of</strong>f.<br />

2452T Elevations <strong>of</strong> pro-inflammatory cytokines/<br />

chemokines in patients with Aicardi-Goutières<br />

syndrome. J. L. Schmidt, A. Takanohashi, M. Prust, K. F.<br />

Gold, J. Wang, H. Gordish-Dressman, G. Rice, H. Gornall,<br />

M. Bloom, Y. J. Crow, P. Lebon, K. Nagaraju, A. Vanderver.<br />

2453F Strategy for genotyping triplet repeats unstable<br />

sequences. S. Lindo_Samanamud, O. Ortega, M.<br />

Cornejo-Olivas, V. Marca, P. Mazzetti.<br />

2454W Cleavage and polyadenylation specificity factor<br />

1 regulates alternative splicing <strong>of</strong> interleukin 7 receptor<br />

exon 6. S. G. Gregory, I. Evsyukova, S. Bradrick, M. A.<br />

Garcia-Blanco.<br />

2455T Functional analysis <strong>of</strong> ASNS variant identified in<br />

progressive microcephaly and brain atrophy patients.<br />

Y. Hitomi, E. K. Ruzzo, D. L. Silver, Y. Anikster, D. B.<br />

Goldstein.<br />

2456F Impaired PPAR� function underlies<br />

mitochondrial demise and neurodegeneration<br />

in Huntington’s disease: Mechanistic basis and<br />

therapeutic implications. A. S. Dickey, V. V. Pineda, A.<br />

Buttgereit, M. M. Torres, T. Tsunemi, A. R. La Spada.<br />

2457W NHEJ1 deficiency causes abnormal<br />

development <strong>of</strong> the cerebral cortex. B. El Waly, E.<br />

Buhler, M. R. Haddad, F. Watrin, L. Villard.<br />

2458T KCTD13 is a major driver <strong>of</strong> mirrored<br />

neuroanatomical phenotypes associated with the<br />

16p11.2 copy number variant. C. Golzio, J. Willer, M.<br />

E. Talkowski, E. C. Oh, Y. Taniguchi, S. Jacquemont, A.<br />

Reymond, M. Sun, A. Sawa, J. S. Gusella, A. Kamiya, J. S.<br />

Beckmann, N. Katsanis.<br />

2459F miR-137 expression in schizophrenia and bipolar<br />

disorder brains. I. Guella, A. Sequeira, B. Rollins, F. Torri,<br />

M. P. Vawter, F. Macciardi.<br />

2460W Common gene co-expression network analysis<br />

in schizophrenia and bipolar disorder. S. Hong, X. Chen,<br />

L. Jin, M. Xiong.<br />

2461T Delusion-associated SNPs in NRG3 show<br />

regulatory potential, dysregulate NRG3 splicing and<br />

differentially bind to nuclear proteins. M. Zeledón,<br />

M. Taub, N. Eckart, R. Wang, M. Szymanski, P. Chen,<br />

A. Pulver, J. A. McGrath, P. Wolyniec, D. Avramopoulos,<br />

A. Sawa, D. Valle.<br />

2462F USF1 regulates sleep and circadian traits in<br />

humans. H. M. Ollila, K. M. Rytkönen, K. Silander,<br />

M. Perola, V. Salomaa, M. Härmä, S. Puttonen,<br />

T. Porkka-Heiskanen, T. Paunio.<br />

2463W Sodium channel mutations and epilepsy.<br />

J. E. O’Brien, M. H. Meisler.<br />

2464T Phosphorylation and regulation <strong>of</strong> FMRP.<br />

M. Santoro, S. Warren.<br />

2465F The cis-regulatory effect <strong>of</strong> an Alzheimer’s<br />

disease-associated polymorphic poly-T locus on<br />

expression <strong>of</strong> TOMM40 and APOE genes. O. Chiba-<br />

Falek, C. Linnertz, W. Gottschalk, D. Crenshaw, M. Lutz,<br />

J. Allen, S. Saith, M. Mihovilovic, L. Anderson, K. Welsh-<br />

Bohmer, A. Roses.<br />

2466W Apolipoprotein E �4 as a factor in the evaluation<br />

<strong>of</strong> the genetic risk <strong>of</strong> Alzheimer’s dementia in Filipinos.<br />

M. Daroy, C. Casingal, C. Mapua, D. Florendo, R. Matias,<br />

J. Dominguez, St. Luke’s Dementia Study Group.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2467T Functional testing <strong>of</strong> schizophrenia associated<br />

variants in NOS1AP. C. T. Ramirez, N. Wratten, Y. Huang,<br />

A. Dulencin, J. Millonig, V. J. Vieland, A. S. Bassett, L. M.<br />

Brzustowicz.<br />

2468F MIR137, a candidate gene for schizophrenia:<br />

identification <strong>of</strong> targets and downstream effects.<br />

A. L. Collins, R. J. Bloom, Y. Kim, P. F. Sullivan.<br />

2469W Schizophrenia mir137 risk genotype is<br />

associated with DLPFC hyperactivation. T. G. M. van<br />

Erp, I. Guella, M. P. Vawter, F. Torri, J. Fallon, F. Macciardi,<br />

S. G. Potkin.<br />

2470T A loss-<strong>of</strong>-function variant in the human histidyltRNA<br />

synthetase (HARS) gene is neurotoxic in vivo. A.<br />

Antonellis, A. Vester, G. Velez-Ruiz, H. M. McLaughlin, J.<br />

R. Lupski, K. Talbot, J. M. Vance, S. Zuchner, R. H. Roda,<br />

K. H. Fischbeck, L. G. Biesecker, G. Nicholson, A. A. Beg,<br />

NISC Comparative Sequencing <strong>Program</strong>, NIH.<br />

2471F Neuronal expression <strong>of</strong> FIG4 and<br />

neurodegeneration. G. M. Lenk, C. J. Ferguson,<br />

M. H. Meisler.<br />

2472W Global mapping <strong>of</strong> FUS-binding sites and global<br />

pr<strong>of</strong>iling <strong>of</strong> FUS-mediated RNA metabolisms in the<br />

mouse brain. K. Ohno, A. Masuda, S. Ishigaki, Y. Fujioka,<br />

Y. Iguchi, M. Katsuno, A. Shibata, F. Urano, G. Sobue.<br />

2473T Sortilin-related receptor 1 is associated with<br />

cognitive impairment in Filipinos. C. R. Casingal, M. L.<br />

G. Daroy, C. A. Mapua, D. J. A. Florendo, J. C. Dominguez,<br />

St. Luke’s Dementia Study Group.<br />

2474F Identifying neuropsychological and cognitive<br />

endophenotypes <strong>of</strong> schizophrenia-associated<br />

exonic variants <strong>of</strong> NPAS3 and COMT. L. M. Luoma,<br />

G. Macintyre, F. B. Berry, D. LaFreniere, S. Purser, A.<br />

Beierbach, P. Tibbo, D. W. Cox, S. Purdon.<br />

2475W Production <strong>of</strong> IL-6 is altered in primary human<br />

macrophages carrying 255Adel PARK2 gene variation. R.<br />

H. M. Sindeaux, A. C. Senegaglia, R. P. Munhoz, H. A. Teive,<br />

S. Raskin, M. M. A. Stefani, M. T. Mira, V. S. Sotomaior.<br />

2476T Broadening the role <strong>of</strong> FMRP targets across<br />

autism spectrum disorders. J. Steinberg, C. Webber.<br />

2477F Expanded hexanucleotide GGGGCC repeat<br />

RNA associated with ALS/FTD is sufficient to cause<br />

neurodegeneration. Z. Xu, M. Poidevin, H. Li, T. Wingo,<br />

P. Jin.<br />

2478W An integrated and systematic approach to<br />

autism pathway analysis. Z. Lin, S. J. Sanders, J. K.<br />

Lowe, D. H. Geschwind, M. State, H. Zhao.<br />

2479T RNA sequencing in iPSC-derived neurons<br />

identifies gene expression changes associated with<br />

22q11.2 microdeletion syndrome. Y. Tian, S. Pasca, J.<br />

Ou, A. Krawisz, J. BernsteinJon, J. Rapoport, J. Hallmayer,<br />

S. Horvath, M. Pellegrini, R. Dolmetsch, D. Geschwind,<br />

ACE <strong>Genetics</strong> Consortium.<br />

POSTER SESSIONS 213<br />

2480F The effects <strong>of</strong> inherited deletions on<br />

neurocognition in Canadian children with 22q11.2<br />

deletion syndrome. E. Chow, A. Ho, D. Young, S.<br />

Langlois, C. Cytrabaum, A. Rideout, S. Dyack.<br />

2481W Brain-derived neurotrophic factor (BDNF)<br />

Val66Met and adulthood chronic stress interact to<br />

affect depressive symptoms. R. Jiang, B. H. Brummett,<br />

M. A. Babyak, I. C. Siegler, R. B. Williams.<br />

2482T miRNA expression in the prefrontal cortex <strong>of</strong><br />

suicide completers. J. P. Lopez, R. Lim, B. Labonte, C.<br />

Cruceanu, J. P. Yang, V. Yerko, C. Ernst, N. Mechawar, P.<br />

Pavlidis, G. Turecki.<br />

2483F Distinct gene expression and DNA methylation<br />

perturbations in PTSD with severe child abuse versus<br />

no PTSD with no child abuse. D. Mehta, T. Klengel, K.<br />

N. Conneely, A. K. Smith, A. Altmann, M. Rex-Haffner, A.<br />

Loeschner, M. Gonik, K. B. Mercer, B. Bradley, B. Müller-<br />

Myshok, K. J. Ressler, E. B. Binder.<br />

2484W Frequency <strong>of</strong> polymorphisms <strong>of</strong> the alcohol<br />

dehydrogenase enzyme (ADH1B and ADH1C) and<br />

aldehyde dehydrogenase enzyme (ALDH) in the<br />

Brazilian population. G. P. M. Antonialli, B. Coprerski, R.<br />

M. Minillo, M. P. Migliavacca, D. Brunoni, A. B. A. Perez.<br />

2485T Serotonin transporter (SLC6A4) and receptor<br />

(5-HT2A) gene polymorphisms in healthy Brazilian<br />

individuals with diverse ethnic backgrounds. B.<br />

Coprerski, M. P. Micliavacca, A. B. A. Perez, A. P. P. Costa,<br />

D. Brunoni.<br />

2486F Regulatory effects <strong>of</strong> genes associated with<br />

schizophrenia. N. Eckart, R. Wang, J. McGrath, P.<br />

Wolyniec, M. Zeledòn, M. Szymanski, A. Pulver, D. Valle,<br />

D. Avramopoulos.<br />

2487W Genome-wide association study <strong>of</strong> 32,143<br />

individuals reveals several novel associations in<br />

schizophrenia. C. O’Dushlaine, S. Ripke, J. Moran, K.<br />

Chambert, P. Sklar, S. Purcell, C. Hultman, S. McCarroll,<br />

P. Sullivan, Swedish Schizophrenia Consortium.<br />

2488T Genome-wide association study reveals genes<br />

influencing the rate <strong>of</strong> cognitive decline among<br />

persons with Alzheimer’s disease are distinct from<br />

those associated with disease risk. R. Sherva, Y.<br />

Tripodis, D. Bennett, L. A. Chibnik, P. K. Crane, P. De<br />

Jager, L. B. Farrer, J. Shulman, R. C. Green.<br />

2489F Genome-wide scan for copy number variation<br />

association with age at onset <strong>of</strong> Alzheimer’s disease.<br />

K. Szigeti, D. Lal, Y. Li, R. Doody, K. Wilhelmsen, L.<br />

Yan, S. Liu, C. Ma, Texas Alzheimer Research and Care<br />

Consortium.<br />

2490W Utilizing eQTL networks to identify genes<br />

relevant to autism in the 16p11.2 region. Y. Cheng,<br />

W. Lauren.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


214 POSTER SESSIONS<br />

2491T A genomic instability model <strong>of</strong> autism: Global<br />

copy number burden associated with autism. N. Katiyar,<br />

S. Girirajan, A. Srikanth, K. H. Yeoh, S. J. Khoo,<br />

F. Tassone, R. Hansen, I. Hertz-Picciotto, E. E. Eichler,<br />

I. N. Pessah, S. B. Selleck, M. D. Ritchie.<br />

2492F The impact <strong>of</strong> glutamate and gammaaminobutyric<br />

acid receptor signaling in non-syndromic<br />

autism. A. Mohamed-Hadley, D. Hadley, Z. Wu, C. Kao,<br />

A. Kini, J. Glessner, R. Pellegrino, C. Kim, K. Thomas, H.<br />

Hakonarson, AGP Consortium.<br />

2493W Chromosome 15q11.2 is associated with<br />

schizophrenia risk in a set <strong>of</strong> patients. D. Rudd, M.<br />

Axelsen, S. Casey, S. Mugge, N. Andreasen, T. Wassink.<br />

2494T Genome-wide copy number analysis on<br />

schizophrenia in Han Chinese. E. Wong, A. W. Butler,<br />

Q. Wang, S. S. Cherny, T. Li, P. C. Sham.<br />

2495F Rare copy number variants in schizophrenia<br />

and bipolar disorder in a Latino population. C. Xu, A. N.<br />

Blackburn, S. Gonzalez, E. C. Villa, M. Ramirez, J. Zavala,<br />

M. Rodriguez, C. Camarillo, J. Ordonez, R. Armas, S. A.<br />

Contreras, R. J. Leach, D. Flores, D. Jerez, A. Ontiveros,<br />

H. Nicolini, D. Lehman, M. Escamilla.<br />

2496W Genome-wide copy number variation analysis<br />

<strong>of</strong> narcolepsy in the Japanese population. M. Yamasaki,<br />

T. Miyagawa, H. Toyoda, K. Seik Soon, A. Koike, T. Sasaki,<br />

Y. Honda, M. Honda, K. Tokunaga.<br />

2497T Integrating GWAS and protein-protein<br />

interaction network identifies a subnetwork implicated<br />

in alcohol dependence. S. Han, B. Z. Yang, H. Kranzler,<br />

F. Lindsay, H. Zhao, J. Gelernter.<br />

2498F APP associated with late-onset Alzheimer<br />

disease in autopsy-confirmed dataset. T. Montine, G. W.<br />

Beecham, R. Rajbhandary, K. L. Hamilton, A. C. Naj, E. R.<br />

Martin, R. Mayeux, J. L. Haines, L. Farrer, G. Schellenberg,<br />

M. A. Pericak-Vance, Alzheimer’s Disease <strong>Genetics</strong><br />

Consortium.<br />

2499W An association study comparing children with<br />

extreme high and extreme low obsessive-compulsive<br />

traits in the general population. P. D. Arnold, V. Sinopoli,<br />

J. Crosbie, L. Park, A. Dupuis, A. Paterson, R. J. Schachar.<br />

2500T Irish high-density schizophrenia families are<br />

enriched for common polygenic effects. T. B. Bigdeli,<br />

S. A. Bacanu, B. T. Webb, B. S. Maher, D. L. Thiselton, B.<br />

Wormley, F. A. O’Neill, D. Walsh, A. H. Fanous, B. P. Riley,<br />

K. S. Kendler.<br />

2501F Genome-wide association study for maternal<br />

effects in autism. S. Buyske, E. S. Stenroos, W. G.<br />

Johnson.<br />

2502W Analysis <strong>of</strong> putative pathogenic CNVs in autistic<br />

patients <strong>of</strong> Portuguese origin. I. C. Conceição, B. A.<br />

Oliveira, C. Correia, J. Coelho, C. Café, J. Almeida, S.<br />

Mouga, F. Duque, G. Oliveira, A. M. Vicente.<br />

2503T GWAS identifies biologically relevant SNP<br />

associations with sexual partnering behavior. J.<br />

Gelernter, H. R. Kranzler, R. Sherva, R. Koesterer, L.<br />

Almasy, H. Zhao, L. A. Farrer.<br />

2504F A genome-wide association study <strong>of</strong> alcohol<br />

dependence using a hybrid design. L. M. Hack, A.<br />

E. Adkins, B. T. Webb, B. S. Maher, D. G. Patterson, D.<br />

Walsh, C. A. Prescott, D. M. Dick, K. S. Kendler, B. P. Riley.<br />

2505W Genetic analysis <strong>of</strong> tobacco use in the Swedish<br />

Twin Registry: Genome-wide association studies <strong>of</strong><br />

cigarette and snus consumption. P. A. Lind, D. Cesarini,<br />

D. J. Benjamin, P. D. Koellinger, P. K. E. Magnusson, M.<br />

Johannesson, S. E. Medland.<br />

2506T Genome-wide association study for intracranial<br />

aneurysm in the Japanese population. S. Low, A.<br />

Takahashi, M. Kubo, Y. Nakamura.<br />

2507F Genome-wide association study identified<br />

susceptibility loci associated with nicotine dependence<br />

in a Japanese population. D. Nishizawa, K. Shinya, J.<br />

Hasegawa, N. Sato, F. Tanioka, H. Sugimura, K. Ikeda.<br />

2508W Genome-wide meta-analysis <strong>of</strong> autism<br />

spectrum disorders (ASD) supports A2BP1 as an ASD<br />

candidate gene. Y. S. Park, J. Jaworski, I. Konidari, P.<br />

Whitehead, M. L. Cuccaro, E. R. Martin, J. L. Haines, M. A.<br />

Pericak-Vance.<br />

2509T A polygenic analysis <strong>of</strong> autism, depression<br />

and schizophrenia risk alleles’ effect on reproductive<br />

fitness in the general population. R. A. Power, R. Uher,<br />

S. Ripke, C. M. Lewis, P. McGuffin, P. Lichtenstein, H.<br />

Wallum.<br />

2510F Maternal genetic effects on autism risk: Results<br />

from the Early Markers for Autism study. J. F. Quinn,<br />

L. C. Croen, L. W. Weiss.<br />

2511W Genome-wide pathway analysis in multiple<br />

cohorts implicates histone genes and inflammation<br />

in hippocampal atrophy. V. K. Ramanan, L. Shen, J. D.<br />

West, S. Kim, S. L. Risacher, K. Nho, Y. Wang, J. Wan, T.<br />

M. Foroud, L. A. Farrer, A. J. Saykin, Alzheimer’s Disease<br />

Neuroimaging Initiative.<br />

2512T Dissection <strong>of</strong> genetic architecture <strong>of</strong> bipolar<br />

disorder and schizophrenia: Results from a combined<br />

dataset <strong>of</strong> nearly 40,000 individuals. S. Ripke, D. M.<br />

Ruderfer, Psychiatric Genomics Consortium.<br />

2513F The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health and<br />

Aging: Genome-wide association study <strong>of</strong> anxiety<br />

disorders. L. Shen, T. H<strong>of</strong>fmann, M. Kvale, L. Sakoda, D.<br />

Ranatunga, L. Walter, S. Sciortino, D. Ludwig, Y. Banda, S.<br />

Hesselson, P. Kwok, R. Risch, C. Schaefer.<br />

2514W Genome-wide association <strong>of</strong> structural<br />

MRI data in a large, normally developing, pediatric<br />

population. P. M. A. Sleiman, T. Satterthwaite, K. Ruparel,<br />

C. Kim, R. Chiavacci, M. E. Calkins, R. C. Gur, R. E. Gur,<br />

H. Hakonarson.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2515T Gene-based analyses <strong>of</strong> attention deficit<br />

hyperactivity disorder GWAS data. I. D. Waldman, S.<br />

V. Faraone, Psychiatric Genomics Consortium: ADHD<br />

Subgroup.<br />

2516F Genome-wide association study <strong>of</strong> bipolar<br />

disorder with a history <strong>of</strong> binge eating. S. J. Winham,<br />

S. McElroy, S. Crow, M. Frye, C. Colby, D. Walker, D.-S.<br />

Choi, M. Chauhan, J. M. Biernacka.<br />

2517W Variation in genes related to cochlear biology<br />

is strongly associated with adult-onset deafness in<br />

Border Collies. J. S. Yokoyama, E. T. Lam, A. L. Ruhe, C.<br />

A. Erdman, K. R. Robertson, A. A. Webb, D. C. Williams,<br />

M. L. Chang, M. K. Hytonen, H. Lohi, S. P. Hamilton, M.<br />

W. Neff.<br />

2518T Genome-wide association study <strong>of</strong> Korean<br />

patients with autism spectrum disorder. H. Yoo, S. Kim,<br />

M. Park, I. Cho, S. Cho, B. Kim, J. Kim, S. Park, D. H.<br />

Geschwind, Y. Kwak, J. K. Lowe, Korean Autism Genetic<br />

Study Consortium.<br />

2519F Combined genome-wide association study <strong>of</strong><br />

Tourette syndrome and obsessive-compulsive disorder.<br />

D. Yu, TSAICG, IOCFGC, TS GWAS Consortium.<br />

2520W Genome-wide significant evidence <strong>of</strong><br />

association <strong>of</strong> a NUP153 missense variant with familial<br />

late-onset Alzheimer’s disease. A. R. Parrado, B. Hooli,<br />

K. Mullin, L. Gotta, M. Mattheisen, C. Lange, L. Bertram,<br />

R. E. Tanzi.<br />

2521T Beta-amyloid toxicity modifier genes and the<br />

risk <strong>of</strong> Alzheimer’s disease. S. L. Rosenthal, X. Wang,<br />

M. M. Barmada, F. Y. Demirci, O. L. Lopez, M. I. Kamboh.<br />

2522F WTCCC3 and GCAN: A genome-wide<br />

association scan <strong>of</strong> anorexia nervosa. V. Boraska, C.<br />

M. Bulik, D. A. Collier, P. F. Sullivan, E. Zeggini, Genetic<br />

Consortium for Anorexia Nervosa, Wellcome Trust Case<br />

Control Consortium 3.<br />

2523W Novel approach to genome wide association<br />

meta-analysis for bipolar disorder reveals network <strong>of</strong><br />

calcium channel and calcium signaling genes including<br />

epistatic effects. V. J. Vieland, K. A. Walters, K. Tobin, M.<br />

A. Azaro, A. Hare, Y. Huang, S.-C. Seok, T. Lehner, L. M.<br />

Brzustowicz.<br />

2524T Constructing a prediction model for bipolar<br />

disorder using genome-wide association dataset.<br />

L. Chuang, C. Kao, P. Kuo.<br />

2525F Involvement <strong>of</strong> the PTCHD1 gene in autism and<br />

intellectual disability. K. Mittal, K. Sritharan, J. Ross,<br />

A. Vaags, S. Scherer, A. Noor, J. Ellis, J. Vincent.<br />

2526W Genetic schizophrenia risk variants jointly<br />

modulate total brain and white matter volume. A. F.<br />

Terwisscha van Scheltinga, S. C. Bakker, N. E. M. van<br />

Haren, E. M. Derks, J. E. Buizer-Voskamp, H. B. M. Boos,<br />

W. Cahn, H. E. Hulsh<strong>of</strong>f Pol, S. Ripke, R. A. Oph<strong>of</strong>f, R. S.<br />

Kahn, Psychiatric GWAS Consortium.<br />

POSTER SESSIONS 215<br />

2527T PET scans with [ 11 C]Flumazenil demonstrate<br />

a downregulation <strong>of</strong> the GABA A receptor availability<br />

in fragile X syndrome patients. F. Kooy, I. Heulens, C.<br />

D’Hulst, N. Van der Aa, K. Van Laere.<br />

2528F �-Catenin is genetically and biologically<br />

associated with cortical cataract and future Alzheimerrelated<br />

structural and functional brain changes. G. Jun,<br />

J. A. Moncaster, C. Koutras, S. Seshadri, J. Buros, A. C.<br />

McKee, G. Levesque, P. A. Wolf, P. St. George-Hyslop, L.<br />

E. Goldstein, L. A. Farrer.<br />

2529W Genes, brain and cognition in Down syndrome.<br />

J. R. Korenberg, L. Dai, S. Gouttard, J. Edgin, L. Nadel,<br />

E. K. Jeong, J. Anderson, G. Gerig.<br />

2530T The non-invasive quantification <strong>of</strong> muscle<br />

degeneration in facioscapulohumeral muscular<br />

dystrophy with fast bound-pool fraction imaging:<br />

A 3.0T MRI study. H. R. Underhill, S. D. Friedman,<br />

V. L. Yarnykh, D. W. W. Shaw.<br />

2531F Neural cell adhesion gene variation and brain<br />

morphometry in Alzheimer’s disease. K. N. Holohan,<br />

S. L. Risacher, S. Swaminathan, J. D. West, M. Inlow, S.<br />

K. Conroy, V. Ramanan, T. Foroud, L. Shen, A. J. Saykin,<br />

Alzheimer’s Disease Neuroimaging Initiative.<br />

2532W Genetic interactions in focal adhesion and<br />

extracellular matrix pathways are associated with<br />

increase in ventricle size over time in the Alzheimer’s<br />

Disease Neuroimaging Initiative cohort. M. Koran, S.<br />

Meda, M. Sivley, T. Thornton-Wells.<br />

2533T Gene expression <strong>of</strong> GABA receptors and<br />

regulators in peripheral blood <strong>of</strong> a drug naïve firstepisode<br />

psychosis sample. V. K. Ota, C. S. Noto, A.<br />

Gadelha, M. L. Santoro, J. J. Mari, M. I. Melaragno, M. A.<br />

C. Smith, Q. Cordeiro, R. A. Bressan, S. I. Belangero.<br />

2534F Effect <strong>of</strong> DRD1 rs4532 polymorphism on<br />

treatment-resistant schizophrenia. L. .M. N. Spindola, V.<br />

K. Ota, A. Gadelha, A. F. Santos Filho, M. L. Santoro, D. M.<br />

Christ<strong>of</strong>olini, F. T. S. Bellucco, J. J. Mari, M. I. Melaragno,<br />

M. A. C. Smith, R. A. Bressan, S. I. Belangero.<br />

2535W Genetic risk factors (CHRNA5-CHRNA3-CHRNB4)<br />

and smoking cessation among hospitalized patients<br />

with acute myocardial infarction. L.-S. Chen, P. A. Lenzini,<br />

R. G. Bach, J. A. Spertus, L. J. Bierut, S. Cresci.<br />

2536T STXBP1 and KCNQ2 are mutated in the majority<br />

<strong>of</strong> patients having Ohtahara syndrome that does not<br />

evolve into West syndrome. M. Milh, C. Lacoste, J.<br />

Sutera-Sardo, S. Auvin, M.-A. Barthez, A. Kaminska, A.<br />

Roubertie, D. Ville, C. Badens, B. Chabrol, L. Villard.<br />

2537F Identification <strong>of</strong> LRRK2 p.G2019S disease<br />

modifiers. J. Trinh, D. Evans, C. Thompson, A. Donald, B.<br />

Shah, C. Szu Tu, F. Pishotta, C. Vilarino-Guell, R. Amouri,<br />

F. Hentati, R. Gibson, M. Farrer.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


216 POSTER SESSIONS<br />

2538W APOE and SNCA predict cognitive performance<br />

in Parkinson’s disease. I. Mata, J. Leverenz, J.<br />

Trojanowski, A. Siderowf, B. Ritz, S. Rhodes, S. Factor, C.<br />

Wood-Siverio, J. Quinn, K. Chung, A. Espay, F. Revilla, K.<br />

Edwards, T. Montine, C. Zabetian.<br />

2539T Abnormal responses to visual cortex activation in<br />

early stage Huntington disease patients using 31P-NMR<br />

spectroscopy. F. Mochel, T. M. Nguyen, D. Deelchand, D.<br />

Rinaldi, R. Valabregue, C. Wary, A. Durr, P. G. Henry.<br />

2540F Sympathovagal balance in major depressive<br />

disorder: Influence <strong>of</strong> the BDNF and 5-HTTLPR<br />

(serotonin transporter) polymorphisms. A. Perez,<br />

A. R. Brunoni, B. Coprerski, D. Brunoni.<br />

2541W Complex genetic scores can predict smoking<br />

cessation success and uptake <strong>of</strong> addictive substance<br />

use. G. Uhl, D. Sisto, D. Walther, W. Eaton, N. Ialongo, J.<br />

Rose.<br />

2542T Integrated copy number and gene expression<br />

analysis detects a CREB1 association with Alzheimer’s<br />

disease. N. Sule, Y. Li, I. Sheffer, C. Shaw, S. Powell,<br />

B. Dawson, S. Zaidi, K. Bucasas, J. Lupski, K. Wilhelmsen,<br />

R. Doody, K. Szigeti.<br />

2543F Genetic modifiers <strong>of</strong> EEG brain activity during<br />

sleep in humans. S. Warby, H. E. Moore IV, O. Carrillo,<br />

J. Faraco, L. Lin, P. E. Peppard, T. Young, E. Mignot.<br />

2544W The eQTLs in language-related genes reveal a<br />

gene x gene interaction between BDNF and PCDH17<br />

in the human brain. N. Li, S. Y. Cheong, M. Goode, S. A.<br />

Petrill, A. S. Bassett, L. M. Brzustowicz, C. W. Bartlett.<br />

2545T The KIAA0319 gene is associated with language<br />

progression more than its level. S. Tezenas du Montcel,<br />

B. Feng, C. Barr, B. Falissard, M. Boivin, G. Dionne.<br />

2546F Genome-wide association <strong>of</strong> executive function<br />

in a normally developing pediatric cohort. J. J.<br />

Connolly, P. M. A. Sleiman, R. C. Gur, M. E. Calkins, D. J.<br />

Abrams, R. M. Chiavacci, H. Qiu, F. D. Mentch, R. E. Gur,<br />

H. Hakonarson.<br />

2547W Lipidomic pr<strong>of</strong>iling in Lewy body disease brain<br />

autopsies carrying lysosomal storage disorder gene<br />

variants. N. Parmalee, R. B. Chan, N. Park, E. P. Cortes,<br />

J. P. Vonsattel, K. Marder, L. Honig, J. H. Lee, G. Di Paolo,<br />

L. Clark.<br />

2548T Study <strong>of</strong> plasma metabolites levels in discordant<br />

sibling pairs with autism. G. Malerba, R. Wang-Sattler,<br />

E. Trabetti, J. Adamski, P. Prandini, L. Xumerle, C. Zusi, A.<br />

Pasquali, R. Galavotti, P. F. Pignatti, T. Illig, Italian Autism<br />

Network.<br />

2549F Genome scan for cognitive trait loci <strong>of</strong> dyslexia:<br />

Rapid naming and rapid switching <strong>of</strong> colors, letters<br />

and numbers. W. H. Raskind, K. Rubenstein, M.<br />

Matsushita, V. W. Berninger, E. M. Wijsman.<br />

2550W Identification <strong>of</strong> genes and pathways regulated<br />

by epigenetic mechanisms in determining general<br />

intelligence (g) <strong>of</strong> inbred mice. P. Cha, K. Kobayashi, Y.<br />

Ando, C. Yu, S. Yamagata, K. Okada, J. Sese, K. Takao, T.<br />

Miyakawa, T. Toda.<br />

2551T Quantitative linkage analysis with the<br />

endophenotype <strong>of</strong> social responsiveness identifies<br />

genome-wide significant linkage to a narrow region at<br />

8p21.3. J. K. Lowe, D. M. Werling, J. N. Constantino, R. M.<br />

Cantor, D. H. Geschwind.<br />

2552F Nonpathogenic traits: A study <strong>of</strong> susceptibility<br />

to sympathetic yawning. E. T. Cirulli, A. J. Bartholomew,<br />

D. B. Goldstein.<br />

2553W Combined genetic analysis <strong>of</strong> DNA methylation<br />

and gene expression in schizophrenia identifies<br />

disease susceptibility loci. K. R. van Eijk, M. P. M. Boks,<br />

S. de Jong, E. Strengman, R. S. Kahn, S. Horvath, R. A.<br />

Oph<strong>of</strong>f.<br />

2554T Infantile-onset dystonia and juvenile<br />

parkinsonism associated with spastic paraplegia<br />

caused by mutations in SPG11. G. Yoon, B. Baskin, M.<br />

Tarnopolsky, P. Rebeiro, B. Banwell, P. N. Ray.<br />

2555F CNV detection from affymetrix axiom SNP chips<br />

in the early markers for autism study. G. Desachy, L. A.<br />

Croen, L. A. Weiss.<br />

2556W Prioritization <strong>of</strong> whole exome sequencing in<br />

Parkinson disease. J. Farlow, H. Lin, K. Hetrick, H. Ling,<br />

E. Pugh, K. Bowling, P. Jain, Y. Liu, K. Doheny, R. M.<br />

Myers, T. Foroud.<br />

2557T High yield <strong>of</strong> massively parallel sequencing<br />

in autosomal recessive intellectual disability in 23<br />

families: Identification <strong>of</strong> the causative mutation in<br />

12 families. R. Abou Jamra, R. Buchert, S. Uebe, H.<br />

Tawamie, S. H. Eck, E. Graf, K. Eberlein, J. Bauer, E. M.<br />

Dill, C. Blumentritt, F. F. Brockschmidt, M. M. Nöthen, J.<br />

Schumacher, A. Ekici, T. Strom, A. Reis.<br />

2558F Identification <strong>of</strong> rare variants in childhood<br />

onset schizophrenia using exome sequencing. A.<br />

Ambalavanan, S. L. Girard, J. Gauthier, L. Xiong, A.<br />

Dionne-Laporte, D. Spiegelman, E. Henrion, O. Diallo, A.<br />

Levert, P. A. Dion, J. Rapoport, R. Joober, G. A. Rouleau.<br />

2559W The Asp620Asn mutation <strong>of</strong> VPS35 in Japanese<br />

patients with typical Parkinson disease. M. Ando, M.<br />

Funayama, Y. Li, K. Kashihara, Y. Murakami, N. Ishizu, C.<br />

Toyoda, K. Noguchi, T. Hashimoto, N. Nakano, R. Sasaki,<br />

Y. Kokubo, S. Kuzuhara, K. Ogaki, C. Yamashita, H.<br />

Yoshino, H. Tomiyama, N. Hattori.<br />

2560T The Autism Sequencing Consortium: Autism<br />

gene discovery in .20,000 exomes. J. D. Buxbaum, M.<br />

J. Daly, B. Devlin, T. Lehner, K. Roeder, M. W. State for<br />

Autism Sequencing Consortium.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2561F Host genetic contribution to development<br />

<strong>of</strong> progressive multifocal leukoencephalopathy in<br />

the presence <strong>of</strong> immune suppression or immunemodulating<br />

drugs. J. P. Carulli, C. Sun, S. Szak, C. Organ,<br />

A. G. Day-Williams, C. Liu, H. H. Ackerman, T. Olsson,<br />

F. Piehl, P. Cinque, C. S. Tan, I. J. Koralnik, R. P. Viscidi,<br />

L. Gorelik, K. Simon, P. Duda, T. Harris, S. Bushnell,<br />

T. Compton.<br />

2562W Disruption <strong>of</strong> a large intergenic non-coding<br />

RNA in subjects with neurodevelopmental disabilities.<br />

C. Ernst, M. Talkowski, J. Gusella, C. Morton.<br />

2563T A rare haplotype containing two AKAP9<br />

missense mutations identified by whole-exome<br />

sequencing is associated with risk <strong>of</strong> Alzheimer<br />

disease in African <strong>American</strong>s. M. W. Logue, M. Schu,<br />

B. N. Vardarajan, J. Farrell, C. T. Baldwin, M. D. Fallin, L.<br />

A. Farrer.<br />

2564F Transposable elements in schizophrenia:<br />

evolutionary analysis and hypothesis for a functional<br />

role. F. Macciardi, M. Vawter, T. VanErp, F. Torri, B. Lerer,<br />

E. Osimo, J. A. Knowles, S. G. Potkin, C. Pato, M. Pato,<br />

S. Gaudi.<br />

2565W Whole-genome sequencing <strong>of</strong> 50 LRRK2 G2019S<br />

carriers discordant for Parkinson’s disease. C. Y.<br />

McLean, E. Drabant, E. Harrington, C. B. Do, N. Eriksson.<br />

2566T Cumulative mutation load in PDZ domains 4,<br />

5, and 6 <strong>of</strong> glutamate receptor interacting protein 2 in<br />

autism. T. Niranjan, A. Adamczyk, M. Han, R. Mejias, R.<br />

Rose, H. Bravo, M. Taub, C. Schwartz, D. Valle, R. Huganir,<br />

T. Wang.<br />

2567F Candidate genes for sleepwalking from exome<br />

sequencing in an autosomal-dominant family. B.<br />

Schormair, H. Slawik, B. Frauscher, T. Mitterling, E. Graf, T.<br />

Wieland, B. Högl, T. M. Strom, M. Wiegand, T. Meitinger, J.<br />

Winkelmann.<br />

2568W Rare variants in GWAS loci <strong>of</strong> restless legs<br />

syndrome. E. C. Schulte, F. Knauf, B. Schormair, P.<br />

Lichtner, C. Trenkwalder, B. Högl, B. Frauscher, K. Berger,<br />

I. Fietze, N. Gross, K. Stiasny-Kolster, M. Hornyak, W.<br />

Oertel, C. G. Bachmann, W. Paulus, A. Zimprich, A. Peters,<br />

C. Gieger, B. Müller-Myshok, T. Meitinger, J. Winkelmann.<br />

2569T Exome analysis for early-onset amyotrophic<br />

lateral sclerosis with autosomal recessive mode <strong>of</strong><br />

inheritance. Y. Takahashi, K. Higasa, S. Takagi, T. Kurita,<br />

H. Ishiura, J. Mitsui, Y. Fukuda, J. Yoshimura, T. L. Saito,<br />

S. Morishita, J. Goto, S. Tsuji.<br />

2570F Identification <strong>of</strong> candidate genes through<br />

analysis <strong>of</strong> copy number variation in autism families<br />

from Austria. J. B. Vincent, G. Egger, A. Lionel,<br />

H. Mahmood, A. Mikhailov, K. Roetzer, C. Windpassinger,<br />

W. Kaschnitz, S. W. Scherer, E. Petek.<br />

2571W Genetic and functional study <strong>of</strong> the disks largeassociated<br />

protein 2 (DLGAP2) gene as a candidate<br />

gene <strong>of</strong> schizophrenia. M. Cheng, J. Li, S. Luu, S. Hsu,<br />

T. Hu, H. Tsai, C. Chen.<br />

POSTER SESSIONS 217<br />

2572T Targeted sequencing reveals association <strong>of</strong> sets<br />

<strong>of</strong> rare variants in novel candidate genes as well as cell<br />

adhesion and GTPase regulatory pathways with autism<br />

spectrum disorder. A. J. Griswold, J. M. Jaworski, S. H.<br />

Slifer, D. J. Hedges, R. H. Chung, W. F. Hulme, I. Konidari,<br />

P. L. Whitehead, J. A. Rantus, A. R. Diaz, Y. M. Pasco, R.<br />

M. Tursi, S. M. Williams, R. Menon, M. L. Cuccaro, E. R.<br />

Martin, J. L. Haines, J. R. Gilbert, J. P. Hussman, M. A.<br />

Pericak-Vance.<br />

2573F Multiple hits in the neuregulin signaling pathway<br />

in schizophrenia. A. Hatzimanolis, J. McGrath, P.<br />

Wolyniec, V. K. Lasseter, G. Nestadt, R. Wang, T. Li, P.<br />

Wong, D. Valle, A. E. Pulver, D. Avramopoulos.<br />

2574W Discovery <strong>of</strong> rare variants <strong>of</strong> candidate<br />

genes related to nicotine dependence through deep<br />

sequencing. S. Wang, W.-Y. Cui, Z. Yang, J. Yang, J. Z.<br />

Ma, T. J. Payne, C. A. Hodgkinson, D. Goldman, M. D. Li.<br />

2575T Rare deletions at the gephyrin (GPHN) locus<br />

in autism spectrum disorder and schizophrenia. A.<br />

C. Lionel, A. K. Vaags, D. Sato, M. J. Gazzellone, H. Y.<br />

Chen, G. Costain, G. Egger, S. Walker, A. Prasad, C. R.<br />

Marshall, E. B. Mitchell, C. Windpassinger, J. B. Vincent,<br />

B. A. Fernandez, S. Kirmani, J. C. Hodge, A. S. Bassett, S.<br />

W. Scherer.<br />

2576F Reciprocal duplication <strong>of</strong> the Williams-Beuren<br />

syndrome deletion on chromosome 7q11.23 is<br />

associated with schizophrenia. J. G. Mulle, A. E. Pulver,<br />

J. M. McGrath, P. Wolyniec, A. F. Dodd, D. J. Cutler, J.<br />

Sebat, D. Malhotra, G. Nestadt, D. F. Conrad, C. P. Barnes,<br />

M. Hurles, M. Ikeda, N. Iwata, D. Levinson, P. V. Gejman,<br />

A. R. Sanders, J. Duan, A. A. Mitchell, I. Peter, P. Sklar, C.<br />

T. O’Dushlaine, D. Grozeva, M. C. O’Donovan, M. J. Owen,<br />

C. M. Hultman, A. K. Kähler, P. F. Sullivan, G. Kirov, S. T.<br />

Warren, Molecular <strong>Genetics</strong> <strong>of</strong> Schizophrenia Consortium.<br />

2577W Assessing the impact <strong>of</strong> different types <strong>of</strong> de<br />

novo rare variation in whole-exome sequenced autism<br />

spectrum disorders trio families. D. Pinto, M. Fromer,<br />

A. Goldberg, S. M. Purcell, P. Sklar, E. Boerwinkle, M. J.<br />

Daly, B. Devlin, E. H. Cook, K. Roeder, R. A. Gibbs, G. D.<br />

Schellenberg, J. S. Sutcliffe, M. W. State, J. D. Buxbaum<br />

on behalf <strong>of</strong> ARRA Autism Sequencing Consortium and<br />

Autism Sequencing Consortium.<br />

2578T Etiologic rare variants in autism multiplex<br />

families: Exome and CNVs analyses. C. Toma, A. Tristán,<br />

A. Hervás, B. Torrico, R. Valdés-Mas, N. Balmaña, M.<br />

Maristany, X. S. Puente, M. Bayés, B. Cormand.<br />

2579F Utility <strong>of</strong> a comprehensive multi-gene testing<br />

panel for epilepsy and evaluation <strong>of</strong> the expectations<br />

for whole exome sequencing in these disorders.<br />

G. Richard, E. Butler, D. McKnight, K. Retterer, A.<br />

Shanmugham, R. Rubenstein, K. Hruska, E. Haverfield, S.<br />

Aradhya.<br />

2580W Rare variants within PAX6 enhancer elements<br />

are enriched in rolandic epilepsy. L. Addis, T. Chiang,<br />

A. Derkach, S. Newhouse, S. Dobbins, I. Tomlinson, R.<br />

Houlston, L. J. Strug, D. K. Pal.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


218 POSTER SESSIONS<br />

2581T Mutations in the novel protein PRRT2 cause<br />

paroxysmal kinesigenic dyskinesia with infantile<br />

convulsions. H.-Y. Lee, Y. Huang, N. Bruneau, M.<br />

Hermann, E. Quinn, J. Maas, R. Edwards, K. Bhatia, M. K.<br />

Bruno, H. Houlden, J. Jankovic, W. Lee, U. Müller, B.-W.<br />

Soong, K. J. Swoboda, N. Wood, M. Hanna, A. Bowcock,<br />

P. Szepetowski, Y.-H. Fu, L. J. Ptacek.<br />

2582F Identification <strong>of</strong> rare variants under an<br />

alcoholism susceptibility linkage peak in a COGA<br />

family using whole exome sequencing. M. Kapoor, J.<br />

Wang, A. Hinrichs, S. Bertelsen, J. Budde, A. Agrawal, J.<br />

Tischfield, L. Almasy, M. Schuckit, L. Bierut, A. Goate.<br />

2583W Deep resequencing <strong>of</strong> 9 confirmed late-onset<br />

Alzheimer disease loci identifies multiple genomic<br />

regions with potentially functional variants. J. R.<br />

Gilbert, A. C. Naj, L. Wang, M. A. Kohli, K. L. Hamilton, R.<br />

Rajbhandary, P. L. Whitehead, R. M. Carney, B. Levin, E.<br />

A. Crocco, C. B. Wright, G. W. Beecham, E. R. Martin, S.<br />

Zuchner, J. L. Haines, M. A. Pericak-Vance.<br />

2584T Whole exome sequencing in childhood-onset<br />

schizophrenia. K. Ahn, H. Sung, T. Anderson, Y. Yao, J.<br />

Rapoport.<br />

2585F Complete genome sequence based genetic<br />

analysis <strong>of</strong> monozygotic twins discordant for<br />

schizophrenia. C. Castellani, R. O’Reilly, S. Singh.<br />

2586W Exome sequencing <strong>of</strong> extended pedigrees<br />

with late-onset Alzheimer disease identifies TTC3 as<br />

a candidate gene for AD. K. Hamilton, M. A. Kohli, A.<br />

C. Naj, R. Rajbhandary, T. Plitnik, K. John-Williams, P. L.<br />

Whitehead, J. R. Gilbert, E. R. Martin, G. W. Beecham, J.<br />

L. Haines, S. Zuchner, M. A. Pericak-Vance.<br />

2587T Exome sequencing reveals de novo gene<br />

disruptions in children on the autistic spectrum. I.<br />

Iossifov, M. Ronemus, D. Levy, Z. Wang, I. Hakker, J.<br />

Rosenbaum, B. Yamrom, Y. Lee, G. Narzisi, A. Leotta, J.<br />

Kendall, E. Grabowska, B. Ma, L. Rodgers, J. Troge, P.<br />

Andrews, E. Ghiban, J. Parla, R. Demeter, L. L. Fulton, R.<br />

S. Fulton, V. J. Magrini, K. Ye, J. C. Darnell, R. B. Darnell,<br />

E. R. Mardis, R. K. Wilson, M. C. Schatz, W. R. McCombie,<br />

M. Wigler.<br />

2588F Secretin receptor and the associated molecular<br />

processes relevant to autism spectrum disorder. K.<br />

Kojima, T. Yamagata, A. Matsumoto, M. Saito, E. F. Jimbo,<br />

M. Y. Momoi.<br />

2589W Exome sequencing <strong>of</strong> multiplex, schizophrenic<br />

families implicate variants from chromosome 5q in<br />

neurocognitive performance. M. Z. Kos, M. A. Carless,<br />

J. Peralta, E. E. Quillen, R. C. Gur, M. F. Pogue-Geile,<br />

K. Prasad, J. Blangero, V. L. Nimgaonkar, R. E. Gur, L.<br />

Almasy.<br />

2590T Mining for rare genetic variation underlying<br />

psychiatric disorders using family-based sequencing.<br />

S. McCarthy, J. Badner, D. Morris, M. Ayub, M. Kramer, D.<br />

Blackwood, A. Corvin, W. Byerley, W. R. McCombie.<br />

2591F Identification <strong>of</strong> the causative gene for SPG27<br />

by exome capture. A. Noreau, I. A. Meijer, S. L. Girard, D.<br />

Spiegelman, A. Szuto, P. Cossette, P. A. Dion, G. A. Rouleau.<br />

2592W DEC2 gene mutations associated with distinct<br />

sleep phenotypes and sleep length. R. Pellegrino, I.<br />

H. Kavakli, N. Goel, C. Cardinale, D. Dinges, S. Tufik, J.<br />

Hogenesh, A. Pack, H. Hakonarson.<br />

2593T Common and rare variants in obsessivecompulsive<br />

disorder identified by exome and targeted<br />

resequencing. D. Trujillano, S. Ossowski, P. Alonso, C.<br />

Tornador, J. M. Menchón, M. Gratacòs.<br />

2594F Deep whole genome sequencing in 18 Irish<br />

individuals with schizophrenia. B. T. Webb, E. Loken,<br />

T. B. Bigdeli, B. Wormley, F. A. O’Neill, D. Walsh, K. S.<br />

Kendler, B. P. Riley.<br />

2595W The genetic architecture <strong>of</strong> severe nonsyndromic<br />

sporadic intellectual disability. T. Wieland, D.<br />

Wieczorek, E. Graf, S. Endele, T. Schwarzmayr, J. Beygo,<br />

N. Di Donato, A. Dufke, M. Hempel, D. Horn, P. Joset, A.<br />

Röpke, U. Moog, E. Wohlleber, C. Zweier, A. B. Ekici, A.<br />

M. Zink, A. Rump, C. Meisinger, H. Grallert, H. Sticht, A.<br />

Schenck, H. Engels, G. Rappold, P. Wieacker, O. Riess, T.<br />

Meitinger, A. Reis, T. M. Strom, A. Rauch.<br />

2596T A spectrum <strong>of</strong> mutations in 12 PLP1-related<br />

disorders in patients from SARAH network <strong>of</strong><br />

rehabilitation hospitals in Brazil. S. C. L. Santos, D. R.<br />

Carvalho, R. I. Takata, C. E. Speck-Martins.<br />

2597F Association between the NMDA receptor<br />

subunit 2B gene (GRIN2B) gene and Alzheimer’s<br />

disease. F. Trecroci, R. Cittadella, M. Liguori, F. Condino,<br />

P. Spadafora, E. V. De Marco, G. Di Palma, V. Andreoli.<br />

2598W Rare missense variants in CHRNA5 and<br />

CHRNB3 are associated with increased risk <strong>of</strong> alcohol<br />

and cocaine dependence. G. Haller, J. Budde, M.<br />

Kapoor, A. Agrawal, H. Edenberg, J. Kramer, L. Bierut, A.<br />

Goate.<br />

2599T Excess <strong>of</strong> rare variants from targeted<br />

resequencing <strong>of</strong> the NKAPL gene in schizophrenia.<br />

E. K. Loken, D. Brohawn, D. Walsh, F. A. O’Neill, K. S.<br />

Kendler, B. P. Riley.<br />

2600F Exome sequencing <strong>of</strong> singleton trios and quads<br />

to reveal de novo mutations in schizophrenia. A. C.<br />

Watts, T. Walsh, M. K. Lee, S. Gulsuner, A. M. Thornton, J.<br />

McClellan, M. C. King, Genes in Schizophrenia (GENESIS)<br />

Consortium.<br />

2601W Novel missense mutations and partial<br />

deficiency <strong>of</strong> collagen VI in Ullrich congenital muscular<br />

dystrophy. J. Yuan, I. Higuchi, Y. Sakiyama, Y. Inamori,<br />

E. Matsuura, Y. Higuchi, A. Yoshimura, A. Hashiguchi, K.<br />

Higashi, Y. Koreeda, K. Arimura, H. Takashima.<br />

2602T Searching for the genes <strong>of</strong> Tourette’s: The<br />

Tourette International Collaborative <strong>Genetics</strong> Study. G.<br />

A. Heiman, T. V. Fernandez, P. J. Hoekstra, A. Dietrich, R.<br />

A. King, M. W. State, J. A. Tischfield, TIC <strong>Genetics</strong> Team.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2603F Evidence for involvement <strong>of</strong> EIF4G1, not VPS35<br />

variations in Parkinson disease. J. Vance, K. Nuytemans,<br />

G. Bademci, V. Inchausti, S. Zuchner, A. Dressen, C.<br />

Jauregio, D. D. Kinnamon, A. Mehta, Y. Pasco, A. Aviram, A.<br />

Diaz, L. Wang, F. Nahab, C. Singer, W. Hulme, I. Konidari, Y.<br />

Edwards, G. Beecham, E. R. Martin, W. K. Scott.<br />

2604W Revealing the complex nature <strong>of</strong> a monogenic<br />

disease: Exome sequencing <strong>of</strong> Rett syndrome. F. Ariani,<br />

M. A. Mencarelli, E. Grillo, L. Bianciardi, I. Meloni, C. Di<br />

Marco, C. Lo Rizzo, F. Mari, A. Renieri.<br />

2605T De novo indels in autism spectrum disorders. S.<br />

Dong, S. Sanders, A. J. Willsey, M. Murtha, N. DiLullo, L.<br />

Wei, M. State.<br />

2606F Resequencing and promoter methylation<br />

analysis <strong>of</strong> the dopamine D2 receptor gene in<br />

schizophrenia. Y. Chuang, M. Cheng, C. Lu, M. Tsai, Y.<br />

Shen, S. Hsu, C. Chen.<br />

2607W A comprehensive genetic analysis <strong>of</strong> 421<br />

Japanese patients with Charcot-Marie-Tooth<br />

disease using DNA microarray chips. A. Hashiguchi,<br />

A. Yoshimura, Y. Higuchi, T. Nakamura, S. Tokunaga, Y.<br />

Okamoto, H. Takashima.<br />

2608T A new frameshif mutation in the dopamine<br />

receptor D4 exon III VNTR 7-repeat allele. D. S. S. Lobo,<br />

M. Tampakeras, N. Freeman, J. L. Kennedy.<br />

2609F SPG4 mutations in Brazilian patients with<br />

hereditary spastic paraplegia. I. Lopes-Cendes, D. B.<br />

Dogini, C. Cartaxo, S. Raskin, H. A. G. Teive, J. Saute, L.<br />

B. Jardim, M. C. França, Jr.<br />

2610W Changes in the human transcriptome caused by<br />

LMNB1 duplication in a case <strong>of</strong> autosomal dominant<br />

leukodystrophy: An RNA-seq study. P. Cherukuri, D.<br />

Simeonov, K. Fuentes-Fajardo, P. Zumbo, C. Mason, S.<br />

Lin, Y. H. Fu, C. Boerkoel, T. Markello, W. Gahl, C. Toro.<br />

2611T Exome sequencing <strong>of</strong> young onset sporadic<br />

amyotrophic lateral sclerosis trios. A. E. Renton, J. R.<br />

Gibbs, J. O. Johnson, M. A. Nalls, C. Sassi, Y. Abramzon,<br />

C. Edsall, G. Restagno, M. Sabatelli, A. Chiò, B. J. Traynor.<br />

2612F PRRT2 gene missense mutations account for<br />

both paroxysmal kinesigenic dyskinesia and infantile<br />

convulsions in a Chinese pedigree. C. Cai, W. D. Li.<br />

2613W Whole-exome sequencing and homozygosity<br />

analysis to dissect autism, a complex genetic disorder.<br />

M. H. Chahrour, T. W. Yu, E. T. Lim, B. Ataman, M. E.<br />

Coulter, R. S. Hill, C. R. Stevens, C. R. Schubert, ARRA<br />

Autism Sequencing Collaboration, M. E. Greenberg, S. B.<br />

Gabriel, C. A. Walsh.<br />

2614T Gene-based rare variant analyses reveal loci<br />

associated with autism spectrum disorder. N. Dueker,<br />

E. R. Martin, A. J. Griswold, H. N. Cukier, S. Slifer, J.<br />

Jaworski, I. Konidari, P. L. Whitehead, M. Schmidt, D.<br />

J. Hedges, D. Martinez, S. Clarke, M. L. Cuccaro, J. R.<br />

Gilbert, J. L. Haines, M. A. Pericak-Vance.<br />

POSTER SESSIONS 219<br />

2615F Data sharing in the genomic age: Genome<br />

Variant Database for Neuromuscular Diseases. M.<br />

Gonzalez, R. F. Acosta Lebrigio, S. Zuchner.<br />

2616W X-linked Charcot-Marie-Tooth disease type 1<br />

in Japan: Genetic, clinical, and electrophysiological<br />

study <strong>of</strong> 33 cases. Y. Higuchi, A. Yoshimura, T.<br />

Nakamura, S. Tokunaga, A. Hashiguchi, Y. Okamoto, H.<br />

Takashima.<br />

2617T De novo mutations in autism spectrum disorders<br />

revealed by whole genome sequencing. Y. Jiang, X. Jin,<br />

J. Yu, R. K. Yuen, D. Cao, M. Wang, S. Walker, L. Lau, D.<br />

Merico, Y. Shi, Q. Xu, B. Zhou, Z. Hu, B. Cheng, N. Chen,<br />

J. Mei, K. Xia, X. Xu, Y. Wang, Y. Wu, J. Wang, J. Wang,<br />

C. Lajonchere, G. Dawson, H. Yang, A. Shih, B. Devlin, Z.<br />

Sun, S. W. Scherer, Y. Li.<br />

2618F Analysis <strong>of</strong> low-frequency, protein altering<br />

variation in 13,000 individuals from a Swedish<br />

schizophrenia cohort on the exome array. B. M. Neale,<br />

J. Goldstein, C. O’Dushlaine, M. Fromer, G. Genovese, J.<br />

L. Moran, K. Chambert, C. M. Hultman, P. Sklar, S. Purcell,<br />

M. J. Daly, P. F. Sullivan, S. McCarroll.<br />

2619W Search for rare-variant risks <strong>of</strong> Parkinson’s<br />

disease by sequencing <strong>of</strong> candidate genes and exome<br />

sequencing. W. Satake, Y. Suzuki, Y. Ando, T. Nishioka, K.<br />

Syoji, H. Tomiyama, M. Yamamoto, M. Murata, N. Hattori,<br />

S. Sugano, T. Toda.<br />

2620T Rare combination <strong>of</strong> inherited mutations<br />

in a large multigenerational pedigree with autism<br />

spectrum disorder and co-morbid neurodevelopmental<br />

disorders. P. Szatmari, O. Migita, I. O’Connor, A. Prasad,<br />

D. Sato, S. Walker, A. Thompson, S. W. Scherer, D. Pinto.<br />

2621F Resequencing <strong>of</strong> 17 genes in the N-methyl-Daspartate<br />

glutamate system to identify rare variants<br />

affecting risk <strong>of</strong> substance dependence. P. Xie, H. R.<br />

Kranzler, J. H. Krystal, L. A. Farrer, H. Zhao, J. Gelernter.<br />

2622W Widespread novel RNA editing in human brain<br />

tissue, identified by RNA-seq. L. Hou, N. Akula, J.<br />

Wendland, D. T. Chen, X. Jiang, K. Choi, B. K. Lipska, J. E.<br />

Kleinman, F. J. McMahon.<br />

2623T Association <strong>of</strong> the polymorphisms <strong>of</strong> ITPK1 gene<br />

in inositol metabolic pathways with NTDs. Z. Guan, J.-<br />

H. Wang, J. Guo, F. Wang, X.-W. Wang, G.-N. Li, Q. Xie, X.<br />

Han, B. Niu, T. Zhang.<br />

2624F High apolipoprotein E4 allele frequency in FXTAS<br />

patients. M. Mila, F. Silva, I. Madrigal, M.-I. Alvarez-Mora,<br />

R. Oliva, L. Rodriguez-Revenga.<br />

2625W Generation and characterization <strong>of</strong> induced<br />

pluripotent stem cells from patients with the<br />

autosomal dominant disorder spinocerebellar ataxia<br />

type 1. N. Mollema, A. Shanmugam, E. Leathley, D.<br />

Kaufman, H. T. Orr.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


220 POSTER SESSIONS<br />

2626T Quality <strong>of</strong> life in Machado-Joseph disease/<br />

spinocerebellar ataxia type 3 is related to depressive<br />

and extracerebellar disease features. J. A. Saute, R.<br />

D’Ávila, R. M. Castilhos, T. L. Monte, A. F. S. Schuh, K.<br />

C. Donis, G. N. Souza, A. D. Russo, T. C. Gheno, G. V.<br />

Furtado, M. L. Saraiva-Pereira, C. R. M. Rieder, L. B.<br />

Jardim.<br />

2627F A health non penetrant pedigree derives from a<br />

late onset Parkinsonism founder index case with SCA2<br />

and SCA8 expansions. V. Volpini, H. San Nicolas, J.<br />

Corral, L. De Jorge, B. Campos.<br />

2628W Impaired TFEB signaling accounts<br />

for autophagy pathway dysfunction in the<br />

neurodegenerative proteinopathy X-linked spinal and<br />

bulbar muscular atrophy. C. Cortes, Y. Batlevi, J. E.<br />

Young, H. Frankowski, B. L. Sopher, G. A. Garden, A. R.<br />

La Spada.<br />

2629T The histone demethylase KDM5C gene is a<br />

direct target <strong>of</strong> the ARX homeobox transcription<br />

factor. L. Poeta, F. Fusco, D. Drongitis, C. Shoubridge,<br />

G. Manganelli, A. Padula, S. Filosa, M. Courtney, P.<br />

Collombat, M. B. Lioi, J. Gecz, M. V. Ursini, M. G. Miano.<br />

2630F 15q11.2 Microdeletion and FMR1 premutation<br />

in a family with intellectual disabilities and autism. L.<br />

Rodriguez-Revenga, I. Madrigal, M. Mila.<br />

2631W FRAXE molecular diagnosis in individuals<br />

referred for FRAXA screening. A. Javed, G. Ali, L.<br />

Caicedo, I. Marques, R. Santos, P. Jorge.<br />

2632T An isogenic, epi-isoautosomal fibroblast<br />

model to investigate FMR1 premutation-associated<br />

cellular dysfunction. K. A. Koscielska, S. Roenspie, P. J.<br />

Hagerman.<br />

2633F Formation <strong>of</strong> an R-loop at the FMR1 5’UTR:<br />

Unraveling the extra thread <strong>of</strong> FMR1 expression. E. W.<br />

Loomis, F. L. Chédin, P. J. Hagerman.<br />

2634W The role <strong>of</strong> AGG interruptions, alternative<br />

splicing and bidirectional transcription in the stability<br />

and function <strong>of</strong> the FMR1 gene. C. M. Yrigollen, H. Tang,<br />

E. Loomis, G. Filippova, P. J. Hagerman, F. Tassone.<br />

2635T MutL� is required to repair short slipped-DNAs<br />

<strong>of</strong> trinucleotide repeats. G. Panigrahi, M. Slean, J.<br />

Simard, C. Pearson.<br />

2636F Regional alterations <strong>of</strong> transcriptome-wide<br />

AGO:miRNA binding pr<strong>of</strong>iles in Huntington’s disease<br />

patient brains. R. L. Boudreau, P. Jiang, B. L. Gilmore, Y.<br />

Xing, B. L. Davidson.<br />

2637W Large repeat expansions in the C9ORF72<br />

gene contribute to a spectrum <strong>of</strong> neurodegenerative<br />

disorders including Alzheimer disease. M. A. Kohli,<br />

K. John-Williams, R. Rajbhandary, A. Naj, P. Whitehead,<br />

K. Hamilton, R. M. Carney, C. Wright, E. Crocco, H. E.<br />

Gwirtzman, R. Lang, G. Beecham, E. R. Martin, J. Gilbert,<br />

M. Benatar, G. W. Small, D. Mash, G. Byrd, J. L. Haines,<br />

M. A. Pericak-Vance, S. Züchner.<br />

2638T C9ORF72 repeat expansions are a genetic cause<br />

<strong>of</strong> parkinsonism. S. Lesage, I. Le Ber, C. Condroyer,<br />

E. Broussolle, A. Gabelle, S. Thobois, A. Durr, A. Brice,<br />

Parkinson’s Disease <strong>Genetics</strong> Study Group.<br />

2639F Autosomal dominant family history is a highly<br />

sensitive but not exclusive indicator <strong>of</strong> pathogenic<br />

C9ORF72 expansions in frontotemporal dementia and<br />

amyotrophic lateral sclerosis. J. C. Fong, S. J. Sha, L.<br />

Takada, K. J. Rankin, J. S. Yokoyama, N. J. Rutherford,<br />

A. M. Karydas, B. K. Khan, M. C. Baker, M. DeJesus-<br />

Hernandez, M. Pribadi, G. Coppola, D. H. Geschwind, R.<br />

Rademakers, A. L. Boxer, B. L. Miller.<br />

2640W Walking down the molecular pathogenic road <strong>of</strong><br />

ARX polyalanine tract expansions: Where do they part?<br />

C. Shoubridge, K. P. Y. Lee, T. Mattiske, J. Gécz.<br />

2641T Copy number variation <strong>of</strong> the neuronal glucose<br />

transporter 3 and age <strong>of</strong> onset in Huntington’s disease.<br />

A. Vittori, C. Breda, M. Repici, T. F. Outeiro, F. Giorgini, E.<br />

J. Hollox, REGISTRY Investigators <strong>of</strong> EHDN.<br />

2642F Spinocerebellar ataxias in Brazil: Frequencies<br />

and potential modifiers <strong>of</strong> phenotype. R. M. Castilhos,<br />

P. Schaeffer, T. C. Gheno, G. V. Furtado, K. C. Donis, O.<br />

Barsottini, J. L. Pedroso, D. Z. Salarini, F. R. Vargas, M.<br />

A. F. D. Lima, C. Godeiro, L. C. S. Silva, M. B. P. Toralles,<br />

H. Y. Wanderley, P. F. V. Medeiros, S. Santos, H. van den<br />

Linden, E. M. Ribeiro, E. T. Pereira, M. L. Saraiva-Pereira,<br />

L. B. Jardim, Rede Neurogenética.<br />

2643W Comprehensive haplotype analysis <strong>of</strong> the<br />

Huntington’s disease gene. J. Lee, H. Li, J. C. Roach, N.<br />

Goodman, L. Hood, J. A. Kaye, H. Zayed, I. H. Kratter, A.<br />

C. Daub, S. Finkbeiner, R. H. Myers, M. E. MacDonald, J.<br />

F. Gusella.<br />

2644T Brain-specific junctophilins: Function and role<br />

in neurodegeneration. X. Sun, M. Bhat, C. Zhang, W.<br />

Zheng, R. L. Margolis, D. D. Rudnicki.<br />

2645F Repeat associated non-AUG translation in repeat<br />

expansion disorders. T. Zu, B. Gibbens, L. P. W. Ranum.<br />

2646W microRNA expression in Alzheimer’s disease:<br />

An exploratory investigation. L. M. Bekris, F. Lutz, T. J.<br />

Montine, C. E. Yu, E. R. Peskind, J. B. Leverenz.<br />

2647T Behavioral abnormalities <strong>of</strong> knockout mice<br />

<strong>of</strong> Grm3, a candidate gene for schizophrenia<br />

susceptibility. Y. Fukumaki, R. Fujioka, T. Nii, A. Iwaki, A.<br />

Shibata, I. Ito, K. Kitaichi, M. Nomura, S. Hattori, K. Takao,<br />

T. Miyakawa.<br />

2648F Repeat expansion in C9ORF72 in Alzheimer’s<br />

disease. E. Majounie, Y. Abramzon, A. E. Renton, R. Perry,<br />

S. S. Bassett, O. Pletnikova, J. C. Troncoso, J. Hardy, A. B.<br />

Singleton, B. J. Traynor.<br />

2649W Oxr1 is essential for protection against<br />

oxidative stress-induced neurodegeneration. P. L.<br />

Oliver, M. J. Finelli, K. Liu, B. Edwards, E. Bitoun, E. B.<br />

Becker, K. E. Davies.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2650T Joint SNP analysis identifies multiple signals<br />

underlying association between CHRNB3-CHRNA6 and<br />

nicotine dependence. B. Sadler, E. Johnson, N. Saccone,<br />

L. Bierut, A. Goate.<br />

2651F Variation in gene expression related<br />

to schizophrenia-associated neurocognitive<br />

endophenotypes. E. E. Quillen, M. A. Carless, J. Neary, M.<br />

Z. Kos, R. C. Gur, M. F. Pogue-Geile, K. Prasad, J. Blangero,<br />

H. H. H. Göring, V. L. Nimgaonkar, R. E. Gur, L. Almasy.<br />

2652W A genome-wide epigenetic analysis in<br />

monozygotic twins discordant for schizophrenia. F.<br />

Nishimura, A. Yoshikawa, S. Nanko, A. Imamura, Y. Okazaki,<br />

K. Iwamoto, T. Kato, T. Sasaki, K. Kasai, C. Kakiuchi.<br />

2653T microRNA-9 and -206 expression pr<strong>of</strong>ile in<br />

human amyotrophic lateral sclerosis. D. Dogini, A.<br />

Nucci, I. Lopes-Cendes, M. C. França, Jr.<br />

2654F Altered cell growth and mTOR signaling in<br />

idiopathic autism spectrum disorders. A. M. Suzuki, C.<br />

O. F. Machado, K. G. Oliveira, E. Vadasz, M. R. Passos-<br />

Bueno, A. L. Sertie.<br />

2655W Investigating the genetic susceptibility to<br />

epilepsy in animal models using gene expression<br />

studies. A. H. B. Matos, V. D. B. Pascoal, D. R.<br />

Nascimento, M. Martins, C. S. Rocha, J. F. Vasconcellos,<br />

M. T. Chamma, C. V. Maurer-Morelli, A. S. Martins, A. C.<br />

Valle, A. L. B. Godard, I. Lopes-Cendes.<br />

2656T Effects <strong>of</strong> oral L-carnitine administration in<br />

narcolepsy patients. T. Miyagawa, H. Kawamura, M. Obuchi,<br />

A. Ikesaki, A. Ozaki, K. Tokunaga, Y. Inoue, M. Honda.<br />

2657F Discovery <strong>of</strong> genetic syndromes in patients<br />

manifesting with primary neuropsychiatric disorders. J.<br />

So, J. L. Kennedy.<br />

2658W Genomic and bioinformatic analyses <strong>of</strong> sex<br />

differences in autism spectrum disorder. D. M. Werling,<br />

J. K. Lowe, V. Chandran, R. M. Cantor, D. H. Geschwind,<br />

ACE <strong>Genetics</strong> Consortium.<br />

2659T Analysis <strong>of</strong> RBFOX1 gene expression in<br />

lymphoblastoid cell lines <strong>of</strong> discordant ASD sib pairs.<br />

C. Zusi, P. Prandini, G. Malerba, A. Marostica, E. Trabetti,<br />

P. F. Pignatti, Italian Autism Network.<br />

2660F Protein-protein interaction network for autism<br />

spectrum disorders. R. Corominas, X. Yang, G. N. Lin, S.<br />

Kang, Y. Shen, L. Ghamsari, S. A. Wanamaker, S. Tam, M.<br />

Rodriguez, M. Broly, V. Romero, I. Lemmens, M. Tasan, J.<br />

Tavernier, F. P. Roth, M. Calderwood, J. Sebat, K. Salehi-<br />

Ashtiani, D. E. Hill, M. Vidal, T. Hao, L. M. Iakoucheva.<br />

2661W Transcriptome analysis <strong>of</strong> brain-related<br />

diseases in whole blood by RNA sequencing. S.<br />

de Jong, T. Wang, A. P. S. Ori, M. Wiedau-Pazos, E.<br />

Strengman, N. Tran, J. DeYoung, R. S. Kahn, M. P. M.<br />

Boks, S. Horvath, R. A. Oph<strong>of</strong>f.<br />

POSTER SESSIONS 221<br />

Molecular Basis <strong>of</strong> Mendelian<br />

Disorders<br />

2662W The role <strong>of</strong> GTF2IRD1 in the auditory pathology<br />

<strong>of</strong> Williams-Beuren syndrome. C. P. Canales, A. C. Y.<br />

Wong, G. D. Housley, P. W. Gunning, E. C. Hardeman, S.<br />

J. Palmer.<br />

2663T Tricellulin is required to maintain the barrier<br />

function <strong>of</strong> the reticular lamina and protect the<br />

cochlear hair cells from potassium toxicity. G. Nayak, I.<br />

A. Belyantseva, R. Yousaf, S. Edelmann, S. Lee, G. Sinha,<br />

M. Rafeeq, S. M. Jones, C. M. Van Itallie, J. M. Anderson,<br />

A. Forge, G. I. Frolenkov, S. Riazuddin.<br />

2664F Generation and characterization <strong>of</strong> Plp1dup, a<br />

new mouse model <strong>of</strong> Pelizaeus-Merzbacher disease<br />

with tandem genomic duplication. G. Hobson, K. Clark,<br />

L. Sakowski, K. Sperle, L. Banser, D. Bessert, R. Sk<strong>of</strong>f.<br />

2665W Gtf2i copy number affects the growth <strong>of</strong> neural<br />

progenitors in the developing mouse cortex. H. Oh, L.<br />

R. Osborne.<br />

2666T GPM6A is duplicated in a patient with learning<br />

disability and behavioral anomalies and influences<br />

stress response and long-term memory in Drosophila<br />

melanogaster. C. Zweier, A. Gregor, J. Kramer, I.<br />

Schanze, A. B. Ekici, A. Schenck, A. Reis.<br />

2667F FASPS associated Per3 mutation affects<br />

mesenchymal stem cell differentiation. K. Kaasik, C. R.<br />

Jones, Y. H. Xu, S. Nishino, L. J. Ptacek, Y. H. Fu.<br />

2668W Characterization <strong>of</strong> a novel mit<strong>of</strong>usin 2 knockin<br />

mouse model. A. Rebelo, A. Strickland, F. Zhang, J. Price,<br />

J. Silva, R. Wen, B. Bolon, J. Vance, S. Zuchner.<br />

2669T Triply mouse model <strong>of</strong> Tay-Sachs disease shows<br />

altered brain ganglioside pattern. V. Seyrantepe, Z.<br />

Timur.<br />

2670F Deficiency <strong>of</strong> SPECC1L downregulates PI3K-<br />

AKT signaling in the pathogenesis <strong>of</strong> oblique facial<br />

clefts. N. R. Wilson, A. J. Olm-Shipman, L. Pitstick, B. C.<br />

Bjork, I. Saadi.<br />

2671W Transgenic rescue <strong>of</strong> BBS phenotypes in Bbs4<br />

null mice. X. Chamling, S. Seo, K. Bugge, C. C. Searby, A.<br />

V. Drack, K. Rahmouni, V. C. Sheffield.<br />

2672T Overexpression <strong>of</strong> Rai1 in mouse forebrain<br />

neurons is enough to cause most PTLS-like<br />

phenotypes. L. Cao, J. Molina, P. Carmona-Mora, A.<br />

Oyarzo, J. Young, K. Walz.<br />

2673F A zebrafish model for Richieri-Costa-Pereira<br />

syndrome: Knockdown <strong>of</strong> eif4a3 gene results in<br />

crani<strong>of</strong>acial development disorder. L. Alvizi, A. Weiner,<br />

F. Favaro, R. Zechi-Ceide, A. Richieri-Costa, M. Guion-<br />

Almeida, N. Calcaterra, M. R. Passos-Bueno.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


222 POSTER SESSIONS<br />

2674W A glial origin for periventricular nodular<br />

heterotopia caused by impaired expression <strong>of</strong><br />

Filamin-A. A. Carabalona, S. Beguin, E. Pallesi-<br />

Pocachard, E. Buhler, C. Pellegrino, K. Arnaud, P. Hubert,<br />

M. Ouahla, J.-P. Siffroi, S. Khantane, I. Coupry, C. Goizet,<br />

A. Bernabe-Gelot, A. Represa, C. Cardoso.<br />

2675T Mining phenotype and disease models from the<br />

mouse genome informatics resource. J. T. Eppig, S. M.<br />

Bello, H. Dene, A. Anagnostopoulos, H. Onda, R. Babiuk,<br />

M. N. Knowlton, M. Tomczuk, C. L. Smith.<br />

2676F Molecular genetics and modeling <strong>of</strong> a novel<br />

BBS5 mutation. M. H. Al-Hamed, C. V. Lennep, F. Al-<br />

Fadhly, R. J. Simms, B. F. Meyer, J. A. Sayer.<br />

2677W Limb differences in muscle dystrophy and gene<br />

expression in a murine model <strong>of</strong> MDC1A suggest possible<br />

targets for therapy. J. S. Benjamin, R. Marx, R. D. Cohn.<br />

2678T FREM1 deficiency causes a syndromic form <strong>of</strong><br />

congenital diaphragmatic hernia in humans and mice.<br />

T. F. Beck, O. Shchelochkov, Z. Yu, B. Kim, H. Zaveri, B.<br />

Lee, D. W. Stockton, M. Justice, D. A. Scott.<br />

2679F Characterization <strong>of</strong> visual impairment in a Wfs1<br />

mouse model <strong>of</strong> Wolfram syndrome. C. Delettre, D.<br />

Bonnet-Wersinger, Y. Tanizawa, G. Lenaers, C. Hamel.<br />

2680W Gene therapy for X-linked retinitis pigmentosa in<br />

a knockout mouse model <strong>of</strong> RP2. S. Mookherjee, L. Li, A.<br />

K. Ghosh, N. Khan, P. Colosi, H. Khanna, A. Swaroop.<br />

2681T Altered splicing <strong>of</strong> BIN1 muscle-specific<br />

exon in human and Great Danes with progressive<br />

centronuclear myopathies. J. Bohm, N. Vasli, M. Maurer,<br />

B. S. Cowling, W. Kress, G. D. Shelton, U. Schara, J.<br />

Anderson, R. Herrmann, J. Weis, L. Tiret, J. Laporte.<br />

2682F Upregulation <strong>of</strong> androgen-binding protein is<br />

associated with testicular phenotype in Smarcal1 del/del<br />

mice. A. Baradaran-Heravi, C. F. Boerkoel.<br />

2683W A mouse model <strong>of</strong> mut � methylmalonic acidemia.<br />

J. S. Sénac, V. H. Aswani, J. R. Sysol, I. Manoli, C. P. Venditti.<br />

2684T Allelic heterogeneity contributes to variable<br />

ocular dysgenesis caused by Col4a1 and Col4a2<br />

mutations in mice. M. Mao, D. S. Kuo, C. Labelle-<br />

Dumais, M. Jeanne, J. Favor, D. B. Gould.<br />

2685F Tmprss3 loss <strong>of</strong> function impairs cochlear inner<br />

hair cell BK channel properties. B. Delprat, L. Molina, L.<br />

Fasquelle, R. Nouvian, N. Salvetat, H. Scott, M. Guipponi,<br />

F. Molina, J. L. Puel.<br />

2686W Interaction with p97/VCP alters the intracellular<br />

itinerary <strong>of</strong> the copper-transporting ATPase, ATP7A. L.<br />

Yi, S. G. Kaler.<br />

2687T JNK phosphorylation is responsible for the<br />

greater osteogenic potential <strong>of</strong> periosteum derived<br />

fibroblasts harboring the FGFR2 S252W mutation<br />

(Apert syndrome). R. Atique, E. Yeh, H. Matsushita, N.<br />

Alonso, M. R. Passos-Bueno.<br />

2688F Novel p.Leu795Pro INSR mutation with<br />

decreased autophosphorylation in a patient with<br />

Donohue syndrome. T. Hovnik, K. Trebusˇ ak Podkrajsˇ ek,<br />

J. Kovač , N. Bratanič , T. Battelino.<br />

2689W Post-transcriptional regulation <strong>of</strong> DMD by its<br />

3’UTR. A. Larsen, M. Howard.<br />

2690T NPHP10 (SDCCAG8) interacts with components<br />

<strong>of</strong> the multi-aminoacyl-tRNA synthetase complex. K.<br />

Weihbrecht, M. Humbert, V. Sheffield, S. Seo.<br />

2691F Effect <strong>of</strong> the mutations Gly250Val and Leu451Val<br />

on the expression <strong>of</strong> the gene HEXA: Disease causing<br />

or pseudo-mutations. L. Peleg, R. Svirski, Y. Lerental, M.<br />

Karpati, A. J. Simon.<br />

2692W Identification and biochemical characterization<br />

<strong>of</strong> a novel mutation in DDX11 causing Warsaw<br />

breakage syndrome. J.-M. Capo-Chichi, S. Bhati, J.<br />

A. Sommers, T. Yammine, E. Chouery, L. Patry, G. A.<br />

Rouleau, M.-E. Samuels, F. F. Hamdan, J. L. Michaud, R.<br />

M. Brosh, Jr., A. Megarbane, Z. Kibar.<br />

2693T Development <strong>of</strong> a cell-based reporter assay for<br />

the analysis <strong>of</strong> regulatory interactions between FGF23/<br />

KLOTHO/FGFR1, small inhibitors, and downstream<br />

targets. S. Diener, B. Lorenz-Depiereux, T. M. Strom.<br />

2694F The most activating calcium-sensing receptor<br />

mutation is located in the sixth transmembrane domain<br />

and can be corrected with chemical treatments. A.-S.<br />

Lia-Baldini, A. Nizou, C. Magdelaine, F. Sturtz, B. Funalot,<br />

A. Liendhard.<br />

2695W Dysregulated pathways in Cornelia de Lange<br />

syndrome cells mutated in core cohesin genes.<br />

A. Musio, L. Mannini, A. Gimigliano, l. Bianchi, M. A.<br />

Deardorff, F. Cucco, I. D. Krantz, L. Bini.<br />

2696T Conformations <strong>of</strong> slipped-DNA junctions<br />

determine correct or mutagenic repair <strong>of</strong> CAG/<br />

CTG repeats. M. M. Slean, K. Reddy, B. Wu, K. Nichol<br />

Edamura, M. Kekis, F. Nelissen, R. Aspers, M. Tessari, O.<br />

D. Scharer, S. S. Wijmenga, C. E. Pearson.<br />

2697F High incidence <strong>of</strong> SMAD3 mutations in thoracic<br />

aortic aneurysm and/or dissection patients. H.<br />

Morisaki, I. Yamanaka, A. Yoshida, R. Sultana, H. Tanaka,<br />

Y. Iba, H. Sasaki, H. Matsuda, K. Minatoya, T. Kosho, N.<br />

Okamoto, A. Kawame, T. Morisaki.<br />

2698W Clinical exome sequencing leads to the<br />

diagnosis <strong>of</strong> Timothy syndrome in a patient with<br />

prolonged QT, dysmorphic features, seizures, and<br />

intellectual disability. W. Zeng, K. D. Gonzalez, X. Li, H.<br />

M. Lu, H. Lu, E. M. Miller, S. Ware, J. J. Wei.<br />

2699T Mutations in calmodulin cause ventricular<br />

tachycardia and sudden cardiac death. M. Nyegaard,<br />

M. T. Overgaard, M. T. Søndergaard, M. Vranas, E. R. Behr,<br />

L. L. Hildebrandt, J. Lund, P. L. Hedley, A. J. Camm, G.<br />

Wettrell, I. Fosdal, M. Christiansen, A. D. Børglum.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2700F Role <strong>of</strong> SP1-binding site polymorphism <strong>of</strong><br />

COLIAI gene and a sequence variation 713-8 del C <strong>of</strong><br />

TGF�1 polymorphism in osteoporosis in thalassemia<br />

major patients. S. Agarwal, K. Singh, R. Kumar.<br />

2701W Loss-<strong>of</strong>-function mutations in IGSF1 cause<br />

a novel X-linked syndrome <strong>of</strong> TSH deficiency and<br />

macroorchidism. M. Breuning, Y. Sun, B. Bak, N.<br />

Schoenmaker, A. S. P. van Trotsenburg, P. Voshol, E.<br />

Cambridge, J. White, P. le Tisser, S. Mousavy Gharavy, J.<br />

Martinez-Barbera, W. Oostdijk, L. Persani, P. Beck-Peccoz,<br />

T. Davis, A. Hokken-Koelega, C. Ruivenkamp, J. F.J. Laros,<br />

M. Kriek, S. Kant, J. T. den Dunnen, R. Hennekam, K.<br />

Chatterjee, M. Dattani, J. Wit, D. Bernard.<br />

2702T Hyperphagia, leptin, and brain-derived<br />

neurotrophic factor in subjects with Alström syndrome<br />

and BMI-Z matched controls. M. D. Hicks, J. D.<br />

Marshall, P. Maffei, A. E. Hanish, L. A. Hunter, S. M. Brady,<br />

N. M. Sedaka, R. Sherafat Kazemzadeh, J. W. Tsao, G.<br />

Milan, J. Naggert, J. A. Yanovski, J. C. Han.<br />

2703F The Euro-WABB Registry: Differences in molecular<br />

genetic confirmation between monogenic Wolfram,<br />

Alström, and Bardet-Biedl syndromes. A. Farmer, S. Ayme,<br />

P. Maffei, S. Mccafferty, R. Sinnott, W. Mlynarski, V. Nunes, V.<br />

Paquis, K. Parkinson, V. Tillman, T. Barrett.<br />

2704W Biallelic RFX6 inactivation can cause intestinal<br />

atresia with childhood rather than neonatal onset<br />

diabetes. F. H. Sansbury, R. Caswell, H. Lango Allen, S. E.<br />

Flanagan, B. Kirel, S. Ellard, A. T. Hattersley.<br />

2705T Identification <strong>of</strong> a de novo mutation in the<br />

thyroid hormone receptor � gene in a Colombian family<br />

with RTH. M. C. Lozano, L. Mejia, P. Duran, C. Lattig.<br />

2706F Use <strong>of</strong> lineage markers to predict founder effect<br />

<strong>of</strong> E180Splice mutation in GHR gene causing Laron<br />

syndrome: A witness <strong>of</strong> Jewish exodus. F. T. Goncalves,<br />

C. Fridman, E. M. Pinto, Z. Laron, J. Guevara-Aguirre, F.<br />

G. Carsola, D. Damiani, T. S. Lins, O. Shevah, V. Hwa, A.<br />

L. Rosembloom, R. G. Rosenfeld, U. P. Arnhold, A. A. L.<br />

Jorge.<br />

2707W <strong>Genetics</strong> <strong>of</strong> congenital hypogonadotropic<br />

hypogonadism in Denmark. J. Tommiska, P.<br />

Christiansen, N. Jørgensen, J. Lawaetz, A. Juul, T. Raivio.<br />

2708T A rare gain-<strong>of</strong>-function mutation in an<br />

inhibitory upstream open reading frame in CDKN1B 5’<br />

untranslated region causes MEN4 phenotype. G. Occhi,<br />

D. Regazzo, G. Trivellin, F. Boaretto, D. Ciato, S. Ferasin, F.<br />

Cetani, E. Pardi, M. Korbonits, N. Pellegata, G. Opocher, F.<br />

Mantero, C. Scaroni.<br />

2709F Next-generation sequencing to identify cryptic<br />

ABCC8 and HADH splice site mutations in patients<br />

with congenital hyperinsulinaemic hypoglycaemia. S.<br />

Ellard, R. Caswell, M. Weedon, K. Hussain, S. E. Flanagan.<br />

2710W ABCC8 and KCNJ11 gene mutational analysis<br />

in Slovenian patients with neonatal diabetes and<br />

congenital hyperinsulinism. K. Trebusˇ ak Podkrajsˇ ek, M.<br />

Avbelj, T. Hovnik, N. Bratina, N. Bratanič , T. Battelino.<br />

POSTER SESSIONS 223<br />

2711T Severe familial growth hormone deficiency due<br />

to defective U12-dependent processing <strong>of</strong> pituitary<br />

developmental genes. L. A. Perez-Jurado, R. Flores, G.<br />

A. Martos-Moreno, I. Cuscó, J. Argente.<br />

2712F Impaired energy homeostasis and arrested<br />

maturation underlie neutrophil dysfunction in glycogen<br />

storage disease type Ib. H. S. Jun, D. A. Weinstein, Y. M.<br />

Lee, B. C. Mansfield, J. Y. Chou.<br />

2713W A novel mutation in PSTPIP1 is responsible<br />

for PAPA syndrome in a Jordanian child. H. El-Shanti,<br />

F. Al-Amri, B. Fathalla, S. Al-Dosari, M. Al-Mutawa, M.<br />

Kambouris.<br />

2714T Prevalence <strong>of</strong> ��� anti3.7 triplication in betathalassemia<br />

carriers in south <strong>of</strong> Iran. G. Shariati,<br />

M. Hamid, A. H. Saberi, B. Sharififard, B. Keikhaei, M.<br />

Pedram.<br />

2715F Mutational analysis <strong>of</strong> Korean patients with<br />

Diamond-Blackfan anemia. H. Chae, J. Park, M. Kim, A.<br />

Kwon, S. Lee, Y. Kim, J. W. Lee, N. G. Chung, B. Cho, D.<br />

C. Jeong.<br />

2716W Apoptosis is responsible for neutropenia in<br />

Cohen syndrome. L. Duplomb, L. Faivre, A. Hammann,<br />

G. Jego, N. Droin, E. Lopez, B. Aral, N. Gigot, S. El<br />

Chehadeh, F. Huet, P. Callier, J. Thevenon, V. Carmignac,<br />

C. Capron, M.-A. Gougerot-Pocidalo, F. Girodon, J.-N.<br />

Bastie, L. Delva, C. Thauvin-Robinet.<br />

2717T A novel pig model <strong>of</strong> SCID; A tool for cancer and<br />

immune research. N. M. Ellinwood, E. H. Waide, D. M.<br />

Thekkoot, N. Boddicker, R. R. R. Rowland, E. M. Snella, J.<br />

K. Jens, C. R. Wyatt, J. W. Ross, D. Troyer, C. K. Tuggle, J.<br />

C. M. Dekkers.<br />

2718F Polymorphism in the HMOX-1 gene is associated<br />

with high levels <strong>of</strong> HbF in Brazilian patients with sickle<br />

cell anemia. M. B. Melo, G. P. Gil, G. Ananina, M. B.<br />

Oliveira, M. J. Silva, M. N. N. Santos, M. A. C. Bezerra, B.<br />

L. D. Hatzlh<strong>of</strong>er, A. S. Araujo, F. F. Costa.<br />

2719W Beta-thalassemia in the Aegan Region <strong>of</strong><br />

Turkey: Identification <strong>of</strong> a novel deletion mutation. F.<br />

Ozkinay, H. Onay, E. Karaca, E. Arslan, A. Ece, B. Erturk,<br />

M. Tekin, O. Cogulu, Y. Aydinok, C. Vergin.<br />

2720T Development <strong>of</strong> a diagnostic panel for<br />

genetic immunodeficiencies using next-generation<br />

sequencing. E. M. Coonrod, J. Durtschi, A. Kumanovics,<br />

R. L. Margraf, H. R. Hill, K. V. Voelkerding.<br />

2721F Spectrum <strong>of</strong> gene mutations in Chinese patients<br />

with refractory human herpes viruses associated<br />

disease. H. Liu, F. Wang, Y. Zhang, Y. Wang, W. Teng, L.<br />

Guo, C. Tong, T. Wu, Y. Zhao, J. Gu, D. Lu.<br />

2722W Exome sequencing identifies missense IRF2BP2<br />

mutation in a family with autosomal dominant common<br />

variable immunodeficiency. L. Tian, D. Li, M. Keller, K.<br />

Cecilia, E. Frackelton, F. Otieno, H. Hakonarson, J. S.<br />

Orange.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


224 POSTER SESSIONS<br />

2723T C-terminal frameshift truncation and extension<br />

mutation in POU3F4. W. Park, B. Choi, D. Kim, A. Kim.<br />

2724F Dominant allele <strong>of</strong> DFNM1 suppresses DFNB26<br />

associated recessive hearing loss. R. Yousaf, Z. M.<br />

Ahmed, G. Nayak, R. J. Morell, S. Sumanas, E. R. Wilcox,<br />

S. Riazuddin, T. B. Friedman, S. Riazuddin.<br />

2725W Phenome-wide, cross-species comparisons<br />

identify novel disease genes with high accuracy. D. P.<br />

Smedley, C. J. Mungall, S. C. Doelken, S. Köehler, B. J.<br />

Ruef, M. Westerfield, P. N. Robinson, S. E. Lewis, W. C.<br />

Skarnes, Members <strong>of</strong> Mouse <strong>Genetics</strong> Project.<br />

2726T Mutation screening in CYP1B1 in glaucoma<br />

cases from North India. A. Bhardwaj, V. Vanita.<br />

2727F Screening <strong>of</strong> SOX10 and MITF regulatory regions<br />

in Waardenburg syndrome type 2. N. Bondurand, V.<br />

Baral, A. Chaoui, Y. Watanabe, M. Goossens, T. Attie-<br />

Bitach, S. Marlin, V. Pingault.<br />

2728W Utilization <strong>of</strong> gene mapping and candidate gene<br />

mutation screening for diagnosing clinically equivocal<br />

conditions. V. Chini, D. Stambouli, F. M. Nedelea, G. A.<br />

Filipescu, D. Mina, H. El-Shanti, M. Kambouris.<br />

2729T Search for a new gene responsible for nonsyndromic<br />

craniosynostosis. S. El Chehadeh-Djebbar, F.<br />

Di Rocco, C. Collet, M. Le Merrer, J. Puechberty, G. Lefort,<br />

B. Aral, S. Lambert, N. Gigot, M. Payet, C. Ragon, N.<br />

Marle, A.-L. Mosca-Boidron, J.-R. Teyssier, F. Mugneret, C.<br />

Thauvin-Robinet, P. Sarda, L. Faivre, P. Callier.<br />

2730F Mutation screening in CNGA1 in an autosomal<br />

recessive retinitis pigmentosa family. S. Goyal, V. Vanita.<br />

2731W A novel mutation <strong>of</strong> the nicastrin (NCSTN)<br />

gene in a large Indian family with autosomal dominant<br />

hidradenitis suppurativa (or acne inversa). D. Jhala, U.<br />

Ratnamala, T. Y. Mehta, F. M. S. Al-Ali, M. Raveendrababu,<br />

S. S. Chettiar, M. V. Rao, S. Nair, J. J. Sheth, M. R.<br />

Kuracha, S. K. Nath, U. Radhakrishna.<br />

2732T A systematic approach to identifying disease<br />

genes in Mullerian aplasia. H.-G. Kim, H. K. Nishimoto,<br />

R. Ullmann, J. A. Phillips III, Y. Shen, R. H. Reindollar, H. H.<br />

Ropers, V. M. Kalscheuer, L. C. Layman.<br />

2733F Linkage analysis in an autosomal recessive<br />

retinitis pigmentosa family. V. Kumar, S. Saini.<br />

2734W Homozygosity mapping and mutation pr<strong>of</strong>ile<br />

<strong>of</strong> the MYO7A gene in Saudi patients with Usher<br />

syndrome. K. Ramzan, M. Al-Owain, K. Taibah, G. Bin-<br />

Khamis, R. Allam, A. Al-Mostafa, S. Al-Hazza, F. Imtiaz.<br />

2735T Mutation analysis in an autosomal recessive<br />

retinitis pigmentosa family. S. Saini, J. R. Singh, V.<br />

Vanita.<br />

2736F The role <strong>of</strong> APCS and RBP4 genes as modifiers<br />

<strong>of</strong> age-at-onset in familial amyloid polyneuropathy<br />

(FAP ATTRV30M). D. Santos, T. Coelho, J. L. Neto, J. P.<br />

Basto, J. Sequeiros, I. Alonso, C. Lemos, A. Sousa.<br />

2737W Linkage analysis in families with autosomal<br />

dominant corneal dystrophies. D. Singh, V. Vanita.<br />

2738T A novel chromosomal locus in a family with<br />

primary ciliary dyskinesia. R. Parvari, M. Mazor, S.<br />

Alkrinawi, V. C. Sheffield, M. Aviram.<br />

2739F Polymorphism <strong>of</strong> VEGF+674 gene as potential<br />

risk factor for age related macular degeneration in<br />

Indian patients. D. Gupta, V. Gupta, S. Chawla, S. R.<br />

Phadke.<br />

2740W Whole genome analysis identifies mutations<br />

in inositol polyphosphate phosphatase-like 1 as the<br />

cause <strong>of</strong> opsismodysplasia. J. E. Below, D. Earl, K. M.<br />

B<strong>of</strong>ferding, M. J. McMillin, J. Smith, E. Turner, M. Stephan,<br />

L. Al-Gazali, J. Hertecant, D. H. Cohn, D. A. Krakow, D. A.<br />

Nickerson, M. J. Bamshad.<br />

2741T Novel loci for autosomal dominant nocturnal<br />

frontal lobe epilepsy. S. E. Heron, M. Bahlo, K. R. Smith,<br />

P. Hickey, C. Bromhead, C. P. Derry, J. S. Duncan, S.<br />

Howell, S. F. Berkovic, I. E. Scheffer, L. M. Dibbens.<br />

2742F Identification <strong>of</strong> a new gene for X-linked<br />

Charcot-Marie-Tooth neuropathy using linkage and<br />

exome analysis. M. Kennerson, E. Yiu, D. Chuang,<br />

S.-C. Tso, C. Ly, A. Kidambi, G. Perez Siles, M. Ryan, G.<br />

Nicholson.<br />

2743W A novel splice site mutation in Erlin2 gene<br />

causes complicated form <strong>of</strong> hereditary spastic<br />

paraplegia in a Saudi family. S. Majid, S. Bohlega, S.<br />

Hagos, H. Dossari, K. Ramzan, Z. Hassnan.<br />

2744T Clinical and genetic study <strong>of</strong> a new form <strong>of</strong><br />

familial multiple keratoakanthoma in a Tunisian family:<br />

The palmoplantar familial multiple keratoacanthoma.<br />

O. Mamaô, L. Bouss<strong>of</strong>ara, L. Adala, I. Ben Charfeddine, S.<br />

Bouraoui, A. Amara, R. Nouira, M. Denguezli, B. Sriha, M.<br />

Gribaa, A. Saad.<br />

2745F FBLN5 mutation as the cause <strong>of</strong> HMSN I in<br />

a Czech family: Usefulness <strong>of</strong> combination <strong>of</strong> SNP<br />

linkage and exome sequencing analysis. D. Brozˇ ková, P.<br />

Lasˇ sˇ uthová, J. Lisoň ová, M. Kru˚ tová, P. Seeman.<br />

2746W Expansion <strong>of</strong> a repeat motif in the<br />

5’untranslated region <strong>of</strong> EIF4A3 causes crani<strong>of</strong>acial<br />

and limb defects (Richieri-Costa-Pereira syndrome). F.<br />

Favaro, R. M. Zechi-Ceide, L. Alvizi, J. Souza, T. M. Felix,<br />

S. R. F. Twigg, S. J. McGowan, A. O. M. Wilkie, A. Richieri-<br />

Costa, M. L. Guion-Almeida, M. R. Passos-Bueno.<br />

2747T A recurrent mutation <strong>of</strong> keratin 4 gene causing<br />

white sponge nevus in a Japanese family. M. Kimura,<br />

T. Nagao, J. Machida, S. Yamaguchi, A. Shibata, G.<br />

Takeuchi, H. Miyachi, K. Shimozato, Y. Tokita.<br />

2748F Molecular analysis <strong>of</strong> benign familial neonatalinfantile<br />

convulsion in a Japanese family. Y. Yamada, K.<br />

Yamada, D. Fukushi, K. Miura, N. Nomura, A. Yamano, T.<br />

Kumagai, N. Wakamatsu.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2749W A newly identified locus for benign adult familial<br />

myoclonic epilepsy on chromosome 3q26.32-3q28.<br />

P. Yeetong, S. Ausavarat, R. Bhidayasiri, K. Piravej, N.<br />

Pasutharnchat, T. Desudchit, C. Chunharas, J. Loplumlert,<br />

C. Limotai, K. Suphapeetiporn, V. Shotelersuk.<br />

2750T Calpain-5 causes autoimmune uveitis, retinal<br />

neovascularization and photoreceptor degeneration. V.<br />

B. Mahajan, J. M. Skeie, A. G. Bassuk, J. H. Fingert, T. A.<br />

Braun, H. T. Daggett, J. C. Folk, V. C. Sheffield, E. M. Stone.<br />

2751F Soluble ICAM-1 levels are associated to a<br />

protective prognosis in sickle cell retinopathy. P. R. S.<br />

Cruz, T. R. Zaccarioto, F. N. Mitsuuchi, S. A. C. Pereira<br />

Filho, R. P. C. Lira, I. Meyer, M. A. C. Bezerra, K. Y. Fertrin,<br />

F. F. Costa, M. B. Melo.<br />

2752W X-linked CHARGE-like Abruzzo-Erickson<br />

syndrome and classic cleft palate with ankyloglossia<br />

result from, i>TBX22 splicing mutations. P. Stanier, E.<br />

Pauws, E. Peskett, C. Boissin, K. Mengrelis, E. Carta, M.<br />

A. Abruzzo, M. Lees, G. E. Moore, R. P. Erickson.<br />

2753T Enlarged vestibular aqueduct syndrome:<br />

Characterization <strong>of</strong> three new mutations. E. Prera, S.<br />

Arndt, A. Aschendorff, R. Birkenhäger.<br />

2754F A novel molecular basis for Carpenter<br />

syndrome. S. Movva, U. Kotecha, R. Puri, I. C. Verma.<br />

2755W De novo activating mutations in<br />

phosphatidylserine synthase 1 cause a rare mental<br />

retardation-multiple congenital anomalies syndrome.<br />

S. B. Sousa, D. Jenkins, E. Chanudet, A. Barnicoat,<br />

K. Chrzanowska, J. Sá, J. Saraiva, R. Scott, D.<br />

Wattanasirichaigoon, G. Anderson, G. Tasseva, J. Vance,<br />

P. Beales, G. E. Moore.<br />

2756T Exome sequencing <strong>of</strong> a consanguineous<br />

Palestinian kindred with syndromic cleft palate. H.<br />

Shahin, U. Sharaha, M. Lee, S. Saed, J. van Aalst, M. C.<br />

King, T. Walsh.<br />

2757F Mutations in the DOCK6 gene in Adams-Oliver<br />

syndrome. W. Wuyts, A. Laureys, E. Van Hul, M. De<br />

Smedt, K. Storm, N. Van der Aa.<br />

2758W Novel mutations <strong>of</strong> the FGD1 gene in 16<br />

patients with Aarskog-Scott syndrome. T. Kaname,<br />

K. Yanagi, N. Okamoto, K. Kurosawa, Y. Izumikawa,<br />

Y. Fukushima, Y. Makita, M. Tsukahara, A. Altincik, S.<br />

Mizuno, K. Naritomi.<br />

2759T Exome sequencing identifies an IFIH1 mutation<br />

causing Singleton-Merten syndrome by dysregulation<br />

<strong>of</strong> the innate immune response. F. Rutsch, M.<br />

MacDougall, C. Lu, Y. Nitschke, I. Buers, O. Mamaeva, D.<br />

K. Crossman, J. Dong, C. Müller, H. G. Kehl, J. Kleinheinz,<br />

P. Barth, K. Barczyk, D. Bazin, J. Altmüller, H. Thiele, P.<br />

Nürnberg, W. Höhne, A. S. Feigenbaum, R. Hennekam.<br />

2760F Mutations in PVRL1 and PVRL4 genes define<br />

nectinopathies as developmental field disorders <strong>of</strong><br />

ectodermal derivatives and cutaneous syndactyly with<br />

or without cleft lip/palate. E. Agolini, P. Fortugno, L.<br />

B. Ousager, A. Bygum, L. Graul-Neumann, K. Stieler, A.<br />

Kuechler, G. Zambruno, F. Brancati.<br />

POSTER SESSIONS 225<br />

2761W ELN mutations in autosomal dominant cutis<br />

laxa. E. Lawrence, M. McGowan, C. Su, M. Mac Neal, K.<br />

Levine, A. Zaenglein, M. Bodzioch, A. Kiss, Z. Urban.<br />

2762T RIPK4 mutations explain a portion <strong>of</strong> IRF6negative<br />

popliteal pterygium cases. E. J. Leslie, S.<br />

Goudy, M. Cunningham, J. C. Murray.<br />

2763F Sacsin-related ataxia caused by the novel<br />

missense mutation Arg272His in a patient from<br />

Southern Italy. F. Cavalcanti, A. Nicoletti, G. Annesi, P.<br />

Tarantino, M. Gagliardi, G. Mostile, V. Dibilio, A. Quattrone,<br />

A. Gambardella, M. Zappia.<br />

2764W SCA36 molecular analysis in patients with<br />

spinocerebellar ataxia. D. Di Bella, E. Sarto, C. Mariotti,<br />

C. Gellera, S. Magri, F. Taroni.<br />

2765T Germline CAG repeat instability causes<br />

extreme CAG repeat expansion with infantile onset<br />

<strong>of</strong> spinocerebellar ataxia type 2 in <strong>of</strong>fspring. J. Ek, T.<br />

Vinther-Jensen, M. Dunoe, F. Skovby, L. E. Hjermind, J. E.<br />

Nielsen, T. T. Nielsen.<br />

2766F Genetic aspects <strong>of</strong> Dravet syndrome in southern<br />

Italy. M. Gagliardi, P. Tarantino, F. Cavalcanti, M. Sesta, P.<br />

Conti, D. Galeone, G. Tortorella, A. Labate, M. Caracciolo, T.<br />

Mirante, A. Bagal‡, A. Quattrone, A. Gambardella, G. Annesi.<br />

2767W Vacuolar-type H � -ATPase V1A subunit is a<br />

molecular partner <strong>of</strong> Wolfram syndrome 1 protein,<br />

which regulates its stability and expression. S.<br />

Gharanei, M. Zatyka, D. Astuti, J. Fenton, E. Rabai, A. Sik,<br />

Z. Nagy, T. Barrett.<br />

2768T Altered expression <strong>of</strong> carbonic anhydraserelated<br />

protein XI in neuronal cells expressing mutant<br />

ataxin-3. M. Hsieh, W. H. Chang, C. F. Hsu, C. L. Kuo, I.<br />

Nishimori, T. Minakuchi, N. Nukina.<br />

2769F Alterations in RNA splicing underlie<br />

development <strong>of</strong> ataxia in SCA1 mice. M. A. C. Ingram, P.<br />

Bergmann, H. Kang, H. Y. Zoghbi, H. T. Orr.<br />

2770W Clinical spectrum <strong>of</strong> intragenic CAMTA1<br />

rearrangements: From non-progressive congenital<br />

ataxia to intellectual disability. E. Lopez, J. Thevenon,<br />

B. Keren, D. Heron, C. Mignot, C. Altuzara, M. Béri-<br />

Dexheimer, C. Bonnet, L. Burglen, D. Minot, J. Vigneron,<br />

P. Charles, A. Brice, L. Gallagher, J. Amiel, C. Mach, C.<br />

Depienne, D. Doummar, L. Duplomb, V. Carmignac, P.<br />

Callier, A.-L. Mosca-Boidron, V. Roze, B. Aral, F. Razavi, P.<br />

Jonveaux, L. Faivre, C. Thauvin-Robinet.<br />

2771T Analysis <strong>of</strong> human mitochondrial aminoacyl-tRNA<br />

synthetase complexes in patients with MARS2 mutations.<br />

I. Thiffault, F. Sasarman, T. Nishimura, E. A. Shoubridge.<br />

2772F Mutations in GPSM2 cause the brain<br />

malformations and hearing loss <strong>of</strong> Chudley-<br />

McCullough syndrome. D. Doherty, A. E. Chudley, G.<br />

Coghlan, G. E. Ishak, A. M. Innes, E. G. Lemire, R. C.<br />

Rogers, A. A. Mhanni, I. G. Phelps, S. J. M. Jones, S. H.<br />

Zhan, A. P. Fejes, H. Shahin, M. Kanaan, H. Akay, M. Tekin,<br />

B. Triggs-Raine, T. Zelinski, FORGE Canada Consortium.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


226 POSTER SESSIONS<br />

2773W Thrombospondin genes are required for<br />

development <strong>of</strong> normal cochlear function and<br />

maintenance. M. Mustapha, D. Mendus, V. Sundaresan.<br />

2774T Lack <strong>of</strong> the VPS35 Asp620Asn mutation in<br />

southern Italian patients with familial Parkinson’s<br />

disease. G. Annesi, M. Gagliardi, P. Tarantino, F.<br />

Cavalcanti, T. Mirante, M. Caracciolo, A. Bagal‡, A.<br />

Gambardella, A. Quattrone.<br />

2775F Ubiquilin 2 mutations in Italian patients with<br />

amyotrophic lateral sclerosis and frontotemporal<br />

dementia. C. Gellera, C. Tiloca, R. Del Bo, L. Corrado, V.<br />

Pensato, J. Agostini, C. Cereda, A. Ratti, B. Castellotti,<br />

S. Corti, A. Bagarotti, A. Cagnin, P. Milani, C. Gabelli, G.<br />

Riboldi, L. Mazzini, G. Sorarù, S. D’Alfonso, F. Taroni, G. P.<br />

Comi, N. Ticozzi, V. Silani.<br />

2776W <strong>Genetics</strong> <strong>of</strong> primary microcephaly in Indian<br />

families. A. Kumar, V. Bhat, G. Mohan, S. C. Girimaji.<br />

2777T ZIC1 and ZIC4 deletion at 3q24 is not constantly<br />

associated to Dandy-Walker malformation. S. Loddo, V.<br />

Parisi, L. Bernardini, A. Ferraris, A. Capalbo, L. Travaglini,<br />

G. Zanni, M. L. Di Sabato, S. Tumini, A. Novelli, V. Sabolic,<br />

E. Bertini, B. Dallapiccola, E. M. Valente.<br />

2778F A frameshift mutation in the gene encoding<br />

folliculin-interacting protein 2 associated with<br />

hypomyelination and tremors in the Weimaraner. P.<br />

Patel, T. Pemberton, S. Choi, J. Mayer, F.-Y. Li, N. Safra, D.<br />

Bannasch, K. Sullivan, B. Breuhaus, I. Duncan.<br />

2779W Familial cortical myoclonus with a mutation<br />

in NOL3. J. F. Russell, J. L. Steckley, G. Coppola, A. F.<br />

G. Hahn, M. A. Howard, Z. Kornberg, A. Huang, S. M.<br />

Mirsattari, B. Merriman, E. Klein, M. Choi, H.-Y. Lee, A.<br />

Kirk, C. Nelson-Williams, G. Gibson, S. C. Baraban, R. P.<br />

Lifton, D. H. Geschwind, Y.-H. Fu, L. J. Ptacek.<br />

2780T Mutations in PRRT2 result in familial infantile<br />

convulsions with marked variability in clinical<br />

expression and SUDEP. P. Tarantino, G. Palamara,<br />

A. Labate, M. Gagliardi, L. Mumoli, E. Ferlazzo, F.<br />

Cavalcanti, U. Aguglia, G. Incorpora, A. Gambardella, G.<br />

Annesi.<br />

2781F Molecular analysis <strong>of</strong> NIPA1 gene mutations<br />

in patients with spastic paraplegia. F. Taroni, S.<br />

Caldarazzo, E. Sarto, M. Plumari, V. Martinelli, D.<br />

Pareyson, S. Baratta, D. Di Bella.<br />

2782W Incomplete nonsense-mediated decay<br />

facilitates detection <strong>of</strong> a multi-exonic deletion<br />

mutation in SCGE. J. Xiao, K. Marshall, M. LeDoux.<br />

2783T Is<strong>of</strong>orm-selective MeCP2-e1 deficient mice<br />

recapitulate the neurologic defecits <strong>of</strong> Rett syndrome.<br />

D. H. Yasui, K. W. Dunaway, M. S. Golub, N. C. Schanen,<br />

J. M. LaSalle.<br />

2784F ARHGEF26/SGEF controls arteriosclerosis,<br />

retinal fovea, immunity and neurodevelopment. P.<br />

Bitoun, E. Pipiras, B. Benzacken, A. Delahaye.<br />

2785W Homozygosity mapping and exome sequencing<br />

in a Saudi-Arabian family with unspecified juvenile<br />

neurodegeneration. E. Frackelton, P. M. A. Sleiman, L.<br />

Tien, S. Panossian, K. Xu, B. Tweddale, N. Abdel-Magid,<br />

C. Kim, Y. Housawi, H. Hakonarson.<br />

2786T Neuropathology in POL III related disorders:<br />

Myelin loss in 4H syndrome. A. Vanderver, J. Schmidt,<br />

G. Carosso, D. Tonduti, G. Bernard, J. Lai, C. Rossi, M.<br />

Quezado, K. Wong, R. Schiffman.<br />

2787F Identification <strong>of</strong> homozygous WFS1 mutations<br />

(p.Asp211Asn, p.Gln486*) causing severe Wolfram<br />

syndrome and first report <strong>of</strong> male fertility. A. Haghighi,<br />

A. Haghighi, A. Setoodeh, N. Saleh-Gohari, D. Astuti, T.<br />

G. Barrett.<br />

2788W Whole exome sequencing in children<br />

with unclassified, sporadic, early-onset epileptic<br />

encephalopathies. K. R. Veeramah, L. Johnstone, D.<br />

Wolf, R. Sprissler, T. M. Karafet, D. Talwar, R. P. Erickson,<br />

M. F. Hammer.<br />

2789T Determining the genetic architecture <strong>of</strong> Joubert<br />

syndrome. D. O’Day, B. J. O’Roak, I. G. Phelps, J. C.<br />

Dempsey, I. Glass, H. C. Mefford, J. Shendure, D. Doherty.<br />

2790F <strong>Genetics</strong> <strong>of</strong> Joubert syndrome in the French<br />

Candian population. M. Srour, J. Schwartzentruber, F. F.<br />

Hamdan, L. H. Ospina, L. Patry, D. Labuda, C. Massicotte,<br />

S. Dobrzeniecka, J.-M. Capo-Chichi, S. Papillon-<br />

Cavanagh, M. E. Samuels, K. M. Boycott, M. I. Shevell,<br />

R. Laframboise, V. Désilets, D. Amron, E. Andermann,<br />

G. Sebire, B. Maranda, G. A. Rouleau, J. Majewski, J. L.<br />

Michaud, FORGE Canada Consortium.<br />

2791W Mechanisms underlying non-recurrent<br />

microdeletions causing neur<strong>of</strong>ibromatosis type-1. J.<br />

Vogt, K. Bengesser, K. Claes, K. Wimmer, L. Messiaen, L.<br />

Kluwe, V.-F. Mautner, H. Kehrer-Sawatzki.<br />

2792T The DYRK1A gene is a rare cause <strong>of</strong> Angelmanlike<br />

syndrome with severe microcephaly and epilepsy.<br />

J.-B. Courcet, E. Lopez, J. Thevenon, N. Gigot, L. Jego,<br />

C. Ragon, A. Masurel-Paulet, P. Callier, N. Marle, A.-L.<br />

Mosca-Boidron, F. Huet, C. Philippe, L. Lambert, P.<br />

Malzac, L. Faivre, A. Moncla, C. Thauvin-Robinet.<br />

2793F Exome sequencing reveals cause <strong>of</strong><br />

hypomyelinating leukodystrophy. D. L. Dinwiddie, N. A.<br />

Miller, C. J. Saunders, S. E. Soden, G. M. Hobson, S. F.<br />

Kingsmore.<br />

2794W Intractable epilepsy and tau protein pathology<br />

in a child with a defect in the synaptic vesicle recycling<br />

pathway. D. A. Dyment, A. Smith, P. Humphreys, J.<br />

Woulfe, FORGE Canada Consortium, D. E. Bulman, J.<br />

Schwartzentruber, J. Majewski, J. Michaud, K. M. Boycott.<br />

2795T Novel CDKL5 splicing variant in a boy with earlyonset<br />

seizures. R. Polli, G. Ho, E. Leonardi, E. Bettella, E.<br />

Fontana, B. Dalla Bernardina, J. Christodoulou, A. Murgia.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2796F The molecular role <strong>of</strong> GTF2IRD1, a protein<br />

implicated in the neurodevelopmental features <strong>of</strong><br />

Williams-Beuren syndrome. P. Carmona-Mora, J.<br />

Widagdo, K. M. Taylor, R. Tsz-Wai Pang, P. W. Gunning, E.<br />

C. Hardeman, S. J. Palmer.<br />

2797W Contribution <strong>of</strong> POLR3A and POLR3B recessive<br />

mutations to hypomyelinating leucodystrophy. H.<br />

Daoud, M. Tétreault, K. Choquet, W. Gibson, M. Syn<strong>of</strong>zik,<br />

B. Brais, A. Vanderver, G. Bernard.<br />

2798T Identification <strong>of</strong> disease causing mutations in<br />

the serine/threonine kinase VRK1 gene in two siblings<br />

with primary microcephaly, neuropathy and spinal<br />

muscular atrophy. C. Gonzaga-Jauregui, W. Wiszniewski,<br />

J. Reid, D. Muzny, R. A. Gibbs, J. R. Lupski, Baylor-<br />

Hopkins Center for Mendelian Genomics.<br />

2799F Molecular screening <strong>of</strong> patients with CMT2<br />

disease. G. Bergamin, C. Briani, E. Pegoraro, A.<br />

Martinuzzi, E. Battiston, F. Boaretto, M. L. Mostacciuolo.<br />

2800W Novel autosomal recessive syndrome<br />

characterized by manganese deficiency, cerebellar<br />

atrophy, skeletal dysplasia, and cognitive impairment<br />

caused by mutation in SLC39A8. C. L. Beaulieu, M.<br />

Galvez-Peralta, D. Redl, L. Huang, E. G. Puffenberger,<br />

S. C. Hampson, A. E. Chudley, J. N. Scott, R. A. Hegele,<br />

D. R. McLeod, A. E. MacKenzie, D. E. Bulman, J. S.<br />

Parboosingh, D. W. Nebert, A. .M. Innes, K. M. Boycott,<br />

FORGE Canada Consortium.<br />

2801T GNAL is a new causative gene for primary<br />

dystonia. T. Fuchs, R. Saunders-Pullman, I. Masuho, M. San<br />

Luciano, D. Raymond, S. White, E. Ainehsazan, N. Sharma,<br />

M. E. Ehrlich, K. Martemyanov, S. B. Bressman, L. J. Ozelius.<br />

2802F Analysis <strong>of</strong> Aicardi syndrome genome using<br />

array CGH and exome sequencing. W. Liu, M.<br />

Bainbridge, A. Balasa, X. Wang, D. Murdock, R. Gibbs, I.<br />

B. Van den Veyver.<br />

2803W Molecular analysis for Gaucher, Tay-Sach’s and<br />

Sandh<strong>of</strong>f disease in Indian patients. J. J. Sheth, M. A.<br />

Mistri, C. M. Ankleshwaria, P. Tamhankar, A. Bavdekar, CA.<br />

Datar, M. Kamate, S. Gupta, F. J. Sheth.<br />

2804T Progress and challenges in elucidating the<br />

molecular genetic basis <strong>of</strong> cluster headache. L.<br />

Southgate, S. Scollen, W. He, A. Moss, M. A. Simpson,<br />

B. Zhang, L. Xi, T. Schlitt, M. Weale, C. L. Hyde, J. C.<br />

Stephens, C. Sjöstrand, M. B. Russell, M. Leone, S. L.<br />

John, R. C. Trembath.<br />

2805F Japanese Chin dogs with GM2 gangliosidosis are<br />

homozygous for a HEXA missense mutation and are a<br />

potential large animal model for Tay-Sachs disease. D.<br />

Gilliam, A. C. Freeman, D. N. Sanders, R. Zeng, D. A. Wenger,<br />

G. S. Johnson, M. L. Katz, M. Vandenberg, S. Holmes, M.<br />

Kent, R. Rech, E. Howerth, S. R. Platt, D. P. O’Brien.<br />

2806W Identification <strong>of</strong> novel X-linked intellectual<br />

disability genes by human X chromosome exome<br />

sequencing. T. Wang, T. Niranjan, C. Skinner, M. May, L.<br />

Holloway, C. Schwartz.<br />

POSTER SESSIONS 227<br />

2807T Genetic studies to gain insight into the function<br />

<strong>of</strong> the MeCP2 domains in vivo. L. Heckman, H. Zoghbi.<br />

2808F Combination <strong>of</strong> linkage analysis and exome<br />

sequencing identifies a novel form <strong>of</strong> autosomal<br />

recessive syndromic intellectual deficiency linked to DNA<br />

damage response defect. M. Langouet, A. Saadi, C. Bole-<br />

Feysot, P. Nitschke, A. Munnich, M. Chaouch, L. Colleaux.<br />

2809W Neuronal cells generated through differentiation<br />

<strong>of</strong> stem cells isolated from patient’s skin recapitulate<br />

the main features <strong>of</strong> Niemann Pick C disease. A.<br />

Dardis, N. Bergamin, D. Cesselli, S. Zampieri, B. Bembi, A.<br />

Beltrami, C. A. Beltrami.<br />

2810T Severely impaired respiratory chain causes<br />

multisystem apoptosis-driven developmental defects, a<br />

new mitochondrial phenotype in vertebrates. A. Indrieri,<br />

V. van Rahden, V. Tiranti, I. Conte, J. Quartararo, M. Morleo,<br />

D. Iaconis, R. Tammaro, G. Chesi, M. Cermola, R. Tatè, I.<br />

Maystadt, S. Demuth, A. Zvulunov, I. D’Amato, P. G<strong>of</strong>frini, I.<br />

Ferrero, P. Bovolenta, K. Kutsche, M. Zeviani, B. Franco.<br />

2811F Whole exome sequencing reveals novel and<br />

known genes mutations in a cohort <strong>of</strong> centronuclear<br />

myopathy patients. P. Agrawal, O. Ceyhan, K. Schmitz, E.<br />

Dechene, M. Viola, K. Markianos, A. Beggs.<br />

2812W Mutations in the human isoprenoid synthase<br />

domain containing gene are a common cause <strong>of</strong><br />

congenital and limb girdle muscular dystrophies. S.<br />

Cirak, A. R. Foley, R. Herrmann, T. Willer, M. Yau, S. Torelli,<br />

P. Vondracek, R. Helen, C. Longman, R. Korinthenberg, G.<br />

Marruso, P. Nürnberg, UK10K Consortium, V. Plagnol, M.<br />

Hurles, C. Sewry, K. P. Campbell, T. Voit, F. Muntoni.<br />

2813T Prevalence <strong>of</strong> MECP2 mutations among girls<br />

presenting significant clinical overlap between Rett<br />

and Angelman syndromes. T. M. R. de Assis, G. A.<br />

Molfetta, C. A. Ferreira, C. H. P. Grangeiro, W. A. Silva, Jr.<br />

2814F Identification <strong>of</strong> six novel NF1 mutations in<br />

neur<strong>of</strong>ibromatosis type 1 patients from the Azorean<br />

island <strong>of</strong> São Miguel (Portugal). L. Mota-Vieira, B. Campos,<br />

R. Cabral, A. L. Rodrigues, A. Raposo, A. Carvalho.<br />

2815W A pan-European study <strong>of</strong> the pathological<br />

C9orf72 hexanucleotide (G4C2) expansion<br />

associated with frontotemporal lobar degeneration<br />

and amyotrophic lateral sclerosis. J. van der Zee, I.<br />

Gijselinck, L. Dillen, T. Van Langenhove, M. Cruts, C.<br />

Van Broeckhoven, Belgian Neurology Consortium and<br />

European Early-Onset Dementia Consortium.<br />

2816T Identification <strong>of</strong> novel ALS genes using linkage<br />

analysis and next-gen sequencing. K. L. Williams, J.<br />

A. Solski, J. C. Durnall, A. D. Thoeng, S. Warraich, G.<br />

Rouleau, G. A. Nicholson, I. P. Blair.<br />

2817F The distributions <strong>of</strong> two SOD1 missense<br />

mutations in the pet dog population and their<br />

association with canine degenerative myelopathy, a<br />

model for amyotrophic lateral sclerosis. R. Zeng, J. R.<br />

Coates, L. Hansen, G. C. Johnson, F. A. Wininger, M. L.<br />

Katz, G. S. Johnson.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


228 POSTER SESSIONS<br />

2818W Explore the impact <strong>of</strong> parkin mutations in ERassociated<br />

protein degradation: Cellular models for<br />

juvenile PD. M. Alves-Ferreira, S. Morais, J. Sequeiros, I.<br />

Alonso.<br />

2819T A nonsense mutation in DHTKD1 causes<br />

Charcot-Marie-Tooth disease type 2 in a large Chinese<br />

pedigree. M. Gu, W. Xu, L. Sun, W. Guo, J. Ma, S. Chen,<br />

W. Huang, Z. Wang.<br />

2820F Identification <strong>of</strong> the SPG46 gene by nextgeneration<br />

sequencing in four families with autosomal<br />

recessive complicated spastic paraplegia. G. Stevanin,<br />

R. Schüle, K. Smets, E. Martin, S. Zuchner, L. J. Loureiro,<br />

A. Boukhris, A. Rastetter, T. de Coninck, M. Gonzalez, E.<br />

Mundwiller, F. Lamari, G. Gyapay, P. Coutinho, C. Mhiri, P.<br />

de Jongue, E. Kabashi, A. Brice.<br />

2821W A balanced (1q32;14q31) translocation<br />

associated with epilepsy, learning disability and<br />

leukemia has breakpoints in developmental genes as<br />

detected by whole-genome sequencing. M. I. Rees, S.<br />

Ali, R. H. Thomas, J. G. Mullins, M. Kerr, S. K. Chung.<br />

2822T A DYNC1H1 mutation causes a quadricepsdominant<br />

neurogenic muscular atrophy. S. Saitoh, Y.<br />

Tsurusaki, K. Tomizawa, A. Sudo, N. Asahina, H. Shiraishi, J.<br />

Ito, H. Tanaka, H. Doi, H. Saitsu, N. Miyake, N. Matsumoto.<br />

2823F Late-onset Charcot-Marie-Tooth disease 4F<br />

caused by periaxin gene mutation. S. Tokunaga, A.<br />

Hashiguchi, A. Yoshimura, K. Maeda, T. Suzuki, H. Haruki,<br />

T. Nakamura, H. Takashima.<br />

2824W Detection <strong>of</strong> slipped-DNAs at the trinucleotide<br />

repeats <strong>of</strong> the myotonic dystrophy type I disease locus<br />

in patient tissues. M. M. Axford, Y.-H. Wang, M. Nakamori,<br />

M. Zannis-Hadjopoulos, C. Thornton, C. E. Pearson.<br />

2825T A lyonization study in heterozygous females<br />

for X-linked adrenoleukodystrophy. F. S. Pereira, C.<br />

Habekost, U. Matte, L. B. Jardim.<br />

2826F Mutations in CUL4B, a member <strong>of</strong> the Cullin-<br />

RING ubiquitin ligase complex, cause syndromic<br />

X-linked intellectual disability associated with short<br />

stature. A. K. Srivastava, M. Cook, K. Corrier, L. Lee, S. S.<br />

Cathey, F. Bartel, K. R. Holden, C. Skinner, A. D. Chaubey,<br />

B. R. DuPont, N. VerBerkmoes, R. J. Schroer.<br />

2827W Identification <strong>of</strong> novel exon splice enhancers<br />

in the growth hormone gene (GH1) mutated in isolated<br />

GH deficiency. D. Babu, I. Fusco, S. Mellone, M. Godi, A.<br />

Petri, F. Prodam, S. Bellone, P. Momigliano-Richiardi, G.<br />

Bona, M. Giordano.<br />

2828T Functional analysis <strong>of</strong> R75Q dominant mutation<br />

and in cis recessive mutation V37I <strong>of</strong> GJB2 gene<br />

causing hearing loss in a Korean family. J. Kim, J. Jung,<br />

Y. Kim, J. Choi, K. Lee.<br />

2829F Progressive hearing impairment with<br />

homozygous deletion in GJB2 gene (Connexin-26) and<br />

normal newborn hearing screening. N. Lublingh<strong>of</strong>f, E.<br />

Löhle, R. Birkenhäger.<br />

2830W Bestrophin mutation within Ca 2� binding domain<br />

alters Cl � conductance. S. Brar, B. Pattnaik, P. Halbach,<br />

S. Tokarz, D. Pillers.<br />

2831T Functional characterization <strong>of</strong> SLC2A9 allelic<br />

variants in Czech population. B. Stiburkova, O. Hurba, V.<br />

Krylov, A. Mencikova.<br />

2832F Identification <strong>of</strong> a missense mutation outside<br />

the forkhead domain <strong>of</strong> FOXL2 causing a severe form<br />

<strong>of</strong> BPES type II. H. Haghighi-Kakhki, A. Haghighi, H.<br />

Verdin, N. Piri, N. Saleh-Gohari, E. De Baere.<br />

2833W The UBIAD1 prenyltransferase links<br />

menaquione-4 synthesis to cholesterol metabolic<br />

enzymes. M. Nickerson, A. Bosley, J. Weiss, B. Kostiha,<br />

W. Brandt, T. Andresson, T. Okano, M. Dean.<br />

2834T Intergenic or 5’UTR deletion <strong>of</strong> transcription factor<br />

4 (TCF4) gene in Pitt-Hopkins syndrome. J. Lee, S.-U.<br />

Moon, E. Shin, S. Hassed, J. Chanloner, X. Wang, S. Li.<br />

2835F No evidence <strong>of</strong> genetic difference for clinical<br />

severity between monozygotic twins with Rett<br />

syndrome. T. Kubota, K. Miyake, T. Hirasawa, Y.<br />

Minakuchi, A. Toyoada.<br />

2836W Two-nucleotide deletion <strong>of</strong> the ATP7A gene,<br />

leading not to premature termination, but to translation<br />

reinitiation, produces mild phenotype in a male<br />

Menkes disease patient. T. Wada, T. Murakami, H.<br />

Shimbo, H. Osaka, H. Kodama.<br />

2837T Retinoic acid induced 1, RAI1: Molecular and<br />

functional studies to understand its relationship to<br />

neurobehavioral alterations. K. Walz, I. C. Perez, P.<br />

Carmona-Mora, C. Abad, C. P. Canales, L. Cao, A. K.<br />

Srivastava, J. I. Young.<br />

2838F RAB11FIP1 interacts with the BLOC-1 complex<br />

to retrieve melanogenic proteins from the recycling<br />

pathway and a dominant negative mutation in<br />

RAB11FIP1 causes Hermanksy-Pudlak syndrome type<br />

10. A. R. Cullinane, J. Pan, M. A. Merideth, J. A. Curry, J.<br />

G. White, M. Huizing, W. A. Gahl.<br />

2839W Two novel RRM2B gene mutations in a patient<br />

with autosomal recessive progressive external<br />

ophthalmoplegia, encephalopathy and cytochrome c<br />

oxidase deficiency. N. S. Hauser, R. Bai.<br />

2840T Isogenic D4Z4 contracted and non-contracted<br />

immortal muscle cell clones as a model for FSHD. S.<br />

van der Maarel, Y. Krom, J. Dumonceaux, K. Mamchoui,<br />

B. den Hamer, V. Mariot, E. Negroni, L. Geng, R. Tawil, S.<br />

Tapscott, B. van Engelen, V. Mouly, G. Butler-Browne.<br />

2841F MEFV second exon variation analysis in familial<br />

Mediterranean fever. A. K. Kirectepe, G. Celikyapi Erdem,<br />

O. Kasapcopur, E. Tahir Turanli.<br />

2842W Role <strong>of</strong> NLRP7 in recurrent hydatidiform moles<br />

and reproductive wastage. R. Slim, C. Messaed, E.<br />

Akoury, W. Chebaro, W. Buckett, J. Arseneau, P. Sauthier.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2843T A novel GUCY2D mutation, V933A, causes<br />

central areolar choroidal dystrophy. A. E. Hughes, W.<br />

Meng, A. J. Lotery, D. T. Bradley.<br />

2844F Novel splice site mutations in NPHS1 gene in<br />

Indian congenital nephrotic syndrome patients. S.<br />

Sharma, A. Bagga, M. Kabra.<br />

2845W Genetic basis <strong>of</strong> prune belly syndrome:<br />

Screening the candidate genes. L. Baker, S. Harrison, C.<br />

Granberg, C. Villanueva.<br />

2846T DNA copy-number variations in persistent<br />

cloaca patients. S. Harrison, L. Baker.<br />

2847F Whole genome sequencing reveals a deletion<br />

<strong>of</strong> the last exon <strong>of</strong> FAN1 in Basenji dogs with adultonset<br />

Fanconi syndrome. G. S. Johnson, F. H. Farias,<br />

T. Mhlanga-Mutangadura, J. F. Taylor, D. P. O’Brien, R. D.<br />

Schnabel.<br />

2848W Formation <strong>of</strong> a novel N-glycosylation motif in<br />

integrin �3 due to a rare ITGA3 gene polymorphism<br />

causes congenital nephrotic syndrome and interstitial<br />

lung disease. K. Y. Renkema, N. Nicolaou, C. Margadant,<br />

S. H. Kevelam, M. R. Lilien, M. J. S. Oosterveld, M. Kreft,<br />

A. M. van Eerde, R. Pfundt, P. A. Terhal, B. van der Zwaag,<br />

N. Sachs, R. Goldschmeding, N. V. A. M. Knoers, A.<br />

Sonnenberg.<br />

2849T Defining the phenotypic specificity <strong>of</strong> Schimke<br />

immuno-osseous dysplasia. M. Morimoto, C. Myung,<br />

K. Beirnes, D. Leung, H. K. Fam, K. Choi, Y. Huang, C. F.<br />

Boerkoel.<br />

2850F High-throughput mutation analysis in patients<br />

with a nephronophthisis-associated ciliopathy applying<br />

multiplexed barcoded array-based PCR amplification<br />

and next-generation sequencing. E. A. Otto, J. Halbritter,<br />

K. Diaz, B. Tarrier, M. Chaki, C. Fu, J. L. Innis, S. J. Allen,<br />

R. H. Lyons, C. J. Stefanidis, H. Omran, N. A. Soliman.<br />

2851W Founder mutation in RPSPH4A identified in<br />

patients <strong>of</strong> Hispanic descent with primary ciliary<br />

dyskinesia. M. A. Zariwala, M. W. Leigh, S. D. Davis, M.<br />

C. Armstrong, M. L. Daniels, J. L. Carson, M. Hazucha, S.<br />

S. Dell, M. R. Knowles, Genetic Disorders <strong>of</strong> Mucociliary<br />

Clearance Consortium.<br />

2852T Leri’s pleonosteosis results from defective<br />

SMAD signaling. S. Banka, S. Cain, J. Urquhart, S. Carim,<br />

S. Daly, G. Erdem, M. Bottomley, D. Donnai, B. Kerr, H.<br />

Kingston, C. Kielty, W. G. Newman.<br />

2853F Abnormal type I collagen folding and matrix<br />

deposition in a cyclophilin B KO mouse model <strong>of</strong><br />

recessive osteogenesis imperfecta. W. A. Cabral, E.<br />

Makareeva, M. Weis, S. Leikin, D. R. Eyre, J. C. Marini.<br />

2854W Differential contributions <strong>of</strong> P3H1 to collagen<br />

processing in the pathogenesis <strong>of</strong> osteogenesis<br />

imperfecta. E. P. Homan, C. Lietman, I. Grafe, J.<br />

Lennington, R. Morello, W. R. Hogue, D. Napierala, M.<br />

M. Jiang, B. Dawson, T. K. Bertin, Y. Chen, R. Lua, O.<br />

Lichtarge, J. Hicks, M. A. Weis, D. R. Eyre, B. Lee.<br />

POSTER SESSIONS 229<br />

2855T Characterization <strong>of</strong> transient receptor potential<br />

vanilloid channel 4 in metatropic dysplasia primary cell<br />

lines. L. M. Hurd, S. M. Kirwin, K. M. Vinette, M. B. Bober,<br />

W. G. Mackenzie, R. L. Duncan, V. L. Funanage.<br />

2856F Exome sequencing identifies a de novo<br />

missense mutation in TGF-b1 in a sporadic patient<br />

with craniotubular bone dysplasia. D. Li, A. Haghighi,<br />

F. Salehzade, L. Tian, H. Haghighi-Kakhki, C. Kim, E.<br />

Frackelton, F. Otieno, H.-D. Nah, H. Hakonarson.<br />

2857W An intracellular role for FGFR2 in bent<br />

bone dysplasia syndrome. C. L. Neben, B. Idoni, A.<br />

Sarukhanov, D. Krakow, A. E. Merrill.<br />

2858T ZDHHC13 is a key regulator in postnatal<br />

epiphyseal development. I. W. Song, W. R. Li, J. Y. Wu,<br />

M. T. Lee, Y. T. Chen.<br />

2859F Identification <strong>of</strong> novel genes downstream <strong>of</strong><br />

FGFR2 contributing to coronal suture synostosis in<br />

a murine model for Crouzon syndrome. S. Kumar, E.<br />

Peskett, J. A. Britto, E. Pauws.<br />

2860W Identification <strong>of</strong> copy number variants in<br />

413 isolated talipes equinovarus patients: role <strong>of</strong><br />

transcriptional regulators <strong>of</strong> limb development. D. M.<br />

Alvarado, J. G. Buchan, S. L. Frick, J. E. Herzenberg, M.<br />

B. Dobbs, C. A. Gurnett.<br />

2861T Mutation <strong>of</strong> B3GAT3 causes skeletal dysplasia<br />

in a consanguineous clan from Nias. B. S. Budde, S.<br />

Mizumoto, R. Kogawa, C. Becker, J. Altmüller, H. Thiele,<br />

P. Frommolt, M. R. Toliat, J. M. Hämmerle, W. Höhne, K.<br />

Sugahar, P. Nürnberg, I. Kennerknecht.<br />

2862F Mutation analysis <strong>of</strong> the BIN1 gene performed<br />

to evaluate the cause <strong>of</strong> centronuclear myopathy in<br />

two fetuses <strong>of</strong> consanguineous parents from Sudan. N.<br />

Dohrn, A. Petersen, P. Skovbo, I. S. Pedersen, A. Ernst, H.<br />

Krarup, M. B. Petersen.<br />

2863W Novel ROR2 mutations in patients with autosomal<br />

recessive Robinow syndrome. J. Mazzeu, H. Kayserilli,<br />

C. A. Kim, D. Brunoni, P. C. Pieri, A. Richieri-Costa, H. van<br />

Bokhoven, H. G. Brunner, A. M. Vianna-Morgante.<br />

2864T Whole exome sequencing identifies mutations<br />

in the nucleoside transporter gene SLC29A3 in<br />

dysosteosclerosis, a form <strong>of</strong> osteopetrosis. P. Campeau,<br />

J. T. Lu, G. Sule, M.-M. Jiang, Y. Bae, S. Madan, W. Högler,<br />

N. J. Shaw, S. Mumm, R. A. Gibbs, M. P. Whyte, B. H. Lee.<br />

2865F Polymorphisms in osteoporosis and their<br />

associations with bone metabolism. R. Richterová, P.<br />

Cibulková, A. Bóday, D. Stejskal, P. Novosad, P. Fojtík, P.<br />

Hrdý.<br />

2866W Combination <strong>of</strong> whole-genone cytogenetics<br />

array, high-throughput SNP genotyping, homozygosity<br />

mapping and Sanger sequencing identify FXN gene<br />

expansion leading to axonal peripheral neuropathy and<br />

ataxia phenotype in two consanguineous families from<br />

North West Africa. H. Azzedine, B. Hubert, W. Amer, F.<br />

Ferrat, M. Chaouch, F. Lagace, R. Fetni, C. Paisan-Ruiz.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


230 POSTER SESSIONS<br />

2867T Exome sequencing in small families segregating<br />

autosomal dominant non-syndromic hearing loss. H.<br />

Azaiez, E. Shearer, K. Booth, M. Hildebrand, N. Meyer, R.<br />

J. H. Smith.<br />

2868F Application <strong>of</strong> massive parallel sequencing for<br />

mutation discovery and genetic diagnosis <strong>of</strong> hereditary<br />

hearing loss in Chinese DFNA families. H. Yuan, J.<br />

Cheng, Y. Lu, X. Zhou, X. Zhang, R. Choy.<br />

2869W A new gene for autosomal recessive<br />

congenital ichthyosis identified by exome sequencing<br />

demonstrates impact <strong>of</strong> ceramide synthesis and acyl<br />

chain length for keratinocyte terminal differentiation. K.<br />

Eckl, R. Tidhar, M. L. Preil, H. Thiele, I. Hausser, V. Oji, A.<br />

Önal-Akan, S. Brodesser, F. Stock, R. Casper, J. Altmüller,<br />

P. Nürnberg, H. Traupe, A. H. Futerman, H. C. Hennies.<br />

2870T The NIH Undiagnosed Diseases <strong>Program</strong>:<br />

Defining pathogenicity for personalized medicine. C.<br />

F. Boerkoel III, M. C. Malicdan, D. Adams, C. Toro, C. Tifft,<br />

W. A. Gahl, T. Markello.<br />

2871F Efficient search for allelically heterogeneous<br />

disease genes in whole genome or exome datasets. K.<br />

D’Aco, M. A. Aquino, N. M. Pearson.<br />

2872W From large-scale clinical recruitment to<br />

identification <strong>of</strong> a novel mutation in ADAMTSL2 in a<br />

family with Ehler-Danlos syndrome. A. S. Desai, D.<br />

Hadley, L. Tian, C. Kim, E. Frackelton, R. Chiavacci, F. G.<br />

Otieno, F. Mentch, H. Hakonarson, K. Wang, S. Pannosian.<br />

2873T Exome sequencing for the knowledgedriven<br />

and unbiased disease-mutation search <strong>of</strong><br />

mitochondrial respiratory chain disorder. M. Kohda, Y.<br />

Tokuzawa, Y. Moriyama, H. Kato, N. Uehara, Y. Nakachi,<br />

N. Matoba, S. Tamaru, Y. Kishita, T. Yamazaki, M. Mori, K.<br />

Murayama, Y. Mizuno, A. Ohtake, Y. Okazaki.<br />

2874F Exome sequencing for disease gene discovery<br />

in Jeune’s asphyxiating thoracic dystrophy. P. Taylor, S.<br />

Wu, S. F. Nelson, D. H. Cohn, D. Krakow.<br />

2875W Seeking causative genes for human congenital<br />

general anosmia in multiply-affected Israeli families.<br />

A. Alkelai, T. Olender, D. Oz-Levi, I. Keydar, R. Milgrom, E.<br />

Feldmesser, E. Ben-Asher, E. K. Ruzzo, D. B. Goldstein, E.<br />

Pras, D. Lancet.<br />

2876T Studying a locus for bilateral congenital<br />

perisylvian polymicrogyria: Linkage analysis,<br />

cytoscan HD array and target enrichment/sequencing<br />

approaches. F. R. Torres, S. S. Tsuneda, E. H. Yamamoto,<br />

R. Secolin, M. G. Borges, W. T. S. T. Ide, C. S. Rocha, F. M.<br />

Artiguenave, F. Cendes, M. Guerreiro, I. Lopes-Cendes.<br />

2877F Targeted exome sequencing for molecular<br />

diagnostics <strong>of</strong> heterogeneous genetic disorders:<br />

Primary ciliary dyskinesia. J.-L. Blouin, J. Bevillard,<br />

M. Guipponi, C. Gehrig, A. Vannier, F. Santoni, S. E.<br />

Antonarakis, F. Fellmann, S. Fokstuen, R. Lazor.<br />

2878W Mutations affecting components <strong>of</strong> the<br />

SWI/SNF complex cause C<strong>of</strong>fin-Siris syndrome. N.<br />

Matsumoto, Y. Tsurusaki, N. Miyake.<br />

2879T Identifying mutations causing atypical progeria<br />

by exome sequencing and CNV analysis. K. M.<br />

McSweeney, L. B. Gordon, J. Xu, W. Ping, M. F. Arlt, J. Li,<br />

T. Glover.<br />

2880F Diagnostic sequencing applications using the Ion<br />

Torrent. D. Muzny, X. Wang, C. Buhay, M. Wang, H. Dinh, J.<br />

Reid, D. Wheeler, L. Lotta, E. Boerwinkle, R. Gibbs.<br />

2881W Next-generation sequencing reveals an allelic<br />

variant <strong>of</strong> GLI2 in a Turkish pedigree with a unique<br />

clinical phenotype. D. Pehlivan, A. Yesilyurt, C. G.<br />

Gonzaga-Jauregui, E. Karaca, Y. Pehlivan, S. Guran, R. A.<br />

Gibbs, J. R. Lupski.<br />

2882T Rapid and efficient mutation detection in<br />

the hundreds <strong>of</strong> target genes by bench-top next<br />

generation sequencer with custom target capture<br />

method. A. Shimizu, C. Torii, N. Suzuki, H. Mutai, J.<br />

Kudoh, R. Kosaki, T. Matsunaga, K. Kosaki.<br />

2883F Identification <strong>of</strong> candidate genes associated<br />

with autosomal dominant pulmonary fibrosis by wholeexome<br />

sequencing. W. Wiszniewski, C. G. Gonzaga-<br />

Jauregui, T. J. Vece, D. M. Muzny, M. N. Bainbridge, J. G.<br />

Reid, R. A. Gibbs, J. R. Lupski, Baylor-Hopkins Center for<br />

Mendelian Genomics.<br />

2884W Family matters: Exome sequencing can identify<br />

causal variants in isolated probands through familybased<br />

studies. H. Yu, C. R. Coughlin, E. A. Geiger, M.<br />

Friederich, L. Medne, J. E. Ming, E. H. Zackai, J. L. Van<br />

Hove, X. Gai, G. H. Scharer, T. H. Shaikh.<br />

2885T Whole exomic triangulation and systems biology<br />

identify novel pathogenic substrates for autosomal<br />

dominant long QT syndrome. N. J. Boczek, D. J. Tester,<br />

J. R. Giudicessi, T. J. Kamp, M. J. Ackerman.<br />

2886F X-exome sequencing identifies the<br />

causal variant in a large pedigree with X-linked<br />

intellectual disability, truncal obesity, gynecomastia,<br />

hypogonadism and unusual face. J. K. P. van Amstel, M.<br />

Harakalova, M. J. van den Boogaard, R. J. Sinke, S. van<br />

Lieshout, M. van Tuil, K. Duran, I. Renkens, P. A. Terhal,<br />

C. G. F. de Kovel, I. J. Nijman, M. M. van Haelst, N. V. A.<br />

M. Knoers, G. van Haaften, W. P. Kloosterman, R. C. M.<br />

Hennekam, E. Cuppen.<br />

2887W Completing the BBS jigsaw by exome<br />

sequencing and phenotype-genotype correlations:<br />

LZTFL1, a BBSome-related gene associated with<br />

developmental features is BBS17. H. Dollfus, F. Stutzman,<br />

M. Gerard, A. Verioes, E. Schaefer, C. Stoetzel, V. Marion.<br />

2888T Simultaneous identification <strong>of</strong> single nucleotide<br />

mutations and DNA copy number aberrations in<br />

neurodevelopmental disorders by exome sequencing.<br />

A.-M. Sulonen, H. Almusa, H. Edgren, P. Ellonen, L.<br />

Forsstrom, T. Linnankivi, S. Knuutila, J. Saarela.<br />

2889F USP9X mutation in a child with developmental<br />

delay and multiple congenital anomalies. M. S. Brett, A.<br />

H. M. Lai, E. C. P. Lim, J. R. McPherson, B. W. M. Cham,<br />

Z. J. Zang, P. Tan, S. Rozen, E. C. Tan.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2890W Congenital cataracts, hypomyelination,<br />

progressive microcephaly, digital anomalies: A new<br />

recessive syndrome due to mutations in a nucleoporin<br />

gene? E. Geraghty, G. Carvill, I. Glass, R. Kapur, D.<br />

Doherty, H. Mefford.<br />

2891T Trio-exome sequencing identifies mutations<br />

<strong>of</strong> the gene encoding the histone acetyltransferase<br />

KAT6B/MYST4 in individuals with the Young-Simpson<br />

syndrome. K. Kurosawa, K. Enomoto, T. Kondoh,<br />

S. Mizuno, M. Adachi, K. Muroya, Y. Yamanouchi, T.<br />

Nishikawa, N. Furuya, M. Tominaga, T. Naruto, K. Ida, Y.<br />

Kuroda, T. Sengstag, R. Manabe, M. Masuno.<br />

2892F Exome sequencing identifies a missense<br />

mutation <strong>of</strong> ANKRD26 in autosomal dominant<br />

thrombocytopenia. C. Kim, P. M. A. Sleiman, L. Tien,<br />

S. Panossian, K. Xu, B. Tweddale, N. Abdel-Magid, E.<br />

Frackelton, Y. Housawi, H. Hakonarson.<br />

2893W Holoprosencephaly: Identification <strong>of</strong> new<br />

candidate genes by high throughput sequencing <strong>of</strong><br />

family trios. V. David, C. Dubourg, M. de Tayrac, V. Dupé,<br />

M. Aubry, L. Ratié, S. Mercier, J. Mosser, S. Odent.<br />

2894T Exome sequencing reveals a novel de novo<br />

GNAS gene mutation in a boy with usual presentation<br />

<strong>of</strong> pseudohypoparathroidism. M. J. Dasouki, S. E.<br />

Soden, E. G. Farrow, C. J. Saunders, D. L. Dinwiddie, N. A.<br />

Miller, S. F. Kingsmore.<br />

2895F Clinical diagnostic exome identifies novel<br />

mutations in the C20orf7 gene, a mitochondrial<br />

complex I assembly factor, in a Taiwanese infant with<br />

Leigh’s disease. J. J. Wei, K. D. Gonzalez, X. Li, H. M. Lu,<br />

H. Lu, R. Chang, R. Wang, J. Abdenur, W. Zeng.<br />

2896W De novo mutations in MLL cause Wiedemann-<br />

Steiner syndrome. W. D. Jones, D. Dafou, M. McEntagart,<br />

W. J. Woollard, F. V. Elmslie, M. Holder-Espinasse, M.<br />

Irving, M. Lees, A. K. Saggar, S. Smithson, R. C. Trembath,<br />

C. Deshpande, M. A. Simpson.<br />

2897T Targeted resequencing <strong>of</strong> known and candidate<br />

epilepsy genes in 500 patients with epileptic<br />

encephalopathies. G. Carvill, B. J. O’Roak, S. C. Yendle,<br />

J. Cook, N. Krumm, S. F. Berkovic, J. Shendure, I. E.<br />

Scheffer, H. C. Mefford.<br />

2898F Deciphering the genetic basis <strong>of</strong> progressive<br />

myoclonus epilepsies by exome sequencing. M.<br />

Muona, S. F. Berkovic, L. Dibbens, K. L. Oliver, T. Joensuu,<br />

E. Hämäläinen, A. Palotie, A.-E. Lehesjoki.<br />

2899W Mutations in a zinc finger protein cause a novel<br />

autosomal recessive mental retardation syndrome<br />

identified through homozygosity mapping and whole<br />

exome sequencing <strong>of</strong> a single affected individual.<br />

M. Kambouris, T. Ben-Omran, Y. Al-Sarraj, R. Ali, M.<br />

Almureikhi, K. Erraffi, H. El-Shanti.<br />

2900T Exome sequencing <strong>of</strong> seven cases affected<br />

by a congenital muscular dystrophy with hyperlaxity<br />

belonging to five French-Canadian families. M.<br />

Tétreault, G. D’Anjou, J. Mathieu, M. Vanasse, B. Brais.<br />

POSTER SESSIONS 231<br />

2901F Diagnosis <strong>of</strong> syndromic autism using a 62-gene<br />

next-generation sequencing panel: Experience from<br />

a clinical diagnostic laboratory. J. R. Jones, M. J.<br />

Basehore, S. McGee, K. J. Champion, M. J. Friez.<br />

2902W Empowering a clinical genetic setting through<br />

the introduction <strong>of</strong> whole exome sequencing in<br />

prenatal and postnatal investigations. C. Pangalos, B.<br />

Hagnefelt, Z. Agioutantis, C. Konialis.<br />

2903T Use <strong>of</strong> whole exome sequencing to determine<br />

the genetic etiology <strong>of</strong> inherited congenital cataracts.<br />

L. M. Reis, R. C. Tyler, E. V. Semina.<br />

2904F A next-generation sequencing assay for the<br />

diagnosis <strong>of</strong> the Noonan spectrum <strong>of</strong> disorders. A. B.<br />

Santani, T. Tischler, A. Sasson, J. Perin, M. Sarmady, E.<br />

Frackelton, B. Tweddale, N. Abdel-Magid, S. Panossian,<br />

P. Warren, H. Feret, M. Deardorff, A. Wilkens, M. Italia,<br />

B. Ruth, J. Miller, E. Zackai, D. Monos, E. Rappaport, H.<br />

Hakonarson, P. White, C. Stolle.<br />

2905W French Canadian founder mutation in the SBDS<br />

gene causing Shwachman-Diamond Syndrome. L.<br />

Steele, M. Eliou, J. M. Rommens, P. N. Ray, T. L. Stockley.<br />

2906T Confirmation <strong>of</strong> cause and manner <strong>of</strong> death<br />

via a comprehensive cardiac autopsy including whole<br />

exome next-generation sequencing. D. J. Tester, J. J.<br />

Maleszewski, T. M. Kruisselbrink, M. J. Ackerman.<br />

2907F Diagnostic exome sequencing uncovers<br />

Mendelian inheritance in neurological disease. E. C.<br />

Chao, X. Li, K. Gonzalez, A. Fatemi, J. Cohen, W. Zeng.<br />

2908W Whole exome sequencing identifies potential<br />

homozygous mutations in a family with two sisters<br />

with brain malformation. E. Karaca, D. Pehlivan, C. G.<br />

Gonzaga-Jauregui, M. Ozen, A. Yuksel, W. Wiszniewski,<br />

A. Stray-Pedersen, D. Munzy, R. A. Gibbs, J. R. Lupski,<br />

Baylor-Hopkins Center for Mendelian <strong>Genetics</strong>.<br />

2909T Recessive mutations in MYL2 cause infantile<br />

fiber type disproportion and cardiomyopathy. M. A.<br />

J. Weterman, P. B. Barth, K. Y. van Spaendonck-Zwarts,<br />

E. Aronica, B. T. Poll-The, O. Brouwer, J. P. van Tintelen,<br />

Z. Qahar, E. J. Bradley, M. B. de Wissel, L. Salviati, C.<br />

Angelini, L. van den Heuvel, Y. E. M. Thomasse, A. P.<br />

Backx, G. Nuernberg, P. Nuernberg, F. Baas.<br />

2910F Molecular diagnosis in Stargardt’s disease<br />

through a tiered sequencing approach. J. Zaneveld,<br />

H. Wang, F. Wang, L. Mao, K. Zhang, Y. Duan, J. Zhu, J.<br />

Chiang, R. Chen.<br />

2911W Identification <strong>of</strong> mutations in the prostaglandin<br />

transporter gene SLCO2A1 in Japanese patients with<br />

pachydermoperiostosis. J. Kudoh, T. Sasaki, A. Shimizu,<br />

A. Shiohama, A. Hirakiyama, T. Okuyama, A. Seki, K.<br />

Kabashima, A. Otsuka, A. Ishiko, K. Tanese, S. Miyakawa,<br />

J. Sakabe, M. Kuwahara, M. Amagai, H. Okano, M.<br />

Suematsu, H. Niizeki.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


232 POSTER SESSIONS<br />

2912T CIAS1 mutations associate with familial<br />

Mediterranean fever in Turkish patients and a novel<br />

V734G mutation in MEFV. E. Yosunkaya, N. Buyru.<br />

2913F Exome sequencing <strong>of</strong> a dog trio affected with a<br />

canine progressive retinal degeneration. S. J. Ahonen,<br />

H. Lohi.<br />

2914W Mutations in NESP4, a KASH domain protein<br />

linking the nucleus to the cytoskeleton, lead to hearing<br />

impairment in humans and mice. K. B. Avraham, Z.<br />

Brownstein, H. F. Horn, D. R. Lenz, S. Shivatzki, A. Dror, K.<br />

J. Roux, S. Kozlov, B. Burke, C. L. Stewart.<br />

2915T Genetic characterization <strong>of</strong> a large keratinization<br />

disorder cohort, utilizing whole exome sequencing to<br />

discover mutations in known and novel genes. L. M.<br />

Boyden, C. Tian, C. Saraceni, E. Loring, L. Milstone, R. P.<br />

Lifton, H. Vernon, D. Zand, A. S. Paller, K. A. Choate.<br />

2916F X-linked familial focal segmental<br />

glomerulosclerosis with first-degree heart block<br />

caused by a mutation in the NXF5 gene. T. Esposito, R.<br />

A. Lea, B. H. Maher, D. Moses, H. C. Cox, S. Magliocca,<br />

V. D’Alessio, A. Angius, T. Titus, T. Kay, A. Parnham, F.<br />

Gianfrancesco, L. R. Griffiths.<br />

2917W Mutations in SLC52A2 impair rib<strong>of</strong>lavin<br />

transport and cause Brown-Vialetto-Van Laere<br />

syndrome. T. B. Haack, C. Makowski, Y. Yao, E. Graf,<br />

M. Hempel, T. Wieland, U. Tauer, U. Athing, J. A. Mayr, P.<br />

Freisinger, H. Yoshimatsu, K. Inui, T. M. Strom, T. Meitinger,<br />

A. Yonezawa, H. Prokisch.<br />

2918T Identification <strong>of</strong> a causative variant underlying<br />

nonsyndromic autosomal-dominant intellectual<br />

disability in an extended family. N. Jinawath, B. Pupacdi,<br />

E. Wohler, V. Charoensawan, D. Wattanasirichaigoon.<br />

2919F Targeted exome capture and paired-end<br />

massively parallel sequencing reveals new mutations<br />

for human hereditary deafness in the Middle East.<br />

M. Kanaan, Z. Brownstein, A. Abu Rayyan, D. Karfunkel,<br />

D. Dweik, Y. Bhonker, A. Yeheskel, L. Friedman, N. Kol,<br />

O. Yaron, V. Oron-Karni, M. Frydman, N. Shomron, K. B.<br />

Avraham.<br />

2920W Defective ion transport in sweat glands cause<br />

generalized isolated anhidrosis. J. Klar, M. Sobol, K.<br />

Mäbert, M. Tariq, M. Rasool, M. Jameel, T. Naeem, N. A.<br />

Malik, A. Johansson, L. Feuk, S. M. Baig, N. Dahl.<br />

2921T Exome sequencing identifies a novel mutation<br />

in GJA1 as the cause <strong>of</strong> alopecia, leukonychia, skin<br />

hyperkeratosis and crani<strong>of</strong>acial anomalies. Z. Lin, H.<br />

Wang, J. Zhang, Q. Chen, M. Lee, X. Wang, R. Li, Y. Yang.<br />

2922F Mutation discovery in ENU-derived mouse<br />

models for metabolic bone disease by whole<br />

chromosome and whole exome sequencing. B. Lorenz-<br />

Depiereux, S. Sabrautzki, S. Diener, E. Graf, T. Wieland,<br />

A. Benet-Pagès, S. Eck, B. Rathkolb, M. Klaften, J. A.<br />

Aguilar-Pimentel, J. Calzada-Wack, E. Janas, E. Wolf, M.<br />

Ollert, F. Neff, M. Hrabé de Angelis, T. M. Strom.<br />

2923W Exome sequencing identified a novel mutation<br />

in CACNA1S in a Japanese family with malignant<br />

hyperthermia. N. Matoba, H. Iwasa, M. Kohda, Y.<br />

Yatsuka-Kanesaki, Y. Ichihara, H. Kikuchi, Y. Suzuki, S.<br />

Sugano, Y. K. Hayashi, I. Nishino, Y. Okazaki.<br />

2924T Identification <strong>of</strong> a novel missense mutation<br />

in RAD51 in a large family with congenital mirror<br />

movements. O. E. Onat, S. Gulsuner, R. Bilgen, G. M. Dal,<br />

K. Bilguvar, H. Boyaci, K. Doerschner, H. Uysal, M. Gunel,<br />

T. Ozcelik.<br />

2925F De novo mutations <strong>of</strong> the gene encoding the<br />

histone acetyltransferase KAT6B cause genitopatellar<br />

syndrome. M. A. Simpson, C. Deshpande, D. Dafou, L. E.<br />

L. M. Vissers, W. J. Woollard, S. E. Holder, G. Gillessen-<br />

Kaesbach, R. Derks, S. M. White, P. Cohen-Snuijf, S. G.<br />

Kant, L. H. Hoefsloot, W. Reardon, H. G. Brunner, E. M. F.<br />

H. Bongers, R. C. Trembath.<br />

2926W Focal facial dermal dysplasia, type IV is<br />

associated with mutations in CYP26C1. A. Slavotinek, P.<br />

Mehrotra, B. Li, I. Nazarenko, P. Ling-Fung, R. Z. Lao, C.<br />

Chu, M. Yahyavi, C. Chou, A. L. Marqueling, K. Cordoro, I.<br />

Frieden, M.-A. Morren, K. Devriendt, T. Prescott, T. Glaser,<br />

P.-Y. Kwok, M. Petkovich, R. Desnick.<br />

2927T Identity-by-descent mapping reveals a new<br />

locus for primary congenital glaucoma, GLC3E, on<br />

chromosome 19p13.2. H. Verdin, B. P. Leroy, B. D’haene,<br />

F. Coppieters, S. Lefever, P. G. Kestelyn, E. De Baere.<br />

2928F Mutations in HOXB1 cause autosomal<br />

recessive congenital facial palsy with sensorineural<br />

hearing loss and strabismus. B. D. Webb, S. Shaaban,<br />

H. Gaspar, L. F. Cunha, C. R. Schubert, K. Hao, C.<br />

D. Robson, W. Chan, C. Andrews, S. MacKinnon,<br />

D. T. Oystreck, D. G. Hunter, A. J. Iacovelli, X. Ye, A.<br />

Camminady, E. C. Engle, E. W. Jabs.<br />

2929W Genetic heterogeneity underlying female<br />

infertility and sensorineural hearing loss and<br />

identification <strong>of</strong> LARS2 as a third gene for Perrault<br />

syndrome. S. B. Pierce, T. Walsh, R. Michaelson-Cohen,<br />

R. E. Klevit, M.-C. King, K. Gersak, E. Levy-Lahad.<br />

2930T Exome sequencing in apparently recessive<br />

and apparently X-linked HSP families identifies an<br />

ATL1 mutation hotspot which is associated with low<br />

penetrance dominant inheritance. C. Beetz, R. E.<br />

Varga, H. Fadel, R. Schüle, I. Valenzuela, F. Speziani,<br />

G. Rudenskaja, G. Nürnberg, H. Thiele, J. Altmüller, V.<br />

Alvarez, J. Gamez, P. Nürnberg, S. Zuchner.<br />

2931F Autosomal recessive lethal congenital<br />

contractural syndrome type 4 caused by a mutation in<br />

MYBPC1. O. S. Birk, B. Markus, G. Narkis, R. Z. Birk, I.<br />

Cohen, D. Landau.<br />

2932W Exome sequencing <strong>of</strong> a pedigree with caudal<br />

regression syndrome. G. Cheng, E. H. M. Wong, P.<br />

C. Sham, S. S. Cherny, S. Maas, S. W. Scherer, C. R.<br />

Marshall, S. L. Pereira, P. K. H. Tam, M.-M. Garcia-Barceló.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2933T Loss <strong>of</strong> function mutations in OMIM genes<br />

reveal a burden <strong>of</strong> disease susceptibility in a<br />

consanguineous population. K. A. Fakhro, J. L.<br />

Rodriguez-Flores, N. R. Hackett, J. Salit, J. Fuller, J. A.<br />

Malek, L. Chouchane, R. Badii, A. Al-Marri, J. G. Mezey,<br />

R. G. Crystal.<br />

2934F Causal gene discovery in Mendelian disorders<br />

using whole exome sequencing. S. Jhangiani,<br />

M. Bainbridge, J. Lu, M. Wang, H. Dinh, Y. Han, J.<br />

Santibanez, M. Caramins, P. Campeau, B. Lee, J. Reid, J.<br />

Lupski, E. Boerwinkle, D. Muzny, R. Gibbs.<br />

2935W Whole genome sequencing and copy number<br />

analysis <strong>of</strong> exome sequencing in two families with splithand/split-foot<br />

malformation identifies chromosomal<br />

rearrangements affecting putative exonic enhancers. H.<br />

Lango Allen, R. Caswell, P. Turnpenny, C. Turner, C. Wragg,<br />

W. Xie, M. Weedon, X. Xu, S. Ellard.<br />

2936T Searching novel genes for hereditary hearing<br />

loss in multiplex families using next generation<br />

sequencing. Y. H. Lin, C. C. Wu, Y. C. Lu, C. J. Hsu, P. L.<br />

Chen.<br />

2937F Combination <strong>of</strong> genomic technologies and<br />

consanguinity in order to identify pathogenic variants<br />

in recessive disorders. P. Makrythanasis, M. Nelis, F.<br />

Santoni, M. Guipponi, F. Béna, A. Vannier, G. Duriaux-<br />

Sail, S. Gimelli, E. Stathaki, E. Falconnet, S. Temtamy, A.<br />

Megarbane, M. Aglan, M. S. Zaki, S. Fokstuen, A. Bottani,<br />

A. Masri, S. Psoni, S. Kitsiou, H. Fryssira, N. All-Allawi,<br />

A. Sefiani, S. Al-Hait, S. Elalaoui, N. Jalkh, L. Al-Gazali,<br />

F. Al-Jasmi, H. Chaabouni Bouhamed, H. Hamamy, S. E.<br />

Antonarakis.<br />

2938W A single exome variant is the only expected<br />

variant by likelihood ratio for a rare heritable de novo<br />

dominant disorder in a three generation family with<br />

two affected. S. M. Marchegiani, T. C. Markello, L. A.<br />

Wolfe, K. Fuentes-Fajardo, D. R. Adams, W. A. Gahl, J. C.<br />

Mullikin, T. Davis, J. P. Accardi, C. J. Tifft, C. F. Boerkoel,<br />

NISC Comparative Sequencing <strong>Program</strong>.<br />

2939T Whole-genome sequencing identifies mutations<br />

in known and novel genes for early infantile epileptic<br />

encephalopathy. H. C. Martin, A. T. Pagnamenta, K.<br />

Hudspith, A. Rimmer, R. Copley, E. Sadighi Akha, J.<br />

Broxholme, A. Kanapin, J.-B. Cazier, D. Shears, H.<br />

Stewart, D. Bentley, J. Taylor, E. Blair, P. Donnelly.<br />

2940F Novel intellectual disability genes identified by<br />

exome sequencing. R. Rabionet, O. Drechsel, A. Puig, J.<br />

Gonzalez, I. Madrigal, M. I. Alvarez, N. Baena, M. Viñas, S.<br />

Ossowski, M. Guitart, M. Mila, X. Estivill.<br />

2941W Targeted deep resequencing identifies a<br />

mutation in MID2, as causal for X-linked intellectual<br />

disability with varied disease severity. B. K. Thelma, S.<br />

G. Thenral, A. Michealraj, M. Kabra, G. Kaur, R. C. Juyal.<br />

2942T Exome sequencing and functional biology<br />

reveal novel genes causing infantile mitochondrial<br />

encephalopathy. P. Bonnen, A. Besse, T. Donti, S. Lalani,<br />

F. Scaglia, W. Craigen, B. Graham.<br />

POSTER SESSIONS 233<br />

2943F TIMM44 mutations identified by family-based<br />

WES cause severe mitochondrial respiratory chain<br />

disease due to defective mitochondrial protein import.<br />

M. J. Falk, S. Srinivasan, S. Dingley, J. Ostrovsky, M.<br />

Tsukikawa, E. Polyak, E. Place, M. Consugar, J. C. Perin,<br />

N. Avadhani, E. A. Pierce, X. Gai.<br />

2944W A novel form <strong>of</strong> limb girdle muscular dystrophy<br />

caused by impairment <strong>of</strong> an ER-to-Golgi trafficking<br />

component. N. Bögershausen, Y. Li, J. C. von Kleist-<br />

Retzow, R. Wirth, G. Nürnberg, H. Thiele, J. Altmüller, B.<br />

Schoser, P. Nürnberg, R. Heller, B. Wollnik.<br />

2945T Tackling giants with next-generation<br />

sequencing: homozygous or compound heterozygous<br />

truncating mutations <strong>of</strong> TTN from exome analysis<br />

define novel forms <strong>of</strong> cardiomyopathy with skeletal<br />

myopathy. C. Chauveau, C. Julien, H. Marks, R. Foley, A.<br />

L. Kho, B. Talim, M.-C. Arne-Bes, E. Uro-Coste, P. Maury,<br />

A. Vihola, B. Udd, H. Topaloglu, S. Moore, M. Gautel, C.<br />

Bonnemann, M.-E. Samuels, A. Ferreiro.<br />

2946F Exome sequencing for the molecular diagnosis<br />

<strong>of</strong> muscle disorders: Successes and challenges<br />

encountered. K. K. McDonald, J. Stajich, C. P. Blach, A.<br />

E. Ashley-Koch, M. A. Hauser.<br />

2947W Usher-exome: An efficient diagnostic approach<br />

when used in combination with LSDB USHBases,<br />

Variant Manager USHVAM and USMA. A. F. Roux, T.<br />

Besnard, G. Garcia Garcia, D. Baux, C. Vaché, L. Larrieu,<br />

V. Faugère, J. Millan, M. Claustres.<br />

2948T Loss <strong>of</strong> function mutations in HINT1 are a major<br />

cause <strong>of</strong> autosomal recessive axonal neuropathy with<br />

neuromyotonia. M. Zimon, J. Baets, L. Almeida-Souza, J.<br />

Nikodinovic, Y. Parman, E. Battaloglu, V. Guergueltcheva, I.<br />

Tournev, M. Auer-Grumbach, P. De Rijk, T. Müller, E. Fransen,<br />

P. Van Damme, W. Löscher, N. Barisˇ i ć , Z. Mitrovic, S. Previtali,<br />

H. Topaloglu, G. Bernert, A. Beleza-Meireles, B. Ishpekova,<br />

K. Peeters, A. Hahn, S. Züchner, V. Timmerman, P. Van Dijck,<br />

V. Milic Rasic, A. Janecke, P. De Jonghe, A. Jordanova.<br />

2949F Identification <strong>of</strong> novel genes in human primary<br />

immunodeficiency diseases using exome sequencing.<br />

S. Khan, B. Wakeland, C. Liang, M. De la Morena, N. Van<br />

Oers, E. Wakeland.<br />

2950W The ADAMTS18 gene is responsible for autosomal<br />

recessive syndromic retinal dystrophy. S. Banfi, I. Peluso,<br />

F. Testa, M. Pizzo, R. Collin, N. Meola, M. Mutarelli, G.<br />

Dharmalingam, M. Melone, I. Conte, F. Simonelli.<br />

2951T Novel PLP1 gene mutation discovered by whole<br />

genome sequencing in brothers with infantile onset<br />

dopa-responsive dystonia and delayed central nervous<br />

system demyelination. R. L. Margraf, J. Durtschi, K.<br />

Mallempati, J. Bonkowsky, R. Lutz, K. V. Voelkerding, K. J.<br />

Swoboda.<br />

2952F Digenic inheritance in autosomal recessive<br />

non-syndromic hearing loss cases carrying GJB2<br />

heterozygote mutations: Assessment <strong>of</strong> GJB4 and<br />

GJA1. D. Kooshavar, M. R. Noori Daloii, M. Hashemzadeh<br />

Chaleshtori.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


234 POSTER SESSIONS<br />

2953W Exocrine and endocrine pancreatic damage in<br />

cystic fibrosis are associated with SLC26A9. D. Soave,<br />

T. Chiang, M. Miller, D. Su, K. Keenan, W. Li, W. Ip, F.<br />

Wright, S. Blackman, H. Corvol, M. Knowles, G. Cutting,<br />

M. Drumm, L. Sun, J. Rommens, P. Durie, L. Strug.<br />

2954T Clinical findings <strong>of</strong> a three-generation family<br />

with GLA nonsense mutation (W162X). E. Severin, A.<br />

Stan, C. Dragomir, G. J. Sarca.<br />

2955F Targeted array-CGH analysis to identify copynumber<br />

changes underlying ciliopathies. A. Lindstrand,<br />

C. Carvalho, D. Pehlivan, R. D. Clark, C. A. Johnson, H.<br />

Omran, B. Franco, H. Kremer, P. L. Beales, P. J. Scambler,<br />

E. R. Maher, J. R. Lupski, N. Katsanis.<br />

2956W Is the R202Q mutation clinically relevant in<br />

familial Mediterranean fever, though? S. Duzenli, A. O.<br />

Arslan.<br />

2957T Molecular basis <strong>of</strong> microphthalmia/<br />

anophthalmia. N. Chassaing, A. Causse, A. Delahaye, A.<br />

Vigouroux, P. Calvas.<br />

2958F Identification and functional investigation <strong>of</strong><br />

non-coding NIPBL regulatory elements. D. Braunholz,<br />

J. Wilde, L. D. Michelis, K. S. Wendt, E. Watrin, J. Eckhold,<br />

I. D. Krantz, G. Gillessen-Kaesbach, M. A. Deardorff, F. J.<br />

Kaiser.<br />

2959W Molecular genetic studies <strong>of</strong> nonsyndromic<br />

oculocutaneous albinism in the Pakistani population.<br />

T. Jaworek, T. Kausar, N. Tariq, S. Sadia, M. I. Maqsood,<br />

A. Sohail, M. A. Bhatti, M. Ali, S. Riazuddin, R. S. Shaikh,<br />

Z. M. Ahmed.<br />

2960T A case <strong>of</strong> lymphedema with microcephaly and<br />

chorioretinopathy with a mutation in the KIF11 gene. D.<br />

Finegold, E. Lawrence, K. Levine, R. Ferrell.<br />

2961F miRNA-411 negatively regulates YAF2 and<br />

myogenic factors. Y. Chen, N. Harafuji, P. Schneiderat,<br />

M. C. Walter.<br />

2962W Transcriptional pr<strong>of</strong>iling in facioscapulohumeral<br />

muscular dystrophy to identify candidate biomarkers.<br />

F. Rahimov, O. D. King, D. G. Leung, G. M. Bibat, C. P.<br />

Emerson, Jr., K. R. Wagner, L. M. Kunkel.<br />

2963T The second most prevalent mutation <strong>of</strong> fukutin in<br />

Japanese Fukuyama muscular dystrophy. K. Kobayashi,<br />

R. Kato, E. Kondo, M. Osawa, K. Saito, T. Toda.<br />

2964F Molecular study <strong>of</strong> KRT14 mutations for making<br />

a screening panel test for Iranian patient affected with<br />

epidermolysis bullosa. M. Mahdavi, M. Moghaddam, A.<br />

Kakavand, N. Hatamnejadian, B. Sedaghati Khayat, H.<br />

Dehghanpour, A. Ebrahimi.<br />

2965W Mutations in ANO5 in the Norwegian limb<br />

girdle muscle dystrophy population. M. Van Ghelue,<br />

M. Ingebrigtsen, A. Skogstad, B. Hestholm, C. Wahl, S.<br />

I. Mellgren, F. Rasmussen, M. Rasmussen, B. Karimé, C.<br />

Jonsrud.<br />

2966T Mutation <strong>of</strong> the EYS gene implicated in<br />

autosomal recessive retinitis pigmentosa leads to<br />

abnornmal cellular aggregates and cell death. W.<br />

Mustill, P. Kruczek, A. C. Zelh<strong>of</strong>, S. S. Bhattacharya.<br />

Prenatal, Perinatal and<br />

Reproductive <strong>Genetics</strong><br />

2967T Mitochondrial DNA variations in human ova<br />

and blastocyst and its clinical implications and IVF<br />

outcome. M. Shamsi, G. Periyasamy, L. Chawla, N.<br />

Malhotra, N. Singh, S. Mittal, P. Talwar, K. Thangaraj, R.<br />

Dada.<br />

2968T Cumulus cell microRNA pr<strong>of</strong>iles are associated<br />

with oocyte aneuploidy. B. R. McCallie, J. C. Parks, N.<br />

Treff, R. T. Scott, W. B. Schoolcraft, M. G. Katz-Jaffe.<br />

2969T Prenatal diagnosis <strong>of</strong> sirenomelia by combining<br />

two-dimensional ultrasound, new fetal skeletal<br />

rendering, three-dimensional helical computer<br />

tomography and magnetic resonance imaging. X.-L.<br />

Chen, R. Liu, X.-H. Yang, N. Zhong.<br />

2970T Comparative study on quantitative parameters<br />

<strong>of</strong> blood perfusion and microvessel density in placenta<br />

<strong>of</strong> rat model <strong>of</strong> preeclampsia evaluated with contrastenhanced<br />

ultrasound. Y.-Q. Xu, X.-L. Chen, X.-J. Lu,<br />

X.-H. Yang, P.-W. Chen, J.-H. Huang, C. Huang, Z.-L. Lu,<br />

N. Zhong.<br />

2971T Prenatal ultrasound and autopsy findings in<br />

Simpson-Golabi-Behmel syndrome. K. Chong, J.<br />

Jessen, M. Injeyan, K. Fong, S. Salem, S. Keating, P.<br />

Shannon.<br />

2972T Testing the most frequent genetic diseases<br />

optimizes abnormal gene identity and test accuracy<br />

worldwide. R. Lebo.<br />

2973T Single nucleotide polymorphism based method<br />

for fetal fraction quantification in maternal plasma<br />

using massively parallel sequencing. G. Hogg, J. Tynan,<br />

M. Tang, S. Sovath, A. Maer, D. van den Boom, P. Oeth.<br />

2974T The Pregnancy and Health Pr<strong>of</strong>ile Pilot Project:<br />

Evaluating the impact <strong>of</strong> integrating a novel family<br />

history and genetic screening tool on patients,<br />

providers, and clinical practice. E. Edelman, B. Lin, T.<br />

Doksum, B. Drohan, K. Hughes, S. Dolan, V. Edelson, J.<br />

O’Leary, L. Vasquez, S. Copeland, J. Scott.<br />

2975T Chromosomal structural abnormalities among<br />

Filipino couples with recurrent pregnancy losses. E. C.<br />

Cutiongco-de la Paz, A. D. Berboso, E. G. Salonga, C. M.<br />

David-Padilla.<br />

2976T Factor II G20210A and factor V G1691A<br />

mutations and methylenetetrahydr<strong>of</strong>olate reductase<br />

C677T polymorphism in 155 women with repeated<br />

pregnancy loss. S. Seyedhassani, M. Houshmand, M.<br />

Neshan, F. Saeb.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


2977T Functional consequences <strong>of</strong> miscarriage copy<br />

number variations. J. Wen, C. W. Hanna, S. Martell, P. C.<br />

K. Leung, W. P. Robinson, M. Stephenson, E. Rajcan-<br />

Separovic.<br />

2978T The fetal fraction <strong>of</strong> cell-free DNA in maternal<br />

plasma is not affected by a priori risk <strong>of</strong> fetal trisomy.<br />

T. Musci, H. Brar, E. Wang, B. Brar, A. Y. Batey, A.<br />

Oliphant, M. E. Norton.<br />

2979T Role <strong>of</strong> E2F1 in testicular descent and fertility. C.<br />

Jorgez, J. Addai, J. Newberg, V. Vangapandu, A. Sahin, J.<br />

Rosenfeld, L. Lipshultz, D. Lamb.<br />

2980T Study <strong>of</strong> four SNPs in SLC6A14, INSR, TAS2R38<br />

and OR2W3 genes for association with Iranian<br />

idiopathic infertile men. E. Siasi, A. Aleyasin.<br />

2981T NLRP7 subcellular localization in human oocytes<br />

and early cleavage stages. E. Akoury, L. Zhang, M.<br />

Seoud, A. Ao, R. Slim.<br />

2982T <strong>Human</strong> spermatogenic failure purges<br />

deleterious mutation load from the autosomes and<br />

both sex chromosomes, including the gene DMRT1.<br />

D. F. Conrad, A. Lopes, K. I. Aston, F. Carvalho, J.<br />

Goncalves, R. Mathiesen, N. Huang, A. Ramu, J. Downie,<br />

S. Fernandes, A. Amorim, A. Barros, M. Hurles, S.<br />

Moskovtsev, C. Ober, J. Schiffman, P. N. Schlegel, M. De<br />

Sousa, D. T. Carrell.<br />

2983T A homozygous deletion <strong>of</strong> DPY19L2 gene is a<br />

cause <strong>of</strong> globozoospermia in men from the Republic<br />

<strong>of</strong> Macedonia. D. Plaseska-Karanfilska, P. Noveski, S.<br />

Madjunkova, I. Maleva, V. Sotiroska, Z. Petanovski.<br />

2984T Decreased puberty and fertility development<br />

in NELF KO mice due to impaired GnRH neuron<br />

migration. S. Quaynor, L. Chorich, R. Cameron, L.<br />

Layman.<br />

2985T Deficiency <strong>of</strong> PRSS37, a putative trypsin-like<br />

serine protease, causes male infertility from mouse to<br />

human. Z. G. Wang, C. L. Shen, J. B. Liu, J. S. Feng, Y.<br />

Kuang, H. X. Zhang, W. T. Wu, J. Chi, L. Y. Tang, J. Fei.<br />

2986T Changes in placental DNA methylation may be<br />

associated with karyotypically normal miscarriage. C.<br />

W. Hanna, D. E. McFadden, W. P. Robinson.<br />

2987T Co-culture <strong>of</strong> mouse embryonic stem cells with<br />

Sertoli cells promote in vitro generation <strong>of</strong> germ cells.<br />

M. Miryounesi, K. Nayernia, M. Dianatpour, S. Savad, M.<br />

H. Modarressi.<br />

2988T Androgen receptor CAG repeat length may<br />

influence the risk <strong>of</strong> polycystic ovarian syndrome. J. C.<br />

Silas, R. Singh, S. Nirmala Sadasivam, M. N. Sadasivam,<br />

L. Singh, K. Thangaraj.<br />

2989T An analysis <strong>of</strong> the initial experience <strong>of</strong>fering cellfree<br />

fetal DNA testing to pregnant women. J. Taylor, A.<br />

Ables, L. Hudgins.<br />

POSTER SESSIONS 235<br />

2990T Identification <strong>of</strong> messenger RNA <strong>of</strong> fetoplacental<br />

source in maternal plasma <strong>of</strong> women with normal<br />

pregnancies and pregnancies with intrauterin growth<br />

restriction. P. Ayala Ramírez, R. García Robles, J. D.<br />

Rojas, M. Bermúdez, J. Bernal Villegas.<br />

2991T Instant familial haplotyping in conjunction with<br />

embryo analysis in preimplantation genetic diagnosis<br />

using DNA microarrays. G. Altarescu, D. A. Zeevi, S.<br />

Zeligson, S. Perlberg, T. Eldar-Geva, E. J. Margalioth, E.<br />

Levy Lahad, P. Renbaum.<br />

2992T Role <strong>of</strong> cytokines in recurrent miscarriages. F.<br />

Parveen, S. Agrawal.<br />

2993T Developmental neuropsychological assessment<br />

<strong>of</strong> 4-5-year-old children born after preimplantation<br />

genetic diagnosis: A pilot study. G. Sacks, J. Guedalia,<br />

T. Eldar-Geva, T. Gilboa, E. J. Margalioth, E. Levy-Lahad,<br />

G. Altarescu.<br />

2994T Terminological clarification in PGD: Could it<br />

reframe the debate? S. Côté, P. Hamet.<br />

2995T A novel, generic, preimplantation genetic<br />

diagnosis protocol applied to cystic fibrosis involving<br />

mutation detection through high resolution melting<br />

analysis and simultaneous haplotype analysis through<br />

QF-PCR. A. Destouni, M. Poulou, G. Kakourou, C. Vrettou,<br />

J. Traeger-Synodinos, I. Fylaktou, E. Kanavakis, M. Tzetis.<br />

2996T PGD and heteroplasmic mitochondrial DNA<br />

point mutations: A systematic review estimating the<br />

chance <strong>of</strong> healthy <strong>of</strong>fspring. D. M. E. I. Hellebrekers, R.<br />

Wolfe, A. T. M. Hendrickx, I. F. M. de Coo, C. E. de Die, J.<br />

P. M. Geraedts, P. F. Chinnery, H. J. M. Smeets.<br />

2997T Successful pre-implantation genetic diagnosis<br />

in isolated sulfite oxidase deficiency: A happy end to<br />

the saga <strong>of</strong> a devastating neurogenetic disorder. A.<br />

Kondkar, K. Abu-Amero, M. Salih, T. Bosley.<br />

2998T Outcomes <strong>of</strong> 687 in vitro fertilization cycles and<br />

5871 embryos evaluated using 23-chromosome single<br />

nucleotide polymorphism microarray preimplantation<br />

genetic screening for recurrent pregnancy loss. K. J.<br />

Tobler, P. R. Brezina, A. T. Benner, L. Du, B. Boyd, W. G.<br />

Kearns.<br />

2999T Cleavage-stage blastomere biopsy significantly<br />

impairs human embryonic reproductive potential<br />

while blastocyst-stage trophectoderm biopsy does<br />

not: A paired randomized controlled trial utilizing SNP<br />

microarray-based DNA fingerprinting. N. R. Treff, K. M.<br />

Ferry, T. Zhao, J. Su, E. J. Forman, R. T. Scott, Jr.<br />

3000T Comparison <strong>of</strong> two whole genome amplification<br />

methods for preimplantation genetic diagnosis with<br />

HLA typing on beta-thalassaemia. Q. Wang, J. F. C.<br />

Chow, W. S. B. Yeung, E. H. Y. Ng, P. C. Ho.<br />

3001T Preimplantation genetic diagnosis for a carrier<br />

<strong>of</strong> complex chromosome rearrangement resulting in a<br />

healthy <strong>of</strong>fspring. K. Writzl, A. Veble, B. Peterlin.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


236 POSTER SESSIONS<br />

3002T Preimplantation genetic diagnosis in genomic<br />

regions with duplications and pseudogenes: Long<br />

range PCR in the single cell assay. D. A. Zeevi, R.<br />

Ron El, P. Renbaum, E. Kasterstein, D. Strassburger,<br />

D. Komarovsky, B. Maslanski, I. Ben-Ami, O. Bern, A.<br />

Komski, E. Levy Lahad, G. Altarescu.<br />

3003T TAR syndrome diagnosis confirmed by aCGH<br />

analysis. S. Ceylaner, Y. K. Terzi, S. Kalyoncu, F. I. Sahin.<br />

3004T Prenatal detection <strong>of</strong> anophthalmia in three<br />

cases with significantly different neonatal outcomes. T.<br />

Bardakjian, D. Dorsainville, A. Schneider.<br />

3005T Antenatal detection <strong>of</strong> a fetus with bilateral<br />

anophthalmia and pulmonary hypoplasia: A rare case<br />

report. C. C. Albu, D. F. Albu, M. Dumitrescu, E. Severin.<br />

3006T Outcomes following antenatal diagnosis <strong>of</strong><br />

ultrasonographically isolated cleft lip with or without<br />

cleft palate. A. Lehman, L. Burnell, C. Verchere, D.<br />

Pugash, S. Robertson, A. Loo.<br />

3007T cfDNA is not compromised by temperature<br />

stress <strong>of</strong> maternal blood collected in Streck cell-free<br />

DNA BCT. A. Huang, A. Srinivasan, V. Nguyen, J. Cheng,<br />

J. Sprowl, R. Van Luchene, A. Aziz, D. Comstock.<br />

3008T Effective epigenetic biomarker in first-trimester<br />

maternal plasma for non-invasive fetal trisomy 21<br />

detection. J. Lim, D. Lee, S. Kim, M. Kim, S. Park, Y. Han,<br />

M. Kim, M. Kim, K. Choi, H. Ryu.<br />

3009T Prenatal diagnosis <strong>of</strong> a fetus with mosaic<br />

trisomy 18, omphalocele and severe intrauterine<br />

growth restriction: Case report. D. F. Albu, C. C. Albu, A.<br />

Oncescu, E. Severin, M. Dumitrescu.<br />

3010T Chromosomal abnormalities in prenatal diagnosis:<br />

An Indian perspective. B. B. Ganguly, N. N. Kadam.<br />

3011T A powerful ‘smart tip’ method for nucleic acid<br />

extraction and enrichment <strong>of</strong> cell-free fetal DNA<br />

from maternal plasma. A. Gindlesperger, T. Stokes, P.<br />

Belgrader, R. Holmberg.<br />

3012T Prenatal detection <strong>of</strong> a supernumerary dicentric<br />

chromosome 15 through cytogenetics and array CGH<br />

after fetal ultrasound findings <strong>of</strong> micrognathia and<br />

small stomach bubble. J. L. Giordano, L. Cohen, V.<br />

Pulijaal, S. Gelber.<br />

3013T Prenatal diagnosis and fetal autopsy findings in<br />

Aicardi syndrome. M. C. Injeyan, I. Miron, P. Shannon, A.<br />

Malinowski, S. Blaser, D. Chitayat.<br />

3014T High-throughput massively parallel sequencing<br />

for fetal aneuploidy detection from maternal plasma. T.<br />

J. Jensen, T. Zwiefelh<strong>of</strong>er, R. C. Tim, Z. Dzakula, S. K. Kim,<br />

A. R. Mazloom, G. McLennan, C. Deciu, D. van den Boom,<br />

M. Ehrich.<br />

3015T Isolation <strong>of</strong> selected, single chromosomes from<br />

the isolated circulating fetal cells for clonal expansion,<br />

molecular pr<strong>of</strong>iling, and next-generation sequencing.<br />

M. Malecki, R. Malecki.<br />

3016T Noninvasive prenatal sex determination using<br />

massively parallel sequencing in samples from a large<br />

clinical validation study. P. Oeth, A. Mazloom, T. Wang,<br />

G. E. Palomaki, J. A. Canick, A. Bombard, D. van den<br />

Boom, M. Ehrich, C. Deciu.<br />

3017T MeDIP real time qPCR <strong>of</strong> maternal peripheral<br />

blood reliably identifies trisomy 21. P. Patsalis, E.<br />

Tsaliki, C. Spyrou, G. Koumbaris, E. Kypri, S. Kyriakou,<br />

C. Sotiriou, E. Touvana, A. Keravnou, A. Karagrigoriou,<br />

K. Lamnissou, V. Velissariou, C. Sismani, E. A.<br />

Papageorgiou.<br />

3018T Highly accurate non-invasive detection <strong>of</strong> fetal<br />

aneuploidy <strong>of</strong> chromosomes 13, 18, 21, X and Y by<br />

targeted sequencing. M. Rabinowitz, G. Gemelos, M. Hill,<br />

B. Levy, S. McAdoo, M. Savage, Z. Demko.<br />

3019T Accuracy <strong>of</strong> prenatal diagnosis in elective<br />

termination <strong>of</strong> pregnancy. J. Saraiva, F. Ramos, S. Maia,<br />

M. Branco, J. Raposo, J. Sá, S. Sousa, M. Venâncio, R.<br />

Pina, E. Galhano, L. Ramos.<br />

3020T Non-Invasive Chromosomal Evaluation Study:<br />

Results <strong>of</strong> a multicenter, prospective, cohort study for<br />

detection <strong>of</strong> fetal trisomy 21 and trisomy 18. K. Song,<br />

H. Brar, J. Weiss, A. Karimi, L. C. Laurent, A. B. Caughey,<br />

M. H. Rodriguez, J. Williams, III, M. E. Mitchell, C. D. Adair,<br />

H. Lee, B. Jacobsson, M. W. Tomlinson, D. Oepkes, D.<br />

Hollemon, A. B. Sparks, A. Oliphant, M. E. Norton, NICE<br />

Study Group.<br />

3021T Detection <strong>of</strong> fetal sub-chromosomal alterations<br />

in maternal plasma cell-free DNA using massively<br />

parallel sequencing. A. Srinivasan, X. Li, J. Sprowl, A.<br />

Huang, A. Sehnert, R. Rava.<br />

3022T Approach to prenatally diagnosed esophageal<br />

atresia/tracheoesophageal fistula. B. Suskin, S.<br />

Klugman, T. Goldwaser, A. Roe, K. Bajaj.<br />

3023T Quantification <strong>of</strong> fetal DNA in maternal plasma<br />

by massively parallel sequencing using fetal-specific<br />

methylation markers. M. Tang, J. Tynan, S. Sovath, A.<br />

Maer, G. Hogg, D. van den Boom, P. Oeth.<br />

3024T Curated gene set outperforms GWAS data on<br />

pathway-based genetic analysis. J. Padbury, A. Uzun, A.<br />

Dewan, S. Istrail.<br />

3025T Analysis <strong>of</strong> etiology and complications among<br />

1,128, including 493 iatrogenic and 635 spontaneous,<br />

Chinese preterm births. M. Xiao, W. Ren, N. Zhong.<br />

3026T Admixture mapping identifies susceptibility loci<br />

associated with preterm birth in African <strong>American</strong>s.<br />

H. Tsai, X. Liu, X. Hong, G. Wang, T. Chang, Q. Chen, C.<br />

Pearson, D. Caruso, L. Heffner, B. Zuckerman, X. Wang.<br />

3027T Single nucleotide polymorphism in Toll-like<br />

receptor 6 is associated with risk for Ureaplasma<br />

respiratory tract colonization and bronchopulmonary<br />

dysplasia in preterm infants. A. H. Winters, T. D. LeVan,<br />

S. N. Vogel, K. L. Chesko, T. I. Pollin, R. M. Viscardi.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3028T Genome-wide association study <strong>of</strong> preterm<br />

delivery in mothers. F. Geller, B. Feenstra, M. Melbye, R.<br />

Myhre, S. Myking, Early Growth <strong>Genetics</strong> Consortium, T.<br />

I. A. Sørensen, P. Magnus, M. L. Marazita, J. C. Murray, B.<br />

Jacobsson.<br />

3029T Evidence <strong>of</strong> SNP variation in the folic acid<br />

metabolic pathway associates with preterm birth. Y.<br />

Chen, B.-J. Wang, M.-J. Liu, Y. Wang, J. Mao, S.-N. Wang,<br />

J.-R. Dai, H. Li, N. Zhong.<br />

3030T Investigation <strong>of</strong> genetic risk factors for chronic<br />

adult diseases in preterm birth. N. Falah, J. McElroy, V.<br />

Snegovskikh, C. Lockwood, E. Kuczynski, E. Norwitz, J.<br />

Murray, R. Menon, K. Teramo, L. Muglia, T. Morgan.<br />

3031T Maternal SNPs in the p53 pathway: Risk factors<br />

for aneuploidy 21? A. P. C. Brandalize, J. A. Boquett, L.<br />

R. Fraga, L. Schuller-Faccini.<br />

3032T Disomy 21 mosaicism in sperm. E. Iwarsson, U.<br />

Kvist, M. A. Hultén.<br />

3033T DiGeorge sequence due to uncontrolled<br />

maternal gestational diabetes. A. Ludtke, T. Mucci, M.<br />

Aquino, E. Graber, L. Mehta.<br />

3034T Investigation <strong>of</strong> telomere length in newborns<br />

and correlation with gestation age and birth weight.<br />

E. C. Tan, S. N. Lim, Z. Yahya, D. Zeegers, T. Moe, E. E. P.<br />

Kyaw, G. S. H. Yeo, M. P. Hande.<br />

Clinical <strong>Genetics</strong> and Dysmorphology<br />

3035W A case <strong>of</strong> arthrogryposis and mosaic Turner<br />

syndrome. L. Mora, A. Lopez, I. Zarante.<br />

3036F Paternal uniparental disomy 6 and 2q13 deletion<br />

detected prenatally in a patient with cardiac defects,<br />

transient neonatal diabetes mellitus, hydrocephalus<br />

and dysmorphic features. D. Niyazov, C. Tillis, D.<br />

Feliperamirez, A. Robichaux.<br />

3037W Congenital acquired mosaicism for monosomy<br />

7. J. Hiemenga, S. Klemm, J. Foley, H. Toriello.<br />

3038F Overgrowth as a presenting symptom <strong>of</strong> the<br />

22q11.2 duplication syndrome: A novel association. D.<br />

McDonald-McGinn, E. Bratton, K. Dickinson, A. Kohut,<br />

A. Bailey, A. Wilkens, I. Krantz, B. Emanuel, S. Saitta, M.<br />

Deardorff, E. H. Zackai.<br />

3039W Down syndrome patients nutritional evaluation<br />

at the Hospital para el Nino Poblano outpatients. M.<br />

Cortes, J. M. Aparicio, R. J. M. Perez, F. E. P. Romero.<br />

3040F Follow-up <strong>of</strong> patient with non-supernumerary<br />

ring chromosome 7: Clinical manifestations,<br />

cytogenetic and molecular analysis. C. Salas, P. Perez-<br />

Vera, D. Cervantes, R. Cruz-Alcivar, R. Daber, L. Conlin,<br />

L. Leonard, N. B. Spinner, C. Durán-McKinster, V. Del<br />

Castillo-Ruiz.<br />

POSTER SESSIONS 237<br />

3041W Mowat-Wilson syndrome: Case report. J. Acosta<br />

Guio, A. Zarante.<br />

3042F The association <strong>of</strong> low socioeconomic status and<br />

the risk <strong>of</strong> having children with Down syndrome: A report<br />

from the National Down Syndrome Project. J. E. Hunter, E.<br />

G. Allen, L. J. H. Bean, S. B. Freeman, S. L. Sherman.<br />

3043W Surgical intervention for esophageal atresia in<br />

patients with trisomy 18. E. Nishi, T. Nakamura, K. Iio, S.<br />

Mizuno, H. Kawame, Y. Fukushima, T. kosho.<br />

3044F Mosaic supernumerary ring chromosome<br />

3: Does copy number gain <strong>of</strong> FOXP1 contribute<br />

to expressive speech impairment and intellectual<br />

disability? I. Filges, A. Datta, E. Boehringer, L. Suda, B.<br />

Roethlisberger, P. Miny.<br />

3045W Cat eye syndrome: Wide clinical variability in<br />

three patients from the same family. M. I. Melaragno,<br />

S. I. Belangero, A. N. Pacanaro, F. T. Belucco, D. M.<br />

Christ<strong>of</strong>olini, L. D. Kulikowski, R. S. Guilherme, A. Bortolai,<br />

A. R. Dutra, F. B. Piazzon, M. C. Cernach.<br />

3046F Maternally inherited Xq26.2 duplication in a male<br />

<strong>of</strong>fspring with severe prenatal and postnatal growth<br />

deficiency, dysmorphic facial features, hydrocephalus<br />

and developmental delay resembling Russell-Silver<br />

syndrome. L. Tuzovic, J. Wynn, L. Rohena, K. Anyane-<br />

Yeboa, A. Iglesias.<br />

3047W De novo translocation disrupting mediator<br />

complex subunit in a patient with Pierre-Robin<br />

sequence and developmental delay. K. H. Utami, A.<br />

M. Hillmer, E. G. Y. Chew, C. L. Winata, V. Korzh, S.<br />

Mathavan, P. Sarda, S. Davila, V. Cacheux.<br />

3048F 614kb Duplication at chromosome 9q22.32<br />

encompassing PTCH1 gene in a family with reciprocal<br />

translocation (9;20)(q22;q13) and intrafamilial<br />

phenotypic variability. C. Vinkler, D. Lev, A. Singer, A.<br />

Frumkin, M. Davidovich, M. Michelson, Y. Michaeli-Yossef.<br />

3049W Case report: A boy with 49, XXXXY syndrome,<br />

diagnosed by karyotype and a characteristic<br />

phenotype. A. Zarante, J. C. Prieto, O. Moreno.<br />

3050F 6p25 Interstitial deletion in two dizygotic twins<br />

with gyral pattern anomaly and speech and language<br />

disorder. M. Bozza, L. Bernardini, A. Novelli, P. Brovedani,<br />

E. Moretti, R. Canapicchi, V. Doccini, T. Filippi, A. Battaglia.<br />

3051W Microdeletion <strong>of</strong> 19p13.3 in a girl with Peutz-<br />

Jeghers syndrome, intellectual disability, hypotonia,<br />

and dysmorphic features. Y. Kuroda, T. Saito, J. Nagai,<br />

K. Ida, T. Naruto, M. Masuno, K. Kurosawa.<br />

3052F Maternal mosaicism for deletion <strong>of</strong> 22q13.3<br />

resulting in siblings with Phelan-McDermid syndrome.<br />

K. Phelan, B. R. DuPont, R. C. Rogers.<br />

3053W De novo interstitial deletion <strong>of</strong> 3q22.1-q22.3 in<br />

two patients: A new microdeletion syndrome. Y. Wilnai,<br />

W. Wilson, C. Jett, M. Manning.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


238 POSTER SESSIONS<br />

3054F Chromosomal microarray analysis <strong>of</strong> individuals<br />

with autism or learning deficits presenting for genetic<br />

services. J. Roberts, J. Hayes, N. Dzidic, K. Hovanes, M.<br />

Dasouki, M. G. Butler.<br />

3055W A Wolf Hirschhorn-like phenotype in a patient with<br />

a de novo 6q26-q27 deletion and 20p13-p12.1 duplication.<br />

F. Faucz, H. Salomão, R. B. de Alexandre, A. Bonalumi, J.<br />

Souza, J. A. Rosenfeld, S. Raskin, V. S. Sotomaior.<br />

3056F Submicroscopic chromosomal rearrangements<br />

in patients with an Angelman syndrome-like<br />

phenotype. K. Hosoki, T. Ohta, N. Niikawa, S. Saitoh.<br />

3057W Twenty-two year follow-up <strong>of</strong> identical<br />

twins with discordant phenotype due to a ring 13<br />

chromosomal mosaicism in one <strong>of</strong> them. Y. Lacassie.<br />

3058F 12p microRNA expression in fibroblast cell lines<br />

from probands with Pallister-Killian syndrome. K. Izumi,<br />

Z. Zhang, M. Kaur, I. Krantz.<br />

3059W <strong>Genetics</strong> <strong>of</strong> precocious puberty: A proband with<br />

Klinefelter syndrome, maternal uniparental disomy 14<br />

and precocious puberty. K. Reddy, H. Bass, J. Keni.<br />

3060F Molecular genetic testing <strong>of</strong> recurrent<br />

anencephaly in a family without partial trisomy 2p22pter.<br />

C. Sergi, J. Gekas, D. Kamnasaran.<br />

3061W Urethrocystoscopy, diagnostic laparoscopy,<br />

versus testicular descent gonadectomy in a patient<br />

with ambiguous genitalia: A case report. F. Cuellar-<br />

López, J. M. Aparicio, l. de la Torre.<br />

3062F Congenital association VACTERL at the Hospital<br />

para el Nino Poblano, Mexico: Fourteen case reports.<br />

A. Garcia-Guzman, J. M. Aparicio-Rodriguez.<br />

3063W Orthodontic correction in malformated<br />

unilateral teeth structure in a patient with<br />

pseudoachondroplasia: A case report. S. Ochoa, J. M.<br />

Aparicio, D. D. A. Camarillo, S. S. Cabrera.<br />

3064F Hearing loss frequency in a pediatric patient<br />

group at a third level hospital. A. Romero, J. M. Aparicio,<br />

L. P. C. Gallegos.<br />

3065W Diagnostic exome sequencing reveals a de<br />

novo mutation in the DYNC1H1 gene in a sporadic case<br />

<strong>of</strong> developmental delay, seizures, and polymicrogyria.<br />

K. D. Gonzalez, J. Wei, X. Li, H. M. Lu, H. Lu, J. S. Cohen,<br />

R. McClellan, S. Naidu, W. Zeng.<br />

3066F Congenital poikiloderma, fatty infiltration <strong>of</strong><br />

muscles and pulmonary fibrosis: A new syndrome.<br />

S. Mercier, S. Kury, J. M. Mussini, A. Magot, B. Isidor, S.<br />

Barbarot, A. David, S. Bezieau.<br />

3067W Prenatal diagnosis <strong>of</strong> a fetus with a<br />

rare association <strong>of</strong> a multiple heart and renal<br />

malformations: Case report. M. Dumitrescu, D. F. Albu,<br />

C. C. Albu, A. Oncescu, E. Severin.<br />

3068F Complex chromosomal translocation leading to<br />

a dual diagnosis <strong>of</strong> Prader-Willi syndrome and Cri-duchat<br />

in a 14- year-old boy illustrating the importance <strong>of</strong><br />

re-evaluation in an individual with atypical Prader-Willi<br />

phenotype. J. A. Gold, S. Ramanathan.<br />

3069W Molecular characterization <strong>of</strong> SHOX gene and<br />

regulatory regions in patients with idiopathic short<br />

stature from three medical centers in <strong>of</strong> Bogota,<br />

Colombia. T. Vinasco, G. Jaimes, M. Coll, C. Cespedes,<br />

H. Velasco.<br />

3070F Clinical and molecular characterization <strong>of</strong><br />

non-syndromic craniosynostosis: An international<br />

consortium approach. M. L. Cunningham, P. A.<br />

Romitti, C. M. Justice, A. F. Wilson, T. Roscioli, E.<br />

Oláh, B. Bessenyei, M. R. Passos-Bueno, B. Wollnik,<br />

A. O. M. Wilkie, S. A. Boyadjiev Boyd, International<br />

Craniosynostosis Consortium.<br />

3071W Molecular prenatal diagnosis <strong>of</strong> a sporadic<br />

alobar holoprosencephalic fetus: Genotype-phenotype<br />

correlations. J. Gekas, C. Sergi, D. Kamnasaran.<br />

3072F Sonic Hedgehog regulatory region deletion in<br />

a patient with holoprosencephaly. L. Ribeiro-Bicudo,<br />

R. Quiezi, M. Ansari, K. Williamson, A. Richieri-Costa, D.<br />

FitzPatrick.<br />

3073W Associated malformations among infants with<br />

radial ray deficiency. C. Stoll, B. Dott, Y. Alembik, M. P.<br />

Roth.<br />

3074F Or<strong>of</strong>aciodigital syndrome in a group <strong>of</strong> patients<br />

who attended Operation Smile Foundation in Colombia,<br />

between 2005 and <strong>2012</strong>. J. Martinez, I. Briceno, A.<br />

Venegas, S. Bohorquez, M. Montiel, A. Patiño, L. Arias.<br />

3075W A new type <strong>of</strong> acr<strong>of</strong>acial dysplasia: Prenatal<br />

diagnosis and autopsy findings. K. Millar, A. Toi, S.<br />

Keating, P. Shannon, S. Unger, D. Chitayat.<br />

3076F Development <strong>of</strong> a visit assessment tool to address<br />

birth defects and dysmorphology. O. A. Abdul-Rahman, L.<br />

Hayes, B. Loyola, D. A. Stevenson, S. Astley, C. Chambers,<br />

K. L. Jones, H. E. Hoyme, F. Waffern, J. C. Carey.<br />

3077W A new case <strong>of</strong> crani<strong>of</strong>acial microsomia autosomal<br />

dominant associated with complete right side testicular<br />

and scrotal ectopia. J. Rojas Martínez, J. C. Prieto Rivera.<br />

3078F A replication study <strong>of</strong> genome-wide significant<br />

rheumatoid arthritis susceptibility loci in the Pakistani<br />

population. S. F. Jalil, A. Bhatti, F. Y. Demirci, X. Wang, I.<br />

Ahmed, M. Ahmed, M. M. Barmada, J. M. Malik, P. John,<br />

M. I. Kamboh.<br />

3079W A novel missense mutation in PARD3 is<br />

associated with class III malocclusion. T. Nikopensius,<br />

M. Kals, T. Annilo, T. Jagomägi, M. Saag, A. Metspalu.<br />

3080F Genotype/phenotype correlation in Smith-<br />

Magenis syndrome with abnormal 17p deletions.<br />

T. Vilboux, A. C. M. Smith, S. Chandrasekharappa, C.<br />

Ciccone, J. Blancato, W. J. Introne, W. A. Gahl, M. Huizing.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3081W MiR-133a and MiR-422a in human circulating<br />

monocytes are potential microRNA biomarkers<br />

underlying postmenopausal osteoporosis. Y. Wang, L.<br />

Li, B. T. Moore, X. H. Peng, X. Fang, J. M. Lappe, R. R.<br />

Recker, P. Xiao.<br />

3082F Genome-wide mosaic paternal uniparental<br />

isodisomy. J. Kalish, A. Wilkens, S. Mulchandani, E.<br />

Zackai, N. Spinner, M. Bartolomei, L. Conlin, M. Deardorff.<br />

3083W The catalase: Influence <strong>of</strong> C-262 T<br />

polymorphism on keratoconus. S. Torabi Dalivandan,<br />

Z. Salehi, S. Saboohi, M. J. Mohammadi Fatideh, H.<br />

Yourdkhani.<br />

3084F Metabolic abnormalities in Williams-Beuren<br />

syndrome patients and candidate genes. M. G.<br />

Palacios, R. Flores, V. Campuzano, M. del Campo, M.<br />

Segura-Puimedón, L. A. Perez-Jurado.<br />

3085W Bilateral radioulnar synostosis and vertebral<br />

anomalies in a child with a 16p13.3 interstitial deletion.<br />

T. Slavin, A. Tam, K. Lee, S. Lee, W. Burkhalter.<br />

3086F ASTN2 deletions in autism spectrum disorder<br />

and related neuropsychiatric phenotypes. M. T. Carter,<br />

A. C. Lionel, A. K. Vaags, B. A. Fernandez, W. Roberts, P.<br />

Szatmari, C. R. Marshall, S. W. Scherer.<br />

3087W Atypical deletions <strong>of</strong> the Williams-Beuren<br />

syndrome region implicate genes involved in mild<br />

facial phenotype, epilepsy and autistic traits. G. Merla,<br />

L. Micale, C. Fusco, B. Augello, P. Alfieri, M. C. Digilio, D.<br />

Menghini, S. Vicari.<br />

3088F Morphogenesis <strong>of</strong> the face in Wolf-Hirschhorn<br />

syndrome: Three elucidative patients. J. Carey, A.<br />

Calhoun, P. Hammond, A. Lortz, S. South.<br />

3089W Growth hormone receptor gene polymorphism<br />

and Prader-Willi syndrome. M. G. Butler, J. Roberts, J.<br />

Hayes, X. Tan, A. Manzardo.<br />

3090F Molecular characterization and genotype/<br />

phenotype correlation <strong>of</strong> ten patients with structural<br />

rearrangements in the NIPBL gene. Y.-W. Cheng, C. Tan,<br />

K. Arndt, S. Das, D. del Gaudio.<br />

3091W TSC2-PKD1 contiguous deletion syndrome<br />

with aortic stenosis and severe myopia. K. Enomoto, Y.<br />

Sugawara, M. Hotate, Y. Motoyoshi, Y. Hatai, S. Mizutani,<br />

K. Kurosawa.<br />

3092F Jacobsen syndrome: Cognitive-behavioral<br />

pr<strong>of</strong>iles, developmental trajectories, and IQ related to<br />

deletion size. G. Fisch.<br />

3093W Concurrent deletion <strong>of</strong> BMP4 and OTX2<br />

genes: Clinical evidence <strong>of</strong> synergistic effect <strong>of</strong> the<br />

two master genes in ophthalmogenesis. R. Kosaki, T.<br />

Takenouchi, C. Torii, S. Nishina, K. Kosaki.<br />

3094F Interstitial deletion <strong>of</strong> 3.8 Mb in chromosome<br />

6q25.2-6q25.3 in a patient with C<strong>of</strong>fin-Siris syndrome. S.<br />

Mizuno, E. Nishi, Y. Muramatsu, M. Tominaga, K. Kurosawa.<br />

POSTER SESSIONS 239<br />

3095W Detailed neurodevelopmental phenotype <strong>of</strong><br />

a child with a 22q11.2 distal deletion. S. Mosca, L. M.<br />

Langevin, A. C. Lionel, C. R. Marshall, B. Argiropoulos, A.<br />

M. Innes, S. W. Scherer, D. Dewey, J. S. Parboosingh, F.<br />

P. Bernier.<br />

3096F A de novo 163 kb interstitial 1q44 microdeletion in<br />

a boy with thin corpus callosum, psychomotor delay and<br />

seizures. K. Selmer, E. Bryne, O. Rødningen, M. Fannemel.<br />

3097W Genotype phenotype correlation study <strong>of</strong><br />

2q23.1 microdeletion syndrome and characterization <strong>of</strong><br />

three new patients. L. Zhang, H. T. Bjornsson, D. Batista,<br />

G. Wiesner, T. Wang, A. Parikh.<br />

3098F Polycystic kidney disease and a 2.5Mb<br />

duplication on chromosome 3p22.1. K. Dahan, M.<br />

Madhoun, M. Gilliaux, V. Benoit, B. Grisart.<br />

3099W Subtelomeric deletion including the WHSC1<br />

gene located in the critical region <strong>of</strong> the Wolf-<br />

Hirschhorn syndrome. A. L. S. Ludmila Serafim, J. M.<br />

Pina Neto, l. F. Mazzucatto.<br />

3100F Atypical form <strong>of</strong> osteopathia striata with<br />

cranial sclerosis and increased mineral density in<br />

an adolescent female with mosaic chromosome 2<br />

rearrangement. R. Mendoza-Londono, A. Howard, E.<br />

Sochett, L. Dupius, D. J. Stavropoulos, R. C. C. Wong, S.<br />

Robertson, A. M. Joseph-George.<br />

3101W Further evidence <strong>of</strong> the role <strong>of</strong> HOXA genes in<br />

anatomical development. P. A. Mowery-Rushton, R. A.<br />

Schultz, J. B. Ravnan, J. E. Burton, J. Kussmann, J. A.<br />

Rosenfeld, B. C. Ballif, L. G. Shaffer.<br />

3102F 4p16.3 Deletion limited to WHSCR2. N. Okamoto,<br />

K. Shimojima, T. Yamamoto.<br />

3103W Array CGH in 190 Korean patients with<br />

developmental delay and/or intellectual disability: A<br />

single tertiary care university center study. Y. Sohn, C.<br />

Lee, S. Park, J. Yun, E. Jung, H. Kim, S. Yim.<br />

3104F Diagnostic investigation in Rwandan patients<br />

with MR/MCA. A. Uwineza, J. Hitayezu, L. Mutesa.<br />

3105W Clinical features and genomic characterization<br />

<strong>of</strong> two subjects with a pure duplication <strong>of</strong> 9q34. H.<br />

Yoshihashi, M. Ikegami, C. Torii, K. Kosaki.<br />

3106F Osteopathia striata with cranial sclerosis and<br />

developmental delay in a male with a mosaic deletion<br />

in chromosome region Xq11.2. S. Chenier, A. Noor, L.<br />

Dupuis, D. J. Stavropoulos, R. Mendoza-Londono.<br />

3107W Keratoconus associated with Williams-Beuren<br />

syndrome: New case report. M. C. Frasson, M. M. Viana,<br />

L. L. Leao, M. St<strong>of</strong>anko, H. Goncalves-Dornelas, P. S.<br />

Cunha, M. J. B. Aguiar.<br />

3108F Minimal interstitial deletion in a patient with de<br />

novo 15q24 microdeletion syndrome presenting with<br />

severe scoliosis. X. Gao, C. Johnston, S. Sparagana, C.<br />

A. Wise.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


240 POSTER SESSIONS<br />

3109W Microdeletions in 9q33.3-q34.1 may constitute<br />

a contiguous gene deletion syndrome characterized<br />

by developmental delay, microcephaly, mild<br />

dysmorphisms, strabismus, and seizures <strong>of</strong> incomplete<br />

penetrance. J. A. Lee, J. K. Ehret, E. Wohlleber, S. Vogt,<br />

A. M. Zink, E. Rossier, M. Bonin, U. Grassh<strong>of</strong>f, A. Bevot, M.<br />

Mathieu-Dramard, G. Plessis, A. de Broca, S. Kanafani, B.<br />

Röthlisberger, M. Holder-Espinasse, I. Simonic, L. Willatt, P.<br />

Miny, I. Filges, J. Andrieux, H. V. Firth, A. Dufke, H. Engels.<br />

3110F Identification and diagnosis <strong>of</strong> Williams-Beuren<br />

syndrome in a public genetic center in Brazil. M. M.<br />

Viana, M. St<strong>of</strong>anko, P. S. Cunha, H. Goncalves-Dornelas,<br />

M. J. B. Aguiar, S. D. J. Pena.<br />

3111W Implementation <strong>of</strong> molecular karyotyping<br />

in routine diagnostics provides new insights into<br />

the pathophysiology <strong>of</strong> Silver-Russell syndrome. S.<br />

Spengler, M. Begemann, N. Ortiz Brüchle, P. M. Kroisel, B.<br />

Oehl-Jaschkowitz, G. Raabe-Meyer, C. Spaich, P. Blümel,<br />

U. Moog, K. Zerres, T. Eggermann.<br />

3112F Clinical, molecular cytogenetic evaluation and<br />

genotype-phenotype correlation <strong>of</strong> a patient with<br />

partial Jacobsen syndrome without thrombocytopenia<br />

caused by an 13 Mb deletion <strong>of</strong> del(11)(q24.1). J. Moon,<br />

J. Kim, J. Kim, M. Nam, S. Yoon.<br />

3113W Triplication <strong>of</strong> 7q11.23 distal to the critical<br />

region for the Williams-Beuren syndrome. J. G. Pappas,<br />

R. D. Nass, E. Ward, I. K. Gadi.<br />

3114F A de novo 9.0 Mb deletion at chromosome<br />

region 10q21.3-q22.3 associated with severe<br />

psychomotor delay and mild Noonan phenotype:<br />

A case report. S. Baffini, G. Scarselli, L. Castiglia, M.<br />

Vinci, S. Amata, M. Fichera, J. D. Barp, E. Gambineri, E.<br />

Chiappini, M. L. Giovannucci Uzielli.<br />

3115W A first reported case <strong>of</strong> a microdeletion in<br />

8q22.22q23 in Colombia: Phenotypic and genotypic<br />

correlation. P. Paez, S. Perdomo, X. Rojas.<br />

3116F A microdeletion <strong>of</strong> about 831 kb in a young<br />

woman causes a loss <strong>of</strong> more than 30 genes on the<br />

long arm <strong>of</strong> chromosome 17 including a copy <strong>of</strong> the<br />

BRCA1 gene: Implications for genetic counseling and<br />

clinical management. P. M. Kroisel, J. B. Geigl, M. Mach,<br />

C. Pischler, E. Vallant, M. R. Speicher, K. Wagner.<br />

3117W A familial atypical Williams-Beuren deletion<br />

encopassing ELN and part <strong>of</strong> LIMK1 gene. B. Demeer,<br />

F. M. Caron, S. Chenichene, G. Morin, A. Receveur,<br />

H. Copin, A. de Broca, O. Godefroy, D. Sanlaville, M.<br />

Mathieu, P. Saugier-Veber.<br />

3118F 12q21 Deletion syndrome with intellectual<br />

disability and facial dysmorphism. A. Matsumoto, T.<br />

Yamagata, Y. Nozaki, E. F. Jimbo, M. Y. Momoi.<br />

3119W Autism, mild facial dysmorphism, abnormal<br />

EEG, sleep problems and language impairment in<br />

interstitial duplication 15q11-q13 syndrome. N. Urraca,<br />

C. Cleary, E. Pivnick, K. McVicar, V. Brewer, R. Thibert, N.<br />

C. Schanen, M. C. Esmer, D. Lamport, L. T. Reiter.<br />

3120F Mucolipidosis III gamma, tuberous sclerosis,<br />

and polycystic kidney disease caused by a contiguous<br />

gene deletion on chromosome 16p13.3. J. Barea, L.<br />

Bird.<br />

3121W GH deficiency and epilepsy in a patient with a<br />

19q13.3 duplication encompassing the PTH2, KCNC3<br />

and KCNA7genes. M. Vincent, C. Jeandel, J. Puechberty,<br />

C. Coubes, F. Dallavale, F. Rivier, A. Schneider, M. Girard,<br />

N. Ruiz, M. Tournaire, I. Touitou, G. Lefort, P. Sarda, D.<br />

Genevieve.<br />

3122F A large deletion confined to COL4A5 causes<br />

Alport syndrome and diffuse leiomyomatosis. M.J.<br />

N. Sá, R. Sousa, F. T. Costa, F. Carvalho, S. Alves, F.<br />

Carvalho, J. P. Oliveira.<br />

3123W Genetic study <strong>of</strong> a family segregating<br />

Waardenburg-Shah syndrome. L. Cui, H. M. Wong, J.<br />

Zhu, F. de Almeida M., P. H. Tam, M.-M. Garcia-Barceló.<br />

3124F Founder effect <strong>of</strong> spinocerebellar ataxia<br />

type 7 in a Mexican population. Y. Tapia-Guerrero,<br />

O. Hernández-Hernández, M. Maldonado-Rodríguez,<br />

C. Cerecedo-Zapata, N. Leyva, L. Velázquez-Pérez, B.<br />

Cisneros, J. J. Magaña.<br />

3125W Study <strong>of</strong> GJB2, GJB6 and MT-RNR1 m.1555A.G<br />

in Mexican hearing loss patients. M. Arenas-Sordo,<br />

I. Menendez, E. Hernández-Zamora, A. Simarci, D.<br />

Gutierrez, P. Murphy, X. Leyva, F. Huesca, J. Dominguez-<br />

Aburto, M. Tekin.<br />

3126F A family with an OPA1 mutation and associated<br />

hearing loss. C. Williams, H. Stalker, S. Schimpf-<br />

Linzenbold, B. Wissinger.<br />

3127W Cerebrocostomandibular syndrome: Clinical<br />

features <strong>of</strong> three new cases and preliminary analysis<br />

<strong>of</strong> exome sequencing data. D. C. Lynch, E. Lemire, B.<br />

Chodirker, A. M. Innes, J. S. Parboosingh, F. P. Bernier,<br />

FORGE Canada Consortium.<br />

3128F Dandy Walker malformation in a boy with Ellis-van<br />

Creveld dysplasia. J. Davis, E. Carter, P. Brill, C. Raggio.<br />

3129W NEK1 and DYNC2H1 are both involved in short<br />

rib polydactyly Majewski type but not in Beemer<br />

Langer cases. J. El Hokayem, C. Huber, A. Couve, J.<br />

Aziza, G. Baujat, R. Bouvier, D. P. Cavalcanti, F. A. Collins,<br />

M. P. Cordier, A. L. Delezoide, M. Gonzales, D. Johnson,<br />

M. Le Merrer, A. Levy-Mozziconacci, P. Loget, D. Martin-<br />

Coignard, J. Martinovic, G. R. Mortier, M. J. Perez, J.<br />

Roume, G. Scarano, A. Munnich, V. Cormier-Daire.<br />

3130F Refsum disease: Genotype-phenotype<br />

correlation <strong>of</strong> a novel PHYH mutation in a Brazilian<br />

patient. L. A. R. Gabriel, J. Chiang, R. C. C. Filho, L. G.<br />

Freitas, M. P. Avila.<br />

3131W Description <strong>of</strong> sclerocornea in a patient with<br />

van den Ende Gupta syndrome and homozygous<br />

mutation in SCARF2. M. Migliavacca, N. Sobreira, G.<br />

Antonialli, M. Moysés, M. Melaragno, D. Valle, D. Brunoni,<br />

A. Perez.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3132F Two brothers with autosomal-recessive primary<br />

hypertrophic osteoarthropathy caused by homozygous<br />

deletion in HPGD gene: Neonatal findings and longterm<br />

follow-up. B. Tüysüz, S. Yilmaz, K. Bilguvar, O.<br />

Kasapçopur, E. Gül, M. Günel.<br />

3133W Germline mosaicism for a 12q24 deletion<br />

identifies haploinsufficiency <strong>of</strong> MED13L as a cause <strong>of</strong><br />

hypotonia and moderate developmental delay. R. C.<br />

Gallagher, S. Scrivner, K. Brown, A. Collins, M. Saenz.<br />

3134F Genetic analysis <strong>of</strong> the GBA gene in Japanese<br />

familial Parkinson’s disease. Y. Li, M. Funayama, T.<br />

Sekine, L. Li, H. Yoshino, K. Nishioka, H. Tomiyama, N.<br />

Hattori.<br />

3135W Manganese-related T1 hyperintensities <strong>of</strong> the<br />

basal ganglia in hereditary hemorrhagic telangiectasia<br />

with iron-deficiency anemia. M. McKinnon, S. Appel-<br />

Cresswell, B. Jung, S. Langlois.<br />

3136F CASK aberrations in males with Ohtahara<br />

syndrome and cerebellar hypoplasia. H. Saitsu, M.<br />

Kato, H. Osaka, N. Moriyama, H. Horita, K. Nishiyama, T.<br />

Yoshinori, H. Doi, N. Miyake, K. Hayasaka, N. Matsumoto.<br />

3137W Unusual presentation <strong>of</strong> combined saggitalmetopic<br />

synostosis is caused by mutations in the<br />

MSX2 gene: Expanding the phenotype <strong>of</strong> the Bostontype<br />

craniosynostosis syndrome. O. M. Vanakker, A.<br />

Janssen, M. J. Hosen, P. Jeannin, P. J. Coucke, A. De<br />

Paepe.<br />

3138F Automated preparation <strong>of</strong> samples for benchtop<br />

sequencing applications. I. Meek.<br />

3139W Neur<strong>of</strong>ibromatosis type 1 and infantile<br />

my<strong>of</strong>ibromatosis: A shared genetic basis or<br />

independently co-existent entities? S. Krishnamurthi, V.<br />

Cox, H. Guo, K. Rauen.<br />

3140F Homozygosity mapping and candidate gene<br />

cloning identified CLDN10 variation to be possibly<br />

responsible for congenital ichthyosis: Renal<br />

hypokalemia in an Algerian family. S. Hadj-Rabia, Y. Al-<br />

Sarraj, M. Kambouris, C. Bodemer, H. El-Shanti.<br />

3141W Homozygous mutation <strong>of</strong> SIX1 associated with<br />

a severe branchio-oto-renal syndrome phenotype. S. L.<br />

Sawyer, M. A. Thomas, R. Lamont, L. Dimnik, P. Gordon,<br />

X. C. Wei, F. P. Bernier, J. S. Parboosingh, A. M. Innes.<br />

3142F Cardiac malformations associated with germline<br />

WT1 mutations in children presenting with Wilms’<br />

tumor. S. Bowdin, C. Owens, D. Malkin, N. Parkinson, M.<br />

Friedburg, R. Grant.<br />

3143W False positive diagnosis <strong>of</strong> Marfan syndrome in<br />

adult patient with homocystinuria who fulfilled Ghent<br />

criteria. S. Dyack, H. MacDonald, K. Schindeler, A. Rideout.<br />

3144F VCP disease is associated with cytokine<br />

imbalances in patient plasma. E. Dec, F. Zaldivar, M.<br />

Wencel, M. Khare, J. Vesa, V. E. Kimonis.<br />

POSTER SESSIONS 241<br />

3145W Further expansion <strong>of</strong> the Chediak-<br />

Higashi phenotype: Three adult siblings with<br />

neurodegenerative disease and homozygous for a<br />

novel LYST deletion. L. Mehta, C. Cho, F. R. Dembitzer, A.<br />

Szporn, M. C. Chicka, J. D. Wesfeld-Adams.<br />

3146F Familial acanthosis nigricans: Phenotypic<br />

features <strong>of</strong> aberrant area cutanea and hyperpigmented<br />

dots identified by dermoscopy. N. Oiso, M. Miyake, K.<br />

Fukai, A. Kawada.<br />

3147W Clinical clues to differentiate among severe<br />

forms <strong>of</strong> osteogenesis imperfecta. P. Prasun, A. Jay, D.<br />

Stockton.<br />

3148F Description <strong>of</strong> a fetal syndrome associated<br />

with HNF1B mutation and a wide intrafamilial disease<br />

variability. M. Rasmussen, I. Vogel, O. B. Petersen, M.<br />

Ramsing, L. Sunde.<br />

3149W Novel molecular changes and their associated<br />

clinical characteristics in Saudi patients with familial<br />

hemophagocytic lymphohistiocytosis. A. Al-Ahmari, O.<br />

Alsmadi, L. Elbaik, T. Elamin, B. Al-Saud, S. Al-Shambri,<br />

M. Al-Awwami, I. Al-Fawaz, M. Ayas, K. Siddiqui, M.<br />

Viqaruddin, A. Hawwari.<br />

3150F Hip pathology in Majewski osteodysplastic<br />

primordial dwarfism type II. M. B. Bober, A. F. Karatas, A.<br />

L. Duker, K. Rogers, C. Ditro, W. G. Mackenzie.<br />

3151W Boyadjiev-Jabs syndrome: Clinical and<br />

molecular characterization <strong>of</strong> three new patients. S. A.<br />

Boyadjiev Boyd, S. Kim, L. Bivina, E. Zackai, P. L. Crotwell,<br />

K. Õunap, J. Kim.<br />

3152F Schinzel-Gideon syndrome in two Brazilian<br />

patients: Report <strong>of</strong> a novel mutation in SETBP1. E. D. F.<br />

Carvalho, M. Lazar, T. F. Almeida, C. R. D. C. Quaio, G. L.<br />

Yamamoto, K. M. Rocha, C. A. Kim, M. R. Passos-Bueno,<br />

D. R. Bertola.<br />

3153W HOXA10 and HOXA13 sequence variations<br />

in human female genital malformations including<br />

congenital absence <strong>of</strong> the uterus and vagina. A. Ekici,<br />

C. Büttner, P. Strissel, P. Oppelt, S. Renner, S. Brucker, M.<br />

Beckmann, R. Strick.<br />

3154F Establishing a paternal age effect for Crouzon<br />

syndrome with acanthosis nigricans. T. Greer, C.<br />

LaDana, P. Barros-Nunez, F. Di Rocco, C. Collet, E. W.<br />

Jabs, R. L. Glaser.<br />

3155W Characterization <strong>of</strong> hyper-IgM syndrome due to<br />

CD40 deficiency in 11 patients. A. Hawwari, H. Alassiri,<br />

Z. Al-Sum, A. Al-Ghonaium, S. Al-Muhsen, H. Al-Dhekri,<br />

R. Arnaout, O. Alsmadi, E. Borrero, A. Abu-staiteh, H. Al-<br />

Mousa, B. K. Al-Saud.<br />

3156F New insights into the renal aspects <strong>of</strong><br />

hypotrichosis-lymphedema-telangiectasia syndrome<br />

caused by a mutation in the SOX18 gene. S. Moalem, M.<br />

Vikkula, E. Harvey, D. Chitayat.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


242 POSTER SESSIONS<br />

3157W Missense and synonymous TCF4 mutations<br />

are responsible for splicing defects in Pitt-Hopkins<br />

syndrome. M. Nasser, L. Drévillon, A. Briand-Suleau,<br />

J. Ghoumid, T. Gaillon, V. Bodereau, L. Pasquier, M.<br />

Goossens, J. Amiel, D. Héron, I. Giurgea.<br />

3158F Clinical genetics in silico: Use <strong>of</strong> an electronic<br />

medical record in an integrated healthcare system<br />

to identify individuals with undiagnosed Noonan<br />

syndrome. M. E. Nunes, R. E. Barber, S. K. Kwok, R. R.<br />

Wilson, D. J. Levy.<br />

3159W Detailed clinical and or<strong>of</strong>acial phenotype <strong>of</strong><br />

three families with compound heterozygous WNT10A<br />

mutations using three-dimensional imaging methods.<br />

C. W. Ockeloen, C. Vink, S. ten Kate, C. van Heumen, T.<br />

Kleefstra, C. Carels.<br />

3160F Tegumentary manifestations in RASopathies<br />

are common and deserve special attention. C. R. D. C.<br />

Quaio, A. S. Brasil, A. C. Pereira, C. A. Kim, D. R. Bertola.<br />

3161W Molecular analysis and expression studies in<br />

a novel candidate gene for syndromic coloboma. N.<br />

K. Ragge, A. Wyatt, D. Robinson, D. Bunyan, D. Wong, I.<br />

Ragoussis.<br />

3162F Variable expressivity <strong>of</strong> FREM1-related<br />

anomalies in a family with novel mutation. A. Singer, A.<br />

Slavotinek, H. Leiba, S. Josefsberg, C. Vinkler.<br />

3163W Identification <strong>of</strong> a KRIT1 p.Gln201Glu mutation<br />

in a Persian family with multiple cerebral, spinal and<br />

skin cavernous malformations. S. M. Sperber, D. Fathi,<br />

M. Shahbazi, M. M. Motahari, B. Friedman, A. Haghighi.<br />

3164F Novel 3q26 EVI1/MECOM deletion syndrome in a<br />

newborn with multiple severe congenital abnormalities<br />

and bone marrow failure. L. T. van der Veken, M. B.<br />

Bierings, M. C. Maiburg, F. Groenendaal, A. C. Bloem, N.<br />

V. Knoers, A. Buijs.<br />

3165W KIAA 2022-related X-linked intellectual deficiency:<br />

Confirmation <strong>of</strong> a discrete entity in five patients. L. Van<br />

Maldergem, V. M. Kalscheuer, M. Doco-Fenzy, A. Medeira, A.<br />

de Brouwer, E. Landais, L. Villard, J. Dupont.<br />

3166F Extending the phenotype spectrum <strong>of</strong> IQSEC2<br />

mutations: Report <strong>of</strong> a patient with IQSEC2 intragenic<br />

duplication and atypical variant <strong>of</strong> Rett syndrome. M.<br />

Willems, F. Tran Mau-Them, J. Puechberty, G. Lefort, A.<br />

Schneider, I. Touitou, M. Girard, M. Tournaire, N. Ruiz-<br />

Pallares, F. Rivier, S. Drunat, P. Sarda, D. Genevieve.<br />

3167W Mutations in TGF-beta binding domains in<br />

the FBN1 gene result in diverse connective tissue<br />

dysplasia syndromes with short stature. K. H. C. Wu, A.<br />

Baxter, J. R. Pinner, D. Mowat, T. Dudding, B. Bennetts, K.<br />

Holman, E. Ormshaw, T. Gayagay, L. C. Adès, C. L. G<strong>of</strong>f, V.<br />

Cormier-Daire, D. O. Sillence.<br />

3168F Clinical and genetic analysis in Chinese patients<br />

with megalencephalic leukoencephalotathy with<br />

subcortical cysts. M. Guo, Y. Jiang, H. Xie, Y. Wu, J.<br />

Shang, Q. Gu, X. Wu, J. Wang.<br />

3169W Skeletal clinical characteristics <strong>of</strong> osteogenesis<br />

imperfecta caused by haploinsufficiency mutations in<br />

COL1A1. I. M. Benamor, P. Roughley, F. H. Glorieux, F. Rauch.<br />

3170F A new dominant frontonasal dysplasia with<br />

major posterior cranial defect. S. Odent, S. Mercier,<br />

M. de Tayrac, J. Mosser, P. Loget, C. Rozel, S. Jaillard,<br />

J. Milon, L. Riffaud, G. Le Bouar, P. Poulain, E. Martin, C.<br />

Dubourg, V. David.<br />

3171W Cerebrovascular changes in a patient with<br />

Noonan syndrome and a RAF1 mutation. Y. Zarate, A.<br />

Lichty, G. Matheus, K. Champion, K. Clarkson, K. Holden.<br />

3172F EFTUD2 haploinsufficiency leads to syndromic<br />

esophageal atresia. J. Amiel, C. Gordon, M. Oufadem, C.<br />

Decaestecker, A.-S. Jourdain, J. Andrieux, V. Malan, J.-L.<br />

Alessandri, C. Baumann, O. Boute-Benejean, B. Delobel,<br />

D. Lacombe, S. Mehta, I. Simonic, F. Escande, N. Porchet,<br />

S. Manouvrier-Hanu, F. Petit, A. Munnich, M. Vekemans, S.<br />

Lyonnet, L. de Pontual, M. Holder-Espinasse.<br />

3173W Al-Awadi/Raas-Rothshild/Schinzel-Fuhrman<br />

spectrum phenotypes in patients with no mutations<br />

in WNT7A. O. Caluseriu, E. Sherridan, K. M. Girisha, J.<br />

Parboosingh, A. M. Innes, F. P. Bernier.<br />

3174F A long polyphenilalanine repeats expansion<br />

in the RUNX2 gene in a patient with cleidocranial<br />

dysplasia. M. Michelson-Kerman, E. Leshinsky-Silver, D.<br />

Lev, A. Singer, C. Vinkler.<br />

3175W Novel mutation in the ADAMTSL4 gene in a child<br />

with bilateral ectopia lentis and aortic root dilatation:<br />

Expandingthe phenotype? R. L. Sanchez, Z. Ammous,<br />

P. Jayakar.<br />

3176F Mutations in DMD gene identified during clinical<br />

evaluation <strong>of</strong> patients with autism and/or global<br />

developmental delay. J. Moeschler, S. Upton, J. Ozmore.<br />

3177W Copy number variants in monozygotic twins<br />

with neur<strong>of</strong>ibromatosis 1. E. Schorry, E. Sites, D.<br />

Viskochil, D. Stevenson, N. Ullrich, T. Smolarek, L. Martin.<br />

3178F A novel synonymous mutation causing aberrant<br />

splicing on the SLC26A4 gene in a Korean patient with<br />

a hearing loss. Y. Kim, J. Kim, J. Y. Choi, K.-A. Lee.<br />

3179W Overlapping anophthalmia syndromes: SOX2,<br />

the new kid on the block. A. Schneider, T. Bardakjian.<br />

3180F Distinct clinical and neurological features in a<br />

Korean boy with Schinzel - Giedion syndrome caused<br />

by a de novo SETBP1 mutation. J. M. Ko, B. C. Lim, K. J.<br />

Kim, Y. S. Hwang, C. H. Chae.<br />

3181W Crisponi syndrome in a Turkish newborn: A<br />

possible founder mutation in the CRLF1 gene? V.<br />

Benoit, P. Hilbert, M. Deprez, A. Charon, I. Maystadt, S.<br />

Moortgat.<br />

3182F Interference with IS-PCR assays for Inv22<br />

testing <strong>of</strong> hemophilia A. T. Lewis, G. Pont-Kingdon, Y.<br />

Louie, J. Swenson.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3183W Complex ear abnormalities, choanal atresia,<br />

coloboma and renal hypoplasia in a patient with<br />

mutations in CHD7 and EYA1 and microdeletion <strong>of</strong><br />

2q23.1. R. Badilla-Porras, L. Dupuis, T. Stockley, D. J.<br />

Stavropoulos, R. Mendoza-Londono.<br />

3184F Severe CHST3 mutations in two Brazilian<br />

families with spondyloepiphyseal dysplasia with<br />

congenital joint dislocations. W. A. R. Baratela, T. F.<br />

Almeida, G. L. Yamamoto, J. H. Marques, O. Letaif, A. C.<br />

Pereira, C. A. Kim, D. R. Bertola.<br />

3185W Computer-aided facial recognition <strong>of</strong><br />

individuals with FG (Opitz-Kaveggia) syndrome caused<br />

by p.Arg961Trp mutation in MED12. L. Basel-Vanagaite,<br />

L. Karlinsky, L. Wolf, M. Shohat, C. Skinner, C. Rogers, R.<br />

Stevenson, C. M. Schwartz, J. M. Graham, Jr.<br />

3186F Hand abnormalities in Loeys-Dietz syndrome:<br />

Expanding the clinical spectrum. B. Chung, A. Hinek, T.<br />

Bradley, L. Grossse-Wortmann, S. Blaser, D. Chitayat.<br />

3187W Gorlin syndrome: Three unrelated female Mexican<br />

cases. N. O. Dávalos, S. A. Alonso Barragan, I. M. Salazar-<br />

Dávalos, M. A. Aceves-Aceves, S. A. Ramirez-Garcia, L. R.<br />

Topete -Gonzalez, D. A. Fierro-Rodriguez, D. M. Prado, A. R.<br />

Rincon-Sanchez, I. P. Dávalos, D. García-Cruz.<br />

3188F Diamond-Blackfan anemia: A case report and<br />

seven-year follow up. M. G. González-Mercado, L.<br />

Bobadilla-Morales, N. O. Dávalos, D. García-Cruz, A. Corona-<br />

Rivera, C. E. Monterrubio-Ledezma, I. M. Salazar-Dávalos, A.<br />

González-Mercado, M. A. Aceves-Aceves, I. P. Dávalos.<br />

3189W Familial Beare-Stevenson cutis gyrata<br />

syndrome in the absence <strong>of</strong> craniosynostosis. E. Leon,<br />

J. Jung, M. Ririe, D. Stevenson.<br />

3190F Report <strong>of</strong> a novel mutation in the SLC26A2 gene<br />

found in a Colombian adult patient with diastrophic<br />

dysplasia. T. Pineda, A. Rossi, L. Bonafè, A. Superti-<br />

Furga, H. Velasco.<br />

3191W Intragenic NSD1 duplication <strong>of</strong> exons 14-17 in a<br />

patient with Sotos syndrome. S. Ramanathan, R. D. Clark.<br />

3192F Craniosynostosis as a bone anomaly <strong>of</strong> Kabuki<br />

syndrome. A. Shimada, I. Tamada, H. Yoshihashi.<br />

3193W The variable spectrum <strong>of</strong> SMAD4 mutations. J.<br />

van den Ende, N. Van der Aa, T. Boiy.<br />

3194F A new frontonasal dysplasia syndrome<br />

associated with SIX2 deletion. S. L. Zimmerman, H. M.<br />

Saal, Z. M. Ahmed, R. B. Hufnagel.<br />

3195W Importance <strong>of</strong> or<strong>of</strong>acial features and the role<br />

<strong>of</strong> dentistry in the early diagnosis <strong>of</strong> developmental<br />

disorders. Z. ÷ncel Torun, D. Torun, K. Karaer, R. O. Rosti.<br />

3196F Renin receptor/ATP6AP2 gene mutation: An<br />

X-linked cause <strong>of</strong> mental retardation, postnatal<br />

microcephaly and intractable seizures. D. Chitayat, K.<br />

Sirewanda, R. Mendoza, S. Blaser, J. Raiman, J. Jessen,<br />

E. Donner, C. Schwartz.<br />

POSTER SESSIONS 243<br />

3197W SCN1B sequence variations in Iranian patients<br />

with epilepsy, causality or susceptibility? A. Ebrahimi,<br />

M. Moghaddasi, M. Houshmand, S. Zeinali, S. H.<br />

Tonekaboni, M. S. Fallah, M. Mamarabadi.<br />

3198F A novel KCNQ2 mutation in a Mexican-<strong>American</strong><br />

family with benign familial neonatal convulsions. A.<br />

Sznewajs, E. Rider, E. Sherr.<br />

3199W Coronal craniosynostosis and radial ray<br />

hypoplasia: A third report <strong>of</strong> TWIST mutation in a<br />

33-week fetus with diaphragmatic hernia. J. Piard, C.<br />

Collet, F. Arbez-Gindre, L. Van Maldergem.<br />

3200F Identification <strong>of</strong> a novel gene causing fetal<br />

akinesia deformation sequence. M. M. Weiss, G. Tan, M.<br />

Smit, J. I. de Vries, J. P. vd Voorn, I. Kluijt, E. Sistermans,<br />

H. Meijers-Heijboer, S. Gr<strong>of</strong>fen, Q. Waisfisz.<br />

3201W Identification <strong>of</strong> a new syndrome with severe type<br />

<strong>of</strong> cutaneous photosensitivity, mild mental retardation<br />

and short stature caused by KIAA1530 (UVSSA) gene. R.<br />

Sharifi, A. Ahmadi, E. Ozkan, R. Maro<strong>of</strong>ian.<br />

3202F Infantile cerebral and cerebellar atrophy<br />

population screening using PCR-RFLP method. V. Adir,<br />

E. Shahak, E. Golinker, N. Ekhilevitch, Z. U. Borochowitz.<br />

3203W Genotype-phenotype correlation <strong>of</strong> enlarged<br />

vestibular aqueduct syndrome. R. Birkenhager, S. Arndt,<br />

W. Maier, A. Aschendorff, E. Löhle, R. Laszig.<br />

3204F Molecular diagnosis <strong>of</strong> congenital muscular<br />

dystrophies with defective glycosylation <strong>of</strong> alpha<br />

dystroglycan using next-generation sequencing<br />

technology. J. Chae, B. Lim, J. Ko, J. Choi, M. Wo, W.<br />

Park, B. Min.<br />

3205W Various clinical manifestations in 40 cases with<br />

type 1 neur<strong>of</strong>ibromatosis. C. K. Cheon.<br />

3206F Mutation analysis results <strong>of</strong> 5� reductase type<br />

2 enzyme deficiency patients. H. Onay, D. Goksen, A.<br />

Aykut, F. Hazan, S. Darcan, F. Ozkinay.<br />

3207W Griscelli syndrome with RAB 27A mutation and<br />

prenatal diagnosis. I. Panigrahi, R. Suther, B. Behera, A.<br />

Rawat, R. Marwaha.<br />

3208F Molecular diagnosis <strong>of</strong> rare Mendelian diseases<br />

using whole exome sequencing. B. Rodríguez-Santiago,<br />

S. Boronat, J. Argente, I. Valenzuela, M. del Campo, L. A.<br />

Perez-Jurado, L. Armengol.<br />

3209W Next-generation sequencing for low and<br />

high-bone density disorders. G. Sule, P. Campeau, S.<br />

Nagamani, B. Dawson, M. Grover, C. Bacino, J. Lu, E.<br />

Lemire, R. Gibbs, D. Cohn, V. Zhang, L. Wong, B. Lee.<br />

3210F Molecular diagnosis <strong>of</strong> autosomal dominant<br />

polycystic kidney disease using massively parallel<br />

sequencing. Y. Tan, A. Michaeel, G. Liu, J. Blumenfield, S.<br />

Donahue, T. Parker, D. Levine, H. Rennert.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


244 POSTER SESSIONS<br />

3211W Genotype-phenotype correlation in Bardet-<br />

Biedl syndrome. E. Forsythe, K. Sparks, M. S. B. Huda,<br />

J. Hazlehurst, S. Mujahid, P. Carroll, B. McGowan, J. W.<br />

Tomlinson, S. Mohammed, P. L. Beales.<br />

3212F Photoreceptor loss in LCR-deletion associated<br />

blue cone monochromacy: Implications for gene<br />

therapy. R. B. Hufnagel, A. Dubra, R. A. Sisk, J. C.<br />

Gardner, S. Riazuddin, A. J. Hardcastle, A. T. Moore, J.<br />

Neitz, M. Michaelides, M. Neitz, J. Carroll, Z. M. Ahmed.<br />

3213W VCP-associated inclusion body myopathy<br />

with Paget disease <strong>of</strong> bone and/or frontotemporal<br />

dementia: Expanding natural history and genotypephenotype<br />

characterization. M. Khare, S. G. Mehta, R.<br />

Ramani, G. J. Watts, B. Martin, M. Simon, K. E. Osann, S.<br />

Donkervoort, E. Dec, A. Nalbandian, A. Wang, T. Mozaffar,<br />

C. D. Smith, V. E. Kimonis.<br />

3214F A novel short stature syndrome caused by<br />

defects in glycosaminoglycan synthesis due to altered<br />

xylosyltransferase 1 activity. J. Schreml, B. Durmaz,<br />

O. Çog˘ ulu, K. Keupp, F. Beleggia, E. Pohl, E. Milz, G.<br />

Nürnberg, P. Nürnberg, J. Kuhn, M. Coker, S. Kalkan Ucar,<br />

F. Özkinay, B. Wollnik.<br />

3215W Case studies for the clinical diagnosis <strong>of</strong> rare,<br />

congenital, pediatric disorders by whole genome<br />

sequencing. S. Szelinger, V. Narayanan, H. Boman, A. F.<br />

Hahn, J. J. Corneveaux, A. L. Siniard, A. A. Kurdoglu, M. J.<br />

Huentelman, D. W. Craig.<br />

3216F Variable phenotypic spectrum in a cohort<br />

<strong>of</strong> patients with ARID1B mutations. S. Boulanger, L.<br />

Mariage, D. Lederer, S. Moortgat, A. Destree, P. Hilbert, I.<br />

Maystadt.<br />

3217W Whole exome sequencing in patients with<br />

intellectual disabilities. I. Madrigal, U. Liljedahl, M. I.<br />

Alvarez, O. Karlberg, L. Rodriguez-Revenga, A. Mur, A.-C.<br />

Syvänen, M. Mila.<br />

3218F Identification <strong>of</strong> the p.A140V mutation in MECP2<br />

gene in a family with non specific X-linked mental<br />

retardation. I. Maystadt, S. Boulanger, P. Vrielynck, S.<br />

Moortgat, A. Destree, D. Lederer.<br />

3219W Whole exome sequencing identifies titin (TTN)<br />

mutations as a cause <strong>of</strong> centronuclear myopathy.<br />

O. Ceyhan, P. B. Agrawal, K. Schmitz, E. DeChene, K.<br />

Markianos, A. H. Beggs.<br />

3220F Unexpected EGFR3 variants confounding<br />

achondroplasia mutation detection. A. Millson, A. F.<br />

Rope, E. Lyon.<br />

3221W Analysis <strong>of</strong> C9orf72 repeat expansion in<br />

Japanese patients with ALS. K. Ogaki, Y. Li, N. Atsuta,<br />

H. Tomiyama, M. Funayama, H. Watanabe, R. Nakamura,<br />

H. Yoshino, S. Yato, A. Tamura, Y. Naito, A. Taniguchi, K.<br />

Fujita, Y. Izumi, R. Kaji, N. Hattori, G. Sobue, Japanese<br />

Consortium for Amyotrophic Lateral Sclerosis Research<br />

(JaCALS).<br />

3222F Three pycnodysostosis cases with a novel<br />

mutation in cathepsin K gene. T. Ozdemir, T. Atik, E.<br />

Karaca, H. Onay, F. Ozkinay, O. Cogulu.<br />

3223W Application <strong>of</strong> next-generation sequencing for<br />

mutation detection in autosomal dominant polycystic<br />

kidney disease. H. C. Park, A. Kang, J. Y. Jang, Y. Hwang,<br />

H. Kim, M. Han, D. K. Kim, K. Oh, W. Park, H. I. Cheong,<br />

C. Ahn.<br />

3224F Whole exome sequencing identifies a missense<br />

mutation in SEPT2 as a probable cause <strong>of</strong> a new<br />

autosomal dominant syndrome with distinctive face,<br />

ear anomalies, and learning disability. A. Rump,<br />

K. Hackmann, A. Dahl, A. Fischer, M. Schweiger, M.<br />

Schilhabel, A. ElSharawy, A. Franke, E. Schrock, N. Di<br />

Donato.<br />

3225W Oculocutaneous albinism (OCA1A/B): Founder<br />

mutations in the tyrosinase gene in Colombia. O.<br />

Urtatiz, D. Sanabria, M. C. Lattig.<br />

3226F Ophthalmologic findings in Mexican patients with<br />

myotonic dystrophy type I. P. Barojas, J. J. Magaña,<br />

G. Ortega, N. Leyva, B. Cisneros, O. Hernández-Hernández,<br />

E. Barojas.<br />

3227W Molecular diagnosis <strong>of</strong> myotonic dystrophy<br />

type I by PCR Southern method. G.-H. Kim, J.-J. Lee,<br />

S.-H. Choi, J.-Y. Lee, J.-M. Kim, Y.-M. Kim, B. H. Lee,<br />

H.-W. Yoo.<br />

3228F Mutations in FOXP2 cause childhood apraxia<br />

<strong>of</strong> speech: Report <strong>of</strong> a novel intragenic deletion in<br />

an Australian patient. M. S. Hildebrand, S. Turner, J.<br />

Damiano, R. J. H. Smith, M. Bahlo, I. E. Scheffer, A. T.<br />

Morgan.<br />

3229W Exome sequencing identifies a novel MRE11<br />

mutation in a patient with generalized myoclonic<br />

tremor. R. Miyamoto, H. Morino, H. Maruyama, Y. Izumi,<br />

R. Kaji, H. Kawakami.<br />

3230F Pathophysiological features <strong>of</strong> dermatan<br />

4-O-sulfotransferase 1-deficient Ehlers-Danlos<br />

syndrome. T. Kosho, S. Mizumoto, M. Kobayashi, Y.<br />

Fujita, J. Nakayama, N. Miyake, Y. Nomura, A. Hatamochi,<br />

Y. Fukushima, K. Sugahara, N. Matsumoto.<br />

3231W Rupture <strong>of</strong> chordae tendineae as an initial<br />

presentation <strong>of</strong> an haploinsufficiency mutation in<br />

COL3A1. Z. Xu, B. F. Griswold, L. J. Sloper, A. S. Shah, N.<br />

B. McDonnell.<br />

3232F Prenatal diagnosis and identification <strong>of</strong><br />

heterozygous frameshift mutation in PRRX1 in an infant<br />

with agnathia-otocephaly. M. Donnelly, E. Todd, M.<br />

Wheeler, V. D. Winn, D. Kamnasaran.<br />

3233W Identification <strong>of</strong> the disease causing gene in<br />

a familial autosomal recessive form <strong>of</strong> congenital<br />

nystagmus by exome sequencing. B. Isidor, J.<br />

Albuisson, S. Bezieau.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3234F Identification <strong>of</strong> X-linked RPGR ORF15<br />

mutations in females diagnosed with autosomal<br />

dominant retinitis pigmentosa. J. D. Churchill, S. J.<br />

Bowne, L. S. Sullivan, R. A. Lewis, D. K. Wheaton, D. G.<br />

Birch, K. E. Branham, J. R. Heckenlively, S. P. Daiger.<br />

3235W A recurrent 143 kb duplication in TSPAN7 as<br />

a possible cause <strong>of</strong> intellectual disability. J. Hoyer, M.<br />

Krumbiegel, C. Kraus, A. Reis.<br />

3236F Alpha thalassemia /mental retardation X linked:<br />

An uncommon presentation. U. H. Kotecha, R. Puri, C.<br />

Badens, I. C. Verma.<br />

3237W Proteolipid protein 1 gene mutation in 44<br />

Chinese patients with Pelizaeus-Merzbacher disease<br />

and prenatal diagnosis <strong>of</strong> five fetuses in three Chinese<br />

families with PMD probands. J. Wang, D. Li, Y. Wu, H.<br />

Zhao, J. Shang, J. Qin, F. Fang, X. Wu, Y. Jiang.<br />

3238F Four years <strong>of</strong> data from the California Cystic<br />

Fibrosis Newborn Screening <strong>Program</strong> and experiences<br />

<strong>of</strong> the Sutter CF Center. M. Tsang, B. Chipps, M.<br />

Kharrazi, K. Pearson, S. O’Bra.<br />

3239W Polymicrogyria awareness is a critical first<br />

step in facilitating early diagnosis and intervention for<br />

those affected by this rare congenital brain anomaly. C.<br />

Byrge, A. Perszyk, PMG Awareness Organization, Inc.<br />

3240F Novel KIF7 mutations extend the phenotypic<br />

spectrum <strong>of</strong> acrocallosal syndrome. A. Putoux, S.<br />

Nampoothiri, V. Cormier-Daire, N. Laurent, P. Beales, A.<br />

Schnizel, D. Bartholdi, C. Alby, S. Thomas, N. Elkhartoufi, J.<br />

Litzler, F. Encha-Razavi, R. Kannan, A. Munnich, L. Faivre,<br />

N. Boddaert, A. Rauch, M. Vekemans, T. Attie-Bitach.<br />

3241W Goldberg-Shprintzen syndrome: KBP, the<br />

KIAA1279 encoding protein, is located to cytoskeleton,<br />

but not to mitochondria. L. Drévillon, A. Megarbane, B.<br />

Demeer, C. Matar, P. Benit, A. Briand-Suleau, J. Ghoumid,<br />

M. Nasser, V. Bodereau, M. Doco-Fenzy, P. Rustin, D.<br />

Gaillard, M. Goossens, I. Giurgea.<br />

3242F Crani<strong>of</strong>acial and dental development in cardi<strong>of</strong>acio-cutaneous<br />

syndrome: The importance <strong>of</strong> Ras<br />

signaling homeostasis. A. Goodwin, S. Oberoi, M.<br />

Landan, C. Charles, J. Groth, A. Martinez, C. Fairley, W. E.<br />

Tidyman, L. A. Weiss, O. D. Klein, K. A. Rauen.<br />

3243W Sotos syndrome diagnosis confirmed by aCGH.<br />

F. I. Sahin, Y. K. Terzi, M. Derbent.<br />

3244F Expanding (or narrowing) the phenotype <strong>of</strong><br />

Beckwith-Wiedemann syndrome. E. Todd, G. Bellus.<br />

3245W Genetic studies in VACTERL association.<br />

J. Winberg, P. Gustavsson, E. Sahlin, G. Annerén,<br />

E. Iwarsson, P.-J. Svensson, F. Bradley, E. Nordenskjöld,<br />

N. Papadogiannakis, A. Nordgren, A. Nordenskjöld.<br />

3246F A homozygous AHI1 mutation in a Moroccan<br />

consanguineous Joubert syndrome family. L. Baala, S.<br />

Chafai Elalaoui, M. Chalon, N. Elkhartoufi, M. Mansouri, Y.<br />

Kriouele, O. Perche, S. Briault, T. Attie, A. Sefiani.<br />

POSTER SESSIONS 245<br />

3247W Twin discordance and congenital<br />

hydrocephalus. C. Lee, J. T. C. Shieh.<br />

3248F Hallermann-Streiff Syndrome: Case report from<br />

Mongolia. P. Erkhembulgan, M. Purevdorj, T. Altansukh, I.<br />

Purevdorj.<br />

3249W Global gene pr<strong>of</strong>iling identifies a novel<br />

cytoskeleton pathway involved in VCP-associated<br />

myopathy. A. Nalbandian, S. Ghimbovschi, S. Radom-<br />

Aizik, E. H<strong>of</strong>fman, V. Kimonis.<br />

3250F External validation <strong>of</strong> the Bartholdi clinical<br />

scoring system for Silver-Russell syndrome: A report<br />

<strong>of</strong> a Brazilian cohort. G. L. Yamamoto, A. Bonaldi, A. M.<br />

Vianna-Morgante, I. Gomy, C. A. Kim, D. R. Bertola.<br />

Evolutionary and Population <strong>Genetics</strong><br />

3251W Copy number differences <strong>of</strong> putative regulatory<br />

elements shape primate expression pr<strong>of</strong>iles. R. Iskow,<br />

O. Gokcumen, A. Abyzov, J. Malukiewicz, Q. Zhu, A.<br />

T. Sukumar, A. A. Pai, R. E. Mills, L. Habegger, D. A.<br />

Cusanovich, M. A. Rubel, G. H. Perry, M. Gerstein, A. C.<br />

Stone, Y. Gilad, C. Lee.<br />

3252T Linkage disequilibrium, population structuring<br />

and genome-wide association studies reveal<br />

metabolism and crani<strong>of</strong>acial dysmorphology mutations<br />

in the domestic cat. L. A. Lyons, H. Alhaddad, B.<br />

Gandolfi, R. A. Grahn.<br />

3253F Genome-wide scan for identifying selection<br />

footprints in immune related pathways. J. Molineros,<br />

S. Nath.<br />

3254W Signatures <strong>of</strong> selection surrounding large<br />

insertions and deletions in coding regions identified<br />

between modern and Denisovan humans, as well<br />

as four other species <strong>of</strong> primates genome-wide. W.<br />

Guiblet, K. Zhao, D. Ferrer-Torres, C. T. Ruiz-Rodriguez, A.<br />

Roca, S. Massey, J. C. Martínez-Cruzado, T. Oleksyk.<br />

3255T An optimized panel for ancestry informative<br />

markers derived from the Mexican Genome Diversity<br />

Project. J. C. Fernandez-Lopez, A. V. Contreras, M. J.<br />

Gómez-Vázquez, C. Rangel-Escareño, I. Silva-Zollezzi.<br />

3256F A fish-specific transposable element shapes the<br />

repertoire <strong>of</strong> p53 target genes in zebrafish. M. N. Loviglio,<br />

L. Micale, M. Manzoni, C. Fusco, B. Augello, E. Migliavacca,<br />

G. Cotugno, E. Monti, G. Borsani, A. Reymond, G. Merla.<br />

3257W Meiotic recombination hotspots in humans:<br />

Dynamics and controlling factors. L. Odenthal-Hesse,<br />

A. J. Jeffreys.<br />

3258T The MHC linkage haplotype in the Finnish<br />

population. A. Wennerström, M. L. Lokki, MHC Disease<br />

Research Group.<br />

3259F Fine-scale mapping <strong>of</strong> meiotic recombination in<br />

Mongolians and Koreans. T. Bleazard, Y. S. Ju, J. Sung,<br />

J. S. Seo.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


246 POSTER SESSIONS<br />

3260W Heterogeneity in recombination among African<br />

populations. M. Capredon, J. Hussin, J. Quinlan, Y.<br />

Idaghdour, L. Barreiro, T. de Malliard, J. C. Grenier, E.<br />

Gbeha, P. Awadalla.<br />

3261T Linkage disequilibrium patterns in a Brazilian<br />

population: A comparison <strong>of</strong> X chromosome STR<br />

markers with autosomal and Y chromosome STR<br />

markers. S. Oliveira, C. Mendes-Júnior, A. Trindade-Filho.<br />

3262F Association <strong>of</strong> (CCTTT)n polymorphism in the<br />

NOS2A gene with tuberculosis in two population<br />

groups <strong>of</strong> India. M. Jena, P. Das, R. Bamezai.<br />

3263W Purifying selection in mitochondrial proteincoding<br />

genes is highly effective in mammals and<br />

congruent with evolution <strong>of</strong> nuclear genes. S. I.<br />

Nikolaev, K. Popadin, T. Junier, M. Baranova, S. E.<br />

Antonarakis.<br />

3264T Molecular phylogeny <strong>of</strong> an autosomal region<br />

under natural selection. V. A. Canfield, A. Berg, S.<br />

Peckins, S. Oppenheimer, K. C. Cheng.<br />

3265F MtDNA analysis <strong>of</strong> global populations supports<br />

that major population expansions began before<br />

Neolithic time. H. Zheng, S. Yan, Z. Qin, L. Jin.<br />

3266W Different DNA methylation <strong>of</strong> FOXP2 target<br />

genes in adult cortices <strong>of</strong> humans and chimpanzees.<br />

U. Zechner, D. Seifert, E. Schneider, N. El Hajj, B. Navarro,<br />

I. Kondova, R. E. Bontrop, O. Bartsch, T. Haaf.<br />

3267T Skin color variation in the Orang Asli Tribes <strong>of</strong><br />

Peninsular Malaysia. K. C. Ang, M. S. Ngu, K. P. Reid,<br />

M. S. Teh, A. S. Zamzuraida, D. X. R. Koh, A. Berg, S.<br />

Oppenheimer, S. Hood, M. M. Clyde, B. M. Md-Zain, V. A.<br />

Canfield, K. C. Cheng.<br />

3268F Exome and RNA sequencing <strong>of</strong> French-<br />

Canadians reveals an excess <strong>of</strong> rare variants that are<br />

enriched at functionally important sites. A. Hodgkinson,<br />

F. Casals, Y. Idaghdour, J. Hussin, V. Bruat, T. de Malliard,<br />

J.-C. Grenier, J.-P. Goulet, E. Gbeha, E. Hip-Ki, S. Girard,<br />

J.-F. Spinella, V. Saillour, D. Sinnett, G. Rouleau, P.<br />

Awadalla.<br />

3269W Evidence for selection at the BDNF Val66Met<br />

polymorphism in 1000 Genomes Project populations.<br />

C. V. Van Hout, A. G. Clark.<br />

3270T Mobile element evolution <strong>of</strong> the Callithrix<br />

jacchus (common marmoset). M. K. Konkel, J. A.<br />

Walker, B. Ullmer, R. Hubley, A. F. A. Smit, M. A. Batzer for<br />

Marmoset Genome Sequencing and Analysis Consortium.<br />

3271F Association <strong>of</strong> GSTT1, MI and M3 gene<br />

polymorphism with age and quantity <strong>of</strong> smoke in<br />

Northern Indian COPD patients. R. K. Shukla, S. Kant, S.<br />

Bhattacharya, B. Mittal.<br />

3272W Polymorphic miRNA genomic sequences<br />

embedded in CNV sites: A prospective screening in<br />

Brazilian admixed population sample. T. C. L. Lins, D. E.<br />

Jimenez, A. P. M. Barbosa, R. W. Pereira.<br />

3273T Ascertainment bias in microsatellites: Impact on<br />

estimates <strong>of</strong> mutation rates. B. Li, M. Kimmel.<br />

3274F Characterizing recent evolutionary changes on<br />

the human lineage using the high-coverage Denisovan<br />

genome. F. Racimo, M. Kircher, J. Kelso, S. Pääbo,<br />

Archaic Genome Analysis Consortium.<br />

3275W Recurrent tissue-specific mtDNA mutations are<br />

common in humans. S. M. Williams, D. C. Samuels, B. Li,<br />

Z. Song, E. Torstenson, A. Rokas, T. A. Thornton-Wells, J.<br />

H. Moore, T. M. Hughes, R. D. H<strong>of</strong>fman, J. L. Haines, D. P.<br />

Mortlock, C. Li.<br />

3276T Associations <strong>of</strong> human leukocyte antigen G with<br />

resistance and susceptibility to HIV-1 infection in the<br />

Pumwani Sex Worker Cohort. M. Luo, W. Turk, J. Kimani,<br />

C. Wachihi, T. Bielawny, T. Ball, F. Plummer.<br />

3277F Alleles at the rs3212368 SNP at the 3’UTR <strong>of</strong> the<br />

MC1R gene are associated with human pigmentation<br />

by possible microRNA influence. L. A. Marano, A. L.<br />

Simões, E. A. Donadi, C. T. Mendes-Junior.<br />

3278W Targeted re-sequencing <strong>of</strong> 328 inherited<br />

disease-associated genes in a family trio and HapMap<br />

populations using the Ion AmpliSeq Inherited<br />

Disease Panel and Ion PGM semiconductor<br />

sequencing. I. Casuga, B. Kong, D. Joun, S.-M. Chen,<br />

C.-Y. Li, D. Ruff, R. Bennet, M. Shannon.<br />

3279T Sequencing <strong>of</strong> an extended pedigree in Western<br />

chimpanzees. O. Venn, I. Turner, Z. Iqbal, I. Mathieson, N.<br />

de Groot, G. McVean.<br />

3280F Allelic and genotypic associations <strong>of</strong> SNPs <strong>of</strong><br />

the OCA2 and HERC2 genes with eye, hair and skin<br />

pigmentation and the presence <strong>of</strong> freckles in Brazil. E.<br />

S. Andrade, N. C. A. Fracasso, P. S. Strazza Júnior, A. L.<br />

Simões, C. T. Mendes-Junior.<br />

3281W AKT3, ANGPTL4, eNOS3, and VEGFA<br />

associations with high altitude sickness in Han and<br />

Tibetan Chinese at the Qinghai-Tibetan Plateau. N.<br />

Buroker, X.-H. Ning, Z.-N. Zhou, K. Li, W.-J. Cen, X.-F. Wu,<br />

W.-Z. Zhu, C. R. Scott, S.-H. Chen.<br />

3282T A population genetic measure <strong>of</strong> the de novo<br />

mutation rate using identity-by-descent estimates. C. W.<br />

K. Chiang, J. Li, M. G. Ehm, M. R. Nelson, J. Novembre.<br />

3283F Determination <strong>of</strong> PON1 and P2RY12<br />

polymorphisms distribution in Hungary living<br />

population samples. B. Melegh, I. Janicsek, Cs. Sipeky,<br />

B. Duga, B. I. Melegh, L. Jaromi, L. Magyari, J. Bene.<br />

3284W Mapping the genetic diversity <strong>of</strong> HLA haplotype<br />

in Asia populations. W. Y. Saw, R. T. H. Ong, C. C. Khor,<br />

N. Kato, Y. Y. Teo.<br />

3285T Long runs <strong>of</strong> homozygosity contain a higher<br />

fraction <strong>of</strong> all genome-wide deleterious homozygotes<br />

relative to the fraction <strong>of</strong> all genome-wide nondamaging<br />

homozygotes. Z. A. Szpiech, J. Xu, T. J.<br />

Pemberton, W. Peng, S. Zöllner, N. A. Rosenberg, J. Z. Li.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3286F The genetic structure <strong>of</strong> Western Balkan<br />

populations based on autosomal and haploid markers.<br />

K. Tambets, L. Kovacevic, D. Primorac, G. Lauc, A.<br />

Leskovac, Z. Jakovski, K. Drobnic, S. Kovacevic, T. Bego,<br />

E. Metspalu, D. Marjanovic, R. Villems.<br />

3287W Analysis <strong>of</strong> TLR4 SNPs 299 and 399 in a<br />

population <strong>of</strong> full-term Wisconsin infants. D. Pillers, J.<br />

DeValk, M. Baker, S. Schrodi, S. Tokarz.<br />

3288T Using Time to Most Recent Common Ancestor<br />

to detect selection in population samples <strong>of</strong> wholegenome<br />

sequences. H. Hunter-Zinck, A. G. Clark.<br />

3289F Estimating inbreeding coefficients from NGS<br />

data: Impact on genotype calling and allele frequency<br />

estimation. F. G. Vieira, M. Fumagalli, A. Albrechtsen, R.<br />

Nielsen.<br />

3290W Maternal genetic variation near PRKAA1<br />

and EDNRA is associated with birth weight among<br />

residents <strong>of</strong> high altitude. A. W. Bigham, M. J. Wilson,<br />

V. A. Browne, C. G. Julian, E. Vargas, C. Rodriquez, M. D.<br />

Shriver, L. G. Moore.<br />

3291T Selective turnover in human regulatory regions:<br />

Out with the old, in with the new. L. D. Ward, M. Kellis,<br />

ENCODE Project Consortium.<br />

3292F Signs <strong>of</strong> high populational differentiation on the<br />

major histocompatibility complex region on Native<br />

South <strong>American</strong> populations. K. Nunes, E. J. M. Santos,<br />

J. F. Guerreiro, D. Meyer.<br />

3293W High diversity <strong>of</strong> ADH1B gene among the<br />

Tibetans. L. Kang, L. Yan, K. Hu, F. Chen, H. Li.<br />

3294T Natural selection increases mutational<br />

robustness in complex diseases: Mendelian evidence<br />

from early versus late onset common diseases. B. E.<br />

Baysal.<br />

3295F Evolutionary role <strong>of</strong> the human skull: comparing<br />

neutral and selective markers. D. V. Bernardo, T. F.<br />

Almeida.<br />

3296W Characterization <strong>of</strong> human-specific duplicated<br />

neural genes suggests a model <strong>of</strong> functional<br />

antagonism. M. Y. Dennis, F. Antonacci, C. Golzio, J.<br />

Huddleston, T. A. Graves, P. H. Sudmant, D. W. Raible, N.<br />

Katsanis, R. K. Wilson, E. E. Eichler.<br />

3297T A genetic mechanism for Tibetan high-altitude<br />

adaptation. C. D. Huff, F. R. Lorenzo, M. Myllymäki, S.<br />

Swierczek, M. E. Salama, G. L. Semenza, V. Gordeuk, J.<br />

Xing, T. S. Simonson, L. B. Jorde, P. Koivunen, J. T. Prchal.<br />

3298F Selection and migration in spatially structured<br />

populations. I. Mathieson, G. McVean.<br />

3299W Evidence <strong>of</strong> recent positive selection in<br />

Africans at known and novel BMI loci. T. Edwards, G.<br />

J. Papanicolaou, K. North, D. R. Velez Edwards, African<br />

<strong>American</strong> BMI Consortium.<br />

POSTER SESSIONS 247<br />

3300T Characterizing the adaptation to high altitude in<br />

Tibetans. E. Huerta-Sanchez, X. Jin, B. Peter, Y. Liang, M. He,<br />

X. Yi, A. Asan, Y. Shan, P. Ni, J. Wang, R. Nielsen, J. Wang.<br />

3301F Recent positive selection <strong>of</strong> HLA-DPB1*04:01<br />

in Japanese population. M. Kawashima, J. Ohashi, N.<br />

Nishida, K. Tokunaga.<br />

3302W Haplotype signatures <strong>of</strong> negative selection. D.<br />

Ortega Del Vecchyo, J. Novembre.<br />

3303T Genome-wide signatures <strong>of</strong> natural selection in<br />

diverse African populations. L. B. Scheinfeldt, S. Soi, C.<br />

Lambert, D. Hu, A. Coulibaly, H. Hutton, C. Elbers, W. Ko,<br />

W. Beggs, A. Ranciaro, S. Thompson, J. Hirbo, J. Bodo, O.<br />

Doumbo, M. Ibrahim, A. Froment, G. Lema, T. Nyambo, S.<br />

Omar, C. Wambebe, D. Meskel, G. Belay, S. A. Tishk<strong>of</strong>f.<br />

3304F Contrasting selective forces shaping the type-II<br />

C-type lectin receptor family. H. Quach, S. Fornarino, G.<br />

Laval, L. Quintana-Murci.<br />

3305W Balancing selection in the human genome. M.<br />

DeGiorgio, K. E. Lohmueller, R. Nielsen.<br />

3306T Reproduction and immunity-driven natural<br />

selection in the hominid WFDC locus. Z. Ferreira,<br />

S. Seixas, A. Andres, W. Kretzschmar, J. Mullikin, W.<br />

Swanson, M. K. Gonder, S. Tishk<strong>of</strong>f, A. Stone, A. G. Clark,<br />

E. Green, B. Hurle, NIH Intramural Sequencing Center.<br />

3307F Identification <strong>of</strong> hypoxia-tolerance regions in<br />

high-altitude populations. R. Ronen, N. Udpa, D. Zhou,<br />

T. Stobdan, O. Appenzeller, K. Frazer, J. Liang, Y. Li, V.<br />

Bafna, G. Haddad.<br />

3308W Positive selection on base excision repair<br />

pathway in Yoruba and British populations. M. Wang, R.<br />

Li, Y. He, L. Jin.<br />

3309T Expression quantitative trait loci are adaptive to<br />

multiple environmental factors. K. Ye, Z. Gu.<br />

3310F Balancing selection on a non-coding region with<br />

regulatory function. Q. Zhu, O. Gokcumen, L. Mulder, R.<br />

Iskow, C. Austermann, M. Steward, C. Scharer, T. Raj, J.<br />

Boss, S. Sunyaev, A. Price, B. Stranger, V. Simon, C. Lee.<br />

3311W Characterizing selection signatures associated<br />

with high-altitude adaptation in Tibetans. A. Ferrer<br />

Admetlla, Y. Wang, B. Peter, N. Vinckenbosch, E. Sanchez-<br />

Huerta, X. Jin, A. Asan, J. Wang, J. Wang, R. Nielsen.<br />

3312T Detecting population structure and genetic<br />

differentiation from high-throughput re-sequencing<br />

data. M. Fumagalli, T. Korneliussen, T. Linderoth, F. Vieira,<br />

A. Albrechtsen, R. Nielsen.<br />

3313F Different haplotypes in East Asia and Europe<br />

both show positive selection in 1q24. C. Heffelfinger, A.<br />

J. Pakstis, W. C. Speed, M. P. Snyder, K. K. Kidd.<br />

3314W Early origins <strong>of</strong> Southeast Asian ovalocytosis<br />

during the Austronesian expansion. J. A. Wilder, A. M.<br />

Paquette, M. K. Thompson.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


248 POSTER SESSIONS<br />

3315T Local genome diversity studies in Puerto Rico:<br />

Uncovering distribution <strong>of</strong> ancestry proportions<br />

and disease allele frequencies across the island. Y.<br />

M. Afanador, I. Rivera, E. P. Tascón-Peñaranda, J. L.<br />

Rodriguez-Florez, C. A. Winkler, A. V. Washington, E.<br />

Suárez, J. C. Martinez-Cruzado, T. K. Oleksyk, Local<br />

Genome Diversity Studies Consortium.<br />

3316F Indian genome architecture reveals high diversity<br />

and suggests ancient African ancestry. S. Kumar, R.<br />

Singh, N. Banerjee, H. Gowda, M. Kramer, S. Kamalakaran,<br />

V. Varadan, A. Janevski, B. Muthusamy, B. Chakrabarti,<br />

S. M. Srikanth, S. Keerthikumar, T. S. Keshava Prasad, S.<br />

Vivekandandan, V. Makkapati, A. Panigrahi, P. Kumar, P.<br />

van Ho<strong>of</strong>t, E. Ghiban, L. Gelley, S. Muller, G. Atwal, W. R.<br />

McCombie, A. Pandey, A. Chakravarti, N. Dimitrova.<br />

3317W Genetic evidence <strong>of</strong> paleolithic colonization<br />

and neolithic expansion <strong>of</strong> modern humans on the<br />

Tibetan Plateau. B. Su, X. Qi, C. Cui, Y. Peng, X. Zhang,<br />

Z. Yang, H. Zhong, H. Zhang, K. Xiang, X. Cao, Y. Wang,<br />

O. Ouzhuluobu, B. Basang, C. Ciwangsangbu, B. Bianba,<br />

G. Gonggalanzi, T. Wu, H. Chen, H. Shi.<br />

3318T Genomic ancestry and structure <strong>of</strong> the African-<br />

European admixed population <strong>of</strong> the Cape Verde<br />

Islands. S. Beleza, N. A. Johnson, S. I. Candille, D. M.<br />

Absher, I. I. Araújo, A. Correia e. Silva, M. D. Shriver, J.<br />

Rocha, G. S. Barsh, H. Tang.<br />

3319F Mitochondrial DNA in Myanmar: Complete<br />

mitochondrial genome sequencing revealed several<br />

new lineages within macro-haplogroup M. J.<br />

Horst, M. Summerer, G. Erhart, D. Horst, B. Horst, S.<br />

Sanguansermsri, A. Manhart, F. Kronenberg, A. Kloss-<br />

Brandstätter.<br />

3320W Asian expansion <strong>of</strong> modern human out <strong>of</strong><br />

Africa. H. Li.<br />

3321T Using Y-chromosome haplotypes to improve<br />

inferred ancestral origins in European populations.<br />

N. Myres, P. Underhill, R. King, J. Byrnes, K. Noto, S.<br />

Woodward, N. Angerh<strong>of</strong>er, C. Ball, K. Chahine.<br />

3322F Ethiopian genome project. L. Pagani, T. Kivisild, A.<br />

Tarekegn, R. Ekong, C. Plaster, I. Gallego Romero, T. Oljira, E.<br />

Mekonnen, Q. Ayub, S. Q. Mehdi, M. G. Thomas, D. Luiselli,<br />

E. Bekele, N. Bradman, D. J. Balding, C. Tyler-Smith.<br />

3323W Analysis <strong>of</strong> whole mitochondrial genomes from<br />

Iñupiat populations <strong>of</strong> the Alaskan North Slope. J. Raff,<br />

M. Rzhetskaya, J. Tackney, M. G. Hayes.<br />

3324T Genetic ancestrality estimative for Brasilia<br />

population using CODIS autosomal markers. A. E.<br />

Svidzinski, G. C. Dalton, R. C. Toledo, A. C. Arcanjo, S. F.<br />

Oliveira.<br />

3325F The population genetics <strong>of</strong> native Peruvian<br />

populations: Evolutionary inferences and biomedical<br />

implications. E. Tarazona-Santos, L. Pereira, M. Scliar,<br />

R. Zamudio, G. B. Soares-Souza, L. W. Zuccherato, M.<br />

Gouveia, F. Soares, F. Kehdy, W. C. S. Magalhaes, M. R.<br />

Rodrigues, E. Hollox, S. J. Chanock, R. H. Gilman.<br />

3326W Coalescent inference <strong>of</strong> evolutionary<br />

parameters using serially sampled genomic sequence<br />

data: Theory and applications in human population<br />

genetics. D. A. Vasco, M. Kato, Z. Ye, D. Lee, T. Carter, S.<br />

J. Hebbring, A. Rodrgio, S. Schrodi, S. Lin.<br />

3327T Ancestry perception bias in Latin <strong>American</strong><br />

admixed populations. K. Adhikari, A. Ruiz-Linares, G.<br />

Bedoya, C. Bortolini, S. Canizales, C. Gallo, S. Gibbon, R.<br />

Gonzalez, F. Rothhammer, CANDELA Consortium.<br />

3328F OriginMiner : Show me your genes and I’ll tell<br />

you where you come from. M. de Tayrac, M. C. Babron,<br />

E. Génin.<br />

3329W Genetic ancestry and admixture analysis in<br />

a Bermudian population reveals evidence <strong>of</strong> Native<br />

<strong>American</strong> origins consistent with oral histories and<br />

genealogies. J. B. Gaieski, E. Elhaik, A. C. Owings, M. G.<br />

Vilar, A. T. Walia, D. F. Gaieski, R. S. Wells, T. G. Schurr,<br />

The Genographic Consortium.<br />

3330T The MHC and HLA alleleic diversity <strong>of</strong> the<br />

1000 Genome samples. P. Gourraud, N. Cereb, P.<br />

KhanKhanian, M. Maiers, S. Yang, R. Dunivin, M. Feolo, J.<br />

Rioux, S. Hauser, J. Oksenberg.<br />

3331F Identification <strong>of</strong> sickle cell disease alleles in<br />

the Eastern Caribbean population. C. Logronio, M.<br />

Graham, K. Wiitala, P. Gibbons, E. Bashover, C. Headland,<br />

I. McIntosh.<br />

3332W Khoesan genomic signatures in contemporary<br />

populations from Southern Africa. D. C. Petersen,<br />

O. Libiger, R. Hardie, L. I. Hannick, R. Wilkinson, R. H.<br />

Glash<strong>of</strong>f, M. Mukerji, P. Fernandez, N. J. Schork, V. M.<br />

Hayes, Indian Genome Variation Consortium.<br />

3333T Complete mitochondrial DNA genome<br />

sequences from the first New Zealanders: Ancient DNA<br />

and the settlement <strong>of</strong> East Polynesia. E. A. Matisoo-<br />

Smith, M. Knapp, S. Prost, K. A. Horsburgh, J. Stanton,<br />

H. Buckley.<br />

3334F A panel <strong>of</strong> ancestry informative markers<br />

for estimating and correcting potential effects <strong>of</strong><br />

population stratification in Han Chinese. P. Qin, W. Jin,<br />

D. Lu, H. Lou, J. Wang, H. Xu, L. Jin, S. Xu.<br />

3335W Genomic demographics <strong>of</strong> the genetically<br />

isolated Amish populations <strong>of</strong> Ohio and Indiana. L. N.<br />

D’Aoust, A. C. Cummings, L. Jiang, R. Laux, D. Fuzzell, L.<br />

Caywood, L. Reinhart-Mercer, M. Courtenay, W. K. Scott,<br />

M. A. Pericak-Vance, J. L. Haines.<br />

3336T Jethro’s descendants: A journey <strong>of</strong> 1000 years.<br />

E. Friedman, J. Zidan, D. Ben Avraham, T. Maray, G.<br />

Atzmon.<br />

3337F Overview <strong>of</strong> the genetic variations in the Y<br />

chromosome in the Japanese population. Y. Sato, T.<br />

Shinka, A. Yamauchi, Y. Nakahori.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3338W Genome-wide SNP variation in sub-Saharan<br />

Africa is influenced by cultural and ethno-linguistic<br />

affiliation. S. Soi, L. Scheinfeldt, C. Lambert, J. Hirbo, A.<br />

Ranciaro, S. Thompson, J.-M. Bodo, M. Ibrahim, G.<br />

Lema, T. Nyambo, S. Omar, C. Wambebe, D. Meskel, G.<br />

Belay, A. Froment, S. A. Tishk<strong>of</strong>f.<br />

3339T Positive natural selection and recent<br />

evolutionary history in Malays. X. Liu, R. T. H. Ong, L. P.<br />

Wong, W. T. Poh, N. E. Pillai, C. C. Khor, Y. Y. Teo.<br />

3340F Genetic evidence <strong>of</strong> multiple non-Asian<br />

migrations into the New World. N. Angerh<strong>of</strong>er, S.<br />

Woodward, N. Myres, T. Steele, A. Nelson, U. A. Perego,<br />

K. Chahine.<br />

3341W The CARTaGENE Genomics Project : Population<br />

genetics analysis <strong>of</strong> the founding population <strong>of</strong><br />

Quebec. P. Awadalla, J. Hussin, Y. Idaghdour, A.<br />

Hodgkinson, J.-P. Goulet, J.-C. Grenier, T. de Malliard, V.<br />

Bruat, E. Gbeha, M. Capredon, E. Hip-Ki, Y. Payette, C.<br />

Boileau.<br />

3342T The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health<br />

and Aging: Characterizing ancestry <strong>of</strong> the GERA<br />

cohort using genome-wide data. Y. Banda, M. Kvale,<br />

T. H<strong>of</strong>fmann, S. Hesselson, H. Tang, C. Sabatti, D.<br />

Ranatunga, C. Schaefer, P. Kwok, N. Risch.<br />

3343F Population diversity and history <strong>of</strong> the Indian<br />

subcontinent: Uncovering the deeper mosaic <strong>of</strong> substructuring<br />

and the intricate network <strong>of</strong> dispersals. A.<br />

Basu, N. Sarkar Roy, P. P. Majumder.<br />

3344W Mitochondrial origins <strong>of</strong> the Cape Coloureds <strong>of</strong><br />

South Africa. K. G. Beaty, D. L. Phillips, M. Henneberg, M.<br />

H. Crawford.<br />

3345T North African Jewish and non-Jewish<br />

populations form distinctive, orthogonal clusters. C.<br />

Campbell, P. F. Palamara, M. Dubrovsky, L. R. Botigué, M.<br />

Fellous, G. Atzmon, C. Oddoux, A. Pearlman, L. Hao, B.<br />

Henn, E. Burns, C. Bustamante, D. Comas, E. Friedman, I.<br />

Pe’er, H. Ostrer.<br />

3346F Hyper-sharing individuals in founder<br />

populations: Theory and implications to imputation<br />

strategies. S. Carmi, P. Palamara, V. Vacic, T. Lencz, A.<br />

Darvasi, I. Pe’er.<br />

3347W Analytical inference <strong>of</strong> human demographic<br />

history using multiple individual genome sequences. H.<br />

Chen, D. Reich.<br />

3348T Predicting the geographic origin <strong>of</strong> individuals<br />

using genome-wide SNP data. D. J. M. Crouch, M. E.<br />

Weale.<br />

3349F Y chromosome J haplogroups trace post glacial<br />

period expansion from Turkey and Caucasus into the<br />

Middle East. B. Douaihy, D. Platt, M. Haber, A. Salloum, F.<br />

Mouzaya, M. Bou Dagher-Kharrat, G. Khazen, E. Matisoo-<br />

Smith, R. S. Wells, C. T. Smith, P. Zalloua, Genographic<br />

Consortium.<br />

POSTER SESSIONS 249<br />

3350W Genotyping at the DAT1 locus: Determination<br />

<strong>of</strong> VNTR allele frequencies in descendents <strong>of</strong> the<br />

founding families <strong>of</strong> Southwest Louisiana. J. Drost, A.<br />

Figueroa, J. Angle.<br />

3351T A two-sex model for the admixture history<br />

<strong>of</strong> a hybrid population. A. Goldberg, P. Verdu, N. A.<br />

Rosenberg.<br />

3352F Admixed human genomes reveal complex<br />

migration patterns from the early spread <strong>of</strong> modern<br />

humans to the 21st century. S. Gravel, J. M. Kidd, J. K.<br />

Byrnes, A. Moreno-Estrada, F. Zakharia, S. Mushar<strong>of</strong>f, F.<br />

M. De La Vega, C. D. Bustamante.<br />

3353W Quantitative characterization <strong>of</strong> the ancestry <strong>of</strong><br />

the Estonian population. T. Haller, L. Leitsalu-Moynihan,<br />

P. C. Ng, K. Fischer, T. Esko, K. Läll, A. Metspalu.<br />

3354T Demographic inference and whole genome scan<br />

for natural selection in Biaka pygmies from Central<br />

Africa. P. H. Hsieh, K. R. Veeramah, J. D. Wall, R. N.<br />

Gutenkunst, M. F. Hammer.<br />

3355F Analysis <strong>of</strong> contributions <strong>of</strong> archaic genome and<br />

their functions in modern non-Africans. Y. Hu, Q. Ding,<br />

Y. Wang, H. Zheng, L. Jin.<br />

3356W Anisotropic isolation by distance: The main<br />

orientations <strong>of</strong> human genetic differentiation. F. Jay, P.<br />

Sjödin, M. Jakobsson, M. G. B. Blum.<br />

3357T On the use <strong>of</strong> deterministic functions for<br />

deriving approximate coalescent distributions. E.<br />

Jewett, N. Rosenberg.<br />

3358F Exploring population admixture dynamics using<br />

empirical and simulated genome-wide distribution <strong>of</strong><br />

ancestral chromosomal segments. W. Jin, S. Wang, L.<br />

Jin, S. Xu.<br />

3359W Population history and Y-chromsome diversity<br />

<strong>of</strong> the Poqomchi’ Maya <strong>of</strong> Eastern Guatemala. S.<br />

Johnson, A. Justice, M. Crawford.<br />

3360T Local ancestry inference in the Thousand<br />

Genomes Project admixed populations. E. E. Kenny,<br />

B. Maples, C. Churchhouse, A. Gupta Hinch, A. Williams,<br />

Y. Baran, S. Gravel, A. Moreno Estrada, C. Gignoux, F.<br />

Zakharia, A. W. Bigham, M. D. Shriver, A. Ruiz-Linares, G.<br />

Bedoya, T. K. Oleksyk, J. Dutil, J. C. Martinez-Cruzado, E.<br />

Gonzalez Burchard, S. Myers, E. Halperin, J. Marchini, C.<br />

D. Bustamante, 1000 Genomes Consortium.<br />

3361F A likelihood ratio test for sex-bias and its<br />

application to whole-genome sequencing data <strong>of</strong> a<br />

set <strong>of</strong> globally-distributed populations. S. Mushar<strong>of</strong>f, J.<br />

M. Kidd, B. M. Henn, S. Gravel, B. Maples, K. Eilertson,<br />

M. C. Yee, H. M. Cann, G. Euskirchen, M. Snyder, C. D.<br />

Bustamante, S. Ramachandran.<br />

3362W Population structure and genetic diversity in<br />

Argentinean populations. M. Muzzio, J. M. B. Motti, E.<br />

Kenny, L. S. Jurado-Medina, M. C. Yee, J. Beltramo, R.<br />

Santos, T. Cooke, V. Ramallo, M. Schawb, O. Cornejo, G.<br />

Bailliet, C. M. Bravi, C. D. Bustamante.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


250 POSTER SESSIONS<br />

3363T Rediscovering the people who greeted<br />

Columbus through mtDNA sequence analysis. M. A.<br />

Nieves-Colon, E. P. Tascón-Peñaranda, M. Diaz-Matallana,<br />

I. Carrero-Gonzalez, F. Curbelo-Canabal, J. Galanther,<br />

M. L. Perez-Quiñones, H. J. Diaz-Zabala, C. Eng, O. R.<br />

Wever, F. Mercedes de la Cruz, A. Alvarez-Serrano, E. G.<br />

Burchard, J. C. Martínez-Cruzado.<br />

3364F Continent-wide decoupling <strong>of</strong> Y-chromosomal<br />

genetic variation from language and geography in<br />

native South <strong>American</strong>s. M. Nothnagel, L. Roewer, L.<br />

Gusmao, V. Gomes, M. Gonzalez, D. Corach, A. Sala, E.<br />

Alechine, T. Palha, N. Santos, A. Ribeiro-dos-Santos, M.<br />

Geppert, S. Willuweit, M. Nagy, S. Zweynert, M. Baeta,<br />

C. Nunez, B. Martinez-Jarreta, F. Gonzalez-Andrade, E.<br />

Fagundes de Carvalho, D. Aparecida da Silva, J. J. Builes,<br />

D. Turbon, A. M. Lopez Parra, E. Eduardo Arroyo-Pardo, U.<br />

Toscanini, L. Borjas, C. Barletta, S. Santos, M. Krawczak.<br />

3365W Using haplotypes to infer ancestral origins for<br />

recently admixed individuals. K. Noto, J. K. Byrnes,<br />

N. Myres, N. Angerh<strong>of</strong>er, S. R. Woodward, C. A. Ball, K.<br />

Chahine.<br />

3366T Haplotype sharing distributions for fine-scale<br />

demographic reconstruction. P. Palamara, T. Lencz, A.<br />

Darvasi, I. Pe’er.<br />

3367F Inference <strong>of</strong> population splits and mixtures from<br />

genome-wide allele frequency data. J. K. Pickrell, J. K.<br />

Pritchard.<br />

3368W Inferring Y chromosome phylogeny by<br />

sequencing diverse populations. G. D. Poznik, P. A.<br />

Underhill, B. M. Henn, M. C. Yee, E. Sliwerska, G. M.<br />

Euskirchen, L. Quintana-Murci, E. Patin, M. Snyder, J. M.<br />

Kidd, C. D. Bustamante.<br />

3369T Towards understanding the population<br />

substructure and ancestry in Kuwaiti population. R.<br />

Rajagopalan, O. Alsmadi, F. Alkayal, G. Thareja, S. John, P.<br />

Hebbar, A. Thangavel.<br />

3370F The evolutionary history <strong>of</strong> mutations associated<br />

with leukemia. S. Ramachandran, M. Kantesaria, A.<br />

Walia, J. Yang.<br />

3371W Identification <strong>of</strong> regions under selection in the<br />

Gullah African <strong>American</strong> population. P. S. Ramos, S.<br />

Sajuthi, Y. Huang, J. Divers, K. M. Kaufman, J. B. Harley,<br />

R. P. Kimberly, D. L. Kamen, C. D. Langefeld, M. M. Sale,<br />

W. T. Garvey, G. S. Gilkeson.<br />

3372T A genome-wide map <strong>of</strong> Neandertal ancestry<br />

in modern humans. S. Sankararaman, N. Patterson, S.<br />

Mallick, S. Pääbo, D. Reich.<br />

3373F Genetic diversity and migration history <strong>of</strong><br />

indigenous populations from the Central Valley <strong>of</strong><br />

Mexico. T. Schurr, M. Vilar, R. Gomez, H. Zillges, A. Sanders,<br />

A. Owings, J. Gaieski, The Genographic Consortium.<br />

3374W Unexpected relationships and inbreeding in<br />

HapMap phase III populations. E. Stevens, J. Baugher,<br />

M. Shirley, L. Frelin, J. Pevsner.<br />

3375T Class I MHC region genetic markers have<br />

different dinamics than neutral genomic regions in<br />

Brazilian populations. R. C. P. Toledo, A. C. Arcanjo, C.<br />

T. Mendes-Júnior, E. C. Castelli, J. A. Peña, R. V. Andrade,<br />

M. N. Klautau-Guimarães, S. F. Oliveira.<br />

3376F Coalescence-based estimation <strong>of</strong> population<br />

history in the presence <strong>of</strong> admixture from genetic<br />

variation data. M. Tsai, G. Blelloch, R. Ravi, R. Schwartz.<br />

3377W The GenoChip: A new tool for genetic<br />

anthropology. S. Wells, E. Greenspan, S. Staats, T. Krahn,<br />

C. Tyler-Smith, Y. Xue, S. T<strong>of</strong>anelli, P. Francalacci, F.<br />

Cucca, L. Pagani, L. Jin, H. Li, T. G. Schurr, J. B. Gaieski,<br />

C. Melendez, M. G. Vilar, A. C. Owings, R. Gomez, R.<br />

Fujita, F. Santos, D. Comas, O. Balanovsky, E. Balanovska,<br />

P. Zalloua, H. Soodyall, R. Pitchappan, G. Arun Kumar, M.<br />

F. Hammer, B. Greenspan, E. Elhaik.<br />

3378T Genetic, genomic and penotypic<br />

characterization <strong>of</strong> Qinghai Mongolians. J. Xing, U.<br />

Tanna, T. S. Simonson, W. S. Watkins, D. J. Witherspoon,<br />

W. Wu, G. Qing, C. D. Huff, L. B. Jorde, R. L. Ge.<br />

3379F Paleolithic human migrations in East Eurasia by<br />

sequencing Y chromosomes. S. Yan, C. C. Wang, L. Jin.<br />

3380W Reconstructing the history <strong>of</strong> Indigenous<br />

<strong>American</strong> populations from the Thousand Genomes<br />

Project admixed populations <strong>of</strong> the Americas. F.<br />

Zakharia, M. Muzzio, K. Sandoval, A. Moreno-Estrada, S.<br />

Gravel, J. Byrnes, C. R. Guignoux, J. L. Rodriguez-Flores,<br />

B. Maples, W. Guiblet, J. Dutil, E. E. Kenny, A. W. Bigham,<br />

M. D. Shriver, 1000 Genomes Consortium, A. Ruiz-Linares,<br />

T. K. Oleksyk, J. C. Martinez-Cruzado, E. Gonzalez<br />

Burchard, C. D. Bustamante.<br />

3381T The genetic aspect <strong>of</strong> the Slavic settlement<br />

in the East Alps region. A. Zupan, K. Vrabec, T. Dovč ;<br />

drnovšek, D. Glavač .<br />

3382F Principal component analysis produces an<br />

inaccurate representation <strong>of</strong> population structure<br />

under certain conditions. J. Bentham, D. L. Morris, D. S.<br />

Cunninghame Graham, C. L. Pinder, V. Anand, J. E. Wither,<br />

J. D. Rioux, M. E. Alarcón-Riquelme, T. J. Vyse.<br />

3383W The Kaiser Permanente/UCSF Genetic<br />

Epidemiology Research Study on Adult Health and<br />

Aging: Local ancestry estimations in the admixed<br />

individuals <strong>of</strong> the Genetic Epidemiology Research on<br />

Aging cohort. S. I. Candille, N. A. Johnson, Y. Banda, T.<br />

H<strong>of</strong>fman, M. Kvale, C. Sabatti, S. Hesselson, P. Y. Kwok,<br />

C. Schaefer, N. Risch, H. Tang.<br />

3384T Multi-way admixture deconvolution using<br />

phased or unphased ancestral panels. C. Churchhouse,<br />

J. Marchini.<br />

3385F A panel <strong>of</strong> ancestry informative markers for the<br />

South African Coloured population. M. Daya, L. Van der<br />

Merwe, M. Möller, E. Hoal, C. R. Gignoux, J. M. Galanter,<br />

B. M. Henn.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3386W A scalable pipeline for local ancestry inference<br />

using thousands <strong>of</strong> reference individuals. C. B. Do, E.<br />

Durand, J. M. Macpherson, B. Naughton, J. L. Mountain.<br />

3387T Global genome-wide variations comparisons<br />

show a generally homogeneous Levant that has been<br />

recently structured by culture. M. Haber, D. Comas, P.<br />

A. Zalloua.<br />

3388F <strong>Human</strong> and Helicobacter pylori ancestries<br />

in Colombian populations with contrasting risks <strong>of</strong><br />

gastric cancer. N. Kodaman, A. Pazos, M. B. Piazuelo, B.<br />

G. Schneider, C. L. Shaffer, J. Romero-Gallo, T. de Sablet,<br />

L. E. Bravo, K. Wilson, T. Cover, P. Correa, S. Williams.<br />

3389W Deep ancestry within a Neandertal-like region<br />

on human chromosome 12. F. L. Mendez, J. C. Watkins,<br />

M. F. Hammer.<br />

3390T Sub-continental ancestry <strong>of</strong> admixed Caribbean<br />

populations and implications for medical genomics<br />

in the Americas. A. Moreno Estrada, S. Gravel, M. L.<br />

Cuccaro, F. Zakharia, P. Ortiz-Tello, R. J. Martinez, J. L.<br />

McCauley, E. E. Kenny, D. J. Hedges, R. W. Morris, J. K.<br />

Byrnes, S. Acevedo, P. J. Norman, Z. Layrisse, P. Parham,<br />

C. D. Bustamante, E. R. Martin.<br />

3391W Population structure and ancestry inference<br />

under sample selection bias. S. S. Shringarpure, E. P. Xing.<br />

3392T Genome-wide effects <strong>of</strong> sex-specific<br />

incompatibility on neutral introgression. M. Uyenoyama.<br />

3393W Admixture analysis <strong>of</strong> spontaneous hepatitis<br />

C virus clearance among individuals <strong>of</strong> African<br />

descent. G. L. Wojcik, P. Duggal on behalf <strong>of</strong> International<br />

Consortium <strong>of</strong> HCV Spontaneous Resolution.<br />

3394T A genome-wide perspective <strong>of</strong> population<br />

structure and individual admixture in Xinjiang:<br />

Implications for demographic history and complex trait<br />

gene mapping. S. Xu, S. Li, D. Lu, P. Qin, H. Lou, W. Jin,<br />

X. Pan, L. Jin.<br />

3395W Genomics variants in the endogamous Mashadi<br />

Jewish population identified by pooled whole exome<br />

sequencing. H. Ostrer, W. J. Huh, G. Akler, L. U., M.<br />

Popovic, D. Kural, J. Sheffield, E. Burns, G. Atzmon, C.<br />

Oddoux.<br />

3396T An evaluation <strong>of</strong> genetic characteristics <strong>of</strong> two<br />

population isolates from Greece: The HELIC-Pomak<br />

and MANOLIS studies. G. Dedoussis, I. Tachmazidou,<br />

A. E. Farmaki, L. Southam, K. Palin, A. Kolb-Kokocinski,<br />

W. Rayner, E. Daoutidou, I. Ntalla, K. Panoutsopoulou, E.<br />

Tsafantakis, M. Karaleftheri, E. Zeggini.<br />

3397W Genomic variants in the Dominican population<br />

identified by whole exome genotyping using Affymetrix<br />

Axiom Arrays. C. Oddoux, C. Cambell, L. U., H. Ostrer.<br />

3398T A population-based study and subsequent<br />

disclosure <strong>of</strong> autosomal recessive disease-causing<br />

mutations in a founder population. J. X. Chong, R. L.<br />

Anderson, R. Ouwenga, D. J. Waggoner, C. Ober.<br />

POSTER SESSIONS 251<br />

3399W Deep-coverage whole genome sequencing <strong>of</strong><br />

100 Qatari reveals elevated prevalence <strong>of</strong> populationspecific<br />

variants linked to disease. J. L. Rodriguez-<br />

Flores, K. A. Fakhro, N. R. Hackett, J. Salit, J. Fuller, J. A.<br />

Malek, R. Badii, A. Al-Marri, L. Chouchane, R. G. Crystal,<br />

J. G. Mezey.<br />

3400T Single gene disorders in Western India: Cohort<br />

<strong>of</strong> high risk group. C. Ankleshwaria, J. Sheth, H. Patel, J.<br />

Lekshami, F. Sheth.<br />

3401W Study on the distribution <strong>of</strong> rare genetic<br />

variations in the French Canadian population. S. Girard,<br />

L.-P. Lemieux Perreault, I. Mongrain, G. Lettre, J. Rioux,<br />

M. Phillips, S. de Denus, G. A. Rouleau, J.-C. Tardif, M.-P.<br />

Dube.<br />

3402T Identification <strong>of</strong> a novel Native <strong>American</strong> Y<br />

chromosome founding lineage in northwest South<br />

America. L. Roewer, M. Nothnagel, L. Gusmão, V. Gomes,<br />

M. Gonzaléz, D. Corach, A. Sala, E. Alechine, T. Palha, N.<br />

Santos, A. Ribeiro-dos-Santos, M. Geppert, S. Willuweit,<br />

M. Nagy, S. Zweynert, M. Baeta, C. Núñez, B. Martínez-<br />

Jarreta, F. González-Andrade, E. Fagundes de Carvalho,<br />

D. Aparecida da Silva, J. J. Builes, D. Turbón, A. M. Lopez<br />

Parra, E. Arroyo-Pardo, U. Toscanini, L. Borjas, C. Barletta,<br />

S. Santos, M. Krawczak.<br />

3403W Single nucleotide variation analysis <strong>of</strong> protein<br />

domain signatures <strong>of</strong> human genes. J. Freudenberg.<br />

3404T Investigating the evolution <strong>of</strong> deleterious<br />

mutations in the major histocompatibility complex<br />

as a potential explanation for frequently observed<br />

HLA-disease associations. T. L. Lenz, D. M. Jordan, S.<br />

R. Sunyaev.<br />

3405W Quantifying the degree <strong>of</strong> purifying selection<br />

in genes associated with nephrotic syndrome. M. G.<br />

Sampson, M. Kretzler, H. M. Kang.<br />

3406T An assessment <strong>of</strong> population stratification<br />

in rare variant association tests using an analytic<br />

model <strong>of</strong> joint site frequency spectra. M. Reppell, M.<br />

Zawistowski, D. Wegmann, R. Weyant, P. L. St. Jean, M.<br />

G. Ehm, M. R. Nelson, J. Novembre, S. Zöllner.<br />

3407W Estimating and interpreting F ST : The impact <strong>of</strong><br />

rare variants. G. Bhatia, N. Patterson, S. Sankararaman,<br />

A. L. Price.<br />

3408T Are rare and common variant stratification<br />

patterns the same? E. Génin, M.-C. Babron, M. de<br />

Tayrac, D. N. Rutledge, E. Zeggini.<br />

3409W Variant frequency and the scale <strong>of</strong> population<br />

structure. P. Raska, O. De la Cruz Cabrera.<br />

3410T Male-specific common CNVs and complex<br />

gender differences in CNV detected among 808<br />

olfactory receptor loci, in 150 phenotypically normal<br />

individuals from the 1000 Genome Project. F.<br />

Shadravan.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


252 POSTER SESSIONS<br />

3411W Transcriptome sequencing across seven<br />

diverse populations characterizing novel transcript<br />

is<strong>of</strong>orms and allele-specific expression. H. A. Costa, A.<br />

R. Martin, J. M. Kidd, B. M. Henn, M. C. Yee, F. Grubert,<br />

S. B. Montgomery, H. M. Cann, M. P. Snyder, C. D.<br />

Bustamante.<br />

3412T African genome variation project. I. Tachmazidou,<br />

F. Ayele, C. Pomilla, J. Asimit, D. Gurdasani, R. Nsubuga,<br />

D. Shriner on behalf <strong>of</strong> APCDR Investigators.<br />

3413W Inference <strong>of</strong> genetic ancestry using genotype<br />

data from a single individual. C. Chen, S. Lee, S. Pollack,<br />

D. Hunter, P. Kraft, J. Hirschhorn, A. Price.<br />

3414W A unified model <strong>of</strong> meiosis combining<br />

recombination, non-disjunction, interference and<br />

infertility. H. R. Johnston IV, D. J. Cutler.<br />

Epigenetics<br />

3415T Landscape <strong>of</strong> DNA methylation in meningiomas.<br />

F. Gao, L. Shi, J. Russin, L. Zeng, X. Chang, T. Chen, S.<br />

Giannotta, D. Weisenberger, G. Zada, W. Mack, K. Wang.<br />

3416T A panel <strong>of</strong> epigenetic biomarkers <strong>of</strong> NSCLC<br />

identified from a comprehensive microarray-based<br />

DNA methylation analysis. S. C. Guo, X. T. Wang, J. B.<br />

Xu, F. L. Jin, J. C. Wang.<br />

3417T Methylome correlation structure in human aging<br />

brain. G. P. Srivastava, M. L. Eaton, B. T. Keenan, L. B.<br />

Chibnik, J. A. Schneider, M. Kellis, D. A. Bennett, P. L. De<br />

Jager.<br />

3418T Quantifying and normalizing methylation levels<br />

in illumina arrays. H. Xu, D. Ryu, S. Su, X. Wang, R.<br />

Podolsky, V. George.<br />

3419T Bone health at age 49-51 years is associated<br />

with IGF2 DNA methylation levels in the Newcastle<br />

Thousand Families Study cohort. C. Potter, J. C.<br />

McConnell, L. Barrett, R. M. Francis, M. S. Pearce, C. L.<br />

Relton.<br />

3420T NSD1 mutations in Sotos syndrome alter<br />

the DNA methylation landscape <strong>of</strong> genes involved<br />

in somatic growth and neuronal transmission. R.<br />

Weksberg, H. Jin, Y. Chen, D. Grafodatskaya, M. Inbar-<br />

Feigenberg, B. H. Y. Chung, C. Cytrynbaum, S. Choufani.<br />

3421T Aberrant expression <strong>of</strong> DNA methylation,<br />

cellular proliferation and DNA repair genes in<br />

gastric carcinogenesis? D. Q. Calcagno, F. Wisnieski,<br />

T. B. Brilhante, C. O. Gigek, E. S. Chen, M. F. Leal, S.<br />

Demachki, P. P. Assumpção, R. Artigiani, L. G. Lorenco, R.<br />

R. Burbano, M. A. C. Smith.<br />

3422T Novel microRNAs and epigenetic biomarkers for<br />

gastrointestinal stromal tumors. D. Glavač , M. Ravnik-<br />

Glavač .<br />

3423T The epigenetic alteration <strong>of</strong> PPP1R3C in the<br />

colorectal cancer. S. K. Lee, J. W. Moon, J. Kim, H. S.<br />

Kim, S. H. Park.<br />

3424T EGCG applications on HT-29 and MCF-7<br />

cell lines and evaluation <strong>of</strong> tumor suppressor gene<br />

methylation. O. Ozer, Y. K. Terzi, O. Darcansoy Iseri, Z.<br />

Yilmaz Celik, F. I. Sahin.<br />

3425T Methylation, mutational and expression analysis<br />

<strong>of</strong> IL6, IL8 and IL1B on the different tumor tissues.<br />

M. Poulin, A. Meyer, G. Gonzalez, J. Xu, L. Yan. 3426T<br />

Methylation pr<strong>of</strong>iling <strong>of</strong> tumor suppressor genes in invasive<br />

ductal breast carcinoma. Y. K. Terzi, F. I. Sahin, O. Ozer, Z.<br />

Yilmaz Celik, B. Demirhan, M. C. Yagmurdur.<br />

3427T Whole genome bisulfite sequencing <strong>of</strong> acute<br />

lymphoblastic leukemia cells. P. Wahlberg, J. Nordlund,<br />

O. Karlberg, C. Bäcklin, U. Liljedahl, E. Forestier, M.<br />

Gustafsson, G. Lönnerholm, A.-C. Syvänen.<br />

3428T Integrative genomic and epigenomic pr<strong>of</strong>iling<br />

<strong>of</strong> bladder cancer. A. Woloszynska-Read, D. Wang, L.<br />

Yan, Q. Hu, J. Wang, W. Bshara, J. Conroy, K. Guru, C.<br />

Morrison, S. Liu, D. L. Trump, C. S. Johnson.<br />

3429T Differential and sex-specific DNA methylation<br />

<strong>of</strong> the placental LEP promoter in early onset<br />

preeclampsia. K. Hogg, J. D. Blair, M. S. Peñaherrera, K.<br />

Louie, P. von Dadelszen, W. P. Robinson.<br />

3430T A genome-wide DNA methylation association<br />

study <strong>of</strong> young-onset hypertension in Han Chinese<br />

population <strong>of</strong> Taiwan. K. M. Chiang, H. C. Yang, J. W.<br />

Chen, W. H. Pan.<br />

3431T Genome-wide DNA methylation pr<strong>of</strong>iling<br />

<strong>of</strong> monozygotic twins discordant for trisomy 21.<br />

A. Letourneau, M. R. Sailani, F. Santoni, D. Robyr, P.<br />

Makrythanasis, A. Sharp, S. E. Antonarakis.<br />

3432T Genome-wide quantitative DNA methylation<br />

analysis <strong>of</strong> imprinted DMRs in patients with Beckwith-<br />

Wiedemann syndrome by MALDI-TOF MS technology.<br />

T. Maeda, K. Jozaki, H. YAtsuki, K. Higashimoto, H.<br />

Soezima.<br />

3433T Epigenomic features and transcription factor<br />

binding sites associate with hotspots <strong>of</strong> genomic<br />

instability in human germline and in cancer. C. Coarfa,<br />

C. S. Pichot, A. R. Jackson, A. Tandon, S. Raghuraman, S.<br />

Paithankar, A. V. Lee, S. E. McGuire, A. Milosavljevic.<br />

3434T DNA methylation influences lipid and adipokine<br />

pr<strong>of</strong>iles. M. A. Carless, H. Kulkarni, D. L. Rainwater, A. G.<br />

Comuzzie, M. C. Mahaney, J. Blangero.<br />

3435T Identification <strong>of</strong> epigenetic markers underlying<br />

increased risk <strong>of</strong> type 2 diabetes in South Asians: The<br />

EpiMigrant Pilot Study. A. Drong, C. Blancher, M. R.<br />

Jarvelin, C. M. Lindgren, P. Elliott, M. I. McCarthy, J. S.<br />

Kooner, J. C. Chambers.<br />

3436T Epigenome-wide association analysis identified<br />

aging alteration <strong>of</strong> DNA methylation level in the<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


genes related to metabolic pathways. H. Kitajima, K.<br />

Yamamoto.<br />

3437T Alterations in methylation status <strong>of</strong> immune<br />

response genes promoters in cell-free DNA during<br />

a hemodialysis procedure in patients with diabetic<br />

nephropathy and in non-diabetic subjects. M.<br />

Korabecna, E. Pazourkova, A. Horinek, M. Mokrejsova, V.<br />

Tesar.<br />

3438T Genome-wide DNA methylation study <strong>of</strong> obesity<br />

and type 2 diabetes. D. Zhou, D. Zhang, Z. Zhang.<br />

3439T Density <strong>of</strong> inter-individual epigenome variation<br />

uncovered by integrative epigenome mapping at single<br />

base resolution. J. J. Lambourne, S. Busche, V. Adoue, T.<br />

Kwan, M. Caron, G. Bourque, M. Lathrop, T. Pastinen.<br />

3440T Allelic-dropout during PCR in the promoter <strong>of</strong><br />

an imprinted gene potentially caused by interaction<br />

between G-quadruplex structures and DNA<br />

methylation. M. A. Kennedy, A. J. Stevens, S. Stuffrein-<br />

Roberts, A. Gibb, K. Doudney, A. Bagshaw, A. Aitchison,<br />

M. R. Eccles, V. V. Filichev, P. R. Joyce.<br />

3441T <strong>Genetics</strong> <strong>of</strong> global DNA methylation patterns<br />

in adipose tissue from twins and its effect on gene<br />

expression and disease: The MuTHER Study. E.<br />

Grundberg, E. Meduri, J. K. Sandling, A. K. Hedman, S.<br />

Keildson, J. Nisbet, M. Sekowska, A. Wilk, A. Barett, K.<br />

S. Small, J. T. Bell, E. T. Dermitzakis, M. I. McCarthy, T. D.<br />

Spector, P. Deloukas.<br />

3442T A methylome-wide MBD-seq study followed by<br />

replication in a total <strong>of</strong> 3,000 schizophrenia casecontrol<br />

samples identifies new disease biomarkers. K.<br />

A. Aberg, J. L. McClay, S. Nerella, S. L. Clark, G. Kumar,<br />

W. Chen, A. N. Khachane, G. Gao, L. Y. Xie, A. Hudson, J.<br />

Bukszar, C. M. Hultman, P. F. Sullivan, P. K. E. Magnusson,<br />

E. J. C. G. van den Oord, Swedish Schizophrenia<br />

Consortium.<br />

3443T Genome-wide estimation <strong>of</strong> DNA methylation<br />

heritability in CD4 � T-cells from 80 families. D. Absher, L.<br />

Waite, H. Tiwari, D. Arnett.<br />

3444T Epigenetic second hit on gene body <strong>of</strong> PKD1<br />

leads to cystic kidney in ADPKD. J. Bae, Y. Woo, J. Lee,<br />

J. Park, Y. Kim.<br />

3445T Altered DNA methylation in preeclamptic<br />

placentas. J. D. Blair, R. K. C. Yuen, P. von Dadelszen, W.<br />

P. Robinson.<br />

3446T Highly abnormal methylation <strong>of</strong> the placental<br />

genome in the CBAXDBA model <strong>of</strong> pregnancy failure.<br />

S. Brown, E. Bonney, L. Brown.<br />

3447T DNA methylation pr<strong>of</strong>iles <strong>of</strong> paediatric obsessive<br />

compulsive disorder. D. T. Butcher, G. L. Hanna, D. R.<br />

Rosenberg, R. Weksberg, P. D. Arnold.<br />

3448T Complete or partial loss <strong>of</strong> methylation at<br />

the GNAS locus identified in patients referred for<br />

POSTER SESSIONS 253<br />

molecular diagnosis <strong>of</strong> pseudohypoparathyroidism<br />

type 1a. G. S. Charames, S. J. Steinberg, B. A. Karczeski,<br />

M. A. Levine, G. R. Cutting.<br />

3449T DNA methylation <strong>of</strong> ADCYAP1R1 is associated<br />

with childhood asthma in Puerto Ricans. W. Chen, N.<br />

Boutaoui, Y. Y. Han, J. Brehm, C. Schmitz, E. Acosta-<br />

Perez, M. Cloutier, D. Calvert, S. Thornton-Thompson, D.<br />

B. Wakefield, M. Alvarez, A. Colón-Semidey, G. Canino, J.<br />

C. Celedón.<br />

3450T The role <strong>of</strong> DNA methylation in cognitive decline<br />

and Alzheimer’s disease. L. B. Chibnik, B. T. Keenan, G.<br />

Srivastava, M. L. Eaton, A. Meissner, J. A. Schneider, M.<br />

Kellis, D. Bennett, P. L. De Jager.<br />

3451T Distinct DNA methylation signature in ovarian<br />

cancer histological subtypes. M. S. Cicek, D. C.<br />

Koestler, B. L. Fridley, S. M. Armasu, K. R. Kalli, M. C.<br />

Larson, R. A. Vierkant, B. J. Winterh<strong>of</strong>f, J. Chien, J. B.<br />

Fan, M. Bibikova, B. Klotzle, G. Konecny, V. Shridhar, J. M.<br />

Cunningham, E. L. Goode.<br />

3452T Identifying new biomarkers for alcohol use<br />

behaviors in a methylome-wide MBD-seq study. S.<br />

L. Clark, K. A. Aberg, S. Nerella, G. Kumar, J. L. McClay,<br />

W. Chen, L. Y. Xie, A. Hudson, G. Gao, J. Bukszar, C. M.<br />

Hultman, P. K. E. Magnusson, P. F. Sullivan, E. J. C. G. van<br />

den Oord, Swedish Schizophrenia Consortium.<br />

3453T Smoking reduces DNA methylation levels at<br />

multiple genomic loci. P. Deloukas, L. Tsaprouni, T.-P.<br />

Yang, J. Bell, K. J. Dick, S. Kanoni, C. Nelson, E. Meduri, F.<br />

Cambien, C. Hengstenberg, J. Erdmann, H. Schunkert, A.<br />

H. Goodall, W. H. Ouwehand, T. Spector, N. J. Samani.<br />

3454T DNA hypomethylation <strong>of</strong> INS-IGF2 and BACH2<br />

in affected individuals within discordant monozygotic<br />

twins supports a role for epigenetic influences in type<br />

1 diabetes susceptibility. E. Elboudwarej, H. Quach, P.<br />

Ramsay, J. Lane, E. Sinclair, L. Criswell, P. Fain, J. Jeffrey,<br />

G. Eisenbarth, L. Barcellos, J. Noble.<br />

3455T Migration and DNA methylation: A comparison<br />

<strong>of</strong> methylation patterns in type 2 diabetes<br />

susceptibility genes between Indians and Europeans.<br />

H. R. Elliott, G. K. Walia, A. Duggirala, A. Groom, S. U.<br />

Reddy, G. R. Chandak, V. Gupta, M. Laakso, J. M. Dekker,<br />

M. Walker, S. Ebrahim, G. Davey Smith, C. L. Relton, RISC<br />

Consortium.<br />

3456T DNA methylation alterations associated<br />

with autism spectrum disorders. D. Grafodatskaya,<br />

R. Rajendram, Y. Lou, D. T. Butcher, L. Senman, C.<br />

Windpassinger, W. Roberts, S. W. Scherer, R. Weksberg.<br />

3457T A population-based method for identification <strong>of</strong><br />

differential methylation regions among samples. C. L.<br />

Hsiao, C. S. J. Fann, C. J. Chang.<br />

3458T <strong>Genetics</strong> and epigenetics <strong>of</strong> PON1 in Mexican-<br />

<strong>American</strong> children. K. Huen, K. Harley, P. Yousefi, A.<br />

Bradman, L. Barcellos, B. Eskenazi, N. Holland.<br />

3459T Comprehensive DNA methylation pr<strong>of</strong>iling<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


254 POSTER SESSIONS<br />

<strong>of</strong> 3.7 million CpGs with the SureSelect target<br />

enrichment system. K. Jeong, M. Corioni, F. Useche, A.<br />

Shafer, E. Haugen, B. Novak, S. Happe, D. Roberts, J.<br />

Stamatoyannopoulos, E. LeProust.<br />

3460T The development <strong>of</strong> a method for in-solution<br />

hybrid capture <strong>of</strong> bisulfite-converted DNA for targeted<br />

bisulfite sequencing <strong>of</strong> 175 ADME genes. M. Kals, M.<br />

Ivanov, M. Kacevska, A. Metspalu, M. Ingelman-Sundberg,<br />

L. Milani.<br />

3461T Association <strong>of</strong> fetal-derived hypermethylated<br />

RASSF1A concentrations in placenta-mediated<br />

pregnancy complications. S. Kim, M. Kim, S. Park, D.<br />

Lee, J. Lim, J. Han, H. Ahn, J. Chung, M. Ryu.<br />

3462T Epigenome-wide association study <strong>of</strong><br />

rheumatoid arthritis. I. Koh, J. Kim, J. Yoon, B. Kim, I.<br />

Park, K. Kim, Y. Kim, R. Huh, B. Han, S. Bae, J. Bae, J.<br />

Lee.<br />

3463T DNA methylation analysis <strong>of</strong> iPS cells using<br />

whole-genome bisulphite sequencing. D. S. Lee, J. Y.<br />

Shin, Y. S. Ju, J. I. Kim, P. Tonge, M. Puri, A. Nagy, J. S.<br />

Seo.<br />

3464T Advanced genome-wide methylome pr<strong>of</strong>iling<br />

and analysis <strong>of</strong> leukemia reveals novel epigenetic<br />

dynamics. S. Li, A. Akalin, F. Garrett-Bakelman, A.<br />

Melnick, C. Mason.<br />

3465T Differential methylation <strong>of</strong> colorectal adenomas<br />

<strong>of</strong> the right side. J. Li, D. Koestler, J. Baron, A. Dietrich,<br />

G. Tsongalis, L. Butterly, M. Goodrich, C. Marsit, J. Moore,<br />

A. Andrew, A. Srivastava.<br />

3466T Methylation quantitative trait loci and epigenetic<br />

networks underlying asthma-related traits. L. Liang,<br />

S. A. G. Willis-Owen, K. C. C. Wong, A. Binia, G. Davies,<br />

J. M. Hopkin, I. Yang, T. Pastinen, D. A. Schwartz, G.<br />

Abecasis, G. M. Lathrop, M. F. M<strong>of</strong>fatt, W. O. C. M.<br />

Cookson.<br />

3467T Activation <strong>of</strong> silenced tumor suppressor genes<br />

in prostate cancer cells by a novel energy restrictionmimetic<br />

agent. H. Lin, Y. Kuo, Y. Weng, I. Lai, T. Huang, S.<br />

Lin, D. Niu, C. Chen.<br />

3468T Patterns <strong>of</strong> SNP-based genome-wide heritability<br />

<strong>of</strong> methylation in four brain regions. J. Listgarten, G.<br />

Quon, C. Lippert, D. Heckerman.<br />

3469T Statistical models to predict DNA methylation<br />

level across different tissues in human. B. Ma, E.<br />

Wilker, S. A. G. Willis-Owen, K. C. C. Wong, A. Baccarelli,<br />

J. Schwartz, W. O. C. M. Cookson, K. Khabbaz, M. A.<br />

Mittleman, M. F. M<strong>of</strong>fatt, L. Liang.<br />

3470T Comparative DNA methylation in TrkB gene<br />

across brain regions <strong>of</strong> suicide completers. G.<br />

Maussion, B. Labonté, C. Ernst, A. Diallo, J. Yang, N.<br />

Mechawar, G. Turecki.<br />

3471T Methylomic variation In Alzheimer’s disease.<br />

J. Mill, K. Lunnon, M. Volta, R. Smith, J. Powell, Y. Patel,<br />

N. Buckley, J. Cooper, C. Troakes, V. Haroutunian, S.<br />

Lovestone, L. Schalkwyk.<br />

3472T Cytosine modifications and cellular sensitivity to<br />

chemotherapeutics. E. L. Moen, X. Zhang, S. M. Delaney,<br />

L. A. Godley, M. E. Dolan, W. Zhang.<br />

3473T Aberrant promoter hypermethylation <strong>of</strong> MMP16<br />

gene in the colorectal cancer. J. Moon, S. Lee, J. Kim,<br />

G. You, J. Lee, J. Kim, H. Kim, S. Park.<br />

3474T Deep sequencing reveals allelic and<br />

parental inheritance patterns <strong>of</strong> genome-wide DNA<br />

methylation in large number <strong>of</strong> nuclear pedigrees with<br />

schizophrenia. R. A. Oph<strong>of</strong>f, N. Plongthongkum, T. Wang,<br />

Y. Zhang, K. R. Van Eijk, R. S. Kahn, M. P. M. Boks, S.<br />

Horvath, K. Zhang.<br />

3475T Methylation pattern <strong>of</strong> twin groups with Behcet’s<br />

syndrome. M. Ozkilic, B. Shamloo, G. Celikyapi Erdem, E.<br />

Seyahi, H. Yazici, E. Tahir Turanli.<br />

3476T Integrated analysis <strong>of</strong> genome-wide DNA<br />

methylation and gene expression in post-mortem<br />

schizophrenia brain samples. R. Pidsley, J. Viana, C.<br />

Troakes, S. Al-Sarraj, L. Schalkwyk, J. Mill.<br />

3477T Determination <strong>of</strong> methylation pr<strong>of</strong>ile in<br />

patients with schizophrenia. B. Rukova, R. Staneva, S.<br />

Hadjidekova, D. Nikolova, V. Milanova, D. Toncheva.<br />

3478T Association <strong>of</strong> CpG island shore methylation in<br />

peripheral blood with disease state and SNP variants<br />

in the MLH1 region in colorectal cancer patients. A.<br />

Savio, M. Lemire, M. Mrkonjic, S. Gallinger, B. Zanke, T.<br />

Hudson, B. Bapat.<br />

3479T The DNA methylation landscape <strong>of</strong> human<br />

placenta. D. Schroeder, H. Yu, P. Lott, D. Hong, C. Walker,<br />

I. Korf, J. M. LaSalle.<br />

3480T Methylation quantitative trait loci are consistently<br />

detected across ancestry, age and tissue type. A. K.<br />

Smith, V. Kilaru, M. Kocak, L. M. Almli, K. B. Mercer, E. B.<br />

Binder, K. J. Ressler, F. A. Tylavsky, K. N. Conneely.<br />

3481T Whole-genome methylation analysis: New<br />

insights in BEN molecular ethiology. R. Staneva, B.<br />

Rukova, I. Dimova, S. Hadzhidekova, O. Boyanova, M.<br />

Polenakovic, V. Stefanovic, R. Cukuranovic, V. Djonov, A.<br />

Galabov, D. Toncheva.<br />

3482T Genome-wide differences in DNA methylation<br />

identified in children with Williams-Beuren syndrome.<br />

E. Strong, D. Butcher, C. B. Mervis, C. A. Morris, R.<br />

Weksberg, L. R. Osborne.<br />

3483T Genome-wide pr<strong>of</strong>iling <strong>of</strong> 5-formylcytosine in<br />

embryonic stem cells. K. E. Szulwach, C. X. Song, Q.<br />

Dai, Y. Fu, P. Liu, L. Li, Y. Li, G. L. Xu, C. He, P. Jin.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3484T Extremely preterm infants are epigenetically<br />

different from term infants at birth and an epigenetic<br />

legacy <strong>of</strong> preterm birth may remain at 18 years <strong>of</strong> age.<br />

C. Theda, M. Cruickshank, A. Oshlack, P. Sheehan, R.<br />

Saffery, P. Davis, LW. Doyle, J. Craig.<br />

3485T Genome-wide detection and analysis <strong>of</strong> CpG<br />

dinucleotide methylation in cancer fatigue studies. D.<br />

Wang, H. Lee, W. Xiao, C. Hsiao, H. Kim, R. Dionne, L.<br />

Saligan.<br />

3486T Prediction <strong>of</strong> total serum IgE using genomewide<br />

methylation pr<strong>of</strong>ile. X. Wang, S. A. G. Willis-Owen,<br />

K. C. C. Wong, A. Binia, G. Davies, J. M. Hopkin, G. M.<br />

Lathrop, M. F. M<strong>of</strong>fatt, W. O. C. M. Cookson, L. Liang.<br />

3487T Epigenomic pr<strong>of</strong>iling <strong>of</strong> autism spectrum<br />

disorder. C. C. Y. Wong, L. C. Schalkwyk, E. L. Meaburn,<br />

A. Ronald, T. S. Price, R. Plomin, D. H. Geschwind, J. Mill.<br />

3488T Microarray-based genome-wide analyses <strong>of</strong><br />

DNA methylation in hematological malignancies. Y.<br />

Yang, H. Mei, L. Edelmann, A. J. Sharp, I. Peter, V. Najfeld,<br />

C. R. Geyer, J. F. DeCoteau, S. A. Scott.<br />

3489T Discovery <strong>of</strong> cross-reactive probes in the<br />

Illumina Infinium <strong>Human</strong>Methylation450 microarray:<br />

A cautionary tale. Y. Chen, M. Lemire, S. Choufani, D. T.<br />

Butcher, D. Grafodatskaya, B. W. Zanke, R. Weksberg.<br />

3490T Epigenetic changes in response to common<br />

environmental compounds. V. Labrie, I. Rezaian, S.<br />

Konigorski, N. Miller, Y. Li, C. Austin, R. Tice, M. Xia, A.<br />

Ngom, L. Rueda, R. Kustra, A. Petronis.<br />

3491T Regulatory network <strong>of</strong> microRNA action: miR-<br />

199a in health and diseases. S. Gu, Y. K. Suen, W. Y.<br />

Chan.<br />

3492T Gold nanoparticles cause variation in the level <strong>of</strong><br />

methylation in H3K4 and H3K9. A. Polverino, A. Iuliano,<br />

L. Cristino, R. Imperatore, A. Longo, G. Carotenuto, S. De<br />

Nicola, M. Piscopo, L. Fucci, E. Vitale.<br />

3493T Gene methylation and allelic expression imbalance<br />

<strong>of</strong> the CYP1A2 and CYP3A4 genes in human livers. J. Shi,<br />

W. Shou, Z. Niu, Y. Wang, K. Zhang, W. Huang.<br />

3494T 6q24 Transient neonatal diabetes mellitus: 16<br />

years <strong>of</strong> data collection. I. K. Temple, S. Kabwama,<br />

L. Doherty, S. Ennis, E. Cook, L. Harrison, S. Ellard, S.<br />

Flanagan, A. T. Hattersley, J. P. H. Shield, D. J. G. Mackay.<br />

3495T Genome-wide pr<strong>of</strong>iling <strong>of</strong> human uniparental<br />

tissues to search for novel imprinted genes. S. Wen,<br />

W. Wan, A. Balasa, S. Mahadevan, Z. Liu, I. B. Van den<br />

Veyver.<br />

3496T Next generation bisulfite analysis around<br />

a 2.2 kb ICR1 deletion in 11p15.5 reveals variable<br />

hypermethylation explaining reduced penetrance in<br />

BWS families. J. Beygo, V. Citro, D. Prawitt, M. Heitmann,<br />

K. Rademacher, B. Horsthemke, A. Riccio, K. Buiting.<br />

POSTER SESSIONS 255<br />

3497T A noncoding imprinted RNA, MESTIT1 is<br />

essential for the repression in cis <strong>of</strong> KLF14. S. Horike,<br />

M. Meguro-Horike.<br />

3498T MeCP2 is required for chromatin higher-order<br />

structure and dynamics at the imprinted 15q11-q13<br />

locus. M. Meguro-Horike, D. H. Yasui, W. Powell, J. M.<br />

LaSalle, S. Horike.<br />

3499T DNA methylation analysis <strong>of</strong> reciprocal genomewide<br />

UPDs to define imprinted differentially methylated<br />

regions in the human genome. K. Nakabayashi, A. M.<br />

Trujillo, C. Tayama, V. Romanelli, P. Lapunzina, M. Kagami,<br />

H. Soejima, H. Ogata, F. Court, D. Monk, K. Hata.<br />

3500T The imprinted C15orf2 gene in the Prader-Willi<br />

syndrome region encodes a nuclear pore complex<br />

associated protein. L. C. Neumann, Y. Markaki, E.<br />

Mladenov, D. H<strong>of</strong>fmann, K. Buiting, B. Horsthemke.<br />

3501T The ‘language gene’ FOXP2 is not imprinted.<br />

A. C. Thomas, J. M. Frost, F. Khadem, P. Stanier, G. E.<br />

Moore.<br />

3502T Evaluation <strong>of</strong> gene expression pr<strong>of</strong>ile <strong>of</strong><br />

chromatin modification enzymes in ACP02 and ACP03<br />

gastric cell lines. J. C. Santos, R. R. Burbano, M. L.<br />

Ribeiro.<br />

3503T Expression patterns <strong>of</strong> histone acetylation<br />

modifier genes in gastric cancer. F. Wisnieski, D. Q.<br />

Calcagno, M. F. Leal, T. B. Pontes, C. O. Gigek, E. S.<br />

Chen, S. Demachki, L. G. Lourenço, P. P. Assumpção, R.<br />

Artigiani, R. R. Burbano, M. A. C. Smith.<br />

3504T The enzyme holocarboxylase synthetase<br />

mediates biotin-independent gene-silencing through<br />

the recruitment <strong>of</strong> histone deacetilases in the nucleus<br />

<strong>of</strong> human cells. I. Trujillo, T. Barrios-García, S. Reyes-<br />

Carmona, I. Meneses-Morales, A. Leon-Del-Rio.<br />

3505T Epigenetic variation among humans. M.<br />

Kasowski, F. Grubert, S. Kyriazopoulou-Panagiotopoulou,<br />

A. Kundaje, J. Li, D. Spacek, M. Snyder.<br />

3506T Expression <strong>of</strong> mouse Lin28 gene is<br />

epigenetically regulated by histone modification. A.<br />

Pang, A. Title, O. M. Rennert.<br />

3507T Transcriptional and epigenetic variation in<br />

human induced pluripotent stem cells. N. Kumasaka, F.<br />

Rouhani, L. Vallier, A. Bradley, D. Gaffney.<br />

3508T The ratio <strong>of</strong> IGF2/IGF2R in chorionic villus<br />

samples as a biomarker for birth weight. C. Demetriou,<br />

A. Thomas, M. Ishida, S. Abu-Amero, R. Aggarwal, D.<br />

Peebles, A. Syngelaki, K. Nicolaides, L. Regan, G. E. Moore.<br />

3509T Genome-wide studies <strong>of</strong> methylation in<br />

the mouse frontal cortex reveals novel imprinted<br />

differential methylated regions and non-CG<br />

methylation. C. Barr, W. Xie, Y. Feng, K. Wigg, E.<br />

Dempster, L. Gomez, J. Eubanks, B. Ren.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


256 POSTER SESSIONS<br />

3510T An integrated analysis <strong>of</strong> DNA methylation,<br />

histone modifications and gene expression in<br />

monozygotic twins discordant for psoriasis identifies<br />

disease-associated genes. R. Lyle, K. Gervin, G. D.<br />

Gilfillan, M. Hammerø, H. S. Hjorthaug, A. O. Olsen, T.<br />

Hughes, J. R. Harris, D. E. Undlien.<br />

3511T Monozygotic male twins with loss <strong>of</strong><br />

methylation at DMR2 but discordant for clinical<br />

features <strong>of</strong> Beckwith Wiedemann syndrome. J. Lazier,<br />

M. A. Thomas.<br />

3512T Acquired epigenetic and chromosomal<br />

instability alterations are present in adults who<br />

experienced childhood sexual abuse: A discordant<br />

monozygotic twin study. T. York, J. Brumelle, J. Juusola,<br />

K. Kendler, E. Eaves, A. Amstadter, S. Aggen, K. Jones, S.<br />

Latendresse, A. Ferreira-Gonzalez, C. Jackson-Cook.<br />

3513T Genome-wide DNA methylation and gene<br />

expression analyses <strong>of</strong> monozygotic twins discordant<br />

for intelligence levels. C. C. Yu, M. Furukawa, K.<br />

Kobayashi, C. Shikishima, P. C. Cha, J. Sese, H.<br />

Sugawara, K. Iwamoto, T. Kato, J. Ando, T. Toda.<br />

3514T Analysis <strong>of</strong> expressed SNPs identifies new<br />

genes escaping X-chromosome inactivation and<br />

variable extents <strong>of</strong> expression from the inactive X. A.<br />

Cotton, B. Ge, T. Pastinen, C. Brown.<br />

3515T Investigating the role <strong>of</strong> the WICH chromatin<br />

remodeling complex in maintaining facultative<br />

heterochromatin at the human inactive X chromosome<br />

through targeted deletion <strong>of</strong> the BAZ1B gene using<br />

zinc finger nuclease technology. A. E. Culver-Cochran,<br />

B. P. Chadwick.<br />

3516T DNA methylation pr<strong>of</strong>iling in X;autosome<br />

translocations supports a role for repeat elements in<br />

the spread <strong>of</strong> X chromosome inactivation. A. Sharp, N.<br />

Bala, M. Brahmachary, P. Garg, C. Borel.<br />

3517T Tools for epigenetic research. L. Apone, P. Liu, G.<br />

Lohman, E. Cantor, B. Langhorst, D. Munafo, C. Sumner,<br />

E. Yigit, L. Merrill, F. Stewart, T. Evans, E. Dimalanta, T.<br />

Davis.<br />

3518T Sex-influenced epigenetic effects in<br />

chromosomal rearrangements. J. Kapalanga, D. Wong,<br />

N. Nwebube, A. Gandy.<br />

3519T The relationship between paternal uniparental<br />

disomy and clinical features in patients with Beckwith-<br />

Wiedemann syndrome. O. Yasufumi, K. Jozaki, T. Maeda,<br />

H. Yatsuki, K. Higashimoto, H. Soejima.<br />

3520T Streamlined chromosome conformation capture<br />

workflow for the studies <strong>of</strong> human �-globin gene<br />

control by locus control region. C. Woo, C. Liu, S. Dong.<br />

3521T microRNAs in the sclera: Role in ocular growth<br />

regulation and implications for myopia. R. Metlapally, P.<br />

Gonzalez, F. A. Hawthorne, K. Tran-Viet, C. F. Wildsoet, T.<br />

L. Young.<br />

3522T DNA combing assay for detection <strong>of</strong><br />

contraction-dependent facioscapulohumeral muscular<br />

dystrophy (FSHD1). F. Z. Boyar, P. Chan, V. Sulcova, D.<br />

Tsao, R. Owen, P. Walrafen, C. D. Braastad, M. Jocson, W.<br />

Sun, A. Anguiano, C. M. Strom.<br />

3523T RNA editing <strong>of</strong> the SDHB transcripts (C to U) in<br />

peripheral blood monocytes. R. T. Taggart, J. D. Tario, K.<br />

H. De Jong, P. K. Wallace, B. E. Baysal.<br />

3524T FTO levels affect RNA modification and the<br />

transcriptome. T. Berulava, M. Ziehe, L. Klein-Hitpass, E.<br />

Mladenov, J. Thomale, U. Rüther, B. Horsthemke.<br />

3525T Prioritizing candidate functional SNPs at GWAS<br />

loci using epigenomic datasets from ENCODE. K. S. Lo,<br />

C. D. Palmer, J. N. Hirschhorn, G. Lettre.<br />

Bioinformatics and Genomic<br />

Technology<br />

3526W Bioinformatic parallel processing tools<br />

development for mutation identification from whole<br />

exome data following homozygosity mapping<br />

for autosomal recessive disorders. Y. Al-Sarraj, A.<br />

Abouzehry, H. ElShanti, M. Kambouris.<br />

3527F Kailos Blue: A complete cloud-based<br />

bioinformatics solution for management and analysis<br />

<strong>of</strong> targeted sequencing across next-generation<br />

sequencing platforms. R. C. Bachmeyer, D. A. Kloske, B.<br />

Stone, K. E. Varley, D. T. Moore.<br />

3528W Streamlined, accurate low level detection <strong>of</strong><br />

variants in deep, next-generation sequencing data<br />

from amplicons. C. Boysen, M. Matvienko, N. Thomson,<br />

B. Turner, J. Bendtsen, H. Sandmann, J. Jakobsen, P.<br />

Nielsen, A. Joecker, A. Joecker.<br />

3529F De novo assembly by positional sequencing. B.<br />

Bready, P. Goldstein, W. H. Heaton, P. Ianakiev, H.-Y. Li, J.<br />

S. Oliver, J. Thompson.<br />

3530W Translational research in newborn screening:<br />

development <strong>of</strong> informatics tools to support<br />

longitudinal research and accelerate transformations<br />

in clinical practice. A. Brower, B. Bowdish, M. Porter, J.<br />

Pennington, S. Wrazien, J. Loutrel, P. White, M. Watson.<br />

3531F Web-based tool for target sequence capture<br />

assay design. J. Cai, B. Morrow.<br />

3532W wANNOVAR: Annotating genetic variants for<br />

personal genomes via the Web. X. Chang, K. Wang.<br />

3533F Simultaneous analysis <strong>of</strong> common and rare<br />

variants in complex traits. G. Chen, A. Yuan, A. Bentley,<br />

D. Shriner, A. Adeyemo, C. Rotimi.<br />

3534W On combining reference data to improve<br />

imputation accuracy. J. Chen, J. G. Zhang, J. Li, Y. F. Pei,<br />

H. W. Deng.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3535F Improved filtering and annotation <strong>of</strong> nextgeneration<br />

sequencing variants in clinical gene panels.<br />

H. K. Chong, S. Mexal, A. M. Elliott, H. M. Lu, H. Lu, X. Li.<br />

3536W Discovery <strong>of</strong> a cis-regulatory SNP at the<br />

PPARG diabetes risk locus. M. Claussnitzer, H. Grallert,<br />

S. N. Dankel, B. Klocke, H. Lee, S. Hauck, V. Glunk, C.<br />

H<strong>of</strong>fmann, M. Seifert, G. Mellgren, T. Illig, H. Hauner, H.<br />

Laumen.<br />

3537F dbGENO: A web-based complex disease<br />

curation pipeline. D. Cook, J. Dagle, K. Ryckman, J.<br />

Murray.<br />

3538W EVA: Exome Variation Analyzer, a tool for<br />

filtering strategies in medical genomics. S. Coutant,<br />

C. Cabot, A. Lefebvre, M. Léonard, E. Prieur-Gaston, D.<br />

Campion, T. Lecroq, T. Frebourg, H. Dauchel.<br />

3539F Random design tool for additional MIDs for<br />

Roche sequencing platforms. S. H. Eck, B. Grumbt, I.<br />

Nieberle, C. Marschall, K. Hirv, H.-G. Klein.<br />

3540W A functional gene-based test for association<br />

in Tourette’s syndrome and obsessive-compulsive<br />

disorder. P. Evans, TSA Consortium for <strong>Genetics</strong>, The<br />

International OCD Foundation <strong>Genetics</strong> Collaborative.<br />

3541F Statistical considerations for decisions on<br />

applying globin RNA reduction in blood samples for<br />

gene expression experiments. S. Feng, J. Dungan, S.<br />

Gregory, C. Haynes, W. Kraus.<br />

3542W Bi<strong>of</strong>ilter 2.0 for advanced predictive model<br />

development, testing, and hypothesis generation<br />

using expert domain knowledge resources. A. Frase,<br />

J. Wallace, C. Moore, N. Katiyar, S. A. Pendergrass, M. D.<br />

Ritchie.<br />

3543F Iterated correction <strong>of</strong> a diploid parental<br />

reference sequence and its use during exome<br />

alignments for disease gene discovery. T. R. Gall, D. R.<br />

Adams, C. F. Boerkoel, K. Fuentes-Fajardo, W. A. Gahl, P.<br />

Cherukuri, M. Sincan, C. Toro, C. J. Tifft, T. C. Markello.<br />

3544W Kinship index variations among populations<br />

and thresholds for familial searching. J. Ge, B. Budowle.<br />

3545F Transparent, accessible, and robust functional<br />

analysis <strong>of</strong> SNPs. B. Giardine, R. Burhans, C. Riemer, A.<br />

Ratan, R. Harris, G. Von Kuster, R. C. Hardison, Y. Zhang,<br />

W. Miller, Galaxy Development Team.<br />

3546W ParseCNV integrative CNV association s<strong>of</strong>tware<br />

with quality tracking. J. Glessner, H. Hakonarson.<br />

3547F Web-based interactive visual analysis <strong>of</strong> NGS<br />

data using Galaxy. J. Goecks, A. Nekrutenko, J. Taylor,<br />

Galaxy Team.<br />

3548W Computational and informational challenges<br />

in providing clinically-relevant genome interpretation<br />

from high-throughput sequencing data. R. K. Hart,<br />

Locus Development, Inc.<br />

POSTER SESSIONS 257<br />

3549F Capture-recapture models for evaluation <strong>of</strong><br />

algorithms estimating functionality <strong>of</strong> missense<br />

mutations. S. Hicks, S. E. Plon, M. Kimmel.<br />

3550W The Unified Sample Identifier: A universal<br />

sample coding system to manage large numbers<br />

<strong>of</strong> biological samples. P. H<strong>of</strong>fmann, J. E. Bolz, A.<br />

Reinscheidt, T. F. Wienker, S. Cichon, S. Herms.<br />

3551F Systematic evaluations <strong>of</strong> sequencing errors<br />

in next-generation sequencing data. Y. Hu, Y. Liu, J.<br />

Ferguson, I. Silverman, B. Gregory, M. Reilly, M. Li.<br />

3552W EGpr<strong>of</strong>ile: A tool for rapid pr<strong>of</strong>iling analysis <strong>of</strong><br />

epigenetic marks with ChIP-seq data. W. Huang, L. Li.<br />

3553F SOAPfuse detects gene fusions from paired-end<br />

RNA-seq data with single base resolution. W. Jia, K.<br />

Qiu, M. He, P. Song, Q. Zhou, F. Zhou, X. Hu, Y. Li, G. Guo.<br />

3554W Personalized genomics: Personalized pathway<br />

mapping. P. Jia, Z. Zhao.<br />

3555F Correcting for expression heterogeneity while<br />

identifying regulatory hotspots. J. Joo, J. Sul, B. Han,<br />

E. Eskin.<br />

3556W GeneTalk: An expert exchange platform for<br />

assessing rare sequence variants. T. Kamphans, P. M.<br />

Krawitz.<br />

3557F UCSC Genome Browser <strong>2012</strong>: Distributed data,<br />

enhanced interactivity, variant annotation integrator. W.<br />

J. Kent, A. Hinrichs, D. Karolchick, A. Zweig, B. Raney, H.<br />

Clawson, M. Cline, L. Guruvadoo, K. Learned, R. Kuhn, B.<br />

Rhead, T. Dreszer, L. Meyers, C. Li, M. Diekhans, G. Roe,<br />

P. Fujita, D. Haussler.<br />

3558W Curating genomic epidemiology data in the<br />

PAGE study. G. Kumaraguruparan, G. Mehta, A. Q. Nato,<br />

J. L. Ambite, S. Buyske, R. Mayani, C. Cai, J. S. Vockler, E.<br />

Deelman, T. C. Matise.<br />

3559F Predicting causal variants in exome sequencing<br />

<strong>of</strong> Mendelian disorders. J. Kwan, M. X. Li, P. C. Sham.<br />

3560W Analysis <strong>of</strong> Ewing sarcoma NGS transcriptome<br />

data highlights mechanisms <strong>of</strong> cancer progression. M.<br />

Laurance, J. Billaud, C. Bullitt.<br />

3561F Low concordance <strong>of</strong> variant calling algorithms<br />

in exome sequencing. G. Lyon, T. Jiang, G. Sun, W.<br />

Wang, J. Hu, P. Bodily, L. Tian, B. Moore, H. Hakonarson,<br />

J. Wang, M. Yandell, E. Johnson, Z. Wei, K. Wang.<br />

3562W DIVERGENOMEnrich: Expanding information on<br />

a genetic variation database through automatic online<br />

data retrieval. W. Magalhaes, G. Souza, G. Kingman, E.<br />

Tarazona, M. Rodrigues, Epigen-Brazil.<br />

3563F Fast and accurate local ancestry inference on<br />

whole genome-scale data using conditional random<br />

fields. B. Maples, F. Zakharia, S. Gravel, E. Kenny, C.<br />

Bustamante.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


258 POSTER SESSIONS<br />

3564W Exome sequencing <strong>of</strong> Mayo Clinic Biobank<br />

samples for evaluation <strong>of</strong> quality and quantity <strong>of</strong> data.<br />

S. Middha, S. K. McDonnell, Z. C. Fogarty, M. S. DeRycke,<br />

K. J. Johnson, N. M. Lindor, D. J. Schaid, J. E. Olson, J. R.<br />

Cerhan, S. N. Thibodeau.<br />

3565F Genome-wide association study on the world<br />

fastest supercomputer, k computer. K. Misawa, A.<br />

Hasegawa, T. Tsunoda.<br />

3566W A bioinformatics approach for the identification<br />

<strong>of</strong> developmental QTL candidate genes. A. Q. Nato, B.<br />

Li, F. Chen, J. H. Millonig, T. C. Matise.<br />

3567F Multivariate pr<strong>of</strong>iling approach to inference on<br />

differential expression in RNA-seq data with small<br />

sample size. S. Oh, M. Kim, S. Song.<br />

3568W Challenges and approaches to computational<br />

candidate gene prioritization using gene networks. P.<br />

Pavlidis, E. Mercier, J. Gillis.<br />

3569F BlueSNP: An R package for high-scalability<br />

genome-wide association studies on compute<br />

clusters. R. J. Prill, H. Huang, S. Tata.<br />

3570W Fast and accurate identification <strong>of</strong> novel<br />

sequences in de novo human genome assemblies using<br />

NSIT. B. Pupacdi, A. Javed, M. J. Zaki, M. Ruchirawat.<br />

3571F NGS for the masses: Empowering biologists to<br />

improve bioinformatic productivity. K. Qaadri.<br />

3572W Evaluation and visualization <strong>of</strong> functional<br />

perturbations <strong>of</strong> pathways based on whole genome<br />

variations. H. Qin, Y. Y. Shugart.<br />

3573F Use <strong>of</strong> an ad hoc information system to support<br />

data search at a genomics center. H. Qiu, F. Mentch, E.<br />

Frackelton, C. Kim, L. Hermannsson, H. Hakonarson.<br />

3574W Using biosignatures to stratify clinical<br />

response: Evaluation <strong>of</strong> classification methods using<br />

simulated gene expression signatures and real patient<br />

cohorts. P. Ravindran, C. Ooi, L. Kai, H. Zhong, A.<br />

Belousov, H. Bitter.<br />

3575F Mitre: A tool for bulk updates <strong>of</strong> SNP identifiers.<br />

N. W. Rayner, N. Robertson, M. I. McCarthy.<br />

3576W Genomic analysis from sequencer to bedside:<br />

An integrated analysis pipeline for research and<br />

clinical sequencing. J. G. Reid, M. N. Bainbridge, F.<br />

Yu, M. Dahdouli, D. Challis, P. Pham, D. P. Sexton, E.<br />

Boerwinkle, R. A. Gibbs.<br />

3577F <strong>Human</strong> genome pattern mining framework for<br />

complex diseases. M. Riemenschneider, M. Stoll.<br />

3578W A tool for selecting endogenous control for<br />

qRT-PCR using high throughput expression data. C.<br />

S. Rocha, C. V. Maurer-Morelli, I. Lopes-Cendes, F. M.<br />

Artiguenave.<br />

3579F Golden Helix GenomeBrowse: Cloud-enabled<br />

visual analytics <strong>of</strong> DNA and RNA-seq NGS data. G.<br />

Rudy, S. Gardner, M. Thiesen.<br />

3580W Informatics challenges on utilizing nextgeneration<br />

sequencing to advance disease<br />

understanding. S. Saisanit, J. Hakenberg, Y. Li.<br />

3581F Integrated genome-phenome analysis. M. M.<br />

Segal, M. S. Williams, J. G. Gleeson.<br />

3582W Variation data services at NCBI: Archives, tools,<br />

and curation for research and medicine. S. Sherry,<br />

K. Addess, V. Ananiev, C. Chen, D. Church, M. Feolo, J.<br />

Garner, T. Heffron, D. H<strong>of</strong>fman, M. Kholodov, A. Kitts, J.<br />

Lee, J. Lopez, D. Maglott, R. Maiti, L. Phan, G. Riley, W.<br />

Rubinstein, D. Rudnev, Y. Shao, E. Shekhtman, K. Sirotkin,<br />

D. Slotta, R. Tully, R. Villamarin-Salomon, Q. Wang, M. H.<br />

Ward, H. Zhang.<br />

3583F snpActs: A versatile web interface for<br />

annotating and prioritizing SNV data sets. B. Stade, D.<br />

Ellinghaus, B. Petersen, M. Forster, A. Franke.<br />

3584W Games for gene annotation and phenotype<br />

classification. A. I. Su, S. Loguercio, C. Wu, B. M. Good.<br />

3585F HMM-Fisher: A hidden Markov model-based<br />

method for identifying differential methylation. S. Sun,<br />

X. Yu.<br />

3586W Automated HGVS-recommended sequence<br />

variant description. P. Taschner, J. F. J. Laros, M.<br />

Vermaat, J. T. den Dunnen.<br />

3587F RNAseq analysis using the pipeline graphical<br />

workflow environment in neuropsychiatric disorders.<br />

F. Torri, I. D. Dinov, A. Zamanyan, S. Hobel, P. Petrosyan,<br />

Z. Liu, P. Eggert, I. Guella, J. Pierce, A. P. Clark, J. A.<br />

Knowles, J. Ames, C. Kesselman, A. W. Toga, S. Potkin,<br />

M. P. Vawter, F. Macciardi.<br />

3588W ENViz: A Cytoscape plugin for integrative<br />

statistical analysis and visualization <strong>of</strong> multiple sample<br />

matched data sets. A. Tsalenko, A. Kuchinsky, R. Navon,<br />

M. L. Creech, I. Steinfeld, Z. Yakhini.<br />

3589F Determining probability <strong>of</strong> rare variants: Design<br />

implications for family-based sequencing studies. W.<br />

Wang, G. Peng.<br />

3590W Harvest: A web-based biomedical data<br />

discovery and reporting application development<br />

platform. P. S. White, B. Ruth, M. J. Italia, J. Miller, J. W.<br />

Pennington.<br />

3591F Pinpoint: A new algorithm to detect gene-gene<br />

interactions in large-scale genome-wide association<br />

studies. D. Wong, S. Szymczak, J. E. Bailey-Wilson.<br />

3592W A unified analysis framework for detecting<br />

genetic variations from next-generation sequencing<br />

data. C. Xiao, S. Sherry.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3593F HMM-DM: Identifying differential methylation<br />

patterns using a hidden Markov model. X. Yu, S. Sun.<br />

3594W Genotype calling for next-generation<br />

sequencing data from multiple populations. K. Zhang,<br />

D. Zhi.<br />

3595F Detecting structural variants in cancer from<br />

whole genome and exome sequencing. J. Zhang, Y. Shi,<br />

W. Foulkes, J. Majewski.<br />

3596W Causal inference <strong>of</strong> gene regulation based on<br />

sub-network assembly. W. Hsieh, C. Peng, A. Dai, S.<br />

Peng, T. Yen.<br />

3597F Identification <strong>of</strong> candidate variants in population<br />

based whole exome sequencing data through<br />

integration <strong>of</strong> functional prediction with bayesian<br />

penalized regression. J. Lu, A. Sabo, J. Reid, D. Muzny,<br />

E. Boerwinkle, R. Gibbs, ARRA Autism Sequencing<br />

Consortium.<br />

3598W Joint association <strong>of</strong> multiple correlated<br />

phenotypes using matrix-variate linear mixed-models.<br />

N. Furlotte, E. Eskin.<br />

3599F The human gene connectome: A map <strong>of</strong> short<br />

cuts for morbid allele discovery. Y. Itan, S. Y. Zhang,<br />

G. Vogt, A. Abhyankar, L. Quintana-Murci, L. Abel, J. L.<br />

Casanova.<br />

3600W Transcriptome sequencing <strong>of</strong> nPOD type<br />

1 diabetes pancreatic samples for viral sequence<br />

identification. S. Morfopoulou, G. Zhao, R. Ferreira, A.<br />

Pugliese, J. Petrosino, L. Thackray, V. Plagnol, nPOD-Virus<br />

Group.<br />

3601F VARITAS: Variant analysis with rapid<br />

incorporation <strong>of</strong> annotation sources. B. Powell.<br />

3602W Clinical diagnostic tools for family genome and<br />

exome data. A. Russell, F. De La Vega, J. Rule, M. Reese.<br />

3603F ASAP: An easy-to-use pipeline for sequencing<br />

data processing. E. Torstenson, C. Li.<br />

3604W Identifying biological pathways and human<br />

diseases in high-throughput human genetic studies. C.<br />

Xie, X. Mao, J. Huang, Y. Ding, J. Wu, S. Dong, L. Kong, G.<br />

Gao, C. Li, L. Wei.<br />

3605F GenAMap: A visual analytics s<strong>of</strong>tware platform<br />

for eQTL and GWAS analysis. E. Xing, R. Curtis, S. Lee,<br />

S. Shringarpure, J. Yin.<br />

3606W PHV: A high accuracy SNP and indel variant<br />

caller based on the pr<strong>of</strong>ile hidden Markov model. M.<br />

Zhao, W. Lee, G. Marth.<br />

3607F Developing copy number variation based casecontrol<br />

association analysis tool and its application for<br />

disease analysis. Y. Chung, J. H. Kim, H. J. Hu, S. H. Yim,<br />

J. S. Bae, S. Y. Kim.<br />

POSTER SESSIONS 259<br />

3608W DWAC-seq: Dynamic Window Approach for<br />

CNV detection using next-generation targeted and full<br />

genome sequencing tag density. V. Koval, J. van Rooij,<br />

K. Estrada, P. Arp, M. Jhamai, R. Kraaij, A. Uitterlinden, E.<br />

Cuppen, V. Guryev.<br />

3609F Fast detection <strong>of</strong> de novo copy number variants<br />

from case-parent SNP arrays identifies a deletion on<br />

chromosome 7p14.1 associated with non-syndromic<br />

isolated cleft lip/palate. I. Ruczinski, R. B. Scharpf, S.<br />

Younkin, H. Schwender, M. Marazita, A. F. Scott, T. H.<br />

Beaty.<br />

3610W VarioML framework for comprehensive<br />

variation data representation and exchange. M. Byrne,<br />

I. A. C. Fokkema, O. Lancaster, T. Adamusiak, A. Ahonen-<br />

Bishopp, D. Atlan, C. Beroud, M. Cornell, R. Dalgeish, A.<br />

Devereau, G. P. Patrinos, M. A. Swertz, P. E. M. Taschner,<br />

G. A. Thorisson, M. Vihinen, A. J. Brookes, J. Muilu.<br />

3611F Gene-centered viewing, storing and sharing <strong>of</strong><br />

exome/genome variant and phenotype data. J. T. den<br />

Dunnen, I. F. Fokkema, I. C. Lugtenburg, J. Hoogenboom,<br />

Z. Tatum, G. C. P. Schaafsma, M. Vermaat, J. F. J. Laros, P.<br />

E. M. Taschner.<br />

3612W Leveraging metadata for experimental<br />

discovery at the ENCODE portal. E. L. Hong, C. Sloan, V.<br />

Malladi, K. Rosenbloom, G. Barber, G. Binkley, E. T. Chan,<br />

R. Fang, B. C. Hitz, D. Karolchik, V. Kirkup, K. Learned,<br />

J. Long, M. Maddren, M. Wong, A. Zweig, D. Haussler, J.<br />

Kent, J. M. Cherry.<br />

3613F A Bayesian hierarchical generalized linear model<br />

for identifying multiple interacting genes in familybased<br />

case-control studies. J. Li, N. Yi.<br />

3614W A national platform for clinical genetic analysis<br />

<strong>of</strong> high-throughput sequencing data in Norway. M.<br />

C. Eike, H. LÊrum, T. Hughes, S. Bremer, S. Bergan, G.<br />

Thomassen, M. Aanestad, T. Grünfeld, D. E. Undlien.<br />

3615F Haplotyping human genomes using wholegenome<br />

sequence data. V. Bansal.<br />

3616W Comparing protein prediction methods using<br />

disease-causing missense variants. P. Duggal, Y. Kim,<br />

M. K. Tilley, M. M. Parker, A. Maroo, A. P. Klein.<br />

3617F Considerations for the processing and direct-toconsumer<br />

return <strong>of</strong> exome sequences. E. D. Harrington,<br />

C. McLean, A. Shmygelska, A. Chowdry, B. Naughton.<br />

3618W Topological mapping and exploration <strong>of</strong><br />

genotyping data using Iris. J. Paquette, G. Singh, G.<br />

Carlsson, P. Y. Lum.<br />

3619F Development <strong>of</strong> 1920 barcodes for large-scale<br />

targeted sequencing using the Access Array system.<br />

X. Wang, F. Kaper, P. Chen, C. Friedlnader, G. Sun, A. May.<br />

3620W NGS Catalog: A database <strong>of</strong> next-generation<br />

genome sequencing studies in humans. J. Xia, Q.<br />

Wang, P. Jia, B. Wang, W. Pao, Z. Zhao.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


260 POSTER SESSIONS<br />

3621F Genotype imputation via matrix completion. E.<br />

C. Chi, H. Zhou, G. K. Chen, D. Ortega Del Vecchyo, K.<br />

Lange.<br />

3622W Phenome-wide association study <strong>of</strong> common<br />

PXDN variants demonstrates association with aortic<br />

aneurysms. J. Denny, L. Bastarache, G. Bhave, S. McCall,<br />

M. Sample, R. Carroll, P. Peissig, A. Kho, C. McCarty, M.<br />

Brilliant, J. Cowan, R. Chisholm, E. Larson, G. Jarvik, C.<br />

Chute, I. Kullo, D. Roden, B. Hudson.<br />

3623F Rare variant association testing under lowcoverage<br />

and pooling. E. Halperin, J. H. Sul, O. Navon,<br />

B. Han, L. Conde, P. Bracci, J. Riby, C. Skibola, E. Eskin.<br />

3624W BioBin: A bioinformatics tool for biologically<br />

inspired collapsing <strong>of</strong> rare variants. C. B. Moore, J. R.<br />

Wallace, A. T. Frase, S. A. Pendergrass, M. D. Ritchie.<br />

3625F NCBI’s ClinVar: Data archive and tools for<br />

human variation <strong>of</strong> medical interest. D. Maglott, S.<br />

Chitipiralla, D. Church, M. Feolo, J. Garner, W. Jang, J.<br />

Lee, R. Maiti, J. Ostell, L. Phan, G. Riley, W. S. Rubinstein,<br />

D. Shao, S. Sherry, K. Sirotkin, R. Tully, R. Villamarin, M.<br />

Ward.<br />

3626W Estimation <strong>of</strong> haplotype frequencies from<br />

pooled sequence data. D. E. Kessner, J. Novembre.<br />

3627F Leveraging the haplotype information in long<br />

reads for variant calling. A. P. Singh, Y. Shen.<br />

3628W A model <strong>of</strong> binding on DNA microarrays:<br />

Understanding the combined effect <strong>of</strong> probe synthesis<br />

failure, cross-hybridization, DNA fragmentation and<br />

other experimental details <strong>of</strong> affymetrix arrays. Y. A.<br />

Jakubek, D. J. Cutler.<br />

3629F A recursively partitioned mixture model for<br />

clustering time-course gene expression data. D. C.<br />

Koestler, C. J. Marsit, B. C. Christensen, K. T. Kelsey, E. A.<br />

Houseman.<br />

3630W Probing altered gene expression pr<strong>of</strong>iles and<br />

pathways that affect mitochondrial metabolism in<br />

cancer cells and neurodegenerative diseases through<br />

network biology approach. A. D. Yadavalli, N. B. Sepuri.<br />

3631F Drug repositioning through data integration<br />

and advanced classification tools. D. Greco, Y. Zhao, F.<br />

Napolitano, R. Tagliaferri, M. D’Amato, J. Kere.<br />

3632W Gemini: A flexible, scalable analysis framework<br />

for medical and population genomics. U. D. Paila, A. R.<br />

Quinlan.<br />

3633F NOCALLER: A tool to account for missing<br />

genotypes. Z. Kronenberg, C. D. Huff, M. Yandell.<br />

3634W A novel model to predict splicing consequences<br />

<strong>of</strong> intronic nucleotide substitutions in the human<br />

genome. A. Shibata.<br />

3635F Prioritizing disease-linked variants, genes, and<br />

pathways with an interactive whole genome analysis<br />

pipeline for the MedSeq project. S. Kong, K. Lee, K. B.<br />

Hwang, J. M. Bohn, R. C. Green, I. S. Kohane.<br />

3636W The 1000 Genomes Project, data availability<br />

and accessibilty. L. Clarke, H. Zheng Bradley, R. Smith, I.<br />

Streeter, E. Kulesha, I. Toneva, B. Vaughan, P. Flicek, 1000<br />

Genomes Project Consortium.<br />

3637F Bioinformatics optimization for the detection <strong>of</strong><br />

low-level heteroplasmy in the mitochondrial genome in<br />

myelodysplastic syndrome. S. Dames, E. Duncavage, J.<br />

Thompson, P. Shami, K. Eilbeck, M. Salama, R. Mao.<br />

3638W Rare variant discovery in Illumina nextgeneration<br />

sequencing data: Prediction method to<br />

differentiate true variants from false positives. J.<br />

Durtschi, R. L. Margraf, K. V. Voelkerding.<br />

3639F Memory efficient assembly <strong>of</strong> mammalian size<br />

genome. F. Hormozdiari, E. Eskin.<br />

3640W Target capture-assisted sequence assembly for<br />

accurate genotyping <strong>of</strong> insertions and deletions. C. J.<br />

Kennedy, N. Chennagiri, M. A. Umbarger, G. J. Porreca, P.<br />

C. Saunders, V. Greger.<br />

3641F CLC bio’s integrated framework for<br />

identification and comparison <strong>of</strong> genomic variants<br />

in Mendelian diseases. M. Matvienko, A. Joecker, C.<br />

Boysen, U. Appelt, A. Fejes, L. Kahns, S. Mønsted, J.<br />

Grydholt, B. Knudsen, M. Bundgaard, J. Buur Sinding, H.<br />

Handberg, A.-M. Hein, M. Nygaard Ravn, A. Joecker, M.<br />

VÊrum, R. Forsberg.<br />

3642W Sensitivity and resolution <strong>of</strong> whole chromosome<br />

mapping for detection and characterization <strong>of</strong><br />

structural variations in human genomes. R. Moore.<br />

3643F Comparison <strong>of</strong> next-generation sequencing<br />

alignment programs using 215 whole genomes from<br />

the Cache County Study on Memory Health and Aging.<br />

P. G. Ridge, Jr., J. D. Durtschi, C. D. Corcoran, R. G.<br />

Munger, Q. O. Snell, M. J. Clement, K. V. Voelkerding, J.<br />

S. K. Kauwe.<br />

3644W Continuously evolving informatics at a mediumscale<br />

genomics center. L. Watkins, M. Barnhart, J.<br />

Goldstein, S. Griffith, E. Hsu, K. Roberts, D. Snyder, B. Craig,<br />

K. Hetrick, K. Doheny, Center for Inherited Disease Research.<br />

3645F Genotype concordance between low-coverage<br />

whole genome and high-coverage exome sequencing:<br />

Results from the UK10K Study. H. Zheng on behalf <strong>of</strong><br />

UK10K Consortium Cohorts Group.<br />

3646W Genotype calling and haplotype inference<br />

for next-generation sequencing data incorporating<br />

haplotype information in sequencing reads. D. Zhi, K.<br />

Zhang.<br />

3647F Exploring why whole genome sequencing<br />

methods result in different variant calls by comparing<br />

and integrating multiple datasets. J. M. Zook, D.<br />

Samarov, M. Salit.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3648W Next-generation biomarker screening: Using<br />

Roche’s 454 sequencing platform to identify somatic<br />

biomarkers. C. Lasyone, X. Tan, A. Pond, L. Szkotnicki, V.<br />

Venegas, K. B. Thomas, M. Berry, F. Lu.<br />

3649F De novo assembly <strong>of</strong> extremely long singlemolecule<br />

genome maps imaged in Irys nanochannel<br />

arrays. M. Requa, M. Austin, H. Dai, P. Deshpande, O.<br />

Hampton, H. Sadowski, M. Saghbini, M. Xiao, H. Cao.<br />

3650W Defining best practice guidelines for the use <strong>of</strong><br />

NGS applications in genome diagnostics: A national<br />

collaborative study <strong>of</strong> Dutch genome diagnostic<br />

laboratories (LOD). N. van der Stoep, M. M. Weiss, Q.<br />

Waisfisz, C. Ruivenkamp, M. Nelen, J. D. H. Jongbloed, H.<br />

Brüggenwirth, M. van Slegtenhorst, R. Lekanne dit Deprez,<br />

O. Mook, A. Van den Wijngaard, M. Vogel, B. Van der<br />

Zwaag, M. M. A. M. Mannens, Dutch National Board for<br />

DNA-Diagnostics (LOD).<br />

3651F Genome phantasmagoria: Naming genes in<br />

alternative loci. E. Bruford, R. Seal, M. Wright.<br />

3652W Rapid preparation <strong>of</strong> targeted resequencing<br />

libraries from DNA samples using the Access Array<br />

system. C. Friedlander, X. Wang, R. Ramakrishnan.<br />

3653F MitoExome: A custom whole exome kit for<br />

mitochondrial disease research and diagnosis that<br />

captures all MitoCarta genes and the mitochondrial<br />

genome. X. Gai, E. A. Pierce, M. Consugar, M. Lvova, D.<br />

C. Wallace, E. LeProust, M. J. Falk.<br />

3654W High-throughput solution for illumina fragment<br />

library sample preparations. A. Jackson, S. Verrow, M. Blair.<br />

3655F Comparison <strong>of</strong> two next-generation sequencing<br />

technologies on the genomes <strong>of</strong> a trio family. E.<br />

Jorgenson, R. Kazma.<br />

3656W Single-molecule, electronic, solid-state<br />

sequencing <strong>of</strong> M13 DNA. J. S. Oliver, B. Bready, D.<br />

Dederich, J. Freitas, H. Geiser, Y. He, D. Hevroni, M.<br />

Jouzi, H.-Y. Lee, P. Mukhatira, M. Nadel, J. Sariadaridis, J.<br />

Thompson.<br />

3657F Efficient genotyping <strong>of</strong> individuals using<br />

overlapping pool sequencing and imputation. Z. Wang,<br />

F. Hormozdiari, W. Yang, E. Eskin.<br />

3658W Whole-genome sequencing analysis <strong>of</strong> SNPs<br />

and structural variants in DNA from blood versus EBVtransformed<br />

lymphoblasts from the same subject. X.<br />

Zhu, C. Laurent, M. Haney, A. E. Urban, D. F. Levinson.<br />

3659F Genomic capture combined with long read and<br />

short read high-throughput sequencing for assembly<br />

<strong>of</strong> the MHC region. R. J. Bloom, A. L. Collins, A. E.<br />

Byrnes, Q. Langdon, S. Happe, J. Barboza, O. Hardy, G.<br />

Yuan, S. Ranade, P. Mieczkowski, P. F. Sullivan.<br />

3660W Automated pipeline for whole exome/genome<br />

sequencing analysis on Mendelian diseases. Y. Guo,<br />

K. Wang.<br />

POSTER SESSIONS 261<br />

3661F Computational analysis <strong>of</strong> Exome-seq for<br />

disease gene identification with eDIVA. S. Ossowski, R.<br />

Rahman, O. Drechsel.<br />

3662W The biologist’s tool for finding a needle in a<br />

haystack: CLC bio’s platform to identify interesting de<br />

novo and accumulative variants in the whole genome<br />

sequence <strong>of</strong> family trios. N. Thomson, A. Joecker, C.<br />

Boysen, M. Matvienko, U. Appelt, A. Fejes, L. Kahns, S.<br />

Mønsted, J. Grydholt, B. Knudsen, M. Bungaard, J. Buur<br />

Sinding, H. Handberg, A. Hiene, M. Nygaard Ravn, A.<br />

Joecker, M. VÊrum, R. Forsberg.<br />

3663F Ultra-fast clinical sequencing and annotation <strong>of</strong><br />

human genomes on the Illumina HiSeq 2500 platform.<br />

S. Humphray, J. Weir, Z. Kingsbury, T. James, R. Grocock,<br />

P. Saffrey, E. Margulies, K. Hall, D. Bentley, G. Smith, J.<br />

Betley, C. Raczy.<br />

3664W Managing computing resources in large<br />

sequencing studies: Strategies and lessons from<br />

sequencing 2,120 Sardinian genomes. A. Kwong,<br />

C. Sidore, S. Sanna, H. M. Kang, G. Jun, M. Trost,<br />

P. Anderson, T. Gliedt, R. Cusano, M. Pitzalis, M.<br />

Zoledziewska, A. Maschio, F. Busonero, M. Lobina, M.<br />

Balloi, B. Tarrier, C. Brennan, C. Jones, F. Cucca, G.<br />

Abecasis, SardiNIA Project.<br />

3665F Clinical implementation <strong>of</strong> targeted nextgeneration<br />

sequencing in a mid-sized diagnostic<br />

laboratory. H. Racher, L. Dimnik, P. Gordon, M. I. Innes, F.<br />

Bernier, J. S. Parboosingh.<br />

3666W High-fidelity sequencing for detection <strong>of</strong> lowfrequency<br />

single nucleotide variants. K. M. Squire, Z.<br />

Chen, S. F. Nelson.<br />

3667F Species identification by polymorphisms <strong>of</strong><br />

mitochondrial 12S rRNA and 16S rRNA genes. R. Li, L.<br />

Yang.<br />

3668W Rapid and efficient methods for preparing<br />

globin- and rRNA-depleted directional RNA-seq<br />

libraries. C. Kinross, J. Hitchen, N. Caruccio, R.<br />

Sooknanan.<br />

3669F Sequencing performance <strong>of</strong> FFPE DNA in the<br />

SureSelect XT2 Target Enrichment System. J. Barboza,<br />

M. Ramirez, A. Giuffre, J. Ong, H. Ravi, M. Guadalupe, S.<br />

Joshi, M. Visitacion, C. Pabón-Peña, S. Hunt, B. Novak, D.<br />

Roberts, S. Happe, E. LeProust.<br />

3670W Torrent Variant Caller: Enabling next level <strong>of</strong><br />

genomic analysis. D. Brinza, Z. Zhang, E. Tsung, A.<br />

Joyner, C. Scafe, G. Del Mistro, F. Hyland, E. Beasley, S.<br />

Utiramerur.<br />

3671F A next-gen sequencing s<strong>of</strong>tware workflow for<br />

cancer genomics on a desktop computer. M. Keyser, K.<br />

Maxfield, T. Schwei, T. Durfee, A. Pollack-Berti, D. Nash, J.<br />

Stieren, S. Baldwin, R. Nelson, K. Dullea, J. Schroeder, P.<br />

Pinnkas, G. Plunkett III, F. Blattner.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


262 POSTER SESSIONS<br />

3672W Strategy for identification, prediction, and<br />

prioritization <strong>of</strong> non-coding variants <strong>of</strong> uncertain<br />

significance in heritable breast cancer. P. K. Rogan, E.<br />

J. Mucaki, A. Stuart, N. Bryans, E. Dovigi, B. Shirley, J. H.<br />

Knoll, P. J, Ainsworth.<br />

3673F Genomic approach for environmental stress<br />

assessment in coral, Scleronephthya gracillimum. S.<br />

Woo, S. J. Hwang, S. Yum, J. I. Song.<br />

3674W RNA-seq uncovers the influence <strong>of</strong> structural<br />

variants on transcriptome diversity. E. Ait Yahya<br />

Graison, A. Reymond.<br />

3675F Detection <strong>of</strong> local signals in genomics. D.<br />

Siegmund, B. Yakir, N. Zhang.<br />

3676W Gene expression pr<strong>of</strong>iling <strong>of</strong> prokaryotic<br />

samples using LIQA WT kit. N. Guha.<br />

3677F In silico identification <strong>of</strong> microRNA-mRNA target<br />

pairs as potential biomarkers in prostate cancer. J.<br />

Billaud, C. Tavano, D. Toburen.<br />

3678W Active learning for phenotype mapping. C. Hsu,<br />

J. L. Ambite, Y. Arens, L. Lange, S. Sharma, S. Voinea.<br />

3679F Filtering and annotation <strong>of</strong> variants that are<br />

rare: Methods to facilitate the analysis <strong>of</strong> rare germline<br />

genetic variants from massively parallel sequencing<br />

datasets. D. J. Park, T. Nguyen-Dumont, F. Odefrey, A.<br />

Lonie, M. C. Southey, B. J. Pope.<br />

3680W Accurate, efficient next-generation DNA<br />

sequencing for clinical carrier screening. G. J. Porreca,<br />

M. Umbarger, C. Kennedy, P. Saunders, B. Breton, N.<br />

Chennagiri, J. Emh<strong>of</strong>f, V. Greger, D. Maganzini, C. Micale,<br />

M. Nizzari, C. Towne.<br />

3681F High-throughput CFTR full-gene analysis using<br />

Illumina’s MiSeq TruSeq custom amplicon technology.<br />

J. Radecki, S. Lee, H. Lu, S. Mexal, A. Elliott.<br />

3682W Sensitive detection <strong>of</strong> minor variants and viral<br />

haplotypes using Single-Molecule, Real-Time (SMRT ® )<br />

sequencing. A. Sethuraman, Y. Guo, M. Brown, J. Toma,<br />

A. Newton, W. Huang, M. Sugiyama, C. Petropoulos, M.<br />

Mizokami, E. Paxinos.<br />

3683F High-throughput amplicon sequencing using the<br />

personal genome machine. J. Boland, D. Roberson, M.<br />

Cullen, M. Yeager, K. Jacobs, S. Chanock, V. Lonsberry.<br />

3684W A simple method for improving the limit<br />

<strong>of</strong> detection for capillary electrophoresis DNA<br />

sequencing: A comparison <strong>of</strong> methodologies<br />

for KRAS variant detection. C. Davidson, E.<br />

Zeringer, K. J. Champion, M.-P. Gauthier, F. Wang, J.<br />

Boonyaratanakornkit, J. R. Jones, E. Schreiber.<br />

3685F HaloPlex target enrichment from FFPE tissues.<br />

F. Roos, H. Johansson, M. Isaksson, P. Eriksson, L.<br />

Forsmark, F. Dahl.<br />

3686W Optimized sample and library preparation <strong>of</strong><br />

FFPE tumor samples for targeted next-generation<br />

sequencing. N. Udar, R. Haigis, E. B. Jaeger.<br />

3687F TargetRich: Targeted sub-exome sequencing.<br />

I. A. Vasenkova, K. Jansen Spayd, T. Shvetsova, D. A.<br />

Kloske, R. C. Bachmeyer, D. T. Moore, K. E. Varley.<br />

3688W A functional approach to sequence capture<br />

analysis <strong>of</strong> disease pathways. M. Wijdicks, D. Burgess,<br />

M. D’Ascenzo, M. Brockman, J. Wendt, C. Skalitzky, D.<br />

Green, T. Richmond, L. Brown, R. Slezer.<br />

3689F Comparison <strong>of</strong> two NGS preparation methods<br />

for preimplantation and prenatal screening and<br />

diagnostics. J. P. Langmore, E. Kamberov, M.<br />

Mastronardi, T. Tesmer.<br />

3690W Droplet digital PCR enables reliable<br />

discrimination <strong>of</strong> copy number variation. J. R. Berman,<br />

N. Heredia, J. Regan, L. Montesclaros, S. Hodges, C.<br />

Troup, G. Karlin-Neumann.<br />

3691F Integrating high-quality DNA sequence capture<br />

with MiSeq for clinical sequencing. P. Shen, W. Wang, A.<br />

Chi, R. Davis, C. Scharfe.<br />

3692W Improved performance <strong>of</strong> solution based target<br />

enrichment by spike-in <strong>of</strong> individually synthesized<br />

capture probes. G. R. Mehta, Locus Development, Inc.<br />

3693F Accurate multiplexing for clinical next-generation<br />

DNA sequencing. M. A. Umbarger, G. P. Porreca.<br />

3694W Enhanced performance <strong>of</strong> the Illumina MiSeq ®<br />

next-generation sequencing ecosystem. K. Hall, C.<br />

Tregidgo, I. Rasolonjatovo, A. Breton, J. Bwanali, A.<br />

Jackson, E. Vermaas, D. Bond, M. Siu, C. Bruce, A.<br />

Powell, P. Tran, D. McBride, M. Ross.<br />

3695F Single-day, highly multiplexed amplicon<br />

sequencing with MiSeq ® . A. Iyer, A. Tian, K. Chang,<br />

E. Guzman, E. Upsall, I. Lewis, M. Won, W. Chang,<br />

D. Pokholok, R. Haigis, S. Norberg, M. Ronaghi, K.<br />

Gunderson, R. Shen, C. Lin.<br />

3696W WildFire: A simple monoclonal colony<br />

generation technology without emulsion PCR. Z. Ma, K.<br />

Lao, R. Lee, S. Goyal.<br />

3697F Nextera ® Enrichment: A new Nextera library<br />

prep protocol for targeted enrichment supporting 12plex<br />

pre-enrichment sample pooling. P. McInerney, S.<br />

Melnyk, M. Chen, M. Tsan, S. Cooper, H. Grunenwald, M.<br />

Lewis, R. Shen, J. Whitacre.<br />

3698W Development <strong>of</strong> Ion Torrent’s 400-base<br />

sequencing technology. X. Peng, G. Luo, T. Lincecum, E.<br />

Tozer, D. Mazur, K. Aguinaldo, G. Lowman, M. Landes, B.<br />

Strohecker, T. Nikiforov, P. Vander Horn.<br />

3699F From tumor to genome sequence with<br />

nanogram quantities <strong>of</strong> DNA: Ultralow target capture<br />

and DNA-Seq from FFPE samples. M. Phelan, L. Pham,<br />

G. Miyada, S. Kain, T. Cormier.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


3700W GnuBIO desktop sequencer: Fully integrated<br />

DNA preparation sequencing and analysis. T. Raz, A.<br />

Aslam, J. Boyce, N. Nerkizian, J. Emh<strong>of</strong>f, A. Esmall, J.<br />

Fanning, H. Ghandour, K. Moulton, P. Stokes, T. Hung, S.<br />

Kiani, P. Mary, J. Healy.<br />

3701F Utilizing next-generation sequencing for exome<br />

analysis. K. Stangier, F. Ernst, Y. Kumar, T. Paprotka.<br />

3702W Novel enrichment reagent for the study <strong>of</strong> the<br />

human microbiome. F. J. Stewart, G. R. Feehery, E. Yigit,<br />

E. T. Dimalanta, B. W. Langhorst, L. M. Apone, P. Liu, D.<br />

B. Munafo, C. J. Sumner, J. Bybee, L. M. Mazzola, T. B.<br />

Davis, S. Pradhan.<br />

3703F Structural variations identified using solid-state<br />

nanodetectors. J. Thompson, B. Bready, D. Dederich, D.<br />

Hevroni, M. Jouzi, H.-Y. Lee, D. Lloyd, P. Mukhatira, M.<br />

Nadel, J. Oliver, J. Saraidaridis.<br />

3704W Automaton <strong>of</strong> whole exome and targeted<br />

sequencing workflows in a high-throughput lab. M.<br />

Zilka, B. Marosy, A. Robinson, J. Gearhart, B. Craig, J.<br />

Romm, K. Doheny.<br />

3705F Automated genomic DNA QC ensures high<br />

quality data from downstream workflows. M.<br />

Gassmann, D. Rabiller, A. Padmanaban, D. McDade-<br />

Walker.<br />

3706W Optimization <strong>of</strong> a miRNA expression pr<strong>of</strong>iling<br />

workflow for ion semiconductor sequencing. T.<br />

Guettouche, J. Clarke, A. Andersen, L. Navarro, Y.<br />

Cardentey, W. Hulme, G. Bademci, D. Van Booven, D.<br />

Hedges, M. Pericak-Vance, J. Gilbert.<br />

3707F Functionalized nanoparticles for effective DNA<br />

purification. A. Lai, A. Fu.<br />

3708W POP-ONE: A new sieving matrix for<br />

capillary electrophoresis that supports a wide range<br />

<strong>of</strong> applications with a single instrument set-up. J.<br />

A. Romero, B. F. Johnson, F. Mercer, J. A. Fisher, D.<br />

Rodriguez, S. Hung, M. Wenz, W. Liao, J. Lee.<br />

3709F Automation <strong>of</strong> the Agilent target enrichment<br />

portfolio. M. R. Visitacion, J. Karbowski, F. Roos, B. Arezi,<br />

B. Novak, M. Isaksson, A. Giuffre, S. Happe, D. Roberts,<br />

E. Leproust, F. Dahl.<br />

3710W Sequencing <strong>of</strong> complete HLA haplotypes:<br />

Resequencing and population studies. M. S. Won, S.<br />

Norberg, T. Royce, T. Dunn, T. Mann, N. Nemat-Gorgani, L.<br />

A. Guethlein, L. Abi-Rached, L. Tian, K. L. Gunderson, P. J.<br />

Norman, M. Ronaghi, P. Parham.<br />

3711F DNA Sudoku: Hunting rare genetic variations<br />

using combinatorial pooling. D. Esposito, D. Golan, B.<br />

Blumenstiel, Y. Erlich.<br />

3712W From sample collection to bacterial<br />

identification in a single day: 16s rRNA sequencing<br />

using novel primers on the Ion Torrent Personal<br />

Genome Machine. G. S. Watts, M. M. Oshiro, B. W.<br />

Futscher, D. G. Armstrong.<br />

POSTER SESSIONS 263<br />

3713F Very high resolution HLA genotyping with the<br />

454 Life Sciences GS FLX system: Simplification<br />

<strong>of</strong> workflow using fusion primers or a four primer<br />

system. B. N. Hoglund, C. L. Holcomb, T. C. Williams, D.<br />

Goodridge, H. A. Erlich.<br />

3714W Highly multiplexed amplicon preparation<br />

for targeted re-sequencing <strong>of</strong> sample limited<br />

specimens using the Ion AmpliSeq technology and<br />

semiconductor sequencing. C. Li, B. Kong, D. Joun, I.<br />

Casuga, M. Shannon, S. Chen, M. Andersen, D. Ruff, R.<br />

Bennett.<br />

3715F A fast solution to NGS library preparation with<br />

low nanogram DNA input. P. Liu, G. Lohman, E. Cantor,<br />

B. W. Langhorst, E. Yigit, L. M. Apone, D. B. Munafo, C.<br />

Sumner, F. J. Stewart, T. C. Evans, E. T. Dimalanta, T. B.<br />

Davis.<br />

3716W Pre-capture pooling for targeted enrichment <strong>of</strong><br />

libraries for next-generation sequencing. B. Marosy, B.<br />

Craig, A. Robinson, M. Zilka, K. Hetrick, S. Griffith, H. Ling,<br />

J. Romm, K. F. Doheny.<br />

3717F Rapid and accurate semiconductor-based<br />

sequencing <strong>of</strong> human exomes: Workflow and<br />

performance on a familial trio. G. Meredith, G. Bee, L.<br />

Pickle, M. Dudas, G. Del Mistro, C. Scafe, M. Schorn, J.<br />

Miller, M. Minto, B. Reed, G. Fry, J. Gioia, J. Hildebrandt,<br />

P. Leong, M. Reddy, K. Atehortua-Khalsa, M. Sedova, S.<br />

McLaughlin, V. Sheth, M. Shah, D. Thomas, H. Breu, M.<br />

Rhodes, C. Adams, F. Hyland, R. Bennett.<br />

3718W TotalScript: A versatile and robust tool for<br />

RNAseq applications. F. Syed, S. Kuersten, A. Radek, R.<br />

Vaidyanathan.<br />

3719F Automating high-throughput creation<br />

<strong>of</strong> sequencing libraries. J. Bishop, W. Zhang, D.<br />

Mandelman, M. Allen, A. Harris, R. Bennett.<br />

3720W Highest sample quality for molecular analysis<br />

through ambient stabilization technologies: Improved<br />

genome, transcriptome and proteome analysis from<br />

saliva, blood and tissue samples. R. Muller, V. Liberal, S.<br />

Wilkinson, A. Stassinopoulos, J. Muller-Cohn.<br />

3721F Increased sensitivity in whole-genome bisulfite<br />

sequencing: A novel ‘post-bisulfite conversion’ library<br />

construction method for sub-nanogram inputs. R.<br />

Sooknanan, A. Adey, J. Hitchen, J. Shendure, N. Caruccio.<br />

3722W Highly efficient miRNA isolation method using<br />

solid phase reverse immobilization technology and<br />

Biomek automation. B.-N. Lee.<br />

3723F miRNA extraction from human plasma using<br />

high capacity miRNA anti-probe magnetic beads. A.<br />

Zampetaki, T. Xu, A. V. Vlassov, N. Bernard, M. Mayr.<br />

3724W Single Molecule Real-Time (SMRT ® ) sequencing<br />

<strong>of</strong> genes implicated in autosomal recessive diseases.<br />

Y. Guo, A. Bashir, E. Gould, R. Kornreich, L. Edelmann,<br />

T. Brandt, Y. Kasai, J. Chin, E. Paxinos, A. Kasarskis, E.<br />

Schadt.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />

POSTER SESSIONS


264 POSTER SESSIONS<br />

3725F Detection <strong>of</strong> rare somatic mutations using a<br />

simplified, specific digital PCR workflow with zero<br />

dead volume. M. C. Pallas, D. Keys, J. Wilde, J. C. Nurse.<br />

3726W Rapidly pr<strong>of</strong>iling thousands <strong>of</strong> large non-coding<br />

RNAs and mRNAs from nanogram amounts <strong>of</strong> total<br />

RNA using a single microarray design. A. Bergstrom<br />

Lucas, K. Swaminathan, V. Kulkarni, E. LeProust, S.<br />

Fulmer-Smentek.<br />

3727F Development <strong>of</strong> a system based on SMART<br />

technology for robust transcriptome library<br />

preparation from small quantities <strong>of</strong> degraded sample.<br />

M. Bostick, C. Chang, A. Farmer.<br />

3728W Selective sequencing <strong>of</strong> mature transcripts in<br />

the human brain by cytoplasmic RNA-seq. A. Zaghlool,<br />

A. Ameur, J. Halvardson, L. Cavelier, L. Feuk.<br />

3729F Targeted library preparation for Ion Torrent<br />

sequencing using HaloPlex PCR. H. Johansson,<br />

E. Agne, K. Zettermann, M. Isaksson, P. Eriksson, B.<br />

Skarpås, F. Roos, F. Dahl.<br />

3730W SNP genotyping using the Affymetrix ® Axiom ®<br />

2.0 platform. M. Shapero, M. Purdy, H. Dong, S. Hsiung,<br />

R. Kurapati, J. Law, H. Lee, H. Loi, D. Nguyen, P. H. Wang,<br />

A. Yan, C. S. Yu, M. Shirazi.<br />

3731F Information tracking through the use and<br />

customization <strong>of</strong> the Exemplar LIMS in a medium<br />

scale sequencing laboratory. B. Craig, D. Newcomer, S.<br />

Griffith, B. Marosy, A. Robinson, M. Zilka, K. F. Doheny.<br />

3732W Locus reference genomic sequences:<br />

Reference sequences for the reporting <strong>of</strong> clinically<br />

relevant sequence variants. J. A. L. MacArthur, A.<br />

Astashyn, E. Birney, R. Dalgleish, P. Flicek, L. Gil, P.<br />

Larsson, D. Maglott, W. M. McLaren, R. E. Tully, F.<br />

Cunningham.<br />

3733F QC measures for whole exome and targeted<br />

sequencing library prep and enrichment in a highthroughput<br />

lab. A. Robinson, M. Zilka, B. Marosy, B.<br />

Craig, J. Romm, K. Doheny.<br />

3734W Additional annotation enhances biologically<br />

relevant sub classification <strong>of</strong> the Illumina<br />

<strong>Human</strong>Methylation450 BeadChip array. E. Price, A.<br />

Cotton, L. Lam, E. Emberly, C. Brown, W. Robinson, M.<br />

Kobor.<br />

3735F Computer-aided detection <strong>of</strong> defects<br />

in Affymetrix CEL data files. D. C. Edwards, A.<br />

Konkashbaev, A. Pluzhnikov, N. J. Cox, J. B. Tomblin, K.<br />

L. Mueller.<br />

W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present


EXHIBITORS<br />

The purpose <strong>of</strong> the exhibit program is to further the education <strong>of</strong> registrants by providing an<br />

opportunity for exhibitors to present information on products or services relevant to registrants’<br />

pr<strong>of</strong>essional interests. In keeping with that purpose, sale and order-taking (entering into<br />

a contract <strong>of</strong> sale) are discouraged on the exhibit floor and other related convention areas.<br />

Registrants are encouraged to view the exhibits in the Exhibit Hall <strong>of</strong> the Moscone Center<br />

during the following hours:<br />

Wednesday, November 7: 10:00 am – 4:30 pm<br />

Thursday, November 8: 10:00 am – 4:30 pm<br />

Friday, November 9: 10:00 am – 4:30 pm<br />

To assist in locating specific products and services <strong>of</strong> interest, a product and service index<br />

appears immediately after the exhibitor listings. This index is organized alphabetically by<br />

products/services, followed by names <strong>of</strong> exhibiting companies <strong>of</strong>fering the product/services<br />

and their respective booth numbers. Booth numbers also follow the names <strong>of</strong> the exhibiting<br />

companies below.<br />

<strong>ASHG</strong> Central – Exhibit Hall Booth 913, Lower Level South<br />

Visit <strong>ASHG</strong> Central to address membership questions, view sample publications, apply for<br />

membership, and to find out more about <strong>ASHG</strong>. Also available in <strong>ASHG</strong> Central will be editors<br />

<strong>of</strong> The <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (AJHG). The AJHG provides a record <strong>of</strong> research<br />

and review relating to heredity in humans, the application <strong>of</strong> genetic principles in medicine<br />

and public policy, and related areas <strong>of</strong> molecular and cell biology, behavioral, molecular,<br />

biochemical, population and clinical genetics. You can also find more information on the city <strong>of</strong><br />

Boston, Massachusetts, the site <strong>of</strong> <strong>ASHG</strong>’s 2013 Annual Meeting and register to win a gift from<br />

the Boston Convention and Visitor’s Bureau!<br />

<strong>ASHG</strong> Central is located in booth #913, in the very center <strong>of</strong> the Exhibit Hall! It is open during<br />

exhibit hours and will have comfortable seating, charging stations, Wi-Fi access, and much<br />

more! We hope you stop by to see us while visiting the exhibits and posters. You can also<br />

meet <strong>ASHG</strong> <strong>2012</strong> Board and <strong>Program</strong> Committee members during poster session hours. Make<br />

<strong>ASHG</strong> Central your destination for networking, plugging in, and for all the <strong>ASHG</strong> information<br />

you need!<br />

Social Media Zone – Exhibit Hall Booth 1525<br />

The Social Media Zone in the Exhibit Hall is for those who want to explore the world <strong>of</strong> <strong>ASHG</strong><br />

and Social Media. Get better acquainted with Twitter and meet your expert users, or get tips so<br />

you can become a Twitter user! Catch up on the #<strong>ASHG</strong><strong>2012</strong> Twitter stream live, recharge your<br />

devices, use Wi-Fi, and have insightful face-to-face conversations with your fellow attendees.<br />

Stop by to ask questions <strong>of</strong> and meet three top genomics “Tweeps.” Three power Twitter users<br />

will be in the booth daily from 1:00 pm – 1:30 pm:<br />

Wednesday, November 7 Chris Gunter – @girlscientist<br />

Thursday, November 8 William Bush – @vubush<br />

Friday, November 9 Daniel MacArthur – @dgmacarthur<br />

EXHIBITORS


The Heart <strong>of</strong> the Exhibit Hall<br />

Get Answers at the <strong>ASHG</strong> Membership booth<br />

Meet your Editors at the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> booth<br />

Learn about Boston, the destination for <strong>ASHG</strong> 2013<br />

Meet <strong>Society</strong> Leadership<br />

Sit down in our seating area<br />

Recharge your electronics<br />

Network Net with colleagues<br />

Central


We enable people<br />

with life-altering conditions<br />

to lead better lives.<br />

Come visit us at <strong>ASHG</strong> Booth 600.<br />

US/COR-00695<br />

To be as brave as the people we help.


We enable people<br />

with life-altering conditions<br />

to lead better lives.<br />

Come visit us at <strong>ASHG</strong> Booth 600.<br />

US/COR-00695<br />

To be as brave as the people we help.


NOTES


NOTES


VISIT THE EXHIBITS AND POSTERS<br />

Wednesday: 10:00 am – 4:30 pm<br />

Thursday: 10:00 am – 4:30 pm<br />

Friday: 10:00 am – 4:30 pm


FACILITY<br />

STORAGE<br />

1268<br />

1269<br />

1267<br />

1266<br />

1188<br />

1189<br />

1187<br />

1186<br />

980<br />

981<br />

979<br />

978<br />

900<br />

901<br />

899<br />

898<br />

692<br />

693<br />

691<br />

690<br />

612<br />

613<br />

611<br />

610<br />

484<br />

485<br />

483<br />

482<br />

436<br />

437<br />

435<br />

434<br />

FACILITY<br />

STORAGE<br />

EXITS<br />

1398<br />

1399<br />

1397<br />

1396<br />

1338<br />

1339<br />

1337<br />

1336<br />

Statistical <strong>Genetics</strong>/<br />

Genetic Epidemiology<br />

1116<br />

1117<br />

1115<br />

1114<br />

1052<br />

1053<br />

1051<br />

1050<br />

765<br />

763<br />

762<br />

Pharmacogenetics<br />

540<br />

541<br />

539<br />

538<br />

Cancer<br />

<strong>Genetics</strong><br />

Cancer<br />

<strong>Genetics</strong><br />

Cytogenetics<br />

Development<br />

828<br />

829<br />

827<br />

826 Therapy/<br />

764 Genetic Disorders<br />

Metabolic<br />

Disorders<br />

Genome Structure,<br />

Variation/Function<br />

PERS<br />

1410<br />

1411<br />

1385<br />

1384<br />

1350<br />

1351<br />

1325<br />

1324<br />

1290<br />

1291<br />

1245<br />

1244<br />

1210<br />

1211<br />

1165<br />

1164<br />

1130<br />

1131<br />

1101<br />

1100<br />

1066<br />

1067<br />

1037<br />

1036<br />

1002<br />

1003<br />

957<br />

956<br />

922<br />

923<br />

877<br />

876<br />

842<br />

843<br />

813<br />

812<br />

778<br />

779<br />

749<br />

748<br />

714<br />

715<br />

669<br />

668<br />

634<br />

635<br />

589<br />

588<br />

554<br />

555<br />

525<br />

524<br />

506<br />

507<br />

461<br />

460<br />

458<br />

459<br />

413<br />

412<br />

Exit #1<br />

Exit #4<br />

1412<br />

1413<br />

1383<br />

1382<br />

1352<br />

1353<br />

1323<br />

1322<br />

1292<br />

1293<br />

1243<br />

1242<br />

1212<br />

1213<br />

1163<br />

1162<br />

1132<br />

1133<br />

1099<br />

1098<br />

1068<br />

1069<br />

1035<br />

1034<br />

1004<br />

1005<br />

955<br />

954<br />

924<br />

925<br />

875<br />

874<br />

844<br />

845<br />

811<br />

810<br />

780<br />

781<br />

747<br />

746<br />

716<br />

717<br />

667<br />

666<br />

636<br />

637<br />

587<br />

586<br />

556<br />

557<br />

523<br />

522<br />

PERS<br />

100<br />

1426<br />

1427<br />

1369<br />

1368<br />

1366<br />

1377<br />

1309<br />

1308<br />

1306<br />

1307<br />

1229<br />

1228<br />

1226<br />

1227<br />

1149<br />

1148<br />

1146<br />

1147<br />

1085<br />

1084<br />

1082<br />

1083<br />

1021<br />

1020<br />

1018<br />

1019<br />

941<br />

940<br />

938<br />

939<br />

861<br />

860<br />

858<br />

859<br />

797<br />

796<br />

794<br />

795<br />

733<br />

732<br />

730<br />

731<br />

653<br />

652<br />

650<br />

651<br />

573<br />

572<br />

570<br />

571<br />

509<br />

508<br />

40'<br />

Exit #3<br />

10'<br />

PERS<br />

Exit #5 Exit #7 Exit #9 Exit #11 Exit #13 Exit #15<br />

Exit #6<br />

PERS<br />

WOMEN<br />

MEN<br />

RESTROOMS<br />

WF<br />

Phones<br />

POSTER<br />

P OSTER<br />

STORAGE ATTENDANT<br />

PERS<br />

127<br />

N<br />

226 227<br />

O<br />

326<br />

N<br />

327<br />

O<br />

426 427<br />

20'<br />

125 224<br />

N<br />

225<br />

N<br />

324 325 424 425 524<br />

P<br />

P<br />

R<br />

R<br />

O<br />

O<br />

121 220<br />

F<br />

221<br />

I<br />

320<br />

F<br />

321<br />

I<br />

20'<br />

421<br />

20'<br />

T<br />

T<br />

119 218 219 318 319 418 419 518<br />

113<br />

20'<br />

109<br />

210<br />

211<br />

208 209<br />

205<br />

203<br />

312<br />

20'<br />

310 311<br />

308<br />

304 305<br />

302<br />

307<br />

301<br />

20'<br />

20'<br />

406<br />

404 405 504<br />

402<br />

20'<br />

413<br />

30'<br />

411<br />

409<br />

20'<br />

508<br />

20'<br />

400 401 500<br />

SEATING<br />

AREA<br />

527<br />

20'<br />

525<br />

521<br />

519<br />

511<br />

507 606<br />

505 604<br />

503<br />

20'<br />

501<br />

20' 20'<br />

624<br />

620<br />

618 619<br />

610<br />

600<br />

627<br />

625<br />

30'<br />

30'<br />

20' 20'<br />

20'<br />

20'<br />

726<br />

724<br />

718<br />

609<br />

601<br />

PERS<br />

WF<br />

PHONES<br />

PERS<br />

ENTRANCE<br />

PERS<br />

ENTRANCE<br />

Exit #8<br />

Exit #10<br />

TO UPPER<br />

SOUTH LOBBY<br />

725<br />

719<br />

826 827<br />

20'<br />

20'<br />

711<br />

701<br />

20'<br />

20'<br />

824 825<br />

818 819<br />

20'<br />

40'<br />

813<br />

20'<br />

811<br />

807<br />

20'<br />

805<br />

803<br />

20'<br />

801<br />

924<br />

721 820 821<br />

20'<br />

918<br />

910<br />

904<br />

900<br />

WOMEN MEN<br />

WOMEN MEN<br />

RESTROOMS RESTROOMS<br />

1428<br />

1429 1467<br />

1466 1468<br />

1469 1507<br />

1506 1508<br />

1509 1547<br />

1546 1548<br />

1549 1587<br />

1586 1588<br />

1589 1627<br />

1626 1628<br />

1629 1667<br />

1666 1668<br />

1669 1707<br />

1706 1708<br />

1709 1747<br />

1746 1748<br />

1749 1787<br />

1786 1788<br />

1789 1827<br />

1826 1828<br />

1829 1867<br />

1866 1868<br />

1869 1907<br />

1906 1908<br />

1909 1947<br />

1946 1948<br />

1949 1987<br />

1986 1988<br />

1989 2027<br />

2026 2028<br />

2029 2067<br />

2066 2068<br />

2069 2107<br />

2106 2108<br />

2109 2147<br />

2146 2148<br />

2149 2187<br />

2186 2188<br />

2189 2227<br />

2226 2228<br />

2229 2267<br />

2266 2268<br />

2269 2307<br />

2306 2308<br />

2309 2347<br />

2346 2348<br />

2349 2387<br />

2386 2388<br />

2389 2427<br />

2426 2428<br />

2429 2467<br />

2466 2468<br />

2469 2507<br />

2506 2508<br />

2509 2547<br />

2546 2548<br />

2549 2587<br />

2586 2588<br />

2589 2627<br />

2626 2628<br />

2629 2667<br />

2666 2668<br />

2669 2707<br />

2706 2708<br />

2709 2747<br />

2746 2748<br />

2749 2787<br />

2786<br />

Statistical <strong>Genetics</strong>/<br />

Genetic Epidemiology<br />

1446<br />

1447 1449<br />

1448 1486<br />

1487 1489<br />

1488 1526<br />

1527 1529<br />

1528 1566<br />

1567 1569<br />

1568 1606<br />

1607 1609<br />

1608 1646<br />

1647 1649<br />

1648 1686<br />

1687 1689<br />

1688 1726<br />

1727 1729<br />

1728 1766<br />

1767 1769<br />

1768 1806<br />

1807 1809<br />

1808 1846<br />

1847 1849<br />

1848 1886<br />

1887 1889<br />

1888 1926<br />

1927 1929<br />

1928 1966<br />

1967 1969<br />

1968 2006<br />

2007 2009<br />

2008 2046<br />

2047 2049<br />

2048 2086<br />

2087 2089<br />

2088 2126<br />

2127 2129<br />

2128 2166<br />

2167 2169<br />

2168 2206<br />

2207 2209<br />

2208 2246<br />

2247 2249<br />

2248 2286<br />

2287 2289<br />

2288 2326<br />

2327 2329<br />

2328 2366<br />

2367 2369<br />

2368 2406<br />

2407 2409<br />

2408 2446<br />

2447 2449<br />

2448 2486<br />

2487 2489<br />

2488 2526<br />

2527 2529<br />

2528 2566<br />

2567 2569<br />

2568 2606<br />

2607 2609<br />

2608 2646<br />

2647 2649<br />

2648 2686<br />

2687 2689<br />

2688 2726<br />

2727 2729<br />

2728 2766<br />

2767 2769<br />

2768<br />

111<br />

Cardiovascular <strong>Genetics</strong><br />

Genetci Counseling/<br />

Clinical Testing<br />

FLOOR PLAN OF EXHIBIT AND POSTER AREA<br />

<strong>ASHG</strong> 62ND ANNUAL MEETING<br />

MOSCONE CENTER-SOUTH HALLS ABC<br />

ELSI<br />

<strong>Genetics</strong> Education<br />

Health Services<br />

925<br />

20'<br />

923<br />

1022<br />

TO UPPER<br />

SOUTH LOBBY<br />

LOBBY<br />

PERS<br />

1026 1027<br />

20'<br />

20'<br />

1025 1124<br />

1023 1122<br />

Exit #12<br />

1127 1226 1227<br />

20'<br />

1125 1224 1225 1324<br />

PERS<br />

TO UPPER<br />

SOUTH LOBBY<br />

PERS<br />

Exit #14<br />

1427 1526<br />

1425 1524<br />

PERS<br />

WF<br />

PHONES<br />

Complex Traits/Polygenic Disorders Psychiatric <strong>Genetics</strong>, Neurogentics/Neurdegeneration<br />

50'<br />

1220<br />

20'<br />

1320<br />

20'<br />

1321 1420<br />

1520<br />

20'<br />

1521<br />

20'<br />

20'<br />

<strong>ASHG</strong> Central<br />

Membership<br />

1119 1218 1219 1318 1319 1418 1419 1518 1519 1618 1619<br />

AJHG<br />

Charging Station<br />

40'<br />

913<br />

WiFi Zone<br />

1212 P 1312<br />

20'<br />

30' U<br />

1210 B 1211 1310<br />

20' 20'<br />

1311 1410<br />

1413 1512<br />

1411 1510<br />

20'<br />

20'<br />

1511<br />

1613 1712<br />

1611 1710<br />

20'<br />

20'<br />

L<br />

20'<br />

20'<br />

1109 1208 I 1209 1308<br />

C<br />

1609 1708<br />

907 1007<br />

A<br />

T<br />

1307 1406<br />

1506<br />

20'<br />

1606<br />

20'<br />

20'<br />

20'<br />

1102<br />

20'<br />

1105 1204 I 1304<br />

20'<br />

O<br />

1103 N 1203<br />

20'<br />

20'<br />

S<br />

20' 20'<br />

1303 1402<br />

1405 1504<br />

1403 1502<br />

1505 1604<br />

1503 1602<br />

FASEB/<br />

1605 Career<br />

Resources<br />

30'<br />

1603<br />

901<br />

1001 1100 1101 1200 1201 1300 1301 1400 1401 1500 1501 1600 1601 1700<br />

20'<br />

1325<br />

20'<br />

BUSINESS<br />

CENTER<br />

SEATING<br />

AREA<br />

25'<br />

Social<br />

Media 20'<br />

Zone<br />

1525<br />

PERS<br />

Molecular Basis <strong>of</strong><br />

Mendelian Disorders<br />

20'<br />

POSTER<br />

P OSTER ATTENDANT<br />

STORAGE<br />

Exit #16<br />

3094<br />

3093<br />

3095<br />

3096<br />

3170<br />

3169<br />

3171<br />

3172<br />

3246<br />

3245<br />

3247<br />

3248<br />

3322<br />

3321<br />

3323<br />

3324<br />

3402<br />

3401<br />

3403<br />

3404<br />

3486<br />

3485<br />

3487<br />

3488<br />

3570<br />

3569<br />

3571<br />

3572<br />

3652<br />

3651<br />

3653<br />

3654<br />

PERS<br />

Employment<br />

Boards<br />

TC<br />

Electrical for F&B & Water Cooler<br />

F&B<br />

WC<br />

2788<br />

2789<br />

2847<br />

2846<br />

2848<br />

2849<br />

2907<br />

2906<br />

2908<br />

2909<br />

2966<br />

2967<br />

2968<br />

3026<br />

3025<br />

3027<br />

3028<br />

Exit #17<br />

E nt rance Exhibitor Lounge<br />

9m x 14m<br />

(43' x 30')<br />

3716<br />

3715<br />

3717<br />

3718<br />

EMERGENCY<br />

PEDESTRIAN RAMP<br />

PERS<br />

Molecular Basis <strong>of</strong><br />

Mendelian Disorders<br />

Prenatal, Perinatal/<br />

Reproductive <strong>Genetics</strong><br />

Clinical <strong>Genetics</strong>/<br />

Dysmorphology<br />

Evolutionary/<br />

Population <strong>Genetics</strong><br />

Epigentics<br />

Bioinformatics/<br />

Technology<br />

Exit #19<br />

2802<br />

2803<br />

2833<br />

2832<br />

2862<br />

2863<br />

2893<br />

2892<br />

2922<br />

2923<br />

2953<br />

2952<br />

2981<br />

2982<br />

3012<br />

3011<br />

3041<br />

3042<br />

3072<br />

3071<br />

3117<br />

3118<br />

3148<br />

3147<br />

3193<br />

3194<br />

3224<br />

3223<br />

3269<br />

3270<br />

3300<br />

3299<br />

3345<br />

3346<br />

3380<br />

3379<br />

3425<br />

3426<br />

3464<br />

3463<br />

3509<br />

3510<br />

3548<br />

3547<br />

3593<br />

3594<br />

3630<br />

3629<br />

3675<br />

3676<br />

3708<br />

3707<br />

3725<br />

3726<br />

Exit #18<br />

2804<br />

2805<br />

2831<br />

2830<br />

2864<br />

2865<br />

2891<br />

2890<br />

2924<br />

2925<br />

2951<br />

2950<br />

2983<br />

2984<br />

3010<br />

3009<br />

3043<br />

3044<br />

3070<br />

3069<br />

3119<br />

3120<br />

3146<br />

3145<br />

3195<br />

3196<br />

3222<br />

3221<br />

3271<br />

3272<br />

3298<br />

3297<br />

3347<br />

3348<br />

3378<br />

3377<br />

3427<br />

3428<br />

3462<br />

3461<br />

3511<br />

3512<br />

3546<br />

3545<br />

3595<br />

3596<br />

3628<br />

3627<br />

3677<br />

3678<br />

3706<br />

3705<br />

3727<br />

3728<br />

PERS<br />

3735<br />

2816<br />

2817<br />

2819<br />

2818<br />

2876<br />

2877<br />

2879<br />

2878<br />

2936<br />

2937<br />

2939<br />

2938<br />

2995<br />

2996<br />

2998<br />

2997<br />

3055<br />

3056<br />

3058<br />

3057<br />

3131<br />

3132<br />

3134<br />

3133<br />

3207<br />

3208<br />

3210<br />

3209<br />

3283<br />

3284<br />

3286<br />

3285<br />

3359<br />

3360<br />

3694<br />

3693<br />

3362<br />

3361<br />

3443<br />

3444<br />

3446<br />

3445<br />

3527<br />

3528<br />

3530<br />

3529<br />

3611<br />

3612<br />

3614<br />

3613<br />

3691<br />

3692<br />

Moscone<br />

Freeman<br />

Service Desk<br />

Lead<br />

Retrieval<br />

Lead<br />

Retrieval<br />

271<br />

Sales Office<br />

3m x 5m<br />

ES Break<br />

Room<br />

3m x 3m<br />

Crate S torage<br />

6 ' T ABLE<br />

Lead Retrieval<br />

Room<br />

4m x 4m<br />

ES4<br />

ES3<br />

3m x 6m 3m x 6m<br />

ES2<br />

3m x 6m<br />

ES1<br />

3m x 6m


Exhibitors<br />

■ 23andMe, Inc ............................................. 826<br />

Tel: 650-963-8937<br />

Email: mdelsol@23andme.com<br />

URL: http://www.23andme.com<br />

23andMe, Inc. is a leading personal genetics<br />

company dedicated to helping individuals understand<br />

their own genetic information through DNA analysis<br />

technologies and web-based interactive tools. The<br />

vision for 23andMe is to personalize healthcare<br />

by making and supporting meaningful discoveries<br />

through genetic research. More information is<br />

available at www.23andme.com.<br />

■ Abbott Molecular ...................................... 625<br />

Tel: 224-361-7000/800-553-7042<br />

Email: customerservice@abbottmolecular.com<br />

URL: http://www.abbottmolecular.com<br />

Abbott Molecular is a leader in molecular<br />

diagnostics for the analysis <strong>of</strong> DNA, RNA, and<br />

proteins. Our instruments and reagents detect<br />

pathogens and subtle changes in patients’ genes<br />

and chromosomes, permitting earlier diagnosis, the<br />

selection <strong>of</strong> appropriate therapies and improved<br />

monitoring <strong>of</strong> disease progression.<br />

■ Accelrys, Inc. ............................................. 421<br />

Tel: 858-799-5000<br />

Email: byron.konold@accelrys.com<br />

URL: http://www.accelrys.com<br />

Accelrys (NASDAQ:ACCL), a leading scientific<br />

enterprise R&D s<strong>of</strong>tware and services company, <strong>of</strong>fers<br />

industry-leading capabilities in modeling and simulation,<br />

enterprise lab management, workflow and automation<br />

and data management and informatics supporting<br />

improved scientific innovation lifecycle management.<br />

Accelrys electronic lab notebooks include the flexible<br />

Contur ELN, Symyx Notebook by Accelrys and<br />

VelQuest SmartLab. Visit www.accelrys.com.<br />

■ Actelion Pharmaceuticals US, Inc. .......... 401<br />

Tel: 41 61 565 83 65<br />

Email: stephane.dazet@actelion.com<br />

URL: http://www.actelion.com<br />

Actelion US is a biopharmaceutical company focusing<br />

on the discovery, development and commercialization<br />

<strong>of</strong> innovative treatments to serve high unmet<br />

medical needs. Zavesca ® (miglustat) is indicated<br />

for the treatment <strong>of</strong> adult patients with mild to<br />

moderate type 1 Gaucher disease for whom enzyme<br />

replacement therapy is not a therapeutic option.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 273<br />

■ Active Motif, Inc ........................................ 427<br />

Tel: 760-431-1263<br />

Email: rubin@activemotif.com<br />

URL: http://www.activemotif.com<br />

Active Motif: Enabling Epigenetic Research.<br />

Active Motif is dedicated to developing and delivering<br />

innovative cell biology-based research tools and<br />

biocomputing resources that help researchers<br />

worldwide in their quest to elucidate the function,<br />

regulation and interactions <strong>of</strong> the genes and their<br />

encoded proteins.<br />

■ Advanced Analytical ............................... 1304<br />

Tel: 515-296-6600<br />

Email: rschmidt@aati-us.com<br />

URL: http://www.aati-us.com<br />

Advanced Analytical Technologies, Inc.<br />

Our newest instrument, the Fragment Analyzer<br />

Automated CE System, uses capillary electrophoresis<br />

for rapid and accurate analysis <strong>of</strong> Next Gen<br />

Sequencing (NGS) fragment libraries by automating<br />

the separation <strong>of</strong> fragments. Additionally, it can<br />

be used on RNA and genomic DNA. The system<br />

improves workflow and eliminates bottlenecks.<br />

■ Affymetrix, Inc. .......................................... 918<br />

Tel: 408-731-5000/800-223-5281<br />

Email: sales@affymetrix.com<br />

URL: http://www.affymetrix.com<br />

Affymetrix powers the Genome Generation to<br />

advance our understanding <strong>of</strong> human biology and<br />

disease by providing solutions supporting a wide<br />

range <strong>of</strong> applications for genetic origin discovery,<br />

functional characterization, and translational research.<br />

Whether you perform genome-wide association<br />

studies, targeted genotyping, cancer or constitutional<br />

cytogenetics and copy number analysis, wholetranscript<br />

pr<strong>of</strong>iling, microRNA analysis, resequencing,<br />

or in situ hybridization, visit us for proven and tailored<br />

solutions to your research needs.<br />

■ Agilent Technologies ................................ 609<br />

Tel: 800-227-9770<br />

Email: agilent_inquiries@agilent.com<br />

URL: http://www.genomics.agilent.com<br />

Agilent’s portfolio includes the leading SureSelect<br />

and HaloPlex Target Enrichment Next-Generation<br />

Sequencing Platforms, Gene Expression and<br />

Cytogenetic Microarrays, GeneSpring and<br />

Cytogenomics S<strong>of</strong>tware, qPCR, PCR, Mutagenesis,<br />

Cloning, and SureFISH probes. Agilent <strong>of</strong>fers the<br />

Bioanalyzer & TapeStation instruments for sample QC,<br />

and Automation for optimized workflow productivity.<br />

EXHIBITORS


274 EXHIBITORS<br />

■ AGRE-Autism Genetic Resource<br />

Exchange ...................................................... 319<br />

Tel: 323-297-4716<br />

Email: rbutler@agre.org<br />

URL: http://www.agre.org<br />

The Autism Genetic Resource Exchange (AGRE) is<br />

a program <strong>of</strong> Autism Speaks to advance genetic<br />

research in Autism Spectrum Disorders (ASDs).<br />

Genetic biomaterials and clinical data are obtained<br />

from families that have more than one family member<br />

diagnosed with an ASD. The biological samples,<br />

along with the accompanying clinical data, are made<br />

available to AGRE-approved researchers.<br />

■ Alexion Pharmaceuticals ....................... 1410<br />

Tel: 203-272-2596<br />

Email: millerg@alxn.com<br />

URL: http://www.alxn.com<br />

Alexion Pharmaceuticals is a biopharmaceutical<br />

company focused on serving patients with severe<br />

and ultra-rare disorders through the innovation,<br />

development and commercialization <strong>of</strong> lifetransforming<br />

products. Alexion developed and<br />

markets Soliris ® (eculizumab) as a treatment for<br />

patients with PNH and aHUS. Alexion is evaluating<br />

other potential indications for Soliris and is<br />

developing four other innovative product candidates<br />

■ Ambry <strong>Genetics</strong>......................................... 311<br />

Tel: 949-900-5560/866-262-7943<br />

Email: bneal@ambrygen.com<br />

URL: http://www.ambrygen.com<br />

Ambry <strong>Genetics</strong> redefines diagnostic and genomic<br />

services through innovation and ingenuity. Extensive<br />

testing menus include: Diagnostic Exome, Oncology,<br />

Cardiology, Neurology and Pulmonology panels.<br />

Our genomic services focus on next-generation<br />

sequencing, exome sequencing, microarrays, targeted<br />

enrichment, genotyping and bioinformatics to <strong>of</strong>fer<br />

cost effective and research specific solutions. For<br />

more information please visit: www.ambrygen.com<br />

■ <strong>American</strong> Board <strong>of</strong> Medical <strong>Genetics</strong> ..... 225<br />

Tel: 301-634-7315<br />

Email: abmg@abmg.org<br />

URL: http://www.abmg.org<br />

The <strong>American</strong> Board <strong>of</strong> Medical <strong>Genetics</strong> (ABMG),<br />

member board <strong>of</strong> the ABMS, serves the public and<br />

the medical pr<strong>of</strong>ession by promoting and assuring<br />

standards <strong>of</strong> excellence in medical genetics. ABMG<br />

accredits training programs, credentials and certifies<br />

practitioners <strong>of</strong> medical genetics, and fosters life-long<br />

learning through maintenance <strong>of</strong> certification.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ <strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong><br />

and Genomics (ACMG) ................................ 318<br />

Tel: 301-718-9603<br />

Email: acmg@acmg.net<br />

URL: http://www.acmg.net<br />

To improve health through medical genetics, the<br />

<strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong> and Genomics<br />

will define and promote excellence in medical genetics<br />

practice and the integration <strong>of</strong> translational research<br />

into practice; promote and provide medical genetics<br />

education; and increase access to medical genetics<br />

services and integrate genetics into patient care.<br />

■ <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> .... 913<br />

Tel: 866-314-2355<br />

Email: ajhg@ajhg.net<br />

URL: http://www.ajhg.org<br />

The <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (AJHG)<br />

provides a record <strong>of</strong> research and review relating to<br />

heredity in humans, and the application <strong>of</strong> genetic<br />

principles in medicine and public policy, and related<br />

areas <strong>of</strong> molecular and cell biology, behavioral,<br />

molecular, biochemical, population and clinical<br />

genetics.<br />

■ <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> .... 913<br />

Tel: 301-634-7300/(866) HUMGENE<br />

Email: society@ashg.org<br />

URL: http://www.ashg.org<br />

<strong>ASHG</strong> Central is located in booth #913, the very<br />

center <strong>of</strong> the Exhibit Hall! It is open during exhibit<br />

hours and will have comfortable seating, charging<br />

stations, Wi-Fi access, and much more! We hope<br />

you stop by to see us while visiting the exhibits<br />

and posters. You can also meet <strong>ASHG</strong> <strong>2012</strong> Board<br />

and <strong>Program</strong> Committee members during poster<br />

session hours. Make <strong>ASHG</strong> Central your destination<br />

for networking, plugging in, and for all the <strong>ASHG</strong><br />

information you need!<br />

■ Amicus Therapeutics, Inc. ....................... 511<br />

Tel: 609-662-2000<br />

Email: info@amicustherapeutics.com<br />

URL: http://www.amicustherapeutics.com<br />

Amicus Therapeutics is a biopharmaceutical company<br />

at the forefront <strong>of</strong> developing therapies for rare<br />

and orphan diseases. The company is developing<br />

orally administered, small molecule drugs called<br />

pharmacological chaperones, a novel, first-in-class<br />

approach to treating a broad range <strong>of</strong> diseases<br />

including lysosomal storage disorders and diseases <strong>of</strong><br />

neurodegeneration.


■ AnaSpec Inc, Eurogentec Group ........... 1100<br />

Tel: 510-791-9560/800-452-5530<br />

Email: theresa@anaspec.com<br />

URL: http://www.anaspec.com<br />

AnaSpec, EGT Group, a leading provider <strong>of</strong> integrated<br />

proteomic and genomic solutions, <strong>of</strong>fers expertise<br />

in peptides, antibodies, assay kits, fluorescent dyes,<br />

unusual amino acids and qPCR. We have qPCR<br />

mastermixes plates and tubes for every Real Time<br />

PCR platform plus excellent technical support, as<br />

well as housekeeping genes’ primers/probes/assays.<br />

■ Applied Spectral Imaging, Inc................ 1220<br />

Tel: 760-929-2840/800-611-3466<br />

Email: sales@spectral-imaging.com<br />

URL: http://www.spectral-imaging.com<br />

Applied Spectral Imaging makes patient care better<br />

through advanced biomedical imaging. ASI <strong>of</strong>fers<br />

cytogeneticists and pathologists accurate analysis by<br />

providing state- <strong>of</strong>-the-art diagnostic aids. ASI has<br />

over 2,500 systems deployed worldwide, <strong>of</strong>fices in<br />

the U.S., Europe and Asia as well as a global network<br />

<strong>of</strong> over 50 distributors.<br />

■ Applied StemCell, Inc. .............................. 527<br />

Tel: 1-408-773-8007/1-866-497-4180<br />

Email: info@appliedstemcell.com<br />

URL: http://www.appliedstemcell.com<br />

TARGATT Gene Targeting in Cell Lines: Applied<br />

StemCell Inc. (ASC) is a fast growing biotechnology<br />

company with its headquarter based in Menlo Park,<br />

California. With solid expertise and extensive experience<br />

in stem cell and transgene technologies, ASC focuses<br />

on the application <strong>of</strong> new technologies for stem cell<br />

and transgenic communities. Based on Proprietary<br />

Technologies, we <strong>of</strong>fer a customized Fast & Site-<br />

Specific gene targeting service for any cell line for your<br />

projects, e.g.Gene Editing, Gene Modification, Cell-<br />

Based Assays and Drug Screening (HTP Screening).<br />

■ Ariosa Diagnostics .................................. 1609<br />

Tel: 855-927-4672/1-855-9-ARIOSA<br />

Email: ClientServices@ariosadx.com<br />

URL: http://www.ariosadx.com<br />

Ariosa Diagnostics, Inc., is a molecular diagnostics<br />

company committed to providing safe, highly accurate<br />

and affordable prenatal tests for maternal and fetal<br />

health. Led by an experienced team, Ariosa is using its<br />

proprietary technology to perform a directed analysis<br />

<strong>of</strong> cell-free DNA in blood. Ariosas simple blood<br />

test equips pregnant women and their healthcare<br />

providers with reliable information to make decisions<br />

regarding their health, without creating unnecessary<br />

stress or anxiety.The company began operations in<br />

2010 and is headquartered in San Jose, Calif.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 275<br />

■ ARUP Laboratories ................................. 1518<br />

Tel: 801-583-2787/800-242-2787<br />

Email: christina.m.sellers@aruplab.com<br />

URL: http://www.aruplab.com/genetics<br />

ARUP Laboratories is a leading national reference<br />

laboratory <strong>of</strong>fering more than 3,000 tests and test<br />

combinations, ranging from routine screening<br />

tests to esoteric molecular and genetic assays.<br />

ARUP Laboratories <strong>Genetics</strong> Division <strong>of</strong>fers testing<br />

in all areas <strong>of</strong> genetics, including biochemical,<br />

cytogenetics, microarray, and next-generation<br />

sequencing. www.aruplab.com/genetics<br />

■ <strong>ASHG</strong>/FASEB Career Resources ........... 1702<br />

Tel: 860-437-5700<br />

Email: clientserv@jobtarget.com<br />

URL: http://careers.faseb.org<br />

FASEB’s Career Resources are designed to provide<br />

career information and facilitate employment<br />

connections in the life sciences community. These<br />

resources embody new concepts, technologies,<br />

and services, as well as the best <strong>of</strong> our “FASEB<br />

Placement Service.” Our main focus is to help<br />

develop biomedical careers, so whether an<br />

undergraduate, postgraduate, postdoctoral,<br />

seasoned scientist, or an employer seeking to hire<br />

top-notch scientists and pr<strong>of</strong>essionals, the resources<br />

and tools found here are designed to help.<br />

■ Asper Biotech Ltd. .................................. 1418<br />

Tel: 372-7307-295<br />

Email: info@asperbio.com<br />

URL: http://www.asperbio.com<br />

Asper Biotech is a genetic testing company<br />

specialized in retinal disorders, reproductive medicine<br />

and oncology. Asper Ophthalmics testing portfolio<br />

includes a comprehensive panel <strong>of</strong> tests targeting<br />

hereditary eye disorders. Asper Oncogenetics <strong>of</strong>fers<br />

tests to determine predisposition to various cancers.<br />

Asper Reprogenetics provides tests for reproductive<br />

problems and prenatal diagnostics.<br />

■ Asuragen, Inc. ........................................... 503<br />

Tel: 512-681-5200/877-777-1874<br />

Email: jbourland@asuragen.com<br />

URL: http://www.asuragen.com<br />

Asuragen is a fully integrated molecular diagnostic<br />

company using the genome to drive patient<br />

management. We <strong>of</strong>fer diagnostics products and<br />

clinical laboratory services focused on innovative<br />

PCR-based approaches for Fragile X testing (FMR1<br />

gene), AmplideX and Xpansion Interpreter for detection<br />

<strong>of</strong> methylation status and determination <strong>of</strong> AGG<br />

sequence detection (number and location). To learn<br />

more, visit www.asuargen.com.<br />

EXHIBITORS


276 EXHIBITORS<br />

■ Athena Diagnostics ................................ 1308<br />

Tel: 508-756-2886/800-394-4493<br />

Email: melissa.s.hodgson@athenadiagnostics.com<br />

URL: http://www.athenadiagnostics.com<br />

Athena Diagnostics is a leader in diagnostic testing<br />

for neurological diseases. Athena, a division <strong>of</strong> Quest<br />

Diagnostics, is dedicated to providing neurologists<br />

and other physicians and specialists with insights that<br />

can improve patient health. Athena provides the most<br />

comprehensive test menu and intellectual property<br />

portfolio for neurological, endocrine, and renal<br />

conditions through more than 350 diagnostic tests.<br />

■ AutoGen, Inc. ............................................. 807<br />

Tel: 508-429-5965/800-292-5678<br />

Email: info@autogen.com<br />

URL: http://www.autogen.com<br />

The AutoGen FLEX STAR is the finest automated<br />

system available for extracting DNA from large<br />

volumes <strong>of</strong> whole blood, cells and saliva. The FLEX<br />

STAR features positive sample tracking and all the<br />

sample processing capacity you will need for real<br />

productivity. In addition, its outstanding reliability<br />

makes it a system you can count on day in and<br />

day out. Backed by AutoGen’s best in the industry<br />

customer support, the FLEX STAR provides you with<br />

tools you need to PREP WITH CONFIDENCE.<br />

■ Axeq Technologies .................................... 820<br />

Tel: 240-314-0570/1-855-864-2937<br />

Email: jbae@axeq.com<br />

URL: http://www.axeq.com<br />

Axeq Technologies is dedicated to providing a<br />

premier level <strong>of</strong> Next-Generation Sequencing<br />

services to researchers and scientists worldwide.<br />

Axeq represents a high level <strong>of</strong> dedication to quality<br />

<strong>of</strong> work, customer services and scientific integrity.<br />

Axeq also embraces the highest standard U.S. and<br />

European business practices and ethical standards.<br />

■ Baylor College <strong>of</strong> Medicine, Medical<br />

<strong>Genetics</strong> Laboratories................................. 711<br />

Tel: 713-798-6555/800-411-4363<br />

Email: medgen@bcm.tmc.edu<br />

URL: http://www.bcmgeneticlabs.org<br />

Baylor College <strong>of</strong> Medicine’s, Medical <strong>Genetics</strong><br />

Laboratories <strong>of</strong>fer a broad range <strong>of</strong> diagnostic<br />

genetics tests including DNA diagnostics,<br />

sequencing, cytogenetics, FISH diagnostics, cancer<br />

cytogenetics, chromosomal microarray analysis,<br />

whole exome sequencing, biochemical genetics, and<br />

mitochondrial DNA analysis. Please visit our booth for<br />

more information.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ BC Platforms Ltd ...................................... 819<br />

Tel: 358 9 2517 7340<br />

Email: info@bcplatforms.com<br />

URL: http://www.bcplatforms.com<br />

BC Platforms provides advanced data management<br />

solutions for GWAS, SNP and next-generation<br />

sequencing projects. Combine genotypes and<br />

phenotypes to create efficient workflows for highperformance,<br />

distributed data analysis using over<br />

30 academic s<strong>of</strong>tware programs. A web-interface<br />

provides multiple users parallel access to the<br />

database for secure data analysis and results sharing.<br />

■ Beckman Coulter, Inc. ............................ 1601<br />

Tel: 800-742-2345<br />

URL: http://www.beckmancoulter.com<br />

■ BGI ............................................................ 1419<br />

Tel: 617-500-2741<br />

Email: info@bgiamericas.com<br />

URL: http://www.bgiamericas.com<br />

BGI, the worlds largest genomics organization, provides<br />

comprehensive sequencing and bioinformatics services<br />

for medical, agricultural and environmental applications.<br />

With cutting-edge technologies and an experienced<br />

team that has generated over 250 publications in top<br />

tier journals, BGI delivers rapid, cost-effective, and<br />

high quality results that enable researchers to achieve<br />

scientific breakthroughs.<br />

■ Biobase Corporation .............................. 1319<br />

Tel: 978-922-1643/800-305-0670<br />

Email: info@biobase-international.com<br />

URL: http://www.biobase-international.com<br />

BIOBASE is a leading provider <strong>of</strong> manually-curated<br />

databases for molecular diagnostics. The <strong>Human</strong> Gene<br />

Mutation Database (HGMD ® ) and Genome Trax<br />

<strong>of</strong>fers well-structured data, assembled by qualified<br />

experts, organized in an easily searchable manner that<br />

enables researchers to make clinical interpretations <strong>of</strong><br />

data arising from next-generation sequencing efforts.<br />

■ BioChain Institute Inc ............................. 1611<br />

Tel: 510-783-8588/888-762-2568<br />

Email: info@biochain.com<br />

URL: http://www.biochain.com<br />

BioChain provides high quality processed bio-sample<br />

products and analysis services for translational<br />

medicine, clinical product research and development.<br />

BioChains’ products and services are available for<br />

DNA and RNA sequencing, PCR and RT-qPCR, gene<br />

expression, DNA/RNA purification, protein extraction/<br />

purification, and expression analysis.


■ BioDiscovery, Inc. ..................................... 813<br />

Tel: 310-414-8100<br />

Email: customerservice@biodiscovery.com<br />

URL: http://www.biodiscovery.com<br />

BioDiscovery develops, markets and sells advanced<br />

s<strong>of</strong>tware solutions for the analysis <strong>of</strong> data from<br />

high-throughput microarray and next-generation<br />

sequencing technologies. BioDiscovery provides a<br />

full line <strong>of</strong> modular s<strong>of</strong>tware packages built for power,<br />

versatility, and efficiency spanning image analysis,<br />

microarray data processing, and advanced analysis <strong>of</strong><br />

CNV, expression, and methylation data.<br />

■ BioDot, Inc. ................................................ 308<br />

Tel: 949-440-3685<br />

Email: biodot@biodot.com<br />

URL: http://www.biodot.com<br />

■ BioFire Diagnostics .................................. 719<br />

Tel: 801-736-6354/800-735-6544<br />

Email: cameron.gunary@bi<strong>of</strong>iredx.com<br />

URL: http://www.filmarray.com<br />

Idaho Technologies is now BioFire Diagnostics.<br />

BioFire Diagnostics has a 22 year history <strong>of</strong> PCR<br />

innovation. Our LightScanner ® Hi-Res Melting ®<br />

systems and LCGreen Plus ® reagents will take<br />

your hypotheses to publications more efficiently.<br />

LightScanner systems provide the best quality, most<br />

easily accessed Hi-Res Melting data on the market.<br />

Stop by booth #719 and see why!<br />

■ Bioline USA Inc. ...................................... 1324<br />

Tel: 508-880-8990/888-257-5155<br />

Email: info.us@bioline.com<br />

URL: http://www.bioline.com<br />

Bioline is ISO 9001:2008 certified and one <strong>of</strong> the<br />

worlds few manufacturers <strong>of</strong> dNTPs. Bioline is able to<br />

<strong>of</strong>fer bulk, custom and OEM dNTP services. We have<br />

developed and manufacture more than 300 reagents<br />

and kits for molecular biology, cell analysis and<br />

nucleic acid and protein separation and purification.<br />

■ BioMarin Pharmaceutical Inc. ............... 1619<br />

Tel: 415-506-6700<br />

Email: kward@bmrn.com<br />

URL: http://www.bmrn.com<br />

BioMarin develops and commercializes innovative<br />

biopharmaceuticals for serious diseases and medical<br />

conditions. Approved products include the first and<br />

only enzyme replacement therapies for MPS I and MPS<br />

VI and the first and only FDA-approved medication for<br />

PKU. Visit www.BMRN.com to learn more.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 277<br />

■ BioMarin Scientific Exchange ................ 1524<br />

Tel: 415-506-6781<br />

Email: kward@bmrn.com<br />

URL: http://www.bmrn.com<br />

BioMarin develops and commercializes innovative<br />

biopharmaceuticals for serious diseases and medical<br />

conditions. Approved products include the first<br />

and only enzyme replacement therapies for MPS I<br />

and MPS VI and the first and only FDA-approved<br />

medication for PKU. Visit www.BMRN.com to<br />

learn more.<br />

■ BioNano Genomics, Inc. ........................... 924<br />

Tel: 858-888-7600<br />

Email: info@bionanogenomics.com<br />

URL: http://www.bionanogenomics.com<br />

BioNano Genomics platform provides<br />

unprecedented understanding <strong>of</strong> whole-genome<br />

biology. The technology enables highly parallel<br />

visualization <strong>of</strong> extremely long DNA molecules<br />

at single-molecule scale, capturing biologically<br />

meaningful positional information. By retaining<br />

architectural context, the data facilitates more<br />

complete genome assembly and broad detection <strong>of</strong><br />

structural variants.<br />

■ Bio-Rad ...................................................... 524<br />

Tel: 510-741-1000/800-4-BIORAD<br />

Email: lsg.orders.us@bio-rad.com<br />

URL: http://www.discover.bio-rad.com<br />

Providing instrumentation and reagents to support<br />

life science research. Depend on Bio-Rad for tools,<br />

technologies and expertise to enable genomic<br />

and proteomic analysis. Products for droplet<br />

digital PCR, conventional and real-time PCR, SPR,<br />

transfection, RNAi, biomarker expression pr<strong>of</strong>iling,<br />

xMAP technology, cancer biomarkers, expression<br />

proteomics, electrophoresis, blotting-systems,<br />

chromatography, imaging.<br />

■ BioReliance ............................................... 604<br />

Tel: 301-738-1000/800-553-5372<br />

Email: genomicservices@bioreliance.com<br />

URL: http://www.bioreliance.com<br />

BioReliance Genomics: the premier service provider<br />

supporting clinical trials from Phase I to post market<br />

monitoring. We apply over 60 years <strong>of</strong> regulatory<br />

and validation expertise to novel highly-multiplexed<br />

detection technologies and bioinformatics for RNA<br />

expression analysis and targeted human genotyping,<br />

including NGS and the Illumina VeraCode ADME<br />

core panel.<br />

EXHIBITORS


278 EXHIBITORS<br />

■ BioTeam Inc. .............................................. 109<br />

Tel: 978-304-1222<br />

Email: stan@bioteam.net<br />

URL: http://www.bioteam.net<br />

BioTeam is a unique consulting practice dedicated<br />

to delivering objective, diagnostic solutions to our<br />

clients using technology to solve complex genetic<br />

problems. BioTeam has compiled our best practices<br />

for managing sequencing data into a simple and<br />

cost-effective solution called MiniLIMS. MiniLIMS the<br />

next-generation LIMS you can afford.<br />

■ BioTechniques......................................... 1604<br />

Tel: 212-520-2714<br />

Email: christine.briglia@informausa.com<br />

URL: http://www.biotechniques.com<br />

BioTechniques, the international journal <strong>of</strong> life science<br />

methods, provides open access to first-quality,<br />

peer-reviewed papers on laboratory techniques and<br />

protocols. Now in its 53rd volume, BioTechniques has<br />

over 80,000 print subscribers worldwide. The journal<br />

augments its peer-reviewed content with feature<br />

articles and topic-specific supplements. Visit<br />

www.biotechniques.com for more details.<br />

■ BlueGnome Limited .................................. 209<br />

Tel: 44 1223 885990/800-418-9656<br />

Email: info@cambridgebluegnome.com<br />

URL: http://www.cambridgebluegnome.com<br />

BlueGnome (www.cambridgebluegnome.com)<br />

works with clinical and scientific communities to<br />

design, manufacture and supply microarray-based<br />

products for the investigation <strong>of</strong> genetic disorders.<br />

Products are supplied to hospitals, genetics<br />

centers and IVF clinics worldwide where they are<br />

used to investigate developmental delay, specific<br />

cancers and an associated list <strong>of</strong> known genetic<br />

syndromes.<br />

■ Boreal Genomics ...................................... 724<br />

Tel: 604-822-8268/800-681-5644<br />

Email: info@borealgenomics.com<br />

URL: http://www.borealgenomics.com<br />

Boreal provides systems and laboratory services for<br />

high sensitivity pr<strong>of</strong>iling <strong>of</strong> cancer mutations from<br />

plasma and low tumor content samples.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ Cartagenia ............................................... 1022<br />

Tel: 617-475-5105<br />

Email: info@cartagenia.com<br />

URL: http://www.cartagenia.com<br />

Cartagenia provides reliable s<strong>of</strong>tware allowing genetic<br />

labs and clinicians to perform clinically relevant<br />

analyses efficiently. With BENCH lab CNV for<br />

cytogenetics and BENCH lab NGS for sequencing,<br />

your lab technicians, directors, counselors and<br />

scientists have the right tools and knowledge at their<br />

fingertips supporting variant triage and automating<br />

lab reporting.<br />

■ Cell Press ................................................. 1212<br />

Tel: 617-661-7057/888-437-4636<br />

Email: usinfo-f@elsevier.com<br />

URL: http://www.cell.com<br />

Cell Press publishes the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong><br />

<strong>Genetics</strong>, the premier journal <strong>of</strong> the <strong>American</strong> <strong>Society</strong><br />

<strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>. Visit booth #1212 to learn more<br />

about this exciting partnership and <strong>ASHG</strong> member<br />

discounts on journals, including Cell, Molecular Cell,<br />

and Cell Stem Cell. New for <strong>2012</strong>, Cell Reports an<br />

open access journal spanning the entire life sciences<br />

spectrum. www.cell.com<br />

■ Center for Inherited Disease Research<br />

(CIDR) ........................................................... 119<br />

Tel: 410-550-7116<br />

Email: kimkutchins@jhmi.edu<br />

URL: http://www.cidr.jhmi.edu<br />

The Johns Hopkins University Center for Inherited<br />

Disease Research (CIDR) provides high quality<br />

next-generation sequencing and genotyping services<br />

to investigators working to discover genes that<br />

contribute to common disease. CIDR <strong>of</strong>fers custom<br />

targeted and whole exome sequencing services<br />

as well as GWAS, custom, epigenetic and linkage<br />

genotyping. www.cidr.jhmi.edu<br />

■ Centogene AG ......................................... 1026<br />

Tel: 49 3812036520<br />

Email: <strong>of</strong>fice@centogene.com<br />

URL: http://www.centogene.com<br />

CENTOGENE, The Rare Disease Company, is a global<br />

leader in the field <strong>of</strong> molecular diagnostics. Extremely<br />

short turn-around-times, analysis and interpretation<br />

by medical experts is guaranteed. CENTOGENE<br />

provides prenatal analysis, newborn screening, and<br />

the analysis <strong>of</strong> biomarkers for metabolic diseases.<br />

CENTOGENE works with international partners<br />

developing new orphan drugs.


■ chemagen from PerkinElmer ................. 1426<br />

Tel: 203-925-4602/800-762-4000<br />

Email: CustomerCareUS@perkinelmer.com<br />

URL: http://www.PerkinElmer.com<br />

chemagen is a leading supplier <strong>of</strong> automation and<br />

reagents for fast and reliable magnetic bead based<br />

DNA and RNA extraction for sample volumes from<br />

10 ul to 10 ml for blood, tissues, saliva, bacteria,<br />

food, PCR products, etc. The one instrument<br />

performs all functions with fast processing,<br />

unmatched sample volume range and robust<br />

chemistry.<br />

■ Children’s Hospital <strong>of</strong> Philadelphia ......... 327<br />

Tel: 215-590-6528<br />

Email: RobertsJ1@email.chop.edu<br />

URL: http://www.chop.edu/labs<br />

Founded in 1855, The Children’s Hospital <strong>of</strong><br />

Philadelphia is the birthplace <strong>of</strong> pediatric medicine<br />

in America. A passionate spirit <strong>of</strong> innovation has<br />

driven this renowned institution to pursue scientific<br />

discovery, establish the highest standards <strong>of</strong> care,<br />

and deliver diagnostic services that help children<br />

around the world lead happier, healthier lives.<br />

■ CIHR Institute <strong>of</strong> <strong>Genetics</strong> ..................... 1321<br />

Tel: 613-957-6126<br />

URL: http://www.cihr.gc.ca/e/13147.html<br />

The CIHR Institute <strong>of</strong> <strong>Genetics</strong> supports research<br />

on the human and model genomes and on all<br />

aspects <strong>of</strong> genetics, basic biochemistry and cell<br />

biology related to health and disease, including<br />

the translation <strong>of</strong> knowledge into health policy and<br />

practice, and the societal implications <strong>of</strong> genetic<br />

discoveries.<br />

■ Cincinnati Children’s Hospital Medical<br />

Center ......................................................... 1505<br />

Tel: 513-636-7355<br />

Email: askthelab@cchmc.org<br />

URL: http://www.cincinnatichildrens.org/<br />

clinicallab<br />

The clinical laboratories at Cincinnati Children’s<br />

Hospital Medical Center <strong>of</strong>fer quick, convenient<br />

diagnostic laboratory services designed and<br />

interpreted by world renowned clinical experts.<br />

We have over 400 specialty tests, and have<br />

specialty programs and expertise in molecular<br />

diagnostics, cardiology, immunodeficiencies, and<br />

cytogenetics.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 279<br />

■ City <strong>of</strong> Hope Clinical Molecular Diagnostic<br />

Laboratory .................................................... 321<br />

Tel: 626-256-4673 x 64401/888-826-4362<br />

Email: mdl@coh.org<br />

URL: http://mdl.city<strong>of</strong>hope.org<br />

The City <strong>of</strong> Hope Molecular Diagnostic Laboratory<br />

(MDL) specializes in clinical genetic testing<br />

services for cancer predisposition, coagulopathies,<br />

connective tissue disorders, muscular dystrophies,<br />

neuropsychiatric disorders and pharmacogenetics.<br />

For more up-to-date information about our tests,<br />

please visit our website at http://mdl.city<strong>of</strong>hope.org<br />

■ CLC bio ...................................................... 501<br />

Tel: 617-444-8765<br />

Email: alykkebak@clcbio.com<br />

URL: http://www.clcbio.com<br />

CLC bio is the world’s leading bioinformatics<br />

solution provider and the only one that provides both<br />

desktop and server s<strong>of</strong>tware seamlessly integrated<br />

and optimized for best performance. By developing<br />

their own proprietary algorithms, CLC bio scientists<br />

have successfully parallelized the data calculations<br />

to achieve remarkable improvements in speed over<br />

comparable solutions.<br />

■ Clontech Laboratories, A Takara<br />

Bio company .............................................. 1708<br />

Tel: 608-310-3516<br />

Email: leslie_miller@clontech.com<br />

URL: http://www.clontech.com/takara<br />

Reliable and innovative research reagents from<br />

Takara Bio and Clontech. Our products are trusted<br />

by scientists worldwide for applications from gene<br />

expression analysis using qPCR to high-fidelity PCR,<br />

protein expression, and epigenetics. Move your<br />

research forward with PrimeSTAR ® GXL and Max<br />

polymerases, TaKaRa Ex Taq ® and LA Taq ® , and<br />

PrimeScript RTase.<br />

■ Cold Spring Harbor Laboratory Press ......1209<br />

Tel: 516-422-4005<br />

Email: mazzullo@cshl.edu<br />

URL: http://www.cshlpress.org<br />

Cold Spring Harbor Laboratory continues to shape<br />

contemporary biomedical research and education<br />

with programs in cancer, neuroscience, plant biology,<br />

and quantitative biology. Its Meetings & Courses<br />

program hosts more than 8,000 international<br />

scientists each year and its Press publishes books,<br />

journals, and electronic media for scientists, students,<br />

and the general public.<br />

EXHIBITORS


280 EXHIBITORS<br />

■ Complete Genomics, Inc. ......................... 907<br />

Tel: 650-943-2800<br />

Email: events@completegenomics.com<br />

URL: http://www.completegenomics.com<br />

Through its pioneering sequencing-as-a-service<br />

model, Complete Genomics provides researchers and<br />

clinicians the most accurate whole human genomes.<br />

The ease <strong>of</strong> use and power <strong>of</strong> Complete’s advanced<br />

informatics and analysis provide genomic information<br />

needed to understand, prevent, diagnose and treat<br />

diseases.<br />

■ Connective Tissue Gene Tests ................ 718<br />

Tel: 484-244-2900<br />

Email: inquiries@ctgt.net<br />

URL: http://www.ctgt.net<br />

CTGT is committed to providing the broadest<br />

range <strong>of</strong> molecular diagnostic tests for inherited<br />

connective tissue disorders — about 200 tests<br />

and still growing. CTGT has high test sensitivity,<br />

fast turnaround time, expert advice and superior<br />

customer service.<br />

■ Coriell Institute for Medical Research ........312<br />

Tel: 856-966-7377/800-752-3805<br />

Email: ccr@coriell.org<br />

URL: http://ccr.coriell.org<br />

Coriell Institute for Medical Research is an<br />

independent, non-pr<strong>of</strong>it biomedical research center.<br />

Founded in 1953, Coriell is one <strong>of</strong> the world’s<br />

leading biobanks, distributing biospecimens and<br />

<strong>of</strong>fering custom research and biobanking services<br />

to scientists. Coriell examines the utility <strong>of</strong> genetic<br />

information in personalized medicine through its<br />

CPMC research study.<br />

■ Covaris Inc. .............................................. 1008<br />

Tel: 781-932-3959<br />

Email: info@covarisinc.com<br />

URL: http://www.covarisinc.com<br />

Covaris provides advanced sample preparation<br />

systems for life and analytical science. Covaris<br />

sample prep technologies support a wide variety <strong>of</strong><br />

applications including NGS, ChIP, and proteomics.<br />

Our patented Adaptive Focused Acoustic (AFA)<br />

technology is the industry standard for DNA shearing<br />

and is used by major genome centers and academic<br />

institutions worldwide.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ Cytocell Ltd/Rainbow Scientific, Inc. ..........404<br />

Tel: 860-298-8382/888-831-4247<br />

Email: info@rainbowscientific.com<br />

URL: http://www.rainbowscientific.com<br />

Cytocell celebrates its 20th year as a leading provider<br />

<strong>of</strong> innovative DNA screening solutions for the accurate<br />

detection <strong>of</strong> human genetic diseases. Cytocell<br />

manufactures complete ranges <strong>of</strong> DNA FISH probes for<br />

use in clinical cytogenetics. Please review our updated<br />

list <strong>of</strong> FISH probes for hematological malignancies<br />

including our new full line <strong>of</strong> OncoSight Solid Tumor<br />

FISH probes. Check out www.myprobes.com regarding<br />

their custom FISH probe-making services.<br />

■ Cytonet LLC............................................. 1301<br />

Tel: 919-354-1930<br />

Email: joel.hare@cytonetllc.com<br />

URL: http://www.cytonetllc.com<br />

Cytonet is a biotechnology company with sites in<br />

Germany and Durham, NC USA. Cytonet develops cellbased<br />

products for liver diseases. Liver cells from nontransplantable<br />

livers are recovered and subsequently<br />

transplanted into children with genetic disorders in<br />

approved Phase-II clinical studies. Donated livers are<br />

provided by 50+; US-OPO and Tissue Banks.<br />

■ Data Unlimited International, Inc........... 1503<br />

Tel: 240-631-7933<br />

Email: contact@duii.com<br />

URL: http://www.duii.com<br />

Starfruit Technologies is Laboratory Information<br />

Management System (LIMS) & QA s<strong>of</strong>tware/<br />

database/computer/barcode for genetic and<br />

immunology labs enables sample, patient,<br />

biorepository, billing databases; mutation, variant,<br />

disease, genotype databases, SNP databank;<br />

instrument interface, barcode, QA/QC; worksheet,<br />

workflow, inventory, protocol, image; epidemiological<br />

frequency, trend, geographical distribution, disease/<br />

disorder susceptibility, reporting; 21CFR11, CAP,<br />

CLIA, HIPPA, PHI.<br />

■ Diagenode Inc ........................................... 406<br />

Tel: 862-209-4680<br />

Email: custsupport.na@diagenode.com<br />

URL: http://www.diagenode.com<br />

Diagenode is an international life science company<br />

that develops and commercializes innovative<br />

instruments, reagents and systems for life science<br />

research. Our goal is to develop cutting-edge<br />

products that advance research in the rapidly<br />

evolving field <strong>of</strong> epigenetics. We specialize in <strong>of</strong>fering<br />

a broad range <strong>of</strong> chromatin immunoprecipitation and<br />

DNA methylation products.


■ DNA Genotek ............................................. 900<br />

Tel: 613-723-5757/1-866-813-6354<br />

Email: info@dnagenotek.com<br />

URL: http://www.dnagenotek.com<br />

DNA Genotek is focused on providing high-quality<br />

biological sample collection, stabilization and<br />

preparation products for genetic-based applications<br />

including molecular diagnostics and research <strong>of</strong> both<br />

host and microbial DNA or RNA in oral samples.<br />

The company’s Oragene product line provides<br />

reliability and ease-<strong>of</strong>-use which has resulted in rapid<br />

worldwide adoption by top tier health institutions.<br />

■ DNAnexus, Inc. .......................................... 507<br />

Tel: 650-209-0362<br />

Email: info@dnanexus.com<br />

URL: http://dnanexus.com<br />

DNAnexus is a pioneering, collaborative tool for<br />

the analysis, visualization, and management <strong>of</strong><br />

genomic data. DNAnexus’ foundation is a scalable,<br />

cloud-based platform that is fostering an expanding<br />

ecosystem <strong>of</strong> application developers and researchers<br />

that enables faster data delivery and accelerates the<br />

interpretation <strong>of</strong> genomic data in research and clinical<br />

applications.<br />

■ DNASTAR, Inc............................................ 801<br />

Tel: 608-258-7420/866-511-5090<br />

Email: info@dnastar.com<br />

URL: http://www.dnastar.com<br />

DNASTAR has pioneered development <strong>of</strong> desktop<br />

computer sequence assembly and analysis s<strong>of</strong>tware<br />

to increase life scientists’ productivity for over<br />

25 years. DNASTAR’s products include Lasergene<br />

s<strong>of</strong>tware for traditional sequence analysis and several<br />

other integrated tools for next-generation DNA and<br />

RNA sequence assembly and analysis and protein<br />

sequence and structure visualization.<br />

■ EdgeBio ................................................... 1506<br />

Tel: 301-990-2685/800-326-2685<br />

Email: info@edgebio.com<br />

URL: http://www.edgebio.com<br />

EdgeBio <strong>of</strong>fers next-generation sequencing services.<br />

From experimental design to bioinformatics, EdgeBio<br />

is the perfect solution for all your sequencing needs.<br />

EdgeBio also sells kits for sequencing reaction<br />

cleanup, PCR purification, and plasmid purification,<br />

as well as competent cells.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 281<br />

■ Elsevier .................................................... 1210<br />

Tel: 212-989-5800/888-437-4636<br />

Email: usinfo-f@elsevier.com<br />

URL: http://www.elsevier.com<br />

Explore Elsevier’s high impact genetics journals<br />

and books. Learn the latest in research news<br />

from journals such as The <strong>American</strong> Journal <strong>of</strong><br />

<strong>Human</strong> <strong>Genetics</strong>. Our exciting books on display<br />

include Our Genes, Our Choices, Genomic and<br />

Personalized Medicine and many more. Discover<br />

our electronic research and solution tools via<br />

SciVerse ScienceDirect.<br />

■ Embi Tec .................................................. 1406<br />

Tel: 858-684-3190/800-255-1777<br />

Email: inquiry@embitec.com<br />

URL: http://www.embitec.com<br />

Embi Tec manufactures and distributes innovative,<br />

cost and space effective lab equipment such as the<br />

RunOne Electrophoresis System, MultiCaster<br />

Systems, ViewOne LabLite (miniature white light<br />

box), LightOne Illuminators for setting up and<br />

cherry-picking 96- or 384-well plates, PrepOne<br />

Sapphire (non-UV, blue light box), PrepOne<br />

ImageCatcher and AnyBlood Direct PCR buffers.<br />

■ EMC Isilon ............................................... 1320<br />

Tel: 206-315-7500<br />

Email: info@isilon.com<br />

URL: http://www.emc.com/isilon<br />

EMC© Isilon is the global leader in scale-out<br />

storage. We deliver powerful yet simple solutions<br />

for enterprises that want to manage their data, not<br />

their storage. Isilon’s products are simple to install,<br />

manage and scale, at any size.<br />

■ Emory <strong>Genetics</strong> Laboratory ..................... 211<br />

Tel: 404-778-8499/855-831-7447<br />

Email: dkauke@emory.edu<br />

URL: http://www.geneticslab.emory.edu<br />

Emory <strong>Genetics</strong> Laboratory (EGL) is a worldwide<br />

leader in rare disease clinical genetic testing.<br />

Associated with Emory University’s prestigious<br />

Department <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> in its School <strong>of</strong><br />

Medicine, EGL’s biochemical, cytogenetic, and<br />

molecular laboratories perform integrated and<br />

comprehensive testing including whole exome<br />

sequencing, prenatal microarrays and inherited<br />

metabolic disorder testing.<br />

EXHIBITORS


282 EXHIBITORS<br />

■ Enlis Genomics ......................................... 203<br />

Tel: 510-413-8305<br />

Email: contact@enlis.com<br />

URL: http://www.enlis.com<br />

Overall Winner <strong>of</strong> the 2011 Illumina Data<br />

Excellence Award! Genome analysis made simple.<br />

Our Genome Research s<strong>of</strong>tware is the easiest way to<br />

analyze tens or even hundreds <strong>of</strong> human genomes -<br />

all on a standard desktop or laptop computer. Sign<br />

up for a free trial today.<br />

■ Epicentre (an Illumina company) ........... 1218<br />

Tel: 608-258-3080/800-284-8474<br />

Email: techhelp@epicentre.com<br />

URL: http://www.epicentre.com<br />

Epicentre (an Illumina company) <strong>of</strong>fers innovative,<br />

time-saving kits for gene expression studies.<br />

Featured are the ScriptSeq and TotalScript kits<br />

for rRNA-free RNA-Seq library sample prep in 1<br />

day from any RNA sample. Kits for genomic DNA<br />

purification and microarray target labeling will also be<br />

highlighted.<br />

■ EpigenDx ................................................... 721<br />

Tel: 508-497-9400/800-941-6884<br />

Email: info@epigendx.com<br />

URL: http://epigendx.com<br />

EpigenDx is a genomic and epigenomic research<br />

company that specializes in disease biomarker<br />

discovery and molecular diagnosis. The company<br />

provides the products and services for DNA<br />

methylation analysis and quantitative mutation<br />

analysis. EpigenDx also provides products and<br />

laboratory services for scientific researchers from<br />

academic, government and industrial communities.<br />

■ Epigentek Group Inc ............................... 1127<br />

Tel: 877-374-4368<br />

Email: info@epigentek.com<br />

URL: http://www.epigentek.com<br />

Epigentek is the leading provider <strong>of</strong> epigenetic assay<br />

kits, antibodies, reagents, and services through a<br />

complete and systematic approach. It is the first<br />

and only company to specialize exclusively in<br />

epigenetics and has pioneered the commercialization<br />

<strong>of</strong> many technologies commonly used today in DNA<br />

methylation, histone modification, and chromatin<br />

studies.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ European <strong>Human</strong> <strong>Genetics</strong><br />

Conference 2013 .......................................... 219<br />

Tel: 31 703838901<br />

Email: fvanlaer@rose-international.com<br />

URL: http://www.eshg.org/eshg2013<br />

The European <strong>Human</strong> <strong>Genetics</strong> Conference 2013<br />

will be held in Paris, France, from 8-11 June 2013.<br />

Please visit our booth for more information and ESHG<br />

membership application. To view the conference<br />

program, details on abstract submission and for<br />

online registration for the conference: www.eshg.org/<br />

eshg2013<br />

■ Exiqon ...................................................... 1712<br />

Tel: 781-376-4150/888-647-2879<br />

Email: lac@exiqon.com<br />

URL: http://www.exiqon.com<br />

Exiqon is a leading supplier <strong>of</strong> microRNA research<br />

tools based on our proprietary LNA technology.<br />

Researchers around the world are using our<br />

products to make groundbreaking discoveries<br />

about the correlation between gene activity and the<br />

development <strong>of</strong> cancer and other diseases. Exiqon<br />

Services <strong>of</strong>fers expertise in microRNA pr<strong>of</strong>iling and<br />

biomarker discovery from clinical samples.<br />

■ Expression Analysis .................................. 508<br />

Tel: 919-405-2248/866-293-6094<br />

Email: kmichailo@expressionanalysis.com<br />

URL: http://www.expressionanalysis.com<br />

EA provides cutting-edge genomic sequencing, gene<br />

expression, genotyping, and bioinformatics services<br />

to global pharmaceutical companies, diagnostic test<br />

developers, government agencies, and academic<br />

labs. EA conducts every project under clinicalgrade<br />

quality control and <strong>of</strong>fers the bioinformatics<br />

expertise and computational infrastructure to process<br />

enormous volumes <strong>of</strong> genomic data with consistency<br />

and speed.<br />

■ FASEB ...................................................... 1700<br />

Tel: 301-634-7288<br />

Email: khicks@faseb.org<br />

URL: http://www.faseb.org<br />

Celebrating its Centennial, 100 Years <strong>of</strong> Advancing<br />

the Life Sciences, FASEB is recognized as the<br />

policy voice <strong>of</strong> biomedical researchers, representing<br />

26 scientific societies (over 100,000 members); the<br />

nations largest coalition <strong>of</strong> biomedical researchers.<br />

Products/services include: The FASEB Journal,<br />

Science Research Conferences, MARC travel awards,<br />

and <strong>Society</strong> Management Services.


■ Fluidigm Corporation ............................... 725<br />

Tel: 650-266-6000/866-358-4354<br />

Email: Marketing@fluidigm.com<br />

URL: http://www.fluidigm.com<br />

Fluidigm develops and manufactures innovative<br />

micr<strong>of</strong>luidics solutions for life science systems. These<br />

solutions consist <strong>of</strong> its integrated fluidic circuit (IFC)<br />

technology, with instruments that simplify workflow<br />

and improve accuracy for genomics research<br />

applications, including single-cell gene expression,<br />

high-throughput SNP genotyping and next-generation<br />

sequencing.<br />

■ Geisinger Health System .......................... 821<br />

Tel: 570-214-9725/800-845-7112<br />

Email: jheid1@geisinger.edu<br />

URL: http://Join-Geisinger.org<br />

Geisinger Health System serves nearly 3 million<br />

people in Pennsylvania through a network <strong>of</strong><br />

4 hospitals, 38 community practice sites and over 900<br />

Geisinger physicians. Geisinger has an institutional<br />

commitment to research and a focus on personalized<br />

medicine, and has been nationally recognized for<br />

research, innovative practices and quality care.<br />

■ Gene Codes Corporation ...................... 1310<br />

Tel: 734-769-7249/800-497-4939<br />

Email: info@genecodes.com<br />

URL: http://www.genecodes.com<br />

Gene Codes Corporation develops Sequencher,<br />

DNA sequence analysis s<strong>of</strong>tware for traditional<br />

and next-generation DNA data sets. Geneticists<br />

around the world rely on Sequencher’s intuitive user<br />

interface, speedy alignment algorithms, and powerful<br />

SNP discovery tools to guide them towards results.<br />

Stop by to see our latest release <strong>of</strong> Sequencher.<br />

■ GeneDx .................................................... 1119<br />

Tel: 301-519-2100/800-229-5227<br />

Email: genedx@genedx.com<br />

URL: http://www.genedx.com<br />

GeneDx tests for more than 350 rare Mendelian<br />

disorders using DNA sequencing and deletion/<br />

duplication analysis <strong>of</strong> the associated gene(s), and<br />

<strong>of</strong>fers oligonucleotide microarray-based testing<br />

and next-generation sequencing-based panels for<br />

inherited cardiac disorders, mitochondrial disorders,<br />

and neurodevelopmental disorders. GeneDx <strong>of</strong>fers<br />

MFM and Ob-Gyn diagnostics including prenatal/<br />

maternal risk assessment, and carrier testing.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 283<br />

■ GeneInsight ............................................. 1224<br />

Tel: 617-954-9738<br />

Email: mband@partners.org<br />

URL: http://www.geneinsight.com<br />

GeneInsight Suite is an IT platform, developed at<br />

Partners HealthCare, to streamline the analysis,<br />

interpretation and reporting <strong>of</strong> genetic test results<br />

and facilitate delivery <strong>of</strong> test results to treating<br />

clinicians. The application consists <strong>of</strong> a laboratory<br />

knowledge management application, a clinician<br />

access application and a network infrastructure that<br />

enhances communication.<br />

■ Gene Link, Inc ........................................... 627<br />

Tel: 914-769-1192/800-436-3546<br />

Email: support@genelink.com<br />

URL: http://www.genelink.com<br />

Gene Link is a leading supplier <strong>of</strong> premium custom<br />

complex modified oligonucleotides, siRNA, RNA,<br />

fluorescent probes and other molecular biology<br />

products. Gene Detection System product lines for<br />

triple repeat disorders e.g. Fragile X, Huntington s<br />

disease, Myotonic Dystrophy, FRDA and FRAXE. Gene<br />

Link services include custom probe and siRNA design.<br />

■ GeneTests ................................................ 1413<br />

Tel: 206-221-4674<br />

Email: newgr@u.washington.edu<br />

URL: http://www.genetests.org<br />

GeneTests (www.genetests.org) provides medical<br />

genetics information for physicians, clinicians and<br />

researchers pertaining to diagnosis, management,<br />

and genetic counseling for heritable disorders<br />

through the expert-authored, peer-reviewed<br />

publication GeneReviews, an international genetic<br />

testing Laboratory Directory and Clinic Directory, and<br />

educational materials. Funded by contract from NIH,<br />

sponsored by University <strong>of</strong> Washington, Seattle.<br />

■ Genetic Engineering & Biotechnology<br />

News ........................................................... 1500<br />

Tel: 914-740-2200<br />

Email: smccarthy@bioconferences.com<br />

URL: http://www.genengnews.com<br />

Genetic Engineering & Biotechnology News (GEN) is<br />

the longest-running, most widely read, and largest<br />

circulated global biotechnology news publication.<br />

Published 21 times a year and recently redesigned<br />

to focus on Biobusiness, OMICS, Drug Discovery,<br />

Bioprocessing, and Translational Medicine, GEN<br />

reports on key news developments and technology<br />

trends in the bioindustry.<br />

EXHIBITORS


284 EXHIBITORS<br />

■ <strong>Genetics</strong> <strong>Society</strong> <strong>of</strong> America/G3 - Genes,<br />

Genomes, <strong>Genetics</strong> ..................................... 227<br />

Tel: 301-634-7300/866-486-GENE<br />

Email: society@genetics-gsa.org<br />

URL: http://www.genetics-gsa.org | http://www.<br />

g3journal.org<br />

The <strong>Genetics</strong> <strong>Society</strong> <strong>of</strong> America is a scientific<br />

membership society <strong>of</strong> 5,000 researchers and<br />

educators. GSA established the open-access peerreviewed<br />

journal G3: GENES|GENOMES|GENETICS as<br />

a forum for the publication <strong>of</strong> high-quality foundational<br />

research, including articles on useful genetic and<br />

genomic information and datasets in human genetics.<br />

■ Gene Tools, LLC ...................................... 1401<br />

Tel: 541-929-7840<br />

Email: custsupport@gene-tools.com<br />

URL: http://www.gene-tools.com<br />

Gene Tools manufactures Morpholino oligos for<br />

blocking translation, modifying splicing or inhibiting<br />

miRNA activity. Morpholinos are used in cell cultures,<br />

embryos or, as Vivo-Morpholinos, in adult animals.<br />

Morpholinos are effective, specific, stable and nontoxic.<br />

Backed by PhD-level customer support, Gene<br />

Tools designs and synthesizes Morpholinos and<br />

<strong>of</strong>fers cytosolic delivery options.<br />

■ Genformatic ............................................. 1420<br />

Tel: 512-565-4693<br />

Email: info@genformatic.com<br />

URL: http://www.genformatic.com<br />

Genformatic provides comprehensive genome<br />

sequence analysis services, including optimized<br />

sequence alignment and variant identification, variant<br />

annotation and interpretation <strong>of</strong> phenotypic implications,<br />

and production <strong>of</strong> a prioritized list <strong>of</strong> probable variant<br />

impacts upon health. Genformatic can process one<br />

genome or hundreds <strong>of</strong> genomes in parallel for research<br />

investigations or clinical applications.<br />

■ Genial Genetic Solutions/Rainbow<br />

Scientific, Inc. .............................................. 402<br />

Tel: 860-298-8382/888-831-4247<br />

Email: info@rainbowscientific.com<br />

URL: http://www.rainbowscientific.com<br />

Genial Genetic Solutions <strong>of</strong>fers the robotic MultiPrep<br />

Genie and Cell Sprint Harvesting systems for both<br />

surface culture and suspension culture harvesting.<br />

Our ProCell cytogenetic reagents yield high quality<br />

cytogenetic preparations. Our suite <strong>of</strong> genetic<br />

database s<strong>of</strong>tware products including Shire, iGene<br />

and iPassport QMS, <strong>of</strong>fer integrated multi-discipline<br />

genetic patient management with excellent auditing<br />

and document/process control capabilities.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ GenoLogics ............................................. 1105<br />

Tel: 250-483-7011/866-457-5467<br />

Email: info@genologics.com<br />

URL: http://www.genologics.com<br />

GenoLogics is a leading provider <strong>of</strong> LIMS s<strong>of</strong>tware<br />

specifically designed for next-generation omics<br />

labs. The GenoLogics LIMS delivers end-to-end<br />

management <strong>of</strong> genomics laboratory samples, tests<br />

and results. GenoLogics is uniquely qualified to<br />

meet information management needs <strong>of</strong> the nextgeneration<br />

laboratory by delivering a LIMS that is<br />

scalable, adaptable and useable.<br />

■ Genomatix S<strong>of</strong>tware ................................. 425<br />

Tel: 734-205-5990/877-436-6628<br />

Email: grant@genomatix.com<br />

URL: http://www.genomatix.com<br />

Genomatix is a computational biology company<br />

known for its excellence in science. We have<br />

accumulated extensive data content and developed<br />

multiple s<strong>of</strong>tware applications for understanding<br />

gene regulation for 15+ years. Leveraging this<br />

history <strong>of</strong> excellence in systems biology, Genomatix<br />

now provides a comprehensive, integrated analysis<br />

solution for all NGS applications.<br />

■ Genzyme, a San<strong>of</strong>i Company ................... 901<br />

Tel: 617-768-6512<br />

Email: lena.ortins@genzyme.com<br />

URL: http://www.genzyme.com<br />

Genzyme has pioneered the development and<br />

delivery <strong>of</strong> transformative therapies for patients<br />

affected by rare and debilitating diseases for over<br />

30 years. With a focus on rare diseases and multiple<br />

sclerosis, we are dedicated to making a positive<br />

impact on the lives <strong>of</strong> the patients and families we<br />

serve. Visit www.genzyme.com.<br />

■ GnuBIO, Inc. .............................................. 521<br />

Tel: 617-446-6744<br />

Email: info@gnubio.com<br />

URL: http://www.gnubio.com<br />

GnuBIO is a pioneer in the field <strong>of</strong> scalable DNA<br />

sequencing technology. The GnuBIO technology is<br />

an emulsion-based micr<strong>of</strong>luidic technology. GnuBIO’s<br />

platform seamlessly incorporates all DNA sequencing<br />

functions into one single system (including DNA<br />

enrichment, amplification and sequencing), with<br />

a single user interface producing results in hours<br />

versus days.


■ Golden Helix, Inc. ...................................... 818<br />

Tel: 406-585-8137<br />

Email: info@goldenhelix.com<br />

URL: http://www.goldenhelix.com<br />

Golden Helix helps genetic research groups working<br />

with large-scale DNA-sequencing or microarray<br />

data overcome the frustration and challenges <strong>of</strong><br />

bioinformatic roadblocks. By empowering researchers<br />

with highly effective s<strong>of</strong>tware tools, world-class<br />

support, and complementary analytic services, we<br />

refute the notion that analysis has to be difficult or<br />

time consuming.<br />

■ Greenwood Genetic Center ................... 1027<br />

Tel: 864-941-8110/800-473-9411<br />

URL: http://www.ggc.org<br />

The Greenwood Genetic Center is a nonpr<strong>of</strong>it institute<br />

organized to provide clinical genetic services,<br />

diagnostic laboratory testing, educational resources,<br />

and research in the field <strong>of</strong> medical genetics.<br />

Our laboratory <strong>of</strong>fers biochemical, cytogenetic,<br />

and molecular diagnostic testing. We strive to<br />

Give Greater Care by combining state-<strong>of</strong>-the-art<br />

diagnostics with exceptional service.<br />

■ Hamilton Company ................................. 1613<br />

Tel: 775-858-3000/800-648-5950<br />

Email: kcavallaro@hamiltoncompany.com<br />

URL: http://www.hamiltonrobotics.com<br />

Hamilton Robotics is dedicated to the design<br />

and manufacture <strong>of</strong> automated liquid handling<br />

workstations. Key to our products is our air<br />

displacement pipetting and monitoring technology<br />

and s<strong>of</strong>tware controlling our systems. Our<br />

workstations and s<strong>of</strong>tware serve as a common high<br />

precision and flexible base upon which to provide<br />

automated solutions.<br />

■ Hitachi Solutions America Ltd. .............. 1502<br />

Tel: 650-615-7600<br />

Email: rlynde@miraibio.com<br />

Hitachi Solutions and Hitachi High<br />

Technologies have partnered to leverage<br />

breakthrough technologies to create the secure<br />

infrastructure needed to allow validated genomic<br />

data and related phenotypic data to be combined.<br />

This new platform will give users the ability to<br />

mine and view data in novel ways to make new<br />

discoveries.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 285<br />

■ <strong>Human</strong> Variome Project Intl. Ltd ............. 221<br />

Tel: 61 3 8344-1831<br />

Email: rania@variome.org<br />

URL: http://www.humanvariomeproject.org<br />

The <strong>Human</strong> Variome Project is an international<br />

consortium <strong>of</strong> individuals who are working towards<br />

reducing the burden <strong>of</strong> genetic disease. The aim<br />

<strong>of</strong> the <strong>Human</strong> Variome Project is to ensure that all<br />

information on genetic variation can be collected,<br />

curated, interpreted and shared freely and openly<br />

with the world.<br />

■ Illumina, Inc. ............................................ 1109<br />

Tel: 858-202-4500/800-809-4566<br />

Email: info@illumina.com<br />

URL: http://www.illumina.com<br />

Illumina ® provides innovative sequencing and<br />

array-based solutions for genotyping, copy number<br />

variation analysis, methylation studies, gene<br />

expression pr<strong>of</strong>iling, and low-multiplex analysis <strong>of</strong><br />

DNA, RNA, and protein. We also provide tools and<br />

services that are fueling advances in consumer<br />

genomics and diagnostics, paving the way for<br />

molecular medicine and ultimately transforming<br />

healthcare.<br />

■ Incom, Inc. ............................................... 1300<br />

Tel: 508-909-2200<br />

Email: dar@incomusa.com<br />

URL: http://www.incomusa.com<br />

Incom is a manufacturer <strong>of</strong> glass and polymer fused<br />

fiber optic faceplates and tapers, as well as polymer<br />

and glass micro structures. We have participated<br />

in the development <strong>of</strong> microwell arrays for genome<br />

sequencing, large-area faceplates and tapers for<br />

X-ray applications, and microcapillary arrays for TOF<br />

and neutron detection.<br />

■ Ingenuity Systems, Inc. .......................... 1101<br />

Tel: 650-381-5100<br />

Email: hbullock@ingenuity.com<br />

URL: http://www.ingenuity.com<br />

Ingenuity Systems enables researchers to model,<br />

analyze and understand complex biological systems<br />

foundational to human health and disease. Products<br />

leverage the Ingenuity Knowledge Base and include<br />

IPA, Ingenuity iReport, Ingenuity Variant Analysis,<br />

Ingenuity Analysis Services, and content and custom<br />

services for pharmaceutical, biotech and academic<br />

organizations. Learn more at www.ingenuity.com.<br />

EXHIBITORS


286 EXHIBITORS<br />

■ Innopsys .................................................... 805<br />

Tel: 312-925-8210<br />

Email: contact@innopsys.com<br />

URL: http://www.innopsys.com<br />

Offering the InnoScan 900 and InnoScan 900<br />

fluorescence microarray scanners with optional<br />

autoloaders, Innopsys empowers users with the<br />

fastest reading times and highest resolution on<br />

the market. Innoscan scanners use Mapix, Innopsys<br />

proprietary image acquisition and analysis s<strong>of</strong>tware,<br />

giving customers a user-friendly interface and the<br />

fastest spot-finding on the market.<br />

■ IntegenX Inc. ........................................... 1311<br />

Tel: 925-701-3400<br />

Email: information@integenX.com<br />

URL: http://www.integenX.com<br />

IntegenX Inc. produces automated sample processing<br />

systems and reagent kits for the life sciences and<br />

applied sciences markets. Our Apollo 324 System<br />

automates next-generation library preparation for all<br />

major NGS platforms. GenTegra reagents enable<br />

ambient temperature storage <strong>of</strong> RNA and DNA.<br />

Our products dramatically reduce process time and<br />

expense. www.integenx.com<br />

■ Integrated DNA Technologies, Inc. ......... 301<br />

Tel: 319-626-8400/800-328-2661<br />

Email: custcare@idtdna.com<br />

URL: http://www.idtdna.com<br />

Integrated DNA Technologies (IDT) is a leader in<br />

custom biology for the research and diagnostic<br />

life science market and serves academic research,<br />

biotechnology, and pharmaceutical development.<br />

Products include DNA oligos, qPCR assays, and<br />

custom gene synthesis to support many applications<br />

such as DNA sequencing, SNP detection, and<br />

functional genomics.<br />

■ Integrated <strong>Genetics</strong>/LabCorp .................. 606<br />

Tel: 336-222-7566/800-222-7566<br />

Email: Anders@labcorp.com<br />

URL: http://www.labcorp.com<br />

Integrated <strong>Genetics</strong> is a leading provider <strong>of</strong><br />

reproductive genetic testing services driven by its<br />

commitment to physicians and their patients. With an<br />

expansive menu <strong>of</strong> complex tests and technologies,<br />

Integrated <strong>Genetics</strong> spans the continuum <strong>of</strong> care<br />

from prenatal diagnostics to the largest commercial<br />

genetic counseling network in the laboratory industry.<br />

www.integratedgenetics.com.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ Interactive Bios<strong>of</strong>tware ............................ 413<br />

Tel: 33278770405<br />

Email: contact@interactive-bios<strong>of</strong>tware.com<br />

URL: http://www.interactive-bios<strong>of</strong>tware.com<br />

Interactive Bios<strong>of</strong>tware is the creator <strong>of</strong> Alamut,<br />

the original mutation interpretation s<strong>of</strong>tware used<br />

by leading genetic scientists around the world.<br />

Interactive Bios<strong>of</strong>tware is changing genetic<br />

diagnostics and research by simplifying the mutation<br />

interpretation process, while saving scientists<br />

time, improving outcome quality and enhancing<br />

productivity.<br />

■ Ion Torrent ................................................. 100<br />

Tel: 650-243-6000<br />

Email: sales@iontorrent.com<br />

URL: http://www.iontorrent.com<br />

Life Technologies Corporation (NASDAQ: LIFE)<br />

is a global biotechnology company dedicated to<br />

moving science forward to improve life in meaningful<br />

ways for everyone. Our premier brands are the most<br />

cited, most trusted in the life sciences industry:<br />

Invitrogen, Applied Biosystems ® , Gibco ® , Molecular<br />

Probes ® , Novex ® , TaqMan ® , Ambion ® , and Ion<br />

Torrent.<br />

■ Irvine Scientific.......................................... 620<br />

Tel: 949-261-7800/800-437-5706<br />

Email: amcgrath@irvinesci.com<br />

URL: http://www.irvinesci.com<br />

Irvine Scientific is a leader in the design,<br />

manufacture and distribution <strong>of</strong> cell culture media<br />

and medical devices. Our goal is to develop<br />

and provide unsurpassed products and services<br />

for customers in biopharmaceutical, human<br />

reproductive, regenerative medicine, cytogenetics<br />

and research settings. We support a diverse cross<br />

section <strong>of</strong> the medical industry, from large scale<br />

industrial bioprocessing to IVF clinics and research<br />

in medically oriented areas.<br />

■ JAMA Network ........................................ 1201<br />

Tel: 312-464-5000<br />

Email: millette.jackson-bates@ama-assn.org<br />

URL: http://www.amapublications.org<br />

The JAMA Network is a consortium <strong>of</strong> peer-reviewed<br />

print and online medical publications, published by<br />

the AMA Publishing Group, that includes JAMA and 9<br />

specialty Archives Journals.


■ JMG (BMJ Group) ................................... 1103<br />

Tel: 44 (0)20 7387 4410<br />

Email: reponse.jmg@bmjgroup.com<br />

URL: http://jmg.bmj.com<br />

Journal <strong>of</strong> Medical <strong>Genetics</strong> (JMG) is a leading<br />

international peer reviewed journal covering original<br />

research in human genetics, including reviews <strong>of</strong> and<br />

opinion on the latest developments. Published monthly,<br />

each edition includes original articles, short reports,<br />

review articles, hypothesis articles, book reviews, online<br />

mutation reports and e-letters. Visit jmg.bmj.com to<br />

find out more.<br />

■ JSI medical systems GmbH ................... 1023<br />

Tel: 0049-7825-863620-0<br />

Email: mail@JSI-medisys.com<br />

URL: http://www.JSI-medisys.com<br />

JSI medical systems with U.S. <strong>of</strong>fice in CA is<br />

located in the Black Forest area at southwest<br />

Germany. Our s<strong>of</strong>tware Sequence Pilot is the<br />

leading premium product for analysis <strong>of</strong> next-<br />

generation sequencing, conventional sequencing,<br />

HLA SBT, HLA 454, MLPA and Affymetrix chip<br />

resequencing data. For detailed information see<br />

www.jsi-medisys.com<br />

■ Kailos <strong>Genetics</strong>, Inc. ................................. 310<br />

Tel: 256-327-9800/866-833-6865<br />

Email: mike@kailosgenetics.com<br />

URL: http://www.kailosgenetics.com<br />

TargetRich sets new expectations in targeted<br />

enrichment. A single-tube workflow - from start to<br />

finish - provides a fast, easy and scalable enrichment.<br />

Whether a custom solution, or fixed panel, our<br />

proprietary technology <strong>of</strong>fers the specificity, high<br />

alignment and uniformity for efficient next-generation<br />

sequencing with just 10ng <strong>of</strong> starting material.<br />

■ Kapa Biosystems Inc .............................. 1512<br />

Tel: 781-497-2933/855-527-2246<br />

Email: fritz.tiedt@kapabiosystems.com URL:<br />

http://www.kapabiosystems.com<br />

Kapa Biosystems <strong>of</strong>fers a portfolio <strong>of</strong> best-in-class<br />

PCR reagents engineered using our high-throughput<br />

molecular evolution platform. The novel DNA<br />

polymerases contained within our kits confer<br />

dramatic improvements to performance that enable<br />

results and applications not possible with wild-type<br />

enzymes. Next-generation PCR is defined as the shift<br />

from generalist wild-type enzymes toward designer<br />

specialist enzymes.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 287<br />

■ Karger Publishers ................................... 1208<br />

Tel: 860-675-7834/800-828-5479<br />

Email: karger.susan@snet.net<br />

URL: http://www.karger.com<br />

Karger is pleased to announce the publication <strong>of</strong><br />

An International System for <strong>Human</strong> Cytogenetic<br />

Nomenclature (2013). Other titles include the book<br />

series Genome Dynamics and Monographs in<br />

<strong>Human</strong> <strong>Genetics</strong>; and the journals Cytogenetic and<br />

Genome Research, Journal <strong>of</strong> Nutrigenetics and<br />

Nutrigenomics, Molecular Syndromology, Public<br />

Health Genomics, and Sexual Development.<br />

■ Knome, Inc. ............................................. 1007<br />

Tel: 617-715-1000<br />

Email: aryan@knome.com<br />

URL: http://www.knome.com<br />

Knome is a leading provider <strong>of</strong> human genome<br />

interpretation s<strong>of</strong>tware and services. Medical and<br />

research institutions use our innovative solutions<br />

to identify the genetic basis <strong>of</strong> disease, tumor<br />

growth, and drug response. Designed to accelerate<br />

the discovery process, Knome’s technologies are<br />

helping to pave the transition to molecular-based,<br />

personalized medicine.<br />

■ Kreatech Inc. ............................................. 811<br />

Tel: 919-407-8347/866-572-1432<br />

Email: na-customerservice@kreatech.com<br />

URL: http://www.kreatech.com<br />

Kreatech, Inc. <strong>of</strong>fers POSEIDON FISH probes<br />

with REPEAT-FREE technology. Kreatech has an<br />

extensive portfolio <strong>of</strong> FISH probes and custom design<br />

capability. Kreatech’s labeling technology, ULS - the<br />

Universal Linkage System, allows non-enzymatic,<br />

accurate and fast labeling <strong>of</strong> DNA, RNA and proteins;<br />

one universal labeling system compatible with all<br />

biological samples.<br />

■ Labcyte Inc. ............................................. 1402<br />

Tel: 408-747-2000/1-877-742-6548<br />

Email: info@labcyte.com<br />

URL: http://www.labcyte.com<br />

Labcyte is revolutionizing life science with the<br />

Echo ® liquid handler which uses acoustic energy to<br />

transfer liquids. This touchless technology provides<br />

dramatically better results by eliminating pipette tips<br />

and their associated problems, while saving hundreds<br />

<strong>of</strong> thousands <strong>of</strong> dollars annually in decreased<br />

consumables. Labcyte technologies have broad<br />

application in many fields.<br />

EXHIBITORS


288 EXHIBITORS<br />

■ Laboratory for Molecular Medicine,<br />

PCPGM ....................................................... 1225<br />

Tel: 617-768-8500<br />

Email: lmm@partners.org<br />

URL: http://pcpgm.partners.org/LMM/<br />

The Harvard-affiliated Laboratory for Molecular<br />

Medicine, a CLIA-certified molecular diagnostic<br />

laboratory within the Partners Healthcare Center<br />

for Personalized Genetic Medicine, bridges the gap<br />

between research and medicine by translating genetic<br />

discoveries into clinical testing, including expanding<br />

current disease areas and developing new content for<br />

clinical use on next-generation technologies.<br />

■ Leica Microsystems Corp ........................ 824<br />

Tel: 800-248-0123/800-248-0123<br />

Email: info@leica-microsystems.com<br />

URL: http://www.leica-microsystems.com<br />

■ LGC Genomics/Kbioscience .................. 1125<br />

Tel: 978-232-9430<br />

Email: bonnie.alvarado@lgcgenomics.com<br />

URL: http://www.kbioscience.co.uk/<br />

|http://www.lgc.co.uk/divisions/lgc_genomi<br />

LGC Genomics, now incorporating KBioscience,<br />

<strong>of</strong>fers a powerful array <strong>of</strong> products and services for<br />

nucleic acid extraction, genotyping, and sequencing.<br />

Our novel PCR-based KASP genotyping chemistry<br />

<strong>of</strong>fers superb data quality, maximum flexibility,<br />

and tremendous cost savings versus competing<br />

technologies. Please visit our booth to learn more!<br />

■ Life Technologies ...................................... 601<br />

Tel: 760-603-7200<br />

URL: http://www.lifetechnologies.com<br />

Life Technologies Corporation (NASDAQ: LIFE) is a<br />

global biotechnology company dedicated to moving<br />

science forward to improve life in meaningful ways<br />

for everyone. Our premier brands are the most cited,<br />

most trusted in the life sciences industry: Invitrogen,<br />

Applied Biosystems, Gibco, Molecular Probes,<br />

Novex, TaqMan, Ambion, and Ion Torrent.<br />

■ McGraw-Hill............................................. 1521<br />

Tel: 877-840-2297<br />

Email: digitalsales@mhedu.com<br />

URL: http://www.ommbid.com<br />

As one <strong>of</strong> the world’s premier medical publishers,<br />

McGraw Hill provides geneticists, researchers,<br />

educators, and students with access to OMMBID,<br />

the unparalleled online resource for genetic<br />

contribution to health and disease, as well as<br />

information for the broader medical world.<br />

Visit: www.ommbid.com, www.accessmedicine.com,<br />

and www.accesspediatrics.com to learn more.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ MetaSystems .......................................... 1303<br />

Tel: 617-924-9950/888-489-9959<br />

Email: hwhitney@metasystems.org<br />

URL: http://www.metasystems.org<br />

MetaSystems provides fast, easy-to-use genetic<br />

imaging and high-throughput slide scanning systems:<br />

ikaros for automatic karyotyping, isis for FISH<br />

imaging, CGH, mFISH, high resolution color and<br />

banding analysis, metafer for fully automatic slide<br />

analysis, spot counting, rare cell detection, metaphase<br />

search, array analysis, XCyte DNA probes. Please<br />

visit our website www.metasystems.org<br />

■ Microsonic Systems Inc. .......................... 618<br />

Tel: 408-844-4980<br />

Email: sales@microsonics.com<br />

URL: http://www.microsonics.com<br />

Microsonic Systems Inc. develops acoustics-based<br />

instruments for a broad base <strong>of</strong> life science sample<br />

prep applications. The high-throughput Microsonics<br />

ST300 system with patented ultrasonic technology<br />

provides high quality fragments for NGS; parallel<br />

sample processing and automation maximizes walkaway<br />

time with upgrade path to meet growing needs.<br />

Learn more at www.microsonics.com.<br />

■ MRC-Holland ........................................... 1122<br />

Tel: 31 20 489 1248<br />

Email: info@mlpa.com<br />

URL: http://www.mlpa.com<br />

MRC-Holland is the company that produces and<br />

develops SALSA MLPA probemixes that can be<br />

used for the analysis <strong>of</strong> copy number changes and<br />

methylation status <strong>of</strong> genomic sequences in a wide<br />

variety <strong>of</strong> inherited diseases as well as in tumors.<br />

■ Myriad Genetic Laboratories ................. 1501<br />

Tel: 801-505-5192/800-469-7423<br />

Email: sphillip@myriad.com<br />

URL: http://www.myriadpro.com<br />

Myriad <strong>Genetics</strong> is a leading molecular diagnostic<br />

company dedicated to making a difference in patients<br />

lives through the discovery and commercialization<br />

<strong>of</strong> transformative tests to assess a persons risk <strong>of</strong><br />

developing disease, guide treatment decisions and<br />

assess risk <strong>of</strong> disease progression and recurrence.<br />

■ NanoString Technologies, Inc. ................. 210<br />

Tel: 206-378-6266/888-358-6266<br />

Email: info@nanostring.com<br />

URL: http://www.nanostring.com<br />

NanoString Technologies is a privately held life<br />

sciences company marketing a complete solution for<br />

detecting and counting large sets <strong>of</strong> target molecules<br />

in biological samples.


■ Natera ........................................................ 504<br />

Tel: 650-249-9090 ext 357<br />

Email: ksong@natera.com<br />

URL: http://www.natera.com<br />

Natera provides reproductive genetic tests using<br />

bioinformatics in combination with sequencing<br />

technologies. Tests include preimplantation genetic<br />

diagnosis (PGD) for IVF, rapid turnaround molecular<br />

karyotyping <strong>of</strong> products <strong>of</strong> conception, non-invasive<br />

prenatal paternity testing, and non-invasive prenatal<br />

testing.<br />

■ National Center for Biotechnology<br />

Information ................................................... 224<br />

Tel: 301-496-2475<br />

Email: info@ncbi.nlm.nih.gov<br />

URL: http://www.ncbi.nlm.nih.gov<br />

NCBI provides integrated access to DNA and protein<br />

sequence data, associated mapping data, protein<br />

structures, and MEDLINE. Demonstrations <strong>of</strong> the<br />

GenBank database, the Entrez retrieval system,<br />

PubMed for MEDLINE searching, BLAST and VAST<br />

similarity searches for sequence and structures, and<br />

the BankIt and Sequin sequence submission s<strong>of</strong>tware<br />

will be provided.<br />

■ National <strong>Human</strong> Genome Research<br />

Institute ........................................................ 825<br />

Tel: 301-402-0911<br />

Email: mccrimmono@mail.nih.gov<br />

URL: http://www.genome.gov<br />

The National <strong>Human</strong> Genome Research Institute<br />

(NHGRI) led the National Institutes <strong>of</strong> Health’s (NIH)<br />

contribution to the International <strong>Human</strong> Genome<br />

Project. The human genomed was succesfully<br />

sequenced in 2003. Now, the NHGRI’s mission has<br />

expanded to encompass a broad range <strong>of</strong> studies<br />

aimed at understanding the structure and function <strong>of</strong><br />

the human genome and its role in health and disease.<br />

■ Nature Publishing Group .......................... 500<br />

Tel: 212-726-9200<br />

Email: institutions@us.nature.com<br />

URL: http://www.nature.com<br />

The NPG portfolio combines the excellence <strong>of</strong><br />

Nature its associated research and review journals,<br />

and leading academic and society journals in the<br />

life, physical and clinical sciences. Open access<br />

options are <strong>of</strong>fered through the academic and society<br />

journals, Nature Communications and through<br />

a new fully open access publication: Scientific<br />

Reports<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 289<br />

■ New England Biolabs, Inc. ....................... 904<br />

Tel: 978-380-7388<br />

Email: shnider@neb.com<br />

URL: http://www.neb.com<br />

NEB leads the industry in the discovery and<br />

production <strong>of</strong> enzymes for molecular biology<br />

applications including sample preparation for nextgeneration<br />

sequencing. NEB’s global reputation<br />

for manufacturing products <strong>of</strong> the highest quality<br />

coupled with best in class technical support makes<br />

NEB a first choice for customers demanding<br />

optimized reagents for advanced technologies.<br />

■ NextGxDx ................................................... 411<br />

Tel: 615-236-4569<br />

Email: kmcknight@nextgxdx.com<br />

URL: http://www.nextgxdx.com<br />

NextGxDx is a web-based genetic diagnostics<br />

platform, allowing hospitals and physicians to identify<br />

appropriate genetic tests and cross-reference<br />

multiple laboratories. Enabling physicians to research<br />

tests by patient symptoms, instantly compare<br />

tests across laboratories, and determine existing<br />

relationships, NextGxDx provides physicians with<br />

a single destination for discovering, comparing and<br />

ordering tests.<br />

■ Norgen Biotek Corp. ................................. 208<br />

Tel: 905-227-8848/1-866-667-4362<br />

Email: info@norgenbiotek.com<br />

URL: http://www.norgenbiotek.com<br />

Norgen is an innovative biotechnology company<br />

specializing in sample collection, preservation and<br />

preparation kits. We provide RNA, microRNA, DNA<br />

and protein isolation and clean-up kits based on a<br />

proprietary technology. Norgen also supplies the<br />

most extensive range <strong>of</strong> saliva and urine collection,<br />

concentration and isolation products available to<br />

meet a wide range <strong>of</strong> applications.<br />

■ NVIGEN .................................................... 1403<br />

Tel: 408-830-9988<br />

Email: info@nvigen.com<br />

URL: http://www.nvgien.com<br />

NVIGEN <strong>of</strong>fers customizable nanoparticle services<br />

and prepackaged nanoparticle reagents for research<br />

and industry needs. Our bioentity-conjugated<br />

nanoparticles, with magnetic and optical properties,<br />

provide efficient performance for genomic purification<br />

& extraction, co-immunoprecipitation, molecular and<br />

cell separation, targeted delivery and imaging. Our IP<br />

holds tremendous potential for high-sensitivity,<br />

high-throughput platforms and partnerships alike.<br />

EXHIBITORS


290 EXHIBITORS<br />

■ NXT-Dx ..................................................... 1025<br />

Tel: 32 92650252<br />

Email: maarten.braspenning@nxt-dx.com<br />

URL: http://www.nxt-dx.com<br />

NXT-Dx is a privately owned epigenetics company,<br />

providing methylation and small RNA analysis<br />

services to epigenetics researchers worldwide.<br />

Our services include MBD-based genome-wide<br />

DNA methylation sequencing, bisulfite sequencing,<br />

miRNA and/or lncRNA expression pr<strong>of</strong>iling and RNA<br />

sequencing. We <strong>of</strong>fer full-scope service from sample<br />

shipment, pre-processing, sequencing/RT-QPCR,<br />

bio-informatics to results visualization.<br />

■ Office <strong>of</strong> Rare Diseases Research (NIH) ..... 326<br />

Tel: 301-402-4336/888-205-2311<br />

Email: ordr@mail.nih.gov<br />

URL: http://rarediseases.info.nih.gov<br />

The Office <strong>of</strong> Rare Diseases Research (ORDR)<br />

supports and coordinates rare disease research,<br />

responds to research opportunities and provides<br />

information on rare diseases. ORDR serves the needs<br />

<strong>of</strong> patients who have any one <strong>of</strong> the thousands <strong>of</strong> rare<br />

diseases known today. ORDR coordinates and fosters<br />

relationships with patient advocacy groups to academic<br />

institutions as well as other NIH Institutes and Centers.<br />

■ Omixon Biocomputing .................................205<br />

Tel: 36 705748001<br />

Email: attila.berces@omixon.com,<br />

boglarka.fekete@omixon.com<br />

URL: http://www.omixon.com<br />

Omixon provides s<strong>of</strong>tware for next-generation<br />

sequencing data analysis with its flagship product<br />

Omixon Target. Omixon Target was designed with<br />

the vision <strong>of</strong> assisting diagnostics laboratories to<br />

adapt NGS technologies. The underlying mapping,<br />

alignment and variant calling algorithms are intended<br />

to meet the high precision and analysis quality control<br />

requirements <strong>of</strong> diagnostics labs.<br />

■ OpGen, Inc ............................................... 1124<br />

Tel: 301-869-9683<br />

Email: jmacemon@opgen.com<br />

URL: http://www.opgen.com<br />

OpGen, Inc. provides whole genome analysis<br />

systems and services for sequence assembly, strain<br />

typing and comparative genomics applications.<br />

Genomics research and public health labs use<br />

OpGen’s technology to produce high-resolution,<br />

ordered, restriction maps from single DNA molecules<br />

that provide a comprehensive view <strong>of</strong> genomic<br />

architecture. Learn more at www.OpGen.com<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ Otogenetics Corporation ......................... 827<br />

Tel: 855-686-4363/855-686-4363<br />

Email: sales@otogenetics.com<br />

Otogenetics Corporation based in suburb <strong>of</strong><br />

Atlanta, GA specializes in <strong>of</strong>fering high coverage<br />

sequencing for panels <strong>of</strong> disease genes or<br />

pathway-focused genes (e.g., whole exome <strong>of</strong><br />

various species, deafness genes, cancer genes,<br />

cardiomyopathy genes, etc.) and apply NGS for<br />

RNA-Seq and pr<strong>of</strong>iling <strong>of</strong> epigenetic modifications<br />

<strong>of</strong> genomic DNA.<br />

■ Oxford Gene Technology .......................... 302<br />

Tel: 44 (0)1865 856800<br />

Email: contact@ogt.co.uk<br />

URL: http://www.ogt.co.uk<br />

OGTs CytoSure range <strong>of</strong> aCGH products provides<br />

the complete array solution for constitutional<br />

and cancer cytogenetics: from high resolution<br />

oligonucleotide arrays, including the ISCA designs<br />

and the new cancer +SNP combination array using<br />

OGTs proprietary SNP chemistry, to optimized<br />

labeling kits and cytogenetically focused analysis and<br />

interpretation s<strong>of</strong>tware.<br />

■ Oxford Nanopore Technologies Ltd ........ 418<br />

Tel: 44 845 034 7900<br />

Email: info@nanoporetech.com<br />

URL: http://www.nanoporetech.com<br />

Oxford Nanopore Technologies is developing the<br />

electronic devices GridION and MinION for the direct<br />

analysis <strong>of</strong> single molecules including DNA, RNA/<br />

miRNA and proteins. Please visit exhibition booth to<br />

find out more. www.nanoporetech.com<br />

■ Oxford University Press.......................... 1200<br />

Tel: 800-451-7556<br />

Email: custserv.us@oup.com<br />

URL: http://www.oup.com/us<br />

Oxford University Press publishes some <strong>of</strong> the most<br />

respected genetics books and journals in the world,<br />

including <strong>Human</strong> Molecular <strong>Genetics</strong>. Our booth will<br />

feature Common Malformations, by Lewis Holmes<br />

and Achieving Justice in Genomic Translation, edited<br />

by Burke, et al., and the rest <strong>of</strong> Oxford’s leading<br />

books in genetics.


■ Pacific Biosciences .................................. 610<br />

Tel: 650-521-8003<br />

Email: info@pacificbiosciences.com<br />

URL: http://www.pacificbiosciences.com/<br />

The PacBio RS, a high resolution genetic analyzer,<br />

helps scientists solve genetically complex problems.<br />

Based on single-molecule, real-time (SMRT)<br />

technology, it enables: targeted sequencing to<br />

comprehensively characterize genetic variations;<br />

de novo genome assembly to identify, annotate<br />

and decipher genomic structures; and DNA base<br />

modification identification to help characterize<br />

epigenetic regulation.<br />

■ Palmyra S<strong>of</strong>tware.................................... 1519<br />

Tel: 510-423-3144<br />

Email: info@palmyras<strong>of</strong>tware.com<br />

URL: http://www.palmyras<strong>of</strong>tware.com<br />

Palmyra S<strong>of</strong>tware develops visual s<strong>of</strong>tware to<br />

automate computational analysis <strong>of</strong> high-throughput<br />

data, focusing on NGS sequencing data. The<br />

s<strong>of</strong>tware enables biologists and bioinformaticians<br />

alike to easily organize multiple analysis runs,<br />

from execution to results files. The s<strong>of</strong>tware also<br />

encourages efficiency <strong>of</strong> computational resources,<br />

re-using workflows and tracing history <strong>of</strong> results.<br />

■ Partek Incorporated ............................... 1307<br />

Tel: 314-878-2329<br />

Email: tsilber@partek.com<br />

URL: http://www.partek.com<br />

Partek provides s<strong>of</strong>tware for next-generation<br />

sequencing, microarray, and qPCR data analysis<br />

and visualization that empowers biologists to find<br />

biological meaning within their data. With an intuitive<br />

interface designed for researchers, Partek’s complete<br />

solution takes raw data to statistical and pathway<br />

analysis that allows true multi omics integration.<br />

■ PerkinElmer, Inc. Life Sciences &<br />

Technology ................................................. 1325<br />

Tel: 203-925-4602/800-762-4000<br />

Email: CustomerCareUS@perkinelmer.com<br />

URL: http://www.PerkinElmer.com<br />

PerkinElmer’s Life Sciences & Technology division<br />

<strong>of</strong>fers a wide range <strong>of</strong> automation and detection<br />

solutions for genomics and cellular imaging,<br />

including state-<strong>of</strong>-the art micr<strong>of</strong>luidics, lab<br />

automation and liquid handling systems for NGS<br />

supported by the Geospiza informatics platform.<br />

Visit us at booth 1325.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 291<br />

■ Pfizer ........................................................ 1511<br />

Tel: 212-733-2323<br />

Email: sandra.kusek@pfizer.com<br />

URL: http://www.pfizer.com<br />

At Pfizer, we apply science and our global<br />

resources to improve health and well-being at<br />

every stage <strong>of</strong> life. Every day, Pfizer colleagues<br />

work across developed and emerging markets<br />

to advance wellness, prevention, treatments and<br />

cures that challenge the most feared diseases <strong>of</strong><br />

our time.<br />

■ Phalanx Biotech Group ............................ 307<br />

Tel: 650-320-8669<br />

Email: info@onearray.com<br />

Phalanx Biotech Group provides genomic<br />

products and services worldwide to academic,<br />

pharmaceutical, biotech, and clinical research<br />

communities. Our expertise in expression pr<strong>of</strong>iling<br />

and genetic analysis stems from our excellence<br />

as an ODM <strong>of</strong> OneArray ® gene expression<br />

microarrays, CytoOneArray ® targeted chromosomal<br />

microarrays, and comprehensive knowledge<br />

developed as an application-focused service<br />

provider.<br />

■ PhenX Toolkit ............................................ 125<br />

Tel: 919-541-6954<br />

Email: hmp@rti.org<br />

URL: http://www.phenxtoolkit.org<br />

The PhenX Toolkit is a web-based catalog that<br />

<strong>of</strong>fers high-priority measures for consideration<br />

and inclusion in genome-wide association studies<br />

(GWAS) and large-scale genomic research efforts.<br />

With the Toolkit, investigators can identify highquality,<br />

standard measures to add to a new or<br />

ongoing study, and will simplify comparisons<br />

across studies.<br />

■ The PMD Foundation, Inc......................... 324<br />

Tel: 302-383-7748<br />

Email: PMDChair@pmdfoundation.org<br />

URL: http://www.pmdfoundation.org<br />

The PMD Foundation is a 501(c)3 non-pr<strong>of</strong>it<br />

organization formed to make a world where there<br />

is no Pelizaeus Merzbacher Disease. We do this by<br />

raising awareness and serving: PMD Children and<br />

their Families, the General Public, the Researchers<br />

and the Clinicians.<br />

EXHIBITORS


292 EXHIBITORS<br />

■ POSSUM - Murdoch Childrens Research<br />

Institute ........................................................ 218<br />

Tel: 61 3 83416277<br />

Email: possum@mcri.edu.au<br />

URL: http://www.possum.net.au.<br />

POSSUMweb is a dysmorphology database. NEW<br />

RELEASE fully web-based version, with free-text<br />

search, greater inter-activity, even use on your<br />

ipad. Assists clinicians in diagnosing syndromes in<br />

patients, using traits and images. Useful teaching<br />

tool, around 4000 syndromes including multiple<br />

malformations, chromosomal abnormalities,<br />

skeletal dysplasias, metabolic disorders, extensive<br />

trait atlas.<br />

■ Prevention<strong>Genetics</strong> LLC ........................ 1318<br />

Tel: 715-387-0484<br />

Email: s.samuels@preventiongenetics.com<br />

URL: http://www.preventiongenetics.com<br />

Prevention<strong>Genetics</strong> <strong>of</strong>fers Next-Gen, Clinical<br />

DNA Testing and DNA Banking services. We <strong>of</strong>fer<br />

clinical sequencing tests for over 500 genes.<br />

Our experienced team <strong>of</strong> geneticists provide fast<br />

turnaround times, outstanding personalized service,<br />

and the most reasonable prices in the industry. Our<br />

lab is fully CLIA accredited. To learn more visit www.<br />

preventiongenetics.com.<br />

■ Progeny S<strong>of</strong>tware, LLC ............................ 518<br />

Tel: 561-859-0773/800-776-4369<br />

Email: info@progenygenetics.com<br />

URL: http://www.progenygenetics.com<br />

Since 1996, Progeny has been the pedigree data<br />

management s<strong>of</strong>tware <strong>of</strong> choice for over 1900 sites<br />

in over 78 countries. Now available, an online Family<br />

History Questionnaire that integrates into your EMR,<br />

or any system. Sample tracking and genotype data<br />

management s<strong>of</strong>tware also available. See a demo at<br />

Booth 518.<br />

■ Prognosys Biosciences, Inc. .................... 304<br />

Tel: 858-459-2428<br />

Email: info@prognosysbio.com<br />

URL: http://www.prognosysbio.com<br />

Sequensys, a division <strong>of</strong> Prognosys Biosciences,<br />

<strong>of</strong>fers next-generation sequencing services. These<br />

now include MiSeq services, Voila! study-level RNA-<br />

Seq analysis, and Rivia target enrichment kits.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ Promega Corporation ............................. 1405<br />

Tel: 608-274-4330<br />

Email: mary.oconnell@promega.com<br />

URL: http://www.promega.com<br />

Promega Corporation is a world leader in applying<br />

molecular biology and biochemistry to the<br />

development <strong>of</strong> innovative, high value products for<br />

the life sciences. Stop by our booth to learn about<br />

our latest solutions for nucleic acid purification from<br />

blood and other sample types as well as products for<br />

qPCR and RT-qPCR.<br />

■ Pubget, Inc. ............................................. 1520<br />

Tel: 800-584-1899<br />

Email: marketing@pubget.com<br />

URL: http://www.pubget.com<br />

Pubget develops cloud-based content access tools<br />

for researchers. The core product, Pubget.com,<br />

is a site for legally finding and directly retrieving<br />

research papers. Pubget.com provides access to<br />

content for over 500 libraries worldwide. Pubget’s<br />

corporate services include marketing solutions,<br />

such as display advertising, API and textmining<br />

solutions.<br />

■ Public Library <strong>of</strong> Science ....................... 1606<br />

Tel: 415-568-3172<br />

Email: cassadi@plos.org<br />

URL: http://www.plos.org<br />

Public Library <strong>of</strong> Science (PLOS) is a nonpr<strong>of</strong>it<br />

open access publisher, membership, and advocacy<br />

organization with a mission to accelerate progress in<br />

science and medicine by leading a transformation in<br />

research communication.<br />

■ QIAGEN Inc. ............................................. 1001<br />

Tel: 800-426-8157/800-426-8157<br />

Email: customercare-us@qiagen.com<br />

URL: http://www.qiagen.com<br />

QIAGEN is the leading global provider <strong>of</strong> sample<br />

and assay technologies that are used to transform<br />

biological materials into valuable molecular<br />

information. QIAGEN markets more than 500<br />

products around the world, selling both consumable<br />

kits and automation systems to four customer<br />

classes: Academia, Applied Testing, Pharma , and<br />

Molecular Diagnostics.


■ RainDance Technologies, Inc. ................. 910<br />

Tel: 781-861-6300<br />

Email: marketing@raindancetech.com<br />

URL: http://www.RainDanceTech.com<br />

RainDance Technologies, the Digital Biology<br />

Company, is pioneering the use <strong>of</strong> high-throughput<br />

picodroplet-based analysis in human health and life<br />

science research. The complete RainDance solution<br />

includes automated instrumentation, customizable<br />

bioinformatics and high-value consumables and<br />

reagents for next-generation DNA sequencing and<br />

digital PCR applications.<br />

■ Rare Disease Therapeutics, Inc. ............. 419<br />

Tel: 615-399-0700<br />

Email: tpodgorski@raretx.com<br />

URL: http://www.raretx.com<br />

Rare Disease Therapeutics, Inc. is Americas first<br />

exclusively orphan drug company committed to<br />

developing and marketing drugs for rare disorders.<br />

RDT is dedicated to patients with unmet medical<br />

needs that have been overlooked by other<br />

pharmaceutical companies and distributes Orfadin ®<br />

(nitisinone) for hereditary tyrosinemia type I and<br />

Cystadane ® (betaine anhydrous for oral solution) for<br />

homocystinuria.<br />

■ Recombine LLC ........................................ 525<br />

Tel: 646-470-7422<br />

Email: alex@recombine.com<br />

URL: http://www.recombine.com<br />

Recombine is a clinical genetic testing company. We<br />

provide an integrated service covering everything<br />

from sample collection to patient counseling. We<br />

leverage new and powerful genotyping technologies<br />

to provide state-<strong>of</strong>-the-art, comprehensive and cost<br />

effective diagnostics. We simplify the genetic testing<br />

process so you can focus on caring for your patients.<br />

■ Roche Applied Science ............................ 701<br />

Tel: 317-521-4468<br />

Email: heather.easterling@roche.com<br />

URL: http://www.roche-applied-science.com<br />

Roche Applied Science supplies an extensive<br />

portfolio <strong>of</strong> instruments and kits to support<br />

translational research. Our enabling technologies<br />

include the LightCycler 480 Instrument, MagNA<br />

Pure 96 Instrument, and custom qPCR assays.<br />

We also provide solutions for targeted sequencing,<br />

including the GS Junior and GS FLX Systems, and<br />

NimbleGen sequence capture.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 293<br />

■ Rubicon Genomics, Inc. ........................... 803<br />

Tel: 734-368-1705<br />

Email: langmore@rubicongenomics.com<br />

URL: http://www.rubicongenomics.com<br />

Rubicon provides proprietary ThruPLEX, OmniPLEX,<br />

and PicoPLEX kits for the most rapid, sensitive<br />

and reproducible preparation <strong>of</strong> clinical samples<br />

(including single cells, plasma, FFPE-tissue<br />

and immunoprecipitates). Kits for research and<br />

diagnostics are available from Rubicon, distributors,<br />

and OEM partners for genetic, epigenetic, and<br />

expression analysis using NGS, arrays and PCR.<br />

■ RUCDR ..................................................... 1102<br />

Tel: 732-445-1027 x40058<br />

Email: jmckiml@dls.rutgers.edu<br />

URL: http://www.rucdr.org<br />

By utilizing a technologically advanced infrastructure<br />

and the highest quality biomaterials, RUCDR has<br />

become a world leader in support <strong>of</strong> genetics<br />

research. RUCDR scientists work to convert<br />

precious biosamples into renewable resources<br />

thereby extending research capabilities. We <strong>of</strong>fer<br />

comprehensive biobanking, sequencing, nucleic acid<br />

and functional analytics and stem cell services.<br />

■ Sage Science Inc. ................................... 1510<br />

Tel: 888-744-2244<br />

Email: alex@sagescience.com<br />

URL: http://www.sagescience.com<br />

Sage Science manufactures the Pippin Prep and<br />

BluePippin DNA size selection systems for NGS<br />

library construction. An automated alternative manual<br />

gel purification, the platform uses pre-cast agarose<br />

gel cassettes collects sized DNA fragments in buffer.<br />

In addition to savings in time and effort, Pippin-sized<br />

libraries provide superior sequencing results.<br />

■ Sanford Research ..................................... 325<br />

Tel: 605-312-6413<br />

Email: liz.donohue@sanfordhealth.org<br />

URL: http://www.sanfordresearch.org/cords<br />

Here at Sanford Research, we are committed to<br />

finding cures and advancing therapies into rare<br />

diseases. To further this mission, we established the<br />

Coordination <strong>of</strong> Rare Diseases at Sanford (CoRDS) —<br />

a national rare disease registry designed to accelerate<br />

research into these rare conditions. CoRDS collects<br />

and stores basic contact and clinical information on<br />

individuals <strong>of</strong> any age who have been diagnosed<br />

with a rare disease (undiagnosed individuals are also<br />

eligible for enrollment).<br />

EXHIBITORS


294 EXHIBITORS<br />

■ SCC S<strong>of</strong>t Computer ................................ 1618<br />

Tel: 727-789-0100<br />

Email: sales@s<strong>of</strong>tcomputer.com<br />

URL: http://www.s<strong>of</strong>tcomputer.com<br />

SCC S<strong>of</strong>t Computer’s comprehensive genetics<br />

information management suite <strong>of</strong>fers a full range <strong>of</strong><br />

genetics tools to automate workflow in the laboratory.<br />

This suite <strong>of</strong>fers a selection <strong>of</strong> Cytogenetics,<br />

Molecular, Flow Cytometry, HLA (immunogenetics),<br />

Diagnostic Pathology, and Biochemistry systems that<br />

are highly configurable and allow for unique, userdefined<br />

protocols.<br />

■ Science/AAAS ......................................... 1312<br />

Tel: 202-326-6417/800-731-4939<br />

Email: membership@aaas.org<br />

URL: http://www.aaas.org<br />

Since 1848, AAAS and its members have worked<br />

together to advance science and serve society. As<br />

part <strong>of</strong> these efforts, AAAS publishes Science, a<br />

multidisciplinary peer-reviewed journal, and <strong>of</strong>fers<br />

programs focused on science policy, international<br />

cooperation, science education, diversity, and career<br />

development for scientists.<br />

■ SciGene ...................................................... 619<br />

Tel: 408-733-7337/800-342-2119<br />

Email: custserv@scigene.com<br />

URL: http://www.scigene.com/<br />

SciGene equipment automates the complex, tedious<br />

benchwork required to process DNA microarrays<br />

for CMA testing. Starting with patient DNA,<br />

specialized instruments perform labeling through<br />

post-hybridization processing; producing consistently<br />

high quality arrays ready for scanning. SciGene<br />

automation boosts productivity, lowering costs,<br />

reducing re-test rates and standardizing tests for<br />

more reliable results.<br />

■ Sequenom, Inc. ......................................... 519<br />

Tel: 858-202-9000<br />

Email: aloria@sequenom.com<br />

URL: http://www.sequenom.com<br />

Sequenom <strong>of</strong>fers instrumentation and reagents for<br />

highly sensitive, robust nucleic acid detection. Cited<br />

in >1,500 publications, the MassARRAY System<br />

has proven its utility for genetic analysis and GWAS<br />

validation. The system <strong>of</strong>fers high-throughput, costeffective<br />

validation <strong>of</strong> somatic mutations and other<br />

biomarkers downstream <strong>of</strong> sequencing. Sequenom<br />

also <strong>of</strong>fers custom research services.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ SeqWright, Inc. .......................................... 726<br />

Tel: 713-528-4363/800-720-4363<br />

Email: admin@seqwright.com<br />

URL: http://www.seqwright.com<br />

SeqWright, Inc. is a full-service CLIA certified and<br />

GLP compliant nucleic acid technology CRO focused<br />

on traditional and next-generation sequencing. The<br />

companys mission is to drive scientific and medical<br />

innovation by helping to facilitate and accelerate the<br />

research, development and regulatory submission<br />

efforts <strong>of</strong> its customers.<br />

■ Seven Bridges Genomics ....................... 1204<br />

Tel: 617-714-4921<br />

Email: team@sbgenomics.com<br />

URL: http://www.sbgenomics.com<br />

The IGOR platform by Seven Bridges Genomics<br />

is a cloud computing system that enables clinical/<br />

translational researchers to manage and scale<br />

their own analysis <strong>of</strong> next-generation sequencing<br />

data. We enable whole-exome and whole-genome<br />

analysis with the leading peer-reviewed tools;<br />

scientists can apply and cite cutting-edge methods<br />

with no hardware or programming experience<br />

required.<br />

■ Shire ........................................................... 600<br />

Tel: 617-349-0200<br />

URL: http://www.shire.com<br />

Shire HGT, a business within the Shire group<br />

<strong>of</strong> companies, is committed to developing,<br />

manufacturing, and commercializing therapies for rare<br />

genetic diseases. The company achieves this through<br />

collaboration with academic researchers, physicians<br />

and patient associations, with the goal <strong>of</strong> providing<br />

therapies for patients worldwide.<br />

■ Signature Genomics from<br />

PerkinElmer ................................................ 1327<br />

Tel: 203-925-4602/800-762-4000<br />

Email: CustomerCareUS@perkinelmer.com<br />

URL: http://www.PerkinElmer.com<br />

Signature Genomics from PerkinElmer <strong>of</strong>fers<br />

whole genome microarray assessment with<br />

combined results <strong>of</strong> CNE and TA from more than<br />

1,800 oncogenes, all from one sample, using one<br />

technology. The analysis and report are provided<br />

by Signature Genomics’ OncoGlyphix ® s<strong>of</strong>tware.<br />

Signature’s Hematology Diagnosis <strong>of</strong>fering is fully<br />

validated while our Solid Tumor <strong>of</strong>fering is well into<br />

development.


■ SimulConsult, Inc. ................................... 1266<br />

Tel: 617-879-1670<br />

Email: genome@simulconsult.com<br />

URL: http://www.simulconsult.com<br />

SimulConsult provides diagnostic decision<br />

support tools for medical pr<strong>of</strong>essionals that save<br />

time. The Genome-Phenome Analyzer provides<br />

clinical correlations among patient findings, labs<br />

and annotated variant tables with SimulConsult’s<br />

manually curated, computational database <strong>of</strong><br />

diseases and their findings, and can be used<br />

for panels and WES/WGS in CLIA and research<br />

laboratories.<br />

■ S<strong>of</strong>t<strong>Genetics</strong>, LLC. .................................. 1219<br />

Tel: 814-237-9340/888-791-1270<br />

Email: info@s<strong>of</strong>tgenetics.com<br />

URL: http://www.s<strong>of</strong>tgenetics.com<br />

Featuring NextGENe s<strong>of</strong>tware for analysis <strong>of</strong> all NGS<br />

data; enhanced capabilities and functionalities added<br />

to GeneMarker and New GeneMarkerMTP, multiple<br />

template Processor. New ChimerMarker, Chimerism<br />

Analysis and long term monitoring s<strong>of</strong>tware and<br />

Mutation Surveyor s<strong>of</strong>tware for the analysis <strong>of</strong><br />

Sanger Sequences. S<strong>of</strong>t<strong>Genetics</strong> is providing<br />

demonstrations and 30-day trials.<br />

■ Sony DADC .............................................. 1411<br />

Tel: 43 (0) 6246 880-0<br />

Email: biosciences@sonydadc.com<br />

URL: http://biosciences.sonydadc.com<br />

Sony DADC, centered in Salzburg, Austria helps<br />

companies globally respond to the challenges <strong>of</strong><br />

the rapidly growing Life Sciences and IVD market<br />

by <strong>of</strong>fering OEM development as well as ISO 13485<br />

certified mass manufacturing and supply <strong>of</strong> polymerbased<br />

smart consumables (including content filling,<br />

packaging and global logistics).<br />

■ Spiral <strong>Genetics</strong> .......................................... 113<br />

Tel: 206-634-2918<br />

Email: dreesbl@spiralgenetics.com<br />

Spiral <strong>Genetics</strong> <strong>of</strong>fers three advantages for DNA<br />

sequence data analysis: speed, accuracy and scale.<br />

The company’s cloud-based bioinformatics platform<br />

is easy to access and analyze, from reads to variants,<br />

for a whole human genomes’ worth <strong>of</strong> data in<br />

3 hours.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 295<br />

■ Springer ................................................... 1211<br />

Tel: 212-460-1500/800-777-4643<br />

Email: exhibits-ny@springer.com<br />

URL: http://www.springer.com<br />

Get hands-on experience with Springer’s multiformat<br />

publishing model: print — eBook — MyCopy<br />

(printed eBooks for US$ 24.95). Our mission is to<br />

support your research. Come browse our books in<br />

your preferred format: print, online, or iPad. Ensure<br />

optimized print and electronic dissemination <strong>of</strong> your<br />

work! Get Read. Publish With Springer. http://www.<br />

springer.com<br />

■ STARLIMS ................................................ 1400<br />

Tel: 954-964-8663<br />

Email: sales@starlims.com<br />

URL: http://www.starlims.com<br />

STARLIMS has nearly 25 years <strong>of</strong> experience working<br />

with hundreds <strong>of</strong> laboratories in the clinical and<br />

diagnostic sectors. STARLIMS solutions are based<br />

on the same award-winning platform that has helped<br />

laboratories around the world achieve their analytical,<br />

regulatory and business objectives. Its unified webbased<br />

platform includes LIMS, ELN and SDMS.<br />

■ Streck ....................................................... 1600<br />

Tel: 800-843-0912<br />

Email: custserv@streck.com<br />

URL: http://www.streck.com<br />

Streck develops and manufactures products for<br />

clinical and research laboratories. Streck’s core<br />

technology is cell stabilization, and the pioneering<br />

research has led to the development <strong>of</strong> a number<br />

<strong>of</strong> patented products for use in hematology,<br />

immunology and flow cytometry. Streck’s<br />

innovative products include blood collection tubes<br />

and molecular diagnostic products.<br />

■ SurModics ............................................... 1006<br />

Tel: 952-500-7000<br />

Email: bsmith@surmodics.com<br />

URL: http://www.surmodicsivd.com<br />

SurModics IVD <strong>of</strong>fers protein stabilizers for<br />

immunoassays, conjugates, and microarrays (all<br />

with BSA-free versions), blocking reagents, BioFX<br />

colorimetric and chemiluminescent substrates,<br />

secondary antibodies, and several accessory<br />

reagents, autoimmune and infectious disease<br />

antigens from Diarect AG, activated microarray slides,<br />

and custom in vitro diagnostic surface chemistries.<br />

EXHIBITORS


296 EXHIBITORS<br />

■ SwitchGear Genomics .............................. 305<br />

Tel: 650-323-6763<br />

Email: rinis@switchgeargenomics.com<br />

SwitchGear Genomics <strong>of</strong>fers a full, simplified<br />

luciferase-based reporter assay solution with<br />

18,000 human promoter reporters, 12,000 3’UTR<br />

reporters, validated inducible promoters, synthetic<br />

response elements, and optimized reagents to study<br />

gene regulation as it occurs in living cells. Utilizing a<br />

novel synthetic luciferase gene with industry-leading<br />

brightness, the LightSwitch System measures the<br />

impact <strong>of</strong> transcript regulation and translational<br />

efficiency in cell-based systems.<br />

■ Tecan .......................................................... 405<br />

Tel: 919-361-5200/800-352-5128<br />

Email: claire.rhodes@tecan.com<br />

URL: http://www.tecan.com<br />

Tecan is a leading global provider <strong>of</strong> laboratory<br />

instruments and solutions. The company specializes<br />

in the development, production and distribution<br />

<strong>of</strong> instruments and automated workflow solutions<br />

for laboratories in the life sciences sector. Its<br />

clients include pharmaceutical and biotechnology<br />

companies, university research departments, forensic<br />

and diagnostic laboratories.<br />

■ Therapeutics for Rare and Neglected<br />

Diseases .......................................................220<br />

Tel: 301-827-2533<br />

Email: trnd@mail.nih.gov<br />

URL: http://trnd.nih.gov<br />

The Therapeutics for Rare and Neglected<br />

Diseases (TRND) program is an effort to encourage<br />

and speed the development <strong>of</strong> new drugs for rare and<br />

neglected diseases. TRND provides an opportunity<br />

to gain access to rare and neglected disease drug<br />

development capabilities, expertise, and clinical/<br />

regulatory resources in a collaborative environment.<br />

■ Thermo Scientific ...................................... 624<br />

Tel: 800-678-5599<br />

Email: info@nanodrop.com<br />

URL: http://www.thermoscientific.com<br />

Demand Thermo Scientific products to accelerate<br />

discovery and move science forward. The Thermo<br />

Scientific portfolio includes a broad array <strong>of</strong><br />

high-quality instruments, reagents, laboratory<br />

consumables, equipment, and services designed to<br />

help you run your laboratory at peak performance,<br />

from start to finish. See the entire Thermo Scientific<br />

lineup at www.thermoscientific.com<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

■ Time Logic ................................................. 426<br />

Tel: 760-431-1263/877-222-9543<br />

Email: tlsales@activemotif.com<br />

URL: http://www.timelogic.com/<br />

About TimeLogic For the past 15 years, TimeLogic<br />

has been providing high-throughput computing<br />

solutions for the bioinformatics community. Our<br />

FPGA-based DeCypher systems deliver industryleading<br />

price to performance and provide faster<br />

results and lower operational costs than alternative<br />

solutions. Find out more and schedule your own<br />

benchmark tests at www.timelogic.com<br />

■ Transgenomic, Inc. ................................... 505<br />

Tel: 402-452-5400/888-813-7253<br />

Email: info@transgenomic.com<br />

URL: http://www.transgenomic.com<br />

Transgenomic, Inc. advances personalized<br />

medicine in cancer and inherited diseases through<br />

proprietary technologies and clinical and research<br />

services. Transgenomic has three divisions:<br />

Diagnostic Tools produces equipment, reagents, and<br />

consumables for molecular testing and cytogenetics.<br />

Pharmacogenomic Services supports oncology<br />

preclinical and clinical trials. Clinical Laboratories<br />

provides molecular diagnostics.<br />

■ trinean ...................................................... 1605<br />

Tel: 00 3292727535<br />

Email: tony.montoye@trinean.com<br />

URL: http://www.trinean.com<br />

Trinean <strong>of</strong>fers the DropSense96 platform for<br />

high throughput and label-free DNA-RNAprotein<br />

quantification. This micr<strong>of</strong>luidic-based<br />

reader performs UV/VIS scans on 96 droplets (2l)<br />

within 5 minutes. In-depth spectral analysis by<br />

the innovative cDrop s<strong>of</strong>tware allows specific<br />

quantification by defining the spectral contribution <strong>of</strong><br />

the target molecule and co-purified substances within<br />

samples.<br />

■ UAB Medical Genomics Laboratory ........ 320<br />

Tel: 205-934-5562<br />

Email: medgenomics@uab.edu<br />

URL: http://www.genetics.uab.edu/medgenomics<br />

The Medical Genomics Laboratory (MGL) is a<br />

CAP-certified, non-pr<strong>of</strong>it clinical laboratory at the<br />

University <strong>of</strong> Alabama at Birmingham, <strong>of</strong>fering<br />

comprehensive testing for common and rare genetic<br />

disorders. The MGL specializes in testing for all forms<br />

<strong>of</strong> the neur<strong>of</strong>ibromatoses, including NF1, Legius<br />

syndrome, NF2, segmental NF, spinal NF, NF-Noonan<br />

and schwannomatosis.


■ UCLA Clinical Genomics Center ............. 923<br />

Tel: 310-775-5884<br />

Email: scwebb@mednet.ucla.edu<br />

URL: http://www.pathology.ucla.edu/genomics<br />

The comprehensive services <strong>of</strong> the UCLA Clinical<br />

Genomics Center, performed within CLIA-certified<br />

and CAP-accredited laboratories, include an<br />

extensive menu <strong>of</strong> genetic and genomic testing<br />

for hereditary disorders (including whole exome<br />

sequencing), cancer diagnosis and management,<br />

and genetic counseling. Other areas <strong>of</strong> expertise<br />

include Sanger sequencing, FISH diagnostics, and<br />

chromosomal microarray.<br />

■ The University <strong>of</strong> Chicago Genetic<br />

Services ........................................................409<br />

Tel: 773-834-0555/888-824-3637<br />

Email: ucgslabs@genetics.uchicago.edu<br />

URL: http://dnatesting.uchicago.edu<br />

Our laboratory is committed to high quality genetic<br />

diagnostics and translational research toward the<br />

development <strong>of</strong> tests for orphan diseases. Our<br />

focus is neurodevelopmental disorders. Some<br />

<strong>of</strong> our services include genetic testing for brain<br />

malformation syndromes, microcephaly, epileptic<br />

encephalopathy and Cornelia de Lange syndrome.<br />

■ University <strong>of</strong> Southern California,<br />

Information Sciences Institute ...................226<br />

Tel: 310-822-1511<br />

Email: arens@isi.edu<br />

The University <strong>of</strong> Southern California’s Information<br />

Sciences Institute and the University <strong>of</strong> North<br />

Carolina, Chappel Hill, funded by NHLBI’s Phenotype<br />

Finder IN Data Resources (PFINDR) program, are<br />

developing advanced informatics approaches to<br />

categorize and correlate phenotypic measures across<br />

multiple datasets to improve data reuse and facilitate<br />

novel discoveries.<br />

■ USB products from Affymetrix ................. 925<br />

Tel: 216-765-5000/800-321-9322<br />

Email: usbcustomerservice<br />

@affymetrix.com<br />

URL: http://usb.affymetrix.com<br />

Affymetrix ® , Inc. <strong>of</strong>fers a broad line <strong>of</strong> USB ®<br />

molecular biology products and biochemicals for all<br />

<strong>of</strong> your research needs. Choose from ExoSAP-IT ®<br />

reagent for PCR cleanup, VeriQuest qPCR Master<br />

Mixes, DNA polymerases, PrepEase ® purification<br />

products for DNA, RNA, and protein purification,<br />

modifying enzymes, cloning kits, nucleotides, and<br />

more. Visit usb.affymetrix.com.<br />

= First time exhibitor<br />

Shaded = Meeting Supporter<br />

EXHIBITORS 297<br />

■ V&P Scientific, Inc. .................................. 1425<br />

Tel: 858-455-0643/800-455-0644<br />

Email: sales@vp-scientific.com<br />

URL: http://www.vp-scientific.com<br />

V&Ps 96, 384 and 1536 pin tools transfer nanoliter<br />

through microliter volumes to microplates, agar,<br />

membranes, glass slides. Unique stirring systems<br />

for mixing in microplates and reservoirs keep cells,<br />

particulates and magnetic beads in suspension for<br />

pipetting. Hand-Held Magnetc Bead Separation<br />

Blocks for rapid manual separation and washing in<br />

microplates.<br />

■ Wiley - Blackwell ..................................... 1203<br />

Tel: 201-748-6000<br />

Email: info@wiley.com<br />

URL: http://www.wiley.com<br />

Wiley-Blackwell is the international scientific,<br />

technical, medical and scholarly publishing business<br />

<strong>of</strong> John Wiley & Sons, with strengths in every major<br />

academic and pr<strong>of</strong>essional field and partnerships<br />

with many <strong>of</strong> the world’s leading societies. For more<br />

information, please visit www.wileyblackwell.com or<br />

http://onlinelibrary.wiley.com/<br />

■ Zymo Research Corporation ................... 400<br />

Tel: 949-679-1190/888-882-9682<br />

Email: ssanchez@zymoresearch.com<br />

URL: http://www.zymoresearch.com<br />

Since 1994, Zymo Research has been <strong>of</strong>fering<br />

innovative, quality, and easy-to-use tools for<br />

Epigenetics research and DNA/RNA purification. As<br />

“The Epigenetics Company” Zymo Research is an<br />

industry leader in epigenetic product and service<br />

development. Our products are well known for their<br />

quality, affordability, efficiency, and unparalleled<br />

technical and customer support.<br />

EXHIBITORS


The Heart <strong>of</strong> the Exhibit Hall<br />

Get Answers at the <strong>ASHG</strong> Membership booth<br />

Meet your Editors at the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> booth<br />

Learn about Boston, the destination for <strong>ASHG</strong> 2013<br />

Meet <strong>Society</strong> Leadership<br />

Sit down in our seating area<br />

Recharge your electronics<br />

Network Net with colleagues<br />

Central


96- AND 384-WELL TRACKING DEVICE/<br />

PIPETTING AID<br />

Embi Tec .............................................................. 1406<br />

ACCOUNTING & FINANCIAL SERVICES<br />

FASEB ................................................................. 1700<br />

AFFINITY-PURIFIED SECONDARY ANTIBODIES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Epigentek Group Inc. ........................................... 1127<br />

SurModics ........................................................... 1006<br />

AFFYMETRIX CHIP RESEQUENCING ANALYSIS<br />

JSI medical systems GmbH ................................ 1023<br />

AGAROSE<br />

Affymetrix, Inc. ...................................................... 918<br />

USB products from Affymetrix .............................. 925<br />

AGG MAPPING<br />

ASURAGEN, INC. .................................................. 503<br />

ALLELE SPECIFIC EXPRESSION ANALYSIS<br />

EpigenDx ............................................................... 721<br />

ALPHA FETO-PROTEIN TESTING (AFP)<br />

ARUP Laboratories .............................................. 1518<br />

ALZHEIMER TESTING SERVICES<br />

Athena Diagnostics ............................................. 1308<br />

ANALYTICAL SERVICES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Expression Analysis ............................................... 508<br />

Genformatic ......................................................... 1420<br />

Golden Helix, Inc. .................................................. 818<br />

Knome, Inc. ......................................................... 1007<br />

RUCDR ................................................................ 1102<br />

Seven Bridges Genomics .................................... 1204<br />

ARM PROBES<br />

MetaSystems ....................................................... 1303<br />

ASSOCIATION<br />

BC Platforms Ltd ................................................... 819<br />

FASEB ................................................................. 1700<br />

Golden Helix, Inc. .................................................. 818<br />

<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />

ASSOCIATION MANAGEMENT SERVICES<br />

FASEB ................................................................. 1700<br />

AUTOIMMUNE ANTIGENS<br />

SurModics ........................................................... 1006<br />

AUTOMATED GENETIC ANALYSIS<br />

INSTRUMENTATION<br />

Advanced Analytical ............................................ 1304<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

PRODUCT AND SERVICE INDEX<br />

299<br />

Beckman Coulter, Inc. ......................................... 1601<br />

BioNano Genomics, Inc. ....................................... 924<br />

Diagenode Inc ....................................................... 406<br />

Genformatic ......................................................... 1420<br />

Innopsys ................................................................ 805<br />

Labcyte Inc. ......................................................... 1402<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

NanoString Technologies, Inc................................ 210<br />

Pacific Biosciences ............................................... 610<br />

RainDance Technologies, Inc. ............................... 910<br />

RUCDR ................................................................ 1102<br />

Sequenom, Inc. ..................................................... 519<br />

AUTOMATED KARYOTYPING<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

AUTOMATED LIQUID HANDLING WORKSTATIONS<br />

Agilent Technologies ............................................. 609<br />

Beckman Coulter, Inc. ......................................... 1601<br />

Diagenode Inc ....................................................... 406<br />

Labcyte Inc. ......................................................... 1402<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

AUTOMATED NUCLEIC ACID PURIFICATION<br />

INSTRUMENTATION<br />

AutoGen, Inc. ........................................................ 807<br />

Beckman Coulter, Inc. ......................................... 1601<br />

chemagen from PerkinElmer ............................... 1426<br />

IntegenX Inc. ....................................................... 1311<br />

RUCDR ................................................................ 1102<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

BAC DNA ISOLATION<br />

AutoGen, Inc. ........................................................ 807<br />

chemagen from PerkinElmer ............................... 1426<br />

EdgeBio ............................................................... 1506<br />

Epicentre (an Illumina company) ......................... 1218<br />

SeqWright, Inc. ...................................................... 726<br />

Zymo Research Corporation ................................. 400<br />

BACTERIAL ELECTROPORATION SYSTEMS<br />

Bio-Rad ................................................................. 524<br />

BAR CODE<br />

Data Unlimited International, Inc. ........................ 1503<br />

BIOCHEMICAL ANALYSES<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Greenwood Genetic Center ................................. 1027<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Tecan ..................................................................... 405<br />

PRODUCT INDEX


300 PRODUCT AND SERVICE INDEX<br />

BIOCHEMICAL REAGENTS<br />

Affymetrix, Inc. ...................................................... 918<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Epicentre (an Illumina company) ......................... 1218<br />

Epigentek Group Inc. ........................................... 1127<br />

Gene Tools, LLC .................................................. 1401<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Roche Applied Science ......................................... 701<br />

USB products from Affymetrix .............................. 925<br />

BIOCHEMICALS<br />

Affymetrix, Inc. ...................................................... 918<br />

Gene Tools, LLC .................................................. 1401<br />

SurModics ........................................................... 1006<br />

USB products from Affymetrix .............................. 925<br />

BIOINFORMATICS<br />

Gene Codes Corporation .................................... 1310<br />

BIOLOGICALS<br />

Alexion Pharmaceuticals ..................................... 1410<br />

SurModics ........................................................... 1006<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

BIOMARKERS<br />

Exiqon ................................................................. 1712<br />

BIOMATERIALS<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

Diagenode Inc ....................................................... 406<br />

RUCDR ................................................................ 1102<br />

BIOTINYLATED ANTIBODIES<br />

Epigentek Group Inc. ........................................... 1127<br />

SurModics ........................................................... 1006<br />

BISULFITE SEQUENCING<br />

NXT-Dx ................................................................ 1025<br />

BLOOD DNA PURIFICATION<br />

AutoGen, Inc. ........................................................ 807<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

Embi Tec .............................................................. 1406<br />

Gene Link, Inc ....................................................... 627<br />

RUCDR ................................................................ 1102<br />

Zymo Research Corporation ................................. 400<br />

BLOTTING EQUIPMENT<br />

Bio-Rad ................................................................. 524<br />

BLOTTING MEMBRANES<br />

Bio-Rad ................................................................. 524<br />

BOOKS, JOURNALS, AND ELECTRONIC<br />

PUBLICATIONS<br />

Cold Spring Harbor Laboratory Press ................. 1209<br />

BOOKS, JOURNALS, ENCYCLOPEDIAS,<br />

PUBLICATIONS<br />

<strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> ................... 913<br />

Cold Spring Harbor Laboratory Press ................. 1209<br />

Elsevier ................................................................ 1210<br />

FASEB ................................................................. 1700<br />

Greenwood Genetic Center ................................. 1027<br />

<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />

Karger Publishers ................................................ 1208<br />

Oxford University Press ....................................... 1200<br />

Springer ............................................................... 1211<br />

BUCCAL DNA PURIFICATION<br />

AutoGen, Inc. ........................................................ 807<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

RUCDR ................................................................ 1102<br />

Tecan ..................................................................... 405<br />

Zymo Research Corporation ................................. 400<br />

CANCER GENE PANELS<br />

SeqWright, Inc. ...................................................... 726<br />

cDNA<br />

Bioline USA Inc. ................................................... 1324<br />

chemagen from PerkinElmer ............................... 1426<br />

Epicentre (an Illumina company) ......................... 1218<br />

Gene Link, Inc ....................................................... 627<br />

IntegenX Inc. ....................................................... 1311<br />

QIAGEN Inc. ........................................................ 1001<br />

SeqWright, Inc. ...................................................... 726<br />

Thermo Scientific................................................... 624<br />

cDNA LIBRARIES<br />

Agilent Technologies ............................................. 609<br />

BioReliance ........................................................... 604<br />

IntegenX Inc. ....................................................... 1311<br />

SeqWright, Inc. ...................................................... 726<br />

Thermo Scientific................................................... 624<br />

CELL BANKING<br />

BioReliance ........................................................... 604<br />

RUCDR ................................................................ 1102<br />

CELL CULTURE MEDIA<br />

Applied StemCell, Inc. ........................................... 527<br />

Irvine Scientific ...................................................... 620<br />

Life Technologies ................................................... 601<br />

CELL CULTURES<br />

Applied StemCell, Inc. ........................................... 527<br />

BioReliance ........................................................... 604<br />

Coriell Institute for Medical Research ................... 312<br />

RUCDR ................................................................ 1102<br />

CELL DISRUPTORS<br />

Diagenode Inc ....................................................... 406


CELL SEPARATION EQUIPMENT<br />

Diagenode Inc ....................................................... 406<br />

CELLULAR IMAGING<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

CELLULAR ISOLATION PRODUCTS<br />

NVIGEN ............................................................... 1403<br />

CHARACTERIZATION<br />

SeqWright, Inc. ...................................................... 726<br />

CHEMICALS<br />

USB products from Affymetrix .............................. 925<br />

CHEMILUMINESCENCE SYSTEMS<br />

Gene Link, Inc ....................................................... 627<br />

SurModics ........................................................... 1006<br />

CHIP PRODUCTS<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Covaris Inc. ......................................................... 1008<br />

Diagenode Inc ....................................................... 406<br />

Innopsys ................................................................ 805<br />

IntegenX Inc. ....................................................... 1311<br />

Oxford Gene Technology ....................................... 302<br />

Recombine LLC ..................................................... 525<br />

RUCDR ................................................................ 1102<br />

Sony DADC ......................................................... 1411<br />

trinean .................................................................. 1605<br />

CHIP-SEQ<br />

Axeq Technologies ................................................ 820<br />

CHROMATIN IMMUNOPRECIPITATION<br />

PRODUCTS<br />

Diagenode Inc ....................................................... 406<br />

CHROMATOGRAPHY WORKSTATIONS<br />

Transgenomic, Inc. ................................................ 505<br />

CHROMOSOMAL ABERRATIONS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

BioDiscovery, Inc. .................................................. 813<br />

Cartagenia ........................................................... 1022<br />

GeneDx ................................................................ 1119<br />

MetaSystems ....................................................... 1303<br />

MRC-Holland ....................................................... 1122<br />

Oxford Gene Technology ....................................... 302<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

RUCDR ................................................................ 1102<br />

Seven Bridges Genomics .................................... 1204<br />

Signature Genomics from PerkinElmer ............... 1327<br />

CHROMOSOMAL ANEUPLOIDY SCREENING<br />

Ariosa Diagnostics ............................................... 1609<br />

CHROMOSOMAL MICROARRAY<br />

UCLA Clinical Genomics Center ........................... 923<br />

PRODUCT AND SERVICE INDEX 301<br />

CHROMOSOME ANALYSES<br />

Affymetrix, Inc. ...................................................... 918<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Ariosa Diagnostics ............................................... 1609<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

BlueGnome Limited ............................................... 209<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Golden Helix, Inc. .................................................. 818<br />

Greenwood Genetic Center ................................. 1027<br />

Knome, Inc. ......................................................... 1007<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

NanoString Technologies, Inc................................ 210<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Phalanx Biotech Group ......................................... 307<br />

RUCDR ................................................................ 1102<br />

Seven Bridges Genomics .................................... 1204<br />

Signature Genomics from PerkinElmer ............... 1327<br />

Transgenomic, Inc. ................................................ 505<br />

CHROMOSOME ENUMERATOR PROBES<br />

Abbott Molecular ................................................... 625<br />

Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />

CHROMOSOME IN SITU SYSTEMS<br />

MetaSystems ....................................................... 1303<br />

CHROMOSOME PAINTING SYSTEMS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

CLINICAL TRIAL SUPPORT<br />

SeqWright, Inc. ...................................................... 726<br />

CLONING PRODUCTS<br />

Agilent Technologies ............................................. 609<br />

Bioline USA Inc. ................................................... 1324<br />

EdgeBio ............................................................... 1506<br />

Embi Tec .............................................................. 1406<br />

Epicentre (an Illumina company) ......................... 1218<br />

New England Biolabs, Inc. .................................... 904<br />

USB products from Affymetrix .............................. 925<br />

CMA AUTOMATION EQUIPMENT<br />

SciGene ................................................................. 619<br />

COLUMNS<br />

Transgenomic, Inc. ................................................ 505<br />

COMPETITIVE GENOMIC HYBRIDIZATION<br />

INSTRUMENT<br />

Affymetrix, Inc. ...................................................... 918<br />

MetaSystems ....................................................... 1303<br />

Tecan ..................................................................... 405<br />

COMPUTER SOFTWARE<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BC Platforms Ltd ................................................... 819<br />

Biobase Corporation ........................................... 1319<br />

PRODUCT INDEX


302 PRODUCT AND SERVICE INDEX<br />

BioDiscovery, Inc. .................................................. 813<br />

Cartagenia ........................................................... 1022<br />

CLC bio ................................................................. 501<br />

Data Unlimited International, Inc. ........................ 1503<br />

Enlis Genomics ...................................................... 203<br />

Gene Codes Corporation .................................... 1310<br />

GeneInsight ......................................................... 1224<br />

Genformatic ......................................................... 1420<br />

Golden Helix, Inc. .................................................. 818<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Innopsys ................................................................ 805<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

JSI medical systems GmbH ................................ 1023<br />

Knome, Inc. ......................................................... 1007<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

Omixon Biocomputing .......................................... 205<br />

Oxford Gene Technology ....................................... 302<br />

Palmyra S<strong>of</strong>tware ................................................ 1519<br />

Partek Incorporated............................................. 1307<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

SCC S<strong>of</strong>t Computer ............................................ 1618<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

CONFOCAL SCANNER<br />

Innopsys ................................................................ 805<br />

CONTRACT RESEARCH SYNTHESIS<br />

Knome, Inc. ......................................................... 1007<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

COURSES & CONFERENCES<br />

European <strong>Human</strong> <strong>Genetics</strong> Conference 2013 ....... 219<br />

Science/AAAS ..................................................... 1312<br />

CULTURED CELLS<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

CUSTOM ANTIBODIES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

SurModics ........................................................... 1006<br />

CUSTOM CDNA LIBRARIES<br />

BioReliance ........................................................... 604<br />

SeqWright, Inc. ...................................................... 726<br />

CUSTOM CLONING SERVICE<br />

SeqWright, Inc. ...................................................... 726<br />

CUSTOM DNA PROBES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />

Gene Link, Inc ....................................................... 627<br />

MetaSystems ....................................................... 1303<br />

CUSTOMIZED OLIGOS<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Gene Link, Inc ....................................................... 627<br />

Gene Tools, LLC .................................................. 1401<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

CUSTOM LABORATORY WORKFLOW SYSTEMS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

GeneInsight ......................................................... 1224<br />

CUSTOM MEDIA SERVICES<br />

Irvine Scientific ...................................................... 620<br />

CUSTOM MONOCLONAL ANTIBODY SERVICE<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

CUSTOM MUTATION ANALYSIS<br />

UCLA Clinical Genomics Center ........................... 923<br />

CUSTOM SHOTGUN LIBRARIES<br />

SeqWright, Inc. ...................................................... 726<br />

CUSTOM TARGETED SEQUENCING<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

CUVETTES - ELECTROPORATION<br />

Bio-Rad ................................................................. 524<br />

CYTOGENETIC ANALYZER<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BioNano Genomics, Inc. ....................................... 924<br />

Illumina, Inc. ........................................................ 1109<br />

Leica Microsystems Corp ...................................... 824<br />

Oxford Gene Technology ....................................... 302<br />

Tecan ..................................................................... 405<br />

Transgenomic, Inc. ................................................ 505<br />

CYTOGENETIC TESTING<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

GeneDx ................................................................ 1119<br />

Greenwood Genetic Center ................................. 1027<br />

Innopsys ................................................................ 805<br />

Leica Microsystems Corp ...................................... 824<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Phalanx Biotech Group ......................................... 307<br />

SciGene ................................................................. 619<br />

Signature Genomics from PerkinElmer ............... 1327<br />

Transgenomic, Inc. ................................................ 505<br />

UCLA Clinical Genomics Center ........................... 923<br />

DATABASE MANAGEMENT - CLINICAL GENETICS<br />

BC Platforms Ltd ................................................... 819<br />

Cartagenia ........................................................... 1022<br />

Data Unlimited International, Inc. ........................ 1503<br />

GeneInsight ......................................................... 1224<br />

Genformatic ...............................................................1420<br />

Genial Genetic Solutions/Rainbow<br />

Scientific, Inc. ...................................................... 402<br />

GenoLogics ......................................................... 1105<br />

Interactive Bios<strong>of</strong>tware .......................................... 413


MetaSystems ....................................................... 1303<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

RUCDR ................................................................ 1102<br />

SCC S<strong>of</strong>t Computer ............................................ 1618<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

DATABASE MANAGEMENT - CYTOGENETICS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BC Platforms Ltd ................................................... 819<br />

Cartagenia ........................................................... 1022<br />

Data Unlimited International, Inc. ........................ 1503<br />

Genial Genetic Solutions/Rainbow Scientific, Inc. .....402<br />

MetaSystems ....................................................... 1303<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

SCC S<strong>of</strong>t Computer ............................................ 1618<br />

Signature Genomics from PerkinElmer ............... 1327<br />

DATABASE MANAGEMENT - MOLECULAR<br />

GENETICS<br />

BC Platforms Ltd ................................................... 819<br />

Cartagenia ........................................................... 1022<br />

Data Unlimited International, Inc. ........................ 1503<br />

Genformatic ......................................................... 1420<br />

Genial Genetic Solutions/Rainbow Scientific, Inc. .....402<br />

GenoLogics ......................................................... 1105<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

Laboratory for Molecular Medicine, PCPGM ...... 1225<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

SCC S<strong>of</strong>t Computer ............................................ 1618<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

DATABASE OF BIOTECHNOLOGY JOBS<br />

Science/AAAS ..................................................... 1312<br />

DATABASE PROTEOMICS<br />

Biobase Corporation ........................................... 1319<br />

DATABASES - GENE MAPPING<br />

BC Platforms Ltd ................................................... 819<br />

Biobase Corporation ........................................... 1319<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Knome, Inc. ......................................................... 1007<br />

RUCDR ................................................................ 1102<br />

DATABASES - GENETIC COUNSELING<br />

Natera .................................................................... 504<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

DATABASES - GENETIC ORGANIZATIONS<br />

Natera .................................................................... 504<br />

NextGxDx .............................................................. 411<br />

Sanford Research .................................................. 325<br />

DATABASES - GENETIC TESTING<br />

Biobase Corporation ........................................... 1319<br />

Data Unlimited International, Inc. ........................ 1503<br />

GeneInsight ......................................................... 1224<br />

GeneTests ............................................................ 1413<br />

PRODUCT AND SERVICE INDEX 303<br />

Genformatic ......................................................... 1420<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

MetaSystems ....................................................... 1303<br />

Natera .................................................................... 504<br />

DATABASES - LABORATORIES<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Cartagenia ........................................................... 1022<br />

Data Unlimited International, Inc. ........................ 1503<br />

GeneTests ............................................................ 1413<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

MetaSystems ....................................................... 1303<br />

Natera .................................................................... 504<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

DATABASES - PHENOTYPE/DISEASE<br />

DESCRIPTIONS<br />

BC Platforms Ltd ................................................... 819<br />

Enlis Genomics ...................................................... 203<br />

GeneInsight ......................................................... 1224<br />

GeneTests ............................................................ 1413<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

Knome, Inc. ......................................................... 1007<br />

POSSUM - Murdoch Childrens Research Institute .....218<br />

Sanford Research .................................................. 325<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

DATA COORDINATING CENTER (DCC)<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

DENSITOMETERS<br />

Bio-Rad ................................................................. 524<br />

DIAGNOSTIC AIDS<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

MRC-Holland ....................................................... 1122<br />

POSSUM - Murdoch Childrens Research Institute ...218<br />

Rubicon Genomics, Inc. .......................................... 803<br />

SurModics ........................................................... 1006<br />

DIAGNOSTIC SYSTEMS<br />

Abbott Molecular ................................................... 625<br />

Exiqon ................................................................. 1712<br />

Gene Link, Inc ....................................................... 627<br />

Innopsys ................................................................ 805<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

QIAGEN Inc. ........................................................ 1001<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Signature Genomics from PerkinElmer ............... 1327<br />

DIRECT LABELED PROBES<br />

BlueGnome Limited ............................................... 209<br />

MetaSystems ....................................................... 1303<br />

DISPENSERS<br />

Labcyte Inc. ......................................................... 1402<br />

Tecan ..................................................................... 405<br />

PRODUCT INDEX


304 PRODUCT AND SERVICE INDEX<br />

DNA AMPLIFICATION EQUIPMENT<br />

Agilent Technologies ............................................. 609<br />

Bio-Rad ................................................................. 524<br />

BlueGnome Limited ............................................... 209<br />

Natera .................................................................... 504<br />

QIAGEN Inc. ........................................................ 1001<br />

RainDance Technologies, Inc. ............................... 910<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Streck .................................................................. 1600<br />

DNA ANALYSES<br />

Agilent Technologies ............................................. 609<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Athena Diagnostics ............................................. 1308<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

BioDiscovery, Inc. .................................................. 813<br />

BioFire Diagnostics ............................................... 719<br />

Bioline USA Inc. ................................................... 1324<br />

BioNano Genomics, Inc. ....................................... 924<br />

Bio-Rad ................................................................. 524<br />

BioReliance ........................................................... 604<br />

BlueGnome Limited ............................................... 209<br />

Cartagenia ........................................................... 1022<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

CLC bio ................................................................. 501<br />

Connective Tissue Gene Tests .............................. 718<br />

DNAnexus, Inc. ...................................................... 507<br />

EdgeBio ............................................................... 1506<br />

Enlis Genomics ...................................................... 203<br />

Expression Analysis ............................................... 508<br />

Gene Codes Corporation .................................... 1310<br />

Golden Helix, Inc. .................................................. 818<br />

Greenwood Genetic Center ................................. 1027<br />

IntegenX Inc. ....................................................... 1311<br />

JSI medical systems GmbH ................................ 1023<br />

Knome, Inc. ......................................................... 1007<br />

MetaSystems ....................................................... 1303<br />

MRC-Holland ....................................................... 1122<br />

Myriad Genetic Laboratories ............................... 1501<br />

NanoString Technologies, Inc................................ 210<br />

Natera .................................................................... 504<br />

Omixon Biocomputing .......................................... 205<br />

Pacific Biosciences ............................................... 610<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Phalanx Biotech Group ......................................... 307<br />

Prognosys Biosciences, Inc. ................................. 304<br />

QIAGEN Inc. ........................................................ 1001<br />

RainDance Technologies, Inc. ............................... 910<br />

Recombine LLC ..................................................... 525<br />

RUCDR ................................................................ 1102<br />

Sequenom, Inc. ..................................................... 519<br />

SeqWright, Inc. ...................................................... 726<br />

Seven Bridges Genomics .................................... 1204<br />

Signature Genomics from PerkinElmer ............... 1327<br />

Transgenomic, Inc. ................................................ 505<br />

trinean .................................................................. 1605<br />

UCLA Clinical Genomics Center ........................... 923<br />

DNA CUSTOM SYNTHESIS<br />

Gene Link, Inc ....................................................... 627<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

SeqWright, Inc. ...................................................... 726<br />

DNA DAMAGE DETECTION PRODUCTS<br />

MetaSystems ....................................................... 1303<br />

DNA FINGERPRINTING<br />

BioReliance ........................................................... 604<br />

IntegenX Inc. ....................................................... 1311<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

UCLA Clinical Genomics Center ........................... 923<br />

DNA ISOLATION KITS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

AutoGen, Inc. ........................................................ 807<br />

Bioline USA Inc. ................................................... 1324<br />

chemagen from PerkinElmer ............................... 1426<br />

Diagenode Inc ....................................................... 406<br />

DNA Genotek ........................................................ 900<br />

Epicentre (an Illumina company) ......................... 1218<br />

Epigentek Group Inc. ........................................... 1127<br />

Gene Link, Inc ....................................................... 627<br />

Life Technologies ................................................... 601<br />

NVIGEN ............................................................... 1403<br />

Roche Applied Science ......................................... 701<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Zymo Research Corporation ................................. 400<br />

DNA LABELING PRODUCTS<br />

BioNano Genomics, Inc. ....................................... 924<br />

BlueGnome Limited ............................................... 209<br />

Gene Link, Inc ....................................................... 627<br />

MetaSystems ....................................................... 1303<br />

Oxford Gene Technology ....................................... 302<br />

SciGene ................................................................. 619<br />

DNA MARKERS<br />

Bioline USA Inc. ................................................... 1324<br />

BioReliance ........................................................... 604<br />

Embi Tec .............................................................. 1406<br />

Natera .................................................................... 504<br />

New England Biolabs, Inc. .................................... 904<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

QIAGEN Inc. ........................................................ 1001<br />

Transgenomic, Inc. ................................................ 505<br />

DNA MARKERS & STAIN<br />

Affymetrix, Inc. ...................................................... 918<br />

New England Biolabs, Inc. .................................... 904<br />

DNA METHYLATION ANAYLSIS<br />

Diagenode Inc ....................................................... 406<br />

DNA METHYLATION ASSAY DESIGN AND<br />

VALIDATION<br />

EpigenDx ............................................................... 721


DNA METHYLATION CONTROLS<br />

(HUMAN, RAT, MOUSE)<br />

EpigenDx ............................................................... 721<br />

DNA MUTATION DETECTION PRODUCTS<br />

Advanced Analytical ............................................ 1304<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ASURAGEN, INC. .................................................. 503<br />

Bio-Rad ................................................................. 524<br />

Boreal Genomics ................................................... 724<br />

JSI medical systems GmbH ................................ 1023<br />

MRC-Holland ....................................................... 1122<br />

Omixon Biocomputing .......................................... 205<br />

Pacific Biosciences ............................................... 610<br />

RainDance Technologies, Inc. ............................... 910<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Seven Bridges Genomics .................................... 1204<br />

Transgenomic, Inc. ................................................ 505<br />

DNA PREPARATION<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

Coriell Institute for Medical Research ................... 312<br />

Covaris Inc. ......................................................... 1008<br />

Diagenode Inc ....................................................... 406<br />

DNA Genotek ........................................................ 900<br />

EdgeBio ............................................................... 1506<br />

Epigentek Group Inc. ........................................... 1127<br />

Expression Analysis ............................................... 508<br />

IntegenX Inc. ....................................................... 1311<br />

Microsonic Systems Inc. ....................................... 618<br />

New England Biolabs, Inc. .................................... 904<br />

Prognosys Biosciences, Inc. ................................. 304<br />

RainDance Technologies, Inc. ............................... 910<br />

RUCDR ................................................................ 1102<br />

Sage Science Inc. ................................................ 1510<br />

SciGene ................................................................. 619<br />

SeqWright, Inc. ...................................................... 726<br />

trinean .................................................................. 1605<br />

Zymo Research Corporation ................................. 400<br />

DNA PROBES<br />

Abbott Molecular ................................................... 625<br />

Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />

Gene Link, Inc ....................................................... 627<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

MRC-Holland ....................................................... 1122<br />

Oxford Gene Technology ....................................... 302<br />

Prognosys Biosciences, Inc. ................................. 304<br />

QIAGEN Inc. ........................................................ 1001<br />

DNA PURIFICATION<br />

Affymetrix, Inc. ...................................................... 918<br />

AutoGen, Inc. ........................................................ 807<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

Diagenode Inc ....................................................... 406<br />

DNA Genotek ........................................................ 900<br />

EdgeBio ............................................................... 1506<br />

Epicentre (an Illumina company) ......................... 1218<br />

PRODUCT AND SERVICE INDEX 305<br />

Expression Analysis ............................................... 508<br />

IntegenX Inc. ....................................................... 1311<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Life Technologies ................................................... 601<br />

NVIGEN ............................................................... 1403<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Sage Science Inc. ................................................ 1510<br />

SciGene ................................................................. 619<br />

SeqWright, Inc. ...................................................... 726<br />

Tecan ..................................................................... 405<br />

USB products from Affymetrix .............................. 925<br />

Zymo Research Corporation ................................. 400<br />

DNA RECOVERY DEVICES<br />

Embi Tec .............................................................. 1406<br />

Sage Science Inc. ................................................ 1510<br />

DNA SAMPLES<br />

BC Platforms Ltd ................................................... 819<br />

BioReliance ........................................................... 604<br />

Coriell Institute for Medical Research ................... 312<br />

Diagenode Inc ....................................................... 406<br />

DNA Genotek ........................................................ 900<br />

IntegenX Inc. ....................................................... 1311<br />

QIAGEN Inc. ........................................................ 1001<br />

Rubicon Genomics, Inc. ........................................ 803<br />

RUCDR ................................................................ 1102<br />

trinean .................................................................. 1605<br />

DNA SEQUENCE ANALYSIS SOFTWARE<br />

Agilent Technologies ............................................. 609<br />

BC Platforms Ltd ................................................... 819<br />

BGI ...................................................................... 1419<br />

Cartagenia ........................................................... 1022<br />

DNASTAR, Inc. ...................................................... 801<br />

Enlis Genomics ...................................................... 203<br />

Gene Codes Corporation .................................... 1310<br />

Genformatic ......................................................... 1420<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Illumina, Inc. ........................................................ 1109<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

JSI medical systems GmbH ................................ 1023<br />

Knome, Inc. ......................................................... 1007<br />

Life Technologies ................................................... 601<br />

Natera .................................................................... 504<br />

Omixon Biocomputing .......................................... 205<br />

Pacific Biosciences ............................................... 610<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Prognosys Biosciences, Inc. ................................. 304<br />

RainDance Technologies, Inc. ............................... 910<br />

Seven Bridges Genomics .................................... 1204<br />

Transgenomic, Inc. ................................................ 505<br />

DNA SEQUENCERS<br />

Diagenode Inc ....................................................... 406<br />

Illumina, Inc. ........................................................ 1109<br />

Ion Torrent ............................................................. 100<br />

Life Technologies ................................................... 601<br />

Natera .................................................................... 504<br />

PRODUCT INDEX


306 PRODUCT AND SERVICE INDEX<br />

Pacific Biosciences ............................................... 610<br />

RainDance Technologies, Inc. ............................... 910<br />

Roche Applied Science ......................................... 701<br />

DNA SEQUENCING ACCESSORIES<br />

BioNano Genomics, Inc. ....................................... 924<br />

Covaris Inc. ......................................................... 1008<br />

Diagenode Inc ....................................................... 406<br />

EdgeBio ............................................................... 1506<br />

Epicentre (an Illumina company) ......................... 1218<br />

Illumina, Inc. ........................................................ 1109<br />

IntegenX Inc. ....................................................... 1311<br />

Microsonic Systems Inc. ....................................... 618<br />

New England Biolabs, Inc. .................................... 904<br />

RainDance Technologies, Inc. ............................... 910<br />

Rubicon Genomics, Inc. ........................................ 803<br />

DNA SEQUENCING KITS<br />

Agilent Technologies ............................................. 609<br />

Diagenode Inc ....................................................... 406<br />

EdgeBio ............................................................... 1506<br />

Epicentre (an Illumina company) ......................... 1218<br />

Epigentek Group Inc. ........................................... 1127<br />

Kailos <strong>Genetics</strong>, Inc. .............................................. 310<br />

Natera .................................................................... 504<br />

Pacific Biosciences ............................................... 610<br />

Rubicon Genomics, Inc. ........................................ 803<br />

USB products from Affymetrix .............................. 925<br />

Zymo Research Corporation ................................. 400<br />

DNA SEQUENCING SERVICES<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Athena Diagnostics ............................................. 1308<br />

Axeq Technologies ................................................ 820<br />

BGI ...................................................................... 1419<br />

BioReliance ........................................................... 604<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

Complete Genomics, Inc. ...................................... 907<br />

Connective Tissue Gene Tests .............................. 718<br />

EdgeBio ............................................................... 1506<br />

Expression Analysis ............................................... 508<br />

GeneDx ................................................................ 1119<br />

Illumina, Inc. ........................................................ 1109<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Knome, Inc. ......................................................... 1007<br />

Phalanx Biotech Group ......................................... 307<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Roche Applied Science ......................................... 701<br />

SeqWright, Inc. ...................................................... 726<br />

The University <strong>of</strong> Chicago Genetic Services ......... 409<br />

DNA SEQUENCING SOLUTIONS<br />

BGI ...................................................................... 1419<br />

BioNano Genomics, Inc. ....................................... 924<br />

BioReliance ........................................................... 604<br />

CLC bio ................................................................. 501<br />

Diagenode Inc ....................................................... 406<br />

DNASTAR, Inc. ...................................................... 801<br />

EdgeBio ............................................................... 1506<br />

Epicentre (an Illumina company) ......................... 1218<br />

Expression Analysis ............................................... 508<br />

Genformatic ......................................................... 1420<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Illumina, Inc. ........................................................ 1109<br />

IntegenX Inc. ....................................................... 1311<br />

Ion Torrent ............................................................. 100<br />

Natera .................................................................... 504<br />

Pacific Biosciences ............................................... 610<br />

Prognosys Biosciences, Inc. ................................. 304<br />

RainDance Technologies, Inc. ............................... 910<br />

SeqWright, Inc. ...................................................... 726<br />

Spiral <strong>Genetics</strong> ...................................................... 113<br />

DNA SHEARING<br />

Diagenode Inc ....................................................... 406<br />

DNA SIGNING & STR ANALYSIS<br />

Genformatic ......................................................... 1420<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

SeqWright, Inc. ...................................................... 726<br />

DNA SYNTHESIS PRODUCTS<br />

Gene Link, Inc ....................................................... 627<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

QIAGEN Inc. ........................................................ 1001<br />

Rubicon Genomics, Inc. ........................................ 803<br />

DNA WORKSTATION<br />

IntegenX Inc. ....................................................... 1311<br />

Microsonic Systems Inc. ....................................... 618<br />

QIAGEN Inc. ........................................................ 1001<br />

SciGene ................................................................. 619<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

DRI BLOCK HEATER<br />

SciGene ................................................................. 619<br />

DRUG TARGET/BIOMARKER DISCOVERY AND<br />

VALIDATION<br />

SeqWright, Inc. ...................................................... 726<br />

DYES & LABELING REAGENTS<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

EBV IMMORTALIZATION<br />

RUCDR ................................................................ 1102<br />

EDUCATIONAL RESOURCES<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

Greenwood Genetic Center ................................. 1027<br />

National Center for Biotechnology Information ..... 224<br />

Office <strong>of</strong> Rare Diseases Research (NIH) ................ 326<br />

POSSUM - Murdoch Childrens Research Institute .... 218<br />

Pubget, Inc. .......................................................... 1520<br />

Science/AAAS ..................................................... 1312<br />

ELECTRONIC IMAGING SYSTEMS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Leica Microsystems Corp ...................................... 824


ELECTROPHORESIS ACCESSORIES<br />

Embi Tec .............................................................. 1406<br />

Sony DADC ......................................................... 1411<br />

ELECTROPHORESIS BUFFERS<br />

Embi Tec .............................................................. 1406<br />

SurModics ........................................................... 1006<br />

USB products from Affymetrix .............................. 925<br />

ELECTROPHORESIS EQUIPMENT<br />

Advanced Analytical ............................................ 1304<br />

Agilent Technologies ............................................. 609<br />

Bio-Rad ................................................................. 524<br />

Embi Tec .............................................................. 1406<br />

QIAGEN Inc. ........................................................ 1001<br />

Sage Science Inc. ................................................ 1510<br />

ELECTROPHORESIS PRECAST GELS<br />

Embi Tec .............................................................. 1406<br />

Sage Science Inc. ................................................ 1510<br />

EMPLOYMENT OPPORTUNITIES-CAREER<br />

RESOURCES<br />

Science/AAAS ..................................................... 1312<br />

ENZYME-CONJUGATED ANTIBODIES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Epigentek Group Inc. ........................................... 1127<br />

SurModics ........................................................... 1006<br />

ENZYME REPLACEMENT THERAPY<br />

BioMarin Pharmaceutical Inc. ............................. 1619<br />

Shire ...................................................................... 600<br />

ENZYMES<br />

Bioline USA Inc. ................................................... 1324<br />

Epicentre (an Illumina company) ......................... 1218<br />

Epigentek Group Inc. ........................................... 1127<br />

New England Biolabs, Inc. .................................... 904<br />

QIAGEN Inc. ........................................................ 1001<br />

Roche Applied Science ......................................... 701<br />

USB products from Affymetrix .............................. 925<br />

Zymo Research Corporation ................................. 400<br />

EPIGENETIC PRODUCTS<br />

Diagenode Inc ....................................................... 406<br />

EPIGENETIC SERVICES<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

EXOME SEQUENCING, TARGETED SEQUENCING<br />

Axeq Technologies ................................................ 820<br />

EXPRESSION ANALYSIS SOFTWARE<br />

BC Platforms Ltd ................................................... 819<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Sequenom, Inc. ..................................................... 519<br />

PRODUCT AND SERVICE INDEX 307<br />

FACTOR V MUTATION<br />

ARUP Laboratories .............................................. 1518<br />

FACTOR V MUTATION TESTING<br />

ARUP Laboratories .............................................. 1518<br />

Athena Diagnostics ............................................. 1308<br />

Greenwood Genetic Center ................................. 1027<br />

UCLA Clinical Genomics Center ........................... 923<br />

FAMILIAL MEDITERRANEAN FEVER<br />

UCLA Clinical Genomics Center ........................... 923<br />

FILMARRAY MULTIPLEX PCR MOLECULAR<br />

INFECTIOUS DISEASE TESTING PLATFORM<br />

BioFire Diagnostics ............................................... 719<br />

FILTERS, CUSTOM<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

FILTERS, FILTER SETS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

FILTERS, MULTICOLOR SETS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

FISH SLIDE AUTOMATION EQUIPMENT<br />

SciGene ................................................................. 619<br />

FISH SYSTEMS<br />

Abbott Molecular ................................................... 625<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

Natera .................................................................... 504<br />

SciGene ................................................................. 619<br />

Tecan ..................................................................... 405<br />

FISH TESTING<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

BlueGnome Limited ............................................... 209<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Greenwood Genetic Center ................................. 1027<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

SciGene ................................................................. 619<br />

Signature Genomics from PerkinElmer ............... 1327<br />

UCLA Clinical Genomics Center ........................... 923<br />

FLUORESCENCE IMAGE ANALYSIS EQUIPMENT<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BioNano Genomics, Inc. ....................................... 924<br />

Innopsys ................................................................ 805<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

FLUORESCENCE REPORTER DYES<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

PRODUCT INDEX


308 PRODUCT AND SERVICE INDEX<br />

FLUORESCENT ANTIBODIES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

SurModics ........................................................... 1006<br />

FLUORESCENT FILTERS<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

Tecan ..................................................................... 405<br />

FLUORESCENT IMAGING<br />

Bio-Rad ................................................................. 524<br />

Incom, Inc. ........................................................... 1300<br />

Innopsys ................................................................ 805<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

New England Biolabs, Inc. .................................... 904<br />

NVIGEN ............................................................... 1403<br />

FLUORESCENT SUBSTRATES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

FLUOROGENIC PROBES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

MetaSystems ....................................................... 1303<br />

FLUOROMETER<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

FRAGILE X TESTING<br />

ARUP Laboratories .............................................. 1518<br />

ASURAGEN, INC. .................................................. 503<br />

Athena Diagnostics ............................................. 1308<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Greenwood Genetic Center ................................. 1027<br />

Natera .................................................................... 504<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

RUCDR ................................................................ 1102<br />

Signature Genomics from PerkinElmer ............... 1327<br />

Transgenomic, Inc. ................................................ 505<br />

UCLA Clinical Genomics Center ........................... 923<br />

FREE BETA/PAPP-A SCREENING WITH NUCHAL<br />

TRANSLUCENCY (NT)<br />

ARUP Laboratories .............................................. 1518<br />

FREE BETA PRENATAL SCREENING<br />

ARUP Laboratories .............................................. 1518<br />

FREIDRICH’S ATAXIA<br />

UCLA Clinical Genomics Center ........................... 923<br />

FRET PROBES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Gene Link, Inc ....................................................... 627<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

GEL ELECTROPHORESIS EQUIPMENT<br />

Bio-Rad ................................................................. 524<br />

Diagenode Inc ....................................................... 406<br />

Embi Tec .............................................................. 1406<br />

QIAGEN Inc. ........................................................ 1001<br />

GEL READING APPARATUS<br />

Embi Tec .............................................................. 1406<br />

GENE AMPLIFICATION PROBES<br />

Gene Link, Inc ....................................................... 627<br />

Leica Microsystems Corp ...................................... 824<br />

Natera .................................................................... 504<br />

QIAGEN Inc. ........................................................ 1001<br />

Rubicon Genomics, Inc. ........................................ 803<br />

GENE EXPRESSION MICROARRAYS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

BioDiscovery, Inc. .................................................. 813<br />

Expression Analysis ............................................... 508<br />

Illumina, Inc. ........................................................ 1109<br />

Innopsys ................................................................ 805<br />

Life Technologies ................................................... 601<br />

Natera .................................................................... 504<br />

Oxford Gene Technology ....................................... 302<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Phalanx Biotech Group ......................................... 307<br />

QIAGEN Inc. ........................................................ 1001<br />

RUCDR ................................................................ 1102<br />

SeqWright, Inc. ...................................................... 726<br />

Tecan ..................................................................... 405<br />

GENE EXPRESSION PRODUCTS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

Beckman Coulter, Inc. ......................................... 1601<br />

BGI ...................................................................... 1419<br />

BioDiscovery, Inc. .................................................. 813<br />

Bio-Rad ................................................................. 524<br />

Diagenode Inc ....................................................... 406<br />

Epicentre (an Illumina company) ......................... 1218<br />

Illumina, Inc. ........................................................ 1109<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

Life Technologies ................................................... 601<br />

NanoString Technologies, Inc................................ 210<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Phalanx Biotech Group ......................................... 307<br />

QIAGEN Inc. ........................................................ 1001<br />

Roche Applied Science ......................................... 701<br />

Rubicon Genomics, Inc. ........................................ 803<br />

SciGene ................................................................. 619<br />

Sequenom, Inc. ..................................................... 519<br />

SwitchGear Genomics........................................... 305<br />

Thermo Scientific................................................... 624


GENE FUNCTION DATABASES<br />

Biobase Corporation ........................................... 1319<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

Knome, Inc. ......................................................... 1007<br />

Prognosys Biosciences, Inc. ................................. 304<br />

GENE MAPPING DATABASE<br />

BC Platforms Ltd ................................................... 819<br />

Biobase Corporation ........................................... 1319<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Illumina, Inc. ........................................................ 1109<br />

Natera .................................................................... 504<br />

GENE MAPPING PRODUCTS<br />

Illumina, Inc. ........................................................ 1109<br />

Natera .................................................................... 504<br />

Pacific Biosciences ............................................... 610<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

RUCDR ................................................................ 1102<br />

GENE SYNTHESIS<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

QIAGEN Inc. ........................................................ 1001<br />

Rubicon Genomics, Inc. ........................................ 803<br />

GENE TARGETING<br />

Applied StemCell, Inc. ........................................... 527<br />

Expression Analysis ............................................... 508<br />

Natera .................................................................... 504<br />

Omixon Biocomputing .......................................... 205<br />

QIAGEN Inc. ........................................................ 1001<br />

SeqWright, Inc. ...................................................... 726<br />

Thermo Scientific................................................... 624<br />

GENE TARGETING REAGENTS & VECTORS<br />

Applied StemCell, Inc. ........................................... 527<br />

Gene Tools, LLC .................................................. 1401<br />

Natera .................................................................... 504<br />

SwitchGear Genomics........................................... 305<br />

Thermo Scientific................................................... 624<br />

GENE THERAPY PRODUCTS<br />

Applied StemCell, Inc. ........................................... 527<br />

QIAGEN Inc. ........................................................ 1001<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

GENETICALLY ENGINEERED MICE<br />

Amicus Therapeutics, Inc. ..................................... 511<br />

GENETIC COUNSELING & SERVICES<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Greenwood Genetic Center ................................. 1027<br />

Myriad Genetic Laboratories ............................... 1501<br />

UCLA Clinical Genomics Center ........................... 923<br />

PRODUCT AND SERVICE INDEX 309<br />

GENETIC RESOURCE<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />

Natera .................................................................... 504<br />

NextGxDx .............................................................. 411<br />

POSSUM - Murdoch Childrens Research<br />

Institute ............................................................... 218<br />

GENETIC TESTING - 1A+ MYOTONIC DYSTROPHY<br />

Athena Diagnostics ............................................. 1308<br />

GENETIC TESTING - A-1 ANTITRYPSIN<br />

DEFICIENCY<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Recombine LLC ..................................................... 525<br />

GENETIC TESTING - ANGELMAN SYNDROME<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

GENETIC TESTING - APOE GENOTYPING FOR<br />

HYPERLIPIDEMIA<br />

ARUP Laboratories .............................................. 1518<br />

GENETIC TESTING - BREAST & OVARIAN<br />

Expression Analysis ............................................... 508<br />

MRC-Holland ....................................................... 1122<br />

Myriad Genetic Laboratories ............................... 1501<br />

Omixon Biocomputing .......................................... 205<br />

GENETIC TESTING - CANAVAN DISEASE<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

MRC-Holland ....................................................... 1122<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Recombine LLC ..................................................... 525<br />

GENETIC TESTING - CHARCOT-MARIE-TOOTH<br />

Athena Diagnostics ............................................. 1308<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Connective Tissue Gene Tests .............................. 718<br />

MRC-Holland ....................................................... 1122<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

GENETIC TESTING - CYSTIC FIBROSIS<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Athena Diagnostics ............................................. 1308<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

PRODUCT INDEX


310 PRODUCT AND SERVICE INDEX<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

Natera .................................................................... 504<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Recombine LLC ..................................................... 525<br />

UCLA Clinical Genomics Center ........................... 923<br />

GENETIC TESTING - DUCHENNE MUSCULAR<br />

DYSTROPHY<br />

Athena Diagnostics ............................................. 1308<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

GENETIC TESTING - FACTOR V MUTATION<br />

ARUP Laboratories .............................................. 1518<br />

Athena Diagnostics ............................................. 1308<br />

Greenwood Genetic Center ................................. 1027<br />

Recombine LLC ..................................................... 525<br />

UCLA Clinical Genomics Center ........................... 923<br />

GENETIC TESTING - FAP, DIRECT<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Myriad Genetic Laboratories ............................... 1501<br />

GENETIC TESTING - FRAGILE X<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

ASURAGEN, INC. .................................................. 503<br />

Athena Diagnostics ............................................. 1308<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Greenwood Genetic Center ................................. 1027<br />

Natera .................................................................... 504<br />

Recombine LLC ..................................................... 525<br />

UCLA Clinical Genomics Center ........................... 923<br />

GENETIC TESTING - GAUCHER DISEASE<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Recombine LLC ..................................................... 525<br />

GENETIC TESTING - GENERAL<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Connective Tissue Gene Tests .............................. 718<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Expression Analysis ............................................... 508<br />

GeneDx ................................................................ 1119<br />

Genzyme, a San<strong>of</strong>i Company ................................ 901<br />

Greenwood Genetic Center ................................. 1027<br />

Laboratory for Molecular Medicine, PCPGM ...... 1225<br />

MRC-Holland ....................................................... 1122<br />

NextGxDx .............................................................. 411<br />

Recombine LLC ..................................................... 525<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Transgenomic, Inc. ................................................ 505<br />

UCLA Clinical Genomics Center ........................... 923<br />

The University <strong>of</strong> Chicago Genetic Services ......... 409<br />

GENETIC TESTING, GENERAL, INFORMATION<br />

RESOURCE<br />

GeneTests ............................................................ 1413<br />

GENETIC TESTING - GILBERT SYNDROME<br />

Recombine LLC ..................................................... 525<br />

GENETIC TESTING - HEMOCHROMATOSIS<br />

ARUP Laboratories .............................................. 1518<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

Recombine LLC ..................................................... 525<br />

UCLA Clinical Genomics Center ........................... 923<br />

GENETIC TESTING - HEMOPHILIAS<br />

ARUP Laboratories .............................................. 1518<br />

MRC-Holland ....................................................... 1122<br />

Recombine LLC ..................................................... 525<br />

GENETIC TESTING - HNPCC, DIRECT<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

MRC-Holland ....................................................... 1122<br />

Myriad Genetic Laboratories ............................... 1501<br />

GENETIC TESTING - HNPCC-MS.I<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

GENETIC TESTING INSTRUMENTATION -<br />

ATM GENE<br />

Illumina, Inc. ........................................................ 1109<br />

GENETIC TESTING INSTRUMENTATION -<br />

BREAST CANCER<br />

Illumina, Inc. ........................................................ 1109<br />

SciGene ................................................................. 619<br />

GENETIC TESTING INSTRUMENTATION -<br />

CYSTIC FIBROSIS<br />

Illumina, Inc. ........................................................ 1109<br />

SciGene ................................................................. 619<br />

GENETIC TESTING INSTRUMENTATION -<br />

GAUCHER DISEASE<br />

Genzyme, a San<strong>of</strong>i Company ................................ 901<br />

Illumina, Inc. ........................................................ 1109


GENETIC TESTING INSTRUMENTATION -<br />

LOSS OF HETEROZYGOSITY<br />

Illumina, Inc. ........................................................ 1109<br />

GENETIC TESTING INSTRUMENTATION -<br />

MUSCULAR DYSTROPHY<br />

Illumina, Inc. ........................................................ 1109<br />

GENETIC TESTING - LISSENCEPHALY<br />

SYNDROME<br />

MRC-Holland ....................................................... 1122<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

GENETIC TESTING - NEUROFIBROMATOSIS 1,<br />

DIRECT<br />

ARUP Laboratories .............................................. 1518<br />

Athena Diagnostics ............................................. 1308<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

MRC-Holland ....................................................... 1122<br />

UAB Medical Genomics Laboratory ...................... 320<br />

GENETIC TESTING - PRADER WILLIE<br />

SYNDROME<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

GENETIC TESTING - PROTHROMBIN (FACTOR II)<br />

MUTATION<br />

ARUP Laboratories .............................................. 1518<br />

Greenwood Genetic Center ................................. 1027<br />

Recombine LLC ..................................................... 525<br />

GENETIC TESTING RESOURCE<br />

NextGxDx .............................................................. 411<br />

GENETIC TESTING - RETT SYNDROME<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

Athena Diagnostics ............................................. 1308<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

GeneDx ................................................................ 1119<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

GENETIC TESTING - SPINOCEREBELLAR<br />

ATAXIA 1<br />

Athena Diagnostics ............................................. 1308<br />

MRC-Holland ....................................................... 1122<br />

GENETIC TESTING - TAY SACHS<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ARUP Laboratories .............................................. 1518<br />

PRODUCT AND SERVICE INDEX 311<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

MRC-Holland ....................................................... 1122<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Recombine LLC ..................................................... 525<br />

GENETIC TESTING - TELOMERE DELETIONS &<br />

REARRANGEMENTS<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

GeneDx ................................................................ 1119<br />

MRC-Holland ....................................................... 1122<br />

GENETIC VARIATION SCREENING SERVICES<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Ariosa Diagnostics ............................................... 1609<br />

Connective Tissue Gene Tests .............................. 718<br />

Genformatic ......................................................... 1420<br />

Innopsys ................................................................ 805<br />

Prognosys Biosciences, Inc. ................................. 304<br />

RUCDR ................................................................ 1102<br />

GENE TRANSFER DEVICE<br />

Bio-Rad ................................................................. 524<br />

GENE TRANSFER EQUIPMENT<br />

Bio-Rad ................................................................. 524<br />

GENOMATIX SOFTWARE INC.<br />

Genomatix S<strong>of</strong>tware .............................................. 425<br />

GENOME VIEWER<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

GENOMIC ANALYSIS REAGENTS<br />

BioNano Genomics, Inc. ....................................... 924<br />

BlueGnome Limited ............................................... 209<br />

Illumina, Inc. ........................................................ 1109<br />

New England Biolabs, Inc. .................................... 904<br />

Pacific Biosciences ............................................... 610<br />

Roche Applied Science ......................................... 701<br />

Rubicon Genomics, Inc. ........................................ 803<br />

SciGene ................................................................. 619<br />

Sequenom, Inc. ..................................................... 519<br />

Thermo Scientific................................................... 624<br />

GENOMIC DNAS<br />

Advanced Analytical ............................................ 1304<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ASURAGEN, INC. .................................................. 503<br />

Bioline USA Inc. ................................................... 1324<br />

Gene Link, Inc ....................................................... 627<br />

IntegenX Inc. ....................................................... 1311<br />

New England Biolabs, Inc. .................................... 904<br />

QIAGEN Inc. ........................................................ 1001<br />

Rubicon Genomics, Inc. ........................................ 803<br />

SeqWright, Inc. ...................................................... 726<br />

GENOMIC PURIFICATION<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

PRODUCT INDEX


312 PRODUCT AND SERVICE INDEX<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

Gene Link, Inc ....................................................... 627<br />

IntegenX Inc. ....................................................... 1311<br />

Life Technologies ................................................... 601<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

SeqWright, Inc. ...................................................... 726<br />

GENOMIC PURIFICATION (DNA)<br />

Affymetrix, Inc. ...................................................... 918<br />

AutoGen, Inc. ........................................................ 807<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

Diagenode Inc ....................................................... 406<br />

DNA Genotek ........................................................ 900<br />

Epicentre (an Illumina company) ......................... 1218<br />

Epigentek Group Inc. ........................................... 1127<br />

Expression Analysis ............................................... 508<br />

Gene Link, Inc ....................................................... 627<br />

IntegenX Inc. ....................................................... 1311<br />

QIAGEN Inc. ........................................................ 1001<br />

Rubicon Genomics, Inc. ........................................ 803<br />

SciGene ................................................................. 619<br />

SeqWright, Inc. ...................................................... 726<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

Zymo Research Corporation ................................. 400<br />

GENOTYPING PRODUCTS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Bioline USA Inc. ................................................... 1324<br />

DNA Genotek ........................................................ 900<br />

Fluidigm Corporation ............................................. 725<br />

Gene Codes Corporation .................................... 1310<br />

Illumina, Inc. ........................................................ 1109<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

Innopsys ................................................................ 805<br />

IntegenX Inc. ....................................................... 1311<br />

Life Technologies ................................................... 601<br />

New England Biolabs, Inc. .................................... 904<br />

Pacific Biosciences ............................................... 610<br />

QIAGEN Inc. ........................................................ 1001<br />

Roche Applied Science ......................................... 701<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Sequenom, Inc. ..................................................... 519<br />

GENOTYPING SERVICES<br />

Affymetrix, Inc. ...................................................... 918<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

BGI ...................................................................... 1419<br />

BioReliance ........................................................... 604<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Expression Analysis ............................................... 508<br />

Illumina, Inc. ........................................................ 1109<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Prognosys Biosciences, Inc. ................................. 304<br />

QIAGEN Inc. ........................................................ 1001<br />

Recombine LLC ..................................................... 525<br />

RUCDR ................................................................ 1102<br />

SeqWright, Inc. ...................................................... 726<br />

UCLA Clinical Genomics Center ........................... 923<br />

GENOTYPING SERVICES ‘FREE GENOTYPING’<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

GWAS AND COPY NUMBER/LOH ANALYSIS<br />

EpigenDx ............................................................... 721<br />

GWAS GENOTYPING<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

HARVESTER SYSTEMS<br />

Genial Genetic Solutions/Rainbow<br />

Scientific, Inc. ..................................................... 402<br />

HEATBLOCKS<br />

SciGene ................................................................. 619<br />

HEMOCHROMATOSIS<br />

ARUP Laboratories .............................................. 1518<br />

HIGH RESOLUTION MELTING ANALYSIS<br />

SYSTEMS<br />

BioFire Diagnostics ............................................... 719<br />

HIGH RESOLUTION MELTING REAGENTS,<br />

MASTER MIXES<br />

BioFire Diagnostics ............................................... 719<br />

HIGH RESOLUTION MELTING SOFTWARE<br />

BioFire Diagnostics ............................................... 719<br />

HIGH-THROUGHPUT PRODUCTION<br />

Embi Tec .............................................................. 1406<br />

Expression Analysis ............................................... 508<br />

Illumina, Inc. ........................................................ 1109<br />

IntegenX Inc. ....................................................... 1311<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Labcyte Inc. ......................................................... 1402<br />

Microsonic Systems Inc. ....................................... 618<br />

QIAGEN Inc. ........................................................ 1001<br />

RUCDR ................................................................ 1102<br />

SciGene ................................................................. 619<br />

trinean .................................................................. 1605<br />

HLA NEXT-GENERATION SEQUENCING<br />

ANALYSIS<br />

JSI medical systems GmbH ................................ 1023<br />

HYBRIDIZATION INCUBATORS<br />

SciGene ................................................................. 619<br />

HYBRIDIZATION REAGENTS<br />

Phalanx Biotech Group ......................................... 307


IDENTIFICATION<br />

Data Unlimited International, Inc. ........................ 1503<br />

DNA Genotek ........................................................ 900<br />

IntegenX Inc. ....................................................... 1311<br />

IHC INSTRUMENTATION<br />

Leica Microsystems Corp ...................................... 824<br />

IMAGE ANALYZER<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BioDiscovery, Inc. .................................................. 813<br />

Leica Microsystems Corp ...................................... 824<br />

IMAGING PRODUCTS<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BioDiscovery, Inc. .................................................. 813<br />

Embi Tec .............................................................. 1406<br />

Incom, Inc. ........................................................... 1300<br />

Innopsys ................................................................ 805<br />

Leica Microsystems Corp ...................................... 824<br />

Roche Applied Science ......................................... 701<br />

IMMUNOASSAYS<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Diagenode Inc ....................................................... 406<br />

Leica Microsystems Corp ...................................... 824<br />

QIAGEN Inc. ........................................................ 1001<br />

IMMUNOCHEMICALS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

SurModics ........................................................... 1006<br />

IMMUNOHISTOCHEMISTRY<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

MetaSystems ....................................................... 1303<br />

SurModics ........................................................... 1006<br />

IMMUNOMAGNETIC BEADS<br />

Diagenode Inc ....................................................... 406<br />

INBORN ERRORS OF METABOLISM<br />

Amicus Therapeutics, Inc. ..................................... 511<br />

BioMarin Pharmaceutical Inc. ............................. 1619<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Greenwood Genetic Center ................................. 1027<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

INCUBATORS<br />

SciGene ................................................................. 619<br />

IND ADVICE AND PRODUCT DEVELOPMENT<br />

PLANNING<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

INFECTIOUS DISEASE ANTIGENS<br />

SurModics ........................................................... 1006<br />

PRODUCT AND SERVICE INDEX 313<br />

INFERTILITY - DELETION Y DNA ANALYSIS<br />

ARUP Laboratories .............................................. 1518<br />

Innopsys ................................................................ 805<br />

Natera .................................................................... 504<br />

INFERTILITY TREATMENT<br />

Natera .................................................................... 504<br />

INFORMATION ABOUT RESEARCH FUNDING<br />

OPPORTUNITIES<br />

CIHR Institute <strong>of</strong> <strong>Genetics</strong> ................................... 1321<br />

INFORMATION RESOURCE<br />

GeneTests ............................................................ 1413<br />

NextGxDx .............................................................. 411<br />

Office <strong>of</strong> Rare Diseases Research (NIH) ................ 326<br />

POSSUM - Murdoch Childrens Research<br />

Institute ............................................................... 218<br />

Seven Bridges Genomics .................................... 1204<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

INHIBIN<br />

ARUP Laboratories .............................................. 1518<br />

IN SITU HYBRIDIZATION ANALYSES<br />

BioReliance ........................................................... 604<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

IN SITU INSTRUMENTATION<br />

IntegenX Inc. ....................................................... 1311<br />

Leica Microsystems Corp ...................................... 824<br />

SciGene ................................................................. 619<br />

Tecan ..................................................................... 405<br />

INSTITUTIONAL & NOT-FOR-PROFIT EXHIBITORS<br />

Greenwood Genetic Center ................................. 1027<br />

Science/AAAS ..................................................... 1312<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

INTERNET-BASED INFORMATION RESOURCE<br />

Biobase Corporation ........................................... 1319<br />

GeneTests ............................................................ 1413<br />

<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />

NextGxDx .............................................................. 411<br />

Office <strong>of</strong> Rare Diseases Research (NIH) ................ 326<br />

Pubget, Inc. ......................................................... 1520<br />

Seven Bridges Genomics .................................... 1204<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

INTERPRETATION OF MEDICAL AND HEALTH<br />

IMPLICATIONS OF SNPS, INDELS, CNVS AND<br />

OTHER VARIANTS<br />

Genformatic ......................................................... 1420<br />

IN VIVO - ELECTROPORATION<br />

Applied StemCell, Inc. ........................................... 527<br />

PRODUCT INDEX


314 PRODUCT AND SERVICE INDEX<br />

ISOLATION KITS<br />

Bioline USA Inc. ................................................... 1324<br />

Epigentek Group Inc. ........................................... 1127<br />

Exiqon ................................................................. 1712<br />

New England Biolabs, Inc. .................................... 904<br />

Phalanx Biotech Group ......................................... 307<br />

QIAGEN Inc. ........................................................ 1001<br />

Zymo Research Corporation ................................. 400<br />

LAB AUTOMATION AND LIQUID HANDLING<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

LABELED STREPTAVIDIN<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

LABELS<br />

Data Unlimited International, Inc. ........................ 1503<br />

LABORATORY ANALYSIS SERVICES<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BlueGnome Limited ............................................... 209<br />

Expression Analysis ............................................... 508<br />

Leica Microsystems Corp ...................................... 824<br />

Rubicon Genomics, Inc. ........................................ 803<br />

RUCDR ................................................................ 1102<br />

STARLIMS ........................................................... 1400<br />

LABORATORY ANIMALS<br />

Applied StemCell, Inc. ........................................... 527<br />

LABORATORY DISPOSABLES<br />

Diagenode Inc ....................................................... 406<br />

LABORATORY - GENETIC TESTING & SERVICES<br />

Applied StemCell, Inc. ........................................... 527<br />

Ariosa Diagnostics ............................................... 1609<br />

ASURAGEN, INC. .................................................. 503<br />

Athena Diagnostics ............................................. 1308<br />

BlueGnome Limited ............................................... 209<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Connective Tissue Gene Tests .............................. 718<br />

Diagenode Inc ....................................................... 406<br />

DNA Genotek ........................................................ 900<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Expression Analysis ............................................... 508<br />

Gene Link, Inc ....................................................... 627<br />

Genformatic ......................................................... 1420<br />

Greenwood Genetic Center ................................. 1027<br />

JSI medical systems GmbH ................................ 1023<br />

Laboratory for Molecular Medicine, PCPGM ...... 1225<br />

Leica Microsystems Corp ...................................... 824<br />

Myriad Genetic Laboratories ............................... 1501<br />

Natera .................................................................... 504<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Rubicon Genomics, Inc. ........................................ 803<br />

RUCDR ................................................................ 1102<br />

SeqWright, Inc. ...................................................... 726<br />

Signature Genomics from PerkinElmer ............... 1327<br />

STARLIMS ........................................................... 1400<br />

Transgenomic, Inc. ................................................ 505<br />

UAB Medical Genomics Laboratory ...................... 320<br />

UCLA Clinical Genomics Center ........................... 923<br />

LABORATORY INFORMATION MANAGEMENT<br />

SYSTEM<br />

Data Unlimited International, Inc. ........................ 1503<br />

LASER CAPTURE MICRODISSECTION<br />

Life Technologies ................................................... 601<br />

Rubicon Genomics, Inc. ........................................ 803<br />

LIBRARY SCREENING SERVICES<br />

Applied StemCell, Inc. ........................................... 527<br />

Thermo Scientific................................................... 624<br />

LIQUID CULTURE MEDIA<br />

Irvine Scientific ...................................................... 620<br />

LIQUID HANDLING EQUIPMENT<br />

Embi Tec .............................................................. 1406<br />

Hamilton Company .............................................. 1613<br />

Labcyte Inc. ......................................................... 1402<br />

SciGene ................................................................. 619<br />

Tecan ..................................................................... 405<br />

LNA<br />

Exiqon ................................................................. 1712<br />

LONG NON-CODING RNA EXPRESSION<br />

PROFILING<br />

NXT-Dx ................................................................ 1025<br />

LUCIFERASE-BASED REPORTER PLASMIDS<br />

SwitchGear Genomics........................................... 305<br />

LUMINOMETER<br />

Tecan ..................................................................... 405<br />

LYSOSOMAL STORAGE DISEASES<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Amicus Therapeutics, Inc. ..................................... 511<br />

BioMarin Pharmaceutical Inc. ............................. 1619<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Genzyme, a San<strong>of</strong>i Company ................................ 901<br />

Greenwood Genetic Center ................................. 1027<br />

MACHINE LEARNING<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

MAGNETIC PARTICLES<br />

chemagen from PerkinElmer ............................... 1426<br />

MAGNETIC SEPARATORS<br />

chemagen from PerkinElmer ............................... 1426<br />

Diagenode Inc ....................................................... 406<br />

New England Biolabs, Inc. .................................... 904


MAGVIGEN | MAGNETIC NANOPARTICLES FOR<br />

GENOMIC PURIFICATION<br />

NVIGEN ............................................................... 1403<br />

MAPPING TOOLS<br />

BC Platforms Ltd ................................................... 819<br />

BGI ...................................................................... 1419<br />

Biobase Corporation ........................................... 1319<br />

BioNano Genomics, Inc. ....................................... 924<br />

Knome, Inc. ......................................................... 1007<br />

MASS SPECS<br />

Agilent Technologies ............................................. 609<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

QIAGEN Inc. ........................................................ 1001<br />

Sequenom, Inc. ..................................................... 519<br />

MBD-BASED GENOME-WIDE METHYLATION<br />

SEQUENCING<br />

NXT-Dx ................................................................ 1025<br />

MEDIA<br />

Applied StemCell, Inc. ........................................... 527<br />

Pubget, Inc. ......................................................... 1520<br />

MEDICAL JOURNALS<br />

JMG (BMJ Group) ............................................... 1103<br />

MEETING MANAGEMENT SERVICES<br />

FASEB ................................................................. 1700<br />

MEETINGS AND COURSES<br />

Cold Spring Harbor Laboratory Press ................. 1209<br />

METABOLIC STUDIES<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Greenwood Genetic Center ................................. 1027<br />

METHYLATION PCR<br />

ASURAGEN, INC. .................................................. 503<br />

METHYLOME SEQUENCING<br />

Axeq Technologies ................................................ 820<br />

M-FISH<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

MICROARRAY ANALYSIS SOFTWARE<br />

Partek Incorporated............................................. 1307<br />

MICROARRAY BIOCHIP ANALYSIS<br />

Agilent Technologies ............................................. 609<br />

Athena Diagnostics ............................................. 1308<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

Biobase Corporation ........................................... 1319<br />

BioDiscovery, Inc. .................................................. 813<br />

Coriell Institute for Medical Research ................... 312<br />

PRODUCT AND SERVICE INDEX 315<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

Innopsys ................................................................ 805<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Phalanx Biotech Group ......................................... 307<br />

Signature Genomics from PerkinElmer ............... 1327<br />

MICROARRAY CHAMBERS AND CASSETTES<br />

SciGene ................................................................. 619<br />

MICROARRAY DATA MANAGEMENT SYSTEMS -<br />

DATABASE<br />

BC Platforms Ltd ................................................... 819<br />

Biobase Corporation ........................................... 1319<br />

BioDiscovery, Inc. .................................................. 813<br />

BlueGnome Limited ............................................... 209<br />

Cartagenia ........................................................... 1022<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Signature Genomics from PerkinElmer ............... 1327<br />

MICROARRAYERS<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

MICROARRAY REAGENTS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

BlueGnome Limited ............................................... 209<br />

Epicentre (an Illumina company) ......................... 1218<br />

Illumina, Inc. ........................................................ 1109<br />

Oxford Gene Technology ....................................... 302<br />

Phalanx Biotech Group ......................................... 307<br />

QIAGEN Inc. ........................................................ 1001<br />

Roche Applied Science ......................................... 701<br />

Rubicon Genomics, Inc. ........................................ 803<br />

SurModics ........................................................... 1006<br />

MICROARRAY SCANNERS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

Illumina, Inc. ........................................................ 1109<br />

Innopsys ................................................................ 805<br />

Roche Applied Science ......................................... 701<br />

Tecan ..................................................................... 405<br />

MICROARRAY SLIDES<br />

Agilent Technologies ............................................. 609<br />

BlueGnome Limited ............................................... 209<br />

Incom, Inc. ........................................................... 1300<br />

Oxford Gene Technology ....................................... 302<br />

Phalanx Biotech Group ......................................... 307<br />

Roche Applied Science ......................................... 701<br />

Sony DADC ......................................................... 1411<br />

SurModics ........................................................... 1006<br />

MICRODELETION SYNDROME PROBES<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

MICRODISSECTION<br />

Rubicon Genomics, Inc. ........................................ 803<br />

PRODUCT INDEX


316 PRODUCT AND SERVICE INDEX<br />

MICROFLUIDICS<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

MICROPLATE FLUORESCENCE POLARIZATION<br />

READER<br />

Tecan ..................................................................... 405<br />

MICROPLATE READERS & WASHERS<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

MICROPLATES<br />

Incom, Inc. ........................................................... 1300<br />

Sony DADC ......................................................... 1411<br />

trinean .................................................................. 1605<br />

MICROPLATE WASHERS<br />

Tecan ..................................................................... 405<br />

MICRORNA<br />

Exiqon ................................................................. 1712<br />

MICRORNA ANALYSIS<br />

Phalanx Biotech Group ......................................... 307<br />

MICRORNA MICROARRAYS<br />

Phalanx Biotech Group ......................................... 307<br />

MICRORNA SERVICE<br />

Phalanx Biotech Group ......................................... 307<br />

MICROSCOPES<br />

Leica Microsystems Corp ...................................... 824<br />

MetaSystems ....................................................... 1303<br />

MINI-PREPS - 96 WELL<br />

QIAGEN Inc. ........................................................ 1001<br />

MIRNA EXPRESSION PROFILING<br />

NXT-Dx ................................................................ 1025<br />

MITOCHONDRIAL DNA MUTATION TESTING<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

BioReliance ........................................................... 604<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

GeneDx ................................................................ 1119<br />

JSI medical systems GmbH ................................ 1023<br />

MRC-Holland ....................................................... 1122<br />

Transgenomic, Inc. ................................................ 505<br />

MLPA ANALYSIS<br />

JSI medical systems GmbH ................................ 1023<br />

MOLECULAR BEACONS<br />

Gene Link, Inc ....................................................... 627<br />

MOLECULAR BEACON SYNTHESIS<br />

Gene Link, Inc ....................................................... 627<br />

MOLECULAR BIOLOGY REAGENTS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

ASURAGEN, INC. .................................................. 503<br />

BioFire Diagnostics ............................................... 719<br />

Bioline USA Inc. ................................................... 1324<br />

EdgeBio ............................................................... 1506<br />

Epicentre (an Illumina company) ......................... 1218<br />

Gene Link, Inc ....................................................... 627<br />

Gene Tools, LLC .................................................. 1401<br />

Life Technologies ................................................... 601<br />

New England Biolabs, Inc. .................................... 904<br />

Roche Applied Science ......................................... 701<br />

Rubicon Genomics, Inc. ........................................ 803<br />

USB products from Affymetrix .............................. 925<br />

Zymo Research Corporation ................................. 400<br />

MOLECULAR DIAGNOSTICS<br />

Transgenomic, Inc. ................................................ 505<br />

MOLECULAR INFECTIONS DISEASE TESTING<br />

BioFire Diagnostics ............................................... 719<br />

MOLECULAR MODELING SOFTWARE<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

MOUSE MODELS<br />

Applied StemCell, Inc. ........................................... 527<br />

mRNA ISOLATION<br />

Bio-Rad ................................................................. 524<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

Exiqon ................................................................. 1712<br />

New England Biolabs, Inc. .................................... 904<br />

Prognosys Biosciences, Inc. ................................. 304<br />

QIAGEN Inc. ........................................................ 1001<br />

Roche Applied Science ......................................... 701<br />

SeqWright, Inc. ...................................................... 726<br />

Zymo Research Corporation ................................. 400<br />

mRNA PURIFICATION KIT<br />

Affymetrix, Inc. ...................................................... 918<br />

Bio-Rad ................................................................. 524<br />

chemagen from PerkinElmer ............................... 1426<br />

Epicentre (an Illumina company) ......................... 1218<br />

Gene Link, Inc ....................................................... 627<br />

Tecan ..................................................................... 405<br />

Zymo Research Corporation ................................. 400<br />

MUTATION DETECTION<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

ASURAGEN, INC. .................................................. 503<br />

Bio-Rad ................................................................. 524<br />

Boreal Genomics ................................................... 724<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />

Illumina, Inc. ........................................................ 1109


Interactive Bios<strong>of</strong>tware .......................................... 413<br />

JSI medical systems GmbH ................................ 1023<br />

MRC-Holland ....................................................... 1122<br />

Myriad Genetic Laboratories ............................... 1501<br />

Omixon Biocomputing .......................................... 205<br />

Pacific Biosciences ............................................... 610<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Seven Bridges Genomics .................................... 1204<br />

Transgenomic, Inc. ................................................ 505<br />

UCLA Clinical Genomics Center ........................... 923<br />

MUTATION INTERPRETATION<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

MYCOPLASMA DETECTION SYSTEMS<br />

RUCDR ................................................................ 1102<br />

NDAR FEDERATION<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

NEUROGENETIC TESTING SERVICES<br />

Athena Diagnostics ............................................. 1308<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

GeneDx ................................................................ 1119<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

NEUROLOGICAL TESTING SERVICES<br />

Athena Diagnostics ............................................. 1308<br />

NEW TECHNOLOGY REVIEWS<br />

Science/AAAS ..................................................... 1312<br />

NEXT-GENERATION SEQUENCING<br />

SeqWright, Inc. ...................................................... 726<br />

NEXT-GENERATION SEQUENCING ANALYSIS<br />

JSI medical systems GmbH ................................ 1023<br />

NEXT GENERATION SEQUENCING ANALYSIS<br />

Seven Bridges Genomics .................................... 1204<br />

NEXT-GENERATION SEQUENCING ANALYSIS<br />

SOFTWARE<br />

Partek Incorporated............................................. 1307<br />

NEXT-GENERATION SEQUENCING LIBRARY<br />

PREPARATION<br />

Advanced Analytical ............................................ 1304<br />

NEXTGEN SEQUENCING SAMPLE PREP<br />

Epicentre (an Illumina company) ......................... 1218<br />

NGS DATA ANALYSIS<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

PRODUCT AND SERVICE INDEX 317<br />

NGS SOFTWARE<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

NONCODING RNA<br />

Exiqon ................................................................. 1712<br />

NONINVASIVE PRENATAL TESTING<br />

Ariosa Diagnostics ............................................... 1609<br />

NONISOTOPIC REAGENTS<br />

Gene Link, Inc ....................................................... 627<br />

NONRADIOACTIVE LABELING PRODUCTS<br />

Gene Link, Inc ....................................................... 627<br />

NON-UV LIGHT BOX<br />

Embi Tec .............................................................. 1406<br />

NUCLEIC ACID ISOLATIONS<br />

Bioline USA Inc. ................................................... 1324<br />

chemagen from PerkinElmer ............................... 1426<br />

EdgeBio ............................................................... 1506<br />

Expression Analysis ............................................... 508<br />

Gene Link, Inc ....................................................... 627<br />

Phalanx Biotech Group ......................................... 307<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Roche Applied Science ......................................... 701<br />

Rubicon Genomics, Inc. ........................................ 803<br />

RUCDR ................................................................ 1102<br />

SeqWright, Inc. ...................................................... 726<br />

Zymo Research Corporation ................................. 400<br />

NUCLEIC ACID KITS<br />

chemagen from PerkinElmer ............................... 1426<br />

EdgeBio ............................................................... 1506<br />

Gene Link, Inc ....................................................... 627<br />

IntegenX Inc. ....................................................... 1311<br />

New England Biolabs, Inc. .................................... 904<br />

Phalanx Biotech Group ......................................... 307<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Zymo Research Corporation ................................. 400<br />

NUCLEIC ACID PURIFICATION<br />

Affymetrix, Inc. ...................................................... 918<br />

AutoGen, Inc. ........................................................ 807<br />

chemagen from PerkinElmer ............................... 1426<br />

DNA Genotek ........................................................ 900<br />

EdgeBio ............................................................... 1506<br />

Epigentek Group Inc. ........................................... 1127<br />

Gene Link, Inc ....................................................... 627<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Life Technologies ................................................... 601<br />

QIAGEN Inc. ........................................................ 1001<br />

SeqWright, Inc. ...................................................... 726<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

Zymo Research Corporation ................................. 400<br />

PRODUCT INDEX


318 PRODUCT AND SERVICE INDEX<br />

NUCLEIC ACID QUANTITATION KITS<br />

Agilent Technologies ............................................. 609<br />

ASURAGEN, INC. .................................................. 503<br />

BioNano Genomics, Inc. ....................................... 924<br />

Zymo Research Corporation ................................. 400<br />

NUCLEIC ACID STABILIZATION REAGENTS<br />

DNA Genotek ........................................................ 900<br />

IntegenX Inc. ....................................................... 1311<br />

Zymo Research Corporation ................................. 400<br />

OEM MANUFACTURING<br />

ASURAGEN, INC. .................................................. 503<br />

BioFire Diagnostics ............................................... 719<br />

chemagen from PerkinElmer ............................... 1426<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

New England Biolabs, Inc. .................................... 904<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Zymo Research Corporation ................................. 400<br />

OLIGO ANNEALING<br />

Gene Link, Inc ....................................................... 627<br />

SeqWright, Inc. ...................................................... 726<br />

OLIGONUCLEOTIDE PURIFICATION<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Gene Link, Inc ....................................................... 627<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

trinean .................................................................. 1605<br />

Zymo Research Corporation ................................. 400<br />

OLIGONUCLEOTIDES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Bio-Rad ................................................................. 524<br />

Exiqon ................................................................. 1712<br />

Gene Link, Inc ....................................................... 627<br />

Gene Tools, LLC .................................................. 1401<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Oxford Gene Technology ....................................... 302<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

ONCOLOGY CLINICAL TRIALS<br />

Transgenomic, Inc. ................................................ 505<br />

ONCOLOGY DIAGNOSTIC TOOLS<br />

Transgenomic, Inc. ................................................ 505<br />

ONCOLOGY PRECLINICAL TRIALS<br />

Transgenomic, Inc. ................................................ 505<br />

OVENS<br />

SciGene ................................................................. 619<br />

PCR ENZYMES<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

Bioline USA Inc. ................................................... 1324<br />

Epicentre (an Illumina company) ......................... 1218<br />

Kapa Biosystems Inc ........................................... 1512<br />

New England Biolabs, Inc. .................................... 904<br />

Roche Applied Science ......................................... 701<br />

USB products from Affymetrix .............................. 925<br />

PCR PLASTICS<br />

EdgeBio ............................................................... 1506<br />

Thermo Scientific................................................... 624<br />

PCR/PRIMER DESIGN SOFTWARE<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

PCR PURIFICATION - 96 WELL<br />

chemagen from PerkinElmer ............................... 1426<br />

EdgeBio ............................................................... 1506<br />

Life Technologies ................................................... 601<br />

RUCDR ................................................................ 1102<br />

SeqWright, Inc. ...................................................... 726<br />

Tecan ..................................................................... 405<br />

USB products from Affymetrix .............................. 925<br />

Zymo Research Corporation ................................. 400<br />

PCR-RELATED PRODUCTS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

ASURAGEN, INC. .................................................. 503<br />

BC Platforms Ltd ................................................... 819<br />

BioFire Diagnostics ............................................... 719<br />

Bioline USA Inc. ................................................... 1324<br />

Diagenode Inc ....................................................... 406<br />

EdgeBio ............................................................... 1506<br />

Embi Tec .............................................................. 1406<br />

Exiqon ................................................................. 1712<br />

Fluidigm Corporation ............................................. 725<br />

Illumina, Inc. ........................................................ 1109<br />

Incom, Inc. ........................................................... 1300<br />

IntegenX Inc. ....................................................... 1311<br />

Labcyte Inc. ......................................................... 1402<br />

New England Biolabs, Inc. .................................... 904<br />

RainDance Technologies, Inc. ............................... 910<br />

Streck .................................................................. 1600<br />

Thermo Scientific................................................... 624<br />

USB products from Affymetrix .............................. 925<br />

PEDIGREE DRAWING SOFTWARE<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

PEPTIDE ANTIBODIES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Diagenode Inc ....................................................... 406<br />

Epigentek Group Inc. ........................................... 1127<br />

NVIGEN ............................................................... 1403<br />

PEPTIDES (CUSTOM)<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

PEPTIDE SYNTHESIS REAGENTS<br />

AnaSpec Inc, Eurogentec Group ......................... 1100


PHARMACEUTICALS<br />

Amicus Therapeutics, Inc. ..................................... 511<br />

BioMarin Pharmaceutical Inc. ............................. 1619<br />

Rare Disease Therapeutics, Inc. ............................ 419<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

PHARMACOGENETIC TESTING SERVICES<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

BioReliance ........................................................... 604<br />

Boreal Genomics ................................................... 724<br />

Expression Analysis ............................................... 508<br />

Genformatic ......................................................... 1420<br />

PHARMACOGENOMIC SERVICES<br />

SeqWright, Inc. ...................................................... 726<br />

PHENOTYPE MAPPING<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

PHOTOGRAPHIC EQUIPMENT<br />

Embi Tec .............................................................. 1406<br />

PIPETTES<br />

Hamilton Company .............................................. 1613<br />

PK/ADME<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

PLASMID PURIFICATION<br />

Affymetrix, Inc. ...................................................... 918<br />

AutoGen, Inc. ........................................................ 807<br />

EdgeBio ............................................................... 1506<br />

SeqWright, Inc. ...................................................... 726<br />

trinean .................................................................. 1605<br />

USB products from Affymetrix .............................. 925<br />

Zymo Research Corporation ................................. 400<br />

PLASTIC LABORATORY WARE<br />

SciGene ................................................................. 619<br />

POLYMORPHIC GENETIC MARKERS<br />

BC Platforms Ltd ................................................... 819<br />

PRECAST ACRYLAMIDE GELS<br />

Embi Tec .............................................................. 1406<br />

PRECAST AGAROSE GELS<br />

Embi Tec .............................................................. 1406<br />

Sage Science Inc. ................................................ 1510<br />

PRENATAL INTERPRETIVE SOFTWARE<br />

Genformatic ......................................................... 1420<br />

PRIMERS<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

ASURAGEN, INC. .................................................. 503<br />

Exiqon ................................................................. 1712<br />

PRODUCT AND SERVICE INDEX 319<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Thermo Scientific................................................... 624<br />

PROBES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Exiqon ................................................................. 1712<br />

Gene Link, Inc ....................................................... 627<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

MetaSystems ....................................................... 1303<br />

MRC-Holland ....................................................... 1122<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Thermo Scientific................................................... 624<br />

PROBES - CANCER<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Exiqon ................................................................. 1712<br />

MRC-Holland ....................................................... 1122<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Signature Genomics from PerkinElmer ............... 1327<br />

PROTEIN DETECTION<br />

Innopsys ................................................................ 805<br />

NVIGEN ............................................................... 1403<br />

PROTEIN EXPRESSION KIT<br />

New England Biolabs, Inc. .................................... 904<br />

PROTEIN PURIFICATION<br />

New England Biolabs, Inc. .................................... 904<br />

NVIGEN ............................................................... 1403<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

USB products from Affymetrix .............................. 925<br />

PROTEIN SEQUENCE ANALYSIS SOFTWARE<br />

Knome, Inc. ......................................................... 1007<br />

PROTEOMIC SERVICES<br />

BGI ...................................................................... 1419<br />

PUBLICATIONS<br />

JMG (BMJ Group) ............................................... 1103<br />

PUBLISHER<br />

Science/AAAS ..................................................... 1312<br />

PUBLISHING<br />

JMG (BMJ Group) ............................................... 1103<br />

PURIFICATION SYSTEMS<br />

SciGene ................................................................. 619<br />

qPCR ANALYSIS SOFTWARE<br />

Partek Incorporated............................................. 1307<br />

qPCR PROBES<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Bioline USA Inc. ................................................... 1324<br />

PRODUCT INDEX


320 PRODUCT AND SERVICE INDEX<br />

Exiqon ................................................................. 1712<br />

Illumina, Inc. ........................................................ 1109<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Roche Applied Science ......................................... 701<br />

Thermo Scientific................................................... 624<br />

QUALITY CONTROL SOFTWARE<br />

BC Platforms Ltd ................................................... 819<br />

Data Unlimited International, Inc. ........................ 1503<br />

GeneInsight ......................................................... 1224<br />

Genial Genetic Solutions/Rainbow<br />

Scientific, Inc. ..................................................... 402<br />

QUANTITATIVE EXPRESSION ANALYSIS<br />

Affymetrix, Inc. ...................................................... 918<br />

Biobase Corporation ........................................... 1319<br />

BioReliance ........................................................... 604<br />

Exiqon ................................................................. 1712<br />

Fluidigm Corporation ............................................. 725<br />

NanoString Technologies, Inc................................ 210<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Sequenom, Inc. ..................................................... 519<br />

SeqWright, Inc. ...................................................... 726<br />

Thermo Scientific................................................... 624<br />

QUANTITATIVE PCR ANALYSIS SYSTEM<br />

Agilent Technologies ............................................. 609<br />

ASURAGEN, INC. .................................................. 503<br />

Exiqon ................................................................. 1712<br />

Fluidigm Corporation ............................................. 725<br />

Life Technologies ................................................... 601<br />

NanoString Technologies, Inc................................ 210<br />

Roche Applied Science ......................................... 701<br />

Thermo Scientific................................................... 624<br />

QUENCHER<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

REAGENTS<br />

Agilent Technologies ............................................. 609<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

ASURAGEN, INC. .................................................. 503<br />

Beckman Coulter, Inc. ......................................... 1601<br />

BioFire Diagnostics ............................................... 719<br />

Bioline USA Inc. ................................................... 1324<br />

Diagenode Inc ....................................................... 406<br />

Exiqon ................................................................. 1712<br />

Gene Tools, LLC .................................................. 1401<br />

Genial Genetic Solutions/Rainbow<br />

Scientific, Inc. ..................................................... 402<br />

IntegenX Inc. ....................................................... 1311<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

NanoString Technologies, Inc................................ 210<br />

New England Biolabs, Inc. .................................... 904<br />

NVIGEN ............................................................... 1403<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Thermo Scientific................................................... 624<br />

USB products from Affymetrix .............................. 925<br />

REFERENCE LABORATORY TESTING<br />

Athena Diagnostics ............................................. 1308<br />

Cincinnati Children’s Hospital Medical Center .... 1505<br />

Laboratory for Molecular Medicine, PCPGM ...... 1225<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Transgenomic, Inc. ................................................ 505<br />

UCLA Clinical Genomics Center ........................... 923<br />

REPORTER ASSAYS<br />

SwitchGear Genomics........................................... 305<br />

RESEARCH DATABASE<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

BC Platforms Ltd ................................................... 819<br />

Biobase Corporation ........................................... 1319<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

Pubget, Inc. ......................................................... 1520<br />

Sanford Research .................................................. 325<br />

University <strong>of</strong> Southern California, Information<br />

Sciences Institute ............................................... 226<br />

RESEARCH GRANTS & FELLOWSHIPS<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

CIHR Institute <strong>of</strong> <strong>Genetics</strong> ................................... 1321<br />

RETROVIRAL EXPRESSION SYSTEM<br />

Thermo Scientific................................................... 624<br />

RISK ASSESSMENT<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

RNA<br />

Advanced Analytical ............................................ 1304<br />

BioReliance ........................................................... 604<br />

Coriell Institute for Medical Research ................... 312<br />

DNA Genotek ........................................................ 900<br />

Exiqon ................................................................. 1712<br />

Expression Analysis ............................................... 508<br />

Illumina, Inc. ........................................................ 1109<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

NanoString Technologies, Inc................................ 210<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Seven Bridges Genomics .................................... 1204<br />

Thermo Scientific................................................... 624<br />

RNA/DNA/PROTEIN PURIFICATION FROM THE<br />

SAME SAMPLE<br />

Norgen Biotek Corp............................................... 208<br />

RNA ISOLATION<br />

Bio-Rad ................................................................. 524<br />

BioReliance ........................................................... 604<br />

chemagen from PerkinElmer ............................... 1426<br />

Epicentre (an Illumina company) ......................... 1218<br />

Exiqon ................................................................. 1712<br />

Expression Analysis ............................................... 508<br />

Life Technologies ................................................... 601<br />

New England Biolabs, Inc. .................................... 904<br />

NVIGEN ............................................................... 1403


Phalanx Biotech Group ......................................... 307<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Roche Applied Science ......................................... 701<br />

RNA ISOLATION KITS<br />

AutoGen, Inc. ........................................................ 807<br />

Bioline USA Inc. ................................................... 1324<br />

Bio-Rad ................................................................. 524<br />

chemagen from PerkinElmer ............................... 1426<br />

Diagenode Inc ....................................................... 406<br />

Exiqon ................................................................. 1712<br />

New England Biolabs, Inc. .................................... 904<br />

Phalanx Biotech Group ......................................... 307<br />

Zymo Research Corporation ................................. 400<br />

RNA MARKERS<br />

Affymetrix, Inc. ...................................................... 918<br />

New England Biolabs, Inc. .................................... 904<br />

RNA/MICRORNA PURIFICATION KITS<br />

Norgen Biotek Corp............................................... 208<br />

RNA PURIFICATION<br />

Affymetrix, Inc. ...................................................... 918<br />

BioReliance ........................................................... 604<br />

Expression Analysis ............................................... 508<br />

Life Technologies ................................................... 601<br />

NVIGEN ............................................................... 1403<br />

trinean .................................................................. 1605<br />

USB products from Affymetrix .............................. 925<br />

RNA PURIFICATION KITS<br />

Affymetrix, Inc. ...................................................... 918<br />

Agilent Technologies ............................................. 609<br />

AutoGen, Inc. ........................................................ 807<br />

NVIGEN ............................................................... 1403<br />

USB products from Affymetrix .............................. 925<br />

Zymo Research Corporation ................................. 400<br />

RNA-SEQ SAMPLE PREP KITS<br />

Epicentre (an Illumina company) ......................... 1218<br />

RNA SEQUENCING<br />

NXT-Dx ................................................................ 1025<br />

RNA SYNTHESIS PRODUCTS<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

Exiqon ................................................................. 1712<br />

IntegenX Inc. ....................................................... 1311<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

ROBOTIC ARRAYING SYSTEMS<br />

Labcyte Inc. ......................................................... 1402<br />

ROBOTIC COLONY PICKERS<br />

Hamilton Company .............................................. 1613<br />

ROBOTIC SAMPLE PROCESSORS<br />

Agilent Technologies ............................................. 609<br />

Diagenode Inc ....................................................... 406<br />

PRODUCT AND SERVICE INDEX 321<br />

Hamilton Company .............................................. 1613<br />

IntegenX Inc. ....................................................... 1311<br />

Microsonic Systems Inc. ....................................... 618<br />

SciGene ................................................................. 619<br />

Tecan ..................................................................... 405<br />

ROBOTIC SUPPLIES<br />

Tecan ..................................................................... 405<br />

ROBOTIC WORKSTATIONS<br />

Agilent Technologies ............................................. 609<br />

Beckman Coulter, Inc. ......................................... 1601<br />

chemagen from PerkinElmer ............................... 1426<br />

Diagenode Inc ....................................................... 406<br />

Hamilton Company .............................................. 1613<br />

Microsonic Systems Inc. ....................................... 618<br />

SciGene ................................................................. 619<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

RT-PCR KITS<br />

AnaSpec Inc, Eurogentec Group ......................... 1100<br />

ASURAGEN, INC. .................................................. 503<br />

BioFire Diagnostics ............................................... 719<br />

Bioline USA Inc. ................................................... 1324<br />

Epicentre (an Illumina company) ......................... 1218<br />

Exiqon ................................................................. 1712<br />

Illumina, Inc. ........................................................ 1109<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Life Technologies ................................................... 601<br />

New England Biolabs, Inc. .................................... 904<br />

Roche Applied Science ......................................... 701<br />

Thermo Scientific................................................... 624<br />

USB products from Affymetrix .............................. 925<br />

SALIVA DNA COLLECTION KITS<br />

Norgen Biotek Corp............................................... 208<br />

SALIVA DNA PURIFICATION KITS<br />

Norgen Biotek Corp............................................... 208<br />

SAMPLE ARCHIVING<br />

DNA Genotek ........................................................ 900<br />

Epicentre (an Illumina company) ......................... 1218<br />

IntegenX Inc. ....................................................... 1311<br />

SAMPLE INVENTORY MANAGEMENT<br />

SOLUTIONS<br />

Data Unlimited International, Inc. ........................ 1503<br />

IntegenX Inc. ....................................................... 1311<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

SAMPLE PREPARATION<br />

BC Platforms Ltd ................................................... 819<br />

Beckman Coulter, Inc. ......................................... 1601<br />

Covaris Inc. ......................................................... 1008<br />

Diagenode Inc ....................................................... 406<br />

DNA Genotek ........................................................ 900<br />

Epigentek Group Inc. ........................................... 1127<br />

Expression Analysis ............................................... 508<br />

PRODUCT INDEX


322 PRODUCT AND SERVICE INDEX<br />

IntegenX Inc. ....................................................... 1311<br />

Life Technologies ................................................... 601<br />

Microsonic Systems Inc. ....................................... 618<br />

New England Biolabs, Inc. .................................... 904<br />

Prognosys Biosciences, Inc. ................................. 304<br />

RainDance Technologies, Inc. ............................... 910<br />

Rubicon Genomics, Inc. ........................................ 803<br />

Sage Science Inc. ................................................ 1510<br />

SciGene ................................................................. 619<br />

Tecan ..................................................................... 405<br />

trinean .................................................................. 1605<br />

Zymo Research Corporation ................................. 400<br />

SCIENTIFIC ASSOCIATION<br />

Science/AAAS ..................................................... 1312<br />

SCREENING TESTS<br />

Applied StemCell, Inc. ........................................... 527<br />

BioReliance ........................................................... 604<br />

Greenwood Genetic Center ................................. 1027<br />

MRC-Holland ....................................................... 1122<br />

Thermo Scientific................................................... 624<br />

SEQUENCE ALIGNMENT AND VARIANT<br />

CALLING<br />

Genformatic ......................................................... 1420<br />

SEQUENCE ANALYSIS SOFTWARE<br />

BC Platforms Ltd ................................................... 819<br />

Cartagenia ........................................................... 1022<br />

CLC bio ................................................................. 501<br />

DNASTAR, Inc. ...................................................... 801<br />

EdgeBio ............................................................... 1506<br />

Enlis Genomics ...................................................... 203<br />

Genformatic ......................................................... 1420<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Illumina, Inc. ........................................................ 1109<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

JSI medical systems GmbH ................................ 1023<br />

Knome, Inc. ......................................................... 1007<br />

Life Technologies ................................................... 601<br />

Omixon Biocomputing .......................................... 205<br />

Palmyra S<strong>of</strong>tware ................................................ 1519<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Prognosys Biosciences, Inc. ................................. 304<br />

Seven Bridges Genomics .................................... 1204<br />

Spiral <strong>Genetics</strong> ...................................................... 113<br />

SEQUENCING ACCESSORIES<br />

Diagenode Inc ....................................................... 406<br />

EdgeBio ............................................................... 1506<br />

Epicentre (an Illumina company) ......................... 1218<br />

Illumina, Inc. ........................................................ 1109<br />

IntegenX Inc. ....................................................... 1311<br />

Microsonic Systems Inc. ....................................... 618<br />

New England Biolabs, Inc. .................................... 904<br />

SEQUENCING BUFFERS<br />

EdgeBio ............................................................... 1506<br />

Life Technologies ................................................... 601<br />

USB products from Affymetrix .............................. 925<br />

SEQUENCING QC FOR PRIMERS<br />

Prognosys Biosciences, Inc. ................................. 304<br />

SEQUENCING SERVICES<br />

Axeq Technologies ................................................ 820<br />

Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />

Laboratories........................................................ 711<br />

BGI ...................................................................... 1419<br />

BioReliance ........................................................... 604<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

Complete Genomics, Inc. ...................................... 907<br />

EdgeBio ............................................................... 1506<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Expression Analysis ............................................... 508<br />

GeneDx ................................................................ 1119<br />

Genformatic ......................................................... 1420<br />

Illumina, Inc. ........................................................ 1109<br />

Knome, Inc. ......................................................... 1007<br />

Myriad Genetic Laboratories ............................... 1501<br />

Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />

Prognosys Biosciences, Inc. ................................. 304<br />

RUCDR ................................................................ 1102<br />

SeqWright, Inc. ...................................................... 726<br />

UCLA Clinical Genomics Center ........................... 923<br />

Zymo Research Corporation ................................. 400<br />

SERUM<br />

Exiqon ................................................................. 1712<br />

SIGNAL AMPLIFICATION<br />

Natera .................................................................... 504<br />

SNP ANALYTICAL SERVICES<br />

Axeq Technologies ................................................ 820<br />

BioReliance ........................................................... 604<br />

EdgeBio ............................................................... 1506<br />

Expression Analysis ............................................... 508<br />

Genformatic ......................................................... 1420<br />

Golden Helix, Inc. .................................................. 818<br />

Knome, Inc. ......................................................... 1007<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Prognosys Biosciences, Inc. ................................. 304<br />

RUCDR ................................................................ 1102<br />

SeqWright, Inc. ...................................................... 726<br />

Seven Bridges Genomics .................................... 1204<br />

Signature Genomics from PerkinElmer ............... 1327<br />

UCLA Clinical Genomics Center ........................... 923<br />

SNP DETECTION PROBES<br />

Integrated DNA Technologies, Inc. ........................ 301<br />

Natera .................................................................... 504


SNP GENOTYPING ANALYSIS<br />

EpigenDx ............................................................... 721<br />

SNP SCORING<br />

BioReliance ........................................................... 604<br />

Enlis Genomics ...................................................... 203<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

SNP SCREENING<br />

Ambry <strong>Genetics</strong> ..................................................... 311<br />

BioFire Diagnostics ............................................... 719<br />

Enlis Genomics ...................................................... 203<br />

Fluidigm Corporation ............................................. 725<br />

Genformatic ......................................................... 1420<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

Life Technologies ................................................... 601<br />

Pacific Biosciences ............................................... 610<br />

Seven Bridges Genomics .................................... 1204<br />

SOCIETY<br />

European <strong>Human</strong> <strong>Genetics</strong> Conference 2013 ....... 219<br />

SOFTWARE<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

BC Platforms Ltd ................................................... 819<br />

CLC bio ................................................................. 501<br />

Data Unlimited International, Inc. ........................ 1503<br />

DNAnexus, Inc. ...................................................... 507<br />

DNASTAR, Inc. ...................................................... 801<br />

Enlis Genomics ...................................................... 203<br />

GeneInsight ......................................................... 1224<br />

Genformatic ......................................................... 1420<br />

Genial Genetic Solutions/Rainbow<br />

Scientific, Inc. ..................................................... 402<br />

GenoLogics ......................................................... 1105<br />

Golden Helix, Inc. .................................................. 818<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

JSI medical systems GmbH ................................ 1023<br />

Knome, Inc. ......................................................... 1007<br />

Leica Microsystems Corp ...................................... 824<br />

National Center for Biotechnology Information ..... 224<br />

NextGxDx .............................................................. 411<br />

Omixon Biocomputing .......................................... 205<br />

Oxford Gene Technology ....................................... 302<br />

Palmyra S<strong>of</strong>tware ................................................ 1519<br />

Partek Incorporated............................................. 1307<br />

POSSUM - Murdoch Childrens Research<br />

Institute ............................................................... 218<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

SCC S<strong>of</strong>t Computer ............................................ 1618<br />

Seven Bridges Genomics .................................... 1204<br />

Spiral <strong>Genetics</strong> ...................................................... 113<br />

STARLIMS ........................................................... 1400<br />

SOFTWARE AND DATABASE TOOLS FOR<br />

VARIANT TRIAGE AND LAB REPORTING<br />

AUTOMATION<br />

Cartagenia ........................................................... 1022<br />

PRODUCT AND SERVICE INDEX 323<br />

SOFTWARE - ARRAY ANALYSIS<br />

Agilent Technologies ............................................. 609<br />

BC Platforms Ltd ................................................... 819<br />

Biobase Corporation ........................................... 1319<br />

BioDiscovery, Inc. .................................................. 813<br />

BlueGnome Limited ............................................... 209<br />

Cartagenia ........................................................... 1022<br />

DNASTAR, Inc. ...................................................... 801<br />

Golden Helix, Inc. .................................................. 818<br />

Ingenuity Systems, Inc. ....................................... 1101<br />

Oxford Gene Technology ....................................... 302<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Phalanx Biotech Group ......................................... 307<br />

Signature Genomics from PerkinElmer ............... 1327<br />

SOFTWARE - DATA MANAGING<br />

AGRE-Autism Genetic Resource Exchange .......... 319<br />

BC Platforms Ltd ................................................... 819<br />

BioDiscovery, Inc. .................................................. 813<br />

BlueGnome Limited ............................................... 209<br />

Cartagenia ........................................................... 1022<br />

CLC bio ................................................................. 501<br />

Data Unlimited International, Inc. ........................ 1503<br />

GeneInsight ......................................................... 1224<br />

Genformatic ......................................................... 1420<br />

GenoLogics ......................................................... 1105<br />

Hitachi Solutions America Ltd. ............................ 1502<br />

Interactive Bios<strong>of</strong>tware .......................................... 413<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

SCC S<strong>of</strong>t Computer ............................................ 1618<br />

STARLIMS ........................................................... 1400<br />

SOFTWARE - PEDIGREE DRAWING<br />

BC Platforms Ltd ................................................... 819<br />

Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />

SOLID PHASE EXTRACTION<br />

Hamilton Company .............................................. 1613<br />

SONICATORS & ACCESSORIES<br />

Diagenode Inc ....................................................... 406<br />

SPECTROPHOTOMETER<br />

trinean .................................................................. 1605<br />

SPIN COLUMNS<br />

Zymo Research Corporation ................................. 400<br />

STATISTICAL GENETICS CONSULTATION<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

STORAGE PRODUCTS<br />

DNA Genotek ........................................................ 900<br />

EMC Isilon ........................................................... 1320<br />

SYRINGES<br />

Hamilton Company .............................................. 1613<br />

PRODUCT INDEX


324 PRODUCT AND SERVICE INDEX<br />

TARGET ENRICHMENT KITS<br />

Prognosys Biosciences, Inc. ................................. 304<br />

TELOMERE SPECIFIC PROBES<br />

Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />

MRC-Holland ....................................................... 1122<br />

TEMPLATE PREPARATION KITS<br />

Pacific Biosciences ............................................... 610<br />

TEST KITS<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

Myriad Genetic Laboratories ............................... 1501<br />

Transgenomic, Inc. ................................................ 505<br />

THERMAL CYCLERS<br />

Agilent Technologies ............................................. 609<br />

Bio-Rad ................................................................. 524<br />

Life Technologies ................................................... 601<br />

SciGene ................................................................. 619<br />

Streck .................................................................. 1600<br />

THERMAL PLATE SEALER<br />

Bio-Rad ................................................................. 524<br />

THERMAL PROFILING SYSTEMS<br />

SciGene ................................................................. 619<br />

THERMOSTABLE DNA POLYMERASE<br />

Affymetrix, Inc. ...................................................... 918<br />

New England Biolabs, Inc. .................................... 904<br />

USB products from Affymetrix .............................. 925<br />

TISSUE CULTURE MEDIA<br />

Life Technologies ................................................... 601<br />

TISSUE CULTURES<br />

BioReliance ........................................................... 604<br />

TISSUE MICROSCOPY<br />

PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />

TOXICITY TESTS<br />

Myriad Genetic Laboratories ............................... 1501<br />

Therapeutics for Rare and Neglected Diseases .... 220<br />

TRAINING<br />

Emory <strong>Genetics</strong> Laboratory................................... 211<br />

Laboratory for Molecular Medicine, PCPGM ...... 1225<br />

TRAINING COURSES<br />

BlueGnome Limited ............................................... 209<br />

<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />

TRANSCRIPTION REAGENTS<br />

New England Biolabs, Inc. .................................... 904<br />

TRANSCRIPTOME<br />

Axeq Technologies ................................................ 820<br />

TRANSFECTION REAGENTS<br />

New England Biolabs, Inc. .................................... 904<br />

Thermo Scientific................................................... 624<br />

USB products from Affymetrix .............................. 925<br />

TRAVEL AWARDS<br />

FASEB ................................................................. 1700<br />

TRISOMY DETECTION<br />

Ariosa Diagnostics ............................................... 1609<br />

TWIN ZYGOSITY TESTING<br />

UCLA Clinical Genomics Center ........................... 923<br />

ULTRAVIOLET PRODUCTS -<br />

TRANSILLUMINATORS<br />

Embi Tec .............................................................. 1406<br />

UPD TESTING<br />

Greenwood Genetic Center ................................. 1027<br />

UV/VIS SPECTROPHOTOMETERS<br />

trinean .................................................................. 1605<br />

VARIANT ANNOTATION AND PREDICTION<br />

OF PROBABLE PHENOTYPIC EFFECT OF<br />

VARIANTS<br />

Genformatic ......................................................... 1420<br />

VIDEO CAMERAS (COLOR) FOR MICROSCOPY<br />

Applied Spectral Imaging, Inc. ............................ 1220<br />

WATER BATHS<br />

SciGene ................................................................. 619<br />

WESTERN BLOTTING EQUIPMENT<br />

Bio-Rad ................................................................. 524<br />

Tecan ..................................................................... 405<br />

WESTERN BLOTTING KITS<br />

Bio-Rad ................................................................. 524<br />

WHOLE EXOME SEQUENCING<br />

Center for Inherited Disease Research (CIDR) ...... 119<br />

UCLA Clinical Genomics Center ........................... 923<br />

WHOLE GENOME AND EXOME ANALYSIS<br />

Genformatic ......................................................... 1420<br />

WHOLE GENOME SEQUENCING<br />

Axeq Technologies ................................................ 820<br />

YEAST TWO-HYBRID SYSTEMS<br />

Thermo Scientific................................................... 624


CMEs and CEUs<br />

Poster Sessions are not eligible for CME or CEU credits<br />

For questions, contact ashgmeetings@ashg.org.<br />

CMEs and CEUs 325<br />

Continuing Medical Education Credits (CMEs)<br />

The <strong>ASHG</strong> <strong>2012</strong> Annual Meeting has been planned and implemented in accordance<br />

with the Essential Areas and policies <strong>of</strong> the Accreditation Council for Continuing<br />

Medical Education (ACCME) through the joint sponsorship <strong>of</strong> the <strong>American</strong> College<br />

<strong>of</strong> Medical <strong>Genetics</strong> and Genomics (ACMG) and <strong>ASHG</strong>. ACMG is accredited by<br />

the ACCME to provide continuing medical education for physicians. All educational<br />

programming is developed and must be presented in compliance with all<br />

ACCME accreditation requirements and therefore, ACMG designates this educational<br />

activity for a maximum <strong>of</strong> 25.75 AMA PRA Category 1 Credit(s) TM . Physicians<br />

should only claim credit commensurate with the extent <strong>of</strong> their participation in the<br />

activity.<br />

Procedures: There is a non-refundable $45 fee payable during the registration<br />

process. You can apply for credits through the online application available<br />

November 10, <strong>2012</strong>. The deadline to submit your request is December 28, <strong>2012</strong>.<br />

Attendees may pick up self-reporting tracking forms in either the <strong>ASHG</strong> Office, Room<br />

111 or at the Information Counter located in the Registration Area, North Lobby <strong>of</strong><br />

the Moscone Center. Please see section below for the learning objectives, target<br />

audience, disclosure policy and a list <strong>of</strong> authors with disclosures <strong>of</strong> potential conflicts<br />

<strong>of</strong> interest.<br />

MDs and PhDs should apply for CMEs. The <strong>American</strong> Board <strong>of</strong> Medical <strong>Genetics</strong><br />

(ABMG) will accept CMEs for MDs or PhDs participating in the Maintenance <strong>of</strong><br />

Certification (MOC) program in any ABMG specialty.<br />

Continuing Education Unit Credits (CEUs) for California-Licensed Clinical and<br />

Molecular Laboratory Directors<br />

<strong>ASHG</strong> has been approved for Continuing Education Units for up to 24.5 units through<br />

the Pr<strong>of</strong>essional Acknowledgment for Continuing Education (P.A.C.E. ® ) program for<br />

California-Licensed Clinical and Molecular Laboratory Directors.<br />

Procedures: There is a non-refundable $35 fee payable during the registration<br />

process. Those who registered in advance received an e-mail with instructions and<br />

a copy <strong>of</strong> the self-reporting tracking. You may also pick up your CEU packet in the<br />

<strong>ASHG</strong> Meeting Office, Room 111. The deadline to submit your request for PACE<br />

credits is Monday, December 3, <strong>2012</strong>. No requests will be taken after this date.<br />

Clinical Laboratory Scientists should apply for PACE CEUs. ABMG will accept PACE<br />

CEUs for diplomats participating in the MOC program in the following categories: Clinical<br />

Biochemical Geneticist, Clinical Cytogeneticist, and Clinical Molecular Geneticist.<br />

CMEs and CEUs


326 CMEs and CEUs<br />

Continuing Education Unit Credits (CEUs) for Genetic Counselors<br />

<strong>ASHG</strong> has been approved for up to 25.75 Category 1 CEU credits (25 contact hours)<br />

for genetic counselors through the National <strong>Society</strong> <strong>of</strong> Genetic Counselors (NSGC).<br />

NSGC is approved as an authorized provider <strong>of</strong> continuing education and training by<br />

the International Association for Continuing Education and Training (IACET).<br />

Procedures: There is a non-refundable $40 fee payable during the registration<br />

process. Registrants MUST apply for credits via the online submission system<br />

after the meeting. The submission site will open on Saturday, November 10, <strong>2012</strong>.<br />

The deadline to request credits is Monday, December 3, <strong>2012</strong>. No submissions will<br />

be taken after this deadline. You will need your registration ID in order to successfully<br />

complete the CEU application. Those who registered in advance received an e-mail<br />

with instructions and a copy <strong>of</strong> the tracking form. For your convenience, tracking forms<br />

will also be available in the <strong>ASHG</strong> Meeting Office, Room 111 or at the Information<br />

Center located in the Registration Area, North Lobby.<br />

Genetic Counselors and Nurses should apply for CEUs. The <strong>American</strong> Board <strong>of</strong><br />

Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes<br />

<strong>of</strong> certification and recertification.<br />

<strong>ASHG</strong> <strong>2012</strong> Learning Objectives<br />

All attendees obtaining CME credits will be able to apply the newly acquired knowledge<br />

and methods in the evaluation, diagnosis, intervention, treatment and follow-up <strong>of</strong> patients<br />

with a variety <strong>of</strong> disorders. At the completion <strong>of</strong> the meeting, participants will be able to: (1)<br />

recognize gaps in knowledge <strong>of</strong> facts and new methods in genetics; (2) demonstrate ways<br />

that the new information and its context may be applied in their own practices; (3) better<br />

interpret results <strong>of</strong> complex genetic tests and recognize instances <strong>of</strong> most appropriate<br />

use; and (4) understand in detail the benefits and potential harms <strong>of</strong> utilizing the newest<br />

genetic technologies. The <strong>2012</strong> <strong>ASHG</strong> Annual Meeting will help attendees to:<br />

• Identify and fill gaps in knowledge in human genetics in areas <strong>of</strong> statistical<br />

analysis, full genome sequencing, next-generation sequencing, genetic<br />

neurodegenerative and other disorders, and epigenetics.<br />

• Explain the value and use <strong>of</strong> newest technological methods in full genome<br />

sequencing in diagnosis <strong>of</strong> disorders and family studies.<br />

• Provide context from discussions on the benefits and harms <strong>of</strong> returning<br />

results <strong>of</strong> full genome sequencing to patients.<br />

• Set principles for the provision <strong>of</strong> results and their interpretation in full genome<br />

sequencing and the diagnosis <strong>of</strong> genetic risks and explain how genome<br />

sequencing may be useful in an undiagnosed patient.<br />

• Accrue guidelines for the successful counseling <strong>of</strong> patients receiving complex<br />

genetic results.<br />

• Present the newest results <strong>of</strong> gene therapy trials so clinicians may enroll<br />

patients or apply therapies to appropriate patents.<br />

• Identify and explain the newest non-invasive pre-natal diagnostic methods.<br />

• Integrate results <strong>of</strong> genomic testing into electronic health records and other<br />

methods to store information.


CMEs and CEUs 327<br />

• Recognize methods to utilize centralized databases in the diagnosis and<br />

treatment <strong>of</strong> patients.<br />

<strong>ASHG</strong> <strong>2012</strong> Target Audience<br />

This meeting is targeted to research scientists, clinical and laboratory practitioners<br />

and others interested in the field <strong>of</strong> human genetics and genomics. There is some<br />

special focus on workshops intended for trainees. The program is varied so that<br />

participants may select from several concurrent sessions that fit their specialized<br />

research interests and clinical practice applications.<br />

<strong>Program</strong> Format<br />

Invited Sessions<br />

The <strong>2012</strong> program is highlighted by 24 invited scientific sessions that have been<br />

scheduled over three concurrent time periods. The <strong>Program</strong> Committee reviewed<br />

95 proposals for invited sessions. The review process took into consideration the<br />

merit and timeliness <strong>of</strong> each proposal as well as the need to balance topics in the<br />

overall scientific program. The sessions highlight a wide range <strong>of</strong> topics <strong>of</strong> interest to<br />

genetics practitioners, researchers and counselors. Any conflicts were managed in<br />

the process described above.<br />

Plenary Session Presentations and Platform Sessions (abstract-driven)<br />

The Plenary Session includes a diverse set <strong>of</strong> six presentations, selected from the<br />

top-rated abstracts submitted for this year’s annual meeting as determined by the<br />

<strong>2012</strong> <strong>Program</strong> Committee. Forty-five abstract-driven platform sessions totaling<br />

405 oral presentations have been programmed. There are five sets <strong>of</strong> nine concurrent<br />

platform sessions.<br />

The <strong>Program</strong> Committee had the difficult task <strong>of</strong> determining which abstracts would<br />

be accepted, and in what presentation format. Below is a brief description <strong>of</strong> how this<br />

task was performed:<br />

1. Based on the author’s topic preference and keyword selection, an abstract<br />

was initially reviewed by the <strong>Program</strong> Committee member responsible for<br />

that topic. If it was determined that the abstract would be more appropriately<br />

categorized under another topic, it was transferred to that topic. Sub-topic<br />

designations were helpful in assigning abstracts to the most appropriate topic.<br />

2. Each abstract was then electronically sent to three reviewers (including a<br />

<strong>Program</strong> Committee member) who are experts in the field. Each reviewer<br />

scored the abstracts independently and without knowledge <strong>of</strong> the score given<br />

by the other reviewers. Abstracts were then assigned a score from 1 (highest<br />

priority) to 8 (reject). The best cumulative score that an abstract could obtain<br />

from all three reviewers was a 3 (1+1+1). Any conflicts were managed in the<br />

process described above.<br />

3. In general, abstracts receiving scores within the top 8% for each topic were<br />

selected for platform (oral) presentations. The number <strong>of</strong> available oral<br />

CMEs and CEUs


328 CMEs and CEUs<br />

presentations for a given topic was in rough proportion to the number <strong>of</strong><br />

abstracts submitted for that topic, with some discretion given to the <strong>Program</strong><br />

Committee to adjust for the quality <strong>of</strong> abstracts in each topic in a given year.<br />

This created a total number <strong>of</strong> 411 oral presentations.<br />

4. The top scoring abstracts from each topic were then considered by the<br />

<strong>Program</strong> Committee for possible inclusion in the plenary session. Selection <strong>of</strong><br />

plenary session presentations was based not only on the cumulative scores,<br />

but also on the impact <strong>of</strong> the science being presented and the balance <strong>of</strong><br />

topics in the session. Six abstracts were finally chosen to constitute the<br />

plenary session in recognition <strong>of</strong> the speed at which new, high-impact scientific<br />

discoveries are now being made in human genetics.<br />

5. The concurrent platform sessions were then assembled from the remaining<br />

405 abstracts chosen for oral presentations (step 3 above, minus the 6 plenary<br />

abstracts). Within the constraints that each concurrent session has exactly<br />

nine abstracts, these platform sessions typically contain abstracts grouped<br />

by topic/approach. Some <strong>of</strong> the platform sessions are “multidisciplinary”<br />

sessions centered around a topic and are designed to bring together<br />

investigators interested in that topic from diverse areas <strong>of</strong> genetics.<br />

RECORDED PRESENTATIONS AVAILABLE AFTER THE MEETING<br />

Invited Sessions, Award Presentations, and the Plenary Sessions will be<br />

recorded and posted on the Web site after the meeting.<br />

These recordings are free to meeting registrants.<br />

Visit the <strong>ASHG</strong> Web site in early December to view these presentations.


SPEAKER AND AUTHOR DISCLOSURES<br />

In accordance with the Accreditation Council for Continuing Medical Education<br />

through the joint sponsorship <strong>of</strong> the <strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong> and<br />

Genomics (ACMG) and <strong>ASHG</strong>, all faculty, speakers and moderators must disclose<br />

the existence <strong>of</strong> any financial interest and/or other relationship(s) they might have with<br />

the manufacturer(s) or provider(s) <strong>of</strong> any commercial product(s) or service(s) to be<br />

discussed during their presentation: receiving a salary, royalty, intellectual property<br />

rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or<br />

other ownership interest, excluding diversified mutual funds), or other financial benefit.<br />

Financial benefits are usually associated with roles such as employment, management<br />

position, independent contractor (including contracted research), consulting,<br />

speaking and teaching, membership on advisory committees or review panels, board<br />

membership, and other activities for which remuneration is received or expected.<br />

If members <strong>of</strong> the <strong>ASHG</strong> <strong>2012</strong> <strong>Program</strong> Committee indicated a relationship which<br />

could be perceived by some as a real or apparent conflict <strong>of</strong> interest in planning the<br />

program, the committee member refrained from discussion. The following presenters<br />

have indicated a relationship that within the context <strong>of</strong> their presentation could be<br />

perceived by some as a real or apparent conflict <strong>of</strong> interest but do not consider that<br />

it will influence their presentation. The disclosures have been reviewed and conflict <strong>of</strong><br />

interest resolved or managed. The number following each company name represents<br />

the specific relationship from the list below.<br />

1. Stock options or bond holdings in a for-pr<strong>of</strong>it corporation or self-directed pension plan<br />

2. Research grants, other grants, scholarships, or fellowships<br />

3. Employment (full or part-time)<br />

4. Ownership or partnership<br />

5. Consulting fees or other remuneration<br />

6. Non-remunerative positions <strong>of</strong> influence such as <strong>of</strong>ficer, board member, trustee,<br />

or public spokesperson<br />

7. Receipt <strong>of</strong> royalties<br />

8. Speakers' bureau<br />

9. Receive substantial in-kind or donated goods or services<br />

10. Inventor/patent owner<br />

11. Advisor<br />

12. Collaboration<br />

13. Company owner<br />

14. Receipt <strong>of</strong> travel grants/honoraria<br />

15. Other<br />

• If a presentation is in a platform session, the abstract number is added in<br />

parentheses.<br />

• If a presenter or organizer is not listed, then that person had no relationship to<br />

disclose.<br />

• Disclosures will also be included in presentation slides.<br />

329<br />

SPEAKER/AUTHOR DISCLOSURES


330 SPEAKER AND AUTHOR DISCLOSURES<br />

Abecasis, G., University <strong>of</strong> Michigan/ArticDx - 7;<br />

GlaxoSmithKline - 2 (Session 7)<br />

Ahmed, A., Genzyme Corporation - 2 (715)<br />

Andersen, M., Life Technologies - 3;<br />

Life Technologies - 1 (1237)<br />

Aradhya, S., GeneDx - 3 (332)<br />

Bachmeyer, R. C., Kailos <strong>Genetics</strong> Inc. - 1, 3, 4, 6 (3527)<br />

Bai, R., GeneDx - 3 (330)<br />

Ballif, B. C., Signature Genomic Laboratories,<br />

PerkinElmer, Inc., Spokane, - 3 (884)<br />

Basel-Vanagaite, L., FDNA Ltd., Herzlyia, Israel - 5 (3185)<br />

Bauer, P., Actelion Pharmaceuticals Ltd - 5 (684)<br />

Baxter, S., GeneDx - 3 (1676)<br />

Bergstrom Lucas, A., Agilent Technologies - 3 (3726)<br />

Berman, J. R., Bio-Rad Laboratories - 3 (3690)<br />

Bianchi, D., Verinata Health, Inc. - 1, 2, 5, 11, 12;<br />

McGraw-Hill - 7; Wiley-Blackwell - 3 (Session 79)<br />

Bibikova, M., Illumina, Inc. - 1, 3 (1238)<br />

Biesecker, L. G., Wiley Blackwell - 5; Illumina Corp - 6<br />

(Session 73)<br />

Billaud, J., Ingenuity Systems - 3 (3677)<br />

Bishop, J., Life Technologies - 3 (3719)<br />

Blangero, J., Eli Lilly and Co - 2 (Session 8)<br />

Bloom, R. J., Agilent Technologies - 9, 12; Pacific<br />

Biosciences - 9, 12 (3659)<br />

Bombard, A. T., Sequenom, Inc. - 1, 3; UCSD - 3, 12<br />

(Session 79)<br />

Bostick, M., Clontech Laboratories, Inc - 3 (3727)<br />

Boyar, F. Z., Quest Diagnostics - 3, 10;<br />

Genomic Vision - 10, 12 (3522)<br />

Boysen, C., CLC bio - 3 (3528)<br />

Bready, B., Nabsys - 1, 3, 4, 10, 13 (3529)<br />

Brown, M. P. S., Pacific Biosciences <strong>of</strong> California -<br />

1, 3 (36)<br />

Brownstein, C. A., Boston Children’s Hospital - 3 (1769)<br />

Busche, S., WaferGen - 12 (256)<br />

Carulli, J. P., Biogen Idec - 1, 2, 3, 12 (2561)<br />

Casanova, J.-L., San<strong>of</strong>i-Aventis - 5, 11; Merck - 5<br />

(Session 80)<br />

Casuga, I., Ion Torrent/Life Technologies - 3 (3278)<br />

Chao, E. C., Ambry <strong>Genetics</strong> - 3 (2907)<br />

Cheng, S., Genzyme, a San<strong>of</strong>i Company - 1, 3, 10<br />

(793)<br />

Chiabai, M. A., CNPq - 2; FAP-DF - 2 (1202)<br />

Cho, J. H., Pfizer - 5 (Session 80)<br />

Chowdry, A. B., 23andMe Inc. - 1, 3 (1620)<br />

Cipriani, V., Cambridge Enterprise on behalf <strong>of</strong><br />

Cambridge University - 10; UCL business on behalf<br />

<strong>of</strong> University College London - 10 (2072)<br />

Conklin, B., iPierian Inc - 1 (Session 78)<br />

Conley, Y. P., University <strong>of</strong> Pittsburgh - 10 (1963)<br />

Costa, P., Agilent Technologies - 3 (922)<br />

Dai, X., Academy <strong>of</strong> Finland - 2; University <strong>of</strong><br />

Helsinki - 3; Chancellor’s Travel Grant - 14 (1265)<br />

DaRe, J., Transgenomic, Inc. - 1, 3 (688)<br />

Darnell, R. B., MSKCC (cloning Ri antigen) -<br />

7 (Session 24)<br />

Davidson, C., Life Technologies - 3 (3684)<br />

De La Vega, F., Omicia, Inc. - 1, 3, 5 (1770)<br />

Delio, M., NIH Grant Support - 2 (1494)<br />

de Paor, A., Irish Research Council for the <strong>Human</strong>ities<br />

& Social Sciences - 2 (1812)<br />

Dermitzakis, E. T., DNAnexus - 11 (561)<br />

Dewey, F., Personalis - 5 (1601)<br />

Dickson, P., BioMarin - 2; Genzyme - 2 (785)<br />

Durand, E. Y., 23andMe, Inc. - 3 (179)<br />

Eberle, M. A., Illumina - 1, 3 (942)<br />

Ehm, M. G., GlaxoSmithKline - 1, 2 (649)<br />

Eicher, J. D., J.S. <strong>Genetics</strong> - 1, 4, 7, 10, 11 (1973)<br />

Elboudwarej, E., Novartis - 5; Genentech - 5;<br />

San<strong>of</strong>i-Aventis - 5; GlaxoSmithKilne - 5 (3454)<br />

Erez, A., Neogenis - 12 (165)<br />

Eriksson, N., 23andMe - 1, 3 (114); Boehringer<br />

Ingelheim - 12 (619)<br />

Fagerholm, R., On-Q-ity Inc. - 12 (1171)<br />

Falk, M. J., United Mitochondrial Disease<br />

Foundation - 6 (2943)<br />

Feinerman, B., StemCellRegenMed - 3 (792)<br />

Francke, U., 23andMe, Inc. - 3 (1782)<br />

Friedlander, C., Fluidigm Incorp. - 1, 3 (3652)<br />

Gai, X., Agilent - 12 (3653)<br />

Gajecka, M., PerkinElmer, Inc., Spokane - 3 (934)<br />

Ganesh, S. K., Affymetrix - 11; BioGen Idec - 11 (1639)<br />

Geiss, G., Nanostring Technologies - 1, 3, 10 (1039)<br />

Germain, D. P., Amicus Therapeutics - 14 (772)<br />

Gilbert, D., VitaPath <strong>Genetics</strong>, Inc. - 1, 3 (75)<br />

Goizet, C., Genzyme - 2, 14; Shire - 14; Actelion -<br />

14 (716)<br />

Goker-Alpan, O., Shire HGT - 3, 14, (768)<br />

Gonzalez, K. D., Ambry <strong>Genetics</strong> - 3 (3065)<br />

Green, R. C., 23andMe, Inc. - 9, 12; Pathway<br />

Genomics Corporation - 12 (1825)<br />

Guettouche, T., Caliper - 12; Ion Torrent/Life<br />

Technologies - 14 (3706)<br />

Gunter, C., Kailos <strong>Genetics</strong> - 5 (Session 81)<br />

Hageman, G. S., Sequenom Inc - 5, 11;<br />

Optherion Inc - 10, 15; shareholder (Session 7)<br />

Hagerman, P., US Patent Office - 10; Pacific<br />

Biosciences - 5, 13 (477)<br />

Hagerman, R., Novartis - 2; Roche - 2; Seaside<br />

Therapeutics - 2 (770)<br />

Hart, R. K., Locus Development, Inc. - 1, 3, 4, 10, 13<br />

(3548)<br />

Hartshorne, T., Life Technologies - 3 (1146)<br />

Heckerman, D., Micros<strong>of</strong>t - 1, 3 (1379)<br />

Hegde, M., RainDance - 11; GenomeQuest - 11<br />

(Session 3)<br />

High, K., BioMarin Pharmaceuticals - 5; Bluebird Bio,<br />

Inc. - 1, 5; Bristol-Myers Squibb - 5; Elsevier - 7;<br />

Genzyme, Inc. - 11; INSERM - 15 tool; Jackson<br />

Laboratories - 15; McGraw Hill - 7; Nordic Biotech - 5;<br />

Novo Nordisk - 14, ); PTC Therapeutics - 12;<br />

Sangamo Biosciences|Life Sci (Session 23)<br />

Hirschhorn, J. N., Pfizer - 2 (Session 2, Session 81)<br />

H<strong>of</strong>fman, J., Good Start <strong>Genetics</strong> - 2; Genzyme<br />

Therapeutics - 2 (1729)<br />

Hogg, G., Sequenom Center for Molecular Medicine -<br />

3; Sequenom, Inc. - 3 (2973)<br />

Hoglund, B. N., Roche Molecular Systems - 3 (3713)<br />

Hollox, E. J., Pfizer - 2 (Session 22)<br />

Holstege, H., Life Technologies - 12 (494)<br />

Huang, A., Verinata Health, Inc. - 3 (3007)<br />

Ibrahim, J., Shire HGT - 3, 14 (769)<br />

Jacob, H., Primary <strong>Genetics</strong> - 4 (Session 3)<br />

Jansen Spayd, K., Kailos <strong>Genetics</strong> Inc. - 3 (1245)<br />

Javed, A., Gene Link, Inc - 3 (2631)


Jensen, T. J., Sequenom, Inc. - 1, 3 (3014)<br />

Jeong, K., Agilent Technologies - 3 (3459)<br />

Jiang, R., Williams LifeSkills, Inc. - 1, 4 (2481)<br />

Johnson, F. K., Amicus Therapeutics - 1, 3 (732)<br />

Joun, D., Life Technologies - 3 (1246)<br />

Kaper, F., Illumina, Inc. - 3 (596)<br />

Karczewski, K. J., Personalis - 10 (562)<br />

Kennedy, C. J., Good Start <strong>Genetics</strong> - 1, 3, 10 (3640)<br />

Kitzman, J. O., Univ <strong>of</strong> Washington - 10 (74)<br />

Kong, A., deCode <strong>Genetics</strong> - 3 (Session 75)<br />

Kormanik, K., Hyperion Therapeutics - 2; NIH - 2 (662)<br />

Kutalik, Z., GlaxoSmithKline - 12 (1387)<br />

Laberge, A. M., Fourth Dimension Spine LLC (NYC,<br />

USA) - 2 (1784)<br />

Langmore, J. P., Rubicon Genomics, Inc. - 1, 3, (3689)<br />

Laurance, M., Ingenuity - 3 (3560)<br />

Lebo, R., USPTO-application - 10 (2972)<br />

Le Clerc-Blain, J., Cree Board <strong>of</strong> Health and Social<br />

Services <strong>of</strong> James Bay - 14 (1733)<br />

Ledbetter, D. H., Roche Nimblegen - 5; Celula - 5<br />

(Session 77)<br />

Letra, A., NIH - 2 (1936)<br />

Levy, B., Natera - 1, 5, 11 (73)<br />

Li, C., Life Technologies - 3 (3714)<br />

Li, H., The National Natural Science Foundation <strong>of</strong><br />

China 30770106 - 2 (798)<br />

Li, M., Life Technologies - 14 (399)<br />

Lih, C.-J., Life Technologies - 12 (1068)<br />

Lins, T. C. L., CNPq - 2; CAPES - 2; FAP-DF - 14 (3272)<br />

Liu, P., New England Biolabs - 3 (3715)<br />

Loomis, E. W., Pacific Biosciences <strong>of</strong> California, Inc -<br />

9, 12 (2633)<br />

Lorget, F., BioMarin - 3, 10; INSERM U781 - 12 (763)<br />

Luke, M. M., Celera - 3, 4 (1603)<br />

Luo, M., Mount Sinai School <strong>of</strong> Medicine - 10 (1777)<br />

Lyon, E., Novartis - 5; Complete Genomics - 1, 5;<br />

Oregon Health Sciences - 14; National <strong>Society</strong> <strong>of</strong><br />

Genetic Counselors - 14; University <strong>of</strong> Utah/ARUP<br />

Laboratories- 3; NICHD/NIH- 2; NHGRI/NIH- 2<br />

(Session 3)<br />

Madhusoodanan, J., NextBio - 3 (1183)<br />

Mancini-DiNardo, D., Myriad Genetic Laboratories,<br />

Inc. - 1, 3 (1021)<br />

Manokhina, I., Partnership for Clean Competition - 2<br />

(1760)<br />

Marques, F. A., CNPq - 2; CAPES - 2; FAP-DF - 14 (1880)<br />

Martin, C. L., Emory <strong>Genetics</strong> Laboratory - 3; NIH - 2;<br />

Simons Foundation - 2 (Session 17, Session 77)<br />

Martis, S., MRC Holland - 3 (652)<br />

Marziali, A., Boreal Genomics - 3, 4, 6, 10 (1264)<br />

Matsunami, N., Lineagen Inc. - 1, 2 (2397)<br />

McDonald, M. N., NIH - 2; GlaxoSmithKline funded<br />

ECLIPSE study - 2 (2249)<br />

McInerney, P., Illumina, Inc. - 1, 3; Epicentre, Inc.<br />

(an Illumina company) - 3 (3697)<br />

McKay, G. J., Nutrasight Consultancy Limited - 5 (1897)<br />

Mehta, G. R., Locus Development - 1, 3, 4, 10, 13 (3692)<br />

Menashe, I., MindSpec - 3 (446)<br />

Meredith, G., Life Technologies Corp - 1, 3 (3717)<br />

Mikula, M., Dept Molecular <strong>Genetics</strong>, Quest<br />

Diagnostics Nichols Inst, San - 1, 3 (2260)<br />

Miyagawa, T., Clinical Trial Operations Division, Site<br />

Support Institute C - 3 (2656)<br />

SPEAKER AND AUTHOR DISCLOSURES 331<br />

Morales, A., Informed Medical Decisions, Inc. -<br />

5 (1681)<br />

Moreno, T., Pathway Genomics - 1, 3, 12 (Session 9)<br />

Morford, L., <strong>American</strong> Association <strong>of</strong> Women Dentists -<br />

2; Southern Association <strong>of</strong> Orthodontists - 2 (1147)<br />

Morgan, T., Biomarin - 15; Clinical trial support for all<br />

but the first author (730)<br />

Mountain, J., 23andMe, Inc. - 1, 3 (Session 9)<br />

Mowery-Rushton, P. A., Signature Genomic<br />

Laboratories, PerkinElmer, Inc., Spokane, - 3 (3101)<br />

Moya, P. R., F. H<strong>of</strong>fmann-La Roche AG - 3 (261)<br />

Muller, R., Biomatrica - 3 (3720)<br />

Mullins, M. E., 23andMe, Inc. - 3 (2127)<br />

Munafo, D., New England Biolabs, Inc - 3 (512)<br />

Musci, T., Ariosa Diagnostics - 1, 3 (2978)<br />

Myres, N., AncestryDNA - 3 (3321)<br />

Neale, B. M., Illumina - 14 (2618)<br />

Nestrasil, I., Shire HGT - 2, 5 (714)<br />

Nguyen-Nielsen, M., Edimer Pharmaceuticals<br />

(MA, USA) - 2 (1565)<br />

Nicholls, K., GSK - 1, 3, 14; Amicus - 1, 3, 11, 14 (745)<br />

Niemi, A.-K., United Mitochondrial Disease<br />

Foundation - 2 (744)<br />

Nishida, A., JCR Pharmaceuticals - 3 (781)<br />

Normanno, N., Life Tecnologies - 12 (1060)<br />

Noto, K., Ancestry.com - 1, 3; AncestryDNA - 1 (3365)<br />

Nurmi, E. L., BioMarin - 5; Novartis - 5; Seaside<br />

Therapeutics - 2; Roche - 2 (639)<br />

Nussbaum, R. L., Complete Genomics -<br />

1, 5 (Session 77)<br />

Oeth, P., Sequenom, Inc. - 1; Sequenom Center for<br />

Molecular Medicine - 3 (3016)<br />

Oliver, J. S., Nabsys - 1, 3, 4, 10, 13 (3656)<br />

Ong, F. S., National Institutes <strong>of</strong> Health - 2; Cedars-<br />

Sinai Medical Center - 2; Complete Genomics,<br />

Inc. - 15; Illumina, Inc. - 15; Stock Ownership<br />

(not stock options as in 1) (130)<br />

O’Roak, B. J., Yale University - 10 (10)<br />

Ota, V. K., FAPESP - 2 (2533)<br />

Pallone, N. L., BioMarin - 2; Nutricia - 2; Vitaflo - 2;<br />

Mead Johnson - 2 (742)<br />

Pare, G., Boehringer Ingelheim Pharma Inc. - 2, 5, 8,<br />

12 (617)<br />

Patsalis, P., NIPD <strong>Genetics</strong> Ltd. - 10 (3017)<br />

Peltekova, V., OICR - 2; CIHR - 2; Ontario Research<br />

Funds - 2 (1093)<br />

Peng, Q., QIAGEN - 3 (1263)<br />

Peng, X., Life Technologies - 3 (3698)<br />

Perez-Jurado, L. A., qGenomics - 6, 11 (2711)<br />

Pericak-Vance, M. A., Artic Dx, Inc - 10 (Session 7)<br />

Peterschmitt, M. J., Genzyme - 3 (773)<br />

Phelan, M., NuGEN Technologies, Inc. - 1, 3 (3699)<br />

Porreca, G. J., Good Start <strong>Genetics</strong> - 1, 3, 10 (3680)<br />

Potocki, L., Baylor College <strong>of</strong> Medicine - 3 (Session 28)<br />

Pour-Jafari, H., Hamadan Univ Med Sci - 3 (860)<br />

Powers, N. R., JS <strong>Genetics</strong>, Inc - 4, 7, 10, 11, 13 (2010)<br />

Rabinowitz, M., Natera, Inc. - 3, 1, 10 (3018)<br />

Rath, M., Life Technologies Inc. - 3, 10 (532)<br />

Ray, F. A., KromaTiD Inc. - 1, 3, 4, 10 (948)<br />

Raz, T., GnuBio - 3 (3700)<br />

Rehm, H. L., Partners Healthcare - 3; Complete<br />

Genomics - 11; GenomeQuest - 11; Illumina - 12<br />

(Session 77)<br />

SPEAKER/AUTHOR DISCLOSURES


332 SPEAKER AND AUTHOR DISCLOSURES<br />

Requa, M., BioNano Genomics, Inc - 3 (3649)<br />

Richard, G., GeneDx - 3 (2579)<br />

Richards, S., Life Technologies - 15; Receive<br />

discounted reagents and share data (Session 3)<br />

Rieder, M. J., Adaptive Biotechnologies - 1, 3 (530)<br />

Riley-Gillis, B., H<strong>of</strong>fmann-La Roche - 3 (1252)<br />

Roberts, J. S., 23andMe - 12; Pathway Genomics - 12<br />

(Session 9)<br />

Rodríguez-Santiago, B., Quantitative Medicine<br />

Laboratories - 3 (3208)<br />

Rogan, P. K., Cytognomix - 10 (3672)<br />

Romano-Silva, M., FAPEMIG: CBB-APQ-00075-09 - 2;<br />

CNPq 573646/2008-2 - 2 (2385)<br />

Romero, J. A., Life Technologies - 3 (3708)<br />

Roos, F., Agilent Technologies - 3 (3685)<br />

Rosenfeld, J. A., Signature Genomic Laboratories,<br />

PerkinElmer, Inc. - 3 (274)<br />

Russell, A., Omicia, Inc. - 1, 3, 4 (3602)<br />

Ruvolo, M., Agilent Technologies - 3 (975)<br />

Sá, M. J. N., Harvard Medical School Portugal<br />

<strong>Program</strong> - Junior Award - 2; Fundação para a<br />

Ciência e Tecnologia - 2 (3122)<br />

Saisanit, S., Roche Pharmaceuticals - 3 (3580)<br />

Schiffmann, R., Amicus Therapeutics - 2, 3, 5;<br />

Progrnosys, Biosciences, Inc - 3; Shire <strong>Human</strong><br />

Genetic Therapies - 2, 5 (1684)<br />

Schmidt, J. L., NIHDS/NIH - 2; <strong>American</strong> Academy <strong>of</strong><br />

Neurology - 2; BDF Newlife and National Institutes for<br />

Health Research - 2; USPTO - 3; patent pending (2452)<br />

Schwartz, S., Laboratory Corporation <strong>of</strong> America - 3 (949)<br />

Scott, C. R., Genzyme Corporation - 5 (727)<br />

Segal, M. M., SimulConsult - 3, 4, 10, 13 (3581)<br />

Sidow, A., DNAnexus - 1, 5 (397)<br />

Sikela, J. M., GATC Science LLC - 4, 7, 10, 13<br />

(Session 22)<br />

Siklosi, K. R., Cystic Fibrosis Foundation - 2 (1731)<br />

Smaoui, N., GeneDx - 3 (1765)<br />

Snyder, M. W., Ariosa Diagnostics - 11; Stratos<br />

Genomics - 11; Good Start <strong>Genetics</strong> - 11; Adaptive<br />

TCR - 11 (94)<br />

Soler, C. V., CINAPCE <strong>Program</strong>, Campinas, Brazil -<br />

12 (2233)<br />

Song, K., Ariosa Diagnostics - 1, 3 (3020)<br />

Spritz, R. A., Pfizer - 15; Spouse full-time employee<br />

<strong>of</strong> Pfizer, Inc. (Session 80)<br />

Srinivasan, A., Verinata Health, Inc. - 3 (3021)<br />

Stuenkel, A. J., Ambry <strong>Genetics</strong> - 1, 3 (1767)<br />

Superko, H. R., Celera Corporation, Alameda, CA., - 3;<br />

Medco Research Institute, LLC/an Express Scripts<br />

Company, Bethesda, MD - 1, 3; Ariosa Diagnostics<br />

Inc. - 3 (1714)<br />

Swaroop, A., University <strong>of</strong> Michigan - 7, 10 (Session 7)<br />

Syed, F., Illumina - 3 (3718)<br />

Talkowski, M. E., Signature Genomic Laboratories,<br />

PerkinElmer, Inc - 3 (68)<br />

Tang, M., Sequenom CMM - 3; Sequenom Inc - 1 (3023)<br />

Tanzi, R. E., Prana Biotechnology - 1, 5 (Session 10)<br />

Tavares, P., CGC <strong>Genetics</strong> - 13 (1778)<br />

Tavtigian, S. V., Myriad <strong>Genetics</strong>, Inc. - 7, 10 (1783)<br />

Taylor, J., Ariosa Diagnostics - 5 (2989)<br />

Taylor, J. C., LifeTechnologies - 12; Johnson &<br />

Johnson - 12; AstraZeneca - 12 (133)<br />

Thompson, J., Nabsys - 1, 3, 4, 10, 13 (3703)<br />

Thomson, N., CLC bio - 1, 3 (3662)<br />

Torchia, B., Signature Genomic Laboratories,<br />

PerkinElmer, Inc., Spokane,WA - 3 (902)<br />

Uhl, G., Duke University - 10 (2541)<br />

Umbarger, M. A., Good Start <strong>Genetics</strong> - 1, 3, 10 (3693)<br />

Utz, J., Genzyme - 2; Actelion, Shire - 5; Actelion,<br />

Shire, BioMarin, Genzyme - 8 (1855)<br />

Vaidya, D., Excet Inc - 5 (1710)<br />

Vaidyanathan, R., Epicentre (an illumina Company) - 3;<br />

Illumina - 3 (585)<br />

van der Valk, R. J. P., GlaxoSmithKline - 2 (2168)<br />

Vasenkova, I. A., Kailos <strong>Genetics</strong> Inc. - 3 (3687)<br />

Velasco, H., National University - 3 (703)<br />

Visitacion, M. R., Agilent Technologies, Inc - 3 (3709)<br />

Voorhoeve, E., Signature Genomics Laboratories - 3<br />

(98)<br />

Wang, L.-S., Johnson & Johnson Pharm Res & Dev -<br />

2 (342)<br />

Wang, X., Fluidigm Corp. - 1, 3 (3619)<br />

Watts, G. S., Ion Torrent - 9 (3712)<br />

Wernig, M., Fate Therapeutics - 7, 10; Stem Cells Inc. -<br />

11 (Session 78)<br />

Westbrook, J., Locus Development, Inc. - 1, 3 (1771)<br />

White, M., Hypogen - 1, 4, 11, 13 (245)<br />

Whitley, C. B., Shire <strong>Human</strong> Genetic Therapies - 2, 5,<br />

11, 12, 14 (801)<br />

Wisotzkey, R., NextBio - 3 (1190)<br />

Woo, C., Life Technologies - 3 (3520)<br />

Woo, S., Korean Coral Resources Bank, Ministry <strong>of</strong><br />

Land Transport Mari - 2; Korea Ocean Research and<br />

Development Institute - 2 (3673)<br />

Wu, S., 23andMe, Inc. - 1 (2149)<br />

Xie, P., Merck - 2; Eli Lilly and Co - 5; GlaxoSmithKline<br />

- 5; Alkermes - 5 (2621)<br />

Xue, Z., GlaxoSmithKline - 1, 2, 3 (651)<br />

Yamasaki, M., Central Research Laboratory, Hitachi<br />

Ltd, Tokyo, Japan - 12 (2496)<br />

Yim, P. W., Life Technologies - 3 (486)<br />

Zeng, W., Ambry <strong>Genetics</strong> - 3 (2698)<br />

Zhan, Y., Affymetrix - 1, 3 (1582)<br />

Zhang, Z., UMDF - 6 (534)<br />

Zhao, Z., MolecularMD - 5; GlaxoSmithKline - 11;<br />

Millennium Pharmaceuticals - 11; Illumina - 5 (136)<br />

Zhong, J., Roche - 3 (242)<br />

Ziegler, A., Affymetrix - 12 (1443)<br />

Zimran, A., Protalix Biotherapeutics - 1, 5, 11, 14;<br />

Shire <strong>Human</strong> Genetic Therapies - 8, 14 (788)


1<br />

1000 Genomes Consortium,<br />

331, 3360T, 3380W<br />

1000 Genomes Project, 41<br />

1000 Genomes Project<br />

Consortium, 3636W<br />

16p11.2 European Consortium<br />

Collaborators, 62<br />

A<br />

Aaltonen, L., 997T<br />

Aanestad, M., 3614W<br />

Aartsma-Rus, A., 574W<br />

Ababon, M., 2216F<br />

Ababon, M. R., 2426F<br />

Abad, C., 2837T<br />

Abbasi, F., 1624T<br />

Abbott, D. E., 195<br />

Abd El-Fattah<br />

El- Hashash, O., 214<br />

AbdElHafez, H., 1922F<br />

Abdelhak, S., 105<br />

Abdellaoui, A., 459F<br />

Abdel-Magid, N., 2785W,<br />

2892F, 2904F<br />

Abdelmalek, M., 531F<br />

Abdelmoula Bouayed, N.,<br />

539F<br />

Abdel-Rahman, M. H.,<br />

1197W<br />

Abdenur, J., 2895F<br />

Abdollahi, B. S., 2150F<br />

Abdrabou, W., 2154W<br />

Abd Ruboh, A., 930T<br />

Abdulkareem, N., 1584T*<br />

Abdul-Rahman, O. A., 124,<br />

3076F*<br />

Abdul Razack, A. H., 1083W<br />

AbdusSamad, M., 1300F<br />

Abe, T., 396, 2051F<br />

Abe, Y., 1317T<br />

Abecasis, G., Session 7,<br />

88, 108, 113, 176, 177,<br />

186, 476W, 547F, 641T,<br />

1370W, 1391W, 1429F,<br />

1451W, 1513F, 1516F,<br />

1521T, 1525F, 1533T,<br />

1558F, 1568W, 1923W,<br />

2001W, 2090F, 2102F,<br />

2135F, 2198F, 2308T,<br />

3466T, 3664W<br />

Abecasis, G. R., 46, 117,<br />

154, 157, 170, 276,<br />

1448W, 1545T, 1952F,<br />

2183F, 2329T, 2339F<br />

*Presenting Author<br />

SPEAKER AND AUTHOR INDEX<br />

This index includes an alphabetical listing <strong>of</strong> all speakers, presenting authors, co-authors<br />

and study groups/consortia for the <strong>2012</strong> <strong>ASHG</strong> meeting. Session numbers follow invited<br />

speaker names; abstract numbers follow poster/platform author names. Presenting<br />

author names are noted with an asterisk.<br />

Abel, L., 365, 2003F, 3599F<br />

Abell Aleff, P. C., 1695T<br />

Aberg, K. A., 3442T*, 3452T<br />

Abhyankar, A., 127, 202,<br />

3599F<br />

Abifadel, M., 1607T<br />

Abi-Rached, L., 3710W<br />

Ables, A., 2989T<br />

Abnet, C. C., 1010F, 1076F<br />

Abney, M., Session 75, 278,<br />

1395T, 1488T<br />

Abolhasani, M., 2013W<br />

Abou Jamra, R., 2557T*<br />

Abouzehry, A., 3526W<br />

Abraham, A., 931W<br />

Abramowicz, M., 105<br />

Abrams, A., 794W<br />

Abrams, D. J., 2546F<br />

Abrams, G., 1965W<br />

Abramson, K., 1444F<br />

Abramzon, Y., 2611T, 2648F<br />

Abrantes, P., 1977W<br />

Abrantes, P. C. S., 2085W*<br />

Abruzzo, M. A., 2752W<br />

Absher, D., 434W, 3443T*<br />

Absher, D. M., 2223W,<br />

3318T<br />

Abu-Amero, K., 2997T<br />

Abu-Amero, S., 303, 3508T<br />

Abu Rayyan, A., 2919F<br />

Abu-staiteh, A., 3155W<br />

Abyzov, A., 334, 3251W<br />

Accardi, J. P., 2938W<br />

ACE <strong>Genetics</strong> Consortium,<br />

2479T, 2658W<br />

ACE Network Consortium,<br />

553F<br />

Acevedo, S., 3390T<br />

Aceves-Aceves, M. A.,<br />

3187W, 3188F<br />

Achatz, M. I. W., 1102T,<br />

1217F*<br />

Achermann, J. C., 361<br />

Achkar, J. P., 1466W<br />

Achkar, W. A. L., 1490W<br />

Ackerman, H. H., 2561F<br />

Ackerman, M. J., 2885T,<br />

2906T<br />

Ackerman, S. L., Session 24<br />

Acosta, O., 2296T<br />

Acosta Guio, J., 3041W*<br />

Acosta-Herrera, M., 2296T<br />

Acosta Lebrigio, R. F.,<br />

2615F<br />

Acosta-Perez, E., 3449T<br />

Acquaye, T. K., 626T<br />

Acuna, B., 1289W, 1301W,<br />

1414F, 1455T<br />

Adachi, H., 2129F<br />

Adachi, K., 2440T<br />

Adachi, M., 1795W, 2891T<br />

Adachi, S., 2133W<br />

Adair, C. D., 3020T<br />

Adala, L., 2744T<br />

Adam, M. P., 1753W*<br />

Adam, S., 1840F*, 1846W<br />

Adamczyk, A., 2566T<br />

Adami, H.-O., 991T<br />

Adams, C., 953W, 3717F<br />

Adams, D., 359*, 2870T<br />

Adams, D. J., 105<br />

Adams, D. R., 2938W,<br />

3543F<br />

Adams, E., 784W<br />

Adams, J., 1706T*<br />

Adams, L., 1834F<br />

Adams, M. C., 231*<br />

Adams, S. A., 832F*<br />

Adamski, J., 2226W, 2548T<br />

Adamusiak, T., 3610W<br />

Adane, S., 1268F<br />

Adayev, T., 2449T<br />

Addai, J., 2979T<br />

Addess, K., 3582W<br />

Addis, L., 1531F, 2580W*<br />

Addison, S. M. F., 378<br />

Adebamowo, C., 1003T,<br />

1848W<br />

Adebowale, A., 2063F<br />

Adela Mansilla, M., 2325W<br />

Adès, L. C., 3167W<br />

Adey, A., 3721F<br />

Adey, A. C., 1014W*<br />

Adeyemo, A., 241, 1515T,<br />

1886F, 1959W, 3533F<br />

ADGC, ADNI, GERAD, 340<br />

ADGC Consortium, 343<br />

Adhikari, K., 3327T*<br />

Adhikari, N., 1665T<br />

Adir, V., 3202F*<br />

Adkins, A. E., 2504F<br />

Admiraal, R. J. C., 58<br />

Adoue, V., 569F, 3439T<br />

Adrianto, I., 529F, 1895F,<br />

2084F, 2188T<br />

Afanador, Y. M., 3315T*<br />

Afanasjev, V., 1140W<br />

Afenjar, A., 127, 131<br />

Afi Rawlings-Goss, R., 518W*<br />

African <strong>American</strong> BMI<br />

Consortium, 2131T,<br />

3299W<br />

Afzal, V., 4, 407<br />

Agarwal, A., 2028W, 2318F<br />

Agarwal, P., 649T<br />

Agarwal, S., 2446T, 2700F*<br />

333<br />

Agarwala, V., 2209T*<br />

Agate, S., 2014T<br />

Agatep, B. C., 1714T<br />

AGEN-T2D, DIAGRAM,<br />

MA-T2D and SA-T2D<br />

Consortia, 49<br />

Aggarwal, A., 1235F<br />

Aggarwal, R., 3508T<br />

Aggarwal, S., 555F<br />

Aggarwal, V., 73, 957W,<br />

977W*<br />

Aggen, S., 3512T<br />

Agioutantis, Z., 2902W<br />

Aglan, M., 2937F<br />

Agne, E., 3729F<br />

Agolini, E., 2760F*<br />

Agosti, V., 1985F<br />

Agostini, J., 1732W, 2775F<br />

AGP Consortium, 2492F<br />

Agrap, B., 1172F<br />

Agrawal, A., 2582F, 2598W<br />

Agrawal, P., 2811F*<br />

Agrawal, P. B., 3219W<br />

Agrawal, S., 2353T, 2992T<br />

Aguena, M., 814F, 852F<br />

Aguglia, U., 2780T<br />

Aguiar, M. J. B., 2434T,<br />

3107W, 3110F<br />

Aguiar, V. R. C., 182, 1573F*<br />

Aguiar-Garcia, P., 650T<br />

Aguilar-Chávez, E. A., 2363F<br />

Aguilar-Pimentel, J. A.,<br />

2922F<br />

Aguilar-Salinas, C. A.,<br />

2256W<br />

Aguilera, M., 728T<br />

Aguilera, P., 1053W<br />

Aguinaldo, K., 3698W<br />

Aguirre Hernandez, J.,<br />

1105T*<br />

Agusti, A., 2249F<br />

Aguzzi, R., 773W<br />

Ahaghotu, C., 1009T<br />

Ahearn, J., 458W<br />

Ahituv, N., 246, 1995W<br />

Ahluwalia, T. S., 2317T,<br />

2347T*<br />

Ahmadi, A., 3201W<br />

Ahmadi, K., 44, 583F<br />

Ahmadzadeh, A., 1118F<br />

Ahmed, A., 714T, 715F*<br />

Ahmed, A. F., 2047T<br />

Ahmed, I., 3078F<br />

Ahmed, M., 3078F<br />

Ahmed, R., 931W<br />

Ahmed, S., 209<br />

Ahmed, Z. M., 2724F,<br />

2959W, 3194F, 3212F<br />

SPEAKER AND AUTHOR INDEX


334 SPEAKER AND AUTHOR INDEX<br />

Ahmudavalli, S. M., 300<br />

Ahn, C., 3223W<br />

Ahn, H., 3461T<br />

Ahn, J., 1243T<br />

Ahn, J. W., 906T*<br />

Ahn, K., 1338T, 2584T*<br />

Ahn, Y., 1657T<br />

Aho, H., 1139F<br />

Ahonen, S. J., 2913F*<br />

Ahonen-Bishopp, A.,<br />

3610W<br />

Ahsan, B., 52, 2409W<br />

Ahsan, H., 2025W<br />

Ahting, U., 699F, 782W<br />

Aiello, A., 435F<br />

Ainehsazan, E., 2801T<br />

Ainsworth, P. J., 1138T*,<br />

3672W<br />

Airaud, F., 1204T<br />

Aird, D., 322<br />

Aissat, A., 572W<br />

Aitchison, A., 3440T<br />

Aitman, T. J., 1618T, 2005T<br />

Aittomäki, K., 897W, 1006T,<br />

1117T, 1171T, 1265F<br />

Ait Yahya Graison, E.,<br />

3674W*<br />

Aiyar, L., 320*<br />

Ajay, S., 2293T<br />

Ajbro, K. D., 805F*<br />

Ajit Bolar, N., 80<br />

Akalin, A., 3464T<br />

Akarsu, N., 219<br />

Akay, H., 2772F<br />

Akbari, M., 2013W<br />

Akbari, M. T., 2290T*<br />

Akbari, S., 2135F<br />

Aken, B. L., 506W<br />

Aker, L., 2139W<br />

Akerlund, M., 190<br />

Akerstedt, A. M., 168<br />

Akey, J., 283<br />

Akey, J. M., 10<br />

Akhabir, L., 1465F<br />

Akin, H., 965W, 1106F*<br />

Akinrinade, O., 992F<br />

Akinsanya, K., 1605T<br />

Akiyama, J., 407<br />

Akiyama, J. A., 254<br />

Akler, G., 3395W<br />

Akmen, H. O., 232<br />

Akoume, M.-Y., 2234F<br />

Akoury, E., 2842W, 2981T*<br />

Aksakal, O., 594W<br />

Aktas, S., 1025F<br />

Akula, N., 260*, 2622W<br />

Akushevich, I., 2027F<br />

Akutsu, K., 1697T<br />

Akylbekova, E., 350<br />

Akylbekova, M., 2210F<br />

Akyol, M., 1136F<br />

Al Ageeli, E., 1205F<br />

Al-Ahmari, A., 3149W*<br />

Alaimo, J. T., 640T*<br />

Ala-Koko, L., 1892F<br />

Ala-Korpela, M., 656T, 1623T<br />

Alakulppi, N., 2023T<br />

Alakus, H., 395<br />

Al-Alem, U., 2281T<br />

Al-Ali, F. M. S., 2731W<br />

*Presenting Author<br />

Ala-Mello, S., 252<br />

Al-Amri, F., 2713W<br />

Al-Aqeel, A., 723F*<br />

Al-Aqeel, S., 1266W*<br />

Alarcón-Riquelme, M. E.,<br />

1979F, 2046W, 3382F<br />

Alassiri, H., 3155W<br />

Alasti, F., 419F*<br />

Alavi-Naini, SM., 843F<br />

Al-Awwami, M., 3149W<br />

Al-azzam, S., 856T<br />

Albanes, D., 1012T, 1091F,<br />

1154F<br />

Albers, C. A., 383*<br />

Albers, J. J., 1605T<br />

Albertyn, Z., 242<br />

Albino, E., 1987T*<br />

Albracht, D., 465F<br />

Albrecht, E., 2086T*, 2175W<br />

Albrechtsen, A., 2311T,<br />

2317T, 2347T, 3289F,<br />

3312T<br />

Albright, F., 1328W<br />

Albu, C. C., 3005T*, 3009T,<br />

3067W<br />

Albu, D. F., 3005T, 3009T*,<br />

3067W<br />

Albuisson, J., 3233W<br />

Alby, C., 77, 403, 3240F<br />

Alcaïs, A., 1374T, 2003F<br />

Alcalay, R., 746T<br />

Al-Chalabi, A., 348<br />

Alcivar, 872T<br />

Alda, M., 2338T, 2342F<br />

Al-Dhekri, H., 3155W<br />

Al-Dosari, S., 2713W<br />

Aldrich, J., 1240T<br />

Alechine, E., 3364F, 3402T<br />

Aleman, G., 526W<br />

Alembik, Y., 3073W<br />

Alenius, G. M., 2160W<br />

Alessandri, J.-L., 3172F<br />

Alessandri, M., 1786W,<br />

1787W<br />

Alexander, G. J., 153<br />

Alexander, I. E., 166<br />

Aleyasin, A., 2980T<br />

Al-Fadhly, F., 2676F<br />

Al-Fawaz, I., 3149W<br />

Alfieri, P., 3087W<br />

Alfredsson, L., 1455T<br />

Al-Gazali, L., 8, 160, 2740W,<br />

2937F<br />

Al-Ghonaium, A., 3155W<br />

Alha, P., 1835W<br />

Alhaddad, H., 3252T<br />

Al-Hafid, N., 166<br />

Al-Hait, S., 2937F<br />

Al-Hamed, M. H., 2676F*<br />

Al-Hazza, S., 2734W<br />

Al-Hertani, W., 675F*, 720T<br />

Ali, B. R., 160<br />

Ali, G., 2631W<br />

Ali, M., 2403W, 2959W<br />

Ali, R., 2899W<br />

Ali, S., 2821W<br />

Aliefendioglu, D., 702T<br />

Alikashani, A., 1678T,<br />

1982F, 2319W<br />

Alizadeh, B. Z., 111, 2073W<br />

Alizadeh, S. A., 1096T<br />

Al-Jasmi, F., 2937F<br />

Alkan, C., 14<br />

Al-Kateb, H., 912T, 1028F*<br />

Alkayal, F., 3369T<br />

Alkelai, A., 53, 2875W*<br />

Alkhateeb, A., 1881W*<br />

Alkrinawi, S., 2738T<br />

Allache, R., 1910F*<br />

All-Allawi, N., 2937F<br />

Allam, R., 2734W<br />

Allamand, V., 2436W<br />

Allanson, J., 124, 150, 1852F<br />

Allayee, H., 110<br />

Allegra, M., 218<br />

Allegri, L., 845F<br />

Allen, A. S., 1349W<br />

Allen, C., 1823W*<br />

Allen, E., 1971W*<br />

Allen, E. G., 253, 3042F<br />

Allen, J., 2465F<br />

Allen, M., 1316W, 1377T,<br />

1671T, 1713T, 3719F<br />

Allen, S., 36<br />

Allen, S. J., 406, 2850F<br />

Allik, A., 1832F<br />

Allingham, R. R., 386,<br />

2154W, 2240F, 2263T<br />

Allingham-Hawkins, D.,<br />

1820F*<br />

Allione, A., 1712T<br />

Allon-Shalev, S., 1165T<br />

Al-Maawali, A., 1704T<br />

Almada, B. V. P., 814F, 852F<br />

Al-Mahdawi, S., 761W<br />

Al-Marri, A., 2933T, 3399W<br />

Almarri, M. A., 153<br />

Almasy, A., 1651T<br />

Almasy, L., 1280W, 1406W,<br />

2061W, 2308T, 2309F,<br />

2503T, 2582F, 2589W,<br />

2651F<br />

Almasy, L. A., 1923W<br />

Almeida, B. S., 994T, 1946F<br />

Almeida, J., 2417F, 2502W<br />

Almeida, M., 176, 1280W,<br />

1513F, 2308T, 2339F<br />

Almeida, M. A., 1923W*,<br />

2309F<br />

Almeida, R., 523F<br />

Almeida, T. F., 2232W*,<br />

3152F, 3184F, 3295F<br />

Almeida-King, J., 497F<br />

Almeida-Souza, L., 201,<br />

2948T<br />

Almli, L. M., 1422T, 2420F*,<br />

3480T<br />

Almoguera Castillo, B.,<br />

1659T<br />

Al-Mostafa, A., 2734W<br />

Al-Mousa, H., 3155W<br />

Al-Muhsen, S., 3155W<br />

Almureikhi, M., 2899W<br />

Almusa, H., 327, 2888T<br />

Al-Mutawa, M., 2713W<br />

Al-Olama, A., 1011W<br />

Alonso, A., 1403W, 1585T<br />

Alonso, I., 1964F, 2736F,<br />

2818W<br />

Alonso, N., 2687T<br />

Alonso, P., 2593T<br />

Alonso Barragan, S. A.,<br />

3187W<br />

Al-Owain, M., 2734W<br />

Al-Saad, S., 8<br />

Al-Saffar, M., 8<br />

Al-Sannaa, N., 219<br />

Al-Sarraj, S., 3476T<br />

Al-Sarraj, Y., 2899W, 3140F,<br />

3526W*<br />

Al-Saud, B., 3149W<br />

Al-Saud, B. K., 3155W<br />

Al-Shambri, S., 3149W<br />

Alsmadi, O., 3149W,<br />

3155W, 3369T<br />

Al-Sum, Z., 3155W<br />

Altaescu, G., 788W<br />

Altamirano, M., 1022F<br />

Altamuro, D., 966T<br />

Altansukh, T., 3248F<br />

Altarescu, G., 746T, 2991T*,<br />

2993T, 3002T<br />

Altemose, N., 284<br />

Altenmüller, E., 200<br />

Alter, B. P., 1196F<br />

Altincik, A., 2758W<br />

Altinors, N., 1013F<br />

Altiokka Uzun, G., 2396F,<br />

2412W<br />

Altman, R. B., 633T, 635T,<br />

646T<br />

Altmann, A., 2483F<br />

Altmüller, J., 2759T, 2861T,<br />

2869W, 2930T, 2944W<br />

Altshuler, D., 176, 208, 249,<br />

280, 1677T, 2209T<br />

Altug, T., 2429F<br />

Al-Turki, S., 101, 216, 364<br />

Altuzara, C., 2770W<br />

Altuzarra, C., 329<br />

Alul, F., 1882T*<br />

Alvarado, C., 398<br />

Alvarado, D. A., 220<br />

Alvarado, D. M., 2860W*<br />

Alvarado, M., 1741W, 1866F<br />

Alvarez, M., 3449T<br />

Alvarez, M. C., 1187F<br />

Alvarez, M. I., 2940F, 3217W<br />

Alvarez, V., 2930T<br />

Alvarez-Mora, M.-I., 2624F<br />

Alvarez-Serrano, A., 3363T<br />

Alver, M., 2144F<br />

Alves, S., 3122F<br />

Alves-Ferreira, M., 2818W*<br />

Alvim-Soares, A., 2385W<br />

Alvizi, L., 2673F*, 2746W<br />

Al-Yahyaee, S. A., 160<br />

Alzheimer’s Disease <strong>Genetics</strong><br />

Consortium, 342, 344,<br />

1476T, 1571W, 2498F<br />

Alzheimer’s Disease<br />

Neuroimaging Initiative,<br />

2511W, 2531F<br />

Alzoubi, K., 855W, 856T*<br />

Amagai, M., 2911W<br />

Amara, A., 1751W, 2744T<br />

Amaral, M. D., 1731W<br />

Amarillo, I. E., 950T<br />

Amata, S., 3114F<br />

Amato, R. S., 432W


Ambalavanan, A., 2338T,<br />

2558F*<br />

Ambannavar, R., 1198T<br />

Ambite, J. L., 1439W,<br />

3558W, 3678W<br />

Ambrosone, C. B., 2202W<br />

Ambs, S., 1003T, 1097F<br />

Ambulos, N., 602T<br />

Amelio, A. L., 1162T*<br />

Amell, A. M., 55, 2224T<br />

Amemiya, A. R., 1753W<br />

Amer, W., 2866W<br />

Ames, J., 3587F<br />

Ameur, A., 3728W<br />

Ameye, G., 2002T<br />

Amiel, J., 126, 843F, 915W,<br />

2770W, 3157W, 3172F*<br />

Amin, N., 109, 459F<br />

Amin Al Olama, A., 205,<br />

1148F*<br />

Amini, P., 1083W<br />

Amiran, R., 858T<br />

Amiri, H., 689F<br />

Amirisetty, S., 578W<br />

Amjad, R., 1956W<br />

Ammarinthnukrowh, P.,<br />

2006F<br />

Ammous, Z., 1633T*,<br />

3175W<br />

Amor, D. J., 217<br />

Amorim, A., 2982T<br />

Amos, C., 1291F, 1399F<br />

Amos, C. I., 593F, 1298W,<br />

1454W<br />

Amouri, R., 2537F<br />

Ampy, F., 1821W<br />

Amr, S. S., 1754W*<br />

Amron, D., 2790F<br />

Amstadter, A., 3512T<br />

Amundadottir, L., 1088F,<br />

1199F<br />

Amyere, M., 1015T*<br />

Amyot, M., 1951T<br />

Anagnostopoulos, A., 2675T<br />

Anand, V., 3382F<br />

Ananiev, V., 3582W<br />

Ananina, G., 426W*, 2718F<br />

Anastosova, V., 1811W<br />

Anaya, J. M., 307, 1979F,<br />

2046W<br />

Anaya, J.-M., 529F, 2084F,<br />

2188T<br />

Anayane-Yeboa, K., 977W<br />

Anchan, R., 78, 82<br />

Ancoli-Israel, S., 2375F<br />

Anctil, J. L., 1951T<br />

Andelfinger, G., 31<br />

Anderlid, B. M., 80<br />

Andermann, E., 2790F<br />

Andersen, A., 3706W<br />

Andersen, C. L., 401<br />

Andersen, E. F., 886T*<br />

Andersen, H. S., 737F<br />

Andersen, M., 1237T*,<br />

1244F, 3714W<br />

Andersen, P. S., 1323T*<br />

Andersen, T. A., 805F<br />

Anderson, A., 1724W<br />

Anderson, C., 1269W,<br />

1518T<br />

*Presenting Author<br />

Anderson, C. A., 153, 354,<br />

1967F, 2101T, 2133W,<br />

2163W<br />

Anderson, G., 2755W<br />

Anderson, J., 2529W, 2681T<br />

Anderson, J. M., 2663T<br />

Anderson, L., 2465F<br />

Anderson, M., 7<br />

Anderson, M. W., 1454W<br />

Anderson, N., 433F, 835F<br />

Anderson, P., 3664W<br />

Anderson, R., 1052F, 1856F<br />

Anderson, R. L., 3398T<br />

Anderson, S., 912T, 1242W<br />

Anderson, T., 2584T<br />

Andersson, A., 31<br />

Andersson, E., 2311T<br />

Andersson, H. C., 666T*,<br />

907W<br />

Andersson, T., 1242W<br />

Andersson Assarsson, J.,<br />

1271F<br />

Andersson-Assarsson, J.<br />

C., 427F*<br />

Ando, J., 3513T<br />

Ando, M., 2559W*<br />

Ando, Y., 2550W, 2619W<br />

Andoni, U., 2436W<br />

Andrade, E. S., 3280F*<br />

Andrade, J. G., 478W<br />

Andrade, R. V., 3375T<br />

Andrade-Lima, L. C., 814F<br />

Andreasen, D., 1194W<br />

Andreasen, N., 2493W<br />

Andreasen, N. C., 422W<br />

Andreassen, K. E., 991T<br />

Andreoli, V., 2597F<br />

Andres, A., 3306T<br />

Andresen, B. S., 737F*<br />

Andresson, T., 1088F,<br />

2833W<br />

Andrew, A., 3465T<br />

Andrew-Faucett, W., 299<br />

Andrews, A. M., 261<br />

Andrews, A. S., 1453F<br />

Andrews, C., 2928F<br />

Andrews, H., 442W<br />

Andrews, L., Session 20<br />

Andrews, P., 2587T<br />

Andrieu-Abadie, N., 54<br />

Andrieux, J., 299, 889W,<br />

911W, 925W, 3109W,<br />

3172F<br />

Andrulis, I. L., 1213T<br />

Anedda, F., 2001W*<br />

Ang, K., 309<br />

Ang, K. C., 3267T*<br />

Ang, W., 2097W, 2164T<br />

Angeles, M., 928T<br />

Angelini, C., 1732W, 1776W,<br />

2909T<br />

Angerh<strong>of</strong>er, N., 3321T,<br />

3340F*, 3365W<br />

Angius, A., 113, 157, 177,<br />

186, 547F, 823F, 1451W,<br />

1516F, 2001W, 2916F<br />

Angle, B., 66<br />

Angle, J., 3350W<br />

Angot, E., 32<br />

Angrist, M., 3<br />

SPEAKER AND AUTHOR INDEX 335<br />

Angstadt, A. Y., 1107W*<br />

Anguiano, A., 876T, 3522T<br />

Anikster, Y., 53, 199, 660T,<br />

731F, 2455T<br />

Ankeleshwaria, C., 700T<br />

Ankeman, K., 2406W<br />

Ankener, W., 544W<br />

Ankleshwaria, C., 3400T*<br />

Ankleshwaria, C. M., 2803W<br />

Annagür, A., 219<br />

Annerén, G., 3245W<br />

Annesi, G., 2763F, 2766F,<br />

2774T*, 2780T<br />

Annesi-Maesano, I., 1941W<br />

Annilo, T., 1163F*, 3079W<br />

Annunziata, F., 735F<br />

Ansari, M., 3072F<br />

Antalfy, B., 234<br />

Antao, N. N., 614T<br />

Anthony, D., 216, 809F<br />

Anthony, S. P., 1186T<br />

Antignac, C., 322, 324<br />

Antoine-Poirel, H., 2002T<br />

Antonacci, F., 3296W<br />

Antonarakis, S. E., 67, 84,<br />

85, 550W, 556W, 561F,<br />

567F, 582W, 807F, 2877F,<br />

2937F, 3263W, 3431T<br />

Antonellis, A., 2470T*<br />

Antonialli, G., 3131W<br />

Antonialli, G. P. M., 2484W*<br />

Antonini, G., 1776W<br />

Antonini, S., 874T<br />

Antoniou, A., 208, 1109F<br />

Antoniou, A. C., 207*, 210,<br />

1492F<br />

Anvar, S. Y., 542W<br />

Anyane-Yeboa, K., 1600T,<br />

3046F<br />

Anyanwu, N., 2082W<br />

Ao, A., 2981T<br />

Aoki, K., 724T<br />

Aoki, M., 396<br />

Aouizerat, B. E., 1965W<br />

Aparecida da Silva, D.,<br />

3364F, 3402T<br />

Aparicio, J. M., 926T*,<br />

1018T, 3039W, 3061W,<br />

3063W, 3064F<br />

Aparicio-Rodriguez, J. M.,<br />

3062F<br />

APCDR Investigators,<br />

3412T<br />

Apel, M., 2160W<br />

Apolo, A. B., 1092W<br />

Apone, L., 512W, 3517T*<br />

Apone, L. M., 3702W,<br />

3715F<br />

Aponte, J., 1686T<br />

Appel, I. M., 980T<br />

Appelbaum, E., 1210T,<br />

2325W<br />

Appel-Cresswell, S., 346,<br />

3135W<br />

Appelt, U., 3641F, 3662W<br />

Appenzeller, O., 3307F<br />

April, C., 1193F, 1238F<br />

Aquino, M., 3033T<br />

Aquino, M. A., 2871F<br />

Aquino-Michaels, K., 646T<br />

Arabzadeh, M., 1056W<br />

Aradhya, S., 103, 332*,<br />

1765W, 2579F<br />

Aragam, J., 1677T<br />

Aragon-Martin, J. A., 1584T,<br />

1675T<br />

Arahata, H., 2400W<br />

Arai, Y., 396<br />

Araki, T., 2435F<br />

Aral, B., 2716W, 2729T,<br />

2770W<br />

Aran, A., 2447F<br />

Aranha, I., 927W*<br />

Arashiro, P., 1776W<br />

Arasimavičius, J., 653T<br />

Araujo, A. S., 426W, 2718F<br />

Araújo, B. P. B., 479F<br />

Araújo, I. I., 3318T<br />

Araujo, M. I., 2043W<br />

Arayssi, T., 1490W<br />

Araz, M., 1402F, 1935W,<br />

1938W<br />

Arbeev, K., 2027F, 2194T<br />

Arbeeva, L., 2194T<br />

Arbez-Gindre, F., 3199W<br />

Arboleda, V., 361*<br />

Arcanjo, A. C., 3324T,<br />

3375T<br />

Archaic Genome Analysis<br />

Consortium, 3274F<br />

Archana, G., 878T<br />

Archibald, A. D., 143<br />

Arciniegas, N., 659F*<br />

arcOGEN Consortium,<br />

2292W<br />

Arden, N., 2189F<br />

Arden, N. K., 2292W<br />

Ardissone, F., 1153T<br />

Ardlie, K., 368*<br />

Ardon, O., 660T*, 689F<br />

Arenas-Aranda, D. J., 1168T<br />

Arenas-Sordo, M., 3125W*<br />

Arends, M. J., 105<br />

Arens, Y., 1439W*, 3678W<br />

Arepalli, S., 564W<br />

Aretz, S., 1005W*<br />

Arezi, B., 3709F<br />

Argente, J., 2711T, 3208F<br />

Argiro, L., 1949F<br />

Argiropoulos, B., 910T,<br />

3095W<br />

Argos, M., 2025W<br />

Ariani, F., 2604W*<br />

Arias, L., 3074F<br />

Arias Vásquez, A., 1498F*<br />

Arimura, K., 2601W<br />

Arimura, Y., 2174F<br />

Arinami, T., 2380T<br />

Ariyoshi, K., 1998W, 1999T<br />

Arjona, D., 330<br />

Arking, D. E., 1403W, 1579F,<br />

1585T<br />

Arlt, M. F., 339*, 2879T<br />

Armas, R., 2495F<br />

Armasu, S. M., 1375F,<br />

1497T, 3451T<br />

Armbrecht, A. M., 2072F<br />

Armengol, L., 3208F<br />

Armory, P., 1082F<br />

Armour, C., 719F<br />

SPEAKER AND AUTHOR INDEX


336 SPEAKER AND AUTHOR INDEX<br />

Armstrong, D. G., 3712W<br />

Armstrong, G., 1447F<br />

Armstrong, L., 1447F<br />

Armstrong, M. C., 2851W<br />

Arnaout, R., 3155W<br />

Arnaud, K., 2674W<br />

Arndt, K., 3090F<br />

Arndt, S., 2753T, 3203W<br />

Arne-Bes, M.-C., 2945T<br />

Arnell, C., 1021T<br />

Arnett, D., 3443T<br />

Arnhold, U. P., 2706F<br />

Arning, M., 630T<br />

Ärnlöv, J., 1624T<br />

Arno, G., 1584T, 1675T*<br />

Arnold, A., 1275W<br />

Arnold, P. D., 2499W*,<br />

3447T<br />

Arobba, B., 1856F<br />

Aroda, V., 1925F<br />

Aronica, E., 2909T<br />

Aronow, B., 2136W<br />

Arp, P., 3608W<br />

ARRA Autism Sequencing<br />

Collaboration, 2613W<br />

ARRA Autism Sequencing<br />

Consortium, 11, 268,<br />

1520W, 1523W, 3597F<br />

ARRA Autism Sequencing<br />

Consortium and Autism<br />

Sequencing Consortium,<br />

2577W<br />

Arroyo-Pardo, E., 3402T<br />

Arseneau, J., 2842W<br />

Arseneault, R., 1951T<br />

Arslan, A. O., 2956W<br />

Arslan, E., 2719W<br />

Artigalás, O., 1851F<br />

Artigiani, R., 3421T, 3503T<br />

Artiguenave, F. M., 2394W,<br />

2876T, 3578W<br />

Artinger, K. B., 819F<br />

Arts, H., 324<br />

Arts, H. H., 216<br />

Artto, V., 2348F<br />

Arun Kumar, G., 3377W<br />

Arveiler, B., 473F*, 841F<br />

Asabere, A., 551F<br />

Asahina, N., 2822T<br />

Asan, A., 3300T, 3311W<br />

Aschard, H., 318*<br />

Aschendorff, A., 2753T,<br />

3203W<br />

Aschim, E. L., 991T<br />

Asgari, N., 2290T<br />

Ash, C., 1093T<br />

Ashe, T. D., 565F<br />

Ashfield, A., 1082F<br />

Ashford, L., 730T<br />

Ashkenazi Genome<br />

Consortium, 17<br />

Ashley, E., 1601T<br />

Ashley-Koch, A., 3, 386,<br />

531F, 1919F, 2135F<br />

Ashley-Koch, A. E., 2340W,<br />

2946F<br />

Ashton-Prolla, P., 1217F<br />

Ashutosh, A., 971W<br />

Asico, L., 245<br />

Asiimwe, E., 1919F<br />

*Presenting Author<br />

Asimit, J., 3412T<br />

Aslam, A., 3700W<br />

Aslam, M., 2086T<br />

Asmal, L., 644T<br />

Asmann, Y. W., 986F,<br />

1214F<br />

Aspers, R., 2696T<br />

Aspesi, A., 1153T<br />

Asselbergs, F. W., 609T,<br />

1606T, 1659T<br />

Asselin, G., 2402F<br />

Assimes, T., 1608T<br />

Assimes, T. L., 115, 434W,<br />

1595T, 1624T<br />

Assumpção, P. P., 1008W,<br />

1132T, 3421T, 3503T<br />

Astashyn, A., 3732W<br />

Astbury, C., 456W, 912T<br />

Astley, S., 3076F<br />

Aston, K. I., 2982T<br />

Astuti, D., 2767W, 2787F<br />

Asunis, I., 2001W<br />

Aswani, V. H., 2683W<br />

Ataman, B., 2613W<br />

Atanur, S., 1618T<br />

Atefi, M., 136<br />

Atehortua-Khalsa, K., 3717F<br />

Ather, S., 667F<br />

Athing, U., 2917W<br />

Atia, J., 1811W*<br />

Atik, T., 965W, 3222F<br />

Atique, R., 2687T*<br />

Atkin, J., 456W<br />

Atkin, J. F., 124<br />

Atkinson, A. L., 143<br />

Atkinson, E., 2362T<br />

Atlan, D., 3610W<br />

Atsuta, N., 3221W<br />

Attanasio, C., 4*<br />

Attarian, S., 328<br />

Attia, J., 2133W<br />

Attie, T., 3246F<br />

Attie-Bitach, T., 2727F,<br />

3240F<br />

Attié-Bitach, T., 77, 403<br />

Attri, S., 802W<br />

Attwood, A. H., 978T<br />

Atwal, G., 3316F<br />

Atwood, L. D., 2030F<br />

Atzeni, R., 157, 177, 1516F<br />

Atzmon, G., 17, 169, 269,<br />

1319W, 1923W, 2308T,<br />

2339F, 3336T, 3345T,<br />

3395W<br />

Au, E., 1756W<br />

Au, P.-Y. B., 1052F*<br />

Aubart, M., 56*<br />

Aubry, M., 2893W<br />

Audi Delaney, L., 131<br />

Audrezet, M.-P., 1728W<br />

Auer, M., 1115F<br />

Auer, P. L., 301, 1408F,<br />

1437T, 2336F, 2337W<br />

Auerbach, A. D., 1069T*<br />

Auer-Grumbach, M., 201,<br />

2948T<br />

Augello, B., 775W, 3087W,<br />

3256F<br />

Augustin, J., 345<br />

Augustine, N. H., 495F<br />

Augusto, D. G., 1405F<br />

Aulchenko, Y. S., 2106W<br />

Aung, T., 2094W<br />

Auro, K., 2059T*<br />

Ausavarat, S., 2749W<br />

Austermann, C., 3310F<br />

Austin, C., 3490T<br />

Austin, H., 611T<br />

Austin, M., 3649F<br />

Autism Genome Project,<br />

2261F<br />

Autism Sequencing<br />

Consortium, 2560T<br />

Auton, A., 285, 1494T<br />

Auvin, S., 2536T<br />

Au-Young, J., 1195T*<br />

Avadhani, N., 2943F<br />

Avallone, B., 808F<br />

Avansini, S. H., 514W*<br />

Avard, D., 1823W<br />

Avbelj, M., 2710W<br />

Avdjieva-Tzavella, D. M.,<br />

923W<br />

Avery, C. L., 1434T<br />

Avihingsanon, Y., 2006F<br />

Avila, M. P., 3130F<br />

Avila, S., 976T<br />

Avila Arreguin, E., 773W<br />

Aviram, A., 270, 2603F<br />

Aviram, M., 2738T<br />

Aviv, A., 1653T<br />

Avraham, K. B., 2914W*,<br />

2919F<br />

Avramopoulos, D., 504W,<br />

2387F, 2461T, 2486F,<br />

2573F<br />

Avrich, A. A., 1295W<br />

Avril, M. F., 1158W<br />

Avsar, T., 2429F, 2450F*<br />

Aw, J., 1872F, 1873F<br />

Awad, D., 1600T<br />

Awadalla, P., 31, 2266T,<br />

3260W, 3268F,<br />

3341W*<br />

Awano, H., 729F, 781W<br />

Awasthi, S., 1287T<br />

Axelsen, M., 2493W<br />

Axelsson, T., 617T, 619T<br />

Axford, M. M., 2824W*<br />

Aya-Bonilla, C. A., 1042T*<br />

Ayala Ramírez, P., 2990T*<br />

Ayas, M., 3149W<br />

Aydinok, Y., 2719W<br />

Ayele, F., 3412T<br />

Aygun, B., 2331W<br />

Aykut, A., 3206F<br />

Ayme, S., 2703F<br />

Aypar, U., 887W*<br />

Ayres, C., 1038W<br />

Ayub, M., 2398T, 2590T<br />

Ayub, Q., 3322F<br />

Ayyub, H., 418W<br />

Azad, A. K., 1108T*<br />

Azadegan, F., 1143W,<br />

1596T, 1739W<br />

Azaiez, H., 2867T*<br />

Azamian, M. S., 1646T<br />

Azaro, M., 2381F<br />

Azaro, M. A., 2523W<br />

Azen, C., 237<br />

Aziz, A., 3007T<br />

Aziz, N., Session 3<br />

Aziza, J., 3129W<br />

Azzedine, H., 2866W*<br />

B<br />

Baaj, S., 865W*<br />

Baala, L., 3246F*<br />

Baas, A. F., 87<br />

Baas, F., 197, 200, 1616T,<br />

2909T<br />

Babatz, T. D., 504W*<br />

Babin, P., 841F<br />

Babiuk, R., 2675T<br />

Babovic-Vuksanovic, D.,<br />

887W<br />

Babron, M.-C., 1496W*,<br />

3408T<br />

Babron, M. C., 3328F<br />

Babrzadeh, F., 398<br />

Babu, D., 2827W*<br />

Babul-Hirji, R., 1872F,<br />

1873F<br />

Babyak, M. A., 2481W<br />

Bacanu, S. A., 2500T<br />

Baccarelli, A., 3469T<br />

Bacchelli, C., 1748W<br />

Bach, R. G., 2535W<br />

Bachmann, C. G., 2568W<br />

Bachmeyer, R. C., 1245W,<br />

3527F*, 3687F<br />

Bacino, C., 432W, 898T,<br />

952T, 3209W<br />

Backes, C., 515F<br />

Bäcklin, C., 3427T<br />

Backus, K., 1116W<br />

Backx, A. P., 2909T<br />

Bacon, C., 1612T<br />

Badarinarayan, N., 1943F,<br />

2303F<br />

Bademci, G., 347, 2603F,<br />

3706W<br />

Badenas, C., 1053W*<br />

Badens, C., 2536T, 3236F<br />

Bader, J. S., 1403W, 1579F<br />

Bader, S., 242<br />

Badfar, S., 1596T<br />

Badii, R., 2933T, 3399W<br />

Badilla-Porras, R., 3183W*<br />

Badner, J., 2590T<br />

Badner, J. A., 1957T<br />

Bae, J., 3444T*, 3462T<br />

Bae, J. S., 3607F<br />

Bae, S., 3462T<br />

Bae, S. C., 1979F, 2046W<br />

Bae, Y., 411, 2864T<br />

Baek, J., 2273F, 2427W*<br />

Baena, N., 2940F<br />

Baere, E., 298<br />

Baert, A., 539F<br />

Baert-Desurmont, S., 1222T<br />

Baeta, M., 3364F, 3402T<br />

Baets, J., 201*, 2948T<br />

Baez-Cabrera, L., 1130F<br />

Baffini, S., 3114F*<br />

Bafna, V., 1043F, 1471F,<br />

3307F<br />

Bagalà, A., 2766F, 2774T


Bagarotti, A., 2775F<br />

Bagdonaite, l., 920T<br />

Bagga, A., 2844F<br />

Baggott, C., 1965W<br />

Baghdadli, A., 2386T<br />

Baghel, K., 764W, 1883F*<br />

Bagheri, N., 1143W*, 1596T,<br />

1739W<br />

Bagnall, R. D., 1664T*<br />

Bagot, M., 29, 1062W<br />

Bagshaw, A., 3440T<br />

Bahce, M., 1136F<br />

Baheti, S., 1695T<br />

Bahi-Buisson, N., 104<br />

Bahlo, M., 2741T, 3228F<br />

Bai, R., 330*, 2839W<br />

Bai, Y., 1945T<br />

Bai, Y.-M., 610T<br />

Baier, H., 810F<br />

Baier, L., 1300F, 1917W,<br />

2038T<br />

Baier, L. J., 2018F, 2124W<br />

Baig, S. M., 2920W<br />

Bailes, A., 456W<br />

Bailes, A. K., 912T<br />

Bailey, A., 3038F<br />

Bailey, J. M., 1957T<br />

Bailey, L., 789W<br />

Bailey, L. B., 1304W<br />

Bailey, M., 340<br />

Bailey, M. H., 1149W*<br />

Bailey, S. M., 948T<br />

Bailey-Wilson, J. E., 1001F,<br />

1081T, 1214F, 1302T,<br />

1363F, 1454W, 1512T,<br />

3591F<br />

Baillie, J. K., 1507F<br />

Bailliet, G., 3362W<br />

Bain, S. M., 978T*<br />

Bainbridge, M., 314, 1742W,<br />

2802F, 2934F<br />

Bainbridge, M. N., 1735W,<br />

1757W, 2883F, 3576W<br />

Baird, L., 2397W<br />

Baird, P., 1072T, 1911W<br />

Bajaj, K., 1793W, 3022T<br />

Bajanowski, T., 86<br />

Bak, B., 2701W<br />

Bak, M., 805F<br />

Bakay, M., 1992W*<br />

Baker, A., 1194W<br />

Baker, C., 12, 14<br />

Baker, E., 2087F<br />

Baker, J., 1198T, 2033F<br />

Baker, L., 2845W*, 2846T<br />

Baker, M., 3287W<br />

Baker, M. C., 2639F<br />

Baker, P., 1671T<br />

Baker, T., 642T<br />

Bakke, P., 2057F, 2249F<br />

Bakker, B., 55<br />

Bakker, S. C., 2526W<br />

Bakour, R., 1268F<br />

Bakthavachalam, V., 2039F,<br />

2049W<br />

Bala, N., 3516T<br />

Balanovska, E., 3377W<br />

Balanovsky, O., 3377W<br />

Balasa, A., 2802F, 3495T<br />

Balasenthil, S., 1095W<br />

*Presenting Author<br />

Balasubramanian, S., 41,<br />

280<br />

Balat, A., 1402F, 1935W,<br />

1938W<br />

Balci, T., 1164W*, 1178F<br />

Baldassano, R., 319,<br />

2229W, 2252F<br />

Baldassano, R. N., 1997F<br />

Baldi, M., 71<br />

Balding, D., 1394W, 1807W*<br />

Balding, D. J., 684T, 3322F<br />

Baldo, G., 691F*<br />

Baldwin, C. T., 343, 2563T<br />

Baldwin, E. E., 886T, 1752W<br />

Baldwin, S., 3671F<br />

Bale, S., 330, 766W, 1765W<br />

Bale, S. J., 222<br />

Bali, D., 2293T<br />

Balkhy, S., 8<br />

Ball, C., 3321T<br />

Ball, C. A., 3365W<br />

Ball, T., 3276T<br />

Ballabio, A., 735F<br />

Ballantyne, C., 1688T<br />

Ballantyne, C. M., 272<br />

Ballard, D. H., 306<br />

Ballew, B., 1196F<br />

Ballif, B. C., 66, 884T*,<br />

3101W<br />

Ballinger, T., 466W<br />

Balloi, M., 3664W<br />

Balmakund, T. M., 1735W<br />

Balmaña, N., 2578T<br />

Balog, J., 55<br />

Balogh, M., 2177F<br />

Balouch, I. A., 2398T<br />

Baluyot, M., 1805W<br />

Balzotti, M., 1021T<br />

Bamezai, R., 3262F<br />

Bamezai, R. N. K., 1993T<br />

Bamshad, M., 2346W<br />

Bamshad, M. J., 55, 74, 94,<br />

148, 171, 301, 1842F,<br />

2740W<br />

Bancr<strong>of</strong>t, E. K., 1109F*<br />

Banda, Y., 112, 118, 421F,<br />

2140T, 2513F, 3342T*,<br />

3383W<br />

Bandera, E. V., 2202W<br />

Bandiera, S., 522W<br />

Bandinelli, S., 2148W<br />

Banerjee, A., 361<br />

Banerjee, N., 3316F<br />

Banerjee, P., 1992W<br />

Banerjee-Basu, S., 446W<br />

Banfi, S., 2950W*<br />

Banikazemi, M., 693F<br />

Banitalebi, G., 2013W<br />

Banka, S., 2852T*<br />

Banks, E., 288<br />

Bannasch, D., 2778F<br />

Banning, M., 979W<br />

Banning, M. J. G., 955W<br />

Bansal, V., 3615F*<br />

Banser, L., 2664F<br />

Banwell, B., 2554T<br />

Bao, S., 557F, 2254T*<br />

Bao, Y., 1146W<br />

Bao, Y. H., 1974W<br />

Bapat, B., 3478T<br />

SPEAKER AND AUTHOR INDEX 337<br />

Baraban, S. C., 2779W<br />

Baradaran-Heravi, A.,<br />

2682F*<br />

Baraitser, M., 124<br />

Baral, V., 842F, 2727F<br />

Baran, Y., 3360T<br />

Barann, M., 567F, 582W<br />

Baranova, M., 3263W<br />

Baratela, W. A. R., 3184F*<br />

Baratta, S., 2781F<br />

Barb, J., 260<br />

Barba, M., 2235W*<br />

Barbalho, P. G., 2373W*<br />

Barbalic, M., 1688T<br />

Barbany, G., 1024T, 1035W,<br />

1126T<br />

Barbarot, S., 3066F<br />

Barbaroux, C., 1205F<br />

Barber, G., 3612W<br />

Barber, R. E., 3158F<br />

Barber, T., 1369F<br />

Barber, T. D., 1235F<br />

Barbosa, A. P. M., 3272W<br />

Barboza, J., 3659F, 3669F*<br />

Barcellos, L., 1415W, 3454T,<br />

3458T<br />

Barcellos, L. F., 1289W,<br />

1301W, 1414F, 1455T,<br />

1924T*<br />

Barcellos, N., 879W<br />

Barcelos, F., 1977W<br />

Barcia, G., 202*<br />

Barczyk, K., 2759T<br />

Bardakjian, T., 810F, 3004T*,<br />

3179W<br />

Bardoni, B., 513F, 817F*<br />

Barea, J., 3120F*<br />

Bareke, E., 394, 1207T,<br />

1215W<br />

Barešová, V., 322<br />

Barett, A., 3441T<br />

Barfield, R. T., 66, 1422T*<br />

Barg, C. J., 142*<br />

Barić, I., 672T<br />

Barillot, M., 841F<br />

Baris, D., 1091F, 1092W<br />

Barisani, D., 1330F<br />

Barisic, N., 201<br />

Barišić, N., 2948T<br />

Barizzone, N., 2095T<br />

Bar-Joseph, I., 53<br />

Barker, A., 78<br />

Barker, J. N., 1927T<br />

Barker, J. N. W. N., 154<br />

Barkovich, A. J., 266<br />

Barletta, C., 3364F, 3402T<br />

Barmada, M. M., 1647T,<br />

1672T, 1673T, 1920W,<br />

1921T, 2040W*, 2099F,<br />

2125T, 2521T, 3078F<br />

Barnard, J., 1659T<br />

Barnes, A. M., 222*<br />

Barnes, C. P., 2576F<br />

Barnes, D. R., 1492F*<br />

Barnes, K., 536W<br />

Barnes, K. C., 158, 171,<br />

1558F, 1900T, 2043W,<br />

2346W<br />

Barnes, L. L., 343<br />

Barnes, S., 690T, 1860F<br />

Barnett, I., 2334W*<br />

Barnhart, M., 3644W<br />

Barnholt, K. E., 626T,<br />

1017W, 2087F*<br />

Barnicoat, A., 2755W<br />

Barnwell, J., 348<br />

Barojas, E., 3226F<br />

Barojas, P., 3226F*<br />

Baron, J., 1292W, 3465T<br />

Barp, J. D., 3114F<br />

Barr, C., 2545T, 3509T*<br />

Barr, T., 2221T<br />

Barragán-Hernandez, M.,<br />

1121F<br />

Barral, S., 1892F<br />

Barreiro, L., 3260W<br />

Barreiro, L. B., 2031W<br />

Barreto da Silva, M.,<br />

1968W, 2017T*<br />

Barrett, A., 44, 583F<br />

Barrett, A. J., 1259F<br />

Barrett, B., 1066T<br />

Barrett, C., 395<br />

Barrett, C. L., 1051T*<br />

Barrett, J., 101, 156*, 291,<br />

364, 453F, 2399F<br />

Barrett, J. C., 35, 37, 153,<br />

354, 1967F<br />

Barrett, J. H., 211*<br />

Barrett, L., 3419T<br />

Barrett, M. T., 1186T<br />

Barrett, T., 2703F, 2767W<br />

Barrett, T. G., 2787F<br />

Barrientos, M. P., 926T<br />

Barrionuevo, B. A., 9<br />

Barrios-García, T., 3504T<br />

Barrois, Y. E. G., 1711T<br />

Barros, A., 2982T<br />

Barros-Nunez, P., 3154F<br />

Barroso, A., 1213T<br />

Barroso, I., 33, 43, 45,<br />

2090F, 2123F, 2147F<br />

Barrowdale, D., 208, 1492F<br />

Barrsos, I., 1954T<br />

Barry, B. J., 266<br />

Barry, W., 147<br />

Barsh, G., 2223W<br />

Barsh, G. S., 3318T<br />

Bar-Shira, A., 704T<br />

Barsottini, O., 2642F<br />

Bartek, J., 1171T<br />

Bartel, F., 2826F<br />

Barth, P., 2759T<br />

Barth, P. B., 2909T<br />

Barth, P. G., 197<br />

Bartha, I., 2050T<br />

Barthez, M.-A., 403, 2536T<br />

Bartholdi, D., 3240F<br />

Bartholomew, A. J., 2552F<br />

Bartkova, J., 1171T<br />

Bartlett, C. W., 2381F,<br />

2544W<br />

Bartlett, J., 245<br />

Bartman, T., 196<br />

Bartoli, M., 328<br />

Bartolomei, M., 3082F<br />

Barton, A., 2160W<br />

Barton, D., 1874F<br />

Barton, L. V., 1717W*<br />

Barts, J., 493F<br />

SPEAKER AND AUTHOR INDEX


338 SPEAKER AND AUTHOR INDEX<br />

Bartsch, O., 849F*, 3266W<br />

Barzilai, N., 1319W<br />

Basang, B., 3317W<br />

Basehore, M. J., 2901F<br />

Basel-Vanagaite, L., 105,<br />

126, 3185W*<br />

Basford, M., 1602T<br />

Bashir, A., 3724W<br />

Bashover, E., 3331F<br />

Baskin, B., 2554T<br />

Baskin, L. S., 1352W, 1885T<br />

Bass, F., 348<br />

Bass, H., 3059W<br />

Bassell, G., 540W<br />

Basset-Seguin, N., 29,<br />

1062W<br />

Bassett, A. S., 2428T,<br />

2467T, 2544W, 2575T<br />

Bassett, S. S., 2648F<br />

Basso, M., 896T, 899W<br />

Bassuk, A., 419F<br />

Bassuk, A. G., 1910F,<br />

2750T<br />

Bastarache, L., 3622W<br />

Bastie, J.-N., 2716W<br />

Bastin, J., 737F<br />

Basto, J. P., 2736F<br />

Basu, A., 3343F*<br />

Batai, K., 1009T*, 2014T<br />

Bates, L., 2405F<br />

Batey, A. Y., 2978T<br />

Bathgate, A., 153<br />

Batish, S. D., 63<br />

Batista, D., 300, 889W,<br />

3097W<br />

Batista, D. A. S., 935W<br />

Batlevi, Y., 2628W<br />

Battaglia, A., 881W*, 3050F<br />

Battaloglu, E., 201, 2948T<br />

Battelino, T., 2688F, 2710W<br />

Battersby, B., 327<br />

Battiston, E., 2799F<br />

Battle, A., 369*, 2372F<br />

Batzer, M. A., 600F, 3270T<br />

Batzoglou, S., 397<br />

Bauchet, M., 2223W<br />

Baudouin, V., 324<br />

Bauduer, F., 716T<br />

Bauer, A., 132<br />

Bauer, C. P., 2102F<br />

Bauer, J., 2557T<br />

Bauer, J. W., 297<br />

Bauer, M., 1176W<br />

Bauer, P., 684T*, 1200W,<br />

1233W<br />

Bauer, T., 236<br />

Bauernh<strong>of</strong>er, T., 1115F<br />

Baugher, J., 3374W<br />

Baujat, G., 915W, 3129W<br />

Baumann, C., 3172F<br />

Baumert, J., 1659T<br />

Baur, J., 534W<br />

Baurecht, H., 1939T, 1942T,<br />

2226W<br />

Bauwens, M., 539F<br />

Baux, D., 2947W<br />

Bauzon, F., 615T<br />

Bavdekar, A., 700T, 2803W<br />

Bawcom, A., 730T<br />

Baxter, A., 3167W<br />

*Presenting Author<br />

Baxter, S., 248, 1676T*,<br />

2021F<br />

Baxter, T., 2221T<br />

Bayés, M., 54, 2303F,<br />

2326T, 2578T<br />

Bayet, B., 2002T<br />

Bayetti, K., 794W<br />

Baylor-Hopkins Center for<br />

Mendelian <strong>Genetics</strong>,<br />

2908W<br />

Baylor-Hopkins Center for<br />

Mendelian Genomics,<br />

360, 2798T, 2883F<br />

Bayoumi, R., 160<br />

Bayrak-Toydemir, P., 225<br />

Baysal, B. E., 3294T*, 3523T<br />

Bazett-Jones, D., 1050W<br />

Bazin, A., 77<br />

Bazin, D., 2759T<br />

BCAC, 209<br />

Bchetnia, M., 778W<br />

Beadling, C., 1237T<br />

BEAGESS Study Investigators,<br />

2190W<br />

Beales, P., 324, 2755W,<br />

3240F<br />

Beales, P. L., 216, 219,<br />

2955F, 3211W<br />

Bean, L. J., 2069F<br />

Bean, L. J. H., 253, 1349W,<br />

3042F<br />

Beasley, E., 133, 1232F,<br />

3670W<br />

Beatty, S., 1897T<br />

Beaty, K. G., 3344W*<br />

Beaty, T., 1076F, 2043W,<br />

2057F, 2325W<br />

Beaty, T. H., 1425T, 1472W,<br />

1512T*, 1558F, 1900T,<br />

2249F, 2346W, 3609F<br />

Beauchamp, C., 1982F<br />

Beaudet, A. L., 314, 430W,<br />

432W, 759W, 898T,<br />

1735W, 1742W, 1757W,<br />

1761W, 2403W<br />

Beaudoin, M., 1906T, 2319W<br />

Beaulieu, C. L., 701F,<br />

2800W*<br />

Beck, C. R., 428W*<br />

Beck, L. A., 1900T<br />

Beck, T., 1093T, 1256F<br />

Beck, T. F., 834F, 839F,<br />

2678T*<br />

Becker, A. B., 1465F<br />

Becker, C., 2861T<br />

Becker, D. M., 1652T, 1710T<br />

Becker, E. B., 2649W<br />

Becker, F., 857W<br />

Becker, J., 806F, 2088W*<br />

Becker, L. C., 1652T, 1710T<br />

Becker, R. C., 1594T<br />

Becker, T., 106, 1332T,<br />

1423F<br />

Beckhaus, T., 782W<br />

Beckman, K. B., 2372F<br />

Beckman, L., 753T<br />

Beckmann, J. S., 62, 110,<br />

299, 1387F, 1800F,<br />

2090F, 2458T<br />

Beckmann, M., 3153W<br />

Beckmann, N. D., 62, 299<br />

Beck-Peccoz, P., 2701W<br />

Bedard, P. L., 135, 1824F<br />

Bedford, J. S., 948T<br />

Bedja, D., 240<br />

Bedoya, G., 3327T, 3360T<br />

Bee, G., 3717F<br />

Beecham, A., 1635T, 2330F<br />

Beecham, A. H., 270*,<br />

1638T, 2049W<br />

Beecham, G., 347, 1871F,<br />

2330F, 2603F, 2637W<br />

Beecham, G. W., 344,<br />

1571W*, 1644T, 1957T,<br />

2498F, 2583W, 2586W<br />

Beekman, M., 119, 1308T,<br />

1436W, 2035T, 2076W,<br />

2080T, 2116T<br />

Been, L., 474W*<br />

Been, L. F., 1933T<br />

Beer, M. A., 258, 545F<br />

Beery, T., 1860F<br />

Beesley, J., 210<br />

Beetz, C., 2930T*<br />

Beg, A. A., 2470T<br />

Beg, M. B., 871W<br />

Begay, T., 988T<br />

Begemann, M., 3111W<br />

Beggs, A., 2811F<br />

Beggs, A. H., 1769W,<br />

3219W<br />

Beggs, W., 3303T<br />

Bego, T., 3286F<br />

Beguin, S., 2674W<br />

Begum, F., 253, 1438F*<br />

Behera, B., 3207W<br />

Behr, E. R., 86, 2699T<br />

Behrendtz, M., 1023W<br />

Behrens, F., 2160W<br />

Behrens, T., 342<br />

Behrens, T. W., 306, 2091W<br />

Beier, D. R., 825F<br />

Beierbach, A., 2474F<br />

Beinat, M., 325<br />

Beiraghi, S., 821F*<br />

Beirnes, K., 2849T<br />

Beiser, A., 123<br />

Beiswanger, C., 966T<br />

Bejerano, G., Session 5, 286*<br />

Bekele, E., 3322F<br />

Bekheirnia, M. R., 314,<br />

1742W<br />

Bekris, L. M., 2646W*<br />

Belaidi, H., 2306F<br />

Belangero, S. I., 2533T,<br />

2534F, 3045W<br />

Belay, G., 3303T, 3338W<br />

Beldjord, C., 890T<br />

Beleggia, F., 3214F<br />

Beleza, A., 1968W, 2017T<br />

Beleza, S., 2223W, 3318T*<br />

Beleza-Meireles, A., 201,<br />

2948T<br />

Belgian Neurology<br />

Consortium and<br />

European Early-Onset<br />

Dementia Consortium,<br />

2815W<br />

Belgrader, P., 3011T<br />

Belgrave, D., 2211W<br />

Belitsky, G., 1180T<br />

Bell, D. A., 257<br />

Bell, G. I., 2192F<br />

Bell, J., 583F, 3453T<br />

Bell, J. T., 44, 2029T, 3441T<br />

Bell, M. J., 1884W*<br />

Bell, R., 293, 1783W<br />

Bellam, N., 1292W<br />

Belleau, P., 1951T*<br />

Bellis, C., 533F, 1912T,<br />

2146T, 2308T*<br />

Bellivier, F., 259<br />

Bello, S. M., 2675T<br />

Bellon, L., 493F<br />

Bellone, M., 1036T<br />

Bellone, S., 2827W<br />

Bellos, E., 429F*<br />

Bellucco, F. T. S., 2534F<br />

Bellus, G., 3244F<br />

Belman, A., 1924T<br />

Belmont, J., 1688T<br />

Belmont, J. W., 337, 1646T,<br />

2158T, 2189F<br />

Belousov, A., 242, 3574W<br />

Below, J., 223<br />

Below, J. E., 49, 2740W*<br />

Belton, J., 255<br />

Belton, R. L., 2185T<br />

Beltrami, A., 2809W<br />

Beltrami, C. A., 2809W<br />

Beltramo, J., 3362W<br />

Belucco, F. T., 3045W<br />

Belyantseva, I. A., 2663T<br />

Bembi, B., 692T*, 2809W<br />

Béna, F., 67, 2937F<br />

Ben-Abdallah-Bouhjar, I.,<br />

944T*<br />

Benachi, A., 72, 894T<br />

Ben-Ami, I., 3002T<br />

Benamor, I. M., 3169W*<br />

Benard, L., 1698T<br />

Ben-Asher, E., 53, 2875W<br />

Benatar, M., 347, 2637W<br />

Ben Avraham, D., 3336T<br />

Benayed, R., 1252T<br />

Bencaz, A., 1081T<br />

Ben Charfeddine, I., 1751W,<br />

2744T<br />

Benchek, P. H., 1575T*<br />

Ben-Chetrit, E., 746T<br />

Bender, F., 685F<br />

Bender, H. A., 168<br />

Bendik, E., 1787W, 1853F<br />

Bendjilali, N., 589F*<br />

Bendsen, E., 805F<br />

Bendtsen, J., 3528W<br />

Bene, J., 3283F<br />

Beneken, C., 1115F<br />

Benet-Pagès, A., 2922F<br />

Bengesser, K., 939W,<br />

2791W<br />

Benhamed, S., 330<br />

Benhamou, S., 1496W<br />

Benistan, K., 772W, 890T<br />

Benit, P., 3241W<br />

Benitez, J., 27, 206, 1150T,<br />

1213T<br />

Benjamin, D. J., 2505W<br />

Benjamin, E. J., 1585T,<br />

1677T


Benjamin, E. R., 1684T<br />

Benjamin, J. S., 2677W*<br />

Benjaminy, S., 1802F*<br />

Ben-Khelifa, H., 944T<br />

Benko, E., 522W<br />

Benlier, N., 1935W, 1938W<br />

Benlloch, S., 205, 1148F,<br />

1011W<br />

Benner, A. T., 2998T<br />

Bennet, R., 3278W<br />

Bennett, C., 214<br />

Bennett, D., 2488T, 3450T<br />

Bennett, D. A., 343, 380,<br />

3417T<br />

Bennett, J., Session 23,<br />

806F*<br />

Bennett, R., 1209W, 1237T,<br />

1246T, 3714W, 3717F,<br />

3719F<br />

Bennetts, B., 3167W<br />

Benoist, C. O., 528W<br />

Benoist-Lasselin, C., 763W<br />

Benoit, V., 3098F, 3181W*<br />

Ben-Omran, T., 8, 2899W<br />

Benowitz, N. L., 642T<br />

Ben-Pazi, H., 2447F<br />

Ben-Salem, S., 160<br />

Ben-Shachar, S., 704T*<br />

Bensussan, A., 29, 1062W<br />

Bentham, J., 3382F*<br />

Bentley, A., 1515T*, 3533F<br />

Bentley, D., 1238F, 2939T,<br />

3663F<br />

Benton, G., 2089T*<br />

Benton, G. M., 1223F, 1620T<br />

Benton, M., 1042T, 1912T<br />

Benyahia, B., 889W<br />

Benyamin, B., 2407T<br />

Benzacken, B., 901W,<br />

973W, 2784F<br />

Ben-Zeev, B., 53, 660T,<br />

731F<br />

Berardinelli, A., 1776W<br />

Berberich, S., 1875F, 1882T<br />

Berberich, S. L., 1344T<br />

Berboso, A. D., 2975T<br />

Berchuk, A., 210<br />

Bercovich, D., 1165T*<br />

Berenson, G. S., 2274W<br />

Berezney, R., 82<br />

Berg, A., 309, 3264T, 3267T<br />

Berg, A. S., 1016F, 1107W<br />

Berg, C., 1012T<br />

Berg, D., 1119W<br />

Berg, J., 645T, 1082F, 1724W<br />

Berg, J. P., 576W<br />

Berg, J. S., 231<br />

Bergadá, I., 361<br />

Bergamin, G., 2799F*<br />

Bergamin, N., 2809W<br />

Bergan, S., 3614W<br />

Bergantino, F., 1060T<br />

Bergbaum, A., 906T<br />

Berge, K. E., 1607T<br />

Bergen, A. W., 642T*<br />

Berger, I. M., 1612T<br />

Berger, K., 2568W<br />

Berglund, L., 619T<br />

Bergman, M., 1857F*<br />

Bergmann, P., 2769F<br />

*Presenting Author<br />

Bergmann, S., 62, 1281T<br />

Bergstrom, D., 983F<br />

Bergstrom Lucas, A., 975W,<br />

3726W*<br />

Berhane, Y. B., 1108T<br />

Béri-Dexheimer, M., 2770W<br />

Berk<strong>of</strong>sky-Fessler, W., 242<br />

Berkovic, S. F., 203, 2741T,<br />

2897T, 2898F<br />

Berletch, J. B., 379<br />

Berlin, D., 966T<br />

Berman, J. R., 3690W*<br />

Bermúdez, M., 2990T<br />

Bern, O., 3002T<br />

Bernabe-Gelot, A., 2674W<br />

Bernal, W., 535F*<br />

Bernaldez, R., 1131W,<br />

1141T<br />

Bernal Villegas, J., 2990T<br />

Bernard, A., 2444F<br />

Bernard, D., 2701W<br />

Bernard, G., 2786T, 2797W<br />

Bernard, N., 3723F<br />

Bernard, O., 325<br />

Bernardinelli, L., 2039F<br />

Bernardini, C., 2235W<br />

Bernardini, L., 881W, 943W,<br />

2777T, 3050F<br />

Bernardo, D. V., 2232W,<br />

3295F*<br />

Bernbaum, J. B., 2443T<br />

Berndt, S., 205, 2080T,<br />

2241W<br />

Berndt, S. I., 108, 1148F,<br />

2090F*, 2202W<br />

Bernert, G., 201, 2948T<br />

Bernier, D., 954T<br />

Bernier, F., 1052F, 3665F<br />

Bernier, F. P., 3095W,<br />

3127W, 3141W, 3173W<br />

Bernier, G., 1226F<br />

Bernier, R., 10, 14, 299,<br />

2406W, 2439W<br />

Berninger, V. W., 2549F<br />

Bernstein, A., 1289W,<br />

1301W, 1414F, 1455T<br />

Bernstein, B., 380<br />

Bernstein, K. E., 130<br />

BernsteinJon, J., 2479T<br />

Beroud, C., 3610W<br />

Beroukhim, R., 266<br />

Berry, D., 2097W<br />

Berry, D. J., 271<br />

Berry, F. B., 2474F<br />

Berry, G. T., 326<br />

Berry, M., 3648W<br />

Berry, R. J., 1304W<br />

Berry, S., 725F*<br />

Berry, S. A., 774W<br />

Berson, E. L., 1756W<br />

Berstein, L., 2202W<br />

Bertelsen, S., 340, 2582F<br />

Berthele, A., 2086T<br />

Berthet, P., 1212W<br />

Bertin, T., 411<br />

Bertin, T. K., 2854W<br />

Bertini, E., 54, 943W, 2777T<br />

Bertola, D. R., 439F, 895W,<br />

2232W, 3152F, 3160F,<br />

3184F, 3250F<br />

SPEAKER AND AUTHOR INDEX 339<br />

Bertolin, C., 1732W*<br />

Bertoni, A., 1661T<br />

Bertram, L., 2520W<br />

Berulava, T., 3524T*<br />

Berutti, R., 113, 157, 177,<br />

547F, 1451W, 2001W<br />

Berwouts, S., 1874F<br />

Besnard, T., 2947W<br />

Besse, A., 2942T<br />

Bessee, A., 676T<br />

Bessenyei, B., 3070F<br />

Bessert, D., 2664F<br />

Bessières, B., 77, 403<br />

Bessling, S. L., 79, 818F<br />

Betancourt, M., 1022F<br />

Betancur, C., 901W<br />

Betley, J., 366, 1176W,<br />

3663F<br />

Betta, P. G., 1153T<br />

Bettella, E., 1755W*, 2795T<br />

Betti, M., 1153T<br />

Betting, L. E., 2233T<br />

Bettinger, J. C., 640T<br />

Betz, R. C., 106<br />

Beunders, G., 98<br />

Beuten, J., 314, 1742W<br />

Bevan, L., 2138F<br />

Bevan, S., 1313W<br />

Bevans, M., 711F<br />

Beverloo, H. B., 980T<br />

Bevillard, J., 2877F<br />

Bevins, C. L., 449F<br />

Bevot, A., 3109W<br />

Beyan, C., 1136F<br />

Beygo, J., 2595W, 3496T*<br />

Bezerra, M. A., 426W<br />

Bezerra, M. A. C., 2718F,<br />

2751F<br />

Bezieau, S., 3066F, 3233W<br />

Bézieau, S., 1204T<br />

Bhagat, G., 1031F<br />

Bhagwat, A. M., 2382W<br />

Bhakta, M. S., 1625T<br />

Bhamani, F. I., 871W*<br />

Bhandari, A., 480W<br />

Bhangale, T., 1539T<br />

Bhangale, T. R., 2091W<br />

Bhanwer, A., 1993T*<br />

Bhanwer, A. J. S., 1703T<br />

Bhardwaj, A., 2726T*<br />

Bhaskar, A., 182<br />

Bhat, M., 2644T<br />

Bhat, V., 2776W<br />

Bhati, S., 2692W<br />

Bhatia, G., 89, 350, 1577W,<br />

3407W*<br />

Bhatia, K., 2581T<br />

Bhatia, T., 2382W<br />

Bhatnagar, S., 984W<br />

Bhatt, D. L., 317<br />

Bhattacharjee, S., 1372F*<br />

Bhattacharya, S., 3271F<br />

Bhattacharya, S. S., 2183F,<br />

2966T<br />

Bhatti, A., 3078F<br />

Bhatti, M. A., 2959W<br />

Bhatti, S., 630T<br />

Bhave, G., 3622W<br />

Bhidayasiri, R., 2749W<br />

Bhide, S., 1758W<br />

Bhonker, Y., 2919F<br />

Bhosle, S., 2005T<br />

Bi, D., 2419T<br />

Bi, W., 432W, 893W, 898T,<br />

952T*, 2395T<br />

Bian, H., 242<br />

Bianba, B., 3317W<br />

Bianchi, D., Session 79,<br />

765W<br />

Bianchi, l., 2695W<br />

Bianciardi, L., 2604W<br />

Bibat, G. M., 2962W<br />

Bibi, S., 1748W<br />

Bibikova, M., 596W, 1238F*,<br />

3451T<br />

Bicalho, M., 2404T<br />

Bick, A. G., 1677T*<br />

Bickel, J. P., 1836F<br />

Bickley, V., 967W<br />

Bidichandani, S. I., 381<br />

Bidlingmaier, M., 2080T<br />

Bieber, M., 1802F<br />

Bieche, I., 1212W<br />

Bielak, L. F., 2275T<br />

Bielawny, T., 3276T<br />

Bielecki, R., 1093T<br />

Bielinski, S. J., 618T, 1351F<br />

Bierings, M. B., 3164F<br />

Biernacka, J. M., 605T*,<br />

1426F, 2516F<br />

Bierut, L., 2114F, 2582F,<br />

2598W, 2650T<br />

Bierut, L. J., 2170T, 2535W<br />

Biesecker, B. B., 316*<br />

Biesecker, L. G., Session<br />

73, 33, 316, 358, 674T,<br />

1690T, 1696T, 2470T<br />

Bieth, E., 572W, 1796W<br />

Biewald, M., 1272W<br />

Bigdeli, T. B., 2500T*, 2594F<br />

Bigelow, A., 1441F*<br />

Bigham, A. W., 3290W*,<br />

3360T, 3380W<br />

Bignon, Y.-J., 1212W<br />

Bilan, F., 77<br />

Bilbao, J. R., 1330F<br />

Bilder, R. M., 639T<br />

Bilgen, R., 2924T<br />

Bilguvar, K., 2924T, 3132F<br />

Billaud, J., 3560W, 3677F*<br />

Billings, L., 249*<br />

Biloglav, A., 1023W<br />

Binder, E. B., 1422T, 2383T,<br />

2483F, 3480T<br />

Bind<strong>of</strong>f, L. A., 2451W<br />

Bing, N., 1491T<br />

Bini, L., 2695W<br />

Binia, A., 3466T, 3486T<br />

Bin-Khamis, G., 2734W<br />

Binkley, G., 3612W<br />

Binquet, C., 1293T<br />

Bint, S., 906T<br />

Birayavci, C., 1164W, 1178F<br />

Biray Avci, C., 1166F*,<br />

1172F<br />

Birch, D. G., 3234F<br />

Birch, P. H., 1840F, 1846W<br />

Birch, S., 2167T<br />

Bird, A. C., 2072F<br />

Bird, L., 3120F<br />

SPEAKER AND AUTHOR INDEX


340 SPEAKER AND AUTHOR INDEX<br />

Bird, T. D., 1753W<br />

Birk, O. S., 2931F*<br />

Birk, R. Z., 2931F<br />

Birkeland, S. R., 339<br />

Birkenhager, R., 3203W*<br />

Birkenhäger, R., 2753T, 2829F<br />

Birmingham, D., 458W<br />

Birnbaum, R. Y., 1995W*<br />

Birney, E., 35, 3732W<br />

Birzele, F., 242<br />

Bis, J. C., 1445W, 1585T,<br />

1592T*, 1599T, 1653T<br />

Bisch<strong>of</strong>f, F. Z., 1255T<br />

Bisgaard, H., 2167T, 2168F<br />

Bisgaard Pedersen, A.-M.,<br />

889W<br />

Bishay, D. L., 968T<br />

Bishop, B., 1729W<br />

Bishop, D. T., 211, 213<br />

Bishop, J., 3719F*<br />

Bishop, K., 664T, 1983W<br />

Bishop, P. N., 2072F<br />

Bishopric, N. H., 86<br />

Bissig, K., 165<br />

Bitner, M., 126<br />

Bitoun, E., 2649W<br />

Bitoun, P., 2784F*<br />

Bitter, H., 3574W<br />

Bitti, P., 2039F<br />

Bivina, L., 3151W<br />

Bizet, A., 324<br />

Bizon, C., 170, 231, 1437T<br />

Bjeda, D., 80<br />

Bjork, B. C., 825F*, 2670F<br />

Bjornsson, H. T., 3097W<br />

Blach, C., 1636T<br />

Blach, C. P., 2946F<br />

Black, G. F., 2003F<br />

Black, P. M., 266<br />

Blackburn, A. N., 2495F<br />

Blackburn, E., 96, 112<br />

Blackett, P. R., 1933T<br />

Blackman, S., 1322W,<br />

2953W<br />

Blackwell, T., 1373W*,<br />

1389T, 1513F, 2375F<br />

Blackwell, T. W., 176,<br />

1923W, 2308T, 2339F<br />

Blackwood, D., 2590T<br />

Black-Ziegelbein, E. A., 60<br />

Blair, E., 2939T<br />

Blair, I. P., 2816T<br />

Blair, J. D., 3429T, 3445T*<br />

Blair, M., 3654W<br />

Blake, T. L., 664T<br />

Blakemore, A. I. F., 1432F,<br />

2162F<br />

Blakesley, R., 1515T<br />

Blancato, J., 3080F<br />

Blanchard, C., 716T, 841F<br />

Blanche, H., 2303F<br />

Blancher, C., 3435T<br />

Blanco, A., 1059W<br />

Blangero, J., Session 8,<br />

176, 533F, 1280W,<br />

1282F, 1406W, 1458T,<br />

1513F, 1912T, 1923W,<br />

2061W, 2146T, 2308T,<br />

2309F, 2339F, 2589W,<br />

2651F, 3434T<br />

*Presenting Author<br />

Blank, R. D., 710T*<br />

Blankenberg, S., 275, 1669T<br />

Blanton, S., 57<br />

Blanton, S. H., 1635T,<br />

1638T*, 1871F<br />

Blasco, M., 546W<br />

Blaser, S., 675F, 3013T,<br />

3186F, 3196F<br />

Blaszkewicz, M., 1335T<br />

Blattmann, P., 1630T<br />

Blattner, F., 3671F<br />

Blauw, H. M., 431F<br />

Blazer, K., 321*<br />

Bleazard, T., 3259F*<br />

Blekhman, R., 537F*, 2029T<br />

Blelloch, G., 3376F<br />

Bleyer, A., 322, 1725W<br />

Blitzer, M., 1729W<br />

Block, G. J., 55, 2224T*<br />

Bloem, A. C., 3164F<br />

Blomenkamp, K., 735F<br />

Blomqvist, C., 1006T,<br />

1117T, 1171T, 1265F<br />

Blondal, T., 1194W<br />

Bloom, M., 2452T<br />

Bloom, R. J., 2468F, 3659F*<br />

Bloss, C. S., Session 9,<br />

146*, 1839W<br />

Blot, W. J., 2202W<br />

Blouin, J.-L., 2877F*<br />

Blow, M. J., 4, 407<br />

Blum, C., 2262W<br />

Blum, M. G. B., 3356W<br />

Blümel, P., 3111W<br />

Blumenfield, J., 3210F<br />

Blumenstiel, B., 322,<br />

1725W*, 3711F<br />

Blumenthal, I., 68, 70,<br />

554W*<br />

Blumentritt, C., 2557T<br />

Blumkin, L., 2447F<br />

Boackle, S. A., 1979F<br />

Boardman, L., 1267T*<br />

Boaretto, F., 1732W, 2708T,<br />

2799F<br />

Bobadilla-Morales, L.,<br />

3188F<br />

Bober, M. B., 2855T, 3150F*<br />

Boca, S. M., 1372F<br />

Bochukova, E., 43<br />

Bock, H.-G., 898T<br />

Boczek, N. J., 2885T*<br />

Bodamer, O. A., 297<br />

Bóday, A., 2865F<br />

Boddaert, N., 202, 329,<br />

522W, 3240F<br />

Boddicker, N., 2717T<br />

Bode, A., 262<br />

Bodemer, C., 128*, 3140F<br />

Bodenh<strong>of</strong>er, U., 95*<br />

Bodereau, V., 3157W,<br />

3241W<br />

Bodily, P., 3561F<br />

Bodmer, W., 181<br />

Bodo, J., 283, 3303T,<br />

3338W<br />

Bodria, M., 845F<br />

Bodzioch, M., 2761W<br />

Boeckxstaens, G. E.,<br />

2088W<br />

Boehm, C., 227<br />

Boehnke, M., 46, 88, 117,<br />

176, 280, 1389T, 1448W,<br />

1452T, 1513F, 1608T,<br />

2090F<br />

Boehringer, E., 3044F<br />

Boeke, J. D., 504W<br />

Boekholdt, S. M., 1604T<br />

Boengers, E. M. H. F., 216<br />

Boerkoel, C., 359, 2442W,<br />

2610W<br />

Boerkoel, C. F., 755W,<br />

2682F, 2849T, 2938W,<br />

3543F<br />

Boerkoel III, C. F., 2870T*<br />

Boerwinkle, E., 121, 170,<br />

174, 183, 187, 192,<br />

272, 349, 648T, 1445W,<br />

1508W, 1520W, 1585T,<br />

1592T, 1599T, 1932W,<br />

2577W, 2880F, 2934F,<br />

3576W, 3597F<br />

Boese, B. J., 2301W<br />

Boesten, I., 708T<br />

Boettger, L. M., 437F<br />

Boezen, H. M., 1330F<br />

B<strong>of</strong>ferding, K. M., 2740W<br />

Bogardus, C., 1300F,<br />

1917W, 2018F, 2038T<br />

Bogdanovic, R., 216<br />

Bögershausen, N., 2944W*<br />

Boggan, J., 2151W<br />

Boggs, B., 330<br />

Bohlega, S., 2743W<br />

Böhm, B., 2160W<br />

Bohm, J., 328, 2681T*<br />

Bohn, J. M., 3635F<br />

Bohnsack, J., 2143T<br />

Bohorquez, S., 951W,<br />

3074F<br />

Bohossian, N., 624T<br />

Bohr, V. A., 2244W<br />

Boileau, C., 56, 1607T,<br />

2266T, 3341W<br />

Boissin, C., 2752W<br />

Boivin, M., 2545T<br />

Boiy, T., 3193W<br />

Bojanowski, M., 1670T<br />

Bojesen, S. E., 206, 210<br />

Bokhoven, H., 672T<br />

Boks, M. P. M., 431F,<br />

2553W, 2661W, 3474T<br />

Boland, J., 30, 1218W,<br />

1517W, 3683F*<br />

Bole-Feysot, C., 104, 324,<br />

403, 2808F<br />

Boles, J. W., 970T<br />

Bolon, B., 2668W<br />

Bolz, J. E., 3550W<br />

Bolze, A., 365*<br />

Boman, H., 2451W, 3215W<br />

Bombard, A., 3016T<br />

Bombard, A. T., Session 79<br />

Bombard, Y., 142, 1841W*<br />

Bommakanti, K., 1601T<br />

Bona, G., 2827W<br />

Bonafè, L., 164, 3190F<br />

Bonaldi, A., 874T, 882T*,<br />

3250F<br />

Bonalumi, A., 870T, 3055W<br />

Bonassi, S., 1153T<br />

Bond, D., 3694W<br />

Bondon-Broders, F., 842F<br />

Bondurand, N., 842F, 843F,<br />

2727F*<br />

Bondy, C. A., 1743W<br />

Bonet, C., 987W<br />

Bonetti, M., 215<br />

Bongers, E. M., 100<br />

Bongers, E. M. F. H., 2925F<br />

Bongers, E. M. H. F., 80<br />

Boni, C., 1759W<br />

Bonilla, E., 1022F<br />

Bonin, M., 1200W*, 3109W<br />

Bonithon-Kopp, C., 1293T<br />

Bonkowsky, J., 2951T<br />

Bonnefont, J.-P., 72<br />

Bonnefont-Rousselot, D.,<br />

1607T<br />

Bonnemann, C., 711F,<br />

2945T<br />

Bonnen, P., 676T, 2942T*<br />

Bonner, J., 463F<br />

Bonnet, C., 2770W<br />

Bonnet-Wersinger, D.,<br />

2679F<br />

Bonneux, S., 2104T<br />

Bonney, E., 3446T<br />

Bonnière, M., 77, 403<br />

Bono, S., 71<br />

Bonomo, J. A., 2310W<br />

Bontrop, R., 285<br />

Bontrop, R. E., 3266W<br />

Bonyadi, M., 57<br />

Booker, J., 688T<br />

Boomsma, D., 434W,<br />

2097W<br />

Boomsma, D. I., 2175W<br />

Boon, L. M., 83, 1015T,<br />

1611T<br />

Boone, P. M., 430W*<br />

Boonvisut, S., 2009F<br />

Boonyaratanakornkit, J.,<br />

3684W<br />

Boos, H. B. M., 2526W<br />

Booth, F., 954T<br />

Booth, F. A., 2422T<br />

Booth, K., 2867T<br />

Boquett, J. A., 3031T<br />

Boran, G., 1624T<br />

Boraska, V., 2522F*<br />

Borck, G., 105*<br />

Borecki, I., 18, 1210T,<br />

2040W<br />

Borecki, I. B., 1641T, 1650T,<br />

1661T, 1913F, 2275T<br />

Borel, C., 3516T<br />

Borenstein, E., 10<br />

Borgan, C., 893W<br />

Borges, M. G., 2394W,<br />

2876T<br />

Børglum, A., 2369F<br />

Børglum, A. D., 2699T<br />

Borgman, S., 1860F<br />

Boright, A. P., 2109W<br />

Borja, J., 2036F<br />

Borjas, L., 3364F, 3402T<br />

Borlido, C., 2408F<br />

Bornman, M. S. R., 1085F<br />

Bornstein, E., 957W


Borochowitz, Z. U., 3202F<br />

Boroevich, K. A., 396,<br />

2051F<br />

Boronat, S., 3208F<br />

Borowsky, M., 326<br />

Borrel, C., 561F<br />

Borrell, M., 1651T<br />

Borrero, E., 3155W<br />

Borsani, G., 3256F<br />

Borsuk, LA., 1165T<br />

Bortolai, A., 3045W<br />

Bortolini, C., 3327T<br />

Bose, P., 2069F, 2312F<br />

Bosl, G., 998F<br />

Bosley, A., 1088F, 2833W<br />

Bosley, T., 2997T<br />

Bosman, A., 807F*<br />

Bosoi, C. M., 1910F<br />

Boss, J., 3310F<br />

Bossé, Y., 1465F, 1655T,<br />

1947W<br />

Bostan, O., 1708T<br />

Boster, J., 2223W<br />

Bostick, M., 3727F*<br />

Boston, J., 1316W, 1377T,<br />

1671T, 1928F, 2037W<br />

Botigué, L. R., 3345T<br />

Bottani, A., 2937F<br />

Bottiglieri, T., 168<br />

Bottomley, M., 2852T<br />

Bottomley, W., 45<br />

Boualga, K., 1268F<br />

Boucher, G., 2319W<br />

Bou Dagher-Kharrat, M.,<br />

3349F<br />

Boudes, P., 732T, 745F<br />

Boudes, P. F., 772W<br />

Boudreau, R. L., 2636F*<br />

Bouffard, G., 1515T<br />

Bougeard-Denoyelle, G.,<br />

1090T, 1222T<br />

Boughey, J. C., 1247F<br />

Bouhlal, Y., 501F*, 1687T<br />

Bouhnik, S., 2234F<br />

Boukhris, A., 2820F<br />

Boulanger, S., 3216F*,<br />

3218F<br />

Bouligand, J., 894T<br />

Boulling, A., 854F*<br />

Bouquillon, S., 299<br />

Bouraoui, S., 2744T<br />

Bourassa, C., 1670T, 2306F<br />

Bourbon, M., 1968W, 2017T<br />

Bourgeois, B. F. D., 266<br />

Bourgeron, T., 259<br />

Bourque, G., 3439T<br />

Bourrat, E., 128<br />

Bourredjem, A., 1293T<br />

Bouss<strong>of</strong>ara, L., 2744T<br />

Boutaoui, N., 3449T<br />

Boute, O., 2002T<br />

Boute-Benejean, O., 3172F<br />

Bouvet, R., 2126F<br />

Bouvier, R., 3129W<br />

Bouzigon, E., 1361W,<br />

1461T, 1941W, 2079W,<br />

2248T<br />

Bova, G. S., 1242W<br />

Boven, L. G., 1619T<br />

Bovolenta, P., 2810T<br />

*Presenting Author<br />

Bowcock, A., 2581T<br />

Bowcock, A. M., 154, 1952F<br />

Bowden, D., 1706T, 2332T<br />

Bowden, D. W., 178, 1648T,<br />

1661T, 1879T, 1888T,<br />

2310W<br />

Bowden, S., 458W<br />

Bowdin, S., 1704T, 1738W,<br />

3142F*<br />

Bowdish, B., 3530W<br />

Bowen, B. M. P. M., 2045F*<br />

Bowen, M., 17<br />

Bower, A., 1856F<br />

Bowes, J., 2160W<br />

Bowling, B., 1860F*, 1861F<br />

Bowling, K., 2556W<br />

Bowne, S. J., 3234F<br />

Bowton, E., 247, 647T<br />

Boxer, A. L., 2639F<br />

Boyaci, H., 2924T<br />

Boyadjiev, S., 1791W<br />

Boyadjiev, S. A., 2151W<br />

Boyadjiev Boyd, S. A.,<br />

3070F, 3151W*<br />

Boyanova, O., 3481T<br />

Boyar, F., 876T<br />

Boyar, F. Z., 3522T*<br />

Boyce, J., 3700W<br />

Boycott, K., Session 74,<br />

198<br />

Boycott, K. M., 131, 701F,<br />

1775W, 2790F, 2794W,<br />

2800W<br />

Boyd, B., 3, 2998T<br />

Boyd, J. H., 1632T<br />

Boyd, K., 1108T<br />

Boyden, L. M., 2915T*<br />

Boyer, J., 1845W<br />

Boyer, T. G., 125<br />

Boysen, C., 3528W*, 3641F,<br />

3662W<br />

Bozon, V., 136<br />

Bozorgmehr, B., 2436W*<br />

Bozza, M., 3050F*<br />

Bozzao, C., 760W<br />

Bozzi, I., 2404T<br />

BPC3, TNBCC, and BCAC,<br />

1150T<br />

Braastad, C. D., 3522T<br />

Bracci, P., 1152W, 3623F<br />

Bracci, P. M., 2055W<br />

Brackett, D., 474W<br />

Bradfield, J., 319, 1915T*,<br />

1996T, 2067W, 2121W,<br />

2229W<br />

Bradford, Y., 247, 1447F<br />

Bradley, A., 3507T<br />

Bradley, B., 2420F, 2483F<br />

Bradley, D. T., 2843T<br />

Bradley, E. J., 197, 2909T<br />

Bradley, F., 3245W<br />

Bradley, M., 1939T<br />

Bradley, T., 1133F, 3186F<br />

Bradman, A., 3458T<br />

Bradman, N., 3322F<br />

Bradrick, S., 2454W<br />

Bradshaw, P., 1047W*<br />

Bradshaw, P. S., 1046F<br />

Brady, S. M., 2702T<br />

Bragat, A. C., 745F<br />

SPEAKER AND AUTHOR INDEX 341<br />

Brage, S., 2359T<br />

Bragg-Gresham, J., 113*,<br />

1568W<br />

Bragin, E., 291<br />

Brahmachary, M., 3516T<br />

Brainbridge, M. N., 1761W<br />

Brais, B., 2797W, 2900T<br />

Bralten, J., 1498F<br />

Brambilla, P., 624T, 2095T<br />

Brancati, F., 131, 2760F<br />

Branch, S., 136<br />

Branco, C. C., 2288F<br />

Branco, M., 3019T<br />

Branco-Madeira, F., 2225F<br />

Brand, S., 1942T<br />

Brandalize, A. P. C., 3031T*<br />

Brandao, L. R., 2330F<br />

Brandl, E., 612T<br />

Brandon, J., 1359T<br />

Brandt, T., 3724W<br />

Brandt, W., 2833W<br />

Branham, K., 2135F<br />

Branham, K. E., 2183F,<br />

3234F<br />

Branson, H., 675F<br />

Brant, S. R., 1381F, 2319W<br />

Brar, B., 2978T<br />

Brar, H., 2978T, 3020T<br />

Brar, S., 2830W*<br />

Brasil, A. S., 3160F<br />

Brasington, R., 2047T<br />

Braslavsky, D., 361<br />

Brass, A., 2231F<br />

Brassat, D., 624T<br />

Bratanič, N., 2688F, 2710W<br />

Bratina, N., 2710W<br />

Bratton, E., 3038F<br />

Braun, T. A., 2750T<br />

Braun, T. R., 1933T*<br />

Braunholz, D., 204, 2958F*<br />

Brautbar, A., 187, 1688T*<br />

Braverman, A. C., 80<br />

Braverman, N., 722T*<br />

Braverman, N. E., 8<br />

Braverman, R., 238<br />

Bravi, C. M., 3362W<br />

Bravo, H., 2566T<br />

Bravo, H. C., 260<br />

Bravo, L. E., 3388F<br />

Braxton, A., 1742W<br />

Braxton, A. A., 1735W,<br />

1761W<br />

Bray, M. S., 2189F<br />

Bray, S. M., 1235F<br />

Brazilian Network Members,<br />

879W<br />

Brazma, A., 567F, 582W<br />

Bready, B., 3529F*, 3656W,<br />

3703F<br />

Breast Cancer Association<br />

Consortium, 206<br />

Brebner, A., 673F, 705F*,<br />

706T, 719F<br />

Breda, C., 2641T<br />

Breden, F., 375<br />

Bredrup, C., 2451W<br />

Brefort, T., 515F<br />

Brehm, J., 3449T<br />

Breit, H., 830F<br />

Brem, R. B., 571F<br />

Breman, A. M., 432W<br />

Bremer, R., 1064F<br />

Bremer, S., 3614W<br />

Bremnes, R. M., 991T<br />

Brémont, F., 572W<br />

Brennan, C., 177, 3664W<br />

Brennan, C. A., 2329T<br />

Brennan, E. P., 2307W<br />

Brennan, K., 2042F<br />

Brennan, M., 2084F<br />

Brennan, P., 1012T, 1496W<br />

Brennand, K. J., 436W<br />

Brennecke, S. P., 2309F<br />

Brenner, S., 499F*<br />

Brenner, S. E., Session 4,<br />

362<br />

Bressac-de Paillerets, B.,<br />

1158W<br />

Bressan, R. A., 2533T,<br />

2534F<br />

Bressman, S. B., 2801T<br />

Bresson, J. L., 129<br />

Breton, A., 3694W<br />

Breton, B., 3680W<br />

Brett, M. S., 2889F*<br />

Breu, H., 1232F, 3717F<br />

Breuhaus, B., 2778F<br />

Breuning, M., 2701W*<br />

Brewer, F., 884T<br />

Brewer, V., 3119W<br />

Brezina, P., 78*<br />

Brezina, P. R., 2998T<br />

Briand, A., 1796W<br />

Briand-Suleau, A., 843F,<br />

894T*, 3157W, 3241W<br />

Briani, C., 2799F<br />

Briault, S., 3246F<br />

Brice, A., 29, 2638T, 2770W,<br />

2820F<br />

Briceno, I., 951W*, 3074F<br />

Brick, K., 417F*, 592W<br />

Brick, L., 103<br />

Bridges, S. L., Jr., 2047T<br />

Briggs, F., 1415W, 1924T<br />

Briggs, F. B. S., 1289W,<br />

1301W, 1414F, 1455T*<br />

Briley, D., 630T<br />

Briley, L., 630T<br />

Brilhante, M. J., 2288F<br />

Brilhante, T. B., 3421T<br />

Brilhante, V., 327<br />

Brill, P., 3128F<br />

Brilliant, M., 2297F, 3622W<br />

Brinkerh<strong>of</strong>f, C. D., 1071W<br />

Brinza, D., 1232F, 3670W*<br />

Briollais, L., 1500T*<br />

Brion, M.-J., 1626T<br />

Brisset, S., 894T<br />

Brisuda, A., 1012T<br />

Britel, L. K., 398<br />

Britto, J. A., 2859F<br />

Brkanac, Z., 2406W<br />

Brockman, M., 3688W<br />

Brockmann, G., 2251T<br />

Brockschmidt, F. F., 106,<br />

2557T<br />

Brodesser, S., 2869W<br />

Brody, J., 584W, 1284T,<br />

1346W, 1503T, 1585T*,<br />

1592T, 1599T<br />

SPEAKER AND AUTHOR INDEX


342 SPEAKER AND AUTHOR INDEX<br />

Broeckelmann, E. M., 837F*<br />

Broeckling, C., 1189T,<br />

1990T<br />

Broer, L., 2175W<br />

Br<strong>of</strong>ferio, A., 1702T<br />

Brohawn, D., 2599T<br />

Brohi, Q., 2075F, 2402F<br />

Broly, M., 2660F<br />

Bromhead, C., 2741T<br />

Bronson, P. G., 2091W*<br />

Brook, A., 2114F<br />

Brook, M., 1150T<br />

Brookes, A. J., 3610W<br />

Brooks, A., 127<br />

Brooks, A. I., 2170T<br />

Brooks, B., 2183F<br />

Brooks, B. P., 664T<br />

Brooks, J., 1167W<br />

Brooks, M., 822F, 1774W<br />

Brooks, M. J., 827F*<br />

Brooks, S., 316<br />

Broomer, A., 1237T<br />

Brophy, P., 419F<br />

Brosch, M., 580W<br />

Brosh, R. M., Jr., 2692W<br />

Brossard, M., 211, 1158W*,<br />

2248T<br />

Brothers, K. B., 247, 631T*<br />

Broussolle, E., 2638T<br />

Brouwer, O., 2909T<br />

Brovedani, P., 3050F<br />

Brower, A., 725F, 3530W*<br />

Brown, A., 546W, 1227W,<br />

1440T*<br />

Brown, A. M. K., 135*,<br />

1256F<br />

Brown, C., 372, 3514T,<br />

3734W<br />

Brown, C. D., 614T<br />

Brown, D., 493F, 738T*<br />

Brown, E. E., 2046W<br />

Brown, J., 686T, 1159T<br />

Brown, K., 3133W<br />

Brown, K. M., 212<br />

Brown, L., 3446T, 3688W<br />

Brown, M., 3682W<br />

Brown, M. A., 152, 209,<br />

2053T<br />

Brown, M. P. S., 36*<br />

Brown, M. R., 202<br />

Brown, N. J., 606T<br />

Brown, S., 3446T*<br />

Brown, S. G., 978T<br />

Brown, S. J., 1216T<br />

Brown, W. T., 1986W, 2449T*<br />

Browne, V. A., 3290W<br />

Brown-Ford, S., 587F*<br />

Brown-Gentry, K., 1377T,<br />

1671T, 1713T, 1928F,<br />

2037W*, 2401T<br />

Brown-Gentry, K. D., 1316W<br />

Browning, B. L., Session 75,<br />

1479T, 1485T, 1487W*,<br />

1537F<br />

Browning, S. R., 1479T*,<br />

1485T, 1487W, 1537F<br />

Brownstein, C. A., 1769W*,<br />

1799W<br />

Brownstein, Z., 2914W,<br />

2919F<br />

*Presenting Author<br />

Broxholme, J., 2939T<br />

Brožková, D., 2745F*<br />

Bruat, V., 31, 2266T, 3268F,<br />

3341W<br />

Bruce, C., 3694W<br />

Bruce, I. N., 2160W<br />

Bruchim, R., 1303F*<br />

Bruckdorfer, K. R., 1626T<br />

Brucker, S., 3153W<br />

Bruckmann, C., 2058W<br />

Brueton, L., 300<br />

Bruford, E., 3651F*<br />

Brüggemann, N., 200<br />

Brüggenwirth, H., 3650W<br />

Bruinenberg, M., 2282F<br />

Brumelle, J., 3512T<br />

Brummett, B. H., 1594T,<br />

2481W<br />

Brunak, S., 2241W<br />

Bruneau, N., 2581T<br />

Brunetti-Pierri, N., 127, 164,<br />

433F, 735F<br />

Brunner, H. G., Session 74,<br />

Session 81, 80, 97, 100,<br />

102, 124, 125, 214,<br />

1734W, 1749W, 2863W,<br />

2925F<br />

Bruno, M. K., 2581T<br />

Bruno, V., 1330F<br />

Brunoni, A. R., 2540F<br />

Brunoni, D., 2484W, 2485T,<br />

2540F, 2863W, 3131W<br />

Bruns, G. A. P., 82<br />

Brunzell, J. D., 1605T<br />

Brusco, A., 550W, 790W<br />

Brusius-Facchin, A. C., 747F<br />

Brussino, A., 550W<br />

Brüstle, O., 236<br />

Bruzel, A., 370<br />

Bruzelius, M., 1651T<br />

Bryan, N., 165<br />

Bryans, N., 3672W<br />

Bryc, K., 178*<br />

Bryne, E., 3096F<br />

Bryois, J., 560W*<br />

Bryson, L., 1724W*<br />

Brzoska, P., 1068W<br />

Brzustowicz, L. M., 2381F,<br />

2426F, 2467T, 2523W,<br />

2544W<br />

Bshara, W., 3428T<br />

Bubela, T., 1802F<br />

Bucasas, K., 2542T<br />

Bucasas, K. L., 2189F,<br />

2336F*, 2337W<br />

Buchan, J. G., 220*, 2860W<br />

Buchanan, D. D., 141,<br />

1067F, 1206W<br />

Buchanan, T. A., 1916F<br />

Buchert, R., 2557T<br />

Buchholz, S., 330<br />

Buchkovich, M., 292*<br />

Buchkovich, M. L., 46,<br />

<strong>2012</strong>F<br />

Buchner, N., 1279T<br />

Buck, D., 2086T<br />

Buckett, W., 2842W<br />

Buckley, H., 3333T<br />

Buckley, K., 1138T<br />

Buckley, M. F., 214, 2151W<br />

Buckley, N., 3471T<br />

Buckstein, M., 1309F<br />

Bucourt, M., 77<br />

Budak, B., 594W<br />

Budde, B. S., 2861T*<br />

Budde, J., 2582F, 2598W<br />

Budenz, D. L., 2154W,<br />

2240F<br />

Budman, D., 1133F<br />

Budowle, B., 3544W<br />

Budunova, I., 1181F<br />

Bueno, D. F., 813F, 814F,<br />

852F<br />

Buermans, H., 813F<br />

Buers, I., 2759T<br />

Buffa, F., 509F<br />

Buffler, P., 2268W<br />

Buffler, P. A., 1924T<br />

Bugge, K., 404, 2215T,<br />

2671W<br />

Bugge, K. E., 387<br />

Buhay, C., 2880F<br />

Buhay, C. J., 1757W<br />

Buhler, E., 2457W, 2674W<br />

Bui, P., 873W<br />

Bui, P. H., 1029W*<br />

Buijs, A., 3164F<br />

Buil, A., 44, 546W*, 560W,<br />

561F, 583F, 1651T<br />

Builes, J. J., 3364F, 3402T<br />

Buitelaar, J., 1498F<br />

Buiting, K., 392, 872T,<br />

3496T, 3500T<br />

Buizer-Voskamp, J., 431F*<br />

Buizer-Voskamp, J. E.,<br />

2526W<br />

Bukowski, R., 537F<br />

Bukshpun, P., 2389T<br />

Bukszar, J., 3442T, 3452T<br />

Bulhões, S. M., 2288F<br />

Bulik, C. M., 2522F<br />

Bull, S. B., 2109W<br />

Bullens, S., 763W<br />

Buller-Burckle, A., 2260T<br />

Bullitt, C., 3560W<br />

Bulman, D., 198<br />

Bulman, D. E., 131, 701F,<br />

2794W, 2800W<br />

Bulstrode, N. W., 303<br />

Bunce, C., 2072F<br />

Bundgaard, M., 3641F<br />

Bundo, M., 2435F<br />

Bungaard, M., 3662W<br />

Büning, C., 1942T<br />

Bunker, C. H., 1672T, 1673T<br />

Bunting, S., 763W<br />

Bunyan, D., 3161W<br />

Burbano, R. R., 1008W,<br />

1132T, 3421T, 3502T,<br />

3503T<br />

Burbidge, L. A., 1021T<br />

Burch, L. H., 606T<br />

Burchard, E. G., 158, 1425T,<br />

2296T, 3363T<br />

Burden, A. F., 1580W<br />

Burdett, L., 1010F, 1012T,<br />

1218W, 1517W<br />

Burdett, T., 2108F<br />

Burdette, L., 30<br />

Burdon, K. P., 1785W<br />

Burgess, D., 3688W<br />

Burgess, K. E., 845F<br />

Burglen, L., 2770W<br />

Burhans, R., 3545F<br />

Burin, M., 685F<br />

Burke, A., 1649T<br />

Burke, B., 2914W<br />

Burke, L., Session 28<br />

Burkett, E., 1853F<br />

Burkhalter, W., 3085W<br />

Burkhardt, H., 2160W<br />

Burkley, B., 646T<br />

Burlet, P., 72<br />

Burnell, L., 3006T<br />

Burnham, N. B., 2443T<br />

Burns, D. K., 637T<br />

Burns, E., 1444F*, 1594T,<br />

1636T, 3345T, 3395W<br />

Burns, K., 1260W<br />

Burns, K. H., 504W<br />

Burns, T., 1889F<br />

Burnside, R. D., 949W<br />

Buroker, N., 727F, 3281W*<br />

Buros, J., 343, 2528F<br />

Burren, O., 453F<br />

Burroughs, A., 153<br />

Burton, C., 1021T<br />

Burton, J., 1014W<br />

Burton, J. E., 3101W<br />

Burtt, N., 169<br />

Burtt, N. P., 172<br />

Burzynski, G. M., 545F<br />

Busche, S., 31, 256*, 394,<br />

1207T, 1215W, 3439T<br />

Busch-Netwich, E., 37<br />

Bush, W., 312, 1668T,<br />

2257T, 2321F<br />

Bush, W. S., 1489F, 1634T,<br />

2298W*<br />

Bushnell, S., 2561F<br />

Buslon, V., 981W<br />

Busonero, F., 113, 157,<br />

177, 276, 1516F, 2001W,<br />

2198F, 2329T, 3664W<br />

Busse, T., 65<br />

Bustamante, C., 285, 2033F,<br />

3345T, 3563F<br />

Bustamante, C. D., 186,<br />

293, 371, 1112F, 1770W,<br />

2087F, 3352F, 3360T,<br />

3361F, 3362W, 3368W,<br />

3380W, 3390T, 3411W<br />

Bustamante, M., 2167T<br />

Butcher, D., 3482T<br />

Butcher, D. T., 3447T*,<br />

3456T, 3489T<br />

Butcher, N. J., 2428T*<br />

Butler, A. W., 2494T<br />

Butler, E., 2579F<br />

Butler, M. G., 3054F,<br />

3089W*<br />

Butler-Browne, G., 2840T<br />

Butt, M., 784W<br />

Butte, A., 2230T<br />

Butte, A. J., 562W, 1462F<br />

Butter, F., 2010W<br />

Butterly, L., 3465T<br />

Buttgereit, A., 2456F<br />

Büttner, C., 3153W<br />

Bützow, R., 1026W


Buur Sinding, J., 3641F,<br />

3662W<br />

Buxbaum, J., 1520W<br />

Buxbaum, J. D., 268, 343,<br />

1530T, 2560T*, 2577W<br />

Buxbaum, S. G., 1715T*<br />

Buxton, J. L., 1432F, 2162F,<br />

2175W<br />

Buyru, N., 2912T<br />

Buys, S., 1213T<br />

Buyske, S., 1608T, 2042F,<br />

2381F, 2501F*, 3558W<br />

Buysse, K., 214<br />

Buzkova, P., 2041T<br />

Bwanali, J., 3694W<br />

Bybee, J., 3702W<br />

Byerley, W., 2590T<br />

Byers, P. H., 80, 1759W<br />

Bygum, A., 2760F<br />

Byrd, G., 2637W<br />

Byrd, G. S., 343<br />

Byrge, C., 3239W*<br />

Byrne, M., 3610W*<br />

Byrnes, A. E., 1532W*,<br />

3659F<br />

Byrnes, J., 3321T, 3380W<br />

Byrnes, J. K., 3352F,<br />

3365W, 3390T<br />

Byrois, J., 561F<br />

Bytautas, J. P., 1824F*<br />

C<br />

Caberg, J.-H., 925W<br />

Cabezas, R., 76<br />

Cabot, C., 3538W<br />

Cabral, D., 1635T, 1638T<br />

Cabral, R., 2814F<br />

Cabral, W. A., 222, 2853F*<br />

Cabrera, L., 1119W<br />

Cabrera, S. S., 3063W<br />

Cabrera-Luque, J., 670T<br />

Cabrera-Rios, M., 659F<br />

Cabriolu, A., 2001W<br />

Cacheux, V., 3047W<br />

Cadby, G., 1153T<br />

Cade, W. H., 2028W, 2185T,<br />

2318F<br />

Cadenne, M., 716T<br />

Café, C., 2417F, 2502W<br />

Caggana, M., 2151W<br />

CAGI Participants, 499F<br />

Cagnin, A., 2775F<br />

Cahayag, R., 784W<br />

Cahill, M., 263<br />

Cahn, W., 2526W<br />

Cai, C., 553F, 844F, 2612F*,<br />

3558W<br />

Cai, F., 1539T<br />

Cai, G., 268<br />

Cai, J., 242, 3531F*<br />

Cai, X., 266<br />

Cai, Z., 1485T*<br />

Caiazzo, C., 71<br />

Caicedo, L., 2631W<br />

Cailler, S., 2113T<br />

Cailley, D., 473F<br />

Cain, C., 2<br />

Cain, S., 2852T<br />

*Presenting Author<br />

Cairney, A. E. L., 1138T<br />

Calcagno, D. Q., 1008W,<br />

1132T, 3421T*, 3503T<br />

Calcaterra, N., 2673F<br />

Caldarazzo, S., 2781F<br />

Caldarelli, M., 2235W<br />

Calderon, J., 1609T*<br />

Calderwood, M., 2660F<br />

Caldwell, D. A., 1834F<br />

Cale, C. M., 1748W<br />

Calender, A., 1293T<br />

Caleshu, C., 1601T<br />

Calhoun, A., 3088F<br />

Calibi, M., 322<br />

Caliebe, A., 1943F<br />

Calik, M., 2396F, 2412W<br />

Calkins, M. E., 2514W,<br />

2546F<br />

Call, W., 2328W<br />

Callahan, L. F., 2047T<br />

Callan, C., 597F<br />

Callens, T., 1139F<br />

Callewaert, B., 128, 129*<br />

Calley, J. N., 1235F<br />

Callier, P., 2716W, 2729T,<br />

2770W, 2792T<br />

Callier, S., 241<br />

Caluseriu, O., 3173W*<br />

Calvas, P., 390, 2957T<br />

Calverley, P. M. A., 2249F<br />

Calvert, D., 3449T<br />

Calvo, S., 1859F<br />

Calvo, S. E., 326<br />

Calzada-Wack, J., 2922F<br />

Camarena, V., 794W<br />

Camargo, L. M., 1343W<br />

Camargo, L. M. A., 2352W<br />

Camarillo, C., 2495F<br />

Camarillo, D. D. A., 3063W<br />

Cambell, C., 3397W<br />

Cambien, F., 3453T<br />

Cambon-Thomsen, A.,<br />

1811W, 1848W<br />

Cambridge, E., 2701W<br />

Camerini-Otero, R. D., 417F,<br />

592W<br />

Cameron, R., 2984T<br />

Camilleri, E., 1042T<br />

Camm, A. J., 2699T<br />

Camminady, A., 2928F<br />

Camp, N., 1001F<br />

Camp, N. J., 1441F<br />

Campbell, C., 1185W,<br />

1309F, 3345T*<br />

Campbell, C. A., 2301W*<br />

Campbell, C. D., 14, 278*<br />

Campbell, F., 630T<br />

Campbell, H., 1383T,<br />

1481W, 2072F, 2366F<br />

Campbell, I. G., 27, 1224W<br />

Campbell, I. M., 229*, 430W<br />

Campbell, K. P., 2812W<br />

Campbell, M., 2043W<br />

Campbell, M. R., 257<br />

Campbell, M. T., 1683T<br />

Campbell, N. G., 268<br />

Campbell, S., 2072F<br />

Campeau, P., 127, 165,<br />

2864T*, 2934F, 3209W<br />

Camper, S. A., 1878W<br />

SPEAKER AND AUTHOR INDEX 343<br />

Campion, D., 345, 3538W<br />

Campos, B., 2627F, 2814F<br />

Campos, M. M., 2183F<br />

Campos Valenzuela, J. A.,<br />

1236W<br />

Camps, C., 509F<br />

Campuzano, V., 3084F<br />

Canales, C. P., 410,<br />

2662W*, 2837T<br />

Canapicchi, R., 3050F<br />

Cancel-Tassin, G., 28, 1001F<br />

CANDELA Consortium,<br />

3327T<br />

Candille, S. I., 581F, 3318T,<br />

3383W*<br />

Canfield, T., 255<br />

Canfield, V., 309<br />

Canfield, V. A., 3264T*,<br />

3267T<br />

Cangul, H., 1708T<br />

Canham, N., 80<br />

Canick, J. A., 3016T<br />

Canino, G., 3449T<br />

Canizales, S., 3327T<br />

Cann, G., 1167W*<br />

Cann, H. M., 371, 3361F,<br />

3411W<br />

Cannon-Albright, L., 28,<br />

1001F, 1149W, 1214F,<br />

1328W*<br />

Canson, D. M., 707F<br />

Cantor, E., 3517T, 3715F<br />

Cantor, R., 2262W<br />

Cantor, R. M., 2056T, 2222F,<br />

2256W, 2415W, 2551T,<br />

2658W<br />

Cantsilieris, S., 1911W*<br />

Cantú, C., 872T<br />

Cantwell, L. B., 342, 343<br />

Canty, A. J., 2109W<br />

Cao, A., 113<br />

Cao, D., 159, 2617T<br />

Cao, H., 3649F<br />

Cao, L., 2672T*, 2837T<br />

Cao, M., 92*, 1776W<br />

Cao, Q.-Y., 1613T*<br />

Cao, X., 3317W<br />

Cao, Y., 1772W<br />

Capalbo, A., 2777T<br />

Capelo, L. P., 852F<br />

Capo-Chichi, J.-M.,<br />

2692W*, 2790F<br />

Capon, F., 154, 1927T<br />

Caporaso, N. E., 30, 1154F<br />

Capra, R., 2095T<br />

Capra, V., 1910F<br />

Capredon, M., 3260W*,<br />

3341W<br />

Capron, C., 2716W<br />

Caputo, S., 1062W, 1212W<br />

Caraballo, L., 2043W<br />

Carabalona, A., 889W,<br />

2674W*<br />

Caracciolo, M., 2766F,<br />

2774T<br />

Caramins, M., 2934F<br />

Carbajo, R., 682T<br />

Cardena, M. M. S. G.,<br />

1629T<br />

Cardenas, R., 1141T<br />

Cárdenas-Cardos, R.,<br />

1131W<br />

Cardentey, Y., 3706W<br />

Cardin, N., 1250F<br />

Cardinale, C., 2229W,<br />

2592W<br />

Cardinale, C. J., 1997F*,<br />

2252F<br />

CARDIoGRAM Consortium,<br />

ADIPOGen Consortium.,<br />

1595T<br />

CARDIoGRAMplusC4D<br />

Consortium, 115<br />

Cardon, L. R., 641T, 649T<br />

Cardoso, C., 889W, 2674W<br />

Cardoso, M. T. O., 1880F<br />

Cardozo, G. P., 776W<br />

CARe Analysis Core, 350<br />

Carels, C., 3159W<br />

Carey, A., 689F<br />

Carey, J., 290, 3088F*<br />

Carey, J. C., 3076F<br />

Carey, J. P., 2301W<br />

Carey, V., 536W<br />

Caria, C. A., 2001W<br />

Carim, S., 2852T<br />

Carless, M., 1912T, 2061W<br />

Carless, M. A., 1406W,<br />

2589W, 2651F, 3434T*<br />

Carling, T., 1241F<br />

Carlins, E., 2219F<br />

Carlo, S., 659F<br />

Carlson, C., 530W, 1925F,<br />

2098T, 2337W<br />

Carlson, C. S., 1408F,<br />

1437T, 2042F<br />

Carlson, E., 603T<br />

Carlsson, G., 3618W<br />

Carlsson, J., 582W<br />

Carlsson, L. M., 1271F<br />

Carlsson, L. M. S., 427F<br />

Carlus, J., 1950W<br />

Carmack, C., 399<br />

Carmi, S., 17, 3346F*<br />

Carmichael, S. L., 1352W*,<br />

1885T<br />

Carmignac, V., 2716W,<br />

2770W<br />

Carmona-Mora, P., 410,<br />

2672T, 2796F*, 2837T<br />

Carneiro, M., 288<br />

Carnevale, A., 956T, 1141T<br />

Carney, R. M., 2583W,<br />

2637W<br />

Caron, F. M., 3117W<br />

Caron, M., 3439T<br />

Caron, O., 1212W<br />

Carosso, G., 2786T<br />

Carotenuto, G., 3492T<br />

Carpenter, C., 651T<br />

Carpenter, K., 166<br />

Carpenter, M., 186<br />

Carpentier, S., 54<br />

Carpintero-Ramirez, G.,<br />

2219F<br />

Carpten, J., 28, 1001F<br />

Carpten, J. D., 1214F,<br />

1240T<br />

Carr, A., 132<br />

Carr, J., 1706T<br />

SPEAKER AND AUTHOR INDEX


344 SPEAKER AND AUTHOR INDEX<br />

Carr, J. J., 1648T, 1661T,<br />

1913F, 2275T<br />

Carraro, D., 1151F<br />

Carrasco, M., 2430W<br />

Carrato, A., 1091F<br />

Carrell, D. T., 2982T<br />

Carrera, C., 1053W<br />

Carrero-Gonzalez, I., 3363T<br />

Carrillo, O., 2543F<br />

Carrillo, T., 2296T<br />

Carrillo-Carrasco, N., 711F,<br />

1702T<br />

Carrington, B., 1983W<br />

Carrington, M., 2217W<br />

Carroll, C. J., 327*<br />

Carroll, J., 3212F<br />

Carroll, J. C., 142, 149, 150,<br />

1827W, 1852F*<br />

Carroll, P., 3211W<br />

Carroll, R., 3622W<br />

Carsola, F. G., 2706F<br />

Carson, A. R., 1239W*<br />

Carson, D. A., 1051T<br />

Carson, J. L., 2851W<br />

Carta, E., 2752W<br />

Carta, L., 81, 767W*, 1698T<br />

Cartault, F., 522W, 915W<br />

Cartaxo, C., 2609F<br />

Carter, C. S., 404*<br />

Carter, E., 826F*, 864T, 3128F<br />

Carter, H., 2180F<br />

Carter, M., 198<br />

Carter, M. T., 3086F*<br />

Carter, N., 101, 291, 364<br />

Carter, T., 3326W<br />

Cartier, N., Session 23<br />

Carty, C., 1608T<br />

Carty, C. L., 1925F*, 2042F<br />

Caruccio, N., 3668W, 3721F<br />

Carulli, J. P., 2561F*<br />

Caruso, D., 3026T<br />

Carvajal-Carmona, L.,<br />

1072T*<br />

Carvalho, A., 2814F<br />

Carvalho, C., 2955F<br />

Carvalho, C. M. B., 61,<br />

337*, 428W, 485F<br />

Carvalho, D. R., 2596T<br />

Carvalho, E., 2043W<br />

Carvalho, E. D. F., 2232W,<br />

3152F*<br />

Carvalho, E. F., 883W<br />

Carvalho, F., 2982T, 3122F<br />

Carvalho, K. M., 883W<br />

Carvalho, M. F., 883W*<br />

Carvalho, M. R. S., 2434T*<br />

Carvil, G. L., 10<br />

Carvill, G., 2890W, 2897T*<br />

Casadei, S., 26, 1089W*,<br />

1226F, 1228T<br />

Casadio, C., 1153T<br />

Casalone, E., 1153T<br />

Casals, F., 31, 3268F<br />

Casals, T., 1768W<br />

Casanova, J.-L., Session<br />

80, 365<br />

Casanova, J. L., 127, 202,<br />

3599F<br />

Casavant, T. L., 60<br />

Cascio, W., 1636T<br />

*Presenting Author<br />

Casella, A., 1229F<br />

Casenave, P., 716T<br />

Casey, G., 1072T<br />

Casey, S., 2493W<br />

Casingal, C., 2466W<br />

Casingal, C. R., 2473T*<br />

Casper, R., 2869W<br />

Cass, C. E., 1297F<br />

Cassidy, A., 645T*<br />

Castaldi, P., 2057F, 2249F<br />

Castañon, M., 1048T<br />

Castelazo-Rodriguez, G.,<br />

1168T<br />

Castellani, C., 1731W,<br />

2585F*<br />

Castelli, E. C., 3375T<br />

Castellotti, B., 2775F<br />

Castéra, L., 1205F<br />

Castiglia, L., 3114F<br />

Castilhos, R. M., 2424W,<br />

2626T, 2642F*<br />

Castilla, E. E., 1936T<br />

Castillo-Fernandez, J. E.,<br />

1129T<br />

Castle, A., 794W<br />

Castle, D., 149, 150, 1827W<br />

Castor, A., 1023W<br />

Castrillo, J. L., 976T<br />

Castro, A. M., 182, 381,<br />

1573F<br />

Castro, C., 1899W<br />

Castro, E. C., 1109F<br />

Castro, J. M., 1111T, 1127F,<br />

1128W<br />

Castro, O., 928T<br />

Castro-Giner, F., 54<br />

Castro-Perez, J. M., 1605T<br />

Casuga, I., 1209W, 3278W*,<br />

3714W<br />

Caswell, J. L., 1576F*<br />

Caswell, R., 2704W, 2709F,<br />

2935W<br />

Catalano, L. M., 66<br />

Cataldo, J., 1965W<br />

Catalona, W., 28, 1001F<br />

Catalona, W. J., 1214F<br />

Catanese, J. J., 1603T<br />

Catania, M. V., 513F<br />

Cathey, S. S., 2826F<br />

Cauchin, E., 1204T<br />

Caughey, A. B., 3020T<br />

Cauley, J. A., 2145W<br />

Caulfield, M. J., 79<br />

Caumes, R., 915W<br />

Causer, V., 2083T<br />

Causga, I., 1246T<br />

Causse, A., 2957T<br />

Caux-Moncoutier, V., 1205F<br />

Cavadino, A., 271<br />

Cavalcanti, D. P., 3129W<br />

Cavalcanti, F., 2763F*,<br />

2766F, 2774T, 2780T<br />

Cavalieri, S., 790W*<br />

Cavalla, P., 2095T<br />

Cavallari, L. H., 646T<br />

Cavalli, R., 790W<br />

Cavelier, L., 3728W<br />

Caywood, L., 3335W<br />

Cazier, J.-B., 2939T<br />

Cazier, J. B., 1640T<br />

CCFR Investigators, Colon<br />

Cancer Family Registry,<br />

National Cancer Institute,<br />

1292W<br />

CCT Consortium, 388<br />

Cebulla, C. M., 1197W<br />

Cecilia, K., 2722W<br />

Cederbaum, S., 165<br />

Cederbaum, S. D., 680T<br />

Cedro-Tanda, A., 1168T*<br />

Cejas, D., 666T<br />

Celedón, J. C., 3449T<br />

Celikyapi, G., 2429F*<br />

Celikyapi Erdem, G., 2841F,<br />

3475T<br />

Celis, A., 2363F<br />

Celli, B., 2249F<br />

Cen, W.-J., 3281W<br />

Cendes, F., 514W, 2233T,<br />

2394W, 2876T<br />

Cengiz, F. B., 57<br />

Center, J. C., 2176T<br />

Center for Inherited Disease<br />

Research, 3644W<br />

Centre for Genome<br />

Diagnostics, 1870F<br />

Cents, R., 2164T<br />

Cepok, S., 2086T<br />

Cereb, N., 3330T<br />

Cerecedo-Zapata, C.,<br />

3124F<br />

Cereda, C., 2775F<br />

Cerhan, J. R., 3564W<br />

Ceris, J., 1338T<br />

Cerise, J., 1407T<br />

Cermola, M., 2810T<br />

Cernach, M. C., 3045W<br />

Cerqueira, A., 1727W<br />

Cerroni, L., 1063T<br />

Cervantes, D., 3040F<br />

Cesaretti, J., 1309F<br />

Cesarini, D., 2505W<br />

Cespedes, C., 3069W<br />

Cesselli, D., 2809W<br />

Cetani, F., 2708T<br />

Ceyhan, O., 2811F, 3219W*<br />

Ceylaner, S., 3003T*<br />

Cha, D., 900T<br />

Cha, P., 2550W*<br />

Cha, P. C., 3513T<br />

Chaabouni Bouhamed, H.,<br />

2937F<br />

Chabchoub, E., 925W<br />

Chabrol, B., 2536T<br />

Chadha-Boreham, H., 684T<br />

Chadwick, B. P., 3515T<br />

Chae, C. H., 3180F<br />

Chae, H., 2715F*<br />

Chae, J., 877W, 3204F*<br />

Chae, Y. M., 846F<br />

Chafai Elalaoui, S., 3246F<br />

Chahine, K., 3321T, 3340F,<br />

3365W<br />

Chahrour, M. H., 8, 2613W*<br />

Chaix, M., 1678T*<br />

Chakarova, C. F., 2183F<br />

Chaki, M., 406*, 2850F<br />

Chakrabarti, B., 3316F<br />

Chakraborty, P., 142, 150<br />

Chakraborty, R., 1660T<br />

Chakravarti, A., 13, 121,<br />

305, 308, 1639T, 2305T,<br />

3316F<br />

Chaleshtori, M. A., 59<br />

Challis, D., 3576W<br />

Challman, T. D., 2439W<br />

Chalmers, D., 1848W<br />

Chalon, M., 3246F<br />

Chalouhi, G., 72<br />

Cham, B. W. M., 2889F<br />

Chamarthi, B., 50*<br />

Chambers, C., 3076F<br />

Chambers, J. C., 110*, 383,<br />

3435T<br />

Chambers, S. K., 1087T<br />

Chambert, K., 284, 290,<br />

1325W, 2487W,<br />

2618F<br />

Chambliss, J., 1081T<br />

Chamling, X., 2671W*<br />

Chamma, M. T., 2655W<br />

Chammas, R., 1008W<br />

Champion, K., 3171W<br />

Champion, K. J., 2901F,<br />

3684W<br />

Chan, A. T., 191<br />

Chan, D., 638T<br />

Chan, E., 865W<br />

Chan, E. T., 3612W<br />

Chan, H., 1905W<br />

Chan, H.-W., 2285F<br />

Chan, I. H. Y., 1930T<br />

Chan, J., 2279F, 2280W<br />

Chan, L. L., 1375F<br />

Chan, P., 3522T<br />

Chan, R. B., 2547W<br />

Chan, W., 2928F<br />

Chan, W. Y., 3491T<br />

Chan, Y., 2364W*<br />

Chanda, P., 1403W*, 1579F<br />

Chandak, G. R., 3455T<br />

Chandirasekar, R., 1044W*<br />

Chandler, R. J., 664T, 669F*<br />

Chandna, P., 1701T<br />

Chandra, A., 1177T<br />

Chandran, V., 1952F, 2658W<br />

Chandrasekharappa, S.,<br />

3080F<br />

Chang, C., 893W, 1249T,<br />

1830F, 1905W, 3727F<br />

Chang, C. C., 1380T<br />

Chang, C. J., 3457T<br />

Chang, D., 183<br />

Chang, E. R., 498W*, 2111F<br />

Chang, G., 989F<br />

Chang, I., 629T<br />

Chang, J., 1027T<br />

Chang, K., 1249T, 3695F<br />

Chang, M. L., 2517W<br />

Chang, R., 2895F<br />

Chang, S., 985T, 1557T*,<br />

1894T<br />

Chang, S.-C., 2285F<br />

Chang, T., 985T*, 1894T,<br />

1905W, 1929W, 3026T<br />

Chang, W., 3695F<br />

Chang, W. H., 2768T<br />

Chang, X., 3415T, 3532W*<br />

Chang, Y.-T., 610T<br />

Chang-Claude, J., 206


Chanloner, J., 2834T<br />

Chanock, S., 191, 205,<br />

1012T, 1097F, 1119W,<br />

1148F, 1154F, 1306F,<br />

1413T, 1517W, 1626T,<br />

2165F, 3683F<br />

Chanock, S. J., 30, 213,<br />

1010F, 1150T, 1160F,<br />

1218W, 1372F, 1390F,<br />

2202W, 3325F<br />

Chan-Seng-Yue, M., 1093T<br />

Chantot-Bastaraud, S.,<br />

973W<br />

Chanudet, E., 303, 2755W<br />

Chan-Yeung, M., 1465F<br />

Chao, E. C., 2907F*<br />

Chaouch, M., 2808F, 2866W<br />

Chaoui, A., 2727F<br />

Chapman, B., 356<br />

Chapman, B. A., 326<br />

Chapman, K., 670T*, 2432F<br />

Chapman, N. H., 2406W*<br />

Chapman, S., 2157W<br />

Chapman, S. J., 1948T<br />

Charames, G. S., 3448T*<br />

Charbonnier, F., 32, 1222T<br />

CHARGE, GBPgen, and<br />

ICBP Investigators, 1637T<br />

CHARGE, GIANT, CARe,<br />

and African <strong>American</strong><br />

Central Adiposity<br />

Consortia, 1896W<br />

CHARGE-BP and ICBP<br />

Consortia, 1639T<br />

CHARGE Consortium<br />

Protein Working Group,<br />

111, 2073W<br />

CHARGE Exome Chip<br />

Genotyping Committee,<br />

1445W<br />

CHARGE Gene Expression<br />

Working Group, 584W<br />

CHARGE Insulin-Like<br />

Growth Factor Working<br />

Group, 2080T<br />

CHARGE Neurology<br />

Working Group, 1592T<br />

CHARGE Nutrition Working<br />

Group, 51<br />

CHARGE Subclinical<br />

Atherosclerosis Working<br />

Group, 1599T<br />

Charland, S. L., 1714T<br />

Charles, A., 1262F<br />

Charles, C., 3242F<br />

Charles, P., 2770W<br />

Charoensawan, V., 2918T<br />

Charon, A., 3181W<br />

Chartterjee, N., 1012T<br />

Chase, J., 728T<br />

Chasman, D., 109, 2165F<br />

Chasman, D. I., 51, 609T,<br />

2056T<br />

Chassaing, N., 124, 2957T*<br />

Chatelain, S. M., 926T,<br />

1018T<br />

Chatterjee, K., 2701W<br />

Chatterjee, N., 1091F,<br />

1306F*, 1372F, 1378F,<br />

1413T<br />

*Presenting Author<br />

Chattopadhyay, K., 1073F*<br />

Chattopadhyay, S., 1278W*<br />

Chatzisevastou-Loukidou,<br />

C., 84<br />

Chaubey, A. D., 2826F<br />

Chaudru, V., 1158W<br />

Chauhan, M., 605T, 2516F<br />

Chauveau, C., 2945T*<br />

Chavez, H. O., 926T<br />

Chávez, M., 2365T*<br />

Chawla, L., 2967T<br />

Chawla, S., 865W, 2739F<br />

Chawner, S., 2405F<br />

Chayama, K., 396<br />

Cheah, F., 1472W<br />

Chebaro, W., 2842W<br />

Chechi, T., 770W<br />

Chedin, F., 552W<br />

Chédin, F. L., 2633F<br />

Chee, M., 1684T<br />

Cheguri, S., 998F, 999W,<br />

1159T<br />

Cheh, M. L., 1859F<br />

Chelin, C., 77<br />

Chemaly, E. R., 1698T<br />

Chen, B., 242<br />

Chen, C., 356, 989F, 1249T,<br />

1390F, 2392T*, 2571W,<br />

2606F, 3413W*, 3467T,<br />

3582W<br />

Chen, C. A., 1781W<br />

Chen, C.-H., 2092T*<br />

Chen, C.-P., 797W<br />

Chen, D., 382<br />

Chen, D. C., 1034F<br />

Chen, D. T., 260, 2622W<br />

Chen, E. S., 1132T, 3421T,<br />

3503T<br />

Chen, F., 123, 1662T, 1688T,<br />

2202W*, 3293W, 3566W<br />

Chen, G., 241, 242, 356,<br />

1324F, 1460W, 1886F,<br />

3533F*<br />

Chen, G. B., 1360F<br />

Chen, G. K., 2131T, 2202W,<br />

3621F<br />

Chen, H., 169, 202,<br />

1346W*, 1369F, 1543F,<br />

1972T, 3317W, 3347W*<br />

Chen, H. Y., 2014T, 2575T<br />

Chen, J., 333, 2251T,<br />

3534W*<br />

Chen, J. H., 1972T*<br />

Chen, J. L., 1054T*<br />

Chen, J. W., 3430T<br />

Chen, K., 511F, 989F<br />

Chen, K. C., 1586T<br />

Chen, L., 50, 1059W<br />

Chen, L.-S., 2535W*<br />

Chen, M., 189, 1201T*,<br />

2419T, 3697F<br />

Chen, M.-R., 2285F<br />

Chen, N., 1095W, 2617T<br />

Chen, P., 399, 1929W*,<br />

2461T, 3619F<br />

Chen, P. K., 1472W<br />

Chen, P. L., 2936T<br />

Chen, P.-W., 2970T<br />

Chen, Q., 2921T, 3026T<br />

Chen., R., 1505W<br />

SPEAKER AND AUTHOR INDEX 345<br />

Chen, R., 385, 562W, 1462F,<br />

1601T, 1779W, 2230T,<br />

2322W*, 2910F<br />

Chen, S., 69, 116, 245,<br />

411*, 785W, 1021T,<br />

2259W*, 2819T, 3714W<br />

Chen, S, M., 1246T<br />

Chen, S.-H., 256, 3281W<br />

Chen, S.-M., 3278W<br />

Chen, S. M., 1209W<br />

Chen, T., 985T, 2444F,<br />

3415T<br />

Chen, T.-J., 907W*<br />

Chen, W., 22, 178, 766W,<br />

1110W, 1354F, 1971W,<br />

1972T, 2135F, 2274W,<br />

3442T, 3449T*, 3452T<br />

Chen, WM., 1662T<br />

Chen, W.-M., 1299T*<br />

Chen, W. M., 123<br />

Chen, W. V., 1298W<br />

Chen, X., 1283W*, 2460W<br />

Chen, X.-L., 2969T*, 2970T<br />

Chen, Y., 80, 411, 722T,<br />

795W, 834F, 989F, 1608T,<br />

2180F*, 2854W, 2961F*,<br />

3029T*, 3420T, 3489T*<br />

Chen, Y. D., 1661T<br />

Chen, Y. D. I., 2337W<br />

Chen, Y. I., 1916F, 2153F<br />

Chen, Y.-T., 2092T<br />

Chen, Y. T., 2858T<br />

Chen, Z., 140*, 1086W,<br />

1108T, 1772W, 3666W<br />

Chenevix-Trench, G., 206,<br />

207, 208, 209, 210*,<br />

1150T, 1492F, 2323T<br />

Cheng, A., 1249T<br />

Cheng, B., 2617T<br />

Cheng, C., 442W<br />

Cheng, C.-H., 2052W<br />

Cheng, C. Y., 429F, 2094W*<br />

Cheng, D., 830F, 1108T<br />

Cheng, E., 940T<br />

Cheng, G., 1930T, 2066F,<br />

2932W*<br />

Cheng, H., 511F, 1660T,<br />

2159F<br />

Cheng, I., 1608T, 1925F,<br />

2042F<br />

Cheng, J., 1779W, 2868F,<br />

3007T<br />

Cheng, K., 309, 1133F<br />

Cheng, K. C., 3264T, 3267T<br />

Cheng, M., 2571W*, 2606F<br />

Cheng, R., 1369F, 2093F*,<br />

2208W<br />

Cheng, S., 793W*, 1677T<br />

Cheng, Y., 2421W, 2490W*<br />

Cheng, Y.-W., 3090F*<br />

Cheng, Z., 14<br />

Chenichene, S., 3117W<br />

Chenier, S., 1872F, 1873F,<br />

3106F*<br />

Chennagiri, N., 3640W,<br />

3680W<br />

Cheon, C. K., 964T, 3205W*<br />

Cheong, H. I., 3223W<br />

Cheong, S. Y., 2069F,<br />

2381F, 2544W<br />

Cherbal, F., 1268F*<br />

Chernos, J., 910T<br />

Cherny, S., 1822F<br />

Cherny, S. S., 1930T,<br />

2066F*, 2494T, 2932W<br />

Cherry, J. M., 3612W<br />

Cherukuri, P., 359, 1515T,<br />

2610W*, 3543F<br />

Chesi, G., 2810T<br />

Chesko, K. L., 3027T<br />

Chesnik, M., 1269W<br />

Chessa, L., 760W*<br />

Chettiar, S. S., 2731W<br />

Chettrit, J., 1204T<br />

Cheung, C. Y. K., 1541W*<br />

Cheung, G., 429F<br />

Cheung, H., 1221W<br />

Cheung, L., 336<br />

Cheung, S., 893W<br />

Cheung, S. W., 13, 229,<br />

430W, 432W, 433F, 898T,<br />

952T, 2395T<br />

Cheung, V., 253, 535F,<br />

544W<br />

Cheung, V. G., 257, 370*,<br />

500W, 1506T<br />

Cheverud, J. M., 272, 2413T<br />

Chevessier, F., 328<br />

Chevillard, C., 1593T*<br />

Chew, E. G. Y., 3047W<br />

Chew, E. Y., 2183F<br />

Chew, S., 1216T<br />

Chhabra, D., 2166W*<br />

Chhibber, A., 2258F*<br />

Chi, A., 3691F<br />

Chi, E. C., 3621F*<br />

Chi, H., 2285F*<br />

Chi, J., 2985T<br />

Chiabai, M. A., 1202F*<br />

Chiaie, B., 298<br />

Chiang, C. W. K., 3282T*<br />

Chiang, J., 2910F, 3130F<br />

Chiang, K. M., 3430T*<br />

Chiang, T., 1322W, 1531F,<br />

2580W, 2953W<br />

Chiano, M., 630T*<br />

Chiappini, E., 3114F<br />

Chiavacci, R., 2252F,<br />

2514W, 2872W<br />

Chiavacci, R. M., 812F,<br />

1997F, 2121W, 2546F<br />

Chiba-Falek, O., 2465F*<br />

Chibnik, L. A., 2488T<br />

Chibnik, L. B., 2250W,<br />

3417T, 3450T*<br />

Chibnik, L. E., 380<br />

Chicka, M. C., 3145W<br />

Chidester, A. M., 2329T<br />

Chien, J., 1238F, 3451T<br />

Chien, L., 629T*<br />

Chien, Y. H., 683F, 706T<br />

Chiesa, J., 1212W<br />

Chikh, A., 1268F<br />

Child, A., 1584T<br />

Child, A. H., 1675T<br />

Chiliza, B., 644T<br />

Chin, E. L. H., 1758W<br />

Chin, J., 3724W<br />

China Atherosclerosis<br />

<strong>Genetics</strong> Consortium, 116<br />

SPEAKER AND AUTHOR INDEX


346 SPEAKER AND AUTHOR INDEX<br />

Chinault, C., 330<br />

Chines, P. S., 46<br />

Ching, B., 1146W, 1195T<br />

Chini, V., 2728W*<br />

Chinnery, P. F., 751F, 2996T<br />

Chiò, A., 2611T<br />

Chiou, M., 655T<br />

Chipendo, P. I., 528W<br />

Chipps, B., 3238F<br />

Chiripal, S., 1216T<br />

Chisholm, R., 3622W<br />

Chisholm, R. L., 618T, 1312F<br />

Chissoe, S., 1686T<br />

Chissoe, S. L., 641T, 649T<br />

Chitale, D. A., 1250F<br />

Chitayat, D., 214, 320, 720T,<br />

1738W, 3013T, 3075W,<br />

3156F, 3186F, 3196F*<br />

Chitipiralla, S., 3625F<br />

Chiu, C. L., 1705T*<br />

Chiu, E., 767W, 1190F,<br />

1698T<br />

Chiu, K., 1249T<br />

Chiu, N.-C., 2285F<br />

Chiyo, T., 799W<br />

Cho, B., 1243T, 2715F<br />

Cho, C., 3145W<br />

Cho, H.-J., 964T*<br />

Cho, I., 2518T<br />

Cho, J., 17, 189, 2204F<br />

Cho, J. H., Session 80,<br />

1320T, 1381F, 2045F,<br />

2319W<br />

Cho, M., 2057F<br />

Cho, M. H., 2249F, 2346W*<br />

Cho, M. K., Session 79,<br />

1804F, 1844F<br />

Cho, S., 1384F, 2200T,<br />

2518T<br />

Cho, T., 933W<br />

Cho, Y. H., 739F*<br />

Choate, K. A., 2915T<br />

Chodirker, B., 3127W<br />

Chodosh, J., 529F, 2188T<br />

Choh, A. C., 2146T<br />

Choi, B., 2723T<br />

Choi, D.-S., 2516F<br />

Choi, H. J., 2053T<br />

Choi, J., 877W, 1657T,<br />

2828T, 3204F<br />

Choi, J. R., 863W<br />

Choi, J. Y., 3178F<br />

Choi, K., 260, 2622W,<br />

2849T, 3008T<br />

Choi, M., 1241F, 2779W<br />

Choi, O.-W., 2262W<br />

Choi, S., 269, 1385W,<br />

2778F<br />

Choi, S.-H., 3227W<br />

Choi, T., 1341T<br />

Choi, Y., 581F, 1504F*<br />

Chokdeemeeboon, C.,<br />

2006F<br />

Chokkalingam, A., 1924T,<br />

2268W<br />

Chong, H. K., 3535F*<br />

Chong, J. X., 278, 3398T*<br />

Chong, K., 2971T*<br />

Chong, S., 2148W<br />

Chong, S. S., 1472W<br />

*Presenting Author<br />

Chong, T., 1093T<br />

Choong, C., 1262F<br />

Choong, D. Y. H., 1224W<br />

Choppa, P., 1251W<br />

Chopra, R., 1701T<br />

Choquet, H., 2269T*<br />

Choquet, K., 2234F, 2797W<br />

Chorich, L., 2984T<br />

Chou, C., 516W, 2926W<br />

Chou, J. Y., 2712F<br />

Chou, W., 1249T<br />

Chouchane, L., 2933T,<br />

3399W<br />

Choudhri, H., 509F*<br />

Choudhry, S., 1352W,<br />

1885T*<br />

Chouery, E., 2692W<br />

Choufani, S., 3420T, 3489T<br />

Chow, C. Y., 2214W*<br />

Chow, E., 2428T, 2480F*<br />

Chow, J. F. C., 3000T<br />

Chow, W. H., 1012T<br />

Chowdhury, M. R., 918T<br />

Chowdhury, R., 253<br />

Chowdhury, S., 1459F<br />

Chowdry, A., 483F, 1223F,<br />

3617F<br />

Chowdry, A. B., 1620T*,<br />

2149T<br />

Choy, R., 2868F<br />

Chrast, J., 506W<br />

Chretien, F., 329<br />

Christacos, N. C., 945W*,<br />

953W<br />

Christensen, B. C., 3629F<br />

Christensen, E., 702T, 737F<br />

Christensen, K., 317*,<br />

1323T, 1472W, 1564F,<br />

1650T, 1921T, 2040W,<br />

2244W, 2295W<br />

Christensen, K. D., 1781W<br />

Christiaans, I., 1616T<br />

Christian, M., 2402F<br />

Christian, S. L., 2389T<br />

Christiani, D. C., 2122T<br />

Christiano, A. M., 2182T<br />

Christiansen, L., 2244W,<br />

2295W<br />

Christiansen, M., 2699T<br />

Christiansen, M. W., 584W,<br />

1284T, 1503T<br />

Christiansen, P., 2707W<br />

Christianson, A., 1877F<br />

Christman, M. F., 632T<br />

Christodoulou, J., 166*,<br />

2795T<br />

Christ<strong>of</strong>olini, D., 899W<br />

Christ<strong>of</strong>olini, D. M., 2534F,<br />

3045W<br />

Christ<strong>of</strong>orides, A., 1240T<br />

Chryst-Ladd, M., 1444F,<br />

1594T<br />

Chrzanowska, K., 2755W<br />

Chu, A. Y., 51*<br />

Chu, C., 1894T, 2926W<br />

Chu, H., 1249T<br />

Chu, J., 536W*, 1468F<br />

Chu, S., 553F<br />

Chu, X., 1945T*, 2078F<br />

Chua, K. H., 1572T<br />

Chuang, D., 2742F<br />

Chuang, L., 2524T*<br />

Chuang, L.-M., 1955F<br />

Chuang, W., 516W<br />

Chuang, Y., 2606F*<br />

Chudin, E., 1684T<br />

Chudley, A. E., 2772F,<br />

2800W<br />

Chun, K., 1227W*<br />

Chung, B., 3186F*<br />

Chung, B. H. Y., 3420T<br />

Chung, C., 1097F<br />

Chung, C. C., 213*, 1372F<br />

Chung, E. M. K., 809F<br />

Chung, H., 2117F<br />

Chung, J., 1008W, 3461T<br />

Chung, K., 2538W<br />

Chung, M., 530W<br />

Chung, N. G., 2715F<br />

Chung, P. H. Y., 1930T<br />

Chung, R. H., 2572T<br />

Chung, S. A., 306<br />

Chung, S. H., 614T<br />

Chung, S. K., 262*, 2821W<br />

Chung, T. Y., 2118W<br />

Chung, W., 299, 330, 1600T,<br />

1676T<br />

Chung, W. K., 1735W,<br />

2439W<br />

Chung, Y., 3607F*<br />

Chunharas, C., 2749W<br />

Church, D., Session 77,<br />

464W*, 3582W, 3625F<br />

Church, J., 362, 728T<br />

Churchhouse, C., 3360T,<br />

3384T*<br />

Churchill, J. D., 3234F*<br />

Chutake, Y. K., 381*<br />

Chute, C., 3622W<br />

Chute, C. G., 618T, 1312F<br />

Ciampi, A., 1411F<br />

Ciana, G., 692T<br />

Ciato, D., 2708T<br />

Cibulková, P., 2865F<br />

Ciccone, C., 711F, 1702T,<br />

3080F<br />

Cicek, M. S., 3451T*<br />

Cichon, S., 259, 420W,<br />

1942T, 3550W<br />

Cicuttini, F. M., 2292W<br />

Ciechanowicz, A., 2102F<br />

Cieck, M., 139<br />

Cieslak-Janzen, J., 251<br />

CIHR Emerging Team in<br />

Genomics in Screening,<br />

150, 1827W<br />

Cil, E., 1708T<br />

Cilio, R., 202<br />

CIMBA, OCAC and BCAC,<br />

210<br />

Cine, N., 2058W<br />

Cingolani, P., 169, 176,<br />

1513F, 1923W, 2308T,<br />

2339F<br />

Cinque, P., 2561F<br />

Cintra, V., 2425T<br />

Cipriani, V., 2072F*<br />

Cirak, S., 2812W*<br />

Cirillo, L., 1269W<br />

Cirkel, G., 400<br />

Cirnes, L., 1747W<br />

Cirulli, E. T., 2552F*<br />

Cisneros, B., 3124F, 3226F<br />

Citro, V., 3496T<br />

Cittadella, R., 2597F<br />

Civallero, G., 685F<br />

Civelek, M., 2256W<br />

Ciwangsangbu, C., 3317W<br />

Clabby, M., 1679T<br />

Claes, C., 59<br />

Claes, G. R. F., 1711T<br />

Claes, K., 423F, 2791W<br />

Claes, P., 1850W, 2223W<br />

Clague, J., 1071W<br />

Clancy, R. R. C., 2443T<br />

Clare, S., 1098W<br />

Clarelli, F., 2095T*<br />

Clark, A., 183<br />

Clark, A. G., 187, 357, 537F,<br />

2029T, 2214W, 3269W,<br />

3288T, 3306T<br />

Clark, A. P., 3587F<br />

Clark, E., 1904F<br />

Clark, K., 2664F<br />

Clark, L., 17, 442W, 1898F,<br />

2377T, 2410T*, 2547W<br />

Clark, L. N., 845F<br />

Clark, R., 869W<br />

Clark, R. D., 2955F, 3191W<br />

Clark, S. L., 3442T, 3452T*<br />

Clark, T., 647T<br />

Clarke, A., 865W, 2099F<br />

Clarke, C., 534W<br />

Clarke, J., 419F, 3706W<br />

Clarke, L., 1543F, 3636W*<br />

Clarke, N. F., 295<br />

Clarke, S., 2614T<br />

Clarkson, K., 3171W<br />

Claussnitzer, M., 3536W*<br />

Claustres, M., 2947W<br />

Clavering, E. K., 1803W<br />

Clawson, H., 3557F<br />

Clayton, A. C., 1145F<br />

Clayton, D. G., 2072F<br />

Clayton, E. W., 631T<br />

Clayton, N., 767W, 1698T<br />

Clayton, P. T., 167<br />

Clayton, S., 101, 291, 364<br />

CLEAR Investigators, 2047T<br />

Cleary, C., 3119W<br />

Cleary, S. P., 141<br />

Clement, M. J., 3643F<br />

Clemmer, G., 623T<br />

Clendenning, M., 1067F<br />

Clerget-Darpoux, F.,<br />

Session 8<br />

Cleveland, J. L., 1162T<br />

Clevert, D.-A., 1483F,<br />

2374T*<br />

Cleves, M. A., 1459F<br />

Cline, M., 3557F<br />

Clinton, C. M., 1799W*,<br />

1836F, 1843W<br />

Cloutier, M., 3449T<br />

Clyde, M. M., 3267T<br />

Clynes, D., 418W<br />

Coa, D., 503F<br />

Coady, S., 2247W<br />

Coakley, D., 774W<br />

Coan, A. C., 514W, 2394W


Coarfa, C., 3433T*<br />

Coates, J., 784W<br />

Coates, J. R., 2817F<br />

Cobat, A., 1374T*, 2003F<br />

Cobb, B., 419F<br />

Cocco, E., 157<br />

Cochran, B. J., 1445W<br />

Codd, V., 2035T, 2175W*<br />

Coe, B. P., 10, 14, 274<br />

Coêlho, C. C., 1405F<br />

Coelho, J., 2502W<br />

Coelho, T., 1296T, 2736F<br />

Coeli-Lacchini, F. B., 479F<br />

Coenen, M. J. H., 243*, 306,<br />

621T<br />

C<strong>of</strong>fee & Caffeine <strong>Genetics</strong><br />

Consortium, 2096F<br />

C<strong>of</strong>fman, K., 904T<br />

Coghill, D., 645T<br />

Coghlan, G., 2772F<br />

Cogulu, O., 965W, 2719W,<br />

3222F<br />

Çogˇulu, O., 3214F<br />

Cohen, I., 2931F<br />

Cohen, J., 2907F<br />

Cohen, J. S., 3065W<br />

Cohen, L., 3012T<br />

Cohen, M., 86<br />

Cohen, N., 958T<br />

Cohen-Snuijf, P., 2925F<br />

Cohn, D., 3209W<br />

Cohn, D. H., 2740W, 2874F<br />

Cohn, G. M., 768W, 769W<br />

Cohn, R. D., 2677W<br />

Cohorts for Heart and Aging<br />

Research in Genetic<br />

Epidemiology, NHLBI<br />

Exome Sequencing<br />

Project, 1585T<br />

Coin, L., 159, 429F, 1432F,<br />

2162F<br />

Coiteiro, D., 2085W<br />

Cok, J., 1119W<br />

Coker, M., 3214F<br />

Colak, R., 1551T*<br />

Col Araz, N., 1402F, 1935W*,<br />

1938W<br />

Colas, C., 1170W<br />

Colby, C., 2516F<br />

Cole, R., 1269W<br />

Cole, S., 1280W<br />

Cole, S. A., 1406W<br />

Coleman, C., 2283W*<br />

Coleman, K., 1494T, 1679T*<br />

Colins, C., 491F<br />

Coll, M., 3069W<br />

Collaboration developed<br />

under Radiogenomics<br />

Consortium, 1309F<br />

Collado, A., 2326T<br />

Colleaux, L., 104, 202, 2808F<br />

Collee, J. M., 27<br />

Collet, C., 2729T, 3154F,<br />

3199W<br />

Collet, J. P., 756W<br />

Colley, A., 66<br />

Collier, D. A., 2522F<br />

Collin, R., 2950W<br />

Collins, A., 3133W<br />

Collins, A. L., 2468F*, 3659F<br />

*Presenting Author<br />

Collins, F., 324<br />

Collins, F. A., 3129W<br />

Collins, F. S., Session 69,<br />

46, 304<br />

Collins, H., 1859F<br />

Collins, I., 1088F, 1199F<br />

Collins, J. A., 265<br />

Collins, J. E., 37<br />

Collins, R., 115, 970T<br />

Collombat, P., 2629T<br />

Colombo, M., 1895F<br />

Colon Cancer Family<br />

Registry, 141, 1067F,<br />

1206W<br />

Colon Cancer Family<br />

Registry, COGENT<br />

Consortium, 1072T<br />

Colón-Semidey, A., 3449T<br />

Colosi, P., 2680W<br />

Colvin, C., 1021T<br />

Comas, D., 3345T, 3377W,<br />

3387T<br />

Combe, J., 1119W<br />

Comeau, M. E., 1979F<br />

Comi, G., 624T<br />

Comi, G. C., 2095T<br />

Comi, G. P., 2775F<br />

Compton, J., 330<br />

Compton, T., 2561F<br />

Comstock, D., 3007T<br />

Comuzzie, A., 1280W<br />

Comuzzie, A. G., 2309F,<br />

3434T<br />

Concannon, P., 1299T<br />

Concas, M. P., 2062T<br />

Conceição, I. C., 2417F,<br />

2502W*<br />

Conde, L., 1104W, 2055W*,<br />

3623F<br />

Condino, F., 2597F<br />

Condreay, L., 630T<br />

Condroyer, C., 2638T<br />

Congia, M., 1516F<br />

Congiu, C., 86<br />

Coniglio, G., 2095T<br />

Conklin, B., Session 78<br />

Conklin, B. R., 1620T<br />

Conkright, M. D., 1162T<br />

Conley, B., 1068W<br />

Conley, Y. P., 1884W, 1963T*<br />

Conlin, L., 3040F, 3082F<br />

Conlon, P., 2082W<br />

Conneely, K. N., 66, 1422T,<br />

2383T, 2420F, 2483F,<br />

3480T<br />

Connolly, J. J., 2546F*<br />

Connolly, M., 131, 750T<br />

Connolly, M. C., 1769W<br />

Connolly, S., 70, 617T, 619T<br />

Conomos, M., 1424W<br />

Conrad, D. F., 560W, 2576F,<br />

2982T*<br />

Conrad, P., 1059W<br />

Conroy, J., 2283W, 3428T<br />

Conroy, S. K., 2531F<br />

Consortium <strong>of</strong> Investigators<br />

<strong>of</strong> Modifiers <strong>of</strong> BRCA1/2<br />

(CIMBA) Collaborators,<br />

207, 208<br />

Constantine, S., 1151F<br />

SPEAKER AND AUTHOR INDEX 347<br />

Constantino, J. N., 2439W,<br />

2551T<br />

Constantino-Casas, F.,<br />

1105T<br />

Consugar, M., 2943F, 3653F<br />

Consugar, M. B., 1756W*<br />

Conta, J., 1842F<br />

Conte, I., 2810T, 2950W<br />

Conte, M. I., 505F*<br />

Conti, D. V., 642T, 1435F<br />

Conti, P., 2766F<br />

Contreras, A. V., 526W*,<br />

3255T<br />

Contreras, S. A., 2495F<br />

CONVERGE Consortium,<br />

355<br />

Conway, K., 1566T<br />

Cook, D., 3537F*<br />

Cook, D. G., 1626T<br />

Cook, E., 13, 3494T<br />

Cook, E., Jr., 1520W<br />

Cook, E. H., 2577W<br />

Cook, J., 2897T<br />

Cook, J. R., 81, 767W, 815F,<br />

1698T*<br />

Cook, M., 2826F<br />

Cook, M. B., 213<br />

Cooke, J. N., 1879T,<br />

2310W*<br />

Cooke, M. S., 1270T<br />

Cooke, T., 3362W<br />

Cooke, T. F., 293*<br />

Cooksley, R., 715F, 801W<br />

Cookson, M. R., 564W<br />

Cookson, W. O. C., 1361W<br />

Cookson, W. O. C. M.,<br />

2102F, 3466T, 3469T,<br />

3486T<br />

Coon, H., 195, 2406W<br />

Coon, M. R., 2329T<br />

Cooney, K., 28*, 1001F<br />

Cooney, K. A., 1080W,<br />

1214F<br />

Coonrod, E. M., 2720T*<br />

Coons, T. A., 1454W<br />

Coop, G., 282<br />

Cooper, B. A., 1965W<br />

Cooper, C., 2292W<br />

Cooper, C. D. O., 219<br />

Cooper, D. N., 939W<br />

Cooper, J., 453F, 3471T<br />

Cooper, M., 1936T<br />

Cooper, R., 1959W, 2063F<br />

Cooper, S., 1167W, 3697F<br />

COPDGene and ECLIPSE<br />

Investigators, 2057F<br />

COPDGene Investigators,<br />

1425T<br />

COPDGene Investigators,<br />

NHLBI Exome<br />

Sequencing Project,<br />

2346W<br />

Cope, H., 3, 1919F<br />

Copeland, S., 2974T<br />

Copigny, F., 1212W<br />

Copin, H., 3117W<br />

Copley, R., 2939T<br />

Coppieters, F., 539F*, 2927T<br />

Coppieters, W., 708T<br />

Coppola, D., 1061F<br />

Coppola, G., 2262W, 2639F,<br />

2779W<br />

Coprerski, B., 2484W,<br />

2485T*, 2540F<br />

Corach, D., 3364F, 3402T<br />

Coram, M., 1504F<br />

Corbin, I., 99*<br />

Corcoran, C. D., 3643F<br />

Corcoran, D., 586W<br />

Corda, E., 1158W<br />

Cordeiro, I., 131<br />

Cordeiro, Q., 2533T<br />

Cordell, H. J., 153<br />

Cordero, S., 1601T<br />

Cordier, M. P., 3129W<br />

Cordisco, M., 83<br />

Cordoro, K., 2926W<br />

Córdova-Fletes, C., 1030T*<br />

Cordova-Solis, I. A., 1168T<br />

Core, L. J., 415F<br />

Coresh, J., 1932W<br />

Corey, M., 1731W<br />

Corioni, M., 3459T<br />

Corless, C., 1237T<br />

Cormand, B., 2578T<br />

Cormier, T., 3699F<br />

Cormier-Daire, V., 127,<br />

324, 403, 915W, 3129W,<br />

3167W, 3240F<br />

Cornejo, O., 3362W<br />

Cornejo, O. E., 293<br />

Cornejo-Olivas, M., 2453F<br />

Cornelis, M., 2096F*<br />

Cornelissen, S., 1117T<br />

Cornell, M., 3610W<br />

Cornes, B., 1346W, 2041T<br />

Cornes, B. K., 269<br />

Corneveaux, J. J., 2104T,<br />

3215W<br />

Cornforth, M. N., 948T<br />

Corominas, R., 480W,<br />

2660F*<br />

Corona-Rivera, A., 3188F<br />

Corrado, L., 2775F<br />

Corral, J., 2627F<br />

Corrales, A., 2296T<br />

Corre, T., 1281T, 2165F,<br />

2366F<br />

Correa, H., 2385W<br />

Correa, P., 3388F<br />

Correia, C., 2261F*, 2417F,<br />

2502W<br />

Correia e. Silva, A., 3318T<br />

Corrier, K., 2826F<br />

Corriveau, R., 853F, 2300F<br />

Cortes, A., 152*<br />

Cortes, C., 2628W*<br />

Cortes, E., 1049F, 1077W<br />

Cortes, E. P., 2547W<br />

Cortes, M., 467F*, 3039W*<br />

Cortese, R., 377*<br />

Cortessis, V., 213<br />

Corti, S., 2775F<br />

Corvin, A., 2590T<br />

Corvol, H., 1322W, 2953W<br />

Corydon, T. J., 737F<br />

Cossette, P., 2306F, 2591F<br />

Cosso, M., 2062T<br />

Cost, G. J., 255<br />

Costa, A., 1293T<br />

SPEAKER AND AUTHOR INDEX


348 SPEAKER AND AUTHOR INDEX<br />

Costa, A. F., 514W<br />

Costa, A. L. F., 514W<br />

Costa, A. P. P., 2485T<br />

Costa, C., 572W, 1768W,<br />

1796W*<br />

Costa, F. F., 426W, 2718F,<br />

2751F<br />

Costa, F. T., 3122F<br />

Costa, H. A., 371, 3411W*<br />

Costa, J. L., 1747W*<br />

Costa, P., 922T*<br />

Costa, R., 1920W<br />

Costa, V. P., 2286W, 2291F<br />

Costain, G., 2575T<br />

Costantini, S., 1060T<br />

Costes, B., 1768W<br />

Côté, G., 1951T<br />

Cote, L., 442W<br />

Côté, S., 2994T*<br />

Cotsapas, C., 1366F*<br />

Cotten, C. M., 3<br />

Cotton, A., 3514T*, 3734W<br />

Cottrell, C. E., 912T*<br />

Cottrell, J., 596W, 942T,<br />

1238F<br />

Cotugno, G., 3256F<br />

Coubes, C., 936T, 3121W<br />

Couch, F., 208<br />

Couch, F. J., 27, 207,<br />

1150T*, 1219T<br />

Couch, R. B., 2189F<br />

Coucke, P., 59, 2225F<br />

Coucke, P. J., 128, 129,<br />

833F, 1790W, 3137W<br />

Coude, F. X., 2431T, 2441F*<br />

Coughlin, C., 451F<br />

Coughlin, C. R., 2884W<br />

Coulet, F., 1170W<br />

Coulibaly, A., 3303T<br />

Coulson, R., 64<br />

Coulter, M. E., 8, 2613W<br />

Coupry, I., 716T, 2674W<br />

Courcet, J.-B., 2792T*<br />

Court, F., 3499T<br />

Courtenay, M., 3335W<br />

Courtenay, M. D., 2028W*,<br />

2318F<br />

Courtens, W., 2002T<br />

Courtney, M., 2629T<br />

Cousminer, D., 2097W*<br />

Cousminer, D. L., 2162F<br />

Coutant, S., 32, 345, 1222T,<br />

3538W*<br />

Coutinho, P., 2820F<br />

Couto, A., 1432F<br />

Couture, C., 1947W<br />

Couve, A., 3129W<br />

Couvelard, A., 29<br />

Covas, D. T., 1045T<br />

Coventry, A., 183<br />

Cover, T., 3388F<br />

Cowan, C., 520W, 1988F<br />

Cowan, J., 3622W<br />

Cowling, B. S., 2681T<br />

Cox, A., 1706T<br />

Cox, A. J., 1648T*, 1661T<br />

Cox, C., 294<br />

Cox, D. W., 2474F<br />

Cox, H., 1912T<br />

Cox, H. C., 2916F<br />

*Presenting Author<br />

Cox, N., 368, 613T, 1480F<br />

Cox, N. J., 40, 424W, 623T,<br />

1003T, 1495F, 2192F,<br />

2196W, 2197T, 2333F,<br />

3735F<br />

Cox, V., 869W, 3139W<br />

Coxson, H. O., 2249F<br />

Coyle, M., 893W<br />

Cozad, R. A., 66<br />

Craft, J., 1021T<br />

Craig, B., 3644W, 3704W,<br />

3716W, 3731F*, 3733F<br />

Craig, D. M., 1594T*<br />

Craig, D. W., 1240T*,<br />

3215W<br />

Craig, J., 3484T<br />

Craig, J. E., 1785W<br />

Craigen, W., 163, 676T,<br />

2942T<br />

Craigen, W. J., 667F*, 683F<br />

Craigie, S., 1827W<br />

Craigie, S. M., 149, 150<br />

Crain, B., 1051T<br />

Crandall, B., 873W<br />

Crane, P., 2098T<br />

Crane, P. K., 342, 2488T<br />

Crapo, J., 2057F<br />

Crapo, J. D., 1425T, 2249F,<br />

2346W<br />

Crary, F., 64<br />

Crawford, B., 686T<br />

Crawford, D., 1377T, 1602T,<br />

1608T, 1928F, 2037W,<br />

2041T, 2098T<br />

Crawford, D. C., 226, 247,<br />

618T, 647T, 1316W,<br />

1447F, 1671T*, 1713T,<br />

2042F, 2298W, 2401T<br />

Crawford, M., 3359W<br />

Crawford, M. H., 3344W<br />

Creadon-Swindell, G., 451F<br />

Cree, A. J., 2072F<br />

Creech, C. B., 247<br />

Creech, M. L., 3588W<br />

Crenshaw, A., 290, 2098T<br />

Crenshaw, D., 2465F<br />

Crenshaw, D. G., 637T,<br />

1382W<br />

Cresci, S., 2535W<br />

Crespo, J., 1977W<br />

Crew, K. D., 1255T<br />

Crider, K. S., 1304W*,<br />

1310W<br />

Crim, C., 2249F<br />

Crisponi, L., 823F, 847F<br />

Cristino, L., 3492T<br />

Criswell, L., 3454T<br />

Criswell, L. A., 306, 1979F<br />

Crobu, F., 547F<br />

Crocco, E., 2637W<br />

Crocco, E. A., 2583W<br />

Croen, L., 463F<br />

Croen, L. A., 7, 2555F<br />

Croen, L. C., 2510F<br />

Cromer, M. K., 1241F*<br />

Crook, D. W., 1948T<br />

Crooks, L., 1518T<br />

Cropp, C., 1512T<br />

Cropp, C. D., 1302T*<br />

Crosbie, J., 2499W<br />

Crosby, J. R., 648T<br />

Crossley, B., 2260T<br />

Crosslin, D., 2098T*<br />

Crosslin, D. R., 1312F,<br />

1447F<br />

Crossman, D. K., 2759T<br />

Croteau-Chonka, D. C.,<br />

108, 1427W, 1954T,<br />

2090F, 2123F, 2147F,<br />

2241W<br />

Crotti, L., 86<br />

Crotwell, P. L., 3151W<br />

Crouch, D. J. M., 1329T,<br />

3348T*<br />

Crouch, J., 148<br />

Crout, R., 2142W, 2156F,<br />

2178W<br />

Crout, R. J., 1464T, 1474F<br />

Crow, S., 605T, 2516F<br />

Crow, Y. J., 2452T<br />

Crowe, C., 456W<br />

Cruceanu, C., 2338T*,<br />

2482T<br />

Cruchaga, C., 340, 342<br />

Cruickshank, M., 3484T<br />

Cruts, M., 2815W<br />

Cruz, A. A., 2043W<br />

Cruz, L. A., 814F, 2414F<br />

Cruz, P., 1983W<br />

Cruz, P. R. S., 426W, 2751F*<br />

Cruz-Alcivar, R., 872T*,<br />

3040F<br />

Cruz-Bautista, I., 2256W<br />

Crystal, R. G., 2933T,<br />

3399W<br />

Cua, C. L., 2069F<br />

Cubells, J. F., 2383T, 2384F<br />

Cubillo, M. A., 926T<br />

Cubillo, M. A. L., 1018T<br />

Cucca, F., 113, 157, 177,<br />

186, 276, 547F, 823F,<br />

1391W, 1451W, 1516F,<br />

2001W, 2198F, 2329T,<br />

3377W, 3664W<br />

Cuccaro, M., 1786W,<br />

1787W*<br />

Cuccaro, M. L., 9, 588W,<br />

2445W, 2508W, 2572T,<br />

2614T, 3390T<br />

Cucco, F., 2695W<br />

Cuccuru, G., 157<br />

Cuckle, H., 274<br />

Cuebas, D., 662T<br />

Cuellar, F. L., 926T, 1018T<br />

Cuellar-López, F., 3061W*<br />

Cuenca-Roldán, T., 1131W<br />

Cuenco, K., 1464T*<br />

Cuenco, K. T., 1474F,<br />

2142W, 2156F<br />

Cuevas, O., 2365T<br />

Cuffe, S., 1108T<br />

Cui, C., 3317W<br />

Cui, H., 683F, 1087T, 1750W<br />

Cui, J., 1916F<br />

Cui, L., 2066F, 3123W*<br />

Cui, W., 722T<br />

Cui, W.-C., 1540F<br />

Cui, W.-Y., 2574W<br />

Cukier, H. N., 9*, 2445W,<br />

2614T<br />

Cukrowska, B., 1330F<br />

Cukuranovic, R., 3481T<br />

Cule, E., 1285F*<br />

Cullen, M., 30, 1218W,<br />

1517W, 3683F<br />

Cullinane, A. R., 709F,<br />

2838F*<br />

Culminskaya, I., 1991F*,<br />

2194T<br />

Culver, J. O., 1071W*<br />

Culver-Cochran, A. E.,<br />

3515T*<br />

Cumiskey, A. M., 2220W<br />

Cummings, A. C., 1489F*,<br />

3335W<br />

Cummings, S. A., 109<br />

Cummings, S. R., 1576F,<br />

2375F<br />

Cumplido, J., 2296T<br />

Cunha, L. F., 2928F<br />

Cunha, P. S., 3107W, 3110F<br />

Cunha-Neto, E., 1593T<br />

Cunliffe, H. E., 1186T<br />

Cunningham, S., 166<br />

Cunningham, F., 3732W<br />

Cunningham, G., 670T<br />

Cunningham, J., 139, 1267T<br />

Cunningham, J. M., 1238F,<br />

3451T<br />

Cunningham, M., 126,<br />

2762T<br />

Cunningham, M. L., 33,<br />

813F, 2151W, 3070F*<br />

Cunninghame Graham, D.<br />

S., 306, 3382F<br />

Cuppen, E., 217, 400*,<br />

423F, 2886F, 3608W<br />

Cuppens, H., 1450F<br />

Cupples, A., 350, 2210F<br />

Cupples, L. A., 111, 117,<br />

170, 174, 317, 349,<br />

1346W, 1585T, 1599T,<br />

1954T, 2030F, 2052W,<br />

2073W, 2123F, 2147F,<br />

2337W<br />

Curbelo-Canabal, F., 3363T<br />

Cureklibatir, I., 1106F<br />

Curhan, G. C., 51<br />

Currall, B. B., 862T*<br />

Curran, J., 176, 1280W,<br />

1513F<br />

Curran, J. E., 533F, 1282F,<br />

1406W, 1923W, 2061W,<br />

2146T, 2308T, 2309F,<br />

2339F*<br />

Curry, B., 971W<br />

Curry, C., 869W<br />

Curry, C. J., 79, 1070F<br />

Curry, J. A., 2838F<br />

Curtin, J. A., 2211W*<br />

Curtis, R., 3605F<br />

Curtis, R. E., 2152T<br />

Cusano, R., 113, 177, 547F,<br />

823F, 3664W<br />

Cusanovich, D. A., 3251W<br />

Cuscó, I., 2711T<br />

Cushion, T. D., 262<br />

Cushman, M., 1662T<br />

Cushman-Spock, L., 1820F<br />

Cusi, D., 845F, 2095T


Cusin, V., 56<br />

Cussenot, O., 1001F, 1214F<br />

Cust, A. E., 212<br />

Custovic, A., 2168F, 2211W<br />

Cutiongco-de la Paz, E. C.,<br />

2975T*<br />

Cutiongco-de la Paz, E. M.,<br />

1805W<br />

Cutler, D. J., 2069F, 2312F,<br />

2576F, 3414W, 3628W<br />

Cutrer, F. M., 2362T<br />

Cutting, G., 1450F, 2953W<br />

Cutting, G. R., 78, 1322W,<br />

1731W, 3448T<br />

Cutts, A., 133<br />

Cvjetkovic, N., 1908W<br />

Cytrabaum, C., 2480F<br />

Cytrynbaum, C., 3420T<br />

Czape, K., 1787W<br />

Czeizel, E., 1936T<br />

Czerwinski, S. A., 2146T<br />

D<br />

Daavittila, I., 1892F<br />

Dabelea, D., 249<br />

Daber, R., 3040F<br />

D’Aco, K., 2871F*<br />

Dada, R., 2967T<br />

Dadaev, T., 205, 1011W,<br />

1109F<br />

d’Adamo, P., 2366F<br />

Dafou, D., 780W, 2896W,<br />

2925F<br />

Daggett, H. T., 2750T<br />

Dagle, J., 3537F<br />

Dagle, J. M., 1344T<br />

D’Agnano, D., 760W<br />

Dahan, K., 3098F*<br />

Dahdouli, M., 3576W<br />

Dahgam, S., 1970F*<br />

Dahl, A., 3224F<br />

Dahl, F., 3685F, 3709F, 3729F<br />

Dahl, M., 702T<br />

Dahl, N., 2920W<br />

Dahl, O., 991T<br />

Dahlin, A., 2166W<br />

Dahlman, K. B., 136<br />

Dahoun, S., 67<br />

Dai, A., 3596W<br />

Dai, C., 516W<br />

Dai, H., 1369F, 3649F<br />

Dai, J.-R., 3029T<br />

Dai, J. Y., 1408F<br />

Dai, L., 538W, 2529W<br />

Dai, Q., 3483T<br />

Dai, X., 1265F*, 1693T,<br />

2415W<br />

Dai, Z., 953W*<br />

Daiger, S. P., 3234F<br />

Dal, G. M., 2924T<br />

D’Alessio, V., 2916F<br />

Daley, D., 1465F*<br />

D’Alfonso, S., 2095T, 2775F<br />

Dalgeish, R., 3610W<br />

Dalgleish, R., 3732W<br />

Dalla Bernardina, B., 2795T<br />

Dallapiccola, B., 105, 943W,<br />

2777T<br />

*Presenting Author<br />

Dallavale, F., 3121W<br />

Dallman, J. E., 297, 2445W*<br />

Dalton, G. C., 3324T<br />

Daly, A., 33, 45, 1676T<br />

Daly, K., 1971W<br />

Daly, M., 252, 322, 333, 352,<br />

1213T, 1520W, 1725W<br />

Daly, M. J., 11, 280, 290,<br />

295, 1523W, 2319W,<br />

2560T, 2577W, 2618F<br />

Daly, S., 2852T<br />

Damaraju, S., 1297F<br />

D’Amato, I., 2810T<br />

D’Amato, M., 2319W, 3631F<br />

Dames, S., 3637F*<br />

Damiani, D., 2706F<br />

Damiani, M., 994T<br />

Damiano, J., 3228F<br />

Danashi, A., 2301W<br />

Dancey, J., 135, 1824F<br />

Danchin, N., 609T<br />

Danda, D., 1701T<br />

Danda, S., 1701T<br />

Dandara, C., 1073F<br />

Danesh, J., 115<br />

Daneshjou, R., 646T*<br />

Dang, C., 2444F<br />

Dang, D., 759W<br />

Dang, D. A., 1998W, 1999T<br />

D’Angelo, A., 808F<br />

D’Angelo, C., 895W*<br />

Danhauser, K., 699F<br />

Daniels, M. L., 2851W<br />

Danila, M. I., 2047T<br />

Danjoh, I., 1277F*<br />

Danjou, F., 2001W<br />

D’Anjou, G., 2900T<br />

Dankel, S. N., 3536W<br />

Dantas, V. G. L., 891W<br />

D’Antoni, S., 513F<br />

Daoud, H., 2306F, 2342F,<br />

2797W*<br />

D’Aoust, L. N., 1489F,<br />

3335W*<br />

Daoutidou, E., 3396T<br />

Daoutidou, K., 2044T<br />

Dara, A., 2255F<br />

Darabi, H., 1934F, 2055W<br />

Darabos, C., 188*<br />

Darbari, D., 1259F<br />

Darbro, B., 419F<br />

Darcan, S., 3206F<br />

Darcansoy Iseri, O., 3424T<br />

Dardis, A., 692T, 2809W*<br />

DaRe, J., 688T*<br />

Darling, T. N., 33<br />

Darnell, J. C., 2587T<br />

Darnell, R. B., Session 24,<br />

2587T<br />

Daroy, M., 2466W*<br />

Daroy, M. L. G., 2473T<br />

Darst, B. F., 1839W*<br />

Darvasi, A., 17, 264, 3346F,<br />

3366T<br />

Darvish, D., 682T<br />

Das, K., 130, 315<br />

Das, P., 3262F<br />

Das, S., 958T, 1432F*,<br />

1737W, 1952F*, 2162F,<br />

3090F<br />

SPEAKER AND AUTHOR INDEX 349<br />

Das, S. K., 2011T*, 2192F<br />

D’Ascenzo, C., 1732W<br />

D’Ascenzo, M., 3688W<br />

Dasgupta, A., 1363F<br />

Dasgupta, N., 161, 690T*<br />

Dasgupta, S., 1885T<br />

da Silva, V. P. M., 1946F<br />

Dasouki, M., 3054F<br />

Dasouki, M. J., 2894T*<br />

Dassopoulos, T., 1381F<br />

Dastani, Z., 1595T*<br />

Dastgir, J., 711F<br />

Datar, C., 700T<br />

Datar, CA., 2803W<br />

Date, H., 52<br />

Datta, A., 3044F<br />

Datta, I., 1895F<br />

Datta, L. W., 1381F<br />

Dattani, M., 2701W<br />

Daub, A. C., 2643W<br />

Dauber, A., 131, 1960T<br />

Dauchel, H., 3538W<br />

Däumer, C., 1943F<br />

Dávalos, I. P., 3187W, 3188F<br />

Dávalos, N. O., 3187W*,<br />

3188F<br />

Davatchi, F., 2150F<br />

Dave, B. J., 968T<br />

Davenport, E. R., 2031W*<br />

Davey Smith, G., 583F,<br />

1318F, 1567F, 1583W,<br />

1626T, 2081F, 2097W,<br />

2164T, 2169W, 3455T<br />

David, A., 403, 1212W,<br />

3066F<br />

David, D. M., 152<br />

David, J., 950T<br />

David, V., 2893W*, 3170F<br />

Davidovic, L., 513F, 817F<br />

Davidovich, M., 3048F<br />

David-Padilla, C. M., 2975T<br />

Davidson, B., Session 23<br />

Davidson, B. L., 2636F<br />

Davidson, C., 3684W*<br />

Davies, A. G., 640T<br />

Davies, C., 142, 493F<br />

Davies, G., 2366F, 3466T,<br />

3486T<br />

Davies, J., 320, 1729W,<br />

1872F, 1873F<br />

Davies, K. E., 2649W<br />

Davies, M., 153, 546W<br />

D’Ávila, R., 2424W, 2626T<br />

Davila, S., 429F, 3047W<br />

Davis, B., 648T, 1346W<br />

Davis, E. C., 129<br />

Davis, E. E., 3*<br />

Davis, J., 433F, 1869F,<br />

3128F*<br />

Davis, L., 1901F<br />

Davis, L. K., 424W*<br />

Davis, M. F., 1489F, 2299T*<br />

Davis, O. S. P., 2164T<br />

Davis, P., 3484T<br />

Davis, R., 1337W, 3691F<br />

Davis, R. J., 393<br />

Davis, R. W., 1112F<br />

Davis, S. D., 2851W<br />

Davis, T., 512W, 2701W,<br />

2938W, 3517T<br />

Davis, T. B., 3702W, 3715F<br />

Davy, G., 1205F<br />

Daw, E. W., 1920W, 1921T<br />

Dawood, K., 1957T<br />

Dawsey, S. M., 1010F,<br />

1076F<br />

Dawson, A. J., 954T*<br />

Dawson, B., 2542T, 2854W,<br />

3209W<br />

Dawson, B. C., 795W<br />

Dawson, G., 2617T<br />

Dawson, L., 1066T<br />

Dawson, L. M., 1084T<br />

Dawson, S. J., 2302T<br />

Day, D., 153<br />

Day, F., 108, 1954T, 2090F,<br />

2123F, 2147F, 2241W<br />

Daya, M., 2007W, 3385F*<br />

Day-Williams, A. G., 169,<br />

2561F<br />

Daza, R., 322<br />

D-CarDia Collaboration, 271<br />

DCCT/EDIC Research<br />

Group, 2109W<br />

DDD and UK10K Projects,<br />

455F<br />

DDD Project, 101, 364<br />

De, G., 1431T<br />

de Alexandre, R., 1151F*<br />

de Alexandre, R. B., 3055W<br />

De Almeida, S., 129<br />

de Almeida M., F., 3123W<br />

Dean, E., 1152W*<br />

Dean, M., 1242W*, 2833W<br />

de Andrade, M., 618T,<br />

1312F, 1375F*, 1447F,<br />

1454W, 1497T, 2098T<br />

de Angelis, A., 808F*<br />

deAngelis, M., 385<br />

DeAngelis, M. M., 1305T*,<br />

2183F<br />

Deans, T. A., 611T<br />

de Araujo, T. K., 1903T<br />

Deardorff, M., 2904F, 3038F,<br />

3082F<br />

Deardorff, M. A., 2695W,<br />

2958F<br />

Deary, I. J., 2072F, 2366F<br />

de Assis, T. M. R., 2813T*<br />

De Backer, J., 128, 2225F<br />

De Baere, E., 539F, 2832F,<br />

2927T<br />

de Bakker, P. I. W., 87, 155,<br />

609T, 1659T, 1934F,<br />

2047T, 2210F<br />

de Becdelièvre, A., 572W,<br />

1768W<br />

De Benedetto, A., 1900T<br />

de Blois, M.-C., 915W<br />

de Boer, A., 609T<br />

de Boer, C. M., 1122W,<br />

1273T<br />

de Boer, E. N., 1619T<br />

DeBoever, C., 395<br />

De Borja, R., 1093T, 1256F<br />

Debortoli, G., 1946F*<br />

de Bot, S. T., 160<br />

Debrabant, B., 2244W<br />

de Broca, A., 3109W,<br />

3117W<br />

SPEAKER AND AUTHOR INDEX


350 SPEAKER AND AUTHOR INDEX<br />

de Brouwer, A., 3165W<br />

de Brouwer, A. P. M., 100,<br />

102, 125, 160*, 672T<br />

Dec, E., 3144F*, 3213W<br />

Decaestecker, C., 3172F<br />

Decanini-Arcaute, H., 1030T<br />

de Carvalho, T., 691F<br />

de Castro, C., 895W<br />

De Castro, C. C. S., 1978T<br />

Decewicz, A., 1649T<br />

de Chadarévian1, J., 924T<br />

DeChene, E., 3219W<br />

Dechene, E., 2811F<br />

DeChene, E. T., 1769W<br />

Deciu, C., 3014T, 3016T<br />

Decker, B., 2219F<br />

Decker, P. A., 1351F<br />

de Coninck, T., 2820F<br />

de Coo, I., 708T<br />

de Coo, I. F. M., 2996T<br />

De Coo, R., 796W*<br />

DeCoteau, J. F., 3488T<br />

de Craen, A. J. M., 2035T<br />

de Denus, S., 3401W<br />

Dederich, D., 3656W, 3703F<br />

de Die, C. E., 2996T<br />

De Dios, J. K., 711F*<br />

Dedoussis, G., 106, 2044T,<br />

2097W, 3396T*<br />

Dedoussis, G. V., 110<br />

Deekajorndech, T., 2006F<br />

Deelchand, D., 2539T<br />

Deelder, A., 2107T<br />

Deelen, J., 2035T*, 2175W<br />

Deelman, E., 3558W<br />

Defebvre, L., 345<br />

DeFelice, M., 322, 1725W<br />

Defoort-Delhemmes, S., 390<br />

Degenhardt, F., 420W<br />

DeGiorgio, M., 3305W*<br />

Degner, J., 2<br />

de Groot, N., 3279T<br />

Deguchi, K., 234<br />

Dehghanpour, H., 2964F<br />

Dehner, L. P., 132<br />

Dei, M., 177, 1516F, 2198F,<br />

2329T<br />

Deidda, F., 157<br />

Deignan, J., 315<br />

Deignan, J. L., 130<br />

Deininger, P., 524W<br />

De Iorio, M., 1285F<br />

Dei Rossi, A., 1198T<br />

De Jaegere, S., 539F<br />

De Jager, P., 624T, 1415W,<br />

2488T<br />

De Jager, P. L., 380*, 528W,<br />

2250W, 3417T, 3450T<br />

DeJesus-Hernandez, M.,<br />

2639F<br />

de Jong, D. J., 243<br />

De Jong, K. H., 3523T<br />

de Jong, S., 2553W,<br />

2661W*<br />

de Jong, V., 348<br />

De Jonghe, P., 201, 2948T<br />

de Jongste, J. C., 2168F<br />

de Jongue, P., 2820F<br />

De Jorge, L., 2627F<br />

Deka, R., 1660T*, 2159F<br />

*Presenting Author<br />

Dekker, J., 255<br />

Dekker, J. M., 3455T<br />

Dekkers, J. C. M., 2717T<br />

de Klein, A., 834F<br />

de Klerk, E., 542W*<br />

de Koning, B., 708T<br />

de Koning-Tijssen, M. A.<br />

J., 200<br />

de Kovel, C. G. F., 2886F<br />

Delabar, J., 84<br />

De la Cruz Cabrera, O.,<br />

3409W<br />

De La Forest, A., 587F<br />

Delahaye, A., 973W, 2784F,<br />

2957T<br />

De la Morena, M., 2949F<br />

Delaneau, O., 90*, 1484W<br />

Delaney, J., 1190F<br />

Delaney, J. T., 247<br />

Delaney, K., 714T, 801W<br />

Delaney, S. M., 614T, 3472T<br />

del Angel, G., 288*<br />

De la Rosa-Alvarado, R.,<br />

1030T<br />

de la Torre, l., 3061W<br />

Delattre, V., 894T<br />

De La Vega, F., 1770W*,<br />

3602W<br />

De La Vega, F. M., 3352F<br />

Del Bo, R., 2775F<br />

Delbono, E., 2154W<br />

del Campo, M., 3084F, 3208F<br />

del Castillo, I., 1<br />

del Castillo, V., 875W, 956T,<br />

976T*<br />

Del Castillo-Ruiz, V., 872T,<br />

3040F<br />

de Leau, M., 1689T<br />

de Leeuw, N., 102, 955W*,<br />

979W<br />

de Léséleuc, L., 2003F<br />

Delettre, C., 2679F*<br />

Deleyiannis, F. W. B., 1936T<br />

Delezoide, A.-L., 77<br />

Delezoide, A. L., 3129W<br />

Delgado, P. A., 873W*<br />

Delgado, R., 694T<br />

Delgado, S., 2049W<br />

del Gaudio, D., 958T,<br />

1737W, 3090F<br />

Del Giudice, E., 943W<br />

Deliard, S., 812F<br />

Deligniere, A., 202<br />

de Ligt, J., 97*, 100, 102,<br />

215, 459F, 1749W<br />

Delio, M., 1494T*<br />

DeLisi, L. E., 2402F<br />

Dell, S. S., 2851W<br />

Dell’Angelica, E. C., 361<br />

Della Santina, C. C., 2301W<br />

Dellefave-Castillo, L.,<br />

1614T, 1683T<br />

Dellinger, A., 531F<br />

Del Mistro, G., 3670W,<br />

3717F<br />

Delobel, B., 299, 3172F<br />

Delon, I., 1257W<br />

De Lonlay, P., 329<br />

de los Campos, G., 2201F<br />

Delot, E., 361<br />

Deloukas, P., 44, 110, 115,<br />

117, 383, 560W, 583F,<br />

1440T, 3441T, 3453T*<br />

Delozier, C. D., 1070F*<br />

Delphin, N., 324, 390<br />

Delpierre, C., 1817W<br />

Delprat, B., 2685F*<br />

del Rosario, M., 955W,<br />

2018F*<br />

Del Solar, M., 81, 767W,<br />

815F<br />

DeLuca, A. P., 60<br />

DeLuca, D., 368<br />

De Luca, V., 2408F*<br />

de Luca, V., 628T<br />

Deluce, J., 612T<br />

Delva, L., 2716W<br />

Del Zompo, M., 2342F<br />

Demachki, S., 1008W,<br />

1132T, 3421T, 3503T<br />

de Malliard, T., 31, 2266T,<br />

3260W, 3268F, 3341W<br />

De Marco, E. V., 2597F<br />

de Marco, L. A., 1902W<br />

De Mari, J., 685F<br />

Demartis, F., 2001W<br />

De Mazancourt, P., 890T<br />

Dembitzer, F. R., 3145W<br />

Dembour, G., 84<br />

de Medeiros, P. F. V., 1217F<br />

Demeer, B., 3117W*, 3241W<br />

de Mello, M. P., 478W, 479F<br />

de Melo, M. B., 2291F<br />

Demenais, F., 211, 1158W,<br />

1361W, 1461T, 1941W,<br />

2079W, 2248T<br />

DeMeo, D., 2057F<br />

Demerath, E., 2165F<br />

Demerath, E. W., 2146T,<br />

2336F<br />

Demeter, R., 2587T<br />

Demetriou, C., 3508T*<br />

Demetriou, M., 1493W<br />

Demichelis, F., 1100F<br />

Deming, S. L., 2202W<br />

Demirci, F. Y., 1647T, 1672T,<br />

1673T, 2099F*, 2125T,<br />

2521T, 3078F Demirhan,<br />

B., 3426T<br />

Demko, Z., 3018T<br />

Demko, Z. P., 73<br />

Demmer, L., Session 28<br />

Demmer, L. A., 66<br />

Demmer, R., 1638T<br />

Demontis, D., 2369F<br />

Demos, M., 750T<br />

Dempsey, J., 2243F<br />

Dempsey, J. C., 2789T<br />

Dempsey Nunez, L., 673F*<br />

Dempster, E., 3509T<br />

de Munnik, S. A., 955W<br />

Demuth, S., 2810T<br />

den Dunnen, J. T., 542W,<br />

574W, 2701W, 3586W,<br />

3611F*<br />

Dene, H., 2675T<br />

Deng, A., 1987T<br />

Deng, F.-Y., 2172W<br />

Deng, H. W., 1473T, 2053T,<br />

3534W<br />

Deng, H.-W., 1404T, 2172W<br />

Deng, L., 2433W<br />

Deng, T., 577F<br />

Deng, X., 379<br />

Deng, Z., 798W<br />

Denguezli, M., 2744T<br />

den Hamer, B., 2840T<br />

den Hertog, J., 215<br />

den Hoed, M., 2282F,<br />

2359T*<br />

De Nicola, S., 3492T<br />

Dennis, J., 205, 206<br />

Dennis, M., 12<br />

Dennis, M. Y., 14, 3296W*<br />

Denny, J., 1602T, 3622W*<br />

Denny, J. C., 247, 618T,<br />

631T, 1312F, 2299T<br />

Denny, J. D., 1345F<br />

Denoncourt, H., 1733W<br />

Denroche, R., 1227W,<br />

1256F<br />

Dent, R., 2236T<br />

Dentici, M. L., 105<br />

Denton, M., 2402F<br />

Deo, R., 1694T<br />

Deo, S. V. S., 1278W<br />

de Oliveira, P., 691F<br />

De Paepe, A., 128, 129,<br />

423F, 833F, 1790W,<br />

2225F, 3137W<br />

de Pagter, M., 400<br />

DePalma, S. R., 1677T<br />

de Paor, A., 1812F*<br />

Depienne, C., 2770W<br />

Deplancke, B., 415F<br />

de Pontual, L., 3172F<br />

Depping, R., 204<br />

De Preux Charles, A. S.,<br />

810F<br />

Deprez, M., 3181W<br />

DePristo, M. A., 41, 280,<br />

288, 295<br />

Dequeker, E., 1874F<br />

de Ravel, T., 539F<br />

Derbent, M., 3243W<br />

Derebery, M., 2184W<br />

de Reuver, H. J. E., 1734W<br />

de Reuver, R., 1749W<br />

De Rijk, P., 2948T<br />

Derijks, L. J. J., 243<br />

Derkach, A., 1412W*,<br />

1531F, 2580W<br />

Derks, E. M., 2526W<br />

Derks, R., 2925F<br />

Dermadi Bebek, D., 982T<br />

Dermitzakis, E., 368, 583F,<br />

1440T<br />

Dermitzakis, E. T., 44, 401,<br />

415F, 546W, 556W,<br />

560W, 561F*, 567F,<br />

582W, 3441T<br />

Deroma, L., 692T<br />

DeRoo, L., 1564F<br />

DeRosa, B. A., 588W*<br />

Derouet, C., 1062W<br />

Derrick, A., 262<br />

Derrien, T., 506W<br />

Derry, C. P., 2741T<br />

Derse, A. R., 1837W<br />

DeRycke, M., 1214F


DeRycke, M. S., 986F*,<br />

1206W, 3564W<br />

de Sablet, T., 3388F<br />

Desachy, G., 99, 1274F,<br />

2555F*<br />

Desai, A. S., 2872W*<br />

Desai, K., 188<br />

Desai, M., 911W<br />

Desai, S., 911W, 1146W<br />

Descamps, B., 2225F<br />

Descamps, V., 29, 1062W<br />

Descartes, M., 884T, 898T<br />

Deschamps, L., 29<br />

Deschenes, M., 1848W<br />

DeScipio, C., 935W<br />

Desguerre, I., 202, 522W<br />

Deshommes, J., 259<br />

Deshpande, C., 2896W,<br />

2925F<br />

Deshpande, P., 3649F<br />

Désilets, V., 2790F<br />

Desir, J., 105<br />

Desmaris, C., 530W<br />

De Smedt, M., 2757F<br />

Desmyter, L., 2002T<br />

Desnick, R., 678T, 2926W<br />

Desnick, R. J., 652T, 1777W<br />

De Sousa, M., 2982T<br />

Despande, S. N., 2382W<br />

Dessein, A., 1949F<br />

Dessein, H., 1949F<br />

DeStefano, A. L., 1592T<br />

Destouni, A., 2995T*<br />

Destree, A., 3216F, 3218F<br />

Destrée, A., 127, 131<br />

Desudchit, T., 2749W<br />

Desvarieux, M., 1638T<br />

Detains, D., 56<br />

de Tayrac, M., 2126F,<br />

2893W, 3170F, 3328F*,<br />

3408T<br />

Deugnier, Y., 2126F<br />

Deuschl, G., 200<br />

Deutsch, S., 84<br />

DeValk, J., 3287W<br />

Deveaux, S., 1212W<br />

Devereau, A., 3610W<br />

Devgan, V., 1263W<br />

De Vilder, E., 1790W*<br />

Devilee, P., 27, 1213T<br />

Devillers, M., 1607T<br />

Devine, M., 1267T<br />

Devine, O. J., 1867F<br />

Devlin, B., 553F, 1433W,<br />

1520W, 2560T, 2577W,<br />

2617T<br />

Devlin, J., 544W<br />

Devlin, J. J., 1603T, 1714T<br />

Devlin, R., 1636T<br />

Devoto, M., 2316W<br />

Devriendt, K., 124, 2926W<br />

De Vries, B., 100*<br />

de Vries, B. B. A., 97, 103,<br />

125, 160, 955W<br />

de Vries, F. A. T., 980T*<br />

De Vries, J., 1848W<br />

de Vries, J. I., 3200F<br />

de Vries, P., 97<br />

Dewal, N., 1231T*<br />

Dewan, A., 76, 3024T<br />

*Presenting Author<br />

Dewar, K., 2262W, 2320T,<br />

2343W<br />

Dewey, D., 3095W<br />

Dewey, F., 1601T*<br />

de Wind, N., Session 4<br />

de Wissel, M. B., 2909T<br />

DeWitt, W., 1255T<br />

De Witte, A., 922T, 975W<br />

DeYoung, J., 2262W,<br />

2661W<br />

De Zubicaray, G., 2054F<br />

D’haene, B., 2927T<br />

Dhanoya, I., 2411F<br />

Dharamrup, S., 66<br />

Dharmalingam, G., 2950W<br />

Dharuri, H., 228*, 2107T<br />

Dhaunsi, G. S., 2267F<br />

Dheedene, A., 59<br />

Dhillon, B., 2072F<br />

Dhillon, K. K., 137*<br />

Dhole, T. N., 1177T<br />

Dhooge, I., 2104T<br />

Dhruva, A., 1965W<br />

D’Hulst, C., 2527T<br />

Dhurandhar, N. V., 1406W<br />

Diallo, A., 3470T<br />

Diallo, O., 1670T, 2342F,<br />

2558F<br />

Diamond, B., 306<br />

Dianatpour, M., 1169F*,<br />

2987T<br />

Dianzani, I., 1153T*<br />

Dias, A., 896T, 899W<br />

Dias, C. M., 1968W, 2017T<br />

Dias, F., 1593T<br />

Dias, L., 1778W<br />

Dias-Baptista, I. M. F.,<br />

2289W<br />

Diaw, L., 1259F<br />

Diaz, A., 2603F<br />

Diaz, A. R., 2572T<br />

Diaz, G., 774W<br />

Diaz, G. A., 168<br />

Diaz, K., 406, 2850F<br />

Diaz-Horta, O., 57<br />

Diaz-Martinez, R., 2019W<br />

Diaz-Matallana, M., 3363T<br />

Diaz-Sanchez, D., 1636T<br />

Diaz-Zabala, H. J., 1074W*,<br />

3363T<br />

Dibbens, L., 2898F<br />

Dibbens, L. M., 2741T<br />

Di Bella, D., 2764W*, 2781F<br />

Di Berardini, F., 2104T<br />

Dib-Haij, S. D., 2448W<br />

Dibilio, V., 2763F<br />

Dichgans, M., 1313W<br />

Dick, D. M., 2022W, 2504F<br />

Dick, J., 1193F<br />

Dick, J. E., 1093T<br />

Dick, K. J., 3453T<br />

Dickel, D. E., 254*<br />

Dickens, C. M., 433F, 465F<br />

Dickerson, C., 250<br />

Dickey, A. S., 2456F*<br />

Dickinson, K., 3038F<br />

Dickinson, K. A., 774W<br />

Dickinson, M., 834F, 839F<br />

Dicks, E., 139, 1084T<br />

Dickson, D. W., 346<br />

SPEAKER AND AUTHOR INDEX 351<br />

Dickson, P., 785W*<br />

Dickson, P. I., 695F, 697F<br />

Dicskon, P., 734T<br />

Didelot, G., 62<br />

Di Donato, N., 2595W, 3224F<br />

Diego, V. P., 1458T*<br />

Diehl, A., 531F<br />

Diehl, E. J., 378<br />

Diekhans, M., 3557F<br />

Diekmann, Y., 2261F<br />

Diekstra, A., 160<br />

Diener, S., 2693T*, 2922F<br />

Dierdorff, J., 419F<br />

Dierking, A., 1763W<br />

DietGen Consortium, 51<br />

Dietrich, A., 2602T, 3465T<br />

Dietz, H., Session 81, 80,<br />

81, 1609T<br />

Dietz, H. C., 79, 240<br />

Di Fiore, P. P., 1<br />

Di Gaetano, C., 1153T,<br />

1712T<br />

Digilio, M. C., 943W, 3087W<br />

Di Gregorio, E., 550W<br />

Dijamco, C., 1782W<br />

Dilks, H., 1377T, 1602T,<br />

1928F, 2037W<br />

Dilks, H. H., 1316W, 1671T<br />

Dill, E. M., 2557T<br />

Dillen, L., 2815W<br />

Dillman, A., 564W<br />

DiLullo, N., 2605T<br />

Dimalanta, E., 512W, 3517T<br />

Dimalanta, E. T., 3702W,<br />

3715F<br />

Di Marco, C., 2604W<br />

DiMauro, S., 232<br />

Dimitrova, N., 3316F<br />

Dimnik, L., 3141W, 3665F<br />

Dimos, J., 236<br />

Dimova, I., 3481T<br />

Di Muzio, A., 1776W<br />

Dindinger, M., 1068W,<br />

1244F<br />

Ding, B., 609T<br />

Ding, H. K., 1723W<br />

Ding, J., 154, 276*, 1391W,<br />

1952F<br />

Ding, K., 1312F<br />

Ding, L., 1203W*<br />

Ding, Q., 3355F<br />

Ding, S., Session 78, 2444F<br />

Ding, T., 1010F, 1076F,<br />

1218W<br />

Ding, Y., 314, 1735W,<br />

1742W, 1757W*, 1761W,<br />

3604W<br />

Ding, Z., 1440T<br />

Dingel, M., 1849W<br />

Dinges, D., 2592W<br />

Dingley, S., 2943F<br />

Dinh, H., 1757W, 2880F,<br />

2934F<br />

Di Nicola, M., 936T<br />

Dinov, I. D., 3587F<br />

Dinur, T., 746T<br />

Dinwiddie, D. L., 366,<br />

2793F*, 2894T<br />

Dion, P., 1670T, 1898F,<br />

2306F<br />

Dion, P. A., 2342F, 2558F,<br />

2591F<br />

Dionne, G., 2545T<br />

Dionne, R., 2221T, 3485T<br />

Dionne-Laporte, A., 1670T,<br />

2342F, 2558F<br />

Dionne laporte, A., 2306F<br />

Di Palma, G., 2597F<br />

Di Paola, J., 1889F<br />

Di Paolo, G., 2547W<br />

Dipchand, A., 1704T<br />

Dipple, K. M., 2238W<br />

Di Rienzo, A., Session 6,<br />

248, 2021F<br />

Di Rocco, C., 2235W<br />

Di Rocco, F., 763W, 2729T,<br />

3154F<br />

di Rocco, M., 127<br />

Di Sabato, M. L., 943W,<br />

2777T<br />

Disanto, G., 2015F<br />

Diskin, S., 2203T<br />

Disteche, C. M., 379*<br />

DiStefano, J. K., 1953W*<br />

Ditro, C., 3150F<br />

Dittwald, P., 432W*, 485F<br />

Diver, W., 1012T<br />

Diver, W. R., 1091F, 1390F,<br />

2202W<br />

Divers, J., 178, 1661T*,<br />

1662T, 3371W<br />

Divon, M., 432W<br />

Dixit, J., 2293T<br />

Dixon, A. K., 33<br />

Dixon, T., 239<br />

Dizier, M.-H., 1361W, 1461T,<br />

1941W*, 2079W, 2248T<br />

Djakovic, S., 508W<br />

Djimde, A., 2255F<br />

Djonov, V., 3481T<br />

Djouadi, F., 737F<br />

Do, C. B., 114, 179, 498W,<br />

1017W, 2089T, 2100W,<br />

2111F, 2115W, 2565W,<br />

3386W*<br />

Do, R., 120*, 350, 1331W,<br />

2199W, 2210F<br />

Doan, B., 1454W<br />

Dobbins, S., 1531F, 2580W<br />

Dobbs, M. B., 220, 2860W<br />

Dobkin, C., 2449T<br />

Dobra, A., 1500T<br />

Dobrovolny, R., 678T<br />

Dobrzeniecka, S., 2790F<br />

Dobson, J. M., 1105T<br />

Dobyns, W., 124<br />

Dobyns, W. B., 2389T<br />

Docampo, E., 2326T<br />

Doccini, V., 881W, 3050F<br />

Doco-Fenzy, M., 3165W,<br />

3241W<br />

Docquier, I., 1015T<br />

Dodd, A. F., 2576F<br />

Dodd, M., 1965W<br />

Dodge, M., 905W<br />

Dodurga, Y., 1025F, 1166F<br />

Doedens, M., 1193F<br />

Doelken, S. C., 2725W<br />

Doerfer, C., 2058W<br />

Doering, J., 591F, 865W<br />

SPEAKER AND AUTHOR INDEX


352 SPEAKER AND AUTHOR INDEX<br />

Doerr, H.-G., 2356T<br />

Doerr, M., 1716W*<br />

Doerschner, K., 2924T<br />

Doevendans, P. A. F. M.,<br />

609T<br />

Dogan, A., 2251T<br />

Dogan Sigva, Z. O., 1164W,<br />

1178F<br />

Dogini, D., 2653T*<br />

Dogini, D. B., 514W, 2609F<br />

Doheny, D., 678T*<br />

Doheny, K., 1447F, 2098T,<br />

2114F, 2139W, 2170T,<br />

2556W, 3644W, 3704W,<br />

3733F<br />

Doheny, K. F., 46, 123,<br />

1448W, 1452T, 3716W,<br />

3731F<br />

Doherty, D., 10, 2772F*,<br />

2789T, 2890W<br />

Doherty, L., 3494T<br />

Doherty, M., 2292W<br />

Doherty, S., 2292W<br />

Dohrn, N., 2862F*<br />

Doi, H., 1290T, 2822T, 3136F<br />

Doksum, T., 2974T<br />

Doktor, T. K., 737F<br />

Dola, E. R., 2422T*<br />

Dolan, C. R., 1753W<br />

Dolan, D. F., 1878W<br />

Dolan, M. E., 614T, 1495F,<br />

2333F, 3472T<br />

Dolan, S., 2974T<br />

Dolgado Bohorquez, E. E.,<br />

432W<br />

Dolgalev, I., 998F<br />

Dollfus, H., 390, 2887W*<br />

Dolmetsch, R., 2479T<br />

Domchek, S. M., 1003T<br />

Domingo, E., 133<br />

Dominguez, J., 2466W<br />

Domínguez, J., 960T<br />

Dominguez, J. C., 2473T<br />

Dominguez-Aburto, J.,<br />

3125W<br />

Domínguez Ortiz, J., 956T*<br />

Dominiczak, A. F., 845F,<br />

2072F<br />

Dommisch, H., 2058W<br />

Dompmartin, A., 83<br />

Dompmartin, J. B., 1015T<br />

Donadi, E., 1593T<br />

Donadi, E. A., 3277F<br />

Donahue, L., 983F<br />

Donahue, S., 3210F<br />

Donald, A., 2537F<br />

Donaldson, P. T., 153<br />

Doneda, D., 696T<br />

Dong, C., 1635T*, 1638T<br />

Dong, H., 3730W<br />

Dong, J., 2759T<br />

Dong, L., 824F, 830F<br />

Dong, S., 412W, 486W,<br />

2605T*, 3520T, 3604W<br />

Dong, Z., 1182W<br />

Donis, K. C., 2424W, 2626T,<br />

2642F<br />

Donkervoort, S., 3213W<br />

Donnai, D., Session 81, 127,<br />

2852T<br />

*Presenting Author<br />

Donnelly, L., 609T<br />

Donnelly, M., 3232F*<br />

Donnelly, P., 181, 285,<br />

2157W, 2939T<br />

Donnelly, P. J., 1340W<br />

Donnelly, R., 1155W<br />

Donner, E., 3196F<br />

Donner, M., 86<br />

Donneyong, M., 2145W<br />

Donovan, J., 1011W<br />

Donovan, J. L., 1148F<br />

Donsante, A., 235, 791W<br />

Donti, T., 661F*, 667F, 676T,<br />

2942T<br />

Doody, R., 2489F, 2542T<br />

Dooley, C. M., 363<br />

Dooley, K., 2069F<br />

Dorfman, R., 1731W<br />

Dörk, T., 1117T<br />

Dornelles, A. D., 696T<br />

Dornelles-Wawruk, H., 903W<br />

Doros, L., 132<br />

Dörr, M., 275<br />

Dorrani, N., 315<br />

Dorsainville, D., 3004T<br />

Dorssers, L. C. J., 1122W<br />

Dorward, H., 709F<br />

Doshi, P., 1901F, 2284T<br />

Dos Santos, L., 1133F<br />

Dossari, H., 2743W<br />

Dott, B., 3073W<br />

Doty, A., 1061F<br />

Doty, C., 265<br />

Doty, S., 826F<br />

Douaihy, B., 3349F*<br />

Doucet, T., 1229F<br />

Doudney, K., 967W*, 3440T<br />

Dougherty, B., 133, 503F<br />

Dougherty, M., 1861F*<br />

Douglas, G., 399<br />

Douglas, J., 1211F<br />

Douglas, S., 198<br />

Doulatov, S., 1193F<br />

Doumatey, A., 241, 1515T,<br />

1886F*<br />

Doumbo, O., 2255F, 3303T<br />

Doummar, D., 2770W<br />

Dousset, V., 716T<br />

Douyard, J., 1729W<br />

Dovč drnovšek, T., 3381T<br />

Dovigi, E., 3672W<br />

Dowdy, E., 1636T<br />

Dowling, N. F., 1304W<br />

Downie, J., 2982T<br />

Downing, J. R., 31<br />

Dowty, J. G., 141<br />

Doxiadis, G., 449F<br />

Doyle, A. J., 79*<br />

Doyle, J., 80<br />

Doyle, J. J., 79, 240<br />

Doyle, LW., 3484T<br />

Doyle, M. A., 1224W<br />

Dozmorov, I., 1901F<br />

Dozmorov, M., 549F<br />

Draaken, M., 1005W<br />

Drabant, E., 2565W<br />

Drabant, E. M., 2100W*<br />

Drack, A. V., 2671W<br />

Dragomir, C., 2954T<br />

Dragosky, M., 773W<br />

Drake, W. M., 780W<br />

Drapeau, P., 1910F<br />

Draper, D., 711F<br />

Drayna, D., 1956W, 1958F<br />

Drechsel, O., 2940F, 3661F<br />

Drehman, B., 1826F<br />

Drenos, F., 122, 1606T<br />

Dresbach, A., 2063F<br />

Dressen, A., 347, 492W,<br />

2603F<br />

Dreszer, T., 3557F<br />

Drévillon, L., 843F, 3157W,<br />

3241W*<br />

Drew, C., 262<br />

Drichel, D., 106<br />

Drigalenko, E., 1406W<br />

Drigalenko, E. I., 1282F<br />

Driman, D. K., 1138T<br />

Driscoll, D., 65<br />

Drnasin, K., 845F<br />

Drobnic, K., 3286F<br />

Drogemoller, B., 644T*<br />

Drohan, B., 2974T<br />

Droin, N., 2716W<br />

Droit, A., 1215W<br />

Drong, A., 3435T*<br />

Drongitis, D., 2629T<br />

Dror, A., 2914W<br />

Drory, V., 63<br />

Drost, J., 3350W*<br />

Drouin, V., 124<br />

Druker, H., 1055F*<br />

Drumm, M., 2953W<br />

Drumm, M. L., 1322W<br />

Drummond, J., 1257W<br />

Drunat, S., 3166F<br />

Drury, S., 1773W<br />

Drury, S. C., 1748W*<br />

Druschel, C. M., 2151W<br />

D’Souza, D., 1093T<br />

Du, L., 2998T<br />

Du, Q. Y., 1723W<br />

Duan, J., 1282F, 2576F<br />

Duan, Q., 622T*, 1427W*,<br />

2166W<br />

Duan, Y., 2910F<br />

Dubé, M., 1670T<br />

Dube, M.-P., 3401W<br />

Dubey, G. K., 588W<br />

Dubinsky, A. N., 508W*<br />

Dubois, B., 2086T<br />

Dubois, J., 2424W<br />

Dubois, S., 1951T<br />

Dubois d’Enghien, C., 1205F<br />

Dubourg, C., 2893W, 3170F<br />

Dubowsky, A., 1785W<br />

Dubra, A., 3212F<br />

Dubrovsky, M., 3345T<br />

Ducci, F., 1597T<br />

Ducker, S., 153<br />

Duclos, J., 1170W*<br />

Duda, P., 2561F<br />

Dudas, M., 3717F<br />

Dudding, T., 198, 3167W<br />

Dudek, S., 226, 1442W<br />

Dudekula, D. B., 1391W<br />

Dudley, J. T., 562W<br />

Dueker, N., 2614T*<br />

Dueker, N. D., 9, 2330F<br />

Duerr, R., 1942T<br />

Duerr, R. H., 1381F, 1466W,<br />

2319W<br />

Duffin, K. C., 1952F<br />

Duffy, E., 1754W<br />

Dufke, A., 2595W, 3109W<br />

Dufour, S., 842F<br />

Duga, B., 3283F<br />

Dugan-Rocha, S., 3<br />

Duggal, P., 1512T, 3393W,<br />

3616W*<br />

Duggan, D., 1608T<br />

Duggirala, A., 3455T<br />

Duggirala, R., 176, 1280W,<br />

1406W, 1513F, 1923W,<br />

2061W, 2308T, 2339F<br />

Dugueperoux, I., 1728W<br />

Duijkers, L., 216<br />

Duijts, L., 2168F<br />

Duker, A. L., 3150F<br />

Dulac, O., 202<br />

Dulencin, A., 2467T<br />

Dullea, K., 3671F<br />

Dumaine, A., 259<br />

Duman, D., 57<br />

Dumanski, J. P., 434W<br />

Dumas, K., 501F, 1687T*<br />

Dumas, L., 433F*<br />

Dumaz, N., 29<br />

Dumitrescu, L., 618T*,<br />

1608T, 1671T<br />

Dumitrescu, L. C., 2298W<br />

Dumitrescu, M., 3005T,<br />

3009T, 3067W*<br />

Dumitriu, A., 2227T*<br />

Dumonceaux, J., 2840T<br />

Dumont, B. L., 278<br />

Dunaif, A., 2327F<br />

Dunaway, K. W., 2783T<br />

Duncan, E. L., 2053T<br />

Duncan, G., 222<br />

Duncan, I., 2778F<br />

Duncan, J. S., 2741T<br />

Duncan, R. L., 2855T<br />

Duncan, S., 587F<br />

Duncavage, E., 3637F<br />

Duncombe, A., 390<br />

Dungan, J., 3541F<br />

Dunham, I., 35<br />

Dunivin, R., 3330T<br />

Dunlap, K., 1919F<br />

Dunlop, J., 1724W<br />

Dunlop, M., 1072T, 2072F,<br />

2366F<br />

Dunn, L., 1965W<br />

Dunn, S. H., 1715T<br />

Dunn, T., 3710W<br />

Dunning, A., 208, 1011W,<br />

1150T<br />

Dunning, A. M., 206, 209,<br />

210<br />

Duno, M., 702T<br />

Dunoe, M., 2765T<br />

Dunston, G., 1926W*,<br />

2043W<br />

Dupé, V., 2893W<br />

Dupérée, A., 778W<br />

Dupius, L., 3100F<br />

Duplomb, L., 2716W*,<br />

2770W<br />

DuPont, B. R., 2826F, 3052F


Dupont, J., 3165W<br />

Dupré, N., 1670T<br />

Dupuis, A., 2499W<br />

Dupuis, J., 269, 279,<br />

1346W, 2337W<br />

Dupuis, L., 103, 1738W*,<br />

3106F, 3183W<br />

Dupuis, S., 556W<br />

Duque, F., 2417F, 2502W<br />

Durakovic, Z., 1660T<br />

Durambure, C., 1090T<br />

Duran, K., 217, 400, 2886F<br />

Duran, P., 2705T<br />

Duran, R., 753T<br />

Durand, C., 841F<br />

Durand, E., 3386W<br />

Durand, E. Y., 179*<br />

Durán-González, J., 2363F<br />

Durán-McKinster, C., 872T,<br />

3040F<br />

Durasi, M., 2450F<br />

Durbin, R., 44, 252, 546W,<br />

1440T<br />

Durfee, T., 3671F<br />

Duriaux-Sail, G., 2937F<br />

Durie, P., 142, 2953W<br />

Durie, P. R., 1322W<br />

Durmaz, A., 965W<br />

Durmaz, B., 965W*, 3214F<br />

Durnall, J. C., 2816T<br />

Durr, A., 2539T, 2638T<br />

Dursun, A., 702T<br />

Durtschi, J., 2720T, 2951T,<br />

3638W*<br />

Durtschi, J. D., 3643F<br />

Duru, N., 984W<br />

Dutch National Board for<br />

DNA-Diagnostics (LOD),<br />

3650W<br />

Dutil, J., 996W, 1074W,<br />

1987T, 3360T, 3380W<br />

Dutra, A. R., 3045W<br />

Dutra, R., 896T, 899W<br />

Dutra-Clarke, A., 1159T<br />

Duttgupta, R., 1142F*<br />

Duzenli, S., 2956W*<br />

Duzkale, N., 1326T*<br />

Dvorakova, L., 570W<br />

Dvoskin, R., 1829W<br />

Dweik, D., 2919F<br />

Dworzynski, P., 2241W<br />

Dyack, S., 167, 2480F,<br />

3143W*<br />

Dyer, T., 1280W, 1513F<br />

Dyer, T. D., 176, 533F, 1406W,<br />

1923W, 2061W, 2146T,<br />

2308T, 2309F, 2339F<br />

Dykxhoorn, D., 489F<br />

Dykxhoorn, D. M., 588W<br />

Dyment, D. A., 1775W,<br />

2794W*<br />

Dzakula, Z., 3014T<br />

Dzenkeviciute, V., 920T<br />

Dzidic, N., 3054F<br />

E<br />

EAGLE, 2164T<br />

Eapen, V., 8<br />

*Presenting Author<br />

Earl, D., 466W, 2740W<br />

Earl, J., 1091F<br />

Early Growth <strong>Genetics</strong><br />

Consortium, 2067W,<br />

2097W, 2162F, 3028T<br />

East, C. E., 2309F<br />

Easton, D., 28, 205, 208,<br />

1001F, 1011W, 1214F<br />

Easton, D. F., 206, 207, 209,<br />

210, 1148F, 1150T<br />

Eaton, A., 1841W<br />

Eaton, M. L., 380, 3417T,<br />

3450T<br />

Eaton, W., 2541W<br />

Eaves, E., 3512T<br />

Eaves, L. J., 2277W<br />

Ebata, R., 1631T<br />

Ebbert, A., 2444F<br />

Ebel, C., 328<br />

Eberhardt, J., 2058W<br />

Eberle, M. A., 596W, 942T*<br />

Eberlein, K., 2557T<br />

Ebers, G., 2015F<br />

Ebert, P. J., 1235F<br />

Ebisawa, M., 2294F<br />

Ebrahim, S., 885W*, 1626T,<br />

3455T<br />

Ebrahimi, A., 1175F, 1615T,<br />

1961F, 1962W, 2964F,<br />

3197W*<br />

Ebran, J. M., 1790W<br />

Eccles, D., 1912T<br />

Eccles, M. R., 3440T<br />

Ece, A., 2719W<br />

Eck, S., 2922F<br />

Eck, S. H., 2557T, 3539F*<br />

Eckart, N., 2461T, 2486F*<br />

Eckert, G., 1969T<br />

Eckhold, J., 204, 2958F<br />

Eckl, K., 2869W*<br />

Ecklund, A., 2103W<br />

Eckman, P., 1665T<br />

ECLIPSE and COPDGene<br />

Coauthors, 2249F<br />

Edberg, J. C., 1979F<br />

Eddy, E., 1953W<br />

Edelman, E., 2974T*<br />

Edelmann, L., 652T, 958T,<br />

1777W, 3488T, 3724W<br />

Edelmann, S., 2663T<br />

Edelson, C., 390<br />

Edelson, V., 2974T<br />

Edenberg, H., 2598W<br />

Edgin, J., 2529W<br />

Edgren, H., 2888T<br />

Edie, S., 310*<br />

Edsall, C., 2611T<br />

Eduardo Arroyo-Pardo, E.,<br />

3364F<br />

Edwards, A., 105<br />

Edwards, B., 2649W<br />

Edwards, D., 2145W<br />

Edwards, D. C., 3735F*<br />

Edwards, K., 1848W,<br />

2538W<br />

Edwards, L. D., 2249F<br />

Edwards, R., 2581T<br />

Edwards, R. P., 993W<br />

Edwards, S., 209, 2006F<br />

Edwards, S. L., 210<br />

SPEAKER AND AUTHOR INDEX 353<br />

Edwards, T., 2063F, 2145W,<br />

3299W*<br />

Edwards, T. L., 2131T<br />

Edwards, Y., 2603F<br />

Eeles, R., 28, 205*, 1001F,<br />

1011W, 1109F, 1214F<br />

Eeles, R. A., 1148F<br />

EGEA Collaborative Group,<br />

1361W, 2079W, 2248T<br />

Egeland, T., 1547W<br />

Egertson, J., 10<br />

Eggens, V. R. C., 197*<br />

Egger, G., 2570F, 2575T<br />

Eggermann, T., 3111W<br />

Eggert, P., 3587F<br />

Eggert, S. L., 2056T*<br />

Ehm, M., 294, 1491T, 1686T<br />

Ehm, M. G., 476W, 641T,<br />

649T*, 3282T, 3406T<br />

Ehmke, B., 2058W<br />

Ehret, G., 1387F<br />

Ehret, G. B., 1639T<br />

Ehret, J. K., 3109W<br />

Ehrich, M., 3014T, 3016T<br />

Ehrlich, M. E., 2801T<br />

Ehrmann, D., 249<br />

Eicher, J. D., 1973F*, 2010W<br />

Eichler, E., 93, 98<br />

Eichler, E. E., 10, 12, 14, 74,<br />

94, 274, 278, 375, 2491T,<br />

3296W<br />

Eickholz, P., 2058W<br />

Eid, J., 477F<br />

Eidem, H., 316<br />

Eike, M. C., 3614W*<br />

Eikelboom, J., 617T<br />

Eiklid, K., 921W<br />

Eilbeck, K., 3637F<br />

Eilertson, K., 3361F<br />

Einarsdottir, E., 2023T,<br />

2177F*<br />

Eini, R., 1122W<br />

Eisenbarth, G., 1330F,<br />

3454T<br />

Eisenberg, D. T. A., 2036F*<br />

Eisinger, F., 1212W<br />

Eisman, J. A., 2176T<br />

Eisner, F., 1115F<br />

Eisner, G., 245<br />

Ek, J., 2765T*<br />

Ek, W. E., 2190W*<br />

Ekelund, E., 1939T<br />

Ekelund, U., 2359T<br />

Ekhilevitch, N., 3202F<br />

Ekici, A., 2557T, 3153W*<br />

Ekici, A. B., 2160W, 2356T,<br />

2595W, 2666T<br />

Eklund, L., 1611T<br />

Eklund, N., 2366F<br />

Ekong, R., 3322F<br />

Ekstrom, C., 1353T*<br />

El Agwany, A., 930T<br />

Elalaoui, S., 2937F<br />

Elamin, T., 3149W<br />

Elangovan, R., 771W<br />

Elazar, Z., 53<br />

Elbaik, L., 3149W<br />

Elbaz, R., 1922F<br />

Elbers, C., 283, 1606T,<br />

3303T<br />

Elboim, C., 1965W<br />

Elboudwarej, E., 1924T,<br />

3454T*<br />

El Chehadeh, S., 2716W<br />

El Chehadeh-Djebbar, S.,<br />

2729T*<br />

Elcioglu, N., 219<br />

Eldar-Geva, T., 2991T,<br />

2993T<br />

Elder, J. T., 154, 1952F<br />

Eldin, K., 661F<br />

Elemento, O., 376<br />

Elghezal, H., 944T<br />

Elhaik, E., 2305T*, 3329W,<br />

3377W<br />

El Hajj, N., 3266W<br />

El-Hattab, A., 163<br />

El Hokayem, J., 3129W*<br />

Elhosary, P. C., 266<br />

Elias, A. F., 658T*<br />

Elias, E., 238*<br />

Eliasson, S. C., 805F<br />

Elie, C., 72<br />

Eliou, M., 2905W<br />

El-Kannishy, G., 1922F*<br />

Elkhartoufi, N., 3240F,<br />

3246F<br />

Elkin, E., 1841W<br />

Ellard, S., 2704W, 2709F*,<br />

2935W, 3494T<br />

Elling, U., 110<br />

Ellinghaus, D., 1942T*,<br />

2103W, 2314T, 3583F<br />

Ellinghaus, E., 154, 2101T*<br />

Ellingson, M. S., 1058F<br />

Ellingwood, S., 886T<br />

Ellinor, P. T., 1585T<br />

Ellinwood, N. M., 695F,<br />

785W, 2717T*<br />

Elliott, A., 3681F<br />

Elliott, A. M., 3535F<br />

Elliott, H. R., 3455T*<br />

Elliott, K. S., 1948T*<br />

Elliott, P., 3435T<br />

Elliott, S., 727F<br />

Ellis, J., 2337W, 2525F<br />

Ellis, M. K., 1948T<br />

Ellison, J., 66<br />

Ellonen, P., 327, 897W, 2888T<br />

Ellsworth, D. L., 1649T*<br />

Ellsworth, R. E., 1002W,<br />

1780W<br />

Elmslie, F. V., 2896W<br />

El Saafi, S., 1949F<br />

Elsea, S. H., 103, 1717W<br />

El-Shanti, H., 2713W*,<br />

2728W, 2899W, 3140F<br />

ElShanti, H., 3526W<br />

ElSharawy, A., 515F*,<br />

2368T, 3224F<br />

Elshimali, Y., 1034F<br />

Elsner, G. L., 871W<br />

Elstein, D., 746T*, 788W<br />

Elston, R. C., Session 8<br />

Elton, L., 432W<br />

El Waly, B., 2457W*<br />

Elyaman, D., 2411F<br />

Emanuael, B., 1494T<br />

Emanuel, B., 65, 3038F<br />

Emberly, E., 3734W<br />

SPEAKER AND AUTHOR INDEX


354 SPEAKER AND AUTHOR INDEX<br />

eMERGE Network, 618T<br />

Emerging Team in Genomics<br />

in Screening, 149<br />

Emerson, C. P., Jr., 2962W<br />

Emerson, J., 171<br />

Emerson, R., 530W<br />

Emery, A. E., Session 68<br />

Emes, R., 809F<br />

Emh<strong>of</strong>f, J., 3680W, 3700W<br />

Emilsson, V., 1436W<br />

Emiroglu, M., 1<br />

Emond, M., 2346W<br />

Emond, M. J., 171*<br />

Emrick, L., 163*<br />

Emsley, R., 644T<br />

Encarnacion, M., 346<br />

Encha-Razavi, F., 77, 403,<br />

3240F<br />

ENCODE Project<br />

Consortium, 3291T<br />

Endele, S., 2595W<br />

Eng, C., 158, 898T, 1075T,<br />

1144T, 1716W, 3363T<br />

Eng, C. M., 314, 1735W,<br />

1742W*, 1757W, 1761W<br />

Eng, L., 1591T<br />

ENGAGE Consortium, 119,<br />

1308T, 2076W, 2175W<br />

ENGAGE (European<br />

Network for Genetic and<br />

Genomic Epidemiology)<br />

Consortium, 190<br />

Engelhardt, B., 372*<br />

Engelman, C., 1267T<br />

Engelman, C. D., 2020T*<br />

Engels, H., 2595W, 3109W<br />

Engle, E. C., 2928F<br />

Engle, J. L., 1016F*<br />

English, M. A., 824F<br />

Enjolras, O., 83<br />

Enjorlas, A., 1015T<br />

Enneman, A., 109<br />

Ennis, S., 2072F, 2283W,<br />

3494T<br />

Enns, G. M., 744T<br />

Enomoto, K., 1795W,<br />

2891T, 3091W*<br />

Enquobahrie, D., 584W,<br />

1284T, 1503T<br />

Enriquez Lencinas, L., 2033F<br />

Entelis, N., 329<br />

Enterline, D., 1919F<br />

EPIC Gastric Cancer<br />

Working Group, 987W<br />

Epigen-Brazil, 3562W<br />

Eppig, J. T., 2675T*<br />

Epping, E., 422W<br />

Eppsteiner, R. W., 60<br />

Erasmus, C. E., 160<br />

Erdem, G., 2852T<br />

Erdman, C. A., 2517W<br />

Erdman, L., 456W, 912T<br />

Erdmann, J., 115, 3453T<br />

Erez, A., 165*, 433F, 795W<br />

Ergul, E. A., 1746W, 1801W*<br />

Erhart, G., 3319F<br />

Erickson, E. A., 2442W*<br />

Erickson, R. L., 213<br />

Erickson, R. P., 2752W,<br />

2788W<br />

*Presenting Author<br />

Erickson, S., 1459F*<br />

Eriksson, F., 434W<br />

Eriksson, J., 109, 252, 656T,<br />

2059T, 2116T, 2134T,<br />

2162F, 2350T<br />

Eriksson, J. G., 2110T,<br />

2173T, 2366F<br />

Eriksson, M., 2427W<br />

Eriksson, N., 106, 114*,<br />

498W, 617T, 619T*, 626T,<br />

1017W, 1782W, 2087F,<br />

2089T, 2100W, 2111F,<br />

2115W, 2127W, 2149T,<br />

2565W<br />

Eriksson, P., 1651T, 3685F,<br />

3729F<br />

Erkan, D., 2330F<br />

Erkhembulgan, P., 3248F*<br />

Erlanger, B., 1229F<br />

Erlich, H. A., 3713F<br />

Erlich, Y., 333, 1797W*,<br />

3711F<br />

Erm, T., 1140W<br />

Ernst, A., 2862F<br />

Ernst, C., 554W, 2482T,<br />

2562W*, 3470T<br />

Ernst, F., 3701F<br />

Ernst, S., 1824F<br />

Ernster, M., 963W<br />

Erogullari, A., 204*<br />

Erraffi, K., 2899W<br />

Erte, I., 2138F<br />

Ertekin-Taner, N., 343<br />

Erturk, B., 2719W<br />

Esbensen, A., 1847W<br />

Escamilla, M., 2495F<br />

Escande, F., 3172F<br />

Escano, C., 245<br />

Escaramís, G., 2303F<br />

Eskenazi, B., 3458T<br />

Eskin, E., 39*, 180, 1337W,<br />

1341T, 1386T, 1480F,<br />

2262W, 3555F, 3598W,<br />

3623F, 3639F, 3657F<br />

Esko, T., 108*, 119, 154,<br />

584W, 1284T, 1308T,<br />

1503T, 1792W, 2076W,<br />

2137T, 2165F, 2241W,<br />

2366F, 3353W<br />

Eslamizadeh, S., 1056W<br />

Esmaeeli Nieh, S., 2389T*<br />

Esmall, A., 3700W<br />

Esmer, M. C., 3119W<br />

Esparza Gordillo, J., 1942T,<br />

2102F*<br />

Espay, A., 2538W<br />

ESP Blood Pressure Project<br />

Team, 1692T<br />

Espeseth, M., 1753W<br />

Espinosa, I., 1054T<br />

Espinosa-Parrilla, Y., 987W*<br />

Espinoza, K., 1658T, 2065T<br />

Esplin, E. D., 869W*<br />

Esplin, S., 1904F<br />

Esposito, C., 1060T<br />

Esposito, D., 3711F*<br />

Esposito, E., 505F<br />

Esposito, F., 624T, 2095T<br />

Esposito, T., 2916F*<br />

Essand, M., 434W<br />

Essioux, L., 242<br />

Ester, A., 952T<br />

Esterberg, E., 1869F<br />

Estes, A., 2406W<br />

Esteves, L. M., 2288F*<br />

Estivill, X., 84, 567F, 582W,<br />

2303F*, 2326T, 2940F<br />

Estour, B., 2278T<br />

Estrada, K., 109, 1334W,<br />

2053T, 2169W, 3608W<br />

Estrada, S. C., 707F<br />

Etain, B., 259<br />

Etchegary, H., 149, 150*,<br />

1827W<br />

Etemadi, A., 1076F<br />

Eubanks, J., 3509T<br />

Eun, B., 908T<br />

Euro, L., 327<br />

EUROBATS Consortium,<br />

546W<br />

European Network for<br />

Genetic and Genomic<br />

Epidemiology<br />

Consortium, 2137T<br />

Euskirchen, G., 3361F<br />

Euskirchen, G. M., 3368W<br />

Evangelou, E., 109<br />

Evans, D., 343, 1567F,<br />

2537F<br />

Evans, D. M., 351, 560W,<br />

1318F, 1528F, 1583W,<br />

2081F, 2164T, 2169W<br />

Evans, D. S., 2145W,<br />

2375F*<br />

Evans, D. W., 2439W<br />

Evans, J. P., 231<br />

Evans, M. D., 1270T<br />

Evans, P., 3540W*<br />

Evans, T., 3517T<br />

Evans, T. C., 3715F<br />

Evenson, M., 912T, 1028F<br />

Everhart, S. L., 1781W*<br />

Eversley, C., 1777W<br />

Evgrafov, O., 2444F<br />

Evrony, G. D., 266<br />

Evsyukova, I., 2454W<br />

Ewing, A. D., 466W*, 1229F<br />

Eyheramendy, S., 1336F*<br />

Eymard, B., 328<br />

Eyre, D. R., 222, 2853F,<br />

2854W<br />

Eyre, S., 2231F<br />

Eyries, M., 1170W<br />

Ezekowitz, M., 619T<br />

Ezekowitz, M. D., 617T<br />

Ezgu, F., 745F<br />

Ezzatizadeh, V., 761W<br />

F<br />

Faas, B. H. W., 955W<br />

Fabbri, H. C., 478W*<br />

Faber, C. G., 2448W<br />

Fabian, J., 969W<br />

Faccini, L., 1851F<br />

Facio, F. M., 316<br />

Factor, S., 2538W<br />

Fadel, H., 2930T<br />

Fadista, J., 47*, 2187W<br />

Fagerholm, R., 1171T*<br />

Fagundes de Carvalho, E.,<br />

3364F, 3402T<br />

Fahiminiya, S., 706T<br />

Fähling, M., 522W<br />

Fahn, S., 442W<br />

Failla, P., 100<br />

Fain, P., 3454T<br />

Fain, P. R., 1454W<br />

Fairfax, B. P., 373*, 563F<br />

Fairley, C., 3242F<br />

Faivre, L., 1293T, 2716W,<br />

2729T, 2770W, 2792T,<br />

3240F<br />

Fakhro, K. A., 2933T*,<br />

3399W<br />

Falah, N., 3030T*<br />

Falcão, R. P., 1045T<br />

Falcao-Alencar, G., 1147T,<br />

2243F<br />

Falconnet, E., 561F, 2937F<br />

Falik-Zaccai, T., 199*<br />

Falissard, B., 2545T<br />

Falk, M., 534W<br />

Falk, M. J., 330, 2943F*,<br />

3653F<br />

Falk, R., 300<br />

Fall, T., 108, 1624T*, 2358W<br />

Fallah, M. S., 3197W<br />

Fallahi-Sichani, M., 1162T<br />

Fallet-Bianco, C., 77<br />

Fallin, M. D., 343, 463F,<br />

1472W, 2563T<br />

Fallon, J., 2469W<br />

Fam, H. K., 2849T<br />

Fan, B., 1887W*<br />

Fan, J. B., 596W, 1193F,<br />

3451T<br />

Fan, J.-B., 942T, 1238F<br />

Fan, J.-H., 1010F<br />

Fan, J. H., 1076F<br />

Fan, S., 1369F<br />

Fan, W., 888T, 1110W*<br />

Fancher, K., 983F<br />

Fanen, P., 572W<br />

Fang, E., 399<br />

Fang, F., 3237W<br />

Fang, J., 1097F<br />

Fang, P., 337<br />

Fang, Q., 1878W*<br />

Fang, R., 3612W<br />

Fang, S., 1291F*, 1409W<br />

Fang, X., 3081W<br />

Fanganiello, R., 852F*<br />

Fann, C., 1557T<br />

Fann, C. S. J., 1380T, 3457T<br />

Fann, S. J., 2245T<br />

Fann, Y., 1774W<br />

Fannemel, M., 3096F<br />

Fanning, J., 3700W<br />

Fanous, A. H., 2500T<br />

Faraco, J., 2543F<br />

Faraone, S., 1498F<br />

Faraone, S. V., 2515T<br />

Faravashi, N., 975W<br />

Fardeau, M., 328<br />

Fardo, D., 1147T, 2243F<br />

Fare, T., 2220W<br />

Fares-Taie, L., 390<br />

Farez, T., 778W


Faria, R. G., 1903T<br />

Farias, F. H., 2847F<br />

Farias, T. D. J., 1405F<br />

Farina, G., 157<br />

Fariss, R. N., 824F, 2183F<br />

Färkkilä, M., 2023T, 2348F<br />

Farley, J., 1186T<br />

Farlow, J., 2556W*<br />

Farmaki, A., 2044T<br />

Farmaki, A. E., 3396T<br />

Farmer, A., 2703F*, 3727F<br />

Farnham, J. M., 1149W<br />

Farokhi, E., 2013W<br />

Farook, V. S., 2339F<br />

Farooqi, I. S., 43<br />

Farrall, M., 115, 1640T<br />

Farrell, J., 385, 2563T<br />

Farrer, L., 385*, 1571W,<br />

2207F, 2498F<br />

Farrer, L. A., 343, 344, 1305T,<br />

1476T, 2503T, 2511W,<br />

2528F, 2563T, 2621F<br />

Farrer, L. B., 2488T<br />

Farrer, M., 2537F<br />

Farrer, M. J., 346<br />

Farrow, E., 366<br />

Farrow, E. G., 2894T<br />

Faruque, M., 2043W<br />

Farwell, L., 1754W<br />

Fasquelle, L., 2685F<br />

Fast, S., 1371T<br />

Fatahi, F., 2008T*<br />

Fatemi, A., 2907F<br />

Fatemifar, G., 1528F*<br />

Fathalla, B., 2713W<br />

Fathi, D., 3163W<br />

Fattal-Valevski, A., 2447F<br />

Faucz, F., 1151F, 3055W*<br />

Faucz, F. R., 870T<br />

Faugère, V., 2947W<br />

Faulkner, G., 1229F<br />

Faury, D., 1182W<br />

Fava, V., 1899W<br />

Fava, V. M., 1978T, 2289W<br />

Favarin, M. C., 1045T<br />

Favaro, F., 2673F, 2746W*<br />

Favor, J., 1689T, 2684T<br />

Fawcett, G. L., 595F, 2413T*<br />

Fazio, S., 1634T<br />

Fazli, H., 860T<br />

Fecenko-Tacka, K., 853F<br />

Feehery, G. R., 3702W<br />

Feely, S. M. E., 1871F<br />

Feenstra, B., 1528F, 3028T<br />

Feenstra, I., 58<br />

Feger, C., 328<br />

Feguson, J., 1642T<br />

Fehrmann, R. S. N., 1284T,<br />

1503T<br />

Fei, J., 2985T<br />

Feigenbaum, A. S., 2759T<br />

Feinerman, B., 792W*<br />

Feingold, E., 22, 253, 1438F,<br />

1464T, 1474F, 2034W,<br />

2069F, 2142W, 2156F,<br />

2178W<br />

Feingold, M., 131<br />

Feitosa, M., 1920W<br />

Feitosa, M. F., 111, 1650T*,<br />

1913F, 2073W, 2275T<br />

*Presenting Author<br />

Fejerman, L., 1075T*<br />

Fejes, A., 3641F, 3662W<br />

Fejes, A. P., 2772F<br />

Feki, A., 67<br />

Feld, R., 1108T<br />

Felder, R., 245<br />

Feldhahn, M., 1200W,<br />

1233W<br />

Feldman, D., 998F<br />

Feldman, M. W., 1112F<br />

Feldmesser, E., 2875W<br />

Feliciani, C., 745F<br />

Feliperamirez, D., 3036F<br />

Felix, J., 111<br />

Felix, J. F., 2073W<br />

Felix, S. B., 1503T<br />

Felix, T., 2270F*<br />

Felix, T. M., 2746W<br />

Fellay, J., 2050T<br />

Fellmann, F., 2877F<br />

Fellous, M., 3345T<br />

Felsenfeld, A., 1845W<br />

Feng, B., 2545T<br />

Feng, F., 1004F<br />

Feng, G., 1666T<br />

Feng, H., 2420F<br />

Feng, J. S., 2985T<br />

Feng, Q., 647T<br />

Feng, S., 521F, 1444F,<br />

1568W*, 3541F*<br />

Feng, T., 1376W*<br />

Feng, Y., 3509T<br />

Fenizia, F., 1060T<br />

Fenton, J., 2767W<br />

Fenwick, A. L., 218<br />

Feolo, M., 3330T, 3582W,<br />

3625F<br />

Ferasin, S., 2708T<br />

Ferec, C., 1728W*<br />

Fereira, J. A., 2395T<br />

Feret, H., 2904F<br />

Ferguson, B., 595F<br />

Ferguson, C. J., 2471F<br />

Ferguson, J., 2204F, 3551F<br />

Ferguson, N., 1065W<br />

Ferlazzo, E., 2780T<br />

Fermano, Z., 2381F<br />

Fernandes, A., 1968W,<br />

2017T<br />

Fernandes, B., 994T<br />

Fernandes, G. R., 776W,<br />

1202F<br />

Fernandes, J. K., 1662T<br />

Fernandes, R., 1747W<br />

Fernandes, S., 2982T<br />

Fernandez, B., 175<br />

Fernandez, B. A., 2575T,<br />

3086F<br />

Fernandez, C., 2274W<br />

Fernandez, L., 196*, 2389T<br />

Fernandez, P., 3332W<br />

Fernandez, T. V., 2602T<br />

Fernandez-Lopez, J. C.,<br />

3255T*<br />

Fernández-Rhodes, L.,<br />

2042F<br />

Fernh<strong>of</strong>f, P., 1679T<br />

Ferrandino, A., 334<br />

Ferrannini, E., 1624T<br />

Ferrante, D., 1153T<br />

SPEAKER AND AUTHOR INDEX 355<br />

Ferrara, A., 2140T<br />

Ferrari, C., 299<br />

Ferrari, I., 903W, 961W<br />

Ferraris, A., 943W, 2777T<br />

Ferrat, F., 2866W<br />

Ferraz-de-Souza, B., 361<br />

Ferreira, A. C. S., 182, 1573F<br />

Ferreira, C. A., 2813T<br />

Ferreira, M. A. R., 2161T,<br />

2323T*<br />

Ferreira, R., 1343W, 3600W<br />

Ferreira, R. C., 2091W<br />

Ferreira, R. G. M., 2352W<br />

Ferreira, S. G., 814F<br />

Ferreira, T., 108, 119, 1308T,<br />

1954T*, 2076W, 2123F,<br />

2137T, 2147F<br />

Ferreira, Z., 3306T*<br />

Ferreira-Gonzalez, A.,<br />

3512T<br />

Ferreiro, A., 2945T<br />

Ferrell, R., 2960T<br />

Ferrell, R. E., 1963T<br />

Ferrer, X., 716T<br />

Ferrer Admetlla, A., 3311W*<br />

Ferrero, I., 2810T<br />

Ferrer-Torres, D., 3254W<br />

Ferretti, V., 135<br />

Ferriero, R., 164*<br />

Ferrucci, L., 1391W, 2148W<br />

Ferry, K. M., 2999T<br />

Fert-Bober, J., 80<br />

Fertrin, K. Y., 2751F<br />

Ferwerda, B., 283<br />

Fesel, C., 1979F<br />

Festen, E. M., 1503T<br />

Fetni, R., 2866W<br />

Fett-Conte, A. C., 2270F<br />

Feuer, E., 1543F<br />

Feuk, L., 2920W, 3728W<br />

Fialho, S. C. M. S., 1405F<br />

Fichera, M., 100, 3114F<br />

Ficicioglu, C., 705F<br />

Field, L. L., 1936T<br />

Fielding, S., 1773W<br />

Fields, S., 311<br />

Fierro-Rodriguez, D. A.,<br />

3187W<br />

Fietze, I., 2568W<br />

Figarella-Branger, D., 328<br />

Figlin, R. A., 651T<br />

Figueira, P., 2385W<br />

Figuera, L. E., 650T, 1111T,<br />

1128W<br />

Figueroa, A., 3350W<br />

Figueroa, J., 1117T, 2296T<br />

Figueroa, J. D., 1091F<br />

Filges, I., 3044F*, 3109W<br />

Filho, R. C. C., 3130F<br />

Filhol, E., 324<br />

Filichev, V. V., 3440T<br />

Filipescu, G. A., 2728W<br />

Filippi, T., 881W, 3050F<br />

Filippova, G., 2634W<br />

Filippova, G. N., 55<br />

Filosa, S., 2629T<br />

Finch, S. J., 1338T, 1359T<br />

FIND Consortium, 1914W<br />

FIND Research Group,<br />

1348F<br />

Finegold, D., 2960T*<br />

Finelli, M. J., 2649W<br />

Fingerlin, T., 433F<br />

Fingert, J. H., 2750T<br />

Finkbeiner, S., 2643W<br />

Finkel, R., 1702T<br />

Finnerup, N. B., 2369F<br />

Fiocchi, C., 1466W<br />

Fiorentino, F., 71*<br />

Fiorillo, E., 1516F<br />

Fiorito, G., 1153T, 1712T<br />

Firinu, D., 1516F<br />

Firl, R., 1267T<br />

Firmino, A., 1946F<br />

Firth, H., 101, 291, 364<br />

Firth, H. V., 3109W<br />

Fisch, A. S., 602T*<br />

Fisch, G., 3092F*<br />

Fischbeck, K. H., 2470T<br />

Fischer, A., 2103W*, 3224F<br />

Fischer, J., 1952F<br />

Fischer, K., 190, 1792W*,<br />

1954T, 2123F, 2144F,<br />

2147F, 2175W, 3353W<br />

Fischl, B., 2444F<br />

Fish, A., 2321F*<br />

Fish, A. E., 1286W<br />

Fishbein, M., 1685T<br />

Fisher, D., 144<br />

Fisher, J. A., 3708W<br />

Fisher, L., 2184W<br />

Fisher, S. A., 968T<br />

Fisher, T., 316<br />

Fisher-Hoch, S. P., 2048F,<br />

2345F<br />

Fishman, E., 80<br />

Fishman, L., 1738W<br />

Fishman, S. J., 83<br />

Fitzgerald, K., 2430W<br />

FitzGerald, O., 2160W<br />

Fitzgerald, T., 101, 364,<br />

455F<br />

Fitzgerald, T. W., 291*<br />

Fitzgerald-Butt, S., 1680T<br />

Fitzgerald-Butt, S. M.,<br />

1646T<br />

Fitzpatrick, A. L., 1653T<br />

FitzPatrick, D., 4, 101, 291,<br />

364, 3072F<br />

Flachsbart, F., 515F, 1943F*,<br />

2295W, 2303F<br />

Flaman, J.-M., 1090T*<br />

Flanagan, J., 732T<br />

Flanagan, J. M., 2331W*<br />

Flanagan, S., 3494T<br />

Flanagan, S. E., 2704W,<br />

2709F<br />

Flannagan, J. M., 648T<br />

Flannery, K. C., 1769W<br />

Flannick, J., 169, 172*,<br />

1677T, 2209T<br />

Flax, J., 2381F<br />

Fleming, A., 361<br />

Fleming, F., 422W<br />

Fleming, M. R., 202<br />

Fleming, M. T., 1878W<br />

Fletez-Brant, C., 545F<br />

Flexeder, C., 2167T<br />

Flicek, P., 464W, 497F,<br />

3636W, 3732W<br />

SPEAKER AND AUTHOR INDEX


356 SPEAKER AND AUTHOR INDEX<br />

Flickinger, M., 1448W*<br />

Flierl, A., 803W<br />

Flint, J., 105, 355<br />

Flodman, P., 1791W<br />

Flogelova, H., 845F<br />

Florendo, D., 2466W<br />

Florendo, D. J. A., 2473T<br />

Florentin-Arar, L., 539F<br />

Florer, J. B., 736T*<br />

Flores, C., 2296T<br />

Flores, D., 2495F<br />

Flores, R., 2711T, 3084F<br />

Florez, J., 249, 2307W<br />

Florez, J. C., 50, 269<br />

Florian, I. S., 849F<br />

Florin, A. T., 1145F<br />

Floyd, J., 1518T*<br />

Fluiter, K., 197<br />

Flutre, T., 273*<br />

Flyvbjerg, A., 2070W, 2358W<br />

Foco, L., 2039F<br />

Fode, P., 1323T<br />

Fogarty, M. P., 46, 1627T,<br />

<strong>2012</strong>F*<br />

Fogarty, S., 2395T<br />

Fogarty, Z. C., 3564W<br />

Foisy, S., 1678T, 1982F*<br />

Fojtík, P., 2865F<br />

Fok, A. S. L., 821F<br />

Fokkema, I. A. C., 3610W<br />

Fokkema, I. F., 3611F<br />

Fokstuen, S., 2877F, 2937F<br />

Foley, A. R., 2812W<br />

Foley, J., 3037W<br />

Foley, R., 2945T<br />

Folk, J. C., 2750T<br />

Folkersen, L., 1651T<br />

Folseraas, T., 2101T<br />

Fölster-Holst, R., 1939T<br />

Folwaczny, M., 2058W<br />

Fombonne, E., 175<br />

Fomous, C., 1762W<br />

Fong, J. C., 2639F*<br />

Fong, J. H., 300<br />

Fong, K., 2971T<br />

Fonseca, A. C. S., 874T*,<br />

882T<br />

Fonseca, S. A. S., 882T<br />

Fonseca-Kelly, Z. D., 1756W<br />

Fonseka, C. Y., 444W<br />

Fontana, E., 2795T<br />

Fontanillas, P., 169, 176,<br />

269<br />

Fontes, A. M., 1045T<br />

Fontes, F., 1977W<br />

Foo, J. N., 1934F*, 2055W<br />

Footz, T., 575F*<br />

Forabosco, A., 847F<br />

Ford, B., 442W<br />

Ford, J., 2043W<br />

Foreman, M. G., 1425T<br />

Forestier, E., 1023W, 1024T,<br />

1035W, 3427T<br />

Forge, A., 2663T<br />

FORGE Canada Consortium,<br />

131, 2772F, 2790F, 2794W,<br />

2800W, 3127W<br />

FORGE Consortium, 701F<br />

Forman, E. J., 2999T<br />

Forman, J., 2354F<br />

*Presenting Author<br />

Forman-Neall, L., 1859F<br />

Fornage, M., 350, 1592T,<br />

2210F, 2269T<br />

Fornarino, S., 3304F<br />

Forni, S., 1684T<br />

Foroud, T., 2136W, 2531F,<br />

2556W<br />

Foroud, T. M., 343, 2511W<br />

Forouhi, N. G., 1626T<br />

Forrest, G., 1605T<br />

Forrester, T., 2158T<br />

Forsberg, L. A., 434W*<br />

Forsberg, R., 3641F, 3662W<br />

Forsblom, C., 2307W<br />

Forsmark, L., 3685F<br />

Forsstrom, L., 2888T<br />

Forster, M., 3583F<br />

Forsythe, E., 3211W*<br />

Fortes, F., 1102T<br />

Fortner, M., 474W<br />

Fortugno, P., 2760F<br />

Fortuna, A., 913W*<br />

Forzano, F., 131<br />

Fosdal, I., 2699T<br />

Foskett, T. J., 824F<br />

Fosså, S. D., 991T<br />

Foster, B., 368<br />

Foster, C., 2043W<br />

Foster, J. G., 103<br />

Foster II, J., 57<br />

Fostira, F., 1191W*, 1228T<br />

Fotia, G., 823F<br />

Foulkes, W., 28, 1001F,<br />

1262F, 3595F<br />

Foulkes, W. D., 1065W,<br />

1214F<br />

Founds, S. A., 1884W<br />

Fountzilas, G., 1228T<br />

Fowler, B., 1874F<br />

Fowler, S. P., 2339F<br />

Fowler, V. G., Jr., 1323T<br />

Fox, A. S., 2413T<br />

Fox, C., 2337W<br />

Fox, C. S., 1954T, 2030F,<br />

2123F, 2147F<br />

Fox, E., 2063F<br />

Fox, E. R., 1677T<br />

Fox, J. E., 884T<br />

Fracasso, N. C. A., 3280F<br />

Frackelton, E., 319, 1996T,<br />

1997F, 2229W, 2252F,<br />

2722W, 2785W*, 2856F,<br />

2872W, 2892F, 2904F,<br />

3573F<br />

Frade, A. F., 1593T<br />

Fraga, L. R., 3031T<br />

Fragata, A., 1593T<br />

Framstaller, P. P., 2116T<br />

França, M. C., Jr., 2609F,<br />

2653T<br />

Francalacci, P., 3377W<br />

Francannet, C., 894T<br />

Francelle, L., 259<br />

Franceschini, N., 111,<br />

1437T, 1599T, 1913F,<br />

2042F, 2063F, 2073W*,<br />

2145W, 2336F, 2337W<br />

Francioli, L., 459F<br />

Francis, R. M., 3419T<br />

Francisco, V., 2085W<br />

Francis-West, P., 814F<br />

Francke, U., Session 57,<br />

114, 1017W, 1782W*,<br />

2089T, 2100W, 2111F,<br />

2115W<br />

Franco, A., 2234F<br />

Franco, B., 808F, 2810T,<br />

2955F<br />

Franco, L. M., 337, 2158T,<br />

2189F*<br />

Francois, G., 2002T<br />

François, S., 716T<br />

Franek, B. S., 2046W<br />

Frank, J., 2087F<br />

Frank, M. B., 529F, 2188T<br />

Franke, A., 154, 515F,<br />

1939T, 1942T, 2058W,<br />

2101T, 2102F, 2103W,<br />

2303F, 2314T*, 2315F,<br />

2319W, 2368T, 3224F,<br />

3583F<br />

Franke, B., 243, 306, 621T,<br />

1498F<br />

Franke, L., 108, 461F, 523F,<br />

1284T, 1330F, 1503T,<br />

1621T, 2088W<br />

Frankel, W. L., 1173W<br />

Frankish, A., 367, 506W<br />

Franklin, C., 2082W*<br />

Franklin, N., 743F*<br />

Frankowski, H., 2628W<br />

Franks, P., 249, 2187W<br />

Franks, P. W., 117, 1954T,<br />

2123F, 2147F<br />

Fransen, E., 59, 2104T*,<br />

2948T<br />

Fransen, K., 461F<br />

Frants, R., 2107T<br />

Franzil, A. M., 692T<br />

Frase, A., 1442W, 3542W*<br />

Frase, A. T., 3624W<br />

Fraser, D., 630T, 1491T<br />

Fraser, R. M., 1383T<br />

Frasson, M. C., 3107W*<br />

Fraumeni, J., 1012T<br />

Frauscher, B., 2567F,<br />

2568W<br />

Frayling, T., 269, 584W,<br />

1284T, 1503T, 1513F<br />

Frayling, T. M., 108, 176,<br />

1624T, 1923W, 2148W,<br />

2241W, 2308T, 2339F<br />

Frazer, K., 3307F<br />

Frazer, K. A., 395, 1051T<br />

Frebourg, T., 32, 345,<br />

1090T, 1212W, 1222T,<br />

3538W<br />

Frederickson, K., 1242W<br />

Fredrich, M., 740T*<br />

Fredrickson, K., 2301W<br />

Freebairn, L., 1295W<br />

Freedland, S., 1185W<br />

Freedman, B., 1706T, 2332T<br />

Freedman, B. I., 1648T,<br />

1661T, 1879T, 1979F,<br />

2046W, 2310W<br />

Freedman, M. L., 1231T<br />

Freedman, N. D., 1010F,<br />

1076F<br />

Freedman, S., 2328W<br />

Freeman, A. C., 2805F<br />

Freeman, C., 1031F<br />

Freeman, N., 2608T<br />

Freeman, S. B., 3042F<br />

Freese, D. K., 718T<br />

Freeze, H. H., 1758W<br />

Freidin, M. B., 2271W*<br />

Freimer, N., 252, 1480F,<br />

2262W, 2343W<br />

Freimer, N. B., 2222F, 2320T<br />

Freisinger, P., 699F, 782W,<br />

2917W<br />

Freitas, E. L., 439F, 891W*,<br />

961W<br />

Freitas, I. S., 1902W<br />

Freitas, J., 3656W<br />

Freitas, L. G., 3130F<br />

Frelin, L., 3374W<br />

French, J., 210<br />

French, J. D., 209<br />

French, S., 981W<br />

French LFS Working Group,<br />

1090T<br />

Freppon, D., 893W<br />

Freudenberg, J., 306,<br />

3403W*<br />

Frey, M. K., 1272W<br />

Frias, S., 875W*, 928T,<br />

956T, 960T, 1048T,<br />

1049F<br />

Frías, S., 976T<br />

Frick, S. L., 2860W<br />

Fridley, B., 139, 603T<br />

Fridley, B. L., 1247F,<br />

1426F*, 3451T<br />

Fridman, C., 1629T*, 2706F<br />

Friedburg, M., 3142F<br />

Frieden, I., 2926W<br />

Friederich, M., 2884W<br />

Friedlander, C., 3652W*<br />

Friedländer, M., 567F<br />

Friedlnader, C., 3619F<br />

Friedman, B., 3163W<br />

Friedman, D. S., 2154W,<br />

2240F<br />

Friedman, E., 3336T*,<br />

3345T<br />

Friedman, J. M., 1840F,<br />

1846W<br />

Friedman, J. S., 2183F<br />

Friedman, L., 2919F<br />

Friedman, R., 2104T,<br />

2184W<br />

Friedman, S. D., 2530T<br />

Friedman, T. B., 2724F<br />

Friend, K., 198<br />

Friez, M. J., 2901F<br />

Frints, S. G. M., 215<br />

Frisch, E., 699F<br />

Fritsch, C., 580W<br />

Froguel, P., 2162F<br />

Frolenkov, G. I., 2663T<br />

Froment, A., 283, 3303T,<br />

3338W<br />

Fromer, M., 290, 1325W,<br />

2577W, 2618F<br />

Frommolt, P., 2861T<br />

Fronick, C., 2325W<br />

Frost, J. M., 3501T<br />

Frucht, S., 442W


Frumkin, A., 3048F<br />

Fry, A., 124<br />

Fry, G., 3717F<br />

Frydman, M., 2919F<br />

Frydman, N., 72<br />

Frydman, R., 72<br />

Frye, M., 605T, 2516F<br />

Fryns, J. P., 124<br />

Fryssira, H., 84, 2937F<br />

Fryzek, J., 1565W<br />

Fu, A., 3707F<br />

Fu, A. Q., 1580W*<br />

Fu, B., 438W<br />

Fu, C., 2850F<br />

Fu, J., 523F<br />

Fu, R., 443F<br />

Fu, W., 10, 283<br />

Fu, Y., 3483T<br />

Fu, Y.-H., 2581T, 2779W<br />

Fu, Y. H., 2423F, 2610W,<br />

2667F<br />

Fu, Y. P., 1092W<br />

Fu, Y.-P., 1091F*<br />

Fucci, L., 3492T<br />

Fuchs, H., 1919F<br />

Fuchs, T., 2801T*<br />

Fuchsberger, C., 46, 88*,<br />

172, 176, 1513F, 1923W,<br />

2308T, 2339F<br />

Fuentes-Fajardo, K., 359,<br />

2610W, 2938W, 3543F<br />

Fuji, N., 726T<br />

Fujii, N., 2400W<br />

Fujimoto, A., 396*<br />

Fujio, K., 1984T<br />

Fujioka, R., 2647T<br />

Fujioka, Y., 2472W<br />

Fujita, H., 2071T<br />

Fujita, K., 52, 3221W<br />

Fujita, M. Q., 1321F<br />

Fujita, P., 3557F<br />

Fujita, R., 3377W<br />

Fujita, Y., 3230F<br />

Fujiwara, T., 2400W<br />

Fukai, K., 3146F<br />

Fukao, A., 1549F<br />

Fukuda, S., 559F<br />

Fukuda, Y., 2409W, 2569T<br />

Fukumaki, Y., 2400W,<br />

2647T*<br />

Fukushi, D., 2748F<br />

Fukushima, Y., 2758W,<br />

3043W, 3230F<br />

Fuller, A., 332<br />

Fuller, C., 2246F*<br />

Fuller, J., 2933T, 3399W<br />

Fullerton, S. M., 1828F*<br />

Fulmer-Smentek, S., 922T,<br />

975W, 3726W<br />

Fulp, J., 1061F<br />

Fulton, L. L., 2587T<br />

Fulton, R., 484W*, 1210T,<br />

2325W<br />

Fulton, R. S., 244, 2587T<br />

Fumagalli, M., 3289F,<br />

3312T*<br />

Fun, J., 1859F<br />

Funalot, B., 2694F<br />

Funanage, V. L., 2855T<br />

Funato, F., 755W<br />

*Presenting Author<br />

Funayama, M., 1730W,<br />

2559W, 3134F, 3221W<br />

Funke, B. H., 1677T, 1754W<br />

Furey, T. S., 292<br />

Furge, K. A., 1186T<br />

Furlan, L., 825F<br />

Furlotte, N., 1337W, 3598W*<br />

Furtado, G. V., 2424W,<br />

2626T, 2642F<br />

Furth, S. L., 2121W<br />

Furukawa, M., 3513T<br />

Furuya, H., 2400W*<br />

Furuya, N., 1795W, 2891T<br />

Fusco, C., 775W, 3087W,<br />

3256F<br />

Fusco, F., 505F, 2629T<br />

Fusco, I., 2827W<br />

Futerman, A. H., 2869W<br />

Futscher, B. W., 3712W<br />

Fuwa, M., 2129F<br />

Fuzzell, D., 3335W<br />

Fylaktou, I., 2995T<br />

G<br />

Gaál, E. I., 1253F<br />

Gaasterland, D., 2154W,<br />

2240F, 2263T<br />

Gaasterland, T., 2154W,<br />

2240F, 2263T<br />

Gaba, C., 1454W<br />

Gabelle, A., 2638T<br />

Gabelli, C., 2775F<br />

Gabis, G., 660T<br />

Gaborieau, V., 1012T,<br />

1496W<br />

Gabriel, L. A. R., 3130F*<br />

Gabriel, S., 8, 280, 322,<br />

1490W, 1725W<br />

Gabriel, S. B., 1677T,<br />

2613W<br />

GABRIEL and EArly<br />

<strong>Genetics</strong> and Lifecourse<br />

Epidemiology Consortia,<br />

2168F<br />

Gaddis, N., 2114F<br />

Gaddis, N. C., 2170T<br />

Gadelha, A., 2533T, 2534F<br />

Gadi, I., 949W<br />

Gadi, I. K., 3113W<br />

Gaede, K. I., 2103W<br />

Gaedigk, R., 811F<br />

Gaffney, D., 3507T<br />

Gaffney, D. J., 153<br />

Gaffney, P., 1901F<br />

Gaffney, P. M., 306, 549F,<br />

566W, 2046W, 2084F<br />

Gage, F. H., 436W<br />

Gagliardi, M., 2763F,<br />

2766F*, 2774T, 2780T<br />

Gahl, W., 359, 755W,<br />

2610W<br />

Gahl, W. A., 709F, 711F,<br />

1702T, 2442W, 2838F,<br />

2870T, 2938W, 3080F,<br />

3543F<br />

Gai, X., 1756W, 2884W,<br />

2943F, 3653F*<br />

Gaieski, D. F., 3329W<br />

SPEAKER AND AUTHOR INDEX 357<br />

Gaieski, J., 3373F<br />

Gaieski, J. B., 3329W*,<br />

3377W<br />

Gail, M. H., 1314T<br />

Gaillard, D., 403, 3241W<br />

Gaillard, R., 2081F<br />

Gaillon, T., 3157W<br />

Gaio, V., 1968W*, 2017T<br />

Gajecka, M., 934T*<br />

Galabov, A., 3481T<br />

Galanello, R., 2001W<br />

Galanter, J. M., 158, 3385F<br />

Galanther, J., 3363T<br />

Galarneau, G., 1906T,<br />

2247W*<br />

Galas, D. J., 195<br />

Galasko, D., 340<br />

Galavotti, R., 2548T<br />

Galaxy Development Team,<br />

3545F<br />

Galaxy Team, 3547F<br />

Galea, S., 435F<br />

Galeone, D., 2766F<br />

Galesi, O., 100<br />

Galhano, E., 3019T<br />

Galimberti, D., 2095T<br />

Galindo, P., 694T<br />

Gall, A., 2163W<br />

Gall, T. R., 3543F*<br />

Gallagher, C. J., 1016F,<br />

1107W<br />

Gallagher, L., 2770W<br />

Gallagher, R. C., 3133W*<br />

Gallant, N. M., 712T*<br />

Gallardo, M., 546W<br />

Gallego Romero, I., 3322F<br />

Gallegos, L. P. C., 3064F<br />

Gallegos, M., Jr., 1111T*<br />

Gallegos, M. P., 1077W,<br />

1127F, 1128W<br />

Gallentine, W. B., 3<br />

Gallinger, S., 141, 1067F,<br />

1079F, 1093T, 1206W,<br />

3478T<br />

Gallo, C., 3327T<br />

Gallo, E., 80<br />

Galluzzi, G., 1776W<br />

Galusca, B., 2278T<br />

Galvez-Peralta, M., 2800W<br />

Gamazon, E., 613T, 2333F<br />

Gamazon, E. R., 269, 424W,<br />

623T, 1003T, 1495F,<br />

2192F, 2196W*, 2197T<br />

Gambardella, A., 2763F,<br />

2766F, 2774T, 2780T<br />

Gambin, A., 432W, 485F<br />

Gambin, T., 432W, 485F*,<br />

898T<br />

Gambineri, E., 3114F<br />

Game, L., 1618T, 2005T<br />

Gameiro, C., 572W<br />

Gamez, J., 2930T<br />

Gámez-Nava, J. I., 2363F<br />

Gammill, H. S., 74, 94<br />

Gammon, A. D., 1058F<br />

Gan, X., 355*<br />

Gandhi, M. K., 1042T<br />

Gandolfi, B., 3252T<br />

Gandy, A., 3518T<br />

Gandy, S., 940T<br />

Ganesh, S., 1663T<br />

Ganesh, S. K., 1408F,<br />

1639T*, 1659T<br />

Gangnon, R., 1267T<br />

Ganguly, A., 140, 391*<br />

Ganguly, B. B., 3010T*<br />

Ganguly, T., 140, 391<br />

Ganna, A., 2105F*<br />

Gantz, B. J., 2301W<br />

Gao, C., 824F<br />

Gao, F., 125, 3415T*<br />

Gao, G., 1354F*, 1410T,<br />

3442T, 3452T, 3604W<br />

Gao, H., 1112F*, 1369F,<br />

2358W*<br />

Gao, J., 1558F*<br />

Gao, L., 1900T, 2043W<br />

Gao, X., 221, 1004F,<br />

2153F*, 2217W, 3108F*<br />

Gao, Y., 36<br />

Gao, Z., 285<br />

Gapstur, S., 205<br />

Gapstur, S. M., 1091F<br />

Garbanati, J., 753T<br />

Garbarini, J., 65<br />

Garbes, L., 236<br />

Garcia, L., 2360F<br />

Garcia, M., 834F, 839F,<br />

2145W, 2165F<br />

García, N., 987W<br />

Garcia, R., 946T*<br />

Garcia, V., 54<br />

Garcia-Barceló, M.-M., 408,<br />

1930T*, 2066F, 2932W,<br />

3123W<br />

Garcia-Blanco, M. A.,<br />

2454W<br />

Garcia-Closas, M., 206,<br />

1091F, 1117T, 1150T<br />

García-Closas, R., 1091F<br />

García-Cruz, D., 3187W,<br />

3188F<br />

Garcia-Figueroa, J., 682T<br />

Garcia Garcia, G., 2947W<br />

Garcia-Guzman, A., 3062F*<br />

Garcia-Hernandez, N.,<br />

1168T<br />

García-Miñaúr, S., 126, 217<br />

García-Ortiz, H., 48<br />

García-Robaina, J. C.,<br />

2296T<br />

García Robles, R., 2990T<br />

Gardeitchik, T., 672T<br />

Garden, G. A., 2628W<br />

Gardner, J., 1291F<br />

Gardner, J. C., 3212F<br />

Gardner, R., 1263W<br />

Gardner, S., 1874F, 3579F<br />

Garg, N., 1587T, 1598T<br />

Garg, P., 3516T<br />

Garg, V., 195<br />

Garge, N., 1392T<br />

Garnai, S., 2135F<br />

Garner, J., 3582W, 3625F<br />

Garraway, L. A., 402<br />

Garrec, C., 1204T*<br />

Garrett, M., 531F*<br />

Garrett, M. E., 2340W<br />

Garrett, T., 2041T<br />

Garrett-Bakelman, F., 3464T<br />

SPEAKER AND AUTHOR INDEX


358 SPEAKER AND AUTHOR INDEX<br />

Garrido, L. M., 1343W,<br />

2352W<br />

Garrido, M. A. H., 1018T<br />

Garrison, E., 41*<br />

Garrison, N., 1813W*<br />

Gartioux, C., 2436W<br />

Garvey, W. T., 1662T, 3371W<br />

Garwood, M., 821F<br />

Gary, D. S., 545F<br />

Gasanova, V., 1181F<br />

Gascon, G. G., 8<br />

Gaspar, H., 2928F<br />

Gaspar, H. B., 1748W<br />

Gaspard, H., 129<br />

Gasparini, P., 1484W,<br />

2128T, 2366F<br />

Gasperini, M., 263<br />

Gass, M., 2360F<br />

Gassmann, M., 3705F*<br />

Gastier-Foster, J., 456W<br />

Gastier-Foster, J. M., 912T<br />

Gates, H. L., Jr., 2087F<br />

Gatinois, V., 936T*<br />

Gatti, R. A., 790W<br />

Gat-Viks, I., 322<br />

Gau, C., 1736W<br />

Gauderman, W. J., 2153F<br />

Gaudet, M., 208<br />

Gaudi, S., 2564F<br />

Gaudreault, N., 1655T<br />

Gauguier, D., 1640T<br />

Gaulton, K., 176, 1513F<br />

Gaulton, K. J., 172, 1519F,<br />

1627T, 2324F*<br />

Gautel, M., 2945T<br />

Gauthier, J., 2306F, 2338T,<br />

2342F, 2558F<br />

Gauthier, M.-P., 532W, 3684W<br />

Gautier, E., 1293T<br />

Gauvin, H., 1478W*<br />

Gavier, M., 1834F<br />

Gawrieh, S., 441F, 1667T<br />

Gayagay, T., 3167W<br />

Gaynor, J. W. G., 2443T<br />

Gayther, S., 139, 210<br />

Gayther, S. A., 1156T<br />

Gazave, E., 183<br />

Gazdar, A., 1454W<br />

Gazula, V., 202<br />

Gazzellone, M. J., 2575T<br />

Gbeha, E., 2266T, 3260W,<br />

3268F, 3341W<br />

Ge, B., 256, 394, 569F,<br />

1207T, 1215W, 3514T<br />

Ge, D., 53, 2335T<br />

Ge, J., 2403W*, 3544W*<br />

Ge, M., 661F<br />

Ge, R. L., 3378T<br />

Gearhart, J., 3704W<br />

Gecz, J., 2629T<br />

Gécz, J., 2640W<br />

Gee, H. Y., 406<br />

Geer, J., 33<br />

GEFOS Consortium, 109,<br />

1334W<br />

Gehrig, C., 561F, 2877F<br />

Gehring, W., 2430W<br />

Geiger, E. A., 819F, 2884W<br />

Geigl, J. B., 1063T*, 1115F,<br />

3116F<br />

*Presenting Author<br />

Geiser, H., 3656W<br />

Geiss, G., 1039T*<br />

Gejman, P. V., 1282F, 2576F<br />

Gekas, J., 3060F, 3071W*<br />

GELAC Study Group, 989F<br />

Gelb, B. D., 82<br />

Gelb, M. H., 727F<br />

Gelber, S., 3012T<br />

Gelernter, J., 2207F, 2497T,<br />

2503T*, 2621F<br />

Geller, F., 1528F, 3028T*<br />

Gellera, C., 2764W, 2775F*<br />

Gelley, L., 3316F<br />

Gelman, A., 53<br />

Geloso, M. C., 2235W<br />

Gelowani, V., 61, 63*<br />

Gemelos, G., 3018T<br />

Gemma, A., 1697T<br />

GENCODE Consortium, 367<br />

Generation Scotland, 1618T<br />

Genereux, D. P., 1580W<br />

Genes in Schizophrenia<br />

(GENESIS) Consortium,<br />

2600F<br />

GENESIS Consortium, 1624T<br />

Genetic Analysis <strong>of</strong> Psoriasis<br />

Consortium, Wellcome<br />

Trust Case Control<br />

Consortium 2, 154<br />

Genetic Consortium for<br />

Anorexia Nervosa,<br />

Wellcome Trust Case<br />

Control Consortium 3,<br />

2522F<br />

Genetic Disorders <strong>of</strong><br />

Mucociliary Clearance<br />

Consortium, 2851W<br />

Genetic Investigation <strong>of</strong><br />

ANthropometric Traits<br />

Consortium, 2123F,<br />

2241W<br />

Genetic Investigation <strong>of</strong><br />

ANthropometric Traits<br />

(GIANT) Consortium,<br />

1954T<br />

<strong>Genetics</strong> <strong>of</strong> Obesity-Related<br />

Liver Disease<br />

Consortium, 2275T<br />

<strong>Genetics</strong> <strong>of</strong> Type-2 Diabetes<br />

Consortium, 88<br />

GENEVA Alcohol<br />

Consumption Working<br />

Group, 2228F<br />

Genevieve, D., 2386T,<br />

3121W, 3166F<br />

Geng, L., 2840T<br />

Geng, Z., 1542T*<br />

Genick, U. K., 1281T<br />

GENIE Consortium, 2307W<br />

Génin, E., 2126F, 3328F,<br />

3408T*<br />

Genographic Consortium,<br />

3329W, 3349F, 3373F<br />

GenoMEL Consortium, 211<br />

Genome <strong>of</strong> the Netherlands<br />

Consortium, 459F<br />

Genome Reference<br />

Consortium, 464W<br />

Genome-Wide Association<br />

Studies <strong>of</strong> Prostate<br />

Cancer in African<br />

<strong>American</strong>s, 1324F<br />

Genomics and Randomized<br />

Trials Network ( GARNET),<br />

123<br />

Genovese, G., 284*, 2618F<br />

GenTAC Consortium, 1700T<br />

GenTAC Investigators,<br />

1743W<br />

Gentry, R. C., 9<br />

Gentschew, L., 1943F<br />

Genuardi, M., 1130F<br />

George, A., 1302T<br />

George, B., 931W<br />

George, E., 1019F<br />

George, M. F., 1289W*,<br />

1301W<br />

George, P., 967W<br />

George, V., 3418T<br />

Georges, M., 256<br />

Geppert, M., 3364F, 3402T<br />

Geraedts, J. P. M., 2996T<br />

Gerafi, S., 858T<br />

Geraghty, E., 2890W*<br />

Geraghty, M. T., 160, 701F*,<br />

719F<br />

Gerard, M., 2887W<br />

Gerards, M., 708T<br />

Gerber, S., 324, 390<br />

Gerdes, M. G., 2443T<br />

Gerety, S., 101, 364<br />

Gerfen, J., 338*<br />

Gerges, N., 1182W<br />

Gerhard, G. S., 2078F<br />

Gerhart, D., 140<br />

Gerig, G., 2529W<br />

Gerkes, E., 126<br />

Germain, D. P., 772W*, 890T<br />

Germain, N., 2278T<br />

Gerrits, M. M., 2448W*<br />

Gerry, N., 966T<br />

Gerry, N. P., 632T<br />

Gersak, K., 2929W<br />

Gershenwald, J., 1291F<br />

Gershon, E. S., 1957T<br />

Gerstein, M., 334, 551F,<br />

2444F, 3251W<br />

Gerstein, M. B., 41, 280<br />

Gertz, E. M., 1958F<br />

Gervin, K., 3510T<br />

Geschwind, D., 553F, 2444F,<br />

2479T<br />

Geschwind, D. H., 2478W,<br />

2518T, 2551T, 2639F,<br />

2658W, 2779W, 3487T<br />

Geske, J., 605T<br />

Gesualdo, L., 845F<br />

Getts, B. C., 1142F<br />

Getz, G., 25, 368, 402<br />

Geuvadis Consortium, 567F,<br />

582W<br />

Gevers, D., 537F<br />

Geyer, C. R., 3488T<br />

Ghaderibarim, F., 2150F<br />

Ghaffarpour, M., 1056W*,<br />

1124F<br />

Ghamsari, L., 2660F<br />

Ghandour, H., 3700W<br />

Gharanei, S., 2767W*<br />

Gharani, N., 632T*<br />

Gharavi, A. G., 845F<br />

Gharib, S., 584W<br />

Gharib, S. A., 1284T, 1503T<br />

Gharizadeh, B., 398<br />

Ghassibe, M., 1640T*, 2002T<br />

Ghatreh, K., 2008T<br />

Gheno, T. C., 2424W,<br />

2626T, 2642F<br />

Ghezzi, A., 2095T<br />

Ghezzi, D., 699F<br />

Ghia, E., 395<br />

Ghiban, E., 2587T, 3316F<br />

Ghiggeri, G. M., 845F<br />

Ghimbovschi, S., 3249W<br />

Ghorab, K., 328<br />

Ghosh, A., 1413T*<br />

Ghosh, A. K., 2680W<br />

Ghosh, J., 971W<br />

Ghosh, K., 1572T<br />

Ghosh, M., 918T<br />

Ghosh, S., 1297F<br />

Ghoshal, U. C., 1137W<br />

Ghoumid, J., 843F*, 3157W,<br />

3241W<br />

Ghoussaini, M., 205, 206,<br />

209*<br />

Giacalone, G., 2095T<br />

Giacobini, M., 188<br />

Giacomini, K. M., 246<br />

Giambartolomei, C., 122,<br />

1621T*<br />

Gianfrancesco, F., 2916F<br />

Giannotta, S., 3415T<br />

GIANT Consortium, 108,<br />

1387F, 2074T, 2090F,<br />

2147F, 2210F<br />

Giardina, E., 2160W<br />

Giardine, B., 3545F*<br />

Gibb, A., 3440T<br />

Gibbens, B., 2645F<br />

Gibbon, S., 3327T<br />

Gibbons, P., 3331F<br />

Gibbons, R., 418W*<br />

Gibbs, J. R., 2148W, 2611T<br />

Gibbs, R., 121, 174, 183,<br />

349, 595F, 1520W,<br />

1585T, 1592T, 1599T,<br />

1854F, 2802F, 2880F,<br />

2934F, 3209W, 3597F<br />

Gibbs, R. A., 3, 244, 314,<br />

360, 648T, 1221W,<br />

1231T, 1735W, 1742W,<br />

1757W, 1761W, 2413T,<br />

2577W, 2798T, 2864T,<br />

2881W, 2883F, 2908W,<br />

3576W<br />

Gibbs, R. J., 564W<br />

Gibson, G., 31, 2779W<br />

Gibson, J., 531F, 2072F<br />

Gibson, Q., 602T<br />

Gibson, R., 2537F<br />

Gibson, R. L., 171<br />

Gibson, W., 2797W<br />

Giedd, J., 433F<br />

Giedraitis, V., 434W<br />

Gieger, C., 110, 190, 1942T,<br />

2086T, 2103W, 2160W,<br />

2175W, 2226W, 2568W<br />

Giffen, C., 1218W<br />

Gigarel, N., 72


Gigek, C. O., 1132T, 3421T,<br />

3503T<br />

Giger, T., 561F<br />

Gignoux, C., 3360T<br />

Gignoux, C. R., 158*, 1425T,<br />

3385F<br />

Gigot, N., 2716W, 2729T,<br />

2792T<br />

Gijselinck, I., 2815W<br />

Gil, A., 1968W, 2017T<br />

Gil, G. P., 426W, 2718F<br />

Gil, L., 3732W<br />

Gilad, Y., 2*, 1514W, 2031W,<br />

3251W<br />

Gilbert, D., 75*<br />

Gilbert, J., 2135F, 2637W,<br />

3706W<br />

Gilbert, J. R., 9, 341, 347,<br />

2378F, 2445W, 2572T,<br />

2583W*, 2586W, 2614T<br />

Gilbert-Dussardier, B., 77<br />

Gilbey, M., 1147T<br />

Gilboa, T., 2993T<br />

Gil-da-Silva-Lopes, V.,<br />

1865F, 2270F<br />

Gil-da-Silva-Lopes, V. L.,<br />

959W, 1903T<br />

Gileadi, O., 219<br />

Giles, G., 28, 205<br />

Giles, G. G., 1148F, 1213T,<br />

1214F<br />

Gilfillan, G. D., 3510T<br />

Gilfix, B. M., 673F<br />

Gilissen, C., 97, 100, 125,<br />

160, 214, 672T, 1749W*<br />

Gilissen, C. F. H. A., 1734W<br />

Gilkeson, G. S., 1662T,<br />

1979F, 2046W, 3371W<br />

Gill, D. F., 614T<br />

Gillanders, E., 1543F<br />

Gillanders, E. M., 211<br />

Gillani, N., 1377T, 1928F<br />

Gillani, N. B., 1316W<br />

Gillen, D., 1493W<br />

Gillessen-Kaesbach, G.,<br />

204, 219, 2925F, 2958F<br />

Gilliam, D., 2805F*<br />

Gilliaux, M., 3098F<br />

Gillis, A. J. M., 1122W<br />

Gillis, J., 447F, 3568W<br />

Gillis, L., 79<br />

Gillis, T., 1964F<br />

Gillisen, C., 216<br />

Gillson, C., 1686T<br />

Gilman, R., 1119W<br />

Gilman, R. H., 3325F<br />

Gilmore, B. L., 2636F<br />

Gilmour, K. C., 1748W<br />

Gilsanz, V., 812F<br />

Gimelli, S., 67, 2937F<br />

Gimigliano, A., 2695W<br />

Gindlesperger, A., 3011T*<br />

Ginno, P., 552W<br />

Ginsburg, G. S., 147<br />

Ginty, D. D., 308<br />

Ginzinger, D., 256<br />

Gioia, J., 3717F<br />

Giordano, J. L., 3012T*<br />

Giordano, M., 1153T,<br />

2827W<br />

*Presenting Author<br />

Giorgini, F., 2641T<br />

Giorgio, E., 550W*<br />

Giovannoni, G., 2015F<br />

Giovannucci Uzielli, M. L.,<br />

3114F<br />

Girard, M., 522W, 936T,<br />

2386T, 3121W, 3166F<br />

Girard, S., 3268F, 3401W*<br />

Girard, S. L., 2558F, 2591F<br />

Giraud, S., 1212W<br />

Giri, N., 1196F<br />

Girimaji, S. C., 2776W<br />

Girirajan, S., 12, 14*, 98,<br />

2491T<br />

Girisha, K. M., 3173W<br />

Girling, A., 1257W<br />

Girodon, E., 572W, 1768W,<br />

1874F*<br />

Girodon, F., 2716W<br />

Giste, E., 255<br />

Giudicessi, J. R., 2885T<br />

Giuffre, A., 3669F, 3709F<br />

Giugliani, C., 1851F<br />

Giugliani, R., 685F*, 691F,<br />

747F, 772W, 879W,<br />

1851F, 2425T<br />

Giulianini, F., 51<br />

Giuliano, F., 124<br />

Giurdanella, M. C., 1712T<br />

Giurgea, I., 843F, 894T,<br />

3157W, 3241W<br />

Gjessing, H. K., 213<br />

Gladman, D., 154, 448W,<br />

1952F<br />

Glahn, D., 2061W<br />

Glahn, D. C., 1923W<br />

Glaser, A., 1612T<br />

Glaser, R. L., 3154F<br />

Glaser, T., 2926W<br />

Glasheen, C., 2114F, 2170T<br />

Glash<strong>of</strong>f, R. H., 3332W<br />

Glaspy, J. A., 136<br />

Glass, D., 44, 546W, 583F,<br />

1440T, 2143T<br />

Glass, I., 2789T, 2890W<br />

Glass, M., 727F<br />

Glassford, M., 1860F<br />

Glavač, D., 3381T, 3422T*<br />

Glazer, N. L., 2080T<br />

Gleeson, J., 267<br />

Gleeson, J. G., 3581F<br />

Glenn, G., 132<br />

Glenn, S. B., 529F, 1979F,<br />

2188T<br />

Glentis, S., 1228T<br />

Glessner, J., 2229W, 2492F,<br />

3546W*<br />

Glessner, J. T., 1996T,<br />

2121W, 2389T<br />

Gliedt, T., 3664W<br />

GliomaScan Consortium,<br />

1372F<br />

Global Lipids <strong>Genetics</strong><br />

Consortium, 117<br />

Glodzik, D., 1481W*<br />

Gloeckner, C. J., 86<br />

Glogowski, E., 1841W<br />

Glorieux, F. H., 3169W<br />

Glotzbach, C., 934T<br />

Glover, T., 2879T<br />

SPEAKER AND AUTHOR INDEX 359<br />

Glover, T. W., Session 22,<br />

339<br />

Glunk, V., 3536W<br />

Glusman, G., 195<br />

Gnirke, A., 322, 1725W<br />

Go, M., 1657T<br />

Go, M. J., 49<br />

Goate, A., 2228F, 2582F,<br />

2598W, 2650T<br />

Goate, A. M., 340, 342, 343<br />

Gobert, D., 56<br />

Gocan, H., 849F<br />

Gockel, I., 2088W<br />

Godard, A. L. B., 2655W<br />

Godbole, K., 911W<br />

Goddard, G. H. M., 1329T<br />

Goddard, K. A. B., 1869F*<br />

Goddard, M., 1360F<br />

Goddard, M. E., 108,<br />

1331W<br />

Godefroy, O., 3117W<br />

Godeiro, C., 2642F<br />

Godfraind, C., 1611T<br />

Godfraind, P.-L., 1015T<br />

Godfrey, M., 1856F*<br />

Godi, M., 2827W<br />

Godley, L. A., 3472T<br />

Godson, C., 2307W<br />

Goecks, J., 3547F*<br />

Goel, N., 2592W<br />

Goel, P., 1715T<br />

Goeman, J. J., 542W,<br />

1436W<br />

Goes, F. S., 2180F, 2305T<br />

Goetz, M., 1247F<br />

Goetzman, E., 657F<br />

G<strong>of</strong>f, C. L., 3167W<br />

G<strong>of</strong>f, D. J., 1051T<br />

G<strong>of</strong>frini, P., 2810T<br />

Goin-Kochel, R., 759W*<br />

Goin-Kochel, R. P., 299,<br />

2439W<br />

Goizet, C., 716T*, 2674W<br />

Goj, V., 845F<br />

Gokcumen, O., 3251W,<br />

3310F<br />

Goker-Alpan, O., 693F,<br />

713F, 768W*, 769W<br />

Goksen, D., 3206F<br />

Golalipour, M. G., 1096T<br />

Golan, D., 1797W, 3711F<br />

Golbus, J. R., 1614T, 1683T<br />

Gold, B., 1242W<br />

Gold, J. A., 3068F*<br />

Gold, K. F., 2452T<br />

Gold, N. B., 326<br />

Goldberg, A., 2577W,<br />

3351T*<br />

Goldberg, R., 3<br />

Goldbladtt, M., 1667T<br />

Goldblatt, J., 1216T<br />

Golden, D. M., 968T<br />

Goldenberg, A., 390, 1551T,<br />

2203T*<br />

Goldgar, D., 1492F<br />

Goldgar, D. E., 1067F,<br />

1213T<br />

Goldin, L. R., 30*, 2191T<br />

Goldlust, I. S., 66*<br />

Goldman, D., 2574W<br />

Goldmann, O., 2251T<br />

Goldmuntz, E., 65<br />

Goldschmeding, R., 2848W<br />

Goldschmidt-Clermont, P.,<br />

1644T<br />

Goldsmith, C. L., 1775W*<br />

Goldstein, A., 330, 1076F,<br />

1517W<br />

Goldstein, A. M., 211,<br />

1010F, 1218W*<br />

Goldstein, D., 53, 235<br />

Goldstein, D. B., 203,<br />

2050T, 2335T, 2455T,<br />

2552F, 2875W<br />

Goldstein, J., 2618F, 3644W<br />

Goldstein, J. I., 290*<br />

Goldstein, L. E., 2528F<br />

Goldstein, P., 3529F<br />

Goldwaser, T., 1793W*,<br />

3022T<br />

Golinker, E., 3202F<br />

Golka, K., 1335T<br />

Gollub, J., 493F, 1142F<br />

Golmard, L., 1205F*<br />

Golovleva, I., 1024T<br />

Golozar, A., 1076F*<br />

Golshani, R., 969W<br />

Golub, M. S., 2783T<br />

Golzio, C., 98, 2458T*,<br />

3296W<br />

Gombojav, B., 1654T*<br />

Gomes, C., 913W<br />

Gomes, V., 3364F, 3402T<br />

Gomez, H. T., 926T<br />

Gomez, L., 3509T<br />

Gomez, R., 3373F, 3377W<br />

Gómez-Almaguer, D., 1030T<br />

Gómez-Vázquez, M. J., 48,<br />

3255T<br />

Gomy, I., 3250F<br />

Goncalves, F. T., 2706F*<br />

Goncalves, J., 2982T<br />

Gonçalves, V., 628T<br />

Gonçalves, V. F., 2376W*<br />

Goncalves-Dornelas, H.,<br />

3107W, 3110F<br />

Goncalves Serra, E., 45<br />

Gonder, M. K., 3306T<br />

Gondim, C. S. E., 747F<br />

Gong, F., 909W<br />

Gong, H., 501F<br />

Gong, L., 633T*, 635T<br />

Gong, T.-W., 1878W<br />

Gong, Y., 2210F<br />

Gong, Z., 1369F<br />

Gonggalanzi, G., 3317W<br />

Gonik, M., 2483F<br />

Gonsales, M., 2393F*<br />

Gonsales, M. C., 2233T<br />

Gonsalves, S., 358, 1690T<br />

Gonsalves, S. G., 1696T<br />

Gonzaga-Jauregui, C., 360,<br />

485F, 2798T*<br />

Gonzaga-Jauregui, C. G.,<br />

2881W, 2883F, 2908W<br />

Gonzales, M., 77, 3129W<br />

Gonzalez, A. J., 1627T<br />

González, C. A., 987W<br />

Gonzalez, D., 362, 1750W<br />

Gonzalez, G., 3425T<br />

SPEAKER AND AUTHOR INDEX


360 SPEAKER AND AUTHOR INDEX<br />

Gonzalez, J., 703F, 2940F<br />

Gonzalez, K., 2907F<br />

Gonzalez, K. D., 2698W,<br />

2895F, 3065W*<br />

Gonzalez, M., 57, 1681T,<br />

2615F*, 2820F, 3364F<br />

Gonzaléz, M., 3402T<br />

Gonzalez, P., 521F, 3521T<br />

Gonzalez, R., 3327T<br />

González, R., 2296T<br />

Gonzalez, S., 2495F<br />

González-Andrade, F.,<br />

3364F, 3402T<br />

Gonzalez Berjon, J., 893W<br />

Gonzalez Burchard, E.,<br />

1075T, 3360T, 3380W<br />

Gonzalez-Herrera, L., 2272T*<br />

González-Llano, O., 1030T<br />

González-López, L., 2363F<br />

González-Mercado, A.,<br />

2363F*, 3188F<br />

González-Mercado, M. G.,<br />

3188F*<br />

Gonzalez-Neira, A., 206<br />

Gonzaludo, N., 620T*<br />

Good, B. M., 3584W<br />

Goodall, A. H., 3453T<br />

Goodarzi, M. O., 1916F*,<br />

2080T<br />

Goode, E., 139<br />

Goode, E. L., 210, 1238F,<br />

3451T<br />

Goode, M., 2544W<br />

Goodier, J., 336*<br />

Goodloe, R., 1316W,<br />

1377T*, 1671T, 2041T<br />

Goodman, N., 2643W<br />

Goodrich, J., 537F<br />

Goodrich, J. K., 2029T*<br />

Goodrich, M., 3465T<br />

Goodridge, D., 3713F<br />

Goodship, J. A., 219<br />

Goodwin, A., 3242F*<br />

Goodwin, E. H., 948T<br />

Goodwin, L., 843F<br />

Goossens, M., 572W, 843F,<br />

894T, 1768W, 1796W,<br />

2727F, 3157W, 3241W<br />

Gopalakrishnan, R., 529F,<br />

2188T<br />

Gopie, J., 1788W<br />

Göraler, S., 2107T<br />

Gordeuk, V., 3297T<br />

Gordish-Dressman, H.,<br />

2452T<br />

Gordon, A., 71<br />

Gordon, A. S., 244*, 301<br />

Gordon, C., 126*, 3172F<br />

Gordon, D., 1338T, 1358W,<br />

1359T<br />

Gordon, E. S., 632T<br />

Gordon, L., 245<br />

Gordon, L. B., 2879T<br />

Gordon, L. N., 606T*<br />

Gordon, P., 3141W, 3665F<br />

Gordon, S. D., 2133W<br />

Gordon-Larsen, P., 1467T,<br />

1913F<br />

Gorelenkov, V., 1762W<br />

Gorelik, L., 2561F<br />

*Presenting Author<br />

Gorin, M. B., 1963T<br />

Goring, H. H. H., 533F,<br />

1406W, 2061W<br />

Göring, H. H. H., 1280W,<br />

1282F*, 1458T, 2651F<br />

Goris, A., 2086T<br />

Gorkin, D. U., 258*<br />

Gorman, K., 2234F*<br />

Gormley, P., 1325W<br />

Gornall, H., 2452T<br />

Gorsic, L. K., 614T<br />

Gorvel, J. P., 1949F<br />

Gosendi, M. E., 129<br />

Gospe, S. M., Jr., 167<br />

Goss, G., 135<br />

GoT2D Consortium, 172,<br />

173, 1519F, 2324F<br />

GoT2D Investigators,<br />

1373W, 1389T<br />

Gotlib, J. R., 1017W<br />

Goto, J., 52, 233, 2409W,<br />

2569T<br />

Goto, S., 52<br />

Goto, Y., 234, 1722W<br />

Gotoh, L., 234<br />

Gotta, L., 2520W<br />

Gottipati, S., 183<br />

Gottlieb, B., 398*<br />

Gottschalk, W., 2465F<br />

Götz, A., 327<br />

Goubran-Botros, H., 259<br />

Goudefroye, G., 77<br />

Goudet, P., 1293T<br />

Goudy, S., 2762T<br />

Gougerot-Pocidalo, M.-A.,<br />

2716W<br />

Gould, D. B., 1689T, 2684T<br />

Gould, E., 3724W<br />

Goulet, J.-P., 2266T, 3268F,<br />

3341W<br />

Goumy, C., 894T<br />

Gourraud, P., 2113T, 3330T*<br />

Gourraud, P.-A., 2039F,<br />

2049W, 2350T<br />

Gouttard, S., 2529W<br />

Gouveia, M., 3325F<br />

Gouya, L., 56<br />

Govi, M., 1776W<br />

Govil, M., 1315F*, 2178W<br />

Gowda, H., 3316F<br />

Gowher, A., 329<br />

Gowrisankar, S., 1754W<br />

Goyal, S., 1891T, 2730F*,<br />

3696W<br />

Goyette, P., 1678T, 2319W*<br />

Graber, E., 3033T<br />

Grabowska, E., 2587T<br />

Grabowski, G., 789W<br />

Grabowski, G. A., 161,<br />

690T, 736T, 749F<br />

Grabs, R., 5<br />

Grace, N. M., 1625T<br />

Gracia, G., 1876F<br />

Grad, I., 67<br />

Grad, R., 1852F<br />

Grady, W., 144<br />

Graetz, C., 2058W<br />

Graf, E., 699F, 2557T,<br />

2567F, 2595W, 2917W,<br />

2922F<br />

Graf, J., 200<br />

Grafe, I., 2854W<br />

Graff, M., 1467T, 1913F<br />

Graff-Radford, N., 343<br />

Grafodatskaya, D., 3420T,<br />

3456T*, 3489T<br />

Graham, B., 661F, 676T*,<br />

2395T, 2942T<br />

Graham, B. H., 667F<br />

Graham, J. M., Jr., 3185W<br />

Graham, M., 3331F<br />

Graham, R., 306, 342<br />

Graham, R. R., 2091W<br />

Grahn, R. A., 3252T<br />

Grallert, H., 2116T, 2595W,<br />

3536W<br />

Granberg, C., 2845W<br />

Grandchamp, B., 29, 56,<br />

1062W<br />

Granell, R., 2167T<br />

Grangeiro, C. H. P., 941W,<br />

2813T<br />

Grant, G., 290, 1919F<br />

Grant, R., 118, 3142F<br />

Grant, R. W., 2140T<br />

Grant, S., 2067W, 2121W,<br />

2229W, 2252F<br />

Grant, S. F. A., 812F,<br />

1307W*, 1915T, 1997F<br />

Grarup, N., 2311T, 2317T*,<br />

2347T<br />

Grassh<strong>of</strong>f, U., 3109W<br />

Gratacòs, M., 2303F, 2593T<br />

Grattau, Y., 84<br />

Graubert, T., 1203W<br />

Graubert, T. A., 301, 1408F<br />

Graul-Neumann, L., 2760F<br />

Gravel, S., 3352F*, 3360T,<br />

3361F, 3380W, 3390T,<br />

3563F<br />

Graves, T., 375, 464W, 465F<br />

Graves, T. A., 3296W<br />

Gravitt, P., 1076F<br />

Gray, J. J., 308<br />

Gray, J. W., 984W<br />

Greally, M. T., 100<br />

Greco, D., 100, 1265F,<br />

3631F*<br />

Greco, F., 1776W<br />

Greely, H., Session 20<br />

Green, D., 3688W<br />

Green, E., 3306T<br />

Green, J., 1066T, 1084T<br />

Green, M. R., 1042T<br />

Green, R. C., Session<br />

73, 317, 343, 1781W,<br />

1825W*, 2488T, 3635F<br />

Green, T., 1454W<br />

Greenawalt, D., 1624T<br />

Greenberg, K., 1859F<br />

Greenberg, M. E., 452W,<br />

2613W<br />

Greenberg, S. M., 1689T<br />

Greenblatt, M. S., Session 4<br />

Greene, A. M., 1269W<br />

Greene, C. S., 1501F<br />

Greene, M. H., 210, 213<br />

Green Snyder, L., 2439W<br />

Greenspan, B., 3377W<br />

Greenspan, E., 3377W<br />

Greenwood, C., 1411F<br />

Greenwood, J., 1791W*<br />

Greer, D., 480W<br />

Greer, S. N., 1046F<br />

Greer, T., 876T*, 3154F*<br />

Greger, V., 1729W, 3640W,<br />

3680W<br />

Gregersen, N., 657F<br />

Gregersen, P., 461F<br />

Gregersen, P. K., 306<br />

Gregor, A., 2666T<br />

Gregory, B., 1642T, 3551F<br />

Gregory, B. L., 500W*<br />

Gregory, P. D., 255, 803W<br />

Gregory, S., 1919F, 3541F<br />

Gregory, S. G., 1444F,<br />

1636T, 2340W, 2454W*<br />

Gregoski, M., 1715T<br />

Greisenegger, S., 1603T<br />

Grenier, J.-C., 31, 2266T,<br />

3268F, 3341W<br />

Grenier, J. C., 3260W<br />

Grether, J., 7<br />

Grether, P., 875W, 928T,<br />

956T, 960T<br />

Gretz, N., 1612T<br />

Gribaa, M., 1751W, 2744T<br />

Gribaldo, L., 1877F<br />

Gribble, S., 101, 291<br />

Grice, D. M., 916T<br />

Griebel, T., 567F, 582W<br />

Griesi Oliveira, K., 2414F*<br />

Griffen, C., 1010F<br />

Griffin, H., 751F<br />

Griffith, S., 3644W, 3716W,<br />

3731F<br />

Griffiths, C. E. M., 154<br />

Griffiths, L. R., 1042T,<br />

1912T*, 2916F<br />

Grigorenko, E., 334<br />

Grill, D. E., 1426F<br />

Grillo, E., 2604W<br />

Grimaldi, L., 2095T<br />

Grimholt, R. M., 643T<br />

Grinberg, L. T., 919W<br />

Grindle, S., 1665T<br />

Grioni, S., 1712T<br />

Gripp, K. W., 124<br />

Grisart, B., 3098F<br />

Griskevicius, L., 1208F<br />

Griswold, A. J., 2445W,<br />

2572T*, 2614T<br />

Griswold, B., 1663T<br />

Griswold, B. F., 3231W<br />

Grochowski, C., 2316W<br />

Grocock, R., 1238F, 3663F<br />

Grocock, R. J., 366<br />

Grody, W. W., 130, 315<br />

Groen, J. L., 200<br />

Groen-Blokhuis, M., 2097W<br />

Groenendaal, F., 3164F<br />

Groeneveld, M. P., 33<br />

Groessner-Schreiber, B.,<br />

2058W<br />

Gr<strong>of</strong>, P., 2338T<br />

Gr<strong>of</strong>fen, A., 98<br />

Gr<strong>of</strong>fen, S., 3200F<br />

Grohé, C., 2103W<br />

Gronberg, H., 205, 1148F<br />

Grønskov, K., 363*


Groom, A., 3455T<br />

Groop, L., 47, 2187W<br />

Groop, P.-H., 2307W<br />

Gropman, A., 239<br />

Gropman, A. L., 330<br />

Gros, P., 649T<br />

Gross, M. D., 2337W<br />

Gross, N., 2568W<br />

Gross, V., 2447F<br />

Grossfeld, P., 870T<br />

Grossman, R., 176, 1513F<br />

Grossman, T. R., 804W*<br />

Grossse-Wortmann, L.,<br />

3186F<br />

Groth, J., 3242F<br />

Grotmol, T., 991T<br />

Grove, M. L., 1445W*<br />

Grover, M., 3209W<br />

Groves, A. K., 840F<br />

Grozeva, D., 2576F<br />

GRS Team, 983F<br />

Grubb, J., 786W<br />

Grubb, R., 1012T<br />

Grubert, F., 371, 551F*,<br />

3411W, 3505T<br />

Gruen, J. R., 1973F, 2010W<br />

Grumbt, B., 3539F<br />

Grummel, V., 2086T<br />

Grundberg, E., 44, 583F,<br />

3441T*<br />

Grunenwald, H., 3697F<br />

Grünewald, A., 200, 204,<br />

672T<br />

Grunewald, J., 2103W<br />

Grünfeld, T., 3614W<br />

Grunstad, J., 176, 1513F<br />

Grydholt, J., 3641F, 3662W<br />

Gschwind, A., 415F<br />

GTEx Consortium, 368<br />

Gu, C. C., 1468F<br />

Gu, D., 116*, 2259W<br />

Gu, J., 2721F<br />

Gu, M., 2819T*<br />

Gu, Q., 3168F<br />

Gu, S., 3491T*<br />

Gu, Z., 3309T<br />

Guadalupe, M., 3669F<br />

Guan, M. X., 1628T*<br />

Guan, T., 457F<br />

Guan, W., 1428T*, 1665T<br />

Guan, Y., 1482T*<br />

Guan, Z., 457F, 2623T*<br />

Guarrera, S., 1153T, 1712T<br />

Guaschino, C., 2095T<br />

Guaschino, R., 1153T<br />

Guauque-Olarte, S., 1655T*<br />

Gucev, Z., 33, 845F<br />

Guchelaar, H. J., 243<br />

Gudjonsson, J. E., 154<br />

Guedalia, J., 2993T<br />

Guedet, M. M., 207<br />

Guedj, F., 765W*<br />

Guekunst, K., 1251W<br />

Guella, I., 2459F*, 2469W,<br />

3587F<br />

Guergueltcheva, V., 201,<br />

2948T<br />

Guerra-Junior, G., 478W,<br />

479F<br />

Guerreiro, J. F., 3292F<br />

*Presenting Author<br />

Guerreiro, M., 2876T<br />

Guerreiro, M. M., 2393F<br />

Guerrini, R., 889W<br />

Guethlein, L. A., 3710W<br />

Guettouche, T., 2185T,<br />

3706W*<br />

Guevara-Aguirre, J., 2706F<br />

Guffanti, G., 435F*<br />

Guha, N., 3676W*<br />

Guha, S., 264<br />

Gui, H., 21<br />

Guia-Padilla, M. T., 1805W<br />

Guiblet, W., 3254W*, 3380W<br />

Guidobono, R., 685F<br />

Guidugli, L., 1219T*<br />

Guignoux, C. R., 3380W<br />

Guigo, R., 368, 567F, 582W<br />

Guigò, R., 506W<br />

Guild, C. S., 272<br />

Guilherme, R. S., 3045W<br />

Guillaume, P., 619T<br />

Guillemyn, B., 2225F<br />

Guillen Ahlers, H., 1269W*<br />

Guilmatre, A., 469F*<br />

Guimiot, F., 77<br />

Guiochon-Mantel, A., 894T<br />

Guion-Almeida, M., 2673F<br />

Guion-Almeida, M. L., 813F,<br />

2746W<br />

Guipponi, M., 561F, 2685F,<br />

2877F, 2937F<br />

Guitart, M., 2940F<br />

Gujral, M., 480W<br />

Gül, E., 3132F<br />

Gulab, S., 167<br />

Gullerud, R. E., 1351F<br />

Gulsuner, S., 287*, 2600F,<br />

2924T<br />

Gulsvik, A., 2057F, 2249F<br />

Gulzar, Z., 1167W<br />

Gun, I., 1801W<br />

Gunawardena, S., 1214F<br />

Gunawardena, S. R.,<br />

1206W*<br />

Gunderson, K., 3695F<br />

Gunderson, K. L., 3710W<br />

Gunduz, C., 1025F, 1106F,<br />

1164W, 1166F, 1178F<br />

Gündüz, C., 1172F*<br />

Gunel, M., 1201T, 2924T<br />

Günel, M., 3132F<br />

Gunning, P. W., 410, 2662W,<br />

2796F<br />

Gunter, C., Session 81<br />

Guo, D., 1789W<br />

Guo, D. C., 1743W<br />

Guo, D. E., 589F<br />

Guo, G., 3553F<br />

Guo, H., 453F, 2251T,<br />

3139W<br />

Guo, J., 457F, 1974W*,<br />

2623T<br />

Guo, L., 2721F<br />

Guo, M., 3168F*<br />

Guo, S., 1681T, 1957T<br />

Guo, S. C., 3416T*<br />

Guo, T., 1494T, 1658T<br />

Guo, W., 1559W*, 1659T,<br />

2819T<br />

Guo, X., 1916F<br />

SPEAKER AND AUTHOR INDEX 361<br />

Guo, Y., 1004F, 1606T*,<br />

1659T, 2121W, 3660W*,<br />

3682W, 3724W*<br />

Guo, Y. W., 1110W<br />

Gupta, D., 2739F*<br />

Gupta, K. K., 2293T<br />

Gupta, M., 607T*<br />

Gupta, N., 918T, 1490W,<br />

1677T<br />

Gupta, S., 2803W<br />

Gupta, V., 2739F, 3455T<br />

Gupta Hinch, A., 3360T<br />

Gur, R. C., 2382W, 2514W,<br />

2546F, 2589W, 2651F<br />

Gur, R. E., 2382W, 2514W,<br />

2546F, 2589W, 2651F<br />

Guralnik, J. M., 2148W<br />

Guran, S., 1136F, 2881W<br />

Gurdasani, D., 1507F*,<br />

3412T<br />

Gurkan, A. M., 2329T<br />

Gurnett, C. A., 220, 2860W<br />

Guru, K., 3428T<br />

Gurusiddappa, S., 134<br />

Guruvadoo, L., 3557F<br />

Guryev, V., 459F, 3608W<br />

Gus, R., 879W<br />

Guse, K., 795W<br />

Gusella, J., 2562W<br />

Gusella, J. F., 68, 70, 82,<br />

103, 554W, 1964F,<br />

2643W<br />

Gusella, J. S., 2458T<br />

Gusev, A., 89, 350, 1320T,<br />

1577W*<br />

Gusmao, L., 3364F<br />

Gusmão, L., 3402T<br />

Gustaffsson, S., 108<br />

Gustafsson, M., 3427T<br />

Gustafsson, S., 117,<br />

2070W*, 2076W, 2090F,<br />

2241W<br />

Gustavsson, P., 3245W<br />

Gut, I., 54, 567F, 582W,<br />

2303F, 2326T<br />

Gut, M., 2303F, 2326T<br />

Gutenkunst, R. N., 3354T<br />

Guthery, S., 195<br />

Guthridge, J. M., 549F,<br />

566W<br />

Gutiérrez, A., 1111T, 1127F<br />

Gutierrez, D., 3125W<br />

Gutíerrez, I. A., 1077W*<br />

Gutiérrez, J., 2365T<br />

Gutierrez, K. S., 2106W*<br />

Gutiérrez, O., 2365T<br />

Gutierrez, S., 1798F<br />

Gutierrez-Achury, J., 155*,<br />

1330F<br />

Gutiérrez-Aguirre, H., 1030T<br />

Gutierrez-Arcelus, M., 415F,<br />

561F<br />

Gutin, N., 1021T<br />

Gutman, L., 2411F<br />

Guttman, M., 322<br />

Guttmann, A., 142<br />

Guxens, M., 2097W<br />

Guy, C., 531F, 1212W<br />

Guy, T., 400<br />

Guyant-Maréchal, L., 345<br />

Guymer, R., 1911W<br />

Guyot, M. C., 850F<br />

Guzeldemir, E., 2058W<br />

Guzman, E., 3695F<br />

Guzman, M., 695F, 924T<br />

Guzman, M. A., 785W<br />

Guzman, M. L., 1658T,<br />

2065T<br />

Gwirtzman, H. E., 2637W<br />

Gyapay, G., 2820F<br />

Gylfe, A., 997T<br />

Gyllensten, U., 2366F<br />

Gymrek, M., 333*, 1797W<br />

H<br />

Ha, T., 493F<br />

Haab, B. B., 1186T<br />

Haack, T. B., 699F, 2917W*<br />

Haaf, T., 849F, 3266W<br />

Haagmans, M., 1616T<br />

Haagmans, M. A., 197,<br />

681F<br />

Haan, E. A., 978T<br />

Haas, B. E., 2256W<br />

Haas, J., 2143T<br />

Haas, R., 534W<br />

Haase, V. G., 2434T<br />

Habashi, J. P., 240*<br />

Habegger, L., 41, 280, 551F,<br />

3251W<br />

Habekost, C., 2825T<br />

Haber, B. A., 2316W<br />

Haber, M., 3349F, 3387T*<br />

Haberberger, B., 699F<br />

Haberberger, B. M., 782W*<br />

Haberkorn, M. J., 1649T<br />

Habibian, R., 962T<br />

Habibul, A., 1638T<br />

Hacia, J., 722T<br />

Hack, L. M., 2504F*<br />

Hacker, D., 415F<br />

Hackett, N. R., 2933T,<br />

3399W<br />

Hackmann, K., 1236W,<br />

3224F<br />

Hacohen, N., 528W<br />

Haddad, G., 3307F<br />

Haddad, M., 791W*<br />

Haddad, M. R., 2457W<br />

Hadjidekova, S., 3477T<br />

Hadjidekova, S. P., 923W*<br />

Hadjixen<strong>of</strong>ontos, A., 270,<br />

2039F*, 2049W<br />

Hadj-Rabia, S., 128, 3140F*<br />

Hadley, D., 845F, 2067W*,<br />

2492F, 2872W<br />

Hadzhidekova, S., 3481T<br />

HaemGen Consortium, 383<br />

HaemGen RBC Consortium,<br />

110<br />

Haerian, B., 1113W*<br />

Haerian, M., 1113W<br />

Haertter, S., 617T<br />

Haessler, J., 1925F<br />

Haga, S. B., 147*<br />

Hageman, G. S., Session 7<br />

Hagenah, J., 200<br />

Hager, J., 1640T, 2278T*<br />

SPEAKER AND AUTHOR INDEX


362 SPEAKER AND AUTHOR INDEX<br />

Hagerman, P., 477F*<br />

Hagerman, P. J., 2632T,<br />

2633F, 2634W<br />

Hagerman, R., 770W*<br />

Hagg, S., 2175W<br />

Hägg, S., 119, 1308T,<br />

2074T*, 2076W, 2137T,<br />

2358W<br />

Haggerty, A. A., 968T<br />

Haghighatfard, A., 1718W*<br />

Haghighi, A., 2787F*, 2787F,<br />

2832F, 2856F, 3163W<br />

Haghighi-Kakhki, H.,<br />

2832F*, 2856F<br />

Hagiwara, M., 781W<br />

Hagnefelt, B., 2902W<br />

Hagos, S., 2743W<br />

Hahn, A., 2948T<br />

Hahn, A. F., 201, 3215W<br />

Hahn, A. F. G., 2779W<br />

Hahn, S., 688T, 1787W,<br />

1853F*, 2330F<br />

Hahn, S. E., 1834F<br />

Haider, M., 2267F*<br />

Haigis, R., 1176W, 3686W,<br />

3695F<br />

Haile, R. W., 141, 1067F,<br />

1079F, 1206W<br />

Hailing, J., 2037W<br />

Haiman, C., 205, 356,<br />

1324F, 1608T, 2131T<br />

Haiman, C. A., 48, 1148F,<br />

1150T, 2042F, 2202W<br />

Haimes, E., 1803W<br />

Hainaut, P., 1102T<br />

Haines, J., 1566T, 2041T,<br />

2135F<br />

Haines, J. L., 9, 15, 270,<br />

343, 344, 347, 1286W,<br />

1447F, 1476T, 1489F,<br />

1571W, 1671T, 1887W,<br />

2028W, 2154W, 2240F,<br />

2263T, 2299T, 2318F,<br />

2445W, 2498F, 2508W,<br />

2572T, 2583W, 2586W,<br />

2614T, 2637W, 3275W,<br />

3335W<br />

Hains, D., 450W, 458W<br />

Hajianpour, A., 962T<br />

Hajjar, R. J., 1698T<br />

Hajkova, Z., 752T<br />

Hakeman, M., 419F<br />

Hakenberg, J., 242, 3580W<br />

Hakim, S., 1691T<br />

Hakker, I., 2587T<br />

Hakonarson, H., 319, 812F,<br />

845F, 1307W, 1606T,<br />

1915T, 1996T, 1997F,<br />

2067W, 2121W, 2229W,<br />

2252F, 2389T, 2492F,<br />

2514W, 2546F, 2592W,<br />

2722W, 2785W, 2856F,<br />

2872W, 2892F, 2904F,<br />

3546W, 3561F, 3573F<br />

Hakonarson, H. H., 1992W,<br />

2443T<br />

Halbach, P., 2830W<br />

Halban, P. A., 556W<br />

Halbritter, J., 406, 2850F<br />

Halder, I., 1647T, 2083T*<br />

*Presenting Author<br />

Haldin, C., 520W<br />

Hale, P., 2136W<br />

Haley, C., 1383T<br />

Haley, K., 811F<br />

Halim, S., 1011W<br />

Halime, S., 1402F<br />

Hall, A. L., 2403W<br />

Hall, I. M., 436W*<br />

Hall, J., 2257T*<br />

Hall, J. L., 1665T*<br />

Hall, K., 343, 3663F,<br />

3694W*<br />

Hall, K. P., 366<br />

Hall, M. A., 1316W*<br />

Hall, P., 206, 208, 1150T,<br />

2108F, 2155T<br />

Hall, R. P., 906T<br />

Hall, S., 642T<br />

Hallam, S., 1729W<br />

Haller, G., 2598W*<br />

Haller, T., 1792W, 3353W*<br />

Hallgrímsdóttir, I., 2311T<br />

Hallgrimsson, B., 4<br />

Halligan, B., 587F<br />

Halligan, G., 924T<br />

Hallmayer, J., 2479T<br />

Halme, L., 2023T<br />

Halperin, E., 180, 3360T,<br />

3623F*<br />

Halprein, E., 1797W<br />

Halushka, M. K., 305<br />

Halvardson, J., 3728W<br />

Hamada, H., 1631T<br />

Hämäläinen, E., 2348F,<br />

2898F<br />

Hamamoto, K., 1631T<br />

Hamamy, H., 2937F<br />

Hambleton, I. R., 1906T<br />

Hamdan, F., 2306F<br />

Hamdan, F. F., 2692W,<br />

2790F<br />

Hamdy, F., 1011W<br />

Hamdy, F. C., 1148F<br />

Hamel, B. C., 125<br />

Hamel, B. C. J., 102<br />

Hamel, C., 390, 2679F<br />

Hamel, N., 1262F<br />

Hamet, P., 2994T<br />

Hamid, M., 679F*, 2714T<br />

Hamidovic, A., 2269T<br />

Hamilton, C. M., 1566T*<br />

Hamilton, K., 2586W*,<br />

2637W<br />

Hamilton, K. L., 344, 2498F,<br />

2583W<br />

Hamilton, R. M., 1678T<br />

Hamilton, S., 491F<br />

Hamilton, S. P., 2517W<br />

Hamman, R. F., 1672T,<br />

1673T<br />

Hammann, A., 2716W<br />

Hammarström, L., 2091W<br />

Hammel, P., 1062W<br />

Hammer, M., 285<br />

Hammer, M. F., 2788W,<br />

3354T, 3377W, 3389W<br />

Hammer, R. R., 1849W<br />

Hämmerle, J. M., 2861T<br />

Hammerø, M., 3510T<br />

Hammet, F., 1213T<br />

Hammond, C. J., 335,<br />

2068T, 2138F<br />

Hammond, J. A., 1566T<br />

Hammond, P., 218, 3088F<br />

Hamolsky, D., 1965W<br />

Hamosh, A., 227*<br />

Hampe, J., 580W*<br />

Hampel, H., 1173W*<br />

Hampson, S. C., 2800W<br />

Hampton, O., 3649F<br />

Hampton, T., 1698T<br />

Hamren, S., 2347T<br />

Hamsten, A., 115, 1651T<br />

Hamza, S., 507F<br />

Han, B., 39, 1337W, 1341T,<br />

1480F*, 1657T, 3462T,<br />

3555F, 3623F<br />

Han, B. J., 846F<br />

Han, E., 1535W*<br />

Han, J., 984W, 3461T<br />

Han, J. C., 2702T<br />

Han, K., 947W<br />

Han, K.-H., 2130W<br />

Han, L., 278, 1488T*<br />

Han, M., 2566T, 3223W<br />

Han, S., 1012T, 1243T*,<br />

2497T*<br />

Han, S. S., 1378F*<br />

Han, X., 2623T<br />

Han, X.-Y., 1218W<br />

Han, Y., 1757W, 2934F,<br />

3008T<br />

Han, Y. Y., 3449T<br />

Hanchard, N. A., 1646T,<br />

2158T*<br />

Hancock, D., 2114F<br />

Hancock, D. B., 1566T,<br />

2170T*<br />

Handberg, H., 3641F,<br />

3662W<br />

Hande, M. P., 3034T<br />

Handel, A., 2015F*<br />

Handsaker, R., 322<br />

Handsaker, R. E., 284,<br />

437F*, 1519F<br />

Hanein, S., 324, 390, 522W<br />

Haney, M., 334, 579F,<br />

3658W<br />

Hanis, C. L., 2192F<br />

Hanish, A. E., 2702T<br />

Hankerd, M., 885W<br />

Hankins, J. S., 2331W<br />

Hankinson, J., 2211W<br />

Hankinson, S., 2165F<br />

Hanks, S., 1211F<br />

Hanna, C. W., 2977T, 2986T*<br />

Hanna, G., 2430W*<br />

Hanna, G. L., 3447T<br />

Hanna, M., 1912T, 2581T<br />

Hanna, N., 56<br />

Hannachi, H., 944T<br />

Hannan, G. N., 916T<br />

Hannan, M., 2052W<br />

Hannequin, D., 345<br />

Hannick, L. I., 3332W<br />

Hänninen, S., 541F<br />

Hanscom, C., 68, 70<br />

Hansen, L., 363, 2817F<br />

Hansen, M., 1445W<br />

Hansen, M. R., 2301W<br />

Hansen, N., 999W, 1159T,<br />

1515T<br />

Hansen, N. F., 1690T<br />

Hansen, R., 2491T<br />

Hansen, R. S., 255<br />

Hansen, T., 1624T, 2311T,<br />

2317T, 2347T<br />

Hansikova, H., 752T<br />

Hanson, E., 299, 2439W<br />

Hanson, R., 584W, 1300F,<br />

2038T*<br />

Hanson, R. L., 1953W,<br />

2018F, 2124W<br />

Hansson, O., 47, 2187W<br />

Hantaï, D., 328<br />

Hantash, F. M., 2260T<br />

Hao, H., 822F*<br />

Hao, K., 1369F*, 1624T,<br />

2928F<br />

Hao, L., 1304W, 3345T<br />

Hao, T., 2660F<br />

Hao, Y., 116<br />

Happe, S., 3459T, 3659F,<br />

3669F, 3709F<br />

Hara, K., 2071T*<br />

Hara, T., 468W*<br />

Harafuji, N., 2961F<br />

Harakalova, M., 217, 672T,<br />

2886F<br />

Harari, O., 340, 2228F*<br />

Harbin, S., 2430W<br />

Harbo, H., 2113T<br />

Harbord, R. M., 1626T<br />

Hardcastle, A. J., 3212F<br />

Hardeman, E. C., 410,<br />

2662W, 2796F<br />

Harden, A., 940T<br />

Hardie, R., 3332W<br />

Hardin, J., 75<br />

Hardin, M., 2057F*<br />

Harding, C. O., 774W<br />

Harding, S. P., 2072F<br />

Hardison, M., 314, 1742W<br />

Hardison, M. T., 677F*<br />

Hardison, R. C., 3545F<br />

Hardwick, J., 1369F<br />

Hardwick, R., 438W<br />

Hardy, J., 374, 564W, 2648F<br />

Hardy, O., 3659F<br />

Hardy, R., 2282F<br />

Hare, A., 2381F*, 2523W<br />

Harewood, L., 62, 299<br />

Hariharan, M., 551F<br />

Häring, H., 1624T<br />

Harismendy, O., 395, 1051T<br />

Haritunians, T., 1445W,<br />

1916F, 2153F<br />

Harkin, T. T., 1068W<br />

Harkins, T., 400, 494W,<br />

1242W<br />

Harkins, T. T., 186, 1244F*,<br />

2301W<br />

Härkönen, J., 496W<br />

Harks, I., 2058W<br />

Harlan, M., 1275W<br />

Harlan, W. R., 1566T<br />

Harley, J., 1901F<br />

Harley, J. B., 529F, 1979F,<br />

2046W, 2084F, 2188T,<br />

3371W


Harley, K., 3458T<br />

Härmä, M., 2462F<br />

Harman, E., 1166F<br />

Harmanci, A., 2444F<br />

Harney, L., 132<br />

Haroutunian, V., 3471T<br />

Harper, J. I., 2102F<br />

Harper, S. M., 1756W<br />

Harper, U., 1302T<br />

Harries, L. W., 2148W<br />

Harrington, E., 483F,<br />

2565W<br />

Harrington, E. D., 3617F*<br />

Harrington, P., 139<br />

Harris, A., 509F, 3719F<br />

Harris, C., 2325W*<br />

Harris, D. J., 82<br />

Harris, E., 630T<br />

Harris, H. R., 2077T<br />

Harris, J., 33, 503F<br />

Harris, J. R., 434W, 3510T<br />

Harris, K., 184<br />

Harris, K. M., 1467T<br />

Harris, M., 969W<br />

Harris, P. C., 1909T<br />

Harris, R., 3545F<br />

Harris, T., 1338T, 2080T,<br />

2561F<br />

Harris, T. B., 109, 2116T,<br />

2145W, 2275T<br />

Harrison, B. W., 1821W<br />

Harrison, C., 32<br />

Harrison, C. J., 1024T<br />

Harrison, L., 3494T<br />

Harrison, S., 2845W, 2846T*<br />

Harroche, A., 915W<br />

Harrow, I., 503F<br />

Harrow, J., 506W<br />

Harrow, J. L., 367<br />

Harry, B., 315<br />

Hart, D. J., 2292W<br />

Hart, E., 2098T<br />

Hart, P. S., 322<br />

Hart, R. K., 3548W*<br />

Hart, R. P., 2433W<br />

Hart, S., 1219T<br />

Hartge, P., 1306F, 1372F,<br />

1413T<br />

Hartikainen, J. M., 1114T*,<br />

1125W<br />

Hartl, C., 172, 288<br />

Hartley, J., 954T<br />

Hartley, J. N., 2422T<br />

Hartman, T. J., 1107W<br />

Hartmann, H., 756W<br />

Hartmann, L. C., 1238F<br />

Hartmannova, H., 752T<br />

Hartsfield, J., 2243F*<br />

Hartsfield Jr., J., 1147T<br />

Hartshorne, C., 145, 1810F<br />

Hartshorne, T., 1146W*<br />

Haruki, H., 2823F<br />

Harvard, C., 491F*, 517F<br />

Harvey, E., 3156F<br />

Harvey, H. S., 1849W<br />

Harvey, I., 1065W<br />

Harvey, K. A., 2155T<br />

Har-Zahav, A., 105<br />

Hasan, Q., 1234T, 1893W<br />

Hasegawa, A., 3565F<br />

*Presenting Author<br />

Hasegawa, I., 1321F<br />

Hasegawa, J., 2507F<br />

Hashemzadeh, M., 1143W,<br />

1596T, 1739W, 2008T,<br />

2013W<br />

Hashemzadeh Chaleshtori,<br />

M., 1421W, 2952F<br />

Hashiguchi, A., 2418W,<br />

2601W, 2607W*, 2616W,<br />

2823F<br />

Hashimoto, K., 627T, 963W<br />

Hashimoto, S., 456W, 912T<br />

Hashimoto, T., 2559W<br />

Hashimoto, Y., 2371T<br />

Hashmi, A., 8<br />

Haskins, M., 1081T<br />

Haslag-Min<strong>of</strong>f, J., 1210T<br />

Hasler, R., 582W<br />

Häsler, R., 567F<br />

Haslett, L. J., 162<br />

Haslett, P., 714T, 801W<br />

Hassan, A., 2408F<br />

Hassan, B., 133<br />

Hassanali, N., 44<br />

Hassed, S., 2834T<br />

Hassell, K., 725F<br />

Hassnan, Z., 2743W<br />

Hassold, T., 250<br />

Hastie, N., 1383T<br />

Hastie, N. D., 2366F<br />

Hastings, P. J., 337<br />

Hastings, R., 1874F<br />

Hata, A., 1631T<br />

Hata, K., 3499T<br />

Hatai, Y., 3091W<br />

Hatamnejadian, N., 1961F,<br />

1962W, 2964F<br />

Hatamochi, A., 3230F<br />

Hattersley, A. T., 2704W,<br />

3494T<br />

Hattori, N., 1730W, 2559W,<br />

2619W, 3134F, 3221W<br />

Hattori, S., 2647T<br />

Hatzimanolis, A., 2573F*<br />

Hatzlh<strong>of</strong>er, B. L. D., 2718F<br />

Hauck, S., 3536W<br />

Haudenschild, C., 369,<br />

1249T, 2372F<br />

Hauenstein, N., 2086T<br />

Haug, K. B. F., 643T<br />

Haugarvoll, K., 2451W*<br />

Hauge, C., 921W<br />

Haugen, E., 3459T<br />

Haugen, T. B., 991T<br />

Haughey, N. J., 658T<br />

Haukanes, B. I., 2451W<br />

Haukkala, A., 1835W<br />

Hauner, H., 3536W<br />

Haupt, B., 786W<br />

Hauptschein, R., 1369F<br />

Hause, R. J., Jr., 614T<br />

Hauser, E., 3<br />

Hauser, E. R., 1444F, 1594T,<br />

1636T<br />

Hauser, M., 3, 386, 531F,<br />

2135F<br />

Hauser, M. A., 1887W,<br />

2154W, 2240F, 2263T,<br />

2946F<br />

Hauser, N., 876T<br />

SPEAKER AND AUTHOR INDEX 363<br />

Hauser, N. S., 2839W*<br />

Hauser, S., 2113T, 3330T<br />

Hauser, S. L., 270, 2299T<br />

Hausmann, L. D., 994T,<br />

1405F<br />

Hausser, I., 2869W<br />

Haussler, D., 466W, 1229F,<br />

3557F, 3612W<br />

Hautaniemi, S., 1117T<br />

Havas-Augustin, D., 1660T<br />

Haverfield, E., 2579F<br />

Havulinna, A. S., 1709T<br />

Hawes, A., 1742W<br />

Hawes, A. C., 314, 1735W,<br />

1757W, 1761W<br />

Hawley, N. L., 2159F<br />

Haworth, C. M. A., 2164T<br />

Hawrylycz, M., 2444F<br />

Hawthorne, F., 521F<br />

Hawthorne, F. A., 3521T<br />

Hawwari, A., 3149W, 3155W*<br />

Hay, J., 1841W<br />

Hayano, T., 482W<br />

Hayasaka, K., 3136F<br />

Hayase, T., 1940F*<br />

Hayashi, S., 914T*<br />

Hayashi, Y. K., 755W,<br />

2923W<br />

Hayden, K. E., 414W*<br />

Hayden, M. R., 265<br />

Hayeck, T., 1360F<br />

Hayeems, R., 320, 1872F*,<br />

1873F<br />

Hayeems, R. Z., 142, 1824F<br />

Hayes, J., 3054F, 3089W<br />

Hayes, L., 3076F<br />

Hayes, M., 2098T<br />

Hayes, M. G., 618T, 1447F,<br />

2036F, 3323W<br />

Hayes, V. M., 1085F, 3332W<br />

Hayflick, S. J., Session 10<br />

Haynes, C., 1444F, 1594T,<br />

1636T, 3541F<br />

Hayward, C., 1383T, 2072F<br />

Hayward, N. K., 212<br />

Hazan, F., 1106F, 3206F<br />

Hazlehurst, J., 3211W<br />

Hazra, A., 1073F<br />

Hazucha, M., 2851W<br />

He, C., 1098W, 1969T*,<br />

3483T<br />

He, G., 1174T<br />

He, J., 1324F*, 1465F<br />

He, J. B., 1259F<br />

He, L., 654T, 1174T*, 2419T<br />

He, L.-J., 1218W<br />

He, M., 1758W, 3300T, 3553F<br />

He, P., 1758W<br />

He, Q., 1434T*<br />

He, W., 503F, 2804T<br />

He, X., 722T, 864T, 1144T,<br />

1433W*, 2246F<br />

He, Y., 3308W, 3656W<br />

He, Z., 93*<br />

Headland, C., 3331F<br />

Healey, C. S., 209<br />

Healy, E., 303<br />

Healy, J., 31, 394, 1207T*,<br />

1215W, 3700W<br />

Heanue, T., 308<br />

Heard-Costa, N., 2030F*,<br />

2123F, 2337W<br />

Heath, A. C., 2056T, 2212T<br />

Heath, G., 1238F<br />

Heath, S., 2303F<br />

Heaton, W. H., 3529F<br />

Heba, T., 831F*<br />

Hebbar, P., 3369T<br />

Hebbring, S., 2297F*<br />

Hebbring, S. J., 3326W<br />

Hebert, A. M., 693F*<br />

Hebert, J. M., 633T, 635T<br />

Hebert, L., 458W<br />

Hebson, C., 1679T<br />

Hecht, J., 298, 1908W*,<br />

2325W<br />

Heckbert, S. R., 1585T<br />

Heckenlively, J., 2135F<br />

Heckenlively, J. R., 2183F,<br />

3234F<br />

Heckerman, D., 1379W*,<br />

3468T<br />

Heckman, L., 2807T*<br />

Hedera, P., 2438F<br />

Hedges, D., 524W, 2330F,<br />

3706W<br />

Hedges, D. J., 9, 270,<br />

2572T, 2614T, 3390T<br />

Hedley, P. L., 2699T<br />

Hedman, A., 583F<br />

Hedman, A. K., 44*, 2187W,<br />

3441T<br />

Heesen, L., 236<br />

Heffelfinger, C., 551F, 3313F*<br />

Heffner, L., 3026T<br />

Heffron, T., 3582W<br />

Hefner, K. S., 529F, 2188T<br />

Hegde, M., Session 3, 66<br />

Hegde, M. R., 1758W<br />

Hegele, R., 1688T<br />

Hegele, R. A., 2800W<br />

Hegele, R. G., 1465F<br />

Heguy, A., 998F<br />

Hehir-Kwa, J., 979W<br />

Hehir-Kwa, J. Y., 100, 459F,<br />

955W<br />

Heid, I., Session 7<br />

Heid, I. M., 1954T, 2123F,<br />

2147F<br />

Heidari, N., 416W*<br />

Heide, H., 782W<br />

Heide, S., 890T<br />

Heijmans, B. T., 1436W<br />

Heikkilä, P., 1171T, 1265F<br />

Heikkinen, T., 1006T*,<br />

1117T, 1171T, 1265F<br />

Heil, S., 853F, 2300F<br />

Heilbuth, T. R., 1902W<br />

Heilmann, S., 106*<br />

Heim, K., 275*, 584W, 782W<br />

Heiman, G. A., 261, 2433W,<br />

2602T*<br />

Heimdal, K., 129<br />

Heimer, G., 660T<br />

Hein, A.-M., 3641F<br />

Heinrich, J., 2167T, 2168F,<br />

2226W<br />

Heinrich, J. K., 1033T<br />

Heinzen, E. L., 203, 266<br />

Heise, E., 1853F<br />

SPEAKER AND AUTHOR INDEX


364 SPEAKER AND AUTHOR INDEX<br />

Heiss, G., 174, 1437T,<br />

1661T, 2041T<br />

Heit, J., 1497T*<br />

Heit, J. A., 1375F<br />

Heitmann, M., 3496T<br />

Heitzer, E., 1063T, 1115F*<br />

Hekimgil, M., 1025F<br />

Helderman-van den Enden,<br />

A. T. J. M., 1711T<br />

Helen, R., 2812W<br />

Helfmann, S., 59<br />

Hellebrekers, D. M. E. I.,<br />

2996T*<br />

Hellenthal, G., 181<br />

Heller, R., 236, 2944W<br />

Hellin, A.-C., 925W<br />

Helliwell, T., 33<br />

Hellwege, J. N., 1888T*<br />

Helms, C., 1952F<br />

Helwi, P., 841F<br />

Helzlsouer, K. J., 1822F<br />

Hem, V., 1762W<br />

Hemani, G., 1394W<br />

Hemmelmann, C., 200<br />

Hemmer, B., 2086T<br />

Hemmrich-Stanisak, G.,<br />

2368T*<br />

Hempel, M., 2595W, 2917W<br />

Henders, A. K., 2133W<br />

Hendershot, L., 1847W<br />

Hendershot, T., 1566T<br />

Henderson, A., 126<br />

Henderson, A. J., 2168F<br />

Henderson, B., 205, 1324F<br />

Henderson, B. E., 1148F,<br />

2131T, 2202W<br />

Henderson, J., 1567F,<br />

2102F, 2167T<br />

Henderson, S., 133<br />

Henderson-MacLennan, N.<br />

K., 1658T, 2065T<br />

Hendricks, A., 1518T,<br />

2304W*<br />

Hendrickx, A. T. M., 2996T<br />

Heneghan, M. A., 153<br />

Heng, M. Y., 2423F*<br />

Hengstenberg, C., 3453T<br />

Hengstler, J., 1335T<br />

Henn, B., 3345T<br />

Henn, B. M., Session 6,<br />

186, 371, 3361F, 3368W,<br />

3385F, 3411W<br />

Hennah, W., 252<br />

Henneberg, M., 3344W<br />

Hennekam, E. A. M., 431F<br />

Hennekam, R., 127, 2701W,<br />

2759T<br />

Hennekam, R. C., 681F<br />

Hennekam, R. C. M., 216,<br />

2886F<br />

Henneman, P., 228, 2107T*,<br />

2116T<br />

Hennies, H. C., 2869W<br />

Hennis, A., 1003T<br />

Henrich, V. C., 107*<br />

Henrion, E., 1670T, 2342F,<br />

2558F<br />

Henrion Caude, A., 522W*<br />

Henrique, H., 1108T<br />

Henry, C., 259<br />

*Presenting Author<br />

Henry, P. G., 2539T<br />

Hentati, F., 2537F<br />

Heppe, D. H. M., 1334W,<br />

2169W<br />

Herder, C., 275<br />

Heredia, N., 3690W<br />

Herman, D. S., 1677T<br />

Herman, G., 456W<br />

Herman, S., 1494T<br />

Hermann, M., 2581T<br />

Hermannsson, L., 3573F<br />

Hermansson, M., 541F<br />

Hermetz, K. E., 66<br />

Herms, S., 420W*, 1005W,<br />

3550W<br />

Hernaez, R., 2275T<br />

Hernandez, B. G., 988T*<br />

Hernandez, D. G., 564W,<br />

2148W<br />

Hernandez, K. N., 707F<br />

Hernandez, N., 415F,<br />

2377T*<br />

Hernandez, P., 1646T<br />

Hernandez, R., Session 6,<br />

589F<br />

Hernandez, R. D., 158<br />

Hernandez, W., 40<br />

Hernandez-Escalante, V.,<br />

2272T<br />

Hernandez Fuentes, M.,<br />

2082W<br />

Hernandez-Fuentes, M. P.,<br />

2260T<br />

Hernández-García, A., 834F<br />

Hernández-Garcia, A.,<br />

839F*<br />

Hernández-Hernández, O.,<br />

3124F, 3226F<br />

Hernández-Zamora, E.,<br />

3125W<br />

Hernesniemi, J., 1253F<br />

Herold, C., 106, 1332T*<br />

Heron, D., 127, 889W,<br />

2770W<br />

Héron, D., 131, 3157W<br />

Heron, S. E., 2741T*<br />

Herrera, P., 1119W<br />

Herrera, V., 1714T<br />

Herrera-Sanchez, F., 2272T<br />

Herring, J. A., 221, 1359T<br />

Herrington, D., 1661T<br />

Herrmann, A., 580W<br />

Herrmann, R., 2681T, 2812W<br />

Hersh, C. P., 2249F<br />

Hershberger, R., 1681T<br />

Hershey, G., 578W<br />

Hershman, D. L., 1255T<br />

Hershman, S. G., 326<br />

Hertecant, J., 2740W<br />

Hertz-Picciotto, I., 2491T<br />

Hervás, A., 2578T<br />

Herzenberg, J. E., 2860W<br />

Herzfeld, T., 2416T<br />

Herzog, E., 72<br />

Hesselson, S., 112, 421F,<br />

2140T, 2513F, 3342T,<br />

3383W<br />

Hesselson, S. E., 118<br />

Hessl, D., 770W<br />

Hester, J., 2332T*<br />

Hester, J. M., 2310W<br />

Hestholm, B., 2965W<br />

Hetland, M., 621T<br />

Hetmanski, J. B., 1425T,<br />

1472W, 1512T<br />

Hetrick, K., 2556W, 3644W,<br />

3716W<br />

Hetrick, K. N., 1448W<br />

Hettige, N., 2408F<br />

Heuberger, A., 1189T<br />

Heulens, I., 2527T<br />

Heuzé, Y., 2151W<br />

Hevroni, D., 3656W, 3703F<br />

Hewitt, A. W., 2068T<br />

Hewitt, S. M., 1092W<br />

Hewson, S., 717F<br />

Heydari Sodejani, S.,<br />

2013W*<br />

Heydari Sodjani, S., 1596T*<br />

Heyer, C. M., 1909T<br />

Heyman, M., 1035W, 1126T<br />

Hiatt, J., 10<br />

Hibaoui, Y., 67*<br />

Hibar, D. P., 2054F<br />

Hibbard, M., 1032W<br />

Hibberd, M., 429F<br />

Hiber, M., 392<br />

Hibino, H., 2370W<br />

Hickerton, C., 143<br />

Hickey, F., 1847W<br />

Hickey, L., 477F<br />

Hickey, P., 2741T<br />

Hickey, S., 456W<br />

Hickman, M., 1567F<br />

Hicks, A. A., 86, 110<br />

Hicks, C., 1116W*<br />

Hicks, D. J., 136<br />

Hicks, J., 2854W<br />

Hicks, J. E., 2378F*<br />

Hicks, M., 1649T<br />

Hicks, M. D., 2702T*<br />

Hicks, P., 2332T<br />

Hicks, P. J., 1661T, 2310W<br />

Hicks, S., 1798F, 3549F*<br />

Hidalgo, A., 1030T<br />

Hidalgo-Miranda, A., 1129T<br />

Hiekkala, M. E., 2348F*<br />

Hiekkalinna, T., 1563T*,<br />

2208W, 2399F<br />

Hiemenga, J., 3037W*<br />

Hiene, A., 3662W<br />

Higasa, K., 2409W, 2569T<br />

Higashi, K., 2601W<br />

Higashimoto, K., 3432T,<br />

3519T<br />

Higgins, A., 1494T<br />

Higgins, A. W., 82<br />

Higgs, D. R., 418W<br />

Higgs, J., 330<br />

Higgs, R. H., 1235F<br />

High, K., Session 23<br />

Highland, H. M., 169, 269*,<br />

2192F<br />

Highnam, G., 469F<br />

Hightower, R. C., 1661T<br />

Higuchi, I., 2601W<br />

Higuchi, Y., 2418W, 2601W,<br />

2607W, 2616W*<br />

Hilal, S., 930T<br />

Hilbers, F. M., 1213T<br />

Hilbers, F. S., 27*<br />

Hilbert, P., 3181W, 3216F<br />

Hildebrand, M., 2867T<br />

Hildebrand, M. S., 60,<br />

3228F*<br />

Hildebrandt, F., 406<br />

Hildebrandt, J., 3717F<br />

Hildebrandt, L. L., 2699T<br />

Hildebrandt, M. A. T., 213<br />

Hill, A., 266<br />

Hill, A. V., 2157W<br />

Hill, A. V. S., 1948T<br />

Hill, D. A., 132<br />

Hill, D. E., 2660F<br />

Hill, D. P., 1339F<br />

Hill, H. R., 495F, 2720T<br />

Hill, M., 3018T<br />

Hill, R. S., 8, 266, 452W,<br />

2613W<br />

Hillier, L., 2320T<br />

Hillmer, A. M., 106, 3047W<br />

Hills, L. B., 266<br />

Hilton, C., 2139W<br />

Himes, B., 2166W<br />

Himes, B. E., 622T, 625T,<br />

638T*<br />

Himmelstein, D. S., 1501F*<br />

Hinckley, J., 1889F*<br />

Hindorff, L., 1608T<br />

Hindorff, L. A., 1845W,<br />

1925F, 2042F, 2108F*,<br />

2155T<br />

Hinds, D., 106, 2161T<br />

Hinds, D. A., 114, 498W,<br />

1017W*, 2089T, 2100W,<br />

2115W<br />

Hinek, A., 3186F<br />

Hingorani, A., 1621T<br />

Hinrichs, A., 2582F, 3557F<br />

Hinzpeter, A., 572W*<br />

Hip-Ki, E., 2266T, 3268F,<br />

3341W<br />

Hippolyte, L., 62, 299<br />

Hira, G., 100<br />

Hirai, H., 468W<br />

Hirai, Y., 468W<br />

Hiraki, L. T., 191*<br />

Hirakiyama, A., 2911W<br />

Hirankarn, N., 2006F,<br />

2064W<br />

Hirano, A., 2174F<br />

Hirasawa, T., 2835F<br />

Hirata, M., 1593T<br />

Hirbo, J., 3303T, 3338W<br />

Hirota, T., 2294F*<br />

Hirschhorn, J., 350, 2210F,<br />

3413W<br />

Hirschhorn, J. N., 23, 108,<br />

1677T, 1906T, 1954T,<br />

1960T, 2090F, 2123F,<br />

2131T, 2147F, 2241W,<br />

2307W, 2364W, 3525T<br />

Hirte, H., 1824F<br />

Hirv, K., 3539F<br />

Hishimoto, A., 2380T<br />

Hitayezu, J., 3104F<br />

Hitchen, J., 3668W, 3721F<br />

Hitomi, Y., 53, 2455T*<br />

Hitz, B. C., 3612W<br />

Hixson, J. E., 1932W


Hixson, P., 893W, 898T,<br />

952T<br />

Hixson, R., 1309F<br />

Hjalgrim, H., 1934F, 2055W<br />

Hjermind, L. E., 2765T<br />

Hjorthaug, H. S., 3510T<br />

Ho, A., 2480F<br />

Ho, B. C., 422W<br />

Ho, C. K., 2238W*<br />

Ho, G., 2795T<br />

Ho, J., 2279F, 2280W<br />

Ho, L.-T., 1955F<br />

Ho, P., 2160W<br />

Ho, P. C., 3000T<br />

Ho, V., 1238F<br />

Hoal, E., 2217W, 3385F<br />

Hoal, E. G., 2003F, 2007W<br />

Hoang, N., 1872F, 1873F*<br />

Hoang, V., 1691T<br />

Hoather, T. M., 1105T<br />

Hobbs, C. A., 1459F<br />

Hobel, S., 3587F<br />

Hobson, G., 2664F*<br />

Hobson, G. M., 2793F<br />

Hochreiter, S., 95, 1483F*,<br />

1486F, 2374T<br />

Hocking, T. A., 978T<br />

Hodge, J. C., 103, 1145F*,<br />

2575T<br />

Hodges, K., 853F<br />

Hodges, S., 3690W<br />

Hodgkinson, A., 2266T,<br />

3268F*, 3341W<br />

Hodgkinson, C. A., 2574W<br />

Hodgkinson, K. A., 454W<br />

Hodgkiss, D., 503F<br />

Hodgson-Jensen, L., 1093T<br />

Hoefsloot, E. H., 58<br />

Hoefsloot, L., 65, 1874F<br />

Hoefsloot, L. H., 2925F<br />

Hoeijmakers, J. G. J.,<br />

2448W<br />

Hoekstra, P. J., 2602T<br />

Hoen, P., 582W<br />

H<strong>of</strong>fman, C., 660T<br />

H<strong>of</strong>fman, D., 3582W<br />

H<strong>of</strong>fman, E., 3249W<br />

H<strong>of</strong>fman, G. E., 357,<br />

1355W*<br />

H<strong>of</strong>fman, J., 907W, 1729W*<br />

H<strong>of</strong>fman, J. D., 1286W*<br />

H<strong>of</strong>fman, R., 458W<br />

H<strong>of</strong>fman, R. D., 3275W<br />

H<strong>of</strong>fman, T., 421F, 1741W*,<br />

3383W<br />

H<strong>of</strong>fman, T. J., 246<br />

H<strong>of</strong>fmann, C., 3536W<br />

H<strong>of</strong>fmann, D., 3500T<br />

H<strong>of</strong>fmann, E. M., 1115F<br />

H<strong>of</strong>fmann, G. F., 699F<br />

H<strong>of</strong>fmann, P., 420W, 1005W,<br />

3550W*<br />

H<strong>of</strong>fmann, R. G., 1475W*<br />

H<strong>of</strong>fmann, S., 1612T<br />

H<strong>of</strong>fmann, T., 112, 2513F,<br />

3342T<br />

H<strong>of</strong>fmann, T. J., 7, 118*,<br />

1250F, 1475W, 2140T<br />

H<strong>of</strong>ker, M. H., 523F<br />

Höfler, G., 1115F<br />

*Presenting Author<br />

H<strong>of</strong>man, A., 87, 584W,<br />

1284T, 1334W, 1503T,<br />

2081F, 2105F, 2169W<br />

H<strong>of</strong>man, N., 1616T<br />

H<strong>of</strong>man, O., 356<br />

H<strong>of</strong>mann, A., 2416T<br />

H<strong>of</strong>mann, K., 105<br />

H<strong>of</strong>mann, N., 2330F<br />

H<strong>of</strong>mann, S., 2103W<br />

Hogan, N. S., 1822F<br />

Högel, J., 939W<br />

Hogenesh, J., 2592W<br />

Hogg, C., 809F<br />

Hogg, G., 2973T*, 3023T<br />

Hogg, K., 645T, 3429T*<br />

Hoggart, C., 1387F, 1528F<br />

Högl, B., 2567F, 2568W<br />

Högler, W., 2864T<br />

Hoglund, B. N., 3713F*<br />

Hogue, W. R., 2854W<br />

Hohjoh, H., 799W<br />

Hohmann, J., 2444F<br />

Höhne, K., 2103W<br />

Höhne, W., 2759T, 2861T<br />

Hoiness, R., 1736W<br />

Hoischen, A., 97, 124, 125,<br />

216<br />

Hojati, Z., 892T<br />

Hokanson, J. E., 1672T,<br />

1673T, 2249F, 2346W<br />

Hokken-Koelega, A., 2701W<br />

Hokonohara, T., 2400W<br />

Hokynar, K., 541F*<br />

Holcomb, C. L., 3713F<br />

Holcomb, K., 1272W<br />

Holden, K., 3171W<br />

Holden, K. R., 2826F<br />

Holden, S., 83<br />

Holder, A. M., 834F<br />

Holder, M., 126<br />

Holder, S. E., 298, 2925F<br />

Holder-Espinasse, M.,<br />

889W, 2896W, 3109W,<br />

3172F<br />

Holinski-Feder, E., 758W,<br />

1005W<br />

Hölker, I., 236<br />

Holladay, J., 1021T<br />

Holland, N., 3458T<br />

Hollemon, D., 3020T<br />

Holley, T., 1186T<br />

Holliday, E. G., 2133W<br />

Holloway, A. K., 195<br />

Holloway, L., 2806W<br />

Hollox, E., 438W*, 450W,<br />

3325F<br />

Hollox, E. J., 449F, 2641T<br />

Holm, I., 921W*<br />

Holm, I. A., 1799W, 1836F*,<br />

1843W<br />

Holman, K., 3167W<br />

Holmberg, R., 3011T<br />

Holmes, C., 235<br />

Holmes, S., 2805F<br />

Holmfeldt, L., 31<br />

Holohan, K. N., 2531F*<br />

Holstege, G., 494W<br />

Holstege, H., 494W*<br />

Holt, A., 407<br />

Holt, R. A., 375<br />

SPEAKER AND AUTHOR INDEX 365<br />

Holzinger, E., 1442W*<br />

Homan, E. P., 2854W*<br />

Homuth, G., 275, 2141F<br />

Honda, M., 2496W, 2656T<br />

Honda, Y., 2496W<br />

Honey, E. M., 131<br />

Hong, C., 2117F<br />

Hong, D., 3479T<br />

Hong, E. L., 3612W*<br />

Hong, H., 1830F<br />

Hong, K., 2060F*<br />

Hong, K.-W., 1622T<br />

Hong, L., 2112W<br />

Hong, M., 551F, 1189T,<br />

1990T, 2273F<br />

Hong, S., 2460W*<br />

Hong, X., 3026T<br />

Honig, L., 2547W<br />

Honig, L. S., 2093F, 2410T<br />

Honore Goltz, H., 1857F<br />

Honti, F., 445F<br />

Honzik, T., 752T<br />

Hood, L., 2643W<br />

Hood, L. E., 195<br />

Hood, R. L., 131<br />

Hood, S., 3267T<br />

Hoogenboom, J., 3611F<br />

Hoogerbrugge, N., 27, 1213T<br />

Hoogstraat, M., 400<br />

Hooker, S., 93<br />

Hooli, B., 2520W<br />

Hooper, A., 1680T<br />

Hooper, C., 1119W<br />

Hooper, W. C., 611T<br />

Hoos, M. B., 1711T<br />

Hoover-Fong, J., 227<br />

Hopkin, J. M., 3466T, 3486T<br />

Hopkin, R., 789W<br />

Hopkins, P., 1875F<br />

Hopkins, T. J., 306<br />

Hopp, K., 1909T*<br />

Hoppe, N., 1848W<br />

Hoppe, T., 105, 1939T<br />

Hoppel, C. L., 741F<br />

Hopper, J., 1492F<br />

Hopper, J. L., 141, 1067F,<br />

1079F, 1206W, 1213T<br />

Hoppman-Chaney, N.,<br />

887W<br />

Hops, H., 642T<br />

Hor, H., 2326T*<br />

Horenstein, R. B., 602T<br />

Horike, S., 3497T*, 3498T<br />

Horikoshi, M., 119, 190,<br />

1308T*, 1528F, 2076W,<br />

2137T<br />

Horinek, A., 3437T<br />

Horita, H., 3136F<br />

Horjales-Araujo, E., 2369F*<br />

Hormozdiari, F., 3639F*,<br />

3657F<br />

Horn, D., 298, 2595W<br />

Horn, F., 849F<br />

Horn, H. F., 2914W<br />

Hornemann, T., 758W<br />

Hornyak, M., 2568W<br />

Horovitz, D. D. G., 1877F<br />

Horpaopan, S., 1005W<br />

Horsburgh, K. A., 3333T<br />

Horst, B., 3319F<br />

Horst, D., 3319F<br />

Horst, J., 126, 3319F*<br />

Horst, J. A., 813F<br />

Horsthemke, B., 392,<br />

3496T, 3500T, 3524T<br />

Horvath, A., 1151F<br />

Horvath, G., 750T<br />

Horvath, R., 751F<br />

Horvath, S., 2256W, 2444F,<br />

2479T, 2553W, 2661W,<br />

3474T<br />

Hoseinpour Pheysi, A.,<br />

779W<br />

Hosen, M. J., 833F*,<br />

1790W, 3137W<br />

Hoskins, J., 1199F<br />

Hoskins, L., 1064F<br />

Hosoda, F., 396<br />

Hosokawa, M., 2174F<br />

Hosoki, K., 3056F*<br />

Hosomichi, K., 482W*<br />

Hosono, N., 396, 2174F<br />

Hosoya, T., 663F<br />

Hosseini, M., 1175F*<br />

Hosseini, R., 407<br />

Hosseini, S. M., 2109W*<br />

Hosseinipanah, M., 860T<br />

Hostetter, G., 1186T<br />

Hotate, M., 3091W<br />

Hotte, S., 1824F<br />

Hotte, S. J., 135<br />

Hottenga, J. J., 2175W<br />

Hou, C., 1996T, 2121W<br />

Hou, L., 189*, 2622W*<br />

Hou, X., 1662T, 1971W<br />

Houdayer, C., 1205F<br />

Houldcr<strong>of</strong>t, C., 2163W*<br />

Houlden, H., 2581T<br />

Houlston, R., 1072T, 1531F,<br />

2580W<br />

Hourlier, T., 506W<br />

Housawi, Y., 2785W, 2892F<br />

Houseman, E. A., 3629F<br />

Houshmand, M., 1056W,<br />

1124F, 1175F, 2367W,<br />

2976T, 3197W<br />

Housley, G. D., 2662W<br />

Houston, G. D., 529F, 2188T<br />

Houwing-Duistermaat, J. J.,<br />

2035T<br />

Hovanes, K., 954T, 3054F<br />

Hovatta, I., 2110T*, 2175W,<br />

2399F<br />

Hovatta, O., 807F<br />

Hovelson, D. H., 641T*<br />

Hoven, V., 2006F<br />

Hovingh, G. K., 1604T,<br />

2205W<br />

Hovnik, T., 2688F*, 2710W<br />

Howald, C., 506W*<br />

Howard, A., 3100F<br />

Howard, E., 474W<br />

Howard, K., 2109W<br />

Howard, M., 538W, 2689W<br />

Howard, M. A., 2779W<br />

Howard, P., 122<br />

Howard, T., 2143T<br />

Howard, T. A., 648T, 2331W<br />

Howell, S., 2158T, 2741T<br />

Howells, O. W., 262<br />

SPEAKER AND AUTHOR INDEX


366 SPEAKER AND AUTHOR INDEX<br />

Howerth, E., 2805F<br />

Howie, B., 88<br />

Howson, J., 453F<br />

Hoyer, J., 3235W*<br />

Hoyme, H. E., 3076F<br />

Hozayen, S., 1665T<br />

Hozumi, Y., 1317T<br />

Hrabé de Angelis, M.,<br />

2922F<br />

Hrdlickova, B., 523F<br />

Hrdý, P., 2865F<br />

Hromatka, B. S., 2111F*<br />

Hruska, K., 2579F<br />

Hruska, K. A., 1661T<br />

Hsi, E., 516W*<br />

Hsiao, C., 989F*, 3485T<br />

Hsiao, C. L., 2245T, 3457T*<br />

Hsiao, G., 493F<br />

Hsieh, A., 1557T<br />

Hsieh, A. R., 1380T*, 2245T<br />

Hsieh, C. L., 1214F<br />

Hsieh, M., 2768T*<br />

Hsieh, P. H., 3354T*<br />

Hsieh, W., 3596W*<br />

Hsiung, C., 629T, 989F,<br />

1608T<br />

Hsiung, C.-A., 1955F<br />

Hsiung, S., 3730W<br />

Hsu, C., 508W, 3678W*<br />

Hsu, C. F., 2768T<br />

Hsu, C. J., 2936T<br />

Hsu, C. N., 1439W, 1925F<br />

Hsu, E., 3644W<br />

Hsu, F. C., 123<br />

Hsu, J., 163<br />

Hsu, L., 1437T, 2268W*,<br />

2337W<br />

Hsu, S., 493F, 2571W,<br />

2606F<br />

Hsu, T. Y., 571F<br />

Hsu, Y., 945W, 953W<br />

Hsu, Y.-H., 1334W, 2052W*<br />

Hsueh, W. A., 1916F<br />

Hu, D., 158, 1075T, 1078T*,<br />

1152W, 1576F, 2195F,<br />

3303T<br />

Hu, F., 1357F, 2165F, 2354F<br />

Hu, F. B., 51<br />

Hu, H., 29*, 195*<br />

Hu, H. H., 1062W<br />

Hu, H. J., 3607F<br />

Hu, J., 904T, 2418W, 3561F<br />

Hu, J. J., 2202W<br />

Hu, K., 1905W, 3293W<br />

Hu, L., 1249T<br />

Hu, M., 1004F<br />

Hu, N., 1010F, 1076F,<br />

1218W<br />

Hu, O., 542W<br />

Hu, P., 1459F, 1508W*<br />

Hu, Q., 3428T<br />

Hu, R., 638T<br />

Hu, T., 1453F*, 2571W<br />

Hu, X., 1040F, 2250W,<br />

3553F<br />

Hu, Y., 170, 1036T, 1231T,<br />

1533T*, 1558F, 3355F*,<br />

3551F*<br />

Hu, Y. J., 1437T*<br />

Hu, Z., 984W, 2617T<br />

*Presenting Author<br />

Hua, X., 1511W<br />

Huang, A., 2779W, 3007T*,<br />

3021T<br />

Huang, B., 962T<br />

Huang, C., 516W, 1381F*,<br />

1894T, 2970T<br />

Huang, C.-C., 1666T*<br />

Huang, F.-Y., 2285F<br />

Huang, H., 241, 1403W,<br />

1515T, 1579F*, 1886F,<br />

3569F<br />

Huang, J., 116, 516W,<br />

668T*, 1509T*, 2259W,<br />

3604W<br />

Huang, J.-H., 2970T<br />

Huang, K., 537F, 1491T*,<br />

1917W*<br />

Huang, L., 198, 575F, 651T,<br />

701F, 1900T, 2800W<br />

Huang, M., 989F<br />

Huang, N., 43, 553F, 2982T<br />

Huang, Q., 673F, 1546F*,<br />

1693T<br />

Huang, R. S., 623T<br />

Huang, S., 613T, 1472W,<br />

2251T*<br />

Huang, S. W., 1586T<br />

Huang, T., 3467T<br />

Huang, W., 519F, 616T,<br />

818F, 1945T, 2819T,<br />

3493T, 3552W*, 3682W<br />

Huang, Y., 1662T*, 2181W*,<br />

2237F*, 2251T, 2262W,<br />

2320T, 2343W*, 2467T,<br />

2523W, 2581T, 2849T,<br />

3371W<br />

Huang, Y. A., 803W<br />

Hubbard, T., 367, 464W,<br />

506W<br />

Hübenthal, M., 2368T<br />

Huber, C., 3129W<br />

Huber, J., 941W, 1037F,<br />

1038W<br />

Huber, W., 551F<br />

Hubert, B., 2866W<br />

Hubert, C., 716T<br />

Hubert, P., 2674W<br />

Hubley, L., 1752W<br />

Hubley, R., 195, 3270T<br />

Hubner, N., 2102F<br />

Hucks, D., 136<br />

Huda, M. S. B., 3211W<br />

Huddleston, J., 375, 3296W<br />

Hudgins, L., 869W, 2989T<br />

Hudson, A., 3442T, 3452T<br />

Hudson, B., 3622W<br />

Hudson, B. I., 1638T<br />

Hudson, M. S., 50<br />

Hudson, T., 3478T<br />

Hudson, T. H., 1093T<br />

Hudson, T. J., 135<br />

Hudspith, K., 2939T<br />

Huebner, C., 1868F*<br />

Huen, K., 3458T*<br />

Huentelman, M. J., 2104T,<br />

3215W<br />

Huerta-Chagoya, A., 48<br />

Huerta-Sanchez, E., 3300T*<br />

Huesca, F., 3125W<br />

Huet, F., 2716W, 2792T<br />

Huether, C., 1860F<br />

Huff, C., 385<br />

Huff, C. D., 195, 3297T*,<br />

3378T, 3633F<br />

Hüffmeier, U., 2160W<br />

Hufnagel, R. B., 3194F,<br />

3212F*<br />

Huganir, R., 13, 2566T<br />

Huggins, G., 2083T<br />

Huggins, W., 1566T<br />

Hughes, A. E., 2843T*<br />

Hughes, D., 772W<br />

Hughes, J., 218<br />

Hughes, K., 2974T<br />

Hughes, M., 78<br />

Hughes, P., 529F, 2188T<br />

Hughes, T., 3510T, 3614W<br />

Hughes, T. M., 3275W<br />

Huh, I.-S., 269<br />

Huh, R., 3462T<br />

Huh, W. J., 3395W<br />

Hui, K., 17<br />

Hui, K. Y., 1320T*<br />

Huizing, M., 709F, 711F,<br />

755W, 1702T, 2838F,<br />

3080F<br />

Huizinga, T., 461F<br />

Hukema, R., 513F<br />

Hulick, P. J., 1225T<br />

Hu˚ lková, H., 322<br />

Hull, A. K., 1016F<br />

Hulme, W., 2603F, 3706W<br />

Hulme, W. F., 9, 341, 2318F,<br />

2572T<br />

Hulsh<strong>of</strong>f Pol, H. E., 2526W<br />

Hulsman, M., 1436W<br />

Hultén, M. A., 3032T<br />

Hultman, C., 290, 1325W,<br />

2487W<br />

Hultman, C. M., 2576F,<br />

2618F, 3442T, 3452T<br />

Humbert, M., 2690T<br />

Humbert, M. C., 323<br />

Hume, S., 1052F<br />

Humphray, S., 366, 1238F,<br />

3663F*<br />

Humphrey, M. B., 566W<br />

Humphreys, K., 1934F,<br />

2055W<br />

Humphreys, M. K., 206<br />

Humphreys, P., 701F,<br />

2794W<br />

Humphries, C. E., 341*<br />

Humphries, S. E., 122<br />

Hung, C., 655T, 1905W,<br />

2392T<br />

Hung, C. Y., 297*<br />

Hung, I. H., 828F*<br />

Hung, S., 3708W<br />

Hung, T., 3700W<br />

Hung, Y.-R., 1955F<br />

Hunt, C. A., 262<br />

Hunt, K. A., 155<br />

Hunt, K. J., 1662T<br />

Hunt, L., 1713T<br />

Hunt, P., 250<br />

Hunt, S., 1608T, 1653T,<br />

3669F<br />

Hunter, D., 205, 2165F,<br />

3413W<br />

Hunter, D. G., 2928F<br />

Hunter, D. J., 51, 1148F,<br />

1150T, 1390F<br />

Hunter, E., 36<br />

Hunter, J., 2063F<br />

Hunter, J. E., 3042F*<br />

Hunter, L. A., 2702T<br />

Hunter-Zinck, H., 3288T*<br />

Huntley, M., 1539T<br />

Huntsman, S., 158, 1075T,<br />

1576F<br />

Huo, D., 1003T<br />

Huovari, E., 1006T<br />

Hurba, O., 2831T<br />

Hurd, L. M., 2855T*<br />

Hurd, T. W., 406<br />

Hurle, B., 3306T<br />

Hurles, M., 43, 61, 101*,<br />

252, 291, 364, 453F,<br />

455F, 553F, 560W, 2576F,<br />

2812W, 2982T<br />

Hurtado, M. L., 926T<br />

Hurtado-Hernandez, L.,<br />

1018T*<br />

Husain, S. A., 1278W<br />

Husami, A., 1764W<br />

Huse, K., 580W<br />

Husemoen, L., 2317T<br />

Husgafvel-Pursiainen, K.,<br />

2120F<br />

Husni, J., 2411F<br />

Huso, N., 79, 240<br />

Huson, S. M., 33<br />

Huss, M., 1976F<br />

Hussain, K., 2709F<br />

Hussain, N., 70, 856T<br />

Hussain, W. M., 1100F<br />

Hussein, S., 1031F<br />

Hussin, J., 31*, 2266T,<br />

3260W, 3268F, 3341W<br />

Hussman, J. P., 2572T<br />

Hutchinson, A., 30, 1160F,<br />

1218W<br />

Hutchinson, H., 136<br />

Hutchinson, J., 1081T<br />

Huttner, A., 334<br />

Hutton, H., 3303T<br />

Huyck, K. L., 2056T<br />

Huyghe, J. R., 46*, 1452T<br />

Huynh, M., 267<br />

Huysseune, A., 833F<br />

Hveem, K., 1608T<br />

Hwa, V., 2706F<br />

Hwang, D., 2437T<br />

Hwang, H., 1590T<br />

Hwang, J.-H., 2119T<br />

Hwang, K. B., 3635F<br />

Hwang, S., 1653T*<br />

Hwang, S. J., 3673F<br />

Hwang, Y., 2437T, 3223W<br />

Hwang, Y. S., 3180F<br />

Hwu, C.-M., 1955F*<br />

Hwu, W.-L., 683F<br />

Hwu, W. L., 706T<br />

Hyde, C., 503F<br />

Hyde, C. L., 2804T<br />

Hyde, T., 2444F<br />

Hyland, F., 1232F, 3670W,<br />

3717F<br />

Hyland, P. L., 1010F*


Hyppönen, E., 271, 2097W<br />

Hysi, P. G., 335*, 2068T<br />

Hytonen, M. K., 2517W<br />

Iaconis, D., 2810T<br />

Iacono, W., 1568W<br />

Iacovelli, A. J., 2928F<br />

Iacoviello, L., 1712T<br />

Iakoucheva, L., 480W<br />

Iakoucheva, L. M., 2660F<br />

Ialongo, N., 2541W<br />

Ianakiev, P., 3529F<br />

Iannaccone, A., 1060T<br />

Ianni, B., 1593T<br />

Iannuzzi, M. C., 1895F<br />

Iba, Y., 2697F<br />

Ibarra, B., 2363F<br />

IBC BP Consortium, 1659T<br />

IBC-Lipids Consortium,<br />

1606T<br />

Ibrahim, J., 768W, 769W*<br />

Ibrahim, M., 3303T, 3338W<br />

Ibrahim, S., 167<br />

Ice, J. A., 529F*, 2084F,<br />

2188T<br />

Ichida, K., 663F<br />

Ichihara, Y., 2923W<br />

Ichikawa, M., 233<br />

Ichikawa, N., 2032T<br />

Ichikawa, Y., 52, 2409W<br />

Ickstadt, K., 1335T<br />

ICPCG, 1080W<br />

Ida, K., 2891T, 3051W<br />

Idaghdour, Y., 31, 2266T*,<br />

3260W, 3268F, 3341W<br />

Ide, W. T. S. T., 2394W,<br />

2876T<br />

Idiyatullin, D., 821F<br />

Idoni, B., 2857W<br />

Ieiri, I., 641T<br />

IFAR Collaboration Team,<br />

1069T<br />

Iglesias, A., 3046F<br />

Ignatius, J., 897W<br />

Igo, R. P., Jr., 1295W,<br />

2020T<br />

Iguchi, Y., 2472W<br />

Iida, M., 2174F<br />

Iijima, H., 1980W<br />

Iijima, K., 729F, 781W<br />

Iijima, M., 627T<br />

Iio, K., 3043W<br />

Ikari, K., 2004W, 2287T<br />

Ikeda, K., 2507F<br />

Ikeda, M., 264, 2576F<br />

Ikeda, Y., 2129F<br />

Ikegami, M., 3105W<br />

Ikemura, M., 52<br />

Ikesaki, A., 2656T<br />

Ikezawa, Z., 627T<br />

Ikram, M. A., 1592T<br />

Iles, M. M., 211<br />

Illei, G. G., 2084F<br />

Illig, T., 275, 2226W, 2548T,<br />

3536W<br />

Illson, M. L., 673F<br />

Im, H., 40, 623T*, 1505W<br />

*Presenting Author<br />

I<br />

Im, H. K., 269, 1495F,<br />

2196W<br />

Im, J. H., 571F<br />

Im, K. M., 1242W<br />

Imai, T., 2294F<br />

Imamura, A., 2652W<br />

Imaz-Rosshandler, I., 1129T<br />

Imbriano, P., 34<br />

Imperatore, R., 3492T<br />

Imtiaz, F., 2734W<br />

Inada, T., 2380T<br />

Inagaki, A., 59<br />

Inagaki, H., 475F*<br />

Inamori, Y., 2601W<br />

Inaoka, T., 1327F<br />

Inaoka, Y., 1321F*<br />

Inazawa, J., 914T<br />

Inbar-Feigenberg, M., 3420T<br />

Inchausti, V., 347, 2603F<br />

Incorpora, G., 2780T<br />

Indian Genome Variation<br />

Consortium, 3332W<br />

Indonesia Schizophrenia<br />

<strong>Genetics</strong> Consortium,<br />

2407T<br />

Indrieri, A., 2810T*<br />

Indugula, S. R., 1660T, 2159F<br />

Ingebrigtsen, M., 2965W<br />

Ingelman-Sundberg, M.,<br />

3460T<br />

Ingelsson, E., 108, 115, 117,<br />

1624T, 1707T, 1954T,<br />

1990T, 2074T, 2090F,<br />

2105F, 2123F, 2147F,<br />

2241W, 2358W<br />

Ingelsson, I., 2070W<br />

Ingelsson, M., 434W<br />

Ingersoll, R., 46<br />

Ingham, N. J., 105<br />

Ingles, S. A., 2202W<br />

Ingram, M. A. C., 2769F*<br />

INHANCE Consortium,<br />

1496W<br />

Inherited Neuropathies<br />

Consortium, 1871F<br />

Injeyan, M., 2971T<br />

Injeyan, M. C., 3013T*<br />

Inlow, M., 2531F<br />

Inman, R., 448W<br />

Innes, A. M., 2772F, 3095W,<br />

3127W, 3141W, 3173W<br />

Innes, A. .M., 2800W<br />

Innes, M. I., 3665F<br />

Innis, J. L., 2850F<br />

Innocenti, F., 613T<br />

Inoko, H., 2253W<br />

Inokuchi, T., 724T<br />

Inoue, I., 482W, 2253W,<br />

2349W<br />

Inoue, K., 234*<br />

Inoue, N., 234<br />

Inoue, S., 589F<br />

Inoue, Y., 2656T<br />

International Consortium for<br />

Prostate Cancer<br />

<strong>Genetics</strong>, 28, 986F,<br />

1001F, 1214F<br />

International Consortium<br />

<strong>of</strong> HCV Spontaneous<br />

Resolution, 3393W<br />

SPEAKER AND AUTHOR INDEX 367<br />

International<br />

Craniosynostosis<br />

Consortium, 3070F<br />

International EndoGene<br />

Consortium, GIANT<br />

Consortium, 2077T<br />

International <strong>Genetics</strong> <strong>of</strong><br />

Ankylosing Spondylitis<br />

and Wellcome Trust Case<br />

Control Consortia, 152<br />

International IBD <strong>Genetics</strong><br />

Consortium, 156, 319,<br />

1967F, 2229W<br />

International Multiple<br />

Sclerosis <strong>Genetics</strong><br />

Consortium, 151, 1415W<br />

International Primary<br />

Sclerosing Cholangitis<br />

Study Group and<br />

Immunochip Consortium,<br />

2101T<br />

Introne, W. J., 3080F<br />

Inui, K., 2917W<br />

Ioan, A., 461F<br />

Ioannidis, J. P. A., 109, 1462F<br />

Ionita-Laza, I., 1530T*<br />

Ionita-Lazza, I., 1431T<br />

Iossifov, I., 2587T*<br />

Iovannisci, D., 1352W<br />

Ip, W., 2953W<br />

Iqbal, Z., 41, 472W, 3279T<br />

Iribarren, C., 118, 434W<br />

Irminger, J., 556W<br />

Irvine, A. D., 83<br />

Irving, M., 2896W<br />

Irving, M. D., 780W*<br />

Irwan, I. D., 1934F<br />

Irwanto, A., 1117T, 2112W*<br />

Irwin, M., 2203T<br />

Isaacs, A., 119, 2106W,<br />

2193W*<br />

Isaacs, W., 28, 1001F<br />

Isaacs, W. B., 1080W, 1214F<br />

Isaksson, M., 3685F, 3709F,<br />

3729F<br />

Isasi, R., 1814F*<br />

Iscan, A., 2396F, 2412W<br />

Ishak, G. E., 2772F<br />

Ishida, M., 3508T<br />

Ishigaki, S., 2472W<br />

Ishiguro, H., 2380T<br />

Ishii, M., 559F*<br />

Ishikawa, K., 598W, 2371T*<br />

Ishiko, A., 2911W<br />

Ishiura, H., 52*, 233, 2409W,<br />

2569T<br />

Ishiy, F. A. A., 852F<br />

Ishiyama, I., 1833W*<br />

Ishizu, N., 2559W<br />

Ishizuka, Y., 2009F<br />

Ishpekova, B., 201, 2948T<br />

Isidor, B., 3066F, 3233W*<br />

Iskow, R., 3251W*, 3310F<br />

Ismail, P., 1083W<br />

Isobe, N., 2113T*<br />

Isohanni, M., 252<br />

Isohanni, P., 327<br />

Isomura, M., 1333F*<br />

Israni, A. K., 1428T<br />

Issa, R., 990W*<br />

Issacs, W., 2202W<br />

Istrail, S., 3024T<br />

Italia, M., 2904F<br />

Italia, M. J., 3590W<br />

Italian Autism Network,<br />

2548T, 2659T<br />

Itan, Y., 3599F*<br />

Itirli, G., 1106F<br />

Ito, H., 52<br />

Ito, I., 2647T<br />

Ito, J., 2822T<br />

Ito, K., 1677T<br />

Iuliano, A., 1985F, 3492T<br />

Ivanov, M., 3460T<br />

Ivanova, M., 838F<br />

Ivanovich, J., 132<br />

Ivarsson, A., 1330F<br />

Iwaki, A., 2400W, 2647T<br />

Iwamoto, K., 2435F, 2652W,<br />

3513T<br />

Iwamoto, S., 2009F*<br />

Iwarsson, E., 3032T*, 3245W<br />

Iwasa, H., 2923W<br />

Iwata, A., 52<br />

Iwata, N., 264, 2576F<br />

Iyengar, S. K., 1295W,<br />

2020T<br />

Iyer, A., 3695F*<br />

Izatt, L., 218<br />

Izatt, T., 1240T<br />

Izumi, K., 3058F*<br />

Izumi, Y., 52, 3221W,<br />

3229W<br />

Izumikawa, Y., 2758W<br />

Izzo, G., 439F*<br />

J<br />

Jaal, J., 1140W<br />

Jabado, N., 1182W<br />

Jabbour, F., 890T<br />

Jablonski, K., 249<br />

Jabre, N. A., 749F<br />

Jabs, E. W., 1472W, 2151W,<br />

2928F, 3154F<br />

Jabusch, H.-C., 200<br />

Jacinto, A., 2085W<br />

Jackson, A., 1608T,<br />

3654W*, 3694W<br />

Jackson, A. R., 3433T<br />

Jackson, A. U., 46, 1954T,<br />

2147F<br />

Jackson, J., 433F<br />

Jackson, J. M., 1310W<br />

Jackson, R., 1408F, 1585T,<br />

1925F, 2145W, 2337W<br />

Jackson, R. D., 109, 2336F<br />

Jackson-Cook, C., 3512T<br />

Jacob, C. M., 131<br />

Jacob, C. O., 1979F, 2046W<br />

Jacob, H., Session 3<br />

Jacobs, G., 515F<br />

Jacobs, K., 1154F, 1517W,<br />

3683F<br />

Jacobs, K. B., 30, 213,<br />

1160F, 1372F<br />

Jacobs, K. J., 1218W<br />

Jacobson, E., 2243F<br />

Jacobson, S. G., 2183F<br />

SPEAKER AND AUTHOR INDEX


368 SPEAKER AND AUTHOR INDEX<br />

Jacobsson, B., 3020T,<br />

3028T<br />

Jaconi, M. E., 807F<br />

Jacquemont, S., 62, 127,<br />

299*, 2458T<br />

Jacques, P., 123<br />

Jaddoe, V., 2164T<br />

Jaddoe, V. W. V., 1334W,<br />

2081F, 2162F, 2168F,<br />

2169W<br />

Jaeger, E. B., 1176W*,<br />

3686W<br />

Jaffe, D., 322<br />

Jaffrey, S., 376<br />

Jagadeesh, A., 2411F*<br />

Jaggawantru, S., 756W<br />

Jagomägi, T., 3079W<br />

Jahangirerad, A. J., 1096T<br />

Jahangiri, M., 1584T, 1675T<br />

Jaillard, S., 3170F<br />

Jaimes, G., 3069W<br />

Jain, P., 2556W<br />

Jain, S., 607T<br />

Jakkula, E., 2350T<br />

Jakobs, M., 1616T<br />

Jakobsen, J., 3528W<br />

Jakobsen, L., 126<br />

Jakobsen, R. R., 805F<br />

Jakobsson, M., 3356W<br />

Jakovski, Z., 3286F<br />

Jakubek, Y. A., 3628W*<br />

Jalaluddin Shariff, D., 1719W<br />

Jalil, S. F., 3078F*<br />

Jalkh, N., 2937F<br />

Jamain, S., 259*<br />

Jamal, S. M., 148, 301,<br />

1842F*<br />

Jamar, M., 925W<br />

Jameel, M., 2920W<br />

James, A. H., 2330F<br />

James, A. L., 1465F<br />

James, J., 2284T<br />

James, J. A., 549F, 1979F,<br />

2046W, 2084F<br />

James, P. A., 1224W<br />

James, S. J., 1459F<br />

James, T., 3663F<br />

Jameton, A., 1856F<br />

Jamieson, C. H. M., 1051T<br />

Jamshidi, M., 1117T*<br />

Janas, E., 2922F<br />

Janavicius, R., 1208F*<br />

Janecke, A., 2948T<br />

Janecke, A. R., 201<br />

Janevski, A., 3316F<br />

Jang, H., 1243T, 1657T<br />

Jang, I. J., 641T<br />

Jang, J. Y., 3223W<br />

Jang, W., 3625F<br />

Jang, Y., 1590T<br />

Janicsek, I., 3283F<br />

Jankipersadsing, S. A., 1330F<br />

Jankovic, J., 2581T<br />

Janmohamed, S. G., 745F<br />

Janousek, S. T., 718T<br />

Jansen, R. C., 1284T, 1503T<br />

Jansen Spayd, K., 1245W*,<br />

3687F<br />

Janson, A. A. M., 574W<br />

Janssen, A., 3137W<br />

*Presenting Author<br />

Janssen, I. M., 160<br />

Janssens, A. C., 2105F<br />

Janssens, S., 423F, 2225F<br />

Januszkiewicz-<br />

Lewandowska, D.,<br />

1057T*, 1184F<br />

Japanese Consortium for<br />

Amyotrophic Lateral<br />

Sclerosis Research<br />

(JaCALS), 3221W<br />

Jaquish, C., 2030F<br />

Jardim, L. B., 2424W*,<br />

2609F, 2626T, 2642F,<br />

2825T<br />

Jarhoor, F., 163<br />

Jarinova, O., 1645T<br />

Jaromi, L., 3283F<br />

Jarvela, I., 2181W<br />

Jarvelin, M., 252<br />

Järvelin, M. R., 271, 656T,<br />

1432F, 1528F, 1597T,<br />

1623T, 2162F*, 2164T,<br />

2173T, 2175W, 2366F,<br />

3435T<br />

Jarvik, G., 1447F, 2098T,<br />

3622W<br />

Jarvik, G. P., 170, 618T,<br />

1312F, 1605T, 1828F,<br />

2443T<br />

Järvinen, H. J., 1026W, 1276T<br />

Jarvis, J. P., 632T<br />

Jasinska, A., 2343W<br />

Jasinska, A. J., 2222F,<br />

2262W*, 2320T<br />

Jasmine, F., 1638T, 2025W<br />

Jasso, K., 2365T<br />

Jaswaney, V., 949W<br />

Jauregio, C., 2603F<br />

Javadi, G. H., 1124F<br />

Javed, A., 1556W*, 2631W*,<br />

3570W<br />

Javitz, H. S., 642T<br />

Jaworek, T., 2959W*<br />

Jaworski, J., 2508W, 2614T<br />

Jaworski, J. M., 9, 2572T<br />

Jaworski, M., 2242T*<br />

Jay, A., 3147W<br />

Jay, A. M., 885W<br />

Jay, F., 3356W*<br />

Jayakar, P., 1633T, 3175W<br />

Je, E., 1230W<br />

Jean, C., 1834F<br />

Jeandel, C., 3121W<br />

Jeandidier, B., 973W<br />

Jeanne, M., 1689T*, 2684T<br />

Jeannin, P., 1158W, 2248T,<br />

3137W<br />

Jee, S. H., 1472W<br />

Jeff, J., 1602T*<br />

Jeffrey, J., 3454T<br />

Jeffreys, A. J., 3257W<br />

Jeffries, N., 2247W<br />

Jego, G., 2716W<br />

Jego, L., 2792T<br />

Jelinska, C., 418W<br />

Jena, M., 3262F*<br />

Jenkins, D., 219, 2755W<br />

Jenkins, E., 859W*<br />

Jenkins, E. C., 1986W<br />

Jenkins, G., 603T<br />

Jenkins, G. D., 1426F,<br />

1449T<br />

Jenkins, L., 1748W<br />

Jenkins, M. A., 141, 1067F,<br />

1079F*, 1206W<br />

Jenkins, S. A., 2072F<br />

Jens, J., 785W<br />

Jens, J. K., 2717T<br />

Jensen, E., 1691T<br />

Jensen, K. M., 1867F<br />

Jensen, R., 2041T<br />

Jensen, T. J., 3014T*<br />

Jensen, T. S., 2369F<br />

Jeong, C., 2021F*<br />

Jeong, D. C., 2715F<br />

Jeong, E. K., 2529W<br />

Jeong, J., 1198T, 2313W<br />

Jeong, K., 3459T*<br />

Jepsen, S., 2058W<br />

Jerez, D., 2495F<br />

Jerome-Majewska, L. A.,<br />

831F, 848F<br />

Jessen, J., 2971T, 3196F<br />

Jesus, G., 1977W<br />

Jeter, J. M., 1087T<br />

Jett, C., 3053W<br />

Jewell, S., 368<br />

Jewett, E., 3357T*<br />

Jeyabalan, A., 1884W<br />

Jhala, D., 2731W*<br />

Jhamai, M., 3608W<br />

Jhangiani, S., 360, 2934F*<br />

Jhun, M. A., 2275T<br />

Ji, S.-M., 1622T<br />

Ji, T., 462W<br />

Jia, J., 1088F*, 1199F<br />

Jia, L., 690T<br />

Jia, P., 136, 3554W*, 3620W<br />

Jia, W., 3553F*<br />

Jia, X., 798W, 1934F, 2047T<br />

Jiang, G., 2279F<br />

Jiang, H., 159<br />

Jiang, L., 1221W, 1505W,<br />

3335W<br />

Jiang, M., 411<br />

Jiang, M. M., 2854W<br />

Jiang, M.-M., 2864T<br />

Jiang, P., 2636F<br />

Jiang, Q., 308*<br />

Jiang, R., 1142F, 2481W*<br />

Jiang, T., 3561F<br />

Jiang, X., 260, 2622W<br />

Jiang, Y., 462W, 1963T,<br />

2617T*, 3168F, 3237W<br />

Jiao, S., 1437T<br />

Jiao, W., 135<br />

Jimbo, E. F., 2588F, 3118F<br />

Jimenez, D. E., 3272W<br />

Jin, F. L., 3416T<br />

Jin, H., 1316W, 1377T,<br />

1928F, 3420T<br />

Jin, J., 579F<br />

Jin, L., 443F, 519F, 1499W,<br />

1508W, 2460W, 3265F,<br />

3308W, 3334F, 3355F,<br />

3358F, 3377W, 3379F,<br />

3394T<br />

Jin, M., 1359T<br />

Jin, P., 382, 2477F, 3483T<br />

Jin, S. C., 1472W<br />

Jin, W., 3334F, 3358F*,<br />

3394T<br />

Jin, X., 159*, 480W, 503F,<br />

2617T, 3300T, 3311W<br />

Jin, Y. J., 846F<br />

Jin, Y.-Y., 797W*<br />

Jinawath, N., 2918T*<br />

Jiralerspong, S., 8, 722T<br />

Jirsa, M., 570W<br />

Jo, E. J., 1298W<br />

Jobanputra, V., 957W,<br />

1031F*, 1600T<br />

Jobling, R., 717F*<br />

Jochim, A., 2086T<br />

Jockel, Y., 2058W<br />

Jocson, M., 3522T<br />

Joe, G., 711F<br />

Joecker, A., 3528W, 3641F,<br />

3662W<br />

Joehanes, R., 584W<br />

Joens, C., 547F<br />

Joensuu, T., 2898F<br />

Johannesson, M., 2505W<br />

Johansen, J., 621T<br />

Johansson, A., 2920W<br />

Johansson, B., 1023W,<br />

1024T, 1035W<br />

Johansson, H., 3685F,<br />

3729F*<br />

Johansson, K., 630T<br />

Johansson, L. F., 1619T<br />

Johansson, M., 1012T<br />

Johansson, P., 1259F<br />

Johansson, S., 2451W<br />

Johbanputra, V., 937W<br />

John, E. M., 1003T, 1075T,<br />

1213T, 2202W<br />

John, P., 2398T, 3078F<br />

John, S., Session 26, 3369T<br />

John, S. L., 503F, 2804T<br />

John, V., 1133F<br />

Johnatty, S., 210<br />

Johns, J., 1256F<br />

Johnson, A., 1091F, 1092W,<br />

1267T, 2063F<br />

Johnson, A. D., 174, 301,<br />

584W<br />

Johnson, B. F., 3708W<br />

Johnson, C. A., 403, 2955F<br />

Johnson, C. S., 3428T<br />

Johnson, D., 218, 3129W<br />

Johnson, E., 2114F*, 2650T,<br />

3561F<br />

Johnson, E. O., 1392T,<br />

2170T<br />

Johnson, F. K., 732T*<br />

Johnson, G. C., 2817F<br />

Johnson, G. S., 2805F,<br />

2817F, 2847F*<br />

Johnson, J., 2210F<br />

Johnson, J. A., 626T, 646T<br />

Johnson, J. O., 2611T<br />

Johnson, K., 765W, 1203W,<br />

1774W, 2054F<br />

Johnson, K. J., 3564W<br />

Johnson, K. R., 1878W<br />

Johnson, M., 1280W, 1394W<br />

Johnson, M. G., 1382W*<br />

Johnson, M. P., 533F, 1282F,<br />

1406W, 2061W, 2309F*


Johnson, N. A., 646T,<br />

3318T, 3383W<br />

Johnson, P., 1626T<br />

Johnson, R., 1267T<br />

Johnson, S., 309, 3359W*<br />

Johnson, T., 1400W*,<br />

1595T, 1659T, 2174F<br />

Johnson, T. A., 1552F*,<br />

2051F, 2071T<br />

Johnson, W. G., 2501F<br />

Johnson, Z., 595F<br />

Johnston, C., 3108F<br />

Johnston, J., 358*<br />

Johnston, J. J., 674T, 1696T<br />

Johnstone, L., 2788W<br />

Johnston IV, H. R., 3414W*<br />

John-Williams, K., 2586W,<br />

2637W<br />

Joint Committee <strong>of</strong><br />

NBSTRN Clinical Centers<br />

Workgroup and NCC/RC<br />

Long-Term Follow-Up<br />

Workgroup, 725F<br />

Jokinen, E. P., 1139F<br />

Jondeau, G., 56<br />

Jones, A., 2444F<br />

Jones, C., 113, 177, 186,<br />

1451W, 3664W<br />

Jones, C. M., 157, 1516F<br />

Jones, C. R., 2667F<br />

Jones, D. E., 153<br />

Jones, D. M., 945W<br />

Jones, G., 2292W<br />

Jones, J., 245, 940T<br />

Jones, J. R., 2901F*, 3684W<br />

Jones, K., 3512T<br />

Jones, K. L., 3076F<br />

Jones, K. W., 1142F<br />

Jones, M., 993W, 1092W<br />

Jones, M. A., 1758W*<br />

Jones, M. P. S., 1302T<br />

Jones, M. R., 1916F<br />

Jones, R. B., 614T<br />

Jones, S. J. M., 2772F<br />

Jones, S. M., 2663T<br />

Jones, T. J., 1878W<br />

Jones, W. D., 2896W*<br />

Jongbloed, J. D. H., 1619T,<br />

3650W<br />

Jongen, E., 708T<br />

Jonges, T., 400<br />

Jonsrud, C., 2965W<br />

Jonsson, R., 2084F<br />

Jonveaux, P., 2770W<br />

Joo, J., 1337W, 3555F*<br />

Joober, R., 2402F, 2558F<br />

Jordan, D. M., 3404T<br />

Jordan, J., 2052W<br />

Jordan, L., 1082F<br />

Jordanova, A., 201, 2948T<br />

Jorde, L. B., Session 81,<br />

195, 600F, 1904F, 3297T,<br />

3378T<br />

Jorge, A. A. L., 2706F<br />

Jorge, P., 2417F, 2631W<br />

Jorgensen, J., 1689T<br />

Jorgensen, M., 2262W<br />

Jorgensen, M. J., 2222F<br />

Jørgensen, N., 2041T,<br />

2707W<br />

*Presenting Author<br />

Jørgensen, T., 2317T, 2347T<br />

Jorgenson, E., 2269T,<br />

3655F*<br />

Jorgez, C., 2979T*<br />

Jose, P., 245<br />

Josefsberg, S., 3162F<br />

Joseph, P., 1295W<br />

Joseph, V., 17, 998F, 999W,<br />

1159T*<br />

Joseph-George, A. M.,<br />

3100F<br />

Joset, P., 2595W<br />

Joshi, A. D., 191<br />

Joshi, P., 1383T*<br />

Joshi, S., 3669F<br />

Jossic, F., 77, 403<br />

Jostins, L., 153, 354,<br />

1967F*<br />

Jouan, l., 2306F<br />

Jouan, L., 2342F*<br />

Jouanolle, A. M., 2126F<br />

Jouhilahti, E. M., 1139F*<br />

Joun, D., 1209W, 1246T*,<br />

3278W, 3714W<br />

Jourdain, A.-S., 3172F<br />

Jouzi, M., 3656W, 3703F<br />

Jovanovic, A., 772W<br />

Jowett, J., 1280W<br />

Jowett, J. B., 2308T<br />

Joy, J. B., 375<br />

Joyce, C., 455F<br />

Joyce, P. R., 3440T<br />

Joyner, A., 3670W<br />

Joyner, A. H., 1232F*<br />

Jozaki, K., 3432T, 3519T<br />

Ju, W., 1986W<br />

Ju, Y., 1248W, 1384F<br />

Ju, Y. S., 3259F, 3463T<br />

Juan, G., 1923W<br />

Juang, J., 1608T<br />

Juárez-Velázquez, R.,<br />

1131W, 1141T*<br />

Judkins, T., 1021T<br />

Juengst, E. T., 1848W<br />

Jugurnauth-Little, S., 205,<br />

1011W<br />

Jula, A., 2173T, 2366F<br />

Julian, C. G., 3290W<br />

Julien, C., 2234F, 2945T<br />

Jumper, C., 2197T*<br />

Jun, G., 170, 176, 343, 385,<br />

1448W, 1476T, 1513F*,<br />

1545T, 2308T, 2339F,<br />

2528F*, 3664W<br />

Jun, H. S., 2712F*<br />

Juneblad, K., 2160W<br />

Jung, B., 3135W<br />

Jung, C. W., 1007F, 1103F<br />

Jung, E., 3103W<br />

Jung, H., 1051T<br />

Jung, J., 2828T, 3189W<br />

Jung, J. K., 846F<br />

Jung, Y., 1248W, 2273F*<br />

Junier, T., 3263W<br />

Junkins, H. A., 1566T,<br />

2108F, 2155T*<br />

Juo, S., 511F, 516W, 2357F<br />

Juo, S. H. H., 1586T<br />

Juonala, M., 2120F<br />

Jurado-Medina, L. S., 3362W<br />

SPEAKER AND AUTHOR INDEX 369<br />

Juretic, N., 2343W<br />

Just, J., 1941W<br />

Just, S., 1612T<br />

Justice, A., 1913F*, 2090F,<br />

2123F, 2147F, 2241W,<br />

3359W<br />

Justice, A. E., 1954T<br />

Justice, C. M., 1983W*,<br />

2151W, 3070F<br />

Justice, M., 389, 840F, 850F,<br />

2678T<br />

Juul, A., 2707W<br />

Juusola, J., 3512T<br />

Juyal, R. C., 2941W<br />

Jyothy, A., 224<br />

K<br />

Kääb, S., 86<br />

Kaad, P.-H., 889W<br />

Kaakinen, M., 190, 1432F,<br />

1597T*, 2162F<br />

Kaariainen, H., 1835W*<br />

Kaasik, K., 2667F*<br />

Kabakchiev, B., 42*<br />

Kabashi, E., 2820F<br />

Kabashima, K., 2911W<br />

Kabesch, M., 2102F, 2226W<br />

Kabra, M., 918T, 2844F,<br />

2941W<br />

Kabwama, S., 3494T<br />

Kacevska, M., 3460T<br />

Kachelries, K., 2252F<br />

Kachelries, K. E., 1997F<br />

Kaci, N., 763W<br />

Kaczmarek, L. K., 202<br />

Kadam, N. N., 3010T<br />

Kaderali, L., 1236W<br />

Kadivar, M., 754W<br />

Kadowaki, T., 2071T<br />

Kagami, M., 3499T<br />

Kaganovich, M., 525F*,<br />

604T<br />

Kahali, B., 2090F, 2241W,<br />

2275T<br />

Kähler, A. K., 2576F<br />

Kahn, J. P., 259<br />

Kahn, R. S., 431F, 2526W,<br />

2553W, 2661W, 3474T<br />

Kahn, S., 249<br />

Kahns, L., 3641F, 3662W<br />

Kähönen, M., 2097W, 2120F<br />

Kai, L., 3574W<br />

Kain, S., 3699F<br />

Kaiser, F. J., 204, 2958F<br />

Kaisermann, M., 1858F*<br />

Kaitila, O., 1015T<br />

Kaji, R., 52, 3221W, 3229W<br />

Kakavand, A., 2964F<br />

Kakiuchi, C., 2370W, 2435F,<br />

2652W<br />

Kaklamani, V., 1292W<br />

Kakourou, G., 2995T<br />

Kalari, K., 603T<br />

Kalari, K. R., 1247F<br />

Kaler, S., 235*<br />

Kaler, S. G., Session 10,<br />

791W, 2686W<br />

Kalia, S. S., 1825W<br />

Kalil, J., 1593T<br />

Kalin, N. H., 595F, 2413T<br />

Kalinsky, K., 1255T<br />

Kalish, J., 3082F*<br />

Kalkanoglu-Sivri, H. S.,<br />

702T<br />

Kalkan Ucar, S., 3214F<br />

Kalkwarf, H. J., 812F<br />

Kallela, M., 2348F<br />

Kalli, K. R., 1238F, 3451T<br />

Kallioniemi, A., 1006T<br />

Kals, M., 3079W, 3460T*<br />

Kalscheuer, V. M., 2732T,<br />

3165W<br />

Kalyoncu, S., 3003T<br />

Kamalakaran, S., 3316F<br />

Kamali, N. P., 1675T<br />

Kamamoto, M., 1574W<br />

Kamarainen, O., 1874F<br />

Kamatani, N., 396, 1643T,<br />

2004W, 2174F<br />

Kamatani, Y., 1640T<br />

Kamate, M., 700T, 2803W<br />

Kamaya, M., 559F<br />

Kamberov, E., 3689F<br />

Kamboh, M. I., 343, 1647T,<br />

1672T, 1673T, 2099F,<br />

2125T, 2521T, 3078F<br />

Kambouris, M., 2713W,<br />

2728W, 2899W*, 3140F,<br />

3526W<br />

Kamel-Reid, S., 135<br />

Kamen, D. L., 1662T, 1979F,<br />

3371W<br />

Kaminker, J., 1539T<br />

Kaminska, A., 202, 2536T<br />

Kaminsky, E. B., 917W<br />

Kamio, Y., 2440T<br />

Kamiya, A., 2458T<br />

Kammerer, C., 1641T, 1650T<br />

Kammerer, C. M., 1672T,<br />

1673T, 1920W, 1921T<br />

Kamnasaran, D., 3060F,<br />

3071W, 3232F<br />

Kamp, A., 82<br />

Kamp, T. J., 2885T<br />

Kamphans, T., 3556W*<br />

Kamps, R., 708T<br />

Kamsteeg, E. J., 160, 216,<br />

1734W*<br />

Kamsteeg, E.-J., 214<br />

Kan, M., 93, 2336F, 2337W*<br />

Kan, S.-H., 695F*, 734T<br />

Kan, S.-h., 785W<br />

Kan, S. H., 697F<br />

Kan, Z., 1369F<br />

Kanaan, M., 2772F, 2919F*<br />

Kanafani, S., 3109W<br />

Kanagawa, M., 232<br />

Kaname, T., 2758W*<br />

Kanapin, A., 2939T<br />

Kanavakis, E., 84, 2995T<br />

Kanber, D., 392<br />

Kanchi, K., 1203W<br />

Kandoth, C., 1203W<br />

Kanesky, A., 858T<br />

Kanetsky, P. A., 211, 213<br />

Kang, A., 3223W<br />

Kang, C., 1248W<br />

Kang, E., 39, 1337W*<br />

SPEAKER AND AUTHOR INDEX


370 SPEAKER AND AUTHOR INDEX<br />

Kang, E. Y., 1480F<br />

Kang, H., 662T, 733F*,<br />

1533T, 2769F<br />

Kang, H.-M., 170<br />

Kang, H. M., 108, 154,<br />

172, 177, 1398T, 1446T,<br />

1448W, 1510F*, 1525F,<br />

1545T, 3405W, 3664W<br />

Kang, J., 1248W<br />

Kang, J. H., 1887W, 2154W,<br />

2240F, 2263T<br />

Kang, K., 900T<br />

Kang, L., 3293W*<br />

Kang, M. S., 2093F<br />

Kang, S., 2660F<br />

Kang, S.-H., 898T<br />

Kang, S.-H. L., 432W, 952T,<br />

2395T<br />

Kang, Y., 2225F<br />

Kangas, A. J., 1623T<br />

Kangas, J., 1611T<br />

Kaniecki, K., 1731W<br />

Kanik, A., 1746W<br />

Kannan, R., 3240F<br />

Kannankeril, P. J., 247<br />

Kannengiesser, C., 29<br />

Kanninga, R., 1330F<br />

Kanno, E., 1984T<br />

Kannu, P., 1738W<br />

Kanoni, S., 106, 115*, 3453T<br />

Kant, S., 2701W, 3271F<br />

Kant, S. G., 131, 2925F<br />

Kantarci, S., 315, 950T*<br />

Kantesaria, M., 3370F<br />

Kanthaswamy, S., 595F<br />

Kao, A. H., 2099F<br />

Kao, C., 2229W*, 2492F,<br />

2524T<br />

Kao, L., 350<br />

Kao, L. W. H., 1381F<br />

Kao, W. H., 1932W<br />

Kao, W. H. L., 2210F<br />

Kao, Y., 2392T<br />

Kapalanga, J., 3518T*<br />

Kaper, F., 596W*, 942T,<br />

3619F<br />

Kaphingst, K. A., 316<br />

Kaplan, J., 324, 390, 2320T<br />

Kaplan, J. R., 2222F<br />

Kaplan, L. D., 2185T<br />

Kaplan, R. C., 2080T<br />

Kaplonski, N., 490W<br />

Kapoor, A., 305*<br />

Kapoor, M., 2582F*, 2598W<br />

Kapoor, R., 1134W, 1135T<br />

Kaprio, J., 252, 2022W,<br />

2110T, 2175W, 2256W,<br />

2350T<br />

Kaptoge, S., 109<br />

Kapur, R., 2890W<br />

Karaca, E., 360, 965W,<br />

2719W, 2881W, 2908W*,<br />

3222F<br />

Karacan, I., 2412W<br />

Karaer, K., 3195W<br />

Karafet, T. M., 2788W<br />

Karagas, M. R., 1091F,<br />

1453F<br />

Karagrigoriou, A., 3017T<br />

Karakas, M., 111, 2073W<br />

*Presenting Author<br />

Karaleftheri, M., 2044T,<br />

3396T<br />

Karasik, D., 1334W<br />

Karatas, A. F., 3150F<br />

Karbaschi, M., 1270T*<br />

Karbowski, J., 3709F<br />

Karchin, R., 1731W, 2180F,<br />

2305T<br />

Karczeski, B. A., 3448T<br />

Karczewski, K., 551F, 568W<br />

Karczewski, K. J., 425F,<br />

562W*, 646T<br />

Kardia, S., 113<br />

Karfunkel, D., 2919F<br />

Karim, L., 708T<br />

Karimé, B., 2965W<br />

Karimi, A., 3020T<br />

Kariminejad, A., 2436W<br />

Kariminejad, M., 2436W<br />

Karimipoor, M., 1118F,<br />

1726W<br />

Kariuki, S. N., 2046W*<br />

Karjalainen, J., 108, 523F,<br />

1503T*<br />

Karki, C., 2020T<br />

Karkucak, M., 590W<br />

Karlberg, O., 567F, 3217W,<br />

3427T<br />

Karlin-Neumann, G., 3690W<br />

Karlinsky, L., 3185W<br />

Karlsen, T. H., 2101T<br />

Karlsson, R., 991T*, 1189T,<br />

1990T<br />

Karma, K., 2181W<br />

Karns, R., 1660T<br />

Karolak, J., 934T<br />

Karolchick, D., 3557F<br />

Karolchik, D., 3612W<br />

Karp, D., 1901F, 2284T<br />

Karp, N. A., 105<br />

Karpati, M., 2691F<br />

Karppinen, A., 1253F<br />

Karppinen, J., 1892F<br />

Karssen, L., 2107T<br />

Karssen, L. C., 459F<br />

Kart, H., 980T<br />

Kartmann, H., 86<br />

Karyadi, D. M., 2219F<br />

Karydas, A. M., 2639F<br />

Kasai, K., 2370W, 2435F,<br />

2652W<br />

Kasai, Y., 3724W<br />

Kasapcopur, O., 2841F<br />

Kasapçopur, O., 3132F<br />

Kasarskis, A., 3724W<br />

Kasberger, J., 2269T<br />

Kaschnitz, W., 2570F<br />

Kascsak, R., 2449T<br />

Kase, R., 132<br />

Kashef-Haghighi, D., 397<br />

Kashif, S., 2075F<br />

Kashihara, K., 2559W<br />

Kashimura, A., 598W*<br />

Kashiwagi, K., 1980W<br />

Kasiman, K., 1707T*<br />

Kask, M., 1140W*<br />

Kasowski, M., 551F, 3505T*<br />

Kasper, R. S., 632T<br />

Kastelein, J. J. P., 1604T<br />

Kasten, M., 200<br />

Kasterstein, E., 3002T<br />

Kasuga, H., 663F<br />

Kasvin-Felton, J., 1366F<br />

Kataja, V., 1125W<br />

Kataoka, N., 781W<br />

Kathiresan, S., 115, 117,<br />

170, 280, 350, 1331W,<br />

1677T, 2199W<br />

Katiyar, N., 2491T*, 3542W<br />

Kato, H., 2873T<br />

Kato, K., 1815W, 1848W*<br />

Kato, M., 3136F, 3326W<br />

Kato, N., 3284W<br />

Kato, R., 2963T<br />

Kato, T., 1549F, 2652W,<br />

3513T<br />

Katsanis, N., 3, 13, 98,<br />

310, 386, 2458T, 2955F,<br />

3296W<br />

Katsanis, S. H., 3<br />

Katsuno, M., 2472W<br />

Katsuya, T., 1987T<br />

Kattman, B. L., 1762W<br />

Katz, M., 784W<br />

Katz, M. L., 2805F, 2817F<br />

Katz, M. S., 306<br />

Katz-Jaffe, M. G., 851F*,<br />

2968T<br />

Kaudwell, G., 1304W<br />

Kauff, N., 1841W<br />

Kauffman, T., 1869F<br />

Kauffman, W. B., 1689T<br />

Kauffmann, F., 1461T,<br />

1941W<br />

Kaufman, D., Session 9,<br />

1829W, 2625W<br />

Kaufman, K., 1901F<br />

Kaufman, K. M., 2046W,<br />

3371W<br />

Kaufmann, S., 1238F<br />

Kaukinen, K., 2023T, 2177F<br />

Kaul, N., 1993T<br />

Kaunisto, M. A., 2348F<br />

Kaur, G., 2941W<br />

Kaur, K., 133<br />

Kaur, M., 861W, 3058F<br />

Kaur, N., 1890W*<br />

Kaur, P., 410<br />

Kaur, R., 1891T*<br />

Kaur, S., 1026W<br />

Kaur, V., 50<br />

Kausar, T., 2959W<br />

Kauwe, J. S. K., 340*,<br />

3643F<br />

Kavakli, I. H., 2592W<br />

Kavalla, R., 2056T<br />

Kavitha, H., 1044W<br />

Kawada, A., 3146F<br />

Kawaguchi, T., 2174F<br />

Kawahara, N., 1290T<br />

Kawakami, H., 3229W<br />

Kawakami, K., 309<br />

Kawal, P., 1177T*<br />

Kawame, A., 2697F<br />

Kawame, H., 3043W<br />

Kawamura, H., 2656T<br />

Kawamura, Y., 663F, 2370W<br />

Kawano, Y., 2400W<br />

Kawarai, T., 52<br />

Kawasawa, Y., 2444F<br />

Kawashima, M., 1831W,<br />

2349W, 3301F*<br />

Kay, C., 265<br />

Kay, D. M., 2151W<br />

Kay, J., 230<br />

Kay, T., 2916F<br />

Kaya, H., 590W<br />

Kayabasi, C., 1178F*<br />

Kayama, T., 1549F<br />

Kaye, F. J., 1162T<br />

Kaye, J., 1848W<br />

Kaye, J. A., 2643W<br />

Kayserili, H., 1, 214, 216<br />

Kayserilli, H., 2863W<br />

Kazan, H., 1551T<br />

Kazazian, H. H., 336, 1229F<br />

Kazkaz, L. A., 1490W<br />

Kazma, R., 1250F, 1469W*,<br />

1496W, 3655F<br />

kConFab, 1224W<br />

kConFab, BCFR, 1213T<br />

kConFab Investigators,<br />

AOCS Group, 1492F<br />

Keane, C., 1042T<br />

Kearney, H. M., 958T<br />

Kearns, M., 1506T<br />

Kearns, W. G., 78, 2998T<br />

Keating, B., 1659T, 2063F<br />

Keating, B. J., 1606T<br />

Keating, S., 2971T, 3075W<br />

Keavney, B., 219<br />

Keddache, M., 573F, 690T<br />

Keegan, C. E., 313<br />

Keegan, L. P., 577F<br />

Keen, K., 123<br />

Keenan, B., 380<br />

Keenan, B. T., 2250W,<br />

3417T, 3450T<br />

Keenan, K., 1322W, 2953W<br />

Keene, K., 1971W<br />

Keene, K. L., 1662T<br />

Keeney, J. G., 433F, 835F*<br />

Keerthikumar, S., 3316F<br />

Kefer, N., 515F<br />

Kehdy, F., 1119W, 3325F<br />

Kehl, H. G., 2759T<br />

Kehrer-Sawatzki, H., 939W,<br />

2791W<br />

Keikhaei, B., 2714T<br />

Keil, T., 2102F<br />

Keildson, S., 44, 583F,<br />

2187W*, 3441T<br />

Keinan, A., 183*, 187<br />

Keith, M. E., 1192T*<br />

Kekis, M., 2696T<br />

Kelempisioti, A., 1892F*<br />

Kellam, P., 1507F, 2163W<br />

Keller, A., 186, 515F, 2368T<br />

Keller, M., 2722W<br />

Keller, M. A., 632T<br />

Keller, M. C., 2239T<br />

Kelley, J. L., 285<br />

Kelley, R. I., 105<br />

Kelliher, E., 322<br />

Kellis, M., Session 5, 380,<br />

3291T, 3417T, 3450T<br />

Kelly, E., 1190F<br />

Kelly, J., 953W, 2284T<br />

Kelly, J. A., 529F, 1901F,<br />

1979F, 2188T


Kelly, J. C., 945W<br />

Kelsey, K. T., 3629F<br />

Kelsh, R. N., 363<br />

Kelso, J., 3274F<br />

Kemmotsu, Y., 1631T<br />

Kemp, J., 1567F, 2081F,<br />

2164T<br />

Kemp, J. P., 1318F, 1528F,<br />

1583W, 2169W*<br />

Kempers, M., 128<br />

Kempers, M. J. E., 80,<br />

955W<br />

Kenan, B., 624T<br />

Kendall, F. D., 330<br />

Kendall, J., 2587T<br />

Kendler, K., 3512T<br />

Kendler, K. S., 2500T,<br />

2504F, 2594F, 2599T<br />

Keni, J., 3059W<br />

Kennedy, C., 1729W,<br />

3680W<br />

Kennedy, C. J., 3640W*<br />

Kennedy, D., 784W<br />

Kennedy, J., 628T<br />

Kennedy, J. L., 612T,<br />

2376W, 2608T, 2657F<br />

Kennedy, M. A., 3440T*<br />

Kennedy, R. B., 1426F<br />

Kennedy, S. H., 2133W<br />

Kennedy-Darling, J., 1269W<br />

Kennerknecht, I., 2861T<br />

Kennerson, M., 2742F*<br />

Kenney, M. C., 1963T<br />

Kenny, E., 3362W, 3563F<br />

Kenny, E. E., 293, 3360T*,<br />

3380W, 3390T<br />

Kent, A., 1848W<br />

Kent, J., 414W, 673F,<br />

1280W*, 3612W<br />

Kent, J. W., 1923W<br />

Kent, J. W., Jr., 1406W<br />

Kent, M., 2805F<br />

Kent, W. J., 3557F*<br />

Kenyon, C., Session 26<br />

Keogh, J., 43<br />

Keong, G. T., 1117T<br />

Keppler-Noreuil, K. M., 82,<br />

404<br />

Keravnou, A., 3017T<br />

Kere, J., 154, 1976F, 3631F<br />

Keren, B., 889W, 2770W<br />

Kerkh<strong>of</strong>, M., 2167T<br />

Kerkis, I., 1102T<br />

Kerlikowske, K., 1576F<br />

Kerns, S., 1309F*<br />

Kerr, B., 2852T<br />

Kerr, D., 1072T<br />

Kerr, E., 142<br />

Kerr, K. F., 1661T<br />

Kerr, M., 2821W<br />

Kerscher, T., 2102F<br />

Kershberg, H., 1866F*<br />

Kersten, F. J., 1<br />

Keshavan, R., 440W*<br />

Keshava Prasad, T. S.,<br />

3316F<br />

Kesler, J., 949W<br />

Kesselman, C., 3587F<br />

Kessner, D., 476W<br />

Kessner, D. E., 3626W*<br />

*Presenting Author<br />

Kestelyn, P. G., 2927T<br />

Ketterer, E. A., 2329T<br />

Kettunen, J., 584W, 656T*,<br />

1284T, 1503T, 2110T,<br />

2173T<br />

Keupp, K., 3214F<br />

Keve, S., 784W<br />

Kevelam, S. H., 2848W<br />

Keydar, I., 2875W<br />

Keys, D., 1146W, 1195T,<br />

3725F<br />

Keyser, M., 3671F*<br />

Khabbaz, K., 3469T<br />

Khabour, O., 855W*, 856T<br />

Khachane, A. N., 3442T<br />

Khadem, F., 3501T<br />

Khademian, H., 682T*<br />

Khader, M., 855W<br />

Khaldi, K., 2306F<br />

Khaledifar, A., 1596T<br />

Khalfallah, O., 817F<br />

Khalil, S., 2302T<br />

Khan, B. K., 2639F<br />

Khan, J., 1259F<br />

Khan, J. C., 2072F<br />

Khan, M., 865W<br />

Khan, N., 2680W<br />

Khan, S., 209, 1265F,<br />

2949F*<br />

Khanduzi, S. R. K., 1096T<br />

KhanKhanian, P., 2113T,<br />

3330T<br />

Khanna, H., 2680W<br />

Khanna, R., 732T<br />

Khantane, S., 2674W<br />

Khare, M., 3144F, 3213W*<br />

Kharrazi, M., 3238F<br />

Khatir, A. S., 1615T<br />

Khatri, S. M., 820F<br />

Khazen, G., 3349F<br />

Khazraee, H., 2008T<br />

Khazraei, H., 1421W<br />

Khil, P., 417F, 592W<br />

Kho, A., 811F, 2098T,<br />

3622W<br />

Kho, A. L., 2945T<br />

Kho, J., 165<br />

Kho, M., 1656T*<br />

Khokher, Z., 682T<br />

Kholodov, M., 3582W<br />

Khoo, S. J., 2491T<br />

Khor, C. C., 2094W, 3284W,<br />

3339T<br />

Khosroheidari, M., 1953W<br />

Ki, A., 963W<br />

Kiani, S., 3700W<br />

Kibar, Z., 850F, 1910F,<br />

2075F, 2692W<br />

Kibel, A., 1210T<br />

Kibriya, M., 2025W<br />

Kida, K., 726T<br />

Kida, M., 1092W<br />

Kida, Y., 598W, 599F*<br />

Kidambi, A., 2742F<br />

Kidd, A., 967W<br />

Kidd, J., 285<br />

Kidd, J. M., 371, 3352F,<br />

3361F, 3368W, 3411W<br />

Kidd, K. K., 3313F<br />

Kidd, L., 1339F<br />

SPEAKER AND AUTHOR INDEX 371<br />

Kido, T., 1179W*, 1831W*<br />

Kiefer, A., 1825W<br />

Kiefer, A. K., 106, 114, 626T,<br />

1017W, 1782W, 2087F,<br />

2089T, 2100W, 2115W*,<br />

2127W, 2149T<br />

Kiehl, T.-R., 2428T<br />

Kiel, D. P., 109<br />

Kielbasa, S., 298<br />

Kielty, C., 2852T<br />

Kiemeney, L. A., 106, 431F<br />

Kiemeney, L. A. L. M., 87<br />

Kievit, W., 621T<br />

Kiezun, A., 25*<br />

Kikuchi, H., 2400W, 2923W<br />

Kilambi, K. P., 308<br />

Kilaru, V., 1422T, 3480T<br />

Kilembe, W., 36<br />

Killary, A., 1095W<br />

Kilpeläinen, T. O., 2116T*<br />

Kilpinen, H., 415F<br />

Kim, A., 2723T<br />

Kim, A. S., 838F<br />

Kim, B., 389*, 2518T, 2678T,<br />

3462T<br />

Kim, B. J., 840F<br />

Kim, C., 319, 895W, 896T,<br />

899W, 1915T, 2121W,<br />

2229W, 2252F, 2492F,<br />

2514W, 2785W, 2856F,<br />

2872W, 2892F*, 3573F<br />

Kim, C. A., 2232W, 2863W,<br />

3152F, 3160F, 3184F,<br />

3250F<br />

Kim, C. E., 812F, 1996T,<br />

1997F<br />

Kim, D., 2723T<br />

Kim, D. H., 1007F, 1103F<br />

Kim, D. K., 3223W<br />

Kim, D. S. K., 2443T*<br />

Kim, E., 1608T<br />

Kim, G. H., 698T<br />

Kim, G.-H., 3227W*<br />

Kim, H., 589F, 947W, 1243T,<br />

1384F*, 2117F*, 2117F,<br />

2200T, 2221T, 3103W,<br />

3223W, 3473T, 3485T<br />

Kim, H.-G., 2732T*<br />

Kim, H. S., 3423T<br />

Kim, I.-K.., 385<br />

Kim, I. K., 1305T<br />

Kim, J., 3, 269, 678T, 866T*,<br />

866T, 867W, 947W,<br />

1248W, 1384F, 1385W*,<br />

2151W, 2200T, 2437T,<br />

2518T, 2828T*, 3112F,<br />

3151W, 3178F, 3423T,<br />

3462T, 3473T<br />

Kim, J. C., 706T*, 719F<br />

Kim, J. H., 470W*, 1975T*,<br />

3607F<br />

Kim, J.-I., 1931F<br />

Kim, J. I., 3463T<br />

Kim, J.-M., 3227W<br />

Kim, J.-W., 1007F, 1103F<br />

Kim, J. Y., 846F*<br />

Kim, K., 66, 1656T, 2437T,<br />

3462T<br />

Kim, K. J., 3180F<br />

Kim, K. M., 698T<br />

Kim, M., 900T, 947W,<br />

1230W, 2715F, 3008T,<br />

3461T, 3567F<br />

Kim, M. O., 846F<br />

Kim, P. M., 1551T<br />

Kim, S., 488W, 1007F,<br />

1103F*, 1103F, 2511W,<br />

2518T, 3008T, 3151W,<br />

3461T*<br />

Kim, S.-H., 1007F, 1103F<br />

Kim, S. H., 846F<br />

Kim, S. J., 863W<br />

Kim, S. K., 3014T<br />

Kim, S. Y., 3607F<br />

Kim, T., 1551T<br />

Kim, T. K., 452W<br />

Kim, W., 1338T<br />

Kim, W. R., 2118W*<br />

Kim, W. Y., 1046F<br />

Kim, Y., 488W*, 947W,<br />

999W, 1248W, 1347T*,<br />

1363F, 1396F, 2060F,<br />

2151W, 2468F, 2715F,<br />

2828T, 3178F*, 3444T,<br />

3462T, 3616W<br />

Kim, Y. J., 269<br />

Kim, Y.-M., 3227W<br />

Kim, Y. M., 698T<br />

Kimani, J., 3276T<br />

Kimball, A., 861W<br />

Kimberly, R. P., 306, 1979F,<br />

2046W, 3371W<br />

Kim-Howard, X., 307,<br />

1572T*<br />

Kimmel, M., 3273T, 3549F<br />

Kimonis, V., 1791W, 2151W,<br />

3249W<br />

Kimonis, V. E., 757W, 3144F,<br />

3213W<br />

Kimura, M., 1574W, 2747T*<br />

Kimura, R., 1327F<br />

King, C. R., 2333F<br />

King, J. S., Session 79<br />

King, M.-C., Session 1, 26,<br />

263, 287, 1089W, 1228T,<br />

2600F, 2756T, 1226F,<br />

2929W<br />

King, O. D., 2962W<br />

King, R., 3321T<br />

King, R. A., 261, 2602T<br />

Kingery, M., 239<br />

Kingman, G., 3562W<br />

Kingsbury, Z., 366, 1238F,<br />

3663F<br />

Kingsmore, S. F., Session 73,<br />

366, 2793F, 2894T<br />

Kingston, H., 2852T<br />

Kingwattanakul, P., 2006F<br />

Kini, A., 2492F<br />

Kini, U., 131<br />

Kinnamon, D., 1544W<br />

Kinnamon, D. D., 2603F<br />

Kinney, D., 1746W*<br />

Kinnula, V., 1114T<br />

Kinoshita, S., 2129F<br />

Kinoshita, T., 298<br />

Kinross, C., 3668W*<br />

Kinsella, M., 1043F<br />

Kinsler, V. A., 303*<br />

Kinstlinger, N., 507F<br />

SPEAKER AND AUTHOR INDEX


372 SPEAKER AND AUTHOR INDEX<br />

Kipps, T. J., 395<br />

Kirby, A., 322*, 1725W<br />

Kirby, J., 348<br />

Kircher, M., 3274F<br />

Kirchh<strong>of</strong>f, M., 889W<br />

Kirchh<strong>of</strong>f, T., 208, 1159T<br />

Kirectepe, A. K., 2841F*<br />

Kirel, B., 2704W<br />

Kiridly, J. F., 306<br />

Kirillova, I., 251<br />

Kirk, A., 2779W<br />

Kirk, E., 131<br />

Kirk, E. P., 217<br />

Kirk, K., 1147T<br />

Kirkup, V., 3612W<br />

Kirmani, S., 2575T<br />

Kirmes, I., 849F<br />

Kirov, G., 1325W, 2576F<br />

Kirsanov, K., 1180T*, 1181F<br />

Kirwin, S. M., 2855T<br />

Kiryiya, M., 1638T<br />

Kiryluk, K., 845F<br />

Kishi, F., 1631T<br />

Kishino, H., 2440T<br />

Kishita, Y., 2873T<br />

Kiss, A., 2761W<br />

Kisselev, S., 442W, 1898F<br />

Kissell, D., 1764W<br />

Kitabayashi, N., 1100F<br />

Kitaichi, K., 2647T<br />

Kitajima, H., 3436T*<br />

Kitamura, Y., 2009F<br />

Kitaoka, T., 1684T<br />

Kitchen, R., 2444F<br />

Kitchens, C. S., 2330F<br />

Kitsiou, S., 84, 2937F<br />

Kittles, R. A., 1009T, 2014T*,<br />

2087F, 2202W, 2281T<br />

Kitts, A., 3582W<br />

Kitzis, A., 77<br />

Kitzman, J., 311<br />

Kitzman, J. O., 74*, 94,<br />

1014W<br />

Kivimaki, M., 1621T<br />

Kivirikko, S., 2002T<br />

Kivisild, T., 3322F<br />

Klaften, M., 2922F<br />

Klambauer, G., 1483F,<br />

1486F<br />

Klanderman, B., 638T<br />

Klar, J., 2920W*<br />

Klautau-Guimarães, M. N.,<br />

3375T<br />

Klebe, S., 29<br />

Kleber, M. E., 2116T<br />

Kleefstra, T., 97, 100, 102,<br />

125, 3159W<br />

Klei, L., 553F<br />

Kleiber, M. L., 378<br />

Klein, A. P., 3616W<br />

Klein, B., 2041T<br />

Klein, B. E., 2109W<br />

Klein, C., 200, 204, 672T<br />

Klein, D., 633T, 635T<br />

Klein, E., 2779W<br />

Klein, H.-G., 3539F<br />

Klein, M. L., 2183F<br />

Klein, O. D., 2151W, 3242F<br />

Klein, R., 208, 2041T,<br />

2109W<br />

*Presenting Author<br />

Klein, R. J., 1100F, 1159T<br />

Klein, T. E., 633T, 635T, 646T<br />

Kleinhanz, R., 2220W<br />

Kleinheinz, J., 2759T<br />

Klein-Hitpass, L., 3524T<br />

Kleinman, J., 2444F<br />

Kleinman, J. E., 260, 2622W<br />

Klemm, S., 3037W<br />

Klemm, T., 2328W<br />

Klengel, T., 1422T, 2483F<br />

Klepacka, D., 905W<br />

Klepp, O., 991T<br />

Kleta, R., 199<br />

Klevit, R. E., 2929W<br />

Klimentidis, Y., 1460W<br />

Klimentidis, Y. C., 2201F*<br />

Kline, A. D., 861W*<br />

Kline, J., 1600T<br />

Klinedinst, D., 310<br />

Klink, B., 1236W<br />

Klobus, A. B., 704T<br />

Klocke, B., 3536W<br />

Kloosterman, W., 400, 423F,<br />

459F, 672T<br />

Kloosterman, W. P., 217,<br />

2886F<br />

Kloske, D. A., 1245W,<br />

3527F, 3687F<br />

Kloss-Brandstätter, A.,<br />

3319F<br />

Klotzle, B., 596W, 3451T<br />

Klovins, J., 608T*<br />

Kluck, N., 106<br />

Kluemper, G., 2243F<br />

Kluger, Y., 579F<br />

Klugman, S., 1793W, 3022T<br />

Kluijt, I., 3200F<br />

Klünemann, H. H., 684T<br />

Klungel, O. H., 243, 609T<br />

Kluwe, L., 2791W<br />

Kmoch, S., 322, 752T<br />

Knapp, M., 2088W, 3333T<br />

Knappskog, P. M., 2451W<br />

Knauf, F., 2568W<br />

Knekt, P., 2110T<br />

Knight, J., 154, 628T,<br />

1927T*, 2376W<br />

Knight, J. C., 373, 563F<br />

Knight, S. J., 218<br />

Knight, S. J. L., 219<br />

Knight-Madden, J., 2043W<br />

Knoener, R., 1269W<br />

Knoers, N. V., 217, 3164F<br />

Knoers, N. V. A. M., 216,<br />

2848W, 2886F<br />

Knoll, J. H., 3672W<br />

Knoppers, B. M., 1823W,<br />

1848W<br />

Knower, W., 2038T<br />

Knowler, W., 249<br />

Knowler, W. C., 1300F,<br />

1953W, 2018F, 2124W<br />

Knowles, D., 1440T<br />

Knowles, J., 2444F<br />

Knowles, J. A., 2564F, 3587F<br />

Knowles, J. W., 1624T<br />

Knowles, M., 2953W<br />

Knowles, M. R., 171, 406,<br />

1322W, 2851W<br />

Knowlton, A. A., 1625T<br />

Knowlton, M. N., 2675T<br />

Knudsen, B., 3641F, 3662W<br />

Knutsen, R., 1699T<br />

Knuutila, S., 2888T<br />

Ko, A., 278<br />

Ko, D. C., 2186F*<br />

Ko, J., 877W, 3204F<br />

Ko, J. M., 787W, 3180F*<br />

Ko, W., 3303T<br />

Kobayashi, G. S., 814F*<br />

Kobayashi, K., 232, 2550W,<br />

2963T*, 3513T<br />

Kobayashi, M., 3230F<br />

Kobayashi, Y., 1771W<br />

Kobes, S., 1953W, 2038T,<br />

2124W<br />

Koboldt, D., 1203W, 1210T<br />

Kobor, M., 3734W<br />

Kobrynski, L. J., 2312F<br />

Kobzik, L., 811F<br />

Kocak, M., 3480T<br />

Koch, C., 328<br />

Koch, M., 328<br />

Kochi, Y., 1984T, 2004W<br />

Kockum, I., 1455T, 1939T,<br />

2276F<br />

Kodama, H., 2836W<br />

Kodama, K., 1462F<br />

Kodaman, N., 3388F*<br />

Kodati, V. L., 1893W<br />

Köehler, S., 2725W<br />

Koellinger, P. D., 2505W<br />

Koen, L., 644T<br />

Koenekoop, R., 1779W<br />

Koenen, K., 435F<br />

Koenig, B., Session 25<br />

Koenig, B. A., 1849W<br />

Koenig, M. K., 1761W<br />

Koesterer, R., 2503T<br />

Koestler, D., 3465T<br />

Koestler, D. C., 3451T,<br />

3629F*<br />

Koetters, T., 1965W<br />

Koga, A., 468W<br />

Kogawa, R., 2861T<br />

Kogevinas, M., 1091F<br />

Kogon, B., 1679T<br />

Koh, D. X. R., 3267T<br />

Koh, I., 3462T*<br />

Kohaar, I., 1091F, 1092W*,<br />

1094F<br />

Kohane, I. S., 1769W,<br />

1836F, 1843W, 3635F<br />

Kohda, K., 2370W<br />

Kohda, M., 2873T*, 2923W<br />

Kohl, I., 895W<br />

Kohl, M., 2315F<br />

Kohlbacher, O., 1200W,<br />

1233W<br />

Kohli, A., 493F<br />

Kohli, M. A., 341, 2583W,<br />

2586W, 2637W*<br />

Kohli, M. M., 347<br />

Kohli, S., 1720W<br />

Kohlmann, W., 1783W<br />

Kohno, Y., 2294F<br />

Kohut, A., 3038F<br />

Koiffmann, C., 895W<br />

Koike, A., 2130W, 2349W*,<br />

2496W<br />

Koike, S., 2435F<br />

Koivisto, K., 2350T<br />

Koivunen, P., 3297T<br />

Koizumi, A., 589F<br />

Koizumi, H., 52<br />

Kojima, K., 2588F*<br />

Kojima, M., 2440T<br />

Kojima, R., 559F<br />

Kok, C., 2007W<br />

Kok, J. N., 1436W<br />

Kokabee, L., 1118F*<br />

Kokabee, M., 1118F<br />

Kokocinski, F., 506W<br />

Koks, S., 154<br />

Kokubo, Y., 1730W, 2559W<br />

Kol, N., 2919F<br />

Kolberg, J. A., 2347T<br />

Kolb-Kokocinski, A., 2044T,<br />

3396T<br />

Kolde, R., 1163F<br />

Kolder, I. C. R. M., 35*<br />

Kolek, V., 2103W<br />

Koller, D., 368, 369, 2136W,<br />

2372F<br />

Kolodkin, A. L., 308<br />

Kolomietz, E., 460W<br />

Kolonel, L. N., 2202W<br />

Kolundzija, A. B., 1957T<br />

Komarovsky, D., 3002T<br />

Komorowski, R., 1667T<br />

Komosa, M., 1046F, 1047W,<br />

1050W<br />

Komski, A., 3002T<br />

Kondkar, A., 2997T*<br />

Kondo, E., 2963T<br />

Kondo, S., 2264F<br />

Kondo, T., 1795W<br />

Kondoh, T., 2891T<br />

Kondova, I., 3266W<br />

Kone, A., 2255F<br />

Konecny, G., 3451T<br />

Konen, O., 105<br />

Kong, A., Session 75, 2279F<br />

Kong, B., 1246T, 3278W,<br />

3714W<br />

Kong, B. S. G., 1209W*<br />

Kong, L., 3604W<br />

Kong, S., 3635F*<br />

Kong, S. W., 1769W<br />

Kong, X., 2249F<br />

Konialis, C., 2902W<br />

Konidari, I., 9, 270, 2049W*,<br />

2318F, 2378F, 2508W,<br />

2572T, 2603F, 2614T<br />

Konigorski, S., 3490T<br />

Konkashbaev, A., 2197T,<br />

2333F, 3735F<br />

Konkel, M. K., 3270T*<br />

Konstantopoulou, I., 1191W,<br />

1228T<br />

Kontula, K., 2023T<br />

Koolen, D. A., 97<br />

Koon, S. J., 1909T<br />

Kooner, J. S., 110, 115,<br />

3435T<br />

Kooperberg, C., 170, 1408F,<br />

1437T, 1608T, 1925F,<br />

2131T<br />

Koornh<strong>of</strong>, P., 1808F<br />

Kooshavar, D., 2952F*


Kooy, F., 2527T*<br />

Kopajtich, R., 699F*<br />

Kopp, J., 2073W<br />

Koppelman, G., 2167T,<br />

2168F<br />

Korabecna, M., 3437T*<br />

Koralnik, I. J., 2561F<br />

Koran, M., 2532W*<br />

Korbel, J., 551F<br />

Korbonits, M., 2708T<br />

Korean Autism Genetic<br />

Study Consortium,<br />

2518T<br />

Koreeda, Y., 2601W<br />

Koren, A., 480W<br />

Korenaga, M., 2130W<br />

Korenberg, J., 538W<br />

Korenberg, J. R., 2529W*<br />

Korendowych, E., 2160W<br />

Korf, I., 552W, 3479T<br />

Korinthenberg, R., 2812W<br />

Kormanik, K., 662T*<br />

Kornak, U., 129<br />

Kornberg, Z., 2779W<br />

Korneliussen, T., 2311T,<br />

3312T<br />

Kornreich, R., 1777W,<br />

3724W<br />

Korponay-Szabo, I., 2177F<br />

Kors, J. A., 2193W<br />

Korshunov, A., 1182W<br />

Korzh, V., 3047W<br />

Kos, M. Z., 2589W*, 2651F<br />

Kosaihira, S., 1697T<br />

Kosaki, K., 2882T, 3093W,<br />

3105W<br />

Kosaki, R., 2882T, 3093W*<br />

Koscielska, K. A., 2632T*<br />

Kosho, T., 3043W<br />

Kosho, T., 2697F, 3230F*<br />

Koskelainen, T., 1892F<br />

Koskinen, S., 1835W, 2350T<br />

Kosma, V.-M., 1114T,<br />

1125W<br />

Kosova, B., 1025F<br />

Kosova, G., 2327F*<br />

Kosoy, R., 2360F<br />

Kostem, E., 1386T*<br />

Koster, R., 213<br />

Kostiha, B., 2833W<br />

Kosuga, M., 726T*<br />

Kotecha, U., 1720W, 2754F<br />

Kotecha, U. H., 3236F*<br />

Kote-Jarai, Z., 205, 1011W*,<br />

1109F, 1148F<br />

Kotkiewicz, H., 465F<br />

Kottgen, A., 1932W<br />

Kotti, S., 609T<br />

Koudijs, M., 400<br />

Koumbaris, G., 3017T<br />

Kousi, M., 3<br />

Koutras, C., 2528F<br />

Kovač, J., 2688F<br />

Kovac, V., 714T, 785W<br />

Kovacevic, L., 3286F<br />

Kovacevic, S., 3286F<br />

Kovach, J. L., 2028W,<br />

2318F<br />

Kovacs, B., 520W<br />

Koval, V., 459F, 3608W*<br />

*Presenting Author<br />

Kowall, N., 2437T<br />

Kowalski, T. W., 2270F<br />

Kowgier, M., 2167T*<br />

Kozak, K., 1093T<br />

Kozan, S., 1136F<br />

Kozel, B., 1699T*<br />

Kozhaya, L., 713F<br />

Kozicz, T., 672T<br />

Kozlov, S., 2914W<br />

Kozlowski, P., 1745W<br />

Kozol, R., 2445W<br />

Kozubek, J., 385<br />

Kozyrskyj, A. L., 1465F<br />

Kraaij, R., 3608W<br />

Kraft, P., 191, 205, 318,<br />

356*, 1148F, 1150T,<br />

1331W, 1390F, 3413W<br />

Krahn, T., 3377W<br />

Kraig, E., 1406W<br />

Kraja, A. T., 1641T*, 1650T<br />

Krakow, D., 838F, 2857W,<br />

2874F<br />

Krakow, D. A., 2740W<br />

Kral, A., 2114F<br />

Kral, A. H., 2170T<br />

Kral, B. G., 1652T<br />

Kramer, J., 2598W, 2666T<br />

Kramer, M., 2180F, 2590T,<br />

3316F<br />

Krantz, I., 3038F, 3058F<br />

Krantz, I. D., 861W, 2695W,<br />

2958F<br />

Kranzler, H., 2207F, 2497T<br />

Kranzler, H. R., 2503T,<br />

2621F<br />

Krapels, I. P. C., 1711T*<br />

Krarup, H., 2862F<br />

Krasnow, R., 642T<br />

Kratochvilova, H., 752T<br />

Kratter, I. H., 2643W<br />

Kratz, C., 213<br />

Kratz, C. P., 132<br />

Kraus, C., 3235W<br />

Kraus, W., 3541F<br />

Kraus, W. E., 1444F, 1594T,<br />

1636T<br />

Krause, A., 1794W<br />

Krauss, R., 1442W<br />

Krauss, R. M., 601T, 615T<br />

Krawczak, M., 580W, 1943F,<br />

3364F, 3402T<br />

Krawisz, A., 2479T<br />

Krawitz, P. M., 298*, 3556W<br />

Kreeftmeijer, J., 400<br />

Kreft, M., 2848W<br />

Kreger, K., 1829W<br />

Kreiger, P. A., 33<br />

Kreimer, A., 193*<br />

Kreiner-Møller, E., 2167T<br />

Kremer, H., 1, 58*, 59,<br />

2955F<br />

Kremmer, E., 86<br />

Krepischi, A. C., 891W,<br />

903W, 919W<br />

Krepischi, A. C. V., 439F<br />

Krepkiy, V., 1152W<br />

Kress, W., 2681T<br />

Kretzler, M., 3405W<br />

Kretzschmar, W., 3306T<br />

Krex, D., 1236W<br />

SPEAKER AND AUTHOR INDEX 373<br />

Krieger, H., 1343W, 2352W<br />

Krieger, J. E., 636T, 1629T<br />

Kriek, M., 2701W<br />

Kringen, M. K., 576W, 643T*<br />

Krinsky-McHale, S., 859W<br />

Krintel, S., 621T<br />

Kriouele, Y., 3246F<br />

Krishnamurthi, S., 3139W*<br />

Krishnappa, R. S., 1957T<br />

Krishnaswami, B., 1232F<br />

Kristiansen, K., 2311T<br />

Kristiansen, W., 991T<br />

Kristiansson, K., 252,<br />

2116T, 2132F<br />

Krist<strong>of</strong>fersson, U., 1877F<br />

Krist<strong>of</strong>ice, M., 885W<br />

Kroes, T., 97<br />

Kroetz, D. L., 2258F<br />

Krogh, V., 1712T<br />

Kroisel, P., 126<br />

Kroisel, P. M., 3111W,<br />

3116F*<br />

Krolewski, A. S., 2313W<br />

Krom, Y., 2840T<br />

Kronenberg, F., 1595T,<br />

3319F<br />

Kronenberg, Z., 195, 3633F*<br />

Kronengold, J., 202<br />

Kronick, J., 720T<br />

Kruczek, P., 2966T<br />

Krueger, G. G., 1952F<br />

Krug, T., 2085W<br />

Krüger, U., 298<br />

Kruglyak, S., 596W<br />

Kruisselbrink, T. M., 2906T<br />

Krumbiegel, M., 3235W<br />

Krumina, Z., 672T<br />

Krumm, N., 10, 12*, 93,<br />

2897T<br />

Krumsiek, J., 2226W<br />

Krupp, D., 2340W*<br />

Krupp, L., 1924T<br />

Kruppa, J., 275<br />

Krus, U., 47<br />

Kruse, E., 507F<br />

Kruszka, P., 721F*<br />

Kru˚ tová, M., 2745F<br />

Krylov, V., 2831T<br />

Krystal, J. H., 2621F<br />

Krystkowiak, P., 345<br />

Kryukov, G., 25<br />

Ku, C. R., 739F<br />

Kuang, Q., 1108T<br />

Kuang, Y., 2985T<br />

Kuang, Y. L., 615T<br />

Kubaski, F., 747F*<br />

Kubisch, C., 1, 105<br />

Kubly, V. J., 1909T<br />

Kubo, M., 396, 627T, 1552F,<br />

1631T, 1643T, 2004W,<br />

2051F, 2071T, 2174F,<br />

2294F, 2506T<br />

Kubota, I., 1549F<br />

Kubota, T., 2835F*<br />

Kuchenbaecker, K., 208*<br />

Kuchenbaecker, K. B., 207<br />

Kuchinsky, A., 3588W<br />

Kuchroo, M., 2250W<br />

Kucinskas, V., 920T*<br />

Kučinskas, V., 653T<br />

Kucinskiene, Z., 920T<br />

Kučinskiene · , Z. A., 653T<br />

Kuczynski, E., 3030T<br />

Kudoh, J., 2882T, 2911W*<br />

Kuechler, A., 2760F<br />

Kuersten, S., 585F, 3718W<br />

Kuga, A., 232<br />

Kugathasan, S., 1381F,<br />

2312F<br />

Kuh, D., 2282F<br />

Kuhn, J., 3214F<br />

Kuhn, R., 3557F<br />

Kuipers, E., 2141F<br />

Kuit, B., 809F<br />

Kuivenhoven, J. A., 2205W<br />

Kujala, E., 1835W<br />

Kujala, P., 1000T<br />

Kujala, U. M., 2134T<br />

Kukreti, R., 607T<br />

Kukshal, P., 2382W*<br />

Kukull, W. A., 343<br />

Kukurba, K., 568W<br />

Kukurba, K. R., 527F*<br />

Kulesha, E., 3636W<br />

Kuliev, A., 251*<br />

Kulikowski, L., 896T*, 899W<br />

Kulikowski, L. D., 3045W<br />

Kulkarni, H., 3434T<br />

Kulkarni, R., 2330F<br />

Kulkarni, S., 912T, 1028F<br />

Kulkarni, V., 975W, 3726W<br />

Kulle, B., 1581T<br />

Kuller, L., 2080T<br />

Kullo, I., 2098T, 3622W<br />

Kullo, I. J., 618T, 1312F,<br />

1447F<br />

Kulminski, A., 1991F, 2027F,<br />

2194T*<br />

Kulzer, J. R., 304*<br />

Kumabe, M., 2046W<br />

Kumagai, T., 2748F<br />

Kumanduri, V., 497F<br />

Kumano, K., 233<br />

Kumanovics, A., 495F,<br />

2720T<br />

Kumar, A., 10, 1188W,<br />

1519F*, 2446T, 2776W*<br />

Kumar, A. A., 2046W<br />

Kumar, G., 3442T, 3452T<br />

Kumar, J., 1990T*<br />

Kumar, P., 3316F<br />

Kumar, R., 1177T, 2700F<br />

Kumar, S., 533F*, 1137W,<br />

2308T, 2339F, 2859F*,<br />

3316F*<br />

Kumar, V., 429F, 1330F,<br />

2088W, 2733F*<br />

Kumar, Y., 3701F<br />

Kumaraguruparan, G.,<br />

3558W*<br />

Kumari, M., 1621T<br />

Kumasaka, N., 2174F,<br />

3507T*<br />

Kummar, S., 1068W<br />

Kundaje, A., 3505T<br />

Kuningas, M., 2366F<br />

Kunkel, L. M., 1836F,<br />

2962W<br />

Kunst, H. P. M., 58, 1220F<br />

Kunstmann, E., 2356T<br />

SPEAKER AND AUTHOR INDEX


374 SPEAKER AND AUTHOR INDEX<br />

Kuo, C., 1570F*<br />

Kuo, C. L., 2768T<br />

Kuo, C.-L., 1364W<br />

Kuo, D. S., 2684T<br />

Kuo, J. Z., 130, 2153F<br />

Kuo, P., 2000F, 2524T<br />

Kuo, W., 1249T<br />

Kuo, Y., 3467T<br />

Kupershmidt, I., 1183T,<br />

1190F<br />

Kupert, E. Y., 1454W<br />

Kuracha, M. R., 2731W<br />

Kurahashi, H., 232, 475F<br />

Kural, D., 3395W<br />

Kurapati, R., 3730W<br />

Kurbatova, N., 567F, 582W<br />

Kurdoglu, A. A., 3215W<br />

Kure, S., 1290T<br />

Kurek, M., 2102F<br />

Kurian, M. A., 1773W<br />

Kurihara, I., 76<br />

Kurita, T., 2569T<br />

Kuroda, Y., 2891T, 3051W*<br />

Kuroiwa, Y., 1290T<br />

Kurokawa, M., 233<br />

Kurosawa, K., 1795W,<br />

2758W, 2891T*, 3051W,<br />

3091W, 3094F<br />

Kurppa, K., 2023T, 2177F<br />

Kurtzberg, J., 3<br />

Kury, S., 3066F<br />

Küry, S., 1204T<br />

Kussmann, J., 3101W<br />

Kuster, J., 1958F<br />

Kusters, B., 1220F<br />

Kustra, R., 3490T<br />

Kusumawhardani, A. A. A.<br />

A., 2407T<br />

Kusunoki, N., 729F<br />

Kutalik, Z., 62, 108, 299,<br />

1281T, 1387F*, 2116T<br />

Kutilova, M., 601T<br />

Kutkowska, A., 216<br />

Kutlar, A., 2247W<br />

Kutsche, K., 2810T<br />

Kutta, A., 814F<br />

Kutuk, O., 1746W<br />

Kuusisto, J., 46, 2256W<br />

Kuusisto, K. M., 992F*<br />

Kuwahara, M., 2911W<br />

Kuzawa, C. W., 2036F<br />

Kuzuhara, S., 1730W,<br />

2559W<br />

Kvale, M., 96, 112*, 421F,<br />

2513F, 3342T, 3383W<br />

Kvale, M. N., 118, 2140T<br />

Kvist, U., 3032T<br />

Kwak, Y., 2518T<br />

Kwan, A., 362, 377<br />

Kwan, J., 1093T, 3559F*<br />

Kwan, S., 21<br />

Kwan, T., 256, 569F,<br />

3439T<br />

Kwok, P., 112, 118, 2140T,<br />

2513F, 3342T<br />

Kwok, P. Y., 620T, 1694T,<br />

3383W<br />

Kwok, P.-Y., 421F, 2926W<br />

Kwok, S. K., 3158F<br />

Kwon, A., 947W*, 2715F<br />

*Presenting Author<br />

Kwon, M. S., 1385W<br />

Kwon, O.-S., 1931F<br />

Kwong, A., 177, 981W,<br />

3664W*<br />

Kyaw, E. E. P., 3034T<br />

Kypri, E., 3017T<br />

Kyriakou, S., 3017T<br />

Kyriazopoulou-<br />

Panagiotopoulou, S.,<br />

3505T<br />

L<br />

Laakman, A., 759W<br />

Laakso, A., 1253F<br />

Laakso, E. O., 47<br />

Laakso, M., 46, 88, 1117T,<br />

1608T, 1624T, 2256W,<br />

3455T<br />

Läärä, E., 1597T<br />

Labalme, A., 944T<br />

Labate, A., 2766F, 2780T<br />

Labelle-Dumais, C., 1689T,<br />

2684T<br />

Laberge, A. M., 1733W,<br />

1784W*<br />

Labonte, B., 2482T<br />

Labonté, B., 3470T<br />

Laborde, S., 716T<br />

Labrèze, C., 83<br />

Labrie, V., 3490T*<br />

Labuda, D., 1478W, 2790F<br />

Lacassie, Y., 3057W*<br />

Lacbawan, L., 693F<br />

Lacerenza, D., 550W<br />

Lach, F., 999W<br />

Lachance, J., 283*<br />

Lachance, S., 850F*<br />

La Chance Touchette, P.,<br />

2306F<br />

Lachenko, S., 302<br />

Lacher, M., 1159T<br />

Lackner, C., 1115F<br />

Lackner, K. J., 1669T<br />

Lacombe, D., 124, 473F,<br />

716T, 841F, 3172F<br />

Lacorte, L., 1119W*<br />

Lacoste, C., 2536T<br />

Lacour, A., 1423F*<br />

Lacro, R. V., 82<br />

LaCroix, A. Z., 2145W<br />

Lacroix, J., 778W*<br />

LaDana, C., 3154F<br />

Ladd-Acosta, C., 463F<br />

Ladeira, M. S., 1187F<br />

Ladenvall, C., 2076W,<br />

2187W<br />

Ladner, M., 1589T<br />

Ladouceur, M., 1678T,<br />

1982F, 2319W<br />

Lærum, H., 3614W<br />

LaFauci, G., 2449T<br />

Lafay-Cousin, L., 1052F<br />

Lafek, M., 750T<br />

Laforêt, P., 328<br />

Laframboise, R., 2790F<br />

LaFramboise, T., 1231T<br />

LaFreniere, D., 2474F<br />

Lafrenière, R. G., 2338T<br />

Lagace, F., 2866W<br />

Laganiere, J., 803W<br />

Lage, K., 805F<br />

Lagou, V., 190*, 2106W<br />

Lagström, S., 897W<br />

Lahjouji, F., 2306F<br />

Lahtinen, T., 327<br />

Lai, A., 3707F*<br />

Lai, A. H. M., 2889F<br />

Lai, C. Q., 2024F<br />

Lai, I., 3467T<br />

Lai, J., 2786T<br />

Lai, P. S., 771W*<br />

Lai, S., 177, 1120T*, 1516F,<br />

2198F, 2329T<br />

Lai, Y. C., 667F<br />

Laidre, P., 1140W<br />

Laine, M., 2058W<br />

Laing, S. M., 745F<br />

Laird, C. D., 1580W<br />

Laird, N., 1431T, 1526W,<br />

2346W<br />

Lajonchere, C., 2617T<br />

Lakshman Kumar, B.,<br />

1044W<br />

Lal, D., 2489F<br />

Lalani, S., 898T, 2942T<br />

Lalani, S. R., 229, 432W,<br />

952T, 2395T<br />

Lalanne, E., 9<br />

Laliberte, A., 76<br />

Läll, K., 1792W, 3353W<br />

Lally, C., 611T<br />

Lally, K. P., 834F<br />

Lalonde, E., 752T<br />

Lam, C. S. P., 2080T<br />

Lam, C. T., 680T*<br />

Lam, E. T., 2517W<br />

Lam, L., 3734W<br />

Lam, V., 2279F, 2280W<br />

LaMadrid-Herrmannsfeldt,<br />

M., 530W<br />

Lamantea, E., 164<br />

Lamari, F., 2820F<br />

Lamb, A. N., 886T<br />

Lamb, D., 2979T<br />

Lambert, B., 2179T<br />

Lambert, B. W., 194<br />

Lambert, C., 3303T, 3338W<br />

Lambert, L., 2792T<br />

Lambert, S., 2729T<br />

Lambourne, J. J., 3439T*<br />

Lambrecht, B., 2225F<br />

Lamb Thrush, D., 912T<br />

Lamb Thrush, L., 456W<br />

Lameijer, E., 459F<br />

Lameiras, L., 1778W<br />

Lamghari, H., 2306F<br />

Lammer, E., 75, 1589T<br />

Lammer, E. J., 1352W,<br />

1885T<br />

Lamnissou, K., 3017T<br />

Lamont, R., 910T, 3141W<br />

Lamontagne, M., 1655T,<br />

1947W*<br />

Lamparter, D., 1387F<br />

Lampe, A. K., 218<br />

Lamport, D., 3119W<br />

Lan, F., 1036T<br />

Lancaster, O., 3610W<br />

Lancet, D., 53, 2875W<br />

Landais, E., 3165W<br />

Landan, M., 3242F<br />

Landau, D., 2931F<br />

Lander, E., 322<br />

Landero, D., 2365T<br />

Landes, M., 3698W<br />

Landi, M. T., 1154F*<br />

Landsverk, M., 666T, 677F<br />

Lane, J., 1988F*, 3454T<br />

Laner, A., 1005W<br />

Lang, A. E., 2428T<br />

Lang, P., 1200W, 1233W<br />

Lang, R., 2637W<br />

Langaee, T., 646T<br />

Langberg, C. W., 991T<br />

Langberg, K. A., 2011T<br />

Langdon, Q., 3659F<br />

Lange, C., 1397W, 1536T,<br />

2057F, 2249F, 2346W,<br />

2520W<br />

Lange, E., 28, 1001F<br />

Lange, E. M., 170, 1214F,<br />

1437T, 1467T<br />

Lange, K., 38, 3621F<br />

Lange, L., 350, 1439W,<br />

2210F, 3678W<br />

Lange, L. A., 170*, 1408F,<br />

1437T, 1467T, 2131T,<br />

2336F, 2337W<br />

Langefeld, C. D., 1648T,<br />

1661T, 1888T, 1979F,<br />

2046W, 2143T, 2310W,<br />

3371W<br />

Langevin, L. M., 3095W<br />

Langevitz, P., 783W<br />

Langford, D. J., 1965W*<br />

Langhorst, B., 512W, 3517T<br />

Langhorst, B. W., 3702W,<br />

3715F<br />

Langlois, S., 2480F, 3135W<br />

Langmore, J. P., 3689F*<br />

Lango Allen, H., 2704W,<br />

2935W*<br />

Langouet, M., 202, 2808F*<br />

Langston, J. W., 803W<br />

Lanktree, M. B., 1659T<br />

Lannfelt, L., 434W<br />

Lanoel, A., 83<br />

Lantman - de Valk,<br />

H. M. J., 102<br />

Lao, K., 3696W<br />

Lao, R. Z., 2926W<br />

Lapasset, L., 857W<br />

Lapham, K., 96, 112<br />

Lapierrre, J.-M., 915W<br />

La Porta, M. L., 1060T<br />

Laporte, J., 328*, 2681T<br />

Lappalainen, I., 497F*<br />

Lappalainen, M., 2023T<br />

Lappalainen, T., 561F,<br />

567F*, 582W<br />

Lappe, J. M., 812F, 3081W<br />

Laprise, C., 665F, 778W,<br />

1361W, 1465F, 1941W<br />

Lapunzina, P., 3499T<br />

Laramie, J., 176, 1513F,<br />

1923W, 2308T, 2339F<br />

Largaespada, D., 1229F<br />

Lari, F., 2341T


Lariviere, M., 31<br />

LaRocque-Abramson, K.,<br />

1636T, 2340W<br />

Laron, Z., 2706F<br />

Laros, J. F. J., 2701W,<br />

3586W, 3611F<br />

Larouche, V., 1065W<br />

Larrieu, L., 2947W<br />

Larsen, A., 1050W, 2689W*<br />

Larsen, E. C., 446W<br />

Larsen, l. A., 805F<br />

Larsen, P., 520W<br />

Larson, D., 1210T*, 2325W<br />

Larson, E., 2098T, 3622W<br />

Larson, E. B., 343, 618T,<br />

1312F, 1828F<br />

Larson, M. C., 3451T<br />

Larson, N. B., 1247F*<br />

Larsson, P., 3732W<br />

LaSalle, J. M., 64, 832F,<br />

2783T, 3479T, 3498T<br />

Laslett, L. L., 2292W<br />

La Spada, A. R., 508W,<br />

565F, 2456F, 2628W<br />

Lasseaux, E., 473F<br />

Lasseter, V. K., 2573F<br />

Lassila, O., 1139F<br />

Laššuthová, P., 2745F<br />

Lasyone, C., 3648W*<br />

Laszig, R., 3203W<br />

Latendresse, S., 3512T<br />

Latha, M. M., 1893W*<br />

Lathi, R., 73<br />

Lathrop, G. M., 1952F,<br />

3466T, 3486T<br />

Lathrop, M., 649T, 1158W,<br />

1361W, 1461T, 1941W,<br />

2072F, 2079W, 2248T,<br />

2303F, 3439T<br />

Latos-Bielenska, A., 845F<br />

Latour, F., 1678T, 1982F<br />

Latourelle, J., 1964F<br />

Lattanzi, W., 2235W<br />

Lattig, C., 2705T<br />

Lattig, M. C., 3225W<br />

Lattimer, I., 1173W<br />

Lau, C., 134<br />

Lau, K. W., 138<br />

Lau, K.-W., 1211F<br />

Lau, L., 175, 2617T<br />

Lau, P., 1645T, 2236T<br />

Lau, S., 2102F<br />

Lau, W. W. S., 1419T*<br />

Lau, Y., 2016W, 2064W<br />

Lau, Y.-F. C., 408, 1179W<br />

Lauc, G., 3286F<br />

Laufer, B. I., 378*<br />

Laughlin, C. P., 639T<br />

Laukaitis, C. M., 1087T<br />

Laumen, H., 3536W<br />

Launay, J. M., 259<br />

Laurance, M., 3560W*<br />

Lauren, W., 2490W<br />

Laurent, C., 3658W<br />

Laurent, L. C., 3020T<br />

Laurent, N., 77, 3240F<br />

Laurenti, E., 1193F*<br />

Laureys, A., 2757F<br />

Laurino, M., 144*<br />

Lauritzen, T., 2347T<br />

*Presenting Author<br />

Laury-Andas, J., 1090T<br />

Lauwerys, B., 2284T<br />

Laux, R., 3335W<br />

Laval, G., 3304F<br />

Lavielle, N., 1158W<br />

LaViolette, C., 988T<br />

Laviolette, M., 1947W<br />

Lavy, J., 2302T<br />

Law, J., 3730W<br />

Law, L., 1889F<br />

Law, M. H., 212*<br />

Lawaetz, J., 2707W<br />

Lawani, M. B., 1162T<br />

Lawless, J. F., 1412W<br />

Lawlor, D. A., 1318F,<br />

1626T<br />

Lawrence, E., 2761W*,<br />

2960T<br />

Lawrence, M. S., 402<br />

Lawrenson, K., 210<br />

Lawson, J. W., 2330F<br />

Lawton, S., 143<br />

Lax, S., 1115F<br />

Layman, L., 2984T<br />

Layman, L. C., 2732T<br />

Layrisse, Z., 3390T<br />

Lay-Son, G., 1658T, 2065T<br />

Lazalde, B., 1121F*<br />

Lazar, M., 1727W, 3152F<br />

Lazaruk, K., 75<br />

Lazarus, P., 1016F, 1107W<br />

Lazier, J., 3511T*<br />

Lazor, R., 2877F<br />

Lazzeroni, L. C., 1356T*,<br />

1393F<br />

Le, S., 734T*, 2069F<br />

Le, S. Q., 695F, 697F, 785W<br />

Lea, A., 1820F<br />

Lea, R., 1042T<br />

Lea, R. A., 1912T, 2916F<br />

Leach, C. T., 1406W<br />

Leach, R. J., 2495F<br />

Leal, G. F., 2270F<br />

Leal, M. F., 1008W*, 1132T,<br />

3421T, 3503T<br />

Leal, S., 19, 93<br />

Leal, S. M., 6*, 1554T,<br />

2336F, 2337W<br />

Leão, L., 2434T<br />

Leao, L. L., 3107W<br />

Learned, K., 3557F, 3612W<br />

Leathley, E., 2625W<br />

Lebbé, C., 29<br />

Lebel, K., 1951T<br />

Lebel, R. R., 871W<br />

Le Ber, I., 345, 2638T<br />

LeBlanc, E., 2020T<br />

LeBlanc, M., 1581T*<br />

Lebo, R., 2972T*<br />

Lebon, P., 2452T<br />

Lebon, S., 299<br />

Le Bouar, G., 3170F<br />

Leboyer, M., 259<br />

Lebre, A.-S., 72<br />

Lebron, J., 310<br />

Le Calvez-Klem, F., 1213T<br />

Leccia, M.-T., 29<br />

Lecerf, J.-M., 1607T<br />

Lechno, S., 849F<br />

Leclerc, G., 778W<br />

SPEAKER AND AUTHOR INDEX 375<br />

Le Clerc-Blain, J., 1733W*<br />

Le Cras, T. D., 2136W<br />

Lecroq, T., 3538W<br />

Ledbetter, D. H., 299, 917W,<br />

2439W<br />

Ledda, M., 1281T<br />

Lederer, D., 3216F, 3218F<br />

Ledet, E., 1040F*<br />

Ledevil, C., 2436W<br />

LeDoux, M., 2782W<br />

LeDoux, M. S., 2438F*<br />

Le Dudal, K., 259<br />

Lee, A., 59, 207, 208,<br />

1109F, 1133F<br />

Lee, A. T., 306<br />

Lee, A. V., 3433T<br />

Lee, B., 164, 165, 389, 411,<br />

774W, 795W, 834F, 839F,<br />

840F, 2678T, 2854W,<br />

2934F, 3209W<br />

Lee, B. H., 698T*, 787W,<br />

2864T, 3227W<br />

Lee, B. K., 463F<br />

Lee, B.-N., 3722W*<br />

Lee, C., 10, 34, 400,<br />

494W, 864T, 1249T*,<br />

3103W, 3247W*,<br />

3251W, 3310F<br />

Lee, C. C., 1068W, 1244F<br />

Lee, C. R., 606T<br />

Lee, D., 258, 545F, 2119T,<br />

3008T, 3326W, 3461T<br />

Lee, D. H., 1654T<br />

Lee, D. S., 3463T*<br />

Lee, E., 1248W, 2117F<br />

Lee, E. J., 739F<br />

Lee, E. Y., 863W<br />

Lee, H., 315*, 361, 739F,<br />

1036T, 1657T*, 1685T,<br />

2117F, 2221T*, 3020T,<br />

3485T, 3536W, 3730W<br />

Lee, H.-J., 1622T<br />

Lee, H. M., 2279F<br />

Lee, H.-Y., 2581T*, 2779W,<br />

3656W, 3703F<br />

Lee, I., 2383T<br />

Lee, J., 267*, 442W, 909W,<br />

1061F, 1243T, 1248W,<br />

1291F, 1385W, 1561F*,<br />

1590T, 1650T, 1657T,<br />

1762W, 2117F, 2437T,<br />

2643W*, 2834T*, 3444T,<br />

3462T, 3473T, 3582W,<br />

3625F, 3708W<br />

Lee, J. A., 3109W*<br />

Lee, J.-E., 1656T<br />

Lee, J. E., 641T<br />

Lee, J. G. H., 129<br />

Lee, J.-H., 1964F<br />

Lee, J. H., 82, 194, 897W,<br />

1563T, 1641T, 2093F,<br />

2179T, 2208W*, 2410T,<br />

2547W<br />

Lee, J.-J., 3227W<br />

Lee, J. M., 9, 588W, 1786W,<br />

1787W, 1834F*<br />

Lee, J.-M., 1964F<br />

Lee, J.-O., 964T<br />

Lee, J. S., 787W, 1558F<br />

Lee, J. W., 2715F<br />

Lee, J.-Y., 3227W<br />

Lee, K., 231, 908T, 1654T,<br />

1656T, 2118W, 2119T,<br />

2828T, 3085W, 3635F<br />

Lee, K.-A., 3178F<br />

Lee, K. P. Y., 2640W<br />

Lee, L., 2826F<br />

Lee, M., 263, 900T, 1218W,<br />

1243T, 1474F*, 1590T,<br />

2142W, 2146T, 2156F,<br />

2437T, 2756T, 2921T<br />

Lee, M. H., 528W<br />

Lee, M. K., 26, 287, 1089W,<br />

1226F, 1464T, 1654T,<br />

2600F<br />

Lee, M. N., 528W*<br />

Lee, M. T., 2858T<br />

Lee, N.-C., 683F<br />

Lee, N. C., 706T<br />

Lee, O., 981W<br />

Lee, P. H., 352*<br />

Lee, R., 3696W<br />

Lee, R. K., 2154W, 2240F,<br />

2263T<br />

Lee, S., 846F, 947W,<br />

1230W*, 1248W, 1384F,<br />

1388W*, 1529W*, 1530T,<br />

1931F*, 2334W, 2663T,<br />

2715F, 3085W, 3413W,<br />

3473T, 3605F, 3681F<br />

Lee, S.-J., 2119T*<br />

Lee, S. K., 3423T*<br />

Lee, S. S.-J., Session 9<br />

Lee, S.-T., 1007F, 1103F<br />

Lee, T., 729F, 781W,<br />

2200T<br />

Lee, W., 1248W*, 2437T,<br />

2581T, 3606W<br />

Lee, Y., 40*, 985T, 1894T*,<br />

1905W, 2587T<br />

Lee, Y. A., 2102F<br />

Lee, Y.-A., 1942T<br />

Lee, Y.-H., 1622T<br />

Lee, Y.-J., 2285F<br />

Lee, Y. K., 846F<br />

Lee, Y. M., 2712F<br />

Leeder, J. S., 811F<br />

Lee-Kirsch, M. L., 2102F<br />

Lees, M., 2752W, 2896W<br />

Lees, M. M., 217<br />

Lefeber, D. J., 214, 672T<br />

Lefebvre, A., 3538W<br />

Lefebvre, J.-F., 1478W<br />

Lefever, S., 2927T<br />

Lefevre, J., 1170W<br />

Leffler, E., 285<br />

LeFloch, A., 1768W<br />

Lefol, C., 1212W<br />

Lefort, G., 857W, 936T,<br />

2386T, 2729T, 3121W,<br />

3166F<br />

Legallic, S., 345<br />

Legeai-Mallet, L., 763W<br />

Legendre, M., 77*, 403<br />

Legendre-Guillemin, V., 778W<br />

Legius, E., 1139F<br />

Le G<strong>of</strong>f, C., 127*<br />

Le G<strong>of</strong>f, W., 127<br />

Legrand, G., 1170W<br />

Legro, R. S., 2327F<br />

SPEAKER AND AUTHOR INDEX


376 SPEAKER AND AUTHOR INDEX<br />

Lehesjoki, A.-E., 2898F<br />

Lehman, A., 750T, 3006T*<br />

Lehman, D., 1513F, 2495F<br />

Lehman, D. M., 176, 1923W,<br />

2308T, 2339F<br />

Lehne, B., 1470T<br />

Lehner, T., 2523W, 2560T<br />

Lehr, T., 617T<br />

Lehrach, H., 582W<br />

Lehtimäki, T., 109, 656T,<br />

1623T, 2059T, 2097W,<br />

2120F, 2350T, 2383T<br />

Lehtinen, M. K., 266<br />

Lehtonen, R., 995F<br />

Lei, J., 824F, 1144T<br />

Leiba, H., 3162F<br />

Leidinger, P., 515F<br />

Leigh, M. J., 770W<br />

Leigh, M. W., 2851W<br />

Leighl, N. B., 1108T<br />

Leijsten, N., 979W<br />

Leijsten, N. F. A., 955W<br />

Leikin, S., 222, 2853F<br />

Lein, E., 2444F<br />

Leipzig, J., 391<br />

Leissner, P., 2255F<br />

Leistner-Segal, S., 747F<br />

Leistritz, D. F., 1759W*<br />

Leite, J., 1851F<br />

Leitsalu-Moynihan, L.,<br />

1792W, 1832F*, 3353W<br />

Lejeune, S., 1212W<br />

Lek, M., 280, 295*, 582W<br />

Lekanne dit Deprez, R.,<br />

1616T, 3650W<br />

Lekshami, J., 3400T<br />

Lelis, A. M., 753T*<br />

Lema, G., 283, 3303T, 3338W<br />

Lemaitre, J. M., 857W<br />

Lemanske, R., 536W<br />

Le Marchand, L., 205,<br />

1079F, 2202W<br />

LeMarchand, L., 1067F,<br />

1206W, 1925F<br />

Lemay, P., 2075F*<br />

Le Merrer, M., 324, 915W,<br />

2729T, 3129W<br />

Le Meur, G., 390<br />

Lemieux Perreault, L.-P.,<br />

3401W<br />

Lemire, E., 3127W, 3209W<br />

Lemire, E. G., 2772F<br />

Lemire, M., 1093T, 3478T,<br />

3489T<br />

Lemley, M., Session 20<br />

Lemke, A. A., Session 25<br />

Lemmelä, S., 2120F*<br />

Lemmens, I., 2660F<br />

Lemmers, R. J. L. F., 55<br />

LeMons, C., 774W<br />

Lemos, C., 1296T*, 2736F<br />

Lemos Silveira-Lucas, E., 131<br />

Lemyre, L., 149, 1827W<br />

Lenaers, G., 2679F<br />

Lench, N. J., 1748W, 1773W*<br />

Lencz, T., 17, 264, 3346F,<br />

3366T<br />

Lenders, J. W. M., 1220F<br />

Lenferna de la Motte, P.,<br />

2411F<br />

*Presenting Author<br />

Leng, N., 1249T<br />

Lenk, G. M., 2471F*<br />

Lenkala, D., 623T<br />

Lenkiewitz, E., 1186T<br />

Lennep, C. V., 2676F<br />

Lennington, J., 2854W<br />

Lenz, D. R., 2914W<br />

Lenz, M., 1851F<br />

Lenz, P., 1092W<br />

Lenz, T. L., 3404T*<br />

Lenzini, P. A., 2535W<br />

Leo, P., 152<br />

Leo, P. J., 2053T<br />

Leon, E., 3189W*<br />

Leonard, L., 2316W, 3040F<br />

Léonard, M., 3538W<br />

Leonardi, E., 1755W, 2795T<br />

Leon-Del-Rio, A., 3504T<br />

Leone, M., 2095T, 2804T<br />

Leong, P., 3717F<br />

Leongamornlert, D., 205,<br />

1011W<br />

Leon-Salazar, V., 821F<br />

Leotta, A., 2587T<br />

Leoyklang, P., 709F*<br />

LEPGen Consortium, 2116T<br />

Leppä, V., 252, 2350T*,<br />

2399F<br />

Leppanen, P. H. T., 1976F<br />

Leppert, M. F., 2397W<br />

Leppert, T., 2397W<br />

Leproust, E., 3709F<br />

LeProust, E., 975W, 3459T,<br />

3653F, 3669F, 3726W<br />

Lerach, H., 567F<br />

Lerch, M. M., 2141F<br />

Leren, T. P., 1607T<br />

Lerental, Y., 2691F<br />

Lerer, B., 2564F<br />

Lermioglu, F., 1172F<br />

Lerner, M., 474W<br />

Leroy, B., 77<br />

Leroy, B. P., 539F, 1790W,<br />

2927T<br />

Lesage, S., 29, 2638T*<br />

Lese Martin, C., 13, 299<br />

Leshinsky-Silver, E., 3174F<br />

Leske, M. C., 1003T<br />

Lesko, S. M., 1107W<br />

Leskovac, A., 3286F<br />

Leslie, E., 2325W<br />

Leslie, E. J., 2762T*<br />

Leslie, N., 789W<br />

Leslie, S., 181*<br />

Lesniak, B. P., 2185T<br />

Lesovaya, E., 1180T, 1181F*<br />

Lessage, S., 1982F<br />

Lessard, C. J., 529F,<br />

2084F*, 2188T<br />

Lessard, J. A., 529F, 2084F,<br />

2188T<br />

Lessov-Schlaggar, C. N.,<br />

642T<br />

Lester, T., 218<br />

Lesueur, F., 1213T<br />

Letaif, O., 3184F<br />

Leth, H., 702T<br />

le Tisser, P., 2701W<br />

Letourneau, A., 67, 85,<br />

561F, 807F, 3431T*<br />

Letra, A., 1936T*<br />

Letra, A. M., 1908W<br />

Lettre, G., 350, 1408F,<br />

1906T*, 2063F, 2210F,<br />

2247W, 2319W, 3401W,<br />

3525T<br />

Leung, D., 2849T<br />

Leung, D. G., 2962W<br />

Leung, H.-T., 2072F<br />

Leung, P. C. K., 2977T<br />

Leusink, M., 609T*<br />

Leuzzi, V., 760W<br />

Lev, D., 2447F, 3048F,<br />

3174F<br />

Levade, T., 54, 716T<br />

LeVan, T. D., 3027T<br />

Levandowsky, E., 400,<br />

1068W, 1244F<br />

Levenstein, M., 1269W<br />

Leverenz, J., 2538W<br />

Leverenz, J. B., 2646W<br />

Levert, A., 2558F<br />

Levesque, G., 2528F<br />

Levesque, M. P., 363<br />

Levi, M., 1604T<br />

Levin, A., 1250F<br />

Levin, A. M., 1895F*<br />

Levin, B., 2583W<br />

Levin, H., 1138T<br />

Levin, J. Z., 554W<br />

Levine, D., 3210F<br />

Levine, D. M., 2190W<br />

Levine, J. D., 1965W<br />

Levine, K., 2761W, 2960T<br />

Levine, M. A., 3448T<br />

Levine, R. L., 1017W<br />

Levine, S., 1820F<br />

Levinson, D., 2576F<br />

Levinson, D. F., 369, 2372F,<br />

3658W<br />

Levitas, A., 1588T<br />

Levitt, P., 2444F<br />

Levy, B., 73*, 937W, 957W,<br />

977W, 1031F, 3018T<br />

Levy, D., 584W, 1600T, 1653T,<br />

1659T, 2063F, 2587T<br />

Levy, D. J., 3158F<br />

Levy, J., 2114F<br />

Levy, J. L., 2170T<br />

Levy, N., 328<br />

Levy, R., 10<br />

Levy, S., 494W, 1239W<br />

Levy, S. M., 1464T<br />

Levy Lahad, E., 2991T, 3002T<br />

Levy-Lahad, E., 2447F,<br />

2929W, 2993T<br />

Levy-Mozziconacci, A.,<br />

3129W<br />

Lewandoski, M., 828F<br />

Lewellen, N., 2<br />

Lewinger, J., 1362T<br />

Lewin-Koh, N. J. I., 1539T*<br />

Lewis, A. P., 74, 94<br />

Lewis, B., 2145W<br />

Lewis, B. A., 1295W<br />

Lewis, C. E., 1661T<br />

Lewis, C. M., 348, 1313W,<br />

1329T*, 2509T<br />

Lewis, D., 2034W*<br />

Lewis, D. M., 529F, 2188T<br />

Lewis, I., 3695F<br />

Lewis, J. P., 602T<br />

Lewis, K., 358, 1690T<br />

Lewis, K. L., 1696T<br />

Lewis, M., 3697F<br />

Lewis, M. E. S., 491F<br />

Lewis, M. H., 1731W<br />

Lewis, R., 1900T, 2043W<br />

Lewis, R. A., 3234F<br />

Lewis, S., 447F, 517F<br />

Lewis, S. E., 2725W<br />

Lewis, T., 3182F*<br />

Ley, R. E., 537F, 2029T<br />

Ley, T., 1203W<br />

Leya, J., 865W<br />

Leyva, N., 9, 3124F, 3226F<br />

Leyva, X., 3125W<br />

Li, A., 121, 174, 648T<br />

Li, B., 93, 869W, 2216F*,<br />

2926W, 3273T*, 3275W,<br />

3566W<br />

Li, C., 1493W, 2204F*, 2207F,<br />

2301W, 3275W, 3557F,<br />

3603F, 3604W, 3714W*<br />

Li, C.-Y., 1209W, 1246T,<br />

3278W<br />

Li, D., 1157F, 1681T, 2136W,<br />

2722W, 2856F*, 3237W<br />

Li, F.-Y., 1750W*, 2778F<br />

Li, G., 2080T, 2145W<br />

Li, G.-N., 457F, 2623T<br />

Li, H., 116, 195, 284, 529F,<br />

798W*, 1242W, 1261T,<br />

2084F, 2188T*, 2246F,<br />

2259W, 2477F, 2643W,<br />

3029T, 3293W, 3320W*,<br />

3377W<br />

Li, H.-Y., 3529F<br />

Li, J., 196, 432W, 1404T,<br />

1473T, 1491T, 2053T,<br />

2121W*, 2172W, 2229W,<br />

2237F, 2332T, 2571W,<br />

2879T, 3282T, 3465T*,<br />

3505T, 3534W, 3613F*<br />

Li, J. B., 289, 527F, 543F,<br />

577F<br />

Li, J. Z., 476W, 2135F, 3285T<br />

Li, K., 3281W<br />

Li, K. P., 170<br />

Li, L., 603T*, 888T*, 1086W,<br />

1612T, 1686T, 2230T*,<br />

2680W, 3081W, 3134F,<br />

3483T, 3552W<br />

Li, M., 21*, 399*, 812F,<br />

1027T, 1040F, 1532W,<br />

1555F, 1642T, 1914W*,<br />

2210F, 2444F, 3551F<br />

Li, M. D., 1540F, 2388W,<br />

2390F, 2574W<br />

Li, M. X., 3559F<br />

Li, N., 2544W*<br />

Li, Q., 5*, 159, 1363F,<br />

1512T, 2048F, 2345F,<br />

2419T<br />

Li, Q. B., 2311T<br />

Li, Q. Z., 1901F, 2284T<br />

Li, R., 106, 277, 618T,<br />

1167W, 1311T*, 1312F,<br />

1411F, 1447F, 2098T,<br />

2921T, 3308W, 3667F*


Li, S., 443F, 909W, 1235F,<br />

1365T, 1369F, 2274W*,<br />

2834T, 3394T, 3464T*<br />

Li, T., 2419T, 2494T, 2573F<br />

Li, W., 441F*, 528W, 844F*,<br />

1322W*, 2953W<br />

Li, W. D., 2612F<br />

Li, W. R., 2858T<br />

Li, X., 568W*, 950T, 1322W,<br />

2094W, 2698W, 2895F,<br />

2907F, 3021T, 3065W,<br />

3535F<br />

Li, Y., 1, 154, 159, 323, 377,<br />

382*, 399, 408*, 480W,<br />

564W, 1027T, 1369F,<br />

1427W, 1437T, 1491T,<br />

1524T, 1532W, 1555F,<br />

1627T, 1730W, 1952F,<br />

2251T, 2254T, 2317T,<br />

2347T, 2489F, 2542T,<br />

2559W, 2617T, 2944W,<br />

3134F*, 3221W, 3307F,<br />

3483T, 3490T, 3553F,<br />

3580W<br />

Li, Y. S., 1110W<br />

Li, Z., 974T*, 1304W, 1546F<br />

Lia-Baldini, A.-S., 2694F*<br />

Lianas, L., 157<br />

Liang, B., 490W<br />

Liang, C., 1901F, 2949F<br />

Liang, J., 2251T, 3307F<br />

Liang, J. Q., 1723W<br />

Liang, K. Y., 1472W<br />

Liang, L., 1027T, 1357F,<br />

1390F, 2102F, 3466T*,<br />

3469T, 3486T<br />

Liang, M., 1540F<br />

Liang, S., 1133F<br />

Liang, W., 1240T<br />

Liang, Y., 3300T<br />

Liao, J., 904T, 2094W<br />

Liao, J. C., 2238W<br />

Liao, O. Y., 1054T<br />

Liao, S.-Y., 2122T*<br />

Liao, W., 3708W<br />

Liao, Y., 511F<br />

Liao, Y. C., 1586T*<br />

Libarkin, J., 1861F<br />

Libener, R., 1153T<br />

Liberal, V., 3720W<br />

Liberton, D. K., 2223W<br />

Libiger, O., 24*, 3332W<br />

Li Chang, H. H., 1138T<br />

Lichanska, AM., 1165T<br />

Lichtarge, O., 2854W<br />

Lichtenstein, P., 2509T<br />

Lichter, P. R., 2154W, 2240F,<br />

2263T<br />

Lichter-Konecki, U., 774W<br />

Lichtner, P., 2086T, 2568W<br />

Lichty, A., 3171W<br />

Lidar, M., 783W<br />

Lidereau, R., 1062W,<br />

1212W<br />

Lidral, A., 2325W<br />

Lie, R., 1564F<br />

Lie, R. T., 1472W<br />

Lieber, D. S., 326*<br />

Lieberman, E., 872T, 875W<br />

Lieden, A., 1939T<br />

*Presenting Author<br />

Liendhard, A., 2694F<br />

Lietman, C., 2854W<br />

Lifton, R., Session 74<br />

Lifton, R. P., 845F, 1241F,<br />

2779W, 2915T<br />

Light, N., 569F*<br />

Ligon, K. L., 266<br />

Ligtenberg, M. J. L., 1220F<br />

Liguori, M., 2597F<br />

Lih, C.-J., 1068W*<br />

Lihm, J., 1338T*<br />

Lilien, M. R., 2848W<br />

Liljedahl, U., 3217W, 3427T<br />

Lilley, J. S., 1634T*<br />

Lillquist, Y., 750T<br />

Lim, B., 680T, 877W*, 3204F<br />

Lim, B. C., 3180F<br />

Lim, E., 280, 624T<br />

Lim, E. C. P., 2889F<br />

Lim, E. T., 11*, 2344T,<br />

2613W<br />

Lim, J., 947W, 3008T*,<br />

3461T<br />

Lim, J.-E., 1622T<br />

Lim, J.-H., 964T<br />

Lim, J. W., 55<br />

Lim, M., 1622T<br />

Lim, R., 2482T<br />

Lim, S., 2328W*<br />

Lim, S. N., 3034T<br />

Lim, Y., 552W*<br />

Lima, B. L., 776W*<br />

Lima, M. A. F. D., 2642F<br />

Lima, R. M., 1880F<br />

Limacher, J.-M., 1212W<br />

Limaye, M., 1015T<br />

Limaye, N., 83, 1611T<br />

Limburg, P. J., 1351F<br />

Limem, K., 1751W<br />

Limon, A., 694T<br />

Limotai, C., 2749W<br />

Lin, A., 103, 124, 126<br />

Lin, A. Y., 1054T<br />

Lin, B., 2974T<br />

Lin, C., 1249T, 3695F<br />

Lin, C.-F., 342, 2316W<br />

Lin, C.-L., 2285F<br />

Lin, C. Y., 1368T<br />

Lin, D., 170, 1027T, 2337W<br />

Lin, D. Y., 1434T, 1437T<br />

Lin, G. N., 2660F<br />

Lin, H., 981W*, 2556W,<br />

3467T*<br />

Lin, I.-H., 610T<br />

Lin, J., 96, 112<br />

Lin, L., 382, 2543F<br />

Lin, M., 1894T, 1905W<br />

Lin, M.-W., 610T*, 1955F<br />

Lin, R., 511F<br />

Lin, S., 1272W, 2419T,<br />

2610W, 3326W, 3467T<br />

Lin, S.-W., 1010F<br />

Lin, W., 985T, 1410T, 1894T<br />

Lin, X., 1529W, 1530T,<br />

2122T, 2334W<br />

Lin, Y., 1235F, 2053T<br />

Lin, Y. C., 2245T<br />

Lin, Y. H., 2936T*<br />

Lin, Y.-Y., 214<br />

Lin, Z., 2478W*, 2921T*<br />

SPEAKER AND AUTHOR INDEX 377<br />

Linares, N., 659F<br />

Lincecum, T., 3698W<br />

Lincoln, P., 804W<br />

Lincoln, S., 1513F, 1923W,<br />

2308T, 2339F<br />

Lincoln, S. E., 176<br />

Lind, J. M., 1705T, 1862F*<br />

Lind, L., 2070W<br />

Lind, P. A., 2212T, 2505W*<br />

Lindberg, M. L., 436W<br />

Lindblad-Toh, K., 322<br />

Linden, D., 684T<br />

Lindenbaum, P., 1204T<br />

Linder, H., 2331W<br />

Linderoth, T., 3312T<br />

Lindfors, K., 2023T<br />

Lindgren, A. M., 70, 284,<br />

862T<br />

Lindgren, C. M., 44, 173,<br />

269, 583F, 1308T, 1954T,<br />

2070W, 2076W, 2077T,<br />

2090F, 2123F, 2147F,<br />

2187W, 2324F, 3435T<br />

Lindhurst, M. J., 33*<br />

Lindor, N. M., 141, 1058F*,<br />

1067F, 1079F, 1206W,<br />

3564W<br />

Lindo-Samanamud, S.,<br />

2453F*<br />

Lindquist, K., 1250F*<br />

Lindsay, F., 2497T<br />

Lindsay, M., 81<br />

Lindsay, M. E., 79, 80<br />

Lindsay, S., 43, 61<br />

Lindstrand, A., 2955F*<br />

Lindstrom, S., 191, 205,<br />

318, 356, 1150T<br />

Linehan, W. M., 1242W<br />

Ling, H., 46, 1254W, 1452T,<br />

1512T, 2556W, 3716W<br />

Ling-Fung, P., 2926W<br />

Linker, S., 524W*<br />

Linn, A., 316<br />

Linnankivi, T., 2888T<br />

Linneberg, A., 2317T<br />

Linnertz, C., 2465F<br />

Lins, T. C. L., 1880F,<br />

3272W*<br />

Lins, T. S., 2706F<br />

Linton, M. F., 1634T<br />

Lioi, M. B., 2629T<br />

Lionel, A., 98, 2570F<br />

Lionel, A. C., 2575T*, 3086F,<br />

3095W<br />

Liou, B., 161<br />

Liou, H., 2392T<br />

Lipinski, S., 2103W<br />

Lipkin, S. L., 1159T<br />

Li-Pook-Than, J., 1505W,<br />

2322W<br />

Lippert, C., 1379W, 3468T<br />

Lipshultz, L., 2979T<br />

Lipska, B. K., 260, 2622W<br />

Lipson, S., 168<br />

Liptak, G. S., 1254W<br />

Lira, R. P. C., 2751F<br />

Lis, J. T., 415F<br />

Lisoňová, J., 2745F<br />

Lissowska, J., 1117T<br />

Listerman, I., 96, 112<br />

Listgarten, J., 1379W,<br />

3468T*<br />

Litscher, S. J., 710T<br />

Little, J., 149, 1827W<br />

Littleton, K. R., 50<br />

Littman, E., 78<br />

Littman, J., 999W<br />

Littrell, J., 441F<br />

Litzelman, K., 1267T<br />

Litzler, J., 3240F<br />

Liu, A., 536W<br />

Liu, C., 412W*, 486W,<br />

1585T, 1896W*, 1974W,<br />

2196W, 2197T, 2561F,<br />

3520T<br />

Liu, C. T., 2030F<br />

Liu, D., 1370W*<br />

Liu, E., 1330F<br />

Liu, E. Y., 1427W, 1555F*<br />

Liu, G., 1016F, 1108T,<br />

3210F<br />

Liu, H., 1257W, 1291F,<br />

2721F*<br />

Liu, J., 368, 602T, 910T*,<br />

924T*, 1117T, 1930T,<br />

2055W, 2112W, 2275T<br />

Liu, J. B., 2985T<br />

Liu, J. J., 1934F<br />

Liu, J. Z., 153*, 2101T,<br />

2163W<br />

Liu, K., 1371T, 2649W<br />

Liu, L., 1433W, 1520W*,<br />

1777W<br />

Liu, M., 1198T<br />

Liu, M.-J., 3029T<br />

Liu, N., 1410T*, 1460W<br />

Liu, P., 61*, 63, 512W, 824F,<br />

1511W*, 3483T, 3517T,<br />

3702W, 3715F*<br />

Liu, R., 2969T<br />

Liu, S., 326, 489F*, 1925F,<br />

2489F, 3428T<br />

Liu, T., 1070F<br />

Liu, V. C. H., 2066F<br />

Liu, W., 314, 613T*, 1735W,<br />

1742W, 1757W, 1761W,<br />

2802F*<br />

Liu, X., 123, 174, 349,<br />

442W*, 864T, 1182W*,<br />

1369F, 1546F, 1693T*,<br />

3026T, 3339T*<br />

Liu, X. L., 1930T<br />

Liu, X. S., 1907F<br />

Liu, Y., 13, 386, 544W,<br />

1019F*, 1098W, 1491T,<br />

1642T*, 2052W, 2145W,<br />

2154W, 2172W, 2240F,<br />

2263T, 2556W, 3551F<br />

Liu, Y. J., 2053T<br />

Liu, Y.-Z., 2172W<br />

Liu, Y. Z., 2053T<br />

Liu, Z., 1357F*, 1644T,<br />

2020T, 3495T, 3587F<br />

Livermore Auer, P., 19*<br />

Livingston, R., 530W<br />

Livneh, A., 783W<br />

Lizano, E., 567F<br />

Llewellyn, K. J., 757W*<br />

Lloreta, J., 1091F<br />

Lloyd, D., 3703F<br />

SPEAKER AND AUTHOR INDEX


378 SPEAKER AND AUTHOR INDEX<br />

Lloyd, D. L., 219*<br />

Lloyd-Evans, E., 162<br />

Lo, C.-L., 829F<br />

Lo, F., 1894T<br />

Lo, K., 601T, 1249T<br />

Lo, K. S., 1906T, 3525T*<br />

Lo, Y., 1521T*<br />

Loane, E., 1897T<br />

Lobina, M., 177, 1516F,<br />

2329T, 3664W<br />

Lobo, D. S. S., 2608T*<br />

Local Genome Diversity<br />

Studies Consortium,<br />

3315T<br />

Locke, A. E., 108, 173, 269,<br />

1954T, 2069F, 2090F,<br />

2123F*, 2147F, 2241W<br />

Lockhart, D. J., 732T, 1684T<br />

Lockhart, N., 1845W<br />

Lockwood, C., 3030T<br />

Locus Development, Inc.,<br />

1766W, 1771W, 3548W,<br />

3692W<br />

Loddo, S., 881W, 943W,<br />

2777T*<br />

Loeschner, A., 2483F<br />

Loeuillet, L., 77, 403<br />

Loeys, B., 79, 80*, 1617T,<br />

1679T, 2387F<br />

L<strong>of</strong>tus, S. K., 258<br />

Logan, A. C., 1112F<br />

Loget, P., 77, 3129W, 3170F<br />

Logronio, C., 3331F*<br />

Logsdon, B. A., 1408F*<br />

Logue, M., 343<br />

Logue, M. W., 2563T*<br />

Loguercio, S., 3584W<br />

Lohi, H., 2213F, 2517W,<br />

2913F<br />

Löhle, E., 2829F, 3203W<br />

Lohman, G., 3517T, 3715F<br />

Lohmann, D., 392<br />

Lohmann, J., 2160W<br />

Lohmann, K., 200*, 204<br />

Lohmueller, K., 182, 281<br />

Lohmueller, K. E., 1573F,<br />

2311T*, 3305W<br />

Lohn, Z., 1846W*<br />

Lohnau, T., 204<br />

Loi, A., 157<br />

Loi, H., 3730W<br />

Lok, K. H., 1662T<br />

Loke, J., 409*, 1185W<br />

Loken, E., 2594F<br />

Loken, E. K., 2599T*<br />

Lokki, M. L., 3258T<br />

Lolkema, M., 400<br />

Lomas, D., 2057F<br />

Lomas, D. A., 2249F<br />

Lomax, M. I., 1878W<br />

London, S., 536W<br />

Londono, D., 1358W*,<br />

1359T<br />

Londsdale, J., 368<br />

Long, J., 3612W<br />

Long, Q., 1457W<br />

Long Life Family Study,<br />

2040W<br />

Longman, C., 2812W<br />

Longo, A., 824F, 3492T<br />

*Presenting Author<br />

Longo, N., 660T, 689F<br />

Longstreth, W. T., 1592T<br />

Lonie, A., 1213T, 3679F<br />

Lönnerholm, G., 3427T<br />

Lonnqvist, J., 252<br />

Lonsberry, V., 3683F<br />

Loo, A., 3006T<br />

Loo, S. K., 639T<br />

Loogers, L., 307<br />

Looijenga, L. H. J., 1122W*,<br />

1273T<br />

Loomes, K. M., 2316W<br />

Loomis, E., 477F, 2634W<br />

Loomis, E. W., 2633F*<br />

Loomis, S., 1887W, 2263T*<br />

Loomis, S. J., 2154W,<br />

2240F<br />

Loos, B. G., 2058W<br />

Loos, R. J., 2116T, 2131T<br />

Loos, R. J. F., 43, 108,<br />

1954T, 2090F, 2123F,<br />

2147F, 2241W, 2282F,<br />

2359T<br />

Lopes, A., 1778W, 2982T<br />

Lopes, F., 913W<br />

Lopes-Cendes, I., 514W,<br />

2233T, 2393F, 2394W,<br />

2609F*, 2653T, 2655W,<br />

2876T, 3578W<br />

Lopez, A., 1141T, 3035W<br />

Lopez, E., 2716W, 2770W*,<br />

2792T<br />

Lopez, I., 1779W<br />

Lopez, J., 3582W<br />

Lopez, J. P., 2338T, 2482T*<br />

Lopez, O. L., 2125T, 2521T<br />

Lopez Camarillo, C., 1048T<br />

López-Hernández, G.,<br />

1131W, 1141T<br />

Lopez Parra, A. M., 3364F,<br />

3402T<br />

Loplumlert, J., 2749W<br />

Loranger, K., 1059W<br />

Lord, G., 2082W<br />

Lord, H., 218<br />

Lorenco, L. G., 3421T<br />

Lorente, B., 1<br />

Lorenz-Depiereux, B.,<br />

2693T, 2922F*<br />

Lorenzo, C., 1888T<br />

Lorenzo, F. R., 3297T<br />

Lorey, F., 362<br />

Lorget, F., 763W*<br />

Lori, A., 2383T*, 2384F<br />

Loring, E., 2915T<br />

Lo Rizzo, C., 2604W<br />

Lortz, A., 3088F<br />

Löscher, W., 2948T<br />

Löscher, W. N., 201<br />

Losfeld, M. E., 1758W<br />

Lossie, A. C., 829F*<br />

Lotery, A. J., 2072F, 2843T<br />

Lott, P., 552W, 3479T<br />

Lotta, L., 2880F<br />

Lou, H., 443F*, 1242W,<br />

3334F, 3394T<br />

Lou, X., 1460W*<br />

Lou, Y., 1232F, 3456T<br />

Loucoubar, C., 2079W,<br />

2248T*<br />

Louie, K., 3429T<br />

Louie, T., 171<br />

Louie, Y., 3182F<br />

Louis, E., 442W, 2377T<br />

Louis, E. D., 1898F<br />

Loureiro, L. J., 2820F<br />

Lourenco, C., 2425T*<br />

Lourenço, C., 895W<br />

Lourenço, L. G., 3503T<br />

Lourenço, N. C. V., 1727W<br />

Louro, I. D., 182, 1573F<br />

Loutrel, J., 3530W<br />

Love, T. W., 2087F<br />

Lovecchio, J., 1133F<br />

Lovelette-Hernandez, A.,<br />

1754W<br />

Lovell, A., 789W<br />

Lovestone, S., 3471T<br />

Lovick, N., 145*, 1810F<br />

Lovicu, M., 847F<br />

Loviglio, M. N., 775W, 3256F*<br />

Low, P. S., 771W<br />

Low, S., 2506T*<br />

Low, S.-K., 2133W<br />

Lowe, J., 553F<br />

Lowe, J. K., 2478W, 2518T,<br />

2551T*, 2658W<br />

Lowman, G., 3698W<br />

Lowndes, S., 982T*<br />

Lowrance, W., 1328W<br />

Loyola, B., 3076F<br />

Lozano, M. C., 2705T*<br />

Lozanovski, V. J., 845F<br />

LSFC Consortium, 665F<br />

Lu, A., 2415W*<br />

Lu, A. T., 2056T<br />

Lu, C., 1203W, 2606F,<br />

2759T<br />

Lu, D., 2721F, 3334F, 3394T<br />

Lu, F., 1251W, 3648W<br />

Lu, H., 2698W, 2895F,<br />

3065W, 3535F, 3681F<br />

Lu, H. M., 2698W, 2895F,<br />

3065W, 3535F<br />

Lu, I., 1736W<br />

Lu, J., 2934F, 3209W,<br />

3597F*<br />

Lu, J. T., 2864T<br />

Lu, L., 28, 1661T<br />

Lu, Q., 638T, 2251T<br />

Lu, W., 82<br />

Lu, X., 116, 134*, 909W,<br />

2259W<br />

Lu, X.-J., 2970T<br />

Lu, X. L., 1974W<br />

Lu, Y., 5, 1249T, 1511W,<br />

1582F, 2048F*, 2345F,<br />

2868F<br />

Lu, Y. C., 2936T<br />

Lu, Y. E., 1298W<br />

Lu, Z., 247<br />

Lu, Z.-L., 2970T<br />

Lua, R., 2854W<br />

Luan, J., 1553W*, 2282F<br />

Luan, J. A., 1365T<br />

Lublingh<strong>of</strong>f, N., 2829F*<br />

Luc, G., 1607T<br />

Luccarini, C., 205<br />

Lucchiari, S., 1751W<br />

Lucena-Araujo, A. R., 1045T<br />

Ludmila Serafim, A. L. S.,<br />

3099W*<br />

Ludtke, A., 3033T*<br />

Ludwig, D., 96, 118, 230,<br />

2513F<br />

Ludwig, K., 1512T<br />

Ludwig-Kubinski, A., 1269W<br />

Ludwin, S., 671F<br />

Luedeke, M., 1080W<br />

Lugo-Trampe, A., 1030T<br />

Lugtenburg, I. C., 3611F<br />

Luiselli, D., 3322F<br />

Lujic, S., 1705T<br />

Luk, J., 1369F<br />

Luke, A., 1959W<br />

Luke, M. M., 1603T*<br />

Lukina, E., 773W<br />

Lukong, J., 1958F<br />

Luksan, O., 570W*<br />

Lulli, P., 760W<br />

Lum, P. Y., 2220W, 3618W<br />

Lumayag, S., 520W<br />

Lumley, T., 1346W, 1585T<br />

Lund, A. M., 737F<br />

Lund, J., 2699T<br />

Lund, L., 1845W<br />

Lundholm, C., 1707T<br />

Lundmark, P., 569F<br />

Lunetta, K., 1571W, 2165F<br />

Lunetta, K. L., 343, 1476T,<br />

2336F<br />

Lunnon, K., 3471T<br />

Luo, G., 3698W<br />

Luo, L., 20, 1401T*<br />

Luo, M., 490W, 1777W*,<br />

3276T*<br />

Luo, R., 553F*<br />

Luo, S., 1167W<br />

Luo, X., 521F<br />

Luo, Y., 354*<br />

Luoma, L. M., 2474F*<br />

Lupien, M., 188<br />

Lupoli, S., 2095T<br />

Lupski, J., 360*, 777W,<br />

2542T, 2934F<br />

Lupski, J. R., 61, 63, 229,<br />

314, 337, 428W, 430W,<br />

432W, 433F, 485F, 898T,<br />

1735W, 1742W, 1761W,<br />

2470T, 2798T, 2881W,<br />

2883F, 2908W, 2955F<br />

Lupton, S. J., 1705T<br />

Luscombe, S., 454W<br />

Lusis, A., 1337W<br />

Lusis, A. J., 39<br />

Luthra, K., 555F<br />

Lutz, C., 983F<br />

Lutz, F., 2646W<br />

Lutz, M., 2465F<br />

Lutz, M. W., 637T*, 1382W<br />

Lutz, R., 2951T<br />

Luu, S., 832F, 2571W<br />

Luukkonen, T. M., 897W*<br />

Luz del Rosario, M., 167<br />

Lvova, M., 3653F<br />

Ly, C., 2742F<br />

Ly, V., 490W<br />

Lybarger, D. J., 1346W<br />

Lyle, P., 136<br />

Lyle, R., 434W, 3510T*


Lynch, D. C., 3127W*<br />

Lynch, J., 262<br />

Lyon, E., Session 3, 1752W,<br />

3220F<br />

Lyon, G., 3561F*<br />

Lyonnet, S., 126, 522W,<br />

843F, 915W, 3172F<br />

Lyons, L. A., 3252T*<br />

Lyons, R., 177<br />

Lyons, R. H., 2329T, 2850F<br />

Lysell, J., 2276F<br />

Lyssenko, V., 190<br />

Lyu, S., 900T<br />

Lyytinen, H., 1976F<br />

M<br />

Ma, B., 2587T, 3469T*<br />

Ma, C., 1352W, 1389T*,<br />

1510F, 1885T, 2419T,<br />

2489F<br />

Ma, J., 31, 593F*, 1399F,<br />

2819T<br />

Ma, J. Z., 2388W, 2390F,<br />

2574W<br />

Ma, L., 183, 187*, 1936T,<br />

2251T<br />

Ma, R., 2280W<br />

Ma, R. C. W., 2279F*<br />

Ma, X., 462W, 1235F<br />

Ma, Y., 1198T*, 1772W*<br />

Ma, Z., 3696W*<br />

Maas, J., 2581T<br />

Maas, R. L., 82<br />

Maas, S., 2932W<br />

Maayan, H., 788W<br />

Mäbert, K., 2920W<br />

Mabuchi, F., 1980W*<br />

Macaranas, O., 803W<br />

MacArthur, D., 41, 567F<br />

MacArthur, D. G., 280*, 295,<br />

582W<br />

MacArthur, J. A. L., 2108F,<br />

2155T, 3732W*<br />

Macaya, D., 1676T<br />

MacBean, E., 1825W<br />

Macciardi, F., 2459F,<br />

2469W, 2564F*, 3587F<br />

Maccioni, L., 2001W<br />

MacCluer, J., 1280W<br />

MacCluer, J. W., 2061W<br />

MacDonald, H., 3143W<br />

MacDonald, I., 1802F<br />

MacDonald, J. R., 460W<br />

MacDonald, M. E., 1964F,<br />

2643W<br />

MacDougall, M., 2759T<br />

Mace, A., 62, 299<br />

Macek, M., 2102F<br />

Macera, M. J., 937W,<br />

957W*, 1031F<br />

MacGregor, S., 212, 2068T,<br />

2133W, 2190W<br />

Macgregor, S., 388*, 2077T<br />

Mach, C., 2770W<br />

Mach, M., 3116F<br />

Machado, C. O. F., 2654F<br />

Machado, J. C., 1747W<br />

Machida, J., 1574W*, 2747T<br />

*Presenting Author<br />

Machiela, M. J., 1390F*<br />

Machielsen, G. C., 955W<br />

Machielsen, T., 979W<br />

Macias-García, B., 1030T<br />

Maciel, P., 913W<br />

Maciel-Guerra, A. T., 478W,<br />

479F<br />

Maciewicz, R. A., 2292W<br />

Macintyre, G., 2474F<br />

Macip, S., 1270T<br />

Mack, W., 3415T<br />

Mackay, D. J. G., 3494T<br />

MacKenzie, A. E., 2800W<br />

MacKenzie, J., 671F<br />

Mackenzie, W. G., 2855T,<br />

3150F<br />

Mackey, D. A., 2068T<br />

Mackey, J. R., 1297F<br />

Mackey, K., 658T<br />

Mackie Ogilvie, C., 906T<br />

MacKinnon, S., 2928F<br />

Macleod, J., 1567F<br />

MacLeod, S. L., 1459F<br />

MacMillan, A., 966T<br />

Mac Neal, M., 129, 2761W<br />

MacNee, W., 2249F<br />

Macpherson, J. M., 498W,<br />

1223F, 3386W<br />

Macpherson, M., 179<br />

Macrae, F., 1130F<br />

Macri, J., 2243F<br />

Macri, V. S., 1585T<br />

Madan, S., 2864T<br />

Madan-Khetarpal, S., 129,<br />

904T, 1744W<br />

Madden, P. A. F., 2056T,<br />

2212T<br />

Maddren, M., 3612W<br />

Madhoun, M., 3098F<br />

Madhusoodanan, J., 1183T*<br />

Madjunkova, S., 2983T<br />

Madore, A.-M., 1941W<br />

Madore, S., 966T<br />

Madrigal, I., 2624F, 2630F,<br />

2940F, 3217W*<br />

Madsen, J., 266<br />

Maeda, K., 52, 2823F<br />

Maeda, S., 2051F, 2071T<br />

Maeda, T., 1833W, 3432T*,<br />

3519T<br />

Mäenpää, H., 1253F<br />

Maer, A., 2973T, 3023T<br />

Maes, H. H., 2277W<br />

Maestrale, G. B., 2062T<br />

Maffei, P., 2702T, 2703F<br />

Maffeo, C., 775W<br />

Maga, M., 821F<br />

Magadi Gopalaiah, V., 523F*<br />

Magalhaes, W., 3562W*<br />

Magalhaes, W. C. S., 3325F<br />

Magaña, J. J., 3124F, 3226F<br />

Maganzini, D., 3680W<br />

Magdelaine, C., 2694F<br />

Mage, D. T., 86<br />

Mager-Heckel, A. M., 329<br />

Magi, R., 108, 2123F,<br />

2144F<br />

Mägi, R., 119, 190, 1308T,<br />

1954T, 2076W*, 2137T,<br />

2147F<br />

SPEAKER AND AUTHOR INDEX 379<br />

MAGIC (Meta-Analyses<br />

<strong>of</strong> Glucose and<br />

Insulin-Related<br />

Traits Consortium)<br />

Investigators, 2106W<br />

Maglio, C., 1271F<br />

Magliocca, S., 2916F<br />

Maglott, D., Session 77,<br />

1762W, 3582W, 3625F*,<br />

3732W<br />

Magnani, C., 1153T<br />

Magnani, J. W., 1585T<br />

Magnani, M., 760W<br />

Magnus, P., 3028T<br />

Magnusson, P. K. E., 991T,<br />

2105F, 2505W, 3442T,<br />

3452T<br />

Magot, A., 3066F<br />

Magoulas, P., 300<br />

Magoulas, P. L., 952T<br />

Magri, S., 2764W<br />

Magrini, V. J., 2587T<br />

Maguire, J., 290<br />

Maguire, M., 497F<br />

Magyari, L., 3283F<br />

Mahadevan, S., 3495T<br />

Mahajan, A., 49*, 119, 169,<br />

190, 1308T, 2070W,<br />

2076W, 2116T, 2137T<br />

Mahajan, V. B., 2750T*<br />

Mahamdallie, S. S., 1211F*<br />

Mahaney, M., 1280W<br />

Mahaney, M. C., 2308T,<br />

2309F, 3434T<br />

Mahaut, C., 127<br />

Mahdavi, M., 1718W,<br />

2964F*<br />

Mahdieh, N., 57<br />

Maher, B. H., 2916F<br />

Maher, B. S., 2500T, 2504F<br />

Maher, E. R., 2955F<br />

Mahesh, A., 1719W<br />

Mahmood, H., 2570F<br />

Mahomva, C., 1845W<br />

Mahon, L., 876T<br />

Mahon, P. B., 2391W*<br />

Mai, M. Q., 1723W<br />

Mai, P. L., 210, 1064F*<br />

Maia, S., 3019T<br />

Maiburg, M. C., 3164F<br />

Maier, A. B., 1436W<br />

Maier, C., 28, 1001F,<br />

1080W*, 1214F<br />

Maier, W., 3203W<br />

Maiers, M., 3330T<br />

Maiese, D. R., 1566T<br />

Maili, L., 1908W<br />

Maillard, A., 62, 299<br />

Maillet, P., 1268F<br />

Maisenbacher, M. K., 73<br />

Maiti, A., 1572T<br />

Maiti, A. K., 307*<br />

Maiti, R., 3582W, 3625F<br />

Maitland-van der Zee,<br />

A.-H., 609T<br />

Maiwald, S., 1604T<br />

Majewski, J., 701F, 706T,<br />

752T, 2790F, 2794W,<br />

3595F<br />

Majid, S., 2743W*<br />

Majounie, E., 2648F*<br />

Majumder, P. P., 3343F<br />

Mak, A., 1694T*<br />

Mak, S. K., 803W<br />

Makareeva, E., 222, 2853F<br />

Makarov, V., 1530T<br />

Mäki, M., 2023T, 2177F<br />

Makino, S., 373, 563F*,<br />

1574W<br />

Makishima, S., 2009F<br />

Makita, Y., 2758W<br />

Makkapati, V., 3316F<br />

Makke, B. J., 2249F<br />

Makowski, C., 2917W<br />

Makri, A., 5<br />

Makrythanasis, P., 84, 561F,<br />

2937F*, 3431T<br />

Maksymowych, W., 448W<br />

Malan, V., 889W, 915W*,<br />

3172F<br />

Malarstig, A., 503F<br />

Malasky, M., 30, 1218W,<br />

1517W<br />

Malats, N., 1091F<br />

Maldonado-Rodríguez, M.,<br />

3124F<br />

Malecki, M., 1020W, 3015T*<br />

Malecki, R., 1020W*, 3015T<br />

Malek, J. A., 2933T, 3399W<br />

Malerba, G., 1361W,<br />

2548T*, 2659T<br />

Maleszewski, J. J., 2906T<br />

Maleva, I., 2983T<br />

Malfait, F., 128, 129, 2225F*<br />

Malheiro, A., 1762W<br />

Malhotra, A., 2124W*<br />

Malhotra, A. K., 264<br />

Malhotra, D., 480W, 2576F<br />

Malhotra, N., 2967T<br />

Malicdan, M. C., 755W*,<br />

2870T<br />

Malig, M., 12, 14, 278, 375<br />

Malik, J. M., 3078F<br />

Malik, N. A., 2920W<br />

Malik, R., 1313W<br />

Malinowski, A., 3013T<br />

Malinowski, J., 2042F*<br />

Maliszewski, K., 432W<br />

Malki, N., 1707T<br />

Malkin, D., 1055F, 3142F<br />

Malladi, V., 3612W<br />

Mallarino, C., 1876F<br />

Mallempati, K., 2951T<br />

Maller, J., 176, 1513F<br />

Malley, J. D., 1363F<br />

Mallick, S., 3372T<br />

Mallott, J. M., 362*<br />

Malloy, M. J., 1694T<br />

Malloy-Diniz, L., 2404T<br />

Mallya, K. S., 639T<br />

Maloney, K. A., 384<br />

Malta, F. S. V., 182, 1573F<br />

Maltête, D., 345<br />

Malukiewicz, J., 3251W<br />

Malvehy, J., 1053W<br />

Malzac, P., 2792T<br />

Mamaeva, O., 2759T<br />

Mamaï, O., 1751W, 2744T*<br />

Mamarabadi, M., 3197W<br />

Mambelli, L. I., 1102T*<br />

SPEAKER AND AUTHOR INDEX


380 SPEAKER AND AUTHOR INDEX<br />

Mamchoui, K., 2840T<br />

Mampilly, G., 911W<br />

Mampilly, T., 911W<br />

Mamula, K. A., 1649T<br />

Manabe, R., 2891T<br />

Manak, J., 422W<br />

Manak, J. R., 419F<br />

Mancardi, G., 2095T<br />

Manchia, M., 2342F<br />

Mancini, G., 124<br />

Mancini, G. M. S., 214, 405*<br />

Mancini-DiNardo, D.,<br />

1021T*<br />

Manco-Johnson, M. J.,<br />

2330F<br />

Mandal, D., 28, 1040F,<br />

1081T*, 1214F, 1454W<br />

Mandal, R. K., 1123T<br />

Mandegar, M. A., 1620T<br />

Mandel, J.-L., 1800F*<br />

Mandell, J., 1226F<br />

Mandell, J. B., 1089W<br />

Mandelman, D., 3719F<br />

Mandl, K. D., 1836F<br />

Mane, S., 2444F<br />

Maneval, D. R., 1304W<br />

Manganelli, G., 2629T<br />

Mangino, M., 1653T, 2116T,<br />

2175W<br />

Mangold, E., 1512T, 2102F<br />

Mangolin, R., 2373W<br />

Mangravite, L., 615T<br />

Manhart, A., 3319F<br />

Manickam, K., 103, 456W<br />

Maniezzo, N. M., 1187F<br />

Manjarrez-Orduño, N., 306*<br />

Manjunath, S. H., 824F<br />

Mankodi, A., 711F<br />

Manley, W., 2426F*<br />

Manlhiot, C., 1704T<br />

Manly, J., 343<br />

Mann, G. J., 212<br />

Mann, K., 906T<br />

Mann, M., 2010W<br />

Mann, S. S., 2072F<br />

Mann, T., 3710W<br />

Mannens, M., 1616T<br />

Mannens, M. M., 681F<br />

Mannens, M. M. A. M.,<br />

3650W<br />

Mannermaa, A., 1114T,<br />

1125W<br />

Mannhalter, C., 1603T<br />

Mannick, K., 299<br />

Mannik, K., 62<br />

Männikkö, M., 1892F<br />

Manning, A., 249, 269, 1151F<br />

Manning, A. K., 48, 50, 173,<br />

176*, 1373W<br />

Manning, J., 2255F<br />

Manning, M., 3053W<br />

Mannini, L., 2695W<br />

Manoharan, A. P., 2091W<br />

Manokhina, I., 1760W*<br />

Manoli, I., 674T*, 721F,<br />

738T, 2683W<br />

Manolio, T., 1447F<br />

Manolio, T. A., 2155T<br />

Manouvrier-Hanu, S., 3172F<br />

Manrique, C. P., 2049W<br />

*Presenting Author<br />

Manschreck, C., 998F, 1159T<br />

Mansfield, B. C., 2712F<br />

Mansoori, M. M., 1096T<br />

Mansoori Derakhsham, S.,<br />

779W<br />

Mansour, S., 127, 129<br />

Mansouri, M., 3246F<br />

Mantero, F., 2708T<br />

Mantha, K., 378<br />

Mantripragada, K. K., 2405F*<br />

Manuck, T., 1904F<br />

Manuel Gonzalez, J., 506W<br />

Manyam, S. R., 2351F*<br />

Manzaneda, F., 2033F<br />

Manzaneda, J., 2033F<br />

Manzardo, A., 3089W<br />

Manzi, S., 2099F<br />

Manzi, S. F., 634T*<br />

Manzoni, M., 3256F<br />

Mao, J., 3029T<br />

Mao, J.-H., 984W<br />

Mao, L., 2910F<br />

Mao, M., 1369F, 2684T*<br />

Mao, R., 689F, 3637F<br />

Mao, X., 3604W<br />

Maples, B., 3360T, 3361F,<br />

3380W, 3563F*<br />

Mapua, C., 2466W<br />

Mapua, C. A., 2473T<br />

Maqsood, M. I., 2959W<br />

Mar, L., 145, 1810F*<br />

Maragh, S., 818F*<br />

Maranda, B., 2790F<br />

Maranian, M. J., 209<br />

Marano, L. A., 3277F*<br />

Maranville, J., 248*<br />

Maranville, J. C., 2021F<br />

Marasca, G., 685F<br />

Marasco, E., 306<br />

Maray, T., 3336T<br />

Marazita, M., 2034W,<br />

2325W, 3609F<br />

Marazita, M. L., 1315F,<br />

1464T, 1472W, 1474F,<br />

1512T, 1936T, 1937F,<br />

2142W, 2156F, 2178W,<br />

3028T<br />

Marble, M., 124<br />

Marca, V., 2453F<br />

Marcelli, M., 113, 177, 186,<br />

1451W, 1516F<br />

March, M. E., 1996T*<br />

Marchan, R., 1335T<br />

Marchand, L., 5, 141<br />

Marchani, E., 1918T*<br />

Marchegiani, S. M., 2938W*<br />

Marchetti, F., 984W<br />

Marchini, J., 90, 91, 1484W,<br />

3360T, 3384T<br />

Marcia, L., 823F, 847F*<br />

Marcinkowska, M., 1745W*<br />

Marder, K., 442W, 2547W<br />

Mardis, E., 1203W, 1210T<br />

Mardis, E. R., 244, 2587T<br />

Marduel, M., 1607T<br />

Marenholz, I., 2102F<br />

Mares, J. A., 2020T<br />

Margadant, C., 2848W<br />

Margalioth, E. J., 2991T,<br />

2993T<br />

Margaritte-Jeannin, P.,<br />

1361W, 1461T, 1941W,<br />

2079W<br />

Margolis, R. L., 2644T<br />

Margraf, R. L., 2720T,<br />

2951T*, 3638W<br />

Margulies, D. M., 1769W,<br />

1799W, 1836F, 1843W<br />

Margulies, E., 3663F<br />

Mari, B., 513F, 817F<br />

Mari, F., 2604W<br />

Mari, J. J., 2533T, 2534F<br />

Mariage, L., 3216F<br />

Mariani, J., 334<br />

Maric, I., 1259F<br />

Mariette, X., 2084F<br />

Marinelli, M., 2164T<br />

Marini, J. C., 222, 2853F<br />

Marini, M. G., 2001W<br />

Marini, N., 75<br />

Marion, M., 2143T<br />

Marion, M. C., 1979F<br />

Marion, V., 2887W<br />

Mariot, V., 2840T<br />

Mariotti, C., 2764W<br />

Maris, J. M., 2203T<br />

Maristany, M., 2578T<br />

Marjan, E., 1108T<br />

Marjanovic, D., 3286F<br />

Marjoram, P., 2153F<br />

Mark, K., 14<br />

Markaki, Y., 3500T<br />

Markello, T., 359, 2610W,<br />

2870T<br />

Markello, T. C., 2938W,<br />

3543F<br />

Markianos, K., 8, 452W,<br />

2811F, 3219W<br />

Markowitz-Shulman, A., 670T<br />

Marks, H., 2945T<br />

Markunas, C., 1919F*<br />

Markus, B., 2931F<br />

Markus, H. S., 1313W<br />

Markward, N. J., 642T<br />

Marle, N., 2729T, 2792T<br />

Marles, S., 491F<br />

Marlin, R., 32, 1222T<br />

Marlin, S., 126, 127, 2727F<br />

Marlton, P., 1042T<br />

Marmol, B., 977W<br />

Marmoset Genome<br />

Sequencing and Analysis<br />

Consortium, 3270T<br />

Marongiu, M., 547F, 823F*,<br />

847F, 1516F, 2001W<br />

Maroo, A., 3616W<br />

Maro<strong>of</strong>ian, R., 3201W<br />

Marostica, A., 2659T<br />

Marosy, B., 3704W,<br />

3716W*, 3731F, 3733F<br />

Maroun, L. E., 2411F<br />

Marqueling, A. L., 2926W<br />

Marques, A. A., 1037F<br />

Marques, F. A., 1880F*<br />

Marques, I., 2631W<br />

Marques, J. H., 3184F<br />

Marques, W., Jr., 2425T<br />

Márquez-Luna, C., 48<br />

Marrero, A. R., 994T,<br />

1405F*, 1946F<br />

Marrosu, M. G., 157<br />

Marruso, G., 2812W<br />

Marschall, C., 3539F<br />

Marsh, C. B., 626T<br />

Marshall, C. R., 175, 460W,<br />

2575T, 2932W, 3086F,<br />

3095W<br />

Marshall, J. D., 2702T<br />

Marshall, K., 2158T, 2782W<br />

Marshall, P., 1848W<br />

Marsidi, A., 1682T<br />

Marsit, C., 3465T<br />

Marsit, C. J., 3629F<br />

Martell, S., 2977T<br />

Martelli, L., 941W*<br />

Martemyanov, K., 2801T<br />

Marth, G., 41, 3606W<br />

Martin, A. L., 916T*<br />

Martin, A. R., 371*, 3411W<br />

Martin, B., 10, 3213W<br />

Martin, C., 713F*<br />

Martin, C. L., Session 77,<br />

917W<br />

Martin, E., 1544W, 1681T,<br />

2820F, 3170F<br />

Martin, E. R., 344, 347,<br />

1571W, 1957T, 2445W,<br />

2498F, 2508W, 2572T,<br />

2583W, 2586W, 2603F,<br />

2614T, 2637W, 3390T<br />

Martin, H. C., 2939T*<br />

Martin, J., 2046W<br />

Martin, L., 39, 3177W<br />

Martin, L. M., 1790W<br />

Martin, M., 2217W<br />

Martín, M. G., 296<br />

Martin, N. G., 106, 212, 351,<br />

2054F, 2056T, 2133W,<br />

2175W, 2212T*<br />

Martin, P., 2231F*<br />

Martin, T., 1152W<br />

Martinaud, O., 345<br />

Martin-Coignard, D., 3129W<br />

Martinelli, B., 691F<br />

Martinelli, V., 624T, 2095T,<br />

2781F<br />

Martinelli Boneschi, F.,<br />

624T*, 2095T<br />

Martinet, D., 299<br />

Martinez, A., 3242F<br />

Martinez, D., 2614T<br />

Martinez, F., 536W<br />

Martinez, J., 864T, 3074F*<br />

Martinez, J. C., 951W<br />

Martinez, R. J., 3390T<br />

Martinez, S., 501F<br />

Martinez-Agosto, J. A., 361<br />

Martinez-Barbera, J., 2701W<br />

Martinez-Barrios, E., 1053W<br />

Martinez-Cruzado, J. C.,<br />

3315T, 3360T, 3380W<br />

Martínez-Cruzado, J. C.,<br />

3254W, 3363T<br />

Martinez-Jarreta, B., 3364F<br />

Martínez-Jarreta, B., 3402T<br />

Martinez-Lopez, M. C.,<br />

2019W<br />

Martinez-Perez, A., 1651T<br />

Martinovic, J., 77, 894T,<br />

3129W


Martins, A. S., 2655W<br />

Martins, M., 1979F*, 2150F,<br />

2655W<br />

Martins, M. T., 852F<br />

Martins-da-Silva, A., 1296T<br />

Martinuzzi, A., 2799F<br />

Martis, S., 652T*<br />

Martos-Moreno, G. A.,<br />

2711T<br />

Marullo, L., 119, 190, 1308T,<br />

2076W, 2137T<br />

Maruyama, H., 3229W<br />

Marvelle, A. F., 1627T<br />

Marwaha, R., 3207W<br />

Marx, R., 2677W<br />

Mary, P., 3700W<br />

März, W., 1595T<br />

Marziali, A., 1264T*<br />

Marzouka, N., 1881W<br />

Masaki, N., 2130W<br />

Maschio, A., 113, 177,<br />

1451W, 1516F, 2001W,<br />

2329T*, 3664W<br />

Mash, D., 368, 2637W<br />

Mash, D. C., 341<br />

Mashevich, M., 858T<br />

Maskeri, B., 1515T<br />

Maslanski, B., 3002T<br />

Maslen, C., 1349W, 1700T*<br />

Maslen, C. L., 1743W,<br />

2069F<br />

Masliah, J., 124<br />

Mason, C., 2610W, 3464T<br />

Mason, C. E., 376*, 1818F<br />

Mason, E., 675F<br />

Mason, T., 1926W<br />

Mason-Suares, H., 338<br />

Masotti, C., 813F<br />

Masri, A., 2937F<br />

Massam, H., 1500T<br />

Massé, K., 841F*<br />

Massey, S., 3254W<br />

Massicotte, C., 2790F<br />

Massie, M. J., 1841W<br />

Massimi, L., 2235W<br />

Massingham, L., 765W<br />

Mastronardi, M., 3689F<br />

Masuda, A., 2472W<br />

Masuho, I., 2801T<br />

Masuno, M., 1795W, 2891T,<br />

3051W<br />

Masurel-Paulet, A., 2792T<br />

Masys, D. R., 1312F<br />

Mata, I., 2538W*<br />

Matanovic, A., 2102F<br />

Matar, C., 3241W<br />

Mateo Leach, I., 110<br />

Materna-Kiryluk, A., 845F<br />

Matharoo, K., 1703T<br />

Mathavan, S., 3047W<br />

Matheny, J., 384<br />

Mathern, G., 267<br />

Matheus, G., 3171W<br />

Mathews, C., 1480F<br />

Mathews, D., 1826F*<br />

Mathews, V., 931W<br />

Mathias, R. A., 158, 171,<br />

1425T, 1558F, 1710T,<br />

1900T, 2043W, 2346W<br />

Mathiesen, R., 2982T<br />

*Presenting Author<br />

Mathieson, I., 16, 3279T,<br />

3298F*<br />

Mathieu, F., 259<br />

Mathieu, J., 2900T<br />

Mathieu, M., 3117W<br />

Mathieu, P., 1655T<br />

Mathieu-Dramard, M.,<br />

3109W<br />

Matias, R., 2466W<br />

Matise, T., 2041T, 2216F<br />

Matise, T. C., 1359T, 2042F,<br />

3558W, 3566W<br />

Matisoo-Smith, E., 3349F<br />

Matisoo-Smith, E. A.,<br />

3333T*<br />

Matoba, N., 2873T,<br />

2923W*<br />

Matoo, S., 1961F*, 1962W<br />

Matos, A. H. B., 2655W*<br />

Matsson, H., 1976F*<br />

Matsubara, Y., 1290T<br />

Matsuda, F., 2004W,<br />

2361W<br />

Matsuda, H., 2697F<br />

Matsui, T., 2174F<br />

Matsuishi, T., 724T<br />

Matsukawa, T., 233*<br />

Matsumoto, A., 2588F,<br />

3118F*<br />

Matsumoto, M., 1447F<br />

Matsumoto, N., 1290T,<br />

2822T, 2878W*, 3136F,<br />

3230F<br />

Matsumoto, T., 2174F<br />

Matsumura, Y., 1327F<br />

Matsunaga, T., 2882T<br />

Matsunami, N., 2397W*<br />

Matsuo, H., 663F*, 2371T<br />

Matsuo, M., 781W<br />

Matsushita, H., 2687T<br />

Matsushita, M., 2549F<br />

Matsuura, E., 2601W<br />

Matsuura, K., 2130W<br />

Matta, J., 996W, 1074W<br />

Matte, U., 691F, 2825T<br />

Matteini, A. M., 2040W<br />

Matteson, P., 2216F<br />

Matteson, P. G., 2426F<br />

Mattheisen, M., 1536T,<br />

2520W<br />

Matthiessen, M., 2057F<br />

Matthijs, G., Session 20<br />

Mattiello, A., 1712T<br />

Mattiske, T., 2640W<br />

Mättö, J., 2023T<br />

Matullo, G., 1153T, 1712T<br />

Matvienko, M., 3528W,<br />

3641F*, 3662W<br />

Matyakhina, L., 332<br />

Mauermann, O., 1115F<br />

Maues de Paula, A., 328<br />

Maugard, C., 1212W<br />

Maurat, E., 716T<br />

Maurer, M., 2681T<br />

Maurer, M. A., 1255T<br />

Maurer-Morelli, C. V., 1903T,<br />

2373W, 2394W, 2655W,<br />

3578W<br />

Maury, P., 2945T<br />

Maussion, G., 3470T*<br />

SPEAKER AND AUTHOR INDEX 381<br />

Mautner, V.-F., 2791W<br />

Mavrothalassitis, G., 218<br />

Mawatari, Y., 2130W<br />

Maxfield, A. B., 820F<br />

Maxfield, K., 3671F<br />

Maxwell, A. P., 2307W<br />

Maxwell, T. J., 272*, 340<br />

May, A., 3619F<br />

May, A. P., 2301W<br />

May, M., 2806W<br />

May, T., 1837W<br />

Mayani, R., 3558W<br />

Mayen, D., 928T, 956T<br />

Mayén, D. G., 875W, 960T<br />

Mayer, F., 691F<br />

Mayer, J., 2778F<br />

Mayerle, J., 2141F<br />

Mayeux, R., 343, 344,<br />

1476T, 1571W, 2040W,<br />

2093F, 2410T, 2498F<br />

Mayhew, C. N., 736T<br />

Mayne, K., 385, 1305T<br />

Mayo, K., 340<br />

Mayo, P., 1286W, 1316W,<br />

1377T, 1671T, 1713T<br />

Mayo, V., 9, 2445W<br />

Mayr, J., 782W<br />

Mayr, J. A., 699F, 2917W<br />

Mayr, M., 3723F<br />

Maystadt, I., 214, 2810T,<br />

3181W, 3216F, 3218F*<br />

Mazery, AC., 104<br />

Mazloom, A., 3016T<br />

Mazloom, A. R., 3014T<br />

Mazor, M., 2738T<br />

Mazur, D., 3698W<br />

Mazzetti, P., 2453F<br />

Mazzeu, J., 2863W*<br />

Mazzeu, J. F., 903W, 961W<br />

Mazzilli, M. C., 1330F<br />

Mazzini, L., 2775F<br />

Mazzola, L. M., 3702W<br />

Mazzucatto, l. F., 3099W<br />

McAdoo, S., 3018T<br />

McAteer, J., 249<br />

McBride, D., 3694W<br />

McBride, K., 1680T*<br />

McBride, K. L., 1646T<br />

McCabe, E. R. B., 1867F<br />

McCabe, L., 1867F<br />

Mccafferty, S., 2703F<br />

McCaleb, M., 804W<br />

McCall, S., 3622W<br />

McCallie, B. R., 851F,<br />

2968T*<br />

McCallion, A. S., 79, 258,<br />

545F, 818F<br />

McCandless, S. E., 741F*,<br />

774W<br />

McCann, B., 1965W<br />

McCann, L., 651T<br />

McCarroll, S., 290, 350,<br />

480W, 1325W, 2487W,<br />

2618F<br />

McCarroll, S. A., 280, 284,<br />

437F, 1519F<br />

McCarthy, L. C., 649T<br />

McCarthy, M., 368, 583F,<br />

1440T, 1513F, 2097W,<br />

2162F<br />

McCarthy, M. I., 44, 119,<br />

176, 280, 582W, 1308T,<br />

1519F, 1954T, 2076W,<br />

2123F, 2137T, 2147F,<br />

2324F, 3435T, 3441T,<br />

3575F<br />

McCarthy, S., 455F, 1518T,<br />

2590T*<br />

McCarty, C., 2098T, 3622W<br />

McCarty, C. A., 618T, 1312F,<br />

1447F, 2154W, 2240F,<br />

2263T<br />

McCauley, J., 151*<br />

McCauley, J. L., 270, 2039F,<br />

2049W, 2299T, 3390T<br />

McClain, L. L., 2125T*<br />

McClaren, B. J., 143<br />

McClay, J. L., 3442T, 3452T<br />

McClellan, B., 1316W,<br />

1377T, 1928F, 2037W<br />

McClellan, B., Jr., 1671T<br />

McClellan, J., 263, 2600F<br />

McClellan, R., 3065W<br />

McCole, R. B., 444W*<br />

McCombie, W. R., 2180F,<br />

2305T, 2587T, 2590T,<br />

3316F<br />

McConnachie, A., 1626T<br />

McConnell, J. C., 3419T<br />

McConnell, M. J., 436W<br />

McCord, R., 255<br />

McCormick, C., 369, 2372F<br />

McCormick, J. B., 1849W*,<br />

2048F, 2345F<br />

McCracken, J. T., 639T<br />

McCuaig, C., 778W<br />

McCulloch, C. E., 589F<br />

McCullough, A. E., 1186T<br />

McDade-Walker, D., 3705F<br />

McDaniel, L., 370<br />

McDavid, A., 2098T<br />

McDonagh, E. M., 633T,<br />

635T*<br />

McDonald, J., 1058F<br />

McDonald, K., 3<br />

McDonald, K. K., 2946F*<br />

McDonald, M., 2057F<br />

McDonald, M. N., 2249F*<br />

McDonald, M. T., 3<br />

McDonald-McGinn, D., 65,<br />

1494T, 3038F*<br />

McDonnell, N., 1663T<br />

McDonnell, N. B., 3231W<br />

McDonnell, S., 1214F<br />

McDonnell, S. K., 986F,<br />

3564W<br />

McElhinny, T., 1861F<br />

McElligott, J., 949W<br />

McElroy, J., 3030T<br />

McElroy, S., 605T, 2516F<br />

McEntagart, M., 2896W<br />

McEvoy, B., 2223W<br />

McEvoy, B. P., 2366F<br />

McEvoy, M., 2133W<br />

McEwen, J. E., 1845W<br />

McEwen, R., 503F<br />

McFadden, D. E., 2986T<br />

McGarvey, S. T., 2159F<br />

McGeachie, M. J., 625T*<br />

McGee, S., 2901F<br />

SPEAKER AND AUTHOR INDEX


382 SPEAKER AND AUTHOR INDEX<br />

McGehee, S., 1702T<br />

McGhee, S., 1658T, 2065T<br />

McGillivary, B., 491F<br />

McGinley, C., 1869F<br />

McGlynn, K., 213<br />

McGough, J. J., 639T<br />

McGovern, D. P., 1381F,<br />

2319W<br />

McGowan, B., 3211W<br />

McGowan, M., 2761W<br />

McGowan, R., 126, 127<br />

McGowan, S., 219<br />

McGowan, S. J., 218, 2746W<br />

McGrath, J., 2486F, 2573F<br />

McGrath, J. A., 2461T<br />

McGrath, J. M., 2576F<br />

McGregor, T. L., 247, 631T<br />

McGue, M., 1568W<br />

McGuffin, P., 2509T<br />

McGuffog, L., 207, 208<br />

McGuire, A., Session 25<br />

McGuire, A. L., 430W,<br />

1797W, 1798F<br />

McGuire, M., 904T<br />

McGuire, M. M., 993W*<br />

McGuire, P. J., 669F<br />

McGuire, S. E., 3433T<br />

McGuire, W., 96<br />

McHenry, T., 1936T<br />

McHugh, N., 2160W<br />

McInerney, P., 3697F*<br />

McInnes, B., 1052F<br />

McIntosh, I., 3331F<br />

McIver, Z., 1259F<br />

McKay, F., 1748W<br />

McKay, G. J., 1897T*<br />

McKay, J., 1012T<br />

McKay, J. D., 1496W<br />

McKean, D., 340<br />

McKee, A. C., 2528F<br />

McKeigue, P., 1481W,<br />

1895F<br />

McKenna, A., 25<br />

McKenney, A., 2033F<br />

McKenzie, C. A., 1906T,<br />

2158T<br />

McKenzie, K., 303<br />

McKeon, M., 1687T<br />

McKew, J., 711F, 1702T<br />

McKinney, A., 456W, 912T<br />

McKinnon, M., 3135W*<br />

McKnight, A. J., 2307W<br />

McKnight, D., 2579F<br />

McLaren, P. J., 2050T*<br />

McLaren, W. M., 3732W<br />

McLaughlin, H. M., 2470T<br />

McLaughlin, J., 1061F,<br />

1803W*<br />

McLaughlin, S., 1244F,<br />

3717F<br />

McLean, C., 483F, 3617F<br />

McLean, C. Y., 2565W*<br />

Mclellan, M., 1203W<br />

McLennan, G., 3014T<br />

McLeod, D. R., 2800W<br />

Mcleod, H., 241<br />

McLeod, H. L., 626T<br />

McMahon, F. J., 260, 261,<br />

2622W<br />

McMahon, K. L., 2054F<br />

*Presenting Author<br />

McMahon, S. B., 503F<br />

McManus, R., 2160W,<br />

2283W<br />

McMaster, M. L., 30, 2191T<br />

McMillin, M. J., 2740W<br />

McMullen, I., 46<br />

McMullen, I. A., 1452T<br />

McNally, E. M., 1614T*,<br />

1683T<br />

McNamara, S., 171<br />

McNeil, D. W., 1464T,<br />

1474F, 2034W, 2142W,<br />

2156F, 2178W<br />

McNeill, N. H., 1684T<br />

McPherson, J. D., 135,<br />

1093T, 1227W, 1256F,<br />

1279T<br />

McPherson, J. R., 2889F<br />

McPherson, R., 1645T,<br />

2236T<br />

McQueen, M. B., 2239T<br />

McQuillan, R., 1383T,<br />

1481W, 2366F<br />

McSweeney, K. M., 339,<br />

2879T*<br />

McTague, A., 1773W<br />

McVean, G., 16, 285, 472W,<br />

3279T, 3298F<br />

McVicar, K., 3119W<br />

McWilliams, R., 603T<br />

Md-Zain, B. M., 3267T<br />

Meaburn, E. L., 3487T<br />

Mead, M., 2325W<br />

Meader, S., 445F*<br />

Means, D., 868T<br />

Mearin, M. L., 1330F<br />

Mechanic, L., 1543F<br />

Mechawar, N., 2482T,<br />

3470T<br />

Meck, J., 332<br />

Mecklin, J.-P., 1026W,<br />

1276T<br />

Meda, S., 2532W<br />

Medeira, A., 3165W<br />

Medeiros, P., 2289W<br />

Medeiros, P. F. V., 747F,<br />

2642F<br />

Medina, E., 2251T<br />

Medina, M., 1442W<br />

Medina, M. W., 601T, 615T<br />

Medina-Gomez, C., 2169W<br />

Medina Gomez, M. C.,<br />

1334W*<br />

Medland, S. E., 351*, 2054F,<br />

2056T, 2505W<br />

Medne, L., 1702T, 1781W,<br />

2884W<br />

Medrano-Hernández, A.,<br />

1131W<br />

Meduri, D., 583F<br />

Meduri, E., 44, 3441T,<br />

3453T<br />

Meehan, B., 1182W<br />

Meek, I., 3138F*<br />

Meese, E., 515F<br />

Mefford, H., 2890W<br />

Mefford, H. C., 10, 2789T,<br />

2897T<br />

Mefford, J., 1548T*, 2258F<br />

Mefford, J. A., 1250F<br />

Megarbane, A., 84, 2692W,<br />

2937F, 3241W<br />

Meguro-Horike, M., 3497T,<br />

3498T*<br />

Mehaffey, M. G., 1068W<br />

Mehdi, S. Q., 3322F<br />

Mehdipour, P., 1169F<br />

Mehravar, E., 682T<br />

Mehrdad, K., 777W<br />

Mehrotra, P., 2926W<br />

Mehrtashfar, S., 1615T*<br />

Mehta, A., 492W, 2603F<br />

Mehta, A. B., 772W<br />

Mehta, D., 1422T, 2483F*<br />

Mehta, G., 3558W<br />

Mehta, G. R., 3692W*<br />

Mehta, L., 3033T, 3145W*<br />

Mehta, S., 3172F<br />

Mehta, S. G., 3213W<br />

Mehta, T. Y., 2731W<br />

Mei, H., 459F, 652T, 958T*,<br />

3488T<br />

Mei, J., 159, 2617T<br />

Mei, R., 369, 2372F<br />

Meigs, J. B., 269, 1346W,<br />

2080T, 2106W, 2337W<br />

Meijer, I. A., 2591F<br />

Meijers-Heijboer, H., 98,<br />

494W, 3200F<br />

Meikle, P. J., 2308T<br />

Meire, F., 539F<br />

Meirelles, O., 276, 1391W*<br />

Meisinger, C., 2595W<br />

Meisler, M. H., 2463W, 2471F<br />

Meissner, A., 380, 2107T,<br />

3450T<br />

Meitinger, T., 86, 275, 567F,<br />

582W, 699F, 782W,<br />

2567F, 2568W, 2595W,<br />

2917W<br />

Mejia, L., 2705T<br />

Mejias, R., 2566T<br />

Mejia-Santana, H., 442W<br />

Mekonnen, E., 3322F<br />

Melaragno, M., 896T, 899W,<br />

3131W<br />

Melaragno, M. I., 2533T,<br />

2534F, 3045W*<br />

Melbye, M., 1528F, 3028T<br />

Melegh, B., 3283F*<br />

Melegh, B. I., 3283F<br />

Melen, E., 2167T, 2168F<br />

Melendez, C., 3377W<br />

Meléndez, R., 875W, 960T<br />

Melin, B. S., 1372F<br />

Melki, J., 54*, 1796W<br />

Mellgren, G., 3536W<br />

Mellgren, S. I., 2965W<br />

Mello, M., 2404T<br />

Mellone, S., 2827W<br />

Mells, G. F., 153<br />

Melnick, A., 3464T<br />

Melnyk, S., 1459F, 3697F<br />

Melo, M. B., 426W, 2286W,<br />

2718F*, 2751F<br />

Melone, M., 2950W<br />

Meloni, A., 823F, 2001W<br />

Meloni, I., 2604W<br />

Meloni, V., 899W<br />

Melton, P. E., 1406W, 2061W*<br />

Meltz Steinberg, K., 375*<br />

Melzer, D., 2148W<br />

Memari, Y., 503F<br />

Members <strong>of</strong> Groupe<br />

d’Étude des Tumeurs<br />

Endocrines, 1293T<br />

Members <strong>of</strong> Mouse<br />

<strong>Genetics</strong> Project, 2725W<br />

Menaa, F., 426W<br />

Menard, A., 438W<br />

Menashe, I., 446W*<br />

Mencarelli, M. A., 2604W<br />

Menchón, J. M., 2593T<br />

Mencikova, A., 2831T<br />

Menck, C. F., 814F<br />

Mendell, J., Session 76<br />

Mendell, N. R., 1338T<br />

Mendes-Júnior, C., 3261T<br />

Mendes-Junior, C. T.,<br />

3277F, 3280F<br />

Mendes-Júnior, C. T., 3375T<br />

Mendez, F. L., 3389W*<br />

Mendez-Dominguez, N.,<br />

2272T<br />

Mendez-Ramírez, N., 1030T<br />

Mendola, A., 1611T<br />

Mendonça, F., 1968W,<br />

2017T<br />

Mendoza, L., 1049F<br />

Mendoza, R., 3196F<br />

Mendoza-Constantino, S.<br />

P., 875W<br />

Mendoza-Londono, R., 103,<br />

1738W, 3100F*, 3106F,<br />

3183W<br />

Mendus, D., 2773W<br />

Menelaou, A., 91*<br />

Menendez, I., 3125W<br />

Meneses-Morales, I., 3504T<br />

Meng, W., 2843T<br />

Meng, Y., 2307W*<br />

Mengel-From, J., 2244W,<br />

2295W<br />

Menghini, D., 3087W<br />

Mengrelis, K., 2752W<br />

Menke-Pluymers, M.,<br />

1788W<br />

Menni, C., 503F, 2138F<br />

Menon, R., 2572T, 3030T<br />

Mensenkamp, A. R., 1220F*<br />

Mentch, F., 319, 2229W,<br />

2252F, 2872W, 3573F<br />

Mentch, F. D., 1997F,<br />

2121W, 2546F<br />

Menten, B., 98, 423F, 2387F<br />

Mentzen, W., 1516F<br />

Menzin, A., 1133F<br />

Meola, N., 2950W<br />

Merath, K., 1667T*<br />

Mercado, D., 2043W<br />

Mercado, T., 1036T<br />

Mercedes de la Cruz, F.,<br />

3363T<br />

Mercer, F., 3708W<br />

Mercer, K. B., 1422T, 2420F,<br />

2483F, 3480T<br />

Mercier, E., 447F*, 517F,<br />

3568W<br />

Mercier, S., 2893W, 3066F*,<br />

3170F


Mercimek- Mahmutoglu,<br />

S., 717F<br />

Merck-Laval-UBC-Groningen<br />

Lung eQTL Consortium,<br />

1947W<br />

Merckx, D. M. L., 2448W<br />

Meredith, G., 3717F*<br />

Mergener, R., 879W<br />

Merico, D., 2617T<br />

Mericq, V., 131<br />

Merideth, M. A., 2838F<br />

Merkies, I. S. J., 2448W<br />

Merkoulovitch, A., 460W<br />

Merla, G., 84, 775W,<br />

3087W*, 3256F<br />

Merner, N., 1898F<br />

Merrick, C., 1082F*<br />

Merrill, A. E., 838F, 2857W<br />

Merrill, D., 1195T<br />

Merrill, J. T., 1979F, 2046W<br />

Merrill, L., 512W, 3517T<br />

Merriman, B., 2779W<br />

Mersha, T., 578W*<br />

Mertz, E. L., 222<br />

Mervis, C. B., 3482T<br />

Mesa, R. A., 1017W<br />

Meskel, D., 3303T, 3338W<br />

Meslin, E. M., 1848W<br />

Messaed, C., 2842W<br />

Messiaen, L., 1139F, 2791W<br />

Messika-Zeitoun, D., 1655T<br />

Messinger, Y., 132<br />

Mester, J., 1144T<br />

MetaXpress Consortium,<br />

275<br />

Metay, C., 1796W<br />

Métay, C., 894T<br />

Metayer, C., 2268W<br />

Metcalf, J. L., 1046F<br />

Metcalfe, S. A., 143*<br />

Metlapally, R., 2328W,<br />

3521T*<br />

Metrustry, S., 2292W<br />

Metrustry, S. J., 2171F*<br />

Metsepalu, A., 1284T,<br />

1503T<br />

Metspalu, A., 109, 584W,<br />

1163F, 1792W, 1832F,<br />

2144F, 2165F, 2175W,<br />

2366F, 3079W, 3353W,<br />

3460T<br />

Metspalu, E., 3286F<br />

Metzker, M. L., 244<br />

Meugnier, E., 2278T<br />

Meulenbelt, I., 584W<br />

Meurer, L., 691F<br />

Mewes, H. W., 86<br />

Mexal, S., 1736W, 3535F,<br />

3681F<br />

Meyer, A., 1117T, 3425T<br />

Meyer, B. F., 2676F<br />

Meyer, D., 3292F<br />

Meyer, E., 1773W<br />

Meyer, F., 691F<br />

Meyer, I., 2751F<br />

Meyer, K., 376<br />

Meyer, K. B., 209<br />

Meyer, M., 1441F<br />

Meyer, N., 2867T<br />

Meyer, N. C., 2301W<br />

*Presenting Author<br />

Meyers, J. L., 2022W*<br />

Meyers, K. J., 2020T<br />

Meyers, L., 3557F<br />

Meyle, J., 2058W<br />

Meyn, M. S., 1046F*,<br />

1047W, 1050W<br />

Meyn, S., 1055F<br />

Meza, C., 1336F<br />

Mezey, J. G., 1355W, 2933T,<br />

3399W<br />

Mhaidat, N., 856T<br />

Mhanni, A., 954T<br />

Mhanni, A. A., 2422T, 2772F<br />

MHC Disease Research<br />

Group, 3258T<br />

Mhiri, C., 2820F<br />

Mhlanga-Mutangadura, T.,<br />

2847F<br />

Miano, M. G., 505F, 2629T<br />

Mias, G. I., 1505W*<br />

Micale, C., 3680W<br />

Micale, L., 775W*, 3087W,<br />

3256F<br />

Miceli-Richard, C., 2084F<br />

Micha, D., 809F<br />

Michaeel, A., 3210F<br />

Michaelides, M., 3212F<br />

Michaeli-Yossef, Y., 3048F<br />

Michaelson, J., 480W*<br />

Michaelson-Cohen, R.,<br />

2929W<br />

Michailidou, K., 206*, 209,<br />

210, 1150T<br />

Michaud, J., 2075F, 2794W<br />

Michaud, J. L., 2692W,<br />

2790F<br />

Michaux, D., 1205F<br />

Michealraj, A., 2941W<br />

Michel, L., 29<br />

Michel, M., 642T<br />

Micheli, R., 760W<br />

Michelini, K., 2<br />

Michelis, L. D., 2958F<br />

Michels, V. V., 1695T<br />

Michelson, M., 3048F<br />

Michelson-Kerman, M.,<br />

3174F*<br />

Michetti, F., 2235W<br />

Michiorri, S., 71<br />

Michot, C., 127<br />

Micliavacca, M. P., 2485T<br />

Middha, S., 1214F, 1695T,<br />

3564W*<br />

Middlebrooks, C. D., 253*<br />

Middleton, M., 133<br />

Middleton, S., 242<br />

Mieczkowski, P., 3659F<br />

Miele, L., 1116W<br />

Migita, O., 2620T<br />

Migliavacca, E., 62*, 84,<br />

415F, 3256F<br />

Migliavacca, M., 3131W*<br />

Migliavacca, M. P., 2484W<br />

Mignot, C., 2770W<br />

Mignot, C. C., 2431T*, 2441F<br />

Mignot, E., 2543F<br />

Mihovilovic, M., 2465F<br />

Mikhailov, A., 2398T, 2570F<br />

Miklos, D. B., 1112F<br />

Mikula, M., 2260T*<br />

SPEAKER AND AUTHOR INDEX 383<br />

Mila, M., 2624F*, 2630F,<br />

2940F, 3217W<br />

Milan, G., 1985F, 2702T<br />

Milani, L., 3460T<br />

Milani, P., 2775F<br />

Milanova, V., 3477T<br />

Milas, M., 1144T<br />

Milburn, J., 142<br />

Miles, S., 96<br />

Miles-Mason, E., 168<br />

Milewicz, D., 1789W<br />

Milewicz, D. M., 1743W<br />

Milgram, R., 1303F<br />

Milgrom, R., 2875W<br />

Milh, M., 2536T*<br />

Mili, A., 1751W*<br />

Mili, F., 611T*<br />

Milic Rasic, V., 201, 2948T<br />

Mill, J., 3471T*, 3476T,<br />

3487T<br />

Millan, J., 2947W<br />

Millar, K., 3075W*<br />

Millen, A. E., 2020T<br />

Miller, B., 2249F<br />

Miller, B. L., 2639F<br />

Miller, D. G., 55*, 2224T<br />

Miller, E., 1674T<br />

Miller, E. M., 2698W<br />

Miller, F. A., 142, 1824F<br />

Miller, F. W., 434W<br />

Miller, J., 2904F, 3590W,<br />

3717F<br />

Miller, J. K., 1279T*<br />

Miller, L. L., 1973F, 2010W<br />

Miller, M., 2953W<br />

Miller, M. A., 494W, 1239W<br />

Miller, M. R., 1322W<br />

Miller, N., 3490T<br />

Miller, N. A., 366, 2793F,<br />

2894T<br />

Miller, N. H., 1983W<br />

Miller, P., 1107W<br />

Miller, R. A., 818F<br />

Miller, S., 1937F*<br />

Miller, S. I., 2186F<br />

Miller, W., 3545F<br />

Millikan, R. C., 2202W<br />

Millonig, J., 2216F, 2467T<br />

Millonig, J. H., 2426F, 3566W<br />

Mills, J. L., 2151W<br />

Mills, P. B., 167<br />

Mills, R., 147<br />

Mills, R. E., 3251W<br />

Mills, T., 2157W<br />

Millson, A., 3220F*<br />

Millwood, I. Y., 2162F<br />

Milne, R. L., 206<br />

Milner, L. C., 1804F*<br />

Milon, J., 3170F<br />

Milosavljevic, A., 432W,<br />

3433T<br />

Milstone, L., 2915T<br />

Milz, E., 3214F<br />

Mimori, T., 2004W<br />

Mimouni-Bloch, A., 731F<br />

Min, B., 933W*, 3204F<br />

Min, J., 583F<br />

Min, J. L., 1522F*<br />

Min, W., 947W<br />

Mina, D., 2728W<br />

Minakuchi, T., 2768T<br />

Minakuchi, Y., 2835F<br />

Minari, J., 1815W*<br />

Minatoya, K., 2697F<br />

Miner, T., 2325W<br />

Ming, J. E., 819F, 2884W<br />

Mingroni-Netto, R. C., 891W<br />

Miniati, D., 816F<br />

Minillo, R. M., 2484W<br />

Minna, J., 1454W<br />

Minor, L. B., 2301W<br />

Minot, D., 2770W<br />

Minster, R. L., 1920W,<br />

1921T, 2159F*<br />

Minto, M., 3717F<br />

Minx, P., 2320T<br />

Miny, P., 3044F, 3109W<br />

Miousse, I. R., 719F<br />

Mira, M., 1899W<br />

Mira, M. T., 1978T, 2289W,<br />

2475W<br />

Mirabelli, D., 1153T<br />

Miralles, M., 2379W<br />

Miranda, D., 2404T<br />

Miranda, D. M., 1902W,<br />

2385W<br />

Miranda, M. L., 1636T<br />

Mirante, T., 2766F, 2774T<br />

Mirel, D., 356, 1447F,<br />

1490W, 2098T<br />

Mirel, D. B., 1960T<br />

Miri Nargesi, M., 1083W*<br />

Mirkin, S., 402<br />

Mirkov, S., 613T<br />

Miro, X., 105<br />

Mirocha, J., 753T<br />

Miron, I., 3013T<br />

Mirsattari, S. M., 2779W<br />

Miryounesi, M., 1169F,<br />

2987T*<br />

Mirzozoda, K., 1898F*,<br />

2410T<br />

Misawa, K., 3565F*<br />

Mishra, A., 764W, 1287T,<br />

1288F, 1587T*, 1598T<br />

Misner, K. J., 1242W<br />

Misra, A., 555F<br />

Misra, S., 1188W<br />

Missmer, S. A., 2077T,<br />

2133W<br />

Missoni, S., 1660T<br />

Mistri, M., 700T*<br />

Mistri, M. A., 2803W<br />

Mistry, P. K., 768W, 769W<br />

Mitchell, A., 1665T<br />

Mitchell, A. A., 2576F<br />

Mitchell, A. D., 2218T<br />

Mitchell, B. D., 602T<br />

Mitchell, E. B., 2575T<br />

Mitchell, F., 239<br />

Mitchell, G., 1224W, 1492F<br />

Mitchell, J. A., 1307W<br />

Mitchell, M. E., 3020T<br />

Mitchell, P., 2068T, 2094W<br />

Mitchell, S., 1713T*<br />

Mitchison, H. M., 216, 809F<br />

Mitrovic, Z., 201, 2948T<br />

Mitsui, J., 52, 233, 2409W,<br />

2569T<br />

Mitsunaga, E., 1505W<br />

SPEAKER AND AUTHOR INDEX


384 SPEAKER AND AUTHOR INDEX<br />

Mitsunaga, S., 2253W<br />

Mitsuuchi, F. N., 2751F<br />

Mittal, B., 1137W, 1188W,<br />

1587T, 1598T*, 2293T,<br />

3271F<br />

Mittal, K., 2398T, 2525F*<br />

Mittal, R. D., 1123T*,<br />

1134W, 1135T<br />

Mittal, S., 2967T<br />

Mittal, T., 1587T, 1598T<br />

Mittelman, D., 469F<br />

Mittelstadt, S. D., 696T<br />

Mitterling, T., 2567F<br />

Mittleman, M. A., 3469T<br />

Miura, K., 2748F<br />

Miwa, A., 729F<br />

Miya, F., 396<br />

Miyachi, H., 1574W, 2747T<br />

Miyada, G., 3699F<br />

Miyadera, H., 1994F*<br />

Miyagawa, T., 2496W, 2656T*<br />

Miyahara, R., 1998W*,<br />

1999T<br />

Miyakawa, S., 2911W<br />

Miyakawa, T., 2550W,<br />

2647T<br />

Miyake, K., 2835F<br />

Miyake, M., 3146F<br />

Miyake, N., 1290T, 2822T,<br />

2878W, 3136F, 3230F<br />

Miyamoto, R., 3229W*<br />

Miyamura, H., 475F<br />

Miyano, S., 396<br />

Miyatake, S., 1290T*<br />

Mizokami, M., 2130W,<br />

3682W<br />

Mizrahi-Man, O., 2031W<br />

Mizumoto, S., 2861T, 3230F<br />

Mizuno, S., 1795W, 2758W,<br />

2891T, 3043W, 3094F*<br />

Mizuno, Y., 2873T<br />

Mizuochi, T., 724T<br />

Mizusawa, H., 2371T<br />

Mizutani, S., 3091W<br />

Mladenov, E., 3500T, 3524T<br />

Mlikotic, A., 785W<br />

Mlynarski, W., 2703F<br />

Mo, F., 491F<br />

Moalem, S., 3156F*<br />

Moayyeri, A., 2138F<br />

Moazami, N., 1056W<br />

Mobasheri, M., 1169F<br />

Mochel, F., 2539T*<br />

Mochida, G. H., 8<br />

Moctezuma-Meza, C.,<br />

1168T<br />

Modarressi, M. H., 1169F,<br />

2987T<br />

Modig, L., 1970F<br />

Moe, T., 3034T<br />

Moen, E. L., 3472T*<br />

Moeschler, J., 3176F*<br />

M<strong>of</strong>fatt, M. F., 1361W,<br />

2102F, 3466T, 3469T,<br />

3486T<br />

Moggio, M., 1776W<br />

Moghadam, M., 1615T<br />

Moghaddam, M., 1961F,<br />

1962W, 2964F<br />

Moghaddasi, M., 3197W<br />

*Presenting Author<br />

Mohamdi, H., 1158W<br />

Mohamed, A. N., 885W<br />

Mohamed-Hadley, A.,<br />

1992W, 2492F*<br />

Mohammad, A., 1061F<br />

Mohammadi, M., 679F<br />

Mohammadi Fatideh, M. J.,<br />

3083W<br />

Mohammed, N., 1352W,<br />

1589T<br />

Mohammed, S., 3211W<br />

Mohammed, S. N., 218<br />

Mohan, G., 2776W<br />

Mohan, R., 481F<br />

Mohan, V., 878T*<br />

Mohila, C. A., 834F<br />

Mohlke, K. L., 46, 117, 292,<br />

304, 1427W, 1608T,<br />

1627T, 1954T, <strong>2012</strong>F,<br />

2090F, 2123F, 2147F,<br />

2241W<br />

Mohr, D. W., 79, 1254W<br />

Mohsen, A.-W., 662T, 733F<br />

Moi, P., 2001W<br />

Mokhonova, E., 1685T<br />

Mokhtarani, M., 774W<br />

Mokrejsova, M., 3437T<br />

Molck, M. C., 959W*<br />

Mole, D., 509F<br />

Molecular <strong>Genetics</strong><br />

<strong>of</strong> Schizophrenia<br />

Consortium, 2576F<br />

Molenda, A., 1257W<br />

Molfetta, G. A., 1037F*,<br />

1038W, 2813T<br />

Molina, B., 875W, 928T,<br />

960T, 976T, 1048T<br />

Molina, F., 2685F<br />

Molina, J., 2672T<br />

Molina, L., 2685F<br />

Molina-Gomes, D., 890T<br />

Molineros, J., 3253F*<br />

Mollema, N., 2625W*<br />

Møller, LB., 702T<br />

Moller, M., 2217W<br />

Möller, M., 2007W*, 3385F<br />

Mollet, I., 47<br />

Møllgård, K., 805F<br />

Mollon, J., 2082W<br />

Mollon, J. E., 1470T*<br />

Momčilovič, D., 2438F<br />

Momigliano-Richiardi, P.,<br />

2827W<br />

Momin, S., 1108T<br />

Momma, K., 755W<br />

Momohara, S., 2004W,<br />

2287T<br />

Momoi, M. Y., 2588F, 3118F<br />

Monare, L. R., 1085F<br />

Moncaster, J. A., 2528F<br />

Moncla, A., 2792T<br />

Monda, K. L., 2131T<br />

Mondal, A. K., 2011T<br />

Mondal, K., 2312F<br />

Mondesert, B., 1678T<br />

Mongini, T., 1776W<br />

Mongrain, I., 3401W<br />

Moninger, T. O., 404<br />

Monk, D., 3499T<br />

Monlleó, I. L., 479F, 2270F<br />

Monlong, J., 567F<br />

Monnot, S., 72<br />

Monos, D., 2904F<br />

Monos, D. S., 1915T<br />

Mønsted, S., 3641F, 3662W<br />

Montaño, A., 786W<br />

Montazer Zohori, M.,<br />

2013W<br />

Monte, T. L., 2424W, 2626T<br />

Monteiro, A. N. A., 1156T<br />

Montenegro, M. A., 2393F<br />

Monterrubio-Ledezma, C.<br />

E., 3188F<br />

Montesclaros, L., 3690W<br />

Montgomery, C. G., 529F,<br />

1895F, 2084F, 2188T<br />

Montgomery, G., 1072T,<br />

2165F<br />

Montgomery, G. W., 212,<br />

351, 2054F, 2056T,<br />

2077T, 2133W, 2212T<br />

Montgomery, S., 568W,<br />

2372F<br />

Montgomery, S. B., 369,<br />

371, 527F, 547F, 561F,<br />

3411W<br />

Monti, E., 3256F<br />

Montiel, M., 951W, 3074F<br />

Montine, T., 2498F*, 2538W<br />

Montine, T. J., 2646W<br />

Montpetit, A., 277<br />

Montsar<strong>of</strong>f, S. Z., 195<br />

Moody, H., 1773W<br />

Moog, U., 300, 2403W,<br />

2595W, 3111W<br />

Mook, O., 1616T*, 3650W<br />

Mook, O. R., 681F<br />

Mookherjee, S., 2680W*<br />

Mook-Kanamori, D., 2162F<br />

Mook-Kanamori, D. O., 228<br />

Moon, J., 866T, 867W,<br />

3112F*, 3473T*<br />

Moon, J. W., 3423T<br />

Moon, S.-U., 2834T<br />

Moore, A. T., 2072F, 3212F<br />

Moore, B., 195, 3561F<br />

Moore, B. T., 3081W<br />

Moore, C., 3542W<br />

Moore, C. B., 3624W*<br />

Moore, D. T., 1245W, 3527F,<br />

3687F<br />

Moore, G. E., 303, 2752W,<br />

2755W, 3501T, 3508T<br />

Moore IV, H. E., 2543F<br />

Moore, J., 3465T<br />

Moore, J. C., 2433W<br />

Moore, J. H., 188, 1339F*,<br />

1453F, 3275W<br />

Moore, L., 1012T<br />

Moore, L. E., 1092W<br />

Moore, L. G., 3290W<br />

Moore, M., 2148W<br />

Moore, R., 3642W*<br />

Moore, S., 2945T<br />

Moore, S. J., 454W<br />

Moorman, A. V., 1024T<br />

Moors, T., 774W<br />

Moortgat, S., 3181W, 3216F,<br />

3218F<br />

Moosavi, A., 1726W*<br />

Mooser, V., 106, 1281T<br />

Mootha, V. K., 326<br />

Mora, L., 3035W*<br />

Mora, T., 597F<br />

Morad, T., 1165T<br />

Moradi Chaleshtori, M., 892T*<br />

Moraes, E., 2404T<br />

Moraes, M. O., 2289W<br />

Morais, S., 2818W<br />

Morales, A., 1681T*<br />

Morales, L., 1074W<br />

Morales, M. A., 1770W<br />

Moralli, D., 509F<br />

Moran, J., 1325W, 2487W<br />

Moran, J. L., 290, 2618F<br />

Moran, K., 140<br />

Morandi, L., 1776W<br />

Morava, E., 672T*<br />

Morcet, J., 2126F<br />

Moreau, A., 1784W, 2234F<br />

Moreau, C., 1478W<br />

Moreau, M., 2114F, 2170T<br />

Morehouse, R., 107<br />

Moreira, B. C., 2434T<br />

Moreira, M., 896T, 899W<br />

Moreira-Filho, C., 899W<br />

Moreland, L. W., 2047T<br />

Morell, R. J., 2724F<br />

Morello, R., 2854W<br />

Moreno, L., 2325W<br />

Moreno, L. M., 1564F, 1937F<br />

Moreno, O., 951W, 3049W<br />

Moreno, S., 259<br />

Moreno, T., Session 9,<br />

1825W<br />

Moreno-De-Luca, A., 2439W*<br />

Moreno-De-Luca, D., 13,<br />

917W<br />

Moreno-Estrada, A., 186,<br />

3352F, 3380W<br />

Moreno Estrada, A., 2033F,<br />

3360T, 3390T*<br />

Moreno-Garcia, M., 848F*<br />

Moreno-Macías, H., 48<br />

Moretti, E., 3050F<br />

Morfopoulou, S., 3600W*<br />

Morford, L., 1147T*, 2243F<br />

Morgan, A. T., 3228F<br />

Morgan, C. T., 1705T<br />

Morgan, D., 385<br />

Morgan, D. J., 1305T<br />

Morgan, J., 983F<br />

Morgan, T., 730T*, 3030T<br />

Mori, K., 2129F<br />

Mori, M., 2873T<br />

Morice-Picard, F., 473F<br />

Morigaki, R., 52<br />

Morimoto, M., 2849T*<br />

Morimura, T., 234<br />

Morin, C., 778W<br />

Morin, G., 3117W<br />

Morino, H., 3229W<br />

Morioka, I., 729F<br />

Morisaki, H., 2697F*<br />

Morisaki, T., 2697F<br />

Morishita, S., 2409W, 2569T<br />

Morissette, R., 1663T*<br />

Morita, M. E., 2394W<br />

Morita, S., 1290T<br />

Moriuchi, H., 1999T


Moriyama, N., 3136F<br />

Moriyama, Y., 2873T<br />

Morizono, H., 669F<br />

Morizono, T., 2051F, 2174F<br />

Morken, M. A., 304<br />

Morlan, J., 1198T<br />

Morleo, M., 2810T<br />

Morley, K., 101, 364<br />

Morley, K. I., 35, 291<br />

Morley, M., 535F<br />

Moroi, S., 2135F, 2154W<br />

Moroi, S. E., 2240F, 2263T<br />

Morren, M.-A., 2926W<br />

Morris, A., 119, 2077T<br />

Morris, A. D., 609T<br />

Morris, A. P., 49, 111*, 169,<br />

190, 269, 1308T, 1954T,<br />

2070W, 2073W, 2076W,<br />

2123F, 2133W, 2137T,<br />

2147F<br />

Morris, C. A., 3482T<br />

Morris, D., 2590T<br />

Morris, D. L., 3382F<br />

Morris, J. A., 37*<br />

Morris, M. A., 1874F<br />

Morris, N., 1376W<br />

Morris, N. J., 1575T<br />

Morris, R. W., 1626T, 3390T<br />

Morrison, A., 349, 1346W<br />

Morrison, A. C., 121, 174*,<br />

1585T<br />

Morrison, B. E., 508W, 565F<br />

Morrison, C., 3428T<br />

Morrison, H., 4<br />

Morrison, J., 1477F*<br />

Morrison, K. E., 348<br />

Morrison, M., 385<br />

Morrison, M. A., 1305T,<br />

2183F<br />

Morrison, S. M., 1859F*<br />

Morrissey, K. M., 246<br />

Morrow, B., 1494T, 1658T,<br />

3531F<br />

Morrow, E. M., 8, 452W<br />

Morse, M., 1869F<br />

Mortensen, A. H., 1878W<br />

Mortier, G., 79, 98<br />

Mortier, G. R., 80, 298,<br />

3129W<br />

Mortlock, D. P., 837F, 3275W<br />

Morton, C., 2562W<br />

Morton, C. C., 68, 70, 82,<br />

284, 554W, 862T, 2056T<br />

MOSAIC and GenISIS<br />

Investigators, 1507F<br />

Mosca, S., 3095W*<br />

Mosca-Boidron, A.-L.,<br />

2729T, 2770W, 2792T<br />

Moseley, K., 237<br />

Moser, A., 722T<br />

Moser, K. L., 1979F, 2046W<br />

Moser, M., 368<br />

Moser, T., 1, 59<br />

Moser Sivils, K., 529F,<br />

2084F, 2188T<br />

Moses, D., 2916F<br />

Moses, E., 1280W<br />

Moses, E. K., 1282F,<br />

1406W, 2061W, 2309F<br />

Moskovtsev, S., 2982T<br />

*Presenting Author<br />

Moskowitz, I. P., 82<br />

Mosley, J. D., 1345F*<br />

Mosley, T. H., 1592T<br />

Mosnier, J. F., 1204T<br />

Mosor, M., 1184F<br />

Moss, A., 2804T<br />

Mosser, J., 2126F*, 2893W,<br />

3170F<br />

Mostacciuolo, M. L.,<br />

1732W, 2799F<br />

Mostafavi, S., 369, 2372F*<br />

Mostile, G., 2763F<br />

Mota, F. M., 2288F<br />

Motahari, B., 1056W,<br />

1124F*<br />

Motahari, M. M., 3163W<br />

Mota-Vieira, L., 2288F,<br />

2814F*<br />

Motazacker, M. M., 2205W*<br />

Motghare, P., 307<br />

Motley, C., 133<br />

Motovalibashi, M., 1421W<br />

Motoya, S., 2174F<br />

Motoyoshi, Y., 3091W<br />

Mott, R., 355<br />

Motti, J. M. B., 3362W<br />

Motulsky, A. G., 1605T<br />

Mou, Y., 1251W<br />

Mouanoutoua, M., 1146W,<br />

1195T<br />

Mouassess, F., 1490W<br />

Mouga, S., 2417F, 2502W<br />

Mougou-Zerelli, S., 403,<br />

944T<br />

Moult, J., 499F<br />

Moulton, K., 3700W<br />

Mouly, V., 2840T<br />

Mountain, J., Session 9,<br />

179, 1825W<br />

Mountain, J. L., 114, 626T*,<br />

1017W, 1782W, 1838F,<br />

2087F, 2089T, 2100W,<br />

2111F, 2115W, 2149T,<br />

3386W<br />

Mourah, S., 29<br />

Mouri, K., 2380T<br />

Mouritzen, P., 1194W*<br />

Mousavy Gharavy, S.,<br />

2701W<br />

Moustafa, K., 259<br />

Mouton, S., 104<br />

Moutsianas, L., 169<br />

Mouzaya, F., 3349F<br />

Movva, S., 1720W, 2754F*<br />

Mowat, D., 843F, 3167W<br />

Mowery-Rushton, P. A.,<br />

3101W*<br />

Mowrey, P., 953W<br />

Mowrey, P. N., 945W<br />

Mowry, E., 1289W, 1301W,<br />

1414F*<br />

Moy, T. F., 1652T<br />

Moy, W., 1282F<br />

Moya, P. R., 261*<br />

Moylan, C., 531F<br />

Moysés, M., 3131W<br />

Mozaffar, T., 3213W<br />

Mrkonjic, M., 3478T<br />

Mrowietz, U., 154<br />

Msilaty-Gross, S., 731F<br />

SPEAKER AND AUTHOR INDEX 385<br />

Mucaki, E. J., 3672W<br />

Mucci, T., 3033T<br />

Muchmore, B., 1155W<br />

Mudd, P. N., Jr., 732T<br />

Muddashetty, R., 540W<br />

Mudgal, P., 2332T<br />

Mudge, J. M., 367*<br />

Mueller, D., 628T<br />

Mueller, D. M., 326<br />

Mueller, K. L., 1973F, 3735F<br />

Mueller, U., 2416T*<br />

Mugge, S., 2493W<br />

Muglia, L., 3030T<br />

Mugnaini, E., 2427W<br />

Mugneret, F., 2729T<br />

Mugniery, E., 763W<br />

Muhammad, E., 1588T*<br />

Mühleisen, T. W., 259<br />

Muilu, J., 3610W<br />

Muir, K. R., 2292W<br />

Mujahid, S., 3211W<br />

Mukaddes, N. M., 8<br />

Mukerji, M., 3332W<br />

Mukhatira, P., 3656W,<br />

3703F<br />

Mukherjee, S., 17, 264*,<br />

342, 1514W<br />

Mukherjee Dey, S., 1097F<br />

Mukhopadhyay, N., 253,<br />

1315F, 2178W*<br />

Mulas, A., 113, 157, 177,<br />

547F, 1451W, 1516F,<br />

2198F, 2329T<br />

Mulchandani, S., 3082F<br />

Mulder, F., 431F<br />

Mulder, L., 3310F<br />

Mulle, J., 2069F<br />

Mulle, J. G., 66, 1349W,<br />

2312F, 2576F*<br />

Mullegama, S. V., 103*<br />

Mullen, L., 1256F<br />

Muller, A., 684T, 1949F<br />

Müller, B. F., 782W<br />

Müller, C., 275, 1669T,<br />

2759T<br />

Muller, R., 3720W*<br />

Muller, S., 3316F<br />

Müller, T., 201, 2948T<br />

Müller, U., 2581T<br />

Muller, Y. L., 1300F*<br />

Muller-Cohn, J., 3720W<br />

Müller-Myshok, B., 2483F,<br />

2568W<br />

Müller-Quernheim, J.,<br />

2103W<br />

Mullighan, C. M., 31<br />

Mulliken, J. B., 83<br />

Mulliken, N., 1015T<br />

Mullikin, J., 358, 1515T,<br />

3306T<br />

Mullikin, J. C., 1690T,<br />

1696T, 2938W<br />

Mullin, K., 2520W<br />

Mullinax, B., 975W<br />

Mullins, J. G., 262, 2821W<br />

Mullins, M., 626T, 2087F<br />

Mullins, M. E., 2127W*<br />

Mullins, R. F., 2215T<br />

Mulukutla, .S., 2083T<br />

Mulvihill, J., 1875F*<br />

Mumm, S., 2864T<br />

Mumoli, L., 2780T<br />

Mumy, A., 1092W, 1094F,<br />

1155W*<br />

Munafo, D., 512W*, 3517T<br />

Munafo, D. B., 3702W,<br />

3715F<br />

Münchau, A., 200<br />

Munchel, S., 596W, 1238F<br />

Mundlos, S., 298<br />

Mundorff, J., 1958F<br />

Mundwiller, E., 2820F<br />

Mungall, C. J., 2725W<br />

Munger, R., 1564F<br />

Munger, R. G., 1472W,<br />

3643F<br />

Munhoz, R. P., 2475W<br />

Munier, P., 522W<br />

Munir, K., 1746W<br />

Muniz, Y. C. N., 994T*,<br />

1405F, 1946F<br />

Munnich, A., 72, 104, 126,<br />

127, 202, 324, 325, 329,<br />

390, 403, 522W, 763W,<br />

915W, 2808F, 3129W,<br />

3172F, 3240F<br />

Muñoz, X., 987W<br />

Muñoz-Montero, S., 1129T<br />

Munroe, P. B., 1659T<br />

Munshi, A., 224*<br />

Munson, J., 2406W<br />

Munson, P., 584W<br />

Munson, P. J., 260<br />

Muntoni, F., 2812W<br />

Munzel, T., 1669T<br />

Munzy, D., 2908W<br />

Muona, M., 2898F*<br />

Mur, A., 3217W<br />

Murabito, J., 2165F<br />

Murabito, J. M., 2336F<br />

Murakami, T., 2836W<br />

Murakami, Y., 298, 2559W<br />

Murali, R., 998F, 999W<br />

Murali, S. G., 710T<br />

Muramatsu, Y., 3094F<br />

Murata, K., 2130W<br />

Murata, M., 2619W<br />

Murayama, K., 2873T<br />

Murayama, S., 52, 2409W<br />

Murdoch, B., 250<br />

Murdock, D., 2802F<br />

Murdock, D. G., 1713T<br />

Mureau, M., 1788W<br />

Murgia, A., 1755W, 2795T<br />

Murgia, F., 2062T, 2128T*<br />

Muroya, K., 1795W, 2891T<br />

Murphy, A., 2014T<br />

Murphy, A. B., 1009T<br />

Murphy, D. L., 261<br />

Murphy, H., 127<br />

Murphy, K. G., 1834F<br />

Murphy, P., 3125W<br />

Murphy, S., 531F<br />

Murphy, T., 750T<br />

Murphy Bollinger, J., 1829W*<br />

Murray, A., 1021T, 2148W,<br />

2165F<br />

Murray, D., 1854F*<br />

Murray, J., 1882T, 2325W,<br />

3030T, 3537F<br />

SPEAKER AND AUTHOR INDEX


386 SPEAKER AND AUTHOR INDEX<br />

Murray, J. C., 74, 94, 1344T,<br />

1472W, 1512T, 1564F,<br />

1937F, 2762T, 3028T<br />

Murray, R. F., Jr., 1821W<br />

Murray, S., 983F<br />

Murray, S. S., 2274W<br />

Murray, T., 1472W, 2043W<br />

Murtha, A., 3<br />

Murtha, M., 2605T<br />

Murty, V. V., 1031F<br />

Murugan, A., 597F*<br />

Musani, S., 178, 350, 2063F,<br />

2210F<br />

Musani, S. K., 2275T*<br />

Muscat, J. E., 1016F,<br />

1107W<br />

Musci, T., 2978T*<br />

Mushar<strong>of</strong>f, S., 3352F,<br />

3361F*<br />

Mushiroda, T., 627T<br />

Musio, A., 2695W*<br />

Musk, A. W., 1465F<br />

Musolf, A., 1359T*<br />

Mussini, J. M., 3066F<br />

Musson, D., 784W<br />

Mussotter, T., 939W*<br />

Mustalahti, K., 2177F<br />

Mustapha, M., 1878W,<br />

2773W*<br />

Mustill, W., 2966T*<br />

Mutai, H., 2882T<br />

Mutarelli, M., 2950W<br />

Mutesa, L., 925W*, 3104F<br />

MuTHER Consortium, 44,<br />

583F, 1440T, 2187W<br />

Muthusamy, B., 3316F<br />

Muthuswamy, S., 2446T*<br />

Muti, C., 56<br />

Muto, K., 1819W, 1830F*,<br />

1833W<br />

Muzny, D., 174, 183, 360,<br />

1585T, 1599T, 1742W,<br />

2798T, 2880F*, 2934F,<br />

3597F<br />

Muzny, D. M., 3, 314, 595F,<br />

648T, 1221W, 1735W,<br />

1757W, 1761W, 2413T,<br />

2883F<br />

Muzzio, M., 293, 3362W*,<br />

3380W<br />

Mychaleckyj, J., 1971W,<br />

2210F<br />

Mychaleckyj, J. C., 1662T,<br />

2313W<br />

Myerburg, R. J., 86<br />

Myers, A., 380<br />

Myers, L., 80<br />

Myers, M., 1059W*<br />

Myers, R. H., 1964F, 2116T,<br />

2227T, 2643W<br />

Myers, R. M., 2556W<br />

Myers, S., 181, 3360T<br />

Myers, S. M., 2439W<br />

Myhre, R., 3028T<br />

Myking, S., 3028T<br />

Myllymäki, M., 3297T<br />

Myouzen, K., 2004W*<br />

Myres, N., 3321T*, 3340F,<br />

3365W<br />

Mysliwiec, V., 2221T<br />

*Presenting Author<br />

Mysore, J. S., 1964F<br />

Myung, C., 2849T<br />

N<br />

Naab, T., 1242W<br />

Näbauer, M., 86<br />

Nabbout, R., 202<br />

Nabika, T., 1333F<br />

Nacak, M., 1402F, 1935W,<br />

1938W*<br />

Nadeau, K., 2322W<br />

Nadel, L., 2529W<br />

Nadel, M., 3656W, 3703F<br />

Nadif, R., 1461T*<br />

Nading, E., 2328W<br />

Nadji, A., 2150F<br />

Naeem, T., 2920W<br />

Naess, K., 672T<br />

Nafisi, S., 2436W<br />

Nag, A., 335, 2068T*<br />

Nagai, A., 1833W<br />

Nagai, J., 3051W<br />

Nagai, T., 1631T<br />

Nagamani, S., 165, 3209W<br />

Nagamani, S. S. C., 433F<br />

Naganawa, M., 914T<br />

Nagao, T., 2747T<br />

Nagappa, J., 2411F<br />

Nagaraja, R., 276, 2001W<br />

Nagaraju, K., 2452T<br />

Nagasaki, M., 396<br />

Nagashima, T., 2264F<br />

Nagaswamy, U., 648T<br />

Naggert, J., 2702T<br />

Nagy, A., 3463T<br />

Nagy, M., 3364F, 3402T<br />

Nagy, Z., 2767W<br />

Nah, H.-D., 2856F<br />

Nahab, F., 347, 2603F<br />

Nahum, O., 977W<br />

Naides, S. J., 2260T<br />

Naidich, T. P., 168<br />

Naidoo, D., 615T<br />

Naidu, S., 3065W<br />

Naim Bushra, M., 930T<br />

Naing, B. T., 1697T<br />

Nair, R. P., 154, 1952F<br />

Nair, S., 2731W<br />

Naito, Y., 3221W<br />

Naitza, S., 1516F, 2198F<br />

Naj, A., 2637W<br />

Naj, A. C., 342, 344*, 2498F,<br />

2583W, 2586W<br />

Najfeld, V., 3488T<br />

Najmabadi, H., 2301W<br />

Naka, I., 1327F*<br />

Nakabayashi, K., 3499T*<br />

Nakachi, Y., 2873T<br />

Nakada, T. A., 1632T<br />

Nakagama, H., 396<br />

Nakagawa, H., 396<br />

Nakagawa, M., 52<br />

Nakahira, K., 475F<br />

Nakahori, Y., 3337F<br />

Nakamori, M., 2824W<br />

Nakamura, H., 396, 1998W,<br />

1999T<br />

Nakamura, M., 663F<br />

Nakamura, R., 3221W<br />

Nakamura, T., 663F, 1317T,<br />

1549F, 2607W, 2616W,<br />

2823F, 3043W<br />

Nakamura, Y., 396, 627T,<br />

1277F, 1552F, 1631T,<br />

1643T, 2004W, 2051F,<br />

2133W, 2174F, 2506T<br />

Nakano, K., 396<br />

Nakano, M., 2129F*<br />

Nakano, N., 2559W<br />

Nakaoka, H., 2253W*<br />

Nakashima, H., 663F<br />

Nakatome, M., 1321F<br />

Nakayama, A., 663F<br />

Nakayama, J., 3230F<br />

Nakayama, K., 2009F<br />

Nakhla, M., 1108T<br />

Näkki, A., 2134T*<br />

Nalbandian, A., 757W,<br />

3213W, 3249W*<br />

Naley, M., 133<br />

Nalls, M., 2063F<br />

Nalls, M. A., 2148W, 2611T<br />

Naluai, A. T., 1970F<br />

Naluai-Cecchini, T., 940T<br />

Nam, M., 866T, 867W*,<br />

3112F<br />

Namavar, Y., 197<br />

Nampoothiri, S., 3240F<br />

Nance, T., 527F<br />

Nancy, A., 931W<br />

Nanda, V., 2216F<br />

Nanko, S., 2652W<br />

Napierala, D., 2854W<br />

Napoletano, S., 71<br />

Napolitano, F., 3631F<br />

Narayanan, D., 2224T<br />

Narayanan, V., 3215W<br />

Narimatsu, H., 1549F<br />

Naritomi, K., 2758W<br />

Narkis, G., 2931F<br />

Narod, S., 1061F<br />

Naruto, T., 2891T, 3051W<br />

Narzisi, G., 2587T<br />

Nascimento, D. R., 2655W<br />

Nascimento, L., 1899W*<br />

Nascimento, L. M., 1978T<br />

Nash, D., 3671F<br />

Nashi, E., 306<br />

Naslavsky, M. S., 1727W*<br />

Nasonkin, I., 827F<br />

Nass, R. D., 3113W<br />

Nassar, N., 231<br />

Nasser, M., 3157W*, 3241W<br />

Nassir, R., 2360F<br />

Nasuti, A., 2300F<br />

Nath, S., 1572T, 3253F<br />

Nath, S. K., 307, 2351F,<br />

2731W<br />

Nath, S. R., 764W*<br />

Nathanson, K. L., 213,<br />

1003T<br />

Nathanson, L., 341<br />

Nato, A. Q., 2216F, 3558W,<br />

3566W*<br />

Natoli, J., 1866F<br />

Nätynki, M., 1611T<br />

Naughton, B., 483F, 3386W,<br />

3617F<br />

Naughton, B. T., 179, 498W,<br />

1223F*, 1620T, 1838F<br />

Navarrete, J., 694T*<br />

Navarrete Meneses, M. P.,<br />

872T, 1022F*<br />

Navarrete-Meneses, P.,<br />

1131W<br />

Navarro, B., 3266W<br />

Navarro, L., 3706W<br />

Navarro, P., 1383T, 1481W<br />

Naviaux, R., 534W<br />

Navin, N., 1258T<br />

Navon, O., 3623F<br />

Navon, R., 3588W<br />

Nayak, G., 2663T*, 2724F<br />

Nayak, R., 1506T*<br />

Nayak, U., 1662T<br />

Naydenov, C., 2151W<br />

Nayernia, K., 2987T<br />

Nazarenko, I., 678T, 2926W<br />

Nazemi, A., 1083W<br />

NCI Breast and Prostate<br />

Cancer Cohort<br />

Consortium, 1390F<br />

Ndumele, C. E., 272<br />

Neal, C. O. S., 1310W*<br />

Neal, D., 1011W<br />

Neal, D. E., 1148F<br />

Neale, B. M., 280, 290,<br />

1523W, 2618F*<br />

Neale, G. A., 2331W<br />

Neary, J., 2651F<br />

Neas, L., 1636T<br />

Nebel, A., 515F, 1943F,<br />

2103W, 2295W, 2303F<br />

Neben, C. L., 2857W*<br />

Nebert, D. W., 487F,<br />

2800W<br />

Nedelea, F. M., 2728W<br />

Neel, B. G., 135<br />

Neeradha, C., 911W<br />

Nees, S. N., 845F<br />

Neff, F., 2922F<br />

Neff, M. W., 2517W<br />

Neff, T., 1237T<br />

Negretto, C., 896T, 899W<br />

Negroni, E., 2840T<br />

Neidich, J. A., 1736W<br />

NEIGHBOR Consortium,<br />

2135F, 2263T<br />

NEIGHBOR Consortium<br />

Investigators, 386<br />

Neill, N. J., 884T<br />

Neison, M., 1491T<br />

Neiswanger, K., 1315F<br />

Neitz, J., 3212F<br />

Neitz, M., 3212F<br />

Neitzel, L., 819F<br />

Nekrutenko, A., 3547F<br />

Nelakuditi, V., 1683T, 1737W<br />

Nelen, M., 1749W, 3650W<br />

Nelen, M. R., 1734W<br />

Nelis, M., 2937F<br />

Nelissen, F., 2696T<br />

Nelson, A., 3340F<br />

Nelson, B., 12, 825F<br />

Nelson, C., 767W, 1595T,<br />

1698T, 3453T<br />

Nelson, C. P., 119, 1308T,<br />

2076W, 2175W


Nelson, H. H., 1229F<br />

Nelson, M., 294, 1686T,<br />

2087F<br />

Nelson, M. R., 476W, 641T,<br />

649T, 3282T, 3406T<br />

Nelson, R., 3671F<br />

Nelson, S., 1447F<br />

Nelson, S. F., 296, 315,<br />

361, 471F, 1685T, 2874F,<br />

3666W<br />

Nelson-Moseke, A. C.,<br />

1087T*<br />

Nelson-Williams, C., 1241F,<br />

2779W<br />

Nemat-Gorgani, N., 3710W<br />

Nematollahi-Mahani, A.,<br />

413F<br />

Nemesure, B., 1003T<br />

Neogi, A., 1719W*<br />

Neph, S., 255<br />

Nerella, S., 3442T, 3452T<br />

Neri, M., 1153T<br />

Nerkizian, N., 3700W<br />

Neshan, M., 2976T<br />

Nesheva, D. V., 923W<br />

Ness, A. R., 1583W<br />

Nessa, A., 2359T<br />

Nestadt, G., 2391W, 2573F,<br />

2576F<br />

Nesterova, M., 1151F<br />

Nestle, F., 583F<br />

Nestle, F. O., 2138F<br />

Nestrasil, I., 714T*, 785W,<br />

801W<br />

Nethander, M., 2080T<br />

Neto, J. L., 2736F<br />

Netterville, J. L., 136<br />

Netto, C. B. O., 696T<br />

Neuberger, J. M., 153<br />

Neuhaus, J., 1965W<br />

Neuhausen, S. L., 1213T<br />

Neuh<strong>of</strong>f, N., 1976F<br />

Neumann, L. C., 3500T*<br />

Neuwirth, C., 1618T<br />

Nevado, J. B., 1610T*<br />

Nevalainen, E. M., 2213F*<br />

Nevanlinna, H., 209, 997T,<br />

1006T, 1117T, 1171T,<br />

1265F<br />

Neveling, K., 58, 100,<br />

1734W, 1749W<br />

Neves, C. T., 1880F<br />

Nevruz, O., 1136F<br />

Newberg, J., 2979T<br />

Newburger, D., 397<br />

Newby, L. K., 1444F<br />

Newcomb, P., 144, 1206W<br />

Newcomb, P. A., 141,<br />

1067F, 1079F<br />

Newcomer, D., 3731F<br />

Newhouse, S., 2580W<br />

Newlin, A. C., 1225T<br />

Newman, A., 2165F<br />

Newman, A. B., 1920W,<br />

1921T, 2040W<br />

Newman, D. L., 1966T<br />

Newman, W. G., 2852T<br />

Newport, D. J., 2384F<br />

Newschaffer, C., 463F<br />

Newsome, J., 1009T, 2014T<br />

*Presenting Author<br />

Newton, A., 3682W<br />

Newton, K., 2098T<br />

Newton Bishop, J. A., 211<br />

Newton-Cheh, C., 1585T,<br />

1677T<br />

Ney, D. M., 710T<br />

Nezarati, M., 124<br />

Ng, B. G., 1758W<br />

Ng, C., 136<br />

Ng, C. L., 2066F<br />

Ng, D., 358, 1690T, 1696T*<br />

Ng, D. P. C., 1757W<br />

Ng, E., 563F<br />

Ng, E. H. Y., 3000T<br />

Ng, K., 135, 1227W<br />

Ng, M., 178, 2280W, 2332T<br />

Ng, M. C., 2131T<br />

Ng, M. C. Y., 1648T, 1879T,<br />

2310W<br />

Ng, P., 735F, 1556W<br />

Ng, P. C., 1792W, 3353W<br />

Ng, S., 26<br />

Ng, W.-F., 2084F<br />

Ngeow, J., 1144T*<br />

Ngom, A., 3490T<br />

Ngu, M. S., 3267T<br />

Nguyen, C., 757W<br />

Nguyen, D., 379, 3730W<br />

Nguyen, D. V., 770W<br />

Nguyen, H. H., 396<br />

Nguyen, K.-D. H., 121*<br />

Nguyen, N. D., 2176T<br />

Nguyen, S. C., 2176T*<br />

Nguyen, T. M., 2539T<br />

Nguyen, T. V., 2176T<br />

Nguyen, V., 3007T<br />

Nguyen-Dumont, T., 1213T,<br />

3679F<br />

Nguyen-Nielsen, M., 1565W*<br />

NHLBI Exome Sequencing<br />

Project, 6, 12, 19, 170,<br />

1692T, 2336F, 2337W<br />

NHLBI Exome Sequencing<br />

Project, Exome<br />

Sequencing Project<br />

Blood Counts Project<br />

Team, 1408F<br />

NHLBI Exome Sequencing<br />

Project - Early Onset<br />

Myocardial Infarction, 120<br />

NHLBI GO Exome<br />

Sequencing Project,<br />

1437T<br />

NHLBI Personal Genomics<br />

Project Team and NHLBI<br />

Exome Sequencing<br />

Project, 301<br />

Nho, K., 2511W<br />

Ni, P., 3300T<br />

Ni, T., 586W<br />

NIAID Center for HIV/AIDS<br />

Vaccine Immunology<br />

(CHAVI), 2335T<br />

Niangaly, A., 2255F<br />

Nica, A., 44, 583F<br />

Nica, A. C., 556W*<br />

NICE Study Group, 3020T<br />

Nicholas, T., 494W, 1239W<br />

Nichol Edamura, K., 2696T<br />

Nicholl, J. K., 978T<br />

SPEAKER AND AUTHOR INDEX 387<br />

Nicholls, K., 745F*, 772W<br />

Nicholls, S. G., 149, 150,<br />

1827W*<br />

Nichols, A. H. G., 1084T*<br />

Nichols, W. C., 2136W<br />

Nicholson, G., 52, 2470T,<br />

2742F<br />

Nicholson, G. A., 2816T<br />

Nickerson, D., 93, 223<br />

Nickerson, D. A., 10, 12,<br />

170, 171, 244, 301, 601T,<br />

1408F, 1605T, 2443T,<br />

2740W<br />

Nickerson, M., 1242W,<br />

2833W*<br />

Nicolae, D. L., 368, 2196W,<br />

2197T, 2333F<br />

Nicolaides, K., 3508T<br />

Nicolaou, N., 2848W<br />

Nicolas, G., 345*<br />

Nicolato, R., 2404T<br />

Nicoletti, A., 2763F<br />

Nicolini, H., 2495F<br />

Nicolson, S. C. N., 2443T<br />

Nicosia, S., 1061F<br />

Nicouleau, M., 390<br />

NIDDK and International<br />

IBD <strong>Genetics</strong> Consortia,<br />

2319W<br />

NIDDK IBD <strong>Genetics</strong><br />

Consortium, 42<br />

Nidey, N., 1937F<br />

Nie, J., 1086W<br />

Nieberle, I., 3539F<br />

Niehaus, D., 644T<br />

Nielsen, F., 1238F<br />

Nielsen, J. E., 2765T<br />

Nielsen, P., 3528W<br />

Nielsen, R., 182, 281,<br />

1573F, 2311T, 2317T,<br />

2347T, 3289F, 3300T,<br />

3305W, 3311W, 3312T<br />

Nielsen, S. J., 1194W<br />

Nielsen, T. T., 2765T<br />

Nielson, C. M., 109<br />

Niemelä, M., 1253F<br />

Niemi, A.-K., 744T*<br />

Nieminen, K. M., 1125W*<br />

Nieminen, T. T., 1276T*<br />

Nieminen-von Wendt, T.,<br />

2399F<br />

Nienhuis, J., 2430W<br />

Nieuwint, A., 98<br />

Nievergelt, C. M., 2375F<br />

Nieves-Colon, M. A., 3363T*<br />

Niewold, T. B., 1979F,<br />

2046W<br />

Nigrin, D. J., 1836F<br />

NIH Intramural Sequencing<br />

Center, 3306T<br />

Nii, T., 2647T<br />

Niikawa, N., 3056F<br />

Niinimaki, J., 1892F<br />

Niizeki, H., 2911W<br />

Nijman, I., 400<br />

Nijman, I. J., 217, 2886F<br />

Nika, M., 2135F<br />

Nikamo, P., 2276F*<br />

Nikiforov, T., 3698W<br />

Nikkel, S. M., 131*<br />

Nikkilä, J., 1099T<br />

Nikkola, E., 2256W<br />

Nikodinovic, J., 201, 2948T<br />

Nikolaev, S. I., 3263W*<br />

Nikolaus, S., 2368T<br />

Nikolova, D., 3477T<br />

Nikopensius, T., 3079W*<br />

Nikpay, M., 2236T*<br />

Nillesen, W., 215<br />

Nillesen, W. M., 125<br />

Niloufar, B., 2037W<br />

Nimgaonkar, V. L., 2382W,<br />

2589W, 2651F<br />

Nimmo, G., 722T<br />

Ning, X.-H., 3281W<br />

Nino, D., 2189F<br />

Nippert, I., 1877F*<br />

Niranjan, T., 2566T*, 2806W<br />

Nirmala Sadasivam, S.,<br />

2988T<br />

Nisbet, J., 44, 583F, 3441T<br />

NISC Comparative<br />

Sequencing <strong>Program</strong>,<br />

1690T, 1983W, 2938W<br />

NISC Comparative<br />

Sequencing <strong>Program</strong>,<br />

NHGRI, NIH Intramural<br />

Sequencing Center, 1261T<br />

NISC Comparative<br />

Sequencing <strong>Program</strong>,<br />

NIH, 2470T<br />

Nishi, E., 3043W*, 3094F<br />

Nishida, A., 781W*<br />

Nishida, N., 2130W*,<br />

2349W, 3301F<br />

Nishikawa, T., 1795W, 2891T<br />

Nishimori, I., 2768T<br />

Nishimoto, H. K., 2732T<br />

Nishimura, C., 419F<br />

Nishimura, D. Y., 404<br />

Nishimura, F., 2370W,<br />

2652W*<br />

Nishimura, T., 2771T<br />

Nishina, S., 3093W<br />

Nishino, I., 755W, 2409W,<br />

2923W<br />

Nishino, S., 2667F<br />

Nishioka, K., 3134F<br />

Nishioka, M., 2435F*<br />

Nishioka, T., 2619W<br />

Nishita, D., 642T<br />

Nishiyama, K., 3136F<br />

Nishiyama, S., 475F<br />

Nishiyama, T., 1574W,<br />

2440T*<br />

Nishizawa, D., 2507F*<br />

Nishizawa, H., 475F<br />

Nitschke, P., 104, 202,<br />

324, 325, 329, 390, 403,<br />

2808F<br />

Nitschke, Y., 2759T<br />

Nitzberg, M., 493F<br />

Niu, B., 457F, 1974W, 2623T<br />

Niu, D., 3467T<br />

Niu, G., 557F<br />

Niu, H., 242<br />

Niu, Q., 1003T<br />

Niu, T., 2172W*<br />

Niu, Z., 314, 1735W,<br />

1742W, 1761W*, 3493T<br />

SPEAKER AND AUTHOR INDEX


388 SPEAKER AND AUTHOR INDEX<br />

Niyazov, D., 3036F*<br />

Nizou, A., 2694F<br />

Nizzari, M., 3680W<br />

Njølstad, I., 1608T<br />

No, D., 682T<br />

Noack, B., 2058W<br />

Nobel, A., 368<br />

Noble, J., 3454T<br />

Nobuta, K., 1249T<br />

Noethen, M. M., 420W,<br />

1512T<br />

Noguchi, K., 2559W<br />

Noguchi, S., 755W<br />

Nohutcu, R., 2058W<br />

Nolan, J. J., 1624T<br />

Nolan, J. M., 1897T<br />

Nolent, F., 54<br />

Nolin, S., 2449T<br />

Nolta, J. A., 1625T<br />

Nolte, D., 2416T<br />

Nomura, M., 2264F*, 2647T<br />

Nomura, N., 2748F<br />

Nomura, Y., 3230F<br />

Nonaka, I., 755W<br />

Noonan, D., 1589T<br />

Noonan, J. P., Session 5<br />

Noor, A., 2525F, 3106F<br />

Noori Daloii, M. R., 2952F<br />

Noponen, N., 1892F<br />

Noppola-Hemmi, J., 1976F<br />

Norberg, S., 3695F, 3710W<br />

Nord, A., 263<br />

Nord, A. S., 4, 254, 407*<br />

Nord, K. H., 1024T<br />

Nordborg, M., 2320T<br />

Nordenskjöld, A., 3245W<br />

Nordenskjöld, E., 3245W<br />

Nordenskjöld, M., 1035W,<br />

1126T, 1939T<br />

Nordgren, A., 1035W,<br />

1126T, 3245W<br />

Nordlund, J., 3427T<br />

Nordmark, G., 2084F<br />

Nordstrom, L., 1186T<br />

Noreau, A., 2591F*<br />

Norman, P. J., 3390T, 3710W<br />

Normanno, N., 1060T*<br />

Norrgrann, P., 1563T<br />

Norris, J., 1330F<br />

Norris, J. M., 1888T<br />

Norsworthy, P., 1618T<br />

North, H., 2411F<br />

North, K., 1608T, 3299W<br />

North, K. E., 170, 1437T,<br />

1467T, 1599T, 1913F,<br />

1925F, 1954T, 2073W,<br />

2090F, 2123F, 2131T*,<br />

2145W, 2147F, 2337W<br />

North, K. N., 295<br />

North <strong>American</strong> Brain<br />

Expression Consortium<br />

and UK Brain Expression<br />

Consortium, 564W<br />

Northrop, L., 957W<br />

Northrop, L. E., 937W*<br />

Norton, M. E., 2978T, 3020T<br />

Norton, N., 1681T<br />

Norwitz, E., 3030T<br />

Noskova, L., 752T<br />

Nothen, M. M., 2102F<br />

*Presenting Author<br />

Nöthen, M. M., 106, 1005W,<br />

1976F, 2088W, 2557T<br />

Nothnagel, M., 580W,<br />

2058W, 2103W, 3364F*,<br />

3402T<br />

Notini, A. J., 1273T<br />

Noto, C. S., 2533T<br />

Noto, K., 3321T, 3365W*<br />

Nouira, R., 2744T<br />

Nouvian, R., 2685F<br />

Novak, B., 3459T, 3669F,<br />

3709F<br />

Novak, S., 2114F<br />

Novak, S. P., 2170T<br />

Novelli, A., 881W, 943W,<br />

2777T, 3050F<br />

Novelli, G., 2160W<br />

Novembre, J., 180, 185,<br />

476W, 1491T, 3282T,<br />

3302W, 3406T, 3626W<br />

Noveski, P., 2983T<br />

Novikov, I., 1303F<br />

Novo-Filho, G., 896T, 899W<br />

Novokmet, N., 1660T<br />

Novosad, P., 2865F<br />

Nowaczyk, M., 124<br />

Nowaczyk, M. J. M., 131,<br />

300*, 701F<br />

Nowak, J., 1057T, 1184F*<br />

Nowak, S., 423F<br />

Nowell, K., 759W<br />

Nowicka, K., 1057T, 1184F<br />

Nozaki, Y., 3118F<br />

nPOD-Virus Group, 3600W<br />

Nsubuga, R., 3412T<br />

Ntalla, I., 2097W, 3396T<br />

Ntzani, E. E., 109<br />

Nucci, A., 2653T<br />

Nuccitelli, A., 71<br />

Nuernberg, G., 105, 2909T<br />

Nuernberg, P., 105, 2909T<br />

Nukina, N., 2768T<br />

Numabe, H., 1816F*<br />

Numata, Y., 234<br />

Nunes, D. H., 1946F<br />

Nunes, H. F., 2291F*<br />

Nunes, K., 3292F*<br />

Nunes, M. E., Session 79,<br />

3158F*<br />

Nunes, V., 2703F<br />

Nuñez, A. F., 926T<br />

Nunez, C., 1330F, 3364F<br />

Núñez, C., 3402T<br />

Nuñez, G., 1320T<br />

Nuñez-Zenteno, A., 650T<br />

Nuotio, M.-L., 2132F*<br />

Nurmi, E. L., 639T*<br />

Nurminen, R., 995F*, 997T<br />

Nürnberg, G., 1, 2930T,<br />

2944W, 3214F<br />

Nürnberg, P., 1, 2759T,<br />

2812W, 2861T, 2869W,<br />

2930T, 2944W, 3214F<br />

Nurse, J. C., 3725F<br />

Nusbaum, C., 322<br />

Nusbaum, S., 915W<br />

Nuytemans, K., 347*, 2603F<br />

Nwebube, N., 3518T<br />

Nyambo, T., 283, 3303T,<br />

3338W<br />

Nyberg, F., 609T, 1970F<br />

Nyegaard, M., 2699T*<br />

Nygaard, M., 2295W*<br />

Nygaard Ravn, M., 3641F,<br />

3662W<br />

Nyholt, D. R., 106, 2056T,<br />

2133W*, 2175W<br />

Nyström, M., 982T<br />

O<br />

Oakhill, K., 1257W<br />

Obayashi, M., 2371T<br />

Ober, C., 278, 536W,<br />

2031W, 2982T, 3398T<br />

Oberfield, S. E., 812F<br />

Oberg, A. L., 1426F<br />

Oberman, B., 1303F<br />

Oberoi, S., 3242F<br />

Obisesan, T. O., 317<br />

O’Bleness, M., 433F, 465F*<br />

O’Bra, S., 3238F<br />

Obraztsova, O., 2005T<br />

O’Brien, D. P., 2805F, 2847F<br />

O’Brien, J. E., 2463W*<br />

O’Bryhim, B. E., 1989W*<br />

Obuchi, M., 2656T<br />

Occhi, G., 2708T*<br />

Ochoa, J., 970T<br />

Ochoa, S., 3063W*<br />

Ochs-Balcom, H., 1086W<br />

Ochs-Balcom, H. M., 2360F<br />

Ockeloen, C. W., 100,<br />

3159W*<br />

O’Connell, J., 1484W*,<br />

2210F<br />

O’Connell, J. R., Session<br />

27, 602T<br />

O’Connell, M. A., 577F<br />

O’Connor, I., 2620T<br />

O’Connor, M., 1740W<br />

Oda, T., 232<br />

O’Day, D., 2789T*<br />

O’Day, D. R., 10<br />

Oddoux, C., 3345T, 3395W,<br />

3397W*<br />

Odeberg, J., 1651T<br />

Odefrey, F., 3679F<br />

Odefrey, F. A., 1213T<br />

Odent, S., 2893W, 3170F*<br />

Odenthal-Hesse, L.,<br />

3257W*<br />

Odom, D., Session 5<br />

O’Donnell, C., 584W, 586W,<br />

1408F<br />

O’Donnell, C. J., 170, 174,<br />

349, 1445W, 1585T,<br />

1599T*, 1677T<br />

O’Donovan, M., 1325W<br />

O’Donovan, M. C., 2576F<br />

O’Dushlaine, C., 290, 333,<br />

2487W*<br />

O’Dushlaine, C., 2618F<br />

O’Dushlaine, C. T., 2576F<br />

Oehl-Jaschkowitz, B.,<br />

3111W<br />

Oei, L., 109*<br />

Oepkes, D., 3020T<br />

Oertel, W., 2568W<br />

Oestergaard, E., 702T*<br />

Oeth, P., 2973T, 3016T*,<br />

3023T<br />

Oetjens, M. T., 647T*<br />

O’Fallon, B. D., 225*<br />

Offenhäuser, N., 1<br />

Offit, K., 17, 27, 207, 208,<br />

998F, 999W, 1159T,<br />

1841W<br />

Ofverholm, I., 1126T*<br />

Ogaki, K., 2559W, 3221W*<br />

Ogata, H., 663F, 3499T<br />

Oghalai, J. S., 840F<br />

Ogundiran, T. O., 1003T<br />

Ogunniyi, A., 1959W<br />

Oguzkan Balci, S., 1402F*,<br />

1935W, 1938W<br />

Oh, B., 1622T*<br />

Oh, E., 13<br />

Oh, E. C., 2458T<br />

Oh, F., 1691T<br />

Oh, G., 628T<br />

Oh, H., 2665W*<br />

Oh, J., 1230W<br />

Oh, K., 3223W<br />

Oh, S., 690T, 3567F*<br />

O’Hanlon, T. P., 434W<br />

O’Hare, J., 893W<br />

Ohashi, J., 1327F, 1994F,<br />

3301F<br />

Ohh, M., 1046F<br />

Ohler, U., 586W<br />

Ohlsson, C., 2080T, 2116T<br />

Ohmen, J., 2184W*<br />

Ohmen, J. D., 2104T<br />

Ohmura, K., 2004W<br />

Ohno, K., 2472W*<br />

Ohno, M., 548W*, 558W,<br />

598W<br />

Ohta, T., 3056F<br />

Ohtake, A., 2873T<br />

O’Huallachain, M., 425F*<br />

Oien, N. C., 3<br />

Oikkonen, J., 2181W<br />

Oikonomopoulos, S., 509F<br />

Oiso, N., 3146F*<br />

Oitmaa, E., 1140W<br />

Ojeda, F., 1669T<br />

Ojha, B. K., 1177T<br />

Oji, V., 2869W<br />

Okabe, T., 800W*<br />

Okada, J., 724T<br />

Okada, K., 1815W, 2440T,<br />

2550W<br />

Okada, T., 799W<br />

Okada, Y., 111, 1490W*,<br />

2004W<br />

Okada-Hatakeyama, M.,<br />

2264F<br />

Okamoto, N., 1290T, 2697F,<br />

2758W, 3102F*<br />

Okamoto, Y., 777W*,<br />

2418W, 2607W, 2616W<br />

Okamura-Ikeda, K., 8<br />

Okano, H., 2911W<br />

Okano, T., 2833W<br />

Okazaki, Y., 2652W, 2873T,<br />

2923W<br />

Okochi, S., 1130F<br />

Okou, D. T., 2312F*


Oksenberg, J., 2113T, 3330T<br />

Oksenberg, J. R., 270,<br />

1924T, 2299T<br />

Okuyama, T., 726T, 2911W<br />

Oláh, E., 3070F<br />

Olatubosun, A., 496W<br />

O’Laughlin, M., 1210T<br />

Oldgren, J., 617T, 619T<br />

O’Leary, J., 2974T<br />

Oleksyk, T., 3254W<br />

Oleksyk, T. K., 3315T,<br />

3360T, 3380W<br />

Olender, T., 53, 2875W<br />

Oler, J. A., 2413T<br />

Olin, A. C., 1970F<br />

Oliphant, A., 2978T, 3020T<br />

Oliva, R., 2624F<br />

Oliveira, B. A., 2417F*,<br />

2502W<br />

Oliveira, E. P. L., 514W<br />

Oliveira, F. A., 2233T<br />

Oliveira, F. M., 1045T*<br />

Oliveira, G., 1239W, 2261F,<br />

2417F, 2502W<br />

Oliveira, J. P., 3122F<br />

Oliveira, K. G., 2654F<br />

Oliveira, L. F. S., 2434T<br />

Oliveira, M., 896T, 899W<br />

Oliveira, M. B., 2286W*,<br />

2291F, 2718F<br />

Oliveira, R. J., 1880F<br />

Oliveira, S., 3261T*<br />

Oliveira, S. A., 1977W,<br />

2085W, 2150F<br />

Oliveira, S. F., 961W, 3324T,<br />

3375T<br />

Oliver, J., 3703F<br />

Oliver, J. S., 3529F, 3656W*<br />

Oliver, K. L., 2898F<br />

Oliver, P. L., 2649W*<br />

Oliver, T., 940T<br />

Olivier, M., 441F, 587F,<br />

1269W, 1667T<br />

Oljira, T., 3322F<br />

Ollert, M., 2922F<br />

Ollila, H. M., 2462F*<br />

Olm-Shipman, A. J., 2265W,<br />

2670F<br />

Olopade, O. I., 1003T<br />

Olsen, A. O., 3510T<br />

Olsen, N., 1901F, 2284T<br />

Olson, J. E., 3564W<br />

Olson, L., 247, 1447F,<br />

2263T<br />

Olson, L. M., 2154W, 2240F<br />

Olson, T. M., 1695T<br />

Olsson, L., 1023W*<br />

Olsson, T., 1455T, 2561F<br />

Olstad, O. K., 576W<br />

Omar, S., 3303T, 3338W<br />

Omarjee, A., 126<br />

Omay, Z., 1201T<br />

Omdal, R., 2084F<br />

Omi, N., 2129F<br />

Omran, H., 2850F, 2955F<br />

Önal-Akan, A., 2869W<br />

Onat, O. E., 2924T*<br />

Onay, H., 2719W, 3206F*,<br />

3222F<br />

Öncel Torun, Z., 3195W*<br />

*Presenting Author<br />

Oncescu, A., 3009T, 3067W<br />

Onda, H., 2675T<br />

O’Neill, C., 763W, 784W<br />

O’Neill, F. A., 2500T, 2594F,<br />

2599T<br />

Onengut-Gumuscu, S.,<br />

1299T<br />

Oner, O., 8<br />

Ong, F. S., 130*<br />

Ong, J., 3669F<br />

Ong, K., 2165F<br />

Ong, K. K., 2282F<br />

Ong, R. T. H., 3284W, 3339T<br />

Ongaco, C., 2139W<br />

Ongen, H., 401*, 556W,<br />

561F<br />

Onkamo, P., 2181W<br />

Onland-Moret, N. C., 609T<br />

Onouchi, Y., 1631T*, 1643T<br />

Onoufriadis, A., 809F*<br />

Ontiveros, A., 2495F<br />

Ooi, C., 3574W<br />

Oonk, A. M. M., 58<br />

Oostdijk, W., 2701W<br />

Oosterveld, M. J. S., 2848W<br />

Oosterwijk, J. C., 27<br />

Oostra, B., 2107T<br />

Oostra, B. A., 2193W<br />

Oostrik, J., 58<br />

Opdal, M. S., 643T<br />

Openshaw, P. J., 1507F<br />

Oph<strong>of</strong>f, R. A., 431F, 2526W,<br />

2553W, 2661W, 3474T*<br />

Opocher, G., 2708T<br />

Oppelt, P., 3153W<br />

Oppeneer, T., 763W<br />

Oppenheimer, S., 3264T,<br />

3267T<br />

Oppo, M., 113, 157, 177<br />

OPTIMED Consortium,<br />

608T<br />

O’Rahilly, S., 33, 43, 45, 583F<br />

Orange, J. S., 2722W<br />

Ordonez, J., 2495F<br />

Ordovas, J. M., 2024F<br />

Ordulu, Z., 68, 70*<br />

O’Reilly, D. D., 454W<br />

O’Reilly, P., 1432F, 2162F<br />

O’Reilly, P. F., 2164T<br />

O’Reilly, R., 2585F<br />

Orellana, C., 103<br />

Organ, C., 2561F<br />

Ori, A. P. S., 2661W<br />

O’Rielly, D., 448W*<br />

Orioli, A., 415F<br />

Orlando, S., 255<br />

Orl<strong>of</strong>f, M., 1144T<br />

Ormond, K., Session 25<br />

Ormond, K. E., 1844F<br />

Ormshaw, E., 3167W<br />

Ornitz, D. M., 828F<br />

Ornt<strong>of</strong>t, T. F., 401<br />

O’Roak, B. J., 10*, 93, 278,<br />

2789T, 2897T<br />

Oron-Karni, V., 2919F<br />

Orosco, L., 956T<br />

O’Rourke, M., 853F<br />

Orr, H. T., 2625W, 2769F<br />

Orr, N., 1150T<br />

Orrù, V., 1516F<br />

SPEAKER AND AUTHOR INDEX 389<br />

Orr-Urtreger, A., 63, 704T<br />

Orta Correia, F., 1968W<br />

Orta Gomes, F., 2017T<br />

Ortega, G., 3226F<br />

Ortega, M., 2049W<br />

Ortega, O., 2453F<br />

Ortega, V., 868T<br />

Ortega Del Vecchyo, D.,<br />

3302W*, 3621F<br />

Ortega-Gutierrez, F. A., 650T<br />

Ortel, T. L., 2330F<br />

Ortiz, R., 1141T<br />

Ortiz, V., 526W<br />

Ortiz Brüchle, N., 3111W<br />

Ortiz-López, R., 1030T<br />

Ortiz-Orozco, R., 650T<br />

Ortiz-Tello, P., 2033F*, 3390T<br />

Ortmann, W., 2091W<br />

Ortoz, R., 1049F<br />

Orwoll, E., 109<br />

Orwoll, E. S., 2375F<br />

Ory, D., 684T<br />

Osaka, H., 234, 2836W,<br />

3136F<br />

Osann, K., 1791W<br />

Osann, K. E., 3213W<br />

Osawa, M., 1321F, 2963T<br />

Osborne, K., 399<br />

Osborne, L. R., 2665W,<br />

3482T<br />

Oshiro, M. M., 3712W<br />

Oshlack, A., 3484T<br />

Osimani, S., 124<br />

Osimo, E., 2564F<br />

Osoegawa, K., 1589T*<br />

Osorio, A., 1213T<br />

Ospina, L. H., 2790F<br />

Ossowski, S., 2303F, 2326T,<br />

2593T, 2940F, 3661F*<br />

Ossowsky, V., 2018F<br />

Ostell, J., 1762W, 3625F<br />

Oster, B., 401<br />

Østergaard, E., 363<br />

Ostergren, J. E., 1849W<br />

Ostrander, E. A., 28, 1001F,<br />

1214F, 2219F*<br />

Ostrer, H., 17, 409, 1185W,<br />

1309F, 2078F, 3345T,<br />

3395W*, 3397W<br />

Ostrosky, P., 1049F<br />

Ostrovnaya, I., 999W<br />

Ostrovsky, J., 534W, 2943F<br />

Oswald, G., 80<br />

Oswald, M., 1133F<br />

Ota, S., 475F<br />

Ota, V. K., 2533T*, 2534F<br />

Otieno, F., 2722W, 2856F<br />

Otieno, F. G., 2872W<br />

Otsuka, A., 2911W<br />

Ott, J., 1892F<br />

Otterud, B., 2397W<br />

Ottman, R., 203<br />

Otto, E. A., 406, 2850F*<br />

Otto, P. A., 874T<br />

Ottoboni, L., 2250W<br />

Ottolini, B., 449F*<br />

Ou, J., 553F, 2479T<br />

Ouahla, M., 2674W<br />

Oualkacha, K., 1411F*<br />

Ouazzani, O., 2306F<br />

Ouchi, K., 1631T<br />

Oud, M., 324<br />

Oud, M. M., 216<br />

Oufadem, M., 3172F<br />

Ouguerram, K., 1607T<br />

Ouled Amar Bencheikh, B.,<br />

2306F*, 2342F<br />

Õunap, K., 3151W<br />

Ounissi-Benkalha1, H., 5<br />

Ousager, L. B., 2760F<br />

Outeiro, T. F., 2641T<br />

Ouwehand, W., 110<br />

Ouwehand, W. H.,<br />

Session 22, 383,<br />

1604T, 3453T<br />

Ouwenga, R., 3398T<br />

Ouzhuluobu, O., 3317W<br />

Ovarian Cancer Association<br />

Consortium, 1156T<br />

Ovcharenko, I., 407, 545F<br />

Overgaard, M. T., 2699T<br />

Ovetsky, M., 1762W<br />

Owen, M., 1325W<br />

Owen, M. J., 2405F, 2576F<br />

Owen, N., 730T<br />

Owen, R., 876T, 3522T<br />

Owens, C., 3142F<br />

Owings, A., 3373F<br />

Owings, A. C., 3329W,<br />

3377W<br />

Oyama, F., 548W, 558W*,<br />

559F, 598W, 599F<br />

Oyarzo, A., 2672T<br />

Oystreck, D. T., 2928F<br />

Oza, A., 1824F<br />

Ozaki, A., 2656T<br />

Ozaki, K., 1631T, 1643T*<br />

Ozaksit, G., 594W<br />

Ozbek, U., 22*, 2396F,<br />

2412W*<br />

Ozcelik, H., 1500T<br />

Ozcelik, T., 287, 2924T<br />

Ozdemir, O., 2412W<br />

Ozdemir, T., 3222F*<br />

Ozdemir, T. R., 1106F<br />

Ozeki, T., 627T*<br />

Ozel, A. B., 2135F*<br />

Ozelius, L., 17<br />

Ozelius, L. J., 2801T<br />

Ozen, M., 2908W<br />

Ozenberger, B. A., 1845W*<br />

Ozer, O., 3424T*, 3426T<br />

Ozhan, N., 1025F<br />

Ozilou, C., 915W<br />

Ozkan, E., 3201W<br />

Ozkilic, M., 3475T*<br />

Ozkinay, C., 1106F<br />

Ozkinay, F., 965W, 1106F,<br />

2719W*, 3206F, 3222F<br />

Özkinay, F., 3214F<br />

Oz-Levi, D., 53*, 2875W<br />

Ozmore, J., 3176F<br />

P<br />

Pääbo, S., 3274F, 3372T<br />

Paananen, J., 46<br />

Paardekooper Overman,<br />

J., 215<br />

SPEAKER AND AUTHOR INDEX


390 SPEAKER AND AUTHOR INDEX<br />

Paavola-Sakki, P., 2023T<br />

Pabón-Peña, C., 3669F<br />

Pabst, S., 2103W<br />

Pacanaro, A. N., 3045W<br />

Pacheco, J., 1312F<br />

Pacheco, J. A., 618T<br />

Pacheco Torres, A., 996W*<br />

Paciolla, M., 505F<br />

Pack, A., 2592W<br />

Padbury, J., 76, 3024T*<br />

Padgett, R. A., Session 24<br />

Padilla, C. D., 1805W*,<br />

1877F<br />

Padilla, S., 1805W<br />

Padioleau, I., 561F<br />

Padmanaban, A., 3705F<br />

Padmanabhan, S., 1626T<br />

Padoan, M., 1153T<br />

Padula, A., 2629T<br />

Padyukov, L., 1934F, 1981T,<br />

2103W, 2160W, 2276F<br />

Paelinck, B., 1617T<br />

Paetau, A., 1253F<br />

Paez, P., 3115W*<br />

Paff, T., 809F<br />

Pagan, C., 259<br />

Pagani, L., 3322F*, 3377W<br />

Page, D., 2297F<br />

Page, E., 1109F<br />

Page, G., 2114F<br />

Page, G. P., 1392T*, 2170T<br />

Pagliarani, S., 1751W<br />

Pagnamenta, A. T., 2939T<br />

Pagon, R. A., 1753W<br />

Pai, A., 2<br />

Pai, A. A., 3251W<br />

Paila, U. D., 3632W*<br />

Painter, J. N., 2056T<br />

Painter, J. P., 2133W<br />

Paisan-Ruiz, C., 2866W<br />

Paithankar, S., 3433T<br />

Paiva, C., 2288F<br />

Pajukanta, P., 2256W<br />

Pak, H., 1590T<br />

Pakalapati, G., 434W<br />

Pakstis, A. J., 3313F<br />

Pal, A., 802W<br />

Pal, D. K., 1531F, 2580W<br />

Pal, T., 1061F*<br />

Pala, M., 547F*, 2001W<br />

Palacios, B., 526W<br />

Palacios, M. G., 3084F*<br />

Palamara, G., 2780T<br />

Palamara, P., 3346F, 3366T*<br />

Palamara, P. F., 17, 3345T<br />

Palejev, D., 334<br />

Palha, T., 3364F, 3402T<br />

Palin, K., 3396T<br />

Pall, H., 348<br />

Pallas, M. C., 3725F*<br />

Paller, A. S., 2915T<br />

Pallesi-Pocachard, E.,<br />

889W*, 2674W<br />

Pallone, N. L., 742T*<br />

Palma, M. G., 926T<br />

Palmas, W., 1661T<br />

Palmeiro, A., 1778W<br />

Palmer, C., 1082F, 2131T<br />

Palmer, C. D., 3525T<br />

Palmer, C. N. A., 115, 609T<br />

*Presenting Author<br />

Palmer, D., 735F<br />

Palmer, L., 1153T<br />

Palmer, L. J., 2167T<br />

Palmer, N., 269<br />

Palmer, N. D., 1661T,<br />

1879T*, 1888T, 2275T,<br />

2310W<br />

Palmer, R., 126, 1773W<br />

Palmer, S. E., 330<br />

Palmer, S. J., 410*, 2662W,<br />

2796F<br />

Palmfeldt, J., 657F<br />

Palomaki, G. E., 3016T<br />

Palomares, M., 1658T,<br />

2065T<br />

Palotie, A., 252, 656T,<br />

897W, 1325W, 1709T,<br />

2059T, 2134T, 2344T,<br />

2348F, 2350T, 2399F,<br />

2898F<br />

Palou, J., 1053W<br />

Pals, G., 809F<br />

Palser, A. L., 2163W<br />

Paltiel, O., 1159T<br />

Paltoo, D., 2247W<br />

Pan, H., 1566T, 1772W<br />

Pan, J., 2838F<br />

Pan, S., 1601T<br />

Pan, W. H., 3430T<br />

Pan, X., 443F, 3394T<br />

Panchal, A., 1256F<br />

Panckeri, K., 853F<br />

Pandey, A., 3316F<br />

Pandey, M. K., 749F*<br />

Pandey, R., 1992W, 1997F,<br />

2252F*<br />

Pandite, L. N., 651T<br />

Pandor, A., 762W*<br />

Panettieri Jr., R. A., 638T<br />

Pang, A., 3506T*<br />

Pang, C. P., 1972T<br />

Pang, H., 531F<br />

Pang, Z., 2433W<br />

Pangalos, C., 2902W*<br />

Pan-Hammarström, Q.,<br />

2091W<br />

Panhuis, T. M., <strong>2012</strong>F<br />

Panicker, V., 1216T<br />

Panico, S., 1712T<br />

Panigrahi, A., 3316F<br />

Panigrahi, G., 2635T*<br />

Panigrahi, I., 3207W*<br />

Pankow, J. S., 1925F,<br />

2337W<br />

Pannosian, S., 2872W<br />

Pannuti, A., 1116W<br />

Panossian, S., 1997F,<br />

2252F, 2785W, 2892F,<br />

2904F<br />

Panoutsopoulou, K., 2044T,<br />

2097W, 2292W*, 3396T<br />

Pantel, K., 1115F<br />

Panzer, J. A., 330<br />

Pao, W., 136, 3620W<br />

Papadogiannakis, N.,<br />

3245W<br />

Papageorgiou, E. A.,<br />

3017T<br />

Papanicolaou, G., 350,<br />

2063F, 2210F<br />

Papanicolaou, G. J., 2131T,<br />

2247W, 3299W<br />

Papasian, C. J., 2053T<br />

Papenhausen, P., 949W<br />

Papillon-Cavanagh, S.,<br />

2790F<br />

Papp, A. C., 609T<br />

Pappas, J. G., 3113W*<br />

Pappatà, S., 1985F<br />

Paprotka, T., 3701F<br />

Paquette, A. M., 3314W<br />

Paquette, J., 3618W*<br />

Paquis, V., 2703F<br />

Paraki, I., 218<br />

Parboosingh, J., 1052F,<br />

3173W<br />

Parboosingh, J. S., 2800W,<br />

3095W, 3127W, 3141W,<br />

3665F<br />

Parc, Y., 1170W<br />

Pardi, E., 2708T<br />

Pardo, L., 98<br />

Pare, G., 617T*<br />

Paré, P. D., 1465F<br />

Paredes, R., 1141T<br />

Paredes-Aguilera, R.,<br />

1131W<br />

Parent, P., 1728W<br />

Parets, S. E., 2384F*<br />

Pareyson, D., 2781F<br />

Parfenov, M. G., 1677T<br />

Parfrey, P., 1066T, 1084T<br />

Parham, P., Session 80,<br />

3390T, 3710W<br />

Pariente, J., 345<br />

Parikh, A., 3097W<br />

Parikh, H., 1088F, 1199F*<br />

Parikh, S., 330<br />

Parikshak, N., 2444F<br />

Parimi, N., 2375F<br />

Parisi, V., 881W, 943W*,<br />

2777T<br />

Parisot, P., 77<br />

Park, A., 1590T, 2042F<br />

Park, B. L., 1975T<br />

Park, C., 1931F<br />

Park, C. S., 1975T<br />

Park, D. J., 1213T, 3679F*<br />

Park, H., 1155W<br />

Park, H. C., 3223W*<br />

Park, I., 1248W, 3462T<br />

Park, J., 947W, 1190F,<br />

1306F, 1450F*, 1657T,<br />

2715F, 3444T<br />

Park, J. E., 1465F<br />

Park, J.-H., 1007F*<br />

Park, K. H., 1305T<br />

Park, K.-H., 385<br />

Park, L., 2499W<br />

Park, M., 2518T<br />

Park, N., 2260T, 2547W<br />

Park, S., 126, 900T, 2518T,<br />

3008T, 3103W, 3461T,<br />

3473T<br />

Park, S. H., 3423T<br />

Park, S. J., 863W<br />

Park, S.-Y., 1622T<br />

Park, T., 1385W<br />

Park, W., 933W, 2723T*,<br />

3204F, 3223W<br />

Park, Y. S., 344, 2508W*<br />

Parker, D., 386<br />

Parker, H. G., 2219F<br />

Parker, M. M., 1425T*,<br />

1512T, 3616W<br />

Parker, T., 3210F<br />

Parker, V. E. R., 33<br />

Parkes, M., 2314T<br />

Parkhurst, E., 1866F<br />

Parkinson, H., 2108F<br />

Parkinson, K., 2703F<br />

Parkinson, N., 3142F<br />

Parkinson’s Disease<br />

<strong>Genetics</strong> Study Group,<br />

2638T<br />

Parks, J. C., 2968T<br />

Park-Simon, T. W., 1117T<br />

Parla, J., 2180F, 2305T,<br />

2587T<br />

Parlamee, N., 17<br />

Parmalee, N., 1898F,<br />

2547W*<br />

Parman, Y., 201, 2948T<br />

Parmar, A. S., 2023T*<br />

Parnaik, R., 361<br />

Parnell, L., 2024F*<br />

Parnham, A., 2916F<br />

Parodi, C., 1589T<br />

Parra, E., 49<br />

Parra, M., 1736W*<br />

Parracciani, D., 2128T<br />

Parrado, A. R., 2520W*<br />

Parrini, E., 889W<br />

Parsons, J., 530W<br />

Parsons, M. J., 818F<br />

Parsons, M. T., 1067F<br />

Parsons, R., 1255T<br />

Partanen, J., 2023T<br />

Partlow, J. N., 8<br />

Parts, L., 44, 583F, 1440T<br />

Partyka, G., 1867F<br />

Parvari, R., 1588T, 2738T*<br />

Parveen, F., 2992T*<br />

Pasalar, P., 1083W<br />

Pasaniuc, B., 89*, 284, 350,<br />

1331W, 1577W<br />

Pasca, S., 2479T<br />

Pasche, B., 1292W<br />

Paschon, D. E., 803W<br />

Pasco, Y., 270, 2603F<br />

Pasco, Y. M., 2572T<br />

Pascoal, V. D. B., 2655W<br />

Pasko, D., 2116T<br />

Paskulin, G., 2434T<br />

Pasmanik-Chor, M., 105<br />

Pasquale, L. R., 51, 1887W,<br />

2135F, 2154W*, 2240F,<br />

2263T<br />

Pasquale, R., 1060T<br />

Pasquali, A., 2548T<br />

Pasquali, M., 686T<br />

Pasquier, L., 3157W<br />

Passan, S., 1342F*<br />

Passini, M., 793W<br />

Passos-Bueno, M. R., 439F,<br />

813F, 814F, 852F, 2414F,<br />

2654F, 2673F, 2687T,<br />

2746W, 3070F, 3152F<br />

Passtoors, W. M., 1436W<br />

Pasternack, D., 1279T


Pasternack, S., 1005W<br />

Pastinen, T., 256, 394,<br />

569F, 649T, 705F, 1207T,<br />

1215W, 3439T, 3466T,<br />

3514T<br />

Pastore, N., 735F*<br />

Pastores, G. M., 768W,<br />

769W, 772W, 773W<br />

Pastorino, R., 2039F<br />

Pastura, P., 2136W<br />

Pasutharnchat, N., 2749W<br />

Pasutto, F., 2160W<br />

Patel, A., 61, 229, 430W,<br />

432W, 893W, 898T*,<br />

952T, 2403W<br />

Patel, C., 2230T<br />

Patel, C. J., 1462F*<br />

Patel, D., 1108T<br />

Patel, H., 3400T<br />

Patel, K., 503F<br />

Patel, M., 750T<br />

Patel, P., 2778F*<br />

Patel, P. J., 1472W<br />

Patel, S. R., 646T<br />

Patel, V. C., 2312F<br />

Patel, Y., 3471T<br />

Paternoster, L., 1528F,<br />

2102F<br />

Paterson, A., 2376W,<br />

2499W<br />

Paterson, A. D., 2109W<br />

Pathak, J., 1351F<br />

Patil, S., 1841W<br />

Patin, E., 3368W<br />

Patino, A., 951W<br />

Patiño, A., 3074F<br />

Patney, H. L., 1649T<br />

Pato, C., 2564F<br />

Pato, M., 2564F<br />

Paton, W., 222<br />

Patrinos, G. P., 3610W<br />

Patry, L., 2692W, 2790F<br />

Patsalis, P., 3017T*<br />

Patsopoulos, N. A., 624T<br />

Patterson, A., 2281T<br />

Patterson, B., 1847W<br />

Patterson, D. G., 2504F<br />

Patterson, M. C., 684T<br />

Patterson, N., 89, 178, 350,<br />

1331W, 1360F, 2210F,<br />

3372T, 3407W<br />

Patti, E., 2095T<br />

Pattnaik, B., 2830W<br />

Patto, J. V., 1977W<br />

Pauciulo, M. W., 2136W*<br />

Paul, D. S., 110, 383<br />

Paul, S. M., 1965W<br />

Paul-Gilloteaux, P., 842F<br />

Pauls, D., 1480F<br />

Paulsson, K., 1023W, 1024T<br />

Paulus, W., 2568W<br />

Paunio, T., 252, 2462F<br />

Pauws, E., 2752W, 2859F<br />

Pavan, W. J., 258<br />

Pavanello, R. C. M., 1727W<br />

Pavlidis, P., 447F, 491F,<br />

517F, 2482T, 3568W*<br />

Pavlovic, A., 1601T<br />

Pawel, B., 924T<br />

Pawitan, Y., 2074T<br />

*Presenting Author<br />

Pawlikowska, L., 589F<br />

Paxinos, E., 3682W, 3724W<br />

Paxinos, E. E., 36<br />

Payet, M., 2729T<br />

Payette, Y., 2266T, 3341W<br />

Payne, F., 33, 45*<br />

Payne, T. J., 2388W, 2390F,<br />

2574W<br />

Paynter, N. P., 51<br />

Pazos, A., 3388F<br />

Pazourkova, E., 3437T<br />

Pearce, K. E., 1145F<br />

Pearce, M. S., 3419T<br />

Pearlman, A., 409, 1185W*,<br />

3345T<br />

Pearson, C., 2635T, 3026T<br />

Pearson, C. E., 2696T,<br />

2824W<br />

Pearson, K., 3238F<br />

Pearson, L., 2083T<br />

Pearson, L. N., 2223W<br />

Pearson, N., 1558F, 1561F<br />

Pearson, N. M., 2871F<br />

Pearson, R. D., 172, 1519F<br />

Peckins, S., 3264T<br />

Peco-Antic, A., 216<br />

Peden, J., 1238F<br />

Pedersen, A. G., 2241W<br />

Pedersen, E. B., 2329T<br />

Pedersen, I. S., 2862F<br />

Pedersen, J. K., 1323T<br />

Pedersen, L., 1565W<br />

Pedersen, N. L., 434W,<br />

2105F, 2175W<br />

Pedersen, O., 1624T, 2116T,<br />

2311T, 2317T, 2347T<br />

Pediatric Imaging<br />

Neurocognition <strong>Genetics</strong><br />

Study, 1973F<br />

Pedram, M., 2714T<br />

Pedrazzoli, J., Jr., 1187F<br />

Pedroso, J. L., 2642F<br />

Peebles, D., 3508T<br />

Pe’er, I., Session 75, 17*,<br />

193, 264, 353, 1231T,<br />

1320T, 3345T, 3346F,<br />

3366T<br />

Peete, J., 493F<br />

Peeters, E. A. J., 214<br />

Peeters, H., 925W<br />

Peeters, K., 201, 2948T<br />

Pegoraro, E., 1732W, 2799F<br />

Pehlivan, D., 337, 360,<br />

777W, 2881W*, 2908W,<br />

2955F<br />

Pehlivan, S., 1402F, 1935W,<br />

1938W<br />

Pehlivan, Y., 2881W<br />

Pei, Y. F., 2053T, 3534W<br />

Pei, Y.-F., 2172W<br />

Peissig, P., 618T, 1312F,<br />

3622W<br />

Peitz, M., 236<br />

Pelak, K., 53, 2335T<br />

Peleg, L., 2691F*<br />

Pellegata, N., 2708T<br />

Pellegrini, M., 2479T<br />

Pellegrino, C., 2674W<br />

Pellegrino, R., 2492F,<br />

2592W*<br />

SPEAKER AND AUTHOR INDEX 391<br />

Peller, L., 674T<br />

Peller, L. C., 1696T<br />

Pellerin, P., 2002T<br />

Pellestor, F., 857W*, 936T<br />

Pellico, M. T., 775W<br />

Pellitteri-Hahn, M., 587F<br />

Peloso, G., 279<br />

Peloso, G. M., 117, 170<br />

Pelte, M. F., 67<br />

Peltekova, V., 1093T*<br />

Peltoketo, H., 1099T<br />

Peltomäki, P., 1026W,<br />

1276T<br />

Peltonen, J., 1139F<br />

Peltonen, S., 1139F<br />

Pelttari, L. M., 997T*<br />

Peluso, I., 2950W<br />

Peluso, P., 477F<br />

Pemberton, T., 2778F<br />

Pemberton, T. J., 3285T<br />

Pemov, A., 1261T*<br />

Peña, J. A., 3375T<br />

Pena, S. D. J., 3110F<br />

Peñaherrera, M. S., 3429T<br />

Penalva, L., 585F<br />

Penchaszadeh, V., 1877F<br />

Pendergrass, S. A., 226*,<br />

625T, 1316W, 2258F,<br />

3542W, 3624W<br />

Peng, B., 1543F*, 1554T<br />

Peng, C., 3596W<br />

Peng, G., 3589F<br />

Peng, J., 763W<br />

Peng, Q., 1263W*<br />

Peng, S., 3596W<br />

Peng, W., 586W, 3285T<br />

Peng, X., 3698W*<br />

Peng, X. H., 3081W<br />

Peng, Y., 3317W<br />

Peng, Z., 1369F<br />

Penland, C. M., 1731W<br />

Penn, J., 688T<br />

Pennacchio, L. A., 4, 254,<br />

407<br />

Pennell, C., 2097W, 2164T<br />

Penninger, J., 110<br />

Pennings, R. J. E., 58<br />

Pennington, J., 3530W<br />

Pennington, J. W., 3590W<br />

Pennison, M. J., 1292W*<br />

Penny, D. J., 1646T<br />

Pensato, V., 2775F<br />

Penzes, P., 263<br />

Peoples, A., 480W<br />

Pepalyte · , I., 653T, 920T<br />

Peppard, P. E., 2543F<br />

Pepperkok, R., 1630T<br />

Peralta, J., 1280W, 2589W<br />

Peralta, J. M., 1923W,<br />

2308T, 2309F, 2339F<br />

Perche, O., 3246F<br />

Perdomo, S., 3115W<br />

Perea-Díaz, F. J., 2363F<br />

Perego, U. A., 3340F<br />

Pereira, A., 1593T<br />

Pereira, A. C., 636T, 1629T,<br />

3160F, 3184F<br />

Pereira, C. S., 941W<br />

Pereira, E. T., 2642F<br />

Pereira, F. A., 840F<br />

Pereira, F. S., 2825T*<br />

Pereira, I. A., 1405F<br />

Pereira, L., 1343W*, 3325F<br />

Pereira, L. C., 2352W<br />

Pereira, L. V., 776W<br />

Pereira, P., 2404T*<br />

Pereira, P. D., 479F<br />

Pereira, R. W., 1202F,<br />

1880F, 2223W, 3272W<br />

Pereira, S., 70<br />

Pereira, S. L., 2932W<br />

Pereira Filho, S. A. C.,<br />

2751F<br />

Pereira-Latini, A. C., 2289W<br />

Pereira- Leal, J. B., 2261F<br />

Perera, M., 646T<br />

Perera, N., 1108T<br />

Perez, A., 2540F*, 3131W<br />

Perez, A.-B., 895W<br />

Perez, A. B. A., 2484W,<br />

2485T<br />

Pérez, C., 2300F<br />

Perez, I. C., 2837T<br />

Perez, M. J., 77, 3129W<br />

Perez, R. J. M., 3039W<br />

Perez, S., 827F<br />

Perez-Jurado, L., 84<br />

Perez-Jurado, L. A., 2711T*,<br />

3084F, 3208F<br />

Perez-Nuño, M., 650T<br />

Perez-Quiñones, M. L.,<br />

3363T<br />

Perez Siles, G., 2742F<br />

Perez-Stable, E., 1075T<br />

Perez-Vera, P., 1141T,<br />

3040F<br />

Pérez-Vera, P., 872T, 1022F,<br />

1131W<br />

Pergadia, M. L., 2212T<br />

Pericak-Vance, M., 492W,<br />

1571W, 3706W<br />

Pericak-Vance, M. A.,<br />

Session 7, 9, 15, 270,<br />

341, 342, 343, 344, 347,<br />

588W, 1476T, 1489F,<br />

1644T, 1834F, 2028W,<br />

2049W, 2154W, 2185T,<br />

2240F, 2263T, 2299T,<br />

2318F, 2330F, 2445W,<br />

2498F, 2508W, 2572T,<br />

2583W, 2586W, 2614T,<br />

2637W, 3335W<br />

Perin, J., 2904F<br />

Perin, J. C., 2943F<br />

Periyasamy, G., 2967T<br />

Perlberg, S., 2447F,<br />

2991T<br />

Perls, T., 2040W<br />

Permaul, J., 1852F<br />

Perola, M., 656T, 1253F,<br />

1436W, 1563T, 2059T,<br />

2132F, 2175W, 2366F,<br />

2462F<br />

Perrault, I., 324*, 390<br />

Perrier, R., 910T, 1052F<br />

Perrin, M., 2126F<br />

Perry, B. J., 845F<br />

Perry, G. H., 3251W<br />

Perry, J. R. B., 111, 2073W,<br />

2165F*<br />

SPEAKER AND AUTHOR INDEX


392 SPEAKER AND AUTHOR INDEX<br />

Perry, R., 2648F<br />

Pers, T., 2090F<br />

Pers, T. H., 2241W*<br />

Persani, L., 2701W<br />

Perseu, L., 2001W<br />

Persico, I., 2062T*<br />

Person, R., 1742W<br />

Person, R. E., 314<br />

Perszyk, A., 687F*, 740T,<br />

743F, 3239W<br />

Pertesi, M., 1213T<br />

Perucha, E., 2082W<br />

Perusse, L., 2116T<br />

Pescarini, J., 1343W,<br />

2352W*<br />

Pescatore, A., 505F<br />

Pesce, L. L., 1614T<br />

Peskett, E., 2752W, 2859F<br />

Peskind, E., 340<br />

Peskind, E. R., 2646W<br />

Pessah, I. N., 2491T<br />

Petanovski, Z., 2983T<br />

Petek, E., 2570F<br />

Petek, L. M., 55, 2224T<br />

Peter, B., 2432F*, 3300T,<br />

3311W<br />

Peter, B. J., 971W<br />

Peter, I., 17, 1320T, 1777W,<br />

2151W, 2576F, 3488T<br />

Peter, J., 2205W<br />

Peterlin, B., 3001T<br />

Peterlongo, P., 27<br />

Peters, A., 275, 2226W,<br />

2568W<br />

Peters, J. A., 1064F<br />

Peters, M. J., 584W*, 1284T,<br />

1503T, 2141F<br />

Peters, U., 1437T, 1608T,<br />

1925F, 2337W<br />

Peterschmitt, M. J., 773W*<br />

Petersen, A., 2862F<br />

Petersen, B., 3583F<br />

Petersen, B.-S., 2315F*<br />

Petersen, D. C., 1085F,<br />

3332W*<br />

Petersen, G., 603T, 1088F,<br />

1161W, 1199F, 1267T<br />

Petersen, M. B., 2862F<br />

Petersen, O. B., 3148F<br />

Peterson, L., 2220W<br />

Peterson, R. E., 2277W*<br />

Petit, F., 3172F<br />

Petkovich, M., 2926W<br />

Petkovič Ramadža, D., 214<br />

Petraroli, R., 1060T<br />

Petrek, M., 2103W<br />

Petri, A., 2827W<br />

Petri, M., 1979F<br />

Petridi, S., 809F<br />

Petrikin, J. E., 366<br />

Petrill, S. A., 2544W<br />

Petronis, A., 377, 3490T<br />

Petropoulos, C., 3682W<br />

Petrosino, J., 3600W<br />

Petrosyan, P., 3587F<br />

Petru, E., 1115F<br />

Petrulis, M., 1879T<br />

Pettersen, B. J., 73<br />

Petukhova, G., 417F, 592W<br />

Petukhova, L., 2182T*<br />

*Presenting Author<br />

Petzl-Erler, M. L., 1405F<br />

Pevsner, J., 3374W<br />

Peyrard-Janvid, M., 1976F<br />

Pezanowski, D., 924T<br />

Pezzolesi, M. G., 2313W*<br />

Pfeifer, S., 285<br />

Pfeiffer, R. M., 1314T<br />

Pfeiffer, W., 494W, 1239W<br />

Pfeufer, A., 86*<br />

Pfister, S., 1182W<br />

Pflückhahn, U., 1200W,<br />

1233W<br />

Pfundt, R., 100, 102, 214,<br />

955W, 979W*, 2848W<br />

PGen Study Group, 1825W<br />

Phadke, S. R., 2739F<br />

Pham, J., 952T<br />

Pham, L., 3699F<br />

Pham, P., 1742W, 1757W,<br />

1761W, 3576W<br />

Pham, P. A., 314, 1735W<br />

Phan, L., 3582W, 3625F<br />

Phan, V., 78<br />

Phanstiel, D. H., 416W<br />

Pharoah, P., 139, 1150T<br />

Pharoah, P. D. P., 206, 209,<br />

210, 1156T<br />

Phelan, C. M., 1156T<br />

Phelan, K., 907W, 3052F*<br />

Phelan, M., 3699F*<br />

Phelps, I. G., 10, 2772F,<br />

2789T<br />

Philip, G. K., 1224W<br />

Philippe, C., 2792T<br />

Phillips, D. L., 3344W<br />

Phillips III, J. A., 2732T<br />

Phillips, J., 730T<br />

Phillips, K., 949W<br />

Phillips, M., 788W, 3401W<br />

Phillips, S. L., 107<br />

Phouanenavong, S., 407<br />

Piard, J., 3199W*<br />

Piaza, A. C. S., 514W<br />

Piazuelo, M. B., 3388F<br />

Piazzon, F., 896T<br />

Piazzon, F. B., 899W*,<br />

3045W<br />

Pibarot, P., 1655T<br />

Picanço, C. G., 941W<br />

Picard, A., 983F<br />

Piccolini, E., 1153T<br />

Piccolo, P., 735F<br />

Picher, M. M., 59<br />

Pichler, M., 1115F<br />

Pichot, C. S., 3433T<br />

Pickering, D. L., 968T*<br />

Pickett, H., 210<br />

Pickle, L., 3717F<br />

Pickrell, J. K., 3367F*<br />

Pic-Taylor, A., 903W*<br />

Pidsley, R., 3476T*<br />

Piehl, F., 2561F<br />

Piehler, A. P., 576W, 643T<br />

Pierard, G. E., 129<br />

Pierce, B., Session 21,<br />

1638T, 2025W*<br />

Pierce, E. A., 1756W, 2943F,<br />

3653F<br />

Pierce, J., 3587F<br />

Pierce, R., 2221T<br />

Pierce, S. B., 2929W*<br />

Pieri, P. C., 2863W<br />

Pierquin, G., 925W<br />

Pietiläinen, K. H., 2256W<br />

Pietiläinen, O., 252*, 2399F<br />

Pietrement, C., 324<br />

Pietrzykowski, A. Z., 507F*<br />

Pignatti, P. F., 1361W,<br />

2548T, 2659T<br />

Piherova, L., 752T<br />

Pihko, H., 327<br />

Pihur, V., 305<br />

Pike, K., 13<br />

Pilarski, R., 1197W*<br />

Pillai, N. E., 3339T<br />

Pillalamarri, V., 68, 70<br />

Pillers, D., 2830W, 3287W*<br />

Pilling, L., 584W<br />

Pilorge, M., 901W<br />

Pilu, R., 157<br />

Pilz, D., 124<br />

Pimenta, G., 2404T<br />

Pimlott, N., 1852F<br />

Pina, R., 3019T<br />

Pina Neto, J. M., 3099W<br />

Pinder, C. L., 3382F<br />

Pineda, M., 684T<br />

Pineda, T., 703F, 3190F*<br />

Pineda, V. V., 2456F<br />

Pineda Alvarez, D., 332<br />

Ping, W., 2879T<br />

Pingault, V., 2727F<br />

Pinner, J. R., 3167W<br />

Pinney, S. M., 1454W<br />

Pinnkas, P., 3671F<br />

Pino-Yanes, M., 2296T*<br />

Pinto, D., 2577W*, 2620T<br />

Pinto, E. M., 2706F<br />

Pinto, F. R., 2373W<br />

Piotrowski, A., 434W<br />

Piper, J., 436W<br />

Pipiras, E., 973W*, 2784F<br />

Pique-Regi, R., 2<br />

Pirags, V., 608T<br />

Piras, M. G., 177, 547F,<br />

1516F, 2198F, 2329T<br />

Piras, R., 157, 847F<br />

Pirastu, M., 2062T, 2128T<br />

Pirastu, N., 1484W, 2128T,<br />

2366F<br />

Piravej, K., 2749W<br />

Pires, F., 1170W<br />

Piri, N., 2832F<br />

Pirim, D., 1672T*<br />

Pirinen, M., 1340W, 2157W<br />

Pirooznia, M., 2180F, 2305T<br />

Piryaei, F., 754W*, 754W,<br />

2367W*, 2367W<br />

Pischler, C., 3116F<br />

Piscopo, I., 808F<br />

Piscopo, M., 3492T<br />

Pishotta, F., 2537F<br />

Piskol, R., 289*, 527F<br />

Pistis, G., 1451W*<br />

Pitchappan, R., 3377W<br />

Piteau, S. J., 671F*<br />

Pitman, T., 658T<br />

Pitstick, L., 2670F<br />

Pittaway, J., 780W<br />

Pitzalis, D., 113<br />

Pitzalis, M., 157, 177, 186,<br />

3664W<br />

Piveta, C. S. C., 479F*<br />

Pivnick, E., 3119W<br />

Pizzo, M., 2950W<br />

Place, E., 534W, 2943F<br />

Place, E. M., 1756W<br />

Plagnol, V., 122, 453F,<br />

1621T, 2072F, 2812W,<br />

3600W<br />

Plajzer-Frick, I., 407<br />

Planchon, A., 401, 556W,<br />

561F<br />

Plaseska-Karanfilska, D.,<br />

2983T*<br />

Plaster, C., 3322F<br />

Platt, A., 185*<br />

Platt, D., 1640T, 3349F<br />

Platt, F. M., 162<br />

Platt, S. R., 2805F<br />

Platzer, M., 580W, 1236W<br />

Plazzer, J. P., 1130F<br />

Plebani, A., 760W<br />

Plecko, B., 756W<br />

Plenge, R. M., 625T, 1490W,<br />

2047T, 2199W, 2210F,<br />

2258F<br />

Pleshko, N., 826F<br />

Plessis, G., 3109W<br />

Pletnikova, O., 2648F<br />

Plitnik, T., 2586W<br />

Plomin, R., 2164T, 3487T<br />

Plon, S. E., 134, 314, 430W,<br />

1221W*, 1735W, 1742W,<br />

1761W, 1798F, 3549F<br />

Plona, T., 13<br />

Plongthongkum, N., 3474T<br />

Plotsky, Y., 1165T<br />

Plourde, F., 1065W*<br />

Plowe, C., 2255F<br />

Plumari, M., 2781F<br />

Plumb, I., 1193F<br />

Plummer, F., 3276T<br />

Plummer, F. A., 490W<br />

Plunkett, K., 952T<br />

Plunkett III, G., 3671F<br />

Pluye, P., 1852F<br />

Pluzhnikov, A., 2333F, 3735F<br />

PMG Awareness<br />

Organization, Inc., 3239W<br />

Pochet, N., 322<br />

Poddie, F., 157<br />

Podolsky, R., 3418T<br />

Poduri, A., 266*<br />

Poeta, L., 2629T*<br />

Pogue, R., 1202F, 1880F<br />

Pogue-Geile, M. F., 2589W,<br />

2651F<br />

Poh, W. T., 3339T<br />

Pohl, E., 1, 3214F<br />

Poidevin, M., 2477F<br />

Poirot, B., 1205F<br />

Pokholok, D., 3695F<br />

Polak, P., 402, 1550W*<br />

Poland, G. A., 1426F<br />

Polasek, O., 1383T<br />

Polenakovic, M., 3481T<br />

Poletta, F., 1936T<br />

Pollack, S., 350, 1331W,<br />

1360F, 2210F, 3413W


Pollack-Berti, A., 3671F<br />

Pollak, M. N., 2080T<br />

Pollak, M. R., 284<br />

Pollard, K. S., Session 5,<br />

195<br />

Pollett, A., 1093T<br />

Polley, S., 450W*<br />

Polli, R., 1755W, 2795T*<br />

Pollin, T., 249<br />

Pollin, T. I., 1671T, 3027T<br />

Poll-The, B. T., 197, 2909T<br />

Polonikov, A. V., 2271W<br />

Polsinelli, G., 2408F<br />

Polverino, A., 1985F, 3492T*<br />

Polyak, E., 534W, 2943F<br />

Polychronakos, C., 5, 277,<br />

1915T<br />

Polzin, K. O., 1286W<br />

Pomilla, C., 3412T<br />

Ponciano-Jackson, D.,<br />

1302T<br />

Pond, A., 3648W<br />

Pond, A. C., 1251W*<br />

Pond, S., 1684T<br />

Pons-Estel, B., 2046W<br />

Pontes, T. B., 1132T, 3503T<br />

Pont-Kingdon, G., 1752W*,<br />

3182F<br />

Pook, M., 761W<br />

Pooley, K. A., 210<br />

Poon, R., 1369F<br />

Popadin, K., 85*, 3263W<br />

Pope, B. J., 1213T, 3679F<br />

Pope, K., 131<br />

Pope, R. M., 323<br />

Poplin, R., 41, 288<br />

Popov, J., 2260T<br />

Popovic, M., 3395W<br />

Poppe, B., 423F<br />

Popper, T., 1108T<br />

Porchet, N., 3172F<br />

Porcu, E., 157, 2198F*<br />

Porcu, L., 2001W<br />

Porkka-Heiskanen, T., 2462F<br />

Porreca, G., 1729W<br />

Porreca, G. J., 3640W,<br />

3680W*<br />

Porreca, G. P., 3693F<br />

Portas, L., 2062T, 2128T<br />

Portela, L. V. C., 2424W<br />

Porter, F. D., 162<br />

Porter, M., 969W*, 3530W<br />

Porter-Gill, P., 1091F,<br />

1092W, 1094F*<br />

Portlock, C., 1159T<br />

Pospiech, H., 1099T<br />

Post, W., 1662T<br />

Post, W. S., 301<br />

Posthuma, D., 98<br />

Postiglione, A., 1985F<br />

Potash, J. B., 369, 2180F,<br />

2305T, 2372F, 2391W<br />

Potkin, S., 3587F<br />

Potkin, S. G., 2469W, 2564F<br />

Potocki, L., Session 28<br />

Potter, B. K., 142, 149, 150,<br />

1827W<br />

Potter, C., 3419T*<br />

Pottier, C., 345<br />

Pottinger, S., 2139W<br />

*Presenting Author<br />

Potts, A., 247<br />

Pouget, J., 328<br />

Poulain, P., 3170F<br />

Poulin, M., 3425T*<br />

Poulizac, P., 716T<br />

Poulou, M., 2995T<br />

Pourahmad, R., 1596T<br />

Pourcain, B. S., 1528F<br />

Pourjafari, B., 860T<br />

Pour-Jafari, H., 860T*<br />

Povysil, G., 1483F, 1486F*<br />

Powell, A., 3694W<br />

Powell, B., 876T, 1221W,<br />

3601F*<br />

Powell, C., 2090F, 2241W,<br />

2328W<br />

Powell, H., 2302T<br />

Powell, J., 778W, 1199F,<br />

3471T<br />

Powell, S., 2542T<br />

Powell, W., 3498T<br />

Powell, W. T., 64*<br />

Power, R. A., 2509T*<br />

Powers, N. R., 1973F,<br />

2010W*<br />

Pöyhönen, M., 897W<br />

Pöyhönen, R., 327<br />

Poznik, G. D., 3368W*<br />

Pozzi, E., 790W<br />

Prabhu, S., 353*<br />

PRACTICAL Consortium,<br />

205, 1148F<br />

Prada, C., 789W*<br />

Pradhan, S., 3702W<br />

Pradhan, V., 1572T<br />

Prado, D. M., 3187W<br />

Prado, W., 1119W<br />

Prahalad, S., 2143T<br />

Prakash, G., 2293T*<br />

Prakash, S. K., 1743W*<br />

Prakruthi, P., 1108T<br />

Pramathan, T., 160<br />

Pramstaller, P. P., 86, 2080T,<br />

2366F<br />

Pranculis, A., 653T*, 920T<br />

Prandini, P., 2548T, 2659T<br />

Pras, E., 53, 783W, 2875W<br />

Prasad, A., 175, 2575T,<br />

2620T<br />

Prasad, K., 2589W, 2651F<br />

Prasad, R., 481F, 802W*<br />

Prasanna, S., 1701T<br />

Prasun, P., 3147W*<br />

Pratt, H., 1969T<br />

Pratt, J. G., 1566T<br />

Pratto, F., 592W*<br />

Prawitt, D., 3496T<br />

Prchal, J. T., 3297T<br />

Predazzi, I., 1668T*<br />

Predazzi, I. M., 1634T<br />

Preethi, T., 878T<br />

Pregizer, S., 837F<br />

Preil, M. L., 2869W<br />

Prenni, J., 1189T, 1990T<br />

Prera, E., 2753T*<br />

Prescott, C. A., 2504F<br />

Prescott, K., 129<br />

Prescott, T., 2926W<br />

Pressey, J. G., 1186T<br />

Presson, A. P., 1867F*<br />

SPEAKER AND AUTHOR INDEX 393<br />

Preto, P., 2393F<br />

Pretorius, M., 606T<br />

PreventCD Group, 1330F<br />

Previtali, S., 2948T<br />

Previtali, S. C., 201<br />

Pribadi, M., 2639F<br />

Price, A., 284, 350, 1360F*,<br />

2199W, 2210F, 3310F,<br />

3413W<br />

Price, A. L., 89, 1331W,<br />

1577W, 3407W<br />

Price, E., 3734W*<br />

Price, J., 2668W<br />

Price, S., 131<br />

Price, T. S., 3487T<br />

Price, V., 167<br />

Priebe, L., 420W<br />

Priest, J. R., 1065W<br />

Prieto, J. C., 3049W<br />

Prieto Rivera, J. C., 3077W<br />

Prieur-Gaston, E., 3538W<br />

Prill, R. J., 3569F*<br />

Priller, J., 684T<br />

Primorac, D., 3286F<br />

Prince, A., 1809W*<br />

Prince, J., 1189T, 1990T<br />

Prince, S., 762W<br />

Prins, B. P., 111, 2073W<br />

Prinz, M., 1591T<br />

Pristauz, G., 1115F<br />

Pritchard, J., 2, 273, 368<br />

Pritchard, J. K., 3367F<br />

Priya, R. R., 2183F*<br />

Probst, F., 898T<br />

Procter, M., 689F*<br />

Prodam, F., 2827W<br />

Pr<strong>of</strong>fitt, J. M., 2309F<br />

Prokisch, H., 275, 584W,<br />

699F, 782W, 2917W<br />

Prokopenko, I., 119, 190,<br />

269, 1308T, 1528F,<br />

2076W, 2106W, 2137T*<br />

Prokunina-Olsson, L.,<br />

510W, 1091F, 1092W,<br />

1094F, 1097F, 1155W<br />

Prom-Wormley, E. C.,<br />

2277W<br />

Proost, D., 1617T<br />

Prosper, B., 842F<br />

Prost, S., 3333T<br />

PROTECT Group, 205<br />

Provenzale, J., 785W<br />

Province, M. A., Session 8,<br />

18, 1641T, 1650T, 1661T,<br />

2093F<br />

Provost, S., 2402F<br />

Prucha, H., 86<br />

Prust, M., 2452T<br />

Przeworski, M., 285<br />

Przybylo, J., 1159T<br />

Psaty, B., 174, 349, 584W,<br />

1599T<br />

Psaty, B. M., 170, 1284T,<br />

1503T, 1585T, 2080T<br />

Psoni, S., 2937F<br />

Psychiatric Genomics<br />

Consortium, 2512T<br />

Psychiatric Genomics<br />

Consortium: ADHD<br />

Subgroup, 2515T<br />

Psychiatric GWAS<br />

Consortium, 2526W<br />

Psychiatric GWAS<br />

Consortium -<br />

Schizophrenia & Autism<br />

Working Group, 352<br />

Psychogios, A., 1682T*<br />

Ptacek, L. J., 2423F, 2581T,<br />

2667F, 2779W<br />

Pu, S., 1872F, 1873F<br />

Puck, J., 362<br />

Puckelwartz, M. J., 1614T,<br />

1683T*<br />

Puddu, A., 847F<br />

Puebla, A. M., 1077W,<br />

1111T, 1127F*, 1128W<br />

Puechberty, J., 857W, 936T,<br />

2386T, 2729T, 3121W,<br />

3166F<br />

Puel, A., 365<br />

Puel, J. L., 2685F<br />

Puente, X. S., 2578T<br />

Puffenberger, E. G., 1052F,<br />

2800W<br />

Puga, A. C., 773W<br />

Pugash, D., 3006T<br />

Puggal, M., 2247W<br />

Pugh, E., 1447F, 2098T,<br />

2556W<br />

Pugh, E. W., 46, 1452T*,<br />

1512T<br />

Pugh, T. J., 1754W<br />

Pugliese, A., 3600W<br />

Puglisi, M. A., 2235W<br />

Puig, A., 2940F<br />

Puig, O., 1252T<br />

Puig, S., 1053W<br />

Puig-Butille, J. A., 1053W<br />

Pulford, D., 630T<br />

Pulijaal, V., 3012T<br />

Pulit, S., 1585T<br />

Pulit, S. L., 1692T*<br />

Pullinger, C. R., 1694T<br />

Pulver, A., 2387F, 2461T,<br />

2486F<br />

Pulver, A. E., 2573F, 2576F<br />

Punaro, M., 2143T<br />

Pupacdi, B., 2918T, 3570W*<br />

Pupavac, M., 848F<br />

Puppala, S., 2339F<br />

Purcell, S., 280, 290, 1325W,<br />

1447F, 2487W, 2618F<br />

Purcell, S. M., 22, 2577W<br />

Purchase, T. R., 454W<br />

Purdie, C., 1082F<br />

Purdon, S., 2474F<br />

Purdue, M., 1012T, 1413T<br />

Purdue, M. P., 1091F<br />

Purdy, M., 3730W<br />

Purevdorj, I., 3248F<br />

Purevdorj, M., 3248F<br />

Puri, M., 3463T<br />

Puri, R., 1720W*, 2754F,<br />

3236F<br />

Purrazzella, J., 391<br />

Purser, S., 2474F<br />

Pursley, A., 952T<br />

Pursley, A. N., 898T<br />

Puschmann, A., 2438F<br />

Pussila, M., 982T<br />

SPEAKER AND AUTHOR INDEX


394 SPEAKER AND AUTHOR INDEX<br />

Putheti, P., 2260T<br />

Putonti, C., 591F<br />

Putoux, A., 3240F*<br />

Puts, D. A., 2223W<br />

Puttonen, S., 2462F<br />

Puura, K., 2383T<br />

Pyatt, R., 98<br />

Pyatt, R. E., 103, 456W, 912T<br />

Pyle, A., 751F*<br />

Pylkäs, K., 1099T<br />

Pyridoxine Dependent<br />

Epilepsy Consortium,<br />

756W<br />

Q<br />

Qaadri, K., 3571F*<br />

Qahar, Z., 2909T<br />

Qazi, A., 1093T<br />

Qi, L., 51, 1357F, 1954T,<br />

2123F, 2147F, 2354F,<br />

2360F*<br />

Qi, Q., 51, 1357F, 2354F*<br />

Qi, X., 3317W<br />

Qi, Y., 1772W<br />

Qi, Z., 963W<br />

Qiao, D., 1536T*<br />

Qiao, Y., 447F, 491F, 517F*<br />

Qiao, Y.-L., 1010F<br />

Qiao, Y. L., 1076F<br />

Qin, D. Q., 1723W<br />

Qin, H., 1404T*, 3572W*<br />

Qin, J., 3237W<br />

Qin, N., 1032W*<br />

Qin, P., 3334F*, 3394T<br />

Qin, S., 654T*<br />

Qin, W., 2407T<br />

Qin, X., 386<br />

Qin, Z., 1558F, 3265F<br />

Qing, G., 3378T<br />

Qiu, C., 1252T<br />

Qiu, F., 1295W<br />

Qiu, H., 2121W, 2546F,<br />

3573F*<br />

Qiu, K., 3553F<br />

Qiu, R., 74, 94<br />

Qiu, W., 536W<br />

Qiu, X., 1108T<br />

Q-MEGA and AMFS<br />

Investigators, 212<br />

Qoqandi, M. A., 1738W<br />

Qu, H., 5<br />

Qu, H. Q., 1915T, 2048F,<br />

2345F*<br />

Qu, K., 1198T<br />

Qu, L., 812F<br />

Qu, Y., 680T<br />

Quach, H., 1289W, 1301W*,<br />

1455T, 1924T, 3304F*,<br />

3454T<br />

Quaio, C. R. D. C., 2232W,<br />

3152F, 3160F*<br />

Quarles, J. M., 2189F<br />

Quartararo, J., 2810T<br />

Quattrone, A., 2763F, 2766F,<br />

2774T<br />

Quaye, L., 2138F*<br />

Quaynor, S., 2984T*<br />

Queiroz, L. S., 514W<br />

*Presenting Author<br />

Quentric, M., 2002T*<br />

Quertermous, T., 1624T<br />

Quesenberry, C., 96<br />

Quezado, M., 2786T<br />

Quh, H., 255<br />

Qui, H., 2229W<br />

Quiezi, R., 3072F<br />

Quillen, E. E., 2223W,<br />

2308T, 2589W, 2651F*<br />

Quindipan, C., 1721W*<br />

Quinlan, A., 12, 1971W<br />

Quinlan, A. R., 3632W<br />

Quinlan, J., 3260W<br />

Quinlan, P., 1082F<br />

Quinn, B., 161<br />

Quinn, E., 2283W, 2581T<br />

Quinn, J., 1274F, 2538W<br />

Quinn, J. F., 2421W, 2510F*<br />

Quintana, M. A., 1435F*<br />

Quintana-Murci, L., Session<br />

6, 3304F, 3368W, 3599F<br />

Quintero, F., 315<br />

Quintero-Rivera, F., 82*<br />

Quinti, I., 760W<br />

Quon, G., 3468T<br />

R<br />

Raabe-Meyer, G., 3111W<br />

Rabai, E., 2767W<br />

Rabban, J., 1059W<br />

Rabe, K., 1161W<br />

Rabès, J.-P., 1607T<br />

Rabiller, D., 3705F<br />

Rabin, K., 134<br />

Rabinowitz, M., 73, 3018T*<br />

Rabionet, R., 84, 2326T,<br />

2940F*<br />

Raby, B., 536W<br />

Rachel, R. A., 824F<br />

Racher, H., 3665F*<br />

Rachiglio, A. M., 1060T<br />

Racimo, F., 3274F*<br />

Racine, B., 1543F<br />

Raczy, C., 3663F<br />

Radecki, J., 3681F*<br />

Radek, A., 585F, 3718W<br />

Rademacher, K., 3496T<br />

Rademakers, R., 2639F<br />

Radfar, L., 529F, 2188T<br />

Radhakrishna, U., 2351F,<br />

2731W<br />

Radhakrishnan, A., 110<br />

Radice, P., 27<br />

Radom-Aizik, S., 3249W<br />

Radovich, M., 1098W<br />

Radwan, Z. H., 1673T*<br />

Raedler, A., 2368T<br />

Rafaels, N., 2043W<br />

Rafaels, N. M., 1900T*<br />

Rafati, S., 1949F<br />

Rafeeq, M., 2663T<br />

Raff, J., 3323W*<br />

Raffan, E., 45<br />

Raffel, L. J., 1916F<br />

Rafi, S. K., 2265W*<br />

Rafiq, M. A., 2398T*<br />

Ragge, N. K., 3161W*<br />

Raggio, C., 826F, 3128F<br />

Raghav, S., 415F<br />

Raghavendra, R., 1295W<br />

Raghuraman, S., 3433T<br />

Ragon, C., 2729T, 2792T<br />

Ragoussis, I., 3161W<br />

Ragoussis, J., 509F<br />

Rahi, J. S., 335<br />

Rahimian, G., 1143W, 1739W<br />

Rahimov, F., 2962W*<br />

Rahman, A., 1070F<br />

Rahman, N., 138, 213, 1211F<br />

Rahman, P., 154, 448W,<br />

454W, 1952F<br />

Rahman, R., 3661F<br />

Rahmioglu, N., 2077T*<br />

Rahmouni, K., 2671W<br />

Rahrmann, E., 1229F<br />

Rai, E., 1901F*, 2284T<br />

Raia, M., 1908W<br />

Raible, D. W., 3296W<br />

Raichel Jacob, R., 1044W<br />

Raijas, P., 2181W<br />

Raik, E., 932T<br />

Raiman, J., 3196F<br />

Raime, K., 1140W<br />

Raimo, S., 505F<br />

Rainwater, D. L., 3434T<br />

Raitakari, O., 656T, 1623T,<br />

2059T, 2097W, 2120F<br />

Raitakari, O. T., 2116T,<br />

2173T, 2366F<br />

Raivio, T., 2707W<br />

Raj, P., 1901F, 2284T<br />

Raj, S., 764W, 1287T*,<br />

1288F, 1294F, 1883F<br />

Raj, S. M., 357*<br />

Raj, T., 2250W*, 3310F<br />

Rajab, A., 1877F<br />

Rajadhyaksha, A., 1633T<br />

Rajagopalan, R., 1605T,<br />

3369T*<br />

Rajagopalan, R. R., 2443T<br />

Rajaraman, P., 1372F<br />

Rajasimha, H., 1774W<br />

Rajasimha, H. K., 2183F<br />

Rajbhandary, R., 344,<br />

1571W, 2498F, 2583W,<br />

2586W, 2637W<br />

Rajcan-Separovic, E., 491F,<br />

517F, 2977T<br />

Rajender, S., 1950W*<br />

Rajendram, R., 3456T<br />

Rajendran, S., 339<br />

Rajive, K., 29<br />

Rajkovic, A., 904T, 971W,<br />

993W, 1744W, 2042F<br />

Rajput, A., 346<br />

Rajput, A. H., 346<br />

Rajput, M. L., 346<br />

Rak, J., 1182W<br />

Rakovic, A., 204<br />

Ralph, P., 282*<br />

Ralston, J. D., 1828F<br />

Ramachandran, D., 1349W,<br />

2069F*, 2312F<br />

Ramachandran, S., 3361F,<br />

3370F*<br />

Ramachandran, V., 1584T<br />

Ramagopalan, S., 2015F<br />

Ramakrishnan, R., 3652W<br />

Ramallo, V., 3362W<br />

Ramanan, V., 2531F<br />

Ramanan, V. K., 2511W*<br />

Ramanathan, S., 3068F,<br />

3191W*<br />

Ramani, R., 3213W<br />

Ramasamy, A., 374, 564W*<br />

Ramaswami, G., 289,<br />

543F*, 577F<br />

Ramazi, S., 1421W*<br />

Ramazi, S. H., 892T<br />

Ramensky, V., 1480F, 2343W<br />

Ramesar, R., 762W<br />

Ramezani, M., 754W<br />

Ramirez, A. R., 647T<br />

Ramirez, C. T., 2467T*<br />

Ramirez, F., 81*, 767W,<br />

815F, 1698T<br />

Ramirez, J., 613T<br />

Ramirez, M., 2495F, 3669F<br />

Ramírez, R., 1127F<br />

Ramirez-Garcia, S. A.,<br />

3187W<br />

Ramirez-Solis, R., 105<br />

Ramke, J., 1305T<br />

Rammamoorthy, S., 261<br />

Rammensee, H. G., 1200W,<br />

1233W<br />

Rammohan, K. W., 2049W<br />

Ramocki, M. B., 229, 299,<br />

337<br />

Ramos, A., 1111T, 1127F,<br />

1128W*<br />

Ramos, E., 241*<br />

Ramos, E. M., 1566T,<br />

1964F*<br />

Ramos, E. S., 941W<br />

Ramos, F., 3019T<br />

Ramos, L., 3019T<br />

Ramos, P., 1186T*<br />

Ramos, P. S., 3371W*<br />

Ramos, S., 928T*<br />

Ramos, Y. F., 584W<br />

Rampersaud, E., 1681T,<br />

2185T<br />

Ramsay, E., 138, 1211F<br />

Ramsay, P., 1455T, 3454T<br />

Ramsay, P. P., 1289W,<br />

1301W<br />

Ramsey, S., 456W, 912T<br />

Ramsey-Goldman, R.,<br />

1979F, 2099F<br />

Ramsing, M., 3148F<br />

Ramsook, S. S., 9<br />

Ramu, A., 2982T<br />

Ramus, S., 139<br />

Ramus, S. J., 1156T*<br />

Ramzan, K., 2734W*,<br />

2743W<br />

Rana, S., 362<br />

Ranade, S., 3659F<br />

Ranatunga, D., 96, 230,<br />

2513F, 3342T<br />

Ranatunga, D. K., 118,<br />

2140T<br />

Ranchalis, J., 1605T<br />

Ranciaro, A., 3303T,<br />

3338W<br />

Randall, J., 108<br />

Randolph, L., 728T*


Raney, B., 3557F<br />

Rangel, C., 526W<br />

Rangel-Escareño, C.,<br />

1129T*, 3255T<br />

Rangrej, J., 1093T<br />

Rank, D., 477F<br />

Rankin, K. J., 2639F<br />

Rantapää-Dahlqvist, S.,<br />

461F<br />

Rantus, J. A., 2572T<br />

Ranum, L. P. W., 2645F<br />

Rao, A. R., 471F*<br />

Rao, D., 2063F<br />

Rao, J. U., 1220F<br />

Rao, K. P., 1234T<br />

Rao, K. R. S. S., 2351F<br />

Rao, M., 1456F*<br />

Rao, M. V., 2731W<br />

Rao, N., 873W<br />

Rao, P., 134<br />

Rao, P. N., 1029W<br />

Raouf, R., 1877F<br />

Raoul, O., 915W<br />

Rapoport, J., 433F, 2479T,<br />

2558F, 2584T<br />

Raposo, A., 2814F<br />

Raposo, J., 3019T<br />

Rappaport, E., 534W, 2904F<br />

Rappold, G., 2595W<br />

Rappold, G. A., 1612T*<br />

Rashkin, S., 641T<br />

Rasi, C., 434W<br />

Raska, P., 3409W*<br />

Raskin, S., 870T*, 2475W,<br />

2609F, 3055W<br />

Raskind, W., 2406W, 2432F<br />

Raskind, W. H., 2549F*<br />

Rasmussen, F., 2965W<br />

Rasmussen, M., 2965W,<br />

3148F*<br />

Rasmussen, S. A., 1867F<br />

Rasmussen-Torvik, L. J.,<br />

2116T<br />

Rasolonjatovo, I., 3694W<br />

Rasool, M., 2920W<br />

Rassenti, L., 395<br />

Rastetter, A., 2820F<br />

Ratain, M., 613T<br />

Ratan, A., 3545F<br />

Ratan, R., 2437T<br />

Ratbi, I., 708T<br />

Ratcliffe, P., 509F<br />

Rath, L., 1309F<br />

Rath, M., 532W*<br />

Rathkolb, B., 2922F<br />

Ratié, L., 2893W<br />

Ratjen, F., 142<br />

Ratnamala, U., 2351F,<br />

2731W<br />

Rattanasopha, S., 1944W<br />

Ratti, A., 2775F<br />

Rauch, A., 2356T, 2595W,<br />

3240F<br />

Rauch, F., 3169W<br />

Rauen, K., 99, 300, 3139W<br />

Rauen, K. A., 1274F, 3242F<br />

Rauhala, H., 1000T<br />

Rau-Murthy, R., 998F,<br />

999W, 1159T, 1841W<br />

Rauramaa, R., 1608T<br />

*Presenting Author<br />

Rautanen, A., 1948T,<br />

2157W*<br />

Rautenstrauss, B., 61,<br />

758W*<br />

Rava, R., 3021T<br />

Raval, R. P., 1130F*<br />

Raveendrababu, M., 2731W<br />

Raveendran, M., 595F*,<br />

2413T<br />

Ravi, H., 3669F<br />

Ravi, R., 3376F<br />

Ravichandran, A., 2328W<br />

Ravichandran, K., 861W<br />

Ravindran, P., 3574W*<br />

Ravnan, J. B., 884T, 3101W<br />

Ravnik-Glavač, M., 3422T<br />

Rawat, A., 3207W<br />

Ray, A., 1356T, 1393F*<br />

Ray, F. A., 948T*<br />

Ray, P. N., 2554T, 2905W<br />

Raychaudhuri, S., 1907F*,<br />

2047T, 2199W, 2210F,<br />

2250W<br />

Rayford, W., 1040F<br />

Raymond, D., 2801T<br />

Raymond, P., 843F<br />

Raymond, V., 1951T<br />

Rayner, N. W., 2044T, 3575F*<br />

Rayner, W., 3396T<br />

Raz, T., 3700W*<br />

Raz, V., 542W<br />

Raza, M. H., 1956W*, 1958F<br />

Razak, A., 1824F<br />

Razavi, F., 2770W<br />

Raznahan, A., 433F<br />

Razzaghian, H. R., 434W<br />

Real, F. X., 1091F<br />

Realini, T., 2154W, 2240F<br />

Reardon, W., 2925F<br />

Rebbeck, T., 283<br />

Rebbeck, T. R., 1003T,<br />

1307W<br />

Rebeiro, P., 2554T<br />

Rebelo, A., 2668W*<br />

Rebollo Mesa, I., 2082W<br />

Receveur, A., 3117W<br />

Rech, R., 2805F<br />

Recker, R. R., 3081W<br />

Reddel, R., 210<br />

Reddy, K., 2696T, 3059W*<br />

Reddy, M., 3717F<br />

Reddy, S. U., 3455T<br />

Rede Neurogenética, 2642F<br />

Redett, R. J., 1472W<br />

Redl, D., 2800W<br />

Redler, S., 106<br />

Redline, S., 2375F<br />

Reed, B., 3717F<br />

Reed, D., 2135F<br />

Reed, R., 784W<br />

Reed, X., 545F*<br />

Reeder, A., 1737W<br />

Rees, E., 1325W<br />

Rees, M. I., 262, 2821W*<br />

Reese, M., 3602W<br />

Reese, M. G., 195, 1770W<br />

Reeves, K., 2300F<br />

Reeves, R., 310<br />

Reeves, R. H., 1349W,<br />

2069F<br />

SPEAKER AND AUTHOR INDEX 395<br />

Regalado, E., 1789W*<br />

Regan, E. A., 2249F<br />

Regan, J., 3690W<br />

Regan, L., 3508T<br />

Regazzo, D., 2708T<br />

Regev, A., 322, 528W<br />

Register, T. C., 1661T<br />

REGISTRY Investigators <strong>of</strong><br />

EHDN, 2641T<br />

Regla-Nava, J. A., 2363F<br />

Rego, E. M., 1045T<br />

Rehermann, B., 1155W<br />

Rehm, H. L., Session 77,<br />

1677T, 1754W<br />

Rehnström, K., 252, 2344T*,<br />

2399F<br />

Rei, N., 1977W<br />

Reich, D., 178, 284, 333,<br />

350, 3347W, 3372T<br />

Reid, J., 349, 360, 1742W,<br />

2798T, 2880F, 2934F,<br />

3597F<br />

Reid, J. G., 314, 1592T,<br />

1735W, 1757W, 1761W,<br />

2883F, 3576W*<br />

Reid, K., 309<br />

Reid, K. P., 3267T<br />

Reid, M., 1906T, 2158T<br />

Reider, M. J., 171<br />

Reilly, E., 1860F<br />

Reilly, M., 1642T, 3551F<br />

Reilly, M. P., 115<br />

Reilly, P., 617T, 619T<br />

Reinateo, S., 100<br />

Reinders, M., 494W<br />

Reinders, M. J. T., 1436W<br />

Reindollar, R. H., 2732T<br />

Reiner, A. P., 170, 1408F,<br />

1437T, 1913F, 2063F,<br />

2131T, 2337W<br />

Reiner, G., 534W<br />

Reiner, J., 917W*<br />

Reinhard, C., 1369F<br />

Reinhard, C. R., 1235F<br />

Reinhart-Mercer, L., 3335W<br />

Reinholdt, L., 983F<br />

Reinier, F., 113, 157, 177,<br />

186, 547F, 1451W<br />

Reinmaa, E., 1284T, 1503T<br />

Reinscheidt, A., 3550W<br />

Reis, A., 154, 2160W*,<br />

2356T, 2557T, 2595W,<br />

2666T, 3235W<br />

Reis, G. S., 1902W*<br />

Reis, L. A. M., 514W<br />

Reis, L. M., 2903T*<br />

Reis, S., 1647T, 2083T<br />

Reish, O., 858T*<br />

Reisi, S., 2013W<br />

Reiss, J., 1869F<br />

Reiter, L. T., 3119W<br />

Reitz, C., 343*<br />

Rejto, P., 1369F<br />

Relton, C. L., 3419T, 3455T<br />

Rembowska, J., 1057T<br />

Remmers, C., 263<br />

Remmert, C. S., 313<br />

Ren, B., 3509T<br />

Ren, H., 1779W<br />

Ren, W., 3025T<br />

Renard, M., 128, 2225F<br />

Renaud, D. L., 718T*<br />

Renbaum, P., 2991T, 3002T<br />

Renda, Y., 54<br />

Rendeiro, P., 1778W<br />

Rendon, A., 110, 383<br />

Renieri, A., 2604W<br />

Renkema, K. Y., 2848W*<br />

Renkens, I., 217, 2886F<br />

Renkonen-Sinisalo, L.,<br />

1026W<br />

Rennard, S., 2249F<br />

Renner, S., 3153W<br />

Rennert, H., 3210F<br />

Rennert, O. M., 3506T<br />

Rensen, J. H. M., 102<br />

Renteria, M. E., 2054F*<br />

Renton, A. E., 2611T*, 2648F<br />

Renwick, A., 138, 1211F<br />

Repetto, G. M., 1658T*,<br />

2065T<br />

Repici, M., 2641T<br />

Repnikova, E. A., 103<br />

Repo, S., 499F<br />

Reppell, M., 3406T*<br />

Represa, A., 889W, 2674W<br />

Reprogen Consortium,<br />

2165F<br />

Requa, M., 3649F*<br />

Reshmi, S., 456W, 912T<br />

Ressler, K. J., 1422T, 2420F,<br />

2483F, 3480T<br />

Restagno, G., 2611T<br />

Restrepo, D., 835F<br />

Restrepo, N., 2041T*<br />

Retterer, K., 2579F<br />

Reuther, J., 1095W*<br />

REVEAL Study Group,<br />

1781W<br />

Reveille, J., 1291F<br />

Revilla, F., 2538W<br />

Rewers, M., 1330F<br />

Rex-Haffner, M., 2483F<br />

Reyes, A., 1022F<br />

Reyes-Carmona, S., 3504T<br />

Reyes-León, A., 1131W*,<br />

1141T<br />

Reyes-Romero, M. A.,<br />

1121F<br />

Reyhani, N., 982T<br />

Reymond, A., 299, 415F*,<br />

506W, 2458T, 3256F,<br />

3674W<br />

Reynolds, A., 463F<br />

Reynolds, J. M., 502W*<br />

Reynolds, R. J., 2047T*<br />

Rezaian, I., 3490T<br />

Reznik-Wolf, H., 53<br />

Rhead, B., 3557F<br />

Rhee, H., 1248W<br />

Rheumatoid Arthritis<br />

Consortium for<br />

Immunochip, 2231F<br />

Rhoda, C., 853F<br />

Rhodenizer, D., 1758W<br />

Rhodes, B., 2005T<br />

Rhodes, K., 1237T<br />

Rhodes, M., 3717F<br />

Rhodes, S., 2026T*,<br />

2538W<br />

SPEAKER AND AUTHOR INDEX


396 SPEAKER AND AUTHOR INDEX<br />

Rhodus, N., 2084F<br />

Rhodus, N. L., 529F, 2188T<br />

Rial-Sebbag, E., 1811W,<br />

1817W*<br />

Rianthavorn, P., 2006F<br />

Riazuddin, S., 1956W,<br />

2663T, 2724F, 2959W,<br />

3212F<br />

Riba, L., 2256W<br />

Ribas, A., 136<br />

Ribeiro, E. M., 2270F, 2642F<br />

Ribeiro, M. L., 1187F*,<br />

3502T<br />

Ribeiro, R. T., 167<br />

Ribeiro-Bicudo, L., 3072F*<br />

Ribeiro-dos-Santos, A.,<br />

3364F, 3402T<br />

Ribeiro-dos-Santos, A. K.,<br />

1629T<br />

Riboldi, G., 2775F<br />

Riboli, E., 987W<br />

Riby, J., 2055W, 3623F<br />

Ricceri, F., 1712T<br />

Ricci, E., 1776W<br />

Ricci, G., 1776W<br />

Riccio, A., 3496T<br />

Riccio Oliveira, R., 2043W<br />

Rice, G., 2452T<br />

Rice, J., 2114F<br />

Rice, J. P., 2170T<br />

Rice, K., 174, 2080T<br />

Rice, L., 741F<br />

Rich, S., 453F, 1408F, 1971W<br />

Rich, S. S., 117, 170, 1299T,<br />

1585T, 1662T, 2313W<br />

Rich, T., 1197W<br />

Richard, C., 714T, 801W<br />

Richard, G., 330, 332,<br />

1676T, 1765W, 2579F*<br />

Richard, P., 2436W<br />

Richard, S., 1212W<br />

Richards, A., 544W<br />

Richards, A. L., 370<br />

Richards, B., 1411F<br />

Richards, J., 391, 2135F<br />

Richards, J. B., 106, 109,<br />

277*, 649T, 1311T, 1595T<br />

Richards, J. E., 2154W,<br />

2240F, 2263T<br />

Richards, S., Session 3<br />

Richardson, A. S., 1467T<br />

Richardson, K., 2024F<br />

Richer, C., 394, 1207T,<br />

1215W<br />

Richieri-Costa, A., 2673F,<br />

2746W, 2863W, 3072F<br />

Richmond, R. C., 1583W*<br />

Richmond, S., 1528F<br />

Richmond, T., 3688W<br />

Richter, A., 1733W<br />

Richter, M. A., 612T<br />

Richter, S. J., 107<br />

Richter, U., 327<br />

Richterová, R., 2865F*<br />

Richtsmeier, J. T., 2151W<br />

Ricks-Santi, L., 1926W<br />

Rico, A., 1060T<br />

Rideout, A., 2480F, 3143W<br />

Rider, D., 1267T<br />

Rider, E., 196, 2389T, 3198F<br />

*Presenting Author<br />

Rider, L. G., 434W<br />

Ridge, P. G., 340<br />

Ridge, P. G., Jr., 3643F*<br />

Ridker, P. M., 51, 109, 609T,<br />

2056T<br />

Ried, J. S., 119, 190, 1308T,<br />

2076W, 2137T, 2226W*<br />

Rieder, C. R. M., 2424W,<br />

2626T<br />

Rieder, M. J., 530W*,<br />

1605T<br />

Riegel, M., 879W*<br />

Rieger, G., 1957T<br />

Riegert-Johnson, D. L.,<br />

1058F<br />

Riemenschneider, M.,<br />

3577F*<br />

Riemer, C., 3545F<br />

Riemersma, M., 214<br />

Riess, O., 1200W, 1233W,<br />

2595W<br />

Riethdorf, S., 1115F<br />

Riethmaier, D., 332<br />

Riethman, H., 861W<br />

Rieu, P. N., 83<br />

Riffaud, L., 3170F<br />

Riffault, A., 1062W<br />

Rijlaarsdam, M. A., 1122W<br />

Riley, B. P., 2500T, 2504F,<br />

2594F, 2599T<br />

Riley, G., 3582W, 3625F<br />

Riley-Gillis, B., 1252T*<br />

Rimm, E. B., 51<br />

Rimmer, A., 2939T<br />

Rimoin, D. L., 130<br />

Rinaldi, D., 2539T<br />

Rinckleb, A. E., 1080W<br />

Rincon-Sanchez, A. R.,<br />

3187W<br />

Rine, J., 75<br />

Rinella, E., 2078F*<br />

Ring, S., 1528F, 1567F,<br />

2081F<br />

Ring, S. M., 560W, 1318F,<br />

1583W, 1973F, 2010W,<br />

2169W<br />

Rinkel, G. J. E., 87<br />

Rinne, T. K., 955W<br />

Rio, M., 104*, 843F, 915W<br />

Rio Deiros, D., 595F<br />

Rion, J. R., 2260T<br />

Rioux, J., 3330T, 3401W<br />

Rioux, J. D., 1381F, 1678T,<br />

1982F, 2319W, 3382F<br />

Ripatti, S., 117, 119, 190,<br />

252, 656T, 1284T, 1308T,<br />

1503T, 1623T, 1709T,<br />

2076W, 2110T, 2137T,<br />

2173T, 2350T, 2399F<br />

Ripke, S., 352, 2487W,<br />

2509T, 2512T*, 2526W<br />

Rippey, C., 263*<br />

Ririe, M., 3189W<br />

Risacher, S. L., 2511W,<br />

2531F<br />

RISC Consortium, 3455T<br />

Risch, H., 1061F<br />

Risch, N., 7*, 96, 112, 118,<br />

230, 279, 421F, 620T,<br />

2140T, 3342T, 3383W<br />

Risch, R., 2513F<br />

Rischmueller, M., 2084F<br />

Riska, S. M., 986F<br />

Rissanen, A., 2256W<br />

Ristaldi, M. S., 2001W<br />

Ristoska-Bojkovska, N.,<br />

845F<br />

Ritchie, M., 1442W, 1602T,<br />

2041T, 2098T<br />

Ritchie, M. D., 226, 618T,<br />

625T, 1312F, 1316W,<br />

1447F*, 2042F, 2258F,<br />

2491T, 3542W, 3624W<br />

Ritchie, W., 1664T<br />

Ritter, D., 1221W<br />

Rittinger, O., 297<br />

Ritz, B., 2026T, 2538W<br />

Rivadeneira, F., 87, 109,<br />

584W, 1284T, 1334W,<br />

1503T, 2053T, 2081F,<br />

2105F, 2169W<br />

Rivard, L., 1678T<br />

Rivas, M., 176, 269, 1513F<br />

Rivas, M. A., 169, 173,<br />

567F, 582W*, 1948T,<br />

2319W, 2324F<br />

Rivera, I., 3315T<br />

Rivera, S., 770W<br />

Rivera-Luna, R., 1131W<br />

Riviello, J. J., 266<br />

Rivier, F., 3121W, 3166F<br />

Rivière, J. B., 124<br />

Rizzo, G., 71<br />

Rizzu, P., 98<br />

Roa, B., 1021T<br />

Roach, J. C., 195, 2643W<br />

Robb, L., 1678T<br />

Robbins, J., 2360F<br />

Robbins, J. A., 2145W<br />

Roberson, D., 3683F<br />

Roberts, A. E., 82<br />

Roberts, A. L., 2005T*<br />

Roberts, D., 3459T, 3669F,<br />

3709F<br />

Roberts, J., 3054F*, 3089W<br />

Roberts, J. M., 1884W<br />

Roberts, J. S., Session 9,<br />

317, 1781W, 1825W<br />

Roberts, K., 3644W<br />

Roberts, M. E., 1058F<br />

Roberts, R., 115<br />

Roberts, W., 175, 3086F,<br />

3456T<br />

Robertson, J., 549F<br />

Robertson, K. R., 2517W<br />

Robertson, M., 967W<br />

Robertson, N., 3575F<br />

Robertson, N. G., 862T<br />

Robertson, S., 3006T,<br />

3100F<br />

Robichaux, A., 3036F<br />

Robins, H., 530W<br />

Robinson, A., 3704W,<br />

3716W, 3731F, 3733F*<br />

Robinson, D., 3161W<br />

Robinson, J., 322, 2020T<br />

Robinson, P. C., 152<br />

Robinson, P. N., 298, 2725W<br />

Robinson, R., 385, 1305T<br />

Robinson, W., 3734W<br />

Robinson, W. P., 2977T,<br />

2986T, 3429T, 3445T<br />

Robson, C. D., 2928F<br />

Robson, M., 998F, 1159T,<br />

1275W, 1841W<br />

Robson, P. J., 1297F<br />

Robyr, D., 550W, 3431T<br />

Roca, A., 3254W<br />

Rocha, C. S., 514W, 2394W,<br />

2655W, 2876T, 3578W*<br />

Rocha, J., 2223W, 3318T<br />

Rocha, K. M., 3152F<br />

Rocha, R. M., 1217F<br />

Roche, O., 324, 390<br />

Rocke, D. M., 1625T<br />

Rockett, K., 2157W<br />

Rockwood, S., 983F*<br />

Roda, R. H., 2470T<br />

Roddy, T. P., 1605T<br />

Rodegher, M., 624T, 2095T<br />

Roden, D., 806F, 1602T,<br />

3622W<br />

Roden, D. M., 247, 618T,<br />

647T, 1312F, 1345F<br />

Roden, M., 275<br />

Rodenburg, R., 672T<br />

Rodgers, L., 2587T<br />

Rødningen, O., 3096F<br />

Rodolico, C., 1776W<br />

Rodrgio, A., 3326W<br />

Rodrigues, A. L., 2814F<br />

Rodrigues, M., 1119W,<br />

3562W<br />

Rodrigues, M. R., 3325F<br />

Rodrigues Jr., V., 1593T<br />

Rodrigues-Peres, R. M.,<br />

1033T*<br />

Rodriguez, A., 1048T,<br />

1049F*, 1432F, 2336F,<br />

2337W<br />

Rodriguez, D., 522W,<br />

3708W<br />

Rodriguez, E., 1939T,<br />

2226W<br />

Rodríguez, E., 1942T<br />

Rodriguez, M., 2495F,<br />

2660F<br />

Rodriguez, M. H., 3020T<br />

Rodriguez, S., 1626T,<br />

2427W<br />

Rodriguez, S. P., 926T<br />

Rodriguez de Alba Freiria,<br />

M., 1874F<br />

Rodriguez-Fernandez, I. A.,<br />

361<br />

Rodriguez-Flores, J. L.,<br />

2933T, 3380W, 3399W*<br />

Rodriguez-Florez, J. L.,<br />

3315T<br />

Rodriguez-Revenga, L.,<br />

2624F, 2630F*, 3217W<br />

Rodríguez-Santiago, B.,<br />

3208F*<br />

Rodriquez, C., 3290W<br />

Roe, A., 3022T<br />

Roe, D., 1087T<br />

Roe, G., 3557F<br />

Roeder, K., 268, 1433W,<br />

1520W, 2560T, 2577W<br />

Roelens, F., 423F


Roenspie, S., 2632T<br />

Roepman, R., 216<br />

Roethlisberger, B., 3044F<br />

Roetzer, K., 2570F<br />

Roewer, L., 3364F, 3402T*<br />

Rogaeva, E., 2428T<br />

Rogan, P. K., 3672W*<br />

Rogatto, S. R., 1217F<br />

Roger, J., 827F<br />

Roger, J. E., 830F*<br />

Rogério, F., 514W<br />

Rogers, C., 3185W<br />

Rogers, J., 595F, 2413T<br />

Rogers, K., 3150F<br />

Rogers, R. C., 2772F, 3052F<br />

Roh, S., 2117F<br />

Rohde, K., 1361W<br />

Rohena, L., 3046F<br />

ROHgen, 2366F<br />

Rohlfs, R. V., 182*, 1573F<br />

Rohrer, M. D., 529F, 2188T<br />

Rojas, J., 2365T<br />

Rojas, J. D., 2990T<br />

Rojas, M., 1851F<br />

Rojas, X., 3115W<br />

Rojas-Martínez, A., 1030T<br />

Rojas Martínez, J., 3077W*<br />

Rojo-Contreras, J., 2363F<br />

Rokas, A., 3275W<br />

Rolfs, A., 704T<br />

Rolinski, B., 782W<br />

Rollins, B., 2459F<br />

Roma, C., 1060T<br />

Roma, G., 1237T<br />

Romalho, A. S., 1731W<br />

Roman, S., 1237T<br />

Roman, T. S., 1627T*<br />

Romana, S., 915W<br />

Romanelli, V., 3499T<br />

Romano, A., 1949F*<br />

Romano, C., 100<br />

Romano, L., 401, 556W,<br />

561F<br />

Romano-Palumbo, L., 415F<br />

Romanos, J., 155, 1330F*<br />

Romano-Silva, M., 2385W*,<br />

2404T<br />

Romeo, M., 624T<br />

Romeo, S., 427F, 1271F*<br />

Romero, A., 3064F*<br />

Romero, F. E. P., 3039W<br />

Romero, J. A., 3708W*<br />

Romero, V., 2660F<br />

Romero-Gallo, J., 3388F<br />

Romigh, T., 1144T<br />

Romitti, P., 1564F<br />

Romitti, P. A., 2151W,<br />

3070F<br />

Romm, J., 1448W, 2114F,<br />

2139W*, 2170T, 3704W,<br />

3716W, 3733F<br />

Romm, J. M., 46, 1452T<br />

Rommens, J., 2953W<br />

Rommens, J. M., 1322W,<br />

1731W, 2905W<br />

Ronaghi, M., 596W, 1167W,<br />

3695F, 3710W<br />

Ronald, A., 3487T<br />

Roncarolo, M.-G.,<br />

Session 23<br />

*Presenting Author<br />

Ron El, R., 3002T<br />

Ronemus, M., 1600T, 2587T<br />

Ronen, R., 3307F*<br />

Roney, E., 63<br />

Rønning, V., 921W<br />

Ronninger, M., 1981T,<br />

2103W<br />

Ronowicz, A., 434W<br />

Rook, M. B., 217<br />

Roomere, H., 1140W<br />

Rooryck, C., 473F<br />

Roos, F., 3685F*, 3709F,<br />

3729F<br />

Root, H., 1050W*<br />

Rope, A. F., 3220F<br />

Ropers, H. H., 2732T<br />

Röpke, A., 2595W<br />

Rosa, F., 1153T, 1712T<br />

Rosa, R. L., 2220W<br />

Rosana, K. M., 2223W<br />

Rosand, J., 1689T<br />

Rosario, M., 979W, 1749W<br />

Rosati, G., 157<br />

Roscioli, T., 214*, 298,<br />

2151W, 3070F<br />

Rose, C., 2143T<br />

Rose, J., 2541W<br />

Rose, J. W., 2397W<br />

Rose, L., 2056T<br />

Rose, L. M., 51<br />

Rose, R., 2566T<br />

Rose, R. J., 2022W<br />

Rosembloom, A. L., 2706F<br />

Rosen, A., 1330F<br />

Rosen, B., 1061F<br />

Rosenbaum, H., 748T*,<br />

773W<br />

Rosenbaum, J., 2587T<br />

Rosenberg, C., 439F, 891W,<br />

903W, 919W, 961W<br />

Rosenberg, D. R., 3447T<br />

Rosenberg, N., 3357T<br />

Rosenberg, N. A., 1534F,<br />

3285T, 3351T<br />

Rosenberg, P., 1012T<br />

Rosenberg, P. S., 1378F<br />

Rosenberg, T., 363<br />

Rosenberg-Belmaker, L.,<br />

334<br />

Rosenblatt, D., 719F*<br />

Rosenblatt, D. S., 673F,<br />

705F, 706T, 848F<br />

Rosenbloom, B., 768W,<br />

769W<br />

Rosenbloom, K., 3612W<br />

Rosenfeld, J., 66, 68, 98,<br />

870T, 2979T<br />

Rosenfeld, J. A., 41, 103,<br />

274*, 805F, 884T, 902T,<br />

1818F*, 2395T, 3055W,<br />

3101W<br />

Rosenfeld, R. G., 2706F<br />

Rosenman, K. D., 1915T<br />

Rosenstein, B., 1309F<br />

Rosenstiel, P., 515F, 567F,<br />

582W, 2103W, 2303F<br />

Rosenthal, E., 1021T<br />

Rosenthal, E. A., 1605T*<br />

Rosenthal, J., 1783W<br />

Rosenthal, S. L., 2521T*<br />

SPEAKER AND AUTHOR INDEX 397<br />

Roses, A., 2465F<br />

Roses, A. D., 637T, 1382W<br />

Rosinski, J., 242<br />

Ross, A., 217<br />

Ross, J., 2525F<br />

Ross, J. W., 2717T<br />

Ross, L. H., 773W<br />

Ross, M., 1291F, 3694W<br />

Ross, T., 494W, 1244F<br />

Ross-Adams, H., 1011W<br />

Rossello, F., 1273T<br />

Rosser, T., 2069F<br />

Rossi, A., 943W, 3190F<br />

Rossi, C., 2786T<br />

Rossi, M., 124, 2399F*<br />

Rossier, E., 3109W<br />

Rossman, M., 1915T<br />

Rostı, R. O., 3195W<br />

Roter, A. H., 972T<br />

Roth, F. P., 2660F<br />

Roth, J., 924T<br />

Roth, L. A., 158<br />

Roth, M. P., 2126F, 3073W<br />

Rothhammer, F., 3327T<br />

Röthlisberger, B., 3109W<br />

Rothman, N., 1012T, 1091F,<br />

1092W<br />

Rothschild, C., 1796W<br />

Rothschild, H., 1081T,<br />

1454W<br />

Rothwell, P. M., 1313W<br />

Rotig, A., 72, 325, 329<br />

Rötig, A., 699F, 782W<br />

Rotimi, C., 241, 1515T,<br />

1886F, 1959W, 3533F<br />

Rottbauer, W., 86, 1612T<br />

Rotter, J., 350<br />

Rotter, J. I., 130, 1445W,<br />

1661T, 1662T, 1916F,<br />

2080T, 2153F, 2210F,<br />

2337W<br />

Rotunno, M., 30, 1218W,<br />

1517W, 2191T*<br />

Rouault, A., 473F<br />

Rouault, T. A., Session 10<br />

Roubertie, A., 2536T<br />

Roughley, P., 3169W<br />

Rouhani, F., 3507T<br />

Rouleau, C., 77<br />

Rouleau, E., 1062W,<br />

1212W*<br />

Rouleau, G., 1480F, 1670T,<br />

1898F, 2306F, 2338T,<br />

2816T, 3268F<br />

Rouleau, G. A., 2342F,<br />

2402F, 2558F, 2591F,<br />

2692W, 2790F, 3401W<br />

Roulstone, S., 2164T<br />

Roume, J., 56, 3129W<br />

Rousseau, F., 1840F<br />

Rousseau, M., 5<br />

Roux, A. F., 2947W*<br />

Roux, AF., 1874F<br />

Roux, K. J., 2914W<br />

Rovelet-Lecrux, A., 345<br />

Rovin, B., 458W<br />

Rowan, D., 786W<br />

Rowe, M., 2347T<br />

Rowell, S., 96<br />

Rowland, R. R. R., 2717T<br />

Rowley, S. M., 1224W<br />

Rowsey, R., 250*<br />

Roy, A., 314<br />

Royce, T., 942T, 3710W<br />

Roy-Gagnon, M.-H., 1478W<br />

Roze, V., 2770W<br />

Rozel, C., 3170F<br />

Rozell, B., 2427W<br />

Rozen, S., 2328W, 2889F<br />

Rozenzhak, S., 395<br />

Rozet, J., 390*<br />

Rozet, J.-M., 324<br />

Rozowsky, J., 551F<br />

Ruan, M. Z. C., 795W*<br />

Ruark, E., 138*, 1211F<br />

Ruau, D., 2230T<br />

Rubel, M. A., 3251W<br />

Rubens, C. E., 74, 94<br />

Rubenstein, J. L. R., 407<br />

Rubenstein, K., 2549F<br />

Rubenstein, L. M., 261<br />

Rubenstein, R., 2579F<br />

Rubicz, R., 1406W*<br />

Rubin, E. M., 4, 407<br />

Rubin, M. A., 1100F<br />

Rubini, M., 2002T<br />

Rubinstein, W., 3582W<br />

Rubinstein, W. S., 1762W*,<br />

3625F<br />

Ruchirawat, M., 3570W<br />

Ruczinksi, I., 350<br />

Ruczinski, I., 1076F, 1472W,<br />

1512T, 1558F, 1900T,<br />

2043W, 3609F*<br />

Rudaitis, V., 1208F<br />

Rudan, I., 1383T, 2366F<br />

Rudan, P., 1660T<br />

Rudd, D., 422W, 2493W*<br />

Rudd, M. K., 66, 338, 938T<br />

Ruden, M., 1009T, 2014T<br />

Rudenskaja, G., 2930T<br />

Ruderfer, D., 1325W<br />

Ruderfer, D. M., 2512T<br />

Rudge, S., 33<br />

Rudnev, D., 3582W<br />

Rudnicki, D. D., 2644T<br />

Rudser, K., 714T<br />

Rudy, G., 3579F*<br />

Rueda, L., 3490T<br />

Rueedi, R., 1281T*<br />

Ruef, B. J., 2725W<br />

Ruff, D., 1209W, 1246T,<br />

3278W, 3714W<br />

Ruffini, E., 1153T<br />

Ruggiero, L., 1776W<br />

Rugo, H., 1965W<br />

Ruhe, A. L., 2517W<br />

Ruigrok, Y. M., 87<br />

Ruivenkamp, C., 2701W,<br />

3650W<br />

Ruiz, N., 3121W<br />

Ruiz, R. G., 926T<br />

Ruíz-Flores, P., 1030T<br />

Ruiz-Linares, A., 1480F,<br />

3327T, 3360T, 3380W<br />

Ruiz-Ortiz, L., 2272T<br />

Ruiz-Pallares, N., 3166F<br />

Ruiz-Rodriguez, C. T.,<br />

3254W<br />

Rukova, B., 3477T*, 3481T<br />

SPEAKER AND AUTHOR INDEX


398 SPEAKER AND AUTHOR INDEX<br />

Rukova, B. B., 923W<br />

Rule, J., 3602W<br />

Rummel, S., 1002W, 1780W*<br />

Rump, A., 1236W, 2595W,<br />

3224F*<br />

Rundek, T., 1635T, 1638T<br />

Runyon, S., 2322W<br />

Runz, H., 1630T*<br />

Ruparel, K., 2514W<br />

Rupchock, A., 1786W*,<br />

1787W, 1853F<br />

Rupert, J. L., 1760W<br />

Rüschendorf, F., 2102F<br />

Russel, R., 1011W<br />

Russell, A., 1770W, 3602W*<br />

Russell, J. A., 1632T<br />

Russell, J. F., 2779W*<br />

Russell, M. B., 2804T<br />

Russell, M. L., 1186T<br />

Russin, J., 3415T<br />

Russo, A., 1153T, 1712T*<br />

Russo, A. D., 2424W, 2626T<br />

Rustin, P., 3241W<br />

Rusu, C., 124<br />

Rusyn, I., 368<br />

Ruth, B., 2904F, 3590W<br />

Rüther, U., 3524T<br />

Rutherford, N. J., 2639F<br />

Rutledge, D. N., 3408T<br />

Rutsch, F., 2759T*<br />

Rutschow, D., 645T<br />

Ruvolo, M., 975W*<br />

Ruzzo, E., 53<br />

Ruzzo, E. K., 203*, 2455T,<br />

2875W<br />

Ryan, A. W., 2160W, 2283W<br />

Ryan, C., 1856F<br />

Ryan, K., 602T<br />

Ryan, M., 2143T, 2742F<br />

Rybicki, B. A., 1250F, 1895F,<br />

2202W<br />

Ryckman, K., 1882T, 3537F<br />

Ryckman, K. K., 1344T*<br />

Ryder, E., 105<br />

Ryder, M., 1021T<br />

Rykiel, G., 240<br />

Rynes, E., 402<br />

Ryten, M., 374, 564W<br />

Rytkönen, K. M., 2462F<br />

Ryu, D., 3418T<br />

Ryu, E., 1351F*<br />

Ryu, H., 2437T, 3008T<br />

Ryu, M., 3461T<br />

Ryvkin, M., 1714T<br />

Rzadzinska, A. K., 1<br />

Rzhetskaya, M., 3323W<br />

S<br />

Sá, J., 1778W, 2755W, 3019T<br />

Sá, M. J. N., 3122F*<br />

Saad, A., 944T, 1751W,<br />

2744T<br />

Saada, N., 314, 1735W,<br />

1742W, 1757W, 1761W<br />

Saadi, A., 2808F<br />

Saadi, I., 2265W, 2670F<br />

Sääf, A., 1939T<br />

Saag, M., 3079W<br />

*Presenting Author<br />

Saal, H. M., 3194F<br />

Saarela, J., 2134T, 2350T,<br />

2888T<br />

Saavalainen, P., 2023T,<br />

2177F<br />

Saba, B., 1593T<br />

Sabatelli, M., 2611T<br />

Sabater-Lleal, M., 1651T<br />

Sabatti, C., 421F*, 431F,<br />

3342T, 3383W<br />

Sabbaghian, N., 1065W,<br />

1262F<br />

Saberi, A. H., 679F, 2714T<br />

Sabeti, P., Session 80<br />

Sabo, A., 3, 648T, 3597F<br />

Sabolic, V., 2777T<br />

Saboohi, S., 3083W<br />

Sabourin, J.-C., 32<br />

Sabova, L., 849F<br />

Sabrautzki, S., 2922F<br />

Sacaglia, F., 898T<br />

Sacco, R., 1638T<br />

Sacco, R. L., 1635T<br />

Saccone, N., 2114F, 2650T<br />

Saccone, N. L., 2170T<br />

Sacerdote, C., 1712T<br />

Sachs, N., 2848W<br />

Sacks, G., 2993T*<br />

Sacks, S., 1470T, 2260T<br />

Sacks, S. H., 2082W<br />

Sadan, S., 660T<br />

Sadasivam, M. N., 2988T<br />

Sadee, W., 609T<br />

Sadeghin, T., 239<br />

Sadeghpour, A., 3<br />

Sadetzki, S., 783W, 1303F<br />

Sadia, S., 2959W<br />

Sadighi Akha, E., 218,<br />

2939T<br />

Sadim, M., 1292W<br />

Sadler, B., 2650T*<br />

Sadler, M., 96<br />

Sadowski, H., 3649F<br />

Saeb, F., 2976T<br />

Saed, S., 2756T<br />

Saeed, S. R., 2302T<br />

Saenen, J., 1617T<br />

Saenz, M., 3133W<br />

Saez, M., 794W<br />

Safatle, H. P. N., 903W,<br />

961W<br />

Safavi, S., 1024T*<br />

Saffery, R., 3484T<br />

Saffrey, P., 366, 3663F<br />

Safina, N. P., 366<br />

Safra, N., 2778F<br />

Saggar, A., 1675T<br />

Saggar, A. K., 2896W<br />

Saghbini, M., 3649F<br />

Sagreiya, H., 646T<br />

Sahin, A., 2979T<br />

Sahin, F. I., 594W, 1013F,<br />

3003T, 3243W*, 3424T,<br />

3426T<br />

Sahlin, E., 3245W<br />

Sahoo, T., 876T<br />

Saiag, P., 1062W<br />

Sai Babu, M., 224<br />

Sailani, M. R., 84*, 3431T<br />

Sailani, S. R., 67<br />

Saillour, V., 31, 394, 1207T,<br />

1215W, 3268F<br />

Saini, S., 1890W, 2733F,<br />

2735T*<br />

Saip, A., 2098T<br />

Saip, S., 2450F<br />

Saisanit, C., 242<br />

Saisanit, S., 3580W*<br />

Saith, S., 2465F<br />

Saito, K., 2963T<br />

Saito, M., 2588F<br />

Saito, T., 3051W<br />

Saito, T. L., 2569T<br />

Saitoh, S., 2822T*, 3056F<br />

Saitsu, H., 1290T, 2822T,<br />

3136F*<br />

Saitta, S., 65*, 1721W,<br />

3038F<br />

Sajan, S., 2389T<br />

Saji, T., 1631T<br />

Sajuthi, S., 3371W<br />

Sakabe, J., 2911W<br />

Sakaguchi, M., 558W, 559F,<br />

598W, 599F<br />

Sakaguti, M., 548W<br />

Sakai, S., 2440T<br />

Sakamoto, L. H. T., 1202F<br />

Sakamoto, M., 1147T<br />

Sakiyama, Y., 2418W,<br />

2601W<br />

Sako, W., 52<br />

Sakoda, L., 230, 2513F<br />

Sakoda, L. C., 2140T*<br />

Sakowski, L., 2664F<br />

Sakurada, Y., 1980W<br />

Sakurai, Y., 663F<br />

Sala, A., 3364F, 3402T<br />

Sala, N., 987W<br />

Salako, B., 1959W<br />

Salam, M. T., 2168F<br />

Salama, M., 3637F<br />

Salama, M. E., 3297T<br />

Salamanca-Gomez, F. A.,<br />

1168T<br />

Salari, K., Session 28<br />

Salarini, D. Z., 2642F<br />

Salas, C., 872T, 1141T,<br />

3040F*<br />

Salas, E., 1111T, 1127F,<br />

1128W<br />

Salas-Labadía, C., 1131W<br />

Salazar, A. M., 1049F<br />

Salazar, D., 712T<br />

Salazar-Dávalos, I. M.,<br />

3187W, 3188F<br />

Salazar-Páramo, M., 2363F<br />

Salazar-Riojas, R., 1030T<br />

Salbert, B. A., 1759W<br />

Sale, M., 178, 1971W<br />

Sale, M. M., 123, 1662T,<br />

3371W<br />

Saleh, M., 649T<br />

Saleheen, D., 115<br />

Saleh-Gohari, N., 2787F,<br />

2832F<br />

Salehi, Z., 3083W<br />

Salehi-Ashtiani, K., 2660F<br />

Salehzade, F., 2856F<br />

Salek, R., 1281T<br />

Salem, R. M., 23*, 2307W<br />

Salem, S., 2971T<br />

Salerno, B., 2078F<br />

Saletore, Y., 376<br />

Salgado, M., 1977W<br />

Salhi, A., 129, 1949F<br />

Salhi, H., 77<br />

Salhi, N., 1268F<br />

Salhi, S., 325*<br />

Salido, E., 981W<br />

Salie, M., 2217W*<br />

Salifoglu, H., 590W*<br />

Saligan, L., 3485T<br />

Salih, M., 324, 2997T<br />

Salimzadeh, L., 1143W,<br />

1739W*<br />

Salit, J., 2933T, 3399W<br />

Salit, M., 3647F<br />

Sallinen, S.-L., 992F<br />

Salloum, A., 3349F<br />

Salo, P., 1253F*, 2175W<br />

Salomaa, V., 656T, 1709T,<br />

1835W, 2110T, 2116T,<br />

2132F, 2173T, 2462F<br />

Salomão, H., 870T, 2289W*,<br />

3055W<br />

Salomons, G. S., 681F<br />

Salonen, R., 897W<br />

Salonga, E. G., 2975T<br />

Salvarinova, R., 750T<br />

Salvatore, J. E., 2022W<br />

Salvetat, N., 2685F<br />

Salviati, L., 2909T<br />

Salvoro, C., 1732W<br />

Sam, M., 1256F<br />

Samango-Sprouse, C., 239*<br />

Samani, N. J., 115, 1659T,<br />

2035T, 2175W, 3453T<br />

Samarov, D., 3647F<br />

Sambrook, J. G., 1604T<br />

Sambyal, V., 1703T<br />

Sammeth, M., 567F, 582W<br />

Samocha, K. E., 1523W*<br />

Samonigg, H., 1115F<br />

Sampaio, M., 1593T<br />

Sampath, P., 2312F<br />

Sample, M., 3622W<br />

Sampson, B., 1591T<br />

Sampson, J., 1160F, 1306F<br />

Sampson, K., 2411F<br />

Sampson, M. G., 845F,<br />

3405W*<br />

Samuel, J., 978T<br />

Samuels, D. C., 72, 3275W<br />

Samuels, M. E., 2790F<br />

Samuels, M.-E., 2692W,<br />

2945T<br />

Sanabria, D., 3225W<br />

Sanada, H., 245<br />

Sanapareddy, N., 242<br />

Sanchez, G., 2311T<br />

Sanchez, R. L., 3175W*<br />

Sanchez, S., 956T, 2055W<br />

Sánchez, S., 875W, 960T*,<br />

976T<br />

Sánchez-García, F., 2296T<br />

Sanchez-Huerta, E., 3311W<br />

Sanchez-Lara, P. A., 300,<br />

2151W<br />

Sánchez-López, J. Y.,<br />

2363F


Sánchez-Machín, I., 2296T<br />

Sánchez-Palacios, A., 2296T<br />

Sand, S. R., 1071W<br />

Sanders, A., 3373F<br />

Sanders, A. R., 1282F,<br />

1957T*, 2576F<br />

Sanders, D. N., 2805F<br />

Sanders, J. L., 1920W*,<br />

2040W<br />

Sanders, S., 13, 553F,<br />

1433W, 2605T<br />

Sanders, S. J., 2478W<br />

Sanders, T. N., 1822F<br />

Sandford, A. J., 1465F<br />

Sandford, R. N., 153<br />

Sandholm, N., 2307W<br />

Sandholt, C. H., 2317T,<br />

2347T<br />

Sandhu, M., 117<br />

Sandhu, M. S., 1507F<br />

Sandi, C., 761W*<br />

Sandi, M., 761W<br />

Sandin, S., 1707T<br />

Sandling, J. K., 44, 3441T<br />

Sandmann, H., 3528W<br />

Sandoval, K., 3380W<br />

Sandoval, L., 682T<br />

Sandoval Mendoza, K.,<br />

2033F<br />

Sandstrom, R., 255<br />

Sandulache, V., 1120T<br />

Sanger, W. G., 968T<br />

Sanghera, D., 474W<br />

Sanghera, D. K., 1933T<br />

Sanghi, D., 764W, 1287T,<br />

1288F, 1294F*, 1883F<br />

Sangkuhl, K., 633T, 635T<br />

Sanguansermsri, S., 3319F<br />

Sanidad, M. A., 945W<br />

Sankararaman, S., 3372T*,<br />

3407W<br />

Sanlaville, D., 944T, 3117W<br />

San Luciano, M., 2801T<br />

San Martin, W. B., 926T<br />

Sanna, S., Session 27, 110,<br />

113, 157, 177, 186, 547F,<br />

1391W, 1451W, 1516F,<br />

2001W, 2198F, 2329T,<br />

3664W<br />

Sanna-Cherchi, S., 845F*<br />

San Nicolas, H., 2627F<br />

Sansbury, F. H., 2704W*<br />

Sanseau, P., 649T<br />

Santago, Y., 255<br />

Santana, J., 2300F<br />

Santangelo, S., 352<br />

Santani, A. B., 2904F*<br />

Santaniello, A., 2113T<br />

Sante, T., 423F<br />

Santen, G. W. E., 55<br />

Santiago, K. M., 1217F<br />

Santibanez, J., 2934F<br />

Santibanez-Koref, M., 751F<br />

Santillan, D. A., 74, 94<br />

Santillan, M. K., 74, 94<br />

Santoni, F., 84, 85, 2877F,<br />

2937F, 3431T<br />

Santoro, F., 1949F<br />

Santoro, L., 1776W<br />

Santoro, M., 2464T*<br />

*Presenting Author<br />

Santoro, M. L., 2533T,<br />

2534F<br />

Santoro, S., 1847W*<br />

Santos, D., 2736F*<br />

Santos, E. J. M., 3292F<br />

Santos, F., 3377W<br />

Santos, J., 492W<br />

Santos, J. C., 1187F, 3502T*<br />

Santos, L. C., 1132T*<br />

Santos, M. M., 2085W<br />

Santos, M. N. N., 2718F<br />

Santos, N., 3364F, 3402T<br />

Santos, P. A. C., 961W*<br />

Santos, P. C. J. L., 636T*<br />

Santos, R., 2417F, 2631W,<br />

3362W<br />

Santos, R. O., 2394W*<br />

Santos, S., 2642F, 3364F,<br />

3402T<br />

Santos, S. A., 941W<br />

Santos, S. C. L., 2596T*<br />

Santos, S. E., 1629T<br />

Santos da Cunha, B., 131<br />

Santos Filho, A. F., 2534F<br />

Sapkota, Y., 1297F*<br />

Sapp, J. C., 33, 674T<br />

Saraceni, C., 2915T<br />

Saraga, M., 845F<br />

Saraidaridis, J., 3703F<br />

Saraiva, J., 2755W, 3019T*<br />

Saraiva-Pereira, M. L.,<br />

2424W, 2626T, 2642F<br />

Sarantaus, L., 982T<br />

Sarasin, A., 1496W<br />

Saraswathy, R., 929W*<br />

Sarca, G. J., 2954T<br />

Sarda, P., 857W, 936T,<br />

2386T*, 2729T, 3047W,<br />

3121W, 3166F<br />

SardiNIA Project, 3664W<br />

Sargan, D. R., 1105T<br />

Sariadaridis, J., 3656W<br />

Sarian, L. O. Z., 1033T<br />

Sarin, A., 1308T<br />

Sarin, A.-P., 119, 2076W,<br />

2137T, 2173T<br />

Sarkar Roy, N., 3343F<br />

Sarmady, M., 2904F<br />

Sarmiento, M., 951W<br />

Sarnowski, C., 1361W*,<br />

2079W<br />

Sarrel, K., 998F, 999W,<br />

1159T<br />

Sarroza, D., 1759W<br />

Sarto, E., 2764W, 2781F<br />

Sarto, G. E., 2020T<br />

Sartor, M. A., 34<br />

Sartor, O., 1040F<br />

Sarukhanov, A., 838F,<br />

2857W<br />

Sasada, T., 2380T<br />

Sasago, K., 1631T<br />

Sasaki, H., 2697F<br />

Sasaki, M., 1697T<br />

Sasaki, R., 1730W, 2559W<br />

Sasaki, T., 2370W, 2496W,<br />

2652W, 2911W<br />

Sasarman, F., 2771T<br />

Sasikala, K., 1044W<br />

Sasner, M., 983F<br />

SPEAKER AND AUTHOR INDEX 399<br />

Sass, J. O., 737F<br />

Sassi, C., 2611T<br />

Sasson, A., 2904F<br />

Satake, W., 2619W*<br />

Sathanoori, M., 904T<br />

Sato, D., 2575T, 2620T<br />

Sato, M., 1830F<br />

Sato, N., 2371T, 2507F<br />

Sato, R., 2129F<br />

Sato, Y., 1631T, 1722W*,<br />

3337F*<br />

Satoh, F., 1321F<br />

Satta, S., 2001W<br />

Sattar, N., 1626T<br />

Satten, G. A., 1349W*<br />

Satterthwaite, T., 2514W<br />

Saugier-Veber, P., 3117W<br />

Saunders, A. M., 637T<br />

Saunders, C. J., 366*,<br />

2793F, 2894T<br />

Saunders, E., 205, 1011W,<br />

1109F<br />

Saunders, P., 1729W,<br />

3680W<br />

Saunders, P. C., 3640W<br />

Saunders-Pullman, R.,<br />

2801T<br />

Saunier, S., 324, 403<br />

Saute, J., 2609F<br />

Saute, J. A., 2626T*<br />

Saute, J. A. M., 2424W<br />

Sauthier, P., 2842W<br />

Savad, S., 1169F, 2987T<br />

Savage, D. B., 33, 45<br />

Savage, M., 3018T<br />

Savage, S. A., 1064F, 1196F*<br />

Savage, S. K., 1799W,<br />

1836F, 1843W*<br />

Saville, B., 247<br />

Savio, A., 3478T*<br />

Savitzki, D., 199<br />

Saw, S. M., 2094W<br />

Saw, W. Y., 3284W*<br />

Sawa, A., 2458T, 2461T<br />

Sawada, T., 1984T<br />

Sawai, H., 2130W<br />

Sawyer, S. L., 3141W*<br />

Saxena, A., 2353T<br />

Saxena, R., 1720W, 1988F<br />

Saydam, G., 1164W, 1178F<br />

Sayer, J. A., 2676F<br />

Saykin, A. J., 2511W, 2531F<br />

Sbardellati, A., 823F<br />

Sboner, A., 2444F<br />

Scafe, C., 3670W, 3717F<br />

Scaglia, F., 163, 759W,<br />

2942T<br />

Scaletsky, I. C. A., 1187F<br />

Scalf, M., 1269W<br />

Scambler, P., 216<br />

Scambler, P. J., 2955F<br />

Scanlan, N. L., 1138T<br />

Scaparo, R. M., 941W<br />

Scarano, G., 3129W<br />

Scaroni, C., 2708T<br />

Scarpini, E., 2095T<br />

Scarselli, G., 3114F<br />

Scelo, G., 1012T<br />

Schaaf, C., 759W<br />

Schaaf, C. P., 2403W<br />

Schaafsma, G. C. P., 3611F<br />

Schaarschmidt, H., 2102F<br />

Schachar, R. J., 2499W<br />

Schacherer, C., 1291F<br />

Schackert, G., 1236W<br />

Schadt, E., 583F, 1621T,<br />

3724W<br />

Schadt, E. E., 1624T,<br />

2220W<br />

Schaefer, A. S., 2058W*<br />

Schaefer, C., 96*, 112, 118,<br />

230, 421F, 620T, 1289W,<br />

1301W, 1414F, 1455T,<br />

2140T, 2513F, 3342T,<br />

3383W<br />

Schaefer, E., 2887W<br />

Schaefer, M., 36<br />

Schaeffer, P., 2642F<br />

Schafer, C. M., 268*<br />

Schäfer, Z., 86<br />

Schaffer, A. A., 1958F*<br />

Schaffer, L. G., 805F<br />

Schaibley, V. M., 476W*<br />

Schaid, D., 28, 1001F,<br />

1214F<br />

Schaid, D. J., 986F, 1449T*,<br />

1497T, 3564W<br />

Schalkwyk, L., 3471T,<br />

3476T<br />

Schalkwyk, L. C., 3487T<br />

Schanen, N. C., 2783T,<br />

3119W<br />

Schanze, I., 2666T<br />

Schara, U., 2681T<br />

Scharer, C., 3310F<br />

Scharer, G., 451F*<br />

Scharer, G. H., 2884W<br />

Scharer, O. D., 2696T<br />

Scharf, J., 1480F<br />

Scharfe, C., 3691F<br />

Scharpf, R. B., 3609F<br />

Scharschmidt, B., 662T<br />

Scharschmidt, B. F., 774W<br />

Schatz, M. C., 2587T<br />

Schaub, F. X., 1162T<br />

Schauer, S., 1236W<br />

Schaumberg, D., 385<br />

Schaumberg, D. A., 1305T<br />

Schawb, M., 3362W<br />

Schecter, S. C., 816F*<br />

Scheel, M., 314, 1735W,<br />

1742W, 1757W, 1761W<br />

Scheet, P., 1041W*, 1258T,<br />

1542T<br />

Scheetz, T. E., 60<br />

Scheffer, H., 97, 243, 621T,<br />

1734W, 1749W<br />

Scheffer, I. E., 203, 2741T,<br />

2897T, 3228F<br />

Schein, J., 375<br />

Scheinfeldt, L., 3338W<br />

Scheinfeldt, L. B., 3303T*<br />

Scheinhardt, M. O., 1669T<br />

Schekman, R., Session 26<br />

Schell, M., 86<br />

Schellenberg, G., 343,<br />

1476T, 1520W, 1571W,<br />

2498F<br />

Schellenberg, G. D., 342,<br />

344, 2316W, 2577W<br />

SPEAKER AND AUTHOR INDEX


400 SPEAKER AND AUTHOR INDEX<br />

Schenck, A., 2595W, 2666T<br />

Schendel, D., 463F<br />

Schepers, D., 79, 80<br />

Scherag, A., 108, 2090F<br />

Scherer, S., 98, 1688T,<br />

2525F<br />

Scherer, S. E., 60, 244<br />

Scherer, S. W., 175, 460W,<br />

2570F, 2575T, 2617T,<br />

2620T, 2932W, 3086F,<br />

3095W, 3456T<br />

Scheuerle, A., 1761W<br />

Schiettecatte, F., 227<br />

Schieve, L., 463F<br />

Schiffman, J., 2982T<br />

Schiffman, R., 2786T<br />

Schiffmann, R., 772W,<br />

1684T*<br />

Schildkraut, J., 1061F<br />

Schildkraut, J. M., 1156T<br />

Schilhabel, M., 3224F<br />

Schillert, A., 200, 275,<br />

1443T, 1669T<br />

Schimpf-Linzenbold, S.,<br />

3126F<br />

Schindeler, K., 3143W<br />

Schlagenhauf, U., 2058W<br />

Schlegel, P. N., 2982T<br />

Schlesinger, D., 919W,<br />

1727W<br />

Schlessinger, D., 113, 177,<br />

276, 547F, 847F, 1391W,<br />

1516F, 2001W, 2198F<br />

Schleutker, J., 28, 992F,<br />

995F, 997T, 1000T,<br />

1001F, 1006T, 1214F,<br />

1302T<br />

Schliekelman, P., 2206T*<br />

Schlitt, T., 1470T, 2804T<br />

Schl<strong>of</strong>f, D., 885W<br />

Schmahmann, J. D., 326<br />

Schmid, B., 2103W<br />

Schmidlen, T. J., 632T<br />

Schmidt, A., 200<br />

Schmidt, B., 1965W<br />

Schmidt, C., 2135F<br />

Schmidt, E., 2427W<br />

Schmidt, E. M., 117<br />

Schmidt, J., 493F*, 1582F,<br />

2786T<br />

Schmidt, J. L., 2452T*<br />

Schmidt, M., 1544W*,<br />

2614T<br />

Schmidt, M. A., 9<br />

Schmidt, M. K., 206, 1117T,<br />

1150T<br />

Schmidtke, J., 1763W*,<br />

1868F, 1877F<br />

Schmidts, M., 216*, 809F<br />

Schmitt, B., 675F<br />

Schmitt, C. A., 2222F*<br />

Schmitt, C. P., 231<br />

Schmitz, C., 3449T<br />

Schmitz, K., 2811F, 3219W<br />

Schmitz-Abe, K., 8<br />

Schmitz-Abe, K. E., 452W*<br />

Schnabel, R. B., 1669T<br />

Schnabel, R. D., 2847F<br />

Schned, A., 1091F<br />

Schned, A. R., 1092W<br />

*Presenting Author<br />

Schneider, A., 770W, 810F,<br />

857W, 936T, 2386T,<br />

3004T, 3121W, 3166F,<br />

3179W*<br />

Schneider, B., 1098W<br />

Schneider, B. G., 3388F<br />

Schneider, E., 3266W<br />

Schneider, J. A., 3417T,<br />

3450T<br />

Schneider, K. U., 1612T<br />

Schneider, S., 1119W<br />

Schneider, V., 464W<br />

Schneiderat, P., 2961F<br />

Schnetz-Boutaud, N., 15,<br />

1286W, 1316W, 1377T,<br />

1671T, 1713T<br />

Schnizel, A., 3240F<br />

Schnutgen, F., 825F<br />

Schoenberger, J., 1021T<br />

Schoenmaker, N., 2701W<br />

Schoenwolf, G. C., 828F<br />

Sch<strong>of</strong>ield, P., 198<br />

Schonberg, S., 953W<br />

Schoolcraft, W. B., 851F,<br />

2968T<br />

Schoonderwoerd, K., 708T<br />

Schorderet, D. F., 854F<br />

Schork, N. J., 24, 146,<br />

1319W, 1839W, 2274W,<br />

3332W<br />

Schormair, B., 2567F*,<br />

2568W<br />

Schorn, M., 3717F<br />

Schorry, E., 3177W*<br />

Schoser, B., 2944W<br />

Schoumans, J., 1035W<br />

Schrader, B. J., 1714T<br />

Schrader, K., 999W, 1841W<br />

Schrader, K. A., 998F*, 1159T<br />

Schraders, M., 58, 214<br />

Schrauwen, I., 59*, 2104T<br />

Schreiber, E., 3684W<br />

Schreiber, S., 200, 515F,<br />

567F, 580W, 582W,<br />

1942T, 1943F, 2058W,<br />

2103W, 2295W, 2303F,<br />

2314T, 2315F, 2368T<br />

Schreml, J., 236, 3214F*<br />

Schrock, E., 1236W*, 3224F<br />

Schrodi, S., 2297F, 3287W,<br />

3326W<br />

Schroeder, C., 1200W,<br />

1233W*<br />

Schroeder, D., 3479T*<br />

Schroeder, J., 3671F<br />

Schroer, R. J., 2826F<br />

Schroyer, R., 745F<br />

Schu, M., 385, 2563T<br />

Schubert, C. R., 2613W,<br />

2928F<br />

Schuberth, C., 1630T<br />

Schuck, R. N., 606T<br />

Schuckit, M., 2582F<br />

Schuele, B., 803W*<br />

Schuemann, B., 622T<br />

Schuh, A., 133<br />

Schuh, A. F. S., 2424W,<br />

2626T<br />

Schüle, R., 2820F, 2930T<br />

Schülke, M., 699F<br />

Schuller-Faccini, L., 3031T<br />

Schully, S. D., 1845W<br />

Schulte, E. C., 2568W*<br />

Schulte-Körne, G., 1976F<br />

Schultz, E. S., 2167T<br />

Schultz, K., 1589T<br />

Schultz, K. A., 132<br />

Schultz, R. A., 3101W<br />

Schultze, J., 2416T<br />

Schulz, B., 129<br />

Schulze, A., 675F<br />

Schumacher, F., 205, 213<br />

Schumacher, F. R., 1148F<br />

Schumacher, J., 1976F,<br />

2088W, 2557T<br />

Schuman, J. S., 2154W,<br />

2240F, 2263T<br />

Schunkert, H., 115, 3453T<br />

Schupf, N., 859W, 1920W<br />

Schurmann, C., 275, 1284T,<br />

2141F*<br />

Schürmann, M., 2103W<br />

Schürmann, P., 1117T<br />

Schurr, E., 1374T, 2003F<br />

Schurr, T., 3373F*<br />

Schurr, T. G., 3329W, 3377W<br />

Schuurs-Hoeijmakers, J. H.<br />

M., 100, 160, 672T<br />

Schwab, R. B., 1051T<br />

Schwab, S. G., 2407T<br />

Schwaderer, A., 458W<br />

Schwartz, A. G., 1454W<br />

Schwartz, C., 2566T,<br />

2806W, 3196F<br />

Schwartz, C. M., 3185W<br />

Schwartz, D. A., 3466T<br />

Schwartz, I. V. D., 696T<br />

Schwartz, J., 3469T<br />

Schwartz, P. J., 86<br />

Schwartz, R., 839F, 3376F<br />

Schwartz, S., 103, 949W*<br />

Schwartz, S. G., 2028W,<br />

2318F<br />

Schwartz, S. M., 213<br />

Schwartz, T., 1239W<br />

Schwartzentruber, J.,<br />

160, 198, 701F, 2790F,<br />

2794W<br />

Schwarz, E., 686T<br />

Schwarzacher, T., 449F<br />

Schwarze, U., 1759W<br />

Schwarzmayr, T., 2595W<br />

Schwei, T., 3671F<br />

Schweiger, M., 3224F<br />

Schwender, H., 1335T*,<br />

1430W, 1472W, 3609F<br />

Schwenk, W. F., 718T<br />

Schwenn, M., 1091F,<br />

1092W<br />

Scionti, I., 1776W*<br />

Sciortino, S., 96, 112, 118,<br />

230*, 620T, 2140T, 2513F<br />

Sciurba, F. C., 129<br />

Scliar, M., 3325F<br />

Sc<strong>of</strong>ield, R. H., 529F, 1979F,<br />

2084F, 2188T<br />

Scolari, F., 845F<br />

Scollen, S., 503F, 2804T<br />

Scollon, S., 1798F*<br />

Scotet, V., 1728W<br />

Scott, A., 2325W<br />

Scott, A. F., 79, 1254W*,<br />

1472W, 1512T, 3609F<br />

Scott, C. E., 33<br />

Scott, C. R., 668T, 727F*,<br />

3281W<br />

Scott, D., 389, 432W<br />

Scott, D. A., 834F*, 839F,<br />

840F, 2678T<br />

Scott, H., 2685F<br />

Scott, J., 2974T<br />

Scott, J. A., 2157W<br />

Scott, J. K., 375<br />

Scott, J. N., 2800W<br />

Scott, K., 2135F<br />

Scott, L. J., 34, 46, 1389T<br />

Scott, M., 1566T<br />

Scott, R., 1686T, 2755W<br />

Scott, R. H., 1773W<br />

Scott, R. J., 916T, 2133W<br />

Scott, R. T., 2968T<br />

Scott, R. T., Jr., 2999T<br />

Scott, S. A., 652T, 958T,<br />

1777W, 3488T<br />

Scott, W., 489F, 492W<br />

Scott, W. K., Session 27,<br />

347, 1489F, 2028W,<br />

2318F*, 2378F, 2603F,<br />

3335W<br />

Scrivner, S., 3133W<br />

Scurr, I. J., 217<br />

Scutti, A., 2300F*<br />

Seal, R., 3651F<br />

Seal, S., 138, 1211F<br />

Sealy, I., 37<br />

Searby, C. C., 323, 404,<br />

2215T, 2671W<br />

Searle, S. M. J., 506W<br />

Sebat, J., 480W, 2576F,<br />

2660F<br />

Sebert, S., 1432F, 2162F<br />

Sebire, G., 2790F<br />

Sebire, N. J., 303<br />

Sebro, R., 279*<br />

Secolin, R., 514W, 2394W,<br />

2876T<br />

Sedaghati Khayat, B.,<br />

1961F, 1962W, 2964F<br />

Sedaka, N. M., 2702T<br />

Sedel, F., 684T<br />

Sedova, M., 3717F<br />

Seebohm, G., 86<br />

Seeley, A. H., 313*<br />

Seeman, P., 2745F<br />

Sefiani, A., 708T, 2937F,<br />

3246F<br />

Segal, B., 2084F<br />

Segal, B. M., 529F, 2188T<br />

Segal, D. J., 1625T*<br />

Segal, H., 1313W<br />

Segal, M., 589F<br />

Segal, M. M., 3581F*<br />

Segel, R., 2447F*<br />

Segers, P., 2225F<br />

Segone, A. M., 1085F<br />

Segref, A., 105<br />

Segura-Puimedón, M.,<br />

3084F<br />

Segurel, L., 285*<br />

Sehar, N., 2075F


Sehmi, J., 110<br />

Sehnert, A., 3021T<br />

Sehrawat, B. S., 1297F<br />

Seibler, P., 204<br />

Seidman, C., 1677T<br />

Seidman, J. G., 1677T<br />

Seifert, D., 3266W<br />

Seifert, M., 822F, 827F,<br />

3536W<br />

Seik Soon, K., 2496W<br />

Seipp, M. T., 495F*<br />

Seixas, S., 3306T<br />

Sekar, R. B., 305<br />

Seki, A., 1685T, 2911W<br />

Seki, Y., 724T<br />

Sekine, T., 3134F<br />

Sekowska, M., 44, 3441T<br />

Seldin, M. F., 2360F<br />

Self, M., 853F, 2300F<br />

Selhub, J., 123<br />

Selinski, S., 1335T<br />

Selkirk, C. G., 1225T*<br />

Selleck, S. B., 2491T<br />

Selleri, L., 365<br />

Sellers, M., 2411F<br />

Sellers, T., 1061F<br />

Sellers, T. A., 1156T<br />

Selmer, K., 3096F*<br />

Sels, J.-W., 1711T<br />

Selvi, N., 1025F*<br />

Semaka, A., 265*<br />

Semenza, G. L., 3297T<br />

Semina, E. V., 2903T<br />

Seminara, D., 28, 1214F<br />

Semple, R. K., 33, 45<br />

Semsarian, C., 1664T<br />

Sen, S., 158, 260<br />

Senac, J., 738T<br />

Sénac, J. S., 2683W*<br />

Senders, C., 2151W<br />

Senegaglia, A. C., 2475W<br />

Seneviratne, C., 2390F<br />

Sengstag, T., 2891T<br />

Sengupta, S., 117, 1429F*<br />

Senman, L., 3456T<br />

Sens, M. M., 1946F<br />

Senter, L., 1740W<br />

Seo, D., 1644T*<br />

Seo, E.-J., 964T<br />

Seo, J., 1248W, 1384F<br />

Seo, J. S., 467F, 1931F,<br />

3259F, 3463T<br />

Seo, M., 933W<br />

Seo, S., 233, 323*, 1267T,<br />

2215T, 2671W, 2690T<br />

Seok, J., 1112F<br />

Seok, S.-C., 2523W<br />

Seok, Y., 863W*<br />

Seoud, M., 2981T<br />

Seow, A., 1934F<br />

Separovic, E., 447F<br />

Sepe, R. M., 735F<br />

Seppala, E., 2213F<br />

Seppälä, I., 2120F<br />

Sepuri, N. B., 3630W<br />

Sequeira, A., 2459F<br />

Sequeiros, J., 1296T, 1964F,<br />

2736F, 2818W<br />

Sergi, C., 3060F*, 3071W<br />

Serin, A., 1201T<br />

*Presenting Author<br />

Serjeant, G., 1906T<br />

Serra, C., 1091F<br />

Serra, D., 2062T<br />

Serra-Juhe, C., 84<br />

Serre, V., 127, 325, 329,<br />

390, 1607T<br />

Sertie, A. L., 2654F<br />

Service, S., 2222F, 2343W<br />

Servidei, S., 54<br />

Sesboué, R., 32<br />

Sese, J., 2550W, 3513T<br />

Seshadri, S., 123, 1592T,<br />

2528F<br />

Sessa, M., 71<br />

Sesta, M., 2766F<br />

Sestan, N., 2444F<br />

Setchell, K. D. R., 161<br />

Sethuraman, A., 3682W*<br />

Setia, S., 1447F<br />

Seto, A., 2381F<br />

Setoodeh, A., 2787F<br />

Settin, A., 1922F<br />

Severi, G., 205, 1148F,<br />

1214F<br />

Severin, E., 2954T*, 3005T,<br />

3009T, 3067W<br />

Sewry, C., 2812W<br />

Sexton, D. P., 314, 1735W,<br />

1757W, 1761W, 3576W<br />

Seyahi, E., 3475T<br />

Seyedhassani, S., 2976T*<br />

Seynaeve, C., 1788W<br />

Seyrantepe, V., 2669T*<br />

Sezerman, O. U., 2450F<br />

Sgardioli, I., 1865F<br />

Sgardioli, I. C., 959W<br />

Sha, Q., 1409W*<br />

Sha, S. J., 2639F<br />

Shaaban, S., 2928F<br />

Shabalin, A. A., 564W<br />

Shabbeer, J., 1714T<br />

Shachar, S. B., 63<br />

Shadravan, F., 3410T*<br />

Shafer, A., 3459T<br />

Shaffer, C. L., 3388F<br />

Shaffer, J., 22, 2034W<br />

Shaffer, J. R., 1464T, 1474F,<br />

2142W*, 2156F, 2178W<br />

Shaffer, L. G., 66, 68, 103,<br />

274, 884T, 902T, 934T,<br />

2395T, 3101W<br />

Shafiee, N. M., 2150F<br />

Shah, A. S., 3231W<br />

Shah, B., 346, 2537F<br />

Shah, E., 1009T, 2014T,<br />

2281T*<br />

Shah, K., 1591T, 1701T*,<br />

1863F*<br />

Shah, K. H., 130<br />

Shah, M., 3717F<br />

Shah, R., 1701T<br />

Shah, S., 998F, 999W*,<br />

1159T, 1841W<br />

Shah, S. H., 1444F, 1594T,<br />

1636T<br />

Shahak, E., 3202F<br />

Shahbazi, M., 3163W<br />

Shahbazi, M. S., 1096T*<br />

Shahid, H., 2072F<br />

Shahin, H., 2756T*, 2772F<br />

SPEAKER AND AUTHOR INDEX 401<br />

Shahmirzadi, L., 1844F*<br />

Shahram, F., 2150F<br />

Shaikh, R. S., 2959W<br />

Shaikh, T., 451F<br />

Shaikh, T. H., 819F, 2884W<br />

Shakir, K., 280<br />

Sham, P., 21<br />

Sham, P. C., 109, 1930T,<br />

2066F, 2494T, 2932W,<br />

3559F<br />

Shameer, K., 1312F*<br />

Shami, P., 3637F<br />

Shamloo, B., 3475T<br />

Shams, S., 440W<br />

Shamsi, M., 2967T*<br />

Shan, Y., 3300T<br />

Shanahan, K., 326<br />

Shang, J., 3168F, 3237W<br />

Shang, Q., 2419T<br />

Shankar, S., 745F, 772W,<br />

1679T<br />

Shanmugam, A., 2625W<br />

Shanmugham, A., 2579F<br />

Shannon, M., 1209W,<br />

1246T, 3278W, 3714W<br />

Shannon, N., 324<br />

Shannon, P., 2971T, 3013T,<br />

3075W<br />

Shao, D., 3625F<br />

Shao, H., 159<br />

Shao, X., 1414F, 1415W*<br />

Shao, Y., 1185W, 1309F,<br />

2078F, 3582W<br />

Shapero, M., Session 76,<br />

3730W*<br />

Shapira, I., 1133F*<br />

Shapiro, A., 1889F<br />

Shapiro, E., 714T, 715F,<br />

801W<br />

Shapiro, E. G., 785W<br />

Sharaha, U., 2756T<br />

Shariati, G., 2714T*<br />

Shariati, G. R., 679F<br />

Sharifi, R., 3201W*<br />

Sharififard, B., 2714T<br />

Sharma, H., 481F*<br />

Sharma, K., 13<br />

Sharma, K. L., 1188W*<br />

Sharma, M., 555F*<br />

Sharma, N., 2801T<br />

Sharma, N. K., 2011T<br />

Sharma, P., 918T*<br />

Sharma, R., 2353T*<br />

Sharma, R. K., 2353T<br />

Sharma, S., 221*, 811F*,<br />

1439W, 2844F*, 3678W<br />

Sharma, V. P., 218<br />

Sharp, A., 84, 3431T, 3516T*<br />

Sharp, A. J., 469F, 3488T<br />

Sharp, S. J., 1553W<br />

Shaw, C., 893W, 898T,<br />

952T, 2542T<br />

Shaw, C. A., 229, 430W,<br />

432W, 2189F<br />

Shaw, C. E., 348<br />

Shaw, D. W. W., 2530T<br />

Shaw, G., 75, 1589T<br />

Shaw, G. M., 1352W, 1885T<br />

Shaw, N. J., 2864T<br />

Shaw, P., 135<br />

Shaw, P. J., 348<br />

Shchelochkov, O., 165, 389,<br />

1882T, 2678T<br />

Shchelochkov, O. A., 840F,<br />

1344T<br />

Shchetynsky, K., 1981T*<br />

Shea, P., 2050T<br />

Shea, P. R., 2335T*<br />

Shearer, E., 60*, 2867T<br />

Shears, D., 217, 2939T<br />

Shechter, N., 783W<br />

Sheehan, P., 3484T<br />

Sheehan, S., 184*<br />

Sheehan, V., 2331W<br />

Sheehan, V. A., 648T*<br />

Sheets, K., 3<br />

Sheffer, I., 2542T<br />

Sheffield, J., 3395W<br />

Sheffield, V., 1588T, 2690T<br />

Sheffield, V. C., 323, 387,<br />

404, 2215T, 2671W,<br />

2738T, 2750T<br />

Sheikh, F., 1155W<br />

Shekar, M., 1183T, 1190F<br />

Shekari Khaniani, M., 779W<br />

Shekhtman, E., 3582W<br />

Sheldon, M., 2433W<br />

Shell, E., 493F<br />

Shelton, G. D., 2681T<br />

Shelton, J., 602T<br />

Shelton, S. E., 2413T<br />

Shen, C., 1249T<br />

Shen, C. L., 2985T<br />

Shen, E., 2444F<br />

Shen, H., 2053T, 2172W<br />

Shen, H. C., 210<br />

Shen, J., 159, 294, 876T,<br />

934T<br />

Shen, L., 230, 1289W,<br />

1301W, 1414F, 1455T,<br />

2140T, 2511W, 2513F*,<br />

2531F<br />

Shen, M., 1945T<br />

Shen, P., 3691F*<br />

Shen, R., 3695F, 3697F<br />

Shen, Y., 554W, 1255T*,<br />

1482T, 2606F, 2660F,<br />

2732T, 3627F<br />

Shendure, J., Session 72,<br />

Session 74, Session 81,<br />

26, 311, 1014W, 2337W,<br />

2789T, 2897T, 3721F<br />

Shendure, J. A., Session 72,<br />

10, 74, 94<br />

Shepard, P., 395<br />

Shephard, R. E., 1664T<br />

Shepherd, F. A., 1108T<br />

Shepherd, J., 1576F<br />

Shepherd, J. A., 812F<br />

Sheppard, B., 463F*<br />

Sher, K., 1566T<br />

Sherafat Kazemzadeh, R.,<br />

2702T<br />

Sheridan, E., 214<br />

Sheridan, M. B., 935W*<br />

Sherman, M., 1117T<br />

Sherman, M. E., 1150T<br />

Sherman, S., 940T<br />

Sherman, S. L., 253,<br />

1349W, 2069F, 3042F<br />

SPEAKER AND AUTHOR INDEX


402 SPEAKER AND AUTHOR INDEX<br />

Sherr, E., 196, 3198F<br />

Sherr, E. H., 299, 2389T<br />

Sherridan, E., 3173W<br />

Sherrill, J. B., 829F<br />

Sherry, S., 3582W*, 3592W,<br />

3625F<br />

Sherva, R., 2488T*, 2503T<br />

Sherwood, A., 530W<br />

Shete, S., 1298W, 1578T<br />

Sheth, F., 700T, 3400T<br />

Sheth, F. J., 911W*, 2803W<br />

Sheth, J., 700T, 911W, 3400T<br />

Sheth, J. J., 2731W, 2803W*<br />

Sheth, V., 1244F, 3717F<br />

Sheu, W., 1608T<br />

Sheu, W. H.-H., 1955F<br />

Shevah, O., 2706F<br />

Shevchenko, Y., 330<br />

Shevell, M. I., 2790F<br />

Shi, A., 532W<br />

Shi, B., 1472W<br />

Shi, H., 3317W<br />

Shi, J., 616T, 1154F, 1199F,<br />

3493T*<br />

Shi, L., 836F, 2151W, 3415T<br />

Shi, M., 551F, 1416T*<br />

Shi, Y., 159, 480W, 486W,<br />

503F, 2617T, 3595F<br />

Shianna, K., 53<br />

Shianna, K. V., 203, 2050T,<br />

2335T<br />

Shibata, A., 729F, 1574W,<br />

2472W, 2647T, 2747T,<br />

3634W*<br />

Shibata, H., 2400W<br />

Shibata, K., 1549F*<br />

Shibata, T., 396<br />

Shibuya, T., 396<br />

Shieh, J. T. C., 501F, 1687T,<br />

3247W<br />

Shield, J. P. H., 3494T<br />

Shiffman, S., 39<br />

Shigemizu, D., 2051F*<br />

Shigeta, R., 493F<br />

Shih, A., 2617T<br />

Shih, S., 1905W<br />

Shikishima, C., 3513T<br />

Shilon-Hadass, A., 660T<br />

Shim, S., 900T*<br />

Shima, J., 1190F<br />

Shimada, A., 3192F*<br />

Shimada, T., 1697T<br />

Shimbo, H., 2836W<br />

Shimizu, A., 2882T*, 2911W<br />

Shimizu, J., 2409W<br />

Shimizu, T., 663F<br />

Shimmin, L. C., 1932W<br />

Shimojima, K., 1290T,<br />

3102F<br />

Shimojo, N., 2294F<br />

Shimozato, K., 1574W,<br />

2747T<br />

Shin, C. S., 2053T<br />

Shin, D., 1590T*<br />

Shin, E., 908T*, 1590T,<br />

2834T<br />

Shin, H. D., 1975T<br />

Shin, J., 1248W, 2437T*<br />

Shin, J. Y., 3463T<br />

Shin, S.-Y., 44, 583F<br />

*Presenting Author<br />

Shin, Y.-B., 1622T<br />

Shink, E., 1951T<br />

Shinka, T., 3337F<br />

Shinomiya, N., 663F<br />

Shinomura, Y., 2174F<br />

Shinya, K., 2507F<br />

Shiohama, A., 2911W<br />

Shiohara, T., 627T<br />

Shirai, T., 1815W<br />

Shiraishi, H., 2822T<br />

Shirakata, Y., 627T<br />

Shirakawa, O., 2380T<br />

Shirakihara, T., 396<br />

Shirazi, M., 957W, 3730W<br />

Shiri, R., 2120F<br />

Shirley, B., 3672W<br />

Shirley, M., 3374W<br />

Shirmardi, A., 2013W<br />

Shiroiwa, K., 2380T<br />

Shirota, R., 1277F<br />

Shirzad, H., 1143W, 1739W<br />

Shiu, C., 1557T<br />

Shiue, C., 413F*<br />

Shivatzki, S., 2914W<br />

Shmueli, D., 2447F<br />

Shmygelska, A., 483F*,<br />

3617F<br />

Shneebaum, N., 2447F<br />

Shoda, H., 1984T<br />

Shoedel, J., 509F<br />

Shoemark, A., 809F<br />

Shohat, M., 105, 3185W<br />

Shohet, J., 134<br />

Shomron, N., 2919F<br />

Shortreed, M., 1269W<br />

Shotelersuk, V., 709F,<br />

1944W*, 2006F, 2749W<br />

Shou, W., 616T*, 3493T<br />

Shoubridge, C., 2629T,<br />

2640W*<br />

Shoubridge, E. A., 2771T<br />

Shoukry, M., 407<br />

Shoval, Y., 199<br />

Shprintzen, R., 1494T<br />

Shrader, J., 711F<br />

Shrestha, D., 864T<br />

Shridhar, V., 1238F, 3451T<br />

Shriner, D., 241, 1515T,<br />

3412T, 3533F<br />

Shringarpure, S., 3605F<br />

Shringarpure, S. S., 3391W*<br />

Shriver, C. D., 1002W,<br />

1780W<br />

Shriver, M., 1850W, 2083T<br />

Shriver, M. D., 2223W*,<br />

3290W, 3318T, 3360T,<br />

3380W<br />

Shtir, C., 453F*<br />

Shu, Y., 1362T*<br />

Shugart, Y., 1527T<br />

Shugart, Y. Y., 1559W,<br />

3572W<br />

Shukla, A., 1232F<br />

Shukla, K. P., 2186F<br />

Shukla, N. K., 1278W<br />

Shukla, R., 918T<br />

Shukla, R. K., 3271F*<br />

Shuldiner, A., 249<br />

Shuldiner, A. R., 602T<br />

Shulman, J., 2488T<br />

Shuman, C., 320, 1872F,<br />

1873F<br />

Shungin, D., 1954T, 2123F,<br />

2147F<br />

Shvetsova, T., 1245W,<br />

3687F<br />

Shy, M., 1871F<br />

Shyong Tai, E., 2041T<br />

Siasi, E., 2980T*<br />

Sibigtroth, C., 784W<br />

Siciliano, G., 1776W<br />

Sicotte, H., 1247F<br />

Sidders, B., 503F<br />

Siddiqui, K., 3149W<br />

Siderowf, A., 2538W<br />

Sidore, C., 113, 157, 177*,<br />

186, 276, 1451W, 1516F,<br />

1568W, 2001W, 2198F,<br />

2329T, 3664W<br />

Sidow, A., 397*<br />

Sidransky, E., Session 10<br />

Sie, D., 494W<br />

Siebel, S., 1702T*<br />

Sieber, O., 1072T<br />

Sieberg, R., 1666T<br />

Siegbahn, A., 617T, 619T<br />

Siegel, P., 1182W<br />

Siegesmund, K., 200<br />

Siegfried, J. D., 1767W<br />

Siegler, I. C., 1594T, 2481W<br />

Siegmund, D., 3675F*<br />

Sierra, F. P., 926T<br />

Siervogel, R. M., 2146T<br />

Siffredi, V., 62<br />

Siffroi, J.-P., 2674W<br />

SIGMA Type 2 Diabetes<br />

Consortium, 48<br />

Sigmon, D. F., 1229F<br />

Signorello, L. B., 2202W<br />

Sigurjonsson, S., 73<br />

Sik, A., 2767W<br />

Sikdar, N., 1097F*<br />

Sikela, J., 465F<br />

Sikela, J. M., Session 22,<br />

433F, 835F<br />

Sikela, M., 433F<br />

Sikka, N., 1644T<br />

Sikkema-Raddatz, B., 1619T<br />

Siklosi, K. R., 1731W*<br />

Sikora, M., 186*<br />

Sikron, F., 783W<br />

Silander, K., 2462F<br />

Silani, V., 2775F<br />

Silao, C. L. T., 707F*<br />

Silas, J. C., 2988T*<br />

Silberbach, M., 1743W<br />

Silberg, J. L., 2277W<br />

Siles, J., 728T<br />

Sill, H., 1115F<br />

Sillanpää, M. J., 1597T<br />

Sillé, F. C. M., 1104W*,<br />

2055W<br />

Sillence, D. O., 3167W<br />

Siltanen, S., 1000T*<br />

Silva, A. C. S., 1902W<br />

Silva, A. G., 891W<br />

Silva, C., 2193W<br />

Silva, E., 324, 390<br />

Silva, F., 2624F<br />

Silva, I. D. C. G., 1008W<br />

Silva, J., 913W, 2668W<br />

Silva, L., 1851F<br />

Silva, L. C. S., 2642F<br />

Silva, M. J., 2718F<br />

Silva, R. M., 1315F, 1936T<br />

Silva, W. A., Jr., 1037F,<br />

1038W, 2813T<br />

Silva, W. L., 2289W<br />

Silva-Zollezzi, I., 3255T<br />

Silveira, S., 1651T<br />

Silveira Lucas, L., 131<br />

Silver, D. L., 2455T<br />

Silverberg, M. S., 42, 1381F,<br />

2319W<br />

Silverman, D. T., 1091F,<br />

1092W<br />

Silverman, E. K., 1425T,<br />

2057F, 2249F, 2346W<br />

Silverman, I., 1642T, 3551F<br />

Silverman, W., 859W<br />

Silverstein, C., 1685T<br />

Silvestri, G., 385, 1305T,<br />

1779W, 1897T<br />

Sim, X., 169, 173*, 269,<br />

1510F<br />

Simanivanh, T., 953W<br />

Simarci, A., 3125W<br />

Simard, J., 207, 208, 1150T,<br />

2635T<br />

Simeonov, D., 2610W<br />

Simino, J., 1637T*<br />

Simioni, M., 959W, 1903T*<br />

Simkin, L., 2003F<br />

Simmons, L. E., 74, 94<br />

Simms, R. J., 2676F<br />

Simões, A. L., 3277F, 3280F<br />

Simões, B. P., 1045T<br />

Simões, R. T., 994T<br />

Simola, K. O. J., 897W<br />

Simon, A. J., 2691F<br />

Simon, D., 841F<br />

Simon, K., 2561F<br />

Simon, M., 127, 3213W<br />

Simon, M. S., 1003T<br />

Simon, T., 609T<br />

Simon, V., 3310F<br />

Simonelli, F., 2950W<br />

Simonic, I., 98, 3109W,<br />

3172F<br />

Simonson, M. A., 2239T*<br />

Simonson, T. S., 3297T,<br />

3378T<br />

Simons VIP Consortium,<br />

and 16p11.2 European<br />

Consortium, 299<br />

Simosky, J. K., 772W<br />

Simpfendorfer, K. R., 306<br />

Simpson, A., 2211W<br />

Simpson, C. L., 1302T,<br />

1454W*<br />

Simpson, D., 1779W<br />

Simpson, M. A., 780W,<br />

2804T, 2896W, 2925F*<br />

Simpson, P., 1475W<br />

Sims, D. J., 1068W<br />

Sims, K., 1684T<br />

Sims, K. B., 326<br />

Simsir, A., 1106F<br />

Sincan, M., 359, 3543F<br />

Sinclair, E., 3454T


Sinclair, S., 750T<br />

Sindeaux, R. H. M., 2475W*<br />

Sindhi, M., 2075F<br />

Sing, C., 183<br />

Sing, C. F., 187<br />

Singer, A., 3048F, 3162F*,<br />

3174F<br />

Singer, C., 347, 2603F<br />

Singh, A. P., 3627F*<br />

Singh, D., 666T, 2737W*<br />

Singh, G., 3618W<br />

Singh, J., 1920W, 1921T*<br />

Singh, J. R., 2735T<br />

Singh, K., 1950W, 2154W,<br />

2240F, 2263T, 2700F<br />

Singh, K. E., 1071W<br />

Singh, L., 2988T<br />

Singh, L. N., 1696T<br />

Singh, N., 2967T<br />

Singh, R., 2988T, 3316F<br />

Singh, S., 2585F<br />

Singh, S. K., 481F<br />

Singh, S. M., 378<br />

Singh, V., 1134W*<br />

Singhi, P., 167<br />

Singleton, A. B., 564W,<br />

2148W, 2648F<br />

Sinha, G., 2663T<br />

Siniard, A. L., 3215W<br />

Sinicina, I., 86<br />

Sinicropi, D., 1198T<br />

Sinke, R. J., 1619T, 2886F<br />

Sin Lo, K. S., 2319W<br />

Sinnett, D., 31, 394, 1207T,<br />

1215W, 3268F<br />

Sinning, C. R., 1669T<br />

Sinnott, R., 2703F<br />

Sinnwell, J., 1247F<br />

Sinnwell, J. P., 1449T, 1497T<br />

Sinopoli, V., 2499W<br />

Sipeky, Cs., 3283F<br />

Sirén, I., 2110T<br />

Sirewanda, K., 3196F<br />

Siriwan, P., 1944W<br />

Siriwardena, K., 720T*<br />

Sirmaci, A., 57<br />

Sironi, M., 438W<br />

Sirotkin, K., 3582W, 3625F<br />

Siscovick, D., 350, 1346W,<br />

2210F, 2337W<br />

Sisk, R. A., 3212F<br />

Siskind, C., 1871F<br />

Sismani, C., 3017T<br />

Sistermans, E., 98, 494W,<br />

3200F<br />

Sisto, D., 2541W<br />

Sistonen, P., 2023T<br />

SISu Consortium, 2344T<br />

Sitaram, U., 931W<br />

Sitaraman, S., 732T, 745F<br />

Sites, E., 3177W<br />

Sitlani, C., 1346W, 1585T<br />

Siu, L., 135<br />

Siu, L. L., 1824F<br />

Siu, M., 3694W<br />

Siu, V. M., 1138T<br />

Siva, A., 2429F, 2450F<br />

Sivakumaran, T. A., 1764W*<br />

Sivapalaratnam, S., 1604T,<br />

1606T<br />

*Presenting Author<br />

Sivaramakrishna<br />

Rachakonda, P., 29<br />

Sivils, K. M., 2284T<br />

Sivley, M., 2532W<br />

Sizer, E., 645T<br />

Sjödin, P., 3356W<br />

Sjöholm, K., 1271F<br />

Sjöstrand, C., 2804T<br />

Sjöström, L., 427F, 1271F<br />

Skalitzky, C., 3688W<br />

Skarnes, W. C., 2725W<br />

Skarpås, B., 3729F<br />

Skeie, J. M., 2750T<br />

Skibola, C., 3623F<br />

Skibola, C. F., 1104W,<br />

2055W<br />

Skinner, C., 2806W, 2826F,<br />

3185W<br />

Skinner, H., 1267T<br />

Skinner, M., 2220W<br />

Skipper, L., 497F<br />

Sklar, P., 290, 1325W,<br />

2487W, 2576F, 2577W,<br />

2618F<br />

Sk<strong>of</strong>f, R., 2664F<br />

Skogstad, A., 2965W<br />

Skol, A. D., 2046W<br />

Skotheim, R. I., 213<br />

Skov, R. L., 1323T<br />

Skovbo, P., 2862F<br />

Skovbo, S., 1565W<br />

Skovby, F., 2765T<br />

Skupien, J., 2313W<br />

Skuse, D., 2383T<br />

Sladek, R., 176, 1513F,<br />

1923W, 2308T, 2339F<br />

Sladkova, J., 752T<br />

Slagboom, E., 2080T<br />

Slagboom, P. E., 1436W,<br />

2035T, 2175W<br />

Slager, S., 1150T<br />

Slama, A., 325<br />

Slate, N. G., 326<br />

Slater, A., 1491T<br />

Slavin, T., 3085W*<br />

Slavotinek, A., 810F, 869W,<br />

2926W*, 3162F<br />

Slawik, H., 2567F<br />

Slean, M., 2635T<br />

Slean, M. M., 2696T*<br />

Sleiman, P. M. A., 1996T,<br />

2121W, 2514W*, 2546F,<br />

2785W, 2892F<br />

Slepushkina, N., 1263W<br />

Slezer, R., 3688W<br />

Slifer, S., 2614T<br />

Slifer, S. H., 9, 2572T<br />

Slim, R., 2842W*, 2981T<br />

Sliwerska, E., 3368W<br />

Sload, J., 652T<br />

Sloan, C., 3612W<br />

Sloan, J., 721F, 738T<br />

Sloan, J. L., 664T*, 674T<br />

Sloper, L., 1663T<br />

Sloper, L. J., 3231W<br />

Slotta, D., 3582W<br />

Slovak, M. L., 945W<br />

Smagulova, F., 417F, 592W<br />

Smaldone, S., 815F*<br />

Small, G. W., 2637W<br />

SPEAKER AND AUTHOR INDEX 403<br />

Small, K., 583F*<br />

Small, K. S., 44, 3441T<br />

Smaoui, N., 330, 1676T,<br />

1765W*<br />

Smart, C., 210<br />

Smedby, K. E., 1934F,<br />

2055W<br />

Smedley, D. P., 2725W*<br />

Smeets, D. F. C. M., 955W<br />

Smeets, H., 708T*, 796W<br />

Smeets, H. J. M., 1711T,<br />

2448W, 2996T<br />

Smeitink, J. A. M., 672T<br />

Smets, K., 2820F<br />

Smiles, A. M., 2313W<br />

Smit, A. F. A., 195, 3270T<br />

Smit, M., 3200F<br />

Smith, A., 701F, 2794W<br />

Smith, A. C. M., 3080F<br />

Smith, A. J. P., 122*<br />

Smith, A. K., 1422T, 2384F,<br />

2483F, 3480T*<br />

Smith, A. V., 2275T<br />

Smith, B. N., 348*<br />

Smith, C., 374, 564W, 1538W<br />

Smith, C. D., 3213W<br />

Smith, C. L., 2675T<br />

Smith, C. T., 3349F<br />

Smith, D., 453F<br />

Smith, E. A., 2047T<br />

Smith, E. N., 395*, 1659T,<br />

2274W<br />

Smith, E. S., 1653T<br />

Smith, G., 671F, 3663F<br />

Smith, G. D., Session 21,<br />

560W, 1528F<br />

Smith, J., 93, 2740W<br />

Smith, J. D., 170, 244<br />

Smith, K., 568W, 2444F<br />

Smith, K. R., 2741T<br />

Smith, L. M., 1269W<br />

Smith, M. A. C., 1008W,<br />

1132T, 2533T, 2534F,<br />

3421T, 3503T<br />

Smith, M. W., 13<br />

Smith, N. L., 1408F<br />

Smith, R., 886T, 3471T,<br />

3636W<br />

Smith, R. A., 34<br />

Smith, R. J. H., 60, 419F,<br />

2301W, 2867T, 3228F<br />

Smith, R. L., 968T<br />

Smith, R. P., 246*<br />

Smith, S., 1186T<br />

Smith, S. C., 1661T<br />

Smith, S. M., 1537F*<br />

Smith, U., 1624T<br />

Smith, W., 774W*<br />

Smithson, S., 2896W<br />

Smithson, S. F., 217<br />

Smogorzewska, A., 999W<br />

Smolarek, T., 3177W<br />

Snegovskikh, V., 3030T<br />

Snell, Q. O., 3643F<br />

Snella, E. M., 2717T<br />

Snieder, H., 2282F<br />

Snijders, A. M., 984W<br />

Snipes, G., 777W<br />

Sniukiene, V., 745F, 772W<br />

Snopkowski, C., 2260T<br />

Snyder, D., 3644W<br />

Snyder, M., 425F, 525F,<br />

551F, 562W, 581F, 604T,<br />

1505W, 1601T, 2322W,<br />

3361F, 3368W, 3505T<br />

Snyder, M. P., 371, 416W,<br />

3313F, 3411W<br />

Snyder, M. W., 74, 94*<br />

So, E., 544W<br />

So, I., 2437T<br />

So, J., 2657F*<br />

So, M. T., 1930T, 2066F<br />

So, W., 2280W<br />

So, W. Y., 2279F<br />

Soares, F., 1151F, 3325F<br />

Soares, R. A. G., 636T<br />

Soares-Souza, G., 1119W<br />

Soares-Souza, G. B.,<br />

3325F<br />

Soave, D., 2953W*<br />

Sobel, E. M., 38<br />

Soblet, J., 83*, 1611T<br />

Sobol, M., 2920W<br />

Sobota, R., 2255F*<br />

Sobral, J., 2150F<br />

Sobreira, C., 2425T<br />

Sobreira, N., 227, 889W,<br />

2387F*, 3131W<br />

Sobue, G., 52, 2472W,<br />

3221W<br />

Socci, N., 998F<br />

Sochett, E., 3100F<br />

Soden, S. E., 366, 2793F,<br />

2894T<br />

Söderberg, S., 2070W<br />

Soejima, H., 3499T, 3519T<br />

Soens, Z. T., 430W<br />

Soerensen, M., 2244W*,<br />

2295W<br />

Soezima, H., 3432T<br />

SOFFOET, 77<br />

Sohail, A., 2959W<br />

Sohn, W. J., 846F<br />

Sohn, Y., 3103W*<br />

Sohn, Y. B., 787W<br />

Soi, S., 3303T, 3338W*<br />

Soini, Y., 1114T<br />

Soininen, P., 1623T<br />

Solanki, N., 1779W<br />

Solberg, A., 991T<br />

Soldano, K., 1919F, 2340W<br />

Sole, G., 1516F<br />

Solé, G., 716T<br />

Soler, C. V., 2233T*<br />

Soliman, N. A., 2850F<br />

Sollier, C., 1182W<br />

Solnick, J. V., 449F<br />

Solomon, T., 1966T*<br />

Solot, C. B. S., 2443T<br />

Solovieff, N., 1325W*<br />

Solovieva, S., 2120F<br />

Solski, J. A., 2816T<br />

Solverson, P., 710T<br />

Solyom, S., 1229F*<br />

Somasundaram, P., 2056T<br />

Somerharju, P., 541F<br />

Sommargren, M., 1766W*<br />

Sommen, M., 59<br />

Sommers, J. A., 2692W<br />

Son, N., 1590T<br />

SPEAKER AND AUTHOR INDEX


404 SPEAKER AND AUTHOR INDEX<br />

Søndergaard, M. T., 2699T<br />

Song, C. X., 3483T<br />

Song, G., 1762W<br />

Song, H., 139*<br />

Song, I. W., 2858T*<br />

Song, J., 1657T<br />

Song, J. I., 3673F<br />

Song, K., 106, 2273F, 3020T*<br />

Song, L., 159<br />

Song, O., 1675T<br />

Song, P., 3553F<br />

Song, S., 3567F<br />

Song, Y., 182, 557F*, 1259F,<br />

2020T, 2246F, 2254T<br />

Song, Y. M., 1654T, 2118W<br />

Song, Y.-M., 1656T, 2119T<br />

Song, Y. S., 184<br />

Song, Z., 3275W<br />

Sonnenberg, A., 2848W<br />

Sood, R., 664T, 824F,<br />

1983W<br />

Soodyall, H., 3377W<br />

Soo-Jin Lee, S., 1844F<br />

Sooknanan, R., 3668W,<br />

3721F*<br />

Soon, W., 416W<br />

Soong, B.-W., 2581T<br />

Sopher, B. L., 2628W<br />

Soplepmann, J., 1140W<br />

Soppet, D., 13<br />

Sorant, A. J. M., 1347T,<br />

1396F<br />

Soranzo, N., 44, 110, 383,<br />

503F, 583F, 1604T,<br />

2082W<br />

Sorarù, G., 1732W, 2775F<br />

Sorbrino, A., 957W<br />

Sørensen, T., 1528F<br />

Sørensen, T. I. A., 2116T,<br />

3028T<br />

Soresina, A. R., 760W<br />

Soria, J. M., 1651T*<br />

Sorosina, M., 624T, 2095T<br />

Sorrentino, G., 1985F<br />

Sorrentino, P., 1985F<br />

Sosa, D., 1048T, 1049F<br />

Sosa, M. X., 13, 308<br />

Sosman, J., 136<br />

Sosnay, P. R., 1731W<br />

Sotiriou, C., 3017T<br />

Sotiroska, V., 2983T<br />

Sotomaior, V. S., 870T,<br />

2475W, 3055W<br />

Sotoodehnia, N., 1585T<br />

Soubeyrand, S., 1645T<br />

Soubrier, F., 1170W<br />

Soucy, P., 207<br />

Soufir, N., 29, 1062W*<br />

Soulier, A., 1817W<br />

Sousa, A., 1296T, 2736F<br />

Sousa, I., 1977W*, 2085W<br />

Sousa, R., 3122F<br />

Sousa, S., 913W, 1747W,<br />

3019T<br />

Sousa, S. B., 2755W*<br />

Soussi-Yanicostas, N., 843F<br />

Soutar, A., 1618T<br />

South, S., 3088F<br />

Southam, L., 2044T, 3396T<br />

Southern, M. R., 1162T<br />

*Presenting Author<br />

Southey, M., 1213T*<br />

Southey, M. C., 27, 3679F<br />

Southgate, L., 2804T*<br />

Souto, J. C., 1651T<br />

Souza, D. O. G., 2424W<br />

Souza, G., 3562W<br />

Souza, G. N., 2424W, 2626T<br />

Souza, I. R., 994T, 1405F,<br />

1946F<br />

Souza, J., 870T, 959W,<br />

2270F, 2746W, 3055W<br />

Souza, L. T., 2270F<br />

Souzeau, E., 1785W*<br />

Sovath, S., 2973T, 3023T<br />

Sovio, U., 2162F<br />

Sovová, J., 322<br />

Spacek, D., 525F, 604T*,<br />

3505T<br />

Spacilova, J., 752T<br />

Spadafora, P., 2597F<br />

Spaeth, J. M., 125<br />

Spaich, C., 3111W<br />

Spain, S. L., 154, 1927T<br />

Spalding, J. D., 497F<br />

Spangler, J., 1244F<br />

Sparagana, S., 3108F<br />

Sparén, P., 1707T<br />

Sparks, A. B., 3020T<br />

Sparks, K., 3211W<br />

Sparso, T., 2311T<br />

Sparsø, T., 2317T, 2347T<br />

Speck-Martins, C. E., 2596T<br />

Spector, E., 451F<br />

Spector, T., 109, 583F,<br />

1440T, 2165F, 2171F,<br />

2292W, 3453T<br />

Spector, T. D., 44, 277,<br />

335, 503F, 546W, 1216T,<br />

1311T, 2029T, 2138F,<br />

2175W, 2359T, 3441T<br />

Speed, D., 1394W*<br />

Speed, W. C., 3313F<br />

Spehlmann, M., 2368T<br />

Speicher, M. R., 1063T,<br />

1115F, 3116F<br />

Speleman, F., 423F<br />

Speliotes, E. K., 1954T,<br />

2090F, 2123F, 2147F,<br />

2210F*, 2241W, 2275T<br />

Spence, S. J., 299<br />

Spencer, C., 2157W<br />

Spencer, C. C. A., 1340W*<br />

Spencer, K., 2041T<br />

Spencer, K. L., 2042F<br />

Spencer, M., 1685T<br />

Spengler, S., 3111W*<br />

Sperber, S. M., 3163W*<br />

Sperl, W., 699F, 782W<br />

Sperle, K., 2664F<br />

Spertus, J. A., 2535W<br />

Speziani, F., 1871F*, 2930T<br />

Spiegelman, D., 1670T,<br />

2306F, 2338T, 2342F,<br />

2558F, 2591F<br />

Spier, I., 1005W<br />

Spindola, L. M. N., 2534F*<br />

Spinella, J., 394*<br />

Spinella, J.-F., 31, 3268F<br />

Spinella, J. F., 1207T,<br />

1215W<br />

Spinner, N., 3082F<br />

Spinner, N. B., 2316W,<br />

3040F<br />

Spiro, J. E., 299, 2439W<br />

Spitali, P., 574W*<br />

Spizzichino, L., 71<br />

Spraggs, C., 630T<br />

Spraggs, C. F., 651T<br />

Sprissler, R., 2788W<br />

Spritz, R. A., Session 80<br />

Sprott, K. M., 1171T<br />

Sprowl, J., 3007T, 3021T<br />

Spruill, I. J., 1662T<br />

Spurdle, A. B., Session 4,<br />

1067F<br />

Spurrell, C. H., 26*, 1089W,<br />

1226F<br />

Spyrou, C., 3017T<br />

Squire, K. M., 3666W*<br />

Srichomthong, C., 709F,<br />

1944W, 2006F<br />

Sriha, B., 2744T<br />

Srikanth, A., 2491T<br />

Srikanth, S. M., 3316F<br />

Srinivasan, A., 3007T,<br />

3021T*<br />

Srinivasan, M., 975W<br />

Srinivasan, R., 362<br />

Srinivasan, S., 2943F<br />

Srinivasan, S. R., 2274W<br />

Sriram, G., 2238W<br />

Sritharan, K., 2525F<br />

Srivastava, A., 931W,<br />

1587T, 1598T, 3465T<br />

Srivastava, A. K., 2826F*,<br />

2837T<br />

Srivastava, D., 195<br />

Srivastava, G., 380, 3450T<br />

Srivastava, G. P., 3417T*<br />

Srivastava, N., 1134W<br />

Srivastava, P., 1135T*<br />

Srivastava, R., 1287T,<br />

1294F, 1883F<br />

Srivastava, R. N., 1288F*<br />

Srivastava, V. M., 931W*<br />

Srour, M., 2790F*<br />

Staats, S., 3377W<br />

Stack, C. A., 632T<br />

Stacpoole, P. W., 164<br />

Stade, B., 3583F*<br />

Stadler, Z., 998F, 1159T,<br />

1841W<br />

Staggs, R., 1665T<br />

Stahl, E., 350, 2199W*<br />

Stahl, E. A., 625T, 1331W,<br />

2210F, 2258F<br />

Ståhle, M., 2276F<br />

Stainier, D., Session 26<br />

Stajich, J., 1919F, 2946F<br />

Stalker, H., 3126F<br />

Stalker, J., 216<br />

St-Amant, M., 1065W<br />

Stamato, T., 1142F<br />

Stamatoyannopoulos, J.,<br />

3459T<br />

Stamatoyannopoulos, J. A.,<br />

255*, 402<br />

Stambolian, D., 2183F<br />

Stambouli, D., 2728W<br />

Stan, A., 2954T<br />

Stanaway, I. B., 10<br />

Stanaway, I. B. S., 2443T<br />

Stančáková, A., 46<br />

Stanek, E. J., 1714T<br />

Staneva, R., 3477T, 3481T*<br />

Stanford, J., 28, 1001F<br />

Stanford, J. L., 1214F,<br />

2202W<br />

Stangier, K., 3701F*<br />

Stanhope, S., 1395T*<br />

Stanier, P., 303, 2752W*,<br />

3501T<br />

Stankiewicz, P., 229, 430W,<br />

432W, 485F, 952T, 2395T,<br />

2403W<br />

Stankiewicz, P. T., Session 22<br />

Stanley, K., 2003F<br />

Stanton, J., 3333T<br />

Staples, J., 223*<br />

Stapleton, E., 239<br />

Stark, A. L., 614T*<br />

Starker, L. F., 1241F<br />

Stassinopoulos, A., 3720W<br />

State, M., 13, 553F, 1433W,<br />

2478W, 2605T<br />

State, M. W., 2560T, 2577W,<br />

2602T<br />

Stathaki, E., 2937F<br />

Staufenbiel, I., 2058W<br />

Stavropoulos, D. J., 103,<br />

3100F, 3106F, 3183W<br />

Stavropoulos, J., 1872F,<br />

1873F<br />

Stavropoulou, A., 1228T*<br />

Stavropoulou, A. V., 1191W<br />

Steck, A. K., 1330F<br />

Steckley, J. L., 2779W<br />

Steel, K. P., 1, 105, 2302T<br />

Steele, L., 2905W*<br />

Steele, P. D., 1759W<br />

Steele, T., 3340F<br />

Steenpass, L., 392*<br />

Steensbjerre Moller, R.,<br />

889W<br />

Stefan, M., 573F*<br />

Stefani, M. M. A., 2475W<br />

Stefanick, M. L., 2145W<br />

Stefanidis, C. J., 2850F<br />

Stefanova, I., 219<br />

Stefanovic, V., 3481T<br />

Stefanowicz, D., 1465F<br />

Stefansson, H., 106, 252<br />

Stefansson, K., 106, 583F,<br />

2165F, 2317T<br />

Steffann, J., 72*<br />

Steger, M., 782W<br />

Stegger, M., 1323T<br />

Stein, C. M., 1295W*<br />

Stein, J., 75<br />

Stein, J. L., 2054F<br />

Stein, L., 135<br />

Stein, L. D., 1093T<br />

Steinbeisser, H., 1612T<br />

Steinberg, J., 2476T*<br />

Steinberg, S. J., 3448T<br />

Steinfeld, I., 3588W<br />

Steinmann, K., 299<br />

Stejskal, D., 2865F<br />

Stemming, J., 1680T<br />

Stemple, D., 363


Stemple, D. L., 37, 214<br />

Stenroos, E. S., 2501F<br />

Stephan, D. A., 2301W<br />

Stephan, M., 2740W<br />

Stephans, J., 1198T<br />

Stephens, J., 383<br />

Stephens, J. C., 503F,<br />

1604T, 2804T<br />

Stephens, K., 1753W<br />

Stephens, M., 273, 1463W,<br />

1514W, 1580W<br />

Stephenson, M., 2977T<br />

Stephenson, R., 1328W<br />

Stergiakouli, E., 2081F<br />

Steri, M., 1516F*, 2198F<br />

Stern, M. C., 1075T<br />

Stern, M.-H., 1205F<br />

Sternberg, C. N., 651T<br />

Stevanin, G., 2820F*<br />

Stevanovic, S., 1233W<br />

Stevens, A. J., 3440T<br />

Stevens, C., 8, 290, 322,<br />

2319W<br />

Stevens, C. R., 2613W<br />

Stevens, E., 3374W*<br />

Stevens, J., 412W, 486W,<br />

532W, 851F, 1146W,<br />

2397W<br />

Stevens, K., 615T<br />

Stevens, V., 1012T<br />

Stevens, V. L., 1390F<br />

Stevenson, D., 3177W,<br />

3189W<br />

Stevenson, D. A., 3076F<br />

Stevenson, R., 3185W<br />

Stevison, L., 285<br />

Stevnsner, T., 2244W<br />

Steward, M., 3310F<br />

Stewart, A., 126<br />

Stewart, C. L., 2914W<br />

Stewart, D. R., 132*, 1261T<br />

Stewart, E. A., 1145F, 2056T<br />

Stewart, F., 512W, 3517T<br />

Stewart, F. J., 218, 3702W*,<br />

3715F<br />

Stewart, H., 2939T<br />

Stewart, R., 1269W<br />

Stewart, W., 1407T*<br />

St. George-Hyslop, P.,<br />

2528F<br />

Stiasny-Kolster, K., 2568W<br />

Stiburkova, B., 2831T*<br />

Stiby, A. I., 1567F*<br />

Sticht, H., 2595W<br />

Stieler, K., 2760F<br />

Stienen, D., 1005W<br />

Stieren, J., 3671F<br />

Still, C., 2078F<br />

Stimpson, K. M., 69*<br />

Stitzel, M. L., 304<br />

Stitziel, N., 2199W<br />

St. Jean, P. L., 476W, 3406T<br />

St. Luke’s Dementia Study<br />

Group, 2466W, 2473T<br />

Stobdan, T., 3307F<br />

Stock, F., 2869W<br />

Stock, R., 1309F<br />

Stöcker, T., 1335T, 1430W*<br />

Stockler, S., 750T*, 756W<br />

Stockley, T., 3183W<br />

*Presenting Author<br />

Stockley, T. L., 2905W<br />

Stockton, D., 885W, 3147W<br />

Stockton, D. W., 2678T<br />

Stoddard, G., 1904F<br />

Stoeger, R., 1580W<br />

Stoessl, A. J., 346<br />

Stoetzel, C., 2887W<br />

St<strong>of</strong>anko, M., 3107W, 3110F<br />

Stojanov, P., 402<br />

Stok, M., 796W<br />

Stokes, P., 3700W<br />

Stokes, T., 3011T<br />

Stoler, J., 2151W<br />

Stoletzki, N., 402<br />

Stolk, L., 2141F<br />

Stoll, C., 3073W*<br />

Stoll, M., 3577F<br />

Stolle, C., 2904F<br />

Stolte- Dijkstra, I., 127<br />

Stone, A., 3306T<br />

Stone, A. C., 3251W<br />

Stone, B., 3527F<br />

Stone, D. U., 529F, 2188T<br />

Stone, E. M., 387, 2750T<br />

Stone, K. L., 2375F<br />

Stone, N., 1309F<br />

Stoppa-Lyonnet, D., 1205F<br />

Storey-Montalvo, G., 2272T<br />

Storm, K., 2757F<br />

Stormo, C., 576W*<br />

Storniolo, A. M., 1098W<br />

Stowe, Z. N., 2384F<br />

St. Pourcain, B., 1318F,<br />

1567F, 1583W, 2081F,<br />

2164T*, 2169W<br />

Strachan, E., 434W<br />

Strader, L. C., 1566T<br />

Straka, R., 1641T<br />

Stram, D., 1324F<br />

Stram, D. O., 1292W,<br />

2202W<br />

Strandgren, C., 2427W<br />

Stranecky, V., 752T<br />

Stranger, B., 3310F<br />

Stranger, B. E., 584W,<br />

1907F, 2250W<br />

Strassburger, D., 3002T<br />

Strasser, D. S., 684T<br />

Strauch, K., 190, 275,<br />

2226W<br />

Strauss, D., 1159T<br />

Strawbridge, R., 2147F<br />

Strawbridge, R. J., 1954T,<br />

2123F<br />

Stray, S. M., 1089W, 1226F<br />

Stray-Pedersen, A., 360,<br />

2908W<br />

Strazza Júnior, P. S., 3280F<br />

Strecker, M., 954T<br />

Strecker, V., 782W<br />

Street, C., 382<br />

Streeter, I., 3636W<br />

Strengman, E., 2553W,<br />

2661W<br />

Strick, R., 3153W<br />

Strickland, A., 2668W<br />

Strike, L., 2054F<br />

Stringham, H. M., 46<br />

Strissel, P., 3153W<br />

Strohecker, B., 3698W<br />

SPEAKER AND AUTHOR INDEX 405<br />

Strom, C. M., 2260T, 3522T<br />

Strom, S. S., 2202W<br />

Strom, T., 567F, 582W,<br />

2557T<br />

Strom, T. B., 2260T<br />

Strom, T. M., 699F, 2567F,<br />

2595W, 2693T, 2917W,<br />

2922F<br />

Strome, E. D., 384<br />

Strong, E., 3482T*<br />

Strong, K. A., 1837W*<br />

Strong, L., 1197W<br />

Strong, L. C., 1221W<br />

Strother, D., 1052F<br />

Stroud, D., 806F<br />

Stroud, T., 884T<br />

Strovel, E., 1729W<br />

Strug, L., 2953W<br />

Strug, L. J., 1322W, 1531F*,<br />

2580W<br />

Strunz, C. M. C., 636T<br />

Strutz-Seebohm, N., 86<br />

Stuart, A., 3672W<br />

Stuart, P. E., 154, 1952F<br />

Stuart, S., 1167W<br />

Stückler, F., 2226W<br />

Stuckless, S., 1066T*<br />

Studer, M., 808F<br />

Study AT1001-013 Principal<br />

Investigators, 732T<br />

Study <strong>of</strong> Osteoporotic<br />

Fractures and<br />

Osteoporotic Fractures<br />

in Men Study Groups,<br />

2375F<br />

Stuenkel, A. J., 1767W*<br />

Stuffrein-Roberts, S., 3440T<br />

Stuhrmann-Spangenberg,<br />

M., 1868F<br />

Sturm, M., 1200W, 1233W<br />

Sturtz, F., 2694F<br />

Sturzeneker, R., 2434T<br />

Stutz, M., 210<br />

Stutzman, F., 2887W<br />

Styrkarsdottir, U., 109<br />

Su, A. I., 3584W*<br />

Su, B., 3317W*<br />

Su, C., 2761W<br />

Su, C.-T., 129<br />

Su, D., 1322W, 2953W<br />

Su, H., 1010F, 1218W<br />

Su, J., 1183T, 2999T<br />

Su, M., 2000F*, 2116T<br />

Su, S., 3418T<br />

Su, W., 989F<br />

Su, Z., 136<br />

Suárez, E., 3315T<br />

Suchi, S., 1765W<br />

Suchiman, H. E. D., 2035T<br />

Suchy, S. F., 330<br />

Suchy-Dicey, A., 584W,<br />

1284T, 1503T<br />

Suda, L., 3044F<br />

Sudbrak, R., 567F, 582W<br />

Sudlow, C. L., 1313W<br />

Sudman, M., 2143T*<br />

Sudmant, P. H., 278, 375,<br />

3296W<br />

Sudo, A., 2822T<br />

Suematsu, M., 2911W<br />

Suemoto, C. K., 919W<br />

Suen, Y. K., 3491T<br />

Suenaga, T., 1631T<br />

Sugahar, K., 2861T<br />

Sugahara, K., 3230F<br />

Sugahara, Y., 548W, 558W,<br />

559F, 599F<br />

Sugalski, R., 433F<br />

Sugano, S., 2619W, 2923W<br />

Sugawara, H., 3513T<br />

Sugawara, Y., 3091W<br />

Sugier, P.-E., 2079W*, 2248T<br />

Sugimoto, K., 1987T<br />

Sugimura, H., 2507F<br />

Sugino, S., 1940F<br />

Sugiyama, M., 2130W,<br />

3682W<br />

Suh, J. Y., 846F<br />

Suhl, J., 540W*<br />

Suhre, K., 228, 2226W<br />

Sui, D., 1291F<br />

Sukhadia, S., 2316W<br />

Suktitipat, B., 1347T,<br />

1396F*, 1690T<br />

Sukumar, A. T., 3251W<br />

Sul, J., 1341T*, 3555F<br />

Sul, J. H., 3623F<br />

Sulcova, V., 3522T<br />

Sule, G., 2864T, 3209W*<br />

Sule, N., 2542T*<br />

Sulem, P., 2317T<br />

Sulis, M. L., 1031F<br />

Sullivan, A. K., 2362T*<br />

Sullivan, B. A., 69, 384*<br />

Sullivan, J., 147<br />

Sullivan, K., 953W, 2778F<br />

Sullivan, L. L., 69, 384<br />

Sullivan, L. S., 3234F<br />

Sullivan, P., 235, 280,<br />

1325W, 2487W<br />

Sullivan, P. F., 290, 1350T,<br />

2468F, 2522F, 2576F,<br />

2618F, 3442T, 3452T,<br />

3659F<br />

Sulonen, A.-M., 2888T*<br />

Sulovari, A., 1339F<br />

Sultan, K., 1133F<br />

Sultan, M., 567F, 582W<br />

Sultana, R., 2697F<br />

Sumanas, S., 2724F<br />

Sumi, S., 2440T<br />

Summar, M., 670T<br />

Summerer, M., 3319F<br />

Sumner, C., 512W, 3517T,<br />

3715F<br />

Sumner, C. J., 3702W<br />

Sun, C., 1625T, 2561F<br />

Sun, G., 1660T, 2159F,<br />

2206T, 3561F, 3619F<br />

Sun, H., 314, 1417F*, 1735W,<br />

1742W, 1757W, 1761W<br />

Sun, J., 3<br />

Sun, L., 798W, 1322W,<br />

1412W, 2109W, 2376W,<br />

2819T, 2953W<br />

Sun, M., 2458T<br />

Sun, N., 2433W*<br />

Sun, P., 1061F<br />

Sun, Q., 165, 537F, 2080T,<br />

2116T<br />

SPEAKER AND AUTHOR INDEX


406 SPEAKER AND AUTHOR INDEX<br />

Sun, S., 1101W, 3585F*,<br />

3593F<br />

Sun, W., 1027T, 1560T*,<br />

2260T, 3522T<br />

Sun, X., 246, 2644T*<br />

Sun, Y., 78, 161*, 690T,<br />

736T, 2063F, 2701W<br />

Sun, Z., 2617T<br />

Sunaga, D. Y., 814F, 2414F<br />

Sundararajan, R., 803W<br />

Sundaresan, V., 2773W<br />

Sunde, L., 3148F<br />

Sunderam, U., 362<br />

Sundramoorthy, A., 880T*<br />

Sundsbak, J. L., 1909T<br />

Sung, H., 1396F, 1690T*,<br />

2584T<br />

Sung, J., 1384F, 1654T,<br />

1656T, 2118W, 2119T,<br />

3259F<br />

Sung, K., 1369F<br />

Sung, S., 900T<br />

Sung, Y., 1608T, 2063F,<br />

2117F<br />

Sung, Y. J., 2116T<br />

Sunkin, S., 2444F*<br />

Sunyaev, S., 402*, 2199W,<br />

2209T, 3310F<br />

Sunyaev, S. R., 1550W,<br />

3404T<br />

Sunyer, J., 2167T, 2168F<br />

Suomalainen, A., 327<br />

Superko, H. R., 1714T*<br />

Superti-Furga, A., 3190F<br />

Suphapeetiporn, K., 709F,<br />

1944W, 2006F*, 2749W<br />

Sur, A. L., 1805W<br />

Surakka, I., 119*, 190,<br />

1308T, 2076W, 2110T,<br />

2137T, 2175W<br />

Surdulescu, G., 503F<br />

Surti, U., 904T*, 971W,<br />

993W, 1744W<br />

Suskin, B., 3022T*<br />

Susswein, L., 688T<br />

Sutcliffe, C., 1316W, 1377T,<br />

1602T, 1671T, 1928F,<br />

2037W<br />

Sutcliffe, J., 1520W<br />

Sutcliffe, J. S., 268, 2577W<br />

Sutera-Sardo, J., 2536T<br />

Suthanthiran, M., 2260T<br />

Suther, R., 3207W<br />

Sutherland, M., 853F<br />

Sutton, V. R., 33, 227<br />

Suvarnan, L., 2234F<br />

Suver, C., 2220W<br />

Suvisaari, J., 252<br />

Suzuk, Y., 2294F<br />

Suzuki, A., 531F, 1984T*,<br />

2004W<br />

Suzuki, A. M., 2654F*<br />

Suzuki, H., 663F, 1631T<br />

Suzuki, M., 475F, 2440T<br />

Suzuki, N., 2882T<br />

Suzuki, S., 2440T<br />

Suzuki, T., 1317T*, 2823F<br />

Suzuki, Y., 1631T, 2174F,<br />

2264F, 2619W, 2923W<br />

Svaneby, D., 1565W<br />

*Presenting Author<br />

Svensson, P., 2369F<br />

Svensson, P.-J., 3245W<br />

Svetkey, L. P., 147<br />

Svidzinski, A. E., 3324T*<br />

Svirski, R., 2691F<br />

Swami, S., 585F<br />

Swaminathan, K., 3726W<br />

Swaminathan, S., 2531F<br />

Swamy, S., 596W<br />

Swan, G. E., 642T<br />

Swan, H., 1835W<br />

Swanson, D. M., 1397W*<br />

Swanson, W., 3306T<br />

Swaroop, A., 385, 822F,<br />

824F, 827F, 830F, 1774W,<br />

2135F, 2183F, 2680W<br />

Swedish Schizophrenia<br />

Consortium, 2487W,<br />

3442T, 3452T<br />

Swedish Schizophrenia<br />

Consortium, ARRA<br />

Autism Sequencing<br />

Consortium, 290<br />

Sweeney, T., 397<br />

Sweetman, L., 1684T<br />

Swenson, J., 3182F<br />

Swerdlow, A., 2165F<br />

Swertz, M. A., 3610W<br />

Swierczek, S., 3297T<br />

Swift, C., 1684T<br />

Swindell, E. C., 1908W<br />

Swindle, K., 1983W<br />

Swinkels, D. S., 306<br />

Swinkels, M. E., 217<br />

Swoboda, K. J., 2581T,<br />

2951T<br />

Sw<strong>of</strong>ford, D. L., 1382W<br />

Syed, F., 3718W*<br />

Syed, S., 83<br />

Symer, D. E., Session 24<br />

Symoens, S., 129, 2225F<br />

Symons, R. C. A., 1989W<br />

Syngelaki, A., 3508T<br />

Syn<strong>of</strong>zik, M., 2797W<br />

Syoji, K., 2619W<br />

Sysoeva, E., 773W<br />

Sysol, J. R., 2683W<br />

Syvänen, A.-C., 567F,<br />

569F, 582W, 617T, 619T,<br />

1624T, 3217W, 3427T<br />

Szabo, C., 1219T<br />

Szafranski, K., 580W,<br />

1236W<br />

Szafranski, P., 432W, 2395T*<br />

Szak, S., 2561F<br />

Szatkiewicz, J. P., 1350T*<br />

Szatmari, P., 175, 2620T*,<br />

3086F<br />

Szekely, A., 334<br />

Szelinger, S., 3215W*<br />

Szepetowski, P., 2581T<br />

Szeto, D., 1605T<br />

Szigeti, K., 2489F*, 2542T<br />

Szkotnicki, L., 3648W<br />

Szkotnicki, L. T., 1251W<br />

Sznajer, Y., 124<br />

Sznewajs, A., 3198F*<br />

Szperl, A., 1330F<br />

Szpiech, Z. A., 3285T*<br />

Szporn, A., 3145W<br />

Szulkin, R., 1189T*<br />

Szulwach, K., 382<br />

Szulwach, K. E., 3483T*<br />

Szuto, A., 2342F, 2591F<br />

Szu Tu, C., 346, 2537F<br />

Szymanska, K., 403<br />

Szymanski, M., 2461T,<br />

2486F<br />

Szymczak, S., 1363F*,<br />

1512T, 1669T, 3591F<br />

T<br />

T1DGC, 1299T<br />

T2D-GENES, 176<br />

T2D-GENES Consortium,<br />

169, 269<br />

Taal, H. R., 2081F, 2162F<br />

Tabara, Y., 2361W*<br />

Tabatabai, Z. L., 408<br />

Tabatabaiefar, M. A., 59<br />

Taber, T., 693F, 713F<br />

Tabet, A. C., 901W*<br />

Tabor, H. K., Session 25,<br />

74, 94, 148, 171, 301*,<br />

1842F<br />

Taboulet, F., 1811W<br />

Tabuteau, S., 716T<br />

Tachdjian, G., 894T<br />

Tachmazidou, I., 2044T,<br />

3396T, 3412T*<br />

Tackney, J., 3323W<br />

Tag, J., 1295W<br />

Taggart, R. T., 3523T*<br />

Taghikhani, A., 1143W,<br />

1739W<br />

Taghizadeh, M., 779W*<br />

Tagliaferri, R., 3631F<br />

Taguri, M., 1290T<br />

Tahar Yacoubi, M., 403<br />

Taher, L., 407, 545F<br />

Taherian, N., 1065W<br />

Tahir Turanli, E., 2429F,<br />

2450F, 2841F, 3475T<br />

Tahmasebifar, A. T., 1096T<br />

Tai, E. S., 2094W<br />

Taibah, K., 2734W<br />

Taira, M., 2409W*<br />

Taja, L., 2365T<br />

Takada, L., 2639F<br />

Takada, T., 663F<br />

Takada, Y., 663F<br />

Takagi, S., 2569T<br />

Takahashi, A., 627T, 1631T,<br />

2004W, 2174F, 2506T<br />

Takahashi, H., 396<br />

Takahashi, K., 1998W,<br />

1999T<br />

Takahashi, M., 799W*<br />

Takahashi, Y., 52, 233,<br />

2409W, 2569T*<br />

Takamura, T., 1888T<br />

Takanari, H., 217<br />

Takanohashi, A., 2452T<br />

Takao, K., 2550W, 2647T<br />

Takashima, H., 2418W*,<br />

2601W, 2607W, 2616W,<br />

2823F<br />

Takata, R. I., 2596T<br />

Takazoe, M., 2174F<br />

Takeda, S., 232<br />

Takenouchi, T., 3093W<br />

Takeshima, Y., 729F, 781W<br />

Takeuchi, G., 2747T<br />

Talajic, M., 1678T<br />

Talasar, A., 1167W<br />

Talbot, K., 2470T<br />

Talebizadeh, Z., 2379W*<br />

Talebzadeh, F., 860T<br />

Talim, B., 751F, 2945T<br />

Talkowski, M., 70, 98,<br />

2562W<br />

Talkowski, M. E., 68*, 103,<br />

554W, 862T, 2458T<br />

Tallila, J., 252<br />

Talmud, P. J., 122, 2175W<br />

Talseth-Palmer, B. A., 916T<br />

Tal-Singer, R., 2249F<br />

Talwar, D., 2788W<br />

Talwar, P., 2967T<br />

Tam, A., 3085W<br />

Tam, C., 2279F, 2280W*<br />

Tam, K., 142<br />

Tam, P. H., 3123W<br />

Tam, P. K. H., 408, 1930T,<br />

2066F, 2932W<br />

Tam, S., 2660F<br />

Tam, T., 675F<br />

Tamada, I., 3192F<br />

Tamakoshi, A., 1833W<br />

Tamari, M., 2294F<br />

Tamaru, S., 2873T<br />

Tambets, K., 3286F*<br />

Tamburrini, G., 2235W<br />

Tamhankar, P., 2803W<br />

Tamiya, G., 1317T, 1549F<br />

Tamm, R., 2144F*<br />

Tammaro, R., 808F, 2810T<br />

Tammela, T. L., 995F, 1000T,<br />

1302T<br />

Tammesoo, M. L., 1832F<br />

Tampakeras, M., 2608T<br />

Tamraz, B., 335<br />

Tamura, A., 3221W<br />

Tan, A., 1446T*<br />

Tan, A. G., 2094W<br />

Tan, C., 1737W, 3090F<br />

Tan, C. S., 2561F<br />

Tan, D. E. K., 1934F<br />

Tan, E. C., 2889F, 3034T*<br />

Tan, G., 3200F<br />

Tan, M. H., 527F<br />

Tan, P., 2889F<br />

Tan, Q., 1365T, 2244W,<br />

2295W<br />

Tan, W., 1242W<br />

Tan, X., 2251T, 3089W,<br />

3648W<br />

Tan, X. X., 1251W<br />

Tan, Y., 1618T, 3210F*<br />

Tanabe, O., 52<br />

Tanaka, H., 396, 2174F,<br />

2697F, 2822T<br />

Tanaka, K., 2133W<br />

Tanaka, M., 233<br />

Tanaka, T., 1391W, 1631T,<br />

1643T, 2080T, 2116T<br />

Tanaka, Y., 2130W<br />

Tanck, M. W., 1604T


Tandon, A., 350, 3433T<br />

Tandy, S. L., 1767W<br />

Taner, N., 380<br />

Tanese, K., 2911W<br />

Tang, C. S., 2161T*, 2323T<br />

Tang, C. S. M., 1930T, 2066F<br />

Tang, F., 491F<br />

Tang, G., 893W*<br />

Tang, H., 159, 421F, 581F,<br />

646T, 1157F, 1408F,<br />

1504F, 2223W, 2634W,<br />

3318T, 3342T, 3383W<br />

Tang, L., 589F<br />

Tang, L. F., 362<br />

Tang, L. Y., 2985T<br />

Tang, M., 2973T, 3023T*<br />

Tang, P., 2254T<br />

Tang, P. L. F., 1694T<br />

Tang, W., 510W*, 1091F,<br />

1092W, 1094F, 1097F,<br />

1155W<br />

Tang, X., 2237F<br />

Tang, Y., 1591T*<br />

Tang, Z., 170, 966T*<br />

Tang, Z.-Z., 1010F<br />

Tang, Z. Z., 1076F<br />

Taniguchi, A., 2004W,<br />

2032T*, 2287T, 3221W<br />

Taniguchi, H., 8<br />

Taniguchi, M., 232*<br />

Taniguchi, T., 137<br />

Taniguchi, Y., 2458T<br />

Tanioka, F., 2507F<br />

Tanizawa, Y., 2679F<br />

Tanna, U., 3378T<br />

Tan-Sindhunata, G. M. B.,<br />

214<br />

Tantau, J., 77<br />

Tantisira, K., 623T, 638T<br />

Tantisira, K. G., 622T, 625T,<br />

811F, 2166W<br />

Tantravahi, U., 765W<br />

Tanzer, A., 506W<br />

Tanzi, R. E., Session 10,<br />

2520W<br />

Tao, J., 411<br />

Tao, K., 1783W<br />

Tao, R., 73<br />

Tapia-Guerrero, Y., 3124F*<br />

Tapscott, S., 2840T<br />

Tapscott, S. J., 55<br />

Tarabishy, Y., 1238F<br />

Tarantino, P., 2763F, 2766F,<br />

2774T, 2780T*<br />

Tarasova, L., 608T<br />

Tarassov, I., 329<br />

Tarazona, E., 3562W<br />

Tarazona-Santos, E.,<br />

1119W, 3325F*<br />

Tardif, J., 665F*<br />

Tardif, J.-C., 3401W<br />

Tardón, A., 1091F<br />

Tare, A., 1988F<br />

Tarekegn, A., 3322F<br />

Tarini, B. A., 313<br />

Tario, J. D., 3523T<br />

Tariq, M., 1674T*, 2920W<br />

Tariq, N., 2959W<br />

Tariq, S., 160<br />

Tarlé, R. G., 1978T*<br />

*Presenting Author<br />

Tarn, C., 853F*, 2300F<br />

Tarnopolsky, M., 2554T<br />

Taroni, F., 2764W, 2775F,<br />

2781F*<br />

Tarrier, B., 1568W, 2329T,<br />

2850F, 3664W<br />

Tartaglia, M., 215<br />

Tarway, M., 1097F<br />

Tasan, M., 2660F<br />

Taschner, P., 3586W*<br />

Taschner, P. E. M., 3610W,<br />

3611F<br />

Tascón-Peñaranda, E. P.,<br />

3315T, 3363T<br />

Tashiro, K., 724T, 2129F<br />

Tashtosh, R., 1881W<br />

Tasic, V., 845F<br />

Taskiran, E., 219<br />

Tasseva, G., 2755W<br />

Tassone, F., 2491T, 2634W<br />

Tat, M., 1167W<br />

Tata, S., 3569F<br />

Tatar, A., 1326T<br />

Tatè, R., 2810T<br />

Tatonetti, N., 646T<br />

Tatum, Z., 3611F<br />

Taub, M., 2461T, 2566T<br />

Taub, M. A., 1512T<br />

Taub, P. J., 2151W<br />

Tauer, U., 2917W<br />

Tavano, C., 3677F<br />

Tavares, A., 691F<br />

Tavares, P., 1778W*<br />

Tavares, V. L. R., 813F*<br />

Tavendale, R., 1082F<br />

Tavernier, J., 2660F<br />

Taviaux, S., 857W, 936T,<br />

2386T<br />

Tavormina, J., 76<br />

Tavtigian, S. V., Session<br />

4, 195, 1067F, 1213T,<br />

1783W*<br />

Tawamie, H., 2557T<br />

Tawil, R., 55, 2840T<br />

Tawk, M., 54<br />

Tay, S. K. H., 771W<br />

Tay, W. T., 2094W<br />

Tayama, C., 3499T<br />

Tayel, S., 930T*<br />

Taylor, A., 1257W<br />

Taylor, H. A., 1677T<br />

Taylor, H. G., 1295W<br />

Taylor, J., 967W, 2939T,<br />

2989T*, 3547F<br />

Taylor, J. C., 133*, 211<br />

Taylor, J. F., 2847F<br />

Taylor, J. G., 1259F<br />

Taylor, J. S., 1272W*<br />

Taylor, K. C., 2145W*<br />

Taylor, K. D., 1445W, 1916F,<br />

2153F<br />

Taylor, K. M., 2796F<br />

Taylor, K. T., 2131T<br />

Taylor, L., 142<br />

Taylor, M., 1318F*<br />

Taylor, N., 1109F<br />

Taylor, P., 315, 2874F*<br />

Taylor, P. L., 1836F<br />

Taylor, P. R., 1010F, 1076F,<br />

1218W<br />

SPEAKER AND AUTHOR INDEX 407<br />

Taylor, S., 218<br />

Taylor, S. P., 1685T<br />

Tayo, B., 1959W*, 2063F<br />

Teckman, J., 735F<br />

Tedeschi, G., 2095T<br />

Tedeschi, H., 514W<br />

Teer, J. K., 1690T, 1696T<br />

Teerlink, C., 1001F*, 1149W<br />

Tegg, E., 932T*<br />

Teglas, S., 107<br />

TeGrootenhuis, L. T., 2301W<br />

Teh, M. S., 3267T<br />

Teichgraeber, J. F., 1908W<br />

Teilum, M. W., 1194W<br />

Teimori, H., 892T<br />

Teive, H. A., 2475W<br />

Teive, H. A. G., 2609F<br />

Teixeira, P., 1593T<br />

Tejasvi, T., 154, 1952F<br />

Tejeda, L., 507F<br />

Tejero, E., 526W<br />

Tekin, M., 57*, 297, 2719W,<br />

2772F, 3125W<br />

Tembe, W., 1240T<br />

te Meerman, G. J., 1284T,<br />

1503T<br />

Temel, S., 1708T*<br />

Temple, I. K., 3494T*<br />

Templeton, A. K., 566W<br />

Temtamy, S., 2937F<br />

Teng, W., 2721F<br />

Teng, Y., 655T*<br />

Tengström, M., 1114T<br />

Tengvall-Linder, M., 1939T<br />

ten Kate, S., 3159W<br />

Tenniswood, M., 1192T<br />

Teo, Y., 1418W<br />

Teo, Y. Y., 2094W, 3284W,<br />

3339T<br />

Tepperberg, J., 949W<br />

Terai, M., 1631T<br />

Teramo, K., 3030T<br />

Terao, C., 2004W, 2361W<br />

Terdiman, J., 1059W<br />

Terhal, P., 217<br />

Terhal, P. A., 2848W, 2886F<br />

Terhorst, L., 1884W<br />

Terk, M., 1309F<br />

Ter Kuile, M., 1788W<br />

Terrier, B., 177<br />

Terry, J. G., 1913F<br />

Terry, M. B., 1213T<br />

Terwilliger, J. D., 194,<br />

897W, 1563T, 2179T*,<br />

2208W<br />

Terwisscha van Scheltinga,<br />

A. F., 2526W*<br />

Terzi, Y. K., 594W, 1013F,<br />

3003T, 3243W, 3424T,<br />

3426T*<br />

Terzioglu, G., 2429F<br />

Tesar, V., 3437T<br />

Tesarova, M., 699F, 752T*<br />

Teslovich, T. M., 46, 169*,<br />

176, 269, 1513F, 1923W,<br />

2308T, 2339F<br />

Tesmer, T., 3689F<br />

Tessari, M., 2696T<br />

Testa, F., 2950W<br />

Tester, D. J., 2885T, 2906T*<br />

Tétreault, M., 2797W,<br />

2900T*<br />

Teumer, A., 275, 584W,<br />

1284T, 1503T, 2080T*<br />

Texas Alzheimer Research<br />

and Care Consortium,<br />

2489F<br />

Teyssier, J.-R., 2729T<br />

Tezcanli Kaymaz, B., 1025F<br />

Tezenas du Montcel, S.,<br />

2545T*<br />

Thacker, M. M., 33<br />

Thackray, L., 3600W<br />

Thair, S. A., 1632T*<br />

Thakkar, P., 865W<br />

Thakur, M. L., 797W<br />

Thangaraj, K., 1950W,<br />

2967T, 2988T<br />

Thangavel, A., 3369T<br />

Thappa, B., 802W<br />

Thareja, G., 3369T<br />

Thauvin-Robinet, C., 403,<br />

2716W, 2729T, 2770W,<br />

2792T<br />

Theda, C., 3484T*<br />

Thedens, D. R., 404<br />

Theis, F. J., 2226W<br />

Theis, J. L., 1695T*<br />

Thekkoot, D. M., 2717T<br />

Thelma, B. K., 2382W,<br />

2941W*<br />

Thenral, S. G., 2941W<br />

Theodore, D., 630T<br />

Thera, M., 2255F<br />

Theusch, E., 601T, 615T*<br />

ThevaDas, K., 1625T<br />

Thevenon, J., 1293T*,<br />

2716W, 2770W, 2792T<br />

Thézé, N., 841F<br />

Thibert, R., 3119W<br />

Thibodeau, S., 28, 1001F,<br />

1267T<br />

Thibodeau, S. N., 986F,<br />

1067F, 1080W, 1206W,<br />

1214F*, 3564W<br />

Thiebaud, P., 841F<br />

Thiede, A., 849F<br />

Thiel, C. T., 2356T*<br />

Thiele, H., 105, 2759T, 2861T,<br />

2869W, 2930T, 2944W<br />

Thiering, E., 2162F<br />

Thiesen, M., 3579F<br />

Thiffault, I., 2771T*<br />

Thilbeault, K. S., 434W<br />

Thiruvahindrapuram, B., 175<br />

Thiselton, D. L., 2500T<br />

Thistlethwaite, P. A., 1051T<br />

Thobois, S., 2638T<br />

’t Hoen, P. A. C., 228, 542W,<br />

567F, 574W<br />

Thoenes, M., 236<br />

Thoeng, A. D., 2816T<br />

Thomale, J., 3524T<br />

Thomas, A., 2181W, 3508T<br />

Thomas, A. C., 303, 3501T*<br />

Thomas, A. W., 658T<br />

Thomas, B., 295, 1248W<br />

Thomas, C. E., 2241W<br />

Thomas, D., 1232F, 1569T*,<br />

3717F<br />

SPEAKER AND AUTHOR INDEX


408 SPEAKER AND AUTHOR INDEX<br />

Thomas, E., 1618T<br />

Thomas, E. R. A., 2005T<br />

Thomas, J., 368<br />

Thomas, K., 2492F<br />

Thomas, K. A., 2121W<br />

Thomas, K. B., 1251W,<br />

3648W<br />

Thomas, L., 29<br />

Thomas, L. I., 727F<br />

Thomas, M. A., 3141W,<br />

3511T<br />

Thomas, M. G., 3322F<br />

Thomas, M. K., 50<br />

Thomas, P., 2262W<br />

Thomas, R. G., 2405F<br />

Thomas, R. H., 262,<br />

2821W<br />

Thomas, S., 403*, 456W,<br />

3240F<br />

Thomasse, Y. E. M., 2909T<br />

Thomassen, G., 3614W<br />

Thompson, A., 45, 1082F,<br />

1088F, 2620T<br />

Thompson, B., 300<br />

Thompson, B. A., 1067F*,<br />

1274F*<br />

Thompson, C., 346, 2537F<br />

Thompson, C. L., Session<br />

76, 1086W<br />

Thompson, E. A., Session 75<br />

Thompson, E. R., 1224W*<br />

Thompson, J., 3529F,<br />

3637F, 3656W, 3703F*<br />

Thompson, J. R., 115<br />

Thompson, M. D., 298<br />

Thompson, M. K., 3314W<br />

Thompson, N. E., 1821W*<br />

Thompson, P. M., 2054F<br />

Thompson, S., 2143T,<br />

3303T, 3338W<br />

Thompson, Z., 1061F<br />

Thomson, N., 3528W,<br />

3662W*<br />

Thorburn, D. R., 326<br />

Thorgeirsson, S., 1199F<br />

Thorisson, G. A., 3610W<br />

Thorland, E. C., 66<br />

Thorleifsson, G., 109, 119,<br />

1308T, 2076W, 2137T<br />

Thorn, C. F., 633T, 635T<br />

Thornton, A. M., 26, 1089W,<br />

1226F, 2600F<br />

Thornton, C., 2824W<br />

Thornton, T., 1424W*<br />

Thornton-Thompson, S.,<br />

3449T<br />

Thornton-Wells, T., 1925F,<br />

2532W<br />

Thornton-Wells, T. A.,<br />

2401T, 3275W<br />

Thorsteinsdottir, U., 115,<br />

2165F, 2317T<br />

Thrush, D. L., 103<br />

Thun, M., 1012T, 1091F,<br />

1154F<br />

Thurman, R. E., 255, 402<br />

Thusberg, J., 496W<br />

Thyagarajan, B., 1921T<br />

Tian, A., 3695F<br />

Tian, C., 2915T<br />

*Presenting Author<br />

Tian, L., 2722W*, 2856F,<br />

2872W, 3561F, 3710W<br />

Tian, Q., 2053T<br />

Tian, S., 1269W<br />

Tian, Y., 553F, 2479T*<br />

Tibben, A., 1788W*<br />

Tibbetts, C., 1165T<br />

Tibbo, P., 2474F<br />

Tibboel, D., 834F<br />

Ticca, A., 2039F<br />

Tice, R., 3490T<br />

TIC <strong>Genetics</strong> Team, 2602T<br />

Ticozzi, N., 2775F<br />

TIDE BC, Treatable<br />

Intellectual Disability<br />

Endeavor in British<br />

Columbia, 750T<br />

Tidhar, R., 2869W<br />

Tidyman, W. E., 3242F<br />

Tiemeier, H., 431F, 2105F,<br />

2164T<br />

Tien, L., 2785W, 2892F<br />

Tienari, P., 2350T<br />

Tien Yin, W., 2041T<br />

Tieva, A., 1026W*<br />

Tiffin, N., 1808F<br />

Tifft, C., 359, 2870T<br />

Tifft, C. J., 2938W, 3543F<br />

Tikhomirov, A., 2333F*<br />

Tikkanen, E., 1709T*<br />

Tiller, G., 1866F<br />

Tilley, M. K., 3616W<br />

Tilling, K., 1583W<br />

Tillis, C., 3036F<br />

Tillman, V., 2703F<br />

Tillmann, H., 531F<br />

Tillmans, L. S., 986F<br />

Tiloca, C., 2775F<br />

Tim, R. C., 3014T<br />

Timman, R., 1788W<br />

Timmerman, V., 201, 2948T<br />

Timmermans, J., 80<br />

Timmers, H. J. L. M., 1220F<br />

Timms, L., 1093T, 1256F*<br />

Timpano, K. R., 261<br />

Timpson, N., 1567F, 2097W,<br />

2164T<br />

Timpson, N. J., 1318F,<br />

1528F, 1583W, 1626T,<br />

2081F*, 2162F, 2169W<br />

Timur, Z., 2669T<br />

Tin, A., 1932W*<br />

Tinat, J., 32, 1222T*<br />

Tincheva, R. S., 923W<br />

Tindall, E. A., 1085F*<br />

Ting, W., 1894T<br />

Tingaud, A., 841F<br />

Tinker, L., 2020T<br />

Tinker, S. W., 253<br />

Tinschert, S., 2403W<br />

Tintle, N., 1371T*<br />

Tiomkin, M., 788W<br />

Tipney, H., 649T<br />

Tipton, l., 249<br />

Tiraboschi, E., 1976F<br />

Tirado, C. A., 873W, 970T*<br />

Tiranti, V., 2810T<br />

Tirapo, C., 1205F<br />

Tiret, L., 2681T<br />

Tirri, D., 2377T<br />

Tischfield, J., 2582F<br />

Tischfield, J. A., 261,<br />

2433W, 2602T<br />

Tischkowitz, M., 1257W*<br />

Tischler, T., 2904F<br />

Tishk<strong>of</strong>f, S., 283, 518W,<br />

3306T<br />

Tishk<strong>of</strong>f, S. A., 3303T,<br />

3338W<br />

Title, A., 3506T<br />

Titus, T., 2916F<br />

Tivey, A., 101, 291, 364<br />

Tiwari, A., 628T<br />

Tiwari, H., 1410T, 3443T<br />

Tiwari, H. K., 434W<br />

Tiziano, F. D., 54<br />

Tjernagel, J., 299<br />

To, K., 2254T<br />

To, M. N., 2384F<br />

Tobias, E., 126<br />

Tobias, J. H., 1528F, 2169W<br />

Tobin, K., 2523W<br />

Tobler, K. J., 2998T*<br />

Toburen, D., 3677F<br />

Tochigi, M., 2370W<br />

Toda, T., 232, 2550W,<br />

2619W, 2963T, 3513T<br />

Todd, E., 3232F, 3244F*<br />

Todd, J., 453F<br />

Todorovic, S., 201<br />

Toes, R., 461F<br />

T<strong>of</strong>anelli, S., 3377W<br />

T<strong>of</strong>fey, D., 2218T<br />

Toga, A. W., 3587F<br />

Tohonen, V., 807F<br />

Toi, A., 3075W<br />

Toji, L., 966T<br />

Tokarz, S., 2830W, 3287W<br />

Tokita, Y., 1574W, 2747T<br />

Tokuda, Y., 2129F<br />

Tokunaga, K., 1994F,<br />

2130W, 2349W, 2496W,<br />

2656T, 3301F<br />

Tokunaga, S., 2418W,<br />

2607W, 2616W, 2823F*<br />

Tokuzawa, Y., 2873T<br />

Toland, A., 1740W*<br />

Toland, A. E., 1274F<br />

Toledo, R. C., 3324T<br />

Toledo, R. C. P., 3375T*<br />

Tolentino, C., 2136W<br />

Toliat, M. R., 2861T<br />

Tolmie, J., 127<br />

Tolstrup, N., 1194W<br />

Toma, A. M., 1528F<br />

Toma, C., 2578T*<br />

Toma, J., 3682W<br />

Tomaselli, G. F., 305<br />

Tomasini, L., 334<br />

Tomatsu, S., 786W*<br />

Tomblin, J. B., 1973F, 3735F<br />

Tomczuk, M., 2675T<br />

Tomelleri, G., 1776W<br />

Tomer, Y., 573F<br />

Tominaga, M., 2891T,<br />

3094F<br />

Tomiuk, M., 954T<br />

Tomiyama, H., 1730W*,<br />

2559W, 2619W, 3134F,<br />

3221W<br />

Tomizawa, K., 2822T<br />

Tomlinson, I., 133, 1072T,<br />

1531F, 2580W<br />

Tomlinson, J. W., 3211W<br />

Tomlinson, M. W., 3020T<br />

Tommerup, N., 805F<br />

Tommiska, J., 2707W*<br />

Toncheva, D., 3477T, 3481T<br />

Toncheva, D. I., 923W<br />

Tonduti, D., 2786T<br />

Tonekaboni, S. H., 3197W<br />

Toneva, I., 3636W<br />

Tong, C., 2721F<br />

Tong, C. H., 1603T<br />

Tong, L., 2025W<br />

Tong, S., 238<br />

Tong, X., 1540F<br />

Tong, X.-Z., 166<br />

Tonge, P., 3463T<br />

Tongkobpetch, S., 709F,<br />

1944W, 2006F<br />

Toniolo, D., 2165F, 2366F<br />

Tönjes, A., 2080T<br />

Toome, K., 1140W<br />

Topacio, D., 1237T<br />

Topaloglu, H., 54, 201, 751F,<br />

2945T, 2948T<br />

Topcuoglu, N., 1025F<br />

Topete -Gonzalez, L. R.,<br />

3187W<br />

TOPIC Study, 243<br />

Topol, E. J., 146, 1239W,<br />

1839W<br />

Topp, S., 348<br />

Topper, S., 1737W*<br />

Topuz, F., 1746W<br />

Torabi Dalivandan, S.,<br />

3083W*<br />

Toralles, M. B. P., 2642F<br />

Torchia, B., 902T*<br />

Torelli, S., 2812W<br />

Torgerson, D. G., 158<br />

Toriello, H., 3037W<br />

Torii, C., 2882T, 3093W,<br />

3105W<br />

Tornador, C., 2303F, 2593T<br />

Tornes, L., 2049W<br />

Torniainen, M., 252<br />

Toro, C., 359, 2610W,<br />

2870T, 3543F<br />

Toro, J. R., 766W, 1012T*<br />

Toro-Ramos, A. J., 2433W<br />

Torres, F. R., 514W, 2876T*<br />

Torres, J. M., 2192F*<br />

Torres, L., 875W, 956T,<br />

1049F<br />

Torres, M., 2153F<br />

Torres, M. M., 2456F<br />

Torres, N., 526W<br />

Torres, T. T., 813F<br />

Torres, V. E., 1909T<br />

Torres-López, J., 1168T<br />

Torres Maldonado, L. C.,<br />

1048T*<br />

Torri, F., 2459F, 2469W,<br />

2564F, 3587F*<br />

Torrico, B., 2578T<br />

Torstenson, E., 1489F,<br />

3275W, 3603F*<br />

Tortorella, G., 2766F


Torun, D., 590W, 1136F*,<br />

3195W<br />

Tosca, L., 894T<br />

Toscanini, U., 3364F, 3402T<br />

Tosi, L. L., 33<br />

Tosi, M., 1222T<br />

Tosolini, L., 1607T<br />

Toth, C. L., 162<br />

Totoki, Y., 396<br />

Tou, B., 894T<br />

Touho, H., 1290T<br />

Touitou, I., 3121W, 3166F<br />

Toung, J., 544W<br />

Toung, J. M., 370<br />

Touraine, R., 84, 127<br />

Tournaire, M., 936T, 3121W,<br />

3166F<br />

Tournev, I., 201, 2948T<br />

Tournier, I., 32*, 1222T<br />

Toussaint, W., 2225F<br />

Toutain, A., 403<br />

Toutain, J., 473F<br />

Touvana, E., 3017T<br />

Tovar, A. R., 526W<br />

Towne, B., 2146T*<br />

Towne, C., 1729W, 3680W<br />

Townsend, A., 1840F,<br />

1846W<br />

Toy, T., 315<br />

Toyama, Y., 2287T<br />

Toyoada, A., 2835F<br />

Toyoda, C., 2559W<br />

Toyoda, H., 2496W<br />

Tozer, E., 3698W<br />

Trabetti, E., 2548T, 2659T<br />

Trabzuni, D., 374, 564W<br />

Trachtenberg, E., 1589T<br />

Tracy, K. L., 1856F<br />

Tracy, R. P., 170, 1408F<br />

Traeger-Synodinos, J.,<br />

2995T<br />

Tragante, V., 1606T<br />

Tragante do O., V., 1659T*<br />

Trager, E., 2135F<br />

Trainer, A. H., 1224W<br />

Tran, A. N., 1126T<br />

Tran, B., 135<br />

Tran, C. K., 1691T<br />

Tran, K., 532W<br />

Tran, N., 2262W, 2320T,<br />

2343W, 2661W<br />

Tran, N. H., 1998W, 1999T<br />

Tran, P., 3694W<br />

Tran, T., 688T<br />

Tranah, G. J., 2375F<br />

Tran Mau-Them, F., 3166F<br />

Tran-Viet, K., 2328W, 3521T<br />

Traupe, H., 2160W, 2869W<br />

Trautmann, U., 2356T<br />

Travaglini, L., 943W, 2777T<br />

Traylor, M., 1313W*<br />

Traynor, B. J., 2611T, 2648F<br />

Treacy, R., 1257W<br />

Treadwell, M., 145, 1810F<br />

Trebušak Podkrajšek, K.,<br />

2688F, 2710W*<br />

Trecroci, F., 2597F*<br />

Trede, N., 365<br />

Treff, N., 2968T<br />

Treff, N. R., 2999T*<br />

*Presenting Author<br />

Tregidgo, C., 3694W<br />

Treherne, A., 766W*<br />

Treloar, S. A., 2056T, 2133W<br />

Trembath, R. C., 154,<br />

1927T, 2804T, 2896W,<br />

2925F<br />

Trembath, R. T., 780W<br />

Trenkwalder, C., 2568W<br />

Trent, J. M., 1186T, 1240T<br />

Treskes, M., 2205W<br />

Tretli, S., 991T<br />

Trevisan, C. P., 1776W<br />

Triche, E., 76<br />

Trifiro, M., 398<br />

Triggs-Raine, B., 2772F<br />

Trimble, V., 2283W<br />

Trindade-Filho, A., 3261T<br />

Trinh, C., 532W<br />

Trinh, J., 346, 2537F*<br />

Trinh, Q., 1093T<br />

Trinh, X. M., 1998W<br />

Trinidad, S. B., 1828F<br />

Trip, M. D., 1604T<br />

Tripodis, Y., 2488T<br />

Tristán, A., 2578T<br />

Trivellin, G., 2708T<br />

Troakes, C., 3471T, 3476T<br />

Troge, J., 2587T<br />

Trojanowski, J., 2538W<br />

Tromp, G., 1447F<br />

Trompet, S., 109<br />

Troncoso, J. C., 2648F<br />

Trost, J., 1021T<br />

Trost, M., 1545T*, 3664W<br />

Trost, M. K., 276<br />

Troup, C., 3690W<br />

Troyanskaya, O. G., 1501F<br />

Troyer, D., 2717T<br />

Trubetskoy, V. V., 1495F*<br />

Trucco, G., 993W<br />

Truitt, B., 1295W, 2020T<br />

Trujillano, D., 2303F, 2593T*<br />

Trujillo, A. M., 3499T<br />

Trujillo, C., 222<br />

Trujillo, I., 3504T*<br />

Trump, D. L., 3428T<br />

Tryka, K. A., 1566T<br />

Trynka, G., 155, 461F,<br />

1330F, 1907F, 2088W<br />

TSA Consortium for<br />

<strong>Genetics</strong>, The<br />

International OCD<br />

Foundation <strong>Genetics</strong><br />

Collaborative, 3540W<br />

Tsafantakis, E., 2044T, 3396T<br />

Tsai, A., 905W*<br />

Tsai, A. C.-H., 432W, 898T<br />

Tsai, E. A.-L., 2316W*<br />

Tsai, H., 2571W, 3026T*<br />

Tsai, M., 2606F, 3376F*<br />

Tsai, P., 511F<br />

Tsai, P.-T., 1955F<br />

Tsai, Y., 989F<br />

Tsai, Y. Y., 1156T<br />

TSAICG, 1480F<br />

TSAICG, IOCFGC, TS GWAS<br />

Consortium, 2519F<br />

Tsakok, T., 2138F<br />

Tsalamlal, A., 29<br />

Tsalenko, A., 3588W*<br />

SPEAKER AND AUTHOR INDEX 409<br />

Tsaliki, E., 3017T<br />

Tsan, M., 3697F<br />

Tsang, K. M., 2421W*<br />

Tsang, M., 3238F*<br />

Tsang, P., 975W<br />

Tsang, S. H., Session 78,<br />

393<br />

Tsao, B. P., 1979F, 2046W<br />

Tsao, D., 3522T<br />

Tsao, J. W., 2702T<br />

Tsao, M.-S., 1108T<br />

Tsaprouni, L., 583F, 3453T<br />

TSB LifeTech Consortium,<br />

133<br />

Tsernikova, N., 1308T,<br />

2076W<br />

Tsetskhladze, Z., 309*<br />

Tsilidis, K. K., 109, 1390F<br />

Tsimiklis, H., 1213T<br />

Tsironi, E. E., 385, 1305T<br />

Tsitlaidou, M., 1228T<br />

’t Slot, R., 400<br />

Tso, S.-C., 2742F<br />

Tsoi, L. C., 154*, 1952F<br />

Tsongalis, G., 3465T<br />

Tsoutsman, T., 1664T<br />

Tsuda, K., 548W, 558W<br />

Tsui, E., 1034F<br />

Tsuji, S., 52, 233, 2349W,<br />

2409W, 2569T<br />

Tsukahara, M., 2758W<br />

Tsukahara, S., 1980W<br />

Tsukikawa, M., 534W,<br />

2943F<br />

Tsuneda, S. S., 2876T<br />

Tsunemi, T., 565F*, 2456F<br />

Tsung, E., 3670W<br />

Tsunoda, T., 396, 1552F,<br />

1631T, 1643T, 2004W,<br />

2051F, 2071T, 2174F,<br />

3565F<br />

Tsuruda, L., 763W, 784W<br />

Tsurusaki, Y., 2822T, 2878W<br />

Tsz-Wai Pang, R., 2796F<br />

Tu, W., 1969T<br />

Tucker, M., 1012T, 1160F,<br />

1517W<br />

Tucker, M. A., 30, 1010F,<br />

1218W<br />

Tufano, J. T., 1828F<br />

Tuff, J. F., 490W*<br />

Tufik, S., 2592W<br />

Tuggle, C. K., 2717T<br />

Tukiainen, T., 656T, 2173T*<br />

Tully, R., 3582W, 3625F<br />

Tully, R. E., 3732W<br />

Tumini, S., 2777T<br />

Tumino, R., 1712T<br />

Tunca, Y., 590W<br />

Tuncer, F. N., 2396F*,<br />

2412W<br />

Tung, J., 1514W<br />

Tung, J. Y., 106, 114, 626T,<br />

1017W, 1782W, 1838F*,<br />

2089T, 2100W, 2111F,<br />

2115W, 2127W, 2149T<br />

Tuomilehto, J., 1608T<br />

Tupler, R., 1776W<br />

Turbon, D., 3364F<br />

Turbón, D., 3402T<br />

Turecek, F., 727F<br />

Turecki, G., 2338T, 2482T,<br />

3470T<br />

Turk, W., 3276T<br />

Turnbull, C., 213<br />

Turner, A., 1645T*, 1774W<br />

Turner, B., 3528W<br />

Turner, C., 2935W<br />

Turner, C. L. S., 217<br />

Turner, E., 10, 2740W<br />

Turner, E. H., 170<br />

Turner, I., 3279T<br />

Turner, I. H. C., 472W*<br />

Turner, K., 935W<br />

Turner, S., 3228F<br />

Turner, T., 13*<br />

Turnherr, S., 415F<br />

Turnpenny, P., 2935W<br />

Tursi, R. M., 2572T<br />

Turunen, U., 2023T<br />

Tuschl, K., 167*<br />

Tusie-Luna, T., 2256W<br />

Tuulio-Henriksson, A., 252<br />

Tüysüz, B., 3132F*<br />

Tuzov, N., 1562W*<br />

Tuzovic, L., 3046F*<br />

Tweddale, B., 2785W,<br />

2892F, 2904F<br />

Twigg, S. R., 219<br />

Twigg, S. R. F., 218*, 2746W<br />

Tybjærg-Hansen, A.,<br />

Session 21<br />

Tylavsky, F. A., 3480T<br />

Tyler, R. C., 2903T<br />

Tyler, S., 490W<br />

Tyler-Smith, C., 41, 3322F,<br />

3377W<br />

Tymrakiewicz, M., 205,<br />

1011W<br />

Tynan, J., 2973T, 3023T<br />

Tyndale, R. F., 642T<br />

Tynninen, O., 1253F<br />

Tyrer, J., 210<br />

Tyrrell, J., 2148W<br />

Tyynismaa, H., 327<br />

Tzadok, M., 660T<br />

Tzeng, J., 1538W*<br />

Tzeng, J. Y., 1350T<br />

Tzetis, M., 2995T<br />

Tziotzios, C., 33<br />

Tzoulis, C., 2451W<br />

U<br />

U., L., 3395W, 3397W<br />

Uda, M., 110, 113, 847F,<br />

2001W<br />

Udagawa, Y., 475F<br />

Udar, N., 1176W, 1963T,<br />

3686W*<br />

Udd, B., 2945T<br />

Uddin, M., 435F, 448W,<br />

454W*<br />

Udelsman, R., 1241F<br />

Udpa, N., 1471F*, 3307F<br />

Uebe, S., 2160W, 2557T<br />

Uebelhoer, M., 1611T*<br />

Ueffing, M., 86<br />

Uehara, D. T., 891W, 914T<br />

SPEAKER AND AUTHOR INDEX


410 SPEAKER AND AUTHOR INDEX<br />

Uehara, N., 2873T<br />

Ueki, M., 1549F<br />

Ueno, M., 2129F<br />

Ueno, Y., 1549F<br />

Ugolini, D., 1153T<br />

Ugur Iseri, S. A., 2396F,<br />

2412W<br />

Uher, R., 2509T<br />

Uhl, G., 2541W*<br />

Uhlhaas, S., 1005W<br />

Uhlmann, W. R., 317<br />

Uhrich, S., 668T<br />

Uicab-Pool, G., 2272T<br />

Uitterlinden, A., 2366F,<br />

3608W<br />

Uitterlinden, A. G., 87, 109,<br />

431F, 584W, 1284T,<br />

1334W, 1503T, 1659T,<br />

2053T, 2081F, 2105F,<br />

2141F, 2165F, 2169W<br />

UK10K, 809F<br />

UK10K, UKIBDGC, 354<br />

UK10K Cohorts Goup,<br />

1411F<br />

UK10K Consortium, 45,<br />

216, 1518T, 2812W<br />

UK10K Consortium Cohorts<br />

Group, 1522F, 3645F<br />

UK10K Statistics Group,<br />

2304W<br />

UK Brain Expression<br />

Consortium, 374<br />

UK <strong>Genetics</strong> Prostate Cancer<br />

Study Collaborators,<br />

PRACTICAL Consortium,<br />

1011W<br />

Ukkola-Vuoti, L., 2181W<br />

UK PBC Consortium and<br />

Wellcome Trust Case<br />

Control Consortium 3,<br />

153<br />

Ukraintseva, S., 2027F*,<br />

2194T<br />

Ulivi, S., 1484W, 2128T<br />

Ullmann, R., 2732T<br />

Ullmer, B., 3270T<br />

Ulloa, R., 57<br />

Ullrich, N., 3177W<br />

Ulmer, M., 386*, 2135F<br />

Ulz, P., 1115F<br />

Um, S., 1591T<br />

Umana, L. A., 1646T*<br />

Umar, M., 1137W*<br />

Umbach, D. M., 1416T<br />

Umbarger, M., 1729W,<br />

3680W<br />

Umbarger, M. A., 3640W,<br />

3693F*<br />

Umekage, T., 2370W<br />

Umeno, J., 2174F<br />

Umesh, A., 1190F<br />

Umicevic Mirkov, M., 621T*<br />

Underhill, H. R., 2530T*<br />

Underhill, P., 3321T<br />

Underhill, P. A., 186, 3368W<br />

Undlien, D. E., 3510T,<br />

3614W<br />

Unger, S., 129, 3075W<br />

Unique Rare Chromosome<br />

Support, 66<br />

*Presenting Author<br />

United Kingdom and<br />

Ireland Renal Transplant<br />

Consortium, the<br />

Wellcome Trust<br />

Case-Control<br />

Consortium 3, 2082W<br />

Uno, S., 2133W<br />

Unutmaz, D., 713F<br />

Upadhyay, R., 1137W<br />

Uppal, S. S., 2267F<br />

Upsall, E., 3695F<br />

Upton, S., 3176F<br />

Urano, F., 2472W<br />

Urano, W., 2032T<br />

Urban, A., 551F, 579F, 2372F<br />

Urban, A. E., 334*, 369,<br />

425F, 3658W<br />

Urban, Z., 129, 820F*,<br />

2761W<br />

Urbanek, M., 2327F<br />

Urdal, P., 643T<br />

Urnov, F. D., 255, 803W<br />

Uro-Coste, E., 2945T<br />

Urquhart, J., 2852T<br />

Urraca, N., 3119W*<br />

Urru, M., 113, 177<br />

Urru, M. F., 1451W, 1516F<br />

Ursini, M. V., 505F, 2629T<br />

Urtatiz, O., 3225W*<br />

Usala, G., 2001W<br />

Useche, F., 3459T<br />

Usher-Ridge, B., 1785W<br />

Utami, K. H., 3047W*<br />

Utiramerur, S., 1232F,<br />

3670W<br />

Utsumi, Y., 663F<br />

Utz, J., 1855F*<br />

Uwineza, A., 3104F*<br />

Uyama, E., 2409W<br />

Uyar Bozkurt, S., 2429F<br />

Uyenoyama, M., 3392T*<br />

Uyguner, O., 1<br />

Uysal, H., 2924T<br />

Uzumcu, A., 1<br />

Uzun, A., 76*, 3024T<br />

V<br />

Vaags, A., 2525F<br />

Vaags, A. K., 2575T, 3086F<br />

Vaccargiu, S., 2128T<br />

Vaccarino, F., 334<br />

Vaché, C., 2947W<br />

Vachin, P., 72<br />

Vachon, C., 1150T<br />

Vacic, V., 3346F<br />

Vadapalli, A., 971W*<br />

Vadasz, E., 2414F, 2654F<br />

Vadlamudi, S., 1627T,<br />

<strong>2012</strong>F<br />

Værum, M., 3641F, 3662W<br />

Vago, P., 894T<br />

Vaidla, K., 1140W<br />

Vaidya, D., 1652T, 1710T*<br />

Vaidya, S., 1234T*<br />

Vaidyanathan, R., 585F*,<br />

3718W<br />

Vainz<strong>of</strong>, M., 1727W<br />

Vairo, F., 696T*<br />

Vairo, F. P., 1217F<br />

Vaitsiakhovich, T., 1332T<br />

Vakil, H., 130<br />

Valabregue, R., 2539T<br />

Valdes, A., 2292W<br />

Valdes, A. M., 2171F,<br />

2341T*<br />

Valdés-Mas, R., 2578T<br />

Valente, A. L., 1002W*<br />

Valente, E. M., 943W, 2777T<br />

Valentini, M., 157, 1516F<br />

Valenzano, K. J., 732T<br />

Valenzuela, I., 2930T, 3208F<br />

Väliaho, J., 496W<br />

Valladares, O., 342, 2316W<br />

Vallance, H., 750T<br />

Vallant, E., 3116F<br />

Vallat, J. M., 328<br />

Valle, A. C., 2655W<br />

Valle, D., Session 28,<br />

Session 74, 227, 520W,<br />

2387F, 2461T, 2486F,<br />

2566T, 2573F, 3131W<br />

Vallender, E., 595F<br />

Valles-Ayoub, Y., 682T<br />

Vallier, L., 3507T<br />

Valsesia, A., 84<br />

Valverde, K., 1781W<br />

van Aalst, J., 2756T<br />

Vanakker, O., 128, 129, 423F<br />

Vanakker, O. M., 833F,<br />

1790W, 3137W*<br />

van Amstel, J. K. P., 2886F*<br />

van Asperen, C. J., 27<br />

Vanasse, M., 2900T<br />

van Attikum, H., 27<br />

Van Baaren, J. M., 588W<br />

van Beek, R., 955W, 979W<br />

van Beelen, E., 58<br />

van Bers, M., 58<br />

van Beusekom, E., 214<br />

van Bever, Y., 980T<br />

Van Binsbergen, E., 423F<br />

van Bokhoven, H., 100, 102,<br />

125, 160, 214, 2863W<br />

van Bon, B. W. M., 97, 100,<br />

103, 124, 125<br />

Van Booven, D., 9, 3706W<br />

Van Broeckhoven, C., 2815W<br />

van Buggenhout, G., 925W<br />

Van Camp, G., 59, 2104T<br />

Van Cauwenbergh, C., 539F<br />

Vance, D. D., 2185T*<br />

Vance, J., 492W, 2603F*,<br />

2668W, 2755W<br />

Vance, J. M., 270, 347,<br />

588W, 1871F, 2185T,<br />

2330F, 2470T<br />

van Dam, R., 2358W<br />

Van Dam, R., 2165F<br />

Van Damme, P., 201, 2948T<br />

Van Damme, T., 129<br />

van de Bunt, M., 2324F<br />

Van de Heyning, P. H.,<br />

2104T<br />

van de Kamp, J., 98<br />

van de Laar, M. A. F., 621T<br />

van den Akker, E. B.,<br />

1436W*<br />

van den Akker, W. M., 160<br />

Van den Berg, L. H., 431F<br />

Vandenberg, M., 2805F<br />

van den Berg, M. P., 1619T<br />

van den Bergen, J. C.,<br />

574W<br />

van den Boogaard, M. J.,<br />

2886F<br />

van den Boom, D., 2973T,<br />

3014T, 3016T, 3023T<br />

van den Bosch, B., 708T<br />

van den Bree, M. B., 2405F<br />

van den Broek, S., 1117T<br />

Van Den Eeden, S., 96<br />

van den Eijnde, R., 574W<br />

van den Elzen, C., 214<br />

van den Ende, J., 3193W*<br />

van den Heuvel, L., 2909T<br />

van den Linden, H., 2642F<br />

van den Oord, E. J. C. G.,<br />

3442T, 3452T<br />

Van den Veyver, I. B., 2802F,<br />

3495T<br />

Van den Wijngaard, A.,<br />

1711T, 3650W<br />

Van der Aa, N., 127, 423F,<br />

2527T, 2757F, 3193W<br />

van der Brug, M., 1539T<br />

van der Burgt, I., 215<br />

van der Harst, P., 110, 383,<br />

609T, 1659T, 2175W<br />

van der Heyden, M. A. G.,<br />

217<br />

Vander Horn, P., 3698W<br />

van de Rijn, M., 1054T<br />

van der Klauw, M. M.,<br />

2282F<br />

van der Laan, M., 1415W<br />

van der Maarel, S., 2840T*<br />

van der Maarel, S. M., 55,<br />

542W<br />

Van der Merwe, L., 3385F<br />

van der Merwe, L., 2007W,<br />

2217W<br />

van der Most, P. J., 2282F<br />

van der Schouw, Y. T.,<br />

1659T<br />

van der Smagt, J. J., 217<br />

van der Stoep, N., 3650W*<br />

van der Valk, R. J. P., 2168F*<br />

van der Veken, L. T., 3164F*<br />

van der Velde-Visser, S.,<br />

160<br />

Vanderver, A., 2452T,<br />

2786T*, 2797W<br />

van der Vleuten, C. J., 83<br />

van der Vliet, P. J., 55<br />

van der Voorn, 3200F<br />

van der Zee, J., 2815W*<br />

van der Zwaag, B., 2848W,<br />

3650W<br />

van der Zwan, Y., 1122W<br />

van de Vondervoort, I.,<br />

100, 160<br />

van de Warrenburg, B. P., 160<br />

van de Warrenburg, B. P. C.,<br />

1734W<br />

Vandeweyer, G., 1617T<br />

van de Zwan, Y., 1273T<br />

van Diemen, C. C., 1330F<br />

Van Dijck, P., 2948T


van Dijk, F., 459F<br />

Van Driest, S. L., 247*, 631T<br />

Vandrovcova, J., 1618T*<br />

van Duijn, C., Session 27,<br />

1592T, 2080T, 2107T<br />

van Duijn, C. M., 2175W,<br />

2193W, 2366F<br />

van Eerde, A. M., 2848W<br />

Van Eijk, K. R., 431F,<br />

2553W*, 3474T<br />

van Engelen, B., 2840T<br />

VanErp, T., 2564F<br />

van Erp, T. G. M., 2469W*<br />

Van Essen, T., 127<br />

Van Eyk, J., 80<br />

Vangapandu, V., 2979T<br />

van Gassen, K. L. I., 1220F<br />

van Gessel, S., 979W<br />

van Gessel, S. L. J., 955W<br />

Van Ghelue, M., 2965W*<br />

van Gilst, W. H., 609T,<br />

2175W<br />

Vangipuram, M., 803W<br />

Van Goor, F., 1731W<br />

van Haaften, G., 217*,<br />

2886F<br />

van Haelst, M. M., 217,<br />

2886F<br />

van Haren, N. E. M., 2526W<br />

van Harssel, J. J. T., 217<br />

van Hasselt, P., 672T<br />

van Heel, D., 155<br />

van Heel, D. A., 1330F<br />

van Helden, P., 2003F<br />

van Helden, P. D., 2007W<br />

van Heumen, C., 3159W<br />

Van Hirtum-Das, M., 1721W<br />

van Ho<strong>of</strong>t, P., 3316F<br />

Van Hout, C. V., 3269W*<br />

Vanhoutte, L., 2225F<br />

Vanhove, C., 2225F<br />

Van Hove, J. L., 2884W<br />

Van Hul, E., 2757F<br />

van Iperen, E. P. A., 1604T*,<br />

1606T<br />

Vanita, V., 1342F, 1890W,<br />

1891T, 2726T, 2730F,<br />

2735T, 2737W<br />

Van Itallie, C. M., 2663T<br />

van Karnebeek, C., 750T,<br />

756W*<br />

van Klinken, J., 2107T<br />

van Kogelenberg, M., 101,<br />

291, 364*<br />

van Koningsbruggen, S.,<br />

681F*<br />

Van Laarhoven, P., 819F*<br />

Van Laer, L., 79, 80, 1617T*<br />

Van Laere, K., 2527T<br />

Van Langenhove, T., 2815W<br />

van Lieshout, S., 217, 400,<br />

2886F<br />

VanLoy, C., 1237T<br />

Van Luchene, R., 3007T<br />

Van Maldergem, L., 129,<br />

3165W*, 3199W<br />

van Marrewijk, C. J., 243<br />

van Meurs, J. B. J., 584W,<br />

1284T, 1334W, 1503T<br />

Vannier, A., 2877F, 2937F<br />

*Presenting Author<br />

Van Oers, N., 2949F<br />

van Ommen, G., 582W<br />

van Ommen, G. J., 567F<br />

van Rahden, V., 2810T<br />

Van Ravenswaaij, C.,<br />

65, 124<br />

van Reeuwijk, J., 214<br />

van Riel, P. C. L., 621T<br />

van Rooij, F. J. A., 111,<br />

2073W<br />

van Rooij, J., 3608W<br />

van Slegtenhorst, M.,<br />

3650W<br />

van Spaendonck-Zwarts, K.<br />

Y., 1619T, 2909T<br />

van ’t H<strong>of</strong>, F. N. G., 87*<br />

Van Til, N., 796W<br />

van Tintelen, J. P., 1619T,<br />

2909T<br />

van Trotsenburg, A. S. P.,<br />

2701W<br />

van Tuil, M., 2886F<br />

van Vliet-Ostaptchouk, J.,<br />

2282F*<br />

Vanwijck, R., 2002T<br />

van Wyk, C., 1794W<br />

van Zutven, L. J. C. M., 980T<br />

van Zuydam, N. R., 609T<br />

van Zwet, E. W., 1436W<br />

van Zyl, S., 1085F<br />

Varadan, V., 3316F<br />

Vardarajan, B., 343, 1476T*<br />

Vardarajan, B. N., 2563T<br />

Varga, R. E., 2930T<br />

Vargas, E., 3290W<br />

Vargas, F. R., 2642F<br />

Vargas, G., 1119W<br />

Varilo, T., 252, 897W<br />

Varley, K. E., 1245W, 3527F,<br />

3687F<br />

Varma, R., 2153F<br />

Varner, M., 1904F<br />

Varret, M., 1607T*<br />

Varvil, T., 2397W<br />

Vasan, R. S., 1677T, 2080T<br />

Vaschalde, Y., 345<br />

Vasco, D. A., 3326W*<br />

Vasconcellos, J. F., 2655W<br />

Vasconcellos, J. P. C.,<br />

2286W, 2291F<br />

Vasenkova, I. A., 1245W,<br />

3687F*<br />

Vasey, S., 630T<br />

Vasishta, R., 802W<br />

Vasli, N., 2681T<br />

Vasquez, L., 2974T<br />

Vasseur, C., 1768W*<br />

Vassilev, L., 242<br />

Vasta, V., 688T<br />

Vasudevan, R., 1083W<br />

Vatanavicharn, N., 712T<br />

Vats, S., 1703T*<br />

Vatta, M., 314, 1735W,<br />

1742W, 1761W<br />

Vattathil, S., 1041W, 1258T*<br />

Vaughan, B., 3636W<br />

Vaughan, T. L., 2190W<br />

Vaughn, C. B., 1086W*<br />

Vaula, G., 550W<br />

Vaur, D., 32<br />

SPEAKER AND AUTHOR INDEX 411<br />

Vawter, M. P., 2459F,<br />

2469W, 2564F, 3587F<br />

Vaysse, A., 1158W, 2079W,<br />

2248T<br />

Vaz, F., 672T<br />

Vazquez, A. I., 2201F<br />

Vear, S., 247<br />

Veatch, O. J., 15*<br />

Veble, A., 3001T<br />

Vecchio-Pagán, B., 1450F<br />

Vece, T. J., 2883F<br />

Vedantam, S., 108, 2090F,<br />

2241W<br />

Vedes, J., 1977W<br />

Vedrenne, V., 329*<br />

Veenma, D., 834F<br />

Veeramah, K. R., 2788W*,<br />

3354T<br />

Vega, J. N., 2401T*<br />

Veillet, J., 54<br />

Vekemans, M., 77, 403,<br />

915W, 3172F, 3240F<br />

Velagaleti, G., 868T*<br />

Velasco, H., 703F*, 3069W,<br />

3190F<br />

Velazquez-Hernandez, N.,<br />

1121F<br />

Velázquez-Pérez, L., 3124F<br />

Velders, F., 2164T<br />

Veldink, J. H., 431F<br />

Veleri, S., 824F*, 827F<br />

Velez Edwards, D. R.,<br />

2131T, 3299W<br />

Velez-Ruiz, G., 2470T<br />

Velissariou, V., 3017T<br />

Velsher, L., 320, 1872F,<br />

1873F<br />

Veltman, I., 216<br />

Veltman, J., Session 73<br />

Veltman, J. A., 58, 97, 100,<br />

102, 160, 214, 672T,<br />

1749W<br />

Venâncio, M., 3019T<br />

Venceslá, A., 987W<br />

Venditti, C. P., 664T, 669F,<br />

674T, 721F, 738T, 2683W<br />

Venegas, A., 951W, 3074F<br />

Venegas, V., 1251W, 3648W<br />

Venema, A., 542W<br />

Venkat, A., 285<br />

Venkatesan, S., 1456F<br />

Venkateswara Rao, A., 224<br />

Venn, O., 285, 3279T*<br />

Vennemann, M., 86<br />

Venselaar, H., 215, 217<br />

Venter, P. A., 1085F<br />

Ventura, A., Session 76<br />

Ventura, M., 74, 94<br />

Venturini, C., 335, 2068T<br />

Vepsäläinen, S., 2348F<br />

Vera, M., 697F*, 734T<br />

Verbeek, A. L. M., 243<br />

VerBerkmoes, N., 2826F<br />

Verbitsky, M., 845F<br />

Vercelli, L., 1776W<br />

Verchere, C., 3006T<br />

Verdin, H., 2832F, 2927T*<br />

Verdu, P., 3351T<br />

Vergara, C., 1900T<br />

Vergara, C. I., 2043W*<br />

Vergin, C., 2719W<br />

Vergult, S., 98, 423F*<br />

Verheijen, F. W., 405<br />

Verhoeven, A., 2107T<br />

Verioes, A., 2887W<br />

Verkarre, V., 1212W<br />

Verloes, A., 124*, 127, 218,<br />

901W<br />

Verma, A., 1316W<br />

Verma, I. C., 1720W, 1877F,<br />

2754F, 3236F<br />

Verma, J., 1720W<br />

Verma, S., 440W<br />

Vermaas, E., 3694W<br />

Vermaat, M., 3586W, 3611F<br />

Vermeer, S., 160, 1734W<br />

Vermeesch, J., 894T<br />

Vermeire, S., 2319W<br />

Vermeulen, S. H., 87, 106,<br />

243, 621T<br />

Vernalis, M. N., 1649T<br />

Vernet, G., 2255F<br />

Vernon, H., 2915T<br />

Vernon-Smith, A., 109<br />

Vernot, B., 283<br />

Verrow, S., 3654W<br />

Verschuuren, J. J. G. M.,<br />

574W<br />

Verstuyft, C., 609T<br />

Verwaijen, P., 681F<br />

Verweij, N., 110<br />

Verwer, L., 98<br />

Vesa, J., 3144F<br />

Vestbo, J., 2249F<br />

Vester, A., 2470T<br />

Vetrini, F., 735F<br />

Vezain, M., 32<br />

Vézina, H., 1478W<br />

Vial, C., 1658T, 2065T*<br />

Vialard, F., 890T*<br />

Viale, A., 998F, 1159T<br />

Viali, S., 2159F<br />

Viana, J., 3476T<br />

Viana, M. M., 3107W,<br />

3110F*<br />

Vianna, G. S., 2434T<br />

Vianna-Morgante, A. M.,<br />

874T, 882T, 2863W,<br />

3250F<br />

Viatte, S., 2231F<br />

Vicari, S., 84, 3087W<br />

Vicente, A. M., 1968W,<br />

2017T, 2261F, 2417F,<br />

2502W<br />

Vidal, H., 2278T<br />

Vidal, M., 2660F<br />

Vidal, R., 394, 1207T,<br />

1215W*<br />

Vidal, V., 1204T<br />

Vieira, A. R., 1315F, 1936T<br />

Vieira, F., 3312T<br />

Vieira, F. G., 3289F*<br />

Vieira, M. L., 2288F<br />

Vieira, T., 1851F*, 1865F*<br />

Vieira, T. P., 959W<br />

Vieland, V. J., 2181W,<br />

2467T, 2523W*<br />

Vierkant, R. A., 3451T<br />

Vigeland, M., 1547W*<br />

Vigneron, J., 2770W<br />

SPEAKER AND AUTHOR INDEX


412 SPEAKER AND AUTHOR INDEX<br />

Vigouroux, A., 2957T<br />

Vigueras, R. M., 2365T<br />

Vihinen, M., 496W*, 992F,<br />

3610W<br />

Vihola, A., 2945T<br />

Viikari, J., 2097W, 2120F<br />

Viikari-Juntura, E., 2120F<br />

Vijai, J., 208, 1841W<br />

Vijayalakshmy, J., 911W<br />

Vijayarangakannan, P., 291,<br />

455F*<br />

Vijzelaar, R., 652T<br />

Vikkula, M., 83, 1015T,<br />

1611T, 2002T, 3156F<br />

Vikman, P., 47<br />

Vikram, N., 555F<br />

Vila, L. M., 1979F<br />

Vilain, E., 315, 361, 950T<br />

Vilar, M., 3373F<br />

Vilar, M. G., 3329W, 3377W<br />

Vilarino-Guell, C., 346*,<br />

2537F<br />

Vilboux, T., 3080F*<br />

Vilhelmsen, K., 363<br />

Vilhjalmsson, B., 350,<br />

1331W*, 1360F, 2199W,<br />

2210F<br />

Villa, E. C., 2495F<br />

Villamarin, R., 3625F<br />

Villamarin-Salomon, R.,<br />

3582W<br />

Villani, A. C., 528W<br />

Villanueva, C., 2845W<br />

Villanueva Dávalos, V.,<br />

2033F<br />

Villar, J., 2296T<br />

Villar, V., 245<br />

Villard, L., 2457W, 2536T,<br />

3165W<br />

Villarreal-Quiroga, P., 1030T<br />

Villarroel, C., 875W, 976T<br />

Ville, D., 2536T<br />

Ville, Y., 72, 77, 403<br />

Villela, D., 919W*<br />

Villems, R., 3286F<br />

Vilo, J., 1163F<br />

Vilske, S., 1006T<br />

Vimaleswaran, K. S., 271*<br />

Viñas, M., 2940F<br />

Vinasco, T., 3069W*<br />

Vincent, J., 2525F<br />

Vincent, J. B., 2398T,<br />

2570F*, 2575T<br />

Vincent, M., 1267T, 3121W*<br />

Vincent, Q., 1361W<br />

Vincenzi, O. C., 1037F,<br />

1038W*<br />

Vinci, M., 3114F<br />

Vinckenbosch, N., 3311W<br />

Vineis, P., 1712T<br />

Vinette, K. M., 2855T<br />

Vink, C., 3159W<br />

Vinkler, C., 3048F*, 3162F,<br />

3174F<br />

Vinod, B., 2113T<br />

Vinson, A., 2218T*<br />

Vinther-Jensen, T., 2765T<br />

Viñuela, A., 546W<br />

Viola, M., 2811F<br />

Viqaruddin, M., 3149W<br />

*Presenting Author<br />

Virani, S., 1688T<br />

Virdis, F., 1516F<br />

Virmond, M. L. C., 2289W<br />

Virmouni, S., 761W<br />

Virtamo, J., 1012T, 1091F<br />

Visakorpi, T., 1000T<br />

Viscardi, R. M., 3027T<br />

Viscidi, R. P., 2561F<br />

Visel, A., 4, 254, 407<br />

Vishwabandya, A., 931W<br />

Visitacion, M., 3669F<br />

Visitacion, M. R., 3709F*<br />

Viskochil, D., 3177W<br />

Visscher, P., 1360F, 2090F,<br />

2200T<br />

Visscher, P. M., 108, 351,<br />

1331W, 2366F<br />

Visser, G., 681F<br />

Visser, J., 2165F<br />

Vissers, L. E. L. M., 97, 100,<br />

102, 160, 214, 215, 672T,<br />

1749W, 2925F<br />

Vista, E. S., 529F, 2188T<br />

Viswanathan, A. C., 2068T<br />

Viswanathan, K., 1901F<br />

Vitale, C., 1985F<br />

Vitale, E., 1985F*, 3492T<br />

Vitart, V., 1383T, 1481W<br />

Vite, C. H., 785W<br />

Vitello, A., 100<br />

Vitiello, G., 943W<br />

Vittori, A., 2641T*<br />

Vivekandandan, S., 3316F<br />

Vives, L., 10, 278<br />

Vlasschaert, M., 460W<br />

Vlassov, A. V., 3723F<br />

Vlummens, P., 129<br />

Vnencak-Jones, C. L., 136<br />

Vo, D., 585F, 893W<br />

Vockler, J. S., 3558W<br />

Vockley, J., 657F*, 662T,<br />

733F<br />

Voegele, C., 1213T<br />

Voelkerding, K. V., 2720T,<br />

2951T, 3638W, 3643F<br />

Voest, E., 400<br />

Vogel, I., 3148F<br />

Vogel, J., 506W<br />

Vogel, K. J., 1225T<br />

Vogel, M., 3650W<br />

Vogel, S. N., 3027T<br />

Vogel, T. W., 404<br />

Vogel, W., 1080W<br />

Voglino, F., 1153T, 1712T<br />

Vogt, G., 3599F<br />

Vogt, J., 939W, 2791W*<br />

Vogt, S., 1005W, 3109W<br />

Voight, B. F., Session 21<br />

Voinea, S., 1439W, 3678W<br />

Voineagu, I., 553F<br />

Voit, T., 2812W<br />

Volar, M., 1093T<br />

Volders, P. G. A., 1711T<br />

Völker, U., 275<br />

Völker-Albert, M. C., 27<br />

Vollenweider, P., 1281T,<br />

2165F<br />

Vollrath, D., 2154W, 2240F,<br />

2263T<br />

Volpi, E., 509F<br />

Volpini, V., 2627F*<br />

Volta, M., 3471T<br />

Völzke, H., 584W, 1954T,<br />

2123F, 2147F<br />

Von Allmen, G., 2395T<br />

von Dadelszen, P., 3429T,<br />

3445T<br />

Vondracek, P., 2812W<br />

VonHoldt, B., 2219F<br />

von Kleist-Retzow, J. C.,<br />

2944W<br />

Von Kuster, G., 3545F<br />

Vonsattel, J. P., 2547W<br />

Vooder, T., 1163F<br />

Voorhees, J. J., 154, 1952F<br />

Voorhoeve, E., 98*<br />

Voorman, A., 174<br />

Vorgia, E., 218<br />

Vorstman, J. A. S., 431F<br />

Vos, Y. J., 1619T*<br />

Võsa, U., 1163F<br />

Vosatka, A., 2220W<br />

Voshol, P., 2701W<br />

Voss, K., 383<br />

Vrabec, K., 3381T<br />

Vranas, M., 2699T<br />

Vreeswijk, M. P. G., 27<br />

Vrettou, C., 2995T<br />

Vrielynck, P., 3218F<br />

Vriend, G., 217<br />

Vrieze, S., 1568W<br />

Vrijenhoek, T., 1870F*<br />

Vrints, C., 1617T<br />

Vu, A., 1147T<br />

Vu, B. J., 803W<br />

Vu, T., 14, 1716W<br />

Vuillaume, M. L., 473F<br />

Vuillemenot, B., 784W*<br />

Vuillot, A., 126<br />

Vulto-van Silfhout, A. T., 97,<br />

100, 125*, 160<br />

Vyhlidal, C., 811F<br />

Vyse, T. J., 306, 2005T,<br />

2046W, 3382F<br />

W<br />

Wachihi, C., 3276T<br />

Wacholder, S., 1413T<br />

Wacklin, P., 2023T<br />

Wada, T., 2836W*<br />

Waddell, L. B., 295<br />

Wade, K. H., 1626T*<br />

Wadelius, C., 617T, 619T<br />

Wadelius, M., 617T, 619T<br />

Waeber, G., 1281T<br />

Waetjen, L. E., 2360F<br />

Wafa, A., 1922F<br />

Waffern, F., 3076F<br />

Wagemaker, G., 796W<br />

Wagenknecht, L. E., 1661T,<br />

2275T<br />

Waggoner, D. J., 3398T<br />

Wagman, C., 2007W<br />

Wagner, E., 1098W*, 1969T<br />

Wagner, J., 1850W*<br />

Wagner, J. K., 2223W<br />

Wagner, K., 3116F<br />

Wagner, K. R., 2962W<br />

Wagner, M., 2143T<br />

Wagner, P., 638T<br />

Wahl, C., 2965W<br />

Wahlberg, P., 3427T*<br />

Wahlfors, T., 995F, 1000T,<br />

1302T<br />

Wahlgren, C. F., 1939T<br />

Wahren-Herlenius, M., 2084F<br />

Waide, E. H., 2717T<br />

Wain, K. E., 1058F<br />

Wainstein, T., 1794W*<br />

Waisfisz, Q., 3200F, 3650W<br />

Waite, L., 434W, 1608T,<br />

3443T<br />

Wakabayashi, Y., 586W*<br />

Wakahiro, M., 196, 2389T<br />

Wakamatsu, N., 2748F<br />

Wakefield, D. B., 3449T<br />

Wakefield, J., 294<br />

Wakefield, S., 658T<br />

Wakelam, M. J. O., 33<br />

Wakeland, B., 1901F, 2949F<br />

Wakeland, E., 2284T*,<br />

2949F<br />

Wakeland, E. K., 1901F<br />

Walcott, F., 1064F<br />

Walczak, A., 597F<br />

Waldan, I., 1498F<br />

Waldek, S., 772W<br />

Waldispuehl-Geigl, J.,<br />

1115F<br />

Waldman, I. D., 2515T*<br />

Wali, N., 37<br />

Walia, A., 3370F<br />

Walia, A. T., 3329W<br />

Walia, G. K., 3455T<br />

Walker, C., 940T*, 3479T<br />

Walker, D., 2516F<br />

Walker, D. L., 605T<br />

Walker, H., 953W<br />

Walker, J. A., 3270T<br />

Walker, M., 1624T, 2116T,<br />

3455T<br />

Walker, N., 453F<br />

Walker, R., 374, 564W<br />

Walker, S., 175*, 2575T,<br />

2617T, 2620T<br />

Wall, J., 285<br />

Wall, J. D., 3354T<br />

Wall, S. A., 218, 2151W<br />

Wallace, A., 2054F<br />

Wallace, D., Session 56<br />

Wallace, D. C., 3653F<br />

Wallace, J., 1667T, 3542W<br />

Wallace, J. R., 3624W<br />

Wallace, M., 1261T<br />

Wallace, P. K., 3523T<br />

Wallace, R., 2020T<br />

Wallasch<strong>of</strong>ski, H., 275,<br />

2080T<br />

Wallenhorst, E., 953W<br />

Wallentin, L., 617T, 619T<br />

Waller, K., 1736W<br />

Walley, K. R., 1632T<br />

Wallum, H., 2509T<br />

Walrafen, P., 3522T<br />

Walsh, C. A., 8, 266, 452W,<br />

2613W<br />

Walsh, D., 2500T, 2504F,<br />

2594F, 2599T


Walsh, J., 1216T<br />

Walsh, M., 889W<br />

Walsh, T., 26, 263, 287,<br />

1089W, 1226F*, 1228T,<br />

2600F, 2756T, 2929W<br />

Walston, J., 1920W<br />

Walter, K., 61, 1518T<br />

Walter, L., 96, 112, 118,<br />

230, 620T, 2513F<br />

Walter, M., 236, 575F,<br />

1200W<br />

Walter, M. A., 1951T<br />

Walter, M. C., 2961F<br />

Walter, P. J., 1398T*<br />

Walters, K. A., 2523W<br />

Walters, L., 456W*<br />

Walters, N., 506W<br />

Walters, R., 1067F<br />

Walther, D., 2541W<br />

Walther, S., 140<br />

Walton, K., 32<br />

Walz, K., 794W, 2672T,<br />

2837T*<br />

Wambebe, C., 3303T,<br />

3338W<br />

Wan, E., 2057F, 2249F<br />

Wan, J., 2511W<br />

Wan, W., 3495T<br />

Wanamaker, S. A., 2660F<br />

Wand, G. S., 2391W<br />

Wanderley, H. Y., 2642F<br />

Wang, A., 3213W<br />

Wang, B., 462W, 519F,<br />

616T, 2203T, 3620W<br />

Wang, B.-J., 3029T<br />

Wang, C., 398, 864T,<br />

1010F, 1112F, 1170W,<br />

1218W<br />

Wang, C. C., 3379F<br />

Wang, D., 1591T, 2221T,<br />

2251T, 3428T, 3485T*<br />

Wang, D. Y., 1887W<br />

Wang, E., Session 24<br />

Wang, E., 2978T<br />

Wang, F., 457F, 1779W*,<br />

1974W, 1997F, 2252F,<br />

2623T, 2721F, 2910F,<br />

3684W<br />

Wang, G., 19, 93, 1369F,<br />

1554T*, 2028W, 2318F,<br />

2337W, 3026T<br />

Wang, G. L., 1974W<br />

Wang, G.-L., 457F<br />

Wang, G. T., 2336F<br />

Wang, H., 255, 458W*,<br />

511F, 1472W, 1779W,<br />

1905W, 2910F, 2921T<br />

Wang, H. M., 2245T*<br />

Wang, I., 544W*<br />

Wang, I. X., 370<br />

Wang, J., 159, 462W,<br />

480W, 503F, 683F*,<br />

962T*, 1235F, 1369F,<br />

1578T*, 1650T, 1685T*,<br />

1750W, 2184W, 2311T,<br />

2317T, 2347T, 2390F,<br />

2452T, 2582F, 2617T,<br />

3168F, 3237W*, 3300T,<br />

3311W, 3334F, 3428T,<br />

3561F<br />

*Presenting Author<br />

Wang, J. C., 3416T<br />

Wang, J.-H., 457F*,<br />

2623T<br />

Wang, J. H., 1974W<br />

Wang, J. J., 2094W<br />

Wang, J. M., 462W<br />

Wang, K., 1889F, 2872W,<br />

3415T, 3532W, 3561F,<br />

3660W<br />

Wang, L., 116, 123, 347,<br />

492W*, 603T, 1010F,<br />

1218W, 1247F, 1291F,<br />

1635T, 1638T, 1974W,<br />

2185T, 2259W, 2583W,<br />

2603F<br />

Wang, L. L., 1034F<br />

Wang, L.-S., 342*, 343,<br />

2316W<br />

Wang, L. S., 1571W<br />

Wang, M., 314, 1292W,<br />

1735W, 1742W, 1757W,<br />

1761W, 2331W, 2617T,<br />

2880F, 2934F, 3308W*<br />

Wang, M. H., 1466W*<br />

Wang, M. Q., 1910F<br />

Wang, M.-S., 457F<br />

Wang, P., 1499W*<br />

Wang, P. H., 3730W<br />

Wang, Q., 206, 308, 2114F,<br />

2170T, 2494T, 3000T*,<br />

3582W, 3620W<br />

Wang, R., 1359T, 2461T,<br />

2486F, 2573F, 2895F<br />

Wang, S., 549F*, 566W,<br />

1417F, 1666T, 2388W,<br />

2390F, 2574W*, 3358F<br />

Wang, S.-N., 3029T<br />

Wang, S. R., 1960T*<br />

Wang, T., 889W, 1333F,<br />

1494T, 1608T, 2566T,<br />

2661W, 2806W*, 3016T,<br />

3097W, 3474T<br />

Wang, W., 319, 1555F,<br />

2229W, 3561F, 3589F*,<br />

3691F<br />

Wang, X., 207, 257*, 909W,<br />

1219T, 1367W*, 1418W*,<br />

1460W, 1464T, 1474F,<br />

1672T, 1673T, 1774W*,<br />

2034W, 2099F, 2125T,<br />

2142W, 2156F*, 2158T,<br />

2178W, 2189F, 2521T,<br />

2802F, 2834T, 2880F,<br />

2921T, 3026T, 3078F,<br />

3418T, 3486T*, 3619F*,<br />

3652W<br />

Wang, X. B., 1647T*<br />

Wang, X. T., 3416T<br />

Wang, X.-W., 457F, 2623T<br />

Wang, Y., 133, 507F,<br />

511F*, 657F, 864T*,<br />

1004F, 1146W, 1291F,<br />

1986W, 2279F, 2280W,<br />

2357F*, 2511W, 2617T,<br />

2721F, 3029T, 3081W*,<br />

3311W, 3317W, 3355F,<br />

3493T<br />

Wang, Y.-H., 2824W<br />

Wang, Y. P., 2053T<br />

Wang, Y. S., 972T*, 1586T<br />

SPEAKER AND AUTHOR INDEX 413<br />

Wang, Z., 213, 245, 519F*,<br />

616T, 1010F, 1088F,<br />

1160F*, 1259F*, 1420F*,<br />

2587T, 2819T, 3657F*<br />

Wang, Z.-G., 457F<br />

Wang, Z. G., 2985T*<br />

Wang-Sattler, R., 2226W,<br />

2548T<br />

Waqar, F., 1673T<br />

Warburton, D., 957W,<br />

1600T*<br />

Warby, S., 2543F*<br />

Ward, E., 3113W<br />

Ward, L., 1216T<br />

Ward, L. D., 3291T*<br />

Ward, M., 3625F<br />

Ward, M. H., 3582W<br />

Ward, P., 1742W<br />

Ward, P. A., 1735W, 1761W<br />

Ward-Caviness, C. K.,<br />

1636T*<br />

Ware, R. E., 648T, 2331W<br />

Ware, S., 1674T, 2698W<br />

Wareham, N. J., 43, 1553W,<br />

1626T, 1686T, 2282F,<br />

2359T<br />

Warman Chardon, J., 198*<br />

Warner, A., 249<br />

Warner, J., 549F<br />

Warner, N., 1320T<br />

Warnich, L., 644T<br />

Warnke, A., 1976F<br />

Warraich, S., 2816T<br />

Warram, J. H., 2313W<br />

Warren, L., 1686T<br />

Warren, P., 2904F<br />

Warren, R., 2217W<br />

Warren, R. L., 375<br />

Warren, S., 540W, 2464T<br />

Warren, S. T., 2576F<br />

Warren, W., 2262W, 2320T*,<br />

2343W<br />

Warrington, N., 2164T<br />

Warrington, N. M., 2162F<br />

Wary, C., 2539T<br />

Washington, A. V., 3315T<br />

Wassel, C. L., 170, 1661T<br />

Wasserscheid, J., 2262W<br />

Wasserstein, M. P., 958T<br />

Wassif, C. A., 162*<br />

Wassink, T., 2493W<br />

Wassink, T. H., 422W*<br />

Wasson, K., 1822F*<br />

Waszak, S., 415F, 551F<br />

Wat, J. J., 834F<br />

Wat, M., 839F<br />

Wat, M. J., 834F<br />

Watanabe, A., 1697T*,<br />

2400W<br />

Watanabe, H., 3221W<br />

Watanabe, R., 1362T<br />

Watanabe, R. M., 46<br />

Watanabe, Y., 724T*, 842F*,<br />

2727F<br />

Watanabe-Makino, K., 396<br />

Waterham, H. R., 681F<br />

Waters, A., 199<br />

Waters, C., 442W<br />

Waters, J. P., 2312F<br />

Waters, W., 978T<br />

Waterworth, D., 1686T*<br />

Waterworth, D. M., 649T<br />

Watkins, D., 673F, 705F,<br />

706T, 719F<br />

Watkins, H., 115<br />

Watkins, J. C., 3389W<br />

Watkins, L., 3644W*<br />

Watkins, W. S., 195, 600F,<br />

3378T<br />

Watman, N., 773W<br />

Watrin, E., 2958F<br />

Watrin, F., 2457W<br />

Watson, C. T., 375<br />

Watson, H., 2043W<br />

Watson, M., 3530W<br />

Watson, R., 83<br />

Watson, S. J., 2163W<br />

Watt, G., 1626T<br />

Watt, J., 967W<br />

Watt, S., 135<br />

Wattanasirichaigoon, D.,<br />

2755W, 2918T<br />

Watts, A. C., 287, 2600F*<br />

Watts, G. J., 3213W<br />

Watts, G. S., 3712W*<br />

Waubant, E., 1924T<br />

Waxman, S. G., 2448W<br />

Wayne, R. K., 2219F<br />

Weale, M. E., 374*, 564W,<br />

1470T, 1927T, 2082W,<br />

2804T, 3348T<br />

Weaver, D. T., 1171T<br />

Webb, A. A., 2517W<br />

Webb, A. E., 66<br />

Webb, B. D., 2928F*<br />

Webb, B. T., 2277W, 2500T,<br />

2504F, 2594F*<br />

Webb, S., 315<br />

Webber, C., 445F, 2476T<br />

Weber, C., 456W, 912T<br />

Weber, T. K., 1130F<br />

Webster, A. R., 2072F<br />

Webster, J., 2301W<br />

Webster, T., 493F, 1582F<br />

Weckselblatt, B., 938T*<br />

Wedel, R., 203<br />

Weedon, M., 2709F,<br />

2935W<br />

Weedon, M. N., 108, 1624T,<br />

2148W<br />

Weeks, D. E., 22, 1464T,<br />

1474F, 1963T, 2142W,<br />

2156F, 2159F, 2178W<br />

Weersma, R., 461F<br />

Wegmann, D., 476W, 3406T<br />

Wehby, G. L., 1564F*,<br />

1937F<br />

Wehrens, X., 667F<br />

Wei, C., 1995W<br />

Wei, J., 1259F, 1736W,<br />

3065W<br />

Wei, J. J., 2698W, 2895F*<br />

Wei, L., 31, 2237F, 2605T,<br />

3604W<br />

Wei, P., 1157F*<br />

Wei, Q., 1291F<br />

Wei, X. C., 3141W<br />

Wei, Z., 319*, 2121W,<br />

2229W, 3561F<br />

Weichenthal, M., 154<br />

SPEAKER AND AUTHOR INDEX


414 SPEAKER AND AUTHOR INDEX<br />

Weidinger, S., 1939T, 1942T,<br />

2102F, 2226W<br />

Weihbrecht, K., 323,<br />

2690T*<br />

Weinberg, C. R., 1416T<br />

Weinberg, S., 1937F<br />

Weinberg, S. M., 1315F<br />

Weinberger, D., 2444F<br />

Weiner, A., 2673F<br />

Weinreb, R. N., 2154W,<br />

2240F, 2263T<br />

Weinshilboum, R., 1247F<br />

Weinstein, D. A., 2712F<br />

Weinstein, G., 123<br />

Weinstein, P., 611T<br />

Weinstein, S., 1012T<br />

Weinstock, G., 2325W,<br />

2343W<br />

Weinstock, G. M., 2262W,<br />

2320T<br />

Weir, B., 294<br />

Weir, J., 3663F<br />

Weir, J. C., 366<br />

Weir, J. M., 2308T<br />

Weis, J., 2681T<br />

Weis, M., 222, 2853F<br />

Weis, M. A., 2854W<br />

Weisburd, J., 1338T<br />

Weisenberger, D., 3415T<br />

Weisfeld-Adams, J. D.,<br />

168*, 958T<br />

Weiss, J., 2833W, 3020T<br />

Weiss, K. M., 194*, 1563T,<br />

2179T, 2208W<br />

Weiss, L., 99<br />

Weiss, L. A., 1274F, 2421W,<br />

2555F, 3242F<br />

Weiss, L. W., 2510F<br />

Weiss, M., 53, 98<br />

Weiss, M. M., 3200F*,<br />

3650W<br />

Weiss, R., 538W*<br />

Weiss, S., 536W<br />

Weiss, S. M., 1225T<br />

Weiss, S. T., 622T, 623T,<br />

638T, 811F, 2166W<br />

Weissglas, D., 2256W*<br />

Weissman, M. M., 369,<br />

2372F<br />

Weissman, S., 334, 425F,<br />

551F, 579F<br />

Weissman, S. M., 1225T<br />

Weitzel, J., 321<br />

Weitzel, J. N., 1071W,<br />

1219T<br />

Weksberg, R., 1872F, 1873F,<br />

3420T*, 3447T, 3456T,<br />

3482T, 3489T<br />

Welch, R. P., 34*<br />

Welch, S., 135, 1824F<br />

Welford, R., 684T<br />

Wellcome Trust Case Control<br />

Consortium, 1466W<br />

Wellcome Trust Case<br />

Control Consortium<br />

(WTCCC2), 1313W<br />

Wells, D. W., 1242W<br />

Wells, J. M., 2189F<br />

Wells, R. S., 3329W, 3349F<br />

Wells, S., 3377W*<br />

*Presenting Author<br />

Welsh-Bohmer, K., 2465F<br />

Welter, D., 2108F<br />

Wen, F., 549F, 566W*<br />

Wen, J., 2977T*<br />

Wen, R., 2668W<br />

Wen, S., 3495T*<br />

Wen, X., 273, 1429F,<br />

1463W*<br />

Wen, Y., 399<br />

Wencel, M., 3144F<br />

Wendland, J., 260, 2622W<br />

Wendland, J. R., 261<br />

Wendschlag, A., 515F<br />

Wendt, D., 763W<br />

Wendt, J., 3688W<br />

Wendt, K. S., 2958F<br />

Weng, Y., 1689T, 3467T<br />

Weng, Z., 397<br />

Wenger, D. A., 2805F<br />

Wenger, N., 611T<br />

Wennerström, A., 3258T*<br />

Wentworth, B., 767W,<br />

1698T<br />

Wentzel, S., 309<br />

Wenz, M., 3708W<br />

Werling, D. M., 2551T,<br />

2658W*<br />

Werneck, R., 1899W<br />

Werneck, R. I., 1978T<br />

Wernig, M., Session 78<br />

Wernovsky, G. W., 2443T<br />

Wert, K. J., 393*<br />

Wertelecki, W., 302*<br />

Wesfeld-Adams, J. D.,<br />

3145W<br />

Weslow-Schmidt, J., 912T<br />

Wessman, M., 2348F<br />

West, A. B., 1235F<br />

West, C., 1965W<br />

West, J. D., 2511W, 2531F<br />

West, R., 397<br />

West, R. B., 1054T<br />

Westbroek, W., 199<br />

Westbrook, J., 1771W*<br />

Westbrook, M. J., 631T<br />

Westendorp, R., 2080T<br />

Westerfield, M., 2725W<br />

Westerman, M. P., 434W<br />

Westgate, K., 2359T<br />

Westh<strong>of</strong>, E., 522W<br />

Westlake, C., 1088F<br />

Weston, N., 2098T<br />

Westra, H., 584W, 1284T*,<br />

1503T<br />

Westra, H.-J., 523F, 1621T,<br />

2088W<br />

Weterman, M. A. J., 2909T*<br />

Wettrell, G., 2699T<br />

Wever, O. R., 3363T<br />

Wevers, R. A., 160, 167,<br />

672T<br />

Wey, G., 730T<br />

Weyant, R., 2034W, 3406T<br />

Weyant, R. J., 1464T, 1474F,<br />

2142W, 2156F, 2178W<br />

Whalen, M. B., 1516F<br />

Wheaton, D. K., 3234F<br />

Wheelan, S., 1229F<br />

Wheeler, B., 1306F<br />

Wheeler, D., 2880F<br />

Wheeler, D. A., 1221W,<br />

1231T<br />

Wheeler, E., 43*<br />

Wheeler, M., 1601T, 2292W,<br />

3232F<br />

Wheeler, W., 1010F<br />

Wheeler, W. A., 1372F<br />

Whelan, F., 639T<br />

Whigham, B., 386<br />

Whincup, P. H., 1626T<br />

Whirl-Carrillo, M., 633T,<br />

635T<br />

Whitacre, J., 3697F<br />

White, C., 2184W<br />

White, C. C., 1599T<br />

White, H., 454W<br />

White, J., 2701W<br />

White, J. G., 2838F<br />

White, J. K., 105<br />

White, K. P., 614T<br />

White, M., 245*<br />

White, P., 2904F, 3530W<br />

White, P. S., 3590W*<br />

White, R., 37<br />

White, R. S., 1989W<br />

White, S., 506W, 1911W,<br />

2801T<br />

White, S. J., 1122W, 1273T*<br />

White, S. M., 131, 2925F<br />

White, W., 1715T<br />

Whitehead, P., 2330F*,<br />

2508W, 2637W<br />

Whitehead, P. L., 9, 270,<br />

2028W, 2049W, 2318F,<br />

2445W, 2572T, 2583W,<br />

2586W, 2614T<br />

Whitehead, P. W., 341<br />

Whitehouse, A., 2164T<br />

Whitehouse, P. J., 317<br />

Whiteman, D., 2190W<br />

Whitfield, J. B., 2212T<br />

Whiting, R., 784W<br />

Whitley, C., 714T, 715F<br />

Whitley, C. B., 801W*<br />

Whitley, W., 1855F<br />

Whitmer, R., 96<br />

Whitsel, E., 2337W<br />

Whittaker, J., 1257W, 1387F<br />

Whittemore, A., 1001F<br />

Whittemore, A. S., 1214F<br />

Whittington, D., 1854F<br />

Whyte, J., 1133F<br />

Whyte, M. P., 2864T<br />

Wibrand, F., 702T<br />

Wichmann, H.-E., 1942T,<br />

2103W, 2160W, 2226W<br />

Wickstrom, E., 797W<br />

Widagdo, J., 2796F<br />

Widen, E., 2059T, 2134T<br />

Widén, E., 2097W<br />

Wide Pissetti, C., 1593T<br />

Wie, J., 2437T<br />

Wieacker, P., 2595W<br />

Wieben, E., 1247F<br />

Wieczorek, D., 2356T,<br />

2595W<br />

Wiedau-Pazos, M., 2661W<br />

Wiederkehr, M., 415F<br />

Wiegand, M., 2567F<br />

Wiegant, W. W., 27<br />

Wieland, T., 567F, 582W,<br />

2567F, 2595W*, 2917W,<br />

2922F<br />

Wiemels, J., 2268W<br />

Wienker, T. F., 3550W<br />

Wieselquist, L., 1820F<br />

Wieskamp, N., 1749W<br />

Wiesner, G., 3097W<br />

Wiest, J. S., 1454W<br />

Wigg, K., 3509T<br />

Wiggs, J., 2135F<br />

Wiggs, J. L., 1887W,<br />

2154W, 2240F, 2263T<br />

Wigler, M., 1600T, 2587T<br />

Wigner, C., 935W<br />

Wiitala, K., 3331F<br />

Wijburg, F. A., 681F<br />

Wijdicks, M., 3688W*<br />

Wijmenga, C., 155, 461F,<br />

523F, 1284T, 1330F,<br />

1503T, 2088W<br />

Wijmenga, S. S., 2696T<br />

Wijsman, E., 1541W<br />

Wijsman, E. M., 1605T,<br />

2406W, 2549F<br />

Wiklund, F., 28, 205, 991T,<br />

1001F, 1148F, 1189T,<br />

1214F, 1990T<br />

Wilcox, A., 1564F<br />

Wilcox, A. J., 1472W<br />

Wilcox, E. R., 2724F<br />

Wilcox, W., 753T<br />

Wilcox, W. R., 712T<br />

Wild, P. S., 275, 1669T<br />

Wild, S., 1481W<br />

Wild, S. H., 1383T<br />

Wilde, J., 2958F, 3725F<br />

Wilde, S., 1669T<br />

Wildenauer, D. B., 2407T*<br />

Wildenauer, M. D. B., 2407T<br />

Wilder, J. A., 988T, 3314W*<br />

Wildman, D., 435F<br />

Wildsoet, C. F., 3521T<br />

Wiley, G., 1901F<br />

Wiley, G. B., 549F<br />

Wiley, L., 312*, 2321F<br />

Wiley, V., 166<br />

Wilfong, A. A., 2395T<br />

Wilhelmsen, K., 2489F, 2542T<br />

Wilhelmsen, K. C., 231<br />

Wiliams, N. M., 2405F<br />

Wilichowski, E., 758W<br />

Wilk, A., 44, 3441T<br />

Wilke, M., 696T<br />

Wilke, R. A., 647T<br />

Wilkens, A., 2904F, 3038F,<br />

3082F<br />

Wilkens, L., 2042F<br />

Wilker, E., 3469T<br />

Wilkie, A. O. M., 218, 219,<br />

2151W, 2746W, 3070F<br />

Wilkins-Haug, L. E., 70<br />

Wilkinson, R., 3332W<br />

Wilkinson, S., 3720W<br />

Willaert, A., 833F<br />

Willard, H. F., 147<br />

Willard, M., 1369F<br />

Willard, M. D., 1235F*<br />

Willatt, L., 3109W<br />

Willems, M., 3166F*


Willems, S. M., 1308T,<br />

2076W, 2116T, 2137T<br />

Willemsen, M. A., 100, 160,<br />

214<br />

Willemsen, M. A. A. P., 125,<br />

1734W<br />

Willemsen, M. H., 97, 100,<br />

102*<br />

Willemsen, R., 513F<br />

Willems van Dijk, K., 228,<br />

2107T<br />

Willenborg, C., 115, 119,<br />

1308T, 2076W<br />

Willer, C., 117*<br />

Willer, C. J., 170, 2090F<br />

Willer, J., 2458T<br />

Willer, J. R., 3<br />

Willer, T., 2812W<br />

Williams, A., 178, 3360T<br />

Williams, A. H., 1979F<br />

Williams, A. L., 48*<br />

Williams, B., 1765W<br />

Williams, C., 3126F*<br />

Williams, D. C., 2517W<br />

Williams, F. M. K., 503F<br />

Williams, G., 132<br />

Williams, H., 1325W<br />

Williams, I. M., 162<br />

Williams, J., III, 3020T<br />

Williams, K. L., 2816T*<br />

Williams, M. S., 3581F<br />

Williams, P. M., 1068W<br />

Williams, R. B., 1594T,<br />

2481W<br />

Williams, R. C., 1348F*<br />

Williams, S., 1668T, 3388F<br />

Williams, S. M., 245, 606T,<br />

1634T, 2572T, 3275W*<br />

Williams, S. R., 123*<br />

Williams, T. C., 3713F<br />

Williams, T. N., 2157W<br />

Williams-Blangero, S.,<br />

1280W<br />

Williamson, A. L., 1073F<br />

Williamson, D., 530W<br />

Williamson, K., 3072F<br />

Williford, B., 949W<br />

Willing, M. C., 220<br />

Willis, A., 314, 1735W,<br />

1742W, 1761W<br />

Willis-Owen, S. A. G.,<br />

3466T, 3469T, 3486T<br />

Willsey, A. J., 375, 2605T<br />

Willuweit, S., 3364F, 3402T<br />

Wilnai, Y., 3053W*<br />

Wilson, A. F., 1347T, 1396F,<br />

1690T, 1983W, 2151W,<br />

3070F<br />

Wilson, B. J., 149*, 150,<br />

1827W, 1852F<br />

Wilson, J., 350, 1481W<br />

Wilson, J. F., 1383T, 2366F*<br />

Wilson, J. G., 170, 178, 284,<br />

1408F, 1677T, 2210F,<br />

2337W<br />

Wilson, K., 3388F<br />

Wilson, L., 126<br />

Wilson, L. C., 217, 218<br />

Wilson, M., 334<br />

Wilson, M. J., 3290W<br />

*Presenting Author<br />

Wilson, N. R., 2670F*<br />

Wilson, R., 465F, 809F,<br />

1203W, 1210T, 2325W,<br />

2343W<br />

Wilson, R. K., 375, 2320T,<br />

2587T, 3296W<br />

Wilson, R. R., 3158F<br />

Wilson, S., 247, 1316W,<br />

1928F*<br />

Wilson, S. G., 1216T*<br />

Wilson, T. E., 339<br />

Wilson, W., 3053W<br />

Wilson Sayres, M., 281*<br />

Wiltshire, S., 119, 1308T,<br />

2076W, 2137T<br />

Wimmer, K., 2791W<br />

Win, A. K., 141*, 1079F<br />

Winarni, T. I., 770W<br />

Winata, C. L., 3047W<br />

Winberg, J., 3245W*<br />

Winchester, L., 509F<br />

Winckler, W., 368<br />

Windham, G., 7, 463F<br />

Windpassinger, C., 2570F,<br />

2575T, 3456T<br />

Wineburg, M., 966T<br />

Wineinger, N. E., 434W,<br />

1319W*<br />

Winge, M. C. G., 1939T*<br />

Wingo, T., 2477F<br />

Winham, S., 605T<br />

Winham, S. J., 2516F*<br />

Wininger, F., 784W<br />

Wininger, F. A., 2817F<br />

Winkelmann, J., 2086T,<br />

2567F, 2568W<br />

Winkler, C. A., 2073W, 3315T<br />

Winkler, R., 732T, 772W<br />

Winkler, R. E., 745F<br />

Winkler, S., 200<br />

Winkler, T., 1308T, 2076W<br />

Winkler, T. W., 108, 119,<br />

1954T, 2090F, 2123F,<br />

2147F*<br />

Winn, J., 1440T<br />

Winn, V. D., 3232F<br />

Winney, B., 181<br />

Winquist, E., 135, 1824F<br />

Winqvist, R., 1099T*<br />

Winsvold, B. S., 2348F<br />

Winterh<strong>of</strong>f, B. J., 3451T<br />

Winters, A. H., 3027T*<br />

Wirth, B., 236*<br />

Wirth, R., 2944W<br />

Wise, C., 221, 2143T<br />

Wise, C. A., 1359T, 3108F<br />

Wiseman, R., 1671T<br />

Wiseman, R. W., 595F<br />

Wisjman, E., 1918T<br />

Wisnieski, F., 1132T, 3421T,<br />

3503T*<br />

Wisotzkey, R., 1190F*<br />

Wissinger, B., 3126F<br />

Wissink-Lindhout, W. M.,<br />

102<br />

Wiszniewska, J., 61, 314,<br />

898T, 1742W, 1757W<br />

Wiszniewski, W., 360,<br />

777W, 2798T, 2883F*,<br />

2908W<br />

SPEAKER AND AUTHOR INDEX 415<br />

Wit, J., 2701W<br />

Wit, J. M., 131<br />

Wither, J. E., 3382F<br />

Withers, M., 61<br />

Witherspoon, D. J., 600F*,<br />

3378T<br />

With<strong>of</strong>f, S., 523F<br />

Witkowski, A. M., 33<br />

Witmer, P. D., 520W<br />

Witonsky, D., 248<br />

Witte, D. R., 2317T, 2347T<br />

Witte, J., 75, 1469W, 1548T<br />

Witte, J. S., 1250F, 1352W,<br />

1501F, 1885T, 2202W,<br />

2258F<br />

Witte, T., 2084F<br />

Wittemore, A., 28<br />

Wittig, I., 699F, 782W<br />

Wittwer, C., 673F<br />

Wittwer, C. T., 495F<br />

Witwicki, R. M., 62, 415F<br />

Wo, M., 3204F<br />

Wodak, S., 320, 1872F,<br />

1873F<br />

Wohler, E., 2918T<br />

Wohlleber, E., 2595W,<br />

3109W<br />

Wojcik, G. L., 3393W*<br />

Wojczynski, M. K., 1913F<br />

Wokke, B., 574W<br />

Wold, H., 921W<br />

Wolf, D., 2788W<br />

Wolf, E., 2922F<br />

Wolf, I., 1063T<br />

Wolf, J., 1152W<br />

Wolf, L., 3185W<br />

Wolf, P. A., 123, 2528F<br />

Wolf, W. A., 1799W<br />

Wolfbauer, G., 1605T<br />

Wolfe, L. A., 2938W<br />

Wolfe, R., 2996T<br />

Wolffenbuttel, B. H. R., 2282F<br />

Wolfgeher, D., 1614T, 1683T<br />

Wolfner, M. F., 2214W<br />

Wolk, F., 59<br />

Wöllner, K., 1005W<br />

Wollnik, B., 1*, 2944W,<br />

3070F, 3214F<br />

Wollstein, G., 2154W,<br />

2240F, 2263T<br />

Woloszynska-Read, A.,<br />

3428T*<br />

Wolyniec, P., 2461T, 2486F,<br />

2573F, 2576F<br />

Won, H.-H., 1007F, 1103F<br />

Won, M., 3695F<br />

Won, M. S., 3710W*<br />

Wong, A., 2282F<br />

Wong, A. C. Y., 2662W<br />

Wong, B., 493F<br />

Wong, C., 1338T<br />

Wong, C. C. Y., 3487T*<br />

Wong, D., 3161W, 3518T,<br />

3591F*<br />

Wong, D. A., 315, 680T<br />

Wong, E., 2494T*<br />

Wong, E. H. M., 1930T,<br />

2066F, 2932W<br />

Wong, H. M., 3123W<br />

Wong, K., 256, 2786T<br />

Wong, K. C. C., 3466T,<br />

3469T, 3486T<br />

Wong, K. K. Y., 1930T<br />

Wong, L., 245, 677F, 3209W<br />

Wong, L.-C., 683F<br />

Wong, L. J., 666T<br />

Wong, L.-J., 1750W<br />

Wong, L. P., 3339T<br />

Wong, M., 3612W<br />

Wong, P., 2573F<br />

Wong, R. C. C., 3100F<br />

Wong, S., 64<br />

Wong, S. H., 143<br />

Wong, S.-S., 1235F<br />

Wong, S. S., 614T<br />

Wong, T. Y., 429F, 2094W<br />

Wong, Z., 28<br />

Wong-Ley, L. E., 650T*<br />

Woo, C., 412W, 486W,<br />

3520T*<br />

Woo, M., 877W<br />

Woo, S., 3673F*<br />

Woo, Y., 3444T<br />

Wood, A., 1513F<br />

Wood, A. R., 108, 176,<br />

1923W, 2148W*, 2241W,<br />

2308T, 2339F<br />

Wood, B. M., 1781W<br />

Wood, G. C., 2078F<br />

Wood, N., 2581T<br />

Wood, S., 262<br />

Wooderchak-Donahue,<br />

W., 225<br />

Woodruff, T., 250<br />

Woods, J., 133<br />

Woods, R., 832F, 2262W<br />

Wood-Siverio, C., 2538W<br />

Woodward, S., 3321T, 3340F<br />

Woodward, S. R., 3365W<br />

Woollard, W. J., 2896W,<br />

2925F<br />

Woolstenhulme, N., 1021T<br />

Workalemahu, T., 51, 108,<br />

1954T, 2123F, 2147F<br />

Worley, M., Jr., 1272W<br />

Wormley, B., 2500T, 2594F<br />

Worrall, B. B., 123<br />

Wortmann, S., 672T<br />

Woulfe, J., 2794W<br />

Wouters, E., 2249F<br />

Wouters, M. M., 2088W<br />

Woyciechowski, S., 65<br />

Wragg, C., 2935W<br />

Wraith, J. E., 684T<br />

Wratten, N., 2467T<br />

Wrazien, S., 3530W<br />

Wren, J. D., 549F<br />

Wren, Y., 2164T<br />

Wright, A., 413F, 1481W<br />

Wright, A. F., 1383T, 2072F,<br />

2366F<br />

Wright, C., 101, 291, 364,<br />

2637W<br />

Wright, C. B., 1635T, 2583W<br />

Wright, F., 368, 2953W<br />

Wright, F. A., 171, 1322W,<br />

1532W<br />

Wright, G., 644T<br />

Wright, G. E. B., 1808F*<br />

Wright, M., 1803W, 3651F<br />

SPEAKER AND AUTHOR INDEX


416 SPEAKER AND AUTHOR INDEX<br />

Wright, M. F., 631T<br />

Wright, M. J., 2054F<br />

Wright, W., 1776W<br />

Writzl, K., 61, 3001T*<br />

WTCCC2, 2068T<br />

WTCCC2, Genetic Analysis<br />

<strong>of</strong> Psoriasis Consortium,<br />

I-chip for Psoriasis<br />

Consortium, 1927T<br />

Wu, B., 2696T<br />

Wu, C., 1027T, 2042F, 3584W<br />

Wu, C. C., 1298W*, 2936T<br />

Wu, C.-T., 444W<br />

Wu, D., 2027F<br />

Wu, G., 1502W*<br />

Wu, H., 382, 864T, 1338T<br />

Wu, J., 816F, 1314T*,<br />

1723W, 1954T, 2123F,<br />

2147F, 3604W<br />

Wu, J. Y., 2858T<br />

Wu, J.-Y., 2092T<br />

Wu, K., 623T<br />

Wu, K. H. C., 3167W*<br />

Wu, L., 581F*, 1161W*,<br />

1162T, 2000F<br />

Wu, M., 1262F*<br />

Wu, M. C., 1532W<br />

Wu, Q., 2073W<br />

Wu, S., 1838F, 2149T*, 2874F<br />

Wu, S. W., 2438F<br />

Wu, S. Y., 1003T, 2053T<br />

Wu, T., 1472W*, 2721F,<br />

3317W<br />

Wu, W., 1904F*, 3378T<br />

Wu, W. T., 2985T<br />

Wu, X., 213, 1684T, 3168F,<br />

3237W<br />

Wu, X.-F., 3281W<br />

Wu, Y., 1546F, 1608T*,<br />

1894T, 2617T, 3168F,<br />

3237W<br />

Wu, Y. L., 458W<br />

Wu, Z., 668T, 2492F<br />

Wu-Chou, Y. H., 1472W,<br />

1512T<br />

Wulur, I. H., 1235F<br />

Wunderink, M., 955W, 979W<br />

Wurfel, M. M., 1408F<br />

Würtz, P., 1623T*<br />

Wuyts, W., 2757F*<br />

Wyatt, A., 3161W<br />

Wyatt, C. R., 2717T<br />

Wynn, J., 3046F<br />

Wyrobek, A. J., 984W*<br />

X<br />

Xavier, A. C., 959W<br />

Xavier, J., 2150F*<br />

Xavier, J. M., 1977W,<br />

2085W<br />

Xavier, R. J., 2319W<br />

Xe, Q., 457F<br />

Xerri, O., 390<br />

Xi, L., 2804T<br />

Xi, Q. J., 82<br />

Xia, B., 1099T<br />

Xia, F., 314*, 1742W<br />

Xia, H., 1930T<br />

*Presenting Author<br />

Xia, J., 136, 3620W*<br />

Xia, K., 2251T, 2617T<br />

Xia, M., 242, 3490T<br />

Xia, Q., 2121W<br />

Xia, R., 1041W<br />

Xia, Y., 2227T<br />

Xian, M., 2251T<br />

Xiang, A. H., 1916F<br />

Xiang, K., 3317W<br />

Xiang, Q., 244, 457F<br />

Xiao, C., 3592W*<br />

Xiao, F., 1399F*<br />

Xiao, J., 2438F, 2782W*<br />

Xiao, M., 3025T*, 3649F<br />

Xiao, P., 3081W<br />

Xiao, T., 810F<br />

Xiao, W., 1112F, 1199F,<br />

3485T<br />

Xie, C., 3604W*<br />

Xie, F., 1945T<br />

Xie, H., 1974W, 3168F<br />

Xie, L. Y., 3442T, 3452T<br />

Xie, P., 2621F*<br />

Xie, Q., 2623T<br />

Xie, W., 1546F, 1624T,<br />

1693T, 2935W, 3509T<br />

Xie, Y. Y., 1110W<br />

Xifara, D., 16*<br />

Xing, C., 1368T*<br />

Xing, E., 1388W, 3605F*<br />

Xing, E. P., 2152T, 3391W<br />

Xing, J., 195, 600F, 1904F,<br />

3297T, 3378T*<br />

Xing, Q., 2419T*<br />

Xing, Y., 2636F<br />

Xiong, L., 1670T, 2402F*,<br />

2558F<br />

Xiong, M., 20*, 92, 192,<br />

1401T, 1499W, 1508W,<br />

1527T, 2460W<br />

Xiong, X., 1010F<br />

Xu, C., 651T, 1972T, 2495F*<br />

Xu, G. L., 3483T<br />

Xu, H., 1511W, 1864F*,<br />

1907F, 3334F, 3418T*<br />

Xu, J., 28, 986F, 1001F,<br />

1080W, 1214F, 1369F,<br />

1491T, 1648T, 1661T,<br />

2274W, 2332T, 2879T,<br />

3285T, 3425T<br />

Xu, J. B., 3416T<br />

Xu, K., 2785W, 2892F<br />

Xu, L., 2237F<br />

Xu, N., 1255T<br />

Xu, Q., 2617T<br />

Xu, S., 443F, 520W*, 909W*,<br />

3334F, 3358F, 3394T*<br />

Xu, T., 532W, 3723F<br />

Xu, W., 909W, 1108T, 2819T<br />

Xu, X., 1100F*, 1255T,<br />

2617T, 2935W<br />

Xu, Y., 161, 1298W<br />

Xu, Y.-H., 690T<br />

Xu, Y. H., 2667F<br />

Xu, Y.-Q., 2970T*<br />

Xu, Y. Q., 836F<br />

Xu, Z., 2477F*, 3231W*<br />

Xue, C., 170<br />

Xue, F., 1365T<br />

Xue, X., 2080T<br />

Xue, Y., 41, 130, 3377W<br />

Xue, Z., 641T, 651T*<br />

Xumerle, L., 2548T<br />

Y<br />

Yadak, R., 796W<br />

Yadavalli, A. D., 3630W*<br />

Yaghootkar, H., 1284T,<br />

1503T, 2148W<br />

Yagi, M., 729F*, 781W<br />

Yagmurdur, M. C., 3426T<br />

Yagnik, G., 2151W*<br />

Yahya, Z., 3034T<br />

Yahyavi, M., 810F*, 2926W<br />

Yakhini, Z., 3588W<br />

Yakir, B., 3675F<br />

Yakubovskaya, M., 1180T,<br />

1181F<br />

Yamada, K., 2748F<br />

Yamada, R., 1984T, 2004W<br />

Yamada, T., 2174F<br />

Yamada, Y., 2748F*<br />

Yamagata, S., 2550W<br />

Yamagata, T., 2588F, 3118F<br />

Yamagata, Z., 1819W*,<br />

1833W, 1980W<br />

Yamagata University<br />

Genomic Cohort<br />

Consortium, 1549F<br />

Yamaguchi, S., 1574W,<br />

2747T<br />

Yamakage, M., 1940F<br />

Yamamoto, E. H., 2876T<br />

Yamamoto, G. L., 2232W,<br />

3152F, 3184F, 3250F*<br />

Yamamoto, K., 1574W,<br />

1984T, 2004W, 3436T<br />

Yamamoto, M., 2619W<br />

Yamamoto, N., 1815W<br />

Yamamoto, R., 234<br />

Yamamoto, T., 233, 1290T,<br />

3102F<br />

Yamanaka, H., 2004W,<br />

2032T, 2287T<br />

Yamanaka, I., 2697F<br />

Yamano, A., 2748F<br />

Yamanouchi, Y., 1795W*,<br />

2891T<br />

Yamaoka, M., 2130W<br />

Yamasaki, M., 2496W*<br />

Yamashita, C., 1730W,<br />

2559W<br />

Yamashita, H., 1549F<br />

Yamauchi, A., 3337F<br />

Yamauchi, N., 52<br />

Yamazaki, K., 2174F*<br />

Yamazaki, T., 2873T<br />

Yammine, T., 2692W<br />

Yamrom, B., 2587T<br />

Yan, A., 3730W<br />

Yan, C.-Y., 1216T<br />

Yan, J., 1465F<br />

Yan, K., 1475W<br />

Yan, L., 2489F, 3293W,<br />

3425T, 3428T<br />

Yan, Q., 2445W<br />

Yan, S., 1524T*, 3265F,<br />

3379F*<br />

Yan, W., 1986W<br />

Yanagi, K., 2758W<br />

Yanagi, T., 724T<br />

Yanagihara, I., 475F<br />

Yandell, M., 195, 3561F,<br />

3633F<br />

Yanek, L. R., 1652T*, 1710T<br />

Yang, B. Z., 2497T<br />

Yang, C., 2204F, 2207F*<br />

Yang, F., 438W<br />

Yang, H., 531F, 1249T,<br />

1391W, 1905W*, 2617T<br />

Yang, H. C., 3430T<br />

Yang, I., 3466T<br />

Yang, J., 108, 1331W,<br />

1360F, 2016W*, 2090F,<br />

2200T*, 2388W*, 2574W,<br />

3370F, 3470T<br />

Yang, J. P., 2482T<br />

Yang, K., 1071W<br />

Yang, L., 3667F<br />

Yang, M., 1540F<br />

Yang, M. Y., 80<br />

Yang, P., 989F, 1454W<br />

Yang, Q., 123<br />

Yang, R., 1517W*<br />

Yang, S., 2273F, 3330T<br />

Yang, S. P., 658T<br />

Yang, T., 411, 583F<br />

Yang, T.-P., 44, 3453T<br />

Yang, W., 180*, 586W,<br />

1468F*, 1929W, 2016W,<br />

2064W*, 3657F<br />

Yang, X., 116, 159, 864T,<br />

2220W*, 2660F<br />

Yang, X.-H., 2969T, 2970T<br />

Yang, Y., 314, 821F, 864T,<br />

985T, 1735W*, 1742W,<br />

1757W, 1761W, 1972T,<br />

2921T, 3488T*<br />

Yang, Z., 2390F*, 2574W,<br />

3317W<br />

Yanicostas, C., 843F<br />

Yanikkaya Demirel, G., 2429F<br />

Yannoukakos, D., 1191W,<br />

1228T<br />

Yano, K., 2287T<br />

Yano, S., 237*<br />

Yanovitch, T., 2328W<br />

Yanovski, J. A., 2702T<br />

Yao, W., 1249T<br />

Yao, Y., 2584T, 2917W<br />

Yap, Z., 216<br />

Yarnall, J. M., 1329T<br />

Yarnykh, V. L., 2530T<br />

Yaron, O., 2919F<br />

Yaron, Y., 704T<br />

Yasari Mazandarani, A.,<br />

1961F, 1962W*<br />

Yashin, A., 1991F, 2027F,<br />

2194T<br />

Yaspan, B., 15, 1887W,<br />

2135F<br />

Yaspan, B. L., 2154W,<br />

2240F*, 2263T<br />

Yasuda, C. L., 2394W<br />

Yasufumi, O., 3519T*<br />

Yasui, D. H., 64, 2783T*,<br />

3498T<br />

Yasukawa, K., 1631T


Yasunami, M., 1998W,<br />

1999T*<br />

Yates, J. C., 2249F<br />

Yates, J. R. W., 2072F<br />

Yato, S., 3221W<br />

Yatsenko, S., 904T<br />

Yatsenko, S. A., 971W,<br />

1744W*<br />

Yatsuka-Kanesaki, Y.,<br />

2923W<br />

YAtsuki, H., 3432T<br />

Yatsuki, H., 3519T<br />

Yau, M., 2812W<br />

Yazarlou, F., 1169F<br />

Yazdani, R., 448W<br />

Yazici, H., 3475T<br />

Ye, C., 322, 528W, 1341T<br />

Ye, K., 459F*, 2587T, 3309T*<br />

Ye, L., 859W, 1699T<br />

Ye, X., 1472W, 2151W, 2928F<br />

Ye, Z., 1626T, 2297F, 3326W<br />

Yeager, M., 30, 213, 1012T,<br />

1154F, 1160F, 1218W,<br />

1242W, 1372F, 1517W,<br />

3683F<br />

Yeakley, J., 1176W<br />

Yee, J. K., 695F<br />

Yee, M. C., 293, 371, 3361F,<br />

3362W, 3368W, 3411W<br />

Yeetong, P., 2749W*<br />

Yeh, E., 2687T<br />

Yeh, T., 666T<br />

Yeheskel, A., 2919F<br />

Yehuda, D., 1159T<br />

Yemelyanov, A., 1181F<br />

Yen, T., 3596W<br />

Yendle, S. C., 2897T<br />

Yeo, A., 641T<br />

Yeo, G. S. H., 3034T<br />

Yeoh, K. H., 2491T<br />

Yeow, V., 1472W<br />

Yerges-Armstrong, L. M.,<br />

602T, 2275T<br />

Yerko, V., 2482T<br />

Yesilyurt, A., 2881W<br />

Yeung, W. S. B., 3000T<br />

Yevtushok, L., 302<br />

Yi, K., 2251T<br />

Yi, L., 2686W*<br />

Yi, N., 1292W, 1410T, 3613F<br />

Yi, X., 3300T<br />

Yigit, E., 512W, 3517T,<br />

3702W, 3715F<br />

Yilmaz, E., 2058W<br />

Yilmaz, N., 594W*<br />

Yilmaz, S., 594W, 1164W,<br />

1166F, 3132F<br />

Yilmaz Celik, Z., 1013F*,<br />

3424T, 3426T<br />

Yilmaz Susluer, S., 1178F<br />

Yilmaz Süslüer, S., 1172F<br />

Yim, P., 412W<br />

Yim, P. W., 486W*<br />

Yim, S., 3103W<br />

Yim, S. H., 3607F<br />

Yin, A. H., 1723W<br />

Yin, B., 1757W<br />

Yin, H. W. H., 1034F*<br />

Yin, J., 477F, 2152T*, 3605F<br />

Yin, X., 660T, 1585T<br />

*Presenting Author<br />

Yip, B. H. K., 2066F<br />

Yip, W., 1431T*<br />

Yiu, E., 2742F<br />

Yiu, M., 963W*<br />

Ylaya, K., 1092W<br />

Ylstra, B., 494W<br />

Yntema, H., 215*<br />

Yntema, H. G., 97, 102,<br />

125, 1749W<br />

Yntema, J. B., 216<br />

Yokota, T., 232, 729F<br />

Yokoyama, E., 875W, 976T,<br />

2365T<br />

Yokoyama, J. S., 2517W*,<br />

2639F<br />

Yolken, R., 1406W<br />

Yonath, H., 783W*<br />

Yoneda, M., 245<br />

Yonezawa, A., 2917W<br />

Yoo, H., 2518T*<br />

Yoo, H. W., 698T, 787W*<br />

Yoo, H.-W., 964T, 3227W<br />

Yoo, N., 1230W<br />

Yoo, S., 1248W<br />

Yoo, Y., 1384F<br />

Yoon, E. J., 1338T<br />

Yoon, G., 2554T*<br />

Yoon, J., 1243T, 3462T<br />

Yoon, O. K., 571F*<br />

Yoon, S., 866T, 867W,<br />

3112F<br />

York, T., 3512T*<br />

York, T. P., 1717W<br />

Yoshida, A., 2697F<br />

Yoshida, L. M., 1998W,<br />

1999T<br />

Yoshida, M., 52, 2349W,<br />

2380T*<br />

Yoshida, S., 2287T*<br />

Yoshida, Y., 1333F<br />

Yoshihashi, H., 3105W*,<br />

3192F<br />

Yoshikawa, A., 2370W*,<br />

2652W<br />

Yoshikawa, T., 1631T<br />

Yoshimatsu, H., 2917W<br />

Yoshimura, A., 2418W,<br />

2601W, 2607W, 2616W,<br />

2823F<br />

Yoshimura, J., 2409W,<br />

2569T<br />

Yoshino, H., 52, 2559W,<br />

3134F, 3221W<br />

Yoshino, M., 724T<br />

Yoshinori, T., 3136F<br />

Yoshizawa, G., 1815W<br />

Yoshizawa, J., 1317T<br />

Yosunkaya, E., 2912T*<br />

You, G., 3473T<br />

You, M., 1454W<br />

Young, A., 1515T, 2042F<br />

Young, B. M., 1162T<br />

Young, C., 1869F<br />

Young, D., 2480F<br />

Young, J., 794W*, 1072T,<br />

2672T<br />

Young, J. E., 2628W<br />

Young, J. I., 347, 2837T<br />

Young, J. P., 141, 1067F<br />

Young, K. L., 1467T*<br />

SPEAKER AND AUTHOR INDEX 417<br />

Young, L. J., 2383T<br />

Young, S. P., 168<br />

Young, T., 521F*, 2328W,<br />

2543F<br />

Young, T. L., 454W, 2068T,<br />

3521T<br />

Young, W. L., 589F<br />

Youngblom, J., 145, 1810F<br />

Younkin, S., 3609F<br />

Yourdkhani, H., 3083W<br />

Yourshaw, M., 296*, 315<br />

Yousaf, R., 2663T, 2724F*<br />

Yousefi, P., 3458T<br />

Yousif, F., 1256F<br />

Yrigollen, C. M., 2634W*<br />

Yu, C., 601T*, 2550W<br />

Yu, C. C., 232, 3513T*<br />

Yu, C. E., 2646W<br />

Yu, C. S., 3730W<br />

Yu, C. Y., Session 22, 458W<br />

Yu, D., 1027T, 1480F,<br />

2519F*<br />

Yu, F., 174, 331*, 3576W<br />

Yu, H., 1731W, 2884W*,<br />

3479T<br />

Yu, I., 346<br />

Yu, J., 148*, 174, 963W,<br />

1004F, 1842F, 1930T,<br />

2251T, 2617T<br />

Yu, J. H., 301<br />

Yu, K., 1010F<br />

Yu, L., 1359T<br />

Yu, L.-H., 234<br />

Yu, M., 516W, 1666T<br />

Yu, S., 978T<br />

Yu, T., 2003F*<br />

Yu, T. W., 8*, 452W, 2613W<br />

Yu, X., 3585F, 3593F*<br />

Yu, Z., 389, 834F, 839F,<br />

1493W*, 1969T, 2678T<br />

Yuan, A., 3533F<br />

Yuan, D., 2251T<br />

Yuan, G., 3659F<br />

Yuan, H., 2868F*<br />

Yuan, J., 2601W*<br />

Yuan, Q., 2234F<br />

Yuan, Y., 1269W<br />

Yudk<strong>of</strong>f, M., 534W<br />

Yue, Y., 1235F<br />

Yuen, R., 175<br />

Yuen, R. K., 460W*, 2617T<br />

Yuen, R. K. C., 3445T<br />

Yuksel, A., 2908W<br />

Yum, S., 3673F<br />

Yum, S. W., 330<br />

Yun, J., 3103W<br />

Yund, B., 714T<br />

Yurovsky, A., 561F<br />

Yusuf, S., 617T, 619T<br />

Yuvarani, S., 931W<br />

Yuzyuk, T., 686T*<br />

Z<br />

Zabetian, C., 2538W<br />

Zaccarioto, T. R., 2751F<br />

Zachariadis, V., 1035W*<br />

Zack, D. J., 2154W, 2240F,<br />

2263T<br />

Zackai, E., 65, 1494T,<br />

2904F, 3082F, 3151W<br />

Zackai, E. H., 819F, 2884W,<br />

3038F<br />

Zackai, E. Z., 2443T<br />

Zada, G., 3415T<br />

Zaenglein, A., 2761W<br />

Zaghlool, A., 3728W*<br />

Zaghloul, N., 310<br />

Zagury, J.-F., 90<br />

Zahavich, L., 1704T*<br />

Zahid, S., 1579F<br />

Zahnleiter, D., 2356T<br />

Zahra, R., 508W<br />

Zahrate, M., 324<br />

Zahrieh, D., 768W, 769W<br />

Zai, C., 628T*, 2376W<br />

Zai, G., 612T*<br />

Zaidi, S., 2542T<br />

Zaitlen, N., 89, 350*,<br />

1331W, 1360F, 1577W<br />

Zakariyah, A., 831F<br />

Zakharia, F., 3352F, 3360T,<br />

3380W*, 3390T, 3563F<br />

Zaki, M. J., 3570W<br />

Zaki, M. S., 167, 2937F<br />

Zakov, S., 1043F*<br />

Zaldivar, F., 3144F<br />

Zalloua, P., 1640T, 3349F,<br />

3377W<br />

Zalloua, P. A., 3387T<br />

Zamani, A. R., 860T<br />

Zamanyan, A., 3587F<br />

Zamarron-Licona, E.,<br />

2019W*<br />

Zambruno, G., 2760F<br />

Zamir, I. M., 731F*<br />

Zampella, J., 1260W*<br />

Zampetaki, A., 3723F*<br />

Zampieri, S., 2809W<br />

Zamudio, R., 1119W, 3325F<br />

Zamudio, R. M., 926T<br />

Zamzuraida, A. S., 3267T<br />

Zanardo, E., 896T, 899W<br />

Zand, D., 2915T<br />

Zandi, P. P., 2180F, 2305T,<br />

2391W<br />

Zandi, S., 1093T<br />

Zandoná, A., 896T<br />

Zandoná-Teixeira, A., 899W<br />

Zanetti, G., 157<br />

Zaneveld, J., 1779W,<br />

2910F*<br />

Zang, W., 573F<br />

Zang, Z. J., 2889F<br />

Zaniew, M., 845F<br />

Zanke, B., 377, 3478T<br />

Zanke, B. W., 1093T, 3489T<br />

Zanlonghi, X., 390<br />

Zanni, G., 943W, 2777T<br />

Zannis-Hadjopoulos, M.,<br />

2824W<br />

Zapata, G., 1646T<br />

Zapata, G. E., 2189F<br />

Zappia, M., 2763F<br />

Zara, I., 157*, 186<br />

Zaragkoulias, A., 218<br />

Zaragoza, M. V., 1691T*<br />

Zarante, A., 3041W, 3049W*<br />

Zarante, I., 1876F*, 3035W<br />

SPEAKER AND AUTHOR INDEX


418 SPEAKER AND AUTHOR INDEX<br />

Zarate, Y., 3171W*<br />

Zarbakhsh, B., 1726W<br />

Zarina, L., 608T<br />

Zariwala, M. A., 2851W*<br />

Zariwala, M. B., 406<br />

Zaslav, A., 1036T*<br />

Zattara, H., 1212W<br />

Zatyka, M., 2767W<br />

Zatz, M., 1727W, 1776W<br />

Zavala, J., 2495F<br />

Zavala-Castro, J., 2272T<br />

Zavaleta, M. J., 960T<br />

Zaveri, H., 840F*, 2678T<br />

Zawistowski, M., 476W,<br />

1371T, 3406T<br />

Zayed, H., 2643W<br />

Zaykin, D., 1364W*, 1570F<br />

Zazo Seco, C., 58, 59<br />

Zbar, B., 1242W<br />

Zechi-Ceide, R., 2673F<br />

Zechi-Ceide, R. M., 813F,<br />

2746W<br />

Zechner, U., 849F, 3266W*<br />

Zeegers, D., 3034T<br />

Zeesman, S., 300<br />

Zeevi, D. A., 2991T, 3002T*<br />

Zeggini, E., 2044T*, 2097W,<br />

2292W, 2522F, 3396T,<br />

3408T<br />

Zehnder, J. L., 1017W<br />

Zeidler, C., 1868F<br />

Zeien, G., 422W<br />

Zeinali, S., 1726W, 3197W<br />

Zeissig, S., 2315F, 2368T<br />

Zeissig, Y., 2315F<br />

Zelante, L., 775W<br />

Zeldin, D. C., 606T<br />

Zeledòn, M., 2486F<br />

Zeledón, M., 2461T*<br />

Zelenetz, A., 1159T<br />

Zelenika, D., 2072F<br />

Zelh<strong>of</strong>, A. C., 2966T<br />

Zeligson, S., 2447F, 2991T<br />

Zelinski, T., 2772F<br />

Zeller, T., 275, 1669T*<br />

Zellers, A. D., 1806F*<br />

Zeman, J., 752T<br />

Zembutsu, H., 2133W<br />

Zemel, B. S., 812F*<br />

Zen, P., 2434T<br />

Zender, G., 1680T<br />

Zender, G. A., 1646T<br />

Zeng, C., 245, 2251T<br />

Zeng, L., 3415T<br />

Zeng, Q., 1292W<br />

Zeng, R., 2805F, 2817F*<br />

Zeng, W., 2698W*, 2895F,<br />

2907F, 3065W<br />

Zeng, Z., 1464T, 1474F,<br />

2034W, 2156F<br />

Zerdoumi, Y., 1090T<br />

Zeringer, E., 3684W<br />

Zerres, K., 3111W<br />

Zethelius, B., 2358W<br />

Zettermann, K., 3729F<br />

Zeuner, K. E., 200<br />

Zevallos, J., 1120T<br />

Zeviani, M., 164, 699F,<br />

782W, 2810T<br />

*Presenting Author<br />

Zha, Z., 1256F<br />

Zhai, J., 1232F<br />

Zhan, S. H., 2772F<br />

Zhan, X., 641T, 1510F,<br />

1525F*, 1568W, 2183F<br />

Zhan, Y., 1582F*<br />

Zhang, B., 503F*, 2403W,<br />

2804T<br />

Zhang, C., 1369F, 2080T,<br />

2644T<br />

Zhang, C. K., 189<br />

Zhang, D., 221, 3438T<br />

Zhang, F., 63, 138, 1004F,<br />

2112W, 2668W<br />

Zhang, G., 487F*, 1027T*,<br />

1239W, 1660T<br />

Zhang, H., 893W, 1434T,<br />

2121W, 2184W, 2314T,<br />

3317W, 3582W<br />

Zhang, H. S., 803W<br />

Zhang, H. X., 2985T<br />

Zhang, J., 31, 821F, 888T,<br />

1003T, 2251T, 2921T,<br />

3595F*<br />

Zhang, J. G., 1473T*,<br />

2053T, 3534W<br />

Zhang, K., 283, 519F,<br />

1292W, 1410T, 1764W,<br />

1779W, 2154W, 2240F,<br />

2260T, 2263T, 2910F,<br />

3474T, 3493T, 3594W*,<br />

3646W<br />

Zhang, L., 255, 999W,<br />

1159T, 1275W*, 2053T*,<br />

2172W, 2981T, 3097W*<br />

Zhang, M., 1972T<br />

Zhang, N., 3675F<br />

Zhang, P., 1534F*<br />

Zhang, Q., 18*, 33, 404,<br />

1004F, 1203W, 1369F,<br />

1457W*, 2040W<br />

Zhang, R., 577F*<br />

Zhang, R. Z., 1930T<br />

Zhang, S., 1409W, 2206T<br />

Zhang, S. Y., 3599F<br />

Zhang, T., 135, 457F,<br />

1974W, 2623T<br />

Zhang, T. X., 1472W<br />

Zhang, V., 1750W, 3209W<br />

Zhang, V.-W., 683F<br />

Zhang, W., 49, 110, 161,<br />

1320T, 2292W, 3472T,<br />

3719F<br />

Zhang, X., 159, 462W,<br />

836F, 2016W, 2064W,<br />

2254T, 2868F, 3317W,<br />

3472T<br />

Zhang, Y., 334, 579F*, 600F,<br />

836F*, 1723W*, 1995W,<br />

2016W, 2064W, 2215T*,<br />

2721F, 3474T, 3545F<br />

Zhang, Z., 377, 421F, 457F,<br />

534W*, 2063F*, 3058F,<br />

3438T, 3670W<br />

Zhao, G., 1777W, 3600W<br />

Zhao, H., 189, 1201T,<br />

1283W, 1635T, 2204F,<br />

2207F, 2478W, 2497T,<br />

2503T, 2621F, 3237W<br />

Zhao, H. Z., 1974W<br />

Zhao, J., 192*, 1527T<br />

Zhao, J. H., 1365T*, 1553W,<br />

2359T<br />

Zhao, J.-H., 2282F<br />

Zhao, K., 3254W<br />

Zhao, M., 1101W*, 2237F,<br />

3606W*<br />

Zhao, T., 2999T<br />

Zhao, W., 171<br />

Zhao, X., 1367W<br />

Zhao, X.-L., 1986W<br />

Zhao, Y., 134, 544W, 557F,<br />

2721F, 3631F<br />

Zhao, Z., 136*, 1101W,<br />

2418W, 3554W, 3620W<br />

Zheng, H., 480W, 1369F,<br />

3265F*, 3355F, 3645F*<br />

Zheng, H. F., 109<br />

Zheng, H.-F., 2187W<br />

Zheng, P., 1463W<br />

Zheng, S., 28, 888T<br />

Zheng, S. L., 1080W<br />

Zheng, W., 2202W, 2644T<br />

Zheng, X., 294*, 2098T<br />

Zheng, Y., 1003T*, 1972T<br />

Zheng, Z., 2178W<br />

Zheng, Z. H., 836F<br />

Zheng Bradley, H., 3636W<br />

Zhernakova, A., 461F*, 523F<br />

Zhernakova, D. V., 523F<br />

Zhi, D., 1410T, 1460W,<br />

1502W, 3594W, 3646W*<br />

Zhong, H., 3317W, 3574W<br />

Zhong, J., 242*, 2337W<br />

Zhong, N., 1613T, 1864F,<br />

1877F, 1986W*, 2355W,<br />

2969T, 2970T, 3025T,<br />

3029T<br />

Zhong, W., 1930T<br />

Zhou, B., 458W, 1591T,<br />

2617T<br />

Zhou, D., 3307F, 3438T*<br />

Zhou, E., 1251W<br />

Zhou, F., 3553F<br />

Zhou, H., 38*, 214, 1369F,<br />

1866F, 3621F<br />

Zhou, J., 54, 241, 1515T,<br />

1526W*, 1886F, 2254T<br />

Zhou, J. H., 1986W<br />

Zhou, L., 1540F<br />

Zhou, Q., 3553F<br />

Zhou, S., 1670T*, 2402F<br />

Zhou, S. L., 836F<br />

Zhou, T., 798W<br />

Zhou, X., 462W*, 1514W*,<br />

2254T, 2868F<br />

Zhou, Y., 864T, 1019F<br />

Zhou, Z., 2297F<br />

Zhou, Z.-N., 3281W<br />

Zhu, C., 349*, 2419T<br />

Zhu, D., 2419T<br />

Zhu, G., 174, 2212T<br />

Zhu, H., 557F<br />

Zhu, J., 368, 586W, 1107W,<br />

1540F, 1777W, 2220W,<br />

2910F, 3123W<br />

Zhu, J.-Z., 1613T, 2355W*<br />

Zhu, L., 864T<br />

Zhu, Q., 3251W, 3310F*<br />

Zhu, W.-Z., 3281W<br />

Zhu, X., 350, 369, 579F,<br />

1376W, 1460W, 1466W,<br />

1659T, 1959W, 2063F,<br />

2210F, 2372F, 3658W*<br />

Zhu, X. Z., 2053T<br />

Zhu, Y., 4, 20, 92, 192, 254,<br />

382, 1004F*, 1527T*<br />

Zhu, Z., 2251T<br />

Zhu, Z.-H., 1540F<br />

Zhu, Z.-Q., 457F<br />

Zhu, Z.-X., 1540F*<br />

Zhukov, O., 2260T<br />

Zhurov, A., 1528F<br />

Ziccardi, W., 591F*<br />

Zickus, M., 1667T<br />

Zidan, J., 3336T<br />

Zieba, J., 838F*<br />

Ziebell, S., 422W<br />

Ziegler, A., 200, 275,<br />

1443T*, 1669T<br />

Ziegler, J., 1979F<br />

Ziegler, J. T., 1888T<br />

Ziegler, R. G., 2202W<br />

Ziehe, M., 3524T<br />

Zielenski, J., 1731W<br />

Ziemek, D., 503F<br />

Ziff, J. L., 2302T*<br />

Zigman, W., 859W<br />

Zilka, M., 123, 3704W*,<br />

3716W, 3731F, 3733F<br />

Zill, O., 311*<br />

Zillges, H., 3373F<br />

Zillikens, M. C., 1334W,<br />

1954T, 2123F, 2147F,<br />

2169W<br />

Zimdahl-Gelling, H., 617T<br />

Zimmerman, E., 948T<br />

Zimmerman, J., 1292W<br />

Zimmerman, S. L., 3194F*<br />

Zimmerman-Bier, B., 2381F<br />

Zimmermann, A. F., 1405F<br />

Zimmermann, K., 236<br />

Zimon, M., 201, 2948T*<br />

Zimprich, A., 2568W<br />

Zimran, A., 746T, 773W,<br />

788W*<br />

Zink, A., 186<br />

Zink, A. M., 1005W, 2595W,<br />

3109W<br />

Ziolkowska-Suchanek, I.,<br />

1184F<br />

Zissel, G., 2103W<br />

Ziv, E., 1075T, 1078T,<br />

1152W, 1576F, 2080T,<br />

2195F*<br />

Zivony-Elboum, Y., 199<br />

Zlatopolsky, Z., 251<br />

Zode, G. S., 387*<br />

Zody, M. C., 437F<br />

Zoellner, S., 1542T<br />

Zoghbi, H., 2807T<br />

Zoghbi, H. Y., 2769F<br />

Zoledziewska, M., 113,<br />

157, 177, 1451W, 1516F,<br />

3664W<br />

Zöllner, S., 476W, 1521T,<br />

1534F, 3285T, 3406T


Zondervan, K. T., 44,<br />

583F, 2056T, 2077T,<br />

2133W<br />

Zongaro, S., 513F*<br />

Zook, J. M., 3647F*<br />

Zou, H., 1359T<br />

Zou, J. Z., 1974W<br />

Zou, R., 198<br />

Zu, T., 2645F*<br />

Zuccherato, L. W., 3325F<br />

*Presenting Author<br />

Zuchelli, M., 807F<br />

Zuchner, S., 57, 347,<br />

1681T, 1871F, 2470T,<br />

2583W, 2586W, 2603F,<br />

2615F, 2668W, 2820F,<br />

2930T<br />

Züchner, S., 201, 2637W,<br />

2948T<br />

Zuckerman, B., 3026T<br />

Zufferey, F., 62, 299<br />

SPEAKER AND AUTHOR INDEX 419<br />

Zumbo, P., 376, 1818F,<br />

2610W<br />

Zúñiga, G. M., 1111T<br />

Zupan, A., 3381T*<br />

Zusevics, K. L., 1837W<br />

Zusi, C., 2548T, 2659T*<br />

Zuvich, R. L., 631T<br />

Zvi, T., 704T<br />

Zvulunov, A., 2810T<br />

Zwaigenbaum, L., 175<br />

Zweemer, R., 400<br />

Zweier, C., 2595W, 2666T*<br />

Zweig, A., 3557F, 3612W<br />

Zweynert, S., 3364F,<br />

3402T<br />

Zwick, M. E., 1349W, 2069F,<br />

2312F<br />

Zwiefelh<strong>of</strong>er, T., 3014T<br />

Zwinderman, A. H., 1604T<br />

Zymak-Zakutnia, N., 302<br />

SPEAKER AND AUTHOR INDEX


<strong>ASHG</strong> <strong>2012</strong> MOBILE APP<br />

Download the <strong>ASHG</strong> <strong>2012</strong> Mobile App to your smartphone (iOS, Android, and<br />

Blackberry platforms).<br />

The mobile App brings the meeting to your fingertips wherever you go. Once the App<br />

has been downloaded, you do not need an Internet connection to view information.<br />

See ad on page 422.<br />

RECORDED PRESENTATIONS AVAILABLE AFTER THE MEETING<br />

Invited Sessions, Award Presentations, and the Plenary Sessions will be<br />

recorded and posted on the Web site after the meeting.<br />

These recordings are free to meeting registrants.<br />

Visit the <strong>ASHG</strong> Web site in early December to view these presentations.<br />

During the meeting, attendees are encouraged to post thoughts on exciting scientific<br />

or clinical advances heard at a session or workshop and on challenges that<br />

the field will face by using hashtag #<strong>ASHG</strong><strong>2012</strong> or by posting on the <strong>ASHG</strong><br />

Facebook page. The posts will be monitored and may be discussed at the Closing<br />

Symposium on Saturday.<br />

Twitter: @<strong>Genetics</strong> <strong>Society</strong>, use #<strong>ASHG</strong><strong>2012</strong><br />

Facebook: https://www.facebook.com/<strong>Genetics</strong><strong>Society</strong><br />

Follow <strong>ASHG</strong> on Twitter before and during the week <strong>of</strong> the <strong>2012</strong> Meeting to get the latest<br />

updates, tips, news, and announcements.


The Heart <strong>of</strong> the Exhibit Hall<br />

Get Answers at the <strong>ASHG</strong> Membership booth<br />

Meet your Editors at the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> booth<br />

Learn about Boston, the destination for <strong>ASHG</strong> 2013<br />

Meet <strong>Society</strong> Leadership<br />

Sit down in our seating area<br />

Recharge your electronics<br />

Network Net with colleagues<br />

Central


YOUR GUIDE TO THE <strong>ASHG</strong><br />

<strong>2012</strong> MOBILE APP<br />

info search exhibitors Contacts notes<br />

continuing<br />

education<br />

twitter schedule MAPS notifications


during the <strong>ASHG</strong> Meeting in San Francisco.<br />

• Apply for ACMG membership during the <strong>ASHG</strong> meeting and SAVE $125<br />

on ACMG membership and event registration.<br />

• Enter drawings for a Kindle Fire and a 2013 ACMG Annual Meeting<br />

Registration!<br />

• Check out the Live Online Learning Center and much more!<br />

Plan Now<br />

to Attend!<br />

Don’t Miss Out!<br />

Stop by the<br />

<strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong><br />

and Genomics (ACMG) Booth 318<br />

Mark Your Calendar<br />

• Detailed program, registration, and hotel information<br />

available October <strong>2012</strong> at www.ACMGmeeting.net<br />

• Abstract submission opens: October <strong>2012</strong><br />

• Abstract submission deadline: Friday,<br />

December 7, <strong>2012</strong><br />

2013 ACMG <strong>Genetics</strong> Review Course<br />

• June 2013 •<br />

Info Coming Soon at www.ACMG.net


ESHG 2013<br />

Paris, France, June 8 – 11, 2013<br />

European <strong>Human</strong> <strong>Genetics</strong> Conference<br />

www.eshg.org/eshg2013<br />

This international conference (now in its 46 th year) is a forum for all workers<br />

in human and medical genetics to review advances and develop research<br />

collaborations. The conference has become one <strong>of</strong> the premier events in<br />

the fi eld <strong>of</strong> human genetics with over 2.500 delegates, more than 100<br />

oral presentations, 16 workshops, and 8 educational sessions. The<br />

ESHG conference is where the latest developments in human<br />

genetics are discussed, and where pr<strong>of</strong>essionals from all parts<br />

<strong>of</strong> human genetics meet.<br />

Abstract submission deadline:<br />

February 15, 2013


Natera Introduces Next Generation<br />

Non-Invasive Prenatal Testing<br />

Natera can detect more<br />

chromosomal abnormalities than<br />

other non-invasive tests<br />

• NIPT from Natera provides twice<br />

the disease detection and is the<br />

only test to detect X and Y<br />

chromosome abnormalities<br />

• Natera’s Parental Support<br />

is the only technology with<br />

consistently high detection<br />

accuracy across all five<br />

chromosomes [>99%]:<br />

13, 18, 21, X, and Y.<br />

Natera also <strong>of</strong>fers the following:<br />

• Noninvasive Prenatal Paternity Testing<br />

• Products <strong>of</strong> Conception (POC) Molecular Karyotype<br />

• Preimplantation Genetic Diagnosis (PGD)<br />

• Natera One Multi-Disease Carrier Screening<br />

Contact Mollie Larson at mlarson@natera.com to learn more or to<br />

have kits sent directly to your <strong>of</strong>fice.<br />

Visit us at bOOTh 504<br />

62nd Annual Meeting <strong>of</strong> the <strong>American</strong><br />

<strong>Society</strong> <strong>of</strong> human <strong>Genetics</strong><br />

November 7–9, <strong>2012</strong><br />

www.natera.com | 1-877-476-4743


Let’s talk about NGS and data overload.


NGS is a great discovery tool. But if you’re using it for<br />

validation, you’re wasting valuable time. The Sequenom<br />

MassARRAY® System* gives you the specifi city and<br />

sensitivity you need for research. A proven platform with<br />

over 1,500 peer reviewed publications including GWAS<br />

validation, it delivers accurate results in a matter <strong>of</strong><br />

days. So what did you just fi nd? An essential research<br />

validation tool that pays for itself.<br />

*The MassARRAY System is for Research Use Only. Not for use in diagnostic procedures.


Rich<br />

multimedia<br />

and interactive<br />

features<br />

A new,<br />

innovative<br />

website<br />

Precision<br />

search,<br />

relevant<br />

content<br />

1 network. 1 website.<br />

JAMA and<br />

9 specialty<br />

Archives<br />

Journals<br />

Access the new online home <strong>of</strong> JAMA and the entire JAMA Network.<br />

The JAMA Network website <strong>of</strong>fers fully integrated access to the research, reviews, and<br />

perspectives that shape the future <strong>of</strong> medicine. Spanning all 10 <strong>of</strong> The JAMA Network<br />

journals, it equips you with the medical insights that matter most to your practice.<br />

Join the experts at jamanetwork.com<br />

Please visit us in booth #1201<br />

200 new<br />

articles<br />

every week


PGM for genes. Proton for genomes.<br />

Sequencing for all.<br />

Powered by fast, simple, scalable semiconductor chips,<br />

the Ion PGM Sequencer introduced an entirely new approach<br />

to sequencing, making it dramatically faster and more accessible.<br />

The new Ion Proton Sequencer will go even further. With chip<br />

densities up to 1,000-fold greater than the Ion PGM Sequencer,<br />

the Ion Proton Sequencer will put whole-genome sequencing<br />

within reach <strong>of</strong> every lab.<br />

Visit Life Technologies at booth #601 at <strong>ASHG</strong><br />

or look for the Ion Bus in the Exhibit Hall<br />

Get fast, affordable benchtop sequencing at<br />

lifetechnologies.com/ionsequencing<br />

For research use only. Not intended for any animal or human therapeutic or diagnostic use. The content provided herein may relate to<br />

products that have not been <strong>of</strong>ficially released and is subject to change without notice ©<strong>2012</strong> Life Technologies Corporation. All rights<br />

reserved. The trademarks mentioned herein are the property <strong>of</strong> Life Technologies Corporation or their respective owners. CO03380 0712


The Definitive Evolution <strong>of</strong> Genotyping<br />

Axiom ® Genotyping Solution. Survival <strong>of</strong> the fittest.<br />

Axiom Genotyping Solution is the most powerful genotyping workflow delivering superior coverage<br />

<strong>of</strong> populations, disease genes, and rare variants at an affordable price.<br />

n Unique GWAS, replication, and fine-mapping content on one array<br />

n Unrivaled coverage <strong>of</strong> the exome, disease genes, and functional regions<br />

n Cost-effective custom array design with 100% SNP conversion<br />

Axiom Genotyping Solution adapts to the needs <strong>of</strong> your research—coverage and flexibility like never before.<br />

Contact your Affymetrix representative today or visit www.affymetrix.com/genotype.<br />

Wednesday, Nov. 7, 12:45 – 2:15 PM<br />

Room 302, Esplanade Level (South),<br />

Moscone Center<br />

Enabling the Genome Generation #1:<br />

population-optimized strategies and genotyping<br />

solutions for expanding our understanding <strong>of</strong> the<br />

genetic variations in complex diseases<br />

Join our luncheon seminars:<br />

Coverage<br />

90%<br />

85%<br />

80%<br />

75%<br />

70%<br />

Axiom ® World Array 4<br />

Competing Array<br />

MAF >1%<br />

Thursday, Nov. 8, 12:45 – 2:15 PM<br />

Room 307, Esplanade Level (South),<br />

Moscone Center<br />

Enabling the Genome Generation #2:<br />

next-generation cytogenetics solution for<br />

constitutional and cancer research applications<br />

Box lunch will be provided. First come, first served.<br />

Visit booths #918/920, #925/927. ©Affymetrix, Inc. All rights reserved. “For Research Use Only. Not for use in diagnostic procedures.”<br />

MAF >5%

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!